<SEC-DOCUMENT>0000105770-23-000012.txt : 20230221
<SEC-HEADER>0000105770-23-000012.hdr.sgml : 20230221
<ACCEPTANCE-DATETIME>20230221161823
ACCESSION NUMBER:		0000105770-23-000012
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		125
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230221
DATE AS OF CHANGE:		20230221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEST PHARMACEUTICAL SERVICES INC
		CENTRAL INDEX KEY:			0000105770
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				231210010
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08036
		FILM NUMBER:		23648410

	BUSINESS ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341
		BUSINESS PHONE:		6105942900

	MAIL ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WEST CO INC
		DATE OF NAME CHANGE:	19990405
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>wst-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:6ce7082f-45c4-495e-94eb-caa34b024fa0,g:4770da38-231a-455c-ab1e-d14c8c362bd8,d:8148abfe270d4f15aa2ba9319df722dc--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:wst="http://www.westpharma.com/20221231" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>wst-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY180L2ZyYWc6MGUzMzEwODgxZjg2NGQ5NzkxMzNjZmNmOTcwZmI2NzMvdGFibGU6MTMxNzcxNGU3NmFiNGZmZDlmMGI4ZjUwOTc0YmU5ZDYvdGFibGVyYW5nZToxMzE3NzE0ZTc2YWI0ZmZkOWYwYjhmNTA5NzRiZTlkNl8zLTEtMS0xLTYwMjYz_93faa908-2584-4320-a7f5-db856e3a374f">0000105770</ix:nonNumeric><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY180L2ZyYWc6MGUzMzEwODgxZjg2NGQ5NzkxMzNjZmNmOTcwZmI2NzMvdGFibGU6MTMxNzcxNGU3NmFiNGZmZDlmMGI4ZjUwOTc0YmU5ZDYvdGFibGVyYW5nZToxMzE3NzE0ZTc2YWI0ZmZkOWYwYjhmNTA5NzRiZTlkNl81LTEtMS0xLTYwMjYz_1e90fbb7-c00a-48e6-8319-b2911cc8e7f6">2022</ix:nonNumeric><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY180L2ZyYWc6MGUzMzEwODgxZjg2NGQ5NzkxMzNjZmNmOTcwZmI2NzMvdGFibGU6MTMxNzcxNGU3NmFiNGZmZDlmMGI4ZjUwOTc0YmU5ZDYvdGFibGVyYW5nZToxMzE3NzE0ZTc2YWI0ZmZkOWYwYjhmNTA5NzRiZTlkNl82LTEtMS0xLTYwMjYz_f776569a-f254-4b83-af40-de4f469e5fc3">FY</ix:nonNumeric><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY180L2ZyYWc6MGUzMzEwODgxZjg2NGQ5NzkxMzNjZmNmOTcwZmI2NzMvdGFibGU6MTMxNzcxNGU3NmFiNGZmZDlmMGI4ZjUwOTc0YmU5ZDYvdGFibGVyYW5nZToxMzE3NzE0ZTc2YWI0ZmZkOWYwYjhmNTA5NzRiZTlkNl83LTEtMS0xLTYwMjYz_27dbc909-9ee7-4acb-80c1-2e1de7079908">false</ix:nonNumeric><ix:nonNumeric contextRef="if4a3a8484e4d4e25a93de4d344e4db3b_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMy0wLTEtMS02MDI2Mw_e15719f8-e673-40ca-a352-c8014dfe8702">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_2be9eb86-8ff4-486b-8e82-82feaaba79be">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_2c156bb7-09f9-4046-a1d8-d4f0d3157eef">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_41e09201-abff-4427-8518-3065d9e10039">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="wst-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8766ff13a5c4bffb4105af8ef735b18_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i2a1b49b3369c42dd9827948a3411a736_I20230125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i635169c6599a4431a7816915bd315902_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a763da7bebb49d78fb727a07ced4166_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id962c393773440e097f70db1509b5a4c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9377c7030f9487bb7299e888531cb40_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie47b13e10f5c43f18b3aba014d8b9557_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17b8a1175e024b0b91f80042eb871d9e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ff963c9c54045f29206b3189d452f9b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4a3a8484e4d4e25a93de4d344e4db3b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f410a8c4414410fbda82326f2f5f0cd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idca50b3901184ea9bada9c1613654555_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i532be8bdd25444f5bef6c5a83fa6ec14_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i093b685a4dfa4da18da754958b07c8bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06323a1fbe0b4d548901ae093dc4d002_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f3b7a5c69c84fa1a9361b05a767bfa2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16978dcdc2f041d19d80093c40fff403_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if72c2fa428754de9934583a6add241a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i840ed7b254234d0fbb34c7f7abeabfed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie21b4b5fca6e4ce0884f11bc4cfad4fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida3c98d3c0354b73a89f724be3743416_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1165b131d689444eb6459290c85e0fec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00b5efe1c17b43d2a2fb2ea3402c0e1d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i989eb46562154074b7d4bd40080dadcf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ce53383a53d4f1eb000e413d41ebdf9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c3dc3f33c6e40168b8ee2b01cf1da89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e32d2d077d14623ad4001f6615da739_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i269d9dc747f34c98bd9fd36e958f9112_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic40bf59888ea464bbf38a5e599052b55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bbf7836dda448549d12d0144c47661e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e14a309edfa4014932d060921715d47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80e03154cb7d45b6addb0d566c6a2e5d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21e3c20e3f1049698ccd1b563fee50fd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic414a0567e02472dbd5e6bc8dea1c934_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42428a99c9ed4d9bb8b558e76dc9a6d0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a556c3b4b644d5a2cba539a25d2c52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i297d5b4a9400421e865338046ad94f11_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if051f33d67bc4196a2590dbe46e32868_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3086806657e4a2b89502cfae1ac8883_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e6cb706114942e4aabe6faaacf4e663_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieca2c70046774b70b2ca24e38603bd11_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb415db0220846bbbaee31bca93b64e3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib455f8d389b84c90834d838d768dd859_I20130630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530eb90eb2764a55bb62aac980b27711_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79c8219373a3404aaf82ead0cda46716_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i609b68bdcb584f1fa5a8970ccd1759d3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ff1421dfabb4931b5d3f165e4fa608f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d95a90ba942409fb7eb38c53be370cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i665253b4d08e4da599894b62da126263_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic40393e675034834a4cb5d8ffa391e4c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97e639bd58654edeb8611e423238d72e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fa94e736dee414db6421d8880cc2422_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if045da1a86684296aa4c33ad55d60c95_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7066b92c5e54bc79943066fb6034c7c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51e337fbb71345fca552db98bf16e460_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i452ba88776d94afb84fbc1b35bcbcd24_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic134acff31094622a91b3143a0e96cd0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia177439c331047b2ab87726450ce39bb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i256eab0010ac4440b58c5fa97329532a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc55026ca0ea4cd4b78b9007129033b8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i838a650038204c9eafed9990f5a9ee16_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7120c4b931d4e48b07cf29f80d2b1cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe73169f2a304e4b8511b7c7f5ca3ea2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1c945b9d9124755884c9318597648c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8da7f757b5d415e896679c642747d6e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f44138370e044a39010d4f60177210d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb8186699d064e74a59fc5b34eed6c40_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0faf4f9784a94f7aa7354566da3204c3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic35adedcc7f44b1b9c0fe04681478c95_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6651efd4f764b48adb48d2620a076d6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1147923590ae4023add6d186c7abf72f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f618571d5fc44b591d452151b7e1075_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica414868e28c41ee9837e7414f82083d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica6ef1a0769a4e648ec274538fd0bbea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i057ed2a2629447fe8340db3a494eaafd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7ac37da416447fdb298621d726f8906_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia45b0766113a446a94c89d02189621ed_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93cc0075175a4ee886a144fc0fad49b2_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5259b4fec7824128bebbc2321b046a0f_I20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib525a96790ee419f9313dd7892b7b3dd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b995d9f735c49ffaf75d044a0c03b66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad88a83c00d41a9803dfa1fd8846d50_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6dfe8c8214549d598f7663164c534f1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57893ac1e0eb4f4f94c5d5b585544e57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i867bfde87f4d49c6aa3b2e198dd30265_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9bad476918442d094a0b53fc624ea6b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c3b02cc69744d1c81a95c04444728f3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e1e4b02c23d40809d6f4748ba485f04_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cae435921ec4feeb1ccbe93403e73e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fe30bc7c27942be8f272d9013b321b8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6c9307eae344809bc9eb362136f13b5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6387f13194fa4168b18b7acddc8a7e66_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12cc38a53bbb4b5dab6d38a174b78556_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if85a0ce5a6b94dad8023eed11fefec57_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b1026f47645465da8f39a740c77972a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic052515f57af407a9c8ee85f261cca28_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90934a86885b435589f1b238bebbd8de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i392eaf9fb1b54a2e84e87ce96d573162_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30a3acb1630d4d42961464184cf42df9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a0b48beb7be4ec38b7f1e3807bb5fc1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83da5dac2d5b4be8a4e3cf6b667f2e1c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:WestCompanyMexicoSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c15e3f82e14b2d8ea127a9ace71de2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:AluplastSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id72e5e9a20f24e66a90f5ff4e835e57a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaTapSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3173295a48a4425dafd024e4bcaea4d0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaRubberSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0e46db508ae452ea86af0980f1d1e00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd70574b39b442a999ec4c558f63a4fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93d6a4a1140d4a819a08655c97b0030c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1316e29c4d1347d282b020769df84fb7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10c63b8503e64ef7aecc45e4839041ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c26cc49e6104694b627031996fac9f2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f533fa13e604ceb9279ba3b5b3ac9c4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7263d8dd9a4b44e0ac64eb6919dd3540_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i965965b0db234e199c7a370813f9bac1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c6727e68757499781a9770aa96a5a3f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id22c437a5e7a415c8d04a385cd6d3bf3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3a9837d9b47499480dff64b4fcb6b1d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e0e7a9bae54bee9c9cc1207ec4ae1b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i254460edc0a349ea96b0104f485aed1e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7ef7fb4150d47649071f5f1b4f490d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic17963791fc94a5d9927fcb81798188f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadc79f5eb40040f7a6e4a72ff4148eda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6455ee991aeb451d8b8ebd79daef0cf6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a6b50bf43424e5d8f1090509ea44dcf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93f5765c9a8046e2a6369832660d3253_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia52c083f2095422b99e633dfb6d9a704_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7ccb1f26a7b415b99d59d04309e91b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e1c2074501a4c8e904e282823fdb207_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c253265028c4a42abd68ab7456d94f4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacbba1511dcd486088f2748d91395b33_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cd10fbd48944499bd3e75624d39e738_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id63066ad3a37405a9157d08cee024b89_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59b3a686792245fba4c1cd0fdbe993ad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i978162754bb545bf8cc52ff142f514e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id421927f2814464886c6dde31c2e17a1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie263faaeca58416a9df1dabac7a4b51c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fb1cd1161ef428f901886b8f8bfae4d_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9433ad101e0f40c6a59795056c11ca8d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9775d568a3404cfcb4de79a3df989730_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieef415446df24387a2f0b94ff7a58e73_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ForeignLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if20cb8b7f73343e0b4d7df1ab5592c7f_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">wst:ApplicableMarginMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39fe04778e964e42b69b3e3667134afb_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a3f65e2339e46edbd122c6a7e88c734_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3968429e781944ff917fa69ee5084d06_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9412b7a71714bc19162384ec914aec4_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17f90a6dc27944f087b669925f30371f_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14dd74ecfac74fa98fbdb00352369007_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="instance"><xbrli:measure>wst:instance</xbrli:measure></xbrli:unit><xbrli:unit id="fiscal_quarter"><xbrli:measure>wst:fiscal_quarter</xbrli:measure></xbrli:unit><xbrli:context id="i34794d2072c74e28898377fb07301721_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9e4ff52db72474081a077b4a2d8bf8a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2c00c7463cf41a9988d6d2571c4a4e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36a6e77fe574426b8c780aa1e3956660_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib39e812e09a44972bf2c8d2ad05b403e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf787da5fc004530a7921f12a8628daa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3a2571be15e4bbaa4802e0b11fe9e86_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i861ad8987fa54c699465cafe8d5b03b7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i656ea7823b914cb681c9f806732bce7f_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad4b14762f724836912187aa55021fd3_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>wst:tranche</xbrli:measure></xbrli:unit><xbrli:context id="i34909e1b0bb641229424ae8dea78f236_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bdb4dd782f5429cae42770030a9c63e_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63e7117f5e6c48e3bc16493062149b41_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f365909be2c4a33b9535d9625359634_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb457474142548ada94572d36284f1aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d646a9b7feb4e40a68f41f454b189df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sgd"><xbrli:measure>iso4217:SGD</xbrli:measure></xbrli:unit><xbrli:context id="i569a84a1b6044847a369af6d7becda42_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33954585607a418e8de125d8e2ad1f27_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b6ff425fe5240119fb6fedfde9e6e41_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32dd3ce056004fa288d5cd8119b7d251_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i171c812bedd448199594f8cbe21f5215_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="i43ec8e1a30c24bba9c86e74b4d8c13f9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05eec46fb5e34fe797afbe0315ba7370_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2d66ee6c4f140c5ad3cd9497de7f00a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07c6df090c7a49f4ae2283e42ca80a22_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7adb9161e9af4809af615f27c957ccf7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i647595866ae94d7883d164c13e7576df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1717cad3ed8747cfb39d9d04479a590c_D20171101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="bbl"><xbrli:measure>utr:bbl</xbrli:measure></xbrli:unit><xbrli:context id="icd338cc8a5fe470590598ff0e2475ae0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerBbl"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>wst:bbl</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="id784d712d09342aebd7b7dfe678f761b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a46826c2684460eb4fbb56df6e8152a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c00e1dadfb14a658cb637483c6837c2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab197c4924f34c0db38f5eb19ad7f2b1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i055a22dcb77a4206a028877100a4c97b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e0072e4d3cc422b90a6e91608ad2109_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85e3c3d286034ff49e528b2c9317d171_D20230101-20231231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae7ed9fa03bd445da0742597c1c5438f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3195132dd5345a6887a4340147a0564_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72e42c0a25694e14b9229d1e967b73d5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e06a7878bb94a07b93f4163c017f6ce_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia05c56f7d4da40bab7b1afb3e4f348f7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa12cd493a074d5399af3c418b4c5706_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85aa4b0d24d14148bf70e42bf8953a40_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61e1ccc194684e27aa2be4350e2a59da_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9601ccbfbc6c4c6e969ee2d307d9045c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i735ee47484304157b7f13947a9b6e46a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d8fd0ef4c9d44ccbf513c6e6c38b9b1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i397a9fc92bb541bda84bf523b0f0534c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbf55f1a879b48a78fb1475dceabdc9d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib560936ecece47cf97fd5dfe6464bfb7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice018ed37eaa49149dc6c63f944f178d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd37440709c84ad3812e75fb20e0afa6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e71e4d6cb1c4e27acca2bfaf571e3ac_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63adabb977604bc4a8c06a77bae5bfd4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d0bf9f09bfd45009a95e13ff7570373_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ccb1166712d49a3855a9a39bf66196e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3606e54a0a1946d8bca09748806375ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i450fa254443341388fa92c220d282a50_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66ee7b68af3241c8ba207622f3731e45_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id841a6055f0e4cfbaacfafc0843a3b62_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ecf564c7c8643e083fb3f9bc53dd6e6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i172c5bb368534dc6afd5e93d8d03deaf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a19776470ed4aa9be3c7220853c571b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic31348b180714cf69a4949022e873c8b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86d021ac1cce433bba24d4fee5778a4b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie516db60841b47beab93458349c39d9e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21d6d1e179764319939518be6b4755c8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a05df88c57c4fbba800cd2d6ded4056_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dc769ee573d4b1eb606de264ddf0ea5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i262cd9dc71574d73902a46c241cb2c0d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae52261e94e747a89a158b1da3e74546_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6881855e92e84a999adbd921603e22a5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie73452302c0e415ab2556f3eb20f4c00_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i973d62078ba14495ad1278fd1f4d578d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9da752cb333d421ca18f1e5af162195f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia23aa690efbd45fe8cfcb969d018f680_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a65a38a422f4a89a39109cd74bb897d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i754552b393944baa8e31325d5eba5188_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd279fe6b3354a1d94ce2672678400de_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43611db249a44bdb8e4b0da680b6e710_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc6ce44539154204a8fdfb1e5e3bcb36_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2c88912680242f1a6463abe80fe7cf4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32dd82ca504d4e4e8b1e47b0b4f96b7e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5907fec60b44341a54dc18b426e81a8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66ec8d15453f4f38a06ec86fbf3ff764_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25a6afe95d6949a9b15847a9e5063bda_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7c411ebf213498bbc17286b687febec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4463c41232a04445bcdcb36422deee33_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54f66b73b00546638fb3dfdeea498856_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1ef59879afe401591e29ee824de0517_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia23bb5001acb4d96a0f1e75661196565_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d2482447c6049c1a04840f7c479360b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83c5430234af414c9fcc3b4df8890d9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d763901eafd48cd8a636ca3db465303_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie316bb8a16254f0b8e82e29bc1835be1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d15643e954d4ef2862b5cf9aeaff59b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1371f6ecf2dd4b64b6bf9d8da230988e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ae5843ba66649458ad2eab839e35a52_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b86341c878947cd85fe8ec2548111e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if867c326ea304572bf285d245f2729f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i406f7691b793473590f26cc05c368e11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i805c24fc27444fd38deafff1a2c4bbe9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa5b204c1dc4abc86e2792ad48e7b16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fbcb98a53e34fcb8a183148ece8920b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iade80d0537714f308a08a338374d6b21_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32b73b088654490bb5a6be67066e2ae9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i386979849f4a4ca899ce2778bd52f0d5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54bb101058b8400a88f43f7396f6df6b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaecd545d46d342a39efcb16ad10a6df6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97d694cff77844d882d28c32d629311e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9815180ba0b54d2881441a6cc952417a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie07c502333264b49a0ba4aa4235be632_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79faae59eb5747f094ec247979277f49_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89bf04ee5a4a44318e42a1114576fc19_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ff1cabbd90749c99af71165f285a71c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8a86bade84543889f6b81500c0a8ac5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d46a1f438f8461684e84f9c8c79e508_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d66b7db239e48d5b1af0749bb3ea343_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0662f0d0f62149118e93596ed7214b5c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2a17d2034694fe895103701a3db15e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i063266317845420c9c9604cf2e5a3b01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1289dce1d1384485a949179f19183178_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56913a13b5944c5587eaaa2f5fb63640_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99e48d0827e84674a9f7b673ab8b3adf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8d3089900f144029822b0251c552161_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d37456ab52c475297384d08d55cb38d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if40187b8b7a64ea69df5cf9e017b64fd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0818a4e839d4d98b9c9d2fb94135719_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i572ebcf46c464f8480b6b43ea02ed0cb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc24b95cad0a44dfa74ee686cfc4c554_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e50ef11a0b74e949d7a233e7b69d9df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5c740ee53d14acab5e8ce562e9ed2b3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04413dcc613d457fb097e0213020ab3f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32f586765ed14e30998543a97afb12e6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a24648febc446d97d71a944faf23c8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icadfe694aab14a67aa2e38dfb55e6d5f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d89b5b64b2f47fabc89d28b39c6abb3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ec8f38ddecf4489927d3f56c19b2c35_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c01348d5d61478b9245598d8ff9f61e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id573bfa61009494da99108c926e21d55_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe8ca4226e454ae6ac3d77c3f63f4645_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57bae4fdbc424d98b421183e9aa884b0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35a7a2f289af4db3bb7d06fea36d17ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a283afeb8f40c6817f0e72d6df5ccd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd99140b0fe444a2968f0cf1a36fa8ce_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4be6b9f04b6470da6ab0ab85cb527ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20ebcecb9d2c4a209b92fbebb9207661_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6834a2454c954e5db472d9a40c33b13a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3996b06720ee42ee8d78c7b8b11628f8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5167798386874e29a8044c426c90a599_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c52a1e553d247a3ae76670f5304a50f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia216fe90970d46f4be2d33c145486b81_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4ef8dd22a4a44f7beffb4e9f338e878_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33c784d4eec04d78922a4e192bf59230_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia68e46033cf0466e976bea07f5d6efef_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i238ef97a2c414fa79ce155548aec647a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1b919b91eeb42da9481eb832c9b75c9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2db706bfea84d8885a041634831858e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id638f8160a6944ce83eb5f9cd2ee6de7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i718facb9187748eebcc936a4e7a55f42_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58930e1b5c274240b867fdb589c2ab06_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie41ef75fe7f74deeb695babb739e40e5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d21da9c07e842308653dc6c5d692c08_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i756408cda2044016850493d82b241ade_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc7d817970f475e8dee97b98a3a0b5a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if14b97867296473e92081e449e76b6d4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i614e5023b53d4eab9f1069365d95f319_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i747f5bde668b43608459580452ed13c2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b4e19b379674031b1a3259ea2819573_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8ccc47a7d0f4470933be376826c61d0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5865c2fe32d348938d9c4f301afde2ed_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibacbcc57bab8485890bc85e0309a4c6a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e4d798726024904a0f9840ffb306523_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16b25fe7a8fb4b17a57c7cc7d9884e52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aa30653f5684e34aaab6637e5921d32_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie73ec10e708d43e191bb939a896cda33_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26532d87fb9149e18d431a1b831b2c44_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88b9ad9e7de41e78648c5f18d9cde1c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="plan"><xbrli:measure>wst:plan</xbrli:measure></xbrli:unit><xbrli:context id="ib4919d2983094e91beec7377b6d8b34f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i560792d170344831a5edf3fe6812792a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i628d30d7315b4fcb9acfb4cf5dc8be01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5967145ff293449c900b45f8ce551762_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7479189625164010af6cfb04cc0211f7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63ad9cb3287243e99846b5f6d49f4739_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2541ce86c9e34ed9941101140a5db110_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i316fa955e9204c2a8df463369185dda4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i441202e7fe0646609be36e2f8d0374b0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2b3f6d5c25644418416ca4f73542523_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34d78547c8434c45b5b43dd485a6821a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd65a6a4d2b4b7eb7aa097f7f5a03a8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a6c4ac23e3347c3a9d21b0dba11e268_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b0b580bd80345db9a8c8beba2df1e69_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94503a5d02c7463b985b14ead7a7b3d9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib445602ff9c740f89a59c9435ece0183_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i040620491325464cab7f6d3871ae4699_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i860f084cabda4ae99bb91cfb68d12843_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5585de920d8a464bb8478eab79b4c886_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7283d2db8a4479785b3c3e131984a7d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9ddd8fa84364291bfce3ba201396757_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07075ee510b147ffa069795d9eba1b83_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d6d4961721d423c8fba5c85a67fc33f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaebb04c426c456a84deedfc7f59d594_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i405b25944ffd47c88f31893c248bb5cc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d4d0414b55e42238a7ed8c0cade2d85_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83cbdcf4d95b46f5bb848c5c35e881c4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83e1434feb5c44cf9a2a52c145c85770_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id534095c984248caac7f60f3f82c38bd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee3572e584f746e78e030b73cb5e5f0d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c1ae3f134ee48b5bb585005d7de280b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if09fca4c07fa4958ac80820c3bcd7ee3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03e10a75c10f4d2c8f360deba82d8ee1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3309beddc64147aa9d4c3c624ed71776_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1744b600a2c44fb1857cc5d43e752987_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4be1b95cfcd2431b924119c50bfd5a9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3af093e03e841719efdf12caaaf8448_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18d85779db1a46ba80e1747766668dc9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec9a690a49b4b95844d16d70921814f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cdc53f36f04478eaf3f3e8a7e98afd5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c5650da0a7044278560c89a0b64ccb1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54d8c496618d4192a7e40265b29fe16d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iace17547d7c143dd837ba1fadfa15bea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i937298cf9f8d407e95285a8eda6be83d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb4a0cc0e3284ea38084fdcbfa086cc2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aff134b217b4ead88b196a40da71390_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c5abf4f2b824482ba9d0532f850206a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9281c13bb0b5430aa149c75d799cec31_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6814334eaaa54902a2c168a168c3b713_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i334922c320134f52b9aebb9e98f36274_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8b5e90b3aba4a33ba59bb7ae6badda6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a372d5590a144cba98ee245f1283178_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc59d5e4aad64e88b0465be91ead9923_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if66e95bc7d5b4db2b517555e37322183_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iace9c5cf6693479d9fcaa3c0f9e210d1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24b1ef1156704a4faf188960f756e3c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1636e6221e9b4dcb9d03af54bcedbeba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaddca4ea08004b0ebdf07f53f5328e24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia29fffd4cd604df186eac9f77ff01597_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c8dbef891a41e5b4ae23fc2c17ac38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id96fe41b380c468082cde30cff4a88be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6fdb0e63df94bf78eaf8f55ca5a27cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaba5feb3867044abafc6aeffd95e3f8c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60bb7b31a5774e6f969d94307712c269_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib72dae6b1cc44b23ac0fd1f3ae38ee3e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ac1499da88c4b44b4f74e0201a577ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3b0f7a0791b4b61be68028ab30483bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b93e203f105432f81fbe65326c6917c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0883d5b213a14846b9cecd02fae80c70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09031663d64a4d89be1f2c8ac603f9a3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5758fc91240f44f58c0d8211b63f96e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia12d474c435e416382e99942998771f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0c18c5f3a6c42509cf4b94e0141bcb5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38e1e2edfa654b98a2366d1ba0e981bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bb1b7b296b8458ba1252c6364245ea0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58483908f99e4d18a4072d007a922d3b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d11fb26784407a9537aafa6159e23b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95a83e2185a942eca49ce6709b9ac586_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf9de54a304d46c781f42375b69365a9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i849944f81aab4b96860b7d3e5eb73e20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice7d61872f80427da0d9116b49983311_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f7acdde722448e481784486341104c3_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d2bb17ed48c41dba32219896e2e8175_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i141e60cb61604823b8430879ea150d99_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63527504ecaa4a10a8def5b5ec6f1894_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea43a3c1ca4f40c0bbab919047a0f8b5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9659ef9de2934f93b6fa46288c5b5b6e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69af11490d5b4086ad2dfcf3de8f6296_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffe83e403acf438f85b6dd1d97e8d460_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d19b063b3c34a448674207e911c6ffb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26407107db9342c9bf5081c03e7a3fa3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bd3a366e8d54c4b8cef2c043f15ec29_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec709d90491e43ea967136f7e4512e45_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9559d3f0ca1a41c1b6d4dd22b5a6caa0_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id631ed0f114043709b097d7fd85636b2_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e0e239fe07746a692c5b712876addbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24e6acff1c7640c38b022c848d7af043_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7a20234e76b4aceb4a563d4757f3a25_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d8644e185ba45f1aca8a97124127c09_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i498328cc9bd447608019d68a0f1b2953_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2a5063af9e7457eadff8ecde4a2a0db_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d14abab15aa4e50aae530229040d0ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4f7fd511790420c92f6c02a26a4ae95_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id305d29074a84896bb281161842eac04_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i291db1eaff5d4fe183595c6f835e091c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8495f2ee91834fb1a3f9fe1c93572049_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i680df56be5cb4f5e860aab0cf5b550c7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e05940c83de48978c0c9bb32a9d5626_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i908fccc3de554e288be0804e0e181156_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:YearAfter2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic45bcdf6531a4b0dbe32a45651758dbc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dd0857c331249a9a85539ede4607c70_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6615258597bc4111bd8224a2f4f5be19_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>wst:segment</xbrli:measure></xbrli:unit><xbrli:context id="icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1eda1ab883d470f907fcc4ff3587bdc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bd13159e1454ccd9cfc0a729531fc59_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic968e09b002f4e748bff0a829c35d435_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d70e9583819487dac48027986480d13_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84403c68951c424f99f535d20528d792_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe48c875c32240ab9ed7fce93ce67305_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie01badda3e434997a4b8e06f3311bc9a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99c9f5c6fe924651b98fe035da1577d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8177e6120dec43daa5a7c888989f3da2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b508e52bb8f41c9b7957f921eb2b0b3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42e7467ce0ae48b9a47889bc1ec6fc4a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i431dce423ad841e6844024553fc98f20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aaaf90727654d12b638272fe7f2baf3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6314a6d37b84a358a5605e6ae2afd64_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceb5fd8b48274ee1a5a308d102c6c25e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iead4344cd65d442aa5006dcd0376f4a2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6e0d0a05d1348769f058a2ca5f42aab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62beb24a7bad443180a155119c78b411_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72bb0f0e78f045deaa478696bdea1be9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c8538cbbe04fb58f1ce10c1f2b28e2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia441c6249d0e463fa687f11715bdbe24_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec4132786b74f858bedca0d55bf9841_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4227815e2274453b99190c759250f43_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8c79157ca814df59f4a743dcc90418b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3888aacf77145f3a78e6e7189ee1a05_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fedbb37b25343e993a9a82605d7113a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a5015f6b1c94dec99eecc4b8658eb7e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e406b7e606f451d8091f5d964b93a58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0eff9689ef84a2ea76ecf78183f8827_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i926da543cc9e4398814ddc43ef95c631_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0b0ed6a479d444ea07152748eeca4cc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8828a20eda4045f48764034dedf66337_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3307dfcbc00f42bb8997445de20e4919_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie61e6e97e08a4913b0cba163aed4e5a8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66d771c3fe9d4b339af1cad17d645c10_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95a551fb427249b6a0f0c397412260fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ca67d05039a4c1da64a8404c705ce24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d147dae6a024c4da07595e4f932e0c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idff76b1b03b44f75aa61286e93799b04_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if85fe4e885e9410ea9b477f9f42fe802_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e909081fe504bcd995d3d053a9e6458_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb578834702c45c985e36276eb4e5209_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia70443dc17684967b5578dd38a080142_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib778b3f359db4b4db7b559dbd58c0693_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:SecondQuarter2020AcquisiitonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5177e5970481482dadb3afc395cb325e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:SecondQuarter2020AcquisiitonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb2833c3159542918f26feaf0c1d8860_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb5e02ca65384029bf2dee9c473d0fc2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i244a7dd7a1e34e5aaf1f244eeeca66c7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i585911a48a184294aa02c08de8b96b51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22bf7ca10e524bf19773099096d46440_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61cdd3ab97d6409eb1fd729bbcf4e3bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c1e5aa461254453a205c4e2315ef26e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0becd841990f40bcb28ada9ac03bea59_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45c760b6f46f45a1aca96e9c28532938_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i225515b9f9cc44409112978bbc812f54_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i707beb89e95a42328dcd6d2412aa3f9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cda7d0db84d46a1a162bc0ad54e9fed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d36b5ee016b44859820b1a91b193d45_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f1502fcf310445290cecc08ffe7e7b3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2501ceeb8ed04db1a417a4d65803126e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icee1c6f02c1b44ed8186b856c69cb13a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c5469d65e0b475cb923c823d47d89ba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i142f68e23d4545d08259d4c707844b97_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d3247d3a01544388bce9b89588c6ec3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i073f657af77647788880cd4518a255a0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib989212096a844a7a71240a6d956563a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia67a3626f5f948b5b1895672cce6e96b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8148abfe270d4f15aa2ba9319df722dc_1"></div><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">UNITED STATES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Washington, D.C.&#160;20549</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6M2U4ZTU1ZGQzNTIwNDYxNmI3NjZjMjc2NjViNzdmNjAvdGFibGVyYW5nZTozZThlNTVkZDM1MjA0NjE2Yjc2NmMyNzY2NWI3N2Y2MF8wLTAtMS0xLTYwMjYzL3RleHRyZWdpb246NTI5NjFiNzNhMGZkNDE1ZDhkZjJlMmZjNmFhNGE5ZDNfOQ_a9983404-f9ee-46c2-b5ec-44131cac2f17">10-K</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6MmY4YjBmNGFlMGFlNGRkMDljMzlhZDE4MzFmZjQ1Y2YvdGFibGVyYW5nZToyZjhiMGY0YWUwYWU0ZGQwOWMzOWFkMTgzMWZmNDVjZl8wLTAtMS0xLTYwMjYz_8fb62f81-784a-443d-a550-c183125d98b7">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the fiscal year ended <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8zMjk4NTM0ODg2MDUx_ccb7ab64-79c9-4164-97a4-258382c4c960"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8zMjk4NTM0ODg2MDUx_1310c9e0-5ea4-4847-9745-db0df77367c3">December&#160;31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6Y2VlMDRiOGFkNzQ0NGJhNGJkYWIzMzM5ODEzZWU2ZjkvdGFibGVyYW5nZTpjZWUwNGI4YWQ3NDQ0YmE0YmRhYjMzMzk4MTNlZTZmOV8wLTAtMS0xLTYwMjYz_bbd0fa9d-5eac-4257-91f3-3d43398b7e03">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8xNDA_3ccd2a5a-b02c-492e-88c9-f0c3d75f755c">1-8036</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6OGYzZThkYTE3ZTMwNDQ3YThmMzVmYmQyMmIyNWNkNzQvdGFibGVyYW5nZTo4ZjNlOGRhMTdlMzA0NDdhOGYzNWZiZDIyYjI1Y2Q3NF8wLTAtMS0xLTYwMjYzL3RleHRyZWdpb246Y2U1OGYxYjY2ZmY4NDg1M2FmNjQ5MTMxMDMwOTQzYzVfNQ_337c7f62-675a-4eab-9a6c-8ca17752a02e">WEST PHARMACEUTICAL SERVICES, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:48.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8wLTAtMS0xLTYwMjYz_24e38716-ac46-4dc6-844b-0a68c0eac63c">Pennsylvania</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8wLTEtMS0xLTYwMjYz_a3375e4c-a2f8-4040-9063-31597829e0f9">23-1210010</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8zLTAtMS0xLTYwMjYzL3RleHRyZWdpb246NWVkMjQ4OTZhYzViNDczZThkZjcyMWM4N2IwMzdkZTRfNA_4b0910c0-6b9e-4b89-bcb2-39ab3afcc191">530 Herman O. West Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8zLTAtMS0xLTYwMjYzL3RleHRyZWdpb246NWVkMjQ4OTZhYzViNDczZThkZjcyMWM4N2IwMzdkZTRfOA_b9985590-3fd2-41cf-98a6-6a3afcece19d">Exton</ix:nonNumeric>, <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8zLTAtMS0xLTYwMjYzL3RleHRyZWdpb246NWVkMjQ4OTZhYzViNDczZThkZjcyMWM4N2IwMzdkZTRfMTI_7200bf32-6530-4f20-856a-468965059e26">PA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8zLTEtMS0xLTYwMjYz_3e067466-bbd8-40c2-86e7-f6a3bbbdcbb0">19341-0645</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8xOTg_4b51a9f4-62f2-449c-9d26-ed58ffe9d299">610</ix:nonNumeric>-<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yMDE_47689d89-6b66-449c-a591-c9b6ef500676">594-2900</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.958%"><tr><td style="width:1.0%"></td><td style="width:42.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6ZjNkOTljZTQwOWMyNDFiNmIzNjBhZDIzMGM5YzA2NTUvdGFibGVyYW5nZTpmM2Q5OWNlNDA5YzI0MWI2YjM2MGFkMjMwYzljMDY1NV8xLTAtMS0xLTYwMjYz_8c04f341-00e9-40e4-984e-46689e554626">Common Stock, par value $.25 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6ZjNkOTljZTQwOWMyNDFiNmIzNjBhZDIzMGM5YzA2NTUvdGFibGVyYW5nZTpmM2Q5OWNlNDA5YzI0MWI2YjM2MGFkMjMwYzljMDY1NV8xLTEtMS0xLTYwMjYz_a931ee8f-867b-4208-ad7c-bda4df568f58">WST</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6ZjNkOTljZTQwOWMyNDFiNmIzNjBhZDIzMGM5YzA2NTUvdGFibGVyYW5nZTpmM2Q5OWNlNDA5YzI0MWI2YjM2MGFkMjMwYzljMDY1NV8xLTItMS0xLTYwMjYz_dc0f3925-7466-427e-86aa-09b9b13def96">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act:   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">None</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjgy_ed1a74b5-059f-4af9-8114-2d7589fd4721">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9745;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">No </span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;&#160;&#160;&#160;Yes &#9744;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjg0_cd2cc46e-f372-4bce-a07a-97e21da093da">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9745;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjg2_730b91cd-9e3a-49ad-9fcf-cc4e705785db">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#254; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjkz_68e6dba8-8474-47e4-ae98-33291c3f54d9">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#254; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.&#160;See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.113%"><tr><td style="width:1.0%"></td><td style="width:21.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6NWZkNjk4YWM2M2I5NDc5YjhlNzZjMDVmNjNiZGU5M2UvdGFibGVyYW5nZTo1ZmQ2OThhYzYzYjk0NzliOGU3NmMwNWY2M2JkZTkzZV8wLTAtMS0xLTYwMjYz_1edffb6e-9e73-4c1b-b235-3127694c1994">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6NWZkNjk4YWM2M2I5NDc5YjhlNzZjMDVmNjNiZGU5M2UvdGFibGVyYW5nZTo1ZmQ2OThhYzYzYjk0NzliOGU3NmMwNWY2M2JkZTkzZV8xLTQtMS0xLTYwMjYz_56878f27-732e-4427-bb90-886aec59b12b">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6NWZkNjk4YWM2M2I5NDc5YjhlNzZjMDVmNjNiZGU5M2UvdGFibGVyYW5nZTo1ZmQ2OThhYzYzYjk0NzliOGU3NmMwNWY2M2JkZTkzZV8yLTQtMS0xLTYwMjYz_978a3aa4-19de-4fd1-96f3-ba3ce7da47e1">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjg3_6b6dc182-3cfd-4530-b04d-37654ff53f6e">&#9745;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   &#160;&#160;&#160;&#160;Yes&#160;&#9744;&#160;&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8xMzc0Mzg5NTM0OTkzNw_5fdbf42d-1c97-4120-ac29-1c0f7f2026aa">&#9745;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The aggregate market value of the voting stock held by non-affiliates of the registrant as of June 30, 2022 was approximately $<ix:nonFraction unitRef="usd" contextRef="ic8766ff13a5c4bffb4105af8ef735b18_I20220630" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNDkz_c8fcbaaa-ca75-4275-a16f-b4bae31290c7">22.3</ix:nonFraction>&#160;billion based on the closing price as reported on the New York Stock Exchange.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As of January 25, 2023, there were <ix:nonFraction unitRef="shares" contextRef="i2a1b49b3369c42dd9827948a3411a736_I20230125" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNTg5_e57dbba9-37df-429a-9d2d-67abbe3e0449">74,135,554</ix:nonFraction> shares of the registrant&#8217;s common stock outstanding.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">DOCUMENTS INCORPORATED BY REFERENCE</span><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjkw_67ca1414-63ed-4f35-a3c5-9d68dd929688" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.261%"><tr><td style="width:1.0%"></td><td style="width:68.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Parts Into Which Incorporated</span></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proxy Statement for the 2023 Annual Meeting of Shareholders to be filed not later than 120 days after the end of the fiscal year covered by this Form 10-K.</span></td><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Part III</span></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_10"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.497%"><tr><td style="width:1.0%"></td><td style="width:10.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_13">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_16">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_16">BUSINESS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_19">ITEM 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_19">RISK FACTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_19">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_22">ITEM 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_22">UNRESOLVED STAFF COMMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_22">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_25">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_25">PROPERTIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_25">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_28">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_28">LEGAL PROCEEDINGS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_28">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_31">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_31">MINE SAFETY DISCLOSURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_31">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_34">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_34">24</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_37">PART II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_40">ITEM 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_40">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_40">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_43">ITEM 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_43">RESERVED</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_43">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_46">ITEM 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_46">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_46">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_55">ITEM 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_55">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_55">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_58">ITEM 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_58">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_58">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_142">ITEM 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_142">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_142">86</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_145">ITEM 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_145">CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_145">86</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_148">ITEM 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_148">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_148">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_151">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_151">87</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_154">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_157">ITEM 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_157">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_157">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_160">ITEM 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_160">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_160">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_163">ITEM 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_163">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_163">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_166">ITEM 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_166">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_166">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_169">ITEM 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_169">PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_169">89</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_172">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_175">ITEM 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_175">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_175">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i8148abfe270d4f15aa2ba9319df722dc_178">ITEM 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_178">FORM 10-K SUMMARY</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_178">94</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_181">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_181">95</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, or the context otherwise requires, references in this report to &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;West&#8221; refer to West Pharmaceutical Services, Inc. and its majority-owned subsidiaries. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All trademarks and registered trademarks used in this report are our property, either directly or indirectly through our subsidiaries, unless noted otherwise. Daikyo Crystal Zenith</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Crystal Zenith&#8221;) is a registered trademark of Daikyo Seiko, Ltd. (&#8220;Daikyo&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout this report, references to &#8220;Notes&#8221; refer to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K (&#8220;Form 10-K&#8221;), unless otherwise indicated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information in this Form 10-K is current as of February&#160;21, 2023, unless otherwise specified. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.  BUSINESS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions. Our customers include leading biologic, generic, pharmaceutical, diagnostic, and medical device companies in the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes a commitment to excellence in manufacturing, scientific and technical expertise and management, which enables us to partner with our customers in order to deliver safe, effective drug products to patients quickly and efficiently. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into two global business segments, Proprietary Products and Contract-Manufactured Products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary Products Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Proprietary Products reportable segment offers proprietary packaging, containment solutions and drug delivery systems, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our packaging products include stoppers and seals for injectable packaging systems, which are designed to help ensure drug compatibility and stability with active drug products, while also supporting operational efficiency for customers. These packaging products also includes syringe and cartridge components, including custom solutions for the specific needs of injectable drug applications, as well as administration systems that can enhance the safe delivery of drugs through advanced reconstitution, mixing and transfer technologies. We also provide films, coatings, washing, vision inspection and sterilization processes and services to enhance the quality of our packaging products and mitigate the risk of contamination and compatibility issues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This segment&#8217;s product portfolio also includes drug containment solutions, including Crystal Zenith, a cyclic olefin polymer, in the form of vials, syringes and cartridges. These products can&#160;provide a&#160;high-quality solution to glass incompatibility issues and can stand up to cold storage environments, while reducing the risk of breakage that exists with glass. In addition, we offer a variety of self-injection devices, designed to address the need to provide at-home delivery of injectable therapies. These devices are patient-centric technologies that are easy-to-use and can be combined with connected health technologies that have the potential to increase adherence. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our Proprietary Products product portfolio, we provide our customers with a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. Offering the combination of primary proprietary packaging components, containment solutions, and drug delivery devices, as well as a broad range of integrated services, helps to position us as a leader in the integrated containment and delivery of injectable medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This reportable segment has manufacturing facilities in North and South America, Europe, and Asia, with affiliated companies in Mexico and Japan. Please refer to Item 2, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_25">Properties</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information on our manufacturing and other sites.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract-Manufactured Products Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. These products include a variety of custom contract-manufacturing and assembly solutions, which use technologies such as multi-component molding, in-mold labeling, ultrasonic welding, clean room molding and device assembly. We manufacture customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have vast expertise in product design and development, including in-house mold design, process design and validation and high-speed automated assemblies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This reportable segment has manufacturing operations in North America and Europe. Please refer to Item 2, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_25">Properties</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information on our manufacturing and other sites.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant operations outside of the United States (&#8220;U.S.&#8221;), which are managed through the same business segments as our U.S. operations &#8211; Proprietary Products and Contract-Manufactured Products. Sales outside of the U.S. accounted for 55.4% of our net sales in 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the general business processes are similar to the domestic business, international operations are exposed to additional risks. These risks include currency fluctuations relative to the U.S. Dollar (&#8220;USD&#8221;), multiple tax jurisdictions and, particularly in South America, Eastern Europe, Israel, China and the Middle East, uncertain or changing regulatory regimes, or political and social issues, that could destabilize local markets and affect the demand for our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See further discussion of our international operations, the risks associated with our international operations, and our attempt to minimize some of these risks in Part I, Item 1A, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_19">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Part II, Item 7, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_46">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resources; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Part II, Item 7A, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_55">Quantitative and Qualitative Disclosures About Market Risk</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Note 1, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_79">Basis of Presentation and Summary of Significant Accounting Policies</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under the captions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_109">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Raw Materials</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use three basic raw materials in the manufacture of our products: elastomers, aluminum and plastic. Elastomers include both synthetic and natural materials. We currently have access to adequate supplies of these raw materials to meet our production needs through agreements with suppliers. We are required to carry significant amounts of inventory to meet customer requirements. In addition, some of our supply agreements require us to purchase inventory in bulk orders, which increases inventory levels but decreases the risk of supply interruption.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ a supply chain management strategy in our business segments, which involves purchasing from integrated suppliers that control their own sources of supply. Due to regulatory control over our production processes, sole source availability, and the cost and time involved in qualifying suppliers, we rely on single-source suppliers for many critical raw materials. We generally purchase certain raw materials in the open market and therefore the results of our operations may be affected by price fluctuations. This strategy increases the risk that our supply chain may be interrupted in the event of a supplier production or distribution problem. These risks are managed, when and where possible, by selecting suppliers with multiple manufacturing sites, rigorous quality control systems, surplus inventory levels and other methods of maintaining supply in case of an interruption in production or distribution. Heightened inflation may result in unfavorable conditions, inclusive of an increase in raw material cost. To date, we have been able to manage these conditions without significant disruption to our business.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we work closely with our suppliers, no assurance can be given that these efforts will be successful, and there may be events that cause supply interruption, reduction or termination that adversely impact our ability to manufacture and sell certain products. See further discussion of the risks related to the supply chain and raw materials in Item 1A. </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_19">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our intellectual property, including patents, patent applications, trademarks, copyrights, know-how and trade secrets, is important to our business. We own or license intellectual property rights, including know-how and issued patents and pending patent applications in the U.S. and in other countries, that relate to various aspects of our business. In 2022, more than 150 patents were issued to West across the globe. Certain key value-added and proprietary products and processes are exclusively licensed from Daikyo. We believe, however, that no single patent, technology, trademark, intellectual property asset or license is material in relation to our business as a whole, or to any business segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our business activities are global and are subject to various federal, state, local, and foreign laws, rules, and regulations to healthcare, environmental protection, occupational health and safety, anti-corruption, export control, product safety and efficacy, employment, privacy and other areas. The design, development, manufacturing, marketing and labeling of certain of our products and our customers&#8217; products that incorporate our products are subject to regulation by governmental authorities in the U.S., Europe and other countries, including the U.S. Food and Drug Administration (&#8220;FDA&#8221;), the European Medicines Agency and the National Medical Products Administration (China). Regulatory authorities, including regulatory review and oversight, can impact the time and cost associated with the development and continued availability of our products, and they have the authority to take various administrative and legal actions against West.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Changes in tax policy or trade regulations, or the imposition of new tariffs on imported products, could have an adverse effect on our business and results of operations. Compliance with these laws, rules and regulations did not require material capital expenditures in 2022, and is not expected to have a material effect on our capital expenditures, results of operations and competitive position in 2023 as compared to prior periods. For more information on the potential impacts of government regulations affecting our business, see "Item 1A. </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_19">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">". There were no required material capital expenditures for adherence to our government-led regulatory standards in our facilities in 2022 outside the normal course of business, and there are currently no needed or planned material expenditures for 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">West is also subject to various federal and state laws, and laws outside the United States, concerning fraud and abuse, global anti-corruption, and export control. Many of the agencies enforcing these laws have increased their enforcement actions with respect to healthcare manufacturers in recent years. We remain committed as a company to comply with all laws and regulations applicable to our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Environmental Regulations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various national, state and local provisions regulating the discharge of materials into the environment or otherwise relating to the protection of the environment. Our compliance with these laws and regulations has not had a material impact on our financial position, results of operations or cash flows. There were no required material capital expenditures for environmental controls in our facilities in 2022 and there are currently no needed or planned material expenditures for 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Proprietary Products customers primarily include many of the major biologic, generic, and pharmaceutical drug companies in the world, which incorporate our components and other offerings into their injectable products for distribution to the point of care and ultimate end-user, the patient. Our Contract-Manufactured Products customers include many of the world&#8217;s largest pharmaceutical, diagnostic, and medical device companies. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products components generally are incorporated into our customers&#8217; manufacturing lines for further processing or assembly. Our products and services are sold and distributed primarily through our own sales force and distribution network, with limited use of contract sales agents and regional distributors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ten largest customers accounted for 45.6% of our consolidated net sales in 2022, but none of these customers individually accounted for more than 10% of consolidated net sales. Please refer to Note 3, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_85">Revenue</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Note 19, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_133">Segment Information</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information on our consolidated net sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With our range of proprietary technologies, we compete with several companies across our Proprietary Products product lines. Competition for these components is based primarily on product design and performance, quality, regulatory compliance, and scientific expertise, along with total cost.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there are a number of competitors supplying medical devices and medical device components, including a number of pharmaceutical manufacturers who are also potential customers of our medical devices and components. We compete in this market on the basis of our reputation for quality and reliability in engineering and project management, as well as our knowledge of, and experience in, compliance with regulatory requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have specialized knowledge of container closure components, which is integral to developing delivery systems. With our range of proprietary technologies, we compete with new and established companies in the area of drug delivery devices, including suppliers of prefillable syringes, auto-injectors, safety needles, and other proprietary systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to differentiate ourselves from our competition by serving as a global supplier of integrated drug containment and delivery systems that can provide pre-approval primary packaging support and engineering development, analytical lab services and integrated solutions, regulatory expertise, and after-sale technical support. Customers also appreciate the global scope of our manufacturing capability and our ability to produce many products at multiple sites.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Contract-Manufactured Products business operates in very competitive markets for its products. The competition varies from smaller regional companies to large global assembly manufacturers. Given the cost pressures they face, many of our customers look to reduce costs by sourcing from low-cost locations. We seek to differentiate ourselves by leveraging our global capabilities and by employing new technologies such as high-speed automated assembly, insert-molding, multi-shot precision molding, and expertise with multiple-piece closure systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain our own research-scale production facilities and laboratories for developing new products and offer contract engineering design and development services to assist customers with new product development. Our quality control, regulatory and laboratory testing capabilities are used to ensure compliance with applicable manufacturing and regulatory standards for primary and secondary pharmaceutical packaging components and delivery systems. Technological advances and scientific discoveries have accelerated the pace of change in medical technology. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial development of our new products and services for medical and pharmaceutical applications commonly requires several years. New products that we develop may require separate approval as medical devices, and products that are intended to be used in the packaging and delivery of pharmaceutical products are subject to both customer acceptance of our products and regulatory approval of the customer&#8217;s products following our development period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We continue to pursue strategic initiatives in drug containment components, drug containment systems, novel drug delivery devices, safety and administration systems.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also continue to seek new innovative opportunities for acquisition, licensing, partnering or development of products, services and technologies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybersecurity Governance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our approach to cybersecurity begins with our responsibility for strong governance and controls. Security begins at the top of our organization, where Company leadership consistently communicates the requirements for vigilance and compliance throughout the organization, and then leads by example. The cybersecurity program is led by our Digital and Transformation team, who provide quarterly updates to the Audit Committee of our Board of Directors, annual updates to the Board of Directors, and regular reports to the West Leadership Team about the program, including information about cyber risk management governance and the status of ongoing efforts to strengthen cybersecurity effectiveness. Security controls and processes are developed and maintained to protect sensitive and confidential information while ensuring availability and integrity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also educate and share best practices globally with our employees to raise awareness of cybersecurity threats. As part of our onboarding process, we train all new employees on cybersecurity and maintain an annual retraining for all employees on cybersecurity standards, as well as how to recognize and properly respond to phishing and social engineering schemes. We have deployed a phishing detection system to report suspicious emails, which are flagged for further review, as well as an automated monthly process to retrain employees who do not maintain an acceptable pass rate on our phishing recognition training. Our cybersecurity defenses also utilize technologies such as next generation firewalls, Zero Trust Network Access intrusion detection and prevention measures, security information and event management, anti-malware, advance threat protection, multifactor authentication, network segmentation and encryption to ensure the privacy and security of our customers&#8217; data. We also have a dedicated Security Operations Center, monitoring our applications and infrastructure on a 24-by-7 basis which is integrated with our enterprise crisis management framework. To round out our awareness program, we have specific and regular training for our Digital and Transformation professionals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Ca</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">pital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our People</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we employed approximately 10,700 people, excluding contractors and temporary workers, in our operations throughout the world. During 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, West hired approximately 2,850 new team members and experienced an attrition rate of approximately 22%. The following table presents the approximate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentage of our employees by region: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South America</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the following table presents the approximate percentage of our employees by business unit: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and Marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digital &amp; Technology (D&amp;T)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research &amp; Development</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had the following global gender demographics: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Men</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Women</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Global Employees</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64%</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity, Equity and Inclusion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We actively foster an inclusive and collaborative culture and positive employee experiences for our team members where different views and perspectives are welcomed and valued at West. We are convinced that this approach brings forth innovation, learning and growth for our team members on a global basis. The Chief Executive Officer ("CEO") and the executive team members review diversity, equity and inclusion objectives throughout the year to ensure continuous focus and drive improvement. As of December&#160;31, 2022, four out of the ten members of West's Leadership Team are women, while seven out of the ten members are women and/or people of color.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Training, Compliance and Talent Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We strongly encourage our team members to engage in continuous learning, and provide development opportunities to strengthen individual skills and gain new experiences with the goal to build talent from within. We offer resources such as our tuition reimbursement program and our online learning catalog, with approximately 42,000 courses available. We centrally manage and organize on-the-job training, instructor-led trainings and online trainings in many different languages and topics through our global Learning Management System.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our team members live our values (Passion for Customer, Leadership in Quality and One West Team) as they work together to support our mission to improve patients' lives. West&#8217;s Code of Conduct, available in multiple languages on westpharma.com, provides guidance to our team members on appropriate and ethical conduct. Every team member is required to undergo Code of Conduct and mutual respect in the workplace training annually. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our focus on talent acquisition, performance management, resource planning and leadership assessment are strongly aligned with our diversity, equity and inclusion strategies. We understand that diversity leads to greater innovation, more opportunities, better access to talent and stronger business performance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation and Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">West is committed to providing fair and competitive compensation and benefits programs to attract, retain and reward high-performing team members at all levels. We offer a comprehensive total rewards program to support the health, financial and home-life needs of our team members. Total Rewards at West are defined as the value of the Compensation and Benefits programs offered to employees, which aim to reflect the value of the job and the contribution of the individual, while linking employees&#8217; performance to business and personal results. Based on country of employment, West may provide health care and retirement savings programs as well as paid time off, flexible work schedules, a Global Employee Assistance Program and an Employee Stock Purchase Program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health, Safety and Wellness </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The health and safety of our team members has always been both a top priority and a cultural value. West's commitment to the safety of our teams starts at the top and is driven throughout our business by every level of management and by every team member across the globe. West has a Health, Safety, and Environment ("HSE") Executive Council consisting of C-suite and executive operations leaders to monitor and guide our HSE process. West&#8217;s global HSE team is also a critical component in leading the safety efforts at our sites. Each manufacturing location has dedicated and trained HSE professionals, responsible for general safety oversight at the site. Our Recordable Injury Rate in 2022 was 0.67 per 100 employees. Our HSE and employee well-being focus can also be seen in our focus on quality implementation of Leading Indicator programs and metrics to drive Lagging Indicator performance. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Environmental, Social and Governance (&#8220;ESG&#8221;) Commitment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">West has been committed to ESG topics for many years. During 2022, we continued to increase internal and external awareness of our ESG commitment by expanding our education and communication regarding our ESG program and initiatives and more closely integrating ESG considerations into our business processes. Our ESG program includes a senior-level cross-functional ESG team which has been working with executive leadership, our board and other stakeholders to enhance our ESG framework and ensure alignment with our corporate mission, vision and values. Our long-term strategic priorities include focus on talent attraction, retention and engagement (including efforts to increase the diversity, equity and inclusivity of our workforce to reflect the communities in which we live and work); a climate and greenhouse gas ("GHG") reduction strategy that incorporates renewable energy and reduced absolute and intensity emissions; developing a more sustainable and responsible supply chain; research and development that focuses on issues of sustainability including secondary packaging, beneficial reuse and recyclability; and, reduction of waste and water in our operational processes. These areas of focus are in addition to our commitments to safety, quality, business continuity, as well as business compliance and integrity. Additionally, our philanthropic programs are an essential element of our corporate citizenship especially as we focus on the areas of children&#8217;s health; access to healthcare; and science, technology, engineering and math education. We are also expanding our philanthropic scope to include more sustainability related initiatives.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We solicit input from our employees on ways to improve in these and other ESG areas and see continued progress in these areas as critical to maintaining an engaged and responsible workforce.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.westpharma.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) are available on our website under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors - Financial </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption as soon as reasonably practical after we electronically file the material with, or furnish it to, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). These filings are also available to the public over the Internet at the SEC&#8217;s website, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Part III of this Form 10-K, we incorporate by reference certain information from parts of other documents filed with the SEC and from our Proxy Statement for the 2023 Annual Meeting of Shareholders (&#8220;2023 Proxy Statement&#8221;), which will be filed with the SEC within 120 days following the end of our 2022 fiscal year. Our 2023 Proxy Statement will be available on our website under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors - Annual Reports &amp; Proxy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">when complete.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about our corporate governance, including our Corporate Governance Principles and Code of Conduct, as well as information about our Directors, Board Committees, Committee Charters, and instructions on how to contact the Board, is available on our website under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors - Corporate Governance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">heading. We intend to make any required disclosures regarding any amendments of our Code of Conduct under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors - Corporate Governance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on our website. Information relating to the West Pharmaceutical Services Dividend Reinvestment Plan is also available on our website under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors - Transfer Agent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caption. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on our website does not constitute part of this document.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will provide any of the foregoing information without charge upon written request to our Corporate Secretary, West Pharmaceutical Services, Inc., 530 Herman O. West Drive, Exton, PA 19341.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.  RISK FACTORS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Investing in our common stock involves a high degree of risk. You should consider and carefully read all of the risks and uncertainties described below, as well as other information included in this Annual Report and in our other public filings. The risks described below are not the only ones facing us. The occurrence of any of the following risks or additional risks and uncertainties not presently known to us or that we currently believe to be immaterial could materially and adversely affect our business, financial condition or results of operations. In such case, the trading price of our common stock could decline, and you may lose all or part of your original investment. This Form 10-K also contains forward-looking statements and estimates that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of specific factors, including the risks and uncertainties described below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our disclosure and analysis in this Form 10-K contains some forward-looking statements that are based on management&#8217;s beliefs and assumptions, current expectations, estimates and forecasts. We also provide forward-looking statements in other materials we release to the public as well as oral forward-looking statements. Such statements give our current expectations or forecasts of future events. They do not relate strictly to historical or current facts. We have attempted, wherever possible, to identify forward-looking statements by using words such as &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;anticipate&#8221; and other words and phrases of similar meaning. In particular, these include statements relating to future actions, business plans and prospects, new products, future performance or results of current or anticipated products, sales efforts, expenses, interest rates, foreign-exchange rates, economic effects, the outcome of contingencies, such as legal proceedings, and financial results. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Many of the factors that will determine our future results are beyond our ability to control or predict. Achievement of future results is subject to known or unknown risks or uncertainties, including, without limitation, the risks set forth below. Therefore, actual results could differ materially from past results and those expressed or implied in any forward-looking statement. You should bear this in mind as you consider forward-looking statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless required by applicable securities law, we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. We also refer you to further disclosures we make on related subjects in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K to the SEC.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Global and Economic Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Global economic conditions, including inflation and supply chain disruptions, could continue to adversely affect our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">General global economic downturns and macroeconomic trends, including heightened inflation, capital market volatility, interest rate and currency rate fluctuations, and economic slowdown or recession, may result in unfavorable conditions. Those conditions could negatively affect demand for our products due to customers decreasing their inventories in the near-term or long-term, reduction in sales due to raw material shortages, reduction in research and development efforts, our inability to sufficiently hedge our currency and raw material costs, insolvency of suppliers or customers, and exacerbate some of the other risks that affect our business, financial condition and results of operations. Both domestic and international markets experienced significant inflationary pressures in fiscal year 2022 and inflation rates in the U.S., as well as in other countries in which we operate, are currently expected to continue at elevated levels for the near-term. In addition, the Federal Reserve in the U.S. and other central banks in various countries have raised, and may again raise, interest rates in response to concerns about inflation, which, coupled with reduced government spending and volatility in financial markets, may have the effect of further increasing economic uncertainty and heightening these risks. Interest rate increases or other government actions taken to reduce inflation could also result in recessionary pressures in many parts of the world. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Our results of operations and financial condition may be adversely affected by the ongoing COVID-19 pandemic and other public health epidemics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Our operations expose us to risks associated with a pandemic, or outbreak of contagious diseases in the human population, including the COVID&#8209;19 pandemic. The COVID-19 pandemic has negatively impacted the global economy, disrupted consumer spending and global supply chains, disrupted the labor market, created significant volatility and disruption of financial markets and has resulted in governments around the world implementing stringent measures to help control the spread of the virus.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are subject to risks associated with public health crises, such as pandemics and epidemics, including the COVID-19 pandemic. The nature and extent of future impacts are highly uncertain and unpredictable. While many countries around the world have removed or reduced the restrictions taken in response to the COVID-19 pandemic, the emergence of new variants of the SARS-CoV-2 virus may result in new governmental lockdowns, quarantine requirements or other restrictions to slow the spread of the virus. Any such measures could also impact the global economy more broadly, for example by leading to further economic slowdowns. The global outlook remains uncertain as case counts fluctuate and vaccination and booster rates remain relatively low in many parts of the world. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scope and duration of any future public health crisis, including the potential emergence of new variants of the SARS-CoV-2 virus, the pace at which government restrictions, including, but not limited to, quarantines, &#8220;shelter in place&#8221; and &#8220;stay at home&#8221; order, travel restrictions and other similar measures, are imposed and lifted, the scope of additional actions taken to mitigate the spread of disease, global vaccination and booster rates, may significantly impact our production throughout the supply chain and constrict distribution channels. We are unable to predict the potential future impact that these factors will have on our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Unauthorized access to our or our customers&#8217; information and systems could negatively impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our systems and networks, as well as those of our customers, suppliers, service providers, and banks, have and may in the future become the target of cyberattacks or information security breaches which, in turn, could result in the unauthorized release and misuse of confidential or proprietary information about our company, our employees or our customers, as well as disrupt our operations or damage our facilities or those of third parties. Additionally, our systems are subject to regulation to preserve the privacy of certain data held on those systems. We maintain an extensive network of technical security controls, policy enforcement mechanisms and monitoring systems, in order to address these threats. While these measures are designed to prevent, detect and respond to unauthorized activity in our systems, certain types of attacks could result in financial or information losses and/or reputational harm. If we cannot comply with regulations or prevent the unauthorized access, release and/or corruption of our or our customers&#8217; confidential, classified or personally identifiable information, our reputation could be damaged, and/or we could face financial losses.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be required to incur additional costs to modify or enhance our systems, or to try to prevent or remediate any such attacks. Modifying or enhancing our systems may result in unanticipated or prolonged disruption events, which could have a material adverse effect on our business and/or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are a global company with significant revenues and earnings generated internationally, which exposes us to the impact of foreign currency fluctuations, as well as political and economic risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our net sales and earnings are generated internationally. Sales outside of the U.S. accounted for 55.4% of our consolidated net sales in 2022 and we anticipate that sales from international operations will continue to represent a significant portion of our net sales in the future. In addition, many of our manufacturing facilities and suppliers are located outside of the U.S. and we intend to continue our expansion into emerging and/or faster-growing international markets. Our foreign operations subject us to certain commercial, political and financial risks. Our business in these foreign markets is subject to general political conditions, including any political instability (such as those resulting from war, terrorism and insurrections) and general economic conditions in these markets, such as inflation, deflation, interest rate volatility and credit availability. Additionally, a number of factors, including U.S. relations with the governments of the foreign countries in which we operate, changes to international trade agreements and treaties, increases in trade protectionism, or the weakening or loss of certain intellectual property protection rights in some countries, may affect our business, financial condition and results of operations. Foreign regulatory requirements, including those related to the testing, authorization, and labeling of products and import or export licensing requirements, could affect the availability of our products in these markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to risks associated with general political conditions, our international operations are subject to fluctuations in foreign currency exchange rates. The functional currency for most of our foreign operations is the applicable local currency. As a result, fluctuations in foreign currency exchange rates affect the results of our operations and the value of our foreign assets and liabilities, which in turn may adversely affect results of operations and cash flows and the comparability of period-to-period results of operations. Foreign governmental policies and actions regarding currency valuation could result in actions by the United States and other countries to offset the effects of such fluctuations. Given the unpredictability and volatility of foreign currency exchange rates, ongoing or unusual volatility may adversely impact our business and financial conditions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to reduce our exposure to fluctuations in foreign currency exchange rates, we have entered, and expect to continue to enter, into hedging arrangements, including the use of financial derivatives. There can be no certainty that we will be able to enter into or maintain hedges of these currency risks, or that our hedges will be effective, which could have a significant effect on our financial condition and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, our international operations are governed by the U.S. Foreign Corrupt Practices Act and similar foreign anti-corruption laws. Global enforcement of anti-corruption laws has increased substantially in recent years, with more enforcement proceedings by U.S. and foreign governmental agencies and the imposition of significant fines and penalties. While we have implemented policies and procedures relating to compliance with these laws, our international operations create the risk that there may be unauthorized payments or offers of payments made by employees, consultants, sales agents or distributors. Any alleged or actual violations of these laws may subject us to government investigations and significant criminal or civil sanctions and other liabilities, and negatively affect our reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are exposed to credit risk on accounts receivable and certain prepayments made in the normal course of business. This risk is heightened during periods when economic conditions worsen.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial majority of our outstanding trade receivables are not covered by collateral or credit insurance. In addition, we have made prepayments associated with insurance premiums and other advances in the normal course of business. While we have procedures to monitor and limit exposure to credit risk on trade receivables and other current assets, there can be no assurance such procedures will effectively limit our credit risk and avoid losses, which could have a material adverse effect on our financial condition and operating results.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Industry Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our sales and profitability are largely dependent on the sale of drug products delivered by injection and the packaging of drug products. If the drug products developed by our customers in the future use another delivery system or are reconfigured to require less frequent dosing, our sales and profitability could suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends to a substantial extent on customers&#8217; continued sales and development of products that are delivered by injection. If (i) our customers fail to continue to sell, develop and deploy injectable products; (ii) our customers reconfigure their drug product or develop new drug products requiring less frequent dosing; or (iii) we are unable to develop new products that assist in the delivery of drugs by alternative methods, our sales and profitability may suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to provide comparative value advantages, timely fulfill customer orders, or resist pricing pressure, we will have to reduce our prices, which may reduce our profit margins. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with several companies across our major product lines. Because of the special nature of these products, competition is based primarily on product design and performance, although total cost is becoming increasingly important as pharmaceutical companies continue with aggressive cost-control programs across their operations. Companies often compete on the basis of price. We aim to differentiate ourselves from our competition by being a &#8220;full-service, value-added&#8221; global supplier that is able to provide pre-sale compatibility studies, engineering support, and other services and sophisticated post-sale technical support on a global basis. However, we face continued pricing pressure from our customers and competitors. If we are unable to resist or offset the effects of continued pricing pressure through our value-added services, improved operating efficiencies and reduced expenditures, or if we have to reduce our prices, our sales and profitability may suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation in the pharmaceutical and healthcare industries could adversely affect our future revenues and operating income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pharmaceutical and healthcare industries continue to experience a significant amount of consolidation. As a result of this consolidation, competition to provide goods and services to customers has increased. In addition, group purchasing organizations and integrated health delivery networks have served to concentrate purchasing decisions for some customers, which has placed pricing pressure on suppliers. Further consolidation within the industries we serve could exert additional pressure on the prices of our products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The medical technology industry is very competitive and customer demands and/or new products in the marketplace could cause a reduction in demand. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology industry is subject to rapid technological changes, and we face significant competition across our product lines and in each market in which our products are sold. We face this competition from a wide range of companies, including large medical device companies, some of which have greater financial and marketing resources than we do. We also face competition from firms that are more specialized than we are with respect to particular markets. In some instances, competitors, including pharmaceutical companies, also offer, or are attempting to develop, alternative therapies for diseases that may be delivered via their own, or without, a medical device. The development of new or improved products, processes or technologies by other companies (such as needle-free injection technology) may reduce customer demand for our products or render some of our products or proposed products obsolete or less competitive. In addition, any failure or inability to meet increased customer quality expectations could cause a reduction in demand.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Business and Operational Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disruption in our manufacturing facilities could have a material adverse effect on our ability to make and sell products and have a negative impact on our reputation, performance or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have manufacturing sites throughout the world. In some instances, however, the manufacturing of certain product lines is concentrated in one or only a few of our plants. The functioning of our manufacturing and distribution assets and systems could be disrupted for reasons either within or beyond our control, including, without limitation: extreme weather, water scarcity and other longer-term climatic changes; natural or man-made disasters; pandemic; war; accidental damage; disruption to the supply of material or services; product quality and safety issues; systems failure; workforce actions; or environmental matters. There is a risk that incident management systems in place may prove inadequate and that any disruption may materially adversely affect our ability to make and sell products and therefore, materially adversely affect our reputation, performance or financial condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our international sales and operations are subject to risks and uncertainties that vary by country and which could have a material adverse effect on our business and/or results of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in most of the major pharmaceutical markets in the world. Our international operations and our ability to implement our overall business strategy (including our plan to continue expanding into emerging and/or faster-growing markets outside of the U.S.) are subject to risks and uncertainties that can vary by country, and include: transportation delays and interruptions; political and economic instability and disruptions, including the United Kingdom&#8217;s withdrawal from the European Union; imposition of duties and tariffs; import and export controls; the risks of divergent business expectations or cultural incompatibility inherent in establishing and maintaining operations in foreign countries; difficulties in staffing and managing multi-national operations; labor strikes and/or disputes; and potentially adverse tax consequences. Limitations on our ability to enforce legal rights and remedies with third parties or our joint venture partners outside of the U.S. could also create exposure. In addition, we may not be able to operate in compliance with foreign laws and regulations, or comply with applicable customs, currency exchange control regulations, transfer pricing regulations or any other laws or regulations to which we may be subject, in the event that these laws or regulations change. Any of these events could have an adverse effect on our international operations in the future by reducing the demand for our products or decreasing the prices at which we can sell our products, or otherwise have an adverse effect on our financial condition, results of operations and cash flows. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disruptions in the supply of key raw materials could adversely impact our operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally purchase our raw materials and supplies required for the production of our products in the open market. For reasons of quality assurance, sole source availability or cost effectiveness, many components and raw materials are available and/or purchased only from a single supplier. Due to the stringent regulations and requirements of the FDA and other regulatory authorities regarding the manufacture of our products and the availability of such raw materials, we may not be able to quickly establish additional or replacement sources for these components or raw materials or do so without excessive cost. As a result, a reduction or interruption in supply, or an inability to secure alternative sources of raw materials or components, could have a material adverse effect on our business and/or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Raw material and energy prices have a significant impact on our profitability. If raw material and/or energy prices increase, and we cannot pass those price increases on to our customers, our profitability and financial condition may suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use three basic raw materials in the manufacture of our products: elastomers (which include synthetic and natural material), aluminum and plastic. In addition, our manufacturing facilities consume a wide variety of energy products to fuel, heat and cool our operations. The price and supply of these materials and energy sources are cyclical and volatile, and may be impacted or disrupted for reasons beyond our control, including supplier shutdowns, supplier capacity constraints, transportation delays, inflationary pricing pressures, work stoppages, labor shortages, geopolitical developments and governmental regulatory actions. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, the prices of certain commodities, particularly petroleum-based raw materials, have in the recent past exhibited rapid changes, affecting the cost of synthetic elastomers and plastic. While we generally attempt to pass along increased costs to our customers in the form of sales price increases, historically there has been a time delay between raw material and/or energy price increases and our ability to increase the prices of our products. In some circumstances, we may not be able to increase the prices of our products due to competitive pressure and other factors. If we are unable to pass along increased raw material prices and energy costs to our customers, our profitability, and thus our financial condition, may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are not timely or successful in new-product innovation or the development and commercialization of proprietary multi-component systems, our future revenues and operating income could be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth partly depends on new-product innovation and the development and commercialization of proprietary multi-component systems for injectable drug administration and other healthcare applications. Product development and commercialization is inherently uncertain and is subject to a number of factors outside of our control, including any necessary regulatory approvals and commercial acceptance for the products. The ultimate timing and successful commercialization of new products and systems requires substantial evaluations of the functional, operational, clinical, and economic viability of our products. In addition, the timely and adequate availability of filling capacity is essential to both conducting definitive stability trials and the timing of commercialization of customers&#8217; products in Crystal Zenith vials, syringes and cartridges. Delays, interruptions or failures in developing and commercializing new-product innovations or proprietary multi-component systems could adversely affect future revenues and operating income. In addition, adverse conditions may also result in future charges to recognize impairment in the carrying value of our goodwill and other intangible assets, which could have a material adverse effect on our financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not succeed in finding and completing acquisitions or other strategic transactions, which could have an adverse effect on our business and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically engaged in acquisition activity, and we may in the future engage in acquisitions or other strategic transactions, such as joint ventures or investments in other entities. We may be unable to identify suitable targets, opportunistic or otherwise, for acquisitions or other strategic transactions in the future. If we identify a suitable candidate, our ability to successfully implement the strategic transaction would depend on a variety of factors, including our ability to obtain financing on acceptable terms and to comply with the restrictions contained in our debt agreements. Strategic transactions involve risks, including those associated with integrating the operations or maintaining the operations as separate (as applicable), financial reporting, disparate technologies, and personnel of acquired companies, joint ventures or related companies; managing geographically dispersed operations or other strategic investments; the diversion of management&#8217;s attention from other business concerns; the inherent risks in entering markets or lines of business in which we have either limited or no direct experience; the potential loss of key employees, customers and strategic partners of acquired companies, joint ventures or companies in which we may make strategic investments; and potentially other unknown risks. We may not successfully integrate any businesses or technologies we may acquire or strategically develop in the future and may not achieve anticipated revenue and cost benefits relating to any such strategic transactions. Strategic transactions may be expensive, time consuming and may strain our resources. Strategic transactions may not be accretive to our earnings and may negatively impact our results of operations as a result of, among other things, the incurrence of debt, one-time write-offs of goodwill, additional carrying costs of patent or trademark portfolios, and amortization expenses of other intangible assets. In addition, strategic transactions that we may pursue could result in dilutive issuances of equity securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product defects could adversely affect the results of our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design, manufacturing and marketing of pharmaceutical packaging and medical devices involve certain inherent risks. Manufacturing or design defects, unanticipated use of our products, or inadequate disclosure of risks relating to the use of our products can lead to injury or other adverse events. These events could lead to recalls or safety alerts relating to our products (either voluntary or required by the FDA or similar governmental authorities in other countries), and could result, in certain cases, in the removal of a product from the market. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A recall could result in significant costs, as well as negative publicity and damage to our reputation that could reduce demand for our products. Personal injuries relating to the use of our products can also result in product liability claims being brought against us. In some circumstances, such adverse events could also cause delays in new product approvals. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A loss of key personnel or highly skilled employees could disrupt our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends, in large part, on our ability to retain key employees, including our executive officers and individuals in technical, marketing, sales, and research positions. Competition for experienced employees, particularly for persons with specialized skills, can be intense and has intensified following the COVID-19 pandemic. Our ability to recruit such talent will depend on a number of factors, including compensation and benefits, work location and work environment. If we cannot effectively recruit and retain qualified executives and employees, our business could be adversely affected. Although we believe that we will be able to attract and retain talented personnel and replace key personnel should the need arise, our inability to do so on a timely basis could disrupt the operations of the unit affected or our overall operations. In addition, because of the complex nature of many of our products and programs, we are generally dependent on an educated and highly skilled engineering staff and workforce. Our operations could be disrupted by a shortage of available skilled employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">We may be unable to increase capacity or efficiency at our own manufacturing facilities, which could adversely affect our business, financial condition, and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We must adjust our production capacity as customer demand changes and are focused on increasing capacity at various facilities through our capital strategy. If we are unable to increase capacity levels at the rate we expect, or if unforeseen costs or other challenges associated with increasing that capacity arise, we may not be able to achieve our financial targets.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, we are committed to supporting a full portfolio of our products for our customers. That commitment, along with shifts of product mix and complexity, may result in more frequent equipment change-overs and potentially increased costs because of the high fixed cost nature of our business, causing lower gross margins due to under-absorption of those fixed costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Our results of operations and earnings may not meet guidance or expectations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide public guidance on our expected results of operations for future periods. This guidance is comprised of forward-looking statements subject to risks and uncertainties, including the risks and uncertainties described in this Form 10-K and in our other public filings and public statements, and is based on assumptions we make at the time we provide such guidance. Our guidance may not always be accurate. If, in the future, our results of operations for a particular period do not meet our guidance or the expectations of investment analysts, or if we reduce our guidance for future periods, the market price of our common stock could decline significantly. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">No assurance can be given that we will continue to pay or declare dividends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically paid dividends. However, there can be no assurance that we will pay or declare dividends in the future. The actual declaration and payment of future dividends, the amount of any such dividends, and the establishment of record and payment dates, if any, are subject to determination by our Board of Directors each quarter after its review of our then-current strategy, applicable debt covenants and financial performance and position, among other things. Our declaration and payment of future dividends is subject to risks and uncertainties, including deterioration of our financial condition or position; inability to declare a dividend in compliance with applicable laws or debt covenants; an increase in our cash needs or decrease in available cash; and the business judgment of the Board of Directors that a declaration of a dividend is not in our best interest.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to comply with our obligations under our distributorship or license agreements with Daikyo or the agreements are terminated early or not renewed, we could lose license rights and access to certain product and technology that are important to our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key value-added and proprietary products and processes are licensed from our affiliate, Daikyo, including but not limited to, Crystal Zenith, FluroTec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and B2-coating technologies. Our rights to these products and processes are licensed pursuant to agreements that expire in 2027. However, if the agreements are terminated early or not renewed, our business could be adversely impacted. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Legal and Regulatory Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to regulation by governments around the world, and if these regulations are not complied with, existing and future operations may be curtailed, and we could be subject to liability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a multinational corporation with operations and distribution channels throughout the world, we are subject to and must comply with extensive laws and regulations in the United States and other jurisdictions in which we have operations and distribution channels. For example, the design, development, manufacturing, marketing and labeling of certain of our products and our customers&#8217; products that incorporate our products are subject to regulation by governmental authorities in the U.S., Europe and other countries, including the FDA, the European Medicines Agency and the National Medical Products Administration (China). Complying with governmental regulation can be costly and can result in required modification or withdrawal of existing products and a substantial delay in the introduction of new products. Failure to comply with applicable regulatory requirements or failure to obtain regulatory approval for a new product could subject us to fines, sanctions or other penalties that could negatively affect our reputation, business, financial condition, and results of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global nature of our business also means legal and compliance risks, such as anti-bribery, anti-corruption, fraud, trade, environmental, competition, privacy, and other regulatory matters, will continue to exist and additional legal proceedings and other contingencies will arise from time to time, which could adversely affect us. In addition, the adoption of new laws or regulations, or changes in the interpretation of existing laws or regulations, may result in significant unanticipated legal and reputational risks. Any current or future legal or regulatory proceedings could divert management's attention from our operations and result in substantial legal fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products that incorporate our technologies and medical devices that we produce are subject to regulations and extensive approval or clearance processes, which make the timing and success of new-product commercialization difficult to predict.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of obtaining and maintaining FDA and other required regulatory approvals is expensive and time-consuming. Historically, most medical devices that incorporate our technologies and medical devices that we produce have been subject to the FDA&#8217;s 510(k) marketing approval process, which typically lasts from six to nine months. Supplemental or full pre-market approval reviews require a significantly longer period, delaying commercialization. Changes in regulation on a global scale must be monitored and actions taken to ensure ongoing compliance. Pharmaceutical products that incorporate our technologies and medical devices that we produce are subject to the FDA&#8217;s New Drug Application process, which typically takes a number of years to complete. Additionally, biotechnology products that incorporate our technologies and medical devices that we produce are subject to the FDA&#8217;s Biologics License Application process, which also typically takes a number of years to complete. Outside of the U.S., sales of medical devices and pharmaceutical or biotechnology products are subject to international regulatory requirements that vary from country to country. The time required to obtain approval for sale internationally may be longer or shorter than that required for FDA approval. There is no certainty that any regulatory approval may be obtained or maintained indefinitely, and our ability to launch products to the market and maintain market presence is not guaranteed.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in the regulation of drug products and devices may increase competitive pressure and adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An effect of the governmental regulation of our medical devices and our customers&#8217; drug products, devices, and manufacturing processes is that compliance with regulations makes it difficult to change components and devices produced by one supplier with those from another supplier, due to the large amount of data and information that customers must generate to demonstrate that the components and devices are equivalent and pose no additional risk to the patient. The regulation of our medical devices and our customers&#8217; products that incorporate our components and devices has increased over time. If the applicable regulations were to be modified in a way that reduced the level of data and information needed to prove equivalency for a change from one supplier&#8217;s components or devices to those made by another, it is likely that the competitive pressure would increase and adversely affect our sales and profitability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are not successful in protecting our intellectual property rights, our ability to compete may be affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patents, trademarks and other intellectual property are important to our business. We rely on patent, trademark, copyright, trade secret, and other intellectual property laws, as well as nondisclosure and confidentiality agreements and other methods, to protect our proprietary products, information, technologies and processes. We also have obligations with respect to the non-use and non-disclosure of third-party intellectual property. We may need to engage in litigation or similar activities to enforce our intellectual property rights, to protect our trade secrets or to determine the validity and scope of proprietary rights of others. Any such litigation could require us to expend significant resources and divert the efforts and attention of our management and other personnel from our business operations. There can be no assurance that the steps we will take to prevent misappropriation, infringement or other violation of our intellectual property or the intellectual property of others will be successful. In addition, effective patent, trademark, copyright, and trade secret protection may be unavailable or limited for some of our proprietary products in some countries. Failure to protect our intellectual property or successfully invalidate or defend against intellectual property protections of third parties could harm our business and results of operations. In addition, if relevant and effective patent protection is not available or has expired, we may not be able to prevent competitors from independently developing products and services similar or duplicative to ours. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant developments in U.S. policies could have a material adverse effect on our business and/or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We earn a substantial portion of our income in foreign countries and, as such, we are subject to the tax laws in the United States and numerous foreign jurisdictions. Current economic and political conditions make tax laws and regulations, or their interpretation and application, in any jurisdiction subject to significant change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposals to reform U.S. and foreign tax laws could significantly impact how U.S. multinational corporations are taxed on foreign earnings and could increase the U.S. corporate tax rate. Although we cannot predict whether or in what form these proposals may pass, several of the proposals considered, if enacted into law, could have an adverse impact on our effective tax rate, income tax expense and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize tax rulings and other agreements to obtain certainty in treatment of certain tax matters. These rulings and agreements expire from time to time and may be extended when certain conditions are met or terminated if certain conditions are not met. The impact of any changes in conditions would be the loss of certainty in treatment thus potentially impacting our effective income tax rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to the examination of our tax returns by the United States Internal Revenue Service (&#8220;IRS&#8221;) and other tax authorities. We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of its provision for income taxes. Although we believe our tax provisions are adequate, the final determination of tax audits and any related disputes rapidly change and could be materially different from our historical income tax provisions and accruals. The results of audits or related disputes could have an adverse effect on our financial statements for the period or periods for which the applicable final determinations are made. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, we and our subsidiaries are also engaged in a number of intercompany transactions across multiple tax jurisdictions. Although we believe we have clearly reflected the economics of these transactions and the proper local transfer pricing documentation is in place, tax authorities may propose and sustain adjustments that could result in changes that may impact our mix of earnings in countries with differing statutory tax rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to stringent and changing obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could lead to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm and other adverse business consequences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our own sensitive and proprietary business information, we handle transactional and personal information worldwide.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we must comply with increasingly complex and rigorous, and sometimes conflicting laws, regulatory standards, industry standards, external and internal privacy and security policies, contracts and other obligations that govern the processing of business and personal data by us and on our behalf. For example, the European Union&#8217;s General Data Protection Regulation (the &#8220;EU GDPR&#8221;), the United Kingdom&#8217;s GDPR (the &#8220;UK GDPR&#8221;) and California&#8217;s Consumer Privacy Act of 2018, as amended (the "CCPA") impose obligations on companies regarding the handling of personal data and provide certain individual privacy rights to persons whose data is stored. In addition, it is anticipated that the California Privacy Rights Act of 2020 (&#8220;CPRA&#8221;), effective January 1, 2023, will expand the CCPA. Furthermore, multiple states in the United States have enacted data privacy laws. Additionally, laws in certain jurisdictions require data localization and impose restrictions on the transfer of personal information across border. For example, the EU GDPR generally restricts the transfer of personal information to countries outside of the European Economic Area without appropriate safeguards or other measures. If we cannot implement a valid compliance mechanism for cross-border privacy and security transfers, we may face increased exposure to regulatory actions, substantial fines and injunctions against processing or transferring personal information from Europe or elsewhere.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with existing and forthcoming laws and regulations can be costly and time consuming, and may require changes to our information technologies, systems and practices and to those of any third parties that process personal information on our behalf. If we fail, or are perceived to have failed, to address or comply with obligations related to data privacy and security, we could face significant consequences, including, but not limited to, proceedings against the Company by governmental entities (e.g. investigations, fines, penalties, audits, inspections) or other entities or individuals, additional reporting requirements and/or governmental agency oversight, damage to our reputation and credibility, or inability to process data or operate in certain jurisdictions, any of which could have a negative impact on revenues and profits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changing climate, global climate change regulations and greenhouse gas effects may adversely affect our operations and financial performance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is continuing concern from members of the scientific community and the general public that emissions of GHG and other activities have or will cause significant changes in weather patterns and increase the frequency or severity of extreme weather events, including droughts, hurricanes, wildfires and flooding. These types of extreme weather events have and may continue to adversely impact us, raw material availability, our suppliers, our customers and their ability to purchase our products and our ability to timely manufacture and transport our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe it is likely that the scientific and political attention to issues concerning the extent and causes of climate change will continue, with new and more restrictive legislation regulations and focus on ESG initiatives that could affect our financial condition, results of operations and cash flows. Foreign, federal, state and local regulatory and legislative bodies, such as the SEC, have proposed various legislative and regulatory measures relating to increased transparency and standardization of reporting related to factors that may include climate change, regulating GHG emissions, energy policies, recycling of plastic materials, waste taxes, and other governmental charges and mandates. If additional legislation or regulations were enacted, we could incur increased energy, environmental, administrative and other costs and capital expenditures to comply with the limitations. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with these regulations could result in fines and could affect our business, financial condition, results of operations and cash flows. We could also face increased costs related to defending and resolving legal claims and other litigation related to climate change and any alleged impact of our operations on climate change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, along with other companies in many business sectors have been implementing and expanding ESG and sustainability strategies, specifically ways to track and reduce GHG emissions. As a result, our customers may request that changes be made to our products, procedures or facilities, as well as other aspects of our business, that increase costs and may require the investment of capital or reduction in profit margins if not offset by price increases, customer investment or other cost savings. Failure to provide climate-friendly products or demonstrate GHG reductions could potentially result in loss of market share. Additionally, the costs of procuring energy, including renewable energy, or offsetting GHG emissions to meet our goals, satisfy government regulations or meet the requests of our customers may increase. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to comply with anti-bribery, anti-corruption and anti-money laundering laws could subject us to penalties and other adverse consequences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the Foreign Corrupt Practices Act (the "FCPA"), the U.K. Bribery Act and other anti-bribery, anti-corruption, and anti-money laundering laws in various jurisdictions around the world. The FCPA, the U.K. Bribery Act and similar applicable laws generally prohibit companies, as well as their officers, directors, employees and third-party intermediaries, business partners and agents, from making improper payments or providing other improper things of value to government officials or other persons. We and our third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state owned or affiliated entities and other third parties where we may be held liable for corrupt or other illegal activities, even if we do not explicitly authorize them. While we have policies and procedures and internal controls to address compliance with such laws, we cannot provide assurance that all of our employees and third-party intermediaries, business partners and agents will not take actions in violation of such policies and laws, for which we may be ultimately held responsible. To the extent that we learn that any of our employees or third-party intermediaries, business partners or agents do not adhere to our policies, procedures, or internal controls, we are committed to taking appropriate remedial action. In the event that we believe or have reason to believe that our directors, officers, employees or third-party intermediaries, agents or business partners have or may have violated such laws, we may be required to investigate or to have outside counsel investigate the relevant facts and circumstances. Detecting, investigating and resolving actual or alleged violations can be extensive and require a significant diversion of time, resources, and attention from senior management. Any violation of the FCPA, the U.K. Bribery Act or other applicable anti-bribery, anti-corruption and anti-money laundering laws could result in whistleblower complaints, adverse media coverage, investigations, loss of export privileges, and criminal or civil sanctions, penalties, and fines, any of which may adversely affect our business and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Our operations must comply with environmental statutes and regulations, and any failure to comply could result in extensive costs which would harm our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing of some of our products has involved, and may continue to involve, the use, transportation, storage, and disposal of hazardous or toxic materials and is subject to various environmental protection and occupational health and safety laws and regulations in the countries in which we operate. This has exposed us in the past, and could expose us in the future, to risks of accidental contamination and events of non-compliance with environmental laws. Any such occurrences could result in regulatory enforcement or personal injury and property damage claims or could lead to a shutdown of some of our operations, which could have an adverse effect on our business and results of operations. We currently incur costs to comply with environmental laws and regulations and these costs may become more significant, especially as the laws become more stringent and our use of materials changes.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in reimbursement practices of third-party payers or other cost containment measures could affect the demand for our products and the prices at which they are sold.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales depend, in part, on the extent to which healthcare providers and facilities are reimbursed by government authorities (including Medicare, Medicaid and comparable foreign programs) and private insurers for the costs of our products. The coverage policies and reimbursement levels of third-party payers, which can vary among public and private sources and by country, may affect which products customers purchase and the prices they are willing to pay for those products in a particular jurisdiction. Reimbursement rates can also affect the market acceptance rate of new technologies and products. Reforms to reimbursement systems in the U.S. or abroad, changes in coverage by private payers, or adverse decisions by payers could significantly reduce reimbursement for procedures using our products, which could adversely affect customer demand or the price customers are willing to pay for such products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initiatives to limit the growth of healthcare costs in the U.S. and other countries where we do business may also put industry-wide pressure on medical device or clinical diagnostic pricing. In the U.S., these include, among others, value-based purchasing and managed care arrangements. Governments in other countries are also using various mechanisms to control healthcare expenditures, including increased use of competitive bidding and tenders as well as price regulation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">General Risk Factor</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our share price has been volatile and may fluctuate, and accordingly, the value of an investment in our common stock may also fluctuate. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stock markets in general and our common stock in particular have experienced significant price and trading volume volatility over recent years. The market price and trading volume of our common stock may continue to be subject to significant fluctuations due to factors described under this Item 1A. </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_19">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, as well as economic and geopolitical conditions in general and to variability in the prevailing sentiment regarding our operations or business prospects, as well as, among other things, changing investment priorities of our shareholders. </span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_22"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM IB.  UNRESOLVED STAFF COMMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the filing of this Form 10-K, there were no unresolved comments from the Staff of the SEC.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.  PROPERTIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located at 530 Herman O. West Drive, Exton, Pennsylvania 19341.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our facilities by segment and geographic region. All facilities shown are owned except where otherwise noted.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Type of Facility/ Country</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Manufacturing:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States of America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phoenix, AZ (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Manufactured Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scottsdale, AZ (1) (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tempe, AZ (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Manufactured Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Petersburg, FL (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Rapids, MI </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Manufactured Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kinston, NC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kearney, NE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jersey Shore, PA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Williamsport, PA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Manufactured Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cayey, Puerto Rico</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products and Contract Manufactured Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">South America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sao Paulo</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Horsens</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Austell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Le Nouvion</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Le Vaudreuil</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eschweiler (1) (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stolberg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Waterford</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Manufactured Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kovin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qingpu</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sri City</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jurong (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mold-and-Die Tool Shop: </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States of America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upper Darby, PA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Type of Facility/ Country</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bodmin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stolberg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Analytical Laboratory:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States of America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exton, PA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Technology Center:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bangalore (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products, Contract Manufactured Products</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This manufacturing facility is also used for research and development activities.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This facility is leased in whole or in part.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Proprietary Products reportable segment leases facilities located in Scottsdale, AZ, Radnor, PA, Germany, and Israel for research and development, as well as other activities. Sales offices in various locations are leased under contractual arrangements.</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_28"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.  LEGAL PROCEEDINGS </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.  MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The executive officers of the Company are set forth in this table. Generally, executive officers are elected by the Board of Directors annually at the regular meeting of the Board of Directors following the Annual Meeting of Shareholders. Additionally, executive officers may be elected upon hire or due to a promotion.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Age</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Position</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Silji Abraham</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Technology Officer since December 2020. Senior Vice President, Chief Digital and Transformation Officer from February 2018 to December 2020. Prior to joining West, he most recently served as Executive Vice President and Chief Information Officer of MilliporeSigma, a subsidiary of Merck KGaA, Darmstadt, Germany. Prior to this role, he served as Chief Information Officer at Sigma-Aldrich Corporation, a leading life science and technology company, and worked in various leadership roles at Invensys Operations Management, ArvinMeritor and Chrysler Group.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernard J. Birkett</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial and Operations Officer since July 2022. Senior Vice President and Chief Financial Officer from June 2018 to July 2022. In addition, Treasurer from June 2018 to December 2019 and Principal Accounting Officer from October 2019 to April 2020. Prior to joining West, he spent more than 20 years at Merit Medical Systems, Inc., a leading manufacturer of disposable medical devices, where he served in a number of senior global leadership roles, including Chief Financial Officer and Treasurer, Controller for Europe, Middle East and Africa (EMEA) and Vice President of International Finance.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annette F. Favorite</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Human Resources Officer since October 2015. Prior to joining West, she spent more than 25 years at IBM Corporation, an information technology services company, in a number of strategic and global human resources roles, including Vice President, Global Talent Management, Vice President of Human Resources for Worldwide Software Sales, and Human Resources Leader for the company&#8217;s Southwest European Region, based out of Spain.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eric M. Green</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of the Board since May 2022. Chief Executive Officer since April 2015 and President since December 2015. Prior to joining West, he was Executive Vice President and President of the Research Markets business unit at Sigma-Aldrich Corporation from 2013 to 2015. From 2009 to 2013, he served as Vice President and Managing Director, International, where he was responsible for Asia Pacific and Latin America, and prior thereto, held various commercial and operational roles.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quintin J. Lai</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Strategy and Investor Relations since January 2016. In addition, Corporate Development responsibilities from January 2016 to September 2021. Prior to joining West, he was Vice President of Investor Relations and Corporate Strategy at Sigma-Aldrich Corporation from 2012 to 2015. From 2002 to 2012, he was at Robert W. Baird &amp; Company, where he held various roles, including Managing Director and Senior Equity Research Analyst of the Life Science Tools and Diagnostic sector and Associate Director of Equity Research. </span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kimberly Banks MacKay</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, General Counsel and Corporate Secretary since December 2020. Prior to joining West, from April 2019 to November 2020, she served as Senior Vice President, General Counsel and Corporate Secretary at the Segal Group in New York, a privately held firm specializing in employee benefits and investment consulting. Prior to Segal, she served for over 15 years in a variety of Legal leadership roles for Novartis, a global healthcare company, including Head of U.S. Legal for Novartis Business Service. </span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cindy Reiss-Clark </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Commercial Officer since May 2022. Senior Vice President, Global Markets and Commercial Solutions since November 2019. Vice President and General Manger Biologics Market Unit from September 2018 to November 2019. Prior to joining West, she served as Senior Vice President of Global Marketing at Lonza Pharma and Biotech, a leading Contract Development and Manufacturing Business from October 2017 to July 2018. From January 2016 to September 2017, served as Lonza Pharma and Biotech, Senior Vice President of Global Sales. Prior to Lonza, she served for over 15 years in a variety of Commercial leadership roles at SAFC, a division of Sigma-Aldrich Company.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chad R. Winters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer and Corporate Controller since May 2020. Vice President and Corporate Controller since October 2019. Prior to joining West, he served as Senior Vice President of Finance &amp; Accounting and Controller of Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company. Prior to Amneal, he held roles of increasing responsibility at the Chemours Company, UGI Corporation, and PricewaterhouseCoopers LLP. </span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_37"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;WST.&#8221; As of January&#160;25, 2023, we had 630 shareholders of record, which excludes beneficial owners whose shares were held by brokerage firms, depositaries and other institutional firms in &#8220;street names&#8221; for their customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We paid a quarterly dividend of $0.17 per share on our common stock in each of the first three quarters of 2021; $0.18 per share in the fourth quarter of 2021 and each of the first three quarters of 2022; and $0.19 per share in the fourth quarter of 2022. We will continue to review our ability to pay cash dividends on an ongoing basis and dividends may be declared at the discretion of our Board of Directors. When considering whether to declare a dividend, our Board of Directors will take into account:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">general economic and business conditions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our financial condition and operating results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our available cash and current and anticipated cash needs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our capital requirements;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">contractual, legal, tax and regulatory restrictions on the payment of dividends by us; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">such other factors as our Board of Directors may deem relevant</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, we announced a share repurchase program for calendar-year 2022 authorizing the repurchase of up to 650,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions. During the year ended December&#160;31, 2022, we purchased 563,334 shares of our common stock under the now completed program at a cost of $202.8 million, or an average price of $360.03 per share. During the three months ended December&#160;31, 2022, there were no purchases of our common stock made by us or any of our &#8220;affiliated purchasers&#8221; as defined in Rule 10b-18(a)(3) under the Exchange Act. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Board of Directors approved a share repurchase program under which we may repurchase up to $1.0&#160;billion in shares of common stock. The share repurchase program does not have an expiration date under which we may repurchase common stock on the open market or in privately-negotiated transactions. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following performance graph compares the cumulative total return to holders of our common stock with the cumulative total return of the Standard &amp; Poor&#8217;s 500 Index (&#8220;S&amp;P 500&#8221;) and the Standard &amp; Poor's 500 Health Care Index, for the five years ended December 31, 2022. The performance graph is based on historical data and is not indicative of, or intended to forecast, future performance of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative total return to shareholders is measured by dividing total dividends (assuming dividend reinvestment) plus the per-share price change for the period by the share price at the beginning of the period. The cumulative shareholder return on our common stock is based on an investment of $100 on December 31, 2017 and is compared to the cumulative total return of the S&amp;P indices mentioned above over the period with a like amount invested.</span></div><div style="text-align:center"><img src="wst-20221231_g1.jpg" alt="wst-20221231_g1.jpg" style="height:400px;margin-bottom:5pt;vertical-align:text-bottom;width:400px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Five year total return data obtained from NASDAQ IR Insight </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_43"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.  RESERVED</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_46"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7.&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion is intended to further the reader&#8217;s understanding of the consolidated financial condition and results of operations of the Company. It should be read in conjunction with our consolidated financial statements and the accompanying footnotes included in Part II, Item 8 of this Form 10-K. These historical financial statements may not be indicative of our future performance. This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations contains a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risks discussed in Part I, Item 1A of this Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-U.S. GAAP Financial Measures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purpose of aiding the comparison of our year-over-year results, we may refer to net sales and other financial results excluding the effects of changes in foreign currency exchange rates. Organic net sales exclude the impact from acquisitions and/or divestitures and translate the current-period reported sales of subsidiaries whose functional currency is other than USD at the applicable foreign exchange rates in effect during the comparable prior-year period. We may also refer to adjusted consolidated operating profit and adjusted consolidated operating profit margin, which exclude the effects of unallocated items. The unallocated items are not representative of ongoing operations, and generally include restructuring and related charges, certain asset impairments, and other specifically-identified income or expense items. The re-measured results excluding effects from currency translation, the impact from acquisitions and/or divestitures, and excluding the effects of unallocated items are not in conformity with U.S. Generally Accepted Accounting Principles ("GAAP") and should not be used as a substitute for the comparable U.S. GAAP financial measures. The non-U.S. GAAP financial measures are incorporated in our discussion and analysis as management uses them in evaluating our results of operations and believes that this information provides users with a valuable insight into our overall performance and financial position.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions. Our customers include leading biologic, generic, pharmaceutical, diagnostic, and medical device companies around the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes a commitment to excellence in manufacturing, scientific and technical expertise and management, which enables us to partner with our customers in order to deliver safe, effective drug products to patients quickly and efficiently. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into two global segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment solutions and drug delivery systems, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. We also maintain collaborations to share technologies and market products with affiliates in Japan and Mexico.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 and other Macroeconomic Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West has been actively monitoring the impact of the COVID-19 pandemic globally. Our primary objectives have remained the same throughout the pandemic: to support the safety of our team members and their families and continue to support patients around the world. Our production facilities continue to operate as they had prior to the COVID-19 pandemic, other than for enhanced safety measures intended to prevent the spread of the virus and higher levels of production at certain plant locations to meet additional customer demand. </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our capital and financial resources, including overall liquidity, remain strong. We will continue to closely monitor the COVID-19 pandemic in order to ensure the safety of our people and our ability to serve our customers and patients worldwide.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the twelve months ended December&#160;31, 2022, the war between Russia and Ukraine has not had a material impact on the Company&#8217;s business, financial condition or results of operations as we do not have manufacturing operations or significant commercial relationships in either country. However, the continuation of the Russia-Ukraine military conflict and/or an escalation of the conflict beyond its current scope may further weaken the global economy and could result in additional inflationary pressures and supply chain constraints, including the unavailability and cost of energy. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we experienced higher costs for raw materials and supply chain challenges related to manufacturing equipment. Due to the uncertainty that exists relative to the duration and overall impact of the macroeconomic factors discussed above, our future operating performance, particularly in the short-term, may be subject to volatility. The impacts of macroeconomic conditions on our business, results of operations, financial condition and cash flows are dependent on certain factors, including those discussed in Item 1A. </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_19">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Components of and Key Factors Influencing Our Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the performance of our business, we consider a variety of performance and financial measures. We believe the items discussed below provide insight into the factors that affect these key measures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our net sales results from the sale of goods or services and reflects the net consideration which we expect to receive in exchange for those goods or services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several factors affect our reported net sales in any period, including product, payer and geographic sales mix, operational effectiveness, pricing realization, timing of orders and shipments, regulatory actions, competition, and business acquisitions that involve our customers or competitors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Cost of goods and services sold and gross profit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods and services sold includes personnel costs, manufacturing costs, raw materials and product costs, freight costs, depreciation, and facility costs associated with our manufacturing and warehouse facilities. Fluctuations in our cost of goods sold correspond with the fluctuations in sales units as well as inflationary and other market factors that influence our cost base.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit is calculated as net sales less cost of goods and services sold. Our gross profit is affected by product and geographic sales mix, realized pricing of our products, the efficiency of our manufacturing operations and the costs of materials used to make our products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses relate to our investments in improvements to our manufacturing processes, product enhancements, and additional investments in our elastomeric packaging components, formulation development, drug containment systems, self-injection systems and drug administration consumables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development costs as incurred. Our research and development expenses fluctuate from period to period primarily based on the ongoing improvements to our manufacturing processes and product enhancements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses primarily include personnel costs, incentive compensation, insurance, professional fees, and depreciation. </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Performance Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following tables present a reconciliation from U.S. GAAP to non-U.S. GAAP financial measures: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2022 GAAP</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.73&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment activity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty acceleration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax law changes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2022 adjusted amounts (non-U.S. GAAP)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.58&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During 2022, we recorded a tax benefit of $16.5&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021 GAAP</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.67&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment activity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty acceleration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax law changes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021 adjusted amounts (non-U.S. GAAP)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.58&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During 2021, we recorded a tax benefit of $31.5&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020 GAAP</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment activity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020 adjusted amounts (non-U.S. GAAP)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During 2020, we recorded a tax benefit of $20.8&#160;million associated with stock-based compensation.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)  During 2022, the Company recorded restructuring and related charges of $23.8 million, which primarily included $8.7 million in net severance and post-employment benefits primarily in connection with our plan to adjust our operating cost base and $15.3 million in asset-related charges associated with this plan. During 2021 and 2020, the Company recorded a restructuring and severance related charge of $2.2 million and $7.0 million, respectively, to optimize certain organizational structure within the Company. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 16, </span><span style="background-color:#ffffff;color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="background-color:#ffffff;color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_124">Other Expense (Income</a><a style="background-color:#ffffff;color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_124">)</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of these items.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)  During 2022, we recorded a gross pension settlement charge of $52.2&#160;million within other nonoperating expense (income), which primarily relates to the full settlement of the U.S. qualified defined benefit plan (the "U.S. pension plan"). In 2021 and 2020, we recorded a pension settlement charge each year within other nonoperating expense (income), as it was determined that normal-course lump-sum payments for our U.S. pension plan exceeded the threshold for settlement accounting. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 15, </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_121">Benefit Plans</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of these items.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)  During 2022, the Company recorded $0.7&#160;million of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020. Additionally, the company recorded $2.1&#160;million of amortization expense in association with an acquisition of increased ownership interest in Daikyo. During 2021, the Company recorded $0.8&#160;million of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020. Additionally, the company recorded $2.1&#160;million of amortization expense in association with an acquisition of increased ownership interest in Daikyo. During 2020, the company recorded $0.6&#160;million of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020. Additionally, the company recorded $3.1&#160;million of amortization expense in association with an acquisition of increased ownership interest in Daikyo.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)  During 2021, the Company recorded a $2.8&#160;million impairment charge for certain long-lived and intangible assets within the Proprietary Products segment as it determined the carrying value exceeded the fair value of the assets. $1.9&#160;million of this charge is recorded in Cost of Goods and Services Sold and $0.9&#160;million of the charge is recorded in Selling, General, and Administrative expense, due to the nature of the impaired assets. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)  During 2022, the Company recorded a cost investment impairment charge of $3.5 million. During 2021, the net cost investment activity was $4.3 million, inclusive of an impairment charge of $4.6&#160;million offset by a $0.3&#160;million gain on the sale of a cost investment. During 2020, the Company recorded a cost investment impairment charge of $2.5 million. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)  During 2022, the Company increased its expected tax benefit related to the prepayment of future royalties from one of its subsidiaries by $1.3&#160;million</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company prepaid future royalties from one of its subsidiaries, which resulted in a $18.5&#160;million tax benefit.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)  During 2022, the Company incurred additional tax expense of $5.7&#160;million due to the impact of a tax law change in the state of Pennsylvania enacted during the period. During 2021, the Company recorded a tax benefit of $1.4&#160;million due to the impact of a United Kingdom tax law change enacted during the period.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_49"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items for which further information can be found above in the reconciliation from U.S. GAAP to non-U.S. GAAP financial measures. Discussion of the year-over-year changes for the fiscal year ended December 31, 2021 compared to the fiscal year ended December 31, 2020 and the results of operations and cash flows for the fiscal year ended December 31, 2020 is included in Item 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Management&#8217;s Discussion and Analysis of Financial Condition and Result of Operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on February 22, 2022, and is incorporated herein by reference. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Percentages in the following tables and throughout this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section may reflect rounding adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales, consolidated and by reportable segment:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:35.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022/2021</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021/2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,317.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment sales elimination</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net sales increased by $55.3 million, or 2.0%, in 2022, due to sales price increases of approximately $106&#160;million and a favorable mix of products sold despite a decline in net COVID-19 related activity for COVID-19 vaccines and antiviral treatments. This was partially offset by an unfavorable foreign currency translation impact of $162.6 million. Excluding foreign currency translation effects, consolidated net sales increased by $217.9 million, or 7.7%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products net sales increased by $89.5 million, or 3.9%, in 2022, including an unfavorable foreign currency translation impact of $138.6 million. Excluding foreign currency translation effects, net sales increased by $228.1 million, or 9.8%. The increase is primarily due to growth in our high-value product offerings of approximately $168&#160;million, including our NovaPure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Envision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Westar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products, which is inclusive of sales price increases and an approximately $71&#160;million decline in net COVID-19 related activity for COVID-19 vaccines and antiviral treatments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Contract-Manufactured Products net sales decreased by $34.3 million, or 6.7%, in 2022, including an unfavorable foreign currency translation impact of $24.0 million. Excluding foreign currency translation effects, net sales decreased by $10.3 million, or 2.0%, due to a decline in sales of components for diagnostic devices, offset by sales price increases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents gross profit and related gross margins, consolidated and by reportable segment and by unallocated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022/2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated gross profit</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated gross profit decreased by $39.6 million, or 3.4%, in 2022, including an unfavorable foreign currency translation impact of $60.4 million. Consolidated gross profit margin decreased by 2.1 margin points in 2022, due to increased plant spend to meet ongoing product demand and increased labor and overhead costs, primarily within transportation and compensation, that were driven by inflation. This was offset by increased sales prices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Proprietary Products gross profit decreased by $40.6 million, or 3.7%, in 2022, including an unfavorable foreign currency translation impact of $55.7 million. Proprietary Products gross profit margin decreased by 3.4 margin points in 2022. The decrease is driven by inflationary headwinds of approximately $85&#160;million, additional plant spend to meet ongoing product demand and a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> higher allocation of functional spend from Selling, General and Administrative Costs of approximately $18&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, offset by increased sales prices and a favorable mix of products sold.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products gross profit decreased by $0.9 million, or 1.1%, in 2022, including an unfavorable foreign currency translation impact of $4.7 million. Contract-Manufactured Products gross profit margin increased by 1.0 margin points in 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ue to increased sales prices and production efficiencies, offset by an unfavorable mix of products sold and additional costs driven by inflation of approximately $16&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;) Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents consolidated R&amp;D costs:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022/2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021/2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated R&amp;D costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated R&amp;D costs increased by $5.7 million, or 10.8%, in 2022, as compared to 2021, due to additional research performed to identify new product opportunities, offset by lower annual incentive compensation. Efforts remain focused on the continued investment in elastomeric packaging components, formulation development, drug containment systems, self-injection systems and drug administration consumables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the R&amp;D costs incurred during 2022, 2021 and 2020 related to Proprietary Products.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General and Administrative (&#8220;SG&amp;A&#8221;) Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents SG&amp;A costs, consolidated and by reportable segment and corporate and unallocated items:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022/2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated SG&amp;A costs</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.9&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.0&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">SG&amp;A as a % of net sales</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated SG&amp;A costs decreased by $45.9 million, or 12.7%, in 2022, including a favorable foreign currency translation impact of $7.9 million. The decrease was primarily </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to lower annual incentive compensation and a higher allocation of functional spend to Cost of Goods and Services Sold, offset by an increase in professional fees and salaries and fringe benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products SG&amp;A costs decreased by $32.2 million, or 13.2%, in 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to higher allocation of functional spend to Cost of Goods and Services Sold of approximately $18&#160;million, lower annual incentive compensation of approximately $17&#160;million, and a favorable foreign currency translation impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6.6 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products SG&amp;A costs increased by $5.0 million, or 31.4%, in 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to a higher allocation of functional spend and increased salaries and fringe benefits, partially offset by a reduction in annual incentive compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate SG&amp;A costs decreased by $18.7 million, or 18.3%, in 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to a reduction in mark-to-market expense related to stock-based compensation of approximately $10&#160;million and lower annual incentive compensation of approximately $7&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Expense (Income)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents other expense and income items, consolidated and by reportable segment and corporate and unallocated items:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:61.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions) </span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and unallocated items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated other expense (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense and income items consist of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, contingent consideration, fixed asset impairments and miscellaneous income and charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated other expense (income) changed by $18.9 million in 2022 as compared to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, due to the factors described below, primarily an increase in restructuring and related charges in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Proprietary Products other expense (income) changed by $2.4 million in 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as compared to 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily due to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased gains on foreign exchange transactions of $3.1&#160;million, offset by increased contingent consideration charges of $1.5&#160;million recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as compared to 2021. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Contract-Manufactured Products other expense (income) changed by $0.9 million in 2022 as compared to 2021, primarily due to increased fixed asset impairments of $0.7&#160;million recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as compared to 2021. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and unallocated items</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Corporate and unallocated items changed by $20.4 million in 2022 as compared to 2021. During 2022, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$23.8&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in restructuring and related charges and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in impairment charges related to our cost investme</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nts within Corporate and unallocated items. During </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recorded $2.2&#160;million in restructuring and related charges and a total impairment charge of $4.6&#160;million which was offset by a net gain of $0.3&#160;million on the sale of a cost investment, within Corporate and unallocated items.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Profit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents operating profit and adjusted operating profit, consolidated and by reportable segment, corporate and unallocated items:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.801%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022/2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating profit</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734.0&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.9&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating profit margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted consolidated operating profit</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted consolidated operating profit margin</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated operating profit decreased by $18.3 million, or 2.4%, in 2022, including an unfavorable foreign currency translation impact of $51.8 million, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Proprietary Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Proprietary Products operating profit decreased by $11.7 million, or 1.5%, in 2022, including an unfavorable foreign currency translation impact of $48.1 million, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Contract-Manufactured Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Contract-Manufactured Products operating profit decreased by $6.8 million, or 10.1%, in 2022, including an unfavorable foreign currency translation impact of $3.7 million, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Corporate &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Excluding the unallocated items, Corporate costs decreased by $18.1&#160;million, or 17.9%, in 2022, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Unallocated items - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Please refer to the Financial Performance Summary section above for details.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents interest expense, net, by significant component:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022/2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net, decreased by $0.3 million, or 3.7%, in 2022, primarily due to an increase in capitalized interest driven by higher capital expenditures in 2022, as compared to 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income increased by $4.1 million in 2022, resulting from higher interest rates compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Nonoperating Expense (Income)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other nonoperating expense (income) changed by $55.1&#160;million in 2022, primarily due</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the recording of a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$52.2&#160;million pension settlement charge in 2022, which relieved the historical balance sheet position, inclusive of accumulated other comprehensive income, of the U.S. pension plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was $114.7 million, $107.2 million, and $72.5 million for the years 2022, 2021, and 2020, respectively, and the effective tax rate was 16.9%, 14.3%, and 18.1%, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the effective tax rate in 2022 of 2.6%, or $7.5&#160;million of additional tax expense, is due to the Company's recognition of reserves for unrecognized tax benefits of $19.8&#160;million in 2022, the prepayment of future royalties from one of its subsidiaries in 2021, which resulted in a $18.5&#160;million tax benefit in 2021, as well as a $15.0&#160;million reduction in our tax benefit related to stock-based compensation compared to 2021. This was offset by the tax benefit of $20.6&#160;million recognized for the 2022 termination of our U.S. pension plan as well as a favorable geographic mix of our earnings in jurisdictions with a lower tax rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_127">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our income taxes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity in Net Income of Affiliated Companies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in net income of affiliated companies was $20.7 million, $20.1 million, and $17.4 million for the years 2022, 2021, and 2020, respectively. Equity in net income of affiliated companies increased by $0.6 million, or 3.0%, in 2022, primarily due to favorable operating results at Daikyo and the Mexico affiliates, offset by the impact of foreign currency translation.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash flow data for the years ended December&#160;31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:61.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Cash Provided by Operating Activities </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities increased by $140.0 million in 2022, primarily due to a year over year improvement in working capital management primarily within accounts receivable and inventory, partially offset by a decrease in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Cash Used in Investing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities increased by $35.1 million in 2022, primarily due to increases in capital expenditures for additional manufacturing capacity in 2022 to meet customer demand. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Cash Used in Financing Activities </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities increased by $125.5 million in 2022, primarily due to increases in purchases under our share repurchase program in 2022 and additional debt repayments in 2022 according to the maturity date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents selected liquidity and capital measures as of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:69.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.208%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,335.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include all instruments that have maturities of ninety days or less when purchased. Working capital is defined as current assets less current liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and cash equivalents &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our cash and cash equivalents balance at December&#160;31, 2022 consisted of cash held in depository accounts with banks around the world and cash invested in high-quality, short-term investments. The cash and cash equivalents balance at December&#160;31, 2022 included $317.8 million of cash held by subsidiaries within the U.S. and $576.5 million of cash held by subsidiaries outside of the U.S. For further information on our position regarding permanent reinvestment of foreign subsidiary earnings and profits refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_127">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working capital -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Working capital at December&#160;31, 2022 increased by $252.6 million, or 22.0%, as compared to December&#160;31, 2021, which includes an unfavorable foreign currency translation impact of $6.9&#160;million. Excluding the impact of currency exchange rates, cash and cash equivalents, accounts receivable, and inventories increased by </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$142.2 million, $35.5&#160;million and $49.7&#160;million, respectively, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">while total current liabilities decreased by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$60.8&#160;million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in cash and cash equivalents was due to cash collections from operations, offset by share repurchases, debt repayments and payment of annual incentive compensation during 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The increase in accounts receivable was due to increased sales activity. The increase in inventories that occurred in the period was to ensure we have sufficient inventory on hand to support the needs of our customers. The decrease in total current liabilities was caused by the decline in accrued salaries, wages and benefits and accounts payable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt and credit facilities -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The $44.1 million decrease in total debt at December&#160;31, 2022, as compared to December&#160;31, 2021, resulted from our $42.0&#160;million principal repayment of the Series A notes on July 5, 2022 and quarterly repayments of principal under our Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sources of liquidity include our Credit Facility. At December&#160;31, 2022, we had no outstanding borrowings under the Credit Facility. At December&#160;31, 2022, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $2.4 million, was $497.6 million. We do not expect any significant limitations on our ability to access this source of funds. Please refer to Note 10,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_106">Debt</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our Credit Facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2022, we were in compliance with all of our debt covenants, and we expect to continue to be in compliance with the terms of these agreements throughout 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that cash on hand and cash generated from operations, together with availability under our Credit Facility, will be adequate to address our foreseeable liquidity needs based on our current expectations of our business operations, capital expenditures and scheduled payments of debt obligations to continue to meet customer demand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contractual Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual obligations associated with ongoing business activities are expected to result in cash payments in future periods, and include the following material items: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business creates a need to enter into various commitments with suppliers, including for the purchase of raw materials </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and finished goods. In accordance with U.S. GAAP, these purchase obligations are not reflected in the accompanying consolidated balance sheets. At December&#160;31, 2022, our outstanding unconditional contractual commitments, including for the purchase of raw materials and finished goods, amounted to $96.8 million, of which $70.9 million is due to be paid in 2023. These purchase commitments do not exceed our projected requirements and are in the normal course of business. The Company previously entered into a material supply agreement for butyl polymers used as a principal raw material in a broad range of the Company&#8217;s polymer-based pharmaceutical packaging products.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our long-term debt obligations, net of unamortized debt issuance costs including fixed and variable-rate debt, is further discussed in Note 10, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_106">Debt</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operating lease obligations primarily related to land, buildings, and machinery and equipment, with lease terms through 2047 further discussed in Note 6, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_94">Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis addresses consolidated financial statements that are prepared in accordance with U.S. GAAP. The application of these principles requires management to make estimates and assumptions, some of which are subjective and complex, that affect the amounts reported in the consolidated financial statements. We believe the following accounting policies and estimates are critical to understanding and evaluating our results of operations and financial position: </span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Impairment of Long-Lived Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances, such as a deterioration in general macroeconomic conditions or a change in company strategy, increased competition, declining product demand, plans to dispose of an asset or asset group, or recent financial or legal factors that could impact the expected cash flows, indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Impairment reviews are based on an estimated future cash flow approach that requires significant judgment with respect to future revenue and expense growth rates, selection of appropriate discount rate, asset groupings, and other assumptions and estimates. The Company uses estimates that are consistent with its business plans and a market participant view of the assets being evaluated. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Impairment of Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Considerable management judgment is necessary to estimate fair value. Amounts and assumptions used in our goodwill impairment test, such as future sales, future cash flows and long-term growth rates, are consistent with internal projections and operating plans. Amounts and assumptions used in our goodwill impairment test are also largely dependent on the continued sale of drug products delivered by injection and the packaging of drug products, as well as our timeliness and success in new-product innovation or the development and commercialization of proprietary multi-component systems. Changes in the estimate of fair value, including the estimate of future cash flows, could have a material impact on our future results of operations and financial position. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. If, based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount, then it would not be necessary to perform the quantitative goodwill impairment test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuing identifiable intangible assets requires judgment. For example, for recent identifiable customer relationship intangible asset acquisitions, we applied an excess earnings model, which is a form of the income approach. This approach includes projecting revenues and expenses attributable to the existing customers over the remaining economic life of the customer relationships and then subtracting the required return on net tangible assets and any intangible assets used in the business to estimate any residual excess earnings attributable to the customer relationships. The after-tax excess earnings are then discounted to present value using the respective discount rates. Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. Factors that could trigger an impairment review include the following: 1) significant under-performance relative to historical or projected future operating results; 2) significant changes in the manner of use of the acquired assets or the strategy of the overall business; 3) significant negative industry or economic trends; and 4) recognition of goodwill impairment charges. If we determine that the carrying value of identifiable intangibles may not be recoverable based on the existence of one or more of the above indicators of impairment, we measure recoverability of assets by comparing the respective carrying value of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, we measure an impairment based on the amount in which the net carrying amount of the assets exceeds the fair values of the assets.</span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Benefits:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We maintain funded and unfunded defined benefit pension plans in the U.S. and a number of other countries that cover employees who meet eligibility requirements. In addition, we sponsor postretirement benefit plans which provide healthcare benefits for eligible employees who retire or become disabled. Postretirement benefit plans are limited to only those active employees who met the eligibility requirements as of January 1, 2017. The measurement of annual cost and obligations under these defined benefit pension and postretirement plans are subject to a number of assumptions, which are specific for each of our U.S. and foreign plans. The assumptions, which are reviewed at least annually, are relevant to both the plan assets (where applicable) and the obligation for benefits that will ultimately be provided to our employees. Two of the most critical assumptions in determining pension expense are the discount rate and expected long-term rate of return on plan assets. Other assumptions reflect demographic factors such as retirement age, rates of compensation increases, mortality and turnover, and are evaluated periodically and updated to reflect our actual experience. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. One of the most critical assumptions in determining retiree mental plan expense is the discount rate. Under U.S. GAAP, differences between actual and expected results are generally accumulated in other comprehensive income (loss) as actuarial gains or losses and subsequently amortized into earnings over future periods. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in key assumptions could have a material impact on our future results of operations and financial position. We estimate that every 25-basis point reduction in our long-term rate of return assumption would increase pension expense by $0.1&#160;million, and every 25-basis point reduction in our discount rate would decrease pension expense by $0.0&#160;million. A decrease in the discount rate increases the present value of benefit obligations. Our net pension underfunded balance at December&#160;31, 2022 was $26.1 million, compared to $20.6 million at December&#160;31, 2021. Our underfunded balance for other postretirement benefits was $3.9 million at December&#160;31, 2022, compared to $5.6 million at December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We estimate income taxes payable based upon current domestic and international tax legislation. In addition, deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and country level. Changes in tax legislation, business plans and other factors may affect the ultimate recoverability of tax assets or final tax payments, which could result in adjustments to tax expense in the period such change is determined.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When accounting for uncertainty in income taxes recognized in our financial statements, we apply a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 1, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_79">Basis of Presentation and Summary of Significant Accounting Policies</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements for additional information on our significant accounting policies. </span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_55"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. These risk factors can impact our results of operations, cash flows and financial position. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Foreign Currency Exchange Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales outside of the U.S. accounted for 55.4% of our consolidated net sales in 2022. Virtually all of these sales and related operating costs are denominated in the currency of the local country and translated into USD for consolidated reporting purposes. Although the majority of the assets and liabilities of these subsidiaries are denominated in the functional currency of the subsidiary, they may also hold assets or liabilities denominated in other currencies. These items may give rise to foreign currency transaction gains and losses. As a result, our results of operations and financial position are exposed to changing currency exchange rates. We periodically use forward exchange contracts to hedge certain transactions or to manage month-end balance sheet exposures on cross-currency intercompany loans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2022 and December&#160;31, 2021, the total amount of these forward exchange contracts was Singapore Dollar ("SGD") 601.5 million and $13.4 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of December&#160;31, 2022, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EUR</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,123.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Japanese Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as a cumulative translation adjustment in accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, we entered into a five-year floating-to-floating forward-starting cross-currency swap (the &#8220;cross-currency swap&#8221;) for $90&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#165;9.1&#160;billion ($83.2&#160;million) as of December&#160;31, 2022. Under the cross-currency swap, we receive floating interest rate payments based on USD compounded SOFR plus a margin, in return for paying floating interest rate payments based on Japanese Yen (&#8220;Yen&#8221;) Tokyo Overnight Average Rate ("TONAR") plus a margin. In addition, we receive periodic fixed principal payments of USD in return for paying fixed principal payments of Yen.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A sensitivity analysis of changes in fair value of these contracts outstanding as of December&#160;31, 2022, while not predictive in nature, indicated that a 10% decrease or increase in the foreign currency exchange rates from their level would increase or decrease the fair value of these contracts by $8.9&#160;million or $3.7&#160;million, respectively, the majority of which relates to our hedges of the movement between the Euro and United States Dollar contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Interest Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of our normal borrowing activities, we have long-term debt with both fixed and variable interest rates. Long-term debt consists of our Term Loan and Series B and C notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate risk-sensitive instruments: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.676%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.774%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current Debt:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar denominated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.2</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average interest rate - variable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.56%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar denominated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$53.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$73.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$126.0</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$121.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average interest rate - fixed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.82%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar denominated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$81.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$81.0</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$81.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average interest rate - variable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.56%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A change of 1.0% in variable interest rates would decrease or increase annual interest expense by $0.8&#160;million based on our outstanding debt as of December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. In recent years, raw material costs have fluctuated due to crude oil price fluctuations. We expect this volatility to continue and will continue to pursue pricing and hedging strategies, and ongoing cost control initiatives, to offset the effects on gross profit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From November 2017 through December 2022, we purchased several series of call options for a total of 867,500 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecas</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ted elastomer purchases.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the gain recorded in other expense (income) related to these options was $1.5 million. Dur</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ing 2021, the gain recorded in other expense (income) related to these options was $1.7 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had outstanding contracts to purchase 258,597 barrels of crude oil from December 2022 to September 2024, at a weighted-average strike price of $108.28 per barrel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A sensitivity analysis of changes in brent crude oil prices indicated that a 10% decrease or increase in pricing would decrease or increase the fair value of our commodity call options by $0.5 million or $0.7&#160;million, respectively, as of December&#160;31, 2022.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_58"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2022, 2021 and 2020 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share data)</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.669%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMS0yLTEtMS02MDI2Mw_4f5cafca-f76b-4026-9900-e2f64e6d84af">2,886.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMS00LTEtMS02MDI2Mw_efa1d076-d3eb-423a-a0c9-e836399e400a">2,831.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMS02LTEtMS02MDI2Mw_f77c8a7a-6caf-48ac-b0c9-9f5d10072282">2,146.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMi0yLTEtMS02MDI2Mw_3679da7d-a901-44d3-ae0d-3a4b452ecb4b">1,750.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMi00LTEtMS02MDI2Mw_32386396-4384-4e9a-b0bb-b9e2ea354219">1,655.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMi02LTEtMS02MDI2Mw_18e748aa-cfd1-45e6-87ec-b62c222742c8">1,379.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMy0yLTEtMS02MDI2Mw_d06be643-e559-4012-8e96-d07ae47e31f6">1,136.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMy00LTEtMS02MDI2Mw_6bc445b8-296b-4de7-9070-a8bd798326ca">1,175.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMy02LTEtMS02MDI2Mw_3484bd4e-f7f0-42ae-956d-d65e57c624c1">767.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNC0yLTEtMS02MDI2Mw_59cd215f-492f-4c3f-a54b-ee9d2b58c6cc">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNC00LTEtMS02MDI2Mw_8878477d-ba7e-4a2a-8e28-933186b0f23f">52.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNC02LTEtMS02MDI2Mw_f9c9759b-f346-46c4-a48f-50271560c64d">46.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNS0yLTEtMS02MDI2Mw_691869fa-2143-4462-8f37-dd8414635acc">316.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNS00LTEtMS02MDI2Mw_00c3f880-18a4-4417-9298-877970ea3510">362.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNS02LTEtMS02MDI2Mw_f76e1e77-d7d0-4f0c-b145-b936ab8e48d2">302.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) (Note 16)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNi0yLTEtMS02MDI2Mw_e9ac4ac2-3477-4a1b-9630-1f3598e0a68f">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNi00LTEtMS02MDI2Mw_0bfcbe9f-33cb-4ca9-8be6-9c827054724e">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNi02LTEtMS02MDI2Mw_9aed2bb8-a26c-492c-a199-b8778e5676b6">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNy0yLTEtMS02MDI2Mw_ccb7b7ef-90f1-438c-9218-91e5e0480942">734.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNy00LTEtMS02MDI2Mw_20f5103a-b774-412b-8bd7-ed63d97f6ca2">752.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNy02LTEtMS02MDI2Mw_9d57937d-55a4-45ea-bd74-4ef072804d3e">406.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOC0yLTEtMS02MDI2Mw_22e7166a-a5fe-4943-ae3c-6f112620dcbf">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOC00LTEtMS02MDI2Mw_29b7c8a6-9afd-4d55-b282-3372006b57dc">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOC02LTEtMS02MDI2Mw_0a5227fe-1eb3-4947-9257-9e67022ac7e2">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOS0yLTEtMS02MDI2Mw_3bfa88d4-f7d5-4ed0-ae49-0f8b74365864">5.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOS00LTEtMS02MDI2Mw_4afda712-85a9-453d-b4c4-d7e8f9dd8f51">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOS02LTEtMS02MDI2Mw_d02fce9d-29ca-4bfc-b035-9babdd5eda8f">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other nonoperating expense (income)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTAtMi0xLTEtNjAyNjM_4ccba17f-e379-45f8-86c9-ab50c539d45e">51.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTAtNC0xLTEtNjAyNjM_dc89239b-aec5-4be6-af45-2cd075cf573c">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTAtNi0xLTEtNjAyNjM_981c0380-ecd9-417d-bc17-6df9f63e0ff6">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net income of affiliated companies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTEtMi0xLTEtNjAyNjM_afcd830b-5fe2-41dc-8791-c5327856c2d0">679.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTEtNC0xLTEtNjAyNjM_58a17b02-17e4-468d-b641-cb47bddc4cde">748.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTEtNi0xLTEtNjAyNjM_b7cf4667-f86e-4426-9a35-36110b258c38">401.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTItMi0xLTEtNjAyNjM_b8220741-5368-4399-b5e1-a4da8513ee63">114.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTItNC0xLTEtNjAyNjM_7ba381ff-ae11-4414-b60f-5be0306e20d6">107.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTItNi0xLTEtNjAyNjM_d60632dd-50da-4fe3-8779-a8a7ab0a5bd0">72.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net income of affiliated companies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTMtMi0xLTEtNjAyNjM_91305260-928e-42df-bc11-ad294715ead0">20.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTMtNC0xLTEtNjAyNjM_e8ca5a3d-732a-4ab7-a737-43bfcc4bdb9e">20.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTMtNi0xLTEtNjAyNjM_e33daaab-bf9d-49c5-9186-0a71d510bf5f">17.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTQtMi0xLTEtNjAyNjM_356b2c65-4b06-4cac-b343-8f25f500b491">585.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTQtNC0xLTEtNjAyNjM_7b8c89dd-7313-478c-aa8b-f20cf35016a4">661.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTQtNi0xLTEtNjAyNjM_21160f54-4692-4cc5-9c04-2a540bd330f2">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTctMi0xLTEtNjAyNjM_9f97c460-74ba-470a-b221-bd8645a291c0">7.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTctNC0xLTEtNjAyNjM_b383ce2a-701b-48a5-bb95-b506492feeb7">8.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTctNi0xLTEtNjAyNjM_02d612e8-f1dc-4272-9a85-1d16800443f7">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTgtMi0xLTEtNjAyNjM_44776b8a-3694-4941-a7f2-441b0d4e080f">7.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTgtNC0xLTEtNjAyNjM_4fdae510-74df-461f-b886-11def6b012de">8.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTgtNi0xLTEtNjAyNjM_4e3f9000-b34b-4c9d-aba2-4cb17554a4a9">4.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjEtMi0xLTEtNjAyNjM_6a828c3f-5ad9-4501-89f1-2addc4f84832">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjEtNC0xLTEtNjAyNjM_8841d51c-f7f3-4971-b1a4-09b6cda1a62b">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjEtNi0xLTEtNjAyNjM_841af129-d887-4573-a56b-020efd545c91">73.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjItMi0xLTEtNjAyNjM_f9d20ae2-c8ca-48c5-95c0-d50718715897">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjItNC0xLTEtNjAyNjM_fa713535-60d1-4ad5-9864-2e5ec36507c4">76.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjItNi0xLTEtNjAyNjM_9c83fe26-d37a-435c-bb2b-3acc1177cebc">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_64"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2022, 2021 and 2020</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:62.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.617%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMS0xLTEtMS02MDI2Mw_d9cd07e5-b9c9-45f9-9434-4e207116052b">585.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMS0zLTEtMS02MDI2Mw_0fad30e8-1770-4351-b50a-d02d4b56c592">661.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMS01LTEtMS02MDI2Mw_10d9497e-d5ef-4f5b-8b45-926594e067b8">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjI3MzVhZDg3YTM3MDRjZDVhOWU5NDQwNTIyMzk3OWI0XzIxOTkwMjMyNTU2MTI_99560198-7622-4cd0-8163-15f78d485570">2.2</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjI3MzVhZDg3YTM3MDRjZDVhOWU5NDQwNTIyMzk3OWI0XzIxOTkwMjMyNTU2MTg_250d14e3-319d-49e5-a495-5a92413d2973">2.4</ix:nonFraction>, and $(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjI3MzVhZDg3YTM3MDRjZDVhOWU5NDQwNTIyMzk3OWI0XzIxOTkwMjMyNTU2Mjc_5c1c1ddd-5495-4e4e-bf75-0b1ee23b785b">1.0</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy0xLTEtMS02MDI2Mw_174bd1a8-760a-44a8-97a5-8da16c017bca">47.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy0zLTEtMS02MDI2Mw_664d0d6a-19b8-42f9-ba92-22ccb0d22c33">59.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy01LTEtMS02MDI2Mw_6d6f1a9e-db22-41e9-b8de-ae631aae35ff">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost arising during period, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjFkM2Q4ODA5N2Y0YTQ1YWFhYzY1NjI3MTFjMzZkNmI4XzIxOTkwMjMyNTU2MjI_10eb273e-7c04-4c96-a482-3bfcd26dcfab">0.0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjFkM2Q4ODA5N2Y0YTQ1YWFhYzY1NjI3MTFjMzZkNmI4XzIxOTkwMjMyNTU2MTY_68d5e13c-2920-4329-9d53-946e2bc21652">0.5</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjFkM2Q4ODA5N2Y0YTQ1YWFhYzY1NjI3MTFjMzZkNmI4XzIxOTkwMjMyNTU2MzU_f5463c84-006d-4065-a829-50add55c7487">0.0</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS0xLTEtMS02MDI2Mw_64348537-07b4-4473-a55c-de4cd8e8acb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS0zLTEtMS02MDI2Mw_5772f26a-4448-48ea-87a8-745d518fe673">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS01LTEtMS02MDI2Mw_ea80c75e-92a7-4809-ae63-4fffeed6780e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial (loss) gain arising during period, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmQxNzA3ZDlkZDMwMzQxOTNhOWNkOGMyOGFjZDVhYzUyXzY3_8cb2a7cd-9120-4baa-beea-8cc11f658729">2.4</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmQxNzA3ZDlkZDMwMzQxOTNhOWNkOGMyOGFjZDVhYzUyXzcx_a7eea12c-a094-4240-8ade-2274bcb95d58">2.1</ix:nonFraction>, and $(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmQxNzA3ZDlkZDMwMzQxOTNhOWNkOGMyOGFjZDVhYzUyXzc5_2283c2f5-3389-46b3-97e1-4e0f66715375">0.7</ix:nonFraction>)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi0xLTEtMS02MDI2Mw_3ebbbc9f-4b5f-46a5-a801-64d67734c189">9.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi0zLTEtMS02MDI2Mw_d224b2b4-a390-4beb-94ef-db33970fb13a">5.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi01LTEtMS02MDI2Mw_786e56ba-353d-4614-97c7-48b99bad1e57">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement effects arising during period, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmMwZDk2OGE2NTU4MzQyOTJhNzI1MmY0NjllOWEzMDdhXzYw_cd2c5e51-8632-4050-ab8a-dd180010bb13">20.3</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmMwZDk2OGE2NTU4MzQyOTJhNzI1MmY0NjllOWEzMDdhXzY0_bbb5b3b8-6015-42b0-89c7-4f25b14403af">0.4</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmMwZDk2OGE2NTU4MzQyOTJhNzI1MmY0NjllOWEzMDdhXzcy_5f4317c8-6fd6-4931-977b-7ce294d637bb">0.9</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy0xLTEtMS02MDI2Mw_2c2354f6-81e1-4cd1-9f90-cee2300e0452">31.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy0zLTEtMS02MDI2Mw_fcde61b7-a942-40ec-91f6-346e33545517">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy01LTEtMS02MDI2Mw_57b65994-547b-4ed8-8374-5610ef3759d1">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amortization of actuarial (gain) loss, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjQzNGNhMDdkYjU0ZTQ3MGFhMjE2NzQzYWY0NzNlMmY3XzYz_d84678d7-ae3b-4f3c-82e7-f0ed8b3ab34f">0.1</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjQzNGNhMDdkYjU0ZTQ3MGFhMjE2NzQzYWY0NzNlMmY3XzY3_283b6f58-1f13-466d-9033-6c0ece04c2a3">0.1</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjQzNGNhMDdkYjU0ZTQ3MGFhMjE2NzQzYWY0NzNlMmY3Xzc1_dde5563b-491b-4c3e-8849-2cbe050b93c6">0.0</ix:nonFraction></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC0xLTEtMS02MDI2Mw_3574cd64-30b8-4e43-a354-5f45bd3b4d0e">0.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC0zLTEtMS02MDI2Mw_fbcf16b4-de14-46fd-ba7d-5cb25427f135">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC01LTEtMS02MDI2Mw_982c0c8e-b55c-461d-aa10-c26db37bbb88">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amortization of prior service credit, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmE1ZTEzYTIwYTM3NjRiNDZhMjIxMGI3ODEzMjllYzcwXzYy_2bb5a33f-853c-4d3f-88d8-31c411fcccab">0.0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmE1ZTEzYTIwYTM3NjRiNDZhMjIxMGI3ODEzMjllYzcwXzY2_a2162746-4eae-4036-9cf7-b6fd56f236c6">0.1</ix:nonFraction>), and $(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmE1ZTEzYTIwYTM3NjRiNDZhMjIxMGI3ODEzMjllYzcwXzcz_c85fbc98-7c35-4b66-8f9e-7d85a18add80">0.1</ix:nonFraction>).</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS0xLTEtMS02MDI2Mw_07d070f2-f6e2-40ee-84a7-3b02d055eacc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS0zLTEtMS02MDI2Mw_9569994a-34c5-40ce-a5c9-96f582a92475">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS01LTEtMS02MDI2Mw_f34f2926-c257-4b66-b2c4-e408f5740985">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amortization of other, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtMC0xLTEtNzc1MjQvdGV4dHJlZ2lvbjo4NzRiZTQzNmJkMjg0OWM1OTc1YzM5YzM0MzU0MGE4OV8yMTk5MDIzMjU1NjA1_71d6435b-17bb-40e9-a19b-b7052a082f44">0.1</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtMC0xLTEtNzc1MjQvdGV4dHJlZ2lvbjo4NzRiZTQzNmJkMjg0OWM1OTc1YzM5YzM0MzU0MGE4OV8yMTk5MDIzMjU1NjA4_1de17452-8dfc-4039-bef4-81718f1bfedd">0.0</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtMC0xLTEtNzc1MjQvdGV4dHJlZ2lvbjo4NzRiZTQzNmJkMjg0OWM1OTc1YzM5YzM0MzU0MGE4OV8yMTk5MDIzMjU1NjE3_97023371-9d1b-479a-86e7-0c290a8897c0">0.0</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtMS0xLTEtNjAyNjM_fade6a56-78f2-48c7-8bc8-c6db57c9502d">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtMy0xLTEtNjAyNjM_e33f3491-24e4-482e-949a-9dcb54ea8d04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtNS0xLTEtNjAyNjM_ae40a8a5-a9db-43a2-bbe2-4626de737952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on equity affiliate accumulated other comprehensive income, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo2NjVmZDJjZDRjYjI0MDMxYmQ0MDQzNDUzMzIwMDM3MF85NA_4916b012-493f-4f9e-82de-2818d348f428">0.0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo2NjVmZDJjZDRjYjI0MDMxYmQ0MDQzNDUzMzIwMDM3MF85OA_348d3409-0edf-4413-8fa8-229817d7bd28">0.0</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo2NjVmZDJjZDRjYjI0MDMxYmQ0MDQzNDUzMzIwMDM3MF8xMDY_0ce4375f-2c1e-4f4a-91fb-6b46eed3f97a">0.0</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtMS0xLTEtNjAyNjM_5fa475b7-2479-47d9-9f9e-2e60e985a482">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtMy0xLTEtNjAyNjM_80048c71-3ff8-4552-8026-1a4ba642c6d8">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtNS0xLTEtNjAyNjM_affca5e0-05d7-451a-a4b8-12eb1d7fd945">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on derivatives, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpmYjc2ODY2YzhjYjg0MDgxOTAxMjExMGI3ZjA5M2QzOV81MA_f719fb92-2a76-4c09-9344-0b74d036610f">0.2</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpmYjc2ODY2YzhjYjg0MDgxOTAxMjExMGI3ZjA5M2QzOV81NA_f0dfbfc2-06bc-49ea-bb5c-d960647380f8">0.5</ix:nonFraction>, and $(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpmYjc2ODY2YzhjYjg0MDgxOTAxMjExMGI3ZjA5M2QzOV82Mg_416bbc3a-7565-439f-ae51-ad1de6659385">0.6</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItMS0xLTEtNjAyNjM_fdf04435-65c5-4d9a-b46f-1fb94a941ddb">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItMy0xLTEtNjAyNjM_335acecb-2692-474a-8f83-c9865a41e801">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItNS0xLTEtNjAyNjM_8938bcb8-0bc5-4b8b-9917-359cb400ea1e">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTMtMS0xLTEtNjAyNjM_34e94f6c-9ed6-4719-aacf-5d7817d3a8fe">23.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTMtMy0xLTEtNjAyNjM_9b1f8e4d-cde8-44c9-986c-3a4c42e0b153">49.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTMtNS0xLTEtNjAyNjM_0e33d7b1-862f-476d-989f-3d94dc4d751b">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTQtMS0xLTEtNjAyNjM_64e14bb4-d563-4dee-b1af-c5685b4cf2d8">562.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTQtMy0xLTEtNjAyNjM_e84d3b44-5bff-495a-880d-f70a3a1c906c">612.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTQtNS0xLTEtNjAyNjM_5ea446b4-c227-42af-884c-244218131acc">385.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries at December&#160;31, 2022 and 2021 </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:72.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.764%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMy0xLTEtMS02MDI2Mw_ea97cf07-b40f-4388-a31f-a4449d901499">894.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMy0zLTEtMS02MDI2Mw_31782dcf-5a22-446a-b5ff-73126b703b72">762.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNC0xLTEtMS02MDI2Mw_ddb17ace-3a4e-42b0-b6d9-a96e80b83c29">507.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNC0zLTEtMS02MDI2Mw_cc868796-d381-4300-bb51-005b87cfad8a">489.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNS0xLTEtMS02MDI2Mw_753800ae-6779-41dd-a717-60450e498f2a">414.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNS0zLTEtMS02MDI2Mw_9f3a747e-0a8b-4f89-8638-a89c11558176">378.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNi0xLTEtMS02MDI2Mw_8c7c5106-173e-4a76-9db8-593a12a0312b">103.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNi0zLTEtMS02MDI2Mw_413a5241-9019-47ce-a767-69885266a37c">112.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNy0xLTEtMS02MDI2Mw_e8a58ae4-2f1c-472e-b805-20bdddc10076">1,919.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNy0zLTEtMS02MDI2Mw_6340588f-008d-4882-96ff-6cffbb37ad73">1,742.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfOC0xLTEtMS02MDI2Mw_418f49b2-039d-4a3e-9418-229c35904350">2,386.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfOC0zLTEtMS02MDI2Mw_dc13911c-35ea-45ee-a045-cf10d55c6571">2,215.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfOS0xLTEtMS02MDI2Mw_02943cdc-6188-4a53-8b3f-dc9d12845039">1,228.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfOS0zLTEtMS02MDI2Mw_f834c377-5f88-444f-a904-7e8b5459c67b">1,157.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTAtMS0xLTEtNjAyNjM_d0b8b18d-86e8-4a0e-a30d-66764fe3ce72">1,158.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTAtMy0xLTEtNjAyNjM_9c10f6dd-06ac-4ee2-85cb-b2d9aa0ad0b6">1,057.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTEtMS0xLTEtNjAyNjM_653e95f8-aaf8-4f8e-b0fc-bb6e816ca2f7">104.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTEtMy0xLTEtNjAyNjM_08c8529a-2e30-4aa8-98fc-96a871cfa8c1">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Investments in affiliated companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTItMS0xLTEtNjAyNjM_d875a30e-1a0e-4931-b279-7ce5fcdb5899">204.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTItMy0xLTEtNjAyNjM_e60b7ccb-a384-401a-af5f-6074846a3044">207.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTMtMS0xLTEtNjAyNjM_5c082e0b-5ba8-434f-a25d-dcb21b03fb97">107.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTMtMy0xLTEtNjAyNjM_05f31c87-d593-4843-9236-ea2abff28ae1">109.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTQtMS0xLTEtNjAyNjM_c3a788c8-69e2-4ac0-b758-1d58b65da019">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTQtMy0xLTEtNjAyNjM_0f9fac12-55b8-441c-bd7d-8353e0265684">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTUtMS0xLTEtNjAyNjM_d65d83e4-6d5c-44c0-bd31-7fc2963c8d76">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTUtMy0xLTEtNjAyNjM_e4c8efca-71de-4461-bad7-364b03fc80cd">48.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTYtMS0xLTEtNjAyNjM_31ebfa26-2c42-417e-a425-2350cd8c5342">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTYtMy0xLTEtNjAyNjM_e85ee963-2064-4c38-8452-6a5ce1b37d3e">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTctMS0xLTEtNjAyNjM_c9b9c8cf-f025-417d-8411-238e8e9425b7">38.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTctMy0xLTEtNjAyNjM_368c028c-cb4a-4840-888c-7d9d1c1e902e">39.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTgtMS0xLTEtNjAyNjM_e7e2e3c1-ceaf-4072-8705-f79a9d104044">3,616.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTgtMy0xLTEtNjAyNjM_7eb6d94a-d1cd-49ee-8fe4-4a155a10a76e">3,313.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Notes payable and other current debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="wst:NotesPayableAndOtherDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjItMS0xLTEtNjAyNjM_6227e0d3-5a13-4f31-940e-9fb4a1aae65b">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="wst:NotesPayableAndOtherDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjItMy0xLTEtNjAyNjM_edf37675-b785-401d-8a47-a790798bf281">44.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjMtMS0xLTEtNjAyNjM_c0f59e92-6a98-4a4a-894c-ef23922535a3">215.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjMtMy0xLTEtNjAyNjM_c8798ebf-3d4a-413f-b01e-7a51c879e264">232.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjQtMS0xLTEtNjAyNjM_99a45d12-ca8c-4c96-9e48-8355e02d7b91">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjQtMy0xLTEtNjAyNjM_2726cf0f-f108-4702-85a8-ac207a9ef642">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued salaries, wages and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="wst:AccruedSalariesWagesAndBenefitsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjUtMS0xLTEtNjAyNjM_e322cc2d-1cd7-43c3-8169-f4cd14ee0abd">76.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="wst:AccruedSalariesWagesAndBenefitsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjUtMy0xLTEtNjAyNjM_4530c45f-9334-4666-acc7-0ef46d648ff3">116.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjYtMS0xLTEtNjAyNjM_26c44e56-2f10-4a30-9bce-e900c861c077">24.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjYtMy0xLTEtNjAyNjM_cf7d2a7b-6078-4c87-907e-b5997e6bf057">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjctMS0xLTEtNjAyNjM_4af4e990-7f7c-4316-a8e6-2a8e3d79e900">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjctMy0xLTEtNjAyNjM_0ae39117-2bb0-4b8e-af09-294a91c1c760">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjgtMS0xLTEtNjAyNjM_f1a1ae4e-8c5a-4cba-ac8a-2d086e61d8a6">181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjgtMy0xLTEtNjAyNjM_93754f70-b9ad-4909-81e1-b73b35d7109a">163.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjktMS0xLTEtNjAyNjM_aaffe62d-8bf4-46b4-a1cf-030e1d77e4c9">519.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjktMy0xLTEtNjAyNjM_8908e115-6a80-4e88-9a06-addaf9506267">594.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzAtMS0xLTEtNjAyNjM_c271e6c3-e3d9-4823-9e36-5c3d2705da46">206.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzAtMy0xLTEtNjAyNjM_70e2bc69-a793-4800-a276-06b66d24b7f6">208.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzEtMS0xLTEtNjAyNjM_0a8a432d-2857-4d2f-9759-9d1a890f8550">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzEtMy0xLTEtNjAyNjM_a2d24462-db0d-426d-9005-fc0105628e38">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzItMS0xLTEtNjAyNjM_dce2633e-335e-47cc-a0f3-7441e301c138">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzItMy0xLTEtNjAyNjM_7242d27a-a0e2-4546-9d33-eaf9e676b3ec">40.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzMtMS0xLTEtNjAyNjM_6d862db0-61a0-4fcf-97c0-9d8f2d5fc1f7">93.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzMtMy0xLTEtNjAyNjM_7297295f-5611-456d-ba14-0e9a4c8e5b36">63.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred compensation benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzQtMS0xLTEtNjAyNjM_faba8e53-21ac-4fa2-b131-819c0d07835e">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzQtMy0xLTEtNjAyNjM_4ed69305-f5b1-40b4-b52c-95d1a7c1f492">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzUtMS0xLTEtNjAyNjM_76f41859-658b-40b8-82ab-9d6abf6ba710">51.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzUtMy0xLTEtNjAyNjM_d200ad96-2325-4e44-a0fa-c395da438479">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzYtMS0xLTEtNjAyNjM_d1fa68af-b78f-4912-8f2a-94fe26dcdabb">931.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzYtMy0xLTEtNjAyNjM_68d50bf3-2551-4fcd-8d00-ca6ba61b3fd8">978.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 18)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzgtMS0xLTEtNjAyNjM_79fc0038-4fc8-4830-9316-d56a6ca8d44a"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzgtMy0xLTEtNjAyNjM_9939d750-30af-4c7d-959a-7dbe44babc9f"></ix:nonFraction></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Preferred stock, <ix:nonFraction unitRef="shares" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM18yMg_19e13d95-78d3-43c1-83ad-a312fca0bc5d"><ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM18yMg_1b57f6e5-dc90-40c0-b622-072ec6edea41">3.0</ix:nonFraction></ix:nonFraction> million shares authorized; <ix:nonFraction unitRef="shares" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM181Mg_3ce651e4-5fea-463e-a63a-7385d6ff1426"><ix:nonFraction unitRef="shares" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM181Mg_5ac5890a-ccfd-4999-92d0-9544f225fea9"><ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM181Mg_cffda93a-2d0b-4d34-b248-e082a3fa65d3"><ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM181Mg_ffdc3b72-f48d-4fc0-b726-92fbc09f20ab">0.0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding in 2022 and 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMS0xLTEtNjAyNjM_1d78620a-7abe-4dd3-974c-7b08edd4e842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMy0xLTEtNjAyNjM_9bb9d414-30db-4d12-9b93-f8754571121a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl8yOA_59796a9e-2438-4ee0-a2de-3a00f71c1a63"><ix:nonFraction unitRef="usdPerShare" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl8yOA_b10d407c-6633-4575-ae2e-2e8564e6fdd0">0.25</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl80Mg_005d7ca3-5324-45d5-bc92-241ac152205a"><ix:nonFraction unitRef="shares" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl80Mg_7a4cbe8d-c655-434b-8cc5-11f303726eb4">200</ix:nonFraction></ix:nonFraction> million shares authorized; shares issued: <ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl84Nw_96354407-adc6-42c9-be4f-a7039288b5f3"><ix:nonFraction unitRef="shares" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl84Nw_aa303b8f-dc74-439c-af28-755f0e90fc99">75.3</ix:nonFraction></ix:nonFraction> million in 2022 and 2021; shares outstanding: <ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl8xMzI_ec69bb82-455a-4516-a625-06fd161bb242">74.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl8xNDc_0027d007-c779-481f-ab5f-c029413c8599">74.2</ix:nonFraction> million in 2022 and 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMS0xLTEtNjAyNjM_8320a548-d187-45d8-a6c7-9d94082ef49f">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMy0xLTEtNjAyNjM_e628a2bb-51c1-4399-8840-d03ab97c32d2">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDMtMS0xLTEtNjAyNjM_1968f0f4-2ed6-4013-8f90-7ac9812694ce">232.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDMtMy0xLTEtNjAyNjM_a8242d2b-1895-4bd1-ad0b-2ed84e75a213">249.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDQtMS0xLTEtNjAyNjM_4aa2af68-7ce7-4799-9faa-d10536def98e">2,987.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDQtMy0xLTEtNjAyNjM_0919b2b6-340d-4098-b274-a0fa3e343883">2,456.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDUtMS0xLTEtNjAyNjM_2f194a94-4da3-4105-bcb9-ff92b9a9accf">183.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDUtMy0xLTEtNjAyNjM_5fdfc482-493d-4911-a0c5-be430cc374f2">159.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDYtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjphNTlmNTIwMzNiNzA0YmEzODQyMTdiNDVjMDRmYTJhN18yOQ_953089bc-84a0-4b9a-92b9-98cf309cc157">1.2</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDYtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjphNTlmNTIwMzNiNzA0YmEzODQyMTdiNDVjMDRmYTJhN180NA_2e708559-838c-4a3e-932d-28315f892c8f">1.1</ix:nonFraction> million shares in 2022 and 2021)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDYtMS0xLTEtNjAyNjM_0250598c-f533-4b8b-bf50-a1a023425527">370.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDYtMy0xLTEtNjAyNjM_a696591d-4cfe-4e63-b3ad-b4dcf56f5cfb">229.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDctMS0xLTEtNjAyNjM_5edf9e95-264b-4bc4-82e5-67c307caf192">2,684.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDctMy0xLTEtNjAyNjM_b1e03ad5-8d9e-4f1a-b699-ca2413311ed5">2,335.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Liabilities and Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDgtMS0xLTEtNjAyNjM_26eee2bd-6da0-4921-82c6-54cf2c0755ec">3,616.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDgtMy0xLTEtNjAyNjM_8b7054bd-aa07-46db-af0f-2400ed92eb76">3,313.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_70"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2022, 2021 and 2020</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.884%"><tr><td style="width:1.0%"></td><td style="width:31.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.877%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.673%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of treasury shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a763da7bebb49d78fb727a07ced4166_I20191231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS0xLTEtMS02MDI2Mw_7ae5cc37-0b83-4489-99a8-68829644a21b">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a763da7bebb49d78fb727a07ced4166_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS0zLTEtMS02MDI2Mw_a3b624c9-d79a-4539-882a-43a43693f5fb">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id962c393773440e097f70db1509b5a4c_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS01LTEtMS02MDI2Mw_73a11063-37b1-47fa-bb12-d3160e72004b">272.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib9377c7030f9487bb7299e888531cb40_I20191231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS03LTEtMS02MDI2Mw_06a2fdd7-1103-4c6a-a33e-eaf9deaef192">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9377c7030f9487bb7299e888531cb40_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS05LTEtMS02MDI2Mw_9027f727-b35b-4ead-b064-1989b1e68eaa">118.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie47b13e10f5c43f18b3aba014d8b9557_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS0xMS0xLTEtNjAyNjM_a390ec00-a467-482e-8157-6d6ba79668d0">1,549.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17b8a1175e024b0b91f80042eb871d9e_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS0xMy0xLTEtNjAyNjM_74c43397-2273-42af-b988-3cd1aff99d96">149.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ff963c9c54045f29206b3189d452f9b_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS0xNS0xLTEtNjAyNjM_f97f69fe-a5de-49cf-aab1-f4e13ed411cd">1,573.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMy0wLTEtMS02MDI2Mw_e15719f8-e673-40ca-a352-c8014dfe8702">Effect of modified retrospective application of a new accounting standard</span></span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f410a8c4414410fbda82326f2f5f0cd_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMy0xMS0xLTEtNjAyNjM_0073d25a-a278-4b06-b230-89ad69f21816">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idca50b3901184ea9bada9c1613654555_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMy0xNS0xLTEtNjAyNjM_2c933cdc-0ecc-42c4-b0a5-4e4b7ad529a7">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i532be8bdd25444f5bef6c5a83fa6ec14_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNC0xMS0xLTEtNjAyNjM_b2a108db-0ae1-4711-b9f7-54860aa52ac0">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNC0xNS0xLTEtNjAyNjM_5b683e85-e863-4959-b76b-4372409b12a1">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i093b685a4dfa4da18da754958b07c8bb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNS01LTEtMS02MDI2Mw_e89fcd74-d0d6-466f-af5f-72c2785ee534">5.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i06323a1fbe0b4d548901ae093dc4d002_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNS03LTEtMS02MDI2Mw_aabe7ea4-643e-42c1-a8f7-94cd2ef5e633">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06323a1fbe0b4d548901ae093dc4d002_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNS05LTEtMS02MDI2Mw_227beb71-029d-4058-a313-35151870f76b">65.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNS0xNS0xLTEtNjAyNjM_f07ceff5-42fc-4a58-930c-3b24c8c62899">60.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i06323a1fbe0b4d548901ae093dc4d002_D20200101-20201231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNi03LTEtMS02MDI2Mw_8d451287-2ce2-4391-8529-4966d2443e76">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06323a1fbe0b4d548901ae093dc4d002_D20200101-20201231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNi05LTEtMS02MDI2Mw_37e9201a-f85b-402d-9a53-ca83997ab28e">115.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNi0xNS0xLTEtNjAyNjM_77b035c2-b707-4d0c-9de9-340c9343ad9e">115.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmU5ZDI1MTY3NzM5ODQwMTI4ZWIzNWRlN2JjZmVjZmU5XzI0_48a4ca1b-2956-4367-bb42-4a0aeebc7ac5">0.66</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i532be8bdd25444f5bef6c5a83fa6ec14_D20200101-20201231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNy0xMS0xLTEtNjAyNjM_fedb6af6-d1b9-4af5-9811-6fc4c5d6cefd">48.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNy0xNS0xLTEtNjAyNjM_5ff4ac52-1b59-42a3-af46-e13aaf568b96">48.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f3b7a5c69c84fa1a9361b05a767bfa2_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfOS0xMy0xLTEtNjAyNjM_0ca139af-19ba-427c-b125-a3727c0527ac">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfOS0xNS0xLTEtNjAyNjM_f241ee2d-d114-4bfa-ac18-3d1a8ad5a061">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16978dcdc2f041d19d80093c40fff403_I20201231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtMS0xLTEtNjAyNjM_2de76cb6-d349-4ffe-9d96-5966fe75c833">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16978dcdc2f041d19d80093c40fff403_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtMy0xLTEtNjAyNjM_744f7128-09a0-469e-bbb6-59f1f37ee1e7">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if72c2fa428754de9934583a6add241a8_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtNS0xLTEtNjAyNjM_9af2efe1-342e-4812-9eb6-19f591af0f04">267.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i840ed7b254234d0fbb34c7f7abeabfed_I20201231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtNy0xLTEtNjAyNjM_c71d9ae6-2119-4f21-a80f-cfc0b581c37f">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i840ed7b254234d0fbb34c7f7abeabfed_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtOS0xLTEtNjAyNjM_35897a57-42e5-43fe-9497-d968e520b81f">167.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21b4b5fca6e4ce0884f11bc4cfad4fd_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtMTEtMS0xLTYwMjYz_9655db5e-22c0-47d9-ab25-34f38527b3f8">1,846.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida3c98d3c0354b73a89f724be3743416_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtMTMtMS0xLTYwMjYz_7566c2ed-7f79-4e27-b1fd-0b12282ed87f">110.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1165b131d689444eb6459290c85e0fec_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtMTUtMS0xLTYwMjYz_a2485061-b767-49fa-b497-a45fbb3ad6a6">1,854.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b5efe1c17b43d2a2fb2ea3402c0e1d_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTItMTEtMS0xLTYwMjYz_dd1fe496-9a20-48b8-a5f9-d6a9882794b3">661.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTItMTUtMS0xLTYwMjYz_393c7339-be84-4811-873a-0179c464f7f6">661.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i989eb46562154074b7d4bd40080dadcf_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTMtNS0xLTEtNjAyNjM_6fdf8e19-9bfe-4907-8334-7fe9d601ae2e">18.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4ce53383a53d4f1eb000e413d41ebdf9_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTMtNy0xLTEtNjAyNjM_9813a106-e21e-4839-b571-5992d73ad8ff">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce53383a53d4f1eb000e413d41ebdf9_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTMtOS0xLTEtNjAyNjM_fa92a1a6-60ad-4740-9168-e8a928ccce43">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTMtMTUtMS0xLTYwMjYz_5bcab8a7-feac-4965-a3e8-c840838e5d07">57.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ce53383a53d4f1eb000e413d41ebdf9_D20210101-20211231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTUtNy0xLTEtNjAyNjM_9893d5ea-1e45-427f-8a1b-d4209450be23">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ce53383a53d4f1eb000e413d41ebdf9_D20210101-20211231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTUtOS0xLTEtNjAyNjM_79382c7b-76e4-41c2-9198-ee02c63587ee">137.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTUtMTUtMS0xLTYwMjYz_a0786882-e7fa-4b1d-b502-eff54581705d">137.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTctMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjozOTU0MTkwMDljNDA0M2RkODMzMGU3NTJhMDljOThjMV8yNA_2138608d-c887-4881-9f24-1095344692bf">0.70</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00b5efe1c17b43d2a2fb2ea3402c0e1d_D20210101-20211231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTctMTEtMS0xLTYwMjYz_dea9b033-96dc-4c0c-a021-37d2d6f85573">51.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTctMTUtMS0xLTYwMjYz_81fa2266-81a0-4726-8b77-d9b294d96eb4">51.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c3dc3f33c6e40168b8ee2b01cf1da89_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTgtMTMtMS0xLTYwMjYz_6f8808f1-4d18-4f76-be8a-6816b7c00dff">49.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTgtMTUtMS0xLTYwMjYz_fca820c7-df1d-42de-bac8-c68bd9121896">49.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e32d2d077d14623ad4001f6615da739_I20211231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktMS0xLTEtNjAyNjM_c20d3de7-0aec-4812-9baf-d5f8d2c63366">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e32d2d077d14623ad4001f6615da739_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktMy0xLTEtNjAyNjM_2c4ae4a7-b601-45ab-9f03-fd13c180e24f">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i269d9dc747f34c98bd9fd36e958f9112_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktNS0xLTEtNjAyNjM_fd69fd90-b722-413c-a8da-a663ace6609c">249.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic40bf59888ea464bbf38a5e599052b55_I20211231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktNy0xLTEtNjAyNjM_f0701b97-7988-4b26-9c94-5f017f3c6477">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic40bf59888ea464bbf38a5e599052b55_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktOS0xLTEtNjAyNjM_d5c90732-19fe-4b32-a20e-9db911fa75bc">229.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbf7836dda448549d12d0144c47661e_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktMTEtMS0xLTYwMjYz_96b895bc-4fbb-4876-b894-8d123f26a2c5">2,456.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e14a309edfa4014932d060921715d47_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktMTMtMS0xLTYwMjYz_14b11bf5-1a00-42eb-8d74-53fa2c21ecef">159.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktMTUtMS0xLTYwMjYz_0293c340-4b7d-493e-a716-79e15df76f58">2,335.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e03154cb7d45b6addb0d566c6a2e5d_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjAtMTEtMS0xLTYwMjYz_210db5b2-a300-44e9-9c09-6ba6845e4953">585.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjAtMTUtMS0xLTYwMjYz_d65a517b-7363-4492-8b0f-78ed17422700">585.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21e3c20e3f1049698ccd1b563fee50fd_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjEtNS0xLTEtNjAyNjM_944c83ed-efaa-475f-8456-dfcae1565237">16.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic414a0567e02472dbd5e6bc8dea1c934_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjEtNy0xLTEtNjAyNjM_7886abeb-0d03-4225-893a-6dc572b9ee7a">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic414a0567e02472dbd5e6bc8dea1c934_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjEtOS0xLTEtNjAyNjM_3e62c8d7-e57c-4752-a16a-52b46290019e">61.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjEtMTUtMS0xLTYwMjYz_8449b7d0-cdc4-43b1-9473-4af292924387">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic414a0567e02472dbd5e6bc8dea1c934_D20220101-20221231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjItNy0xLTEtNjAyNjM_555dcb46-bb8a-4e5f-95b9-79502747d0d3">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic414a0567e02472dbd5e6bc8dea1c934_D20220101-20221231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjItOS0xLTEtNjAyNjM_26c24929-c5fe-45da-b45c-998d20bf8f65">202.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjItMTUtMS0xLTYwMjYz_d5ce1161-e5ba-47d3-832f-5115843803f0">202.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjMtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjowNTU3NGJmMDlkNGQ0YjA0YTUxNGJhMTE0YzRkYzdkY18yNA_ad2d9ee9-ef71-42a3-a094-5aebfc273f88">0.74</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80e03154cb7d45b6addb0d566c6a2e5d_D20220101-20221231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjMtMTEtMS0xLTYwMjYz_7a741232-b9d3-4394-ba8e-2eea087ac924">54.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjMtMTUtMS0xLTYwMjYz_3bdacb20-4a78-48e4-b1e1-3ca35f84729a">54.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42428a99c9ed4d9bb8b558e76dc9a6d0_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjQtMTMtMS0xLTYwMjYz_9cfe38f5-6297-4263-baf3-f1be19da4df3">23.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjQtMTUtMS0xLTYwMjYz_e5308f92-133f-45ab-b35d-137bab8d09a4">23.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27a556c3b4b644d5a2cba539a25d2c52_I20221231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtMS0xLTEtNjAyNjM_5d14a073-2703-4688-8622-6ced43a3437b">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a556c3b4b644d5a2cba539a25d2c52_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtMy0xLTEtNjAyNjM_7a7d75df-3625-4c60-9da9-7e151ab75d48">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i297d5b4a9400421e865338046ad94f11_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtNS0xLTEtNjAyNjM_add47d8f-9af1-4ca2-b5a5-26e34d874cf0">232.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if051f33d67bc4196a2590dbe46e32868_I20221231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtNy0xLTEtNjAyNjM_f9b7e0a1-85a8-4d62-abbe-3da9bc54a9ab">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if051f33d67bc4196a2590dbe46e32868_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtOS0xLTEtNjAyNjM_38ea1a15-4223-463c-ace3-39ee083ec77c">370.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3086806657e4a2b89502cfae1ac8883_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtMTEtMS0xLTYwMjYz_9e8cc0d6-8391-4c1b-a11a-7daec7f2a39d">2,987.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e6cb706114942e4aabe6faaacf4e663_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtMTMtMS0xLTYwMjYz_eaded9e3-2411-41eb-b308-80640dc66cc7">183.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtMTUtMS0xLTYwMjYz_6362e37c-cc6b-4db0-ae47-df47735d57d1">2,684.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_73"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2022, 2021 and 2020</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:64.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMi0xLTEtMS02MDI2Mw_fd6da5fb-88c7-45bb-9cd6-f5678cb81178">585.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMi0zLTEtMS02MDI2Mw_5c7cbf08-6475-47fc-a8ea-200977bf6a60">661.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMi01LTEtMS02MDI2Mw_e1c20fcd-c852-42bc-9c6f-e2d0797f6f74">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNC0xLTEtMS02MDI2Mw_f78670f8-351a-48f1-a90d-e7d97bd4df74">116.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNC0zLTEtMS02MDI2Mw_99f5edcd-2fd6-4a2f-bf4a-a266faff57c2">116.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNC01LTEtMS02MDI2Mw_29b436e3-9cb4-4649-a300-34f26d68c150">104.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNS0xLTEtMS02MDI2Mw_123fa73b-daa2-4ef7-9ba4-dd9948cee777">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNS0zLTEtMS02MDI2Mw_3075b779-9587-42dd-a250-b16e35e1dac1">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNS01LTEtMS02MDI2Mw_024893be-cbc1-415f-bfe1-48eadee0c468">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNi0xLTEtMS02MDI2Mw_aff7953c-777c-4e79-b04b-36ab65a977d0">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNi0zLTEtMS02MDI2Mw_aa1c0cfc-2107-4c12-b389-2f58893ceb78">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNi01LTEtMS02MDI2Mw_4b2273c1-dd0d-4aaf-aac6-254e8912d948">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNy0xLTEtMS02MDI2Mw_efe2aaa1-18a4-4de3-9185-fb8f2d10ad1e">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNy0zLTEtMS02MDI2Mw_4f7558fe-784a-42a5-9cb6-de140241ed7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNy01LTEtMS02MDI2Mw_3a378ed8-e08f-4d14-ac74-dc93cf311490">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfOC0xLTEtMS02MDI2Mw_bab92364-48fc-4dd2-85c1-44f914a5aa1d">52.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfOC0zLTEtMS02MDI2Mw_6f18e42e-8bdf-4ee9-840d-ce73fe19c657">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfOC01LTEtMS02MDI2Mw_901029aa-a775-4af9-9210-501b2f294c71">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration payments in excess of acquisition-date liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTAtMS0xLTEtNjAyNjM_639e2ada-fa18-4238-915f-77b3ea6a9067">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTAtMy0xLTEtNjAyNjM_d5727b24-f740-4654-a9e6-59492b959f55">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTAtNS0xLTEtNjAyNjM_62f25357-b69e-4f55-b1fc-a5320a23ac9e">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed asset impairments and sale of equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTEtMS0xLTEtNjAyNjM_1a3dfbcc-1b37-4ecf-b863-69e151ee6ae9">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTEtMy0xLTEtNjAyNjM_38531072-f319-4e7b-a7bc-d22d71881ac3">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTEtNS0xLTEtNjAyNjM_1ca1e7fb-8baf-4b5a-8cfc-43f7f4bdbc70">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTItMS0xLTEtNjAyNjM_d5636950-3d53-47c5-9b75-842004128bf9">30.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTItMy0xLTEtNjAyNjM_caf58470-7f8d-49a3-b80d-cb53294846ca">42.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTItNS0xLTEtNjAyNjM_ef394fbf-2fde-46ca-8ea6-843b69c19e8e">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and other retirement plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="wst:PensionAndOtherPostretirementBenefitExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTMtMS0xLTEtNjAyNjM_568d89da-2595-4121-a6fa-bc34696e24f1">14.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="wst:PensionAndOtherPostretirementBenefitExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTMtMy0xLTEtNjAyNjM_87cd2ee8-40a3-4f00-88c5-673a9ad409ba">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="wst:PensionAndOtherPostretirementBenefitExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTMtNS0xLTEtNjAyNjM_bc86240c-78fe-4659-8a7e-713d0bcd31fb">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in undistributed earnings of affiliates, net of dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTQtMS0xLTEtNjAyNjM_c8c52095-1162-49f5-b2d2-28cbed030e7d">18.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTQtMy0xLTEtNjAyNjM_2e35386e-5206-427f-ac96-70ffcc60d7aa">17.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTQtNS0xLTEtNjAyNjM_31c62254-121b-419a-acdd-ddff22c58cf8">15.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTYtMS0xLTEtNjAyNjM_f3672c3e-4563-4155-ba61-cfea809794dd">35.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTYtMy0xLTEtNjAyNjM_73880cc8-46d5-4755-8ab6-c58c7c8bedd0">123.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTYtNS0xLTEtNjAyNjM_c38bb267-19f6-4eff-9910-b71f1b57700b">46.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTctMS0xLTEtNjAyNjM_4841230a-bb57-494b-8b13-5ed9f4b6fe16">49.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTctMy0xLTEtNjAyNjM_cd0b563e-0efa-4a99-9ae3-8d7d82595b0b">86.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTctNS0xLTEtNjAyNjM_8aadce02-3cf0-414a-98a2-56c0db933cf3">73.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Decrease (increase) in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTgtMS0xLTEtNjAyNjM_e6740913-e0bf-45d1-8e9f-d7263aab813b">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTgtMy0xLTEtNjAyNjM_35e122a1-768c-4141-a88c-030ddabe49b2">7.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTgtNS0xLTEtNjAyNjM_b7ada2b6-ec87-4eac-9d17-497ba2c993bd">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Decrease) increase in accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTktMS0xLTEtNjAyNjM_c448f181-fc84-4b3b-9d51-95c139cf96cf">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTktMy0xLTEtNjAyNjM_ff11a146-28a0-4fb8-8c4f-03beaa7f631c">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTktNS0xLTEtNjAyNjM_2a5ef8ff-81f0-4610-a02f-77473f33b0fa">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in other assets and liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjAtMS0xLTEtNjAyNjM_61287c03-8cbb-46fa-b946-510f6deda22d">58.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjAtMy0xLTEtNjAyNjM_b1c6133b-dc60-410a-819a-213d228c85e0">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjAtNS0xLTEtNjAyNjM_9ce64b6a-32b7-4d96-916a-13bab5a1ce9e">67.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjEtMS0xLTEtNjAyNjM_77e9f414-4e4d-4786-9a2a-9b645f96c58c">724.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjEtMy0xLTEtNjAyNjM_330e7cd3-9e05-4a95-99e5-f804b4a5b6f5">584.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjEtNS0xLTEtNjAyNjM_15adbf6c-d293-427a-9411-d4958b8e4019">472.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjMtMS0xLTEtNjAyNjM_a528de0c-ed61-4faf-88fe-9260d6cd90bc">284.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjMtMy0xLTEtNjAyNjM_b410cd96-5ba4-4f37-bd0f-e9cdd092cf8c">253.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjMtNS0xLTEtNjAyNjM_f7ec34e2-c467-4516-9a18-97a5b2b639a7">174.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjUtMS0xLTEtNjAyNjM_3e56a3c5-6edb-4125-beae-1415abe2a2f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjUtMy0xLTEtNjAyNjM_d778dd41-3def-4688-83e5-7716ecf0f11a">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjUtNS0xLTEtNjAyNjM_e054c6f3-6128-4585-9bb3-78ab07e8b80d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjktMS0xLTEtNjAyNjM_0cdd353a-f932-486f-b1c1-8a75d438adda">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjktMy0xLTEtNjAyNjM_785b17ae-3377-4d32-bad7-b22ebeb1168c">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjktNS0xLTEtNjAyNjM_e1857cd5-f5b5-427a-91bd-70176f61b706">5.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzAtMS0xLTEtNjAyNjM_6041042c-e85e-4793-90d2-904cd1d0004f">288.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzAtMy0xLTEtNjAyNjM_4ccaeae9-a721-4377-bade-d01af3669c82">253.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzAtNS0xLTEtNjAyNjM_d7371ad3-0b30-4de3-8245-043569f3bbf8">179.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt issuance cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzUtMS0xLTEtNjAyNjM_69832912-fe41-4016-b7b5-670d685fb21b">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzUtMy0xLTEtNjAyNjM_503606cd-4776-4272-b08c-7f53e8d8a9f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzUtNS0xLTEtNjAyNjM_e8384f8d-60b7-46d0-bc5e-f813184ead3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzYtMS0xLTEtNjAyNjM_887a1939-4483-4ea9-8e48-6855eac4af54">44.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzYtMy0xLTEtNjAyNjM_eb4b3e72-1d9a-4f88-8c26-e751996d4fa0">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzYtNS0xLTEtNjAyNjM_cdd61093-045e-4e83-958d-69aabf11003e">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividend payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzctMS0xLTEtNjAyNjM_12a9f147-d2fe-405a-a18f-00c29b739ddb">54.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzctMy0xLTEtNjAyNjM_c46345a4-9948-4d76-872f-13769c4447e0">51.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzctNS0xLTEtNjAyNjM_f3842542-e378-4426-830d-9d95a4e2469a">48.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from stock-based compensation awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzktMS0xLTEtNjAyNjM_18dca4a9-7056-4b2d-b3f2-34e833ece702">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzktMy0xLTEtNjAyNjM_d0670d6b-d817-4010-a9d5-bb87f4fc8db2">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzktNS0xLTEtNjAyNjM_513cef9a-f44c-49d3-b563-e05ff1ade98a">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDAtMS0xLTEtNjAyNjM_d6fef02a-d1a4-4dbf-baa6-666c7ea7c8b7">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDAtMy0xLTEtNjAyNjM_e6eea73d-a167-4fb3-a56b-7a1aca4f41dc">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDAtNS0xLTEtNjAyNjM_41a7d925-ad55-4743-bb63-200cffabf58c">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares purchased under share repurchase programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDEtMS0xLTEtNjAyNjM_44850f4a-106d-4f30-9931-f4f3491931c6">202.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDEtMy0xLTEtNjAyNjM_659b5bee-8201-480c-8496-979f11f7fc28">137.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDEtNS0xLTEtNjAyNjM_3e46d3af-a8e4-4545-acae-396436a7ae77">115.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares repurchased for employee tax withholdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDItMS0xLTEtNjAyNjM_060adf3f-634d-4434-9fc8-14200adb5de2">19.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDItMy0xLTEtNjAyNjM_78db419d-30f4-4b67-a6aa-dd08bfe8fa2b">14.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDItNS0xLTEtNjAyNjM_85488171-6d16-4ad1-9b72-4d5674a06381">5.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDMtMS0xLTEtNjAyNjM_6c251667-a847-4763-8ea9-d3262ef6ce59">293.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDMtMy0xLTEtNjAyNjM_8a08a8e5-79b9-40c0-812f-08e27abaaf53">168.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDMtNS0xLTEtNjAyNjM_2a684fb3-4d44-455e-b3f5-67cf220d662f">137.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rates on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDQtMS0xLTEtNjAyNjM_7b57cb91-1035-4125-a732-6af19853b6ee">10.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDQtMy0xLTEtNjAyNjM_ffed1606-dc49-445d-897b-f207030f551c">15.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDQtNS0xLTEtNjAyNjM_d1a58ef9-2617-498b-a927-b7358d816be4">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDUtMS0xLTEtNjAyNjM_cb298086-afde-4a11-941c-cfa4dbcd1436">131.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDUtMy0xLTEtNjAyNjM_fe2a33f9-7565-44f8-933f-b10f0dbf9985">147.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDUtNS0xLTEtNjAyNjM_1b59c4f1-62a8-46cb-a5db-ca558f1d5518">176.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, including cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDYtMS0xLTEtNjAyNjM_39dd7abc-9953-4fdf-826a-01e85b25fef1">762.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1165b131d689444eb6459290c85e0fec_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDYtMy0xLTEtNjAyNjM_25c3088b-b247-43f4-992d-4d1c296b18b0">615.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ff963c9c54045f29206b3189d452f9b_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDYtNS0xLTEtNjAyNjM_1ee33f90-67ac-4daa-9ffc-9df765283d9e">439.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, including cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDctMS0xLTEtNjAyNjM_bed94462-cc17-48d3-9df5-37af2d07ac30">894.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDctMy0xLTEtNjAyNjM_78e95bef-92c2-43aa-9a4a-97912da4f1f6">762.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1165b131d689444eb6459290c85e0fec_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDctNS0xLTEtNjAyNjM_2719ba27-1e30-4e8c-9dd2-544c41a11b50">615.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid, net of amounts capitalized</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTAtMS0xLTEtNjAyNjM_0b8450f2-5ce9-4e34-9ede-be07aa7482b0">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTAtMy0xLTEtNjAyNjM_320481ba-891e-442e-8eee-b43c00965100">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTAtNS0xLTEtNjAyNjM_cb4877db-59a3-4725-823e-311962b639b3">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes paid, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTEtMS0xLTEtNjAyNjM_e79746cc-8a1b-482c-82fd-30a4713c8c4d">109.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTEtMy0xLTEtNjAyNjM_86ba3007-8229-43f8-bc11-e4a1c3b5cef4">171.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTEtNS0xLTEtNjAyNjM_4a695de7-7f8b-4451-87c3-9a56e8cbeb9d">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued capital expenditures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTItMS0xLTEtNjAyNjM_efeec5c6-8961-4798-a4ce-0c2e1a7ae449">33.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTItMy0xLTEtNjAyNjM_a34fcece-a63d-49ec-bb92-29ca2fdcbbcc">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTItNS0xLTEtNjAyNjM_4b9a717f-f39d-4e8e-8924-19605115bc36">31.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared, not paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTMtMS0xLTEtNjAyNjM_e4f1da04-6bb2-4f99-8e6d-105e0a3cba4a">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTMtMy0xLTEtNjAyNjM_921d2ad4-50fc-4599-a434-144dbc069592">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1165b131d689444eb6459290c85e0fec_I20201231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTMtNS0xLTEtNjAyNjM_5f81b86a-4b78-4c48-8881-55cf2bf16d79">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNTk_40eec6d6-3f89-434a-bdff-bf7cde169586" continuedAt="ia9e74a7e29a44e62b3b81c95c9eb9995" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia9e74a7e29a44e62b3b81c95c9eb9995" continuedAt="i5a7543faa0654d47ae839684fd0361b3"><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNDM_de00cd0e-28e6-4661-b48d-73c109762b23" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The consolidated financial statements include the accounts of West Pharmaceutical Services, Inc. ("West") after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities.</span></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West has been actively monitoring the coronavirus (&#8220;COVID-19&#8221;) situation and its impact globally. Our production facilities continue to operate as they had prior to the COVID-19 pandemic, other than for enhanced safety measures intended to prevent the spread of the virus.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyODg_6a710ff1-512a-47e2-8bc0-676850bf749a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyOTc_02c8c5d8-e240-4636-89a2-0fd75755a3e3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash equivalents include time deposits, certificates of deposit and all highly liquid short-term instruments with maturities of three months or less at the time of purchase.</span></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzMzc_b68be3fb-b3fe-4381-922c-cee1d4d6b169" continuedAt="i641c4d5389cd4792afadf5f6f19d515b" escape="true">Accounts Receivable:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i641c4d5389cd4792afadf5f6f19d515b"> Our accounts receivable balance was net of an allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMjA2MQ_690cbc2f-8f6d-46a8-98e6-dad15e6863d8">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMjA2OA_bb884dff-a266-4cd1-ad00-1657660c64cf">0.4</ix:nonFraction> million at December&#160;31, 2022 and 2021, respectively. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzNjU_1a63ed46-b448-45be-b96c-4f07bc882f9b" continuedAt="i99e89a97d8b24852b2efe9499d8878e3" escape="true">Inventories:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i99e89a97d8b24852b2efe9499d8878e3"> Inventories are valued at the lower of cost (on a first-in, first-out basis) or net realizable value.</ix:continuation> The Company provides for cost adjustments for excess, obsolete or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyMzA_ec701153-ce71-49f2-94d2-af2421a92b34" continuedAt="i8c8487db671c412eb22f9e4bb0b8b57d" escape="true">The following is a summary of inventories at December 31:</ix:nonNumeric></span></div><div><ix:continuation id="i8c8487db671c412eb22f9e4bb0b8b57d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:68.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.875%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMS0xLTEtMS02MDI2Mw_c91f29f9-431a-4b84-80e0-6913f03f7ec5">170.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMS0zLTEtMS02MDI2Mw_bb2cc559-a428-4424-8331-ee98994054dd">153.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMi0xLTEtMS02MDI2Mw_818c4f87-1738-452f-af5a-aa26985ffa56">79.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMi0zLTEtMS02MDI2Mw_90390b2f-94a5-4be5-bf29-9e03f853918e">63.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMy0xLTEtMS02MDI2Mw_cc45cdfb-c931-44d3-994c-41d09b33b716">165.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMy0zLTEtMS02MDI2Mw_3a9f6213-ec0a-47c1-9920-0b3cd4fee89d">161.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfNC0xLTEtMS02MDI2Mw_28fdbb54-2365-4b3f-88ad-a360d44f22a2">414.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfNC0zLTEtMS02MDI2Mw_b8bf019d-6e8d-4aa0-9cf2-08d50a78f82a">378.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyODQ_e1558ab0-0e7e-41a8-895d-0cbc1129ea5f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other expense (income). Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.</span></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyODU_4dad5890-691f-45a0-a7e0-b2d90121522c" continuedAt="i466b59d9381b48b4b52860d056a045b9" escape="true">Leases: </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i466b59d9381b48b4b52860d056a045b9">Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.</ix:continuation> We had <ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfNDA2Nw_3dab0b40-534d-42f9-94bd-80f0d82b1a60"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfNDA2Nw_d736a153-a74e-4e71-bb7a-a4c1885069cc">no</ix:nonFraction></ix:nonFraction> finance leases as of December&#160;31, 2022 and 2021. Please refer to Note 6, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_94">Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5a7543faa0654d47ae839684fd0361b3" continuedAt="ie4eb45b08e274c0eb3a6d14a923b3aa6"><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyMzY_cd1984f3-f4bb-4192-a691-a1ca6dcea6e7" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzMDY_0984e4e6-a770-4f9f-95e6-0fafee9ffe07" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuing identifiable intangible assets requires judgment. For example, for recent identifiable customer relationship intangible asset acquisitions, we applied an excess earnings model, which is a form of the income approach. This approach includes projecting revenues and expenses attributable to the existing customers over the remaining economic life of the customer relationships and then subtracting the required return on net tangible assets and any intangible assets used in the business to estimate any residual excess earnings attributable to the customer relationships. The after-tax excess earnings are then discounted to present value using the respective discount rates. Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of <ix:nonNumeric contextRef="ieca2c70046774b70b2ca24e38603bd11_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfNjQ3Mg_a0ea1595-9686-403b-8174-e40a348d8ea7">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ibb415db0220846bbbaee31bca93b64e3_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfNjQ3OA_d2510ef9-cae2-41de-a098-f5388642c21d">25</ix:nonNumeric> years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. Factors that could trigger an impairment review include the following: 1) significant under-performance relative to historical or projected future operating results; 2) significant changes in the manner of use of the acquired assets or the strategy of the overall business; 3) significant negative industry or economic trends; and 4) recognition of goodwill impairment charges. If we determine that the carrying value of identifiable intangibles assets may not be recoverable based on the existence of one or more of the above indicators of impairment, we measure recoverability of assets by comparing the respective carrying value of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, we measure an impairment based on the amount in which the net carrying amount of the assets exceeds the fair values of the assets.</span></div></ix:nonNumeric><div><span><br/></span></div><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyMjM_93f2dc5f-b53e-48a5-8338-d1585acd8324" continuedAt="i98238ae67da343d2843eee28c3ed2861" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Benefits:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_121">Benefit Plans</a></span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i98238ae67da343d2843eee28c3ed2861">, for a more detailed discussion of our pension and other retirement plans.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie4eb45b08e274c0eb3a6d14a923b3aa6" continuedAt="i0f70258b15164ff39db85ca038a9fb4a"><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzNDQ_c4595592-2125-4565-9385-b05539a3d72b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#8217;s gain or loss is initially reported as a component of other comprehensive income (&#8220;OCI&#8221;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#8217;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNzQ_06988d4a-7771-4e1f-8846-d81731a8473c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.</span></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNTc_9894fc3a-aada-45e0-b5cc-5f24ad63f3b4" continuedAt="i75493b4ac97c4ce59ec2714a06662df8" escape="true">Revenue Recognition:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i75493b4ac97c4ce59ec2714a06662df8"> Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less. In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less.</ix:continuation> Please refer to Note 3, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_85">Revenue</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_85">,</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. </span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNTE_eb7cede9-f98d-4dd0-b99d-99e9bfe8b762" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.</span></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyODI_2a4feb7a-6eec-48ad-90e5-748dff881557" continuedAt="i72743e09eaa84f0bb21ed7ac7e1cd624" escape="true">Research and Development</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i72743e09eaa84f0bb21ed7ac7e1cd624">: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are primarily expensed as incurred.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:EnvironmentalCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzNDI_ac005ee8-dc13-489b-8568-62c37bc9fdd5" continuedAt="i5d306cb46b15495c89cfd6ecd19adf43" escape="true">Environmental Remediation and Compliance Costs</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5d306cb46b15495c89cfd6ecd19adf43">: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.</ix:continuation> </span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="wst:LegalMattersContingenciesAndLegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzMzQ_a67b6653-a9cc-4fcd-b9f6-b237f54882b1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.</span></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0f70258b15164ff39db85ca038a9fb4a"><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzNTM_215b4b43-0581-413e-abb4-a95c356d9596" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. Please refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_127">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other expense (income). The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.</span></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzNjA_dfd0a1d3-7488-4402-a668-c8a0bcbf4f70" continuedAt="ifb5bfd003d86492d9787c5b3135f9460" escape="true">Stock-Based Compensation</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifb5bfd003d86492d9787c5b3135f9460">: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model.</ix:continuation> Please refer to Note 14, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_118">Stock-Based Compensation</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a more detailed discussion of our stock-based compensation plans.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNDY_711351b5-43fa-4ea7-8658-7ec074ef4957" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.</span></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184Mi9mcmFnOjFiZTFkNjkyNDI5ZDQyNDViMTY2ZTJlNTcwN2MyNzM5L3RleHRyZWdpb246MWJlMWQ2OTI0MjlkNDI0NWIxNjZlMmU1NzA3YzI3MzlfMTcwNQ_44109f00-9152-4a2d-9237-f39a7e1f15c1" continuedAt="i77ecf59e8531404abe05040e1c4be14e" escape="true">New Accounting Standards</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i77ecf59e8531404abe05040e1c4be14e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Standards</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184Mi9mcmFnOjFiZTFkNjkyNDI5ZDQyNDViMTY2ZTJlNTcwN2MyNzM5L3RleHRyZWdpb246MWJlMWQ2OTI0MjlkNDI0NWIxNjZlMmU1NzA3YzI3MzlfMTY5NQ_c2589b87-9f2c-43cf-9e66-7aab172054c9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2021, the Financial Accounting Standards Board ("FASB") issued guidance that seeks to improve the transparency of financial disclosures for government assistance received by business entities. The amendment requires disclosures for transactions with a government accounted for by applying a grant or contribution accounting model by analogy, including (1) the types of transactions, (2) the accounting for those transactions, and (3) the effect of those transactions on an entity&#8217;s financial statements. This guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance as of January 1, 2022, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued guidance which provides optional expedients and exceptions to address the impact of reference rate reform where contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate need to be discontinued. This guidance was effective upon issuance and generally can be applied through December 31, 2022. We adopted this guidance during the year by executing amendments to certain contracts to replace the use of LIBOR. The adoption did not have a material impact on our financial statements.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfNTc1Mw_17a24ba9-e5f8-4197-aab5-9d47714f1cd2" continuedAt="i173db5c5470b4ca68fc770ed696b20fa" escape="true">Revenue</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i173db5c5470b4ca68fc770ed696b20fa" continuedAt="i22ace351e4364f0db03c770abee6d1d5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time, following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i22ace351e4364f0db03c770abee6d1d5" continuedAt="i25dc2f76bf9b4e0e84285c26659e1f02"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $<ix:nonFraction unitRef="usd" contextRef="ib455f8d389b84c90834d838d768dd859_I20130630" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfMTkyOQ_42957aae-b254-4e63-8215-b033d0149010">20.0</ix:nonFraction> million received in June 2013 in return for the exclusive use of the SmartDose&#174; technology platform within a specific therapeutic area. As of December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i530eb90eb2764a55bb62aac980b27711_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfMjE5OTAyMzI2MjEwMg_135fba3c-d015-42b3-9143-d161a54467cb">3.0</ix:nonFraction> million of deferred income related to this payment, of which $<ix:nonFraction unitRef="usd" contextRef="i530eb90eb2764a55bb62aac980b27711_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfMjE5OTAyMzI2MjA4OQ_8986b8d5-72cc-439e-a38d-ec2bde945295">0.9</ix:nonFraction> million was included in other current liabilities and $<ix:nonFraction unitRef="usd" contextRef="i530eb90eb2764a55bb62aac980b27711_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfMjE5OTAyMzI2MjA5NQ_cfa93440-3cef-49c8-8da6-f0fb0791e942">2.1</ix:nonFraction> million was included in other long-term liabilities. The deferred income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfNTc1MA_9990c319-de09-4d77-88c1-2f377984c6a4" continuedAt="ia4aad2cdbb734e8899604431d6e2d087" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by market group:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i79c8219373a3404aaf82ead0cda46716_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMS0xLTEtMS02MDI2Mw_d173e432-306a-4953-8444-0f01a58df36f">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i609b68bdcb584f1fa5a8970ccd1759d3_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMS0zLTEtMS02MDI2Mw_8f461743-242b-4b8f-83a8-d02c3afdba1d">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ff1421dfabb4931b5d3f165e4fa608f_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMS01LTEtMS02MDI2Mw_46604bc5-9e79-4f28-a611-4866b02eef23">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d95a90ba942409fb7eb38c53be370cb_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMi0xLTEtMS02MDI2Mw_98e2bd9a-c1ef-4a82-b3ea-f1620df2adbf">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i665253b4d08e4da599894b62da126263_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMi0zLTEtMS02MDI2Mw_4a187e69-f31a-42ed-adb6-edfe9968f659">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic40393e675034834a4cb5d8ffa391e4c_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMi01LTEtMS02MDI2Mw_68ac9074-fe52-4bcb-ba29-bb7a35838b46">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97e639bd58654edeb8611e423238d72e_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMy0xLTEtMS02MDI2Mw_222080b8-bfef-42e2-84a3-f55074eb44d7">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7fa94e736dee414db6421d8880cc2422_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMy0zLTEtMS02MDI2Mw_52753e62-2d0d-4123-acc2-4018671aaf88">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if045da1a86684296aa4c33ad55d60c95_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMy01LTEtMS02MDI2Mw_10125750-9a3a-4cf2-92cf-030675fb9adb">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if7066b92c5e54bc79943066fb6034c7c_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNC0xLTEtMS02MDI2Mw_e99ebfeb-8ae3-4d36-979b-836579d7ab16">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51e337fbb71345fca552db98bf16e460_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNC0zLTEtMS02MDI2Mw_5202d0a8-ceb4-43e3-bb25-1efe2f972285">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i452ba88776d94afb84fbc1b35bcbcd24_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNC01LTEtMS02MDI2Mw_c342bf7a-0c59-41e3-a865-d8f4e7a6a940">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNS0xLTEtMS02MDI2Mw_2e2ef74a-7cbc-4de8-96db-55eccc17cc62">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNS0zLTEtMS02MDI2Mw_2b38c6e1-beaf-473b-9bd6-092f41f7d1b7">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNS01LTEtMS02MDI2Mw_21a89dce-05b8-43b8-ab6c-746342ab4689">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by product category: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Components</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic134acff31094622a91b3143a0e96cd0_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMS0xLTEtMS02MDI2Mw_d3dd203c-cf97-4942-bb24-294482d2c6d7">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia177439c331047b2ab87726450ce39bb_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMS0zLTEtMS02MDI2Mw_95cf1c19-22cb-471a-a305-6c8182d5897a">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i256eab0010ac4440b58c5fa97329532a_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMS01LTEtMS02MDI2Mw_0375193b-ae2a-4fd4-ac53-76c71ea4519c">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Delivery Devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifc55026ca0ea4cd4b78b9007129033b8_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMi0xLTEtMS02MDI2Mw_3120926a-44ed-42d2-8593-fd3bc41a15ba">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i838a650038204c9eafed9990f5a9ee16_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMi0zLTEtMS02MDI2Mw_49dfa752-b75c-4b92-b32a-0114b77ee887">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7120c4b931d4e48b07cf29f80d2b1cb_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMi01LTEtMS02MDI2Mw_7980e550-5b35-42d3-a681-c0e2dfee5a1d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard Packaging </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe73169f2a304e4b8511b7c7f5ca3ea2_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMy0xLTEtMS02MDI2Mw_69cfa500-5021-442e-826d-d8699932fe83">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1c945b9d9124755884c9318597648c1_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMy0zLTEtMS02MDI2Mw_d77747b5-bec3-4193-a8df-cc965e1176c6">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8da7f757b5d415e896679c642747d6e_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMy01LTEtMS02MDI2Mw_cb6bf1c9-b628-4e05-9380-9373a60ec227">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f44138370e044a39010d4f60177210d_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNC0xLTEtMS02MDI2Mw_03fb7254-6786-43eb-b831-fc216ecaec51">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb8186699d064e74a59fc5b34eed6c40_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNC0zLTEtMS02MDI2Mw_ea0e9de2-f251-4581-9b1d-acc1e04bd29c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0faf4f9784a94f7aa7354566da3204c3_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNC01LTEtMS02MDI2Mw_3919fafa-42e3-4547-b8f1-54cac92eb085">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNS0xLTEtMS02MDI2Mw_826024a8-9dda-4395-8d64-63f68d95b418">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNS0zLTEtMS02MDI2Mw_09f51e2e-1c03-46e0-b28e-91eb831e2a03">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNS01LTEtMS02MDI2Mw_10175688-7e68-49c0-9425-717fa7d04be9">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i25dc2f76bf9b4e0e84285c26659e1f02" continuedAt="if56d06670955432882543d4a4d437280"><ix:continuation id="ia4aad2cdbb734e8899604431d6e2d087"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by geographic location: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.708%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.708%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.712%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic35adedcc7f44b1b9c0fe04681478c95_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMS0xLTEtMS02MDI2Mw_a8365e5a-0b7d-4598-8550-b5627f34d43f">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if6651efd4f764b48adb48d2620a076d6_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMS0zLTEtMS02MDI2Mw_826cb741-7f25-4c1a-9a44-56fde729010b">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1147923590ae4023add6d186c7abf72f_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMS01LTEtMS02MDI2Mw_9580eb5a-00c2-499c-9f46-4de4b23e5b07">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f618571d5fc44b591d452151b7e1075_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMi0xLTEtMS02MDI2Mw_ec543c0b-da23-4e81-b38c-070aead721f4">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica414868e28c41ee9837e7414f82083d_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMi0zLTEtMS02MDI2Mw_7d4f723a-a7a6-4f35-9e56-0ac081c7e202">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica6ef1a0769a4e648ec274538fd0bbea_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMi01LTEtMS02MDI2Mw_4b4d062b-7f0a-4af6-bbc9-d5a9f7beee39">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i057ed2a2629447fe8340db3a494eaafd_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMy0xLTEtMS02MDI2Mw_6017a576-894a-405b-8181-4dbfb8c0a3b8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if7ac37da416447fdb298621d726f8906_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMy0zLTEtMS02MDI2Mw_913e86fc-c362-4ddf-8406-9756c5b5c675">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia45b0766113a446a94c89d02189621ed_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMy01LTEtMS02MDI2Mw_e7a15b26-dc31-4358-81d4-7f0a27d1d5bb">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfNC0xLTEtMS02MDI2Mw_72f6a40d-1ea7-424a-b704-53c07a0f01f5">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfNC0zLTEtMS02MDI2Mw_37888031-9dae-4f7e-890d-e70f561982a0">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfNC01LTEtMS02MDI2Mw_40c30d95-a58a-4cae-9df1-22b700bc6c1e">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets and liabilities result from transactions with revenue primarily recorded over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet within other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfNTc1Mg_af62cefb-c7d4-40e0-b13e-c2c80adeb813" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets and liabilities, excluding amounts included in accounts receivable, net:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:83.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfMS0xLTEtMS02MDI2Mw_0fdc13ad-ba7f-4e22-b23f-12528db26c7a">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2022</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfMi0xLTEtMS02MDI2Mw_9039d9d2-02cf-478a-9c5f-b2b31cb61673">16.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contract assets - increase (decrease)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="wst:ContractWithCustomerAssetIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfMy0xLTEtMS02MDI2Mw_aa89347d-7699-47ca-a590-e4a69553ebc4">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfNS0xLTEtMS02MDI2Mw_250030f8-89a8-4a15-b724-fe16ddc9f912">61.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2022</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfNi0xLTEtMS02MDI2Mw_019ccf8c-c6dc-41d0-b0a1-8f4437c049b7">68.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred income - (increase) decrease</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfNy0xLTEtMS02MDI2Mw_13157613-3265-4abd-8b24-cc622ecd54d4">6.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="if56d06670955432882543d4a4d437280">Contract assets are included within other current assets and deferred income is included within other current liabilities and other long-term liabilities. The increase in deferred income during 2022 was primarily due to additional cash payments of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfNTQ5NzU1ODIxNDc0_6f67e586-5fe3-4f6a-bcc4-4462f208a57e">88.3</ix:nonFraction> million received in advance of satisfying future performance obligations, partially offset by the recognition of current year revenue of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="wst:ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfNTQ5NzU1ODIxNDgx_313c0f70-4bb6-4c1e-901f-21f9538e2eb5">54.2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfMjE5OTAyMzI2MjgwMQ_247990e9-06df-40d8-8e6b-86e66db6a253">28.0</ix:nonFraction>&#160;million of revenue was recognized that was included in deferred income at the beginning of the year.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_88"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMTQyMA_ff9a1568-0e39-4864-8976-410e46433772" continuedAt="i9c3af7790c52481696a0cc1aa6757395" escape="true">Net Income Per Share</ix:nonNumeric></span></div><ix:continuation id="i9c3af7790c52481696a0cc1aa6757395" continuedAt="i930890de50a740289329b7d8a4e0e8d3"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMTQyNw_be987646-fd7e-406e-9688-24452fa8ef94" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMS0xLTEtMS02MDI2Mw_2444aaff-efc2-48d5-b766-393fe624f199">585.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMS0zLTEtMS02MDI2Mw_77d23912-3c84-431b-bad4-6aa521fa08e9">661.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMS01LTEtMS02MDI2Mw_a06bcbc5-284c-46c2-b8a5-28c5c2087ec8">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMi0xLTEtMS02MDI2Mw_ebb3ea10-d5d7-4874-ae5a-943c3d97a212">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMi0zLTEtMS02MDI2Mw_5c842602-0aa3-4ee7-b751-4841e3fda6f7">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMi01LTEtMS02MDI2Mw_1ff0f1f0-da18-4b77-899c-acd58d347925">73.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMy0xLTEtMS02MDI2Mw_48c7c857-ea14-40db-a933-411fe450f521">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMy0zLTEtMS02MDI2Mw_776476ed-7cf4-490e-9283-41ab3dc40d82">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMy01LTEtMS02MDI2Mw_4d05d16c-748f-4eb4-bc8f-741562de2991">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfNS0xLTEtMS02MDI2Mw_76d336d1-b605-446e-8dbb-276754254ff2">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfNS0zLTEtMS02MDI2Mw_0275229d-5420-4325-a865-3798ebd36ed5">76.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfNS01LTEtMS02MDI2Mw_ad3a38a0-fe43-4979-b008-3dfa055436ac">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i930890de50a740289329b7d8a4e0e8d3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021 and 2020, there were <ix:nonFraction unitRef="shares" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE1_47655efb-668c-426a-9d45-8c4498d6f5d9">0.2</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE5_6cbadc5a-b8f2-4669-8870-3dfb079c4e9d">0.0 million</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjI3_c8a2fd5d-1d18-4eab-9715-52c681306f20">0.0 million</ix:nonFraction> shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2021, we announced a share repurchase program for calendar-year 2022 authorizing the repurchase of up to <ix:nonFraction unitRef="shares" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="INF" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfNTA4_aa2e90b4-c0a9-4d24-8930-1c638256c91c">650,000</ix:nonFraction> shares of our common stock from time to time on the open market or in privately-negotiated transactions. There were <ix:nonFraction unitRef="shares" contextRef="i93cc0075175a4ee886a144fc0fad49b2_D20221001-20221231" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfNjcx_47e10520-9fe2-4f5b-9461-c7ceedbe4706">no</ix:nonFraction> shares purchased during the three months ended December 31, 2022. During the year ended December 31, 2022, we purchased <ix:nonFraction unitRef="shares" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE5OTAyMzI1NzUzOA_3d77feaa-c7d3-4bc8-b270-62635f2b8b7a">563,334</ix:nonFraction> shares of our common stock under the now completed program at a cost of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE5OTAyMzI1NzU0Mg_3a0b7096-56e4-4e5c-94ab-d7cb4120cee1">202.8</ix:nonFraction> million, or an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE5OTAyMzI1NzU0OA_05e3da1a-3a3b-485a-b472-e05e2a3f8cd7">360.03</ix:nonFraction> per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2023, the Board of Directors approved a share repurchase program under which we may repurchase up to $<ix:nonFraction unitRef="shares" contextRef="i5259b4fec7824128bebbc2321b046a0f_I20230221" decimals="-8" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE5OTAyMzI1Nzc4Mw_d3f5f17d-2174-482d-a4ad-4b71ff35492d">1.0</ix:nonFraction>&#160;billion in shares of common stock. The share repurchase program does not have an expiration date under which we may repurchase common stock on the open market or in privately-negotiated transactions. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions.</span></div></ix:continuation><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5:  <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfNTUx_8f201bab-049b-4447-82e9-db7229632d79" continuedAt="i77bef25d1de84c808b4c411a1dd115ba" escape="true">Property, Plant and Equipment</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i77bef25d1de84c808b4c411a1dd115ba"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfNTUw_7b9bb7fb-90fd-472c-9200-c9631089700b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of gross property, plant and equipment at December 31 is presented in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected useful lives (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib525a96790ee419f9313dd7892b7b3dd_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMS0zLTEtMS02MDI2Mw_c240af8d-7d18-46b6-8666-ff8c43d82f2a">29.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b995d9f735c49ffaf75d044a0c03b66_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMS01LTEtMS02MDI2Mw_526f4f79-e9b9-4ec0-8e40-04cd061ee97e">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9ad88a83c00d41a9803dfa1fd8846d50_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMi0xLTEtMS02MDI2My90ZXh0cmVnaW9uOjk4OWNiZjhlZmYyODQzMjM4NGZjMjc1ZGQ1ZjA0NWY5XzQ_784f9267-6134-4698-bcc2-4de642bf3474">15</ix:nonNumeric>-<ix:nonNumeric contextRef="id6dfe8c8214549d598f7663164c534f1_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMi0xLTEtMS02MDI2My90ZXh0cmVnaW9uOjk4OWNiZjhlZmYyODQzMjM4NGZjMjc1ZGQ1ZjA0NWY5Xzc_22953641-9bd1-4da6-83de-8b3b738f73aa">35</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57893ac1e0eb4f4f94c5d5b585544e57_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMi0zLTEtMS02MDI2Mw_9410276a-8881-407e-b1d6-784fd54567a2">663.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i867bfde87f4d49c6aa3b2e198dd30265_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMi01LTEtMS02MDI2Mw_31476866-ef62-4027-9874-45e98656b22e">644.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9bad476918442d094a0b53fc624ea6b_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMy0xLTEtMS02MDI2My90ZXh0cmVnaW9uOjU4MDFiOTBlYWNkYzQxZGQ5NzVhMDkxNTkyNTI3MTE0XzQ_e3d86c31-d0b4-4881-ac2c-778950df0dea">5</ix:nonNumeric>-<ix:nonNumeric contextRef="i1c3b02cc69744d1c81a95c04444728f3_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMy0xLTEtMS02MDI2My90ZXh0cmVnaW9uOjU4MDFiOTBlYWNkYzQxZGQ5NzVhMDkxNTkyNTI3MTE0Xzc_67c02208-ce8c-4c74-8581-7ffdc73e0426">12</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1e4b02c23d40809d6f4748ba485f04_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMy0zLTEtMS02MDI2Mw_ac4842de-c567-455c-87c6-32285be46ecb">1,039.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cae435921ec4feeb1ccbe93403e73e3_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMy01LTEtMS02MDI2Mw_fb7724fa-dd09-4156-a54b-42e91141cbbf">976.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds and dies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2fe30bc7c27942be8f272d9013b321b8_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNC0xLTEtMS02MDI2My90ZXh0cmVnaW9uOmRmYTNlODdjYjk0OTRmMTA5YmVhMDNkOGM4YWU2YTFkXzQ_7924bb1e-5052-418c-b6bd-2271b1983f3c">4</ix:nonNumeric>-<ix:nonNumeric contextRef="ia6c9307eae344809bc9eb362136f13b5_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNC0xLTEtMS02MDI2My90ZXh0cmVnaW9uOmRmYTNlODdjYjk0OTRmMTA5YmVhMDNkOGM4YWU2YTFkXzc_ebc275bb-b844-4122-b27e-b5e4339a1add">7</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6387f13194fa4168b18b7acddc8a7e66_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNC0zLTEtMS02MDI2Mw_d4c92a73-c22b-4824-9c5c-272e3e71d936">154.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12cc38a53bbb4b5dab6d38a174b78556_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNC01LTEtMS02MDI2Mw_fc2443c9-499e-4441-a792-241ff96fe24c">139.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if85a0ce5a6b94dad8023eed11fefec57_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNS0xLTEtMS02MDI2My90ZXh0cmVnaW9uOmU5YjVjYWM0YTMzNjRhYTU4NWQ3MmY0NmY4NDY3MGE2XzQ_15a5c0af-0ec1-4b32-bdb4-d9aee8b22359">3</ix:nonNumeric>-<ix:nonNumeric contextRef="i1b1026f47645465da8f39a740c77972a_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNS0xLTEtMS02MDI2My90ZXh0cmVnaW9uOmU5YjVjYWM0YTMzNjRhYTU4NWQ3MmY0NmY4NDY3MGE2Xzc_cd72eae1-f9de-4a21-b607-5670df7e7cca">10</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic052515f57af407a9c8ee85f261cca28_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNS0zLTEtMS02MDI2Mw_d00f2177-2bdb-4ee4-934f-5b624b5dd7ff">193.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90934a86885b435589f1b238bebbd8de_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNS01LTEtMS02MDI2Mw_2f14b988-2b31-4aa2-9f41-c352a90ecb08">182.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i392eaf9fb1b54a2e84e87ce96d573162_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNi0zLTEtMS02MDI2Mw_2d43ea6f-2214-4648-9509-5b2e3f0cf832">305.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a3acb1630d4d42961464184cf42df9_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNi01LTEtMS02MDI2Mw_1cf6a594-d6c2-4896-a8d7-af03763f4464">242.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNy0zLTEtMS02MDI2Mw_49e2f6b9-b617-45d1-8aaf-57b5ec1ad95b">2,386.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNy01LTEtMS02MDI2Mw_8a904b0e-ea1a-4575-9c21-45a7c912cc47">2,215.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfMjA4_287db232-681e-4c23-a691-ce35e81463a0">116.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfMjEy_b84b6434-1389-4c0f-879b-538153ee6421">116.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfMjE5_a8902f4c-2583-448b-b13f-19b87cd4a6fd">104.7</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest on borrowings during the active construction period of major capital projects. Capitalized interest is added to the cost of the underlying assets and is amortized over the useful lives of the assets. Capitalized interest for the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfNTIw_bd57703a-c833-4dbd-a891-0ed2b3a3ad1d">3.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfNTI0_c5b4de93-69d4-4dab-9dc2-8e16162dd86b">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfNTMx_8dae0194-1c24-461a-91b6-5c16922aefc9">1.4</ix:nonFraction> million, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6:  <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNDU1Mg_f4829b49-fb51-4b86-a04e-dcc632f41382" continuedAt="i7e7ab83f5261476fb266190d6fb20af1" escape="true">Leases</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7e7ab83f5261476fb266190d6fb20af1" continuedAt="iac9d6b48231a44a1b4869ceb6125c292"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases provide us with an option, exercisable at our sole discretion, to terminate the lease or extend the lease term for <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="wst:LesseeOperatingLeaseOptionToTerminateTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNjk1_95b09907-ad25-45c9-8d7e-07d5370a8c33">one year</ix:nonNumeric> or more. At this time, the Company is not able to assert whether any of these options will be exercised. We had <ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfODEw_3bcf5a27-49b2-41b5-b652-786ed7267c06"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfODEw_89dd71bc-f671-43ae-a45e-4057e4a62e74">no</ix:nonFraction></ix:nonFraction> finance leases as of December&#160;31, 2022 and 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iac9d6b48231a44a1b4869ceb6125c292" continuedAt="i22120cb6fa494bfa9c50dfd6295d1058"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNDU1Mw_f485950d-61fe-48e8-b50d-e81b1772ea45" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMS0xLTEtMS02MDI2Mw_2b254a86-f285-40e3-8189-013c70ff85af">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMS0zLTEtMS02MDI2Mw_c48b6831-aeaf-4eed-a95a-422968e5498f">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMS01LTEtMS02MDI2Mw_5d7037a2-9cd7-4846-ac0e-3801065a6de1">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMi0xLTEtMS02MDI2Mw_2a082607-855a-47e0-b5eb-c9a1ed0fda47">1.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMi0zLTEtMS02MDI2Mw_68e28a66-e9bc-4d42-b32b-0540831be5fe">1.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMi01LTEtMS02MDI2Mw_e35cd381-27e6-43de-8490-3bfe11de4469">0.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMy0xLTEtMS02MDI2Mw_202e0927-270a-4f42-ab50-ac5b0ab7d8d6">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMy0zLTEtMS02MDI2Mw_61c00cef-07c6-43d6-be3b-311f47235723">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMy01LTEtMS02MDI2Mw_54240934-e3f0-44b5-a1ee-4cce9c3f6f0b">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfNC0xLTEtMS02MDI2Mw_1659f139-98ed-418f-887c-5e816ff49f8c">23.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfNC0zLTEtMS02MDI2Mw_0209409d-5418-4a0f-b538-eb22b2392d0d">18.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfNC01LTEtMS02MDI2Mw_4ce66099-e183-451e-ada3-a970d77b6743">17.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNDU1NA_c246c6ab-15dc-48a0-9b12-d605952de778" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:64.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfMi0xLTEtMS02MDI2Mw_9bbac164-db5e-4d73-855f-96c81ccf9763">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfMi0zLTEtMS02MDI2Mw_53fb6a8b-8dc0-4a4e-9f3c-efbb6a124e2f">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfMi01LTEtMS02MDI2Mw_d4112fc0-09a3-4d5b-ab2a-fa666e05ab46">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfNC0xLTEtMS02MDI2Mw_bad9e350-ae45-40ed-a79b-b1d27c680ca2">47.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfNC0zLTEtMS02MDI2Mw_526b728d-4ec5-48fd-b7eb-d3c6f16183b1">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfNC01LTEtMS02MDI2Mw_ce908111-31b2-437c-b6f2-7ce2a59bec54">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and December&#160;31, 2021, the weighted average remaining lease term for operating leases was <ix:nonNumeric contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfMzg1Mg_031e14c8-e169-499b-870b-9563013cd8f1">9.31</ix:nonNumeric> years and <ix:nonNumeric contextRef="i635169c6599a4431a7816915bd315902_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfMzg2NQ_a8ab9fab-2042-43ba-8e40-8ac003799eeb">10.7</ix:nonNumeric> years and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfMzkxNw_4ab84230-3a42-40eb-a624-2a9a33bc1f68">3.25</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfMzkyNA_c4521921-9df4-42a2-8fa7-7cf7367910c6">3.58</ix:nonFraction>%, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNDU1NQ_d13110ef-1ac7-4fa8-a8f2-80253da6c703" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfMi0xLTEtMS02MDI2Mw_77be45aa-54a8-4c57-8457-a4f51185444b">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfMy0xLTEtMS02MDI2Mw_fc5aa80b-2203-4b8b-8d83-6f67556030eb">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfNC0xLTEtMS02MDI2Mw_8ef319d4-0c31-4ff0-b9a2-cf65a38afa4c">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfNS0xLTEtMS02MDI2Mw_72499332-1e8f-4f8c-9b5d-fe6a4ee9c1e7">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfNi0xLTEtMS02MDI2Mw_2024acd5-753e-4a9b-8b05-d64ac2f1163f">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfNy0xLTEtMS02MDI2Mw_330d427d-db9d-467d-b9ce-55e244f4840d">50.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfOC0xLTEtMS02MDI2Mw_fabaa885-715f-4c55-9bed-1542f4324aed">126.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfOS0xLTEtMS02MDI2Mw_36aabffe-39cb-479c-959a-845b3f5b1374">17.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfMTAtMS0xLTEtNjAyNjM_b119c6cf-1e12-4efc-9382-22c121d1ad06">109.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i22120cb6fa494bfa9c50dfd6295d1058"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to adopt practical expedients around the combination of lease and non-lease components and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of <ix:nonNumeric contextRef="i5a0b48beb7be4ec38b7f1e3807bb5fc1_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNDQzNQ_6ab610e2-04ce-444a-9b64-9523cee0c5f6">12</ix:nonNumeric> months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.</span></div></ix:continuation><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7:  <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTk1Mw_8615dd4e-5b42-4040-a5f4-d1c67f28147a" continuedAt="i7e2d8a13938d4782bd302a2e8670cd31" escape="true">Affiliated Companies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7e2d8a13938d4782bd302a2e8670cd31"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTk1Ng_881d6876-cb63-4de2-b201-e03f6715781f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the following affiliated companies were accounted for under the equity method:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The West Company Mexico, S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83da5dac2d5b4be8a4e3cf6b667f2e1c_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RhYmxlOjI0NzZjZDMzMzhkYTQwOWRhNjQxYTNlODMwZWE5Yjc3L3RhYmxlcmFuZ2U6MjQ3NmNkMzMzOGRhNDA5ZGE2NDFhM2U4MzBlYTliNzdfMS0yLTEtMS02MDI2Mw_034aeff5-2091-4c3e-8bd5-0ee4cd1fd57f">49</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aluplast S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03c15e3f82e14b2d8ea127a9ace71de2_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RhYmxlOjI0NzZjZDMzMzhkYTQwOWRhNjQxYTNlODMwZWE5Yjc3L3RhYmxlcmFuZ2U6MjQ3NmNkMzMzOGRhNDA5ZGE2NDFhM2U4MzBlYTliNzdfMi0yLTEtMS02MDI2Mw_4421ac54-3440-4a16-a4ab-8858016df4e8">49</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Tap S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id72e5e9a20f24e66a90f5ff4e835e57a_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RhYmxlOjI0NzZjZDMzMzhkYTQwOWRhNjQxYTNlODMwZWE5Yjc3L3RhYmxlcmFuZ2U6MjQ3NmNkMzMzOGRhNDA5ZGE2NDFhM2U4MzBlYTliNzdfMy0yLTEtMS02MDI2Mw_d3b3c864-2708-4638-b26e-881eb17e152d">49</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Rubber S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3173295a48a4425dafd024e4bcaea4d0_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RhYmxlOjI0NzZjZDMzMzhkYTQwOWRhNjQxYTNlODMwZWE5Yjc3L3RhYmxlcmFuZ2U6MjQ3NmNkMzMzOGRhNDA5ZGE2NDFhM2U4MzBlYTliNzdfNC0yLTEtMS02MDI2Mw_bc94ebbc-1ac8-4305-8edf-6a3be60af47b">49</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daikyo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie0e46db508ae452ea86af0980f1d1e00_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RhYmxlOjI0NzZjZDMzMzhkYTQwOWRhNjQxYTNlODMwZWE5Yjc3L3RhYmxlcmFuZ2U6MjQ3NmNkMzMzOGRhNDA5ZGE2NDFhM2U4MzBlYTliNzdfNS0yLTEtMS02MDI2Mw_ba3f5938-9492-46ea-9724-02d39d5e392c">49</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unremitted income of affiliated companies included in consolidated retained earnings amounted to $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNDg0_5d599fc3-ab0c-4d00-9c32-b08101ed4db4">133.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNDg4_0daaf56c-3561-47e3-affc-47a46bee64e0">115.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1165b131d689444eb6459290c85e0fec_I20201231" decimals="-5" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNDk1_54998a8e-fd94-436f-ae50-5a9e872915db">98.2</ix:nonFraction> million at December&#160;31, 2022, 2021 and 2020, respectively. Dividends received from affiliated companies were $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNTgw_7e99cd18-d93f-42cb-b2b2-d830aec2ead3">2.6</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNTkw_1e0123bb-bb4f-46f4-863b-291f2f70c209">2.7</ix:nonFraction> million in 2021 and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNjAz_48c6cd0d-f697-4d42-803e-c0c0f59d9f63">1.6</ix:nonFraction> million in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity in net unrealized gains of Daikyo&#8217;s investment securities and derivative instruments, as well as pension adjustments, included in accumulated other comprehensive loss was $<ix:nonFraction unitRef="usd" contextRef="ie0e46db508ae452ea86af0980f1d1e00_I20221231" decimals="-5" name="wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNzk2_60f9c182-c711-45dc-9838-f6bef709b36f">1.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ifd70574b39b442a999ec4c558f63a4fb_I20211231" decimals="-5" name="wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfODAw_87b9e08c-fdd1-470c-b53e-b6234cdb8656">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i93d6a4a1140d4a819a08655c97b0030c_I20201231" decimals="-5" name="wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfODA3_8cf5e025-c4cf-4be7-9fb0-f97b94bd0b58">0.6</ix:nonFraction> million at December&#160;31, 2022, 2021 and 2020, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases from, and royalty payments made to, affiliates totaled $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfOTE2_b89d8fc6-9ced-4924-af33-699f592bf86b">167.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfOTIw_5cef63b8-289a-4db1-ad50-f146149f8fd5">155.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfOTI3_d8389268-a787-42d2-98f0-0e72d8eebcb8">143.3</ix:nonFraction> million, respectively, in 2022, 2021 and 2020, of which $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfOTcy_3b9cda32-bf62-4230-9f09-b8257325aacd">31.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfOTc5_0293d891-d757-4966-bb6e-36debb7192d4">25.5</ix:nonFraction> million was due and payable as of December&#160;31, 2022 and 2021, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="wst:SalesToEquityMethodInvestees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTIwMA_50ed50d5-db6f-484d-91d9-59d9f50e8653">14.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="wst:SalesToEquityMethodInvestees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTIwNA_b182e0e0-7312-47eb-ad7c-b56e184e8e1e">12.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="wst:SalesToEquityMethodInvestees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTIxMQ_4f45ab8a-8c25-43c2-b1fe-79a1385688bd">9.7</ix:nonFraction> million, respectively, in 2022, 2021 and 2020, of which $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DueFromAffiliates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTI1Ng_2ee6abdd-6d7d-4a72-9266-bb0446505681">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DueFromAffiliates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTI2Mw_cc48cb1c-da22-441c-b510-5bfd25395d00">2.3</ix:nonFraction> million was receivable as of December&#160;31, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTQ1MA_eda71417-b7a7-44c8-84ac-dfc853a68452">197.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTQ1Nw_24ea57ad-5bd3-4e25-a7cc-26223e4b8796">201.2</ix:nonFraction> million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTYwNg_e7c33eff-23be-4a6d-b9b7-f9bbf910a189">7.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTYxMw_17d36e9a-0dd5-48e9-8cf0-5834f1d9590c">6.5</ix:nonFraction> million, respectively. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_100"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8:  <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY3Ng_5c315420-57b5-4f3c-9884-7aeae4d4ae45" continuedAt="i40638b3fa0cb4bc2adda081bf0213031" escape="true">Goodwill and Intangible Assets</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i40638b3fa0cb4bc2adda081bf0213031" continuedAt="i43f780212dea483ea4443c9019afdff2"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY4NQ_31bb2319-9a38-4288-b19c-16a7c293ded8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill by reportable segment were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1316e29c4d1347d282b020769df84fb7_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzEtMS0xLTEtNjAyNjM_d15b2288-81a1-48d6-8c0e-d329051656c7">80.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c63b8503e64ef7aecc45e4839041ee_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzEtMy0xLTEtNjAyNjM_af03b307-f78b-4392-a365-3a53b400d814">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1165b131d689444eb6459290c85e0fec_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzEtNS0xLTEtNjAyNjM_24852907-0cfd-4636-ae24-4d4b8bd0e885">111.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill recorded due to acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c26cc49e6104694b627031996fac9f2_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzItMS0xLTEtNjAyNjM_3881e9f0-3d7f-402b-a175-5c5c6db3559f">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f533fa13e604ceb9279ba3b5b3ac9c4_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzItMy0xLTEtNjAyNjM_7c183f52-ba5f-4a1a-a60f-e744516be6fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzItNS0xLTEtNjAyNjM_d353d8f4-5df9-4ad7-b37d-fa178dc391e9">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c26cc49e6104694b627031996fac9f2_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtMS0xLTEtNjE4ODc_231bcd3b-cb3b-4b68-9a55-57b5fd2abf87">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f533fa13e604ceb9279ba3b5b3ac9c4_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtMy0xLTEtNjE5MjE_7f115319-5414-4b32-9894-0ad64c2d6842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtNS0xLTEtNzA2Mzc_c882eb1f-e503-4a76-aeb3-74bb65c67650">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c26cc49e6104694b627031996fac9f2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtMS0xLTEtNjAyNjM_927b3dba-9ed6-4177-ac23-ff0446290500">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f533fa13e604ceb9279ba3b5b3ac9c4_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtMy0xLTEtNjAyNjM_19bfc636-8c88-4183-82ae-93271f708036">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtNS0xLTEtNjAyNjM_06abcb7f-d35f-4d92-be0d-c151e6a37af1">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7263d8dd9a4b44e0ac64eb6919dd3540_I20211231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzQtMS0xLTEtNjAyNjM_9428fc9b-8d4d-4f3f-b4df-ec321a339fa0">80.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i965965b0db234e199c7a370813f9bac1_I20211231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzQtMy0xLTEtNjAyNjM_a38c8849-d4a8-4bca-95e5-e1045c23d165">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzQtNS0xLTEtNjAyNjM_0580bc7c-b368-4ea0-9d0a-601f5bf97144">109.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c6727e68757499781a9770aa96a5a3f_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzctMS0xLTEtNjAyNjM_f027c347-6092-4e1b-8a7b-48c4c53f3932">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id22c437a5e7a415c8d04a385cd6d3bf3_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzctMy0xLTEtNjAyNjM_1c152a18-5f4e-40af-b677-69499ab0ed4a">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzctNS0xLTEtNjAyNjM_d1709ffe-20e9-4f71-bde5-d47758c469c9">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3a9837d9b47499480dff64b4fcb6b1d_I20221231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzgtMS0xLTEtNjAyNjM_c7ca8d2f-9bdb-48b7-a51b-570549d95738">77.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e0e7a9bae54bee9c9cc1207ec4ae1b_I20221231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzgtMy0xLTEtNjAyNjM_64d212e7-e85c-40b2-b159-d1663c66bccd">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzgtNS0xLTEtNjAyNjM_6863e145-dde2-4ae1-9970-43312f43056d">107.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzE1Mg_c709bcc1-cc95-4201-9c3d-6a591b1da506">0.1</ix:nonFraction>&#160;million of accumulated goodwill impairment losses.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY3NQ_ff72c7a7-46a6-49f8-8a22-192777275575" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and accumulated amortization as of December 31 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licensing</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254460edc0a349ea96b0104f485aed1e_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItMS0xLTEtNjAyNjM_98baa46a-e4a4-4a1c-875b-5fc1e9bc1e9d">24.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i254460edc0a349ea96b0104f485aed1e_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItMy0xLTEtNjAyNjM_afda62a6-4d97-4621-a14c-5add709bdb37">20.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254460edc0a349ea96b0104f485aed1e_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItNS0xLTEtNjAyNjM_2d05c105-41c1-4499-8b6a-6e75c782d64f">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ef7fb4150d47649071f5f1b4f490d2_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItNy0xLTEtNjAyNjM_d5ea83c7-4150-4fe4-b36c-4c5acec41809">25.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7ef7fb4150d47649071f5f1b4f490d2_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItOS0xLTEtNjAyNjM_53cc99f7-0d07-474b-9d90-e4ed97672688">19.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ef7fb4150d47649071f5f1b4f490d2_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItMTEtMS0xLTYwMjYz_d1e5c44b-087c-4ff1-bb8f-44dfba47ea3a">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17963791fc94a5d9927fcb81798188f_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtMS0xLTEtNjAyNjM_7866679a-a7d9-4ea1-8d3f-b2540b7f5f7b">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic17963791fc94a5d9927fcb81798188f_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtMy0xLTEtNjAyNjM_6f62ff79-b7a4-4712-b6af-7f9dfa9b1c3b">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17963791fc94a5d9927fcb81798188f_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtNS0xLTEtNjAyNjM_55376bda-c437-42a2-a24e-d81b6ed06ba3">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc79f5eb40040f7a6e4a72ff4148eda_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtNy0xLTEtNjAyNjM_7e2a3abe-6d1a-44a7-9054-8ed2a84e1c73">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc79f5eb40040f7a6e4a72ff4148eda_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtOS0xLTEtNjAyNjM_73b8ab8c-9382-4906-9df7-f12c24c82e24">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc79f5eb40040f7a6e4a72ff4148eda_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtMTEtMS0xLTYwMjYz_5ddfaed3-6a5f-4d63-a684-b1a0b387f637">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6455ee991aeb451d8b8ebd79daef0cf6_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtMS0xLTEtNjAyNjM_88dc2719-1c83-4a2a-ab52-74da52fa7ba1">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6455ee991aeb451d8b8ebd79daef0cf6_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtMy0xLTEtNjAyNjM_9f2cd134-8858-4989-82b9-3acf4e582b93">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6455ee991aeb451d8b8ebd79daef0cf6_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtNS0xLTEtNjAyNjM_a233b6df-74d7-4243-bcf5-78cda816f96b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a6b50bf43424e5d8f1090509ea44dcf_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtNy0xLTEtNjAyNjM_d1da99c2-0c56-4adb-8462-043a610457db">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a6b50bf43424e5d8f1090509ea44dcf_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtOS0xLTEtNjAyNjM_f2af789b-7b1d-4794-9d15-52294e04cc56">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a6b50bf43424e5d8f1090509ea44dcf_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtMTEtMS0xLTYwMjYz_71349e28-3527-4bec-b6f5-d84905b08b98">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f5765c9a8046e2a6369832660d3253_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtMS0xLTEtNjAyNjM_ba66580a-ab31-4799-8778-0fe2ba38d7d5">39.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93f5765c9a8046e2a6369832660d3253_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtMy0xLTEtNjAyNjM_143a2ed6-a0d7-46c4-8e9b-4f1ebcd825b7">27.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f5765c9a8046e2a6369832660d3253_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtNS0xLTEtNjAyNjM_d64ce6c1-5040-4c44-bb83-fb36c023ed1b">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52c083f2095422b99e633dfb6d9a704_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtNy0xLTEtNjAyNjM_de660d4b-020c-419e-a881-f19f912878d3">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia52c083f2095422b99e633dfb6d9a704_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtOS0xLTEtNjAyNjM_a76db902-f8a8-46bc-85ef-988fed1d0fa3">25.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52c083f2095422b99e633dfb6d9a704_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtMTEtMS0xLTYwMjYz_5e2f082f-0c71-4ce0-93f4-4e81a229e92c">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ccb1f26a7b415b99d59d04309e91b2_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtMS0xLTEtNjAyNjM_b5d25b5b-222b-4ac1-b0a7-c8e78db2fca0">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7ccb1f26a7b415b99d59d04309e91b2_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtMy0xLTEtNjAyNjM_82479573-0c1a-4c26-b4d8-098e38fd68d9">10.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ccb1f26a7b415b99d59d04309e91b2_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtNS0xLTEtNjAyNjM_55a6348d-f728-444c-87c1-5ac660e62cba">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1c2074501a4c8e904e282823fdb207_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtNy0xLTEtNjAyNjM_4ed954bc-38b7-4676-85c4-e63176aadeed">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e1c2074501a4c8e904e282823fdb207_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtOS0xLTEtNjAyNjM_51b799b9-fc16-42e6-84fc-c6ed4989d783">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1c2074501a4c8e904e282823fdb207_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtMTEtMS0xLTYwMjYz_d5f10b9c-f310-4bb4-a346-0d00837654e1">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctMS0xLTEtNjAyNjM_acd851e5-9676-4d00-933f-3e08a3f451c7">80.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctMy0xLTEtNjAyNjM_e30f227e-4de7-40e1-ba56-4c53e3eb66e1">61.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctNS0xLTEtNjAyNjM_a24538ff-4b95-4e9d-b690-a9dc4cd4688a">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctNy0xLTEtNjAyNjM_086c3fc7-50fc-4cc4-972f-ec6cf2710c30">81.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctOS0xLTEtNjAyNjM_5d4632a0-e83b-408d-8a32-fa22f4162c7f">58.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctMTEtMS0xLTYwMjYz_04f62d23-d8b9-4fd0-b9ef-2c7ffaa98199">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i43f780212dea483ea4443c9019afdff2">The cost basis of intangible assets includes a foreign currency translation loss of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzM2Ng_cad79b69-18bd-494b-bc41-b98c0fcfa31b">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzQxMA_c22b5342-e686-487f-9c84-987f93b43669">1.3</ix:nonFraction> million for the years ended December&#160;31, 2022 and 2021, respectively. Amortization expense for the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzUxNw_d562f728-4522-4f71-8223-332de1e812c4">3.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzUyMQ_f9977536-dfa6-4bce-b44e-74e665870540">5.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzUyOA_72bd794a-eef1-41f4-8226-d30df1a8aabd">4.4</ix:nonFraction> million, respectively. Estimated annual amortization expense for the next five years is as follows: 2023 - $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzYyOA_5b50aabe-41fc-433f-b1f5-bae2ea35ffea">3.6</ix:nonFraction>&#160;million, 2024 - $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzYzNw_0bc58f3b-41e1-4ab9-bb49-13b8d134f427">3.6</ix:nonFraction>&#160;million, 2025 - $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY0Ng_5419b227-8427-4453-99ad-3691c0d13dbe">3.0</ix:nonFraction>&#160;million, 2026 - $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY1NQ_900d22a0-293e-4502-8c1b-279697e8845d">2.6</ix:nonFraction>&#160;million and 2027 - $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY2Nw_804c71f0-60fb-46cb-b613-54e04a0989ed">2.4</ix:nonFraction>&#160;million.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_103"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9:  <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90ZXh0cmVnaW9uOmNhMTE3Y2UzNmJmNzQ1MWVhYmIzNmExYTA3MWZjMWVjXzEyMQ_ea4108e5-8b53-4f79-b802-b88a456733c5" continuedAt="i7ca86a82d4004518a892f3bf22e898f1" escape="true">Other Current Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7ca86a82d4004518a892f3bf22e898f1"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90ZXh0cmVnaW9uOmNhMTE3Y2UzNmJmNzQ1MWVhYmIzNmExYTA3MWZjMWVjXzExMg_885eb8d1-fcdb-4f20-b104-6ef481191236" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities as of December 31 included the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzEtMS0xLTEtNjAyNjM_c6b6835c-88b0-463c-9dac-b1301539d8fd">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzEtMy0xLTEtNjAyNjM_f8bc2d6d-be2c-403d-b8f7-e5640c9781e3">48.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzItMS0xLTEtNjAyNjM_06979366-4617-4ce8-91cc-b445240bff44">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzItMy0xLTEtNjAyNjM_24c98969-cab9-48a0-9702-62b522377a62">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions, rebates and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzMtMS0xLTEtNjAyNjM_b8a4df02-ab5b-4048-9fe7-231e18c2214c">32.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzMtMy0xLTEtNjAyNjM_fba6c340-beb3-454b-bcbd-6beabc2e00e7">38.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued retirement plans (excluding pension)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzQtMS0xLTEtNjAyNjM_a50ee23b-491d-434b-8132-08fcc5bb2502">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzQtMy0xLTEtNjAyNjM_d470f59e-e97b-4d2e-85f7-749c96e27461">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes other than income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzUtMS0xLTEtNjAyNjM_e82b3380-48e9-45e1-a53a-46411df01bf5">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzUtMy0xLTEtNjAyNjM_9ed8db70-2065-4f87-9651-8b2858fa1c2f">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzYtMS0xLTEtNjAyNjM_e734ab00-29df-4b66-9dd1-a9cef021e3ed">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzYtMy0xLTEtNjAyNjM_958891c8-71b7-4406-b85b-e5da251e0d05">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzctMS0xLTEtNjAyNjM_6776c70e-ebd3-48d6-bc3c-c84172624ab6">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzctMy0xLTEtNjAyNjM_78bf946f-2617-4b7b-b3b6-b2be6b97c4a1">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzgtMS0xLTEtNjAyNjM_5bea443e-05cb-4876-a344-7a43190cfff3">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzgtMy0xLTEtNjAyNjM_9d7bac88-19ec-4af0-91f1-2112f2685330">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzktMS0xLTEtNjAyNjM_d764bf35-5018-4579-b561-652d22cc45c4">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzktMy0xLTEtNjAyNjM_df9a0c8f-e0af-4ac5-8cf4-3f07fee30a20">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzEwLTEtMS0xLTYwMjYz_fcc3a755-4ccd-4812-9f91-f214ccf30e42">33.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzEwLTMtMS0xLTYwMjYz_cd96cbc3-9810-402c-a587-f237720123c2">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzExLTEtMS0xLTYwMjYz_451af49d-9f7b-4362-b146-6353b939e683">181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzExLTMtMS0xLTYwMjYz_4d365a10-747f-4633-b698-3a2c458c154f">163.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0NzQ_285b7039-ee53-4100-a812-63507b137f1b" continuedAt="iade68e79a3db4fa3874419ef2e4301d0" escape="true">Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iade68e79a3db4fa3874419ef2e4301d0" continuedAt="ib8c29cafdc734badb8593bf4ecb763c2"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0NTg_31ba6c07-0423-42c8-b1d0-97a8719439ff" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2022 with the exception of the Series A notes which are as of December&#160;31, 2021. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.485%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, due December 31, 2024 (<ix:nonFraction unitRef="number" contextRef="i5c253265028c4a42abd68ab7456d94f4_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzYtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpmMmY2MzIxNjA1ODY0MTIxODE4ZDAyMTY3ZGJmN2FmZl8zOA_a050a4ca-ef6d-4596-a502-c54e01dd8f99">5.56</ix:nonFraction>%)</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c253265028c4a42abd68ab7456d94f4_I20221231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzYtMS0xLTEtNjAyNjM_b58d1e5b-1013-45e5-b1f5-f7adb93a30ae">83.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacbba1511dcd486088f2748d91395b33_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzYtMy0xLTEtNjAyNjM_207fbfc4-05c5-488b-8825-1621794899f5">85.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A notes, due July 5, 2022 (<ix:nonFraction unitRef="number" contextRef="i0cd10fbd48944499bd3e75624d39e738_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzctMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkZjM2ZjkxZmY0Y2Q0OTdkOGM4MzU1MGM4NzEyMmFiNF8zOA_05ebfe2c-fd58-4b3a-a57c-560b5ad2bb6c">3.67</ix:nonFraction>%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd10fbd48944499bd3e75624d39e738_I20221231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzctMS0xLTEtNjAyNjM_e8384199-48d8-495b-9cd9-751cbfe156e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id63066ad3a37405a9157d08cee024b89_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzctMy0xLTEtNjAyNjM_8997d9b3-a0e9-40c8-b4c5-e6ae1667f92d">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B notes, due July 5, 2024 (<ix:nonFraction unitRef="number" contextRef="i59b3a686792245fba4c1cd0fdbe993ad_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzgtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjphNmZkYmQzNWRiNDY0ODFiOWY1OTUzN2IzMWQ2NzcwYl8zOA_6fa562e3-fb2c-40b2-961d-7d1f49f5e8bd">3.82</ix:nonFraction>%)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59b3a686792245fba4c1cd0fdbe993ad_I20221231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzgtMS0xLTEtNjAyNjM_7af9a59c-a02b-4f5b-af43-ce6bfa069c5f">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i978162754bb545bf8cc52ff142f514e6_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzgtMy0xLTEtNjAyNjM_c2d74216-d639-47dd-816f-4881e4f69dcc">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C notes, due July 5, 2027 (<ix:nonFraction unitRef="number" contextRef="id421927f2814464886c6dde31c2e17a1_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzktMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo2MmVjNGUwMTU0MmE0MWNkYWQyMGQ5ZTA4OGYzOTU3ZF8zOA_3aa688e4-b878-4f73-aef1-99ea9e4dd447">4.02</ix:nonFraction>%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id421927f2814464886c6dde31c2e17a1_I20221231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzktMS0xLTEtNjAyNjM_b5a04c46-aea3-4fb6-b2b0-cf73342dc004">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie263faaeca58416a9df1dabac7a4b51c_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzktMy0xLTEtNjAyNjM_f6f94168-dd9d-431f-894f-03bb96f112ac">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEwLTEtMS0xLTYwMjYz_e571525b-b788-4026-b5ef-852c9c227e56">209.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEwLTMtMS0xLTYwMjYz_eaa4e9db-f4eb-4dda-995f-7b4de98ec684">253.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs for Term Loan and Series notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzExLTEtMS0xLTYwMjYz_a0cfb206-5a25-4d42-8a49-795b5173f5b5">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzExLTMtMS0xLTYwMjYz_743952df-0f67-4f2f-85d3-0d9a61ccae19">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEyLTEtMS0xLTYwMjYz_a26e7eeb-be78-4dce-b158-56a2d4da3b4e">208.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEyLTMtMS0xLTYwMjYz_bdab3c61-f7a1-47d5-ae69-126ac8ec6c98">253.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEzLTEtMS0xLTYwMjYz_ef56aa48-e564-4519-aa7b-0181de684afc">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEzLTMtMS0xLTYwMjYz_397ca5a3-fa05-47d0-a880-b2da34be2a55">44.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzE0LTEtMS0xLTYwMjYz_9f601cdf-a3a2-4101-8a5e-f306d859368e">206.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzE0LTMtMS0xLTYwMjYz_cd6bcd95-63af-48bb-8a24-bf41f244b613">208.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib8c29cafdc734badb8593bf4ecb763c2" continuedAt="i442d9a81330740c1adf3c57f1cf26cab"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we amended and extended the existing credit facility (entered into in March 2019), which was scheduled to expire in March 2024, from $<ix:nonFraction unitRef="usd" contextRef="i7fb1cd1161ef428f901886b8f8bfae4d_I20220228" decimals="-5" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjQzMA_a4e9d321-0687-4ed1-a67d-03c892b5c0a3">300.0</ix:nonFraction>&#160;million to a $<ix:nonFraction unitRef="usd" contextRef="i9433ad101e0f40c6a59795056c11ca8d_I20220331" decimals="-5" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjQ2MQ_dcb05886-4dcc-4c35-8132-d37d08c55bac">500.0</ix:nonFraction>&#160;million senior unsecured revolving credit facility by entering into a Second Amendment and Joinder and Assumption Agreement (the "Amended Credit Agreement"). The Amended Credit Agreement, which expires March 2027, contains a senior unsecured, multi-currency revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="i9433ad101e0f40c6a59795056c11ca8d_I20220331" decimals="-5" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjQ5Mg_e36ea276-5204-4621-884f-f863a8176c2c">500.0</ix:nonFraction>&#160;million, with sublimits of up to $<ix:nonFraction unitRef="usd" contextRef="i9775d568a3404cfcb4de79a3df989730_I20220331" decimals="-5" name="wst:CreditFacilityIsAvailableForSwingLineLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjUyMg_5b3fe981-931e-4849-ab7a-110b797f8978">50.0</ix:nonFraction>&#160;million for swing line loans for Domestic Borrowers in U.S. dollars and a $<ix:nonFraction unitRef="usd" contextRef="ieef415446df24387a2f0b94ff7a58e73_I20220331" decimals="-5" name="wst:CreditFacilityIsAvailableForSwingLineLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjU1MQ_9834819e-6c87-4a39-8e4b-eeaa37110ad7">40.0</ix:nonFraction>&#160;million swing line loan for West Pharmaceuticals Services Holding GmbH and up to $<ix:nonFraction unitRef="usd" contextRef="i9433ad101e0f40c6a59795056c11ca8d_I20220331" decimals="-5" name="wst:CreditAvailableForTheIssuanceOfLettersOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjU4MA_9da7a7f5-3485-4945-a991-03298993df21">50.0</ix:nonFraction>&#160;million for the issuance of standby letters of credit. The credit facility may be increased from time-to-time by the greater of (a) $<ix:nonFraction unitRef="usd" contextRef="i9433ad101e0f40c6a59795056c11ca8d_I20220331" decimals="-5" name="wst:LineOfCreditFacilityAdditionalBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjYxMA_94ad247c-520b-4d00-bd8e-e5ff66a545f2">929.0</ix:nonFraction>&#160;million or (b) EBITDA for the preceding <ix:nonNumeric contextRef="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331" name="wst:DebtInstrumentIncreaseInFacilityPrecedingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzgyNDYzMzcyMTcxODE_b5b54302-6e89-4c1d-896b-4a59cd19a5a8">twelve month</ix:nonNumeric> period in the aggregate through an increase in the revolving credit facility, subject to the satisfaction of certain conditions. Borrowings under the credit facility bear interest, at the Company&#8217;s option, at either: (a) the Term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) plus <ix:nonFraction unitRef="number" contextRef="if20cb8b7f73343e0b4d7df1ab5592c7f_D20220301-20220331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY0MA_f86959e6-1613-4266-bfdb-b27ef2c906bb">0.10</ix:nonFraction>% plus an applicable margin; or (b) a base rate defined as the highest of: (i) the Bank of America &#8220;prime rate&#8221;; (ii) the Federal Funds effective rate plus <ix:nonFraction unitRef="number" contextRef="i39fe04778e964e42b69b3e3667134afb_D20220301-20220331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY1Mw_b25620d9-1f4d-42f0-b5cd-34a232847ac2">0.50</ix:nonFraction>%; and (iii) Term SOFR plus <ix:nonFraction unitRef="number" contextRef="i8a3f65e2339e46edbd122c6a7e88c734_D20220301-20220331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY2Ng_3058aa24-700f-4063-a052-84dc76a201a9">1.00</ix:nonFraction>%. The applicable margin is based on the ratio of the Company&#8217;s Net Consolidated Debt to its modified EBITDA, ranging from <ix:nonFraction unitRef="number" contextRef="i3968429e781944ff917fa69ee5084d06_D20220301-20220331" decimals="5" name="wst:DebtInstrumentApplicableMarginRatio" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY3NQ_d3fae930-3b7a-406f-8bae-eece700e488a">0</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="ie9412b7a71714bc19162384ec914aec4_D20220301-20220331" decimals="5" name="wst:DebtInstrumentApplicableMarginRatio" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY4Mw_23e603b2-4be3-47c4-95ee-0da574d91dc7">37.5</ix:nonFraction> basis points for base rate loans and <ix:nonFraction unitRef="number" contextRef="i17f90a6dc27944f087b669925f30371f_D20220301-20220331" decimals="5" name="wst:DebtInstrumentApplicableMarginRatio" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY5NA_7deb2ef1-00ea-4480-963d-4d967d338a04">87.5</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i14dd74ecfac74fa98fbdb00352369007_D20220301-20220331" decimals="5" name="wst:DebtInstrumentApplicableMarginRatio" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjcwNg_4a12ad68-2ceb-4d68-b7d5-71bc511b7d7e">137.5</ix:nonFraction> basis points for Term SOFR loans. The Amended Credit Agreement contains financial covenants providing that the Company shall not permit the ratio of the Company&#8217;s Net Consolidated Debt to its Modified EBITDA to be greater than <ix:nonFraction unitRef="number" contextRef="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331" decimals="1" name="wst:DebtInstrumentRatioOfDebtToEBITDA" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjcxNw_e71d10a7-c9ba-4942-a695-968448598f00">3.5</ix:nonFraction> to 1; provided that, no more than <ix:nonFraction unitRef="instance" contextRef="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331" decimals="INF" name="wst:DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjczMA_586a7291-5abd-4510-810a-f237d9307d70">three</ix:nonFraction> times during the term of the Amended Credit Agreement, upon the occurrence of a Qualified Acquisition for each of the <ix:nonFraction unitRef="fiscal_quarter" contextRef="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331" decimals="INF" name="wst:DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjczNg_07b52159-6387-4523-8cc3-68d207d68ad1">four</ix:nonFraction> fiscal quarters of the Company immediately following such Qualified Acquisition, the ratio set forth above shall be increased to <ix:nonFraction unitRef="number" contextRef="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331" decimals="1" name="wst:DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjc0Mg_b877d114-fc6a-4026-a8d6-7a41e32ad945">4.0</ix:nonFraction> to 1. The Amended Credit Agreement also contains customary limitations on liens securing indebtedness of the Company and its subsidiaries, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of December&#160;31, 2022 and 2021, total unamortized debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i34794d2072c74e28898377fb07301721_D20220101-20221231" decimals="-5" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzIwMTQ_eaaf42f1-a37d-48fc-ac47-c5db39410543">1.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia9e4ff52db72474081a077b4a2d8bf8a_D20210101-20211231" decimals="-5" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzIwMjE_948b173c-2274-4e1c-9e9c-a21f8f9b734f">0.1</ix:nonFraction>&#160;million, respectively, were recorded in other current assets and other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had <ix:nonFraction unitRef="usd" contextRef="ic2c00c7463cf41a9988d6d2571c4a4e9_I20221231" decimals="-5" name="us-gaap:LongTermLineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzIxODk_01d03abe-4c0e-4092-953d-909fd0fb8ebf">no</ix:nonFraction> outstanding borrowings under the Credit Facility. At December&#160;31, 2022, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i36a6e77fe574426b8c780aa1e3956660_I20221231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzIzNTI_284c2f15-cc6b-4578-a139-20aa6a0e0923">2.4</ix:nonFraction> million, was $<ix:nonFraction unitRef="usd" contextRef="ic2c00c7463cf41a9988d6d2571c4a4e9_I20221231" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzIzNjA_2c0db4d1-7bd0-4749-917b-ed687b48cbb4">497.6</ix:nonFraction> million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we entered into a First Amendment and Incremental Facility Amendment (the &#8220;First Amendment&#8221;) to the Credit Agreement. Pursuant to the First Amendment and the Credit Agreement, we established the Term Loan in the amount of $<ix:nonFraction unitRef="usd" contextRef="ib39e812e09a44972bf2c8d2ad05b403e_I20191231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzI2NDY_d21bacda-d4db-4af7-a796-54cf1ba5e53e">90.0</ix:nonFraction>&#160;million, which is due on December 31, 2024. Borrowings under the Term Loan bear interest at the three-month Term SOFR plus <ix:nonFraction unitRef="number" contextRef="icf787da5fc004530a7921f12a8628daa_D20190101-20191231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzI3NjA_f7e8f60b-3bc6-4a37-8161-f4dbb87f38b7">87.5</ix:nonFraction> basis points. As of December&#160;31, 2022 and 2021, there were unamortized debt issuance costs remaining of $<ix:nonFraction unitRef="usd" contextRef="ie3a2571be15e4bbaa4802e0b11fe9e86_D20220101-20221231" decimals="-5" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzI4NTA_a21b81ef-766b-473f-b1b6-2003c8518b99">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i861ad8987fa54c699465cafe8d5b03b7_D20210101-20211231" decimals="-5" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzI4NTc_5db58576-157b-4f80-ab6a-f5b579aa0d0d">0.1</ix:nonFraction>&#160;million, respectively, which are being amortized as additional interest expense over the term of the Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i5c253265028c4a42abd68ab7456d94f4_I20221231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzI5Nzk_a6d51983-4d05-4425-9820-8f2cdbe87b5e">83.2</ix:nonFraction>&#160;million in borrowings under the Term Loan, of which $<ix:nonFraction unitRef="usd" contextRef="i5c253265028c4a42abd68ab7456d94f4_I20221231" decimals="-5" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzMwMjY_a08b7994-8c1f-4cdd-891c-ef68266f2e62">2.2</ix:nonFraction>&#160;million was classified as current and $<ix:nonFraction unitRef="usd" contextRef="i5c253265028c4a42abd68ab7456d94f4_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzMwNTk_2bfc126f-241c-4791-a5f3-2bccb5e9e383">81.0</ix:nonFraction>&#160;million was classified as long-term. Please refer to Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_109">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for a discussion of the foreign currency hedge associated with the Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Private Placement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, we concluded a private placement issuance of $<ix:nonFraction unitRef="usd" contextRef="i656ea7823b914cb681c9f806732bce7f_I20121231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzMzMDI_68dffc6d-b41f-4c88-8d52-353b3953738d">168.0</ix:nonFraction> million in senior unsecured notes. The total amount of the private placement issuance was divided into <ix:nonFraction unitRef="tranche" contextRef="iad4b14762f724836912187aa55021fd3_I20121231" decimals="INF" name="wst:DebtInstrumentNumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0MDA_ce47e0aa-ff06-4528-9ddc-1a73ce355e4e">three</ix:nonFraction> tranches - $<ix:nonFraction unitRef="usd" contextRef="i34909e1b0bb641229424ae8dea78f236_I20121231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0MTQ_969ccb11-70ed-458d-b5a7-1560f2009f8b">42.0</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i34909e1b0bb641229424ae8dea78f236_I20121231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0MTc_494109b7-ad92-43b6-9829-05d452ffec8e">3.67</ix:nonFraction>% Series A Notes due July 5, 2022, $<ix:nonFraction unitRef="usd" contextRef="i2bdb4dd782f5429cae42770030a9c63e_I20121231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0NDM_6c875fb1-5da3-4fe4-9578-7a9c71a2d734">53.0</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i2bdb4dd782f5429cae42770030a9c63e_I20121231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0NDY_03dbb4c2-8e44-4f64-855e-d8cc91c0e223">3.82</ix:nonFraction>% Series B Notes due July 5, 2024, and $<ix:nonFraction unitRef="usd" contextRef="i63e7117f5e6c48e3bc16493062149b41_I20121231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0NzY_cd7cba2d-fb93-40ce-9b26-57757ef1777e">73.0</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i63e7117f5e6c48e3bc16493062149b41_I20121231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0Nzk_9560f5a9-8189-4979-8d7e-a86956469a65">4.02</ix:nonFraction>% Series C Notes due July 5, 2027 (the &#8220;Notes&#8221;). The Notes rank pari passu with our other senior unsecured debt. The weighted average of the coupon interest rates on the Notes outstanding as of December&#160;31, 2022 is <ix:nonFraction unitRef="number" contextRef="i656ea7823b914cb681c9f806732bce7f_I20121231" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM2NDk_31334534-0afa-4501-ad7b-ae77633a387b">3.94</ix:nonFraction>%. As of December&#160;31, 2022 and 2021, there were unamortized debt issuance costs remaining of $<ix:nonFraction unitRef="usd" contextRef="i5f365909be2c4a33b9535d9625359634_I20221231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM3MjY_a9d6fe4b-85ef-4bed-97f1-ee036dbd91cc">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ieb457474142548ada94572d36284f1aa_I20211231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM3MzM_7847f27e-368c-4a19-b8a2-eee763cbbccc">0.3</ix:nonFraction>&#160;million, respectively, which are being amortized as additional interest expense over the term of the Notes.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i442d9a81330740c1adf3c57f1cf26cab"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2022, we were in compliance with all of our debt covenants. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest costs incurred during 2022, 2021 and 2020 were $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQyNTM_49ad84ba-f54d-43af-bd7e-3f48cf29f807">11.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQyNTc_e3791735-4e37-4465-9394-aa167bd48782">10.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQyNjQ_55bc5005-b015-49f9-813d-7140cad4c0d2">9.6</ix:nonFraction> million, respectively. The aggregate annual maturities of long-term debt, excluding unamortized debt issuance costs, are as follows: $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQzOTI_ec98b1aa-6a9f-431f-9f59-3b36eb2f1cf1">2.2</ix:nonFraction> million in 2023, 2024 - $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0MDc_9625cfb7-f770-4d13-91b2-e4e812da100d">134.0</ix:nonFraction> million, 2025 - $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0MTY_e76bd1d8-0c7f-4112-8115-087e88e81bb3">0.0 million</ix:nonFraction>, 2026 - $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0MjU_4b49875b-2357-45ab-839e-bf9f46e01062">0.0 million</ix:nonFraction>, 2027 - $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0MzQ_26386afe-9b78-450e-9f15-11359fa2044a">73.0</ix:nonFraction> million, and thereafter - $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0NTU_a51e8149-a38a-4233-b6b0-f89bb2691b45">0.0 million</ix:nonFraction>.</span></div></ix:continuation><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_109"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQ4Mjc_7d6e1f1e-8822-4bb1-96d9-dba8c26fcaca" continuedAt="i33e41aa9ddcf488e8ad94dfbf786d45d" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i33e41aa9ddcf488e8ad94dfbf786d45d" continuedAt="ieddd2e057ce34cf198d351e5602d6064"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2022 and December&#160;31, 2021, the total amount of these forward exchange contracts was Singapore Dollar ("SGD") <ix:nonFraction unitRef="sgd" contextRef="i5d646a9b7feb4e40a68f41f454b189df_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0Xzk1NQ_f7766175-871c-4f91-8541-706d751cc61f">601.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i569a84a1b6044847a369af6d7becda42_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0Xzk2Mg_b545c7ef-a845-4e60-8a6b-71c623cf498e">13.4</ix:nonFraction> million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to <ix:nonNumeric contextRef="i33954585607a418e8de125d8e2ad1f27_D20220101-20221231" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzEwOTE_d21e9bd7-7409-4b33-9353-c76c37e9f655">eighteen months</ix:nonNumeric>, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQ4MTc_c0c4898b-c7c2-4a48-af3f-ccd8cb68833d" continuedAt="iaa158717b22e4571ae60289e8e46a62b" escape="true">As of December&#160;31, 2022, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</ix:nonNumeric></span></div><div><ix:continuation id="iaa158717b22e4571ae60289e8e46a62b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EUR</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b6ff425fe5240119fb6fedfde9e6e41_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzItMS0xLTEtNjAyNjM_969542fe-ced8-431f-8290-261ddf210757">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i32dd3ce056004fa288d5cd8119b7d251_I20221231" xsi:nil="true" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzItMy0xLTEtNjAyNjM_e76669b2-53e1-4745-87fe-2185b181bb56"></ix:nonFraction></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i32dd3ce056004fa288d5cd8119b7d251_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzItNC0xLTEtNjAyNjM_5c22dbb4-5551-40df-bd8c-f480842db9be">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i171c812bedd448199594f8cbe21f5215_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzMtMS0xLTEtNjAyNjM_961e1fd7-7fac-46d4-b80e-1af984b37da9">6,123.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ec8e1a30c24bba9c86e74b4d8c13f9_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzMtMy0xLTEtNjAyNjM_50b37af8-ace8-4801-b9e9-8066d980f615">31.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i43ec8e1a30c24bba9c86e74b4d8c13f9_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzMtNC0xLTEtNjAyNjM_0b79f215-fd0e-4f7f-ae9c-9952dfc4eede">15.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sgd" contextRef="i05eec46fb5e34fe797afbe0315ba7370_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzQtMS0xLTEtNjAyNjM_2130cbe7-3975-43b7-9031-9e6546d80388">62.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d66ee6c4f140c5ad3cd9497de7f00a_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzQtMy0xLTEtNjAyNjM_06c97741-bdd1-4dc4-a2ed-ff80e64dca99">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ia2d66ee6c4f140c5ad3cd9497de7f00a_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzQtNC0xLTEtNjAyNjM_70470dfc-ff79-4fa2-9fea-3dc3623aac4f">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Japanese Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as cumulative translation adjustments within accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we entered into a <ix:nonNumeric contextRef="i07c6df090c7a49f4ae2283e42ca80a22_D20191201-20191231" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQ4NDY_2ef4f1bb-e2ae-4741-90ae-7faf3d46931f">five-year</ix:nonNumeric> floating-to-floating forward-starting cross-currency swap (the &#8220;cross-currency swap&#8221;) for $<ix:nonFraction unitRef="usd" contextRef="i7adb9161e9af4809af615f27c957ccf7_I20191231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzIxMDU_ab317b7c-8a00-4754-aab4-eb317a89f2b6">90</ix:nonFraction>&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#165;<ix:nonFraction unitRef="jpy" contextRef="i647595866ae94d7883d164c13e7576df_I20221231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzIyMjM_1baa79f6-0748-4d45-8ca8-6d287b93e6bd">9.1</ix:nonFraction>&#160;billion ($<ix:nonFraction unitRef="usd" contextRef="i647595866ae94d7883d164c13e7576df_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzIyMjc_02b51888-da2e-4fba-b5ce-211d05ce196a">83.2</ix:nonFraction>&#160;million) as of December&#160;31, 2022. Under the cross-currency swap, we receive floating interest rate payments based on USD compounded SOFR plus a margin, in return for paying floating interest rate payments based on Japanese Yen ("Yen") Tokyo Overnight Average Rate ("TONAR") plus a margin. In addition, we receive periodic fixed payments of USD in return for paying fixed principal payments of Yen.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ieddd2e057ce34cf198d351e5602d6064" continuedAt="i2e63ee4f46bf4382b444bc6912560f70"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From November 2017 through December 2022, we purchased several series of call options for a total of <ix:nonFraction unitRef="bbl" contextRef="i1717cad3ed8747cfb39d9d04479a590c_D20171101-20221231" decimals="0" name="us-gaap:DerivativeNonmonetaryNotionalAmountVolume" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzMwNDY_f44ad468-ee80-44a8-ab80-b95ecbde3d7f">867,500</ix:nonFraction> barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had outstanding contracts to purchase <ix:nonFraction unitRef="bbl" contextRef="icd338cc8a5fe470590598ff0e2475ae0_I20221231" decimals="0" name="us-gaap:DerivativeNonmonetaryNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzMyNzQ_3c614552-3bff-43b5-a89a-79e008d38cb6">258,597</ix:nonFraction> barrels of crude oil from December 2022 to September 2024, at a weighted-average strike price of $<ix:nonFraction unitRef="usdPerBbl" contextRef="icd338cc8a5fe470590598ff0e2475ae0_I20221231" decimals="2" name="us-gaap:DerivativeAveragePriceRiskOptionStrikePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzMzNTc_802a73ac-557a-468e-be4c-f87aa48f2bcb">108.28</ix:nonFraction> per barrel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_112">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the balance sheet location and fair values of our derivative instruments as of December&#160;31, 2022 and 2021.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQ4MjY_2a4f4961-5257-4095-abe0-f1eccc6650c4" continuedAt="id814ecf2e08d456e9fac33c5eb1ade8a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.046%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged item (intercompany loan)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id784d712d09342aebd7b7dfe678f761b_D20220101-20221231" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzMtMS0xLTEtNjAyNjM_0b8be09f-2a83-4919-991d-21b8f4d98f98">28.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a46826c2684460eb4fbb56df6e8152a_D20210101-20211231" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzMtMy0xLTEtNjAyNjM_bb18b513-e6c4-4ac9-b745-56a5a1b8c586">22.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c00e1dadfb14a658cb637483c6837c2_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzMtNS0xLTEtNjAyNjM_6b843f90-3d2d-41f4-9dbf-50ad48e518d4">28.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative designated as hedging instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id784d712d09342aebd7b7dfe678f761b_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzQtMS0xLTEtNjAyNjM_2238b083-d553-42a8-a1f9-5e13411f5db5">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a46826c2684460eb4fbb56df6e8152a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzQtMy0xLTEtNjAyNjM_c391173a-6a31-4bc7-9428-88cce357259c">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c00e1dadfb14a658cb637483c6837c2_D20200101-20201231" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzQtNS0xLTEtNjAyNjM_c3a72195-35ac-4a67-9ff2-74f16ae812a9">28.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id784d712d09342aebd7b7dfe678f761b_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzUtMS0xLTEtNjAyNjM_d48baab1-23f7-4b48-8934-468fdea576e6">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a46826c2684460eb4fbb56df6e8152a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzUtMy0xLTEtNjAyNjM_3f652d05-52c9-4422-a4ed-39b467622abe">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c00e1dadfb14a658cb637483c6837c2_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzUtNS0xLTEtNjAyNjM_d0abd8a3-01cd-4b32-9683-168a6362defe">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzYtMS0xLTEtNjAyNjM_e83b5cbb-76d0-491a-92aa-4fae7a70cf3c">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzYtMy0xLTEtNjAyNjM_d034179e-d603-4a2a-9dfa-23d57f2031be">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzYtNS0xLTEtNjAyNjM_9f5ade80-bf91-4947-be02-42643f1c213c">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge. The amounts recognized in earnings, pre-tax, for forward point components for the years ended December&#160;31, 2022, 2021 and 2020 were $<ix:nonFraction unitRef="usd" contextRef="iab197c4924f34c0db38f5eb19ad7f2b1_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQwMjc_65415806-aa7d-4e8f-b1e8-8f11d90f3104">4.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i055a22dcb77a4206a028877100a4c97b_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQwMzE_b6a04712-a31d-4636-93d9-ba866eff6a60">2.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5e0072e4d3cc422b90a6e91608ad2109_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQwMzg_8bc8edbb-8e78-49e1-8b40-5fa435c4f66a">6.3</ix:nonFraction> million, respectively. We expect to recognize $<ix:nonFraction unitRef="usd" contextRef="i85e3c3d286034ff49e528b2c9317d171_D20230101-20231231" decimals="-5" sign="-" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQwNzk_c0e99abc-f53f-4d24-aedf-4dc43ceb2f31">3.2</ix:nonFraction> million in earnings, pre-tax, for forward point components in 2023.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2e63ee4f46bf4382b444bc6912560f70" continuedAt="if8c1daf22f814b9ab40f67d39b3f86b4"><ix:continuation id="id814ecf2e08d456e9fac33c5eb1ade8a" continuedAt="ieb279ca4828d4055b2b01c0f929aa0d8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.278%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae7ed9fa03bd445da0742597c1c5438f_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzMtMS0xLTEtNjAyNjM_053d6e92-333d-48c9-93a2-ff5dd8fc6002">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3195132dd5345a6887a4340147a0564_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzMtMy0xLTEtNjAyNjM_620c34e8-b2a2-4e2f-adf9-5d6e259845a3">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e42c0a25694e14b9229d1e967b73d5_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzMtNS0xLTEtNjAyNjM_38bb6850-8814-44ca-accd-59e6d98ffa18">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab197c4924f34c0db38f5eb19ad7f2b1_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzQtMS0xLTEtNjAyNjM_a74d5029-5b05-4886-aef7-2ac695eda496">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055a22dcb77a4206a028877100a4c97b_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzQtMy0xLTEtNjAyNjM_85b4e9d3-0c6d-4fe4-880a-bf8e25b7a4ff">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e0072e4d3cc422b90a6e91608ad2109_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzQtNS0xLTEtNjAyNjM_ddc672db-70a6-44f6-9a53-218263069158">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts (hedges of net sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e06a7878bb94a07b93f4163c017f6ce_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzYtMS0xLTEtNjAyNjM_49510597-601f-4f09-af10-13ff17147421">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia05c56f7d4da40bab7b1afb3e4f348f7_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzYtMy0xLTEtNjAyNjM_11841515-1967-405a-b343-7a4486173464">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa12cd493a074d5399af3c418b4c5706_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzYtNS0xLTEtNjAyNjM_4029e736-7130-44ce-a5cc-e299281ae778">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts (hedges of cost of goods and services sold)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85aa4b0d24d14148bf70e42bf8953a40_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzctMS0xLTEtNjAyNjM_f62a5088-3fe5-4f89-b2f6-4b22cefc8b05">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61e1ccc194684e27aa2be4350e2a59da_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzctMy0xLTEtNjAyNjM_299a14f7-f57a-4959-8e56-20a66a717f7f">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9601ccbfbc6c4c6e969ee2d307d9045c_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzctNS0xLTEtNjAyNjM_340021bd-bd83-4790-87d9-ed250dba1c68">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735ee47484304157b7f13947a9b6e46a_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzgtMS0xLTEtNjAyNjM_0f31687c-7d5c-4125-83a8-262dd0355940">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d8fd0ef4c9d44ccbf513c6e6c38b9b1_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzgtMy0xLTEtNjAyNjM_2121481a-81e7-4644-a530-dbd6eb9b132c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397a9fc92bb541bda84bf523b0f0534c_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzgtNS0xLTEtNjAyNjM_a587746d-bfaa-41e0-9581-872424504290">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbf55f1a879b48a78fb1475dceabdc9d_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzktMS0xLTEtNjAyNjM_68f99285-4a56-442d-b3c9-99e9b1d8e4ab">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib560936ecece47cf97fd5dfe6464bfb7_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzktMy0xLTEtNjAyNjM_3bab29ce-e25a-4748-99b3-1d1ca78c636f">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice018ed37eaa49149dc6c63f944f178d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzktNS0xLTEtNjAyNjM_25c47c9c-ddac-4340-bee5-a1655cd71cad">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd37440709c84ad3812e75fb20e0afa6_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEyLTEtMS0xLTYwMjYz_f9c6e7ad-0c5e-48d7-95e4-bfd9b5f0a1d6">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e71e4d6cb1c4e27acca2bfaf571e3ac_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEyLTMtMS0xLTYwMjYz_eda88651-3f2f-46df-ac6c-268f3c004726">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63adabb977604bc4a8c06a77bae5bfd4_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEyLTUtMS0xLTYwMjYz_8f7cbc3e-bb46-4cf9-9516-61da9bc9d838">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d0bf9f09bfd45009a95e13ff7570373_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEzLTEtMS0xLTYwMjYz_65ed8324-64a8-4af1-9042-48cb25d7fd22">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ccb1166712d49a3855a9a39bf66196e_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEzLTMtMS0xLTYwMjYz_10567b7a-283d-42b1-8cec-b9a99a28f13f">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3606e54a0a1946d8bca09748806375ab_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEzLTUtMS0xLTYwMjYz_47fec0ef-a10b-46b5-940e-722732361484">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae7ed9fa03bd445da0742597c1c5438f_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzMtMS0xLTEtNjAyNjM_2d33a97f-0cc8-45cd-a709-0294661fe3f9">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3195132dd5345a6887a4340147a0564_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzMtMy0xLTEtNjAyNjM_5d6d31e2-235e-478e-8f36-a39a12dcda70">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72e42c0a25694e14b9229d1e967b73d5_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzMtNS0xLTEtNjAyNjM_29cf427a-719d-4508-9fac-84c59543c9ba">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab197c4924f34c0db38f5eb19ad7f2b1_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzQtMS0xLTEtNjAyNjM_fe2bce99-7395-44f1-adce-592c17e0d3a6">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i055a22dcb77a4206a028877100a4c97b_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzQtMy0xLTEtNjAyNjM_7094353f-4630-4a9e-93e1-b70106ab12fe">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e0072e4d3cc422b90a6e91608ad2109_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzQtNS0xLTEtNjAyNjM_2ca2592a-d841-42f5-b13a-9ee7ad7ff83e">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e06a7878bb94a07b93f4163c017f6ce_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzYtMS0xLTEtNjAyNjM_86fe1968-2212-4604-862c-e54c09dd28ff">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia05c56f7d4da40bab7b1afb3e4f348f7_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzYtMy0xLTEtNjAyNjM_d9b96d6c-c391-4e02-b89c-9391864ee3b8">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa12cd493a074d5399af3c418b4c5706_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzYtNS0xLTEtNjAyNjM_c1b9ae93-cc7f-432b-ab19-8b8bec468c2b">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85aa4b0d24d14148bf70e42bf8953a40_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzctMS0xLTEtNjAyNjM_c564b6f3-91c5-45ef-af48-6d85c16bbee8">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61e1ccc194684e27aa2be4350e2a59da_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzctMy0xLTEtNjAyNjM_f29bc9b3-d940-4148-b6c9-31e3f5e661ad">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9601ccbfbc6c4c6e969ee2d307d9045c_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzctNS0xLTEtNjAyNjM_3dea3ac6-a651-4c4c-9330-9a81c3f46f79">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450fa254443341388fa92c220d282a50_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzktMS0xLTEtNjAyNjM_2f3cb8e5-4c53-4f6b-b31d-12ad79067437">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ee7b68af3241c8ba207622f3731e45_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzktMy0xLTEtNjAyNjM_4f450e93-9954-4e8c-9d8c-daceb9557d4d">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id841a6055f0e4cfbaacfafc0843a3b62_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzktNS0xLTEtNjAyNjM_00b6e8f5-3892-4c34-939e-754a0b0fd0f9">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf55f1a879b48a78fb1475dceabdc9d_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEwLTEtMS0xLTYwMjYz_8cdeed9a-aca0-4241-84bf-f75da2d55dee">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib560936ecece47cf97fd5dfe6464bfb7_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEwLTMtMS0xLTYwMjYz_0886cf1a-1a6d-4daf-a07c-2e85de3f376c">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice018ed37eaa49149dc6c63f944f178d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEwLTUtMS0xLTYwMjYz_6b8afb33-d0b2-410e-8c8d-35f41a2d3014">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd37440709c84ad3812e75fb20e0afa6_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEzLTEtMS0xLTYwMjYz_b5d89709-d19a-4d20-96cd-204ae2488ab6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e71e4d6cb1c4e27acca2bfaf571e3ac_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEzLTMtMS0xLTYwMjYz_18e5e10b-e367-4f72-b406-25bc0d1dccbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63adabb977604bc4a8c06a77bae5bfd4_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEzLTUtMS0xLTYwMjYz_72055a3e-98f0-4558-91ff-f99eefea6f81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d0bf9f09bfd45009a95e13ff7570373_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzE0LTEtMS0xLTYwMjYz_bc8796d3-72bf-4a6c-a078-36f469421d5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ccb1166712d49a3855a9a39bf66196e_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzE0LTMtMS0xLTYwMjYz_1f3544a8-a234-4db0-be78-96cae66156a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3606e54a0a1946d8bca09748806375ab_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzE0LTUtMS0xLTYwMjYz_429a365d-a013-4388-96d1-a16f292e21d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if8c1daf22f814b9ab40f67d39b3f86b4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the above table which summarizes the effects of derivative instruments designated as fair value hedges within the other expense (income) line in our consolidated statements of income for the years ended December 31. <ix:continuation id="ieb279ca4828d4055b2b01c0f929aa0d8" continuedAt="i335d5114c9c2445682839c281b950ca1">The following table summarizes the effects of derivative instruments designated as cash flow and net investment hedges by line item in our consolidated statements of income for the years ended December 31:</ix:continuation></span></div><div><span><br/></span></div><div><ix:continuation id="i335d5114c9c2445682839c281b950ca1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ecf564c7c8643e083fb3f9bc53dd6e6_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzEtMS0xLTEtNjAyNjM_6cd6aa6d-a969-4998-8f5a-e95fe10ca789">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i172c5bb368534dc6afd5e93d8d03deaf_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzEtMy0xLTEtNjAyNjM_20901595-6a1b-4b26-b12a-730f195d11a3">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a19776470ed4aa9be3c7220853c571b_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzEtNS0xLTEtNjAyNjM_a247df6b-d2a2-445a-84d9-8ca9df2df6e7">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic31348b180714cf69a4949022e873c8b_D20220101-20221231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzItMS0xLTEtNjAyNjM_f6d461a2-b14d-4c4c-bcbf-076dfa759f11">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86d021ac1cce433bba24d4fee5778a4b_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzItMy0xLTEtNjAyNjM_d0b56130-6bb5-43d2-b209-16b5f4a01fba">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie516db60841b47beab93458349c39d9e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzItNS0xLTEtNjAyNjM_947a86bc-1c6d-43fa-87ff-6c6f4c0e291b">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d6d1e179764319939518be6b4755c8_D20220101-20221231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzQtMS0xLTEtNjAyNjM_a8ff493c-1c04-4346-822d-536c75d477ac">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a05df88c57c4fbba800cd2d6ded4056_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzQtMy0xLTEtNjAyNjM_fd5cb270-da59-46bc-a2bf-fefbdab53507">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc769ee573d4b1eb606de264ddf0ea5_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzQtNS0xLTEtNjAyNjM_8281716d-a1fd-401c-878f-b9b4b5018fc7">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQ4MzE_03c415c1-35f1-4cad-9928-26ff854ca22b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262cd9dc71574d73902a46c241cb2c0d_D20220101-20221231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzItMS0xLTEtNjAyNjM_fc93148e-6ec7-482e-9bf8-d6b5d271086c">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae52261e94e747a89a158b1da3e74546_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzItMy0xLTEtNjAyNjM_f19d5b43-63cc-4903-ad83-3e1fb2ac9abc">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6881855e92e84a999adbd921603e22a5_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzItNS0xLTEtNjAyNjM_632d95db-eaf2-4ea9-976e-5555d988a9fa">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73452302c0e415ab2556f3eb20f4c00_D20220101-20221231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzMtMS0xLTEtNjAyNjM_5fa5eba4-5ddd-403a-8894-62f671447863">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d62078ba14495ad1278fd1f4d578d_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzMtMy0xLTEtNjAyNjM_b8874654-04b9-4a62-9c54-1dea7fa805bd">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9da752cb333d421ca18f1e5af162195f_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzMtNS0xLTEtNjAyNjM_32f2eff1-641a-4926-9d66-dd0207da1cf0">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022 and 2021, there was no material ineffectiveness related to our hedges.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUyOTY_0457e2c9-aac5-4b3c-98a4-069357d38467" continuedAt="if7345e682e1440f2bdbbbfc337a2fc78" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if7345e682e1440f2bdbbbfc337a2fc78" continuedAt="i7f591eecbdc0429580a521e15389eca2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div><div style="margin-top:9pt;padding-left:18pt"><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUyOTc_53858e0f-6972-4888-9220-29bfb558d762" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzQtMS0xLTEtNjAyNjM_53c5e814-4927-416f-b261-54e3f38b767e">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzQtMy0xLTEtNjAyNjM_503c5f18-e6f6-44f0-87b2-0147ca2cce6d">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzQtNS0xLTEtNjAyNjM_a3a155b9-1c09-4d15-ace9-9e23e369b4fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzQtNy0xLTEtNjAyNjM_a8d75911-3f19-4796-bb68-7a3ce5faa499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzUtMS0xLTEtNjAyNjM_7340758f-eded-4d44-a802-8fcc09e0a7f6">4.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzUtMy0xLTEtNjAyNjM_a18875cb-6f15-4cad-b600-65c19ef3a281">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzUtNS0xLTEtNjAyNjM_4f23f3a0-983c-47ab-81f2-dcfd15028e24">4.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzUtNy0xLTEtNjAyNjM_f240b563-0c52-4328-9251-ad0cb206f5aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i754552b393944baa8e31325d5eba5188_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzYtMS0xLTEtNjAyNjM_3eea58b1-e5c6-4de4-95d8-232db9c80131">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd279fe6b3354a1d94ce2672678400de_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzYtMy0xLTEtNjAyNjM_1b92fe92-9a94-472b-a094-7cb621db30aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43611db249a44bdb8e4b0da680b6e710_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzYtNS0xLTEtNjAyNjM_b532c36c-fc72-42a8-b2c0-4e5bfd7fc127">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc6ce44539154204a8fdfb1e5e3bcb36_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzYtNy0xLTEtNjAyNjM_7b7f8a84-827a-45f5-9111-fbe78aaa16bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2c88912680242f1a6463abe80fe7cf4_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzctMS0xLTEtNjAyNjM_0f1dcd8d-6686-4476-bb0b-acd8728e9ee7">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32dd82ca504d4e4e8b1e47b0b4f96b7e_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzctMy0xLTEtNjAyNjM_1929734d-ceaf-4b91-9d13-63024409ba14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5907fec60b44341a54dc18b426e81a8_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzctNS0xLTEtNjAyNjM_7b8a461e-dda4-4d8a-935c-622a99e1bada">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ec8d15453f4f38a06ec86fbf3ff764_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzctNy0xLTEtNjAyNjM_dcec7645-e75e-4374-9f28-96f29be989dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzgtMS0xLTEtNjAyNjM_32f72b74-d693-406e-aa23-36e32ce664fa">32.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzgtMy0xLTEtNjAyNjM_be11aefe-a0ba-4e8f-ac9d-94483882bac0">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzgtNS0xLTEtNjAyNjM_c8a1c10e-216e-4095-a5d2-263831bf2ba8">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzgtNy0xLTEtNjAyNjM_1574a7af-337b-40d1-833e-72390597149d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEwLTEtMS0xLTYwMjYz_59701525-b576-43f6-8fa2-7a3b0528b6cd">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEwLTMtMS0xLTYwMjYz_47d72b92-4354-4d6d-8d08-c162445462fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEwLTUtMS0xLTYwMjYz_2c937c9b-101a-4087-9bc6-026fbaf6178a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEwLTctMS0xLTYwMjYz_5764a3b4-782a-4d4d-b439-8f39f744f394">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzExLTEtMS0xLTYwMjYz_cdccc486-31f0-4037-84d4-a20f1ceeacbd">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzExLTMtMS0xLTYwMjYz_2eff3923-d297-4760-bc7b-22528040a10c">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzExLTUtMS0xLTYwMjYz_21ca9a31-257e-404a-b628-f2a595e4f99f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzExLTctMS0xLTYwMjYz_e8565197-ff99-4072-a949-5b082ef3a232">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a6afe95d6949a9b15847a9e5063bda_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEzLTEtMS0xLTYwMjYz_d1b75b56-6548-430a-b876-dcb99d77de73">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7c411ebf213498bbc17286b687febec_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEzLTMtMS0xLTYwMjYz_c5e5e0c8-8dd5-4aa7-8bfe-8e8ab0e50c84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4463c41232a04445bcdcb36422deee33_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEzLTUtMS0xLTYwMjYz_094cb21b-7bad-48f3-bdec-22718295bf43">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f66b73b00546638fb3dfdeea498856_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEzLTctMS0xLTYwMjYz_0ea8e949-18ee-4c40-a722-7785d35c673d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzE0LTEtMS0xLTYwMjYz_5b333b40-90c7-48e1-8bd7-9b5fedf1a18f">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzE0LTMtMS0xLTYwMjYz_b9c15cf5-c42e-41bc-a09d-7efca35d87e2">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzE0LTUtMS0xLTYwMjYz_57cb9565-f05c-4d09-8e0f-ea5945c43e6f">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzE0LTctMS0xLTYwMjYz_bdd13ef0-518e-408c-ab02-938c0d6bcf49">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzQtMS0xLTEtNjAyNjM_0de22cb2-b785-4e70-862f-a80815a54378">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzQtMy0xLTEtNjAyNjM_0911552f-b815-46bd-994e-c5b93232d301">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ef59879afe401591e29ee824de0517_I20211231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzQtNS0xLTEtNjAyNjM_b94a06dd-5fe1-476d-9933-e61b012750d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzQtNy0xLTEtNjAyNjM_4cbb6b63-cfaa-4614-bc85-9d8a2518063c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzUtMS0xLTEtNjAyNjM_1c752a53-8ce1-4a6f-9c99-e477c9e3ba67">14.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzUtMy0xLTEtNjAyNjM_0492b7b7-9d79-47e1-88d9-5a8121378fd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ef59879afe401591e29ee824de0517_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzUtNS0xLTEtNjAyNjM_a62d3c22-4c6a-46cf-b527-3df8d342d17a">14.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzUtNy0xLTEtNjAyNjM_c0528adb-9b53-48ee-97c9-0f169ace09eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d2482447c6049c1a04840f7c479360b_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtMS0xLTEtNzA2NDY_06e533d5-4ed9-4917-88ed-e824f3c39bbc">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83c5430234af414c9fcc3b4df8890d9f_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtMy0xLTEtNjIyMzE_af698ba5-1601-42af-8225-e077f513c1e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d763901eafd48cd8a636ca3db465303_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtNS0xLTEtNjIyMjM_92fe2a4a-be2c-4385-ae19-821bab825536">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie316bb8a16254f0b8e82e29bc1835be1_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtNy0xLTEtNjIyMzU_53f29b4a-6334-494c-bd29-b02c26e06a70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d15643e954d4ef2862b5cf9aeaff59b_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtMS0xLTEtNjAyNjM_2294f9f3-4b45-4890-8a26-561c2fb3c6a9">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1371f6ecf2dd4b64b6bf9d8da230988e_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtMy0xLTEtNjAyNjM_4dee0409-5528-4c16-8bde-3149d959ad10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae5843ba66649458ad2eab839e35a52_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtNS0xLTEtNjAyNjM_e70f3fa4-9cbe-4eca-a285-e61249d287dd">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b86341c878947cd85fe8ec2548111e7_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtNy0xLTEtNjAyNjM_cc0ca5db-370d-43a1-8e37-9760da23e117">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzctMS0xLTEtNjAyNjM_00b9ee55-509e-4c95-b775-0b295c69836b">36.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzctMy0xLTEtNjAyNjM_f96eb9ef-ac7e-4932-86b6-e1de350321a7">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ef59879afe401591e29ee824de0517_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzctNS0xLTEtNjAyNjM_42c9b85f-68bb-437b-9538-39ebbd2d24ce">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzctNy0xLTEtNjAyNjM_24ee5790-4900-4192-ad85-f8d8c6963088">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzktMS0xLTEtNjAyNjM_9fafc4c9-8355-4950-ab8a-8d1f1a3ae995">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzktMy0xLTEtNjAyNjM_a731e114-2a0a-475b-84a8-3814e4b24333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ef59879afe401591e29ee824de0517_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzktNS0xLTEtNjAyNjM_fa801393-fd47-4f62-875f-b7282d6729fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzktNy0xLTEtNjAyNjM_be7c9228-0fbb-4dd5-9173-94252d29155d">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEwLTEtMS0xLTYwMjYz_13361af8-1d45-42a8-b061-6be8b6ab899a">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEwLTMtMS0xLTYwMjYz_ffe90df3-f851-48f1-9025-67a620791efa">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ef59879afe401591e29ee824de0517_I20211231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEwLTUtMS0xLTYwMjYz_8af8ca44-d48c-4084-bbd2-6dd98ea02d1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEwLTctMS0xLTYwMjYz_44ac0945-5925-469e-9b95-7f44646bc0fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if867c326ea304572bf285d245f2729f3_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEyLTEtMS0xLTYwMjYz_c32b4ccf-d8fb-4a81-b867-9a68f480aa1d">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i406f7691b793473590f26cc05c368e11_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEyLTMtMS0xLTYwMjYz_dcc59fdd-6e36-473c-b089-ec80eed72252">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805c24fc27444fd38deafff1a2c4bbe9_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEyLTUtMS0xLTYwMjYz_7a785cdb-da76-4a01-a9cf-1a4063794cd9">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa5b204c1dc4abc86e2792ad48e7b16_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEyLTctMS0xLTYwMjYz_408851e4-f1e8-4a33-b65d-285986cf4641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEzLTEtMS0xLTYwMjYz_8f34bf64-e2f8-4737-ac51-d41f688f2085">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEzLTMtMS0xLTYwMjYz_7a746292-fb06-4c94-ac2f-2f21715106d3">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ef59879afe401591e29ee824de0517_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEzLTUtMS0xLTYwMjYz_f0d23c5a-8d79-4ab3-8e5b-e6c4838a520a">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEzLTctMS0xLTYwMjYz_4020901b-253c-4d8c-b0bd-d18a59a7b943">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7f591eecbdc0429580a521e15389eca2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of the contingent consideration liability, within current and long-term liabilities, related to the SmartDose&#174; technology platform (the &#8220;SmartDose&#174; contingent consideration&#8221;) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#8217; investment selections and is included within other long-term liabilities. The fair value of the cross-currency swap, included within other long-term assets, is valued using a market approach. Please refer to Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_109">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our derivatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities, and is classified as Level 2 within the fair value hierarchy. At December&#160;31, 2022, the estimated fair value of long-term debt was $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUxNTI_1d4f05d4-da96-4dd6-b5c4-768224a2739e">201.8</ix:nonFraction> million compared to a carrying amount of $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUxODg_0610e38f-7eb4-4703-b1f5-6ecb2320c8b7">206.7</ix:nonFraction> million. At December&#160;31, 2021, the estimated fair value of long-term debt was $<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUyNDY_52894503-0bc6-4f97-a0bb-128e8ce22735">217.9</ix:nonFraction> million and the carrying amount was $<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUyNzc_1172fc93-64cb-43bd-9a18-5fb365d76c28">208.8</ix:nonFraction> million.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_115"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13:  <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90ZXh0cmVnaW9uOmQ4NWNkMTg1N2NmMzQ4ODdiODE3ZTljY2IyNjI0MmFkXzQ1OA_7e99c6ad-3181-494c-a713-df92c2407522" continuedAt="ifd8d39d491f84362a2d4c889a577a3e2" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifd8d39d491f84362a2d4c889a577a3e2"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90ZXh0cmVnaW9uOmQ4NWNkMTg1N2NmMzQ4ODdiODE3ZTljY2IyNjI0MmFkXzQ2OQ_b15a0875-2234-4424-bf1e-22506bdaadda" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.358%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and other postretirement plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fbcb98a53e34fcb8a183148ece8920b_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEtMS0xLTEtNjAyNjM_b97d880f-4e1d-459f-a4b5-b452b76b6863">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iade80d0537714f308a08a338374d6b21_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEtMy0xLTEtNjAyNjM_81e04fe0-96af-4133-ae4a-225c325169a3">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32b73b088654490bb5a6be67066e2ae9_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEtNS0xLTEtNjAyNjM_86e7648f-2476-48ef-88a0-e53bbf79d131">40.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i386979849f4a4ca899ce2778bd52f0d5_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEtNy0xLTEtNjAyNjM_4f8a6abd-2da3-4104-8765-c129afb0a71f">108.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17b8a1175e024b0b91f80042eb871d9e_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEtOS0xLTEtNjAyNjM_bb37e1da-ea9a-4b0c-8145-859c6f7b4ba8">149.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54bb101058b8400a88f43f7396f6df6b_D20200101-20201231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzItMS0xLTEtNjAyNjM_32141f90-dda9-476e-89ab-1770c21ad6f7">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecd545d46d342a39efcb16ad10a6df6_D20200101-20201231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzItMy0xLTEtNjAyNjM_0f582526-45f7-46c7-bfa8-2e4162dfc7bc">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97d694cff77844d882d28c32d629311e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzItNS0xLTEtNjAyNjM_e99b4c20-28cd-4f79-9429-c52a82957a9c">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9815180ba0b54d2881441a6cc952417a_D20200101-20201231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzItNy0xLTEtNjAyNjM_adb656d4-d030-48cd-965a-70f4eca471c4">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzItOS0xLTEtNjAyNjM_242613b1-2fa1-4b62-885d-bdc63ac9b42a">40.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54bb101058b8400a88f43f7396f6df6b_D20200101-20201231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzMtMS0xLTEtNjAyNjM_4199141b-25f9-4c0a-a26b-0b9f602f9445">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecd545d46d342a39efcb16ad10a6df6_D20200101-20201231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzMtMy0xLTEtNjAyNjM_2d0b3c79-5f5b-45cf-b7a1-6f931f80a9f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d694cff77844d882d28c32d629311e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzMtNS0xLTEtNjAyNjM_6e5deb43-1d87-408d-a170-63212f439d8b">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9815180ba0b54d2881441a6cc952417a_D20200101-20201231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzMtNy0xLTEtNjAyNjM_cbb532f6-b436-4445-8115-c33f0b323b52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzMtOS0xLTEtNjAyNjM_eebd6e09-0129-46d4-b166-214167e08e68">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54bb101058b8400a88f43f7396f6df6b_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzQtMS0xLTEtNjAyNjM_1352ad29-27b1-4962-bf4b-b55aee8fd8f4">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecd545d46d342a39efcb16ad10a6df6_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzQtMy0xLTEtNjAyNjM_33616ead-f4c2-499c-9c13-15364d7266f8">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97d694cff77844d882d28c32d629311e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzQtNS0xLTEtNjAyNjM_fe51f511-adcc-4d85-a8b5-78ebc86a221b">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9815180ba0b54d2881441a6cc952417a_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzQtNy0xLTEtNjAyNjM_e9fdabb1-3905-4003-97ef-88304c088018">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzQtOS0xLTEtNjAyNjM_67d4823a-8a5d-4836-ad74-bf8ab474c99a">39.0</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie07c502333264b49a0ba4aa4235be632_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzUtMS0xLTEtNjAyNjM_6033fd51-ef03-47ef-9619-3e6e8f24250c">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79faae59eb5747f094ec247979277f49_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzUtMy0xLTEtNjAyNjM_c56c4d81-451c-4a5c-91ac-368577fb355b">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89bf04ee5a4a44318e42a1114576fc19_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzUtNS0xLTEtNjAyNjM_ca5afa6a-c652-41ca-bbc8-c3bd06c7467b">40.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ff1cabbd90749c99af71165f285a71c_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzUtNy0xLTEtNjAyNjM_9cdaa459-ea68-4018-bc57-951f35fa87d9">68.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida3c98d3c0354b73a89f724be3743416_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzUtOS0xLTEtNjAyNjM_cf1cc49e-ed63-4ca3-b1e8-1c981a1c4f0d">110.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8a86bade84543889f6b81500c0a8ac5_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzYtMS0xLTEtNjAyNjM_c45013af-5d51-47ab-a379-c19989549cfa">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46a1f438f8461684e84f9c8c79e508_D20210101-20211231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzYtMy0xLTEtNjAyNjM_f346f681-4881-44de-8a63-47673b5de77f">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d66b7db239e48d5b1af0749bb3ea343_D20210101-20211231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzYtNS0xLTEtNjAyNjM_30b70030-f5f8-4ad2-8592-a1027c0d27d7">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0662f0d0f62149118e93596ed7214b5c_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzYtNy0xLTEtNjAyNjM_c2fd6983-b1a1-4631-a53f-cf62f51fc463">59.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzYtOS0xLTEtNjAyNjM_82993d79-c528-4bf0-b56b-3e0af9df6ba3">52.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8a86bade84543889f6b81500c0a8ac5_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzctMS0xLTEtNjAyNjM_1a1c682f-ab82-4599-bcaa-dd020928277f">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46a1f438f8461684e84f9c8c79e508_D20210101-20211231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzctMy0xLTEtNjAyNjM_b1dbe6d4-85ca-4e15-9c42-4c9562c64a51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d66b7db239e48d5b1af0749bb3ea343_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzctNS0xLTEtNjAyNjM_4a2ce4e9-a287-4c8b-9e2c-a48f55defbeb">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0662f0d0f62149118e93596ed7214b5c_D20210101-20211231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzctNy0xLTEtNjAyNjM_57e6a276-4458-4f9b-864b-85a198bf2ab6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzctOS0xLTEtNjAyNjM_a49dcfc1-1a76-478a-bc90-36c984509c69">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8a86bade84543889f6b81500c0a8ac5_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzgtMS0xLTEtNjAyNjM_808238ce-2c6d-4161-96d9-bbba4a8ef5f0">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46a1f438f8461684e84f9c8c79e508_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzgtMy0xLTEtNjAyNjM_beeea04f-813f-4400-800f-b5eb586ecfd0">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d66b7db239e48d5b1af0749bb3ea343_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzgtNS0xLTEtNjAyNjM_475d668d-d32b-47b9-8947-9607dd7d18c9">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0662f0d0f62149118e93596ed7214b5c_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzgtNy0xLTEtNjAyNjM_174cf572-d7bd-4252-a40e-f7fb4da8780e">59.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzgtOS0xLTEtNjAyNjM_0a957779-430c-46d9-b4c6-b00164331668">49.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2a17d2034694fe895103701a3db15e7_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzktMS0xLTEtNjAyNjM_5de69996-3b6e-489a-9ccd-eb34ed33178a">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063266317845420c9c9604cf2e5a3b01_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzktMy0xLTEtNjAyNjM_271a692a-c445-43f6-931a-195813df80a4">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1289dce1d1384485a949179f19183178_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzktNS0xLTEtNjAyNjM_05a0a597-8b10-4500-8582-88bf298010de">31.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56913a13b5944c5587eaaa2f5fb63640_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzktNy0xLTEtNjAyNjM_0897af1a-5878-405e-ba3d-3e24be8dec53">128.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e14a309edfa4014932d060921715d47_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzktOS0xLTEtNjAyNjM_2db3ff80-7114-42a4-a854-96660e7b5b2e">159.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99e48d0827e84674a9f7b673ab8b3adf_D20220101-20221231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEwLTEtMS0xLTYwMjYz_94189774-8c11-4a44-b721-7a8217ecdacd">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d3089900f144029822b0251c552161_D20220101-20221231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEwLTMtMS0xLTYwMjYz_bf89dcb4-def9-4538-9ed6-b23f3ad41d61">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d37456ab52c475297384d08d55cb38d_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEwLTUtMS0xLTYwMjYz_44e61a2b-ab78-42db-ab6a-9c3e38246e4d">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if40187b8b7a64ea69df5cf9e017b64fd_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEwLTctMS0xLTYwMjYz_3e617c31-fd99-4b7d-b5e1-9d23b624a788">47.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEwLTktMS0xLTYwMjYz_0befaebb-f0ba-4f7d-9c92-84f82e9a8a02">56.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99e48d0827e84674a9f7b673ab8b3adf_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzExLTEtMS0xLTYwMjYz_5fb3f871-099a-4e7f-8780-65a24f0794dc">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d3089900f144029822b0251c552161_D20220101-20221231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzExLTMtMS0xLTYwMjYz_85b67c77-21a9-4762-a4f7-7a5eb09647b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d37456ab52c475297384d08d55cb38d_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzExLTUtMS0xLTYwMjYz_44e2971b-bb04-4ac7-abf9-9292e09f83e3">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40187b8b7a64ea69df5cf9e017b64fd_D20220101-20221231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzExLTctMS0xLTYwMjYz_44f7b411-3fcc-4e1f-bd61-9f0974a71aa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzExLTktMS0xLTYwMjYz_ecf7e0ea-4247-476c-bbaf-42841a7670d5">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99e48d0827e84674a9f7b673ab8b3adf_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEyLTEtMS0xLTYwMjYz_7117ad93-a0c8-476a-a67c-cce8dfa672a0">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d3089900f144029822b0251c552161_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEyLTMtMS0xLTYwMjYz_da9dae30-b0f3-4de1-8c43-442fe3c9b56b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d37456ab52c475297384d08d55cb38d_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEyLTUtMS0xLTYwMjYz_177c4dce-efe9-4162-b2c1-d36a95491771">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if40187b8b7a64ea69df5cf9e017b64fd_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEyLTctMS0xLTYwMjYz_faadeedf-f9f6-4bf5-978d-3c662d2308e6">47.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEyLTktMS0xLTYwMjYz_ca9c1151-0c14-4861-89bd-6f689cfd7efd">23.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0818a4e839d4d98b9c9d2fb94135719_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEzLTEtMS0xLTYwMjYz_339477a0-d97f-481b-9b77-c94f9918e7f4">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i572ebcf46c464f8480b6b43ea02ed0cb_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEzLTMtMS0xLTYwMjYz_edad405b-6746-43b6-8179-a18c47fb61e9">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc24b95cad0a44dfa74ee686cfc4c554_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEzLTUtMS0xLTYwMjYz_5c4a28ce-e203-4fe6-9817-7a575441952a">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e50ef11a0b74e949d7a233e7b69d9df_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEzLTctMS0xLTYwMjYz_6dde1da7-5548-4f3c-a68f-18f8831995de">175.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e6cb706114942e4aabe6faaacf4e663_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEzLTktMS0xLTYwMjYz_9d7bb0cf-d47e-4e7f-92be-fe5ef9190c51">183.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90ZXh0cmVnaW9uOmQ4NWNkMTg1N2NmMzQ4ODdiODE3ZTljY2IyNjI0MmFkXzQ2MQ_59ef8eda-ccb6-4374-af57-6f412247876b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:34.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.360%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Detail of components</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on derivatives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5c740ee53d14acab5e8ce562e9ed2b3_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzItMi0xLTEtNjAyNjM_e308d694-87b6-4ee2-8d2e-19b5ff221887">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04413dcc613d457fb097e0213020ab3f_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzItNC0xLTEtNjAyNjM_8e0ec28c-8fd6-4eb5-b75e-eb2da36b844d">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32f586765ed14e30998543a97afb12e6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzItNi0xLTEtNjAyNjM_d16554f5-83ba-45c9-90bf-d7e59a058d86">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5c740ee53d14acab5e8ce562e9ed2b3_D20220101-20221231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzMtMi0xLTEtNjAyNjM_2f5efe0b-4e86-4643-aa1d-6a7bfda527af">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04413dcc613d457fb097e0213020ab3f_D20210101-20211231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzMtNC0xLTEtNjAyNjM_ac9165ac-048e-4844-b6ba-5030d4fe0afc">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32f586765ed14e30998543a97afb12e6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzMtNi0xLTEtNjAyNjM_4f63ed2b-8969-4069-94f6-b034f1c2185f">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5c740ee53d14acab5e8ce562e9ed2b3_D20220101-20221231" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzQtMi0xLTEtNjAyNjM_f255ffe9-d508-4fd4-9348-ac9cb4ead5a3">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04413dcc613d457fb097e0213020ab3f_D20210101-20211231" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzQtNC0xLTEtNjAyNjM_ce34f36d-470d-4d5d-a079-6d67e03839d0">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32f586765ed14e30998543a97afb12e6_D20200101-20201231" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzQtNi0xLTEtNjAyNjM_8884d662-75f2-43a0-961f-25485d307626">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1a24648febc446d97d71a944faf23c8_D20220101-20221231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzUtMi0xLTEtNjAyNjM_77e54f52-afe0-4109-91af-b2262ac1775b">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icadfe694aab14a67aa2e38dfb55e6d5f_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzUtNC0xLTEtNjAyNjM_ec82e128-805e-44c8-93a3-ad975c93500d">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d89b5b64b2f47fabc89d28b39c6abb3_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzUtNi0xLTEtNjAyNjM_26c309b0-9922-4147-8971-52c9aec46cac">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ec8f38ddecf4489927d3f56c19b2c35_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzYtMi0xLTEtNjAyNjM_a8021121-bbc1-4b7a-ab8b-8013de819f55">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c01348d5d61478b9245598d8ff9f61e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzYtNC0xLTEtNjAyNjM_f0dd713e-05d4-4848-a2a9-e15186aa582b">2.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id573bfa61009494da99108c926e21d55_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzYtNi0xLTEtNjAyNjM_0fb9aa64-70d1-4ecb-bdfa-979a124e62ea">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ec8f38ddecf4489927d3f56c19b2c35_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzctMi0xLTEtNjAyNjM_2f7d78a7-c0fb-454a-83ee-c14562f34908">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c01348d5d61478b9245598d8ff9f61e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzctNC0xLTEtNjAyNjM_5da0517d-5208-495c-bf43-c4b4ff32427e">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id573bfa61009494da99108c926e21d55_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzctNi0xLTEtNjAyNjM_60630498-6e7c-4504-8887-3d1628ce01d2">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ec8f38ddecf4489927d3f56c19b2c35_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzgtMi0xLTEtNjAyNjM_31bb4345-78f6-408a-9c33-21fb8ed391d4">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c01348d5d61478b9245598d8ff9f61e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzgtNC0xLTEtNjAyNjM_ba3344ce-70e4-4c0c-bba5-07d6691f07c5">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id573bfa61009494da99108c926e21d55_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzgtNi0xLTEtNjAyNjM_4042277c-b78b-408f-885b-acfa6ba3e00f">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzExLTItMS0xLTYwMjYz_ce2af7a6-2eaa-45c1-addd-b9f5fc7734da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzExLTQtMS0xLTYwMjYz_b51298b5-e68d-4376-8fb9-7f7506c5e857">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzExLTYtMS0xLTYwMjYz_b2f709ba-111f-4ca7-8178-ede1ccc1e9c5">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEyLTItMS0xLTYwMjYz_32e61eef-9236-4062-8529-77a6fef9dd10">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEyLTQtMS0xLTYwMjYz_f98ce3c9-7d1d-4b29-8363-c0038fbaf151">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEyLTYtMS0xLTYwMjYz_af96c5eb-eb36-4cd7-926b-e614bf532e87">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEzLTItMS0xLTYwMjYz_3ec66b47-d035-4b93-8824-f8839d89afb5">52.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEzLTQtMS0xLTYwMjYz_e56ca579-37ac-48cf-b634-f2e8f0f81b96">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEzLTYtMS0xLTc3NjMx_fbafb532-ece6-42a6-a69a-28b73b9ac574">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE0LTItMS0xLTYwMjYz_097e431c-0de4-4aae-8df8-eb5a64862fb2">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE0LTQtMS0xLTYwMjYz_ce17d297-504e-4879-9c15-42c2fcec0498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE0LTYtMS0xLTYwMjYz_05d669bc-b8bf-4a78-8f27-e652a5fdc55e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE1LTItMS0xLTYwMjYz_4fed5688-09a1-4e8d-bc5c-acd6bf088a7b">52.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE1LTQtMS0xLTYwMjYz_7aed06be-eef7-48ae-a896-f793d940a08f">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE1LTYtMS0xLTYwMjYz_5a7c0eb1-209a-4cbc-80d5-163378fbb9e3">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE2LTItMS0xLTYwMjYz_aea5b87c-298b-4abb-81cc-18cc64b02ab7">20.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE2LTQtMS0xLTYwMjYz_6bbc82ed-90a4-48a5-b6d8-02871c6d969a">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE2LTYtMS0xLTYwMjYz_6c21fcf1-2c87-481e-bc30-8adf4986afd1">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE3LTItMS0xLTYwMjYz_d222d32f-2fd7-4960-a29b-469b8f4cdf9f">31.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE3LTQtMS0xLTYwMjYz_2d211a77-7a83-45b4-8f80-942fcb0108fa">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE3LTYtMS0xLTYwMjYz_29af54c9-b6ef-47d7-a535-b2797f568f4b">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe8ca4226e454ae6ac3d77c3f63f4645_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE4LTItMS0xLTYwMjYz_890280d6-0e61-4d5e-a210-b57dc8550cb7">32.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57bae4fdbc424d98b421183e9aa884b0_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE4LTQtMS0xLTYwMjYz_18c16551-bcfc-45c9-b820-16c088c88c82">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7a2f289af4db3bb7d06fea36d17ae_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE4LTYtMS0xLTYwMjYz_a238ecf0-f1f7-456e-a65d-59b9cd604765">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_121">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_118"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyNjQ_f5562dc5-3010-4842-848c-472c9645dc7b" continuedAt="i4b14974d817747028d646c979ec932a6" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4b14974d817747028d646c979ec932a6" continuedAt="i80a8ef4860cf411a87a4a224a8928d44"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#8220;2016 Plan&#8221;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At December&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzQ1MQ_d1640efd-755f-4085-8749-586de5f79e1e">1,681,526</ix:nonFraction> shares remaining in the 2016 Plan for future grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options and stock appreciation rights reduce the number of shares available by <ix:nonFraction unitRef="shares" contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231" decimals="INF" name="wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzU5Mw_c7a1b273-7ec0-4018-bf4f-4564c3d292f0">one</ix:nonFraction> share for each award granted. All other awards under the 2016 Plan will reduce the total number of shares available for grant by an amount equal to <ix:nonFraction unitRef="shares" contextRef="ie7a283afeb8f40c6817f0e72d6df5ccd_D20220101-20221231" decimals="INF" name="wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc0NA_f1a6b43a-d886-46a5-8b33-00ec7ba79948">2.5</ix:nonFraction> times the number of shares awarded. If awards made under previous plans would entitle a plan participant to an amount of West stock in excess of the target amount, the additional shares (up to a maximum threshold amount) will be distributed under the 2016 Plan.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyNDk_15803c4a-a60a-4b2b-a7f5-2ae53ae29c76" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option and appreciation rights</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd99140b0fe444a2968f0cf1a36fa8ce_D20220101-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzEtMS0xLTEtNjAyNjM_0cef63f9-d96f-4d52-bf3a-3a42e08088a1">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4be6b9f04b6470da6ab0ab85cb527ce_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzEtMy0xLTEtNjAyNjM_b5bfea4e-ea61-435c-9dac-9c0f5778e884">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20ebcecb9d2c4a209b92fbebb9207661_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzEtNS0xLTEtNjAyNjM_adf86233-d51c-423e-8544-a71f6faa02c0">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, stock-settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6834a2454c954e5db472d9a40c33b13a_D20220101-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzItMS0xLTEtNjAyNjM_c86685f6-f427-439f-b0b9-9584b099f2ed">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3996b06720ee42ee8d78c7b8b11628f8_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzItMy0xLTEtNjAyNjM_18a73eea-cf17-4541-9ce3-58074c59d442">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5167798386874e29a8044c426c90a599_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzItNS0xLTEtNjAyNjM_4480f49a-0805-4774-a75a-74172ef8c0f2">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, cash-settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzMtMS0xLTEtNjAyNjM_727678bb-5bca-4327-93fe-ca50e4ebd70c">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c52a1e553d247a3ae76670f5304a50f_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzMtMy0xLTEtNjAyNjM_a3864292-6027-42a5-8c02-ab91fdc61a18">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia216fe90970d46f4be2d33c145486b81_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzMtNS0xLTEtNjAyNjM_a9760ce9-a51c-4b0c-ab2d-001db38233fd">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, dividend equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4ef8dd22a4a44f7beffb4e9f338e878_D20220101-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzQtMS0xLTEtNjAyNjM_174b9e49-d7a0-4f18-9aad-93a92732e26e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c784d4eec04d78922a4e192bf59230_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzQtMy0xLTEtNjAyNjM_9d5a8f04-5a9e-4411-8b60-14c0e8fad2aa">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia68e46033cf0466e976bea07f5d6efef_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzQtNS0xLTEtNjAyNjM_650cbb58-e089-4353-a28d-8aa9a111c8de">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzUtMS0xLTEtNjAyNjM_c5d385bc-df61-4ceb-beaf-bc3033f93094">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i238ef97a2c414fa79ce155548aec647a_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzUtMy0xLTEtNjAyNjM_0582a949-156a-4de9-98d6-1f16f5880fb9">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b919b91eeb42da9481eb832c9b75c9_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzUtNS0xLTEtNjAyNjM_7f2d067a-09b9-4a56-8bcd-ec1e95f8d50a">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans and restricted share awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2db706bfea84d8885a041634831858e_D20220101-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzYtMS0xLTEtNjAyNjM_b94af526-4cd7-4c29-b58c-b9da8028c5d4">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id638f8160a6944ce83eb5f9cd2ee6de7_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzYtMy0xLTEtNjAyNjM_66a05c1c-780d-40a7-9cec-dc9331e60e74">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718facb9187748eebcc936a4e7a55f42_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzYtNS0xLTEtNjAyNjM_7033ee9b-f225-4b98-9a61-2cc7bbdd0147">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzctMS0xLTEtNjAyNjM_58679a6a-983c-439d-bb31-21fa9c82a2f5">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzctMy0xLTEtNjAyNjM_eeb38042-5c86-46e4-8b21-8badaa1e58fa">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzctNS0xLTEtNjAyNjM_d3287b5c-72d3-4fa8-9b09-1ad78e6bb6c6">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates expected forfeitures. The amount of unrecognized compensation expense for all non-vested awards as of December&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzEzMjA_9c440b01-8ace-404c-b14c-02374920dc92">28.9</ix:nonFraction> million, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzEzOTM_293803a5-babc-4383-b531-c13fde95ef2b">1.6</ix:nonNumeric> years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted to employees vest in equal increments. All awards expire <ix:nonNumeric contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzE0OTk_55ed9083-c53e-4fdf-be57-e854f8386b36">10</ix:nonNumeric> years from the date of grant. Upon the exercise of stock options, shares are issued in exchange for the exercise price of the options. </span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i80a8ef4860cf411a87a4a224a8928d44" continuedAt="idd50ac9b3834491e9a3ec70dae48acef"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyODQ_dc62e0ef-226b-440b-bbea-eef259bf247e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding options:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:60.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzEtMS0xLTEtNjAyNjM_6e9badaf-e049-41e3-8a74-6ea6fdab9235">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzItMS0xLTEtNjAyNjM_6b54a5df-382d-4ab0-baf1-12ad4e510cdc">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzMtMS0xLTEtNjAyNjM_0e24f790-2e77-4c70-879b-0774561ae48e">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzQtMS0xLTEtNjAyNjM_5ab52d49-5781-428a-9b51-abd4bb3702dc">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzUtMS0xLTEtNjAyNjM_10383282-cb2f-443b-9079-fa7532b0c519">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzYtMS0xLTEtNzI1MTQ_849434d2-9d09-4b36-9c01-524957ae3f82">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzYtMS0xLTEtNjAyNjM_b51e2ec4-ef1c-487a-b247-9ab1ec50cf60">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:60.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzEtMS0xLTEtNjAyNjM_2cddacd5-bad9-4ad7-9fdd-e674a426697a">101.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzItMS0xLTEtNjAyNjM_8255c80f-df55-435f-85a0-1371eadd5b62">364.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzMtMS0xLTEtNjAyNjM_0ac8afbe-ce96-44b0-ad8d-9f23cb189662">83.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzQtMS0xLTEtNjAyNjM_2df02d99-665d-4e5d-b2f1-b6af48bd6237">224.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzUtMS0xLTEtNjAyNjM_89e2beac-9814-4fef-ad1b-7ab624fbe2a1">118.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest, December 31</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzYtMS0xLTEtNzI1MDQ_5c951539-90b6-42b7-9bb7-e13e116a48db">116.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzYtMS0xLTEtNjAyNjM_1a548430-480b-4107-bf19-308914b63a0b">84.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the weighted average remaining contractual life of options outstanding and of options exercisable was <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzE4MjA_9fc89af9-b05f-4266-9feb-6623bf394b93">4.8</ix:nonNumeric> years and <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzE4MzM_f62dc658-950f-44bc-8a60-8a65f0754791">4.0</ix:nonNumeric> years, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the aggregate intrinsic value of total options outstanding was $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzE5MzE_60e94451-13c9-4960-a772-2c2595a7aa1c">241.4</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzE5NDQ_08969107-3325-4656-856b-5d2caf483173">225.6</ix:nonFraction> million represented vested options.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options was estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted average assumptions in 2022, 2021 and 2020: a risk-free interest rate of <ix:nonFraction unitRef="number" contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxODY_98711a81-6b05-413a-a329-d977b9985d95">1.8</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i58930e1b5c274240b867fdb589c2ab06_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxOTA_ecdf8c91-66b7-4394-b3f0-5ea13f0dc896">0.8</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="ie41ef75fe7f74deeb695babb739e40e5_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxOTg_59d8ee72-0355-4139-8e7c-e7cc129b4a0b">1.3</ix:nonFraction>%, respectively; stock volatility of <ix:nonFraction unitRef="number" contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIyMzY_df160480-e304-452a-a42b-e05b95d1b255">25.1</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i58930e1b5c274240b867fdb589c2ab06_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIyNDA_e798b1c7-6fd1-480e-bb52-8740cd131393">23.9</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="ie41ef75fe7f74deeb695babb739e40e5_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIyNDg_151baa80-8dbd-4cb4-8a32-54fc54c0cec0">22.4</ix:nonFraction>%, respectively; and dividend yields of <ix:nonFraction unitRef="number" contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIyODk_ab0f0079-03e8-4ad8-bed7-ecdfaa1aa670">0.2</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i58930e1b5c274240b867fdb589c2ab06_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIyOTM_ca3dc5a3-dcfe-43fb-b01d-714740f051a2">0.3</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="ie41ef75fe7f74deeb695babb739e40e5_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIzMDE_a5a393ac-3eeb-49a7-b1bf-b4c011505ffb">0.4</ix:nonFraction>%, respectively. Stock volatility is estimated based on historical data and the impact from expected future trends. Expected lives, which are based on prior experience, averaged <ix:nonNumeric contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI0ODA_16d87623-4ce9-4af3-8e2a-f028ee6bbfd6"><ix:nonNumeric contextRef="i58930e1b5c274240b867fdb589c2ab06_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI0ODA_7dbee8c1-93b8-4abf-aa4b-1c7f74bf940e">5.6</ix:nonNumeric></ix:nonNumeric> years for 2022 and 2021 and <ix:nonNumeric contextRef="ie41ef75fe7f74deeb695babb739e40e5_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxOTkwMjMyNjM4NTM_880e3f04-5a10-47dc-9461-d4ff25dd3022">5.7</ix:nonNumeric> years for 2020. The weighted average grant date fair value of options granted in 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI2MDc_8fd91f76-2b8c-4b3d-8515-d7c80c20588e">96.43</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI2MTE_c5b15c15-308e-44bd-a024-ffe4a7429f1b">64.51</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI2MTg_4cd39e2c-3578-4877-9354-5c4f063278f2">40.28</ix:nonFraction>, respectively. Stock option expense is recognized over the vesting period, net of forfeitures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, the intrinsic value of options exercised was $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI4MTA_0b516679-5a24-47f9-a9e7-b59a0e4a8f91">60.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI4MTQ_7da7dd6d-7ab7-45a5-a84a-742844dec979">147.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI4MjE_9d93f729-d357-45d7-9f78-f02b7e1ce4fa">88.8</ix:nonFraction> million, respectively. The grant date fair value of options vested during those same periods was $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI5MTM_eeb15c23-e573-4ea2-8592-8653a91d0e3c">8.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI5MTc_5224d242-dd26-4be5-95e8-0591972b01cb">8.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI5MjQ_a875e980-32b5-4451-8f8c-3be716f2373d">8.4</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock appreciation rights (&#8220;SARs&#8221;) granted to eligible international employees vest in equal annual increments over <ix:nonNumeric contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzMwODY_fc2b5b9b-2e9b-47cb-be7b-803a59cfb554">4</ix:nonNumeric> years of continuous service. All awards expire <ix:nonNumeric contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzMxMzA_7c157952-79b2-4cdd-98d7-5f0fdb682659">10</ix:nonNumeric> years from the date of grant. The fair value of each cash-settled SAR is adjusted at the end of each reporting period, with the resulting change reflected in expense. As of December&#160;31, 2022, SARs outstanding were <ix:nonFraction unitRef="shares" contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzMzMjY_12306caf-b349-4deb-a955-ae6f1b9bb470">20,402</ix:nonFraction>, all of which were cash-settled. Upon exercise of a cash-settled SAR, the employee receives cash for the difference between the grant date price and the fair market value of the Company&#8217;s stock on the date of exercise. As a result of the cash settlement feature, cash-settled SARs are recorded within other long-term liabilities. Upon exercise of a stock-settled SAR, shares are issued in exchange for the exercise price of the stock-settled SAR. As a result of the stock settlement feature, stock-settled SARs are recorded within equity.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idd50ac9b3834491e9a3ec70dae48acef" continuedAt="i98b99f6be51d412bb92a9a15ee6162bb"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyNjM_fbe1884b-40cd-4138-9092-0c069f9a664a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding SARs:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:60.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i756408cda2044016850493d82b241ade_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzEtMS0xLTEtNjAyNjM_a5eb2504-d9aa-46ae-b8f7-c078622215e9">21,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzItMS0xLTEtNjAyNjM_396a5baf-2717-42db-b7a9-2f88ce0908b2">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzMtMS0xLTEtNjAyNjM_f4ba2f0e-a744-4671-bf23-8f12419878dd">1,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzQtMS0xLTEtNjAyNjM_d0dd3bdf-4a76-46f9-af86-076658efcd48">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzUtMS0xLTEtNjAyNjM_c88a79fb-29d7-4f3c-9ba6-9d522b0cbb85">20,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and expected to vest, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzYtMS0xLTEtNzI1MTY_66d383a7-a781-4ba6-b438-c3e5123216cf">20,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and exercisable, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzYtMS0xLTEtNjAyNjM_be29bd96-0333-42d1-8fc9-e2f589924418">17,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:60.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i756408cda2044016850493d82b241ade_I20211231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzItMS0xLTEtNjAyNjM_66ae7732-0d8d-4b73-b488-4e8589ea7c8a">88.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzMtMS0xLTEtNjAyNjM_b5c923dd-6c41-43ba-9d10-a64d8e733c8c">369.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzQtMS0xLTEtNjAyNjM_90149076-be8f-4343-ba5e-ec3a5df7bcdd">54.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzUtMS0xLTEtNjAyNjM_fd0dee62-bec7-471c-b612-b4086a370b07">21.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzYtMS0xLTEtNjAyNjM_89133271-df1b-4aee-872e-5ccdd8ffd282">97.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and expected to vest, December 31</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzctMS0xLTEtNzI1MTg_d3555198-dd53-41ec-9c4d-95f1cf823483">97.28</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and exercisable, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzctMS0xLTEtNjAyNjM_f6deeb7c-48af-4c93-b937-bc66c44edffc">74.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Awards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to stock options and SAR awards, we grant performance share unit (&#8220;PSU&#8221;) awards to eligible employees. These awards are earned based on the Company&#8217;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock, whereas recipients of cash-settled PSU awards are entitled to receive a payment in cash per unit based on the fair market value of a share of our common stock at the end of the performance period.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyNjc_cc11e299-8422-414b-bdca-fc11a465d0e1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding stock-settled PSU awards:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:60.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbc7d817970f475e8dee97b98a3a0b5a_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzEtMS0xLTEtNjAyNjM_a28e5132-e3f7-4af0-9898-5f94bba0c009">164,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzItMS0xLTEtNjAyNjM_d292de2e-8551-4d44-9b76-2ea6a5216042">32,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzMtMS0xLTEtNjAyNjM_523855ca-a9b1-4333-a0d1-4549ab6f1453">68,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzQtMS0xLTEtNjAyNjM_6bb1f2ae-8922-4771-8632-879e554900a6">144,490</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzUtMS0xLTEtNjAyNjM_0119eccf-531a-47c5-917b-a373745ee7b7">7,966</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i614e5023b53d4eab9f1069365d95f319_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzYtMS0xLTEtNjAyNjM_57c6af54-0375-4274-8740-e978110b0492">112,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icbc7d817970f475e8dee97b98a3a0b5a_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzktMS0xLTEtNjAyNjM_bdb8caee-7ba1-4de5-8c3d-d94ad0d1d160">179.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzEwLTEtMS0xLTYwMjYz_ba01a35b-f26f-49f4-a8dc-55675b8eb786">362.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzExLTEtMS0xLTYwMjYz_119fb080-f461-4956-8593-158047aa7f33">106.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzEyLTEtMS0xLTYwMjYz_a6c916b3-8d1f-4fd0-b408-ef7bd1d50cf4">369.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzEzLTEtMS0xLTYwMjYz_6cd170e9-d360-4f6b-b08f-8079ab1434b1">240.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i614e5023b53d4eab9f1069365d95f319_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzE0LTEtMS0xLTYwMjYz_7471539b-37d9-469d-9599-ca4ca3d8f72e">278.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i98b99f6be51d412bb92a9a15ee6162bb" continuedAt="i975a024db03d420fb116bd9925e9f937"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares earned under PSU awards may vary from <ix:nonFraction unitRef="number" contextRef="i747f5bde668b43608459580452ed13c2_D20220101-20221231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzQ3NTM_ebafab32-cd95-4159-99aa-3072c6973a9c">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i0b4e19b379674031b1a3259ea2819573_D20220101-20221231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzQ3NTk_b5c75370-a035-4a94-94d4-5e3e3e470b5f">200</ix:nonFraction>% of an employee&#8217;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures. The weighted average grant date fair value of stock-settled PSU awards granted during the years 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzUxMzM_44d49ba2-e3dc-4b40-94a8-86bf14f6455e">362.40</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="ib8ccc47a7d0f4470933be376826c61d0_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzUxMzc_6a46bb6e-b26c-446f-b9a5-c317663e5f95">333.58</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i5865c2fe32d348938d9c4f301afde2ed_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzUxNDQ_63f70d1c-8758-4b8a-a04e-8ff5a44c3836">177.31</ix:nonFraction>, respectively. Including forfeiture and target achievement expectations, we expect that the stock-settled PSU awards will convert to <ix:nonFraction unitRef="shares" contextRef="i614e5023b53d4eab9f1069365d95f319_I20221231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzUyODA_04c2fd16-921d-44de-819b-a3094cd2e3b4">94,480</ix:nonFraction> shares to be issued over an average remaining term of <ix:nonNumeric contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzUzMzc_9f4bd6f8-20a1-4473-9a1d-40e5c808442a">one year</ix:nonNumeric>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of cash-settled PSU awards is also based on the market price of our stock at the grant date. These awards are revalued at the end of each quarter based on changes in our stock price. As a result of the cash settlement feature, cash-settled PSU awards are recorded within other long-term liabilities.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyNTY_204b2226-a77f-408e-aa0f-d2ea5435b3ad" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding cash-settled PSU awards:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:60.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibacbcc57bab8485890bc85e0309a4c6a_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzEtMS0xLTEtNjAyNjM_e4bd0367-e0b3-4cd0-8425-f99cec68c1fb">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzItMS0xLTEtNjAyNjM_9d5b9504-4293-40ae-a05a-de2ea0a3daf1">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzMtMS0xLTEtNjAyNjM_7bc68d20-630d-457c-84b8-1ae3d6e27209">507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzQtMS0xLTEtNjAyNjM_fc6b935e-b690-4d8c-b754-1f3b97bd2a7d">1,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzUtMS0xLTEtNjAyNjM_d58b5d09-1295-43d5-850b-4c1dbb3e1132">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e4d798726024904a0f9840ffb306523_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzYtMS0xLTEtNjAyNjM_37057a59-d248-43ad-bdfc-12f5e93d2de9">890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:60.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibacbcc57bab8485890bc85e0309a4c6a_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzEtMS0xLTEtNjAyNjM_8ce54f9d-767b-4edf-a67e-bf13a4cbffa7">169.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzItMS0xLTEtNjAyNjM_707a9069-7b6f-4845-b089-144aa683f74f">369.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzMtMS0xLTEtNjAyNjM_ad664428-3c74-48c2-9500-aa2fb76f559f">104.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzQtMS0xLTEtNjAyNjM_3c898fe4-0fc5-40b6-b90b-897ffa7a08e0">369.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzUtMS0xLTEtNjAyNjM_1b624a37-aeea-431d-9e9a-25d94d811120">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2e4d798726024904a0f9840ffb306523_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzYtMS0xLTEtNjAyNjM_5963f885-a15f-4c20-aba4-dc40c005a402">242.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer an Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which provides for the sale of our common stock to eligible employees at <ix:nonFraction unitRef="number" contextRef="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzU5MDY_3cfa2e1f-23b5-4fb4-b0dd-ed69bf5afc37">85</ix:nonFraction>% of the current market price on the last trading day of each quarterly offering period. Payroll deductions are limited to <ix:nonFraction unitRef="number" contextRef="i16b25fe7a8fb4b17a57c7cc7d9884e52_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYwMzA_177d2c52-8d48-4470-b646-59b074d65a65">25</ix:nonFraction>% of the employee&#8217;s base salary, not to exceed $<ix:nonFraction unitRef="usd" contextRef="i16b25fe7a8fb4b17a57c7cc7d9884e52_I20221231" decimals="-3" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYwNzg_45b1ed69-3d62-43f8-a964-b4e921e1ecfc">25,000</ix:nonFraction> in any one calendar year. In addition, employees may not buy more than <ix:nonFraction unitRef="shares" contextRef="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYxNTI_17aa71bb-cbb2-4439-9dbe-400038142ab8">2,000</ix:nonFraction> shares during any offering period (<ix:nonFraction unitRef="shares" contextRef="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYxOTA_77bb18ae-8205-4267-815c-bff2f6768962">8,000</ix:nonFraction> shares per year). Purchases under the ESPP were <ix:nonFraction unitRef="shares" contextRef="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYyNDE_ede85acb-41ae-4739-b350-d8a64c775009">27,894</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="i238ef97a2c414fa79ce155548aec647a_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYyNTI_1271ab6d-7b4b-4d48-bd07-b2ad6e04686d">27,016</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="ia1b919b91eeb42da9481eb832c9b75c9_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYyNjY_2850f99d-41ab-4feb-ab04-bba936d0ca55">36,494</ix:nonFraction> shares for the years 2022, 2021 and 2020, respectively. At December&#160;31, 2022, there were approximately <ix:nonFraction unitRef="shares" contextRef="i16b25fe7a8fb4b17a57c7cc7d9884e52_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYzNTE_832709c5-4053-4f58-83b9-98169e910968">3,738,000</ix:nonFraction> shares available for issuance under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Plans and Restricted Share Awards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred compensation plans include a Non-Qualified Deferred Compensation Plan for Non-Employee Directors, under which non-employee directors may defer all or part of their annual cash retainers. The deferred fees may be credited to a stock-equivalent account. Amounts credited to this account are converted into deferred stock units based on the fair market value of <ix:nonFraction unitRef="shares" contextRef="i9aa30653f5684e34aaab6637e5921d32_D20220101-20221231" decimals="INF" name="wst:DeferredCompensationArrangementWithIndividualConversionUnit" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzY4MzA_ac08b34c-49c5-4754-9f30-de6916f028e4">one</ix:nonFraction> share of our common stock on the last day of the quarter. For deferred stock units ultimately paid in cash, a liability is calculated at an amount determined by multiplying the number of units by the fair market value of our common stock at the end of each reporting period. In addition, deferred stock awards are granted on the date of our annual meeting, and are distributed in shares of common stock. In 2022, we granted <ix:nonFraction unitRef="shares" contextRef="ie73ec10e708d43e191bb939a896cda33_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzcyNTU_84355e6a-93b3-484f-a52b-ac4f87a0dc4f">4,827</ix:nonFraction> deferred stock awards, with a weighted grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie73ec10e708d43e191bb939a896cda33_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzczMjI_a5264433-bb67-4d29-937f-1e8dc3724f4a">300.78</ix:nonFraction>. In 2021, we granted <ix:nonFraction unitRef="shares" contextRef="i26532d87fb9149e18d431a1b831b2c44_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzczNDY_2a05a75a-e9e3-4176-b37e-ff036619cc42">6,034</ix:nonFraction> deferred stock awards, with a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i26532d87fb9149e18d431a1b831b2c44_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc0MDQ_c5ae5283-f8a1-4349-a1cd-76dbbe272c39">338.38</ix:nonFraction>. Similarly, a non-qualified deferred compensation plan for eligible employees provides for the conversion of compensation into deferred stock units. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i975a024db03d420fb116bd9925e9f937"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the <ix:nonFraction unitRef="plan" contextRef="ia88b9ad9e7de41e78648c5f18d9cde1c_I20221231" decimals="INF" name="wst:DeferredCompensationArrangementWithIndividualNumberOfPlans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc1NzA_28409861-94bd-4e13-9b4b-9cf04052a03d">two</ix:nonFraction> deferred compensation plans held a total of <ix:nonFraction unitRef="shares" contextRef="ia88b9ad9e7de41e78648c5f18d9cde1c_I20221231" decimals="INF" name="wst:DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc2MTc_385c3546-d625-46b7-8a5c-7a8493369529">383,792</ix:nonFraction> deferred stock units, including <ix:nonFraction unitRef="shares" contextRef="ia88b9ad9e7de41e78648c5f18d9cde1c_I20221231" decimals="INF" name="wst:DeferredStockUnitsPayableInCash" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc2NTI_5a2cc44a-fcff-4371-b742-a018bddb7dda">9,366</ix:nonFraction> units to be paid in cash.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, during 2022, we granted <ix:nonFraction unitRef="shares" contextRef="ib4919d2983094e91beec7377b6d8b34f_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc3MTc_f365f3a1-8dcd-451d-9205-22fc8018c4b5">9,648</ix:nonFraction> restricted share awards at a weighted grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib4919d2983094e91beec7377b6d8b34f_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc3ODM_715a2af2-001d-4309-b940-90a961b8bd90">310.52</ix:nonFraction> per share to employees under the 2016 Plan. During 2021, we granted <ix:nonFraction unitRef="shares" contextRef="i560792d170344831a5edf3fe6812792a_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc4NTI_ebad866c-2e17-4267-8093-5195a93b8a0f">6,002</ix:nonFraction> restricted share awards at a weighted grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i560792d170344831a5edf3fe6812792a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc5MTg_5775c63f-568a-478e-986c-0ac88898d2cd">312.41</ix:nonFraction> per share to employees under the 2016 Plan. During 2020, we granted <ix:nonFraction unitRef="shares" contextRef="i628d30d7315b4fcb9acfb4cf5dc8be01_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxOTkwMjMyNjM4OTI_0f89a980-3eb8-40a9-9701-11f060fc2e2f">8,721</ix:nonFraction> restricted share awards at a weighted grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i628d30d7315b4fcb9acfb4cf5dc8be01_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxOTkwMjMyNjM4OTY_48f7a1d8-541d-4c6a-948d-e55f6bf358e0">200.35</ix:nonFraction> per share to employees under the 2016 Plan. The fair value of these awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period.</span></div></ix:continuation><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzgwMDE_6e4bef0a-7acf-4e4a-bfe3-87ce2ba82295" continuedAt="i7d41044676384322a206c3cc28a0d54a" escape="true">Benefit Plans </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7d41044676384322a206c3cc28a0d54a" continuedAt="ie8084d8cf42d42248ae73205d51c7d6c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our U.S. and international subsidiaries sponsor defined benefit pension plans. In addition, we provide minimal death benefits for certain U.S. retirees and pay a portion of healthcare costs for retired U.S. salaried employees and their dependents. Benefits for participants are coordinated with Medicare when possible. We also sponsor a defined contribution plan for certain salaried and hourly U.S. employees. Our 401(k) plan contributions were $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ4OA_1da5a3ad-2386-4510-be8d-87fae94b484f">22.8</ix:nonFraction> million for 2022, $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ5OQ_3daf23bd-27e7-4d2b-bf0d-fbc56f99c76b">19.5</ix:nonFraction> million for 2021 and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzUxMw_113fa090-800a-4c40-983e-7c039e4ff1c8">16.8</ix:nonFraction> million for 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension and Other Retirement Benefits</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzgwMTI_ec6b3372-0d59-4b0e-8d62-d360ad45a2fc" continuedAt="i7179110567ba49e785d50b7a42874f4c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost and other amounts recognized in OCI were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtMS0xLTEtNjAyNjM_9e03eca6-0852-4ee4-9742-6a108bb1d2b1">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtMy0xLTEtNjAyNjM_1feb771c-371d-4a78-b78a-cbf3a173d791">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtNS0xLTEtNjAyNjM_3c1ba90e-713b-4ee0-9d1c-03abe5cda0fa">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtNy0xLTEtNjAyNjM_f514688c-f3dd-4b1b-8ef4-c287357cf683">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtOS0xLTEtNjAyNjM_0d1b77bb-1a1c-4c77-893c-d8118c12bd34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtMTEtMS0xLTYwMjYz_a86e7d47-ce4e-4171-adad-ee68bfd665a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtMS0xLTEtNjAyNjM_99456715-9f3c-4688-a0e8-afe59cb3bb8a">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtMy0xLTEtNjAyNjM_40518726-7a0a-44a8-8d70-27e54cc0ca43">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtNS0xLTEtNjAyNjM_04bf606c-4250-400f-afb5-5d0f245663fe">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtNy0xLTEtNjAyNjM_a04b0a09-f4c9-490e-aafe-ccff712936d2">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtOS0xLTEtNjAyNjM_5edef238-4338-424a-a07c-9d62ef5d99db">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtMTEtMS0xLTYwMjYz_7d73d31a-a7f6-4a94-8c10-6338df2caa19">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtMS0xLTEtNjAyNjM_a4ba013b-559f-4a70-83e4-f881a28025c4">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtMy0xLTEtNjAyNjM_a10ae0eb-f58a-4e98-aeb5-77d6d653c857">11.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtNS0xLTEtNjAyNjM_178de7ab-79a9-4ddd-897b-a03b8e48cdf8">11.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtNy0xLTEtNjAyNjM_2523bf88-191a-4423-88a9-b7c6440c0dd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtOS0xLTEtNjAyNjM_2a31e586-d516-4d4a-8625-61371d4a804b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtMTEtMS0xLTYwMjYz_949338cf-128a-4f60-af14-86466998260d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtMS0xLTEtNjAyNjM_39979153-63da-4917-9e48-bcacb244716f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtMy0xLTEtNjAyNjM_6ad6d7d2-65d5-4abe-8d10-de26b910de26">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtNS0xLTEtNjAyNjM_195a9026-03e7-4d35-a680-8c695c5c368b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtNy0xLTEtNjAyNjM_4ef80348-3ba6-4377-ae91-5b26ed923142">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtOS0xLTEtNjAyNjM_04889ba8-2034-404a-a242-91ae8025943e">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtMTEtMS0xLTYwMjYz_fd5148bb-8f55-4ee9-b731-611f6e380909">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtMS0xLTEtNjAyNjM_05491a4f-decb-4243-8cf5-9b28b1e9fc99">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtMy0xLTEtNjAyNjM_c270cb75-3588-4f1e-859c-c05596286ef6">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtNS0xLTEtNjAyNjM_534a59ef-cdd6-4480-bed7-93a65b4cdea7">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtNy0xLTEtNjAyNjM_31dd0a42-1d53-467e-90cb-0f4add74070e">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtOS0xLTEtNjAyNjM_5402751e-c776-467e-b6e5-bf8c06d4dcda">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtMTEtMS0xLTYwMjYz_22e3a1ac-45e3-43ab-9a6d-a2cde4c04ff3">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktMS0xLTEtNjAyNjM_5b3ee8a5-2aa7-4bf3-a11c-1217901ed27e">52.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktMy0xLTEtNjAyNjM_126389d1-4125-4478-a7b1-2877a62d74a6">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktNS0xLTEtNjAyNjM_58025b61-53fd-4cf3-b5d2-a6cfc105dcaf">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktNy0xLTEtNjAyNjM_c04f4331-206f-4dd2-947c-4c71a06ba421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktOS0xLTEtNjAyNjM_a8dd0908-73f6-429a-abb0-7f457b852e69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktMTEtMS0xLTYwMjYz_cf261c72-e468-43db-9807-445d6cebf178">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTEtMS0xLTYwMjYz_e82f5fdf-5e39-4545-8a4a-53e0e0429a39">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTMtMS0xLTYwMjYz_333db657-f0f1-4ee9-bc0c-e22ca63664c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTUtMS0xLTYwMjYz_53a77c89-edec-41f6-917a-99f5586ae92e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTctMS0xLTYwMjYz_8e7c5b97-23c5-4b76-a7c4-d4d9911c074d">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTktMS0xLTYwMjYz_14eb7ee3-6397-4c71-997b-9176808af931">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTExLTEtMS02MDI2Mw_d5dfacd8-4597-4fe6-b6f3-5086e7fb6f10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTEtMS0xLTYwMjYz_cc9b202e-3697-45fd-bfc0-c2d1d1f7e66c">54.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTMtMS0xLTYwMjYz_9660b910-decf-47d6-ba18-2a37c4bd48c8">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTUtMS0xLTYwMjYz_43602cb3-cfd6-4332-a5ef-3e4c31da4d98">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTctMS0xLTYwMjYz_d25d2368-8598-47ed-bd38-a5bcabae231b">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTktMS0xLTYwMjYz_36193b6a-fd48-4e2b-a0cb-1b0f38b7a9f4">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTExLTEtMS02MDI2Mw_279b4017-e89b-4270-ae5c-9b87723cdf9e">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (gain) arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTEtMS0xLTYwMjYz_4d7a07f9-f4cb-4833-b92b-3e3d2f9cd200">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTMtMS0xLTYwMjYz_df32f012-c3b0-4899-af6e-3d101f7e5485">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTUtMS0xLTYwMjYz_a9433e11-0dce-4db5-9700-df5fd9d60e10">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTctMS0xLTYwMjYz_604f82bd-67d8-413b-bdd1-62711b05c9f8">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTktMS0xLTYwMjYz_9ee66caf-6217-4550-af99-ca4a515a943a">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTExLTEtMS02MDI2Mw_3d93d96d-1366-4377-b15a-ce0e7d9e20e8">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTEtMS0xLTYwMjYz_fbbc4a41-ec80-427d-a0ec-7fc0c1abe86c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTMtMS0xLTYwMjYz_8a308029-815c-495e-9564-597fa0a3c807">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTUtMS0xLTYwMjYz_3fd7d4b1-2850-4a83-9c3a-613c65e53d2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTctMS0xLTYwMjYz_f08bd9ee-22d6-4f74-904a-d4185dac51b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTktMS0xLTYwMjYz_6aea0165-a405-42e4-b765-8ae7829ee435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTExLTEtMS02MDI2Mw_4a576a63-fffd-4e66-b7d0-73f5542dda8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTEtMS0xLTYwMjYz_1ca6055b-2cd0-4b5f-9fe5-ae5a125b5bf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTMtMS0xLTYwMjYz_86c87f73-5d97-4acc-9a71-9d8c45624365">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTUtMS0xLTYwMjYz_512f8a24-bcfb-4cd4-ad2c-014cb5974356">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTctMS0xLTYwMjYz_c9f92258-8b34-460b-9a57-4deacf73e3b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTktMS0xLTYwMjYz_93256487-17f1-4670-bf24-aab1cb89d2b9">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTExLTEtMS02MDI2Mw_55c9d415-5f14-49c0-bb68-fcec72588d10">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial (loss) gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTEtMS0xLTYwMjYz_e9332a88-87ab-401b-8a35-ac32a9779acd">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTMtMS0xLTYwMjYz_fb739419-9925-4ad2-a40b-8263bcac52bc">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTUtMS0xLTYwMjYz_7f7a1567-60fb-4123-bdf5-026cbb5a49b7">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTctMS0xLTYwMjYz_1a3a5cff-c415-45ed-ad0a-2dd87b8ebf13">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTktMS0xLTYwMjYz_e6279c14-9626-4d64-b5fe-c7f97fbab49f">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTExLTEtMS02MDI2Mw_335a567a-ed3c-4b97-9a69-3a8973d7a3bb">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTEtMS0xLTYwMjYz_38e3323d-3a77-4ef8-bc62-6841041caf05">52.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTMtMS0xLTYwMjYz_3e92a83c-fc90-4b05-a61b-a8cc3d3d5beb">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTUtMS0xLTYwMjYz_dfc9f1d6-ba41-44a7-99a1-a42cf7df0295">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTctMS0xLTYwMjYz_008c11d4-6d1d-49d8-b000-634cf45e3ec2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTktMS0xLTYwMjYz_8066a174-5520-4475-b1db-5fe8a5053502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTExLTEtMS02MDI2Mw_e6b1a342-5165-42db-b27e-04c4b183dc03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTEtMS0xLTYwMjYz_b2c3104f-b1d8-4339-b257-6ad14b90aa85">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTMtMS0xLTYwMjYz_984e454f-1b38-494b-b4b0-786e45f270ff">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" sign="-" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTUtMS0xLTYwMjYz_21e945b3-1e53-4bca-a3a9-968596ad06b5">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTctMS0xLTYwMjYz_ea6a50d1-cb18-46d0-8ea3-bc3a3b4df0b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTktMS0xLTYwMjYz_4e5a2ef9-c3d0-45d9-9996-1f8a064484d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTExLTEtMS02MDI2Mw_f9e55912-4a6b-41b6-975a-3da3dac7cceb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTEtMS0xLTYwMjYz_815abf37-0094-4156-b968-6b0bf0c169f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTMtMS0xLTYwMjYz_2d89f27f-2ba1-4786-a3aa-25185d8b046b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTUtMS0xLTYwMjYz_ad3950d1-c3a8-436b-b800-c83c6120c1f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTctMS0xLTYwMjYz_0b63f588-930b-4513-a424-96867f4ba7bb">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTktMS0xLTYwMjYz_15d30260-d441-4a7c-bf2b-bfdc267e4c85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTExLTEtMS02MDI2Mw_1bd388a1-e14a-41cf-b9d8-e4e9f26a8d7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in OCI</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTEtMS0xLTYwMjYz_82d4822e-7ab8-4b15-be28-2de297331c72">39.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTMtMS0xLTYwMjYz_304f90d3-bcc3-46c0-a154-7a46d7ecb168">12.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTUtMS0xLTYwMjYz_d1ab57fd-35c9-48c6-97c7-6165727fc1ce">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTctMS0xLTYwMjYz_c7c7901e-a747-409d-a06e-0b525a85acc7">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTktMS0xLTYwMjYz_7cc77dca-d429-4a28-86d4-35a993e2302d">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTExLTEtMS02MDI2Mw_1b981c33-5be0-4414-81ae-67103a18a6cd">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTEtMS0xLTYwMjYz_b93bc5ba-e7d7-48cc-aca7-f5daaee36797">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTMtMS0xLTYwMjYz_9ce98c07-13cd-4120-bb3b-1542da773275">13.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTUtMS0xLTYwMjYz_1c5cdb90-afb0-42ac-8bfd-3adfe7ee8ba0">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTctMS0xLTYwMjYz_9d4e9bb3-285e-4040-8a0f-3841887bfb2d">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTktMS0xLTYwMjYz_bf238d77-9085-4a12-95a6-12049f335efc">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTExLTEtMS02MDI2Mw_7b3a6108-70e2-4182-a11b-178eb25ac4f6">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie8084d8cf42d42248ae73205d51c7d6c" continuedAt="idb34a85a6ffe4173820d4c153b0ee072"><ix:continuation id="i7179110567ba49e785d50b7a42874f4c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit cost by geographic location is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:43.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7479189625164010af6cfb04cc0211f7_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItMS0xLTEtNjAyNjM_9967d7cd-8b87-4117-bd2e-913cc38bddc6">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63ad9cb3287243e99846b5f6d49f4739_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItMy0xLTEtNjAyNjM_5405f987-4031-4778-b191-27a3f3a849e2">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2541ce86c9e34ed9941101140a5db110_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItNS0xLTEtNjAyNjM_d0f10e8c-717e-4e6d-9382-22f22662b279">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i316fa955e9204c2a8df463369185dda4_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItNy0xLTEtNjAyNjM_c8ed87be-d9b4-4943-a71e-be9fb64d5881">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i441202e7fe0646609be36e2f8d0374b0_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItOS0xLTEtNjAyNjM_73fa96ce-c002-4cca-a2e1-0c57ecde5bc6">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2b3f6d5c25644418416ca4f73542523_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItMTEtMS0xLTYwMjYz_1b01d1a0-0a70-4bf4-8bb9-7f61f5f50960">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d78547c8434c45b5b43dd485a6821a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtMS0xLTEtNjAyNjM_a39327c9-86f0-4d1d-bc7c-e61a5764de67">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd65a6a4d2b4b7eb7aa097f7f5a03a8_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtMy0xLTEtNjAyNjM_2ba5479d-10d9-43d9-96e1-1c66c880af66">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a6c4ac23e3347c3a9d21b0dba11e268_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtNS0xLTEtNjAyNjM_07785db0-500c-4970-a166-6e9b783b966e">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b0b580bd80345db9a8c8beba2df1e69_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtNy0xLTEtNjAyNjM_66d1892d-65c4-4944-9760-25d159159a0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94503a5d02c7463b985b14ead7a7b3d9_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtOS0xLTEtNjAyNjM_d3831c52-2526-457c-a544-8cc5644747b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib445602ff9c740f89a59c9435ece0183_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtMTEtMS0xLTYwMjYz_25419785-695f-4986-8814-47e251a43057">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtMS0xLTEtNjAyNjM_f16b7c1e-0765-4fbf-94c7-b6cec596d8f9">54.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtMy0xLTEtNjAyNjM_859e5440-4e33-470d-9ebe-ca2229a2c48d">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtNS0xLTEtNjAyNjM_04ad1e50-7952-4793-9cd0-98f9689de73d">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtNy0xLTEtNjAyNjM_e3e54ad4-3eb5-4a81-bfb9-5e683261239c">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtOS0xLTEtNjAyNjM_3821bed9-cf4d-4d23-b58e-d2d9b36758e8">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtMTEtMS0xLTYwMjYz_d8c4b911-b8fb-4248-b450-4f9e1f8ac17b">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost component included within net periodic benefit cost is considered employee compensation and is therefore presented within the selling, general, and administrative and costs of goods and services sold financial statement line items of our consolidated statements of income. The remaining components of net periodic benefit cost are reported separately and are therefore presented within the other nonoperating expense (income) financial statement line item of our consolidated statements of income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During 2021, the Company approved the termination of our U.S. qualified defined benefit pension plan (the "U.S. pension plan"). During 2021, a Notice of Intent to Terminate was sent to all interested parties and in 2022 a favorable determination letter was received from the Internal Revenue Service. During 2022, lump sum payments were offered to all current employees and former employees with vested benefits under the U.S. pension plan. A cash contribution of $<ix:nonFraction unitRef="usd" contextRef="i040620491325464cab7f6d3871ae4699_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIxOTkwMjMyNjU1MTc_4c0d85d3-7c10-4c61-a370-7394d2aff6a3">7.1</ix:nonFraction>&#160;million was made by the Company to ensure the U.S. pension plan was fully funded in preparation for the group annuity contract purchase which was executed in August of 2022 to settle the outstanding benefit obligations, as well as to cover any ancillary benefits and expenses remaining. During 2022, we recorded </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIxOTkwMjMyNjQyMzI_665c7078-041a-42a0-8d9a-d6347898ff2d">52.2</ix:nonFraction>&#160;million pension settlement charge within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_2be9eb86-8ff4-486b-8e82-82feaaba79be"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_2c156bb7-09f9-4046-a1d8-d4f0d3157eef"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_41e09201-abff-4427-8518-3065d9e10039">other nonoperating expense (income)</span></span></span>, which primarily related to the full settlement and relief of the historical balance sheet position, inclusive of accumulated other comprehensive income, of the U.S. pension plan. During 2021 and 2020, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIxOTkwMjMyNjQ0MzA_ef760436-e23f-4b1b-a216-81b463906492">1.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIxOTkwMjMyNjQ0Mzg_da05ec7d-9f5b-46b6-b733-e996f85250dc">3.7</ix:nonFraction>&#160;million, respectively, pension settlement charge within other nonoperating expense (income), as we determined that normal-course lump-sum payments for the U.S. pension plan exceeded the threshold for settlement accounting under U.S. GAAP for the year.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we contributed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i040620491325464cab7f6d3871ae4699_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIxOTkwMjMyNjczMzQ_4c0d85d3-7c10-4c61-a370-7394d2aff6a3">7.1</ix:nonFraction>&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our U.S. pension plan. During 2021, we did <ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzE3NjQ_43e12636-4f7d-42bb-8510-77acea9c4b4c"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzE3NjQ_c6d8fee3-4355-4309-acf5-a31adb5e6ac4">no</ix:nonFraction></ix:nonFraction>t contribute to our U.S. pension plan. </span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idb34a85a6ffe4173820d4c153b0ee072" continuedAt="iac91c46a1890415fab9aaa719f6f3c1f"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3Xzc5OTI_4c27a324-2cb4-4b95-8290-aef009a286dd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzMtMS0xLTEtNjAyNjM_764fe824-1ea1-4d43-b06f-7ddf777148b3">269.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i860f084cabda4ae99bb91cfb68d12843_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzMtMy0xLTEtNjAyNjM_5e552e90-f942-4235-9122-b5e88bfc1ad2">298.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzMtNS0xLTEtNjAyNjM_927f7e34-391e-4ab7-b5f4-8b2ee9b5f7dd">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5585de920d8a464bb8478eab79b4c886_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzMtNy0xLTEtNjAyNjM_1c414593-1283-4a23-a147-476a0d0c67f8">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzQtMS0xLTEtNjAyNjM_00d5af3e-8c39-44b3-8170-825fa77a36db">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzQtMy0xLTEtNjAyNjM_0a27f56e-a677-423a-ae09-8080b755dacc">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzQtNS0xLTEtNjAyNjM_08e98a16-c1fd-40c6-88fa-57ed067f391b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzQtNy0xLTEtNjAyNjM_ae3548c5-1bfb-476c-85b7-58cc32a318b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzUtMS0xLTEtNjAyNjM_4a8e9d34-3f12-4210-9617-a52114c3df89">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzUtMy0xLTEtNjAyNjM_e959da5d-e350-4ad0-895f-a9ed3b382c1d">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzUtNS0xLTEtNjAyNjM_71e7eaf1-b4c4-412e-9ffa-f95fef35fbbb">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzUtNy0xLTEtNjAyNjM_8e5373cd-2274-4680-8c0a-704b29f907d3">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzYtMS0xLTEtNjAyNjM_fc4722a5-d247-456a-b018-9378439216f6">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzYtMy0xLTEtNjAyNjM_bad7c415-88c3-4772-aa53-d1c42e3373c7">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzYtNS0xLTEtNjAyNjM_6d537773-6632-40b9-9b79-e0c34d21521f">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzYtNy0xLTEtNjAyNjM_c8376b99-c515-4a15-ad74-525c04f3334f">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzctMS0xLTEtNjAyNjM_b7f91db2-a1dc-41e3-825e-ce8cfd08d5e3">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzctMy0xLTEtNjAyNjM_f8fe4574-b3e8-4307-a4e0-d2b6ccb44c14">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzctNS0xLTEtNjAyNjM_9c58299e-3b12-4af2-8d3e-a490bcc4a34b">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzctNy0xLTEtNjAyNjM_517fc113-6d00-4bf3-bc0e-a957c2c580a2">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments/transfers in</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAmendments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzgtMS0xLTEtNjAyNjM_8c2167e9-f265-4d67-85a2-9568e17f7ee3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzgtMy0xLTEtNjAyNjM_b485d495-1c5f-4222-ae34-9dbb4ddbec82">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAmendments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzgtNS0xLTEtNjAyNjM_671396d5-c7ab-4e0c-8f12-c58e3c4460dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAmendments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzgtNy0xLTEtNjAyNjM_84b053db-f581-4847-bb49-8ba999b3c27b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzktMS0xLTEtNjAyNjM_ad0d6740-2036-40dc-a0b5-dff78343ef80">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzktMy0xLTEtNjAyNjM_03053644-08ee-4b31-a52a-50baeac2a2ff">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzktNS0xLTEtNjAyNjM_8b272539-51ad-4a5a-be58-0051611d7a8c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzktNy0xLTEtNjAyNjM_0186a023-d505-4da4-ac10-943d4730a46a">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzExLTEtMS0xLTYwMjYz_b778594f-20e0-4a64-92ed-81f6853b5631">174.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzExLTMtMS0xLTYwMjYz_bc0436a8-b4d4-4e82-8678-cf7583a34b73">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzExLTUtMS0xLTYwMjYz_e11433bc-f72c-418a-9dcc-ef4c70cf5ba0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzExLTctMS0xLTYwMjYz_e57554ea-be18-4e9c-ba3e-8e88992c5464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEyLTEtMS0xLTYwMjYz_2aa5cfc9-09c9-4620-b5bb-eb07ca1ef1f1">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEyLTMtMS0xLTYwMjYz_8afebc1f-5af2-441f-b3d7-ad9be826d194">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEyLTUtMS0xLTYwMjYz_aca679bb-f6eb-4dd6-9651-c3e6e073955d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEyLTctMS0xLTYwMjYz_57209d62-941d-41d6-a478-c18423647144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, December 31</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEzLTEtMS0xLTYwMjYz_f2d322a6-5a09-4ec4-b0af-f5fb7adaa8b9">55.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEzLTMtMS0xLTYwMjYz_628c899c-8853-431f-ae4f-e5ee7c6d8c95">269.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEzLTUtMS0xLTYwMjYz_cd02b2ba-505b-40b7-a14d-7688d4699425">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEzLTctMS0xLTYwMjYz_60394c17-bc60-44ae-8599-518b5402df16">5.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE2LTEtMS0xLTYwMjYz_a4a280db-d569-4efc-a9b6-7cd6ecb29b4e">249.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i860f084cabda4ae99bb91cfb68d12843_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE2LTMtMS0xLTYwMjYz_35598c9a-39e2-4009-97a7-4ec6b3bfef43">258.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE2LTUtMS0xLTYwMjYz_d18399b3-2c2b-4ee4-afbf-04ff8a18122e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5585de920d8a464bb8478eab79b4c886_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE2LTctMS0xLTYwMjYz_6882cf13-96e3-415f-96b1-6600032d86e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE3LTEtMS0xLTYwMjYz_d767471b-68f0-4197-8a02-2162bfab229a">42.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE3LTMtMS0xLTYwMjYz_ed891734-b466-492d-bb73-5d23351159e1">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE3LTUtMS0xLTYwMjYz_f3eb7fb6-e42e-4eeb-a072-3b4d7c408ea1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE3LTctMS0xLTYwMjYz_579448ec-e7a8-45db-9345-d3c3b72d6a3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE4LTEtMS0xLTYwMjYz_12d0af1f-ecf0-45ad-9c70-77ae2637670a">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE4LTMtMS0xLTYwMjYz_eff4b586-2d77-40f6-8de7-cd7c529ff268">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" sign="-" name="wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE4LTUtMS0xLTYwMjYz_ad2f458b-7ff6-4afd-8e14-2e422851f90c">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" sign="-" name="wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE4LTctMS0xLTYwMjYz_53f313aa-44ca-463b-a7eb-8c98887c4d49">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE5LTEtMS0xLTYwMjYz_99efa2ff-10fc-45ac-a9e9-6735ee61679f">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE5LTMtMS0xLTYwMjYz_eebff0cc-20c0-42b4-8eb6-3e3d4608b3ee">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE5LTUtMS0xLTYwMjYz_9ca601bd-5a44-4096-a23a-c3b6fccfe323">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE5LTctMS0xLTYwMjYz_2103ebac-c3d0-44db-8f24-80d97506389d">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIwLTEtMS0xLTYwMjYz_43737c87-9a18-4794-be95-e5875abd2a5d">7.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIwLTMtMS0xLTYwMjYz_e4caf5dc-79ac-4d40-a7b8-ea650c4ba158">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIwLTUtMS0xLTYwMjYz_7b222c4b-5090-4974-8547-3adc36eaf7bb">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIwLTctMS0xLTYwMjYz_08937585-805d-4fc8-9352-c4571662e92d">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIyLTEtMS0xLTYwMjYz_5b490b21-dbc3-446b-9588-483ac2beb152">174.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIyLTMtMS0xLTYwMjYz_f8bff4f8-1cf8-4fda-8196-220d8c64bfa3">13.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIyLTUtMS0xLTYwMjYz_6b07ca50-7707-43e5-b63f-4174ea8d585c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIyLTctMS0xLTYwMjYz_1196b741-c021-4950-a10a-ab679f41314b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIzLTEtMS0xLTYwMjYz_bd1ea3f9-ac15-4c2c-a4b3-0462f16a5577">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIzLTMtMS0xLTYwMjYz_8ff69cf9-201b-4836-8405-3f1ee00085ca">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIzLTUtMS0xLTYwMjYz_54fd96b7-0dc6-4a71-8589-870c8ba0899a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIzLTctMS0xLTYwMjYz_3a7e889d-c456-438c-adcf-4d29a95975fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, December 31</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI0LTEtMS0xLTYwMjYz_c2d7a972-d5e8-4f60-aeac-c0350e9a9584">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI0LTMtMS0xLTYwMjYz_ee5915c6-f54b-48a3-ba12-b552950df5e9">249.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI0LTUtMS0xLTYwMjYz_6ef5a8a8-d14b-4a5f-ada2-d6a9dce26da3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI0LTctMS0xLTYwMjYz_a8faf470-2c71-4c82-a823-4b03f397df5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI2LTEtMS0xLTYwMjYz_6d18ebdf-1ddb-40c3-a625-b4cf34b98c1a">26.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI2LTMtMS0xLTYwMjYz_d7cd86ed-1d9f-47d4-adf2-1f992311b56e">20.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI2LTUtMS0xLTYwMjYz_3717a381-08f6-4d26-a3f6-d3d413ea051c">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI2LTctMS0xLTYwMjYz_8e626a08-2444-4a9b-aa71-d4935fac03fb">5.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International pension plan assets, at fair value, included in the preceding table were $<ix:nonFraction unitRef="usd" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIwNjg_66c60a0d-2091-4621-817a-1fbab5ba6286">29.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i07075ee510b147ffa069795d9eba1b83_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIwNzU_f390e778-d6f6-449c-81ee-96c9607d9897">49.3</ix:nonFraction> million at December&#160;31, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3Xzc5ODU_c90752e9-b7e9-4111-9585-1aed85603d1c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in the balance sheet were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="-5" name="wst:AssetsDefinedBenefitPlansNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzItMS0xLTEtNjAyNjM_ffec6801-3c1f-48ad-842b-a13d57a8628e">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" name="wst:AssetsDefinedBenefitPlansNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzItMy0xLTEtNjAyNjM_4fdc9a57-2bd5-48f1-9926-2244787fea53">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" name="wst:AssetsDefinedBenefitPlansNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzItNS0xLTEtNjAyNjM_62d4f81c-3b67-40dd-9448-662adb5f14e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" name="wst:AssetsDefinedBenefitPlansNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzItNy0xLTEtNjAyNjM_ac2d8d4e-b9bb-4744-aa9a-92a52caaa3ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzMtMS0xLTEtNjAyNjM_b75c62ad-bd22-4213-a2e7-cb27a7b4bb1b">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzMtMy0xLTEtNjAyNjM_45606093-7e56-4240-81a1-6ea9ad763aba">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzMtNS0xLTEtNjAyNjM_f1894429-7b44-4fb5-b39e-88a1b84dfe2d">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzMtNy0xLTEtNjAyNjM_4283e9f1-7636-4154-8cf4-2fc635cf43f5">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzQtMS0xLTEtNjAyNjM_547acc5c-a8c3-47c7-b54b-f9b856be05ec">24.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzQtMy0xLTEtNjAyNjM_0a4dafef-8f04-41f7-af7c-13db269bb406">35.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzQtNS0xLTEtNjAyNjM_ca11d6a6-6bbc-461c-9913-07702351e798">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzQtNy0xLTEtNjAyNjM_a6af5d1f-a4bb-4e7c-8ac1-c92c7277fb2a">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzUtMS0xLTEtNjAyNjM_fe98be48-b966-4982-922e-9f048f4ef324">26.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzUtMy0xLTEtNjAyNjM_b83bdaf5-f2b9-4670-bcb5-5f37d99c35e2">20.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzUtNS0xLTEtNjAyNjM_6456b382-4841-4957-977b-e62c0d6dd3bc">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzUtNy0xLTEtNjAyNjM_29e5a4f6-2fca-4915-888c-88bed6036823">5.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3Xzc5OTM_412a0b90-1f41-4a97-abae-87d9a2abb97b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts in accumulated other comprehensive loss, pre-tax, consisted of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzItMS0xLTEtNjAyNjM_b9ddb0be-1f6b-4219-8bf0-79be5cf0387e">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzItMy0xLTEtNjAyNjM_f1f5e4d9-fba7-48e4-b9f0-eb7be99ea856">56.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzItNS0xLTEtNjAyNjM_ddbf0c52-e694-4feb-9474-65fc74dccd7a">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzItNy0xLTEtNjAyNjM_9951bf1c-d462-4494-85bc-263d42439de4">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzQtMS0xLTEtNjAyNjM_13729888-0905-44c1-869b-1a4a39f67bf7">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzQtMy0xLTEtNjAyNjM_6d72d229-4fd7-4f78-88fc-fb18e1749c4b">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzQtNS0xLTEtNjAyNjM_3f0cf811-bef3-42c3-8596-207d6821728d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzQtNy0xLTEtNjAyNjM_d3779421-0acb-4a30-ac88-194939da3c41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzUtMS0xLTEtNjAyNjM_8f6780ed-ead1-4e68-8546-d1bfcf20e494">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzUtMy0xLTEtNjAyNjM_889282aa-1f8a-4a2a-bde1-d3a2db3f6095">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzUtNS0xLTEtNjAyNjM_3f6747f9-3027-441b-82f3-99c561fb85c3">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzUtNy0xLTEtNjAyNjM_9a258d45-9ff7-4d8d-ae8a-9db60f63b58b">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iac91c46a1890415fab9aaa719f6f3c1f" continuedAt="i871774e9af514022bc4c5f9fffe242a6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation for all defined benefit pension plans was $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIzMjM_1cee180f-f816-43d6-8456-e6c4b06dd8f6">52.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIzMzA_adba7b28-5b00-4411-a381-56bfb26326a9">265.2</ix:nonFraction> million at December&#160;31, 2022 and 2021, respectively, including $<ix:nonFraction unitRef="usd" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIzNzE_3fef8bfe-5d98-4e4b-806c-295f4ea8300f">46.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i07075ee510b147ffa069795d9eba1b83_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIzNzg_8b963f94-0b32-4202-910e-b92263279440">73.0</ix:nonFraction> million, respectively, for international pension plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our United Kingdom qualified defined benefit pension plan had plan assets in excess of its obligations. As of December&#160;31, 2021, our U.S. and United Kingdom qualified defined benefit pension plan had assets in excess of its obligations. As of December&#160;31, 2022 and December&#160;31, 2021, our other defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3Xzc5Nzg_7a56f86b-e377-4ca2-84cc-1bfcb235c285" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows. The expected benefit payments listed correspond to regular ongoing benefit payments expected to be made by the plan during future years. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzEtMS0xLTEtNjAyNjM_5c4ffe3b-36bc-497d-ad8f-9c5c5d8c51e8">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzEtMy0xLTEtNjAyNjM_3793bbca-cc53-4b06-a5bb-4d44089d8770">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzEtNS0xLTEtNjAyNjM_bf693dd4-561d-4694-ac77-35ea1ce5e7b2">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzItMS0xLTEtNjAyNjM_e48bb9b4-ff0f-4a71-9aa6-b0107fe1ba0c">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzItMy0xLTEtNjAyNjM_42d237a6-7895-44dc-bd3a-544dc7cd890c">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzItNS0xLTEtNjAyNjM_94607b17-61a8-4917-98e2-1449b2c35558">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzMtMS0xLTEtNjAyNjM_43a6e70a-99ef-4657-919a-c3ae9f22b345">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzMtMy0xLTEtNjAyNjM_2bc8668e-f5c2-4ea5-b672-fa6f1af7c3f8">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzMtNS0xLTEtNjAyNjM_d12e3154-5239-40ad-9873-28452a883f00">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzQtMS0xLTEtNjAyNjM_bf66da91-4c41-4ea7-9307-1935d2af60b5">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzQtMy0xLTEtNjAyNjM_a6f2949f-f8d6-4b20-8cf7-d45de784b71b">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzQtNS0xLTEtNjAyNjM_aeca8c3d-9939-485f-a56d-085f7f173415">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzUtMS0xLTEtNjAyNjM_bae557cb-f747-4657-afc8-3c110c0338d2">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzUtMy0xLTEtNjAyNjM_0ed53322-4dbe-4d22-bd6c-7ac1b341ead1">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzUtNS0xLTEtNjAyNjM_6a4acf85-acec-49ec-b175-85110549c806">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 to 2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzYtMS0xLTEtNjAyNjM_27d9a924-4f1f-4ae9-aa1a-0c0f633a02d9">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzYtMy0xLTEtNjAyNjM_3a856ea6-2410-4836-829d-1a050a796076">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzYtNS0xLTEtNjAyNjM_862fe971-29b9-4786-b099-79fc927717d2">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231" decimals="-5" name="wst:DefinedBenefitPlanExpectedFutureBenefitPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzctMS0xLTEtNjAyNjM_78c6ba3f-526b-4422-8c1e-2a83c08dff30">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="-5" name="wst:DefinedBenefitPlanExpectedFutureBenefitPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzctMy0xLTEtNjAyNjM_c3e19168-14cb-44ee-a609-a90d8b8bb6a2">32.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="wst:DefinedBenefitPlanExpectedFutureBenefitPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzctNS0xLTEtNjAyNjM_eb011b50-0bce-41e0-8eb7-e400df97962c">42.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, we expect to contribute $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzM0MTI_17a11d31-4c64-4ff1-b49a-373ce81255bd">0.6</ix:nonFraction>&#160;million to pension plans, all of which is in the U.S. In addition, we expect to contribute $<ix:nonFraction unitRef="usd" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzM0OTg_f405dc09-81e8-447a-8b6a-b0ffa332e9c3">0.6</ix:nonFraction>&#160;million for other retirement benefits in 2023. We periodically consider additional, voluntary contributions depending on the investment returns generated by pension plan assets, changes in benefit obligation projections and other factors. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzgwMTc_4bb15520-1c4a-4df6-b42e-44e9915800ad" continuedAt="ide9c885d1dda4faca2134bffd5cc00c7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit cost were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItMS0xLTEtNjAyNjM_44a22a96-db4a-4972-aef1-4597e838e829">2.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItMy0xLTEtNjAyNjM_ad5b73ef-a9f4-4d2a-937e-8053ceb4c2b2">2.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItNS0xLTEtNjAyNjM_33db72ba-08f8-4b05-9208-2bbcbc8a0dc9">2.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItNy0xLTEtNjAyNjM_e69ed932-2a9a-4170-bd5a-63cbd7d2d56b">2.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItOS0xLTEtNjAyNjM_6b4ac755-7276-4582-9f84-b256f49b78ba">2.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItMTEtMS0xLTYwMjYz_bda143ec-7801-4721-be3f-2235c76ea77e">3.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtMS0xLTEtNjAyNjM_53ec76d8-7e7c-4e18-944c-311be6bbda46">2.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtMy0xLTEtNjAyNjM_04d7cc96-498b-4de9-8526-a7fa840040ef">2.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtNS0xLTEtNjAyNjM_234a497d-c216-4682-a152-229121b77a7b">2.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtNy0xLTEtNzA3Mjk_5900b4c3-711f-4ae9-9238-4c2e022abc80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtOS0xLTEtNzA3Mjk_b3f136cb-a036-4010-980e-16e5985de2e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtMTEtMS0xLTcwNzI5_cb60cf87-2452-4b19-a69f-e1902804c3e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtMS0xLTEtNjAyNjM_675a7604-ca07-462c-a5bd-d412f666874d">4.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtMy0xLTEtNjAyNjM_8e7e5485-b65b-42e6-8b6c-699319f672a0">4.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtNS0xLTEtNjAyNjM_1733d8ea-b4fc-48f2-9239-53ac9549d20f">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtNy0xLTEtNzA3Mjk_0257b1b5-3fb2-4b88-bfe9-f91a23a44f06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtOS0xLTEtNzA3Mjk_2e92e468-4e24-4404-b80f-3c722cec71e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtMTEtMS0xLTcwNzI5_d1d7a7ba-a103-40be-b405-47b1adcf453e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine the benefit obligations were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzItMS0xLTEtNjAyNjM_01578f2e-6380-40d1-b5cd-1a4a207845c0">4.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzItMy0xLTEtNjAyNjM_0fea5ef2-4ad4-431d-9dd7-c17b0983f07c">2.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzItNS0xLTEtNjAyNjM_37c8e134-fccf-4bd2-815d-d8263d223dc0">5.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzItNy0xLTEtNjAyNjM_a5709e87-93a9-4c74-89f8-c1a1578e9bff">2.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzMtMS0xLTEtNjAyNjM_d8e6f773-9b60-4539-beac-8a18291b66ca">3.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzMtMy0xLTEtNjAyNjM_c92523c2-b47d-40ad-bdc5-9be441b79b81">2.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzMtNS0xLTEtNzA3MzI_3a6d7702-7597-4f89-93e8-56ec5ce722fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzMtNy0xLTEtNzA3MzI_77201a6b-ce94-4327-8c30-1bcbafc6848c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate used to determine the benefit obligations for U.S. pension plans was <ix:nonFraction unitRef="number" contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQxNzE_3ee2aa85-7660-4b10-8027-4f6b35d2d4b7">5.55</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="icaebb04c426c456a84deedfc7f59d594_I20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQxNzg_883bc9bc-efee-45cf-b74b-9614f9b35af3">2.95</ix:nonFraction>% as of December 31, 2022 and 2021, respectively. The weighted average discount rate used to determine the benefit obligations for all international plans was <ix:nonFraction unitRef="number" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQzMzQ_3150983e-5dc5-418e-8421-e75daf478ddf">4.20</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i07075ee510b147ffa069795d9eba1b83_I20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQzNDE_7c9af3d8-b9a9-4419-a292-2bf527ff8a17">1.32</ix:nonFraction>% as of December 31, 2022 and 2021, respectively. The weighted average rate of compensation increase for all international plans was <ix:nonFraction unitRef="number" contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ0NzE_63432b87-f040-4788-abc1-f3757dcc4269">3.09</ix:nonFraction>% for 2022 and <ix:nonFraction unitRef="number" contextRef="i07075ee510b147ffa069795d9eba1b83_I20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ0ODU_99ba03f4-8882-4715-92bd-3429db69a143">2.79</ix:nonFraction>% for 2021, while there was no rate increase for the U.S. plans since they are frozen. Other retirement benefits were only available to U.S. employees. The expected long-term rate of return for U.S. plans was <ix:nonFraction unitRef="number" contextRef="i040620491325464cab7f6d3871ae4699_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ3Mzk_f1adc29e-0a22-40c9-bfaf-eb11af2fc21e">3.70</ix:nonFraction>% for 2022, <ix:nonFraction unitRef="number" contextRef="i405b25944ffd47c88f31893c248bb5cc_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ3NTA_d63183bc-a62e-4d8d-82db-e1bbdf03bfc2">5.10</ix:nonFraction>% for 2021 and <ix:nonFraction unitRef="number" contextRef="i6d4d0414b55e42238a7ed8c0cade2d85_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ3NjQ_b91c6897-3c56-435d-bba7-9d43572d3729">5.10</ix:nonFraction>% for 2020. </span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i871774e9af514022bc4c5f9fffe242a6" continuedAt="i3bc45a58da4b4253bacc7f49152278d0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumed healthcare cost trend rate used to determine benefit obligations was <ix:nonFraction unitRef="number" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="4" name="us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ4NTg_4f480ce9-19a2-40b7-8b51-ebe45b85dfc2">6.75</ix:nonFraction>% for all participants in 2022, decreasing to <ix:nonFraction unitRef="number" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ5MDM_8fd9b6f5-ede2-448a-8485-8faaf4f77a75">5.0</ix:nonFraction>% by 2030. The assumed healthcare cost trend rate used to determine net periodic benefit cost was <ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="4" name="wst:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzUwMDA_62d17063-e66b-4676-b8c1-98a364d738ba">6.25</ix:nonFraction>% for all participants in 2022, decreasing to <ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" name="wst:DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzUwNDU_3cb32024-c494-400c-99be-20a391ad7299">5.0</ix:nonFraction>% by 2027.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The defined pension plan benefit obligation decreased for the year ended December&#160;31, 2022 primarily due to settlement losses recognized during the year, as well as an increase in the discount rate used to calculate the obligation. The net actuarial losses will be impacted in future periods by actual asset returns, discount rate changes, currency exchange rate fluctuations, actual demographic experience, and certain other factors. The other retirement plan benefit obligation decreased due an increase in the discount rate used to calculate the obligation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company has cash balance plans and other plans with promised interest crediting rates. For these plans, the interest crediting rates are set in line with plan rules or country legislation and do not change with market conditions. </span></div><div><span><br/></span></div><ix:continuation id="ide9c885d1dda4faca2134bffd5cc00c7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The weighted average interest crediting rating used to determine net periodic benefit cost by geographic location for our pension plans, at December 31, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7479189625164010af6cfb04cc0211f7_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzEtMS0xLTEtNjAyNjM_a8caf1b6-b7e1-4f90-9ef5-33f54c4886ec">3.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63ad9cb3287243e99846b5f6d49f4739_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzEtMy0xLTEtNjAyNjM_3339d27a-56e0-414d-ab0b-db7fa4405f87">3.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2541ce86c9e34ed9941101140a5db110_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzEtNS0xLTEtNjAyNjM_2e8645a0-8e92-44e7-bd0d-b6727a85dc5c">3.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34d78547c8434c45b5b43dd485a6821a_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzItMS0xLTEtNjAyNjM_9031d4fe-6c42-4285-ada9-09c9d91f8db1">1.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1fd65a6a4d2b4b7eb7aa097f7f5a03a8_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzItMy0xLTEtNjAyNjM_37beb615-425f-4728-b40c-92fdfa3f361f">0.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a6c4ac23e3347c3a9d21b0dba11e268_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzItNS0xLTEtNjAyNjM_dd168ba1-a10a-4f43-ab80-6ddbb23ee200">0.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3Xzc5NzI_bb0e7e1c-0709-4853-adf9-f089c516dce9" continuedAt="i181110608b8447c2917aacb514b52ebb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83cbdcf4d95b46f5bb848c5c35e881c4_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzEtMS0xLTEtNjAyNjM_fc8dd683-df84-4d1d-ae2c-3f600a513e18">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83e1434feb5c44cf9a2a52c145c85770_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzEtMy0xLTEtNjAyNjM_2ba770be-f1c1-43bc-b7d1-905b2045762f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id534095c984248caac7f60f3f82c38bd_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzItMS0xLTEtNjAyNjM_f0a25780-ec19-455b-9e8b-3c770ce124e3">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee3572e584f746e78e030b73cb5e5f0d_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzItMy0xLTEtNjAyNjM_def04753-0c7d-4a74-8ca9-fdc9ea3ecae9">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c1ae3f134ee48b5bb585005d7de280b_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzMtMS0xLTEtNjAyNjM_03a2866e-952a-4771-8a96-1e6fbc9b3df2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if09fca4c07fa4958ac80820c3bcd7ee3_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzMtMy0xLTEtNjAyNjM_45865c04-a972-4704-aa4d-7103070007c8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzQtMS0xLTEtNjAyNjM_5cde5233-351b-45f3-a4ec-f87841cf1230">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzQtMy0xLTEtNjAyNjM_c01f792c-cbc6-4cc9-84ec-d3cd09344ca9">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diversification across and within asset classes is the primary means by which we mitigate risk. We maintain guidelines for all asset and sub-asset categories in order to avoid excessive investment concentrations. Fund assets are monitored on a regular basis. If at any time the fund asset allocation is not within the acceptable allocation range, funds will be reallocated. We also review the fund on a regular basis to ensure that the investment returns received are consistent with the short-term and long-term goals of the fund and with comparable market returns. We are prohibited from pledging fund securities and from investing pension fund assets in our own stock, securities on margin or derivative securities.</span></div><div><span><br/></span></div><ix:continuation id="i181110608b8447c2917aacb514b52ebb" continuedAt="i1755f3eede2f458a8d663d62ea6ddb97"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the target asset allocations and acceptable allocation ranges across:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target allocation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation range</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03e10a75c10f4d2c8f360deba82d8ee1_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzEtMS0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjNTZkNjFlYWJlZDY0MWVjOGJmNjliZGIzMTNhNmI1M180_f904946e-f42e-4af5-a40b-e589b5aefeda">27</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3309beddc64147aa9d4c3c624ed71776_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzEtMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjoxYmFjMWJiMzE5OGU0YjljOWYxMTAyOWQ2NjRhMzU0NV80_dfb6f0b8-7fa9-4ef9-952e-9204d461155d">25</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i1744b600a2c44fb1857cc5d43e752987_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzEtMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjoxYmFjMWJiMzE5OGU0YjljOWYxMTAyOWQ2NjRhMzU0NV85_e9c9126c-bd64-40e0-ab9b-fd877dc4fa78">30</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4be1b95cfcd2431b924119c50bfd5a9d_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzItMS0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpmODllMmY4MDE3MjM0ZWMzYmY5ZTE2NjZjZWFmMzc1Nl80_b2e44142-6a4b-4441-a284-a02fb0760b2e">68</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3af093e03e841719efdf12caaaf8448_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzItMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo3YjU5ODZmZjM2ZTg0YTcxOGUwNjdiMDBlNmIxZGI4N180_adde2318-f9b4-405f-9f57-56f4643773ff">63</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i18d85779db1a46ba80e1747766668dc9_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzItMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo3YjU5ODZmZjM2ZTg0YTcxOGUwNjdiMDBlNmIxZGI4N185_89de2294-c232-4293-92ce-94bcffcc6c5f">68</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ec9a690a49b4b95844d16d70921814f_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzMtMS0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo0ZDk0ZmUyOWU5Yzk0NDY1ODcxZmYwY2EwNzA2YzQ3Zl80_e97f29e0-d357-4eb5-82d4-c5f7e2d1ff5f">5</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1cdc53f36f04478eaf3f3e8a7e98afd5_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzMtMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkMmYxMzk1NTkzOTA0MGRhOTA4NGMwOTBjZmIzZjE4OF80_62228ea0-5578-4e47-8627-ce51eb0e4fc5">2</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i7c5650da0a7044278560c89a0b64ccb1_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzMtMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkMmYxMzk1NTkzOTA0MGRhOTA4NGMwOTBjZmIzZjE4OF85_1c1668e7-554e-4ab4-818f-5676ebe9150e">7</ix:nonFraction>%</span></div></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3bc45a58da4b4253bacc7f49152278d0"><ix:continuation id="i1755f3eede2f458a8d663d62ea6ddb97"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_112">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#8220;NAV&#8221;) have not been classified in the fair value hierarchy.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d8c496618d4192a7e40265b29fe16d_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzMtMS0xLTEtNjAyNjM_60761b9a-eb6e-4624-9588-3ddfd7a157e1">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace17547d7c143dd837ba1fadfa15bea_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzMtMy0xLTEtNjAyNjM_8151ae51-26ae-41f6-a44e-ff45733304c6">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i937298cf9f8d407e95285a8eda6be83d_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzMtNS0xLTEtNjAyNjM_10c2e96f-b291-4cf4-ac3d-f72859f97816">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb4a0cc0e3284ea38084fdcbfa086cc2_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzMtNy0xLTEtNjAyNjM_d55a3ca3-7c5c-43ee-a9f0-ab5d27de17c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aff134b217b4ead88b196a40da71390_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzYtMS0xLTEtNjAyNjM_08524c0a-3419-4961-ae44-e26e9cd79122">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c5abf4f2b824482ba9d0532f850206a_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzYtMy0xLTEtNjAyNjM_a70900ad-5a90-4fc2-94a0-d78af7ccf5f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9281c13bb0b5430aa149c75d799cec31_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzYtNS0xLTEtNjAyNjM_fd463562-f6cd-4072-89e1-41904b9d4625">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6814334eaaa54902a2c168a168c3b713_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzYtNy0xLTEtNjAyNjM_0ce03421-ea10-47bf-84ac-2bcc94cf620e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i334922c320134f52b9aebb9e98f36274_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzgtMS0xLTEtNjAyNjM_18df85c5-c5af-4577-8ad9-e8673075bacc">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b5e90b3aba4a33ba59bb7ae6badda6_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzgtMy0xLTEtNjAyNjM_06fb0ad4-3777-405a-84e0-00062fd16d09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a372d5590a144cba98ee245f1283178_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzgtNS0xLTEtNjAyNjM_d5808d30-a90e-425a-ba25-1606e59a2bde">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc59d5e4aad64e88b0465be91ead9923_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzgtNy0xLTEtNjAyNjM_9252047e-3be5-44db-8882-69004c619b12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66e95bc7d5b4db2b517555e37322183_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzExLTEtMS0xLTYwMjYz_b5c98ed8-d8f9-401e-a6de-5203f3762610">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace9c5cf6693479d9fcaa3c0f9e210d1_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzExLTMtMS0xLTYwMjYz_6b68b8b0-feea-4bb2-b2fc-43378c018e45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b1ef1156704a4faf188960f756e3c3_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzExLTUtMS0xLTYwMjYz_17989927-7baa-4eef-898c-85596d484651">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1636e6221e9b4dcb9d03af54bcedbeba_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzExLTctMS0xLTYwMjYz_81105411-6e82-4e12-b9c1-d8bc7906d871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaddca4ea08004b0ebdf07f53f5328e24_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzEyLTEtMS0xLTYwMjYz_35bf9ac0-55e7-4b40-96da-8b04a09305a7">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzEyLTMtMS0xLTYwMjYz_b378e9c9-f500-41cc-82c1-2f069c42bfd9">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzEyLTUtMS0xLTYwMjYz_1462535e-f6c1-47a2-8239-ca955bc9c2c8">28.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzEyLTctMS0xLTYwMjYz_0e68cdd4-3539-41b1-8d5c-627e388e2ff8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia29fffd4cd604df186eac9f77ff01597_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzEzLTEtMS0xLTYwMjYz_36e46575-f96a-443e-80a4-f124d2dc2045">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzE0LTEtMS0xLTYwMjYz_5409a9de-3c3b-4fda-b48e-3a7e7d626234">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c8dbef891a41e5b4ae23fc2c17ac38_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzMtMS0xLTEtNjAyNjM_772ca351-ab2a-4e87-a851-77adb9df1829">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id96fe41b380c468082cde30cff4a88be_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzMtMy0xLTEtNjAyNjM_3b975188-ac7a-4a64-ba2a-5a9e09a0169a">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fdb0e63df94bf78eaf8f55ca5a27cd_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzMtNS0xLTEtNjAyNjM_e3212d0e-0ef2-46b9-ae7e-959278985892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba5feb3867044abafc6aeffd95e3f8c_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzMtNy0xLTEtNjAyNjM_42e6c11f-024f-4dc0-a323-b5038a0b6ccc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60bb7b31a5774e6f969d94307712c269_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzYtMS0xLTEtNjAyNjM_36dcc2f3-1a70-42f3-85a4-3cd448d93ee6">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib72dae6b1cc44b23ac0fd1f3ae38ee3e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzYtMy0xLTEtNjAyNjM_34e0da23-b525-4883-8cff-92ec87446908">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ac1499da88c4b44b4f74e0201a577ba_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzYtNS0xLTEtNjAyNjM_05775ee2-2c09-49ae-9682-a6f5ef430eab">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b0f7a0791b4b61be68028ab30483bf_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzYtNy0xLTEtNjAyNjM_4e31eb02-64a3-413a-9f99-fcb049c5ba47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b93e203f105432f81fbe65326c6917c_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzgtMS0xLTEtNjAyNjM_40b4161c-7089-4520-82aa-0dbb618762d7">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0883d5b213a14846b9cecd02fae80c70_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzgtMy0xLTEtNjAyNjM_3375cb4a-63e8-440d-b448-4ec30949698b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09031663d64a4d89be1f2c8ac603f9a3_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzgtNS0xLTEtNjAyNjM_dffb21d5-3fa1-42b6-a5e5-7c7050194acc">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5758fc91240f44f58c0d8211b63f96e8_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzgtNy0xLTEtNjAyNjM_f156eacc-c492-4d55-809a-15d6d8147146">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia12d474c435e416382e99942998771f6_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEwLTEtMS0xLTYwMjYz_2330288b-af2e-4605-9a20-059c7e79e775">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c18c5f3a6c42509cf4b94e0141bcb5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEwLTMtMS0xLTYwMjYz_e754982c-af5b-4f3c-a535-3db3e7d89a42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38e1e2edfa654b98a2366d1ba0e981bf_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEwLTUtMS0xLTYwMjYz_e8730abf-b930-4d39-91ac-62f790b4dad4">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bb1b7b296b8458ba1252c6364245ea0_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEwLTctMS0xLTYwMjYz_7649b5e2-a217-4889-98e3-e17eca8f4381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58483908f99e4d18a4072d007a922d3b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEyLTEtMS0xLTYwMjYz_05fe8bc5-6196-4c8a-a71a-fbe2b825921b">49.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEyLTMtMS0xLTYwMjYz_d5a7941b-c271-48ff-8069-feb232f414d9">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ef59879afe401591e29ee824de0517_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEyLTUtMS0xLTYwMjYz_57ff5022-73e6-445f-b326-e5d90b184e92">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEyLTctMS0xLTYwMjYz_6238cbfa-2994-4a97-9604-6377e57b45b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d11fb26784407a9537aafa6159e23b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEzLTEtMS0xLTYwMjYz_0d9d60fc-c27f-4961-9782-3cf3831bccda">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzE0LTEtMS0xLTYwMjYz_b2e45b53-2e8a-4a2e-adb2-44fa0021ff59">249.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_124"></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzM0NzI_b01ca7ac-9636-4138-a6a6-2dc2ac5a4221" continuedAt="i154bfe7d46ee423999a06eab3d620445" escape="true">Other Expense (Income) </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i154bfe7d46ee423999a06eab3d620445" continuedAt="ie4cd6e4aa70f4ff19d1c94446fc2ad78"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzM0NTI_879fc917-efc7-4153-95d4-512a3b3cee65" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income) consisted of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and post-employment benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzItMS0xLTEtNjAyNjM_a26311ae-d7b1-43b4-8687-5638b11b64ca">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzItMy0xLTEtNjAyNjM_2d39eee7-20fa-4808-bc51-b0bbbb56f936">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzItNS0xLTEtNjAyNjM_de72216d-9061-411e-9f17-c307d42c4074">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzMtMS0xLTEtNjAyNjM_e56b269c-3e90-4578-8369-67aebcc95436">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzMtMy0xLTEtNjAyNjM_2ec14764-d736-4504-8da9-903c8cadcbe6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzMtNS0xLTEtNjAyNjM_574ef23b-1e80-42af-9f37-3d574954ce61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzQtMS0xLTEtNjAyNjM_72ac94e9-adcc-451c-bcb0-c1f23b4cfa3e">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzQtMy0xLTEtNjAyNjM_0bb18811-e3d6-4500-a7b3-6ef292feace2">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherRestructuringCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzQtNS0xLTEtNjAyNjM_6359c0ef-78be-4b97-8b1e-417ca7cb330d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and related charges</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzUtMS0xLTEtNjAyNjM_b3d40d0c-9ec6-41c4-9bd2-3d199232016a">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzUtMy0xLTEtNjAyNjM_202443b7-b9f3-4661-a886-b3b936a44ad1">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzUtNS0xLTEtNjAyNjM_5f6a1da1-681e-41be-9174-21d5b93b7150">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset impairments and sale of equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzYtMS0xLTEtNjAyNjM_fae84aba-32ae-418d-921e-672121d7c64b">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzYtMy0xLTEtNjAyNjM_f9d36c95-be69-4330-8aa9-1775be1213f6">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzYtNS0xLTEtNjAyNjM_bb38e493-9a26-4155-845b-fad41a5529b3">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on oil hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzgtMS0xLTEtNjAyNjM_ced57049-1a63-4b55-9c66-c839d7b14598">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzgtMy0xLTEtNjAyNjM_b1f63b7f-7ef6-4550-becc-ebcf8f8f98d4">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzgtNS0xLTEtNjAyNjM_8107d313-eb9b-4f12-93d9-6867b3b738b2">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEwLTEtMS0xLTYwMjYz_a8038ad3-d5c5-4641-b2de-5217b38ca06b">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEwLTMtMS0xLTYwMjYz_305baae8-236d-4601-832f-e24f14d25ccb">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEwLTUtMS0xLTYwMjYz_2ef538b2-989e-473d-a6cf-fd36f84b8f4f">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange transaction gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzExLTEtMS0xLTYwMjYz_37e379c8-4008-4eb8-9ece-a3aa7a83b059">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzExLTMtMS0xLTYwMjYz_924fe8f5-746a-44d4-b6bc-c07572b06c58">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzExLTUtMS0xLTYwMjYz_045888f5-ecda-4fc5-8874-7fc7f85a57f4">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment activity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEyLTEtMS0xLTYwMjYz_27411d54-d018-4a25-a8c8-0226f04932b5">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEyLTMtMS0xLTYwMjYz_c64e06db-abff-4def-b72b-b68461bf6761">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEyLTUtMS0xLTYwMjYz_55302856-c130-4334-9ebe-73c4cc35abcd">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEzLTEtMS0xLTYwMjYz_7721bdc1-7bda-4529-a5ee-37a0fb548ccd">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEzLTMtMS0xLTYwMjYz_05c93230-4e2c-4a82-89c1-d0125b0b6213">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEzLTUtMS0xLTYwMjYz_83d8b71c-0087-42d8-aa70-ffcb96ac3c5e">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income) </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzE0LTEtMS0xLTYwMjYz_a82c969e-808e-4311-bbb4-b32d9955f7d3">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzE0LTMtMS0xLTYwMjYz_053d4cf2-ff72-466b-a9b3-478d337d0eb6">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzE0LTUtMS0xLTYwMjYz_d83966d2-6714-4d97-9c68-35132270abd0">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and Related Charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company approved a restructuring plan to adjust our operating cost base to better respond to the macroeconomic factors influencing our business. These changes are expected to be implemented over a period of up to <ix:nonNumeric contextRef="i95a83e2185a942eca49ce6709b9ac586_D20221201-20221231" name="wst:RestructuringAndRelatedActivitiesPeriodOfImplementation" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjQyMTM_23f389f9-0289-4c89-83ef-991e0f43f103">twelve months</ix:nonNumeric> from the date of the approval. The plan is expected to require restructuring and related charges of approximately $<ix:nonFraction unitRef="usd" contextRef="iaf9de54a304d46c781f42375b69365a9_I20221231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjQyNDM_8e748ba1-325d-40d1-8e0e-6f3d84a41889">25</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i849944f81aab4b96860b7d3e5eb73e20_I20221231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjQyNTY_31f11023-21b3-4d5e-aa2b-9e051a716460">27</ix:nonFraction>&#160;million, with annualized savings in the range of $<ix:nonFraction unitRef="usd" contextRef="ice7d61872f80427da0d9116b49983311_D20221201-20221231" decimals="-6" name="us-gaap:EffectOnFutureEarningsAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjQzMTk_06e152bc-aadb-410b-a9ff-a9c5871e0b01">22</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i5f7acdde722448e481784486341104c3_D20221201-20221231" decimals="-6" name="us-gaap:EffectOnFutureEarningsAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjQzMDY_09b38d68-9913-43c2-9ff8-d019b19a3d8b">24</ix:nonFraction>&#160;million. Included within the expected restructuring charges is an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzEyMDk0NjI3OTE1MTU0_e56b269c-3e90-4578-8369-67aebcc95436">15.3</ix:nonFraction> million representing the net book value of long-lived fixed assets held in our production facilities that were determined to have no future use to the Company. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2Xzc2OTY1ODE0MDI0Mzk_aaf8d90f-b51d-46c9-a66e-fa4237c91048" continuedAt="id229ac3614b14695bee26ea2bcb53aa4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:39.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d2bb17ed48c41dba32219896e2e8175_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzEtMS0xLTEtNzQ5NDc_ca668d02-8b71-4cc4-8942-3cd2af1b754f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141e60cb61604823b8430879ea150d99_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzEtMy0xLTEtNzQ5NDk_002735a7-bc43-4e78-95d9-2886a10d36cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63527504ecaa4a10a8def5b5ec6f1894_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzEtNy0xLTEtNzQ5NTM_65857265-a915-4c1a-ac06-cdae02766bce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea43a3c1ca4f40c0bbab919047a0f8b5_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzItMS0xLTEtNzQ5NDc_8a231fdc-6370-4f84-8956-266846e78c7f">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9659ef9de2934f93b6fa46288c5b5b6e_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzItMy0xLTEtNzQ5NDk_4dd6b1a9-f571-453b-99dc-b9e033d4409b">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69af11490d5b4086ad2dfcf3de8f6296_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzItNy0xLTEtNzQ5NTM_f1d7b399-7664-4545-99c9-dc5395697d85">25.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea43a3c1ca4f40c0bbab919047a0f8b5_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzMtMS0xLTEtNzQ5NDc_9e50f83f-4fa7-4335-96bc-9e1d3b67b990">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9659ef9de2934f93b6fa46288c5b5b6e_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzMtMy0xLTEtNzQ5NDk_75b3e059-29c4-4597-bb16-87cbea254be4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69af11490d5b4086ad2dfcf3de8f6296_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzMtNy0xLTEtNzQ5NTM_1383b345-e544-4f39-8582-962d40056f31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffe83e403acf438f85b6dd1d97e8d460_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzQtMS0xLTEtNzQ5NDc_e576c428-d38a-49de-8d77-c39018082d4d">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d19b063b3c34a448674207e911c6ffb_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzQtMy0xLTEtNzQ5NDk_62f1b3da-b079-4a35-a034-cd23864c01d7">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26407107db9342c9bf5081c03e7a3fa3_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzQtNy0xLTEtNzQ5NTM_753b9b74-a589-4259-a72c-429b90cafb45">25.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, our Board of Directors approved a restructuring plan designed to optimize certain organizational structures within the Company to better support our continued growth and business priorities. These changes were implemented over a period of approximately <ix:nonNumeric contextRef="i8bd3a366e8d54c4b8cef2c043f15ec29_D20200701-20200731" name="wst:RestructuringAndRelatedActivitiesPeriodOfImplementation" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzM4OA_15865e15-bb5f-434f-83e0-c09c604abc03">twenty-four months</ix:nonNumeric> from the date of the approval. The plan is expected to have annualized savings in the range of $<ix:nonFraction unitRef="usd" contextRef="iec709d90491e43ea967136f7e4512e45_D20200701-20200731" decimals="-5" name="us-gaap:EffectOnFutureEarningsAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2Xzc2OTY1ODE0MDMzOTg_b65c6dea-6f75-48a0-892e-51109730c8e1">0.9</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i9559d3f0ca1a41c1b6d4dd22b5a6caa0_D20200701-20200731" decimals="-5" name="us-gaap:EffectOnFutureEarningsAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjAwNTE_33f861e4-e124-40c1-90fb-ad10667367e4">1.6</ix:nonFraction>&#160;million. Since its approval, we recorded a net pre-tax amount equal to $<ix:nonFraction unitRef="usd" contextRef="id631ed0f114043709b097d7fd85636b2_I20200731" decimals="-5" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjAwMzc_dd1df71d-f525-40d0-8a13-db23e0baad46">5.2</ix:nonFraction>&#160;million in restructuring and related charges associated with this plan.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie4cd6e4aa70f4ff19d1c94446fc2ad78"><ix:continuation id="id229ac3614b14695bee26ea2bcb53aa4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2020 restructuring plan:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0e239fe07746a692c5b712876addbe_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzEtMS0xLTEtNjAyNjM_2919b750-15ed-44c6-91f5-e8a72131d73a">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24e6acff1c7640c38b022c848d7af043_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzEtNC0xLTEtNjAyNjM_3d9613c0-bc32-4adb-9b6f-75a5544e4f95">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7a20234e76b4aceb4a563d4757f3a25_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzEtNi0xLTEtNjAyNjM_1e4810f2-10f7-44ba-ba0f-cf2d25b2c3c9">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d8644e185ba45f1aca8a97124127c09_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzItMS0xLTEtNjAyNjM_07db4614-38e8-487b-a03e-399a4b81dc2e">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i498328cc9bd447608019d68a0f1b2953_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzItNC0xLTEtNjAyNjM_55d61ab9-3f67-45ac-b846-d0f85326a464">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2a5063af9e7457eadff8ecde4a2a0db_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzItNi0xLTEtNjAyNjM_a139d97c-0051-4309-9ea7-514dcc9bacf1">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d8644e185ba45f1aca8a97124127c09_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzMtMS0xLTEtNjAyNjM_9c11bce5-ba63-4723-82a3-8702ef855118">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i498328cc9bd447608019d68a0f1b2953_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzMtNC0xLTEtNjAyNjM_1f9f5d96-fecb-4073-84c5-23de4228f597">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2a5063af9e7457eadff8ecde4a2a0db_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzMtNi0xLTEtNjAyNjM_13521904-94a1-4e47-8a56-aaaeb3ed5aa1">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d14abab15aa4e50aae530229040d0ef_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzQtMS0xLTEtNjAyNjM_9aef67f3-5e69-4716-b4a3-e71867d9ab72">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f7fd511790420c92f6c02a26a4ae95_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzQtNC0xLTEtNjAyNjM_d864fc3d-0018-400a-b42f-2a43fe2f429a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id305d29074a84896bb281161842eac04_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzQtNi0xLTEtNjAyNjM_58429d32-dbbf-43b9-a9b0-32af306839ef">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration represents changes in the fair value of the SmartDose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contingent consideration. Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_112">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oil Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021 and 2020, we recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjI4NDk_ced57049-1a63-4b55-9c66-c839d7b14598">1.5</ix:nonFraction>&#160;million, a gain of $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjI4NTk_b1f63b7f-7ef6-4550-becc-ebcf8f8f98d4">1.7</ix:nonFraction>&#160;million, and a loss of $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjI4NjU_8107d313-eb9b-4f12-93d9-6867b3b738b2">0.2</ix:nonFraction>&#160;million, respectively, related to oil hedges. Please refer to Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_109">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our hedging activity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost Investment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, specific to our cost method investments, we recorded a total impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjMxNzk_27411d54-d018-4a25-a8c8-0226f04932b5">3.5</ix:nonFraction> million. During 2021, specific to our cost method investments, we recorded a total impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzI3MDQ_1800e932-0c64-4f2c-a7b3-7703a63553ab">4.6</ix:nonFraction>&#160;million which was offset by a net gain of $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzE2NDkyNjc0NDUyMzk_f68d24c8-184d-46d7-8268-428b8f934e6c">0.3</ix:nonFraction>&#160;million on the sale of a cost investment. During 2020, specific to our cost method investments, we recorded a total impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjMxMDE_55302856-c130-4334-9ebe-73c4cc35abcd">2.5</ix:nonFraction> million.</span></div></ix:continuation><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1NTQ_28d565b5-735e-4c3c-ad04-e6f33594b9f2" continuedAt="ibd74a9c55038433583ea3ea8766004c7" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibd74a9c55038433583ea3ea8766004c7" continuedAt="i9d13ef8056da49398906d915fb8e7137"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global organization, we and our subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. As of December 31, 2022, the statute of limitations for the U.S. federal tax years 2017 through 2022 remain open to examination. For U.S. state and local jurisdictions, tax years 2013 through 2022 are open to examination. We are also subject to examination in various foreign jurisdictions for tax years 2015 through 2022.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1NDI_517709ea-418d-4bb5-9952-d5b92653d115" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzEtMS0xLTEtNjAyNjM_7c3a3659-2acb-49e2-b31f-2309fbf00fe4">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1165b131d689444eb6459290c85e0fec_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzEtMy0xLTEtNjAyNjM_873cb623-7c11-4aa8-af94-005fe2703b99">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ff963c9c54045f29206b3189d452f9b_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzEtNS0xLTEtNzk5NDI_27651b4e-cb97-4747-8b18-3c37d4536cd9">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzItMS0xLTEtNjAyNjM_24886cc2-5f95-4dfd-b85c-e4f0551062f2">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzItMy0xLTEtNjAyNjM_c1e796cb-0712-4dfd-bc50-45542b7fa135">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzItNS0xLTEtNzk5NDI_52e20424-62f5-4b4d-ab88-c751600f22cd">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) due to prior year position</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzMtMS0xLTEtNjAyNjM_f8a8fe80-6045-4f9b-a203-0a03e1f975ca">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzMtMy0xLTEtNjAyNjM_59bb123c-7b9f-4919-80b1-7039316aac91">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzMtNS0xLTEtNzk5NDI_a742b7f6-b0b8-4da3-8475-5905bbc23158">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction for expiration of statute of limitations/audits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzQtMS0xLTEtNjAyNjM_60a28ef2-edff-44c7-8f5c-83b7a495f8ef">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzQtMy0xLTEtNjAyNjM_c0f96c97-89e2-4557-9d52-7cae2e3112f2">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzQtNS0xLTEtNzk5NDI_428de074-bdb2-47a5-9219-e70da6e0d414">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzUtMS0xLTEtNjAyNjM_9eaa81d0-649d-4133-a9aa-07ccfb16f8b6">36.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzUtMy0xLTEtNjAyNjM_e84ef6e9-88f2-4fff-a590-8be6ea7a7af5">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1165b131d689444eb6459290c85e0fec_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzUtNS0xLTEtNzk5NTA_8e8a3f7e-e48e-4c67-bad6-eafb890185ad">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we had balances in accrued liabilities for interest and penalties of $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzY4MQ_0cb17eb3-1737-494b-8e8f-e24cb63ac2d6">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzY4OA_3c11d74b-287f-4bf3-8b48-245ade9064ec">0.5</ix:nonFraction> million at December&#160;31, 2022 and 2021, respectively. As of December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzczNg_1fd2ddab-5317-4083-a619-f88f21215bcd">36.5</ix:nonFraction> million of total gross unrecognized tax benefits, which, if recognized, $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjAxNDk_1fd2ddab-5317-4083-a619-f88f21215bcd">36.5</ix:nonFraction> million would favorably impact the effective income tax rate. It is reasonably possible that, due to the expiration of statutes and the closing of tax audits, the amount of gross unrecognized tax benefits may be reduced by approximately $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzEwMzU_09ebd363-abd7-4663-b59a-74ff40e5a2b5">1.7</ix:nonFraction> million during the next twelve months, which would favorably impact our effective tax rate.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9d13ef8056da49398906d915fb8e7137" continuedAt="idd8a1bfc80e1424aa41082366a0dce69"><div style="margin-bottom:10pt"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1MjM_a12b415a-eddd-4a84-8ad6-7256c5311138" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income before income taxes and equity in net income of affiliated companies are:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzEtMS0xLTEtNjAyNjM_dab1f7b1-ef67-46df-a5a4-af321c8154b5">394.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzEtMy0xLTEtNjAyNjM_361e0119-f357-4efa-9b37-29a59d6e2576">420.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzEtNS0xLTEtNjAyNjM_a3a6f97b-e00b-4ff7-aff3-09246607d7ac">227.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzItMS0xLTEtNjAyNjM_770a1b0f-2712-4391-ba6e-cc14423a4daa">285.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzItMy0xLTEtNjAyNjM_3e17332e-54bc-4458-a1e7-9343a726c161">328.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzItNS0xLTEtNjAyNjM_480bea16-c1b7-4a0e-8c2d-e0372f0672b1">174.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income before income taxes and equity in net income of affiliated companies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzMtMS0xLTEtNjAyNjM_2359f821-bab4-437e-8c86-bdb892e540ab">679.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzMtMy0xLTEtNjAyNjM_75f2576c-7e40-4154-810c-07a7b14aadde">748.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzMtNS0xLTEtNjAyNjM_97fc8b4d-7dc2-4f63-aa1c-824d698d5a06">401.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1NTI_562cbd5b-c126-4ac6-b35e-c8680e3fb86b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related provision for income taxes consists of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzItMS0xLTEtNjAyNjM_1162d7f7-2c7a-42e5-a563-cec15b10e578">75.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzItMy0xLTEtNjAyNjM_e3160cd1-3768-4fca-ba81-b06a70cf8cf7">64.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzItNS0xLTEtNjAyNjM_8b3b5ba9-8e3b-4826-9f3a-26eff3491145">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzMtMS0xLTEtNjAyNjM_549ea035-ab1e-425c-8b67-9caaaccebea5">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzMtMy0xLTEtNjAyNjM_f1647822-1663-4f4d-8bf0-d3764322897f">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzMtNS0xLTEtNjAyNjM_89067e9c-7226-4f47-8759-98b399aa9268">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzQtMS0xLTEtNjAyNjM_e77d702a-18db-44c0-a120-e263a097d804">61.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzQtMy0xLTEtNjAyNjM_4db594d7-0911-40c7-acca-2ea240dd0375">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzQtNS0xLTEtNjAyNjM_98c4309b-2b3c-46ee-a18a-c57db1db3df7">46.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzUtMS0xLTEtNjAyNjM_b68a6c40-6d35-423e-9bcb-2aa9cc09b3f3">145.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzUtMy0xLTEtNjAyNjM_f0496c5a-6e4d-48ad-86a5-02e026ccf922">150.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzUtNS0xLTEtNjAyNjM_54f93b8f-d6b7-4e83-a8c6-38e277c23e3b">78.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzctMS0xLTEtNjAyNjM_f7eadd92-0a5b-4e18-9373-72f18b25d73c">20.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzctMy0xLTEtNjAyNjM_7db317e4-2df9-4086-ab29-a66d9a4be033">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzctNS0xLTEtNjAyNjM_8efd8ffb-3802-423e-b1eb-604fde5d16ef">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzgtMS0xLTEtNjAyNjM_a7d42ae0-312d-4b92-915d-77ea62ee00c2">10.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzgtMy0xLTEtNjAyNjM_26a02c97-6483-4a13-8217-1aa60aa5ac20">50.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzgtNS0xLTEtNjAyNjM_465b7f97-6d51-4089-bcff-1b28172b322f">6.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzktMS0xLTEtNjAyNjM_d8128fb5-1727-4083-88d5-473ca91124b5">30.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzktMy0xLTEtNjAyNjM_166ce3a4-e9c7-49f1-b1a0-8e962f1c652f">42.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzktNS0xLTEtNjAyNjM_ab4916ea-3025-454f-b843-64dc52404c10">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzEwLTEtMS0xLTYwMjYz_469bdff4-807c-42fd-8bf0-da41cfffdd5c">114.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzEwLTMtMS0xLTYwMjYz_35c7878d-e71f-4af0-93b0-1f635c27271a">107.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzEwLTUtMS0xLTYwMjYz_dfeb5112-9fb5-4738-a1bc-00189de0a928">72.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1MjY_464e9691-d9bd-4247-ad4b-3265a9503747" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of our deferred tax assets and liabilities at December 31 are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzItMS0xLTEtNjAyNjM_173d9148-5756-4ffa-a275-15ab659540c2">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzItMy0xLTEtNjAyNjM_48a67069-e55b-4dc9-aa93-9350bd5dff0c">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzMtMS0xLTEtNjAyNjM_240ed16e-3f7f-4d42-86d5-6c6c62440622">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzMtMy0xLTEtNjAyNjM_9016da3f-2a3d-4804-bb0e-8eeb2955a2ec">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzUtMS0xLTEtNjAyNjM_0000fcc7-bf02-4d4a-b564-8e1916d6d374">31.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzUtMy0xLTEtNjAyNjM_2f82584f-d365-40dc-9ca9-48c5dfae7596">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty acceleration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="wst:DeferredTaxAssetsRoyaltyAcceleration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzYtMS0xLTEtNjAyNjM_54796912-e8b6-42e1-a501-ddc0506ace56">46.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="wst:DeferredTaxAssetsRoyaltyAcceleration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzYtMy0xLTEtNjAyNjM_b980d068-2cc3-48ff-81a6-ac296186fe00">45.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzctMS0xLTEtNjAyNjM_3d556406-c599-4440-9992-97a589c4d560">25.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzctMy0xLTEtNjAyNjM_7cf24c1c-b28b-4b91-bfc4-d65be46bcf05">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzgtMS0xLTEtNzkwNzk_440b5c1b-283f-400c-b568-c96f28553457">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzgtMy0xLTEtNzkwODc_d6d89a72-842d-416d-abce-0584c04015c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="wst:DeferredTaxAssetsLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzktMS0xLTEtNzk0MDc_4b2ceefb-b8b9-4bbb-bc66-887e31255a10">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="wst:DeferredTaxAssetsLeasingArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzktMy0xLTEtNzk0MTU_b31c607c-fe68-4ad2-8354-b36e33f1ceb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzgtMS0xLTEtNjAyNjM_bf38dca2-d2e2-43b3-a64c-07ccf66864f9">13.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzgtMy0xLTEtNjAyNjM_7c49d0d5-ce79-4adb-8143-6f1919f2ee9b">12.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzktMS0xLTEtNjAyNjM_e2280501-1a6b-4ccf-89c5-330f5e5ce087">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzktMy0xLTEtNjAyNjM_998f39a7-e5e7-4fdd-b578-3ced281d767e">92.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzExLTEtMS0xLTYwMjYz_15fbab9c-800f-490c-9553-c352e945f73a">53.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzExLTMtMS0xLTYwMjYz_ef3f8857-0705-4f11-9ec2-6b35a92a44a5">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzEyLTEtMS0xLTYwMjYz_13bb1fc2-db78-467b-82ac-74e3169df3bd">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzEyLTMtMS0xLTYwMjYz_8a112877-6df7-405c-be6c-5f2d52a15a85">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE1LTEtMS0xLTc5NDI1_63409564-a5de-4554-9db9-b28a49b7f2b1">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE1LTMtMS0xLTc5NDMz_de2c0d43-cd57-405e-bf6b-6974f98c649e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzEzLTEtMS0xLTYwMjYz_b3443bab-89e1-4ee6-81eb-70a682a9f6b2">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" sign="-" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzEzLTMtMS0xLTYwMjYz_8ee44185-ff0f-4ab9-a31a-3269c7691bec">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE0LTEtMS0xLTYwMjYz_6cd3a823-d396-4f30-91ea-34f45972782d">79.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE0LTMtMS0xLTYwMjYz_63066e0b-bb2a-41d2-87b9-64690c2e4bbf">48.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE1LTEtMS0xLTYwMjYz_ddbd441f-b3ad-4460-8812-5dda4730823b">51.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE1LTMtMS0xLTYwMjYz_15b8b661-11b4-4f49-9625-813edd9bb47b">43.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idd8a1bfc80e1424aa41082366a0dce69" continuedAt="ib01b6759dc1f4ab2a4fc26355f1f8eaf"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1MjA_9f471e7c-066f-4cff-892a-5df6a1b822d8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes and equity in net income of affiliated companies is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal corporate tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEtMS0xLTEtNjAyNjM_d592dea2-2bff-4770-88d6-e68c2d41271f">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEtMy0xLTEtNjAyNjM_6d0b1288-1285-460a-97b3-6121a02e2a18">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEtNS0xLTEtNjAyNjM_9a5bc859-13e7-4aad-b1e8-d80518b47919">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on international operations other than U.S. tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzItMS0xLTEtNjAyNjM_957d08c8-7410-4d00-aa77-1f72f89b90b4">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzItMy0xLTEtNjAyNjM_924c6e2f-aed8-4720-8d57-060a7495e51d">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzItNS0xLTEtNjAyNjM_f31772be-1795-44b7-b928-aa1c68327f62">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reserves for unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzUtMS0xLTEtNjAyNjM_9e886565-12f0-46d1-b3a7-6f45c1d6b7be">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzUtMy0xLTEtNjAyNjM_ce4d9789-cc2f-4dd3-ac6b-3aa20093686c">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzUtNS0xLTEtNjAyNjM_1f53ae71-348b-403b-bf65-4d66fec84cca">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on international earnings, net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzYtMS0xLTEtNjAyNjM_4a33b5c7-13da-45ba-bca2-53f434c68a54">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzYtMy0xLTEtNjAyNjM_17a9cce3-d966-41b8-8691-1f36ec9bc4bb">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzYtNS0xLTEtNjAyNjM_2bb1c276-34cd-4717-9f04-0501648c48a2">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-Derived Intangible Income Deductions (FDII)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzctMS0xLTEtNjAyNjM_6e8e4431-28de-4818-8b1f-e21b192723ec">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzctMy0xLTEtNjAyNjM_5210fbe5-091b-47f3-9b3c-408a7da16bb2">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzctNS0xLTEtNjAyNjM_01cb97d7-f1c4-4f87-b82f-e5f6e3647b0f">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzgtMS0xLTEtNjAyNjM_c48d00a5-f124-418a-8491-90787d536ced">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzgtMy0xLTEtNjAyNjM_4a037726-99f9-43fb-aab9-da5eb51b386b">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzgtNS0xLTEtNjAyNjM_bf4cd3d8-3ddb-4697-81a3-a1b7eb8f4812">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzktMS0xLTEtNjAyNjM_d76280b3-08b0-4ad0-abac-d2ed46ba6d1f">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzktMy0xLTEtNjAyNjM_30f2a725-1a56-4307-bab3-ce7840a674ec">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzktNS0xLTEtNjAyNjM_e1c1cef1-edc0-4379-bcaa-80c83ff0727f">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on share-based payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEwLTEtMS0xLTYwMjYz_8af706ae-75c9-4e1b-b9e2-460a1fbe7909">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEwLTMtMS0xLTYwMjYz_90395113-f1c2-481f-ac9b-306e3f06a4ce">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEwLTUtMS0xLTYwMjYz_a707a1de-d3ee-4ccd-a0ec-909678894ecf">5.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty acceleration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzExLTEtMS0xLTYwMjYz_c7defb44-bc21-4da0-bf28-65a6fae96f3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzExLTMtMS0xLTYwMjYz_94c8248b-1ec1-4c05-a193-aa4355200764">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzExLTUtMS0xLTYwMjYz_35325a27-04e0-45ab-8df4-08fe52828a3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEyLTEtMS0xLTYwMjYz_61f32694-a9dd-46ab-a62e-65174691e140">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEyLTMtMS0xLTYwMjYz_6255316e-ea00-4ab3-9a29-ec253b44b8a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEyLTUtMS0xLTYwMjYz_453e9680-12c8-4c35-af40-4b21e16de18d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE0LTEtMS0xLTYwMjYz_8b241ffb-31e1-4e1c-af8d-d4c795ad2caa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE0LTMtMS0xLTYwMjYz_7f0cac59-e362-4a66-8224-60e88db59e4e">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE0LTUtMS0xLTYwMjYz_bb01bbe5-8121-4c3e-81b8-7c906f4d1da2">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE3LTEtMS0xLTYwMjYz_5bce9f40-6e19-47a9-9a70-188770e403c0">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE3LTMtMS0xLTYwMjYz_261bda97-30f7-4a49-980b-47847340fd24">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE3LTUtMS0xLTYwMjYz_746be511-bce5-4caf-94bd-95d5fb61ed2e">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE4LTEtMS0xLTYwMjYz_6f7c3bf2-dab4-44b5-81a4-aa8ec5306464">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE4LTMtMS0xLTYwMjYz_a6b2be04-2479-4d33-805d-7be7e372d436">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE4LTUtMS0xLTYwMjYz_a03d9cd0-ef30-477d-828b-88ba298253aa">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we recorded tax expense of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzEyMDk0NjI3OTE0MTU4_04a8bf7e-5a3d-482a-9ef9-ee291e17acef">5.7</ix:nonFraction>&#160;million due to the impact of tax law changes enacted during the year, $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="wst:EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjU3MzM_5749458b-d6f6-4985-940c-a3fab27c9064">19.8</ix:nonFraction>&#160;million of tax expense due to the Company's recognition of reserves for unrecognized tax benefits, and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjU3NDg_93146d4d-4535-4eac-94e7-b57246c1491c">16.5</ix:nonFraction>&#160;million associated with stock-based compensation. A tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjU3NzA_37528d27-d097-4fc2-8b99-86852f1ea665">20.6</ix:nonFraction>&#160;million was recognized for the 2022 termination of our U.S. pension plan. The company did not elect to reclassify to retained earnings the stranded tax effects on items within AOCI related to the Tax Cuts and Jobs Act of 2017, and therefore included within the $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjU3OTg_37528d27-d097-4fc2-8b99-86852f1ea665">20.6</ix:nonFraction>&#160;million pension termination benefit is a deferred tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjU4MDE_dcaa2cdb-e057-4f51-989a-24f1c1159e35">8.0</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we recorded a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzE5MzY_3c40c0d8-013d-40eb-b010-c2913ef48116">1.4</ix:nonFraction>&#160;million due to the impact of tax law changes enacted during 2021, a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationTaxSettlementsOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjAzNjI_c3ea7480-42d3-457b-9a75-eabbaa8b75b4">18.5</ix:nonFraction>&#160;million due to the Company's prepayment of future royalties from one of its subsidiaries, and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIwMjE_ea9f1cd0-5bb9-4b9d-86b0-08d4d7ee06bd">31.5</ix:nonFraction>&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we recorded a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxMTI_5ffc9744-1759-4e44-a535-06f90e3bc845">0.5</ix:nonFraction>&#160;million due to the impact of tax law changes enacted during 2020 and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxODE_b77953ed-765d-4632-80c7-a1044c146fa4">20.8</ix:nonFraction>&#160;million associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i291db1eaff5d4fe183595c6f835e091c_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIyNjU_537ba243-4874-4d1f-ac7c-1647ac6ba873">123.2</ix:nonFraction> million created a deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIzMDA_fe66ff6e-041f-4b62-9a90-769c7deec8ee">7.3</ix:nonFraction> million, while foreign operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i8495f2ee91834fb1a3f9fe1c93572049_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIzNTA_1da817ba-946c-4842-b7e3-e5e704206d68">18.4</ix:nonFraction> million created a deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIzODU_14a8e96e-a449-4ce3-b2f0-2b2c4fab6191">2.9</ix:nonFraction> million. Management estimates that certain state and foreign operating loss carryforwards are unlikely to be utilized and the associated deferred tax assets have been appropriately reserved. In 2022, it was determined that $<ix:nonFraction unitRef="usd" contextRef="i680df56be5cb4f5e860aab0cf5b550c7_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzI1OTU_5a4a41ba-bb74-453b-ace9-ca585409c7d7">3.8</ix:nonFraction> million of previously reserved state loss carryforwards were more likely than not to be utilized prior to expiration. State loss carryforwards expire as follows: $<ix:nonFraction unitRef="usd" contextRef="i4e05940c83de48978c0c9bb32a9d5626_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzI3NTI_73a5462d-06fd-4e46-b7f1-c1cd6eede8e5">4.7</ix:nonFraction> million in 2023 and $<ix:nonFraction unitRef="usd" contextRef="i908fccc3de554e288be0804e0e181156_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzI3NjU_e5110ab3-01f6-403e-a7cd-0829add7c8cc">118.5</ix:nonFraction> million thereafter. Foreign loss carryforwards total $<ix:nonFraction unitRef="usd" contextRef="i8495f2ee91834fb1a3f9fe1c93572049_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzI4NTk_1da817ba-946c-4842-b7e3-e5e704206d68">18.4</ix:nonFraction> million, <ix:nonFraction unitRef="usd" contextRef="i8495f2ee91834fb1a3f9fe1c93572049_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzMyOTg1MzQ4OTc3NDk_7090b52c-bc42-4b6e-83ee-0c975c5de16f">none</ix:nonFraction> of which will expire.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we utilized all of our remaining U.S. federal research and development credit carryforwards. State research and development credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ic45bcdf6531a4b0dbe32a45651758dbc_I20191231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzMwNDE_7f8f8cc8-325e-409c-9b66-f22b99b8d50d">1.8</ix:nonFraction>&#160;million created a deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="i5ff963c9c54045f29206b3189d452f9b_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzMwNzY_2edd55c9-e28b-499e-b337-42b1cf8ddf5d">1.4</ix:nonFraction>&#160;million. As of December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i2dd0857c331249a9a85539ede4607c70_I20221231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzMwOTA_5c74e066-0fd6-46ea-954d-90253c5b4c5c">0.4</ix:nonFraction> million of state research and development credits expire in 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib01b6759dc1f4ab2a4fc26355f1f8eaf">Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzM5ODc_12fafd7d-5af5-45d0-a877-e51ed9afe134">893.1</ix:nonFraction>&#160;million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.</ix:continuation></span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzkyNw_a32f0adb-6b1c-4d38-8eb4-013ae407fa03" continuedAt="i42182207787f4e17b3f5c9a9acf1c21d" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i42182207787f4e17b3f5c9a9acf1c21d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we were obligated under various operating lease agreements. Please refer to Note 6, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_94">Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we were obligated under various defined benefit pension plans in the U.S. and other countries that cover employees who meet eligibility requirements. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_121">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, our outstanding unconditional contractual commitments, including for the purchase of raw materials and finished goods, amounted to $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzUzMA_51b5eaef-3b0d-4c17-847e-cfb0c2dbe53a">96.8</ix:nonFraction> million, the majority of which is to be paid in the next two years, with $<ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzU5OA_ed3ee6fc-5e17-4e33-a7ea-5b9e7e141256">70.9</ix:nonFraction> million due to be paid in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="i36a6e77fe574426b8c780aa1e3956660_I20221231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzY1OQ_284c2f15-cc6b-4578-a139-20aa6a0e0923">2.4</ix:nonFraction> million supporting the reimbursement of workers&#8217; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $<ix:nonFraction unitRef="usd" contextRef="i6615258597bc4111bd8224a2f4f5be19_I20221231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzgxNw_a5ab54f2-2cb8-4564-a843-4906b35c0776">3.3</ix:nonFraction> million at December&#160;31, 2022, of which $<ix:nonFraction unitRef="usd" contextRef="i6615258597bc4111bd8224a2f4f5be19_I20221231" decimals="-5" name="us-gaap:LossContingencyReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzgzNg_c9528322-d064-4c90-a59e-00fb954395f8">0.7</ix:nonFraction> million is in excess of our deductible and, therefore, is reimbursable by the insurance company.</span></div></ix:continuation><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 19:&#160;&#160;<ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzQwNTA_3669715e-8cfe-4f5c-a87d-130f3f076e86" continuedAt="ie081bb9cfc9448dbbf76699793c10c2d" escape="true">Segment Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie081bb9cfc9448dbbf76699793c10c2d" continuedAt="i2e939b37a9c7424987f06ee4c9478d9f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into <ix:nonFraction unitRef="segment" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3Xzc5_977a1ba3-8062-4b6a-873f-492a195e7330">two</ix:nonFraction> reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chief Operating Decision Maker ("CODM") evaluates the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that the CODM considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The segment operating profit metric is what the CODM uses in evaluating our results of operations and the financial measure that provides a valuable insight into our overall performance and financial position. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzQwNjg_31945fc1-ed65-459a-ae95-838d0d0bfac7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales information about our reportable segments, reconciled to consolidated totals:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzItMS0xLTEtNjAyNjM_81745313-5dcc-401d-a6cc-77a730db3b2b">2,406.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1eda1ab883d470f907fcc4ff3587bdc_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzItMy0xLTEtNjAyNjM_edd35757-eb19-4ce2-b4a8-cca4fad258e5">2,317.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd13159e1454ccd9cfc0a729531fc59_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzItNS0xLTEtNjAyNjM_0eec7555-ba2e-4c87-ae8f-0122632e32b5">1,648.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic968e09b002f4e748bff0a829c35d435_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzMtMS0xLTEtNjAyNjM_2ba2c348-9e26-47a4-ad17-bae7a05f3828">480.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d70e9583819487dac48027986480d13_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzMtMy0xLTEtNjAyNjM_c793ff6c-ab0c-4f66-8b35-2b02c3c82aa9">514.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84403c68951c424f99f535d20528d792_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzMtNS0xLTEtNjAyNjM_a3dd12c4-b302-441e-b2c0-c1ee55117ebf">498.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment sales elimination</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe48c875c32240ab9ed7fce93ce67305_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzQtMS0xLTEtNjAyNjM_1be9e3a9-d745-4b4e-a43e-611a3ddf1ef9">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie01badda3e434997a4b8e06f3311bc9a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzQtMy0xLTEtNjAyNjM_3165e39c-2787-4a80-9c10-1c1c564ce7f0">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99c9f5c6fe924651b98fe035da1577d1_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzQtNS0xLTEtNjAyNjM_3d20f7a5-b94c-4d68-8d85-250dd3faac5a">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzUtMS0xLTEtNjAyNjM_4a84edb0-c0bd-4766-8269-a6244eef50c9">2,886.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzUtMy0xLTEtNjAyNjM_e00a773b-4142-442b-939d-3b3083e7e730">2,831.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzUtNS0xLTEtNjAyNjM_ba585696-65a6-487a-82d8-decf0d004686">2,146.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2e939b37a9c7424987f06ee4c9478d9f" continuedAt="ib51a4318cdfe4414a8dc025b6ddf5415"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any customers accounting for greater than 10% of consolidated net sales.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzQwNDA_1293bd29-cf16-4395-9aee-a4b0ee42b441" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Lived Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8177e6120dec43daa5a7c888989f3da2_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzItMS0xLTEtNjAyNjM_e45e8a26-4370-4420-a4c5-4734ac79ee60">1,286.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b508e52bb8f41c9b7957f921eb2b0b3_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzItMy0xLTEtNjAyNjM_b1f0b7e5-0468-4e0b-8307-5fe6b2c7ed3e">1,198.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e7467ce0ae48b9a47889bc1ec6fc4a_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzItNS0xLTEtNjAyNjM_0fbf2ac0-1572-4310-a16f-27c3cd01597d">975.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i431dce423ad841e6844024553fc98f20_I20221231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzItNy0xLTEtNjAyNjM_8dad6def-19cc-41f1-a963-887ee80d1e25">611.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aaaf90727654d12b638272fe7f2baf3_I20211231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzItOS0xLTEtNjAyNjM_68262e0d-0dea-4c22-a28d-d808513560de">504.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6314a6d37b84a358a5605e6ae2afd64_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzMtMS0xLTEtNjAyNjM_ef8823b5-3522-437f-a9ae-068756b98ff5">398.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceb5fd8b48274ee1a5a308d102c6c25e_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzMtMy0xLTEtNjAyNjM_710a72e8-8b52-4a7e-b2f5-359ee6b7fc39">474.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iead4344cd65d442aa5006dcd0376f4a2_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzMtNS0xLTEtNjAyNjM_a7114ab0-06d9-4298-920b-2a20cd450369">282.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e0d0a05d1348769f058a2ca5f42aab_I20221231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzMtNy0xLTEtNjAyNjM_fd2e7334-28e8-402f-84da-489d8bbf274f">139.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62beb24a7bad443180a155119c78b411_I20211231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzMtOS0xLTEtNjAyNjM_717981a3-1592-4310-8c3a-68e883f82c33">124.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72bb0f0e78f045deaa478696bdea1be9_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzQtMS0xLTEtNjAyNjM_b1526553-664c-4392-bd55-466221385ecf">240.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c8538cbbe04fb58f1ce10c1f2b28e2_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzQtMy0xLTEtNjAyNjM_47b3ca87-00ad-4351-a02f-6cea649fab92">247.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia441c6249d0e463fa687f11715bdbe24_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzQtNS0xLTEtNjAyNjM_f81c0ee2-44a5-4f09-a76f-8f34b570803b">226.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec4132786b74f858bedca0d55bf9841_I20221231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzQtNy0xLTEtNjAyNjM_7a90e454-46a3-40c6-94a0-ac03d5791120">179.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4227815e2274453b99190c759250f43_I20211231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzQtOS0xLTEtNjAyNjM_1a51d76f-9a6a-4476-b7e1-bf1a43d44c97">187.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c79157ca814df59f4a743dcc90418b_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzUtMS0xLTEtNjAyNjM_9e75b459-53b2-43a8-8e98-6a5a54389dc6">237.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3888aacf77145f3a78e6e7189ee1a05_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzUtMy0xLTEtNjAyNjM_74f809d3-98d9-4900-bdec-5845f8ecca7e">213.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fedbb37b25343e993a9a82605d7113a_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzUtNS0xLTEtNjAyNjM_90bbfea4-b6b3-46b0-91e1-c449b63c07a4">172.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a5015f6b1c94dec99eecc4b8658eb7e_I20221231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzUtNy0xLTEtNjAyNjM_a762aefa-eaff-4bab-9496-deb6facab3e0">68.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e406b7e606f451d8091f5d964b93a58_I20211231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzUtOS0xLTEtNjAyNjM_67219233-d425-4449-b399-79b6784b2e9d">86.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other European countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0eff9689ef84a2ea76ecf78183f8827_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzYtMS0xLTEtNjAyNjM_c127e554-5790-43f9-964e-740dfa3124dd">359.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926da543cc9e4398814ddc43ef95c631_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzYtMy0xLTEtNjAyNjM_fa23448d-b389-4a87-9cc1-a1f162686077">341.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b0ed6a479d444ea07152748eeca4cc_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzYtNS0xLTEtNjAyNjM_7550dce4-e524-4dcb-aa7c-4115de169230">236.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8828a20eda4045f48764034dedf66337_I20221231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzYtNy0xLTEtNjAyNjM_e45057e1-b0db-4bca-9b08-b7f660388b1d">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3307dfcbc00f42bb8997445de20e4919_I20211231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzYtOS0xLTEtNjAyNjM_28552504-63ff-4e88-9182-53562eb4e065">65.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie61e6e97e08a4913b0cba163aed4e5a8_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzctMS0xLTEtNjAyNjM_c150b44f-0b3f-4369-9f26-a3b9fa912abf">364.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66d771c3fe9d4b339af1cad17d645c10_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzctMy0xLTEtNjAyNjM_d3ea254c-3d56-4111-902c-b9a230114c86">357.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a551fb427249b6a0f0c397412260fb_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzctNS0xLTEtNjAyNjM_180a00ff-836d-4e3a-b298-437c9a04093e">253.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ca67d05039a4c1da64a8404c705ce24_I20221231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzctNy0xLTEtNjAyNjM_c2a6b0f1-624e-4007-8844-c13d191f10bf">182.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d147dae6a024c4da07595e4f932e0c5_I20211231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzctOS0xLTEtNjAyNjM_119696f8-dd28-4a8e-a4a6-3dd0efef31e4">160.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzgtMS0xLTEtNjAyNjM_e68f407d-2277-4723-b34b-5764d2f31559">2,886.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzgtMy0xLTEtNjAyNjM_2f3813b3-0697-465b-8300-51563f95216a">2,831.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzgtNS0xLTEtNjAyNjM_a94ffe92-b67c-4816-849a-02f52397790d">2,146.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzgtNy0xLTEtNjAyNjM_c17fc5c7-350f-4e10-a71f-b4f03522c9e9">1,262.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzgtOS0xLTEtNjAyNjM_10f01335-1056-41d7-aed5-17d21f0cbd63">1,126.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzQwNjU_aa09b51f-1922-4c7a-a00b-aa193a89a4fb" continuedAt="i3b25eed35c8c44518e4ede3daa9e3f81" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following tables provide summarized financial information for our segments:</span></div><div><span><br/></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Proprietary Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzItMS0xLTEtNjAyNjM_ce339642-1c87-4a3b-9d1f-a2d396b81fa7">784.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1eda1ab883d470f907fcc4ff3587bdc_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzItMy0xLTEtNjAyNjM_1be49f16-2096-48ca-b46f-5fe6549db845">796.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd13159e1454ccd9cfc0a729531fc59_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzItNS0xLTEtNjAyNjM_9a361778-a220-44ec-bea3-acc020d928d6">434.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic968e09b002f4e748bff0a829c35d435_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzMtMS0xLTEtNjAyNjM_a3c156e5-c0ca-4d04-bd7d-91ef46dbdb75">60.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d70e9583819487dac48027986480d13_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzMtMy0xLTEtNjAyNjM_164a4a52-2855-4e00-94f1-077fd0c4b8f2">67.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84403c68951c424f99f535d20528d792_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzMtNS0xLTEtNjAyNjM_89e1b591-505c-4de6-8bd4-87113c807a76">68.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business segment operating profit</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idff76b1b03b44f75aa61286e93799b04_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzQtMS0xLTEtNjAyNjM_267befc8-bef4-414a-b449-7b10a816fdad">844.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if85fe4e885e9410ea9b477f9f42fe802_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzQtMy0xLTEtNjAyNjM_09384de5-9f7f-4985-a214-9128e7944f17">863.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e909081fe504bcd995d3d053a9e6458_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzQtNS0xLTEtNjAyNjM_9633a5c0-75f2-4ca3-9382-7bf72cda1a5c">503.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzYtMS0xLTEtNjAyNjM_e89e166b-0cad-4961-902f-5aa4dc3aff37">23.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzYtMy0xLTEtNjAyNjM_7e816ced-4485-4baa-8250-fa314a99879b">37.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzYtNS0xLTEtNjAyNjM_f6fee8c4-10b9-4bda-a39d-17dfebe161de">34.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate general costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzctMS0xLTEtNjAyNjM_1d5a5fed-43d5-48ca-bf62-044eba6cbcf5">59.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzctMy0xLTEtNjAyNjM_5d85b44f-49c7-487e-ae26-2192f76ab6d0">63.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzctNS0xLTEtNjAyNjM_700fa7c9-b705-4662-ae77-a3b7fce5bfe3">52.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated Items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzktMS0xLTEtNjAyNjM_fc278836-f8ce-470f-823f-361754e832b0">23.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzktMy0xLTEtNjAyNjM_539aca39-8f45-4d70-8f1d-2093a872fb01">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzktNS0xLTEtNjAyNjM_9554746b-79ba-4e4a-abb1-cbcf25796444">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEwLTEtMS0xLTYwMjYz_0c9f5147-37a4-4982-b432-bd1fbfb09959">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEwLTMtMS0xLTYwMjYz_903f244c-8d79-42bc-8907-d7ac0e3864ad">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEwLTUtMS0xLTYwMjYz_bc40306e-7e82-46d9-a0d3-d1fb96da7b6d">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzExLTEtMS0xLTYwMjYz_43a9a577-6b09-40ac-bf94-9be3f6bca851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzExLTMtMS0xLTYwMjYz_7f0eb6e3-f23c-4b2b-b7ce-3fd8faf082cd">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzExLTUtMS0xLTYwMjYz_de417057-405c-4c6e-8836-bc3213982687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment activity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" name="wst:CostInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEyLTEtMS0xLTYwMjYz_6e75f243-c1fa-4a05-b4bb-42a4cd9b891e">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="wst:CostInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEyLTMtMS0xLTYwMjYz_f9b5afae-851a-4066-9755-3bc68803f70d">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231" decimals="-5" name="wst:CostInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEyLTUtMS0xLTYwMjYz_35c3a5a4-2a17-48e7-9ab1-1f9445318d9e">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Corporate and Unallocated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE2LTEtMS0xLTYwMjYz_72f39769-157d-4b23-b3cf-ac111448092a">110.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE2LTMtMS0xLTYwMjYz_3c903d66-7f86-43e8-b235-19184328bcad">111.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE2LTUtMS0xLTYwMjYz_dabc6d9b-c1fa-448c-91d8-de251746bf29">96.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated operating profit</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE3LTEtMS0xLTYwMjYz_e9843085-5672-4862-9398-e524f047f746">734.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE3LTMtMS0xLTYwMjYz_137a5453-e5ca-40b8-af33-bccf9e1c6d00">752.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE3LTUtMS0xLTYwMjYz_6cb16fbd-cde0-4f82-a8a9-d54e5bf249f1">406.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (income) and other nonoperating expense (income), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE4LTEtMS0xLTYwMjYz_0b377ed2-dd97-42d3-a4b4-b8c5e386a874">54.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE4LTMtMS0xLTYwMjYz_b3640308-3e5e-47c5-a632-21dea827370c">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE4LTUtMS0xLTYwMjYz_f29bca9e-74bb-4dc4-a3bb-6ebb7282cc04">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net income of affiliated companies</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE5LTEtMS0xLTYwMjYz_3f2eb807-0899-4a79-9f5c-903f24193243">679.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE5LTMtMS0xLTYwMjYz_4790a683-4a60-4686-a2cf-fdaf1a851565">748.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE5LTUtMS0xLTYwMjYz_5c262033-991b-4e8e-879f-1de68b920b46">401.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) During 2022, the Company recorded restructuring and related charges of $<ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjEwMjI_fc278836-f8ce-470f-823f-361754e832b0">23.8</ix:nonFraction> million, which primarily included a charge of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjExMTQ_a26311ae-d7b1-43b4-8687-5638b11b64ca">8.7</ix:nonFraction> million in net severance and post-employment benefits primarily in connection with our plan to adjust our operating cost base and $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjExNjE_e56b269c-3e90-4578-8369-67aebcc95436">15.3</ix:nonFraction> million in asset-related charges associated with this plan. During 2021 and 2020, the Company recorded a restructuring and severance related charge of $<ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjAwNjE_539aca39-8f45-4d70-8f1d-2093a872fb01">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjAwNTQ_9554746b-79ba-4e4a-abb1-cbcf25796444">7.0</ix:nonFraction> million, respectively, to optimize certain organizational structure within the Company.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib51a4318cdfe4414a8dc025b6ddf5415"><ix:continuation id="i3b25eed35c8c44518e4ede3daa9e3f81" continuedAt="i7cd5b5df13d542ab849b06ac532c55f2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) During 2022, 2021 and 2020, the company recorded $<ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjAyOTQ_0c9f5147-37a4-4982-b432-bd1fbfb09959">0.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib778b3f359db4b4db7b559dbd58c0693_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzI2ODA_81a1b743-2181-4a3d-a537-64c3468a95fb">0.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5177e5970481482dadb3afc395cb325e_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjAxMDY_11df3dd1-3c74-4ada-b2bb-60b29b4c2082">0.6</ix:nonFraction>&#160;million, respectively, of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) During 2021, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjAzMDY_7f0eb6e3-f23c-4b2b-b7ce-3fd8faf082cd">2.8</ix:nonFraction> million impairment charge for certain long-lived and intangible assets within the Proprietary Products segment as it determined the carrying value was not fully recoverable. $<ix:nonFraction unitRef="usd" contextRef="ifb2833c3159542918f26feaf0c1d8860_D20210101-20211231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzMxOTE_08b4f6a2-ad90-4f4a-9e08-d3da18561c9f">1.9</ix:nonFraction>&#160;million of this charge is recorded in Cost of Goods and Services Sold and $<ix:nonFraction unitRef="usd" contextRef="ieb5e02ca65384029bf2dee9c473d0fc2_D20210101-20211231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzMyNDc_51dbe0e5-c78c-4f8f-a6e3-4a915ac45d17">0.9</ix:nonFraction>&#160;million of the charge is recorded in Selling, General, and Administrative expense, due to the nature of the impaired assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5) During 2022, the Company recorded a cost investment impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA0MDE_27411d54-d018-4a25-a8c8-0226f04932b5">3.5</ix:nonFraction> million. During 2021, the net cost investment activity was equal to $<ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="wst:CostInvestmentImpairment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA0MTk_f9b5afae-851a-4066-9755-3bc68803f70d">4.3</ix:nonFraction> million, inclusive of an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA0MDc_1800e932-0c64-4f2c-a7b3-7703a63553ab">4.6</ix:nonFraction>&#160;million partially offset by a $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA0MTE_f68d24c8-184d-46d7-8268-428b8f934e6c">0.3</ix:nonFraction>&#160;million gain on the sale of a cost investment. During 2020, the Company recorded a cost investment impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA0MTU_55302856-c130-4334-9ebe-73c4cc35abcd">2.5</ix:nonFraction> million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6) During 2022, the Company recorded </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA1MDE_665c7078-041a-42a0-8d9a-d6347898ff2d">52.2</ix:nonFraction>&#160;million pension settlement charge, which primarily related to the full settlement and relief of the historical balance sheet position, inclusive of accumulated other comprehensive income, of the U.S. pension plan. During 2021 and 2020, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA5Mzk_ef760436-e23f-4b1b-a216-81b463906492">1.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjEyNjU_da05ec7d-9f5b-46b6-b733-e996f85250dc">3.7</ix:nonFraction>&#160;million, respectively, pension settlement charge, as we determined that normal-course lump-sum payments for the U.S. pension plan exceeded the threshold for settlement accounting under U.S. GAAP for the year.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 16, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8148abfe270d4f15aa2ba9319df722dc_124">Other Expense (Income)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of unallocated items. </span></div><div><span><br/></span></div><ix:continuation id="i7cd5b5df13d542ab849b06ac532c55f2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide summarized financial information for our <ix:nonFraction unitRef="segment" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzM5Nzc_977a1ba3-8062-4b6a-873f-492a195e7330">two</ix:nonFraction> reportable segments and corporate and unallocated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244a7dd7a1e34e5aaf1f244eeeca66c7_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzItMS0xLTEtNjAyNjM_c551816f-4bca-47ec-9232-a1c68347d210">2,578.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i585911a48a184294aa02c08de8b96b51_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzItMy0xLTEtNjAyNjM_a35fdff9-7a65-45ca-933f-26f482fcf0a5">2,152.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bf7ca10e524bf19773099096d46440_I20221231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzMtMS0xLTEtNjAyNjM_9d6b411d-2f19-4abb-9f29-f4e6c07f3bda">480.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61cdd3ab97d6409eb1fd729bbcf4e3bb_I20211231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzMtMy0xLTEtNjAyNjM_97e029d5-29b5-473e-8c69-0bb9e0b7e3cf">443.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c1e5aa461254453a205c4e2315ef26e_I20221231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzQtMS0xLTEtNjAyNjM_34fb2627-8875-4a86-8f0d-9a6ae2be841f">558.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0becd841990f40bcb28ada9ac03bea59_I20211231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzQtMy0xLTEtNjAyNjM_f18698cd-b8fb-455b-95bc-9005ad0af1ff">717.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzUtMS0xLTEtNjAyNjM_dca8db49-2364-4f1d-a5d4-f1dfd9edce35">3,616.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzUtMy0xLTEtNjAyNjM_7ed4c3e8-99cb-4893-b90e-306ac41e54e2">3,313.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Depreciation and Amortization</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzItMS0xLTEtNjAyNjM_11c5cc48-fd12-4eda-8fe6-5cae716a3124">96.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1eda1ab883d470f907fcc4ff3587bdc_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzItMy0xLTEtNjAyNjM_6ee64f83-ad01-41b2-805a-4856be005926">93.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd13159e1454ccd9cfc0a729531fc59_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzItNS0xLTEtNjAyNjM_5c28a470-715e-4571-8f87-eb7523beb2ba">84.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic968e09b002f4e748bff0a829c35d435_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzMtMS0xLTEtNjAyNjM_84c3529d-dec9-444c-9962-a9a52fa74ebf">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d70e9583819487dac48027986480d13_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzMtMy0xLTEtNjAyNjM_e5171f0a-6fb1-4f02-a1b1-b24c5faf928e">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84403c68951c424f99f535d20528d792_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzMtNS0xLTEtNjAyNjM_8309b8c0-d8de-487b-8601-072aea06b478">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzQtMS0xLTEtNjAyNjM_5fd7e25e-cb8b-4b95-b817-4b18421906ec">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzQtMy0xLTEtNjAyNjM_e44684df-aad8-4fdb-92c0-9fd3b7971158">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzQtNS0xLTEtNjAyNjM_d162d722-04fe-4408-b78b-6228f5f98b48">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzUtMS0xLTEtNjAyNjM_a62cda55-28b4-4c71-8508-b6581ec360aa">120.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzUtMy0xLTEtNjAyNjM_f47b5dda-7597-4d96-b864-36f08b9b6eb8">122.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzUtNS0xLTEtNjAyNjM_1a0b86fb-b879-4ba5-88cf-d8037c64f608">109.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Capital Expenditures</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzktMS0xLTEtNjAyNjM_f18f61d3-3ff5-4be3-b05d-05924633d81a">237.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1eda1ab883d470f907fcc4ff3587bdc_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzktMy0xLTEtNjAyNjM_337dbb94-d4f1-4c6d-8e14-bff3b9c2f97e">218.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd13159e1454ccd9cfc0a729531fc59_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzktNS0xLTEtNjAyNjM_5ad2175b-f80f-454f-bb72-b3dc6ac9d6f7">139.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic968e09b002f4e748bff0a829c35d435_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEwLTEtMS0xLTYwMjYz_2aa16ff1-8682-4f24-a745-93ebcf5dcf1c">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d70e9583819487dac48027986480d13_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEwLTMtMS0xLTYwMjYz_9755bae8-6911-4ee1-95cc-2790052abfdd">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84403c68951c424f99f535d20528d792_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEwLTUtMS0xLTYwMjYz_b60f47ca-9069-48c3-a82a-d56e9a312144">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzExLTEtMS0xLTYwMjYz_f7c40591-3cd8-4b63-8b12-2dc0e39e34be">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzExLTMtMS0xLTYwMjYz_b1721069-250d-4a46-97e4-8c625e0bdd5f">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzExLTUtMS0xLTYwMjYz_141936d5-cd1d-45fb-90a5-2d46a8292f38">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEyLTEtMS0xLTYwMjYz_b8808d88-7ef5-4cf8-903e-98e0bb01319d">284.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEyLTMtMS0xLTYwMjYz_6f9fb9ad-4124-44f3-b565-343da477c879">253.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEyLTUtMS0xLTYwMjYz_67e6b0e5-770a-4bf1-bc36-5af2356e82a5">174.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_136"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Board of Directors and Shareholders of West Pharmaceutical Services, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of West Pharmaceutical Services, Inc. and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, and the related consolidated statements of income, comprehensive income, equity and cash flows for each of the three years in the period ended December 31, 2022, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended December 31, 2022 appearing under Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Internal Control - Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Internal Control - Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2013) issued by the COSO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Basis for Opinions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Critical Audit Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Provision for Income Taxes </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As described in Notes 1 and 17 to the consolidated financial statements, the Company&#8217;s consolidated deferred tax assets were $130.7 million, net of a valuation allowance of $13.3 million, as of December 31, 2022, and income tax expense was $114.7 million for the year ended December 31, 2022. As a global organization, the Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. As disclosed by management, management estimates income taxes payable based upon current domestic and international tax legislation. Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to estimates of future taxable income, generally at the respective subsidiary company and the country level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The principal considerations for our determination that performing procedures relating to the provision for income taxes is a critical audit matter are the significant judgment by management in determining the income tax provision due to the Company&#8217;s global footprint and complexity in the various tax laws applicable in determining the Company&#8217;s effective tax rate. This in turn led to a high degree of auditor judgment, effort, and subjectivity in performing procedures and in evaluating audit evidence related to the income tax provision. Also, the audit effort involved the use of professionals with specialized skill and knowledge.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to income taxes, including controls over the determination of the income tax provision. These procedures also included, among others, (i) testing the income tax provision, including testing the Company&#8217;s rate reconciliation, return to provision adjustments, permanent and temporary differences, and financial data used in the income tax provision calculation, and (ii) testing the accuracy of the income tax rates utilized in the provision. Professionals with specialized skill and knowledge were used to assist in evaluating the appropriateness of management&#8217;s application of relevant income tax law in certain jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzYvZnJhZzoxMWNlODk5ZDIwMWI0MGFiODg3NGQ3MTk3OTdhZTgzNS90ZXh0cmVnaW9uOjExY2U4OTlkMjAxYjQwYWI4ODc0ZDcxOTc5N2FlODM1XzkzMDQ_e7e456d2-28a8-4ce7-8e42-59f12238ec60">PricewaterhouseCoopers LLP</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzYvZnJhZzoxMWNlODk5ZDIwMWI0MGFiODg3NGQ3MTk3OTdhZTgzNS90ZXh0cmVnaW9uOjExY2U4OTlkMjAxYjQwYWI4ODc0ZDcxOTc5N2FlODM1XzkzMDY_05d9f049-9ce0-4a9c-90ba-c3427c4ee0e4">Philadelphia, Pennsylvania</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;21, 2023 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1963.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_139"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_142"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_145"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosure controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this annual report, is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to our management, including our CEO and Chief Financial Officer (&#8220;CFO&#8221;), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Our disclosure controls include some, but not all, components of our internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was performed under the supervision and with the participation of our management, including our CEO and CFO, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934), as of the end of the period covered by this Form 10-K. Based on this evaluation, our CEO and CFO have concluded that, as of December&#160;31, 2022, our disclosure controls and procedures are effective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934. Our internal control over financial reporting is a process designed under the supervision of our CEO and CFO to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2022 based on the framework established in &#8220;Internal Control-Integrated Framework (2013)&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this assessment, management has determined that our internal control over financial reporting was effective as of December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Internal control over financial reporting has inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to reduce, though not eliminate, this risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of our internal control over financial reporting as of December&#160;31, 2022 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report, which is included herein. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Controls</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter ended December&#160;31, 2022, there have been no changes to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_148"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B.  OTHER INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_151"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C.  DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_154"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_157"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10.  DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information is incorporated by reference from the discussion under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proposal 1 - Election of Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance Documents and Policies - Ethics and Our Code of Business Conduct</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting and Other Information - Shareholder Proposals or Nominations; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Board and Director Information and Policies - Committees - Audit Committee </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our 2023 Proxy Statement. The balance of the information required by this item is contained in the discussion entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Information About Our Executive Officers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Part&#160;I of this Form 10-K.</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_160"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11.  EXECUTIVE COMPENSATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about director and executive compensation is incorporated by reference from the discussion under the headings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Director Compensation, Compensation Committee Report, Compensation Discussion and Analysis,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Tables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our 2023 Proxy Statement. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_163"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="padding-left:9pt;text-indent:-6.75pt"><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this Item is incorporated by reference from the discussion under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Ownership </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our 2023 Proxy Statement. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information Table</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information about the grants of stock options, all share units and other rights under all of the Company&#8217;s equity compensation plans as of the close of business on December 31, 2022. The table does not include information about tax-qualified plans such as the West 401(k) Plan or the West Contract Manufacturing Savings and Retirement Plan.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.948%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">to be Issued Upon</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrants and Rights (a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrants and Rights (b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining Available for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Future Issuance Under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plans (Excluding Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reflected in Columns (a)) (c)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by security holders</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,271,723&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.49&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,419,834&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by security holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,271,723&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.49&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,419,834&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Includes 1,179,919 outstanding stock options, 9,371 stock appreciation rights, 113,443 performance share units, 18,016 restricted retention share units, and 121,086 deferred stock-equivalents units under the 2016 Plan. Includes 704,137 outstanding stock options, 11,031 stock appreciation rights, and 97,592 deferred stock-equivalents units under the 2011 Plan (which was terminated in 2016). Includes 17,128 deferred stock-equivalents under the 2007 Omnibus Incentive Compensation Plan (which was terminated in 2011). The average term of remaining options is 4.8 years. No future grants or awards may be made under the terminated plans.&#160;The total includes restricted performance share units at 100% of grant. The restricted performance share unit payouts were at 189.25%, 154.52%, and 82.61% in 2022, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All share units and deferred stock-equivalent units are excluded when determining the weighted-average exercise price of outstanding options. </span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents 3,738,308 shares reserved under the Company&#8217;s Employee Stock Purchase Plan and 1,681,526 shares remaining available for issuance under the 2016 Plan.&#160;The estimated number of shares that could be issued for 2022 from the Employee Stock Purchase Plan is 172,368.&#160;This number of shares is calculated by multiplying the 84 shares per offering period per participant limit by 2,052, the number of current participants in the plan. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><div id="i8148abfe270d4f15aa2ba9319df722dc_166"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information called for by this Item is incorporated by reference from the discussion under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance Documents and Policies - Related Person Transactions and Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our 2023 Proxy Statement. Information about director independence is incorporated by reference from the discussion under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance Documents and Policies - Director Independence </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our 2023 Proxy Statement.</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_169"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14.  PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information is incorporated by reference from the discussion under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Auditors and Fees - Fees Paid to PricewaterhouseCoopers LLP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Auditors and Fees - Audit Committee Policy on Pre-Approval of Audit and Permissible Non-Audit Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our 2023 Proxy Statement.</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_172"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_175"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15.&#160;&#160;EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) 1.  Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are included in Part II, Item 8:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Income for the years ended December&#160;31, 2022, 2021 and 2020 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Comprehensive Income for the years ended December&#160;31, 2022, 2021 and 2020 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets at December&#160;31, 2022 and 2021 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Equity for the years ended December&#160;31, 2022, 2021 and 2020 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2022, 2021 and 2020 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firm (PCAOB ID <ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90ZXh0cmVnaW9uOjZhYTRkNzcxM2E0OTQzNDZiMTc4MzQ4YzllZjU5YTE1XzU5MQ_5ce6d603-eff0-4af2-8aac-213ecd2b1557">238</ix:nonNumeric>)</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) 2.  Financial Statement Schedules</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90ZXh0cmVnaW9uOjZhYTRkNzcxM2E0OTQzNDZiMTc4MzQ4YzllZjU5YTE1XzEzMzU_48608d1f-179b-420e-bef9-7c0fd7b4f992" continuedAt="i9ff3b1e2d06242dd8cf6ea83eea29f29" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule II - Valuation and Qualifying Accounts</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">beginning of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">period</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">end of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">period</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c760b6f46f45a1aca96e9c28532938_I20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzMtMS0xLTEtNjAyNjM_43187723-c75e-4992-aa49-759ac2a41ec4">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225515b9f9cc44409112978bbc812f54_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzMtMi0xLTEtNjAyNjM_fefec616-b946-4a6b-a2aa-88514527f67e">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225515b9f9cc44409112978bbc812f54_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzMtMy0xLTEtNjAyNjM_fe4e8c63-36c6-4da5-bb21-10f1b6ff7497">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707beb89e95a42328dcd6d2412aa3f9d_I20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzMtNC0xLTEtNjAyNjM_bfd6e697-c8ff-472d-bfb2-8dd248994fd7">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cda7d0db84d46a1a162bc0ad54e9fed_I20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzQtMS0xLTEtNjAyNjM_ec77492f-8e06-4dab-a6e1-4f982ba1400c">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d36b5ee016b44859820b1a91b193d45_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzQtMi0xLTEtNjAyNjM_8997cb23-e7bc-479b-b14d-ac55b352288f">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d36b5ee016b44859820b1a91b193d45_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzQtMy0xLTEtNjAyNjM_5f886b46-819b-4441-b372-5ae7feb445bb">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1502fcf310445290cecc08ffe7e7b3_I20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzQtNC0xLTEtNjAyNjM_a387c642-b66a-4db1-a165-c205b341793e">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzUtMS0xLTEtNjAyNjM_74732121-b2f9-458e-a83b-c5406c0c0487">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzUtMi0xLTEtNjAyNjM_efff2307-47b6-4b99-93a3-ef587953fb43">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzUtMy0xLTEtNjAyNjM_c04aea19-fa8c-462c-bfdd-5c5851adbbe4">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzUtNC0xLTEtNjAyNjM_625f0b03-ea4f-4d52-a872-b249e6c07494">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2501ceeb8ed04db1a417a4d65803126e_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzktMS0xLTEtNjAyNjM_bfdc0362-f866-4c0d-9722-81c51b8bc764">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icee1c6f02c1b44ed8186b856c69cb13a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzktMi0xLTEtNjAyNjM_2f2ff20a-1cba-466e-b405-df00fe1633f8">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icee1c6f02c1b44ed8186b856c69cb13a_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzktMy0xLTEtNjAyNjM_ad486fed-b3b0-41b8-adfb-84532604dba7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c760b6f46f45a1aca96e9c28532938_I20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzktNC0xLTEtNjAyNjM_7361b9c6-aa23-4e57-b14d-a1c3c226d764">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c5469d65e0b475cb923c823d47d89ba_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzEwLTEtMS0xLTYwMjYz_74e31b6c-555d-4e00-bbea-ad4ad91f409e">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142f68e23d4545d08259d4c707844b97_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzEwLTItMS0xLTYwMjYz_53eec05e-563a-4ad0-8210-351d297b5809">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142f68e23d4545d08259d4c707844b97_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzEwLTMtMS0xLTYwMjYz_6d1ab576-490e-45dd-b6a0-971a812236b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cda7d0db84d46a1a162bc0ad54e9fed_I20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzEwLTQtMS0xLTYwMjYz_ba408879-f845-4d81-9c0b-d1119a8e1a26">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1165b131d689444eb6459290c85e0fec_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzExLTEtMS0xLTYwMjYz_36bdd8af-8cea-4b12-8cf0-766f3fe5c998">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzExLTItMS0xLTYwMjYz_a888e6c3-8ba1-433e-8a89-56dc41305b89">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzExLTMtMS0xLTYwMjYz_ec23034c-165a-4d4e-89ce-0d10102a4119">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635169c6599a4431a7816915bd315902_I20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzExLTQtMS0xLTYwMjYz_cc481175-7e26-40f3-bd26-8c52959dc8e2">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3247d3a01544388bce9b89588c6ec3_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE1LTEtMS0xLTYwMjYz_b12d36ae-5915-4db6-abdd-d1cc9a64f32d">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073f657af77647788880cd4518a255a0_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE1LTItMS0xLTYwMjYz_49b9c90c-ba73-4a32-8cac-4cdb61e05745">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i073f657af77647788880cd4518a255a0_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE1LTMtMS0xLTYwMjYz_c078b99b-9cff-44af-b31a-4a897855a356">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2501ceeb8ed04db1a417a4d65803126e_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE1LTQtMS0xLTYwMjYz_557c9120-5f9e-420b-9099-c1760c104829">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib989212096a844a7a71240a6d956563a_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE2LTEtMS0xLTYwMjYz_9502eeb0-67f3-4e38-84e1-57e10675f695">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia67a3626f5f948b5b1895672cce6e96b_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE2LTItMS0xLTYwMjYz_d66c2dc9-a59a-4db4-b966-064be865c03e">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia67a3626f5f948b5b1895672cce6e96b_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE2LTMtMS0xLTYwMjYz_bc3883ee-5a9b-4b60-986b-886c464e3535">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c5469d65e0b475cb923c823d47d89ba_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE2LTQtMS0xLTYwMjYz_f13688b4-e59f-491a-9adb-116844d786a5">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ff963c9c54045f29206b3189d452f9b_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE3LTEtMS0xLTYwMjYz_2a0395d4-77fb-46d5-ab8b-5e1707ee4a02">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE3LTItMS0xLTYwMjYz_da8fbf15-11fb-46f5-811e-9cdba18be4d0">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE3LTMtMS0xLTYwMjYz_6ddfde6d-8d7a-4919-b558-224226dee875">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1165b131d689444eb6459290c85e0fec_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE3LTQtMS0xLTYwMjYz_536b1d88-3e1f-47b8-ac82-4f22bc087676">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="padding-left:27pt"><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9ff3b1e2d06242dd8cf6ea83eea29f29" continuedAt="i8eeff9bb40d0458d92b1a82f34b522e4">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i8eeff9bb40d0458d92b1a82f34b522e4">Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules are omitted because they are either not applicable, not required or because the information required is contained in the consolidated financial statements or notes thereto.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;See subsection (a) 3. above.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Financial Statements of affiliates are omitted because they do not meet the tests of a significant subsidiary at the 20% level.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577020000045/ex31articlesofincorpor.htm">Our Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Form 10-Q report for the quarter ended June 30, 2020, filed July 24, 2020).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577021000014/wpsbylawamendmentsfinalfeb.htm">Our Bylaws, as amended through February 23, 2021 (incorporated by reference from our Form 8-k, filed March 1, 2021).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/0000105770-99-000016-index.html">Form of stock certificate for common stock (incorporated by reference to Exhibit 4 to the Company's 1998 Form 10-K, filed May 6, 1999)</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577020000045/ex31articlesofincorpor.htm">Article 5, 6, 8(c) and 9 of our Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Form 10-Q report for the quarter ended June 30, 2020, filed July 24, 2020).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000105770/000010577021000014/wpsbylawamendmentsfinalfeb.htm">Article I and V of our Bylaws, as amended through February 23, 2021 (incorporated by reference from our Form 8-k, filed March 1, 2021).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577021000008/ex44descriptionofregistere.htm">Description of Registered Securities (incorporated by reference to Exhibit 4.4 to the Company's 2020 Form 10-K, filed February 23, 2021).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments defining the rights of holders of long-term debt securities of West and its subsidiaries constituting less than 10% of West's total assets have been omitted.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577019000016/exh101march282019creditagr.htm">Credit Agreement, dated as of March 28, 2019, between West, certain of its subsidiaries, the lenders party thereto from time to time, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an Issuing Lender; Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, Wells Fargo Securities, LLC, MUFG Bank, Ltd., and JPMorgan Chase Bank, N.A., as Joint Lead Arrangers and Joint Bookrunners, and Wells Fargo Bank, National Association, MUFG Bank, Ltd., and JPMorgan Chase Bank, N.A., as Co-Syndication Agents (incorporated by reference from our Form 8-k, filed April 1, 2019).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577021000083/char1-1826719v3xlibortrans.htm">LIBOR Transition Amendment to the Credit Agreement, dated as of March 28, 2019, between West, each of the lenders party thereto from time to time, and Bank of America, N.A (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended September 30, 2021, filed October 28, 2021).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577022000010/compiledsecondamendment-we.htm">Credit Agreement Second Amendment and Joinder and Assumption Agreement, dated as of March 31, 2022, between West, certain of its subsidiaries, the lenders party thereto from time-to-time, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an Issuing Lender; BOFA Securities, Inc., Wells Fargo Securities, LLC, U.S. Bank National Association, and JPMorgan Chase Bank, N.A., as Joint Lead Arrangers and Joint Bookrunners, and Wells Fargo Bank, National Association, U.S. Bank National Association, and JPMorgan Chase Bank, N.A., as Co-Syndication Agents (incorporated by reference from our Form 8-k, filed April 1, 2022).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577020000015/ex102firstamendmentand.htm">First Amendment and Incremental Facility Amendment, dated as of December 30, 2019, between West, each of the lenders party thereto from time to time, and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.2 to the Company's 2019 10-K file February 24, 2020).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577012000048/exh10_1.htm">Note Purchase Agreement, dated July 5, 2012, among the Company and the Purchasers named therein (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed July 10, 2012).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000011/exhibit101executiveemploym.htm">Employment Agreement, dated as of April 13, 2015, between us and Eric M. Green (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated April 15, 2015). </a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000013/exh101indemnificationagree.htm">Indemnification Agreement, dated as of April 24, 2015, between us and Eric M. Green (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated April 30, 2015).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000013/exh102retentionawardagreem.htm">Sign-On Retention Award Notice, dated as of April 24, 2015, from us to Eric M. Green (incorporated by reference to Exhibit 10.2 to the Company's Form 8-K dated April 30, 2015).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577018000022/exh101employmentagreement.htm">Employment Agreement, dated May 29, 2018, between us and Bernard J. Birkett (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed June 21, 2018).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577016000101/ex101employmentagreement.htm">Employment Agreement, dated August 28, 2016, between David Montecalvo and us (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended September 30, 2016, filed October 31, 2016).</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000162828022003342/exh109kmagreement.htm">Employment Agreement dated November 4, 2020, between Kimberly MacKay and us (incorporated by reference to Exhibit 10.9 to the Company's Form 10-K report for the year ended December 31, 2021 filed February 22, 2022).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000162828022003342/siljiabrahamofferletter.htm">Employment Agreement dated February 8, 2018, between Silji Abraham and us (incorporated by reference to Exhibit 10.10 to the Company's Form 10-K report for the year ended December 31, 2021 filed February 22, 2022).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000016/exhibit1017.htm">Supplemental Employees&#8217; Retirement Plan, as amended and restated effective January 1, 2008 (incorporated by reference to Exhibit 10.17 to the Company's 2008 Form 10-K report, filed February 27, 2009).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577020000057/ex10102020amendedresta.htm">Non-Qualified Deferred Compensation Plan for Designated Employees, as amended and restated effective January 1, 2020 (incorporated by reference to Exhibit 10.10 to the Company's Form 10-Q report for the quarter ended September 30, 2020, filed October 23, 2020).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577014000005/ex1026nqdeferredcompensati.htm">Deferred Compensation Plan for Outside Directors, as amended and restated effective June 30, 2013 (incorporated by reference to Exhibit 10.26 to the Company's 2013 Form 10-K report, filed February 27, 2014).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577021000030/amendmentno1to2016omnibusi.htm">2016 Omnibus Incentive Compensation Plan, as amended through May 4, 2021 (incorporated by reference from our Form 8-k, filed May 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577011000025/inctiveplan.htm">2011 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed May 6, 2011).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465907023945/a07-6354_2def14a.htm#a2007OmnibusIncentiveCompensation_015515">2007 Omnibus Incentive Compensation Plan effective as of May 1, 2007 (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Form 8-K filed May 4, 2007).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465906032995/a06-10941_1ex10d2.htm">Form of Executive 2006 Non-Qualified Stock Option Award is incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended March 31, 2006, filed May 10, 2006).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465906051878/a06-15767_1ex10d1.htm">Form of Director 2006 Non-Qualified Stock Option Award Notice (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended June 30, 2006, filed August 7, 2006).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465906051878/a06-15767_1ex10d2.htm">Form of Director 2006 Stock Unit Award Notice (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended June 30, 2006, filed August 7, 2006).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465907058768/a07-19128_1ex10d2.htm">Form of Director 2007 Deferred Stock Award, issued pursuant to the 2007 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended June 30, 2007, filed August 3, 2007).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465908031034/a08-11514_1ex10d2.htm">Form of 2008 Non-Qualified Stock Option and Performance-Vesting Share Unit Award, issued pursuant to the 2007 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended March 31, 2008, filed May 8, 2008).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000016/exhibit1041.htm">Form of Director 2008 Deferred Stock Award, issued pursuant to the 2007 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.41 to the Company's 2008 Form 10-K report, filed February 27, 2009).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000049/exhibit101.htm">Form of 2009 Supplemental Long-Term Incentive Award (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended September 30, 2009, filed November 14, 2009).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577014000016/ex1012014ltipaward.htm">Form of 2014 Long-Term Incentive Plan Award (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended March 31, 2014, filed May 8, 2014).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577014000046/ex1012014rsuawardletter.htm">Form of 2014 Stock-Settled Restricted Stock Unit Award (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended June 30, 2014, filed August 1, 2014).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1022019psuawardagreement.htm">Form of 2019 Performance Stock Unit (PSU) Award issued under the 2016 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended March 31, 2019, filed May 8, 2019).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1032019stockoptionawarda.htm">Form of 2019 Stock Option Award issued under the 2016 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.3 to the Company's Form 10-Q report for the quarter ended March 31, 2019, filed May 8, 2019).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000002/exh10.htm">Indemnification agreements between us and each of our directors (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K report filed January 6, 2009).</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000050/ex101change-inxcontrolagre.htm">Form of Change-in-Control Agreement between us and certain of our executive officers (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended September 30, 2017, filed October 31, 2017).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577005000400/exh10d.htm">Agreement, effective as of January 1, 2005, between us and The Goodyear Tire &amp; Rubber Company (incorporated by reference to Exhibit 10d to the Company's Form 10-Q report for the quarter ended June 30, 2005, filed August 9, 2005).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000027/exhibit101.htm">First Agreement, effective as of July 1, 2008, to amend Agreement between us and The Goodyear Tire &amp; Rubber Company (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended March 31, 2009, filed May 6, 2009).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577016000101/ex102goodyearamendment.htm">Second Agreement, dated August 16, 2016, to amend Agreement between us and The Goodyear Tire &amp; Rubber Company and us (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended September 30, 2016, filed October 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000011/ex1039distributoragreement.htm">Distributorship Agreement, dated and effective January 18, 2017, between Daikyo Seiko, Ltd. and us (incorporated by reference to Exhibit 10.39 to the Company's 2016 Form 10-K report filed February 28, 2017).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000011/ex1040licenseagreement_2016.htm">Amended and Restated Technology Exchange and CrossLicense Agreement, dated and effective January 18, 2017, between Daikyo Seiko, Ltd. and us (incorporated by reference to Exhibit 10.40 to the Company's 2016 Form 10-K report, filed February 28, 2017).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577018000032/ex102amendedagreement.htm">Amended Agreement, dated and effective July 2, 2018, between Daikyo Seiko, Ltd. and us (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended June 30, 2018, filed July 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000040/exh101amendmentagreeme.htm">Amendment Agreement, dated as of October 15, 2019, between us and Daikyo Seiko, Ltd., (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed October 16, 2019).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577020000002/exh101exxonsupplyagree.htm">Global Master Supply Agreement by and between ExxonMobil Chemical Company and us, entered into on January 10, 2020, and effective January 1, 2019 through December 31, 2023 (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K report filed January 16, 2020).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex21listofsubsidiaries_2022.htm">Subsidiaries of the Company.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex23consent_2022.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex311ceo302certification_2.htm">Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex312cfo302certification_2.htm">Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex321ceo906certification_2.htm">Certification by the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex322cfo906certification_2.htm">Certification by the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL for the cover page of this Annual Report on Form 10-K, included in the Exhibit 101 Inline XBRL Document Set.</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We agree to furnish to the SEC, upon request, a copy of each instrument with respect to issuances of long-term debt of the Company and its subsidiaries.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management compensatory plan.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain portions of this exhibit have been omitted and filed separately with the SEC pursuant to a confidential treatment order of the SEC. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Portions of this exhibit (indicated therein by asterisks) have been omitted for confidential treatment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Furnished, not filed. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_178"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10-K SUMMARY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i8148abfe270d4f15aa2ba9319df722dc_181"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, West Pharmaceutical Services, Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WEST PHARMACEUTICAL SERVICES, INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant)</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By: /s/ Bernard J. Birkett</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernard J. Birkett</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President, Chief Financial and Operations Officer</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;21, 2023 </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of West Pharmaceutical Services, Inc. and in the capacities and on the dates indicated.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Eric M. Green</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Executive Officer and Chair of the Board</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eric M. Green</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bernard J. Birkett</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Financial and Operations Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernard J. Birkett</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Chad R. Winters</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer and Corporate Controller</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chad R. Winters</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark A. Buthman</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark A. Buthman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ William F. Feehery, Ph.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William F. Feehery, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert F. Friel</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert F. Friel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas W. Hofmann</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas W. Hofmann</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Molly E. Joseph</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molly E. Joseph</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Deborah L.V. Keller</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deborah L.V. Keller</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Myla P. Lai-Goldman, M.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Myla P. Lai-Goldman, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Douglas A. Michels</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Douglas A. Michels</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Paolo Pucci</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paolo Pucci</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stephen Lockhart, Ph.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen Lockhart, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>2
<FILENAME>ex21listofsubsidiaries_2022.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3e68728aef014f91a49da1f0c1e09799_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUBSIDIARIES OF THE COMPANY</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.026%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">State&#47; Country of Incorporation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Ownership</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent Co.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tech Group Europe Limited (dba West)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tech Group Grand Rapids, Inc. (dba West)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TGPR Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WD SG Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Services and Solutions, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Contract Manufacturing, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharma. Services IL, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Packaging (China) Company Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Packaging India Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Products Ireland, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Argentina S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Asia, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Australia Pty. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services AZ, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Beograd d.o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serbia</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Brasil Ltda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Colombia S.A.S.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Cornwall Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Danmark A&#47;S</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Delaware Acquisition, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Deutschland GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services France S.A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Group Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Hispania S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding II GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding Danmark ApS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding Ireland North, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding Ireland South, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding Japan, GK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holdings Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Italia S.r.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Korea Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Lakewood, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Normandie SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services of Delaware, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services of Florida, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Shanghai Medical Rubber Products Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Singapore Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Switzerland GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Venezuela C.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Venezuela</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Verwaltungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>3
<FILENAME>ex23consent_2022.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1319762614404e9a881aa62c8e734cc8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-106977, 333-143129, 333-156492, 333-171453, 333-174153 and 333-211088) of West Pharmaceutical Services, Inc. of our report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">dated</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:107%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">February&#160;21, 2023 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline"> </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Philadelphia, Pennsylvania</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;21, 2023&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>ex311ceo302certification_2.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9af4a1ca7450401bbf7dc724e4110427_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Eric M. Green, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of West Pharmaceutical Services, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Eric M. Green           </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eric M. Green</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Chief Executive Officer, Chair of the Board of Directors</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;21, 2023 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>ex312cfo302certification_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic3d4444534dc4016a01ad756edfc95bd_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Bernard J. Birkett, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of West Pharmaceutical Services, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President, Chief Financial and Operations Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;21, 2023 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>ex321ceo906certification_2.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="icd9819a72fa646e3a60782192361c59b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of West Pharmaceutical Services, Inc. (the &#8220;Company&#8221;) for the period ended December&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Eric M. Green, President and Chief Executive Officer, Chair of the Board of Directors of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Eric M. Green</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eric M. Green</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Chief Executive Officer, Chair of the Board of Directors</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;21, 2023</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>ex322cfo906certification_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ief8f42df101f42ef9d5d4e5327b828aa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of West Pharmaceutical Services, Inc. (the &#8220;Company&#8221;) for the period ended December&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Bernard J. Birkett, Senior Vice President, Chief Financial and Operations Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President, Chief Financial and Operations Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;21, 2023</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>wst-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6ce7082f-45c4-495e-94eb-caa34b024fa0,g:4770da38-231a-455c-ab1e-d14c8c362bd8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:wst="http://www.westpharma.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.westpharma.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.westpharma.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.westpharma.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>0000003 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000006 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000007 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITY" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITYParenthetical" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYParenthetical">
        <link:definition>0000009 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000010 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingStandards" roleURI="http://www.westpharma.com/role/NewAccountingStandards">
        <link:definition>0000012 - Disclosure - New Accounting Standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.westpharma.com/role/Revenue">
        <link:definition>0000013 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.westpharma.com/role/NetIncomePerShare">
        <link:definition>0000014 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipment" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipment">
        <link:definition>0000015 - Disclosure - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.westpharma.com/role/Leases">
        <link:definition>0000016 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompanies" roleURI="http://www.westpharma.com/role/AffiliatedCompanies">
        <link:definition>0000017 - Disclosure - Affiliated Companies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssets">
        <link:definition>0000018 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilities" roleURI="http://www.westpharma.com/role/OtherCurrentLiabilities">
        <link:definition>0000019 - Disclosure - Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.westpharma.com/role/Debt">
        <link:definition>0000020 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments">
        <link:definition>0000021 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.westpharma.com/role/FairValueMeasurements">
        <link:definition>0000022 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>0000023 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.westpharma.com/role/StockBasedCompensation">
        <link:definition>0000024 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.westpharma.com/role/BenefitPlans">
        <link:definition>0000025 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncome" roleURI="http://www.westpharma.com/role/OtherExpenseIncome">
        <link:definition>0000026 - Disclosure - Other Expense (Income)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.westpharma.com/role/IncomeTaxes">
        <link:definition>0000027 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.westpharma.com/role/CommitmentsandContingencies">
        <link:definition>0000028 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.westpharma.com/role/SegmentInformation">
        <link:definition>0000029 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccounts" roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts">
        <link:definition>0000030 - Disclosure - Schedule II - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000031 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.westpharma.com/role/RevenueTables">
        <link:definition>0000033 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.westpharma.com/role/NetIncomePerShareTables">
        <link:definition>0000034 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentTables" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTables">
        <link:definition>0000035 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.westpharma.com/role/LeasesTables">
        <link:definition>0000036 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompaniesTables" roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTables">
        <link:definition>0000037 - Disclosure - Affiliated Companies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>0000038 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesTables" roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables">
        <link:definition>0000039 - Disclosure - Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.westpharma.com/role/DebtTables">
        <link:definition>0000040 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>0000041 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables">
        <link:definition>0000042 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>0000043 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.westpharma.com/role/StockBasedCompensationTables">
        <link:definition>0000044 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTables" roleURI="http://www.westpharma.com/role/BenefitPlansTables">
        <link:definition>0000045 - Disclosure - Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeTables" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeTables">
        <link:definition>0000046 - Disclosure - Other Expense (Income) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.westpharma.com/role/IncomeTaxesTables">
        <link:definition>0000047 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.westpharma.com/role/SegmentInformationTables">
        <link:definition>0000048 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails">
        <link:definition>0000049 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.westpharma.com/role/RevenueNarrativeDetails">
        <link:definition>0000050 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenueRecognitionDetails" roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails">
        <link:definition>0000051 - Disclosure - Revenue - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractsAssetsandLiabilitiesDetails" roleURI="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails">
        <link:definition>0000052 - Disclosure - Revenue - Contracts Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareScheduleofReconciliationofSharesDetails" roleURI="http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails">
        <link:definition>0000053 - Disclosure - Net Income Per Share - Schedule of Reconciliation of Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareNarrativesDetails" roleURI="http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails">
        <link:definition>0000054 - Disclosure - Net Income Per Share - Narratives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails">
        <link:definition>0000055 - Disclosure - Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNarrativeDetails" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails">
        <link:definition>0000056 - Disclosure - Property, Plant and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.westpharma.com/role/LeasesNarrativeDetails">
        <link:definition>0000057 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails">
        <link:definition>0000058 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCashFlowandSupplementalInformationDetails" roleURI="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails">
        <link:definition>0000059 - Disclosure - Leases - Lease Cash Flow and Supplemental Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>0000060 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>0000060 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompaniesScheduleofInvestmentsDetails" roleURI="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails">
        <link:definition>0000061 - Disclosure - Affiliated Companies - Schedule of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompaniesNarrativeDetails" roleURI="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails">
        <link:definition>0000062 - Disclosure - Affiliated Companies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGoodwillDetails" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails">
        <link:definition>0000063 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>0000064 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails">
        <link:definition>0000065 - Disclosure - Goodwill and Intangible Assets - Intangible Assets by Major Class (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesDetails" roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails">
        <link:definition>0000066 - Disclosure - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtDetails" roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails">
        <link:definition>0000067 - Disclosure - Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtDetails_1" roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails_1">
        <link:definition>0000067 - Disclosure - Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.westpharma.com/role/DebtNarrativeDetails">
        <link:definition>0000068 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsNarrativeDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails">
        <link:definition>0000069 - Disclosure - Derivative Financial Instruments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails">
        <link:definition>0000070 - Disclosure - Derivative Financial Instruments - Foreign Exchange Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails">
        <link:definition>0000071 - Disclosure - Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails">
        <link:definition>0000072 - Disclosure - Fair Value Measurements - Fair Value of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsOtherFinancialInstrumentsDetails" roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails">
        <link:definition>0000073 - Disclosure - Fair Value Measurements - Other Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>0000074 - Disclosure - Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails">
        <link:definition>0000075 - Disclosure - Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>0000076 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails">
        <link:definition>0000077 - Disclosure - Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockOptionsActivityDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails">
        <link:definition>0000078 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockAppreciationRightsAwardActivityDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails">
        <link:definition>0000079 - Disclosure - Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails">
        <link:definition>0000080 - Disclosure - Stock-Based Compensation - Nonvested Performance-based Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansNarrativeDetails" roleURI="http://www.westpharma.com/role/BenefitPlansNarrativeDetails">
        <link:definition>0000081 - Disclosure - Benefit Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansComponentsofNetPeriodicBenefitCostDetails" roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails">
        <link:definition>0000082 - Disclosure - Benefit Plans - Components of Net Periodic Benefit Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails">
        <link:definition>0000083 - Disclosure - Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAmountsRecognizedinBalanceSheetDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails">
        <link:definition>0000084 - Disclosure - Benefit Plans - Amounts Recognized in Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
        <link:definition>0000085 - Disclosure - Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansExpectedBenefitPaymentsDetails" roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails">
        <link:definition>0000086 - Disclosure - Benefit Plans - Expected Benefit Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAssumptionsUsedDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails">
        <link:definition>0000087 - Disclosure - Benefit Plans - Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" roleURI="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails">
        <link:definition>0000088 - Disclosure - Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAllocationofPlanAssetsDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails">
        <link:definition>0000089 - Disclosure - Benefit Plans - Allocation of Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails">
        <link:definition>0000090 - Disclosure - Other Expense (Income) - Schedule of Other (Income) Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeNarrativeDetails" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails">
        <link:definition>0000091 - Disclosure - Other Expense (Income) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails">
        <link:definition>0000092 - Disclosure - Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>0000093 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000094 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeBeforeIncomeTaxesDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails">
        <link:definition>0000095 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeTaxExpenseDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails">
        <link:definition>0000096 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>0000097 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveIncomeTaxReconciliationDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails">
        <link:definition>0000098 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000099 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.westpharma.com/role/SegmentInformationNarrativeDetails">
        <link:definition>0000100 - Disclosure - Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSalesbyProductGroupDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails">
        <link:definition>0000101 - Disclosure - Segment Information - Sales by Product Group (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails">
        <link:definition>0000102 - Disclosure - Segment Information - Sales and Long-lived Assets by Geographic Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentFinancialInformationDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails">
        <link:definition>0000103 - Disclosure - Segment Information - Segment Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsDetails" roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails">
        <link:definition>0000104 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="wst_OtherEuropeCountriesMember" abstract="true" name="OtherEuropeCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_DebtInstrumentRatioOfDebtToEBITDA" abstract="false" name="DebtInstrumentRatioOfDebtToEBITDA" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome" abstract="false" name="ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_SeniorCNotesDue2027Member" abstract="true" name="SeniorCNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_CreditAvailableForTheIssuanceOfLettersOfCredit" abstract="false" name="CreditAvailableForTheIssuanceOfLettersOfCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_NetSalesMember" abstract="true" name="NetSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" abstract="false" name="ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" abstract="false" name="DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_StandardPackagingMember" abstract="true" name="StandardPackagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_CreditFacilityIsAvailableForSwingLineLoans" abstract="false" name="CreditFacilityIsAvailableForSwingLineLoans" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_DefinedBenefitPlanExpectedFutureBenefitPayments" abstract="false" name="DefinedBenefitPlanExpectedFutureBenefitPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ContractWithCustomerAssetIncreaseDecrease" abstract="false" name="ContractWithCustomerAssetIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_LineOfCreditFacilityAdditionalBorrowingCapacity" abstract="false" name="LineOfCreditFacilityAdditionalBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ScheduleOfIntangibleAssetsByMajorClassTable" abstract="true" name="ScheduleOfIntangibleAssetsByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_DeferredTaxAssetsRoyaltyAcceleration" abstract="false" name="DeferredTaxAssetsRoyaltyAcceleration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_DebtInstrumentApplicableMarginRatio" abstract="false" name="DebtInstrumentApplicableMarginRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" abstract="false" name="ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" abstract="false" name="OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" abstract="false" name="ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="wst_RevolvingCreditFacilityDue2024Member" abstract="true" name="RevolvingCreditFacilityDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" abstract="false" name="ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" abstract="false" name="LegalMattersContingenciesAndLegalCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" abstract="false" name="LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" abstract="false" name="RestructuringAndRelatedActivitiesPeriodOfImplementation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="wst_AssetsDefinedBenefitPlansNoncurrent" abstract="false" name="AssetsDefinedBenefitPlansNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded" abstract="false" name="DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod" abstract="false" name="DebtInstrumentIncreaseInFacilityPrecedingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_YearAfter2022Member" abstract="true" name="YearAfter2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" abstract="true" name="AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ContractManufacturedProductsMember" abstract="true" name="ContractManufacturedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_SmartDoseMember" abstract="true" name="SmartDoseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_SecondQuarter2020AcquisiitonMember" abstract="true" name="SecondQuarter2020AcquisiitonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" abstract="false" name="EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="wst_TermLoanDue2024Member" abstract="true" name="TermLoanDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_SeniorBNotesDue2024Member" abstract="true" name="SeniorBNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_DeferredStockUnitsPayableInCash" abstract="false" name="DeferredStockUnitsPayableInCash" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_HighValueProductDeliveryDevicesMember" abstract="true" name="HighValueProductDeliveryDevicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ContractWithCustomerAssetRollForward" abstract="true" name="ContractWithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_BiologicsCustomersMember" abstract="true" name="BiologicsCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ProprietaryProductsMember" abstract="true" name="ProprietaryProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_SeniorNotesDue2022Member" abstract="true" name="SeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="wst_SalesToEquityMethodInvestees" abstract="false" name="SalesToEquityMethodInvestees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="wst_PharmaTapSADeCVMember" abstract="true" name="PharmaTapSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ExpirationPeriodAxis" abstract="true" name="ExpirationPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_OtherCurrentLiabilitiesAbstract" abstract="true" name="OtherCurrentLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_ComputerHardwareAndSoftwareMember" abstract="true" name="ComputerHardwareAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_DeferredTaxAssetsLeasingArrangements" abstract="false" name="DeferredTaxAssetsLeasingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_PharmaCustomersMember" abstract="true" name="PharmaCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" abstract="false" name="DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="wst_The2020RestructuringPlanMember" abstract="true" name="The2020RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_CostInvestmentImpairment" abstract="false" name="CostInvestmentImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ContractWithCustomerLiabilityRollForward" abstract="true" name="ContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition" abstract="false" name="DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="wst_ContractManufacturedCustomersMember" abstract="true" name="ContractManufacturedCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_Year2021Member" abstract="true" name="Year2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition" abstract="false" name="DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="wst_DebtInstrumentNumberOfTranches" abstract="false" name="DebtInstrumentNumberOfTranches" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="wst_ExpirationPeriodDomain" abstract="true" name="ExpirationPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_OtherMutualFundsMember" abstract="true" name="OtherMutualFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_PharmaRubberSADeCVMember" abstract="true" name="PharmaRubberSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" abstract="false" name="DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_PensionAndOtherPostretirementBenefitExpenseNet" abstract="false" name="PensionAndOtherPostretirementBenefitExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ApplicableMarginMember" abstract="true" name="ApplicableMarginMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_NotesPayableAndOtherDebtCurrent" abstract="false" name="NotesPayableAndOtherDebtCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_Year2022Member" abstract="true" name="Year2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_DaikyoSeikoLtdDaikyoMember" abstract="true" name="DaikyoSeikoLtdDaikyoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_WestCompanyMexicoSADeCVMember" abstract="true" name="WestCompanyMexicoSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_LesseeOperatingLeaseOptionToTerminateTerm" abstract="false" name="LesseeOperatingLeaseOptionToTerminateTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="wst_AluplastSADeCVMember" abstract="true" name="AluplastSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_StockSettledPSUAwardsMember" abstract="true" name="StockSettledPSUAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_HighValueProductComponentsMember" abstract="true" name="HighValueProductComponentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" abstract="false" name="ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="wst_StockOptionAndAppreciationRightsMember" abstract="true" name="StockOptionAndAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_CashSettledPSUAwardsMember" abstract="true" name="CashSettledPSUAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" abstract="false" name="DeferredCompensationArrangementWithIndividualNumberOfPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" abstract="false" name="PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_The2022RestructuringPlanMember" abstract="true" name="The2022RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" abstract="true" name="PerformanceVestingSharesOrUnitsDividendEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_OtherIncomeExpense" abstract="false" name="OtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_EmployeeStockPurchasePlanEsppMember" abstract="true" name="EmployeeStockPurchasePlanEsppMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" abstract="false" name="DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_PatentsAndLicensingMember" abstract="true" name="PatentsAndLicensingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_GenericsCustomersMember" abstract="true" name="GenericsCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_DeferredCompensationArrangementWithIndividualConversionUnit" abstract="false" name="DeferredCompensationArrangementWithIndividualConversionUnit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" abstract="false" name="DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="wst_AssetRelatedChargesMember" abstract="true" name="AssetRelatedChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_AccruedSalariesWagesAndBenefitsCurrent" abstract="false" name="AccruedSalariesWagesAndBenefitsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" abstract="true" name="ScheduleOfIntangibleAssetsByMajorClassLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_WeightedAverageSharesOutstandingAbstract" abstract="true" name="WeightedAverageSharesOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>wst-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6ce7082f-45c4-495e-94eb-caa34b024fa0,g:4770da38-231a-455c-ab1e-d14c8c362bd8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ac704166-e70d-4eaf-840b-51903cb455ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e9ac9a9-5544-48ed-8590-33da159b8ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ac704166-e70d-4eaf-840b-51903cb455ab" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e9ac9a9-5544-48ed-8590-33da159b8ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_21a728d4-d177-4ddd-9841-8cc05231111d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ac704166-e70d-4eaf-840b-51903cb455ab" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_21a728d4-d177-4ddd-9841-8cc05231111d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6dabb581-e811-4cb7-86a5-39efd9109f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b61146ba-8d26-4996-8488-7b9dbf6de1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6dabb581-e811-4cb7-86a5-39efd9109f8c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b61146ba-8d26-4996-8488-7b9dbf6de1c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1ac74d35-4f8a-4a14-a98c-557440a29afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6dabb581-e811-4cb7-86a5-39efd9109f8c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1ac74d35-4f8a-4a14-a98c-557440a29afd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b802b473-48e6-45a8-9117-1f24a0c943f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6dabb581-e811-4cb7-86a5-39efd9109f8c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b802b473-48e6-45a8-9117-1f24a0c943f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_65c80bad-e4b5-412f-a6fe-986ac2e60cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0e3e1476-945f-41f9-8d30-855f65f02716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_65c80bad-e4b5-412f-a6fe-986ac2e60cb2" xlink:to="loc_us-gaap_GrossProfit_0e3e1476-945f-41f9-8d30-855f65f02716" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0f7af598-fc81-44fc-babc-457d20870f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_65c80bad-e4b5-412f-a6fe-986ac2e60cb2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0f7af598-fc81-44fc-babc-457d20870f3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_29720165-4c37-4cc0-8468-548b3a52d535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_65c80bad-e4b5-412f-a6fe-986ac2e60cb2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_29720165-4c37-4cc0-8468-548b3a52d535" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_d9652067-cf69-4af1-9893-c8734411bea9" xlink:href="wst-20221231.xsd#wst_OtherIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_65c80bad-e4b5-412f-a6fe-986ac2e60cb2" xlink:to="loc_wst_OtherIncomeExpense_d9652067-cf69-4af1-9893-c8734411bea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c17a86bc-dbea-40d5-9369-5b75547e6582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f1a50ec8-79ef-4761-a065-2d9ab94909eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c17a86bc-dbea-40d5-9369-5b75547e6582" xlink:to="loc_us-gaap_OperatingIncomeLoss_f1a50ec8-79ef-4761-a065-2d9ab94909eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b16b8186-6c20-4d8c-bb7f-2c0e3512d4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c17a86bc-dbea-40d5-9369-5b75547e6582" xlink:to="loc_us-gaap_InterestExpense_b16b8186-6c20-4d8c-bb7f-2c0e3512d4aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_29d50034-a67b-44a9-8797-dff00ca830da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c17a86bc-dbea-40d5-9369-5b75547e6582" xlink:to="loc_us-gaap_InvestmentIncomeNet_29d50034-a67b-44a9-8797-dff00ca830da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_206fa4f9-dfd8-4706-94f3-d5ead6582547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c17a86bc-dbea-40d5-9369-5b75547e6582" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_206fa4f9-dfd8-4706-94f3-d5ead6582547" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3e1ea227-898a-4460-97b5-dcb6539a74b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3a6c4e2a-6336-4691-8c14-23bd3460f6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3e1ea227-898a-4460-97b5-dcb6539a74b8" xlink:to="loc_us-gaap_NetIncomeLoss_3a6c4e2a-6336-4691-8c14-23bd3460f6e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3381bc99-e3f0-45b5-a345-de5ff9e0a3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3e1ea227-898a-4460-97b5-dcb6539a74b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3381bc99-e3f0-45b5-a345-de5ff9e0a3d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6ffa8e1b-1595-4d62-a2e7-60e9250d6f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_97fa50ab-521a-4c09-b7b4-fec04ba21344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6ffa8e1b-1595-4d62-a2e7-60e9250d6f7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_97fa50ab-521a-4c09-b7b4-fec04ba21344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_f17f4e03-2a9f-4ba7-b2ae-16c840bee853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6ffa8e1b-1595-4d62-a2e7-60e9250d6f7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_f17f4e03-2a9f-4ba7-b2ae-16c840bee853" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_f5d89bb7-9c65-48e2-a787-3bfa48a4796c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6ffa8e1b-1595-4d62-a2e7-60e9250d6f7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_f5d89bb7-9c65-48e2-a787-3bfa48a4796c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_df338642-cfae-4153-b6bb-aa61e013740c" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6ffa8e1b-1595-4d62-a2e7-60e9250d6f7b" xlink:to="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_df338642-cfae-4153-b6bb-aa61e013740c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_d956a8b3-dd09-405f-a750-6c37b1d8189b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6ffa8e1b-1595-4d62-a2e7-60e9250d6f7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_d956a8b3-dd09-405f-a750-6c37b1d8189b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_62cce97a-b215-4cd7-80b9-e5615d0fbbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6ffa8e1b-1595-4d62-a2e7-60e9250d6f7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_62cce97a-b215-4cd7-80b9-e5615d0fbbb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_1778f339-f44d-4139-9283-5af068d91a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6ffa8e1b-1595-4d62-a2e7-60e9250d6f7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_1778f339-f44d-4139-9283-5af068d91a8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ccfe3f28-9259-40fa-9f6e-94e00eed36ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6ffa8e1b-1595-4d62-a2e7-60e9250d6f7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ccfe3f28-9259-40fa-9f6e-94e00eed36ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_9fd4c608-1751-4889-b64b-f2a459c8fcbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6ffa8e1b-1595-4d62-a2e7-60e9250d6f7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_9fd4c608-1751-4889-b64b-f2a459c8fcbd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ca791472-ba75-48de-b9cc-c078d46ce08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4cbb459a-8f05-4e1c-8013-02d0b3ed249a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ca791472-ba75-48de-b9cc-c078d46ce08a" xlink:to="loc_us-gaap_Liabilities_4cbb459a-8f05-4e1c-8013-02d0b3ed249a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_bebc5832-7138-412a-b571-a698449ad00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ca791472-ba75-48de-b9cc-c078d46ce08a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_bebc5832-7138-412a-b571-a698449ad00c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d6993033-42e9-490e-96a0-568e6f5f116d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ca791472-ba75-48de-b9cc-c078d46ce08a" xlink:to="loc_us-gaap_StockholdersEquity_d6993033-42e9-490e-96a0-568e6f5f116d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c401aca6-88f9-4ae3-a2ed-a770eea83e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0a6f4ddb-a4a1-43f8-8140-2fde8b6a18ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c401aca6-88f9-4ae3-a2ed-a770eea83e5b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0a6f4ddb-a4a1-43f8-8140-2fde8b6a18ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d4e90a42-466a-438c-a432-775ce34d67f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c401aca6-88f9-4ae3-a2ed-a770eea83e5b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d4e90a42-466a-438c-a432-775ce34d67f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b6c5eb1e-a9ec-4e6d-ba3f-a3ea903f90f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c401aca6-88f9-4ae3-a2ed-a770eea83e5b" xlink:to="loc_us-gaap_InventoryNet_b6c5eb1e-a9ec-4e6d-ba3f-a3ea903f90f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_313a1db9-29a5-48a1-8078-fc130b5ac52e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c401aca6-88f9-4ae3-a2ed-a770eea83e5b" xlink:to="loc_us-gaap_OtherAssetsCurrent_313a1db9-29a5-48a1-8078-fc130b5ac52e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_91edc1e7-e17d-4e86-90d7-af96a1c4f576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f679f68b-b658-469c-9c04-5b66537ea5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_91edc1e7-e17d-4e86-90d7-af96a1c4f576" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f679f68b-b658-469c-9c04-5b66537ea5b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b7ddd69a-aa57-489f-be5a-33743e77b080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_91edc1e7-e17d-4e86-90d7-af96a1c4f576" xlink:to="loc_us-gaap_AccountsPayableCurrent_b7ddd69a-aa57-489f-be5a-33743e77b080" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_65e1bd1c-abb2-4490-8a29-67799ebf2f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_91edc1e7-e17d-4e86-90d7-af96a1c4f576" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_65e1bd1c-abb2-4490-8a29-67799ebf2f4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_d99b265c-71c4-4910-8709-61cf89c04aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_91edc1e7-e17d-4e86-90d7-af96a1c4f576" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_d99b265c-71c4-4910-8709-61cf89c04aed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ce05deda-4bff-4b20-8c1b-4efcf94b7c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_91edc1e7-e17d-4e86-90d7-af96a1c4f576" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ce05deda-4bff-4b20-8c1b-4efcf94b7c6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent_7b406262-429d-4581-9c33-acae91d68122" xlink:href="wst-20221231.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_91edc1e7-e17d-4e86-90d7-af96a1c4f576" xlink:to="loc_wst_NotesPayableAndOtherDebtCurrent_7b406262-429d-4581-9c33-acae91d68122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_1a02b62b-1ef5-43d7-9c31-c278445813db" xlink:href="wst-20221231.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_91edc1e7-e17d-4e86-90d7-af96a1c4f576" xlink:to="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_1a02b62b-1ef5-43d7-9c31-c278445813db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5e5755eb-544b-4a8b-a5bd-8bfae0cfa2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_92a87c27-1fdd-47dd-99eb-a26844b46acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5e5755eb-544b-4a8b-a5bd-8bfae0cfa2b1" xlink:to="loc_us-gaap_PreferredStockValue_92a87c27-1fdd-47dd-99eb-a26844b46acc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5606d813-7b1b-4fe5-b5cd-9c5eb95bac35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5e5755eb-544b-4a8b-a5bd-8bfae0cfa2b1" xlink:to="loc_us-gaap_CommonStockValue_5606d813-7b1b-4fe5-b5cd-9c5eb95bac35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_27b2aca2-3a96-410c-8cf5-8e346c4d058c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5e5755eb-544b-4a8b-a5bd-8bfae0cfa2b1" xlink:to="loc_us-gaap_AdditionalPaidInCapital_27b2aca2-3a96-410c-8cf5-8e346c4d058c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_20950a2e-09fb-423d-b00f-f22b36209303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5e5755eb-544b-4a8b-a5bd-8bfae0cfa2b1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_20950a2e-09fb-423d-b00f-f22b36209303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_18c55688-ba6a-45f8-873f-ef8aac433332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5e5755eb-544b-4a8b-a5bd-8bfae0cfa2b1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_18c55688-ba6a-45f8-873f-ef8aac433332" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_7875e056-b3d7-4a3f-8cf6-0eb94d3f72e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5e5755eb-544b-4a8b-a5bd-8bfae0cfa2b1" xlink:to="loc_us-gaap_TreasuryStockValue_7875e056-b3d7-4a3f-8cf6-0eb94d3f72e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e72991df-8f0e-4699-9ab4-3c2a4aba566d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b0352ed2-cdce-4106-bc46-ba5e0f1cd08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e72991df-8f0e-4699-9ab4-3c2a4aba566d" xlink:to="loc_us-gaap_LiabilitiesCurrent_b0352ed2-cdce-4106-bc46-ba5e0f1cd08d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_9083173d-f638-4041-a32d-500f6cc3e9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e72991df-8f0e-4699-9ab4-3c2a4aba566d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_9083173d-f638-4041-a32d-500f6cc3e9b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ead0bd8c-49dd-462a-858b-0524eaff9cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e72991df-8f0e-4699-9ab4-3c2a4aba566d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ead0bd8c-49dd-462a-858b-0524eaff9cbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2ed74813-aa63-425c-ac86-05cd7cd4a8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e72991df-8f0e-4699-9ab4-3c2a4aba566d" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2ed74813-aa63-425c-ac86-05cd7cd4a8c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_aa224dfa-7e0d-4ee6-bc17-ce40d17a2476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e72991df-8f0e-4699-9ab4-3c2a4aba566d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_aa224dfa-7e0d-4ee6-bc17-ce40d17a2476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0a8e3029-050a-4b30-b4b9-e64d600f88a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e72991df-8f0e-4699-9ab4-3c2a4aba566d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0a8e3029-050a-4b30-b4b9-e64d600f88a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_baf59ef4-fda6-4c3f-ac39-a97cdda741c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e72991df-8f0e-4699-9ab4-3c2a4aba566d" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_baf59ef4-fda6-4c3f-ac39-a97cdda741c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3a60d63d-e020-4099-945b-7eb17ea012eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_73b5a3f8-9684-4e8a-afe3-36236b918b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a60d63d-e020-4099-945b-7eb17ea012eb" xlink:to="loc_us-gaap_AssetsCurrent_73b5a3f8-9684-4e8a-afe3-36236b918b25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5703748c-c233-4161-89f2-6b62044a8c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a60d63d-e020-4099-945b-7eb17ea012eb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5703748c-c233-4161-89f2-6b62044a8c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_616aee99-f28d-4127-9387-2f503bd4f3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a60d63d-e020-4099-945b-7eb17ea012eb" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_616aee99-f28d-4127-9387-2f503bd4f3c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fb67dadb-d87d-4785-a442-5734cce798a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a60d63d-e020-4099-945b-7eb17ea012eb" xlink:to="loc_us-gaap_Goodwill_fb67dadb-d87d-4785-a442-5734cce798a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_bb5c65de-cfaa-4e23-a7a0-8ecb802b9827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a60d63d-e020-4099-945b-7eb17ea012eb" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_bb5c65de-cfaa-4e23-a7a0-8ecb802b9827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2d4c5a2b-54a8-4f0a-a87b-e210f0de48eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a60d63d-e020-4099-945b-7eb17ea012eb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2d4c5a2b-54a8-4f0a-a87b-e210f0de48eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e40729bc-6c2a-47b2-b20e-b7202d487670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a60d63d-e020-4099-945b-7eb17ea012eb" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e40729bc-6c2a-47b2-b20e-b7202d487670" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4db50e42-6c51-40f0-a72a-e123d2d40353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a60d63d-e020-4099-945b-7eb17ea012eb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4db50e42-6c51-40f0-a72a-e123d2d40353" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_b1d30c10-029b-438b-8fa8-fd4d2e656362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3a60d63d-e020-4099-945b-7eb17ea012eb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_b1d30c10-029b-438b-8fa8-fd4d2e656362" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0a9ff747-13a1-4663-ad6e-de633bdddfb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4bc7134f-e895-4f4c-b8f4-8ca9d48b117e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_0a9ff747-13a1-4663-ad6e-de633bdddfb4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4bc7134f-e895-4f4c-b8f4-8ca9d48b117e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_edb203e2-0f11-4234-8f2d-80bdc5b82c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_0a9ff747-13a1-4663-ad6e-de633bdddfb4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_edb203e2-0f11-4234-8f2d-80bdc5b82c5e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31a8cd06-a9e5-464d-b62e-d69e575eb3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d66f4712-8db3-4506-86b4-2b9d402f5fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31a8cd06-a9e5-464d-b62e-d69e575eb3bb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d66f4712-8db3-4506-86b4-2b9d402f5fa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3aa72984-3e07-47ed-ad21-b7faef1ca3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31a8cd06-a9e5-464d-b62e-d69e575eb3bb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3aa72984-3e07-47ed-ad21-b7faef1ca3dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4851511f-bf17-4684-9f3e-7f41fc54400d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31a8cd06-a9e5-464d-b62e-d69e575eb3bb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4851511f-bf17-4684-9f3e-7f41fc54400d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_acc29440-22de-478e-b705-f6b443224251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31a8cd06-a9e5-464d-b62e-d69e575eb3bb" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_acc29440-22de-478e-b705-f6b443224251" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7835c609-22ab-4a89-b5d6-bc314abff80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a2bbe765-de3d-4868-84d7-7acbca1b9489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7835c609-22ab-4a89-b5d6-bc314abff80b" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a2bbe765-de3d-4868-84d7-7acbca1b9489" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_afbbb6ce-a2e1-4438-9ae8-7538238c50cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7835c609-22ab-4a89-b5d6-bc314abff80b" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_afbbb6ce-a2e1-4438-9ae8-7538238c50cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_df463b93-3684-496d-a7f9-2dee31f7db4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7835c609-22ab-4a89-b5d6-bc314abff80b" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_df463b93-3684-496d-a7f9-2dee31f7db4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5caa165b-8f2f-43eb-997a-04380368a8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7835c609-22ab-4a89-b5d6-bc314abff80b" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5caa165b-8f2f-43eb-997a-04380368a8ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_bb86d6e8-24aa-43d7-820d-f6f27e0b6210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7835c609-22ab-4a89-b5d6-bc314abff80b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_bb86d6e8-24aa-43d7-820d-f6f27e0b6210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9bd00f06-ad16-4efb-87a4-f18ada27b450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7835c609-22ab-4a89-b5d6-bc314abff80b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9bd00f06-ad16-4efb-87a4-f18ada27b450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_0d4f406d-6457-4bec-994d-09f396eccbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7835c609-22ab-4a89-b5d6-bc314abff80b" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_0d4f406d-6457-4bec-994d-09f396eccbd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d33658d2-1a9a-4f5a-b2eb-55235ee9c19d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_114a1699-0c80-4690-9b23-d880e754c940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d33658d2-1a9a-4f5a-b2eb-55235ee9c19d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_114a1699-0c80-4690-9b23-d880e754c940" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_aacb6fda-9fbd-487d-88d0-e7e39b1051c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d33658d2-1a9a-4f5a-b2eb-55235ee9c19d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_aacb6fda-9fbd-487d-88d0-e7e39b1051c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_62664d9b-304f-43c4-8135-fcaa8b0e0a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d33658d2-1a9a-4f5a-b2eb-55235ee9c19d" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_62664d9b-304f-43c4-8135-fcaa8b0e0a37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0a104c52-7c50-4673-ab4e-0cd283d79aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_NetIncomeLoss_0a104c52-7c50-4673-ab4e-0cd283d79aaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_0819b51e-4bd4-418e-badd-9aedb3b93348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_Depreciation_0819b51e-4bd4-418e-badd-9aedb3b93348" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_a7423d74-02dd-4239-8dd0-a5146c8124d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_AdjustmentForAmortization_a7423d74-02dd-4239-8dd0-a5146c8124d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_de2e7444-5485-4d68-83ea-1e7f446a5d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_ShareBasedCompensation_de2e7444-5485-4d68-83ea-1e7f446a5d74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_124540e3-22ff-4e4a-ac37-29fb9c042dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_124540e3-22ff-4e4a-ac37-29fb9c042dd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_0092aabf-59c4-4c7f-bae1-099aaac778a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_0092aabf-59c4-4c7f-bae1-099aaac778a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_8a65e407-e83e-4369-8433-2c07758ca7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_8a65e407-e83e-4369-8433-2c07758ca7d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_889c3551-9d16-49fe-8c8b-ac0d7ab7b3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_889c3551-9d16-49fe-8c8b-ac0d7ab7b3be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_633f34b7-6cf4-4735-afea-9f39f401b78f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_633f34b7-6cf4-4735-afea-9f39f401b78f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet_b542503d-8cb8-43f2-81d6-63e568f89722" xlink:href="wst-20221231.xsd#wst_PensionAndOtherPostretirementBenefitExpenseNet"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet_b542503d-8cb8-43f2-81d6-63e568f89722" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_b1eb03e0-800c-4d0b-b086-ccef1557d6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_b1eb03e0-800c-4d0b-b086-ccef1557d6ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7d33031d-fd78-42b5-9e11-4554cc264dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7d33031d-fd78-42b5-9e11-4554cc264dcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c242de49-d1c6-4a09-a0ff-f9afce292098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c242de49-d1c6-4a09-a0ff-f9afce292098" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_23a7678c-7332-4db7-9534-64f66e62c1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_23a7678c-7332-4db7-9534-64f66e62c1d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b1066c55-e906-42e1-883e-1c82d1fb25f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b1066c55-e906-42e1-883e-1c82d1fb25f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_8a68a036-bd5a-45f7-a600-0daa00d0067c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a1e0647-8cd2-43f7-aa6d-0b29cb364d95" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_8a68a036-bd5a-45f7-a600-0daa00d0067c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_576ce614-39bc-4e30-9110-86438bdbad86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_58a7b042-b41e-41ea-a8db-f4ceb5f5c706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_576ce614-39bc-4e30-9110-86438bdbad86" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_58a7b042-b41e-41ea-a8db-f4ceb5f5c706" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4363540e-5d50-4ca8-880b-e7c3525b62f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_576ce614-39bc-4e30-9110-86438bdbad86" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4363540e-5d50-4ca8-880b-e7c3525b62f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_c0a8d78f-b512-4bee-a1f6-f12e5dc700f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_576ce614-39bc-4e30-9110-86438bdbad86" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_c0a8d78f-b512-4bee-a1f6-f12e5dc700f1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#NetIncomePerShareScheduleofReconciliationofSharesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7d18f641-cbe9-4438-b46d-a86dbfbbb39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f56a6eb-0cd6-4d4e-ac53-330927930113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7d18f641-cbe9-4438-b46d-a86dbfbbb39f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f56a6eb-0cd6-4d4e-ac53-330927930113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_229c543d-0045-4b07-8a7f-9282753d1dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7d18f641-cbe9-4438-b46d-a86dbfbbb39f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_229c543d-0045-4b07-8a7f-9282753d1dd8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_72b3ab3b-9092-4c5f-9ac4-013d313f770c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_0337aabd-7b00-44be-a188-2b95f953ba01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_72b3ab3b-9092-4c5f-9ac4-013d313f770c" xlink:to="loc_us-gaap_OperatingLeaseCost_0337aabd-7b00-44be-a188-2b95f953ba01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_8be98bd0-bdaf-44b2-9ae7-923a538ed425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_72b3ab3b-9092-4c5f-9ac4-013d313f770c" xlink:to="loc_us-gaap_ShortTermLeaseCost_8be98bd0-bdaf-44b2-9ae7-923a538ed425" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_056569f0-306a-433e-8ebe-367897f50be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_72b3ab3b-9092-4c5f-9ac4-013d313f770c" xlink:to="loc_us-gaap_VariableLeaseCost_056569f0-306a-433e-8ebe-367897f50be3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_206040b7-6917-460e-853f-68df065914f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_abea37a5-0012-4c7e-9b08-88b466deb97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_206040b7-6917-460e-853f-68df065914f0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_abea37a5-0012-4c7e-9b08-88b466deb97f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8d293a52-7699-46c6-ae8e-598d535c09bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_206040b7-6917-460e-853f-68df065914f0" xlink:to="loc_us-gaap_OperatingLeaseLiability_8d293a52-7699-46c6-ae8e-598d535c09bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="wst-20221231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_36bcbb7c-7334-4822-b160-2a4a5312daa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_586293a7-90a1-4dd2-bc68-e6f50440a51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_36bcbb7c-7334-4822-b160-2a4a5312daa2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_586293a7-90a1-4dd2-bc68-e6f50440a51e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_dda152fb-adb3-4701-b701-08a6f9bdec52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_36bcbb7c-7334-4822-b160-2a4a5312daa2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_dda152fb-adb3-4701-b701-08a6f9bdec52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3f641b16-8e74-43b5-a3bc-288dc5b3eb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_36bcbb7c-7334-4822-b160-2a4a5312daa2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3f641b16-8e74-43b5-a3bc-288dc5b3eb8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5a28bbc1-5ebe-4c04-b36b-b5992db2b383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_36bcbb7c-7334-4822-b160-2a4a5312daa2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5a28bbc1-5ebe-4c04-b36b-b5992db2b383" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a40e99a7-47bd-4f5f-9ae9-105944ede7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_36bcbb7c-7334-4822-b160-2a4a5312daa2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a40e99a7-47bd-4f5f-9ae9-105944ede7f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8fca6c67-127c-414a-ad8e-7fe626e21a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_36bcbb7c-7334-4822-b160-2a4a5312daa2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8fca6c67-127c-414a-ad8e-7fe626e21a76" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5a6574bc-dd46-4f75-8840-5fb085269068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_db4dd888-cc7c-4daf-b132-95103d940f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5a6574bc-dd46-4f75-8840-5fb085269068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_db4dd888-cc7c-4daf-b132-95103d940f2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fb8a338e-5ac2-4904-9910-669c18180056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5a6574bc-dd46-4f75-8840-5fb085269068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fb8a338e-5ac2-4904-9910-669c18180056" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9737f9af-acfe-4941-a93f-4bbfc96c864a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:to="loc_us-gaap_RestructuringReserve_9737f9af-acfe-4941-a93f-4bbfc96c864a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_8e8214b4-4628-4c58-a752-264ebbd7fb63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_8e8214b4-4628-4c58-a752-264ebbd7fb63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_f17f0afa-80f5-4e37-a3e8-8666ad5844b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_f17f0afa-80f5-4e37-a3e8-8666ad5844b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_2372b3bc-767b-4821-9e65-f64cfa7a5e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:to="loc_us-gaap_DividendsPayableCurrent_2372b3bc-767b-4821-9e65-f64cfa7a5e30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_78c0366e-e390-4500-ba11-48ecbcf9d3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:to="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_78c0366e-e390-4500-ba11-48ecbcf9d3c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_cfa1fb7d-238a-41ae-aa90-01ae05dc5ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:to="loc_us-gaap_DeferredRevenueCurrent_cfa1fb7d-238a-41ae-aa90-01ae05dc5ab7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_aad265d6-b950-4f1e-9b8f-e2065c1ad907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:to="loc_us-gaap_InterestPayableCurrent_aad265d6-b950-4f1e-9b8f-e2065c1ad907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_a6d634ba-bab4-4145-8214-8692848343c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_a6d634ba-bab4-4145-8214-8692848343c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_04a1e8a7-f27f-4804-8e8d-2b4bffd082b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_04a1e8a7-f27f-4804-8e8d-2b4bffd082b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_4a0ecdc3-d38b-42d5-be61-a4cb0f90f2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_b438ca67-e2db-4179-ae08-494fdc4e2617" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_4a0ecdc3-d38b-42d5-be61-a4cb0f90f2ca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b766f6da-03cd-4a05-b368-1a0b988ad5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_7222e38e-a702-4220-8d1b-3e7edfd7d037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_b766f6da-03cd-4a05-b368-1a0b988ad5ee" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_7222e38e-a702-4220-8d1b-3e7edfd7d037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_a2e17c22-5e6d-4934-8fc2-4e94e63467e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_b766f6da-03cd-4a05-b368-1a0b988ad5ee" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_a2e17c22-5e6d-4934-8fc2-4e94e63467e0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails_1" xlink:type="simple" xlink:href="wst-20221231.xsd#DebtScheduleofDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtScheduleofDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f744f121-862d-4b0a-ac0d-517b6024747d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_13cfc364-d036-4d65-a557-67968c4a8f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f744f121-862d-4b0a-ac0d-517b6024747d" xlink:to="loc_us-gaap_LongTermDebtCurrent_13cfc364-d036-4d65-a557-67968c4a8f3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_54a7c60f-4675-404e-a645-1768f353266f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f744f121-862d-4b0a-ac0d-517b6024747d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_54a7c60f-4675-404e-a645-1768f353266f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_3a85354f-59a4-4a7c-b984-96e47f8f3eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_f74ba140-73ab-43e0-9cb1-8a73933eae38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_3a85354f-59a4-4a7c-b984-96e47f8f3eb4" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_f74ba140-73ab-43e0-9cb1-8a73933eae38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_2d393fdb-7e9c-43f3-86d0-2c38fa52c902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_3a85354f-59a4-4a7c-b984-96e47f8f3eb4" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_2d393fdb-7e9c-43f3-86d0-2c38fa52c902" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_b7b67664-0de8-419e-a91e-bd9f03342ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_3a85354f-59a4-4a7c-b984-96e47f8f3eb4" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_b7b67664-0de8-419e-a91e-bd9f03342ae1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b329cbdc-62b7-45d1-b5c8-96b6e36dadde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_375bd522-ea62-4c2b-912a-01309bc0f05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b329cbdc-62b7-45d1-b5c8-96b6e36dadde" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_375bd522-ea62-4c2b-912a-01309bc0f05d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_c40be172-4e46-4c74-9986-533545c8facd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b329cbdc-62b7-45d1-b5c8-96b6e36dadde" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_c40be172-4e46-4c74-9986-533545c8facd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_173f90ff-a160-416b-965f-c771aeaee83b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b329cbdc-62b7-45d1-b5c8-96b6e36dadde" xlink:to="loc_us-gaap_DerivativeAssets_173f90ff-a160-416b-965f-c771aeaee83b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_120eef31-1f6d-4959-843c-ca71f7dcea9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fe66d5de-128f-459c-95d4-a6ee9d2151e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_120eef31-1f6d-4959-843c-ca71f7dcea9d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fe66d5de-128f-459c-95d4-a6ee9d2151e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_56135539-68f8-417c-8862-51b7f35d072d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_120eef31-1f6d-4959-843c-ca71f7dcea9d" xlink:to="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_56135539-68f8-417c-8862-51b7f35d072d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4df9a7b0-164f-4f5d-91c6-0cfdf6bbc790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_120eef31-1f6d-4959-843c-ca71f7dcea9d" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4df9a7b0-164f-4f5d-91c6-0cfdf6bbc790" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_baffdfbd-783d-4834-88b4-7e40e0fbf63c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_16f1229b-192b-48f8-b2de-51503ce7e56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_baffdfbd-783d-4834-88b4-7e40e0fbf63c" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_16f1229b-192b-48f8-b2de-51503ce7e56b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_99b5ba5d-8150-4f65-9111-746f84f6794a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_baffdfbd-783d-4834-88b4-7e40e0fbf63c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_99b5ba5d-8150-4f65-9111-746f84f6794a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_f589dd24-50ec-41ad-82f4-8fcedac1c527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_94dbfc4a-a02e-4fd7-b328-870a6733b6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_f589dd24-50ec-41ad-82f4-8fcedac1c527" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_94dbfc4a-a02e-4fd7-b328-870a6733b6b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_922996c7-3228-4db4-a113-1f63ee31bed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_f589dd24-50ec-41ad-82f4-8fcedac1c527" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_922996c7-3228-4db4-a113-1f63ee31bed8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2542cde4-5cc0-4772-b14e-e60f8d79dd89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_0d6204b4-a470-4863-ac52-cbf3711617be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2542cde4-5cc0-4772-b14e-e60f8d79dd89" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_0d6204b4-a470-4863-ac52-cbf3711617be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_25c8c7e2-8e19-4310-8986-046bc13d42b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2542cde4-5cc0-4772-b14e-e60f8d79dd89" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_25c8c7e2-8e19-4310-8986-046bc13d42b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e8d1cbd9-2fd0-4eb8-9132-97d041483652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2542cde4-5cc0-4772-b14e-e60f8d79dd89" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e8d1cbd9-2fd0-4eb8-9132-97d041483652" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_6a6d5b07-4348-4540-9a9f-cc38358facf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2542cde4-5cc0-4772-b14e-e60f8d79dd89" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_6a6d5b07-4348-4540-9a9f-cc38358facf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_57206689-d224-455e-9a81-45c7d8014bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2542cde4-5cc0-4772-b14e-e60f8d79dd89" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_57206689-d224-455e-9a81-45c7d8014bba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_79c8d2bd-9f08-43b4-a2c1-ee5fd84cd7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2542cde4-5cc0-4772-b14e-e60f8d79dd89" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_79c8d2bd-9f08-43b4-a2c1-ee5fd84cd7db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_40866d81-e3d1-4061-95f5-e5868b519a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2542cde4-5cc0-4772-b14e-e60f8d79dd89" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_40866d81-e3d1-4061-95f5-e5868b519a8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b180283-c775-4596-9a12-c8e45f9fa771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_ee0fabc3-bd99-41c0-ae07-9cf74c554474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b180283-c775-4596-9a12-c8e45f9fa771" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_ee0fabc3-bd99-41c0-ae07-9cf74c554474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_b6e63044-36a6-47ac-b632-89b96bfbf02a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b180283-c775-4596-9a12-c8e45f9fa771" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_b6e63044-36a6-47ac-b632-89b96bfbf02a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_7997f951-3ca8-43dd-9479-7b5034f6fc22" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b180283-c775-4596-9a12-c8e45f9fa771" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_7997f951-3ca8-43dd-9479-7b5034f6fc22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_fcdeffbc-b0ef-449d-8b17-ff9ec366b47f" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b180283-c775-4596-9a12-c8e45f9fa771" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_fcdeffbc-b0ef-449d-8b17-ff9ec366b47f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_befba7d5-04f5-41e6-b4ee-574dd3315c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b180283-c775-4596-9a12-c8e45f9fa771" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_befba7d5-04f5-41e6-b4ee-574dd3315c4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax_e9ea0315-41eb-40ca-8ad9-d4cf3f14e9a5" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b180283-c775-4596-9a12-c8e45f9fa771" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax_e9ea0315-41eb-40ca-8ad9-d4cf3f14e9a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_4fbfa75d-26c2-42c2-887b-d5318a5c48d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1b180283-c775-4596-9a12-c8e45f9fa771" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_4fbfa75d-26c2-42c2-887b-d5318a5c48d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_577b93d7-7541-40cf-86a1-1ac5fd5cfc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_524f795f-471a-4815-b195-5fbccfaf82fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_577b93d7-7541-40cf-86a1-1ac5fd5cfc4f" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_524f795f-471a-4815-b195-5fbccfaf82fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_837fee10-c871-4efe-a745-207777fdb19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_577b93d7-7541-40cf-86a1-1ac5fd5cfc4f" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_837fee10-c871-4efe-a745-207777fdb19b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansAmountsRecognizedinBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_88989bd7-46f5-433e-af45-f5c6359d71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_c52afb08-80fe-499f-93fe-03aa57b43fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_88989bd7-46f5-433e-af45-f5c6359d71e6" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_c52afb08-80fe-499f-93fe-03aa57b43fd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f271a656-2cb1-4681-813a-de3b50dfe34d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_88989bd7-46f5-433e-af45-f5c6359d71e6" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f271a656-2cb1-4681-813a-de3b50dfe34d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent_befc6ddc-7265-48b0-8aea-b89dd5409f48" xlink:href="wst-20221231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_88989bd7-46f5-433e-af45-f5c6359d71e6" xlink:to="loc_wst_AssetsDefinedBenefitPlansNoncurrent_befc6ddc-7265-48b0-8aea-b89dd5409f48" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_86e10d05-004e-4043-a1ab-99557473cf9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_bee943f8-ebe3-400b-8b2d-5af1e7b401b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_86e10d05-004e-4043-a1ab-99557473cf9b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_bee943f8-ebe3-400b-8b2d-5af1e7b401b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_b16f0b35-2b17-4584-8612-34e0efe6e027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_86e10d05-004e-4043-a1ab-99557473cf9b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_b16f0b35-2b17-4584-8612-34e0efe6e027" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansExpectedBenefitPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_62ba8459-0418-4aa7-bad5-7e4d1b352bc0" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b90e91db-ab88-4b09-a387-acb9bbd4f80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_62ba8459-0418-4aa7-bad5-7e4d1b352bc0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b90e91db-ab88-4b09-a387-acb9bbd4f80d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_acfd2bf2-6353-49e2-842b-923547f6b1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_62ba8459-0418-4aa7-bad5-7e4d1b352bc0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_acfd2bf2-6353-49e2-842b-923547f6b1d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f6d1d2b0-4b2e-4dac-ab6f-e5801062dc17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_62ba8459-0418-4aa7-bad5-7e4d1b352bc0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f6d1d2b0-4b2e-4dac-ab6f-e5801062dc17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_ea870c99-13aa-4150-9729-3dd72fd75ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_62ba8459-0418-4aa7-bad5-7e4d1b352bc0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_ea870c99-13aa-4150-9729-3dd72fd75ccd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_9bc4cd6c-b7f0-47d8-8a87-ff8d975934f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_62ba8459-0418-4aa7-bad5-7e4d1b352bc0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_9bc4cd6c-b7f0-47d8-8a87-ff8d975934f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d275de76-74c4-4e02-8e9d-a39efb0d4fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_62ba8459-0418-4aa7-bad5-7e4d1b352bc0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d275de76-74c4-4e02-8e9d-a39efb0d4fba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_18420a48-8aa6-443e-a29d-54e95a40404d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_5a1c899c-eeec-4ba4-b697-3f6f48c45766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_18420a48-8aa6-443e-a29d-54e95a40404d" xlink:to="loc_us-gaap_SeveranceCosts1_5a1c899c-eeec-4ba4-b697-3f6f48c45766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_67261ab8-0d72-471d-88e1-3df448f71c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_18420a48-8aa6-443e-a29d-54e95a40404d" xlink:to="loc_us-gaap_AssetImpairmentCharges_67261ab8-0d72-471d-88e1-3df448f71c59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_8954a1fa-dfb3-41c0-8693-ea23e40c4564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_18420a48-8aa6-443e-a29d-54e95a40404d" xlink:to="loc_us-gaap_OtherRestructuringCosts_8954a1fa-dfb3-41c0-8693-ea23e40c4564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_402b5e5b-c691-47d5-8768-1a5429f9b79a" xlink:href="wst-20221231.xsd#wst_OtherIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0c73a982-3757-4420-8946-2d553a11c24e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_402b5e5b-c691-47d5-8768-1a5429f9b79a" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0c73a982-3757-4420-8946-2d553a11c24e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_c1db05f2-1f9b-42f6-91f0-2967ed45a7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_402b5e5b-c691-47d5-8768-1a5429f9b79a" xlink:to="loc_us-gaap_GainLossOnInvestments_c1db05f2-1f9b-42f6-91f0-2967ed45a7c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7f525629-6f56-49f2-ab63-a6f4e7ccf58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_402b5e5b-c691-47d5-8768-1a5429f9b79a" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7f525629-6f56-49f2-ab63-a6f4e7ccf58c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_e4edf8df-28c7-44e0-86e8-25c9274982ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_402b5e5b-c691-47d5-8768-1a5429f9b79a" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_e4edf8df-28c7-44e0-86e8-25c9274982ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_27981381-65c7-42ca-a1cc-37fcf659a34b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_402b5e5b-c691-47d5-8768-1a5429f9b79a" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_27981381-65c7-42ca-a1cc-37fcf659a34b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d4046786-dd43-4901-9c50-64e977f712b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_402b5e5b-c691-47d5-8768-1a5429f9b79a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d4046786-dd43-4901-9c50-64e977f712b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_3cfa0195-8c0d-4cee-a817-8e492692fe67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_402b5e5b-c691-47d5-8768-1a5429f9b79a" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_3cfa0195-8c0d-4cee-a817-8e492692fe67" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_73cdae26-6081-4d7c-81ff-8cce3e7dfc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a683b4cb-0b96-49fc-8f03-a73f0b496e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_73cdae26-6081-4d7c-81ff-8cce3e7dfc7d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a683b4cb-0b96-49fc-8f03-a73f0b496e45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e1d67540-6684-40a8-84d5-28f96716da35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_73cdae26-6081-4d7c-81ff-8cce3e7dfc7d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e1d67540-6684-40a8-84d5-28f96716da35" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_28b566ac-1676-400c-be60-34b735b5ef12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_43f7d730-07f2-4027-8d22-ec060d633356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_28b566ac-1676-400c-be60-34b735b5ef12" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_43f7d730-07f2-4027-8d22-ec060d633356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_23965cf5-16c4-4ed2-813f-2920935f433c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_28b566ac-1676-400c-be60-34b735b5ef12" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_23965cf5-16c4-4ed2-813f-2920935f433c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_850ed71b-328f-4790-9511-1fb9813e94ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_28b566ac-1676-400c-be60-34b735b5ef12" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_850ed71b-328f-4790-9511-1fb9813e94ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ce816c80-1554-41a0-ad04-f43b6852be13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_afd7492b-d5f1-4d7b-b61c-755b9ea8b4c4" xlink:href="wst-20221231.xsd#wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ce816c80-1554-41a0-ad04-f43b6852be13" xlink:to="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_afd7492b-d5f1-4d7b-b61c-755b9ea8b4c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_79a28edf-5088-4d6b-8796-e570f9ee6cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ce816c80-1554-41a0-ad04-f43b6852be13" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_79a28edf-5088-4d6b-8796-e570f9ee6cb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_334b6b79-ac5f-4dbe-80a5-cafbe9e1ea83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ed68c17c-e1a4-44a6-a0e6-bb917c8056b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_334b6b79-ac5f-4dbe-80a5-cafbe9e1ea83" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ed68c17c-e1a4-44a6-a0e6-bb917c8056b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_832ae6ad-8e72-44c0-84f3-7fb68e1af90d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_334b6b79-ac5f-4dbe-80a5-cafbe9e1ea83" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_832ae6ad-8e72-44c0-84f3-7fb68e1af90d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_8374fd2c-ef8d-44c3-b9bb-19666c6c8fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_217181d1-b919-48cb-b434-4119f76eddcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_8374fd2c-ef8d-44c3-b9bb-19666c6c8fcc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_217181d1-b919-48cb-b434-4119f76eddcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_572ff9b4-b8be-460c-bf69-ba2e87f76c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_8374fd2c-ef8d-44c3-b9bb-19666c6c8fcc" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_572ff9b4-b8be-460c-bf69-ba2e87f76c69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8b8a084c-fdb0-4f5c-a6f5-829e08a3a541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_8374fd2c-ef8d-44c3-b9bb-19666c6c8fcc" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8b8a084c-fdb0-4f5c-a6f5-829e08a3a541" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_76381623-ea81-4233-aad1-3eb0d6db9b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_8374fd2c-ef8d-44c3-b9bb-19666c6c8fcc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_76381623-ea81-4233-aad1-3eb0d6db9b9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsLeasingArrangements_b05f666c-b068-4d68-a29f-1f63435a9c09" xlink:href="wst-20221231.xsd#wst_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_8374fd2c-ef8d-44c3-b9bb-19666c6c8fcc" xlink:to="loc_wst_DeferredTaxAssetsLeasingArrangements_b05f666c-b068-4d68-a29f-1f63435a9c09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsRoyaltyAcceleration_5647d989-945d-4ee5-bb94-ca2c1e0e4f74" xlink:href="wst-20221231.xsd#wst_DeferredTaxAssetsRoyaltyAcceleration"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_8374fd2c-ef8d-44c3-b9bb-19666c6c8fcc" xlink:to="loc_wst_DeferredTaxAssetsRoyaltyAcceleration_5647d989-945d-4ee5-bb94-ca2c1e0e4f74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_67d8926e-ae95-448c-aad5-0919e640746a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_8374fd2c-ef8d-44c3-b9bb-19666c6c8fcc" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_67d8926e-ae95-448c-aad5-0919e640746a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_b096e0f4-fa67-4261-9b13-c54c62f0554f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_8374fd2c-ef8d-44c3-b9bb-19666c6c8fcc" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_b096e0f4-fa67-4261-9b13-c54c62f0554f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_dc8df6ca-7d91-491b-bc23-c3894cd41154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_bc7f040a-79b7-4570-a442-4e5a279fd780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_dc8df6ca-7d91-491b-bc23-c3894cd41154" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_bc7f040a-79b7-4570-a442-4e5a279fd780" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6af991af-0942-4042-9e63-c6aef73fa730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_dc8df6ca-7d91-491b-bc23-c3894cd41154" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_6af991af-0942-4042-9e63-c6aef73fa730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_4c1b2167-1d87-4a83-a5e1-e39f39fef3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_f72ddbf6-59b6-4841-936f-80582b91fc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_4c1b2167-1d87-4a83-a5e1-e39f39fef3b6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_f72ddbf6-59b6-4841-936f-80582b91fc8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_b82ee958-30bb-4ec2-9cfc-105c7a6c38fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_4c1b2167-1d87-4a83-a5e1-e39f39fef3b6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_b82ee958-30bb-4ec2-9cfc-105c7a6c38fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2ee32053-f096-4fbf-866f-42a4595e8984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_4c1b2167-1d87-4a83-a5e1-e39f39fef3b6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2ee32053-f096-4fbf-866f-42a4595e8984" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_756ca936-54de-4bdb-b57e-87c69fc0d943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_4c1b2167-1d87-4a83-a5e1-e39f39fef3b6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_756ca936-54de-4bdb-b57e-87c69fc0d943" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1abd8015-0909-46ab-a90c-3ba70be11b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1abd8015-0909-46ab-a90c-3ba70be11b2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_da9ebd10-d56f-4864-b93a-b0b74a4abec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_da9ebd10-d56f-4864-b93a-b0b74a4abec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_52453255-9eee-4474-bc69-80a9f3b6c3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_52453255-9eee-4474-bc69-80a9f3b6c3bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_c51a7b6f-d3a8-44d8-9af5-5e8a2223d024" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_c51a7b6f-d3a8-44d8-9af5-5e8a2223d024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_8e638304-9176-4782-8bd3-693eee61999d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_8e638304-9176-4782-8bd3-693eee61999d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent_8b1c5619-ee8a-4dd4-a783-f1336e289112" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent_8b1c5619-ee8a-4dd4-a783-f1336e289112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_d9eeda8f-de47-44ec-9b60-87fde687e1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_d9eeda8f-de47-44ec-9b60-87fde687e1aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dfefb2f0-b344-47fb-a3d9-37d1ee402481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dfefb2f0-b344-47fb-a3d9-37d1ee402481" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent_edb13498-a3cc-4dbf-9005-b19a597b93d8" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent_edb13498-a3cc-4dbf-9005-b19a597b93d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_f4daecb3-bd0f-406b-a390-f3c1c2241da7" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_f4daecb3-bd0f-406b-a390-f3c1c2241da7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_c700da1f-9d15-4165-b500-396c1d5d9683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_c700da1f-9d15-4165-b500-396c1d5d9683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_0e1f0fc9-67ab-46a0-b0e2-d997916edc27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a0b5f81-8c55-46aa-b5cd-cd8113434057" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_0e1f0fc9-67ab-46a0-b0e2-d997916edc27" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c72e4d46-b1b5-4198-837f-8dcbc375e03d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_209d11b0-f7c1-404d-a656-bdd2b060f464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c72e4d46-b1b5-4198-837f-8dcbc375e03d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_209d11b0-f7c1-404d-a656-bdd2b060f464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8da4fd3b-1b9e-4ddb-ba54-c40b2418bbef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c72e4d46-b1b5-4198-837f-8dcbc375e03d" xlink:to="loc_us-gaap_OperatingIncomeLoss_8da4fd3b-1b9e-4ddb-ba54-c40b2418bbef" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>wst-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6ce7082f-45c4-495e-94eb-caa34b024fa0,g:4770da38-231a-455c-ab1e-d14c8c362bd8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDSTATEMENTSOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="extended" id="i354ac03495fa4b6189ab001aa8db2547_CONSOLIDATEDSTATEMENTSOFEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_58fe2ea8-dd36-4897-907f-d2ddcdae028f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_9224827c-e41c-4d24-ad0f-a5afcb9bc369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_58fe2ea8-dd36-4897-907f-d2ddcdae028f" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_9224827c-e41c-4d24-ad0f-a5afcb9bc369" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_58fe2ea8-dd36-4897-907f-d2ddcdae028f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8f755fe8-830f-48ce-9c42-f95441431032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_SharesIssued_8f755fe8-830f-48ce-9c42-f95441431032" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_b45471ed-7d16-4778-a876-17df19abdd93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_TreasuryStockCommonShares_b45471ed-7d16-4778-a876-17df19abdd93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6a176d73-6ba2-4478-a1e9-713362e435d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_StockholdersEquity_6a176d73-6ba2-4478-a1e9-713362e435d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d5769efa-8dc5-4c21-9242-5179e9330e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_NetIncomeLoss_d5769efa-8dc5-4c21-9242-5179e9330e12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1aeea1de-f5dd-4458-a620-cdef4764ddec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1aeea1de-f5dd-4458-a620-cdef4764ddec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_be135300-4ece-4ef9-ab8c-8a53bd430dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_be135300-4ece-4ef9-ab8c-8a53bd430dc7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_71640c7b-a5ef-4472-aceb-9325efad4eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_71640c7b-a5ef-4472-aceb-9325efad4eb8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_aad37ea4-f6bb-4ff7-b554-1a9d648de648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_aad37ea4-f6bb-4ff7-b554-1a9d648de648" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_38015865-a46d-4edb-a991-f5343e83843e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_DividendsCommonStockCash_38015865-a46d-4edb-a991-f5343e83843e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b0e7a137-c3f8-4144-a25c-912add1910c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b0e7a137-c3f8-4144-a25c-912add1910c2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_64dd2553-a6c5-4a27-9da0-b97977d92cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_17d0f890-559c-4bad-96b7-3f6c74eb8061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7f7e0aff-1c7c-4bf6-9703-7cfd84e6aeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_45f11181-d22a-4f53-bb11-45902080e625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_58fe2ea8-dd36-4897-907f-d2ddcdae028f" xlink:to="loc_us-gaap_StatementTable_45f11181-d22a-4f53-bb11-45902080e625" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3a840a72-859d-4e71-959e-0100eeb1556e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_45f11181-d22a-4f53-bb11-45902080e625" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3a840a72-859d-4e71-959e-0100eeb1556e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3a840a72-859d-4e71-959e-0100eeb1556e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a840a72-859d-4e71-959e-0100eeb1556e" xlink:to="loc_us-gaap_EquityComponentDomain_3a840a72-859d-4e71-959e-0100eeb1556e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a840a72-859d-4e71-959e-0100eeb1556e" xlink:to="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f466aed5-aaf8-4d33-a11f-ba51744fda9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:to="loc_us-gaap_CommonStockMember_f466aed5-aaf8-4d33-a11f-ba51744fda9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_770e864c-b034-4018-b171-07bfab4a803a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_770e864c-b034-4018-b171-07bfab4a803a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_fb4e185a-8554-4358-868c-9dcbe346f775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:to="loc_us-gaap_TreasuryStockCommonMember_fb4e185a-8554-4358-868c-9dcbe346f775" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_316c8be5-9a7d-4184-877c-55129fbf8e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:to="loc_us-gaap_RetainedEarningsMember_316c8be5-9a7d-4184-877c-55129fbf8e1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6603063e-d888-47f1-afd4-5012a640f864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6603063e-d888-47f1-afd4-5012a640f864" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5472a847-7c61-4ac2-a295-18497318d2ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_45f11181-d22a-4f53-bb11-45902080e625" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5472a847-7c61-4ac2-a295-18497318d2ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5472a847-7c61-4ac2-a295-18497318d2ce_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5472a847-7c61-4ac2-a295-18497318d2ce" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5472a847-7c61-4ac2-a295-18497318d2ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71f9420a-fac6-4425-9aca-870cf9d266a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5472a847-7c61-4ac2-a295-18497318d2ce" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71f9420a-fac6-4425-9aca-870cf9d266a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a19963b4-0628-4d5f-b1ab-ca0e2434da6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71f9420a-fac6-4425-9aca-870cf9d266a7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a19963b4-0628-4d5f-b1ab-ca0e2434da6a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="extended" id="i7d5affa474704e84b8ad5f8836dcdecc_BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5571fde1-079d-4302-8fe5-a0497e59a03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d530369c-6160-4392-97de-812dd8bad8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5571fde1-079d-4302-8fe5-a0497e59a03c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d530369c-6160-4392-97de-812dd8bad8dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4f14e9d6-b005-497c-bca6-90cb415a8572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5571fde1-079d-4302-8fe5-a0497e59a03c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4f14e9d6-b005-497c-bca6-90cb415a8572" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_445fde7c-70de-4161-b56f-a749c90c4140" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4f14e9d6-b005-497c-bca6-90cb415a8572" xlink:to="loc_srt_RangeAxis_445fde7c-70de-4161-b56f-a749c90c4140" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_445fde7c-70de-4161-b56f-a749c90c4140_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_445fde7c-70de-4161-b56f-a749c90c4140" xlink:to="loc_srt_RangeMember_445fde7c-70de-4161-b56f-a749c90c4140_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8cc8a4b0-bb46-46fd-bb43-77f4db869166" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_445fde7c-70de-4161-b56f-a749c90c4140" xlink:to="loc_srt_RangeMember_8cc8a4b0-bb46-46fd-bb43-77f4db869166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f109426d-a658-4c32-8cc6-17816654c4b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8cc8a4b0-bb46-46fd-bb43-77f4db869166" xlink:to="loc_srt_MinimumMember_f109426d-a658-4c32-8cc6-17816654c4b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2f8ce81b-38ef-4ed9-8643-417506f3ea2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8cc8a4b0-bb46-46fd-bb43-77f4db869166" xlink:to="loc_srt_MaximumMember_2f8ce81b-38ef-4ed9-8643-417506f3ea2a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueNarrativeDetails" xlink:type="extended" id="i691f02c84ba44dc788ff36a1c67e7ae0_RevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_60945ef2-49c9-473b-b89b-baffa9a94bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_60945ef2-49c9-473b-b89b-baffa9a94bb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6d8c0d5e-33c2-4148-9e61-240185642862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6d8c0d5e-33c2-4148-9e61-240185642862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_e66bc6de-6e9b-406b-b6a4-cab2fec5ab26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_e66bc6de-6e9b-406b-b6a4-cab2fec5ab26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_58c176fd-275b-48fc-b7a6-b0f9d62fbaf0" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_58c176fd-275b-48fc-b7a6-b0f9d62fbaf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome_31742ad6-f1d4-4d75-9a8f-217addef65cf" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome_31742ad6-f1d4-4d75-9a8f-217addef65cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2ea43aa3-e3a9-4cd8-bd95-7110fe61946b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2ea43aa3-e3a9-4cd8-bd95-7110fe61946b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f463e8fe-62f6-4d5a-afb7-71167650c32a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f463e8fe-62f6-4d5a-afb7-71167650c32a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4ceed61c-166a-433a-b358-1c8358915615" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f463e8fe-62f6-4d5a-afb7-71167650c32a" xlink:to="loc_srt_ProductOrServiceAxis_4ceed61c-166a-433a-b358-1c8358915615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4ceed61c-166a-433a-b358-1c8358915615_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4ceed61c-166a-433a-b358-1c8358915615" xlink:to="loc_srt_ProductsAndServicesDomain_4ceed61c-166a-433a-b358-1c8358915615_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e1310c92-efa7-4480-ad28-1f5d8f01d95d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4ceed61c-166a-433a-b358-1c8358915615" xlink:to="loc_srt_ProductsAndServicesDomain_e1310c92-efa7-4480-ad28-1f5d8f01d95d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_d84c0f1d-6efd-4c07-a752-e1f78f4d1a07" xlink:href="wst-20221231.xsd#wst_SmartDoseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e1310c92-efa7-4480-ad28-1f5d8f01d95d" xlink:to="loc_wst_SmartDoseMember_d84c0f1d-6efd-4c07-a752-e1f78f4d1a07" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#RevenueRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended" id="i1352280bf8f6482fb5502798de18a879_RevenueRevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_362e28c7-d0c3-49b6-8826-377a5da470e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_57757c56-0789-4a26-b35b-ee3c744719f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_362e28c7-d0c3-49b6-8826-377a5da470e0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_57757c56-0789-4a26-b35b-ee3c744719f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_362e28c7-d0c3-49b6-8826-377a5da470e0" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ec7e2ec7-e03e-4446-9345-c1d337187281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ec7e2ec7-e03e-4446-9345-c1d337187281" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ec7e2ec7-e03e-4446-9345-c1d337187281_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ec7e2ec7-e03e-4446-9345-c1d337187281" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ec7e2ec7-e03e-4446-9345-c1d337187281_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3a5a9561-2d2d-49c8-bfee-c5fa7f7e88cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ec7e2ec7-e03e-4446-9345-c1d337187281" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3a5a9561-2d2d-49c8-bfee-c5fa7f7e88cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_4a79d088-f56d-4bb2-90c3-c40ded23c55f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3a5a9561-2d2d-49c8-bfee-c5fa7f7e88cf" xlink:to="loc_us-gaap_SalesRevenueNetMember_4a79d088-f56d-4bb2-90c3-c40ded23c55f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4aa50b30-6b98-409c-8e85-7874c1f04b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4aa50b30-6b98-409c-8e85-7874c1f04b5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4aa50b30-6b98-409c-8e85-7874c1f04b5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4aa50b30-6b98-409c-8e85-7874c1f04b5d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4aa50b30-6b98-409c-8e85-7874c1f04b5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7164a53b-1034-4dcb-8efe-9e4e2d294783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4aa50b30-6b98-409c-8e85-7874c1f04b5d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7164a53b-1034-4dcb-8efe-9e4e2d294783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_20aaa984-215b-44e3-8d71-3da270dfe42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7164a53b-1034-4dcb-8efe-9e4e2d294783" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_20aaa984-215b-44e3-8d71-3da270dfe42b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_45d82017-9639-4e54-a3b6-f5627eb603f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7164a53b-1034-4dcb-8efe-9e4e2d294783" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_45d82017-9639-4e54-a3b6-f5627eb603f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_a812a001-80a7-403c-b0cb-0accc8e10087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7164a53b-1034-4dcb-8efe-9e4e2d294783" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_a812a001-80a7-403c-b0cb-0accc8e10087" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_456d2bf7-283e-4f3d-a40c-aa7c80374361" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_srt_MajorCustomersAxis_456d2bf7-283e-4f3d-a40c-aa7c80374361" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_456d2bf7-283e-4f3d-a40c-aa7c80374361_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_456d2bf7-283e-4f3d-a40c-aa7c80374361" xlink:to="loc_srt_NameOfMajorCustomerDomain_456d2bf7-283e-4f3d-a40c-aa7c80374361_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_456d2bf7-283e-4f3d-a40c-aa7c80374361" xlink:to="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember_2bc3a4c1-c1e3-4a98-8282-f1464fc1d6df" xlink:href="wst-20221231.xsd#wst_BiologicsCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:to="loc_wst_BiologicsCustomersMember_2bc3a4c1-c1e3-4a98-8282-f1464fc1d6df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember_d3cb25d9-327c-4518-9a0f-2b75b6b4b5f9" xlink:href="wst-20221231.xsd#wst_GenericsCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:to="loc_wst_GenericsCustomersMember_d3cb25d9-327c-4518-9a0f-2b75b6b4b5f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember_e4b2a989-e0f1-4a20-a1f8-9723cc79ecdc" xlink:href="wst-20221231.xsd#wst_PharmaCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:to="loc_wst_PharmaCustomersMember_e4b2a989-e0f1-4a20-a1f8-9723cc79ecdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember_e898244b-12d9-4227-a968-67c99083d413" xlink:href="wst-20221231.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:to="loc_wst_ContractManufacturedCustomersMember_e898244b-12d9-4227-a968-67c99083d413" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_61c15810-4872-4181-b838-9b615ebadf67" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_srt_ProductOrServiceAxis_61c15810-4872-4181-b838-9b615ebadf67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_61c15810-4872-4181-b838-9b615ebadf67_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_61c15810-4872-4181-b838-9b615ebadf67" xlink:to="loc_srt_ProductsAndServicesDomain_61c15810-4872-4181-b838-9b615ebadf67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_61c15810-4872-4181-b838-9b615ebadf67" xlink:to="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductComponentsMember_bc2e2563-ec70-43f1-a6b3-6feb0af419a7" xlink:href="wst-20221231.xsd#wst_HighValueProductComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:to="loc_wst_HighValueProductComponentsMember_bc2e2563-ec70-43f1-a6b3-6feb0af419a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductDeliveryDevicesMember_2c830d43-f9b2-43da-a58e-bf253445ad02" xlink:href="wst-20221231.xsd#wst_HighValueProductDeliveryDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:to="loc_wst_HighValueProductDeliveryDevicesMember_2c830d43-f9b2-43da-a58e-bf253445ad02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember_871aa0e3-ef05-4dbb-ba80-f3f2dd217b8c" xlink:href="wst-20221231.xsd#wst_StandardPackagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:to="loc_wst_StandardPackagingMember_871aa0e3-ef05-4dbb-ba80-f3f2dd217b8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_cf83bfb6-1dee-483b-bf18-5a978b7c35f8" xlink:href="wst-20221231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:to="loc_wst_ContractManufacturedProductsMember_cf83bfb6-1dee-483b-bf18-5a978b7c35f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_abd1b3e4-8d2b-47c2-ba82-4565ffa6e27f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_srt_StatementGeographicalAxis_abd1b3e4-8d2b-47c2-ba82-4565ffa6e27f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_abd1b3e4-8d2b-47c2-ba82-4565ffa6e27f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_abd1b3e4-8d2b-47c2-ba82-4565ffa6e27f" xlink:to="loc_srt_SegmentGeographicalDomain_abd1b3e4-8d2b-47c2-ba82-4565ffa6e27f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5860750e-f92f-4249-9257-5d47d442f358" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_abd1b3e4-8d2b-47c2-ba82-4565ffa6e27f" xlink:to="loc_srt_SegmentGeographicalDomain_5860750e-f92f-4249-9257-5d47d442f358" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_ab60cdc6-27f9-4482-9cd7-d6bc5f51ec92" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5860750e-f92f-4249-9257-5d47d442f358" xlink:to="loc_srt_AmericasMember_ab60cdc6-27f9-4482-9cd7-d6bc5f51ec92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_b70d4bde-7c2d-4a96-99d2-d16b2dc1c861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5860750e-f92f-4249-9257-5d47d442f358" xlink:to="loc_us-gaap_EMEAMember_b70d4bde-7c2d-4a96-99d2-d16b2dc1c861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_fc4e30bc-316f-4651-b279-b564ef7b7d8a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5860750e-f92f-4249-9257-5d47d442f358" xlink:to="loc_srt_AsiaPacificMember_fc4e30bc-316f-4651-b279-b564ef7b7d8a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#NetIncomePerShareNarrativesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails" xlink:type="extended" id="i0328f64d2abd46828a38d1724a3896f9_NetIncomePerShareNarrativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d09aed9-5126-4c17-9aff-0a171011bef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d09aed9-5126-4c17-9aff-0a171011bef6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_5d18d21d-e894-4983-9fc5-a68da598ca2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_5d18d21d-e894-4983-9fc5-a68da598ca2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9c7a091a-e284-4863-a8b5-9868866f1bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9c7a091a-e284-4863-a8b5-9868866f1bc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9a77536f-23be-4df5-a5a0-fe41ba95f4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9a77536f-23be-4df5-a5a0-fe41ba95f4da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_b9e4c627-9688-43dc-99d6-89161765b371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_b9e4c627-9688-43dc-99d6-89161765b371" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_82208c5c-7b1c-482c-a487-d75cdfc57400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_82208c5c-7b1c-482c-a487-d75cdfc57400" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_dc107d8c-d7ec-48ff-a493-2c35d8a25f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_82208c5c-7b1c-482c-a487-d75cdfc57400" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_dc107d8c-d7ec-48ff-a493-2c35d8a25f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_dc107d8c-d7ec-48ff-a493-2c35d8a25f97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_dc107d8c-d7ec-48ff-a493-2c35d8a25f97" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_dc107d8c-d7ec-48ff-a493-2c35d8a25f97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_dcf09c86-cbe4-4295-88ad-34e4d6c2f82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_dc107d8c-d7ec-48ff-a493-2c35d8a25f97" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_dcf09c86-cbe4-4295-88ad-34e4d6c2f82f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dde84d79-50ad-4f8c-be7d-1dd149edb244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_dcf09c86-cbe4-4295-88ad-34e4d6c2f82f" xlink:to="loc_us-gaap_SubsequentEventMember_dde84d79-50ad-4f8c-be7d-1dd149edb244" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="extended" id="i9d53d0fa8fd945cba8bc913cd14dfbd8_PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7b42169-1ead-4867-9757-16737aef26df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ac088f4a-e122-4c45-bf34-7c5a90cb8376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7b42169-1ead-4867-9757-16737aef26df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ac088f4a-e122-4c45-bf34-7c5a90cb8376" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_928d4db0-bb8f-4748-bff5-1cf939ffa4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7b42169-1ead-4867-9757-16737aef26df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_928d4db0-bb8f-4748-bff5-1cf939ffa4a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0def709f-a09c-4a46-b3bb-55bf479adbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7b42169-1ead-4867-9757-16737aef26df" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0def709f-a09c-4a46-b3bb-55bf479adbfb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3865e130-97a1-4870-a406-4b37a43caa83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0def709f-a09c-4a46-b3bb-55bf479adbfb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3865e130-97a1-4870-a406-4b37a43caa83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3865e130-97a1-4870-a406-4b37a43caa83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3865e130-97a1-4870-a406-4b37a43caa83" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3865e130-97a1-4870-a406-4b37a43caa83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3865e130-97a1-4870-a406-4b37a43caa83" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_e8fc7dab-ad51-4ee5-8aef-5c0d8af1dbce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_us-gaap_LandMember_e8fc7dab-ad51-4ee5-8aef-5c0d8af1dbce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_a3f81262-bbff-4271-a195-8a4670d23be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_a3f81262-bbff-4271-a195-8a4670d23be0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_10edfc35-9ce3-4478-a8bd-94cea997e353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_10edfc35-9ce3-4478-a8bd-94cea997e353" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_1f2db4e1-8d7d-491f-9691-e29ed45a579a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ToolsDiesAndMoldsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_us-gaap_ToolsDiesAndMoldsMember_1f2db4e1-8d7d-491f-9691-e29ed45a579a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ComputerHardwareAndSoftwareMember_395ed3ee-2cf9-4b4b-8eb8-cdae0cfa7897" xlink:href="wst-20221231.xsd#wst_ComputerHardwareAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_wst_ComputerHardwareAndSoftwareMember_395ed3ee-2cf9-4b4b-8eb8-cdae0cfa7897" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_802a9406-206e-4885-b380-6db98ee98ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_us-gaap_ConstructionInProgressMember_802a9406-206e-4885-b380-6db98ee98ed1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6dc10a4a-d7dc-4024-81dc-a73fca7a1fd5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0def709f-a09c-4a46-b3bb-55bf479adbfb" xlink:to="loc_srt_RangeAxis_6dc10a4a-d7dc-4024-81dc-a73fca7a1fd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6dc10a4a-d7dc-4024-81dc-a73fca7a1fd5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6dc10a4a-d7dc-4024-81dc-a73fca7a1fd5" xlink:to="loc_srt_RangeMember_6dc10a4a-d7dc-4024-81dc-a73fca7a1fd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17abdd33-a994-4412-8267-9f43e8763628" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6dc10a4a-d7dc-4024-81dc-a73fca7a1fd5" xlink:to="loc_srt_RangeMember_17abdd33-a994-4412-8267-9f43e8763628" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e22484c3-3c61-4682-8dbc-8c1b648750e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_17abdd33-a994-4412-8267-9f43e8763628" xlink:to="loc_srt_MinimumMember_e22484c3-3c61-4682-8dbc-8c1b648750e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f98d59a3-5bcf-41ad-903a-908d5963f4af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_17abdd33-a994-4412-8267-9f43e8763628" xlink:to="loc_srt_MaximumMember_f98d59a3-5bcf-41ad-903a-908d5963f4af" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i81fa2b35692f41518ff8fdc2f2e29764_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm_a454961c-ee91-40c9-9bb7-28d0710e4094" xlink:href="wst-20221231.xsd#wst_LesseeOperatingLeaseOptionToTerminateTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm_a454961c-ee91-40c9-9bb7-28d0710e4094" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_03cd5c39-02e7-4d41-9dd0-ff5fb21dfbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_us-gaap_FinanceLeaseLiability_03cd5c39-02e7-4d41-9dd0-ff5fb21dfbf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_aeee950e-e4b3-4f70-aa37-3729e2e7cec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_aeee950e-e4b3-4f70-aa37-3729e2e7cec6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9f1c3890-2081-4193-ba34-ab5f8cdfce73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9f1c3890-2081-4193-ba34-ab5f8cdfce73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b1360514-6dc2-45b7-8546-496b7d2083dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b1360514-6dc2-45b7-8546-496b7d2083dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ee6b1b4b-97f6-4166-822a-b27bf10bed66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ee6b1b4b-97f6-4166-822a-b27bf10bed66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_18c7cf21-e2d6-4f4c-9c7d-031c7d01761c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ee6b1b4b-97f6-4166-822a-b27bf10bed66" xlink:to="loc_srt_RangeAxis_18c7cf21-e2d6-4f4c-9c7d-031c7d01761c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18c7cf21-e2d6-4f4c-9c7d-031c7d01761c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_18c7cf21-e2d6-4f4c-9c7d-031c7d01761c" xlink:to="loc_srt_RangeMember_18c7cf21-e2d6-4f4c-9c7d-031c7d01761c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0521e6af-5fe3-45d0-9021-f810da4b494a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_18c7cf21-e2d6-4f4c-9c7d-031c7d01761c" xlink:to="loc_srt_RangeMember_0521e6af-5fe3-45d0-9021-f810da4b494a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_15641509-35b5-475c-a857-f453fe1a9b2e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0521e6af-5fe3-45d0-9021-f810da4b494a" xlink:to="loc_srt_MaximumMember_15641509-35b5-475c-a857-f453fe1a9b2e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#AffiliatedCompaniesScheduleofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails" xlink:type="extended" id="ifc3cdd1c2a834054b58ef659ba7e1c34_AffiliatedCompaniesScheduleofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8561cc81-8cf0-4a4d-aeda-b78633e78a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_58a8b9fe-f5e0-46e1-850e-a8959f4e4327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8561cc81-8cf0-4a4d-aeda-b78633e78a8c" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_58a8b9fe-f5e0-46e1-850e-a8959f4e4327" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_be89ef48-ff94-4aad-ba3d-c523fcc5c22d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8561cc81-8cf0-4a4d-aeda-b78633e78a8c" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_be89ef48-ff94-4aad-ba3d-c523fcc5c22d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_119e6099-770e-487a-901d-d6836505a7a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_be89ef48-ff94-4aad-ba3d-c523fcc5c22d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_119e6099-770e-487a-901d-d6836505a7a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_119e6099-770e-487a-901d-d6836505a7a1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_119e6099-770e-487a-901d-d6836505a7a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_119e6099-770e-487a-901d-d6836505a7a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_119e6099-770e-487a-901d-d6836505a7a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WestCompanyMexicoSADeCVMember_6cb0ff4c-e2c7-4635-9f96-69e7c9f88759" xlink:href="wst-20221231.xsd#wst_WestCompanyMexicoSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:to="loc_wst_WestCompanyMexicoSADeCVMember_6cb0ff4c-e2c7-4635-9f96-69e7c9f88759" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AluplastSADeCVMember_b045f83a-46d6-464c-b6ad-a41896d0e5cc" xlink:href="wst-20221231.xsd#wst_AluplastSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:to="loc_wst_AluplastSADeCVMember_b045f83a-46d6-464c-b6ad-a41896d0e5cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaTapSADeCVMember_4cde6062-1a16-4bf1-ab68-2143647854bf" xlink:href="wst-20221231.xsd#wst_PharmaTapSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:to="loc_wst_PharmaTapSADeCVMember_4cde6062-1a16-4bf1-ab68-2143647854bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaRubberSADeCVMember_9f75ba2b-bc93-4993-b59a-720c00c7b8ff" xlink:href="wst-20221231.xsd#wst_PharmaRubberSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:to="loc_wst_PharmaRubberSADeCVMember_9f75ba2b-bc93-4993-b59a-720c00c7b8ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_ea4606f4-a38d-4caa-98bb-47cc7032ff4d" xlink:href="wst-20221231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_ea4606f4-a38d-4caa-98bb-47cc7032ff4d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#AffiliatedCompaniesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails" xlink:type="extended" id="i85045521605d434b98fe882d645dfb30_AffiliatedCompaniesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_0723256b-4b16-4fc4-9d83-154aacdbcd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_0723256b-4b16-4fc4-9d83-154aacdbcd69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_4b18bd61-01d8-4c93-a905-cd748da9fb67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_4b18bd61-01d8-4c93-a905-cd748da9fb67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_2e3513b2-64f9-40e0-b61c-7f88e947b3d5" xlink:href="wst-20221231.xsd#wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_2e3513b2-64f9-40e0-b61c-7f88e947b3d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_a120a8f5-a2c0-4678-8cf0-c38dd374cfa4" xlink:href="wst-20221231.xsd#wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_a120a8f5-a2c0-4678-8cf0-c38dd374cfa4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_14faee7c-22d4-4f0c-b080-08d2d990be25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_14faee7c-22d4-4f0c-b080-08d2d990be25" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesToEquityMethodInvestees_cc96316c-02b0-418d-98c2-eb0141578add" xlink:href="wst-20221231.xsd#wst_SalesToEquityMethodInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_wst_SalesToEquityMethodInvestees_cc96316c-02b0-418d-98c2-eb0141578add" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates_2b3027e7-daa2-462d-9235-eda4133cbaec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_DueFromAffiliates_2b3027e7-daa2-462d-9235-eda4133cbaec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_8034305b-5cc3-4386-838f-62c91762721c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_EquityMethodInvestments_8034305b-5cc3-4386-838f-62c91762721c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c0293baa-662a-4fec-adb1-ad1b1e1041f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c0293baa-662a-4fec-adb1-ad1b1e1041f0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1dae6deb-56ee-4ab0-b9d6-1edb90144077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1dae6deb-56ee-4ab0-b9d6-1edb90144077" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_01fe66ad-aa92-46c6-bcc3-622e6376da3d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1dae6deb-56ee-4ab0-b9d6-1edb90144077" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_01fe66ad-aa92-46c6-bcc3-622e6376da3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_01fe66ad-aa92-46c6-bcc3-622e6376da3d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_01fe66ad-aa92-46c6-bcc3-622e6376da3d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_01fe66ad-aa92-46c6-bcc3-622e6376da3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8fd0c182-05d3-4c0c-938a-ba9f205fca09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_01fe66ad-aa92-46c6-bcc3-622e6376da3d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8fd0c182-05d3-4c0c-938a-ba9f205fca09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_6edc3a61-920e-4183-8efa-6f0f1d09fec0" xlink:href="wst-20221231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8fd0c182-05d3-4c0c-938a-ba9f205fca09" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_6edc3a61-920e-4183-8efa-6f0f1d09fec0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended" id="i13ce37c389b14779aa158dea159abedf_GoodwillandIntangibleAssetsGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_b788fac7-73fe-410f-a8fd-b9551434226e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_b788fac7-73fe-410f-a8fd-b9551434226e" xlink:to="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0eecb988-173e-490b-b442-8abeb2477e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:to="loc_us-gaap_Goodwill_0eecb988-173e-490b-b442-8abeb2477e48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a6601b0c-6452-4b58-9a86-2e6703366630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a6601b0c-6452-4b58-9a86-2e6703366630" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_37368e37-97e9-4ed3-bf50-348be4815b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_37368e37-97e9-4ed3-bf50-348be4815b78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a534ec7a-187d-4021-a97c-d8bd61844ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a534ec7a-187d-4021-a97c-d8bd61844ccf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_81bfb106-c726-426c-aaad-67aa61be1f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2786fa22-3cea-44b8-b8d6-ea9d66f79bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_b788fac7-73fe-410f-a8fd-b9551434226e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2786fa22-3cea-44b8-b8d6-ea9d66f79bb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6b46a448-8efa-46e0-bd3d-bbeca6c5ea32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2786fa22-3cea-44b8-b8d6-ea9d66f79bb6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6b46a448-8efa-46e0-bd3d-bbeca6c5ea32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6b46a448-8efa-46e0-bd3d-bbeca6c5ea32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6b46a448-8efa-46e0-bd3d-bbeca6c5ea32" xlink:to="loc_us-gaap_SegmentDomain_6b46a448-8efa-46e0-bd3d-bbeca6c5ea32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_670a964b-e777-4ca6-85ff-de3b360d38af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6b46a448-8efa-46e0-bd3d-bbeca6c5ea32" xlink:to="loc_us-gaap_SegmentDomain_670a964b-e777-4ca6-85ff-de3b360d38af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_03caf10e-74de-4495-aed8-1855f2e2f7d4" xlink:href="wst-20221231.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_670a964b-e777-4ca6-85ff-de3b360d38af" xlink:to="loc_wst_ProprietaryProductsMember_03caf10e-74de-4495-aed8-1855f2e2f7d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_c69f3547-6a2b-4172-9bb9-f86bcfa12bed" xlink:href="wst-20221231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_670a964b-e777-4ca6-85ff-de3b360d38af" xlink:to="loc_wst_ContractManufacturedProductsMember_c69f3547-6a2b-4172-9bb9-f86bcfa12bed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="extended" id="i7c76458c58944c878ed2cd2f5a36bd99_GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails">
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_e5aaeecf-88c8-47f3-9cb9-01efb7f5eba4" xlink:href="wst-20221231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4ccfeb3f-5ded-4895-a31c-540fc9bd39d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_e5aaeecf-88c8-47f3-9cb9-01efb7f5eba4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4ccfeb3f-5ded-4895-a31c-540fc9bd39d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a7fe8691-b608-4955-a41c-5c20f5212f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_e5aaeecf-88c8-47f3-9cb9-01efb7f5eba4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a7fe8691-b608-4955-a41c-5c20f5212f4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7d760931-ec8c-4b7f-bd6a-da58390bf5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_e5aaeecf-88c8-47f3-9cb9-01efb7f5eba4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7d760931-ec8c-4b7f-bd6a-da58390bf5a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_92df9f3c-5662-40e7-a37f-7d4e45a0cb27" xlink:href="wst-20221231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_e5aaeecf-88c8-47f3-9cb9-01efb7f5eba4" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_92df9f3c-5662-40e7-a37f-7d4e45a0cb27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d043e550-8616-4d56-a328-4bef6493b068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_92df9f3c-5662-40e7-a37f-7d4e45a0cb27" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d043e550-8616-4d56-a328-4bef6493b068" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d043e550-8616-4d56-a328-4bef6493b068_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d043e550-8616-4d56-a328-4bef6493b068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d043e550-8616-4d56-a328-4bef6493b068_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d043e550-8616-4d56-a328-4bef6493b068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PatentsAndLicensingMember_c0853cab-e88e-44ba-8238-e259a9e844c1" xlink:href="wst-20221231.xsd#wst_PatentsAndLicensingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:to="loc_wst_PatentsAndLicensingMember_c0853cab-e88e-44ba-8238-e259a9e844c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_7376f268-c73e-4b32-b71c-5eaaef02411c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_7376f268-c73e-4b32-b71c-5eaaef02411c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_f95986ff-d5eb-4e2e-b863-6fed7bb19f18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:to="loc_us-gaap_TrademarksMember_f95986ff-d5eb-4e2e-b863-6fed7bb19f18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_66d027fd-fa0a-44fb-8053-8c4654b4e115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_66d027fd-fa0a-44fb-8053-8c4654b4e115" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_e35794d3-271a-4932-ab76-7f2a1eff63d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:to="loc_us-gaap_CustomerContractsMember_e35794d3-271a-4932-ab76-7f2a1eff63d8" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DebtScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="extended" id="i119b012da54147cc9b871fde350ebed4_DebtScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2efa19a-d26f-4644-b5e9-b72f94af953f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2efa19a-d26f-4644-b5e9-b72f94af953f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c591e546-260f-4293-b117-36edc9e0852d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c591e546-260f-4293-b117-36edc9e0852d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_ae77e9f2-926d-4daa-b616-dbd8602d9b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_ae77e9f2-926d-4daa-b616-dbd8602d9b9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_08c01db2-af16-4daf-a4fd-a4091eb16a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_LongTermDebt_08c01db2-af16-4daf-a4fd-a4091eb16a0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_042e9c32-1f4f-4834-8d59-c1fa58a9f4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_LongTermDebtCurrent_042e9c32-1f4f-4834-8d59-c1fa58a9f4a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_862dea52-2320-483b-bbc3-b5b248e2ecf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_862dea52-2320-483b-bbc3-b5b248e2ecf0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_00d50a14-fe41-40a2-a82c-a96de492bf2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_DebtInstrumentTable_00d50a14-fe41-40a2-a82c-a96de492bf2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5dad6cd0-f1a4-464a-b2f1-f01fc65fc239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_00d50a14-fe41-40a2-a82c-a96de492bf2e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5dad6cd0-f1a4-464a-b2f1-f01fc65fc239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5dad6cd0-f1a4-464a-b2f1-f01fc65fc239_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5dad6cd0-f1a4-464a-b2f1-f01fc65fc239" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5dad6cd0-f1a4-464a-b2f1-f01fc65fc239_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5dad6cd0-f1a4-464a-b2f1-f01fc65fc239" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_c56cdbaa-b42f-4928-960b-1b2bf61fdb7f" xlink:href="wst-20221231.xsd#wst_TermLoanDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:to="loc_wst_TermLoanDue2024Member_c56cdbaa-b42f-4928-960b-1b2bf61fdb7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_9773f540-10ad-49c5-b424-72cdd8b2fab8" xlink:href="wst-20221231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:to="loc_wst_SeniorNotesDue2022Member_9773f540-10ad-49c5-b424-72cdd8b2fab8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_5b7dd830-bfa0-4a20-8be9-5b7ca2a86a50" xlink:href="wst-20221231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:to="loc_wst_SeniorBNotesDue2024Member_5b7dd830-bfa0-4a20-8be9-5b7ca2a86a50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_7a4a7288-4ae7-45d2-93fc-602667a6fcc9" xlink:href="wst-20221231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:to="loc_wst_SeniorCNotesDue2027Member_7a4a7288-4ae7-45d2-93fc-602667a6fcc9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="extended" id="i0d02116f27404e1db0e4f0474dcfc034_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_a6beeb1b-dfd0-4b46-ab58-befec93b798b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_a6beeb1b-dfd0-4b46-ab58-befec93b798b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_cb7aefbb-0eee-452b-93b6-53d3f6198ea6" xlink:href="wst-20221231.xsd#wst_CreditFacilityIsAvailableForSwingLineLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_cb7aefbb-0eee-452b-93b6-53d3f6198ea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditAvailableForTheIssuanceOfLettersOfCredit_37a6c62a-4f1a-4464-a006-4dd0f1304515" xlink:href="wst-20221231.xsd#wst_CreditAvailableForTheIssuanceOfLettersOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_CreditAvailableForTheIssuanceOfLettersOfCredit_37a6c62a-4f1a-4464-a006-4dd0f1304515" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_c2f8924c-aeda-415a-9198-11d3ffb09fa1" xlink:href="wst-20221231.xsd#wst_LineOfCreditFacilityAdditionalBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_c2f8924c-aeda-415a-9198-11d3ffb09fa1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod_db88a5b1-801c-44fe-a181-5cf078972832" xlink:href="wst-20221231.xsd#wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod_db88a5b1-801c-44fe-a181-5cf078972832" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4a0c4841-119e-49d5-9ba3-f637f592b53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4a0c4841-119e-49d5-9ba3-f637f592b53d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentApplicableMarginRatio_51700be2-3987-4159-ac4c-2eade81abbc2" xlink:href="wst-20221231.xsd#wst_DebtInstrumentApplicableMarginRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentApplicableMarginRatio_51700be2-3987-4159-ac4c-2eade81abbc2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentRatioOfDebtToEBITDA_5821fe9c-121c-491a-8d6d-700cdf5c86ad" xlink:href="wst-20221231.xsd#wst_DebtInstrumentRatioOfDebtToEBITDA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentRatioOfDebtToEBITDA_5821fe9c-121c-491a-8d6d-700cdf5c86ad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded_8f4dba32-9f51-4135-b9cc-15c3b43f338c" xlink:href="wst-20221231.xsd#wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded_8f4dba32-9f51-4135-b9cc-15c3b43f338c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition_f3daeff7-87fd-41e8-8424-305b1e2247f0" xlink:href="wst-20221231.xsd#wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition_f3daeff7-87fd-41e8-8424-305b1e2247f0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition_d8f49f0a-0184-4f81-bdd3-e93505c934d8" xlink:href="wst-20221231.xsd#wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition_d8f49f0a-0184-4f81-bdd3-e93505c934d8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_c613677e-60f6-476a-a98d-06af08dc1fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_c613677e-60f6-476a-a98d-06af08dc1fe6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_4bf244da-cd06-4678-9fac-4bff803f7f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LongTermLineOfCredit_4bf244da-cd06-4678-9fac-4bff803f7f23" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e92912da-6fa7-4f75-a295-3efc18699066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LineOfCredit_e92912da-6fa7-4f75-a295-3efc18699066" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_84f92389-ca38-425c-9a62-7d5c8ac81f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_84f92389-ca38-425c-9a62-7d5c8ac81f2a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_550d9019-f40b-46c0-9172-b5c0ba60492d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_550d9019-f40b-46c0-9172-b5c0ba60492d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a67946bb-cdb5-423b-8e64-18691de8fdef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a67946bb-cdb5-423b-8e64-18691de8fdef" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_97de6603-6536-49bc-a679-6821044d3830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LongTermDebtCurrent_97de6603-6536-49bc-a679-6821044d3830" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f309e347-dffd-468e-8100-e68720b80f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f309e347-dffd-468e-8100-e68720b80f50" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfTranches_2289eccf-a6b4-4e8b-949b-96490f09b563" xlink:href="wst-20221231.xsd#wst_DebtInstrumentNumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentNumberOfTranches_2289eccf-a6b4-4e8b-949b-96490f09b563" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_623667a2-2a22-4e21-a22e-089c4c8a3286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_623667a2-2a22-4e21-a22e-089c4c8a3286" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_740ddddc-e9e1-476a-be94-7a8c8dfb4721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_740ddddc-e9e1-476a-be94-7a8c8dfb4721" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_75640144-a087-4526-9226-23567d9ac2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_75640144-a087-4526-9226-23567d9ac2d2" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_54deb7f2-73a3-4714-813f-5c6ab565b996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_InterestExpenseDebt_54deb7f2-73a3-4714-813f-5c6ab565b996" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_254dddc8-304a-4d0d-9123-ca77a1a2642a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_254dddc8-304a-4d0d-9123-ca77a1a2642a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_356aa0f2-15c1-4c86-af45-25f606a7f150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_356aa0f2-15c1-4c86-af45-25f606a7f150" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3e632d63-5ef9-4f81-9abf-3e1e14f4087a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3e632d63-5ef9-4f81-9abf-3e1e14f4087a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f41f7ed0-4cde-40ce-894e-e556667c58a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f41f7ed0-4cde-40ce-894e-e556667c58a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_625279fa-50b2-4531-ad44-77e1a96c7252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_625279fa-50b2-4531-ad44-77e1a96c7252" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_f6d0a92e-53b3-40d0-a9bc-5c089e396edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_f6d0a92e-53b3-40d0-a9bc-5c089e396edd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9e84cf27-974e-4bc2-87d2-700a76ce120f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9e84cf27-974e-4bc2-87d2-700a76ce120f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9e84cf27-974e-4bc2-87d2-700a76ce120f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9e84cf27-974e-4bc2-87d2-700a76ce120f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9e84cf27-974e-4bc2-87d2-700a76ce120f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_58035808-8323-4051-bc21-0a2317aee0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9e84cf27-974e-4bc2-87d2-700a76ce120f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_58035808-8323-4051-bc21-0a2317aee0b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_6863308e-1d14-49f7-b6e0-7fa0309b986e" xlink:href="wst-20221231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_58035808-8323-4051-bc21-0a2317aee0b6" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_6863308e-1d14-49f7-b6e0-7fa0309b986e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_309571a1-c44c-429c-a1f5-dc9d0db91d83" xlink:href="wst-20221231.xsd#wst_TermLoanDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_58035808-8323-4051-bc21-0a2317aee0b6" xlink:to="loc_wst_TermLoanDue2024Member_309571a1-c44c-429c-a1f5-dc9d0db91d83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_85dcd5af-feab-41f6-9205-081867e0e77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_58035808-8323-4051-bc21-0a2317aee0b6" xlink:to="loc_us-gaap_SeniorNotesMember_85dcd5af-feab-41f6-9205-081867e0e77a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_13c8cf3d-18c0-4707-88fd-9406dcbc6938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_us-gaap_CreditFacilityAxis_13c8cf3d-18c0-4707-88fd-9406dcbc6938" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_13c8cf3d-18c0-4707-88fd-9406dcbc6938_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_13c8cf3d-18c0-4707-88fd-9406dcbc6938" xlink:to="loc_us-gaap_CreditFacilityDomain_13c8cf3d-18c0-4707-88fd-9406dcbc6938_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_13c8cf3d-18c0-4707-88fd-9406dcbc6938" xlink:to="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_2697b536-9088-455b-9c26-cf232af12f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_2697b536-9088-455b-9c26-cf232af12f6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember_ea73645b-7ff4-40c0-a381-7b44a670dbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:to="loc_us-gaap_ForeignLineOfCreditMember_ea73645b-7ff4-40c0-a381-7b44a670dbf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_7e552103-5fe9-489d-b259-6facd8080673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:to="loc_us-gaap_LetterOfCreditMember_7e552103-5fe9-489d-b259-6facd8080673" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2f4963c4-5b7d-499c-a6ac-df4eaf5953b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2f4963c4-5b7d-499c-a6ac-df4eaf5953b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_dc768257-e000-4a94-a42d-66a6d169a5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_us-gaap_VariableRateAxis_dc768257-e000-4a94-a42d-66a6d169a5de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_dc768257-e000-4a94-a42d-66a6d169a5de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_dc768257-e000-4a94-a42d-66a6d169a5de" xlink:to="loc_us-gaap_VariableRateDomain_dc768257-e000-4a94-a42d-66a6d169a5de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_dc768257-e000-4a94-a42d-66a6d169a5de" xlink:to="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ApplicableMarginMember_f5666e9f-dfa8-4bee-bf09-10a2e49833d5" xlink:href="wst-20221231.xsd#wst_ApplicableMarginMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:to="loc_wst_ApplicableMarginMember_f5666e9f-dfa8-4bee-bf09-10a2e49833d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_0d4d64d2-dd59-42e9-9823-3ca1582d2e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_0d4d64d2-dd59-42e9-9823-3ca1582d2e31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_5afb3491-2eaf-43c7-91f2-012f4dcd0d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_5afb3491-2eaf-43c7-91f2-012f4dcd0d95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_de54364f-ec5e-4684-bcb9-1e4b15d8ee63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:to="loc_us-gaap_BaseRateMember_de54364f-ec5e-4684-bcb9-1e4b15d8ee63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3aa4e41e-40f7-4d4e-b0a1-16e39880f5c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_srt_RangeAxis_3aa4e41e-40f7-4d4e-b0a1-16e39880f5c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3aa4e41e-40f7-4d4e-b0a1-16e39880f5c7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3aa4e41e-40f7-4d4e-b0a1-16e39880f5c7" xlink:to="loc_srt_RangeMember_3aa4e41e-40f7-4d4e-b0a1-16e39880f5c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd732d75-f69f-4b7a-b883-711ae7a51473" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3aa4e41e-40f7-4d4e-b0a1-16e39880f5c7" xlink:to="loc_srt_RangeMember_dd732d75-f69f-4b7a-b883-711ae7a51473" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6982338e-2c24-4446-a7bd-cd4f34264104" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dd732d75-f69f-4b7a-b883-711ae7a51473" xlink:to="loc_srt_MinimumMember_6982338e-2c24-4446-a7bd-cd4f34264104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_746a2dcf-d8b5-4ff6-9662-79c926399fe7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dd732d75-f69f-4b7a-b883-711ae7a51473" xlink:to="loc_srt_MaximumMember_746a2dcf-d8b5-4ff6-9662-79c926399fe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e40f0474-faf9-4228-8e4b-2b5c85220e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_us-gaap_DebtInstrumentAxis_e40f0474-faf9-4228-8e4b-2b5c85220e47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e40f0474-faf9-4228-8e4b-2b5c85220e47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e40f0474-faf9-4228-8e4b-2b5c85220e47" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e40f0474-faf9-4228-8e4b-2b5c85220e47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9dbc00e3-9e5f-4739-8dbf-633299aff83b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e40f0474-faf9-4228-8e4b-2b5c85220e47" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9dbc00e3-9e5f-4739-8dbf-633299aff83b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_77f0aa17-a55c-43e7-b04b-804aab49189c" xlink:href="wst-20221231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9dbc00e3-9e5f-4739-8dbf-633299aff83b" xlink:to="loc_wst_SeniorNotesDue2022Member_77f0aa17-a55c-43e7-b04b-804aab49189c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_7e922f7c-348f-4f5c-bf67-b48d8630a4cf" xlink:href="wst-20221231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9dbc00e3-9e5f-4739-8dbf-633299aff83b" xlink:to="loc_wst_SeniorBNotesDue2024Member_7e922f7c-348f-4f5c-bf67-b48d8630a4cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_2390b179-a69c-4d94-84b0-bddbc60024f4" xlink:href="wst-20221231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9dbc00e3-9e5f-4739-8dbf-633299aff83b" xlink:to="loc_wst_SeniorCNotesDue2027Member_2390b179-a69c-4d94-84b0-bddbc60024f4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DerivativeFinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="extended" id="iabc01c49e89d44a0a6afc855d273bd41_DerivativeFinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e5c6fa33-2c19-4d69-a63a-32bd56509481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e5c6fa33-2c19-4d69-a63a-32bd56509481" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_247d6aff-ed16-4809-b4bf-6d46dc5c8c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeTermOfContract_247d6aff-ed16-4809-b4bf-6d46dc5c8c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_d325ee78-3603-4773-b2a8-7128d7229baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNonmonetaryNotionalAmountVolume"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_d325ee78-3603-4773-b2a8-7128d7229baf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_c22334ae-8b05-4df0-bb82-4d812cb207db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNonmonetaryNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_c22334ae-8b05-4df0-bb82-4d812cb207db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_037cd2ba-dc5c-446b-8857-9b1c3f7219a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_037cd2ba-dc5c-446b-8857-9b1c3f7219a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_7aba03d2-d5c3-47a8-b8e6-5d0fe46d0167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_7aba03d2-d5c3-47a8-b8e6-5d0fe46d0167" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_665111d6-ece7-4c0b-8c3c-1dbcb916e79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_665111d6-ece7-4c0b-8c3c-1dbcb916e79e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_665111d6-ece7-4c0b-8c3c-1dbcb916e79e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_665111d6-ece7-4c0b-8c3c-1dbcb916e79e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_665111d6-ece7-4c0b-8c3c-1dbcb916e79e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_665111d6-ece7-4c0b-8c3c-1dbcb916e79e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_52f3086b-2b79-45f5-89a1-51cbebfc66a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:to="loc_us-gaap_ForwardContractsMember_52f3086b-2b79-45f5-89a1-51cbebfc66a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_27df820e-16e4-4a0e-b4c9-5b8dac3ef7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_27df820e-16e4-4a0e-b4c9-5b8dac3ef7a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_a974d4af-f4dc-4c6f-a55b-0e8940c24450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_a974d4af-f4dc-4c6f-a55b-0e8940c24450" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember_7c72c9e0-2f15-4e07-8cf0-7619833c3ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:to="loc_us-gaap_OptionMember_7c72c9e0-2f15-4e07-8cf0-7619833c3ec7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_b97c6dd6-c81b-419e-a070-080edc5a3f87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:to="loc_srt_CurrencyAxis_b97c6dd6-c81b-419e-a070-080edc5a3f87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_b97c6dd6-c81b-419e-a070-080edc5a3f87_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_b97c6dd6-c81b-419e-a070-080edc5a3f87" xlink:to="loc_currency_AllCurrenciesDomain_b97c6dd6-c81b-419e-a070-080edc5a3f87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_0f400229-519d-4e75-bfa6-dd5d35ce972a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_b97c6dd6-c81b-419e-a070-080edc5a3f87" xlink:to="loc_currency_AllCurrenciesDomain_0f400229-519d-4e75-bfa6-dd5d35ce972a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_8fb1e92e-ac5b-4730-a23c-c514d1f694ca" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_0f400229-519d-4e75-bfa6-dd5d35ce972a" xlink:to="loc_currency_SGD_8fb1e92e-ac5b-4730-a23c-c514d1f694ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_b481b08d-0344-4fc6-a1a8-5238aa7756da" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_0f400229-519d-4e75-bfa6-dd5d35ce972a" xlink:to="loc_currency_USD_b481b08d-0344-4fc6-a1a8-5238aa7756da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b3b9267-51e0-452a-919b-4f1ab0ab2fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b3b9267-51e0-452a-919b-4f1ab0ab2fc2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6b3b9267-51e0-452a-919b-4f1ab0ab2fc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b3b9267-51e0-452a-919b-4f1ab0ab2fc2" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6b3b9267-51e0-452a-919b-4f1ab0ab2fc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e570c339-9f18-41aa-9a5a-696ae0b221e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b3b9267-51e0-452a-919b-4f1ab0ab2fc2" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e570c339-9f18-41aa-9a5a-696ae0b221e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_82f9b55d-be70-417d-be7c-9b27a282cdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e570c339-9f18-41aa-9a5a-696ae0b221e2" xlink:to="loc_us-gaap_FairValueHedgingMember_82f9b55d-be70-417d-be7c-9b27a282cdd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_0e497a71-6ee0-4778-86fa-fcabb09d258b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e570c339-9f18-41aa-9a5a-696ae0b221e2" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_0e497a71-6ee0-4778-86fa-fcabb09d258b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1dbf457e-7f70-4968-b19c-b433f69bd14e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:to="loc_srt_StatementScenarioAxis_1dbf457e-7f70-4968-b19c-b433f69bd14e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1dbf457e-7f70-4968-b19c-b433f69bd14e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1dbf457e-7f70-4968-b19c-b433f69bd14e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1dbf457e-7f70-4968-b19c-b433f69bd14e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_399b4320-2a30-4a8e-a765-d8ebc85d0c46" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1dbf457e-7f70-4968-b19c-b433f69bd14e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_399b4320-2a30-4a8e-a765-d8ebc85d0c46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b26c0fe7-b350-4e87-95ad-c91cc66d0aca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_399b4320-2a30-4a8e-a765-d8ebc85d0c46" xlink:to="loc_srt_ScenarioForecastMember_b26c0fe7-b350-4e87-95ad-c91cc66d0aca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="extended" id="icea96ae6ccdb48188aafdec9216ef93e_DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4be8f02a-1c2d-4e34-a0f9-004b71145cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_65ee2452-2460-4235-b2e2-ea1735f2c3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4be8f02a-1c2d-4e34-a0f9-004b71145cea" xlink:to="loc_us-gaap_DerivativeNotionalAmount_65ee2452-2460-4235-b2e2-ea1735f2c3f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_4be8f02a-1c2d-4e34-a0f9-004b71145cea" xlink:to="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_85f982f6-11aa-4866-9267-b1e6af13bf03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_85f982f6-11aa-4866-9267-b1e6af13bf03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_85f982f6-11aa-4866-9267-b1e6af13bf03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_85f982f6-11aa-4866-9267-b1e6af13bf03" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_85f982f6-11aa-4866-9267-b1e6af13bf03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9b4735a8-d850-43e6-9619-3ac822a040b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_85f982f6-11aa-4866-9267-b1e6af13bf03" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9b4735a8-d850-43e6-9619-3ac822a040b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_791628dc-2969-4921-bbd9-776678906eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9b4735a8-d850-43e6-9619-3ac822a040b1" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_791628dc-2969-4921-bbd9-776678906eb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5c0177c4-35f5-4486-a2ef-16f0d4941892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:to="loc_us-gaap_HedgingDesignationAxis_5c0177c4-35f5-4486-a2ef-16f0d4941892" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5c0177c4-35f5-4486-a2ef-16f0d4941892_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5c0177c4-35f5-4486-a2ef-16f0d4941892" xlink:to="loc_us-gaap_HedgingDesignationDomain_5c0177c4-35f5-4486-a2ef-16f0d4941892_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6f610b82-cec0-4d15-a60a-796d4ef9dacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5c0177c4-35f5-4486-a2ef-16f0d4941892" xlink:to="loc_us-gaap_HedgingDesignationDomain_6f610b82-cec0-4d15-a60a-796d4ef9dacd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c5bb7b48-2163-4ce3-9146-ecad2d5ef1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_6f610b82-cec0-4d15-a60a-796d4ef9dacd" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c5bb7b48-2163-4ce3-9146-ecad2d5ef1a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_642b560d-5970-43b4-b0cc-da484aa1a2e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:to="loc_srt_CurrencyAxis_642b560d-5970-43b4-b0cc-da484aa1a2e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_642b560d-5970-43b4-b0cc-da484aa1a2e1_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_642b560d-5970-43b4-b0cc-da484aa1a2e1" xlink:to="loc_currency_AllCurrenciesDomain_642b560d-5970-43b4-b0cc-da484aa1a2e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_584b0970-86e1-431f-90e4-0e7cffa5c3b9" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_642b560d-5970-43b4-b0cc-da484aa1a2e1" xlink:to="loc_currency_AllCurrenciesDomain_584b0970-86e1-431f-90e4-0e7cffa5c3b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_c1d517e3-6471-46e3-8c7c-f063b455e944" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_584b0970-86e1-431f-90e4-0e7cffa5c3b9" xlink:to="loc_currency_USD_c1d517e3-6471-46e3-8c7c-f063b455e944" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_991c1673-e9bf-4d21-ae73-e527846fd0ab" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_584b0970-86e1-431f-90e4-0e7cffa5c3b9" xlink:to="loc_currency_JPY_991c1673-e9bf-4d21-ae73-e527846fd0ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_4f9fd2ab-dfaf-45a4-b544-1625874e36bf" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_584b0970-86e1-431f-90e4-0e7cffa5c3b9" xlink:to="loc_currency_SGD_4f9fd2ab-dfaf-45a4-b544-1625874e36bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_af6e74eb-09fd-44ce-83f6-fd5a8aa3757d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:to="loc_us-gaap_PositionAxis_af6e74eb-09fd-44ce-83f6-fd5a8aa3757d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_af6e74eb-09fd-44ce-83f6-fd5a8aa3757d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_af6e74eb-09fd-44ce-83f6-fd5a8aa3757d" xlink:to="loc_us-gaap_PositionDomain_af6e74eb-09fd-44ce-83f6-fd5a8aa3757d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_52c6b31d-b6ac-448e-aa6d-e1e653ec35ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_af6e74eb-09fd-44ce-83f6-fd5a8aa3757d" xlink:to="loc_us-gaap_PositionDomain_52c6b31d-b6ac-448e-aa6d-e1e653ec35ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_1e1164c5-4eea-468e-83ec-27c4b82bff4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_52c6b31d-b6ac-448e-aa6d-e1e653ec35ac" xlink:to="loc_us-gaap_LongMember_1e1164c5-4eea-468e-83ec-27c4b82bff4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_645d6d91-48f3-460d-b340-19097537ca0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_52c6b31d-b6ac-448e-aa6d-e1e653ec35ac" xlink:to="loc_us-gaap_ShortMember_645d6d91-48f3-460d-b340-19097537ca0f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended" id="i7781964dfb4247f6aed3d8cc7011b9b7_DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_d8552a4b-0119-4a66-9844-dbd9084e3679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_d8552a4b-0119-4a66-9844-dbd9084e3679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_4a2e1d42-30de-450e-b9c1-db979e4bfeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_4a2e1d42-30de-450e-b9c1-db979e4bfeb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_23b0a69e-4af3-4cf6-a69f-22be6c0052b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_23b0a69e-4af3-4cf6-a69f-22be6c0052b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_8837d883-a619-439e-9976-34ef9c31ff37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_8837d883-a619-439e-9976-34ef9c31ff37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_9fb61898-163f-47cd-8971-e263b6b394c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_9fb61898-163f-47cd-8971-e263b6b394c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_bf508c32-100c-40c5-9600-b6460dc8700e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_bf508c32-100c-40c5-9600-b6460dc8700e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_62282f46-93cb-4d1f-852a-5b3f25b5f7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_62282f46-93cb-4d1f-852a-5b3f25b5f7d8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_32c5176d-c8d1-4da5-a963-456c345b99f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_32c5176d-c8d1-4da5-a963-456c345b99f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_7884d4ba-5d3e-40e6-8670-6b2444831e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_7884d4ba-5d3e-40e6-8670-6b2444831e7e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_366a2b13-0f9f-4b84-8e4f-71413670e690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_366a2b13-0f9f-4b84-8e4f-71413670e690" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ff9b7cde-6525-4ecb-b7f8-5a5eb0060465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ff9b7cde-6525-4ecb-b7f8-5a5eb0060465" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ff9b7cde-6525-4ecb-b7f8-5a5eb0060465_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ff9b7cde-6525-4ecb-b7f8-5a5eb0060465" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ff9b7cde-6525-4ecb-b7f8-5a5eb0060465_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ff9b7cde-6525-4ecb-b7f8-5a5eb0060465" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_26fa1b21-eaa5-4fac-9751-d81162dfe533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_26fa1b21-eaa5-4fac-9751-d81162dfe533" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember_0ac064f4-16e4-4052-bc59-7df575344ef1" xlink:href="wst-20221231.xsd#wst_NetSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:to="loc_wst_NetSalesMember_0ac064f4-16e4-4052-bc59-7df575344ef1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9712bb87-f3a7-4db4-ab42-3e4c0d027935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:to="loc_us-gaap_CostOfSalesMember_9712bb87-f3a7-4db4-ab42-3e4c0d027935" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_c5187e05-f831-4e92-9b64-61a1a9b09b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:to="loc_us-gaap_InterestExpenseMember_c5187e05-f831-4e92-9b64-61a1a9b09b34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09cb795a-f342-4deb-877b-a24677098d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09cb795a-f342-4deb-877b-a24677098d18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_09cb795a-f342-4deb-877b-a24677098d18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09cb795a-f342-4deb-877b-a24677098d18" xlink:to="loc_us-gaap_HedgingRelationshipDomain_09cb795a-f342-4deb-877b-a24677098d18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f5c8d9d0-450b-4351-9d31-902e4bf9a5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09cb795a-f342-4deb-877b-a24677098d18" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f5c8d9d0-450b-4351-9d31-902e4bf9a5ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c2ed2004-e8a4-4c43-bd48-a5a0415280e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f5c8d9d0-450b-4351-9d31-902e4bf9a5ff" xlink:to="loc_us-gaap_FairValueHedgingMember_c2ed2004-e8a4-4c43-bd48-a5a0415280e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_77d18d0c-87b3-40bd-b756-1d32754e959e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f5c8d9d0-450b-4351-9d31-902e4bf9a5ff" xlink:to="loc_us-gaap_CashFlowHedgingMember_77d18d0c-87b3-40bd-b756-1d32754e959e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_48e452cb-6e9b-4b1a-8010-713d3715cc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f5c8d9d0-450b-4351-9d31-902e4bf9a5ff" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_48e452cb-6e9b-4b1a-8010-713d3715cc3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_83cf23a2-738c-4aaf-b7f9-80ec2e66297f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_83cf23a2-738c-4aaf-b7f9-80ec2e66297f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_83cf23a2-738c-4aaf-b7f9-80ec2e66297f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_83cf23a2-738c-4aaf-b7f9-80ec2e66297f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_83cf23a2-738c-4aaf-b7f9-80ec2e66297f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_83cf23a2-738c-4aaf-b7f9-80ec2e66297f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b417ed4c-dc5c-4dd6-a878-3bcc69243039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b417ed4c-dc5c-4dd6-a878-3bcc69243039" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_9b7c0b48-1d2a-47a0-be4f-103c6ad79997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:to="loc_us-gaap_TreasuryLockMember_9b7c0b48-1d2a-47a0-be4f-103c6ad79997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_fef1c703-a9cf-4077-9339-1e1a5ec2e1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:to="loc_us-gaap_CurrencySwapMember_fef1c703-a9cf-4077-9339-1e1a5ec2e1bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember_95a2cae9-56e0-447b-93d6-77bde8c7dab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:to="loc_us-gaap_CommodityOptionMember_95a2cae9-56e0-447b-93d6-77bde8c7dab8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_062c6c04-2adc-407e-aedd-129d55d718b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:to="loc_us-gaap_HedgingDesignationAxis_062c6c04-2adc-407e-aedd-129d55d718b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_062c6c04-2adc-407e-aedd-129d55d718b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_062c6c04-2adc-407e-aedd-129d55d718b8" xlink:to="loc_us-gaap_HedgingDesignationDomain_062c6c04-2adc-407e-aedd-129d55d718b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_250157d7-240a-46ea-aa67-d7f369e62d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_062c6c04-2adc-407e-aedd-129d55d718b8" xlink:to="loc_us-gaap_HedgingDesignationDomain_250157d7-240a-46ea-aa67-d7f369e62d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ed9d6f26-6d71-4aa3-8bb3-17f8b06165dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_250157d7-240a-46ea-aa67-d7f369e62d9d" xlink:to="loc_us-gaap_NondesignatedMember_ed9d6f26-6d71-4aa3-8bb3-17f8b06165dd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="extended" id="i3fe4ae6e47094a15a34b5fccd5172322_FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9870ee48-73bf-46cc-9c45-d271f5d0e879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9870ee48-73bf-46cc-9c45-d271f5d0e879" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_79111a20-3bc0-498f-99ac-322c018bc777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_79111a20-3bc0-498f-99ac-322c018bc777" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_9efe438f-e2a1-4286-b056-5cf16484313d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_9efe438f-e2a1-4286-b056-5cf16484313d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_001282bf-d4b8-468e-8115-3b86f28a40ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:to="loc_us-gaap_DerivativeAssets_001282bf-d4b8-468e-8115-3b86f28a40ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_bb2af9d6-efe9-49f1-952e-13c78c5441c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_bb2af9d6-efe9-49f1-952e-13c78c5441c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9870ee48-73bf-46cc-9c45-d271f5d0e879" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_345993dc-65a9-4b66-8141-e36059950728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_345993dc-65a9-4b66-8141-e36059950728" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_10db8f27-0cb9-4587-b9d6-f8ab0b773271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:to="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_10db8f27-0cb9-4587-b9d6-f8ab0b773271" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_818d1ad7-a293-4466-be75-0a4c5f10ecc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_818d1ad7-a293-4466-be75-0a4c5f10ecc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_9d7bd63c-d186-4782-9a5b-ceb3efbf9ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_9d7bd63c-d186-4782-9a5b-ceb3efbf9ebd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_779a3c24-e02d-4548-b57c-30f060fbeefd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9870ee48-73bf-46cc-9c45-d271f5d0e879" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_779a3c24-e02d-4548-b57c-30f060fbeefd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e3e095af-5918-40b5-bce4-05df4e5893d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_779a3c24-e02d-4548-b57c-30f060fbeefd" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e3e095af-5918-40b5-bce4-05df4e5893d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3e095af-5918-40b5-bce4-05df4e5893d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e3e095af-5918-40b5-bce4-05df4e5893d2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3e095af-5918-40b5-bce4-05df4e5893d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d43def83-f853-438a-b396-5801d60083a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e3e095af-5918-40b5-bce4-05df4e5893d2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d43def83-f853-438a-b396-5801d60083a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c457a143-7629-481b-b92b-52814d63451f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d43def83-f853-438a-b396-5801d60083a8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c457a143-7629-481b-b92b-52814d63451f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_884ec4a0-8130-4523-99e0-5e272d196e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d43def83-f853-438a-b396-5801d60083a8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_884ec4a0-8130-4523-99e0-5e272d196e6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8e1c6a87-c7dc-4f70-ae17-fb69f0838d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d43def83-f853-438a-b396-5801d60083a8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8e1c6a87-c7dc-4f70-ae17-fb69f0838d1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2694aa33-ad00-4f3b-b79f-7add86e2f9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_779a3c24-e02d-4548-b57c-30f060fbeefd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2694aa33-ad00-4f3b-b79f-7add86e2f9c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2694aa33-ad00-4f3b-b79f-7add86e2f9c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2694aa33-ad00-4f3b-b79f-7add86e2f9c8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2694aa33-ad00-4f3b-b79f-7add86e2f9c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00dbe439-75ba-44be-8e45-2a414d802cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2694aa33-ad00-4f3b-b79f-7add86e2f9c8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00dbe439-75ba-44be-8e45-2a414d802cc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_52cf50d9-e21d-4d20-b0b1-3066f407b18e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00dbe439-75ba-44be-8e45-2a414d802cc4" xlink:to="loc_us-gaap_CurrencySwapMember_52cf50d9-e21d-4d20-b0b1-3066f407b18e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityMember_0f988a78-0199-4905-8897-c3287270597e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00dbe439-75ba-44be-8e45-2a414d802cc4" xlink:to="loc_us-gaap_CommodityMember_0f988a78-0199-4905-8897-c3287270597e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1b0b036f-096b-4448-9d8f-9a7c0217d2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00dbe439-75ba-44be-8e45-2a414d802cc4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1b0b036f-096b-4448-9d8f-9a7c0217d2f0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="ic6a52edaf964487082113551aea0f7ff_AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1765280-e85d-4b1b-bac2-6249c6feba1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1765280-e85d-4b1b-bac2-6249c6feba1f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6497dcc9-e8a0-40cb-9193-77a0461ec5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:to="loc_us-gaap_StockholdersEquity_6497dcc9-e8a0-40cb-9193-77a0461ec5d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_d3e1e3de-bdc4-4a85-a8ee-c517a8a25e01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_d3e1e3de-bdc4-4a85-a8ee-c517a8a25e01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8d5fc50a-da79-4d02-ad24-989f006401d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8d5fc50a-da79-4d02-ad24-989f006401d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_862fc192-f91a-4275-a6c7-cf1da011dff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_862fc192-f91a-4275-a6c7-cf1da011dff9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_23b98619-620f-483f-b24f-7de4d2fcc325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_43575d02-dc9c-459d-87cd-cebc7cfc5838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1765280-e85d-4b1b-bac2-6249c6feba1f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_43575d02-dc9c-459d-87cd-cebc7cfc5838" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_75633de8-83b0-431f-9234-9b28251f62bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_43575d02-dc9c-459d-87cd-cebc7cfc5838" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_75633de8-83b0-431f-9234-9b28251f62bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_75633de8-83b0-431f-9234-9b28251f62bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_75633de8-83b0-431f-9234-9b28251f62bf" xlink:to="loc_us-gaap_EquityComponentDomain_75633de8-83b0-431f-9234-9b28251f62bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_75633de8-83b0-431f-9234-9b28251f62bf" xlink:to="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_20213872-b901-4724-b731-9f316911caaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_20213872-b901-4724-b731-9f316911caaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_f6d4f99f-8698-49e8-bb41-23b0521911ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_f6d4f99f-8698-49e8-bb41-23b0521911ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ac292762-3a90-46b7-9808-b17cd240eab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ac292762-3a90-46b7-9808-b17cd240eab1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f44f63ab-7d4b-4c04-a0a8-5e161224831a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f44f63ab-7d4b-4c04-a0a8-5e161224831a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b4a5b445-cad5-46be-a0ba-a39339b3325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b4a5b445-cad5-46be-a0ba-a39339b3325e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="extended" id="i8701fe0d6318450fa9783e31b976c823_AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3a89af6-4954-41a6-803d-baeb0352d46e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3a89af6-4954-41a6-803d-baeb0352d46e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1f083515-3ca4-4ff5-8cdd-1d6e40b90282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1f083515-3ca4-4ff5-8cdd-1d6e40b90282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_8938d2e5-d79e-4984-a8c7-914e25b7609c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_OtherIncome_8938d2e5-d79e-4984-a8c7-914e25b7609c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_75307cbb-0a08-4529-a2fd-8e79575aaff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_InterestExpense_75307cbb-0a08-4529-a2fd-8e79575aaff9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6b8dc802-267a-4077-a42e-492ee4e123f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6b8dc802-267a-4077-a42e-492ee4e123f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_f0539d16-f134-43a7-9f10-0c9aae0a4c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_f0539d16-f134-43a7-9f10-0c9aae0a4c25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_d3de4501-1f20-414d-b127-b125ba9d4334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_d3de4501-1f20-414d-b127-b125ba9d4334" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_b9b3ccf6-3894-4efb-b939-3c84c7755ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_b9b3ccf6-3894-4efb-b939-3c84c7755ab0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_33294ed1-49c2-45c7-a6f4-289704a25e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_33294ed1-49c2-45c7-a6f4-289704a25e91" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a8481333-9370-4fca-a449-f5117576602b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a8481333-9370-4fca-a449-f5117576602b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a8b4b093-7604-4c7f-9c65-43f7b09eecef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_NetIncomeLoss_a8b4b093-7604-4c7f-9c65-43f7b09eecef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_919b9ab9-2e06-4559-9fe5-7ac03571cd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_919b9ab9-2e06-4559-9fe5-7ac03571cd7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_919b9ab9-2e06-4559-9fe5-7ac03571cd7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_919b9ab9-2e06-4559-9fe5-7ac03571cd7a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_919b9ab9-2e06-4559-9fe5-7ac03571cd7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bee59241-00c6-479a-bdf8-613fc41ab854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_919b9ab9-2e06-4559-9fe5-7ac03571cd7a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bee59241-00c6-479a-bdf8-613fc41ab854" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_b89cde33-888b-4d61-b89f-cc1290a469b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bee59241-00c6-479a-bdf8-613fc41ab854" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_b89cde33-888b-4d61-b89f-cc1290a469b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_272bdd7d-c33e-4e8d-99a3-f6cfc8f04dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_272bdd7d-c33e-4e8d-99a3-f6cfc8f04dc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_272bdd7d-c33e-4e8d-99a3-f6cfc8f04dc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_272bdd7d-c33e-4e8d-99a3-f6cfc8f04dc4" xlink:to="loc_us-gaap_EquityComponentDomain_272bdd7d-c33e-4e8d-99a3-f6cfc8f04dc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_99121055-84a9-4327-9d9f-ffc9d42430c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_272bdd7d-c33e-4e8d-99a3-f6cfc8f04dc4" xlink:to="loc_us-gaap_EquityComponentDomain_99121055-84a9-4327-9d9f-ffc9d42430c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f9f98b36-f610-4a61-9cb6-78dd915036e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_99121055-84a9-4327-9d9f-ffc9d42430c7" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f9f98b36-f610-4a61-9cb6-78dd915036e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_64668cf8-995c-4724-bcc3-18f89a957257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_99121055-84a9-4327-9d9f-ffc9d42430c7" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_64668cf8-995c-4724-bcc3-18f89a957257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a54d3583-0374-4a18-a5e0-17bb2f8d35b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a54d3583-0374-4a18-a5e0-17bb2f8d35b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a54d3583-0374-4a18-a5e0-17bb2f8d35b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a54d3583-0374-4a18-a5e0-17bb2f8d35b9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a54d3583-0374-4a18-a5e0-17bb2f8d35b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7c9f4486-b0db-4bc0-9a98-d18a3ba344cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a54d3583-0374-4a18-a5e0-17bb2f8d35b9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7c9f4486-b0db-4bc0-9a98-d18a3ba344cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_0a41e504-98b2-4e56-82c2-6c1e0db565a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7c9f4486-b0db-4bc0-9a98-d18a3ba344cd" xlink:to="loc_us-gaap_ForeignExchangeContractMember_0a41e504-98b2-4e56-82c2-6c1e0db565a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_c20682f4-90c4-4d59-a561-5daffa23ddc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7c9f4486-b0db-4bc0-9a98-d18a3ba344cd" xlink:to="loc_us-gaap_TreasuryLockMember_c20682f4-90c4-4d59-a561-5daffa23ddc3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended" id="ie8cc64a552e34e02ab82112cdd965e56_StockBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_eb24e81b-2787-43cd-a25a-a9c9410b589c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_eb24e81b-2787-43cd-a25a-a9c9410b589c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_62958605-ae28-49f6-bcf8-e568a8bef920" xlink:href="wst-20221231.xsd#wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_62958605-ae28-49f6-bcf8-e568a8bef920" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_777ad16e-d324-470d-917e-041717570ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_777ad16e-d324-470d-917e-041717570ba0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_81162d6e-c9b3-4037-90bf-dbeb66058aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_81162d6e-c9b3-4037-90bf-dbeb66058aff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_70f9e032-b657-49a9-a29d-552df42539a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_70f9e032-b657-49a9-a29d-552df42539a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_062f6782-9a3c-4505-bf3d-7961d141325d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_062f6782-9a3c-4505-bf3d-7961d141325d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_5cd43274-aa6c-4878-a8d9-ac76e3769b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_5cd43274-aa6c-4878-a8d9-ac76e3769b69" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_3df73cc8-a5f8-4263-9614-37274cf1f307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_3df73cc8-a5f8-4263-9614-37274cf1f307" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_fe14aa29-f34f-4f73-a070-4cfc6fea4f63" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_fe14aa29-f34f-4f73-a070-4cfc6fea4f63" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_6021f9f5-db7f-4bf6-a95c-915f978a3d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_6021f9f5-db7f-4bf6-a95c-915f978a3d25" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_b7c6b38c-f43d-4ff6-b9f7-6e59b50bac6a" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_b7c6b38c-f43d-4ff6-b9f7-6e59b50bac6a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_20e4793b-61c6-47a9-8e0a-68594c6d83b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_20e4793b-61c6-47a9-8e0a-68594c6d83b7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit_2c76c9e5-0f5d-48a7-9c13-e7dced4a9160" xlink:href="wst-20221231.xsd#wst_DeferredCompensationArrangementWithIndividualConversionUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit_2c76c9e5-0f5d-48a7-9c13-e7dced4a9160" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_17f1880a-60f4-45ed-ac22-516e327b2e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_17f1880a-60f4-45ed-ac22-516e327b2e71" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0d87d678-3486-4d42-a5b1-e4cf38abc426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0d87d678-3486-4d42-a5b1-e4cf38abc426" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_4c066bfe-205f-45f0-806a-d7ae721743b2" xlink:href="wst-20221231.xsd#wst_DeferredCompensationArrangementWithIndividualNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_4c066bfe-205f-45f0-806a-d7ae721743b2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_76b06b72-5c31-4a85-92a3-51f3a9aa7c66" xlink:href="wst-20221231.xsd#wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_76b06b72-5c31-4a85-92a3-51f3a9aa7c66" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredStockUnitsPayableInCash_69b14389-8ede-4ff1-a5ec-4d7ad7218dba" xlink:href="wst-20221231.xsd#wst_DeferredStockUnitsPayableInCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_DeferredStockUnitsPayableInCash_69b14389-8ede-4ff1-a5ec-4d7ad7218dba" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9ed5a177-5e68-4635-952f-471df70726f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:to="loc_us-gaap_AwardTypeAxis_9ed5a177-5e68-4635-952f-471df70726f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ed5a177-5e68-4635-952f-471df70726f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9ed5a177-5e68-4635-952f-471df70726f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ed5a177-5e68-4635-952f-471df70726f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9ed5a177-5e68-4635-952f-471df70726f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_aa388339-b2c7-4f67-8464-1bc19e625d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_us-gaap_EmployeeStockOptionMember_aa388339-b2c7-4f67-8464-1bc19e625d56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_ecb492cc-8efa-4872-979b-b835b716d15e" xlink:href="wst-20221231.xsd#wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_ecb492cc-8efa-4872-979b-b835b716d15e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_8dcdc7a4-726c-4a34-b706-6b409c3e3b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_8dcdc7a4-726c-4a34-b706-6b409c3e3b9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_c383375f-f502-411e-82e1-1284a2e86d20" xlink:href="wst-20221231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_wst_StockSettledPSUAwardsMember_c383375f-f502-411e-82e1-1284a2e86d20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_2a08188d-95c6-4100-b448-6a5a1e5407e0" xlink:href="wst-20221231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_2a08188d-95c6-4100-b448-6a5a1e5407e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_73b3730e-2715-4a63-8bca-453960f17c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_us-gaap_RestrictedStockMember_73b3730e-2715-4a63-8bca-453960f17c19" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_a196cca7-34d2-4ae5-baaf-f1529fcacd02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_a196cca7-34d2-4ae5-baaf-f1529fcacd02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_a196cca7-34d2-4ae5-baaf-f1529fcacd02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_a196cca7-34d2-4ae5-baaf-f1529fcacd02" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_a196cca7-34d2-4ae5-baaf-f1529fcacd02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_465f4691-90db-4223-a3ef-522ab48fdce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_a196cca7-34d2-4ae5-baaf-f1529fcacd02" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_465f4691-90db-4223-a3ef-522ab48fdce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_403a4c13-9091-477f-a642-9ec08c700f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_465f4691-90db-4223-a3ef-522ab48fdce2" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_403a4c13-9091-477f-a642-9ec08c700f57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e6234c1f-ccbc-4618-8262-b40eb91c1f99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:to="loc_srt_RangeAxis_e6234c1f-ccbc-4618-8262-b40eb91c1f99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e6234c1f-ccbc-4618-8262-b40eb91c1f99_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e6234c1f-ccbc-4618-8262-b40eb91c1f99" xlink:to="loc_srt_RangeMember_e6234c1f-ccbc-4618-8262-b40eb91c1f99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a0f7702f-52e2-4830-a828-29c1b4642da0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e6234c1f-ccbc-4618-8262-b40eb91c1f99" xlink:to="loc_srt_RangeMember_a0f7702f-52e2-4830-a828-29c1b4642da0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0bbf7cf4-7e03-4bbc-80ff-a16b9e6b4e80" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a0f7702f-52e2-4830-a828-29c1b4642da0" xlink:to="loc_srt_MinimumMember_0bbf7cf4-7e03-4bbc-80ff-a16b9e6b4e80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c966eaf8-fea4-4d51-9068-18987db63ef3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a0f7702f-52e2-4830-a828-29c1b4642da0" xlink:to="loc_srt_MaximumMember_c966eaf8-fea4-4d51-9068-18987db63ef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_501bb5af-a485-4061-a9cf-7ca4f062e21e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:to="loc_srt_TitleOfIndividualAxis_501bb5af-a485-4061-a9cf-7ca4f062e21e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_501bb5af-a485-4061-a9cf-7ca4f062e21e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_501bb5af-a485-4061-a9cf-7ca4f062e21e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_501bb5af-a485-4061-a9cf-7ca4f062e21e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a7d58eb-9456-4e91-8076-97ff173a8afe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_501bb5af-a485-4061-a9cf-7ca4f062e21e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a7d58eb-9456-4e91-8076-97ff173a8afe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_1dbabd9d-f762-46db-b50b-476e52e79205" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a7d58eb-9456-4e91-8076-97ff173a8afe" xlink:to="loc_srt_DirectorMember_1dbabd9d-f762-46db-b50b-476e52e79205" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="extended" id="i252cfa39f0114acaaeab100043a8370d_StockBasedCompensationAllocationofSharebasedCompensationCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17be5e38-3f5a-4927-bd26-01ab5d65a92e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_23ce6d39-8d16-460c-9eed-81fc0d63f907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17be5e38-3f5a-4927-bd26-01ab5d65a92e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_23ce6d39-8d16-460c-9eed-81fc0d63f907" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95c80cee-249b-4a1e-b787-d777bb7e65aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17be5e38-3f5a-4927-bd26-01ab5d65a92e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95c80cee-249b-4a1e-b787-d777bb7e65aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0aebd705-db50-4f10-bfc0-bbdf708cb1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95c80cee-249b-4a1e-b787-d777bb7e65aa" xlink:to="loc_us-gaap_AwardTypeAxis_0aebd705-db50-4f10-bfc0-bbdf708cb1e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aebd705-db50-4f10-bfc0-bbdf708cb1e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0aebd705-db50-4f10-bfc0-bbdf708cb1e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0aebd705-db50-4f10-bfc0-bbdf708cb1e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0aebd705-db50-4f10-bfc0-bbdf708cb1e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockOptionAndAppreciationRightsMember_3205665c-07cd-4d1a-b5cf-6e73e3c27faf" xlink:href="wst-20221231.xsd#wst_StockOptionAndAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_wst_StockOptionAndAppreciationRightsMember_3205665c-07cd-4d1a-b5cf-6e73e3c27faf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_880f2258-c39a-4f79-8f56-315ce5e2d97d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_us-gaap_PerformanceSharesMember_880f2258-c39a-4f79-8f56-315ce5e2d97d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_2b175825-d416-454b-87ba-40330cdec322" xlink:href="wst-20221231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_wst_CashSettledPSUAwardsMember_2b175825-d416-454b-87ba-40330cdec322" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_185d2056-306b-485f-bc14-70ac0eec04bd" xlink:href="wst-20221231.xsd#wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_185d2056-306b-485f-bc14-70ac0eec04bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_9eb6f15a-30d2-412c-9275-8e5d4859fda9" xlink:href="wst-20221231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_9eb6f15a-30d2-412c-9275-8e5d4859fda9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_9994d04f-7046-45ac-83ff-b631b1ec5a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_9994d04f-7046-45ac-83ff-b631b1ec5a39" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationStockOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="extended" id="i0d0dc1aed6ec4fcd8bd3fc06c09ef30e_StockBasedCompensationStockOptionsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_364eb7e4-04b9-42be-a588-7d2432df24eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_364eb7e4-04b9-42be-a588-7d2432df24eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_92e6c7d9-faeb-4825-8707-9f9de7bedeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_92e6c7d9-faeb-4825-8707-9f9de7bedeb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_32fd2929-7fb2-4080-87e0-05fdb0a6caeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_32fd2929-7fb2-4080-87e0-05fdb0a6caeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_53119246-0d34-4365-95e7-677e11c9707d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_53119246-0d34-4365-95e7-677e11c9707d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c6d681e7-632b-43de-8ef6-da3d8456498a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c6d681e7-632b-43de-8ef6-da3d8456498a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6fe19b7c-0a7a-4396-be00-a810d045bb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6fe19b7c-0a7a-4396-be00-a810d045bb8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f34d177d-1fb5-4fd6-ba56-07fefe86c92b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6fe19b7c-0a7a-4396-be00-a810d045bb8c" xlink:to="loc_us-gaap_AwardTypeAxis_f34d177d-1fb5-4fd6-ba56-07fefe86c92b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f34d177d-1fb5-4fd6-ba56-07fefe86c92b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f34d177d-1fb5-4fd6-ba56-07fefe86c92b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f34d177d-1fb5-4fd6-ba56-07fefe86c92b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_baf880ac-82d4-45ae-b7d4-2d6a20987dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f34d177d-1fb5-4fd6-ba56-07fefe86c92b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_baf880ac-82d4-45ae-b7d4-2d6a20987dcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1879e548-28ba-4b17-bc02-70ebc9a8410e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_baf880ac-82d4-45ae-b7d4-2d6a20987dcc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1879e548-28ba-4b17-bc02-70ebc9a8410e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationStockAppreciationRightsAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="extended" id="ifd913358b4b8484192ce5c3c9d5d824f_StockBasedCompensationStockAppreciationRightsAwardActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2723fcf0-c2f5-4628-8584-c098a8885751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2723fcf0-c2f5-4628-8584-c098a8885751" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_ea3ced4d-677c-4f9f-8fcc-19e769566f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_ea3ced4d-677c-4f9f-8fcc-19e769566f6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_fa07a400-11ea-40ad-83d6-fea37aa73154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_fa07a400-11ea-40ad-83d6-fea37aa73154" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1da953b9-70ba-4a13-b903-57a5da0749e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1da953b9-70ba-4a13-b903-57a5da0749e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_835b1174-3662-4d7a-8200-f9a437d6fa1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_835b1174-3662-4d7a-8200-f9a437d6fa1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_a2e80a52-87c8-4ef4-9698-7d851750c7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber_292c6b3b-9011-4749-b5da-ab0a1ad2f350" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber_292c6b3b-9011-4749-b5da-ab0a1ad2f350" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber_42a78086-2d9a-41d1-b89a-0732dd238b08" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber_42a78086-2d9a-41d1-b89a-0732dd238b08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_8a4922d7-bd43-490b-8384-c9dfbd2a398f" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_8a4922d7-bd43-490b-8384-c9dfbd2a398f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_843f55d8-7926-4749-864f-ffe07a64a5c0" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_843f55d8-7926-4749-864f-ffe07a64a5c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_37ba1f39-562d-4294-802b-cae28bf1110c" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_37ba1f39-562d-4294-802b-cae28bf1110c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_3e6def2c-4155-49e1-bbfb-23cc4263a194" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_3e6def2c-4155-49e1-bbfb-23cc4263a194" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6ed5d02b-f1ba-44ef-8ba7-46bb3d321256" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice_76f73212-51ad-469a-bbf9-85d551ceade9" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice_76f73212-51ad-469a-bbf9-85d551ceade9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice_95cd27d5-f4a0-4fcb-bebd-26148bb2cc60" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice_95cd27d5-f4a0-4fcb-bebd-26148bb2cc60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a51d1629-5768-4cfb-8544-b2edf9e9cb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a51d1629-5768-4cfb-8544-b2edf9e9cb2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c23d33ee-ee43-4709-a621-fe803d5c87e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a51d1629-5768-4cfb-8544-b2edf9e9cb2a" xlink:to="loc_us-gaap_AwardTypeAxis_c23d33ee-ee43-4709-a621-fe803d5c87e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c23d33ee-ee43-4709-a621-fe803d5c87e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c23d33ee-ee43-4709-a621-fe803d5c87e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c23d33ee-ee43-4709-a621-fe803d5c87e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_df51f9ad-0573-4b26-8938-2619fa644e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c23d33ee-ee43-4709-a621-fe803d5c87e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_df51f9ad-0573-4b26-8938-2619fa644e83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_3fe63ee1-d213-4d4b-97f0-f2136b7f2e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_df51f9ad-0573-4b26-8938-2619fa644e83" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_3fe63ee1-d213-4d4b-97f0-f2136b7f2e33" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="extended" id="iafc1e44186a140ecb16768097cf6a118_StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_d2061124-3fab-4fe7-a079-d2c938d3d3b6" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_d2061124-3fab-4fe7-a079-d2c938d3d3b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_b70136f7-6719-4a31-81f9-6980597cfb13" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_b70136f7-6719-4a31-81f9-6980597cfb13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_10dae595-57dd-4075-8cd6-488aa211fc97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_10dae595-57dd-4075-8cd6-488aa211fc97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30251c39-e04f-40aa-a772-a0ab1fd6fd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30251c39-e04f-40aa-a772-a0ab1fd6fd3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c39b1eca-2bcf-4789-a70f-ce32cd250c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c39b1eca-2bcf-4789-a70f-ce32cd250c71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_0e6839e2-86b5-404b-bbf0-4eb3f9af031b" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_0e6839e2-86b5-404b-bbf0-4eb3f9af031b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e754a9dc-023d-41de-8358-03007ca2b1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e754a9dc-023d-41de-8358-03007ca2b1f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5286fbc7-b196-47cd-9103-8078c1cd86a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5286fbc7-b196-47cd-9103-8078c1cd86a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_70f8112a-e08b-4203-ac2e-7a6c1434640f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b484dc42-f2cf-48b6-b1f9-80c456a95d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b484dc42-f2cf-48b6-b1f9-80c456a95d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_332cafad-e0db-4d1a-a4de-7f56bcf32538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_332cafad-e0db-4d1a-a4de-7f56bcf32538" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_8ffa42a2-75c8-4899-ac91-ed09c0d06c0f" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_8ffa42a2-75c8-4899-ac91-ed09c0d06c0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ec4f381c-f16e-4222-aff8-e0d9af229e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ec4f381c-f16e-4222-aff8-e0d9af229e38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6b6d9151-0ae7-474e-b4f0-a05ea08ede41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6b6d9151-0ae7-474e-b4f0-a05ea08ede41" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_878a31b7-5f46-4c99-9ced-f5b57842ad95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a11644a5-35d5-4120-aa6e-3d4d5d4c509b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:to="loc_us-gaap_AwardTypeAxis_a11644a5-35d5-4120-aa6e-3d4d5d4c509b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a11644a5-35d5-4120-aa6e-3d4d5d4c509b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a11644a5-35d5-4120-aa6e-3d4d5d4c509b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a11644a5-35d5-4120-aa6e-3d4d5d4c509b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71c278d7-1779-4b06-af0b-2f1cead84a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a11644a5-35d5-4120-aa6e-3d4d5d4c509b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71c278d7-1779-4b06-af0b-2f1cead84a6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_d74d3dea-e9dc-4ee4-87bd-860d5cab026c" xlink:href="wst-20221231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71c278d7-1779-4b06-af0b-2f1cead84a6e" xlink:to="loc_wst_StockSettledPSUAwardsMember_d74d3dea-e9dc-4ee4-87bd-860d5cab026c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_46cd78b0-0093-4a29-a696-9a829b7ebd6a" xlink:href="wst-20221231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71c278d7-1779-4b06-af0b-2f1cead84a6e" xlink:to="loc_wst_CashSettledPSUAwardsMember_46cd78b0-0093-4a29-a696-9a829b7ebd6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b3a350a5-e184-48d2-86a4-c7889fff969d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71c278d7-1779-4b06-af0b-2f1cead84a6e" xlink:to="loc_us-gaap_RestrictedStockMember_b3a350a5-e184-48d2-86a4-c7889fff969d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ecd09520-8e9a-44ae-83e7-cc6f0b0e4d8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:to="loc_srt_RangeAxis_ecd09520-8e9a-44ae-83e7-cc6f0b0e4d8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ecd09520-8e9a-44ae-83e7-cc6f0b0e4d8f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ecd09520-8e9a-44ae-83e7-cc6f0b0e4d8f" xlink:to="loc_srt_RangeMember_ecd09520-8e9a-44ae-83e7-cc6f0b0e4d8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_74a80c85-6155-4837-82ed-f01a9934c2f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ecd09520-8e9a-44ae-83e7-cc6f0b0e4d8f" xlink:to="loc_srt_RangeMember_74a80c85-6155-4837-82ed-f01a9934c2f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_39774969-694f-4294-8f2c-a396bd647b22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_74a80c85-6155-4837-82ed-f01a9934c2f0" xlink:to="loc_srt_MinimumMember_39774969-694f-4294-8f2c-a396bd647b22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d499f2ff-cbc1-4582-9bc6-cfabab30492b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_74a80c85-6155-4837-82ed-f01a9934c2f0" xlink:to="loc_srt_MaximumMember_d499f2ff-cbc1-4582-9bc6-cfabab30492b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_7ba60958-2d4a-4db2-b5e4-8c36db120824" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:to="loc_srt_TitleOfIndividualAxis_7ba60958-2d4a-4db2-b5e4-8c36db120824" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7ba60958-2d4a-4db2-b5e4-8c36db120824_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_7ba60958-2d4a-4db2-b5e4-8c36db120824" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7ba60958-2d4a-4db2-b5e4-8c36db120824_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3b71dbd3-eb6a-471a-8637-7a8e75767ef2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_7ba60958-2d4a-4db2-b5e4-8c36db120824" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3b71dbd3-eb6a-471a-8637-7a8e75767ef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_43d0e9b1-2b73-4333-a4fd-b790d4bb7a6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3b71dbd3-eb6a-471a-8637-7a8e75767ef2" xlink:to="loc_srt_DirectorMember_43d0e9b1-2b73-4333-a4fd-b790d4bb7a6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_5e3560bf-d670-4f59-b640-4cee10902275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_5e3560bf-d670-4f59-b640-4cee10902275" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_5e3560bf-d670-4f59-b640-4cee10902275_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_5e3560bf-d670-4f59-b640-4cee10902275" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_5e3560bf-d670-4f59-b640-4cee10902275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_ba2241fa-eda4-43c8-965b-0aed90748718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_5e3560bf-d670-4f59-b640-4cee10902275" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_ba2241fa-eda4-43c8-965b-0aed90748718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_4e13072e-bf62-4105-93af-433f89217f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_ba2241fa-eda4-43c8-965b-0aed90748718" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_4e13072e-bf62-4105-93af-433f89217f10" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="extended" id="i1daa7f3ae3c84d648b0813b3cb9055ce_BenefitPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_514f358d-0529-410e-87a5-0651d1c6068c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_514f358d-0529-410e-87a5-0651d1c6068c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_2f26551f-e44f-4860-bcac-59d3b9b462bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_2f26551f-e44f-4860-bcac-59d3b9b462bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_1555e2e8-077f-43b5-9f62-50fc674f199b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_1555e2e8-077f-43b5-9f62-50fc674f199b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_1f731539-7110-400c-bea0-b8dbba2a5b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_1f731539-7110-400c-bea0-b8dbba2a5b42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a2bb1f32-d0df-4351-9d72-437a9b510457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a2bb1f32-d0df-4351-9d72-437a9b510457" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_4d743681-70f8-4193-baf4-634b75cde372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_4d743681-70f8-4193-baf4-634b75cde372" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_c83d5979-ac03-4dbe-9bfd-fccf8253b723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_c83d5979-ac03-4dbe-9bfd-fccf8253b723" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_16fcc818-f36e-41ad-8ab2-2d2d5296b23e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_16fcc818-f36e-41ad-8ab2-2d2d5296b23e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0cb4e15d-8b32-418d-b00f-c9badcbc2d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0cb4e15d-8b32-418d-b00f-c9badcbc2d10" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d7826ba0-4646-4de5-915c-b8c105eec2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d7826ba0-4646-4de5-915c-b8c105eec2cb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_6b9bf79b-8546-479c-a29f-7911c97f1168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_6b9bf79b-8546-479c-a29f-7911c97f1168" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_0c48552a-0a55-4895-b138-7c1dd3b622b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_0c48552a-0a55-4895-b138-7c1dd3b622b7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_d11b6d41-4dce-46da-a788-14ff11969d68" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_d11b6d41-4dce-46da-a788-14ff11969d68" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_8ea42fff-4c6e-4cbb-bef4-03f8be1a971e" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_8ea42fff-4c6e-4cbb-bef4-03f8be1a971e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_64a3769a-4152-449b-836e-115c7168418a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_64a3769a-4152-449b-836e-115c7168418a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_3bad1afc-b875-46aa-b030-6cd03fe822c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_64a3769a-4152-449b-836e-115c7168418a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_3bad1afc-b875-46aa-b030-6cd03fe822c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_3bad1afc-b875-46aa-b030-6cd03fe822c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3bad1afc-b875-46aa-b030-6cd03fe822c2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_3bad1afc-b875-46aa-b030-6cd03fe822c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f9b6ec1b-e261-4533-9bc5-2eb755a6077f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3bad1afc-b875-46aa-b030-6cd03fe822c2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f9b6ec1b-e261-4533-9bc5-2eb755a6077f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_479a5228-137d-40f3-9021-7e2f6f2d4505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f9b6ec1b-e261-4533-9bc5-2eb755a6077f" xlink:to="loc_us-gaap_DomesticPlanMember_479a5228-137d-40f3-9021-7e2f6f2d4505" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1abd0f1c-aa74-4117-b0c3-2b67948ca30d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_479a5228-137d-40f3-9021-7e2f6f2d4505" xlink:to="loc_country_US_1abd0f1c-aa74-4117-b0c3-2b67948ca30d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_8864c5b5-42ca-4146-8740-1169dcde7455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f9b6ec1b-e261-4533-9bc5-2eb755a6077f" xlink:to="loc_us-gaap_ForeignPlanMember_8864c5b5-42ca-4146-8740-1169dcde7455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_82bbae80-6b78-4579-8534-a8673856af8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_64a3769a-4152-449b-836e-115c7168418a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_82bbae80-6b78-4579-8534-a8673856af8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_82bbae80-6b78-4579-8534-a8673856af8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_82bbae80-6b78-4579-8534-a8673856af8f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_82bbae80-6b78-4579-8534-a8673856af8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_10ccfada-237c-4fdd-aead-4da6ca83d3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_82bbae80-6b78-4579-8534-a8673856af8f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_10ccfada-237c-4fdd-aead-4da6ca83d3ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9c8fe8af-0fe4-42c7-8a43-e391344dbeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_10ccfada-237c-4fdd-aead-4da6ca83d3ee" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9c8fe8af-0fe4-42c7-8a43-e391344dbeb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_47aad40e-fb00-413b-81f1-f4ec1a388644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_10ccfada-237c-4fdd-aead-4da6ca83d3ee" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_47aad40e-fb00-413b-81f1-f4ec1a388644" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended" id="i94bb5499d0704b56b10eaa2c82a6e89e_BenefitPlansComponentsofNetPeriodicBenefitCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_085bc4b7-8c68-4f9f-b9d4-526d5c287576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_085bc4b7-8c68-4f9f-b9d4-526d5c287576" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_5e97461e-dfbc-4d7a-95f9-5182b2bca403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_5e97461e-dfbc-4d7a-95f9-5182b2bca403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_5b7e50c0-5e32-481e-ab0b-efd41387bfed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_5b7e50c0-5e32-481e-ab0b-efd41387bfed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5a3d8f66-a40f-487a-8508-3c8acae94963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5a3d8f66-a40f-487a-8508-3c8acae94963" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_650edfcd-5088-4d3d-ae46-58a657cd56f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_650edfcd-5088-4d3d-ae46-58a657cd56f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_70017b39-025c-4b64-9291-8a9c7fe09515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_70017b39-025c-4b64-9291-8a9c7fe09515" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_deba4e9c-573c-4836-9e14-44fcbf7e2bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_deba4e9c-573c-4836-9e14-44fcbf7e2bd0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_54cda807-3bd3-4f44-bf05-b3636d8885e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_54cda807-3bd3-4f44-bf05-b3636d8885e4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f565960b-6720-4f2c-a6d3-feb0763f0eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f565960b-6720-4f2c-a6d3-feb0763f0eee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_085bc4b7-8c68-4f9f-b9d4-526d5c287576" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_57489ab7-900e-4d4f-8fb5-b4572414af82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_57489ab7-900e-4d4f-8fb5-b4572414af82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_62a756b5-1098-44c2-b488-c8c391a962f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_62a756b5-1098-44c2-b488-c8c391a962f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_55eebf6b-5c1b-45fa-a081-d94532d78039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_55eebf6b-5c1b-45fa-a081-d94532d78039" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_fd3afda4-3617-46d9-b2c2-aa309ace3bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_fd3afda4-3617-46d9-b2c2-aa309ace3bb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_c052a7b9-3370-4099-953a-39e28ed3b5ab" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_c052a7b9-3370-4099-953a-39e28ed3b5ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_f675ab16-6890-4dc2-9aa6-2c6087353038" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_f675ab16-6890-4dc2-9aa6-2c6087353038" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax_6979ae8f-d993-45b2-8436-8b55003ac053" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax_6979ae8f-d993-45b2-8436-8b55003ac053" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f0f8fb14-1576-40a6-87ca-0e38a001e749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f0f8fb14-1576-40a6-87ca-0e38a001e749" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_fe7805cc-f5c5-48ff-bc02-afac6104b63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_085bc4b7-8c68-4f9f-b9d4-526d5c287576" xlink:to="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_fe7805cc-f5c5-48ff-bc02-afac6104b63e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e4db2740-13af-45c9-beb9-51342e18d90b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_085bc4b7-8c68-4f9f-b9d4-526d5c287576" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e4db2740-13af-45c9-beb9-51342e18d90b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a84a4685-2d0b-4b83-8cc7-c8bc639dd426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e4db2740-13af-45c9-beb9-51342e18d90b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a84a4685-2d0b-4b83-8cc7-c8bc639dd426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a84a4685-2d0b-4b83-8cc7-c8bc639dd426_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a84a4685-2d0b-4b83-8cc7-c8bc639dd426" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a84a4685-2d0b-4b83-8cc7-c8bc639dd426_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b42982b0-7e05-42ac-8658-3aa3d5392fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a84a4685-2d0b-4b83-8cc7-c8bc639dd426" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b42982b0-7e05-42ac-8658-3aa3d5392fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7e3832e5-123f-437d-afbb-ee62a0f6eabe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b42982b0-7e05-42ac-8658-3aa3d5392fd3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7e3832e5-123f-437d-afbb-ee62a0f6eabe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e067fbc3-d030-4f65-9de0-4de66348701c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b42982b0-7e05-42ac-8658-3aa3d5392fd3" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e067fbc3-d030-4f65-9de0-4de66348701c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_ebcbf54c-ccf4-45c2-a868-6472b060154e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e4db2740-13af-45c9-beb9-51342e18d90b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_ebcbf54c-ccf4-45c2-a868-6472b060154e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ebcbf54c-ccf4-45c2-a868-6472b060154e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ebcbf54c-ccf4-45c2-a868-6472b060154e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ebcbf54c-ccf4-45c2-a868-6472b060154e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_36ac43b3-f888-4f53-80b6-f6beb8e463d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ebcbf54c-ccf4-45c2-a868-6472b060154e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_36ac43b3-f888-4f53-80b6-f6beb8e463d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_cd7f168e-21e6-439a-8d9c-3efdba73d5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_36ac43b3-f888-4f53-80b6-f6beb8e463d4" xlink:to="loc_us-gaap_DomesticPlanMember_cd7f168e-21e6-439a-8d9c-3efdba73d5b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8b98e042-a418-441f-96e3-781de4ff7243" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_cd7f168e-21e6-439a-8d9c-3efdba73d5b8" xlink:to="loc_country_US_8b98e042-a418-441f-96e3-781de4ff7243" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_e1e5bc21-66f5-43c4-8b81-d6da6d2e6228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_36ac43b3-f888-4f53-80b6-f6beb8e463d4" xlink:to="loc_us-gaap_ForeignPlanMember_e1e5bc21-66f5-43c4-8b81-d6da6d2e6228" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="extended" id="i0329dc4c68db4001a042ef7522a2a73d_BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_088ff525-385a-4c71-b53a-cc59f478455b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_088ff525-385a-4c71-b53a-cc59f478455b" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f5e0eb26-467b-47a7-b4ed-5042e6e38bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f5e0eb26-467b-47a7-b4ed-5042e6e38bbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_13103ade-d4a0-4b4c-afd1-2d749ecf7fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_13103ade-d4a0-4b4c-afd1-2d749ecf7fae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_e0954c29-5780-4913-b79d-6824d209e565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_e0954c29-5780-4913-b79d-6824d209e565" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_33ed0cb3-0406-4992-95a6-4318c712f1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_33ed0cb3-0406-4992-95a6-4318c712f1a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_656e5c80-c59e-4978-a75e-2b38e66d3ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_656e5c80-c59e-4978-a75e-2b38e66d3ff6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_98567cb0-e791-40a3-96bd-1607b41a6bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_98567cb0-e791-40a3-96bd-1607b41a6bf8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c1caa277-f4b9-4989-a5a1-134b464a812c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c1caa277-f4b9-4989-a5a1-134b464a812c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_8d74ba5e-5330-4135-a6de-794e1072b03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_8d74ba5e-5330-4135-a6de-794e1072b03e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_4205eaae-7764-4fd3-a06b-207ef366604e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_4205eaae-7764-4fd3-a06b-207ef366604e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7162e7aa-24c3-47df-94f0-6d5773a4246a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_088ff525-385a-4c71-b53a-cc59f478455b" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_51b706e1-07c6-4940-b457-4b841cbdf33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_51b706e1-07c6-4940-b457-4b841cbdf33d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_f8f6a693-45ae-4cf5-a83d-0228b57ea218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_f8f6a693-45ae-4cf5-a83d-0228b57ea218" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_17c6f6f2-39a5-4e22-ac88-80d976e42f60" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_17c6f6f2-39a5-4e22-ac88-80d976e42f60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_03d34a99-615a-4973-838d-9622f6742e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_03d34a99-615a-4973-838d-9622f6742e13" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_a1513f7b-e1fe-4718-a527-e1ca3b0020e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_a1513f7b-e1fe-4718-a527-e1ca3b0020e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3260d2fd-d14d-4104-8b34-60c6b4f8dd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3260d2fd-d14d-4104-8b34-60c6b4f8dd1b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_ab1ee012-6b75-4b31-a537-9fb51fb1cd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_ab1ee012-6b75-4b31-a537-9fb51fb1cd27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e50b6e1d-79f2-4aa8-8a99-444fdcc54abc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_f3874b6d-ba10-4698-a649-c5b0100f82e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_088ff525-385a-4c71-b53a-cc59f478455b" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_f3874b6d-ba10-4698-a649-c5b0100f82e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_dcbc4f6a-7269-447e-b226-000bc7004e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_088ff525-385a-4c71-b53a-cc59f478455b" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_dcbc4f6a-7269-447e-b226-000bc7004e6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0db08ba0-6698-4af0-9b07-27c194f882c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_dcbc4f6a-7269-447e-b226-000bc7004e6e" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0db08ba0-6698-4af0-9b07-27c194f882c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0db08ba0-6698-4af0-9b07-27c194f882c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0db08ba0-6698-4af0-9b07-27c194f882c2" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0db08ba0-6698-4af0-9b07-27c194f882c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f0cf327a-299c-42f9-bf27-8524e790c378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0db08ba0-6698-4af0-9b07-27c194f882c2" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f0cf327a-299c-42f9-bf27-8524e790c378" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8c09b736-f693-4074-a69a-2d0214d87be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f0cf327a-299c-42f9-bf27-8524e790c378" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8c09b736-f693-4074-a69a-2d0214d87be0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_bdb0b8f0-4933-4e46-b03a-a3f5fce47ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f0cf327a-299c-42f9-bf27-8524e790c378" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_bdb0b8f0-4933-4e46-b03a-a3f5fce47ca6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansAmountsRecognizedinBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="extended" id="iba559c15f3124564a7bb1aaa1ccd401b_BenefitPlansAmountsRecognizedinBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent_adf624ab-1f31-486d-bb66-90f27eee101f" xlink:href="wst-20221231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:to="loc_wst_AssetsDefinedBenefitPlansNoncurrent_adf624ab-1f31-486d-bb66-90f27eee101f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_c0b00ccf-1fdd-4c0d-b38a-029de83f504d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_c0b00ccf-1fdd-4c0d-b38a-029de83f504d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f4f306ed-af6b-4113-b05a-f4f464f8e6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f4f306ed-af6b-4113-b05a-f4f464f8e6b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_1490756b-1c3f-4462-a02a-a47e3b520f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_1490756b-1c3f-4462-a02a-a47e3b520f11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_64e4b51c-df7c-4bdc-af12-5ef3dddc2c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_64e4b51c-df7c-4bdc-af12-5ef3dddc2c03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_6e639771-87a1-495d-92b0-f4a1ed63eb41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_64e4b51c-df7c-4bdc-af12-5ef3dddc2c03" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_6e639771-87a1-495d-92b0-f4a1ed63eb41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6e639771-87a1-495d-92b0-f4a1ed63eb41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6e639771-87a1-495d-92b0-f4a1ed63eb41" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6e639771-87a1-495d-92b0-f4a1ed63eb41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cac11901-17c7-4d0d-b221-eb336e2aae43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6e639771-87a1-495d-92b0-f4a1ed63eb41" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cac11901-17c7-4d0d-b221-eb336e2aae43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_99561d08-eedd-42b0-a314-df3ea3e9bf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cac11901-17c7-4d0d-b221-eb336e2aae43" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_99561d08-eedd-42b0-a314-df3ea3e9bf4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b634f24c-f7ab-4cf8-ba75-809203029f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cac11901-17c7-4d0d-b221-eb336e2aae43" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b634f24c-f7ab-4cf8-ba75-809203029f81" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i47f8ec845372485f9cfe810264dc3c5d_BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fa7759bb-e6eb-4a7d-9b38-05d968fc5ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4e98748f-35d2-4fc7-9d4c-c468fc7629cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fa7759bb-e6eb-4a7d-9b38-05d968fc5ae6" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4e98748f-35d2-4fc7-9d4c-c468fc7629cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_4e4a3867-ea5f-444e-80b8-fe7f0f87f867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fa7759bb-e6eb-4a7d-9b38-05d968fc5ae6" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_4e4a3867-ea5f-444e-80b8-fe7f0f87f867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_d96c55a3-5811-4ed6-b665-3882641cd0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fa7759bb-e6eb-4a7d-9b38-05d968fc5ae6" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_d96c55a3-5811-4ed6-b665-3882641cd0d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e9e6efc2-d037-4b58-85b8-83b03482a9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fa7759bb-e6eb-4a7d-9b38-05d968fc5ae6" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e9e6efc2-d037-4b58-85b8-83b03482a9ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_538461b4-357b-44d0-8603-28854903c78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e9e6efc2-d037-4b58-85b8-83b03482a9ce" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_538461b4-357b-44d0-8603-28854903c78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_538461b4-357b-44d0-8603-28854903c78a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_538461b4-357b-44d0-8603-28854903c78a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_538461b4-357b-44d0-8603-28854903c78a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2cec0312-fb0c-44e2-a289-7a591dcd1e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_538461b4-357b-44d0-8603-28854903c78a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2cec0312-fb0c-44e2-a289-7a591dcd1e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_c0081672-ee2e-47d7-8a0e-3a4d54a0e9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2cec0312-fb0c-44e2-a289-7a591dcd1e87" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_c0081672-ee2e-47d7-8a0e-3a4d54a0e9fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_c589531e-3b8b-49c8-9a8f-4eeacca2b0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2cec0312-fb0c-44e2-a289-7a591dcd1e87" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_c589531e-3b8b-49c8-9a8f-4eeacca2b0dd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansExpectedBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="extended" id="ia8a20856bb574a2fb84bcf5f8e9128c6_BenefitPlansExpectedBenefitPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_f5345acf-b3db-46da-a9d3-2311fde2d0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_f5345acf-b3db-46da-a9d3-2311fde2d0de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_0ecf9955-e230-4441-89aa-51d545254ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_0ecf9955-e230-4441-89aa-51d545254ea7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f751443a-1fe0-4607-bfa5-f0cbad2fc288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f751443a-1fe0-4607-bfa5-f0cbad2fc288" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_b5b4a9f8-616a-4e7c-b5a4-bd64e43a0e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_b5b4a9f8-616a-4e7c-b5a4-bd64e43a0e02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_890e90a1-50a6-4bfc-9947-6a8500bf2e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_890e90a1-50a6-4bfc-9947-6a8500bf2e47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_f6f71604-d249-4bbe-99a9-11af5168922a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_f6f71604-d249-4bbe-99a9-11af5168922a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_32bd07f5-d1df-4a1e-9a55-806921053b1e" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_32bd07f5-d1df-4a1e-9a55-806921053b1e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_cdd7a627-2d7f-4bc3-b34a-c0b663ebac38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_cdd7a627-2d7f-4bc3-b34a-c0b663ebac38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_adaa8df8-c87a-4a7d-965c-b5b3395113a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_cdd7a627-2d7f-4bc3-b34a-c0b663ebac38" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_adaa8df8-c87a-4a7d-965c-b5b3395113a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_adaa8df8-c87a-4a7d-965c-b5b3395113a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_adaa8df8-c87a-4a7d-965c-b5b3395113a3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_adaa8df8-c87a-4a7d-965c-b5b3395113a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_77625ba4-be4e-4e4f-8810-70473b2eb965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_adaa8df8-c87a-4a7d-965c-b5b3395113a3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_77625ba4-be4e-4e4f-8810-70473b2eb965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_332880b6-63f4-49f6-a434-d0316003efbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_77625ba4-be4e-4e4f-8810-70473b2eb965" xlink:to="loc_us-gaap_DomesticPlanMember_332880b6-63f4-49f6-a434-d0316003efbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_80d82e28-6a69-4575-be06-10a37e6ee97a" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_332880b6-63f4-49f6-a434-d0316003efbe" xlink:to="loc_country_US_80d82e28-6a69-4575-be06-10a37e6ee97a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_11a28b43-a218-48f0-9334-d177b02463b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_77625ba4-be4e-4e4f-8810-70473b2eb965" xlink:to="loc_us-gaap_ForeignPlanMember_11a28b43-a218-48f0-9334-d177b02463b0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansAssumptionsUsedDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="extended" id="ie86aeeeaf3fc4afe969775edbfe2522c_BenefitPlansAssumptionsUsedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9ffa7a03-dc50-4be1-9038-99bb9e72c2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_786285fa-0543-4dc7-af89-2935795768e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9ffa7a03-dc50-4be1-9038-99bb9e72c2a6" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_786285fa-0543-4dc7-af89-2935795768e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_413ce44d-fb20-441b-ab01-bdd810183df1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_786285fa-0543-4dc7-af89-2935795768e6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_413ce44d-fb20-441b-ab01-bdd810183df1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_3862b9db-a956-4eab-9d38-2ea2a0c6f7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_786285fa-0543-4dc7-af89-2935795768e6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_3862b9db-a956-4eab-9d38-2ea2a0c6f7e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_ba93582e-1c5b-4db6-888e-d625b5f5cc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_786285fa-0543-4dc7-af89-2935795768e6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_ba93582e-1c5b-4db6-888e-d625b5f5cc79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_8282333e-b7b9-4730-afca-309ef45a51d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9ffa7a03-dc50-4be1-9038-99bb9e72c2a6" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_8282333e-b7b9-4730-afca-309ef45a51d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a2dfc3e0-d1a9-4638-bc22-955909088c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_8282333e-b7b9-4730-afca-309ef45a51d6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a2dfc3e0-d1a9-4638-bc22-955909088c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_34a0f493-d0b9-4ddf-b280-73d1fd58476f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_8282333e-b7b9-4730-afca-309ef45a51d6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_34a0f493-d0b9-4ddf-b280-73d1fd58476f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ea24567f-16f7-4e4e-ab90-0729c8f21a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9ffa7a03-dc50-4be1-9038-99bb9e72c2a6" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ea24567f-16f7-4e4e-ab90-0729c8f21a3f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_003ea7a1-0fa9-4224-a72c-c1603efdcec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ea24567f-16f7-4e4e-ab90-0729c8f21a3f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_003ea7a1-0fa9-4224-a72c-c1603efdcec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_003ea7a1-0fa9-4224-a72c-c1603efdcec3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_003ea7a1-0fa9-4224-a72c-c1603efdcec3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_003ea7a1-0fa9-4224-a72c-c1603efdcec3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6fc8c171-b5f9-4cf2-9ba7-9c8756ef5dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_003ea7a1-0fa9-4224-a72c-c1603efdcec3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6fc8c171-b5f9-4cf2-9ba7-9c8756ef5dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8d223f95-ced5-4d60-b739-e11bd463029a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6fc8c171-b5f9-4cf2-9ba7-9c8756ef5dc9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8d223f95-ced5-4d60-b739-e11bd463029a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8599790c-73b4-4373-83c7-11f622ecb0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6fc8c171-b5f9-4cf2-9ba7-9c8756ef5dc9" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8599790c-73b4-4373-83c7-11f622ecb0ad" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" xlink:type="extended" id="i67ae09eb4b39475a9e7e08b3e7fa50fa_BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_83051640-881d-42cc-b425-5caa74b3a48f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_d34dfbd4-e5b1-4220-ae57-433e45514fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_83051640-881d-42cc-b425-5caa74b3a48f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_d34dfbd4-e5b1-4220-ae57-433e45514fe2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bde9ff48-85c9-49e4-9b95-be71ce49859d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_83051640-881d-42cc-b425-5caa74b3a48f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bde9ff48-85c9-49e4-9b95-be71ce49859d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_665a969d-26f1-472d-ab77-2330a1c85541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bde9ff48-85c9-49e4-9b95-be71ce49859d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_665a969d-26f1-472d-ab77-2330a1c85541" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_665a969d-26f1-472d-ab77-2330a1c85541_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_665a969d-26f1-472d-ab77-2330a1c85541" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_665a969d-26f1-472d-ab77-2330a1c85541_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0cacc123-6d68-49c8-8a9c-5197e3507fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_665a969d-26f1-472d-ab77-2330a1c85541" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0cacc123-6d68-49c8-8a9c-5197e3507fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_97a13bde-2d86-4bd6-a47d-447b0b26ac41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0cacc123-6d68-49c8-8a9c-5197e3507fad" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_97a13bde-2d86-4bd6-a47d-447b0b26ac41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_7c8d1160-4ff1-4180-9a51-7ffa077c2549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bde9ff48-85c9-49e4-9b95-be71ce49859d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_7c8d1160-4ff1-4180-9a51-7ffa077c2549" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_7c8d1160-4ff1-4180-9a51-7ffa077c2549_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_7c8d1160-4ff1-4180-9a51-7ffa077c2549" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_7c8d1160-4ff1-4180-9a51-7ffa077c2549_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_5fd2a47e-be6b-410c-b142-9c063e6b82c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_7c8d1160-4ff1-4180-9a51-7ffa077c2549" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_5fd2a47e-be6b-410c-b142-9c063e6b82c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_c92263c1-c876-47a1-a380-c81447e4de13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5fd2a47e-be6b-410c-b142-9c063e6b82c5" xlink:to="loc_us-gaap_DomesticPlanMember_c92263c1-c876-47a1-a380-c81447e4de13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_01d48467-7285-4d2e-a04c-511137c0b007" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_c92263c1-c876-47a1-a380-c81447e4de13" xlink:to="loc_country_US_01d48467-7285-4d2e-a04c-511137c0b007" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_088f1efa-8201-4405-8084-8dd9f848e144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5fd2a47e-be6b-410c-b142-9c063e6b82c5" xlink:to="loc_us-gaap_ForeignPlanMember_088f1efa-8201-4405-8084-8dd9f848e144" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansAllocationofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="extended" id="i8237ded3a0514acf9bcd65589d6e0500_BenefitPlansAllocationofPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5754e407-cef3-471b-a3ad-b751278ee772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_e091858e-a18e-4581-ac46-b068fd1f2e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5754e407-cef3-471b-a3ad-b751278ee772" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_e091858e-a18e-4581-ac46-b068fd1f2e5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_8d36e7db-4f90-4db4-9ffd-76a0682cb67d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5754e407-cef3-471b-a3ad-b751278ee772" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_8d36e7db-4f90-4db4-9ffd-76a0682cb67d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6eb51139-72b0-49a3-b018-f39ed84725ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5754e407-cef3-471b-a3ad-b751278ee772" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6eb51139-72b0-49a3-b018-f39ed84725ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5754e407-cef3-471b-a3ad-b751278ee772" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3b399f6b-44a6-4490-9495-21ed2e9b9e52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:to="loc_srt_RangeAxis_3b399f6b-44a6-4490-9495-21ed2e9b9e52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b399f6b-44a6-4490-9495-21ed2e9b9e52_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3b399f6b-44a6-4490-9495-21ed2e9b9e52" xlink:to="loc_srt_RangeMember_3b399f6b-44a6-4490-9495-21ed2e9b9e52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0b352f4c-7e62-4497-8ba7-f946903e705a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3b399f6b-44a6-4490-9495-21ed2e9b9e52" xlink:to="loc_srt_RangeMember_0b352f4c-7e62-4497-8ba7-f946903e705a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6813309c-9b7c-455c-81ad-2937554d0b78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0b352f4c-7e62-4497-8ba7-f946903e705a" xlink:to="loc_srt_MinimumMember_6813309c-9b7c-455c-81ad-2937554d0b78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_04af34d7-5b76-4765-919d-8c9b50fb178f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0b352f4c-7e62-4497-8ba7-f946903e705a" xlink:to="loc_srt_MaximumMember_04af34d7-5b76-4765-919d-8c9b50fb178f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8bdbdc04-5df4-4bde-b943-99badaddf714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8bdbdc04-5df4-4bde-b943-99badaddf714" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_8bdbdc04-5df4-4bde-b943-99badaddf714_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8bdbdc04-5df4-4bde-b943-99badaddf714" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_8bdbdc04-5df4-4bde-b943-99badaddf714_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8bdbdc04-5df4-4bde-b943-99badaddf714" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember_4670eebd-2380-4e95-b331-16aa37a24af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_us-gaap_DefinedBenefitPlanCashMember_4670eebd-2380-4e95-b331-16aa37a24af3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_aa9fc15f-e70c-4987-aa99-e933bbd7b52c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_aa9fc15f-e70c-4987-aa99-e933bbd7b52c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_02ec84d4-4e09-4fa0-a48d-bbd1877778cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_02ec84d4-4e09-4fa0-a48d-bbd1877778cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_427fdf9e-56ef-4e3b-8765-2ee2e4e75260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_us-gaap_OtherInvestmentsMember_427fdf9e-56ef-4e3b-8765-2ee2e4e75260" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_12b4abfb-5a38-4c01-99b0-f60b360da9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_us-gaap_MutualFundMember_12b4abfb-5a38-4c01-99b0-f60b360da9a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherMutualFundsMember_a4a3aa23-2748-43c5-82f2-5d788e1827dd" xlink:href="wst-20221231.xsd#wst_OtherMutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_wst_OtherMutualFundsMember_a4a3aa23-2748-43c5-82f2-5d788e1827dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8522664b-781d-486b-b706-9ec68ee8a318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8522664b-781d-486b-b706-9ec68ee8a318" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8522664b-781d-486b-b706-9ec68ee8a318_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8522664b-781d-486b-b706-9ec68ee8a318" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8522664b-781d-486b-b706-9ec68ee8a318_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f10124d1-e1df-454a-8366-323954c38fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8522664b-781d-486b-b706-9ec68ee8a318" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f10124d1-e1df-454a-8366-323954c38fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_733f48a5-fd03-4e1a-85a2-1cd1d4edbcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f10124d1-e1df-454a-8366-323954c38fed" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_733f48a5-fd03-4e1a-85a2-1cd1d4edbcc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_94ab58f1-277f-4700-aacb-cb45e51e8674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_733f48a5-fd03-4e1a-85a2-1cd1d4edbcc9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_94ab58f1-277f-4700-aacb-cb45e51e8674" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_caf7b064-1bfb-4b95-8fb5-5424782338e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_733f48a5-fd03-4e1a-85a2-1cd1d4edbcc9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_caf7b064-1bfb-4b95-8fb5-5424782338e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5bd4360a-0a4e-4434-8d60-c2a65b5e75bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_733f48a5-fd03-4e1a-85a2-1cd1d4edbcc9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5bd4360a-0a4e-4434-8d60-c2a65b5e75bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_1849e22e-11b5-42bb-b824-01c9ab21f64a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f10124d1-e1df-454a-8366-323954c38fed" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_1849e22e-11b5-42bb-b824-01c9ab21f64a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_fde29c12-2606-4f2a-a7dd-ec1eb4f3f0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_fde29c12-2606-4f2a-a7dd-ec1eb4f3f0c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_fde29c12-2606-4f2a-a7dd-ec1eb4f3f0c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_fde29c12-2606-4f2a-a7dd-ec1eb4f3f0c1" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_fde29c12-2606-4f2a-a7dd-ec1eb4f3f0c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_52e08510-80e5-4805-8251-1747ede42d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_fde29c12-2606-4f2a-a7dd-ec1eb4f3f0c1" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_52e08510-80e5-4805-8251-1747ede42d85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_86cdea22-920f-4fc1-b1bf-bc707e82d2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_52e08510-80e5-4805-8251-1747ede42d85" xlink:to="loc_us-gaap_DomesticPlanMember_86cdea22-920f-4fc1-b1bf-bc707e82d2a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eedacbef-0837-43b1-bc70-60f070b9114b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_86cdea22-920f-4fc1-b1bf-bc707e82d2a6" xlink:to="loc_country_US_eedacbef-0837-43b1-bc70-60f070b9114b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherExpenseIncomeNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="extended" id="idc331de351174b2fabbb81ae932636f5_OtherExpenseIncomeNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_84bd1f15-18a7-4595-8ca3-86ce84edd652" xlink:href="wst-20221231.xsd#wst_RestructuringAndRelatedActivitiesPeriodOfImplementation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_84bd1f15-18a7-4595-8ca3-86ce84edd652" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_51cb76fb-d954-4ff4-9339-975bc1290e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_51cb76fb-d954-4ff4-9339-975bc1290e06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureEarningsAmount_f9093460-2428-444b-86c2-158326cc362e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOnFutureEarningsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_EffectOnFutureEarningsAmount_f9093460-2428-444b-86c2-158326cc362e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_32a4bc2a-60f7-40f6-ab23-248d8140f94e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_AssetImpairmentCharges_32a4bc2a-60f7-40f6-ab23-248d8140f94e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_eb55e0ae-0758-4a14-b79e-ff66beaa279f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_eb55e0ae-0758-4a14-b79e-ff66beaa279f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4dd5d523-d5cf-4f63-9f91-ae6610f449e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4dd5d523-d5cf-4f63-9f91-ae6610f449e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_1c404aa0-1d7b-4e76-b2b9-3f2744c574ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_GainLossOnInvestments_1c404aa0-1d7b-4e76-b2b9-3f2744c574ff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_b850de0a-8e8e-4d9d-acc6-d76032d502a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_b850de0a-8e8e-4d9d-acc6-d76032d502a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_d457da99-b879-4d64-9a4b-ba24fd497ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_d457da99-b879-4d64-9a4b-ba24fd497ee0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable_e824cd0f-f876-4b84-ac95-34162a6bf85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsTable_e824cd0f-f876-4b84-ac95-34162a6bf85d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_4152b124-e5ae-4a46-a61b-272956eb16c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_e824cd0f-f876-4b84-ac95-34162a6bf85d" xlink:to="loc_us-gaap_RestructuringPlanAxis_4152b124-e5ae-4a46-a61b-272956eb16c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_4152b124-e5ae-4a46-a61b-272956eb16c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_4152b124-e5ae-4a46-a61b-272956eb16c0" xlink:to="loc_us-gaap_RestructuringPlanDomain_4152b124-e5ae-4a46-a61b-272956eb16c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_06e071f2-8f3e-4baa-866e-375685b8c5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_4152b124-e5ae-4a46-a61b-272956eb16c0" xlink:to="loc_us-gaap_RestructuringPlanDomain_06e071f2-8f3e-4baa-866e-375685b8c5d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2022RestructuringPlanMember_7b23ce65-0ecf-4c65-84e4-962095561614" xlink:href="wst-20221231.xsd#wst_The2022RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_06e071f2-8f3e-4baa-866e-375685b8c5d3" xlink:to="loc_wst_The2022RestructuringPlanMember_7b23ce65-0ecf-4c65-84e4-962095561614" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2020RestructuringPlanMember_9b53c25e-3e23-44f8-b6e6-aa85f9a10c65" xlink:href="wst-20221231.xsd#wst_The2020RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_06e071f2-8f3e-4baa-866e-375685b8c5d3" xlink:to="loc_wst_The2020RestructuringPlanMember_9b53c25e-3e23-44f8-b6e6-aa85f9a10c65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_08de622f-0722-4afa-8b30-66f35adda48c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_e824cd0f-f876-4b84-ac95-34162a6bf85d" xlink:to="loc_srt_RangeAxis_08de622f-0722-4afa-8b30-66f35adda48c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_08de622f-0722-4afa-8b30-66f35adda48c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_08de622f-0722-4afa-8b30-66f35adda48c" xlink:to="loc_srt_RangeMember_08de622f-0722-4afa-8b30-66f35adda48c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_682ef4f2-f422-4383-b84e-3c15a1f3277d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_08de622f-0722-4afa-8b30-66f35adda48c" xlink:to="loc_srt_RangeMember_682ef4f2-f422-4383-b84e-3c15a1f3277d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2a92b72e-eaba-41db-8816-ea5918f07079" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_682ef4f2-f422-4383-b84e-3c15a1f3277d" xlink:to="loc_srt_MinimumMember_2a92b72e-eaba-41db-8816-ea5918f07079" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9310db44-aefc-4c6e-93d1-9db7ea85428b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_682ef4f2-f422-4383-b84e-3c15a1f3277d" xlink:to="loc_srt_MaximumMember_9310db44-aefc-4c6e-93d1-9db7ea85428b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" xlink:type="extended" id="i2a502dfb1d184ea7a790ff4df04d2e2b_OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1d6e5c1d-65cb-478d-9038-7513a7005b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d6e5c1d-65cb-478d-9038-7513a7005b24" xlink:to="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b1f29c58-7deb-44dd-b6c6-23f778cbc43c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:to="loc_us-gaap_RestructuringReserve_b1f29c58-7deb-44dd-b6c6-23f778cbc43c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_cbb2084e-cd45-4af3-b9a3-51af91d04c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:to="loc_us-gaap_RestructuringCharges_cbb2084e-cd45-4af3-b9a3-51af91d04c20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_df32048a-418c-44c6-b66d-7f1bd32c9575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:to="loc_us-gaap_PaymentsForRestructuring_df32048a-418c-44c6-b66d-7f1bd32c9575" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d0b2eecc-7f29-4565-ba7c-be9adcb5893a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_49ea6803-8aab-46e2-afb6-cdcfa55e4a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d6e5c1d-65cb-478d-9038-7513a7005b24" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_49ea6803-8aab-46e2-afb6-cdcfa55e4a10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_8fbd0dda-aec6-4aa1-a16c-8b398f52c00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_49ea6803-8aab-46e2-afb6-cdcfa55e4a10" xlink:to="loc_us-gaap_RestructuringPlanAxis_8fbd0dda-aec6-4aa1-a16c-8b398f52c00e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8fbd0dda-aec6-4aa1-a16c-8b398f52c00e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_8fbd0dda-aec6-4aa1-a16c-8b398f52c00e" xlink:to="loc_us-gaap_RestructuringPlanDomain_8fbd0dda-aec6-4aa1-a16c-8b398f52c00e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_c391a6dd-a036-46e8-b6bc-b68c40aff973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_8fbd0dda-aec6-4aa1-a16c-8b398f52c00e" xlink:to="loc_us-gaap_RestructuringPlanDomain_c391a6dd-a036-46e8-b6bc-b68c40aff973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2022RestructuringPlanMember_1a09b98d-c164-423d-be6c-960943954ce6" xlink:href="wst-20221231.xsd#wst_The2022RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_c391a6dd-a036-46e8-b6bc-b68c40aff973" xlink:to="loc_wst_The2022RestructuringPlanMember_1a09b98d-c164-423d-be6c-960943954ce6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2020RestructuringPlanMember_31a7ff5b-305f-44f4-98c0-d4e43180d10c" xlink:href="wst-20221231.xsd#wst_The2020RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_c391a6dd-a036-46e8-b6bc-b68c40aff973" xlink:to="loc_wst_The2020RestructuringPlanMember_31a7ff5b-305f-44f4-98c0-d4e43180d10c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_d4e815e0-5b4e-412a-a5c3-500f8636a2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_49ea6803-8aab-46e2-afb6-cdcfa55e4a10" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_d4e815e0-5b4e-412a-a5c3-500f8636a2e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d4e815e0-5b4e-412a-a5c3-500f8636a2e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d4e815e0-5b4e-412a-a5c3-500f8636a2e2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d4e815e0-5b4e-412a-a5c3-500f8636a2e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_9e2b5ec1-0fea-45a9-ab63-f8eedba530cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d4e815e0-5b4e-412a-a5c3-500f8636a2e2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_9e2b5ec1-0fea-45a9-ab63-f8eedba530cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_e487d5fb-5ebd-42e6-8116-97afb09787dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_9e2b5ec1-0fea-45a9-ab63-f8eedba530cd" xlink:to="loc_us-gaap_EmployeeSeveranceMember_e487d5fb-5ebd-42e6-8116-97afb09787dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember_893e5f88-b29b-4b77-bb60-b947d247f18e" xlink:href="wst-20221231.xsd#wst_AssetRelatedChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_9e2b5ec1-0fea-45a9-ab63-f8eedba530cd" xlink:to="loc_wst_AssetRelatedChargesMember_893e5f88-b29b-4b77-bb60-b947d247f18e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_3b643032-ae15-49c1-8e62-449da040eefe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_9e2b5ec1-0fea-45a9-ab63-f8eedba530cd" xlink:to="loc_us-gaap_OtherRestructuringMember_3b643032-ae15-49c1-8e62-449da040eefe" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="iaaee16860dd146d0b85a08f459e8b7fa_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_bd22f437-b208-46cf-af8a-28e5f859ea8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_bd22f437-b208-46cf-af8a-28e5f859ea8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_42e2680e-c8fd-44e8-81fe-3ea2514e53c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_42e2680e-c8fd-44e8-81fe-3ea2514e53c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2fd5c22e-c363-455f-ac0d-cfa8fa6d3d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2fd5c22e-c363-455f-ac0d-cfa8fa6d3d6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_f73457e6-b7fb-4b91-8389-b9e41f07c20d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_f73457e6-b7fb-4b91-8389-b9e41f07c20d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount_13c51774-360b-4f84-873c-baae047b2886" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount_13c51774-360b-4f84-873c-baae047b2886" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount_aacb06a7-0d72-4bc9-a0ca-d74d90c7399c" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount_aacb06a7-0d72-4bc9-a0ca-d74d90c7399c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount_bc924501-735c-4927-94d6-e0d638ddfaa4" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount_bc924501-735c-4927-94d6-e0d638ddfaa4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlementsOther_04899b5b-fda6-4f55-9b03-8ba939c97168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlementsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlementsOther_04899b5b-fda6-4f55-9b03-8ba939c97168" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_36c154c2-1f49-48aa-acba-dedde74d2125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_36c154c2-1f49-48aa-acba-dedde74d2125" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_15f5ab81-e85a-4588-8acc-1ee6797b8957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_OperatingLossCarryforwards_15f5ab81-e85a-4588-8acc-1ee6797b8957" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_f62225be-3206-48aa-997f-cb3140a9148a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_f62225be-3206-48aa-997f-cb3140a9148a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3d07387c-97ed-494e-be87-43e116d0c8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3d07387c-97ed-494e-be87-43e116d0c8eb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_0e335544-ff9c-4d11-91dc-92e868d0b313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_0e335544-ff9c-4d11-91dc-92e868d0b313" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_3c8a91f4-0c36-4a9b-840c-7a5e1a70db5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_3c8a91f4-0c36-4a9b-840c-7a5e1a70db5c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_921b2171-bbee-4b7c-a45f-f1c209e23fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_921b2171-bbee-4b7c-a45f-f1c209e23fa8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8447278d-2177-469e-82a6-ff02d8405ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8447278d-2177-469e-82a6-ff02d8405ba5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8447278d-2177-469e-82a6-ff02d8405ba5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8447278d-2177-469e-82a6-ff02d8405ba5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8447278d-2177-469e-82a6-ff02d8405ba5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_256f6009-f27c-40ef-8aa0-987411e79fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8447278d-2177-469e-82a6-ff02d8405ba5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_256f6009-f27c-40ef-8aa0-987411e79fa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_24d5e59b-7be1-4110-9668-eed7cbbb38c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_256f6009-f27c-40ef-8aa0-987411e79fa0" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_24d5e59b-7be1-4110-9668-eed7cbbb38c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_eb4f1ac6-dd26-49b7-8355-fbacf0210f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_256f6009-f27c-40ef-8aa0-987411e79fa0" xlink:to="loc_us-gaap_ForeignCountryMember_eb4f1ac6-dd26-49b7-8355-fbacf0210f95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodAxis_cf6e30db-a6ea-4c75-9d30-0e7439a6604f" xlink:href="wst-20221231.xsd#wst_ExpirationPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:to="loc_wst_ExpirationPeriodAxis_cf6e30db-a6ea-4c75-9d30-0e7439a6604f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain_cf6e30db-a6ea-4c75-9d30-0e7439a6604f_default" xlink:href="wst-20221231.xsd#wst_ExpirationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_wst_ExpirationPeriodAxis_cf6e30db-a6ea-4c75-9d30-0e7439a6604f" xlink:to="loc_wst_ExpirationPeriodDomain_cf6e30db-a6ea-4c75-9d30-0e7439a6604f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain_8b6916bf-afdc-4994-8bbc-21303a20a8b6" xlink:href="wst-20221231.xsd#wst_ExpirationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_wst_ExpirationPeriodAxis_cf6e30db-a6ea-4c75-9d30-0e7439a6604f" xlink:to="loc_wst_ExpirationPeriodDomain_8b6916bf-afdc-4994-8bbc-21303a20a8b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2021Member_6b26aad7-2f20-4400-9a85-4a9f51576e8d" xlink:href="wst-20221231.xsd#wst_Year2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_8b6916bf-afdc-4994-8bbc-21303a20a8b6" xlink:to="loc_wst_Year2021Member_6b26aad7-2f20-4400-9a85-4a9f51576e8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2022Member_4b380d70-cf66-4e99-bc0d-6e534513e203" xlink:href="wst-20221231.xsd#wst_Year2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_8b6916bf-afdc-4994-8bbc-21303a20a8b6" xlink:to="loc_wst_Year2022Member_4b380d70-cf66-4e99-bc0d-6e534513e203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2022Member_ad3a0be2-1942-43fa-9dac-4192915cb50b" xlink:href="wst-20221231.xsd#wst_YearAfter2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_8b6916bf-afdc-4994-8bbc-21303a20a8b6" xlink:to="loc_wst_YearAfter2022Member_ad3a0be2-1942-43fa-9dac-4192915cb50b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_bf7c6e43-abf0-4468-ad81-8efc98f4ef1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_bf7c6e43-abf0-4468-ad81-8efc98f4ef1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_bf7c6e43-abf0-4468-ad81-8efc98f4ef1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_bf7c6e43-abf0-4468-ad81-8efc98f4ef1d" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_bf7c6e43-abf0-4468-ad81-8efc98f4ef1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_cdae3770-ccb1-42d4-ab4e-a1164f0bad82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_bf7c6e43-abf0-4468-ad81-8efc98f4ef1d" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_cdae3770-ccb1-42d4-ab4e-a1164f0bad82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_f3b718d5-d7b4-46f3-9f30-9fd84052526e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_cdae3770-ccb1-42d4-ab4e-a1164f0bad82" xlink:to="loc_us-gaap_ResearchMember_f3b718d5-d7b4-46f3-9f30-9fd84052526e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ie5fc12d10aa5430ba70b3f3c0a758c1c_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_6fff304e-8ce9-476e-bc7a-838b59c1533a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_6fff304e-8ce9-476e-bc7a-838b59c1533a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_95ad6d44-8fb7-4951-89c3-05f2e41d1c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_95ad6d44-8fb7-4951-89c3-05f2e41d1c1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_1e681d04-cc60-4561-b7fc-113569e5818e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_LineOfCredit_1e681d04-cc60-4561-b7fc-113569e5818e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2df44a44-af8a-44ad-a8ce-d9dce32ccae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2df44a44-af8a-44ad-a8ce-d9dce32ccae2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyReceivable_ab06e9af-a8f6-4b41-b469-8180f5ddc224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_LossContingencyReceivable_ab06e9af-a8f6-4b41-b469-8180f5ddc224" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1d048a10-2a3b-436c-b872-6b9e36c7d544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:to="loc_us-gaap_CreditFacilityAxis_1d048a10-2a3b-436c-b872-6b9e36c7d544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1d048a10-2a3b-436c-b872-6b9e36c7d544_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1d048a10-2a3b-436c-b872-6b9e36c7d544" xlink:to="loc_us-gaap_CreditFacilityDomain_1d048a10-2a3b-436c-b872-6b9e36c7d544_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7819b02a-a576-41d7-94a9-d76ad6cbd47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1d048a10-2a3b-436c-b872-6b9e36c7d544" xlink:to="loc_us-gaap_CreditFacilityDomain_7819b02a-a576-41d7-94a9-d76ad6cbd47b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_c38f8d44-a87f-45bc-9513-9f30b5197c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7819b02a-a576-41d7-94a9-d76ad6cbd47b" xlink:to="loc_us-gaap_LetterOfCreditMember_c38f8d44-a87f-45bc-9513-9f30b5197c30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_17fa33ca-774f-420b-b6da-88935286632d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_17fa33ca-774f-420b-b6da-88935286632d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_17fa33ca-774f-420b-b6da-88935286632d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17fa33ca-774f-420b-b6da-88935286632d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_17fa33ca-774f-420b-b6da-88935286632d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0a314cf6-4627-4ece-8901-f8821a0e67de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17fa33ca-774f-420b-b6da-88935286632d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0a314cf6-4627-4ece-8901-f8821a0e67de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_a1a9899f-48b7-4bb0-98f2-ca958466abb3" xlink:href="wst-20221231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0a314cf6-4627-4ece-8901-f8821a0e67de" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_a1a9899f-48b7-4bb0-98f2-ca958466abb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a9412838-200d-4550-abf1-d7f1f381a561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a9412838-200d-4550-abf1-d7f1f381a561" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_a9412838-200d-4550-abf1-d7f1f381a561_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a9412838-200d-4550-abf1-d7f1f381a561" xlink:to="loc_us-gaap_LossContingencyNatureDomain_a9412838-200d-4550-abf1-d7f1f381a561_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e4e728bf-6473-4f37-96ef-b858a71d546e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a9412838-200d-4550-abf1-d7f1f381a561" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e4e728bf-6473-4f37-96ef-b858a71d546e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceClaimsMember_79fec2ea-b795-4ba8-9750-46a5c6d98285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e4e728bf-6473-4f37-96ef-b858a71d546e" xlink:to="loc_us-gaap_InsuranceClaimsMember_79fec2ea-b795-4ba8-9750-46a5c6d98285" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#SegmentInformationSalesbyProductGroupDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="extended" id="i9bc47aeab60a42b5a5e7090f8e06edfa_SegmentInformationSalesbyProductGroupDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_da3f2890-2ff9-429e-9c0a-dc9dcf6813ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b959041f-d2ab-4036-8580-d7ba27a1ae6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_da3f2890-2ff9-429e-9c0a-dc9dcf6813ad" xlink:to="loc_us-gaap_Revenues_b959041f-d2ab-4036-8580-d7ba27a1ae6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_4d8eb0f0-b072-46b7-9f38-7a33129914a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_da3f2890-2ff9-429e-9c0a-dc9dcf6813ad" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_4d8eb0f0-b072-46b7-9f38-7a33129914a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_31b83fb0-3878-4c1e-82e3-72d8e1c6c84f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_4d8eb0f0-b072-46b7-9f38-7a33129914a5" xlink:to="loc_srt_ConsolidationItemsAxis_31b83fb0-3878-4c1e-82e3-72d8e1c6c84f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_31b83fb0-3878-4c1e-82e3-72d8e1c6c84f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_31b83fb0-3878-4c1e-82e3-72d8e1c6c84f" xlink:to="loc_srt_ConsolidationItemsDomain_31b83fb0-3878-4c1e-82e3-72d8e1c6c84f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6bc05504-8f49-43bf-90a7-fcccb1157ef1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_31b83fb0-3878-4c1e-82e3-72d8e1c6c84f" xlink:to="loc_srt_ConsolidationItemsDomain_6bc05504-8f49-43bf-90a7-fcccb1157ef1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2afa76c9-a97a-497e-bc5d-eb9f0b394f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6bc05504-8f49-43bf-90a7-fcccb1157ef1" xlink:to="loc_us-gaap_OperatingSegmentsMember_2afa76c9-a97a-497e-bc5d-eb9f0b394f28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_6ef6de3a-78db-41ad-9396-bee85409e23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6bc05504-8f49-43bf-90a7-fcccb1157ef1" xlink:to="loc_us-gaap_IntersegmentEliminationMember_6ef6de3a-78db-41ad-9396-bee85409e23d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a2ec0d29-75b8-483e-8969-b3ad403c7da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_4d8eb0f0-b072-46b7-9f38-7a33129914a5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a2ec0d29-75b8-483e-8969-b3ad403c7da8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a2ec0d29-75b8-483e-8969-b3ad403c7da8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2ec0d29-75b8-483e-8969-b3ad403c7da8" xlink:to="loc_us-gaap_SegmentDomain_a2ec0d29-75b8-483e-8969-b3ad403c7da8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f4a597d3-776b-4160-b648-aaa0415c9e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2ec0d29-75b8-483e-8969-b3ad403c7da8" xlink:to="loc_us-gaap_SegmentDomain_f4a597d3-776b-4160-b648-aaa0415c9e91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_05b974b6-1663-4dd1-b013-e911680ac780" xlink:href="wst-20221231.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f4a597d3-776b-4160-b648-aaa0415c9e91" xlink:to="loc_wst_ProprietaryProductsMember_05b974b6-1663-4dd1-b013-e911680ac780" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_a0836e73-bd33-4be8-82e5-29e1ba269b1c" xlink:href="wst-20221231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f4a597d3-776b-4160-b648-aaa0415c9e91" xlink:to="loc_wst_ContractManufacturedProductsMember_a0836e73-bd33-4be8-82e5-29e1ba269b1c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" xlink:type="extended" id="if7baedb028be4290af7f4b4f8b3fc256_SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_94b8120a-1b0e-4c7a-ac25-68621d7ac4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_78ba2914-c668-42bd-821f-6356181a8ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_94b8120a-1b0e-4c7a-ac25-68621d7ac4c0" xlink:to="loc_us-gaap_Revenues_78ba2914-c668-42bd-821f-6356181a8ccf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_89f26ad8-c512-4e4f-82bb-5c7874d39dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_94b8120a-1b0e-4c7a-ac25-68621d7ac4c0" xlink:to="loc_us-gaap_NoncurrentAssets_89f26ad8-c512-4e4f-82bb-5c7874d39dbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2a20fdc1-a3a8-40d5-acab-571947391d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_94b8120a-1b0e-4c7a-ac25-68621d7ac4c0" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2a20fdc1-a3a8-40d5-acab-571947391d94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e8da6a46-55ca-4cd0-9abd-a32f0fc0ebbf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2a20fdc1-a3a8-40d5-acab-571947391d94" xlink:to="loc_srt_StatementGeographicalAxis_e8da6a46-55ca-4cd0-9abd-a32f0fc0ebbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e8da6a46-55ca-4cd0-9abd-a32f0fc0ebbf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e8da6a46-55ca-4cd0-9abd-a32f0fc0ebbf" xlink:to="loc_srt_SegmentGeographicalDomain_e8da6a46-55ca-4cd0-9abd-a32f0fc0ebbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e8da6a46-55ca-4cd0-9abd-a32f0fc0ebbf" xlink:to="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d77f2c7d-0e1f-49d5-9d01-994f0287ea76" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_country_US_d77f2c7d-0e1f-49d5-9d01-994f0287ea76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_7711281d-8a48-4d88-bf0f-e105a67e0f22" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_country_DE_7711281d-8a48-4d88-bf0f-e105a67e0f22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_8220d3dc-7535-43a8-91cb-c97b6da003de" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_country_IE_8220d3dc-7535-43a8-91cb-c97b6da003de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_7d19dd9c-53a7-4c00-b643-aa3c18f08ade" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_country_FR_7d19dd9c-53a7-4c00-b643-aa3c18f08ade" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherEuropeCountriesMember_67f7e826-4d79-4ffb-9bcb-cfbdbb899d55" xlink:href="wst-20221231.xsd#wst_OtherEuropeCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_wst_OtherEuropeCountriesMember_67f7e826-4d79-4ffb-9bcb-cfbdbb899d55" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCountriesMember_da9cfcca-2635-4123-99b9-397212bda6b7" xlink:href="wst-20221231.xsd#wst_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_wst_OtherCountriesMember_da9cfcca-2635-4123-99b9-397212bda6b7" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended" id="i716e0aeb268040b7a1018bd3bbb0bbb0_SegmentInformationSegmentFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6cfe4966-1261-4cf7-b562-647d93b28ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_OperatingIncomeLoss_6cfe4966-1261-4cf7-b562-647d93b28ee5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4ab34073-8f49-4895-9ba6-18df59169c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_ShareBasedCompensation_4ab34073-8f49-4895-9ba6-18df59169c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_eac35670-740b-489a-a576-6b5fd29844e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_eac35670-740b-489a-a576-6b5fd29844e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6a1c4b9d-2d21-4e84-b608-5ee9cc483eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_RestructuringCharges_6a1c4b9d-2d21-4e84-b608-5ee9cc483eba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4b806e30-d50d-4432-b790-e5a0279b5f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4b806e30-d50d-4432-b790-e5a0279b5f63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_90bcc207-261c-42ef-aa95-56b0fa8ee301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_AssetImpairmentCharges_90bcc207-261c-42ef-aa95-56b0fa8ee301" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CostInvestmentImpairment_16c17614-5ba0-446b-8675-69b2af7d0452" xlink:href="wst-20221231.xsd#wst_CostInvestmentImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_wst_CostInvestmentImpairment_16c17614-5ba0-446b-8675-69b2af7d0452" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_798fd9d2-18bc-4826-95a5-d8cd6051ab27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_798fd9d2-18bc-4826-95a5-d8cd6051ab27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_423e38c0-ef88-457e-baf6-b20e568d4b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_423e38c0-ef88-457e-baf6-b20e568d4b5a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_059ac3c7-702e-4c1b-a888-8ccbcb6b5c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_059ac3c7-702e-4c1b-a888-8ccbcb6b5c7b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5159184f-46bb-4132-b3a8-9cfdf6ce9417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_Assets_5159184f-46bb-4132-b3a8-9cfdf6ce9417" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f4834b4c-ae01-45d5-ae95-32940733798c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f4834b4c-ae01-45d5-ae95-32940733798c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_38bb9ba7-b218-4f83-9692-0ff12c6f063b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_38bb9ba7-b218-4f83-9692-0ff12c6f063b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_11298593-322d-4759-9ff4-1e197daab158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_11298593-322d-4759-9ff4-1e197daab158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_11298593-322d-4759-9ff4-1e197daab158_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_11298593-322d-4759-9ff4-1e197daab158" xlink:to="loc_us-gaap_SegmentDomain_11298593-322d-4759-9ff4-1e197daab158_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_443ab004-c1d5-489c-88db-27325897eb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_11298593-322d-4759-9ff4-1e197daab158" xlink:to="loc_us-gaap_SegmentDomain_443ab004-c1d5-489c-88db-27325897eb0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_5a48fb71-92f1-4a90-99ff-499c8bda211d" xlink:href="wst-20221231.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_443ab004-c1d5-489c-88db-27325897eb0f" xlink:to="loc_wst_ProprietaryProductsMember_5a48fb71-92f1-4a90-99ff-499c8bda211d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_42eb7461-6259-4996-97ba-1e2dcee37b2e" xlink:href="wst-20221231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_443ab004-c1d5-489c-88db-27325897eb0f" xlink:to="loc_wst_ContractManufacturedProductsMember_42eb7461-6259-4996-97ba-1e2dcee37b2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_57463a28-0e0e-4b99-9eaa-3c503eff2a71" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:to="loc_srt_ConsolidationItemsAxis_57463a28-0e0e-4b99-9eaa-3c503eff2a71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_57463a28-0e0e-4b99-9eaa-3c503eff2a71_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_57463a28-0e0e-4b99-9eaa-3c503eff2a71" xlink:to="loc_srt_ConsolidationItemsDomain_57463a28-0e0e-4b99-9eaa-3c503eff2a71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4a423b50-a57c-46b4-b09b-bb727d8cd8ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_57463a28-0e0e-4b99-9eaa-3c503eff2a71" xlink:to="loc_srt_ConsolidationItemsDomain_4a423b50-a57c-46b4-b09b-bb727d8cd8ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d5eb8b8f-a41c-49ca-b53a-79590fa9a197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4a423b50-a57c-46b4-b09b-bb727d8cd8ec" xlink:to="loc_us-gaap_OperatingSegmentsMember_d5eb8b8f-a41c-49ca-b53a-79590fa9a197" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_a8b87ac2-79cd-49e3-96e1-c1183caa5357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4a423b50-a57c-46b4-b09b-bb727d8cd8ec" xlink:to="loc_us-gaap_CorporateNonSegmentMember_a8b87ac2-79cd-49e3-96e1-c1183caa5357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f4b7d367-59bb-4fd5-a09d-9e9fae1f2a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f4b7d367-59bb-4fd5-a09d-9e9fae1f2a2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4b7d367-59bb-4fd5-a09d-9e9fae1f2a2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f4b7d367-59bb-4fd5-a09d-9e9fae1f2a2c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4b7d367-59bb-4fd5-a09d-9e9fae1f2a2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f20b963a-abc8-4783-b36f-f2d8f04af60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f4b7d367-59bb-4fd5-a09d-9e9fae1f2a2c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f20b963a-abc8-4783-b36f-f2d8f04af60a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SecondQuarter2020AcquisiitonMember_d84a44e5-1f93-4bef-aba2-97bf290e333e" xlink:href="wst-20221231.xsd#wst_SecondQuarter2020AcquisiitonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f20b963a-abc8-4783-b36f-f2d8f04af60a" xlink:to="loc_wst_SecondQuarter2020AcquisiitonMember_d84a44e5-1f93-4bef-aba2-97bf290e333e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_73854152-1d75-450d-9714-014716686dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_73854152-1d75-450d-9714-014716686dfb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_73854152-1d75-450d-9714-014716686dfb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_73854152-1d75-450d-9714-014716686dfb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_73854152-1d75-450d-9714-014716686dfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9dc7838a-6bf1-4b73-8e19-de823d3c8837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_73854152-1d75-450d-9714-014716686dfb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9dc7838a-6bf1-4b73-8e19-de823d3c8837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f457544d-89d2-4fe2-8da4-d331f43a965c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9dc7838a-6bf1-4b73-8e19-de823d3c8837" xlink:to="loc_us-gaap_CostOfSalesMember_f457544d-89d2-4fe2-8da4-d331f43a965c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6d5cad82-e5e6-4d1f-843b-593ea77a616c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9dc7838a-6bf1-4b73-8e19-de823d3c8837" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6d5cad82-e5e6-4d1f-843b-593ea77a616c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended" id="id1a56454789a49b6b20d82aae86aec8a_ScheduleIIValuationandQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_54f49cae-8692-41d4-9630-61e3e14b9416" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_54f49cae-8692-41d4-9630-61e3e14b9416" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_5d9db614-2996-488d-b7e4-2472860067ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_5d9db614-2996-488d-b7e4-2472860067ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4934dbd9-2c8d-4fc8-bccb-ee8896b50537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4934dbd9-2c8d-4fc8-bccb-ee8896b50537" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d0d7d5f2-c767-444b-a9e6-60fb871b75a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d0d7d5f2-c767-444b-a9e6-60fb871b75a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_18c4f9e3-4fbc-4098-8fa5-93ba666db18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c1a221d-ff3e-4ccc-822a-25955996c3fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_54f49cae-8692-41d4-9630-61e3e14b9416" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c1a221d-ff3e-4ccc-822a-25955996c3fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_67155607-08a5-4497-8939-97041cdc3c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c1a221d-ff3e-4ccc-822a-25955996c3fb" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_67155607-08a5-4497-8939-97041cdc3c2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_67155607-08a5-4497-8939-97041cdc3c2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_67155607-08a5-4497-8939-97041cdc3c2b" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_67155607-08a5-4497-8939-97041cdc3c2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_435b2736-99d6-41ca-bd40-15cc038621e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_67155607-08a5-4497-8939-97041cdc3c2b" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_435b2736-99d6-41ca-bd40-15cc038621e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_af2b6e4d-4ad4-4d34-b517-8a2978df1fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_435b2736-99d6-41ca-bd40-15cc038621e1" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_af2b6e4d-4ad4-4d34-b517-8a2978df1fcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_7c2d4722-2237-40c1-8066-2908b1db6fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_435b2736-99d6-41ca-bd40-15cc038621e1" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_7c2d4722-2237-40c1-8066-2908b1db6fc5" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>wst-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6ce7082f-45c4-495e-94eb-caa34b024fa0,g:4770da38-231a-455c-ab1e-d14c8c362bd8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_84b7f624-340f-4436-a1d5-77f82f582083_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_8b7359cc-efaa-4300-81f7-2a60fbdd41de_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_b293eccf-2797-4e50-9f46-1196791f61e3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c130cfcf-b26d-4eb3-9c0a-026db42ce63b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_387d6e61-ac62-44e5-a6f1-09eb3de8f26c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:to="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_c7428940-55d2-4db2-8380-a478687cb86d_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_36457aa8-72e9-4314-8067-68e809c59bbc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice_242ae7cd-729b-4be6-8d7d-b388684bf9ca_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Vested and Expected to vest, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Vested and Expected to vest, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_eb10ee76-073b-4e62-98a6-2bfa06114389_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ae86dbde-c576-4c27-ba6f-8a41e3d5d9aa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_d12c34eb-4b73-45ce-9372-66d8e1904b93_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_73a09ce2-b859-44de-9de4-287cd774a584_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost investment activity</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_6b780ddb-2849-4b84-a30f-3a3031438cc9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_4da5c185-e7a3-4bac-9701-7fe9e4bb2a2f_negatedLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_f20a2ab4-f568-457b-9425-30343214bb8c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_fd10714e-e71b-4486-9f5d-6e8028d54d28_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_1b66b8ae-bb24-4fba-95ec-c84bd34d1a5e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_f16d1860-6e78-45f9-a9e8-00ee092b4d65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost arising during period, net of tax of $0.0, $0.5, and $0.0</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_56165f4c-cbb2-4d94-85e0-92983470926a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency hedge contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_391a67fb-40e5-4a0a-8bcd-32707423dd70_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_b6cca7ef-16f4-4e5a-8a56-263f7e026519_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_bc67d9fb-53ec-4e5c-b7c3-7b5808501fd2_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ultimate healthcare cost trend rate, net periodic benefit cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:to="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_392dc5e7-a43d-48a3-8ad4-6ea6a7364cbf_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06d56544-ada0-4acd-895a-37509f5a1981_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d79deada-9c89-492d-83c4-026819e07e1f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_2c3aea9f-61b2-43ba-ba73-34798307087d_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f1dea3a9-5592-4f68-841f-5fa7a9dc4684_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_8bdc9224-da88-4e92-af8b-efdb54256ecf_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax asset (liability)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_84ea7d24-502d-481d-b694-efc457774e41_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments above/(below) target (in shares)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0c197a5a-596e-467f-a4c8-2d61e32d8786_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, stated interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_52ecd55a-1eb7-46ec-9fac-486a7c00215d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_df144327-4413-46f5-b832-59ed9c399bc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sales and Long-Lived Assets, by Geographical Areas</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_a37a901e-d27c-43b0-b055-66601c29dc0d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_2da102f9-b3b4-4c77-83f1-12297bc690ab_terseLabel_en-US" xlink:label="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Types Other than Stock Options and Stock Appreciation Rights</link:label>
    <link:label id="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_label_en-US" xlink:label="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Types Other than Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Types Other than Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:href="wst-20221231.xsd#wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:to="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e1116e07-487f-4226-bd00-033e9194cd8b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_40c8714b-79ad-4324-a8a1-2a9c749f57c3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_200c01b5-2ddb-45ef-82d7-84f7cf9d37d5_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed healthcare cost trend rate, net periodic benefit cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:to="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_552e735e-3367-4d27-a12f-aa6f7fe99267_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_f6879dd4-1d98-4b5d-9ce5-607ccc1a6e2f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9b4e51bb-144e-4132-a7ea-bafa03d0d7e3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive options excluded from computation of diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_0463b50f-28cf-41eb-a58b-4e5189353c75_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes other than income</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Taxes Other than Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyGainLossMember_70c1c1f9-2225-47c1-bef8-87c2114fe01d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyGainLossMember_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Gain (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:to="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_6d1571bf-0eec-4d03-bbce-30773a2085a9_terseLabel_en-US" xlink:label="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares reduced for each award granted (in shares)</link:label>
    <link:label id="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_label_en-US" xlink:label="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction In Number Of Shares Available For Grant For Each Award Granted</link:label>
    <link:label id="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_documentation_en-US" xlink:label="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction In Number Of Shares Available For Grant For Each Award Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:href="wst-20221231.xsd#wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:to="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_a63450d9-52e1-404f-a8ef-c6bdd7d234c6_terseLabel_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C notes, due July 5, 2027 (4.02%)</link:label>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_label_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior C Notes Due 2027 [Member]</link:label>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_documentation_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior C Notes Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member" xlink:href="wst-20221231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorCNotesDue2027Member" xlink:to="lab_wst_SeniorCNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_826d9371-d66e-4f0c-94ec-a5c864c4004a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_1159ec91-97c3-4fbf-817b-ae15197d549c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_3c84c70d-f335-43d3-9054-f4892619ccc8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a5105e52-824c-4aa4-87dc-802cafc793fc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_df74bb0d-8ecd-435d-ab00-ccc0d1fc353f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_2f5827db-c15a-4f71-bbc8-8e2a5be8c574_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_a2b50521-2f28-4e78-bac6-1a82f072d1ec_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_e40f0919-e102-4658-94f1-c0225881047e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to current year position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_45ded66a-b654-413b-b775-914e5f61f6a7_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_055f6d47-e362-498d-b796-85dcd7bbc21d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_5e714e89-6be9-4904-9869-0693df79ecc4_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9162082a-bbee-49e0-990d-821d0cc2f4e1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1bd16d50-61c3-4952-ab1d-5d574931a56f_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ded1ed1c-a8ad-40a2-b407-8b2d661485e1_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_0ed139e6-cb31-484f-b01c-0b0b60bae814_terseLabel_en-US" xlink:label="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, additional borrowing capacity</link:label>
    <link:label id="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_label_en-US" xlink:label="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Additional Borrowing Capacity</link:label>
    <link:label id="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_documentation_en-US" xlink:label="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Additional Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:href="wst-20221231.xsd#wst_LineOfCreditFacilityAdditionalBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:to="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_b6f06e84-2cb4-4c2f-9c0f-69dadadd32e2_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_b37a372b-ca4e-49ba-8a40-90bfe5ac3e3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_7edfd5c8-ebaa-4728-8669-939e65c65265_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit supporting the reimbursement of workers' compensation and other claims</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_99f0efe0-338d-4b9e-9987-3cb2df4f2992_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm_9feb9ee8-bd7b-471e-99bc-a4d520baef12_terseLabel_en-US" xlink:label="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, operating lease, terminate term (in years)</link:label>
    <link:label id="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm_label_en-US" xlink:label="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option To Terminate, Term</link:label>
    <link:label id="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm_documentation_en-US" xlink:label="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option To Terminate, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:href="wst-20221231.xsd#wst_LesseeOperatingLeaseOptionToTerminateTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:to="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_c78601ff-6d58-44e4-9378-41ab29a75b3f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on undistributed earnings of subsidiaries</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_01ff2980-5913-49b1-b6eb-cc5638e19065_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_db1809ab-6e11-4859-baa1-e239fa177cbe_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life of options outstanding (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_4617282b-f99b-4eac-8072-39aff49d29d1_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_5f091ab1-be3b-410f-a385-4f171cf530a7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains (losses)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_8c76d6cc-fdd1-4b14-a339-0f8b0a7f6c6c_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_3f968627-aaa1-4b65-b10d-a13b34885903_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_0f856d3d-96bb-4883-8781-e7e2eef900e1_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_c9bca6c2-0adf-4c74-aab3-733b9b341c7d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued commissions, rebates and royalties</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_00dce897-c49c-4fda-b3de-76c051804bad_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_414d213b-c1ed-4f58-8116-f001d02dd8c4_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_1fc4c507-708f-48ba-bd47-49f59fbb6c61_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b91544cf-a021-46f5-b304-75c2f736fa12_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember_62cfb3af-69aa-41a0-b67f-9263db41fb47_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Debt Security [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:to="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_62dfa489-3374-45b3-93fa-08e5aa42b1f9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_38c69894-c5c6-4c17-ba1f-d16b39a9dcc5_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_9256f2bd-9c64-4452-8739-b459d76ae917_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_89e40520-2ebe-4463-a819-12bdac506e4a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ea73c32e-0151-4327-9ecc-901a19ad5902_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3539534c-ed4b-496f-a928-dd1fe02747f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ff79ca7-61e4-4226-89b0-5abe646ac10d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_4851a7d2-de94-495c-a479-b64952ec9667_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_28b6b119-717d-45e4-be7e-8e38ba6bad44_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_8783b744-e37a-420d-a164-10128a1bc039_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reclassification out of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_c19f9092-c640-4754-8974-049ac655917e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0392106c-5463-41fb-a66d-8e6323a22693_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_869f7eac-a23e-4477-91c5-823999311d0d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d612e9de-a861-453a-80e6-3353324c848f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_587b64f5-4d7b-4419-b92d-59980d242e48_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity affiliate investment AOCI</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ff2fafa7-4e3c-48cb-b769-cb47a5fd6114_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_506c55fb-a312-428d-81e8-caada5b8800b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fbfdb3b3-0a78-4359-8df4-48371fde9d50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_c7f8f710-1889-4c83-8e20-be7cbe7d7263_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_ce46314b-95ee-4215-b1ba-98b3ff1b2ec5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected useful lives (years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_91515287-5d93-400f-b045-1e18870bcf0b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_2982a9c8-ab92-45fc-b78b-1825257e6e28_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_657eb744-7845-4cfe-b61a-fddb376fe817_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_bca08355-1131-4041-b2b6-a6a136118c83_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and post-employment benefits</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6b7fa5f2-46e7-4811-a544-c0fe56686a2b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_422d6ae3-591b-4044-8342-3b386c3d7678_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_335a7307-4f6d-4f81-b384-8572ed9dc9b1_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit</link:label>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticLineOfCreditMember" xlink:to="lab_us-gaap_DomesticLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_57c840ee-fc60-48fe-b92e-45c95d27a65d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_9ed036b4-61d6-446b-b6d8-26329ebff7ab_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_a3e65822-86b3-4092-8040-c35f83e0ac79_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_c87dc3fd-64de-460c-83ea-1abad6350a0f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StockSettledPSUAwardsMember_1379f42a-db5b-4b3f-b816-1545bd1270e6_terseLabel_en-US" xlink:label="lab_wst_StockSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled PSU awards</link:label>
    <link:label id="lab_wst_StockSettledPSUAwardsMember_label_en-US" xlink:label="lab_wst_StockSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Settled PSU Awards [Member]</link:label>
    <link:label id="lab_wst_StockSettledPSUAwardsMember_documentation_en-US" xlink:label="lab_wst_StockSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Settled PSU Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember" xlink:href="wst-20221231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StockSettledPSUAwardsMember" xlink:to="lab_wst_StockSettledPSUAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_82c63257-84aa-4e19-89a4-0303fb0d74d2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges, amount of gain (loss) recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_1a9da361-b150-4260-9a54-387d277fd10e_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative (gain) loss recognized in income, fair value hedges</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CreditAvailableForTheIssuanceOfLettersOfCredit_a210b041-662b-465b-818a-16bebbaf293a_terseLabel_en-US" xlink:label="lab_wst_CreditAvailableForTheIssuanceOfLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount available for issuance of letters of credit</link:label>
    <link:label id="lab_wst_CreditAvailableForTheIssuanceOfLettersOfCredit_label_en-US" xlink:label="lab_wst_CreditAvailableForTheIssuanceOfLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Available For The Issuance Of Letters Of Credit</link:label>
    <link:label id="lab_wst_CreditAvailableForTheIssuanceOfLettersOfCredit_documentation_en-US" xlink:label="lab_wst_CreditAvailableForTheIssuanceOfLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Available For The Issuance Of Letters Of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditAvailableForTheIssuanceOfLettersOfCredit" xlink:href="wst-20221231.xsd#wst_CreditAvailableForTheIssuanceOfLettersOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CreditAvailableForTheIssuanceOfLettersOfCredit" xlink:to="lab_wst_CreditAvailableForTheIssuanceOfLettersOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_6289046b-bca6-4a6e-9d91-2a56b9e27df7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Contract with Customer, Asset and Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_f3905c97-3c0f-4997-8771-149e5e4d06d9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_f12b61c2-be75-4f7b-9e86-fc68f8547516_terseLabel_en-US" xlink:label="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation</link:label>
    <link:label id="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters, Contingencies and Legal Costs [Policy Text Block]</link:label>
    <link:label id="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_documentation_en-US" xlink:label="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters, Contingencies and Legal Costs [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:href="wst-20221231.xsd#wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:to="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_41747577-8111-4992-a22d-0bb9218887e9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f3e33f70-566a-4f78-b509-87d717aade45_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_953219db-8589-419f-a9f7-98477c82a559_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_e60aa6b7-a420-4bbe-93fe-c82b2ce35fe8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_11157ece-5371-4be6-bb5f-7016ec33cf86_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_73f63f8f-0c84-45c2-b56c-516a1ee063d0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_44404579-5e85-48a9-9efe-1afa124ec7b8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_6f180962-923e-46be-a2ef-dbd34c732b29_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_431a2b61-8821-4894-9c59-a8f60ff8a683_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_9e4602e5-1883-499a-93c3-81f1f81167f9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_02906f3d-a310-432c-a751-30f3f46d96a5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on international operations other than U.S. tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_6ca150ee-f8fe-427f-a5a0-ca607cf54bed_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent_4ddfd55b-a966-4d65-a1c8-d5d04d1334a3_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount due and payable to affiliates</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_240ce774-ba81-45eb-9886-db028c58e9f4_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_c6a1fd2e-6cc1-4779-bc10-e32ac25f345f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_e9229ac8-2864-4eb5-9a15-54315e52dabd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_7ab9017c-20c3-43cc-aa79-c0d494190687_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_e19ef3f9-97b1-464b-a85d-de2ef5416a15_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_3dd2c4bf-17c9-4ea2-a0c1-258117769ac8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f85d1089-1a25-4840-8400-436c049af55c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period for recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_297e84b5-8de8-46c7-839d-7c10aea8f0ab_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life of options exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_ff9087f9-182c-4f48-8dd4-da6ccf6c35c9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_d93f9efa-1d54-45ac-9c2e-2c340bb974f2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_d8f30a29-17a5-44e9-9af6-53863a905ffb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_9112fab3-152b-4788-b1cb-054b4c30d7e7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_4c346548-87f0-4c3b-a758-46891262681b_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_4f7f2499-bafa-4560-be02-b05dd82b6972_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_60e95310-1c62-4303-b557-3981cdeec914_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_fd6f0b64-f781-4b68-9d95-fb00785b17ac_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, noncurrent</link:label>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_13cc5c37-4929-487c-9697-fe7c30485dc1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12d0e80a-d633-4362-a0e3-8425af30f37a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_8fef3cad-4249-49d7-b8e0-580789b00b13_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7d6ceedf-2e59-4327-b272-7e5e7e770ef6_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_2ab010bf-b286-4825-bd43-74496f66eb06_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, Middle East, Africa</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_edecc321-b828-4c74-8079-3bfaf6f7c6aa_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual funds</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_21b730fd-b146-42ff-accd-c4f1e34008aa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_c037b178-d730-430d-9179-47b67234c3b2_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsTable_3e7b4df9-1b13-4c14-be22-3c113896803b_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:to="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_a2f8f833-0e6e-4514-a5da-08409fec4cd9_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_0ac4b842-c040-4f7b-8060-5e73da8ef567_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8076ff40-e055-454a-9382-0874f92c7b75_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredStockUnitsPayableInCash_d37a4fc2-9464-4695-ac70-43bfcb871d5a_terseLabel_en-US" xlink:label="lab_wst_DeferredStockUnitsPayableInCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of deferred stock units payable in cash (in shares)</link:label>
    <link:label id="lab_wst_DeferredStockUnitsPayableInCash_label_en-US" xlink:label="lab_wst_DeferredStockUnitsPayableInCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Units Payable In Cash</link:label>
    <link:label id="lab_wst_DeferredStockUnitsPayableInCash_documentation_en-US" xlink:label="lab_wst_DeferredStockUnitsPayableInCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Units Payable In Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredStockUnitsPayableInCash" xlink:href="wst-20221231.xsd#wst_DeferredStockUnitsPayableInCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredStockUnitsPayableInCash" xlink:to="lab_wst_DeferredStockUnitsPayableInCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9ed125bd-e0a8-4670-a3dc-22a7e3be9cfa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from stock-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_b6534174-373e-47ee-8083-47c59947b4d7_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ddb04fb8-a448-47bf-a4a4-ac6fac59fdc6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f7e0b8d-7602-4722-9220-1ff873be1133_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d029c41a-f930-4709-a3e9-f0a0583dcbaf_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a43f05ca-8580-4bd7-95b6-b35c12d7936d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_5e5a8984-0b44-4b35-b148-c6f13e76b141_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_8e1967a6-4476-4a76-a3a4-a29721524b8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. research and development credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3da07663-f185-4032-b5ed-0b241b16dfe5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program, average cost per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AssetsDefinedBenefitPlansNoncurrent_57eccc1a-59f4-4ca4-a35a-c489363de5da_terseLabel_en-US" xlink:label="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_wst_AssetsDefinedBenefitPlansNoncurrent_label_en-US" xlink:label="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Defined Benefit Plans, Noncurrent</link:label>
    <link:label id="lab_wst_AssetsDefinedBenefitPlansNoncurrent_documentation_en-US" xlink:label="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of assets, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:href="wst-20221231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:to="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_af47b25e-c177-4ecb-b915-f84ef2cf56d3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PatentsAndLicensingMember_c454dd83-32b6-4cdf-9be4-19f0d8db1951_terseLabel_en-US" xlink:label="lab_wst_PatentsAndLicensingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and licensing</link:label>
    <link:label id="lab_wst_PatentsAndLicensingMember_label_en-US" xlink:label="lab_wst_PatentsAndLicensingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Licensing [Member]</link:label>
    <link:label id="lab_wst_PatentsAndLicensingMember_documentation_en-US" xlink:label="lab_wst_PatentsAndLicensingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Licensing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PatentsAndLicensingMember" xlink:href="wst-20221231.xsd#wst_PatentsAndLicensingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PatentsAndLicensingMember" xlink:to="lab_wst_PatentsAndLicensingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b3444093-fddd-496b-a7e7-e915bc952fe9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_3a7f1c21-c834-46d8-bdc3-4bdeb511c4cb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_96753b76-8b10-4c28-a4ab-9bf25c81246b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1b1daeb1-4a22-4980-9677-2ed29d52bb28_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_ea3ceedc-f257-45dc-becf-8a4daf33635d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_ba80c2d7-2873-425a-9207-b5e35b777963_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7fdc45b0-ed0c-4b46-ac40-030773559996_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27f32d49-1e01-485c-9594-c89826cca57e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b2081c6d-2c85-4b26-9c8e-1a0353a55157_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_ab44d0fe-9349-4950-90e9-3dcbfafffeb4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerAssetIncreaseDecrease_0d8e2ed4-4671-41f4-9f4d-261154198315_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in contract assets - increase (decrease)</link:label>
    <link:label id="lab_wst_ContractWithCustomerAssetIncreaseDecrease_label_en-US" xlink:label="lab_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Increase (Decrease)</link:label>
    <link:label id="lab_wst_ContractWithCustomerAssetIncreaseDecrease_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerAssetIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:to="lab_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_4c492b08-0127-42bc-90db-5da0059b27ba_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_0bd56b1a-34ee-4e53-805b-9d08a234fc35_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected contribution to the plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_99426362-ce0d-43c5-9c92-54d83d70ffd9_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_fdc278ea-748c-4500-8772-0598837042ac_terseLabel_en-US" xlink:label="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and state</link:label>
    <link:label id="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal, State and Local Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal, State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:href="wst-20221231.xsd#wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_07e8bf57-452a-47ba-a7a3-2c63bb5b8488_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) increase in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_1fa13686-599b-479a-8439-0c4665a15c8a_terseLabel_en-US" xlink:label="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related activities, period of implementation (up to)</link:label>
    <link:label id="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_label_en-US" xlink:label="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Activities, Period Of Implementation</link:label>
    <link:label id="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_documentation_en-US" xlink:label="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Activities, Period Of Implementation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:href="wst-20221231.xsd#wst_RestructuringAndRelatedActivitiesPeriodOfImplementation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:to="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_db2fef46-23d8-4e04-9860-99bd80fd63c6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_fc9f9089-42cd-4fe4-a9fa-c97e4b556c8a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net sales</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_32c892b4-9326-45c0-90e5-918d9fb0c7f2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related cost, cumulative cost incurred</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_8051947a-4ae9-43ba-900d-94cb75bb6805_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c25d7180-c62e-4b1d-aac5-6d27164e21c3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax_534ce781-eab3-4827-8208-49d5da239acf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of other, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_261be7f7-5959-4817-a967-8836efe6a526_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_7baefe4b-4cad-41c5-81cd-f405fbe0c035_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_ac4fd47d-2dce-47f2-8921-6886b63a42c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_232ee439-834d-40ff-82e7-f6e30824526c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3b19f082-313e-4023-9f0e-55af034a8700_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_dc5a97bb-8ac3-4bf5-b514-b11c00e6f3a2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_029ecf73-5b7f-493f-a5f3-f937583f4f55_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_5d76ac27-38e5-446f-9040-874b50586090_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Unallocated</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityOptionMember_93b67c77-6fb2-486b-8f5a-c6670ac39c46_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity call options</link:label>
    <link:label id="lab_us-gaap_CommodityOptionMember_label_en-US" xlink:label="lab_us-gaap_CommodityOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityOptionMember" xlink:to="lab_us-gaap_CommodityOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_2a310d32-dff6-4258-b4f6-64f66d0bf3a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (gain) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_df693352-a86b-41b6-8d83-2104eae6e64e_terseLabel_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Products</link:label>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_label_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Customers [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_documentation_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember" xlink:href="wst-20221231.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractManufacturedCustomersMember" xlink:to="lab_wst_ContractManufacturedCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_46809c70-9313-4238-a660-9dbbdfb1ab55_terseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement effects arising during period, tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_label_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:to="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_09d28c6b-3a65-4355-904a-794811f7e779_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_cc6c60fa-9a15-4aaf-8b34-bfbc4f3007aa_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_94428582-a26e-4823-adf3-dbe7da1c9f4a_terseLabel_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable and other current debt</link:label>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_label_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Other Debt, Current</link:label>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_documentation_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Other Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent" xlink:href="wst-20221231.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_NotesPayableAndOtherDebtCurrent" xlink:to="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_503d34e3-86a6-4b00-aa17-fee5f2a02ee0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_08d7cee6-0d13-4ecf-b898-d21647c1b554_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_c9bb745e-69d7-4e8f-a521-eccad3fddf6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limitation on payroll deductions of employee's base salary (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_091ae0cf-bfdd-4b20-9669-e9d0f4f98886_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_de256a0c-0d73-4833-bf8b-2cfe32d131ee_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity related to stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_6f97247c-318f-474c-a98d-a55c3ceaed6a_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_9b892f0c-f3f5-4f71-969d-8326b3d30c60_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase programs</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_f1c13545-0a7b-4685-9289-7942ba8d432e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_b310f2bd-e4c4-4ea9-8295-62162bece208_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_cde1d707-4543-47b3-ac48-0b61188cbf51_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_d1aa8037-d26e-4a18-afff-56e580e46b23_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivative instruments, net, pretax</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b47fbbca-2d2a-42c2-9d5e-43b9b0ecaf2c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1b26cc98-419d-49cf-a326-7abf855bff13_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_2efaecae-9049-425d-ac00-ce0e5b8e737c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_7e4dd213-40c9-4472-a677-90da5f401a08_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_979f79a7-32a2-44d7-87aa-0b5000c09cff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_c6058503-ffbb-41c9-8f53-1c0415e8b617_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_6bfa5c9d-d5fc-46df-b224-ac718e9ba7e8_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b9beda69-9e96-45e8-8d85-2af51de3702e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DebtInstrumentApplicableMarginRatio_fc555437-be8f-4c8b-9e77-9b4a26384704_terseLabel_en-US" xlink:label="lab_wst_DebtInstrumentApplicableMarginRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable margin ratio</link:label>
    <link:label id="lab_wst_DebtInstrumentApplicableMarginRatio_label_en-US" xlink:label="lab_wst_DebtInstrumentApplicableMarginRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Applicable Margin Ratio</link:label>
    <link:label id="lab_wst_DebtInstrumentApplicableMarginRatio_documentation_en-US" xlink:label="lab_wst_DebtInstrumentApplicableMarginRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Applicable Margin Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentApplicableMarginRatio" xlink:href="wst-20221231.xsd#wst_DebtInstrumentApplicableMarginRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DebtInstrumentApplicableMarginRatio" xlink:to="lab_wst_DebtInstrumentApplicableMarginRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_30e8e4fc-2759-4e72-bb3b-ba3ace461550_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_5972e3a7-ac8a-476b-8d11-9584902e4169_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International plans</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_921f8bdb-ce5b-4f8d-84f6-c9d1dc294ec8_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3eb64066-ca2a-4467-a805-5c52f58b0255_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_384c3b04-74ed-4df9-b53f-7f1f16aebf1c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized R&amp;D expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_936c83ce-69a0-45f0-bbef-2be1a1f1c020_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_06ac46c7-5f72-4f74-9c0a-f736932e673c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_a79eeff7-abd4-4b25-bcca-4bd79fb88e42_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_6a814b6d-2e97-47e3-bb56-7615efb671ed_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_2e0bfff5-44d1-4c2b-9b3a-76833ed4acd0_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_5a6dbaec-feb7-492e-851a-acbf59d87b93_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_92098a77-842a-4e96-9744-a3aa86c1c010_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_6df847cd-1d49-4abf-90dd-30ae17a6360a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits on share-based payments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_2bbe4796-877f-4f24-8929-10bc4d48991b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_9fb6152b-3367-411d-ac63-b6312cf05994_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Expense (Income)</link:label>
    <link:label id="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Income And Expense, By Component [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Income and Expense, by Component [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:href="wst-20221231.xsd#wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:to="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_67ff57db-033b-438c-904c-a8560cb0dc56_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee, per year (in shares)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_41ece63c-cfc5-459e-8515-1fbca5f30963_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_badcc844-c9ff-498c-8982-d3e2dc6a5836_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate carrying amount of investment in affiliated companies that are not accounted for under the equity method</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_8cc69b44-a51a-4fb0-9576-59aa97cee9d8_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_adfcef96-4982-4e99-86f4-c23fdd6cab5f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7f310d30-c8e2-4c9f-985e-41b8fe6f4316_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in affiliated companies</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_54091587-2abc-4fe9-b562-6d046aa60973_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_8118cb6d-b9be-4b59-a0ca-b3adfb0457f5_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_3f4b1fa3-416a-4de1-b925-985dbb06f639_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5b4faa50-17cf-45c9-b7c3-3103914ec882_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_4e17fc7a-6205-494e-bf25-62ecba8596da_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d921e1ca-36fb-4de4-a482-a80048c1c6c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0ed5ce73-aa9f-4bda-a6f2-4465da69c8ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6684f542-c19e-480f-8253-cafb3a181c79_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_d74bb473-9c07-4124-994e-eb1a77cdad9d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_10caa83e-8dba-4109-8772-96294b1bdfcc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_b37844fd-cce9-43c1-a1f0-cea21f55034a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_985f66a7-4e7f-43e7-9350-8a8959c03ba6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_fd3acd9f-ebbc-4789-b191-0a9c4b123c41_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_3b62963b-5f57-4c90-a273-4a89c071511a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_7087abba-732a-4ddc-862b-54511be626da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlementsOther_03e1f023-9508-4442-8503-dcd26d597b1c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlementsOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from prepayment of future royalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlementsOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlementsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlementsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlementsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxSettlementsOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxSettlementsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_675628ba-c014-45bd-afc3-bafcb1d5d448_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_e66b28b4-24d2-48f5-86b9-cbff4ec1806e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_2e9c38fe-f97b-45b1-86ac-b8b54a089b68_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_fa6bdef2-3fdc-409f-b7f9-4e26adea8b80_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement loss</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_label_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement Gain (Loss), Before Tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement Gain (Loss), Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:to="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_eccda5ab-d40a-4776-8533-16b2327c0ed8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_a9eccc64-db89-4ecd-996a-bc7b617aed41_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.25 per share; 200 million shares authorized; shares issued: 75.3 million in 2022 and 2021; shares outstanding: 74.1 million and 74.2 million in 2022 and 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_b5061c45-766c-4c97-99da-f44a322ee386_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_32cf9f6d-f73e-4b6a-9fa7-b8b0c5418d79_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_aa19df71-623f-4263-af65-6032703a1246_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SalesToEquityMethodInvestees_294b8039-ccd9-4619-8b0c-7cafe5220c53_terseLabel_en-US" xlink:label="lab_wst_SalesToEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to affiliates</link:label>
    <link:label id="lab_wst_SalesToEquityMethodInvestees_label_en-US" xlink:label="lab_wst_SalesToEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to Equity Method Investees</link:label>
    <link:label id="lab_wst_SalesToEquityMethodInvestees_documentation_en-US" xlink:label="lab_wst_SalesToEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesToEquityMethodInvestees" xlink:href="wst-20221231.xsd#wst_SalesToEquityMethodInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SalesToEquityMethodInvestees" xlink:to="lab_wst_SalesToEquityMethodInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_0abf5447-0aea-442a-a2e6-87125e16ed88_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other items</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_d5f2643e-3eac-479f-90ee-557975e25ec8_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_aa35eb21-a8f5-4252-8e03-f5fd0e074d3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_TermLoanDue2024Member_956893cf-314b-49cc-9123-2e0244e16417_terseLabel_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, due December 31, 2024 (5.56%)</link:label>
    <link:label id="lab_wst_TermLoanDue2024Member_label_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due 2024 [Member]</link:label>
    <link:label id="lab_wst_TermLoanDue2024Member_documentation_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member" xlink:href="wst-20221231.xsd#wst_TermLoanDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_TermLoanDue2024Member" xlink:to="lab_wst_TermLoanDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_15b3affb-8e4e-44d2-b4e2-e8d77c6429d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income)</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9ed392f3-eadd-4b13-a71e-050dc54df50a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, including cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2185e93d-e696-42bd-a72f-6dce45d853ef_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, including cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4f5b1621-107c-47a9-baf3-9e27283941fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PharmaRubberSADeCVMember_bebab68a-1850-4b79-927e-fec705b005eb_terseLabel_en-US" xlink:label="lab_wst_PharmaRubberSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Rubber S.A. de C.V.</link:label>
    <link:label id="lab_wst_PharmaRubberSADeCVMember_label_en-US" xlink:label="lab_wst_PharmaRubberSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Rubber S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_PharmaRubberSADeCVMember_documentation_en-US" xlink:label="lab_wst_PharmaRubberSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Rubber S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaRubberSADeCVMember" xlink:href="wst-20221231.xsd#wst_PharmaRubberSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PharmaRubberSADeCVMember" xlink:to="lab_wst_PharmaRubberSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_c871f307-eb1b-407c-9573-1bee19197f18_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_1a4504cc-a133-4010-a624-a6c5a88cc1de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlement charge</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_e0354dc2-561e-433e-90b6-4b56d8ee5c70_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_4b59dfff-a0fd-4705-b5b1-0f4a64bdb996_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_1f8bc4dd-f3df-4d25-9fe2-81b3842b065e_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_79021926-259d-4019-99e7-438ef2190792_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_bb680fb1-b060-4514-b5a5-ae02bde1eccb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_5955e384-4f93-4ae2-ae06-79bf3a9d5dca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining term of shares issued at conversion</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3ffcd7ce-a969-45db-95da-0dbb754d7d09_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_902d6ab5-2511-4c5c-a4f5-8e3a3a0a6e56_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life of finite-lived intangible assets (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_ce9137ed-eaf2-4a35-b375-fd9857f57178_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_bf4f93c9-edf9-4939-b196-8f24e9035d72_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_62af41d4-3fa0-4d52-8a6b-2d8b7639466d_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c375075e-a04c-42b5-8ef5-f0bfcca78b67_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_2932ac62-04a7-4974-9a22-08fc65d3a63c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill recorded due to acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PharmaCustomersMember_319f66a1-0eba-44d7-a78b-e9047c61e4ed_terseLabel_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma</link:label>
    <link:label id="lab_wst_PharmaCustomersMember_label_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Customers [Member]</link:label>
    <link:label id="lab_wst_PharmaCustomersMember_documentation_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember" xlink:href="wst-20221231.xsd#wst_PharmaCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PharmaCustomersMember" xlink:to="lab_wst_PharmaCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_f6f464ab-4a03-4960-b8e3-b510bd2b8e43_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount_b001c5db-8fd1-4e9b-a086-bf4995fecfd2_negatedTerseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Tax Benefit, Amount</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Tax Benefit, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2c29a610-ef43-4ba8-8681-e6da59f9fdc2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7114cac6-30c0-40c5-a767-c825f29f50dc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_78f98028-3958-4ae1-a628-fd1c7d896f12_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_915e5623-1745-4bff-9874-2fe5fcf97a31_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on derivatives, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_49e5d5f0-5727-47b5-8a71-ba29dcb25879_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_627fc0b3-bed1-419e-9e23-50a9ef9d0302_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_e060e542-555b-4edb-a488-108da068b738_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_ad39feea-9e7b-43e1-a275-8c590d1695a4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of current market price for sales to eligible employees (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_e23d8a38-8b81-412d-a141-ff770e025301_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract (in months)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherEuropeCountriesMember_b81e6fb9-af17-4c4d-9d5a-a7c250a6607f_terseLabel_en-US" xlink:label="lab_wst_OtherEuropeCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other European countries</link:label>
    <link:label id="lab_wst_OtherEuropeCountriesMember_label_en-US" xlink:label="lab_wst_OtherEuropeCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Europe Countries [Member]</link:label>
    <link:label id="lab_wst_OtherEuropeCountriesMember_documentation_en-US" xlink:label="lab_wst_OtherEuropeCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Europe Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherEuropeCountriesMember" xlink:href="wst-20221231.xsd#wst_OtherEuropeCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherEuropeCountriesMember" xlink:to="lab_wst_OtherEuropeCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a4ecc864-2771-4208-8909-2b4aeb86dc18_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_9d95852f-ff9b-4d57-a7ec-04b850462ad6_verboseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares to be issued upon conversion (in shares)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_133ce802-a09e-4a74-ba07-9e71ef0f9d35_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_ad4b8864-4a85-4d3c-8933-26d9f52c7d1b_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Line Items]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_documentation_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:href="wst-20221231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:to="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a9d4370d-d6d1-4496-8f9a-61142e48a191_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_8422a3e5-100d-4edd-9ba3-40160ab4d2d1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs Activity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerAssetRollForward_614276d4-0017-4b1c-8b53-e6f940b6e01b_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerAssetRollForward_label_en-US" xlink:label="lab_wst_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerAssetRollForward" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerAssetRollForward" xlink:to="lab_wst_ContractWithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_db9a80ab-11c7-47d2-a3bd-cc0f86964970_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_2aa8c3c0-c639-47be-90a3-a24e43c44b3a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_507e681f-db28-4f1d-880d-cc0c78cb250e_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance cost</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_8de9a4b1-9351-4d87-948b-bd80013ab174_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SGD_8132de8f-7a24-40dc-a662-e81d17fb5042_terseLabel_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SGD</link:label>
    <link:label id="lab_currency_SGD_label_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SGD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SGD" xlink:to="lab_currency_SGD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_58711678-c7a5-456f-8c1f-3583b1d5f0bd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average assumptions used in benefit obligations:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_ebb1c782-b1a7-421c-b084-9395fb039e97_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_a681bac0-b83c-4814-b74a-b66c250d1175_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (1.2 million and 1.1 million shares in 2022 and 2021)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_e52c3eaf-1b2b-4a1b-90c0-d69a82476f24_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_8b7548c4-73ee-4d4c-8c81-6bec6ded1905_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income)</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d386a1be-60f5-452b-8476-c058ea7b0ca1_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_74971712-6668-4d50-9aba-2717d17be316_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plans and restricted share awards</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation, Share-Based Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:to="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorNotesDue2022Member_b0200629-dc4a-409f-ae46-0c4644193b70_terseLabel_en-US" xlink:label="lab_wst_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A notes, due July 5, 2022 (3.67%)</link:label>
    <link:label id="lab_wst_SeniorNotesDue2022Member_label_en-US" xlink:label="lab_wst_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior A Notes Due 2022 [Member]</link:label>
    <link:label id="lab_wst_SeniorNotesDue2022Member_documentation_en-US" xlink:label="lab_wst_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior A Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member" xlink:href="wst-20221231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorNotesDue2022Member" xlink:to="lab_wst_SeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_577a96e8-bb0b-4fc3-b3a6-c12c20a19fe3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on equity affiliate accumulated other comprehensive income, net of tax of $0.0, $0.0, and $0.0</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_39efa7bc-0d2d-4004-bb8d-ac888cb148aa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_e17360dc-3f97-4304-9565-f9677d9a6397_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_32bd9f7c-9779-40a9-afad-23186335e3e1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_1bab52b0-10a3-4204-b52a-291c45ba7d5b_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_NetSalesMember_190187c2-128c-4196-b45d-4982b56b22ba_terseLabel_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_wst_NetSalesMember_label_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales [Member]</link:label>
    <link:label id="lab_wst_NetSalesMember_documentation_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember" xlink:href="wst-20221231.xsd#wst_NetSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_NetSalesMember" xlink:to="lab_wst_NetSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_d6ab91e0-26d2-4094-92a4-cde8862589e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sell</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a3d7167f-afce-4acf-9c72-c001957acd20_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_00212715-ed13-4eaf-9cf7-71a315cb0163_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_6cbbd250-a5c2-480c-b1e5-fecd6dfa4e6e_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_b7f9cce4-95fd-4886-bf57-2f4ecac80ecd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign-Derived Intangible Income Deductions (FDII)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, FDII, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_824be4df-28a6-4c39-8af9-452abba6b1d5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_6c528d7a-4536-4f58-8fbe-b55a96984b3f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on derivatives, net of tax of $0.2, $0.5, and $(0.6)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_6ebf1f03-acad-40b3-bd2d-8e67c781900d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod_a4c13c19-d815-499b-a462-ecc8e10a676a_terseLabel_en-US" xlink:label="lab_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preceding period (in months)</link:label>
    <link:label id="lab_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod_label_en-US" xlink:label="lab_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase In Facility, Preceding Period</link:label>
    <link:label id="lab_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod_documentation_en-US" xlink:label="lab_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase In Facility, Preceding Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod" xlink:href="wst-20221231.xsd#wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod" xlink:to="lab_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_979b116a-346b-4bbb-9a6d-0e1ffa8bb4b6_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling Costs</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_The2020RestructuringPlanMember_96f3ebcf-7e49-43f0-a1e0-8a33fa5956a1_terseLabel_en-US" xlink:label="lab_wst_The2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan</link:label>
    <link:label id="lab_wst_The2020RestructuringPlanMember_51f389b5-1661-4798-9503-c53d921a05da_verboseLabel_en-US" xlink:label="lab_wst_The2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan</link:label>
    <link:label id="lab_wst_The2020RestructuringPlanMember_label_en-US" xlink:label="lab_wst_The2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Restructuring Plan [Member]</link:label>
    <link:label id="lab_wst_The2020RestructuringPlanMember_documentation_en-US" xlink:label="lab_wst_The2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2020RestructuringPlanMember" xlink:href="wst-20221231.xsd#wst_The2020RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_The2020RestructuringPlanMember" xlink:to="lab_wst_The2020RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_def5b604-ad07-49a2-b79b-8479dae0b3e5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_a2f3cfff-a0e7-4c98-be77-61a7de75c127_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_79a13a3b-b8b2-42a1-acd3-ff8a72571d64_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_64934c2d-4e30-4af2-bfe6-a9d382ed0ae2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8736bb74-2e30-4d2e-b87d-f0b78331954b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_b7519edb-e020-4b9b-b83f-21a48cc5b0a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_3b7ca220-d99a-4f4b-9652-ebcc0ff85407_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Deferred Compensation Arrangements, Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_5fb10616-d4f0-493c-8b29-8945f87792a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_861da589-6035-444e-bd31-946338aaa695_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_225b02f0-6c7a-431c-9c17-8f5da4f860c5_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit_17da82ca-9a43-4fc4-996a-d443802878dc_terseLabel_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation conversion unit (in shares)</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit_label_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Conversion Unit</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit_documentation_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Conversion Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:href="wst-20221231.xsd#wst_DeferredCompensationArrangementWithIndividualConversionUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:to="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_af3945e7-686d-416c-9be8-f3bc40bce231_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ToolsDiesAndMoldsMember_27715ed2-6e20-43db-8509-a87bcd83a1da_terseLabel_en-US" xlink:label="lab_us-gaap_ToolsDiesAndMoldsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds and dies</link:label>
    <link:label id="lab_us-gaap_ToolsDiesAndMoldsMember_label_en-US" xlink:label="lab_us-gaap_ToolsDiesAndMoldsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tools, Dies and Molds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ToolsDiesAndMoldsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ToolsDiesAndMoldsMember" xlink:to="lab_us-gaap_ToolsDiesAndMoldsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_4b11dab5-0227-4dce-be0c-f874c5b90be9_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding unconditional contractual commitments for the purchase of raw materials, utilities and equipment</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_09c4c6fb-faac-4e93-a564-5aa4e3803364_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d0166f33-87a7-4af8-9c31-1c0ae631a645_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net of tax of $2.2, $2.4, and $(1.0)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_e3f03e7e-8fc8-493a-b5b9-e79c7c3669b8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Items [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee2d5375-07b0-4da2-9446-e4ffca316b6a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_e27127db-4cfb-49e7-9f5d-1bb3c6408dec_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_a108a5d8-5145-4380-93f1-39bd757f43a1_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0c74c16d-cd9f-495f-b1af-2a7b9ff0b396_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_1094ddac-af9f-48fa-9fa9-cb07b28a30e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_8eba2ab8-161b-42a2-83bb-e4fac80dd296_terseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on undistributed earnings of subsidiaries</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Undistributed Earnings Of Subsidiaries, Percentage</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Undistributed Earnings Of Subsidiaries, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_e910c0c1-5ce3-4c9c-a196-ce66db47c16c_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets By Major Class [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:href="wst-20221231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:to="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_51d1a24c-ef67-4a5e-8c7d-4ff93b957910_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8ea4557e-8e5d-4c0a-b6da-a24d00a310c8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_461dc94b-191d-4bc0-b8fc-5afd696996c8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for insurance obligations</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_e3b2679b-2eec-48dd-9c64-aa6c1f4d995c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest (as a percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_70677380-f792-42dc-92c0-5d2a0cbf8174_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_5319d3fb-24d9-40a6-af37-05c4376acdf7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target allocation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_fd98ae82-a051-4060-869c-0b52a24f6f62_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_d27701ba-5d2a-41f5-bb9d-b24f4860221c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, 3.0 million shares authorized; 0.0 shares issued and outstanding in 2022 and 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_b475593b-689c-4407-bc0d-9317054ab786_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed healthcare cost trend rate, benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_2d878f32-8f8a-4cb7-b6a6-a61900c63779_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CostInvestmentImpairment_1dda9b32-c33d-48d4-ba86-b9fa5859fec0_negatedTerseLabel_en-US" xlink:label="lab_wst_CostInvestmentImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost investment activity</link:label>
    <link:label id="lab_wst_CostInvestmentImpairment_label_en-US" xlink:label="lab_wst_CostInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost investment impairment</link:label>
    <link:label id="lab_wst_CostInvestmentImpairment_documentation_en-US" xlink:label="lab_wst_CostInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost investment impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CostInvestmentImpairment" xlink:href="wst-20221231.xsd#wst_CostInvestmentImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CostInvestmentImpairment" xlink:to="lab_wst_CostInvestmentImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_a11c9b68-1795-4631-8142-e7bd276b140a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_c8f99217-551e-44fd-971d-4e74719072b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Obligations, Net of Current Maturities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_6d897b07-12f9-4474-b0d1-c1911be6e364_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome_4f077b22-3f35-4a28-b652-7813ae8cc485_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized during the period</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome_label_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Revenue Recognized From Deferred Income</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Revenue Recognized From Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome" xlink:to="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_4d4928a9-0bdc-44cd-bac8-ecb11977569b_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_f22a1cdd-6ac5-446b-9831-de7b8c97f278_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_b656bf4c-8579-4f4d-a060-6fc83ec25bee_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_2cba406c-c4ed-44a8-a2b3-946ffd220707_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_09c37931-759b-4df0-beec-0ae2bff6976b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes and equity in net income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1086d01a-7f3f-4ece-9017-afd1fe3e4201_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes and equity in net income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2409b4cc-d569-4333-a284-dac1ee8c5676_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_f8d2fd1d-df7b-478f-a27b-2552f468d3e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Share-based Compensation Costs by Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_03054d09-cda6-40ca-8a73-cc78c2d2dee4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_fcdc8ee7-8401-4752-b7a4-92445b060f86_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_db5f830b-421c-4661-873e-6649f14438b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of actuarial (gain) loss, net of tax of $(0.1), $0.1, and $0.0</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_18a01c2a-3cfb-49b4-82a5-3995180e9739_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_f743d7ee-8a76-4a9d-8006-29979f336c0b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unremitted income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings, Undistributed Earnings from Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:to="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_03f9f79b-1483-403f-9330-bc4f934c4e1b_terseLabel_en-US" xlink:label="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units, dividend equivalents</link:label>
    <link:label id="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_label_en-US" xlink:label="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-vesting Shares or Units Dividend Equivalents [Member]</link:label>
    <link:label id="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_documentation_en-US" xlink:label="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-vesting Shares or Units Dividend Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:href="wst-20221231.xsd#wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:to="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4011d442-6221-4eaa-869a-0c2f7840a12f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_c80cfe69-bed1-4809-a0ba-927c7742d44e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative (gain) loss on hedged item, fair value hedges</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_2439a2ea-5e63-4c41-9bbd-e24b833d1dfe_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_4a64c244-bca6-4e01-8eae-546fc72c6e82_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5bccec34-ed6e-41e7-b038-a685ad9f40b9_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of equity awards, based on the treasury stock method (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_d8ff7c83-a4d6-4b36-82c9-ab3eb19adcb3_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_d2d90bf7-5101-4087-8774-e31d3bf2ccbf_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contracts</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b451d0cc-69fe-4f91-80ce-85658ed5adf4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_93e53a20-d619-47ef-baac-3aa60af68b23_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_bc00af55-242a-4a47-a0cf-2646aebc2476_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_109aa577-6615-4781-b5b4-63ebe1c5c235_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c55895ca-f6ee-4cad-8bf1-396fcd7661f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset impairments and sale of equipment, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1e3d709c-922a-46f1-a077-b9df7e74ab05_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_fd986bb7-042b-4729-85e3-2267f9d1a121_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_f9c6e286-7328-4694-a749-a39ff9297385_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participants&#8217; contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_b0948f9a-cced-4e27-8fe2-3d75e91bb067_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ea6f40ae-9234-479b-bc2a-0cf22025ced3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_76d84322-5f4b-405c-99db-616d7738f602_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other charges</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_42206955-0dd3-4a6f-9c08-15d1075f8f5c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_4edd50a9-f540-41a5-ba93-ddc38e044dad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_401a79bb-933b-4df3-a406-fc5d28e4f3cf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_6db353ed-0ebe-4f01-866e-2c10c4ed5e96_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_a8eaa894-a23a-42c9-8571-4194731edfa8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_91a12daa-637c-4974-851a-06fb4d0b91cc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards, expiration period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_025a07f0-300f-4dcd-a7f2-ae24498e9450_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Currency Contracts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_fa7fd9cb-2a7b-4c7a-87d6-5acb7d339553_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of cost method investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_e099b9a1-e7ca-46d1-bad4-9734d02f0b59_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionMember_4efd756b-2b26-4c9f-bc79-d38f9c82be15_terseLabel_en-US" xlink:label="lab_us-gaap_OptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Call Options</link:label>
    <link:label id="lab_us-gaap_OptionMember_label_en-US" xlink:label="lab_us-gaap_OptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Held [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionMember" xlink:to="lab_us-gaap_OptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_da29f9b7-82eb-48fd-9867-951e0b055be5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense (benefit) from impact of tax law changes enacted</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRollForward_94be0aa2-8871-4887-a70b-1ca07e50948a_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRollForward" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward" xlink:to="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_2ab4dab8-8c63-4292-a28a-3084739a2c98_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherMutualFundsMember_657502d7-6109-4f6f-8339-c3d4ea82ba7a_terseLabel_en-US" xlink:label="lab_wst_OtherMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other mutual funds</link:label>
    <link:label id="lab_wst_OtherMutualFundsMember_label_en-US" xlink:label="lab_wst_OtherMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Mutual Funds [Member]</link:label>
    <link:label id="lab_wst_OtherMutualFundsMember_documentation_en-US" xlink:label="lab_wst_OtherMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Mutual Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherMutualFundsMember" xlink:href="wst-20221231.xsd#wst_OtherMutualFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherMutualFundsMember" xlink:to="lab_wst_OtherMutualFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition_54c6f4c5-7091-49af-8d15-0c3edafe8c6a_terseLabel_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of quarters following acquisition</link:label>
    <link:label id="lab_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition_label_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Fiscal Quarters Following Acquisition</link:label>
    <link:label id="lab_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition_documentation_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Fiscal Quarters Following Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition" xlink:href="wst-20221231.xsd#wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition" xlink:to="lab_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_613c0082-823a-4802-95b7-851df5ee8ff8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_b874be18-d4d1-4c3f-8bb3-6237ca09835e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain recognized in earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:to="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_524fc51b-1b6c-4764-8965-17beddc63d03_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, average price risk option strike price</link:label>
    <link:label id="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_label_en-US" xlink:label="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Average Price Risk Option Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:to="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_53651339-f964-4f6f-bf67-4caf58985ba1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_b6ff36fd-3309-41bd-b982-4b1b8204033a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, unused commitment level</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_18466ed0-5266-4c85-9a20-bce018de2391_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of total options vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6e38e236-c53e-4e1b-b2d1-bb30d74555d2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_ee8681ac-13ad-4e15-86bb-8c26c280fbac_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_ed1d5783-afeb-4769-8261-5c1bb3abfaa2_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_9e72416b-7c94-4ae3-bb8a-bcadd1b1ec37_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_462154a7-eccd-40d7-a771-9434ec94c92c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and converted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3b4868b4-1e42-40e8-81e1-93c4b6a96c92_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_9af12be8-98e5-4ea9-940d-3162807639e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Share Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3fb50bd5-5f38-4e6f-8792-7753e43004c0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_9ac7a6ac-6a6a-4a59-a084-eedba227d476_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_cb5960bd-a123-44b9-bb76-f1371c54f74f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_93df2f4f-a050-4652-907c-8be26cd5a025_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a7ea4688-288c-4257-a2db-6440c6f3b1a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9adeac5d-e834-473e-973a-b55747d00a7f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0ee01f57-a4d3-4efe-b0db-fa8bb761c311_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8522fa71-c312-4be0-bb5c-23fcc91903ae_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4ad4c3af-ad4f-452f-be57-19e1428dec49_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9e6f2cd-de66-4dc2-b5d5-a5e70ec74818_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_642fce9e-c7b8-4ca6-8a88-f02b2a2a81f7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reserves for unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b6fd1b61-a234-4ef1-9c8f-8853f6b554f1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_da0063e2-28e1-431d-afa0-5b5fdac194f7_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_4af836ff-9283-491a-81db-b0f8d9d20fc0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_4bb82bdc-efb5-4800-8097-54d741cb5851_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_beb3547c-abd3-45ed-9aa5-7ada04247fdb_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_0438a214-2d49-4689-ac3a-3e7803b32fdf_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_e023c008-7b3d-48c2-87e9-f76dfcef936e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average of the coupon interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_2ba41a71-11eb-4e6f-9b3b-05a4c3e3912f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2a1695a7-87d5-4e3c-adde-4135f1a3c19a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_66ec99a6-673e-4e10-bb90-3b686fb5be24_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_b301c455-177c-4293-8793-88ffb4c9e8a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1f9bcf46-44e6-4f38-9b54-482941b76439_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_e5674d26-eae9-46b1-9eff-0ca3db082262_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7904cd8c-1012-403c-a1f9-3d390cc3780e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_d92f6cc6-12dc-4ee3-9402-d364d6956d4c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a96365d1-e231-40ff-a8f4-0da59387c7a0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fe38948c-87a6-422d-a09d-1c621fa41f55_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_6d7834d0-cc14-44ae-8709-9e2a25dfd028_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative contract term</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c1e593f5-87d3-4af3-b468-a5bf03e1d394_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_733f274d-0459-4c7d-9af4-1556e9387225_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_861c82b7-ecec-4ddf-9943-a3455dc5706a_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_fbbd8a66-4cee-443a-8777-f5a68c519e11_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Basic to Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_9243216c-f5a5-43fc-ac6c-e715fb752433_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan contributions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Other Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity" xlink:to="lab_us-gaap_ProceedsFromOtherEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1c1c7b3c-ee00-4f20-800a-c29d98681bb0_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_cf319fe5-1119-4e86-bf2e-2d63ce7e4632_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other retirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_c52bbfbb-4060-47c7-be77-25ba07049fe0_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2daac7b9-c333-4a7b-b3b8-ca72d373d2ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dddb02ab-af27-44fc-b583-60d10d69c506_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_ac9e147a-b426-4a6c-b621-e69d5938cf55_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_29617e48-a535-4bed-8f55-afb93962beb0_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limitation on payroll deductions of employee's base salary, amount</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_092f046e-5156-4e5d-9398-6f614fa7da3b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability payments due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9e07e316-1d72-483e-b5e0-f34e1a1d613a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_25c08bc1-f8c3-4af9-84c9-5f7e2b969ca3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain (loss) arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_42452623-8977-4bb1-bebc-d6edba4ec29c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_eedcbee0-39b1-49fd-beb5-5f972f5161aa_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_1e5e8a30-641a-4ba4-8e15-dc9957b9efc8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Deferred Compensation [Axis]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_84f28f7c-00f9-44c5-8e3c-ed9e59df3803_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendments/transfers in</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_bdca38ad-a3ec-406a-ba74-45dd472edf1f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_55617de5-8aef-4f54-bd0d-9cbe78a0e3a5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_78f2ccd2-30e8-4c47-8a0c-62eefe6f5994_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_b7fa872f-efde-4d2c-8be2-d2470434e266_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and severance related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_b18110b4-5a33-4532-8649-31ec40bca833_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_36fcda24-5bfb-4a16-88ed-9152b6692bcf_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring , ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_1533f5c2-0bf9-4ad1-82c4-3f5f2a7babd7_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred income - (increase) decrease</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_39605122-abb5-4716-9f10-9ce6f05a73e3_totalLabel_en-US" xlink:label="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in net periodic benefit cost and OCI</link:label>
    <link:label id="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_25daefc0-4244-45dd-81b1-d6c67e4efd61_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation assets</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_98c52eaf-f13b-40bd-87ae-c17163939b5d_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual payout range</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3f66ef12-e170-4cdd-879a-3acdf74d783d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_a17938ff-76aa-4f6f-a5dd-76b65257ace8_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount_d8286fdc-05ce-43fa-bbfe-a4ae65269985_negatedTerseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from termination of pension plans</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Termination Of Pension Plan, Amount</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Termination Of Pension Plan, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_fbc99b95-3a2a-48a3-b5f8-663c1241263c_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative (gain) loss on amount excluded from effectiveness testing, fair value hedges</link:label>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_label_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:to="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber_4df0a113-5f68-40ab-ada4-87ea1427d2d6_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable (in shares)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Exercisable, Number</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a389cb7b-cf64-42d3-ad6b-998da04dadb5_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_58163431-0ebd-49c3-abe1-8572caafd298_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction for expiration of statute of limitations/audits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_16d71ae9-2752-47c0-b541-83e6b2c930eb_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e112de74-6182-414e-af5a-ec6cb35f6e62_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount_6f96381c-a8e0-4587-b5a2-af4d0fdd52f1_terseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense from recognition of reserves for unrecognized tax benefits</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Recognition Of Reserves For Unrecognized Tax Benefits, Amount</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Recognition Of Reserves For Unrecognized Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2b144d2c-2128-4daa-9cbe-d2a1eac85ccb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_d860d7b7-a231-4aba-a93a-dade91bb4c7e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_c0ab7232-ff2e-4018-a88e-c8cd17d5c6bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_cbfb6701-a17c-4f23-a6fe-15c12214f98a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_c865a79f-59dd-4d25-9d0a-7b3e3ff3ec5b_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b6463c40-6c6e-4b95-a4e1-0be9d349d8c9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6adef990-03de-44dd-a118-f63e19d77e72_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_7fc98492-6e74-4267-bf2e-95d203155939_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_41dd25ef-234a-4707-97b5-389120032f61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6e62f9c6-9a8f-41a9-8f4e-9a605f6a483b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_b55e90c8-f977-4ac7-9b67-9c435c0087b6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_cf0efc73-dab4-4c2d-93b2-76c04b608cdb_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_929d10ff-df6a-43b5-afed-c46f24d77fc2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_aa24824e-3085-49d8-9eb9-27cf90b1c5d5_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_185a984b-87cb-4428-8d73-e2dc93bc8732_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_6f555e44-bbbe-453e-a58a-07adc2dc56bc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_84e779cd-92b3-496d-9070-6dc0f45d02f3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_35c1f735-237c-482b-b4a8-bbbeebba58bc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets, December 31, 2021</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_b6ba4553-3406-483b-bb24-e5f8c1826ff2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets, December 31, 2022</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_3d816935-5ed4-4eb7-a975-2b0a3edc7436_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_e493766b-0649-4831-89fd-cb1296067e61_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, state and local</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_278096aa-c6c8-4ff2-a990-4961235930dc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_e4804050-1dd0-48eb-a257-fd9bc9ee09b5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_2ca59aed-7f40-469c-8c7c-c819b5d8a544_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_36500f47-b3df-4aa6-9979-12078175f622_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_ab8b41b2-fb70-49ec-808f-1a05ecd2417f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of other, net of tax of $0.1, $0.0, and $0.0</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_b707a693-2c35-499b-81a7-6da229e2c3ba_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_386fefa5-096d-4a58-8f05-10c1339c47e6_terseLabel_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Due 2024</link:label>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_label_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Due 2024 [Member]</link:label>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_documentation_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member" xlink:href="wst-20221231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RevolvingCreditFacilityDue2024Member" xlink:to="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_The2022RestructuringPlanMember_706ec3d5-d455-46f9-b5d8-561eed40dd41_terseLabel_en-US" xlink:label="lab_wst_The2022RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Restructuring Plan</link:label>
    <link:label id="lab_wst_The2022RestructuringPlanMember_label_en-US" xlink:label="lab_wst_The2022RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2022 Restructuring Plan [Member]</link:label>
    <link:label id="lab_wst_The2022RestructuringPlanMember_documentation_en-US" xlink:label="lab_wst_The2022RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2022 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2022RestructuringPlanMember" xlink:href="wst-20221231.xsd#wst_The2022RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_The2022RestructuringPlanMember" xlink:to="lab_wst_The2022RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_35823708-891c-4c88-b610-4580ce0f111b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_bdfd47f4-845a-4f46-b8c5-f763f61a2d62_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_070796ce-49db-4ff5-9477-3db12cea262d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity call options</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_11608e0e-6fba-4221-af49-2c3c90c3b248_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_59aaa2b7-5c2b-4caa-ac57-b9630af2db23_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status</link:label>
    <link:label id="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Changes In Fair Value Of Plan Assets, Projected Benefit Obligations And Net Funded Status [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:href="wst-20221231.xsd#wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:to="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_GenericsCustomersMember_ffac1891-52dc-4257-84ed-0af164607e45_terseLabel_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics</link:label>
    <link:label id="lab_wst_GenericsCustomersMember_label_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics Customers [Member]</link:label>
    <link:label id="lab_wst_GenericsCustomersMember_documentation_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember" xlink:href="wst-20221231.xsd#wst_GenericsCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_GenericsCustomersMember" xlink:to="lab_wst_GenericsCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_662dd778-6b16-4a15-8e39-01a41e307668_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related cost, expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b7989d82-9933-4649-992a-f4069fff0e49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ae6275a9-46ba-4a23-bc90-bcf9c8e648b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_3dcf679b-279e-419d-9593-a5ee3c0df6ab_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherCosts_76dfc914-364c-44b2-810a-3a65126bbaeb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherCosts_db35f177-62f7-4b97-89d3-6c438b7072eb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherCosts_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanOtherCosts" xlink:to="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_77ce72cf-4426-4d16-9ad8-a888d87969f0_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_89595889-b781-4a36-9861-8758305ea555_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_808aebad-7af0-4741-bd01-507a932168fc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromAffiliates_6d70eb5e-aeac-4c11-a153-ada618eedde6_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount receivable from affiliates</link:label>
    <link:label id="lab_us-gaap_DueFromAffiliates_label_en-US" xlink:label="lab_us-gaap_DueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromAffiliates" xlink:to="lab_us-gaap_DueFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_53cf5507-2dd1-4b4d-bd71-9bcf5e6cfc52_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_bc342106-54c3-465e-b1b3-d6cbb50c6e2a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_3424d0b7-4cdb-4b49-8d2a-48b704953a7d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01708a2b-eef8-4f2a-80d0-cf736e4c52e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested PSU Awards [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_332dc215-0fca-4e45-9e8b-c07bb98b39f6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_2a63b1e5-9444-4fca-b2f5-69f6303c68f3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_84735dc7-5ce8-415b-9ef5-8ff05a9743bf_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_3e32e9e5-140d-4da3-b040-05c1e575edb8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_ef050d64-2dee-4643-beab-317ec72c6310_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_fa71eb32-383b-4a17-825d-81723a71682a_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_9ff39d34-9a1c-4740-926b-19a0b36278d5_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_34efc7c5-49e7-4d32-aa04-2d40e2962841_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease due to prior year position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_21110fb7-b35e-4afe-b88b-b42fdb8b1f20_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other charges</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_06c8b59b-59ff-4def-a9ce-cefe15f2504b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0a43e64d-5355-4bae-a8b7-1dd9ec75e595_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_687d96b5-1967-45a7-9b53-3472734ba64e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_80409d50-5d52-40a0-b747-af21afbb9643_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_8c8e0e19-44ac-4b26-92b5-688a89384782_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ApplicableMarginMember_9ba2bf35-dcab-409d-b29e-52eb0d3a58c9_terseLabel_en-US" xlink:label="lab_wst_ApplicableMarginMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin</link:label>
    <link:label id="lab_wst_ApplicableMarginMember_label_en-US" xlink:label="lab_wst_ApplicableMarginMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin [Member]</link:label>
    <link:label id="lab_wst_ApplicableMarginMember_documentation_en-US" xlink:label="lab_wst_ApplicableMarginMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ApplicableMarginMember" xlink:href="wst-20221231.xsd#wst_ApplicableMarginMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ApplicableMarginMember" xlink:to="lab_wst_ApplicableMarginMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmount_00690e1e-3c9e-4bad-8788-998a244bf35d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, nonmonetary notional amount outstanding</link:label>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Nonmonetary Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNonmonetaryNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:to="lab_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_5966d296-2d70-41cc-8b5e-2f0ba098393c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_64cd8ff0-747c-480d-8cae-436066138d5b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_cdf5508e-b962-4c72-a1ba-50acb3fae445_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PharmaTapSADeCVMember_7b561558-7576-4dd3-a5ae-3c241fedf9e8_terseLabel_en-US" xlink:label="lab_wst_PharmaTapSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Tap S.A. de C.V.</link:label>
    <link:label id="lab_wst_PharmaTapSADeCVMember_label_en-US" xlink:label="lab_wst_PharmaTapSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Tap S.A de C.V. [Member]</link:label>
    <link:label id="lab_wst_PharmaTapSADeCVMember_documentation_en-US" xlink:label="lab_wst_PharmaTapSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Tap S.A de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaTapSADeCVMember" xlink:href="wst-20221231.xsd#wst_PharmaTapSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PharmaTapSADeCVMember" xlink:to="lab_wst_PharmaTapSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AluplastSADeCVMember_f3d387a3-e5bf-4355-82a6-c9cf41a1c509_terseLabel_en-US" xlink:label="lab_wst_AluplastSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aluplast S.A. de C.V.</link:label>
    <link:label id="lab_wst_AluplastSADeCVMember_label_en-US" xlink:label="lab_wst_AluplastSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aluplast S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_AluplastSADeCVMember_documentation_en-US" xlink:label="lab_wst_AluplastSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aluplast S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AluplastSADeCVMember" xlink:href="wst-20221231.xsd#wst_AluplastSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AluplastSADeCVMember" xlink:to="lab_wst_AluplastSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f29af203-c92b-429d-9e6e-84ddc1c13501_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_e895a622-b796-4fbc-8160-3f2918d79ee0_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable_66df76c7-c2dd-4b3f-9b3c-35f5810da791_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable_label_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets By Major Class [Table]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable_documentation_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:href="wst-20221231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:to="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_0048f9e6-0a2e-4e8a-9cb0-e5d0c530b4ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service credit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_fb6a4b14-49b5-4b62-ad12-93e902030ad8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8537df9f-8c09-4afe-8352-971882e839bf_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_39f2f806-4d42-4073-8919-6402d1041d4b_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_fefa5175-9d2c-4e43-b8b1-1549e8fa34ea_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f90da184-e4c6-4700-990f-a866812443e9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems_867955fb-f0e8-4fe3-883b-7b08ee4c04e7_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_88fa874e-6c08-486c-b37a-7d2d52349e2d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on investment securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_77d2f52a-c5c2-434a-bf26-a487896ef8da_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units, stock-settled</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_4bcf88e6-83d6-4733-bba1-7f993e7fd35c_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_23a7124f-73b6-46ff-92d9-b1d43ab7783f_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_3406742e-8f25-4afa-bc79-b7f48b0dd4be_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6850fa79-8baf-446a-ac90-48221c0ee4ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_058d3c8e-ce1a-497e-83ca-d52e9904301a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c31beaf8-9974-4e9d-b595-ce8a14aafc5a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_ddfe9f86-3283-4838-80fc-15c471a195ea_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_02293d12-9cc6-4ac2-a974-b182b737b588_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified out</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_5fbfd1ca-d7a8-442b-b312-fcedfe5efe1d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, nonmonetary notional amount, volume</link:label>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_label_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Nonmonetary Notional Amount, Volume</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNonmonetaryNotionalAmountVolume"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:to="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_9b189712-8e80-4750-a392-51937b051ca3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_6ca71259-e46c-401b-a578-9484948f386a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DebtInstrumentRatioOfDebtToEBITDA_42ab683b-47b9-4eb6-a6c1-5929fa352d4f_terseLabel_en-US" xlink:label="lab_wst_DebtInstrumentRatioOfDebtToEBITDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of debt to EBITDA</link:label>
    <link:label id="lab_wst_DebtInstrumentRatioOfDebtToEBITDA_label_en-US" xlink:label="lab_wst_DebtInstrumentRatioOfDebtToEBITDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Ratio Of Debt To EBITDA</link:label>
    <link:label id="lab_wst_DebtInstrumentRatioOfDebtToEBITDA_documentation_en-US" xlink:label="lab_wst_DebtInstrumentRatioOfDebtToEBITDA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Ratio Of Debt To EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentRatioOfDebtToEBITDA" xlink:href="wst-20221231.xsd#wst_DebtInstrumentRatioOfDebtToEBITDA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DebtInstrumentRatioOfDebtToEBITDA" xlink:to="lab_wst_DebtInstrumentRatioOfDebtToEBITDA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_c41dd09a-b2a6-4f11-9c5f-4d424e8deed3_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_20c37836-51f0-46fb-81ae-1310dfa50070_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_d4e575d6-f3fd-4456-ae8c-2e90f09865fc_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_ae4af5e4-b37e-45b8-9480-15f4c60f05a0_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_851df7d0-70e7-4cdc-8a97-c9a5fa4008f4_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation benefits</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_719a5f46-6dd8-4e5c-b7d5-061c529781f3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_cd3ef45e-f60e-4bed-a9de-ebb696aed414_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value of options vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd6bcab9-92ae-4757-bbc7-50b6e3250b54_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_fbeff14c-6d3a-4668-ac27-d0611bf4fee2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_9e61c603-6eb3-4657-a6e2-98eb57209c52_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CashSettledPSUAwardsMember_6c0dbcf1-0e96-429e-a26e-c766537c5ef6_terseLabel_en-US" xlink:label="lab_wst_CashSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units, cash-settled</link:label>
    <link:label id="lab_wst_CashSettledPSUAwardsMember_label_en-US" xlink:label="lab_wst_CashSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-Settled PSU Awards [Member]</link:label>
    <link:label id="lab_wst_CashSettledPSUAwardsMember_documentation_en-US" xlink:label="lab_wst_CashSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-Settled PSU Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember" xlink:href="wst-20221231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CashSettledPSUAwardsMember" xlink:to="lab_wst_CashSettledPSUAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_e2624b05-11e1-4637-b622-49da62d79d5d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0312dced-3b6e-47db-b175-1cdc7e8c985d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_1e9aedcf-e60a-4d7b-932f-c7cc4a4af81c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_79f8475f-2fb3-4a28-8d96-fee48e295e3c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_cade5357-61a1-4cde-81d8-687622ba1aa2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_7b91799c-1fe6-409e-80e6-a5fe5d7f8437_terseLabel_en-US" xlink:label="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Deferred Compensation, All Types [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_label_en-US" xlink:label="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_bc63be7c-f757-4c32-85bf-2ebc56a8f02d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fd425d97-d86d-435a-aa5b-38185b1eface_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) on Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceClaimsMember_09571331-af70-491a-8ad4-54d00d9becd5_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Claims</link:label>
    <link:label id="lab_us-gaap_InsuranceClaimsMember_label_en-US" xlink:label="lab_us-gaap_InsuranceClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceClaimsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceClaimsMember" xlink:to="lab_us-gaap_InsuranceClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_2ce8764a-4d17-4402-a0a9-99529738ac07_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment sales elimination</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_f18e7037-609a-4ab2-b24f-0011d1710a87_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_171a0372-0fe9-4de0-aea3-b488abb1742e_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Germany</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_26ce6aea-0341-436b-b7c2-7e037f0acbb4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 to 2032</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ComputerHardwareAndSoftwareMember_c2a966e7-a8ec-4bdc-aa43-28acda4e8103_terseLabel_en-US" xlink:label="lab_wst_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer hardware and software</link:label>
    <link:label id="lab_wst_ComputerHardwareAndSoftwareMember_label_en-US" xlink:label="lab_wst_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware and Software [Member]</link:label>
    <link:label id="lab_wst_ComputerHardwareAndSoftwareMember_documentation_en-US" xlink:label="lab_wst_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ComputerHardwareAndSoftwareMember" xlink:href="wst-20221231.xsd#wst_ComputerHardwareAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ComputerHardwareAndSoftwareMember" xlink:to="lab_wst_ComputerHardwareAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_15bc34eb-a859-4b8e-8fc9-c68fab7bd1d4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_7bf9c559-1fad-4aea-a064-ac9426c95a91_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredTaxAssetsLeasingArrangements_9798af90-5e7b-4cff-993b-84c87f35cfad_terseLabel_en-US" xlink:label="lab_wst_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_wst_DeferredTaxAssetsLeasingArrangements_label_en-US" xlink:label="lab_wst_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:label id="lab_wst_DeferredTaxAssetsLeasingArrangements_documentation_en-US" xlink:label="lab_wst_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsLeasingArrangements" xlink:href="wst-20221231.xsd#wst_DeferredTaxAssetsLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredTaxAssetsLeasingArrangements" xlink:to="lab_wst_DeferredTaxAssetsLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8bc1c330-13aa-485b-8568-6f942dab4e04_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, foreign</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7b2ed9ea-3fa5-4325-957b-c3d5f1d479e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_28f591fc-b334-4b9a-8e12-9d1ad0afe012_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_a2c88a29-7d57-4389-af97-c03f2cefdcc3_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_5c0d974d-e504-43f3-a91a-5be54304d589_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension benefits</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_fc123143-7324-49ff-93a1-807e69c3110e_terseLabel_en-US" xlink:label="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in unrealized gains (losses) in securities available-for-sale and derivative instruments</link:label>
    <link:label id="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_label_en-US" xlink:label="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect</link:label>
    <link:label id="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_documentation_en-US" xlink:label="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:href="wst-20221231.xsd#wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:to="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_e3d035b4-36e5-4d60-945b-e8adbef63f55_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber_65b7b4f8-62c7-44c7-a7b8-b9c41a40e4ba_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Expected to Vest, Number</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Expected to Vest, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CreditFacilityIsAvailableForSwingLineLoans_a3bc87c7-bd2b-4c42-93fd-2a412766bb44_terseLabel_en-US" xlink:label="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility is available for swing-line loans</link:label>
    <link:label id="lab_wst_CreditFacilityIsAvailableForSwingLineLoans_label_en-US" xlink:label="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility is available for swing-line loans</link:label>
    <link:label id="lab_wst_CreditFacilityIsAvailableForSwingLineLoans_documentation_en-US" xlink:label="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This refers to credit facility is available for swing-line loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:href="wst-20221231.xsd#wst_CreditFacilityIsAvailableForSwingLineLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:to="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_83a76551-60eb-4cbc-a3b0-aeb1e974bb39_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_81c8f321-7dbf-487f-9e80-32ebc6af8461_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_14a30cfb-fc08-42df-b406-732dd77249d2_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StandardPackagingMember_88c59444-a53d-4628-be2e-d9d349749993_terseLabel_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Packaging</link:label>
    <link:label id="lab_wst_StandardPackagingMember_label_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Packaging [Member]</link:label>
    <link:label id="lab_wst_StandardPackagingMember_documentation_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Packaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember" xlink:href="wst-20221231.xsd#wst_StandardPackagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StandardPackagingMember" xlink:to="lab_wst_StandardPackagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_e136c632-41aa-47a2-9497-786e05c35f13_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, noncurrent</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_d24f6742-b1ba-4694-97c1-f2c05f525234_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_b3134645-3671-4822-b3c4-b642e9a2a1a8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to prior year position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_04bc1403-2247-468a-ab0e-a12d964e2994_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan assets measured at NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_97109008-17b5-4327-935c-7cc544abf408_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_96a8d1ca-8769-4df7-b528-e7c9df878bd9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_703bae30-ab9e-48ad-9909-a3ed25966f4e_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_4bb43cb1-e8a3-4c66-ada8-a58789aa2001_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_632c2ee3-bae1-4fbe-a191-ddcbabeb6a57_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_22331fd0-bf59-48af-bef9-e678bcab2f00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_85913ca2-4db0-47f3-be5d-ae7b6525ce7a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_22c562cf-aac8-4f8d-8771-f4a355c3faae_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquisition-related intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_5583b90a-0743-4d88-a5ed-0feb18139c8b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_2f88596d-ba85-49b2-944e-5726562467e2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, net of amounts capitalized</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2b4d1f60-0eeb-436f-83c7-6a6c643781e6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_8f120aed-7043-4180-9647-8a96ffd1be9f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOnFutureEarningsAmount_fe48f32d-2cd4-4828-ae93-8a535c50e44b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOnFutureEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on future earnings, amount</link:label>
    <link:label id="lab_us-gaap_EffectOnFutureEarningsAmount_label_en-US" xlink:label="lab_us-gaap_EffectOnFutureEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on Future Earnings, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureEarningsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOnFutureEarningsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOnFutureEarningsAmount" xlink:to="lab_us-gaap_EffectOnFutureEarningsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_131aae66-22f4-4b0a-aeaf-c29b1d9460a1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension and other postretirement plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_fc967c35-d224-4de5-b3c7-171f9e0dc8df_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Defined Benefit Pension and Other Postretirement Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_d8f0a133-a21b-4f75-b0f4-26a307e91cd7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_73ce42f2-4a5f-4ac0-bdd5-945a0f6f18ae_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f969e902-40dc-470e-b1bd-e7150cb4a804_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c81855d7-4d60-4077-8c6b-c111a6e3fc34_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_3a18d363-7b72-4b24-bb9e-c54498e26964_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractManufacturedProductsMember_94fa973d-9136-4bea-99b1-c1f67870ca4c_terseLabel_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Products</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_cd520ab6-a72b-47f2-bd86-5dcd3ef32a7c_verboseLabel_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Products</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_label_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufactured Products [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_documentation_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufactured Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember" xlink:href="wst-20221231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractManufacturedProductsMember" xlink:to="lab_wst_ContractManufacturedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_095026f8-f603-469b-aa8d-6887d2531076_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_68a6a2ac-5fa0-4738-a723-44e678ec3a60_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_16073d3c-3270-40c5-9279-973eb409ac4f_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Employee Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2bc7f9b3-887f-4c85-bcd8-804115e2dfc1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_8a0e8f95-e80d-4633-8e20-5dc97f6681d4_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_cb026069-3746-498c-885b-c8a0c12df27c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_41b3cbc8-980b-425d-86f5-5e73de7217b5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_77cecd07-4207-495d-9216-2e5b704cdc5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Year2021Member_423d442b-9a49-4214-b337-3c27cd9fb227_terseLabel_en-US" xlink:label="lab_wst_Year2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2022</link:label>
    <link:label id="lab_wst_Year2021Member_label_en-US" xlink:label="lab_wst_Year2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2021 [Member]</link:label>
    <link:label id="lab_wst_Year2021Member_documentation_en-US" xlink:label="lab_wst_Year2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2021Member" xlink:href="wst-20221231.xsd#wst_Year2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Year2021Member" xlink:to="lab_wst_Year2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1a98ab21-4b33-4aa3-a845-2194797ff2c5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_db5c0ba5-5d8f-49bb-b7fe-10799f8bf687_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_ec86ae63-3985-4fd6-9f66-b8890d7f85ed_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments received in advance</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_label_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) Due To Additional Cash Payments</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) Due To Additional Cash Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:to="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_47fe7118-1431-4755-94a4-835ee84081b1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_c71bb753-57c4-4595-b749-2c005b447fd3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_e5385df2-24bb-4ab7-8a05-6d006e061d38_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax_9aa96fef-cefb-4a2c-903b-e5d63a8fc7fe_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax_label_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Other Costs, before Tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Other Costs, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" xlink:to="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_1b9fe196-60dc-4662-afd1-76548c5c61b8_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_8fa80388-a459-4e11-8173-83b580057743_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_943641f3-f8f8-4817-b41a-e1f22447cf61_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_c0f239f8-3a6e-49a4-bb70-90d39a143a25_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_96608e2f-53e8-4dd8-b85d-404c11240568_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance under the 2016 Plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_ef5e9541-70b7-4f5a-ac13-cde0f8954191_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_8d95beee-6f09-4902-b58d-d870bb257a68_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4d470b36-9b20-431a-ab02-bc20567d5859_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_19b19fa2-4f1d-49aa-b051-7e43728b63d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and converted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_66197911-2e6d-424f-b754-03d53d368473_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-Based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_aa39ca61-e9f9-4e97-a9f3-3777555168f9_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_a1257a9a-3b27-4e80-b815-d1f1fd9a4f5a_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_4e46e1c9-7ffe-4a2e-82f8-4202f5b04a93_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet_d2ae1ab3-c3f0-4260-b43a-c080949d564e_terseLabel_en-US" xlink:label="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other retirement plans, net</link:label>
    <link:label id="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet_label_en-US" xlink:label="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Other Postretirement Benefit Expense, Net</link:label>
    <link:label id="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet_documentation_en-US" xlink:label="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of pension and other (such as medical, dental and life insurance) postretirement benefit costs recognized during the period for (1) defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss) on assets, prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments) and for (2) defined contribution plans (to the extent that a plan's defined contributions to an individual's account are to be made for periods in which that individual renders services, the net cost for a period is the contribution called for in that period; if a plan calls for contributions for periods after an individual retires or terminates, the estimated cost is accrued during the employee's service period); net of cash contributed during the reporting period by the entity to fund its benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:href="wst-20221231.xsd#wst_PensionAndOtherPostretirementBenefitExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:to="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_45fb3bb0-12ae-46f3-8cd8-a86f648e1c2a_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401 (k) plan contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_fb4c0a48-b322-4930-9472-e1c09bb8ed6c_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_09e5b3c7-fcf6-41a9-8f3e-a8e7457537a5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_e9c9310f-2e03-4ad9-8032-7573f86b5a5a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan assets in the fair value hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_4113c53a-172f-4d58-896b-b18166542f77_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_a9d1314b-d8d2-488f-aa33-a1e6d9e5e302_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">France</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Year2022Member_c2734bb3-d690-4299-b67c-4ed89c611cd6_terseLabel_en-US" xlink:label="lab_wst_Year2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2023</link:label>
    <link:label id="lab_wst_Year2022Member_label_en-US" xlink:label="lab_wst_Year2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2022 [Member]</link:label>
    <link:label id="lab_wst_Year2022Member_documentation_en-US" xlink:label="lab_wst_Year2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2022Member" xlink:href="wst-20221231.xsd#wst_Year2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Year2022Member" xlink:to="lab_wst_Year2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_b3571d0a-4553-403f-8b55-a485e9de37d7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ExpirationPeriodAxis_dac5aa62-0227-4944-a467-0c8e5f84429c_terseLabel_en-US" xlink:label="lab_wst_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:label id="lab_wst_ExpirationPeriodAxis_label_en-US" xlink:label="lab_wst_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:label id="lab_wst_ExpirationPeriodAxis_documentation_en-US" xlink:label="lab_wst_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodAxis" xlink:href="wst-20221231.xsd#wst_ExpirationPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ExpirationPeriodAxis" xlink:to="lab_wst_ExpirationPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b0220ee7-9f6f-485e-a872-95e0c5f1a59b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_bc5edaa8-3864-4542-840e-03c3f6128550_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DebtInstrumentNumberOfTranches_91214e13-e61e-482a-ae25-46d1aa425639_terseLabel_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of tranches</link:label>
    <link:label id="lab_wst_DebtInstrumentNumberOfTranches_label_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Tranches</link:label>
    <link:label id="lab_wst_DebtInstrumentNumberOfTranches_documentation_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfTranches" xlink:href="wst-20221231.xsd#wst_DebtInstrumentNumberOfTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DebtInstrumentNumberOfTranches" xlink:to="lab_wst_DebtInstrumentNumberOfTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_f21da406-284f-4d9f-ac0e-31b47c8b9d25_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_label_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:to="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_e2aa88d4-2d3d-4bc1-b800-98a52687f459_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a304d3af-bbd4-4807-a380-fd0d265a4ae4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_2e3bffd3-d775-445c-b733-7e5cc6a6f52c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in undistributed earnings of affiliates, net of dividends</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_85a3ed1a-4bba-4568-a572-f6e7c0f08212_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c11d9cfb-ed25-4b7f-99dc-cb6ed2584d84_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_6bb503c3-2731-492c-9881-f04b558027b5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense (income) and other nonoperating expense (income), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_f088bdba-8de2-4abf-abd7-5ffe5f759c50_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_1f6f2be4-9b26-4e09-8a0a-556a43443925_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_9282719d-497f-4a30-a6fd-ff451d934fae_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8eecdd66-bf68-4ac1-b318-a97fab0eba7b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_4c3d900f-b7eb-4f4d-a7c4-9cbfca3ba490_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6de07107-4b22-462d-bd5a-4230e0b25b6e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7246d615-974e-4b8f-9332-d24ff699d4d9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7018e142-1cff-4b26-b9ee-5b58032c30c9_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_a0e37518-a751-49c7-8369-f12d73542c4a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_a5c028eb-a97f-48d8-9b77-9d2f36d29863_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_5330ace1-e1b2-4dc5-9e27-527f0d590963_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_519ec3cd-a77e-4825-a814-fd37e2585eae_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_5e6e8643-3c4b-49b3-b84c-6a1200dacd8c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_418df2e7-fb4a-4baf-a831-926d3c78b2db_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_490f5174-9eaf-496c-94ec-00dfc77f1852_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_472a3f55-d7f2-4fb4-adae-f5fc500e6032_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_993ee824-04d7-4550-85a1-29b8139ba941_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_e5656841-3117-43f3-9bf7-884ba6f40463_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b5c8e458-cc90-403e-97f9-562d8a2a3816_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_af446092-04cf-4402-8c2a-8857a4283f92_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_8c55d725-49cd-4f08-aefa-a2293fd87d5f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_18845c37-8726-45ad-9d51-46b2b015f939_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial (loss) gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AssetRelatedChargesMember_4bf1ca91-5fb6-40a2-ab59-426270b64484_terseLabel_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-related charges</link:label>
    <link:label id="lab_wst_AssetRelatedChargesMember_label_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Related Charges [Member]</link:label>
    <link:label id="lab_wst_AssetRelatedChargesMember_documentation_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Related Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember" xlink:href="wst-20221231.xsd#wst_AssetRelatedChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AssetRelatedChargesMember" xlink:to="lab_wst_AssetRelatedChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_4d98038b-f14a-4ce9-ae43-1e9669faf719_terseLabel_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of deferred compensation plans</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_label_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Number Of Plans</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_documentation_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Number Of Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:href="wst-20221231.xsd#wst_DeferredCompensationArrangementWithIndividualNumberOfPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:to="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d1997ff6-0d08-4377-88b2-8883bf080a7e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_02b1bb5e-62c3-4af7-b443-db80865c4996_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_cd088ba5-bb90-43a1-a157-45c86c83c057_terseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. tax on international earnings, net of foreign tax credits</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation Of Foreign Earnings, Net Of Foreign Tax Credits, Percent</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation Of Foreign Earnings, Net Of Foreign Tax Credits, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_9395ba24-760b-418a-9ecf-3a811df6c4c7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_110a58d5-fbbe-4050-8826-fe1366fc330c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_a8d78536-6ed7-445a-9109-e86beb80d706_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a6def7a8-673c-4a31-84d4-00ff0218a676_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_b6f58c9a-d41c-49d2-9faf-919d3b225a3d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_3c22af0e-2b2b-43ec-ae4c-9360282421a0_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyReceivable_21c2390a-3af1-40b9-9cd8-96ab4392c361_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reimbursable by the insurance company</link:label>
    <link:label id="lab_us-gaap_LossContingencyReceivable_label_en-US" xlink:label="lab_us-gaap_LossContingencyReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyReceivable" xlink:to="lab_us-gaap_LossContingencyReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_6e85dbef-245f-45ec-9df5-a3aaea015854_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_bef02988-f0ef-4004-9cd0-b1cb8591baca_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_5c258b56-516f-4c7d-862d-b1927ad6ba56_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c8ff6267-b4a0-4c3e-8709-141d07c80ed8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ce4b964-9e40-4bd2-adb7-0e49651024f1_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares assuming dilution (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_40d03711-001a-40c4-97d5-55dfe3cd5488_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_858f2444-0aab-4c59-9ceb-667d7a9de6dc_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7019954b-afe6-4492-aebd-92a410ec7fd6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_HighValueProductComponentsMember_9a145621-be61-4f8e-b929-4b96096bffdf_terseLabel_en-US" xlink:label="lab_wst_HighValueProductComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Product Components</link:label>
    <link:label id="lab_wst_HighValueProductComponentsMember_label_en-US" xlink:label="lab_wst_HighValueProductComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Product Components [Member]</link:label>
    <link:label id="lab_wst_HighValueProductComponentsMember_documentation_en-US" xlink:label="lab_wst_HighValueProductComponentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Components [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductComponentsMember" xlink:href="wst-20221231.xsd#wst_HighValueProductComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_HighValueProductComponentsMember" xlink:to="lab_wst_HighValueProductComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_25c14d3e-773c-4957-b9c8-a02c21074d02_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_290888dd-b899-4668-8f7a-f8152297852c_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_a583d14e-59f0-44eb-b61b-c47a210c5743_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_c26bd6b9-b2c5-4987-aa91-b1b1a0cb4a9d_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement effects arising during period, net of tax of $20.3, $0.4, and $0.9</link:label>
    <link:label id="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_label_en-US" xlink:label="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Loss, Defined Benefit Plans Settlement Effects, Net Of Tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The adjustment out of other comprehensive income for settlement effects recognized as a component of net periodic benefit cost during the period, net of tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:to="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c8ed8be9-c3e9-4627-876e-ed1847995fa2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30d70d40-988f-4bfd-a5f1-f1b09d9d1e9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_d10a4728-1e79-4c88-af3e-a23a083c9525_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c8df358a-2cfa-45b3-a97d-a6a2bbe69e86_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_f02f439c-b59d-4156-853b-e632411f81c0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_0954eab9-2eac-49e0-98e5-5a05093b3673_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_78bfe551-87bc-4e5d-ad11-722253d6ea3a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_9b7fc12f-9ac4-46ba-814a-caaceee254f2_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_86aabe45-22b0-48b2-b96c-cf7cbe6bba60_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1e8d1237-092d-4eee-bad0-628acd438ad2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated goodwill impairment losses</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_06859ecd-492c-4901-9345-0346dc66a95c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_ee960ddf-9b95-4385-b629-b0f9fc431145_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_1561c4ab-2c3d-463e-a78f-4a0558f49d81_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b33aa781-6032-48de-b0f0-c7880fba549b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_32bd9a6d-b9ef-44ba-a90b-b7b36b56aa3c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_648d20ec-38dd-4356-bccb-218372bd03e9_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_52809e7b-026b-41ea-a122-cf28dcd0a284_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange transaction gains</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_536218c1-6b76-41e2-a484-dc84ad40b275_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_6ead95c4-7369-423f-84a5-87a6f42a4f18_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation gains (losses)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a492f591-fb04-42f2-a917-46bc733410b8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_510cd900-4c90-426d-acb4-8f78f9622dbc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_757d34cd-0cab-45b2-bce2-61cfa47f8077_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DaikyoSeikoLtdDaikyoMember_74413a0f-edf9-41b8-82c6-f1dc944e9a10_terseLabel_en-US" xlink:label="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daikyo</link:label>
    <link:label id="lab_wst_DaikyoSeikoLtdDaikyoMember_label_en-US" xlink:label="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daikyo Seiko, Ltd. (Daikyo) [Member]</link:label>
    <link:label id="lab_wst_DaikyoSeikoLtdDaikyoMember_documentation_en-US" xlink:label="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daikyo Seiko, Ltd. (Daikyo) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember" xlink:href="wst-20221231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DaikyoSeikoLtdDaikyoMember" xlink:to="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_12ce94d1-70cd-472e-b0a5-9630c2f32a90_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c5b36aca-d0f1-4a60-b679-85ce32c7633f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock-based compensation awards</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashMember_530f0fff-998c-48b2-9cc0-643be7dcdfef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3867fa25-227f-42a7-8b63-c2ad77e3cda7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_bebf1e49-f936-4bfc-9c36-f4e083bda22a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_ed4e758a-eada-467a-82ce-390715b205b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_4dc1ddce-6409-4c6d-a3c7-ad14b66ee06f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_d724655a-b7d9-49c6-92a8-72f37b29bc91_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_a4643277-f14a-4265-8387-86e7b186ea25_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual maturities of long-term debt [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_26226e70-5a96-4f46-93e4-74361063df99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Appreciation Rights Award Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_44c25a7a-e596-4ab6-a7d2-af29fb9712fc_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_9d557b4f-fd61-410c-9281-8e52a31b56ea_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalCostsPolicy_1b11cd95-87e4-4890-9a4e-eff5ecb4a52a_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation and Compliance Costs</link:label>
    <link:label id="lab_us-gaap_EnvironmentalCostsPolicy_label_en-US" xlink:label="lab_us-gaap_EnvironmentalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalCostsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalCostsPolicy" xlink:to="lab_us-gaap_EnvironmentalCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EmployeeStockPurchasePlanEsppMember_90a6ee68-2154-477d-95a2-3bc1e3615526_terseLabel_en-US" xlink:label="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_wst_EmployeeStockPurchasePlanEsppMember_label_en-US" xlink:label="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:label id="lab_wst_EmployeeStockPurchasePlanEsppMember_documentation_en-US" xlink:label="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember" xlink:href="wst-20221231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EmployeeStockPurchasePlanEsppMember" xlink:to="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_f4964685-1327-4350-9f52-3e2cb7ca9d08_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal corporate tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_a1f45c44-9e99-4e37-bc80-93ddc57cdc95_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredTaxAssetsRoyaltyAcceleration_d1e48a8e-0d39-44cd-94fc-a0a50e5dc766_terseLabel_en-US" xlink:label="lab_wst_DeferredTaxAssetsRoyaltyAcceleration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty acceleration</link:label>
    <link:label id="lab_wst_DeferredTaxAssetsRoyaltyAcceleration_label_en-US" xlink:label="lab_wst_DeferredTaxAssetsRoyaltyAcceleration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Royalty Acceleration</link:label>
    <link:label id="lab_wst_DeferredTaxAssetsRoyaltyAcceleration_documentation_en-US" xlink:label="lab_wst_DeferredTaxAssetsRoyaltyAcceleration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Royalty Acceleration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsRoyaltyAcceleration" xlink:href="wst-20221231.xsd#wst_DeferredTaxAssetsRoyaltyAcceleration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredTaxAssetsRoyaltyAcceleration" xlink:to="lab_wst_DeferredTaxAssetsRoyaltyAcceleration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_49dc73bb-5f85-4e66-8f5d-9d65dd8fdd62_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5153a9d9-bf11-4406-842c-02f6c0ba1dd2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_08c9a4b1-ee3e-47fb-85e8-876b00417d8f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_df7df90e-4e0f-43fa-b872-f47d11bba30e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ba1b352a-4913-4b95-86c7-9371f258e19c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_3282cdf7-ad2f-4b78-9ab9-a8c98f68b880_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial (loss) gain arising during period, net of tax of $(2.4), $2.1, and $(0.7)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a9638751-ddda-4204-8fdb-1f7fb9d2db6a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax effect</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ee0a47fd-9e2f-4a82-a969-a0a5054339e5_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_c8237db3-c74b-4da4-86cd-d8eb60642726_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding unconditional contractual commitments due to be paid in 2021</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_35dc656a-766b-44fb-aa19-7b8de1858007_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual with Relationship to Entity [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8e24c890-ed5e-478f-ab0b-5b03936fc5a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_1f3e2183-4413-4582-bd5d-8c75771cdb50_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a66d980c-14b5-41d3-a790-c8760ac5d002_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other nonoperating expense (income)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_c9e02500-b044-4676-a1e0-3befe3dd4ece_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments above/(below) target (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_5cb1243c-cf4a-4028-b1e3-199702be8485_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments not designated as hedging instruments, gain (loss), net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_6a72674d-f857-4c17-8e6c-2f551cf4dfd6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on oil hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_720d43b9-6c1a-4e25-8a38-8e5e1ac303a3_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on oil hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_b2ccf6fe-bc44-407a-b5fc-a906c3c28e28_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_WestCompanyMexicoSADeCVMember_66cb3c66-3531-414c-966e-10ad0d0401e2_terseLabel_en-US" xlink:label="lab_wst_WestCompanyMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The West Company Mexico, S.A. de C.V.</link:label>
    <link:label id="lab_wst_WestCompanyMexicoSADeCVMember_label_en-US" xlink:label="lab_wst_WestCompanyMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The West Company Mexico, S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_WestCompanyMexicoSADeCVMember_documentation_en-US" xlink:label="lab_wst_WestCompanyMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The West Company Mexico, S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WestCompanyMexicoSADeCVMember" xlink:href="wst-20221231.xsd#wst_WestCompanyMexicoSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_WestCompanyMexicoSADeCVMember" xlink:to="lab_wst_WestCompanyMexicoSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_7b471d15-a8bb-4abb-9f3d-c3670fb1b115_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sales by Significant Product Group</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0056d7c6-5154-49f2-aec1-0a05ddab63a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e3a130e6-8bed-4055-8835-f0d28e383ef5_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return on assets (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_69778452-e7d0-4c51-be53-596eef39bf64_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7af50a70-95d8-4250-b025-dd1cb1510291_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_56f17890-1b0c-4107-acdd-60005678720d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_db954c4b-dcc0-4309-ace9-371331fb9427_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was included in the deferred income balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_20255014-d08d-422d-8f8a-6e317022b500_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_da84a0fe-3575-4f3d-9cc6-220313e1f1ff_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_8108df65-52eb-4678-81dc-80532cd91c2a_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_3df8e04e-c65e-496e-82dd-dccef269b43f_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e5beb2e0-de51-4812-98fc-7fd7eb37f64c_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense for all nonvested awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_304da72e-f85b-4306-87b9-714d4739c9ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of actuarial loss, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_82faa6e8-8340-4ec1-ab3a-a0a642c856cf_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cc4488e6-8788-4c19-b8a3-2fbd3d1e04ce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Activity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_28645420-cd7f-44f8-991b-89b1a5f5d815_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_12001358-3273-447a-8950-011a514555bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of prior service credit, net of tax of $0.0, $(0.1), and $(0.1).</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_38807f2a-46a8-44f2-bf3d-4a9b62639c0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of total options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_9393ac98-1d29-40f2-9347-c6305d8d8509_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherCountriesMember_eb6b4c47-a999-437a-9147-0e3908af4d84_terseLabel_en-US" xlink:label="lab_wst_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_wst_OtherCountriesMember_label_en-US" xlink:label="lab_wst_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_wst_OtherCountriesMember_documentation_en-US" xlink:label="lab_wst_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-European Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCountriesMember" xlink:href="wst-20221231.xsd#wst_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherCountriesMember" xlink:to="lab_wst_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_1f495be6-61dd-4743-9536-99b4ea32c172_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_a07bc698-a237-4682-b827-0fd0169cd911_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends received from affiliated companies</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SmartDoseMember_633b05b2-4bb5-47f4-86a1-78aeb059d0b4_terseLabel_en-US" xlink:label="lab_wst_SmartDoseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmartDose</link:label>
    <link:label id="lab_wst_SmartDoseMember_label_en-US" xlink:label="lab_wst_SmartDoseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmartDose [Member]</link:label>
    <link:label id="lab_wst_SmartDoseMember_documentation_en-US" xlink:label="lab_wst_SmartDoseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmartDose [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember" xlink:href="wst-20221231.xsd#wst_SmartDoseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SmartDoseMember" xlink:to="lab_wst_SmartDoseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_89d3845e-2acf-428e-b720-8df998fcdb6a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_ead4d86e-9d8e-4a75-a4a1-0a84d5f4cf39_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8e658f22-32f3-40f5-b8eb-3291b945a7da_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity related to stock-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_b1ded537-6a3a-4803-87c9-4196ce89966a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_d82cc850-d052-4101-bb72-ad50b33a010d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_ae23c2cb-086f-43bd-b62e-734adbf30ec6_terseLabel_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries, wages and benefits</link:label>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_label_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Wages, and Benefits, Current</link:label>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_documentation_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Wages, and Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:href="wst-20221231.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:to="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_53eb917f-8488-46fd-803f-c03821e7fe96_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_0314b73a-471c-443f-a089-5a06dc0e5da9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StockOptionAndAppreciationRightsMember_e1c952a9-b7d5-4b27-8a61-a8acd45435ce_terseLabel_en-US" xlink:label="lab_wst_StockOptionAndAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option and appreciation rights</link:label>
    <link:label id="lab_wst_StockOptionAndAppreciationRightsMember_label_en-US" xlink:label="lab_wst_StockOptionAndAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Appreciation Rights [Member]</link:label>
    <link:label id="lab_wst_StockOptionAndAppreciationRightsMember_documentation_en-US" xlink:label="lab_wst_StockOptionAndAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockOptionAndAppreciationRightsMember" xlink:href="wst-20221231.xsd#wst_StockOptionAndAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StockOptionAndAppreciationRightsMember" xlink:to="lab_wst_StockOptionAndAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c3f27d89-8637-4097-823a-788f5d032064_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_8df2bf1a-05cd-4482-9026-57f3c37447f9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ultimate healthcare cost trend rate, benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:to="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_HighValueProductDeliveryDevicesMember_3d3774f4-5194-4dc9-a3e0-86b656f4dff3_terseLabel_en-US" xlink:label="lab_wst_HighValueProductDeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Product Delivery Devices</link:label>
    <link:label id="lab_wst_HighValueProductDeliveryDevicesMember_label_en-US" xlink:label="lab_wst_HighValueProductDeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High Value Product Delivery Devices [Member]</link:label>
    <link:label id="lab_wst_HighValueProductDeliveryDevicesMember_documentation_en-US" xlink:label="lab_wst_HighValueProductDeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High Value Product Delivery Devices Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductDeliveryDevicesMember" xlink:href="wst-20221231.xsd#wst_HighValueProductDeliveryDevicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_HighValueProductDeliveryDevicesMember" xlink:to="lab_wst_HighValueProductDeliveryDevicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_WeightedAverageSharesOutstandingAbstract_b0252509-01d8-495c-a45e-7087822ae4ed_verboseLabel_en-US" xlink:label="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_wst_WeightedAverageSharesOutstandingAbstract_label_en-US" xlink:label="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding: [Abstract]</link:label>
    <link:label id="lab_wst_WeightedAverageSharesOutstandingAbstract_documentation_en-US" xlink:label="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WeightedAverageSharesOutstandingAbstract" xlink:href="wst-20221231.xsd#wst_WeightedAverageSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract" xlink:to="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_03f0f73c-d0a9-455c-ae6a-d758f56e1add_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0d70f80b-6654-4467-bc0f-a13d536a5f29_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_e1e21eeb-360c-4df4-b999-6b4fc401398d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_ef64d3ca-817f-4131-ae55-2aa6bbf0ad3e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_b616d021-4dc0-400f-b682-ebbaa0a2bf75_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_e7fd0471-719f-4f52-a9ed-30f8245d18fc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ExpirationPeriodDomain_0d6c4da1-2531-4f7e-92f1-4019a0d24f2d_terseLabel_en-US" xlink:label="lab_wst_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Domain]</link:label>
    <link:label id="lab_wst_ExpirationPeriodDomain_label_en-US" xlink:label="lab_wst_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Domain]</link:label>
    <link:label id="lab_wst_ExpirationPeriodDomain_documentation_en-US" xlink:label="lab_wst_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Expiration Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain" xlink:href="wst-20221231.xsd#wst_ExpirationPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ExpirationPeriodDomain" xlink:to="lab_wst_ExpirationPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_155a7ff2-35f3-4b8c-969d-279eb1300a74_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_70156630-a572-4b32-adda-eca91e874f6b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_c9b443b3-ffb7-4912-803e-f9b1ebaaff6f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherIncomeExpense_7cf26d47-bb0d-42a4-bce2-f711273b259d_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income) (Note 16)</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_c6595e71-2f0d-4050-aab7-8ab4c07bc4fb_negatedTotalLabel_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_label_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_documentation_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense" xlink:href="wst-20221231.xsd#wst_OtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherIncomeExpense" xlink:to="lab_wst_OtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_e21bd9ff-c0f9-4ddd-a756-3b139d5bb39b_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_YearAfter2022Member_4574cb3a-c66a-4f58-97d6-2b4e13d25dc6_terseLabel_en-US" xlink:label="lab_wst_YearAfter2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2023</link:label>
    <link:label id="lab_wst_YearAfter2022Member_label_en-US" xlink:label="lab_wst_YearAfter2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2022 [Member]</link:label>
    <link:label id="lab_wst_YearAfter2022Member_documentation_en-US" xlink:label="lab_wst_YearAfter2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2022Member" xlink:href="wst-20221231.xsd#wst_YearAfter2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_YearAfter2022Member" xlink:to="lab_wst_YearAfter2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignLineOfCreditMember_2c282786-b8c9-4e72-97e1-17ae1f80ebd3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Line of Credit</link:label>
    <link:label id="lab_us-gaap_ForeignLineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_ForeignLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignLineOfCreditMember" xlink:to="lab_us-gaap_ForeignLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c6535dc0-0454-4542-9ef2-de862076f7ed_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SecondQuarter2020AcquisiitonMember_75726a9a-3042-4997-854d-126ccf472b50_terseLabel_en-US" xlink:label="lab_wst_SecondQuarter2020AcquisiitonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Quarter 2020 Acquisiiton</link:label>
    <link:label id="lab_wst_SecondQuarter2020AcquisiitonMember_label_en-US" xlink:label="lab_wst_SecondQuarter2020AcquisiitonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Quarter 2020 Acquisiiton [Member]</link:label>
    <link:label id="lab_wst_SecondQuarter2020AcquisiitonMember_documentation_en-US" xlink:label="lab_wst_SecondQuarter2020AcquisiitonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Quarter 2020 Acquisiiton</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SecondQuarter2020AcquisiitonMember" xlink:href="wst-20221231.xsd#wst_SecondQuarter2020AcquisiitonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SecondQuarter2020AcquisiitonMember" xlink:to="lab_wst_SecondQuarter2020AcquisiitonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityMember_d9c6866c-a894-4b99-997b-6932646f790c_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity call options</link:label>
    <link:label id="lab_us-gaap_CommodityMember_label_en-US" xlink:label="lab_us-gaap_CommodityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityMember" xlink:to="lab_us-gaap_CommodityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_a4d55c54-9285-4801-9cc1-357a49490193_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_6c0e6c1c-ba11-413f-a5ee-913e035ada50_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_29726e3f-01ec-4d43-83c9-b04f0fc0354b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_5bf7d248-7881-45a1-994d-efb368196cef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_4947bdef-015c-4b04-b28a-7bcf062a3ed7_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_2da1c7bb-93e1-4794-931d-b83d2d6214ee_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 18)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_4a0155aa-9e32-4a4a-8665-61f735919bdd_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7225ce35-97e9-42bc-b62c-65f59457f850_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_329dcda2-5d68-46c4-9e22-7df76ff7735d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent_c2981604-72af-4c84-88e8-fd0cb2acd1f9_terseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlement</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Pension Settlement, Percent</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Pension Settlement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_de2946b6-318d-462b-952f-434dbb947f8f_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f77a2c47-ea3b-4c45-850d-5029c779ca07_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_4112b8b5-98e1-4cd1-936b-e766a0823a87_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_fa1afa60-ded5-428d-9247-33c1557a2337_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_58045c8e-d815-482c-9e26-c89cea79996d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_6b7c6b12-eef6-4488-8630-2d8b7e2b28d1_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_0fcdd2d9-766d-4429-8cd4-8664da5d0717_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments in excess of acquisition-date liability</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent_f32c6add-a011-496f-86e0-8ba100920fb6_terseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty acceleration</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Royalty Acceleration, Percent</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Royalty Acceleration, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_e70fa924-0a2f-44d8-a71a-346b39480de6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average interest crediting rating used to determine net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_2703c651-a817-4f21-8f90-fc987ab88af9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_9f8055b3-a1d9-4e51-8342-b1f2cc51556e_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_e767a348-0137-4212-9a76-db310667770f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_9c95473e-b96d-4905-95d5-58af6ff814a7_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings of foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_56c4bff8-30ee-49a4-8cc9-0e0ff6245d39_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_ff4996cd-9aa1-4c43-994a-3d2c3e8c1257_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8f5ce35d-11aa-4244-b10c-d8584442c71f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligation:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_26e9eb71-e7f5-4027-802c-50453d466020_terseLabel_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of deferred stock units (in shares)</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_label_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Share Equivalents Balance</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_documentation_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Share Equivalents Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:href="wst-20221231.xsd#wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:to="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_f4447a7e-763b-4568-932e-5317d2b8e72b_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_4bd05b2a-0041-46a5-a94e-eb3b97dce4df_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_0524f758-ed68-43d4-afa7-4b293cbfc63b_periodStartLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_b0eff992-eaef-4326-8892-530a40590ff1_periodEndLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_22dae12a-bfd4-4e6f-8b5c-407331660597_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_7a30a892-273f-4a4b-b4a3-fdb6ebac91e1_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e1ca3792-80a3-415b-9a9a-1875d5697f55_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_83ad0af7-49a6-4a30-9ecd-21cdf9fed43a_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_94c04b61-9d93-4103-8ae3-8b53ec2a7046_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2921600c-2056-4e15-a185-7ac8a29b3bd7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased for employee tax withholdings</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_cb9a9504-aae9-4148-83d4-4aded65f7108_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_6c0646eb-23ae-4281-a732-6cae7b3035c8_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_b008fd61-11ce-4b44-8e91-7f152fd2acb5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice_51a75ed6-515b-4a4a-b1ce-ced2c563a848_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Vested and Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Vested and Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_45420546-fcb6-4539-a000-92ec78b2443b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued retirement plans (excluding pension)</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Other Retirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_6dc30fc0-5f70-45ec-acfe-855cb56e9733_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_256f6ee3-229e-41a4-ad10-dabbd769df26_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_29652b1a-2c38-4b28-bff3-b341961468e6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities for interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_75ee367e-cca4-4803-8392-85b8b5d9ca31_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed lease interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_0d16de3b-0168-4d1c-a1bc-f71844d5bc58_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AuditInformationAbstract_label_en-US" xlink:label="lab_wst_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_wst_AuditInformationAbstract_documentation_en-US" xlink:label="lab_wst_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AuditInformationAbstract" xlink:href="wst-20221231.xsd#wst_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AuditInformationAbstract" xlink:to="lab_wst_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_aa5a80ec-2d9f-4f11-8234-c2b60b7ff974_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6e46e468-7e28-4fd0-b511-28eec8cd5145_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_baff9a23-b4f3-4e05-ba67-6c1de2cbca09_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_83b411f2-7f25-4230-939b-589620144511_terseLabel_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B notes, due July 5, 2024 (3.82%)</link:label>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_label_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior B Notes Due 2024 [Member]</link:label>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_documentation_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior B Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member" xlink:href="wst-20221231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorBNotesDue2024Member" xlink:to="lab_wst_SeniorBNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_96538e10-039f-44d0-8e69-9740ff4d323c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_6b84c0be-2888-470d-915a-24dfbaafefdb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_6a4e1547-2baa-49ba-afac-2dbaf46fd741_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_7fc46ddb-81aa-4132-97de-8ce8fb236b57_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at January 1</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_675d924a-75bb-429d-8472-e5f9798b1a8b_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_6c3e62e1-7d04-49e2-a2bb-9d08dae9321a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_82e674f0-85e0-4e55-ab60-ad9bfa3a07e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset impairments and sale of equipment, net</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_29c8a3de-4a6c-4ff6-8d50-fa2f7ffd2735_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_661ca5e7-014f-43fc-b5e1-4738fec10053_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of prior service credit, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2233354d-c096-448d-bc6c-7d4e39510933_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_f737acfa-0b93-4ae0-97ab-7a24cac6c207_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_d7fe5941-0149-4109-a99e-a7f6b939f2ad_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a2e5c355-f7f1-4b0e-bc98-d7ecad66193b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_d2ca0f0f-16d4-4f00-91d6-b8731e91a4a8_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated increase (decrease) in the liability for unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ae1276da-1063-44b0-a7c0-14a83f145ef3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_0b794c21-ac6b-4098-bee7-e27871801538_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_c3027665-61c5-4290-a6c2-dbf0f58801ef_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, December 31, 2021</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_1202c4b6-4240-40be-8f5b-4d26ac40a16a_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, December 31, 2022</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_190a66f4-1c7d-46f2-bd8a-20e474c17d84_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_89404360-0a0c-431b-a4db-de9157c47bd9_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ProprietaryProductsMember_9d932805-2f47-4eab-8457-c98b5990e162_terseLabel_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products</link:label>
    <link:label id="lab_wst_ProprietaryProductsMember_label_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products [Member]</link:label>
    <link:label id="lab_wst_ProprietaryProductsMember_documentation_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember" xlink:href="wst-20221231.xsd#wst_ProprietaryProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ProprietaryProductsMember" xlink:to="lab_wst_ProprietaryProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_65078b23-c59b-4769-8ac9-9b8e052d15ab_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_0a4f933e-c71d-4a7d-9c0d-02908a8e6cf7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_7b78279b-eaa0-4185-9eff-e1eef0644a5a_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_c8d635e1-c4ff-4201-800e-cf55efcc86bc_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_708bffee-7644-4eaf-934d-9f15600dff14_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d7dda49b-947c-4377-902a-bd89fb07efbe_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_3d361fed-4dbb-404d-a764-88734696bc30_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt issuance costs for Term Loan and Series notes</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fd516c13-a99d-4cb6-896b-ff830287157b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_55c41296-f998-4adf-9f21-4c3d2724a062_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions By Employer, Net Of Premiums</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions By Employer, Net Of Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:to="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8beb9757-098b-40c6-acc2-9bf8aa5e2888_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_71079788-2f2a-4153-84ef-8c047e7c9683_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_d421a71c-55cb-411e-a81e-919c5e262476_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_a60e9461-c7ba-40f0-9139-d40bfb39b310_totalLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total benefit payments expected</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:to="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_2b6639b0-211d-444b-be56-dc7b20da6b11_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared, not paid</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_3084dce7-5253-445d-a7f1-4c7f46df00bb_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_07221b58-2a6b-4101-9884-31e7bc55f736_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participants&#8217; contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_03c080e4-753f-4f5c-885f-60fdd27766d6_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded_b73dd390-5dd8-4fef-96ee-983a7ca7e9d5_terseLabel_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of instances not to exceed</link:label>
    <link:label id="lab_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded_label_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Instances Ratio Of Debt To EBITDA Exceeded</link:label>
    <link:label id="lab_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded_documentation_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Instances Ratio Of Debt To EBITDA Exceeded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded" xlink:href="wst-20221231.xsd#wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded" xlink:to="lab_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_d0cad660-342f-4d47-a5b0-9bd24cf9829e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_de8ce865-5046-42ab-b28c-74125dffd668_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_3e395757-8c4c-4ecf-9957-6e53497d7bd1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average assumptions used in net periodic benefit cost:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d03abfa5-edd7-4518-af5c-c03c167dea0d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherCurrentLiabilitiesAbstract_99cb9afe-d3b0-4bc7-9343-f432caa5f565_terseLabel_en-US" xlink:label="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Abstract]</link:label>
    <link:label id="lab_wst_OtherCurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Abstract]</link:label>
    <link:label id="lab_wst_OtherCurrentLiabilitiesAbstract_documentation_en-US" xlink:label="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract" xlink:href="wst-20221231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract" xlink:to="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_fbdd2162-9bd0-404d-88be-4b869f873775_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_7781a958-33cc-4d15-b0a3-d2b7ee62e13a_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f9e1084d-981e-424e-adf2-9dd66414c251_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested PSU Awards, Weighted Average Fair Value [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_3b42dc0d-fba2-48ec-9792-04bd7a9ddf05_terseLabel_en-US" xlink:label="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and royalty payments made to affiliates</link:label>
    <link:label id="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_label_en-US" xlink:label="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and Royalty Payments from Equity Method Investees</link:label>
    <link:label id="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_documentation_en-US" xlink:label="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and Royalty Payments from Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:href="wst-20221231.xsd#wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:to="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_8c6f566d-0d98-4b90-abb7-d07b966e302a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_5cffae42-391d-468d-ac82-e7954b5e80cb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_17f3e549-4d24-4e71-995c-b0e4e42afe5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate general costs</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_770fe93e-9d2a-4caa-8072-d2871465af7b_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_90fd4542-aa8d-45b6-9f1a-e9bb1ee9dce7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_32ffb32c-3873-4875-b421-c6d4330aed24_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_8cfc4e2f-3433-485a-87a7-d8930c9d0e08_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_aab806c2-76bd-49e3-94a7-6332072851c5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_BiologicsCustomersMember_0d742b9e-6b3d-40c8-b43c-a9c3c13d310e_terseLabel_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics</link:label>
    <link:label id="lab_wst_BiologicsCustomersMember_label_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics Customers [Member]</link:label>
    <link:label id="lab_wst_BiologicsCustomersMember_documentation_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember" xlink:href="wst-20221231.xsd#wst_BiologicsCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_BiologicsCustomersMember" xlink:to="lab_wst_BiologicsCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_4e628d8d-bb40-4fa3-b47e-6a78b9609842_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Companies</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_ac1ea6cf-93c9-4321-8c44-8cf0e4047279_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-related charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_1871bc48-c88d-4fca-a364-4ec9a46a9c68_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-related charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_3f7b9caf-f83e-42ae-a905-c506e67d059f_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward treasury locks</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_e77f1285-dfbb-49c5-8db7-313ef4b12c1c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition_a769d841-697e-4e31-aa9c-d8e0c4de7936_terseLabel_en-US" xlink:label="lab_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of debt to EBITDA after acquisition</link:label>
    <link:label id="lab_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition_label_en-US" xlink:label="lab_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Ratio Of Debt To EBITDA After Acquisition</link:label>
    <link:label id="lab_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition_documentation_en-US" xlink:label="lab_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Ratio Of Debt To EBITDA After Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition" xlink:href="wst-20221231.xsd#wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition" xlink:to="lab_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_791cd596-585e-451f-a7d3-383bd42ba488_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_81c7a056-1681-41d9-bb81-75d5b4ba2945_terseLabel_en-US" xlink:label="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow and Supplemental information</link:label>
    <link:label id="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_label_en-US" xlink:label="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessee, lease Cash Flow and Supplemental information [Table Text Block]</link:label>
    <link:label id="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_documentation_en-US" xlink:label="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessee, lease Cash Flow and Supplemental information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:href="wst-20221231.xsd#wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:to="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_992a3424-9979-48a2-bc80-5359cde2b121_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>wst-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6ce7082f-45c4-495e-94eb-caa34b024fa0,g:4770da38-231a-455c-ab1e-d14c8c362bd8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.westpharma.com/role/Cover" xlink:type="simple" xlink:href="wst-20221231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5482feef-b046-45f7-8fe6-89c442535885" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_DocumentType_5482feef-b046-45f7-8fe6-89c442535885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_199f9bd4-d747-420c-bb0b-5476ae8260f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_DocumentAnnualReport_199f9bd4-d747-420c-bb0b-5476ae8260f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e66822fb-0b20-4520-b85a-1d9be4f56e61" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_DocumentPeriodEndDate_e66822fb-0b20-4520-b85a-1d9be4f56e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e6878236-b4b6-41f9-8412-8e343dbd0722" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_CurrentFiscalYearEndDate_e6878236-b4b6-41f9-8412-8e343dbd0722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b758a56c-2e41-4364-9206-9042bc2a5a84" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_DocumentTransitionReport_b758a56c-2e41-4364-9206-9042bc2a5a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2f2aaae9-a058-4196-a21d-8e70f1041145" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityFileNumber_2f2aaae9-a058-4196-a21d-8e70f1041145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fadd61d0-251b-4235-9b5f-8a82de89763d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityRegistrantName_fadd61d0-251b-4235-9b5f-8a82de89763d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_387f90bf-a1ba-4b3e-8632-9d10b2952e50" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_387f90bf-a1ba-4b3e-8632-9d10b2952e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_5186c532-fda7-47da-aabb-e5dd8cabc66c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityTaxIdentificationNumber_5186c532-fda7-47da-aabb-e5dd8cabc66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e6eb6279-e346-4f5b-92a8-a9979968cd7f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityAddressAddressLine1_e6eb6279-e346-4f5b-92a8-a9979968cd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c8795e0e-c4a4-4ddd-a378-5b661ad7faab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityAddressCityOrTown_c8795e0e-c4a4-4ddd-a378-5b661ad7faab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_81e733d4-552d-4653-b451-3434ee06364b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityAddressStateOrProvince_81e733d4-552d-4653-b451-3434ee06364b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_367813c0-5c1c-4360-a625-32193bbf5b40" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityAddressPostalZipCode_367813c0-5c1c-4360-a625-32193bbf5b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f52ac3f6-31a5-41fb-b2f7-73e0376d018a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_CityAreaCode_f52ac3f6-31a5-41fb-b2f7-73e0376d018a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ed08cd3d-b7e5-4db3-8bae-e7f62b99e51f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_LocalPhoneNumber_ed08cd3d-b7e5-4db3-8bae-e7f62b99e51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4e37c790-e3c3-4239-b454-eeb42c4bfcf0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_Security12bTitle_4e37c790-e3c3-4239-b454-eeb42c4bfcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_068e1c49-598f-442a-bdeb-f38a7e2f8cd7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_TradingSymbol_068e1c49-598f-442a-bdeb-f38a7e2f8cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_aa292c89-8d82-4042-9612-3f0fa8c3e258" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_SecurityExchangeName_aa292c89-8d82-4042-9612-3f0fa8c3e258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_2d05e9f7-0085-4c45-b3e6-c60dc14c1def" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_2d05e9f7-0085-4c45-b3e6-c60dc14c1def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_2b3c150e-3d24-4caa-949a-ba14e2cc1ea7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityVoluntaryFilers_2b3c150e-3d24-4caa-949a-ba14e2cc1ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4e8cedf5-505f-4fe0-8702-d78312edd01d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityCurrentReportingStatus_4e8cedf5-505f-4fe0-8702-d78312edd01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a855ed5f-130e-41bb-aa2b-02abdd62facb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityInteractiveDataCurrent_a855ed5f-130e-41bb-aa2b-02abdd62facb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_aaef1352-95be-414c-8a3b-2db741f10bf9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityFilerCategory_aaef1352-95be-414c-8a3b-2db741f10bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_444af68d-eaec-4ec6-9f27-1719fe5fdd99" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntitySmallBusiness_444af68d-eaec-4ec6-9f27-1719fe5fdd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_389ab185-3d31-4ab6-a96d-d9adfca89a22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityEmergingGrowthCompany_389ab185-3d31-4ab6-a96d-d9adfca89a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_a2c03825-b6b8-480f-a89a-f9e5be6b750b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_IcfrAuditorAttestationFlag_a2c03825-b6b8-480f-a89a-f9e5be6b750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4444b7c6-4984-4e33-b3d5-599e90f3a66b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityShellCompany_4444b7c6-4984-4e33-b3d5-599e90f3a66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_99a8705a-96a6-4501-963c-96ff6aff9f81" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityPublicFloat_99a8705a-96a6-4501-963c-96ff6aff9f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_fc025497-9dab-4ef7-90e7-00ea276da6de" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_fc025497-9dab-4ef7-90e7-00ea276da6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_6cf195a1-de34-4fc1-9396-3679a1ce09d6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_6cf195a1-de34-4fc1-9396-3679a1ce09d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_81cf2c2c-479b-4cd0-b079-12609bc9e61e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_EntityCentralIndexKey_81cf2c2c-479b-4cd0-b079-12609bc9e61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_da858b6d-5385-4691-a38e-368c98b6200c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_DocumentFiscalYearFocus_da858b6d-5385-4691-a38e-368c98b6200c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_aea3e283-b217-4931-ab15-430fd4ff13f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_DocumentFiscalPeriodFocus_aea3e283-b217-4931-ab15-430fd4ff13f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_009fe5bf-7591-4c44-94fe-f4d44ee61290" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_573ebde4-21bf-4ed5-b157-7d8b0f1666f1" xlink:to="loc_dei_AmendmentFlag_009fe5bf-7591-4c44-94fe-f4d44ee61290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AuditInformation" xlink:type="simple" xlink:href="wst-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_AuditInformationAbstract_bcac6975-0cc7-4d12-a3cf-2aa041528585" xlink:href="wst-20221231.xsd#wst_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_c2cddcb5-2c76-4e39-8694-02aff801bd33" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_AuditInformationAbstract_bcac6975-0cc7-4d12-a3cf-2aa041528585" xlink:to="loc_dei_AuditorName_c2cddcb5-2c76-4e39-8694-02aff801bd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_b7d28148-64fb-4c46-b0b7-3ca59ed07b29" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_AuditInformationAbstract_bcac6975-0cc7-4d12-a3cf-2aa041528585" xlink:to="loc_dei_AuditorLocation_b7d28148-64fb-4c46-b0b7-3ca59ed07b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_0eb61a93-ad1a-4249-9425-7790346499cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_AuditInformationAbstract_bcac6975-0cc7-4d12-a3cf-2aa041528585" xlink:to="loc_dei_AuditorFirmId_0eb61a93-ad1a-4249-9425-7790346499cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_de9d0bb1-80c5-43a7-9903-c5834e855999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_de9d0bb1-80c5-43a7-9903-c5834e855999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5fe90ed5-526e-43e3-8cae-f6de4a4a8130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5fe90ed5-526e-43e3-8cae-f6de4a4a8130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_72f590ac-e84b-4997-8648-aa36e05d1bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_GrossProfit_72f590ac-e84b-4997-8648-aa36e05d1bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_47411cba-1e01-4a2d-9717-dadad6966854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_47411cba-1e01-4a2d-9717-dadad6966854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_43019ff7-f3d5-4f5e-8125-2c5e7e504f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_43019ff7-f3d5-4f5e-8125-2c5e7e504f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_f2016a83-e5c0-4007-b240-e3fd65742670" xlink:href="wst-20221231.xsd#wst_OtherIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_wst_OtherIncomeExpense_f2016a83-e5c0-4007-b240-e3fd65742670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4ac71247-eb8c-4bef-b97b-b88033f65b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_OperatingIncomeLoss_4ac71247-eb8c-4bef-b97b-b88033f65b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4cf5e27c-baf2-498d-aad5-26ecd26bacb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_InterestExpense_4cf5e27c-baf2-498d-aad5-26ecd26bacb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_c6fa59d9-73d2-4ebf-bb89-8e85d65e476b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_InvestmentIncomeNet_c6fa59d9-73d2-4ebf-bb89-8e85d65e476b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8dc7fbe3-0ed2-4238-92af-658dd7aebccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8dc7fbe3-0ed2-4238-92af-658dd7aebccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8950130a-144d-4b0c-95fc-de38de6bcbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8950130a-144d-4b0c-95fc-de38de6bcbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_541ad98e-e73a-4ff1-b736-b06cec75a002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_541ad98e-e73a-4ff1-b736-b06cec75a002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2af2855f-61a9-42ab-9077-9aa139ef75d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2af2855f-61a9-42ab-9077-9aa139ef75d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e634c445-288d-4a66-8f36-ad13b30c8f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_NetIncomeLoss_e634c445-288d-4a66-8f36-ad13b30c8f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d9cfe74b-9a5f-4c16-b90f-b560348cc923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_us-gaap_EarningsPerShareAbstract_d9cfe74b-9a5f-4c16-b90f-b560348cc923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b07d3801-71b4-4417-912f-7bd877005ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d9cfe74b-9a5f-4c16-b90f-b560348cc923" xlink:to="loc_us-gaap_EarningsPerShareBasic_b07d3801-71b4-4417-912f-7bd877005ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a55d4034-9459-4d23-b2b3-0e9fb620b8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d9cfe74b-9a5f-4c16-b90f-b560348cc923" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a55d4034-9459-4d23-b2b3-0e9fb620b8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WeightedAverageSharesOutstandingAbstract_f801cc0f-8cf7-4193-91c9-f7c8cf3d4146" xlink:href="wst-20221231.xsd#wst_WeightedAverageSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06f779b6-5d8e-493f-b495-310fa3bbcf99" xlink:to="loc_wst_WeightedAverageSharesOutstandingAbstract_f801cc0f-8cf7-4193-91c9-f7c8cf3d4146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f4b0b8af-7360-4ec1-8cdf-c16e4bacb53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract_f801cc0f-8cf7-4193-91c9-f7c8cf3d4146" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f4b0b8af-7360-4ec1-8cdf-c16e4bacb53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f222171d-b6e4-49d8-ab70-5d0c3ec1bbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract_f801cc0f-8cf7-4193-91c9-f7c8cf3d4146" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f222171d-b6e4-49d8-ab70-5d0c3ec1bbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_487a62a1-378b-4f28-a6d9-6b8cc34c82e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c9abb06b-113d-4c6f-a1c9-8da44ac4a878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_487a62a1-378b-4f28-a6d9-6b8cc34c82e4" xlink:to="loc_us-gaap_NetIncomeLoss_c9abb06b-113d-4c6f-a1c9-8da44ac4a878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_487a62a1-378b-4f28-a6d9-6b8cc34c82e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_90586b42-d27f-49de-bb37-99b9d8383088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_90586b42-d27f-49de-bb37-99b9d8383088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_ed559240-7486-4cd4-99dc-99b9e3bd326c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_ed559240-7486-4cd4-99dc-99b9e3bd326c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_3d96de19-8f00-4ab0-a943-0fe4cb0705fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_3d96de19-8f00-4ab0-a943-0fe4cb0705fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_e4e372df-17b5-4b5e-a551-838eaac54930" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:to="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_e4e372df-17b5-4b5e-a551-838eaac54930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_47326401-0af9-4247-848d-279d053260d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_47326401-0af9-4247-848d-279d053260d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_ccc045e7-5a18-4003-99b0-0ecf51bbf311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_ccc045e7-5a18-4003-99b0-0ecf51bbf311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_5663c619-0a54-4558-8213-a88efa28ca58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_5663c619-0a54-4558-8213-a88efa28ca58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8189f647-3433-487f-b461-5eab3a6e2ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8189f647-3433-487f-b461-5eab3a6e2ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_4701ede1-bcb3-41a5-845a-3d32a81983d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_4701ede1-bcb3-41a5-845a-3d32a81983d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a98465f2-3da3-4ecc-a4df-337565c0985d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1bc459c4-3ba5-4860-9e0c-27b48b32e21f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a98465f2-3da3-4ecc-a4df-337565c0985d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f77eda3a-ddbc-4591-9c98-b8c629d8c3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_487a62a1-378b-4f28-a6d9-6b8cc34c82e4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f77eda3a-ddbc-4591-9c98-b8c629d8c3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e1fc370-83e0-44b1-abae-4d51ce09e43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_b3b05707-cb71-42dd-9891-3cf23053294d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e1fc370-83e0-44b1-abae-4d51ce09e43d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_b3b05707-cb71-42dd-9891-3cf23053294d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_80a8cfe1-f3dc-4e59-a4cb-4f4697198415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e1fc370-83e0-44b1-abae-4d51ce09e43d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_80a8cfe1-f3dc-4e59-a4cb-4f4697198415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_0ff4f581-d675-4da0-ab26-24fb53e3b4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e1fc370-83e0-44b1-abae-4d51ce09e43d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_0ff4f581-d675-4da0-ab26-24fb53e3b4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_d7636551-272e-4e5f-a742-d8617b690fc9" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e1fc370-83e0-44b1-abae-4d51ce09e43d" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_d7636551-272e-4e5f-a742-d8617b690fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_e6d3176c-113e-4e57-a931-e50cb2a8b0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e1fc370-83e0-44b1-abae-4d51ce09e43d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_e6d3176c-113e-4e57-a931-e50cb2a8b0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_0953c3c8-1290-4a9a-9820-9a2eb6c94b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e1fc370-83e0-44b1-abae-4d51ce09e43d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_0953c3c8-1290-4a9a-9820-9a2eb6c94b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax_a66ecf37-37c1-4fb3-a0a4-191439a986fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e1fc370-83e0-44b1-abae-4d51ce09e43d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax_a66ecf37-37c1-4fb3-a0a4-191439a986fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_e80ee768-2edc-421c-9ec0-1a4fef5a47ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e1fc370-83e0-44b1-abae-4d51ce09e43d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_e80ee768-2edc-421c-9ec0-1a4fef5a47ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_2fa7b075-802f-4692-a8f7-8ead50e7fc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e1fc370-83e0-44b1-abae-4d51ce09e43d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_2fa7b075-802f-4692-a8f7-8ead50e7fc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b5ec4b8b-e0da-4017-a779-438de3fc8057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b5ec4b8b-e0da-4017-a779-438de3fc8057" xlink:to="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7944154b-a82f-44e1-91f6-456c9fe2a4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7944154b-a82f-44e1-91f6-456c9fe2a4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1c2c7e0c-4d3c-436d-8669-0ebd9db30582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7944154b-a82f-44e1-91f6-456c9fe2a4e4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1c2c7e0c-4d3c-436d-8669-0ebd9db30582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_65c93fdd-fad9-4c81-b83e-e61798e9f38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7944154b-a82f-44e1-91f6-456c9fe2a4e4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_65c93fdd-fad9-4c81-b83e-e61798e9f38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_23adb7e7-482e-4d38-bfed-89d26d0d5d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7944154b-a82f-44e1-91f6-456c9fe2a4e4" xlink:to="loc_us-gaap_InventoryNet_23adb7e7-482e-4d38-bfed-89d26d0d5d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ba350d50-7d12-4154-94b7-18e2808d34f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7944154b-a82f-44e1-91f6-456c9fe2a4e4" xlink:to="loc_us-gaap_OtherAssetsCurrent_ba350d50-7d12-4154-94b7-18e2808d34f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_30fb6f76-2760-4301-8580-17902a7f94c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7944154b-a82f-44e1-91f6-456c9fe2a4e4" xlink:to="loc_us-gaap_AssetsCurrent_30fb6f76-2760-4301-8580-17902a7f94c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_47e8293a-6bbb-403d-85ae-f784788ae550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_47e8293a-6bbb-403d-85ae-f784788ae550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f6581d62-b920-4864-8328-7c2408082720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f6581d62-b920-4864-8328-7c2408082720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_115699e4-379d-4f44-ad0a-dbab3c3c80e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_115699e4-379d-4f44-ad0a-dbab3c3c80e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3bbc779c-06c6-4b6a-a77a-4edae33f64d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3bbc779c-06c6-4b6a-a77a-4edae33f64d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e208fe72-b078-485b-9ff3-c8745c482cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e208fe72-b078-485b-9ff3-c8745c482cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7c007671-b1a0-4a5b-8711-a4b48352b6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_Goodwill_7c007671-b1a0-4a5b-8711-a4b48352b6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2abaf00e-ceec-456f-a265-aec018c4030e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2abaf00e-ceec-456f-a265-aec018c4030e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_3e307f7b-6ede-41df-9c38-3ca0ec349a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_3e307f7b-6ede-41df-9c38-3ca0ec349a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_5fc5c13d-23b4-461a-8487-851d16f010e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_5fc5c13d-23b4-461a-8487-851d16f010e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_57035887-8a97-41aa-9813-2076f131d8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_57035887-8a97-41aa-9813-2076f131d8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c657efac-9dcf-4e3f-a953-2904b0b76339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7cd15474-7026-4606-a0e9-15490c74f9b8" xlink:to="loc_us-gaap_Assets_c657efac-9dcf-4e3f-a953-2904b0b76339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b5ec4b8b-e0da-4017-a779-438de3fc8057" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2323697c-952e-4100-9b2c-8b9027990485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2323697c-952e-4100-9b2c-8b9027990485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent_c42f3025-a10f-46bc-a235-d2faeb43f877" xlink:href="wst-20221231.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2323697c-952e-4100-9b2c-8b9027990485" xlink:to="loc_wst_NotesPayableAndOtherDebtCurrent_c42f3025-a10f-46bc-a235-d2faeb43f877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f58faeed-8c92-4d85-beeb-f91b44881b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2323697c-952e-4100-9b2c-8b9027990485" xlink:to="loc_us-gaap_AccountsPayableCurrent_f58faeed-8c92-4d85-beeb-f91b44881b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_311146cd-dfa9-436c-918f-3929fcc397aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2323697c-952e-4100-9b2c-8b9027990485" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_311146cd-dfa9-436c-918f-3929fcc397aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_4358a559-c9bb-4b26-9bd9-42ba9037219f" xlink:href="wst-20221231.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2323697c-952e-4100-9b2c-8b9027990485" xlink:to="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_4358a559-c9bb-4b26-9bd9-42ba9037219f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_4366c457-0ae1-4e9a-9407-5de7b1638ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2323697c-952e-4100-9b2c-8b9027990485" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_4366c457-0ae1-4e9a-9407-5de7b1638ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb95f7d4-d69f-4850-84d5-5ea0bffb8d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2323697c-952e-4100-9b2c-8b9027990485" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb95f7d4-d69f-4850-84d5-5ea0bffb8d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f688793f-f401-40b8-a3fe-a84d9e8cd3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2323697c-952e-4100-9b2c-8b9027990485" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f688793f-f401-40b8-a3fe-a84d9e8cd3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8339a179-c254-4c24-937e-b90d2c060738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2323697c-952e-4100-9b2c-8b9027990485" xlink:to="loc_us-gaap_LiabilitiesCurrent_8339a179-c254-4c24-937e-b90d2c060738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a0cf0939-44c2-4679-aa59-74070d119a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a0cf0939-44c2-4679-aa59-74070d119a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_442eede7-8515-4051-9b40-2e12b8c6ece1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_442eede7-8515-4051-9b40-2e12b8c6ece1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_3a8bdaaa-5a74-4b37-9d81-8a7ced05d527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_3a8bdaaa-5a74-4b37-9d81-8a7ced05d527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ca844547-33dc-4767-a034-2efa7ea9492f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ca844547-33dc-4767-a034-2efa7ea9492f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_c2d14b8d-f33a-4624-ab84-f1df3d7398b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_c2d14b8d-f33a-4624-ab84-f1df3d7398b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_65005ae1-cca9-4207-9e19-656061e9d87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_65005ae1-cca9-4207-9e19-656061e9d87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fed6e9f5-186e-4242-bf69-0228ead3f829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_Liabilities_fed6e9f5-186e-4242-bf69-0228ead3f829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_67677ccb-6fd1-4951-b02f-f1bd1a7bd3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_CommitmentsAndContingencies_67677ccb-6fd1-4951-b02f-f1bd1a7bd3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e78bbc4d-e211-4e1a-bacf-6e1e274d549b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_EquityAbstract_e78bbc4d-e211-4e1a-bacf-6e1e274d549b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_8147cc72-d773-4cb7-8ed0-8f3760522224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e78bbc4d-e211-4e1a-bacf-6e1e274d549b" xlink:to="loc_us-gaap_PreferredStockValue_8147cc72-d773-4cb7-8ed0-8f3760522224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fd137371-4ba5-47d5-b1a8-3c7cbad30056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e78bbc4d-e211-4e1a-bacf-6e1e274d549b" xlink:to="loc_us-gaap_CommonStockValue_fd137371-4ba5-47d5-b1a8-3c7cbad30056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_cd3a5b6d-caf2-4b0f-b9cd-1ac339c26492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e78bbc4d-e211-4e1a-bacf-6e1e274d549b" xlink:to="loc_us-gaap_AdditionalPaidInCapital_cd3a5b6d-caf2-4b0f-b9cd-1ac339c26492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c44e6370-50a9-41db-aecf-582a087d6258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e78bbc4d-e211-4e1a-bacf-6e1e274d549b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c44e6370-50a9-41db-aecf-582a087d6258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a0f8fd4b-5824-4593-bb5e-eaca7fe3277c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e78bbc4d-e211-4e1a-bacf-6e1e274d549b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a0f8fd4b-5824-4593-bb5e-eaca7fe3277c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_b5242888-fc12-4de1-8985-7dd48bfea834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e78bbc4d-e211-4e1a-bacf-6e1e274d549b" xlink:to="loc_us-gaap_TreasuryStockValue_b5242888-fc12-4de1-8985-7dd48bfea834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_614e4763-fb32-4a93-8fb8-52c85a348f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e78bbc4d-e211-4e1a-bacf-6e1e274d549b" xlink:to="loc_us-gaap_StockholdersEquity_614e4763-fb32-4a93-8fb8-52c85a348f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cac532a7-7005-46dc-b3bd-c5844edfd36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a44a22f1-66dc-4526-9f96-4af4b38cb5eb" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_cac532a7-7005-46dc-b3bd-c5844edfd36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2138c45b-9e29-4148-a729-4077ba7f948c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1afb4c65-aec1-4554-a1db-d97d4b40f6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2138c45b-9e29-4148-a729-4077ba7f948c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1afb4c65-aec1-4554-a1db-d97d4b40f6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_72e213b0-e217-4a6d-864c-be0b51e5646f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2138c45b-9e29-4148-a729-4077ba7f948c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_72e213b0-e217-4a6d-864c-be0b51e5646f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7f44f852-f96a-468f-9068-32baf3963a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2138c45b-9e29-4148-a729-4077ba7f948c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7f44f852-f96a-468f-9068-32baf3963a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2dbd1fa4-1cd0-47b5-bd91-8492a7643c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2138c45b-9e29-4148-a729-4077ba7f948c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2dbd1fa4-1cd0-47b5-bd91-8492a7643c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_63cc21f1-e57d-4a2e-9bcc-0bb87494416e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2138c45b-9e29-4148-a729-4077ba7f948c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_63cc21f1-e57d-4a2e-9bcc-0bb87494416e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_aede2563-b7fc-4a91-94bb-22c92a91deeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2138c45b-9e29-4148-a729-4077ba7f948c" xlink:to="loc_us-gaap_CommonStockSharesIssued_aede2563-b7fc-4a91-94bb-22c92a91deeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_edd3acba-c90e-41e6-a437-b9c41d1f6def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2138c45b-9e29-4148-a729-4077ba7f948c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_edd3acba-c90e-41e6-a437-b9c41d1f6def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_da80d008-069b-46cd-b658-baf2cb9c2a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2138c45b-9e29-4148-a729-4077ba7f948c" xlink:to="loc_us-gaap_TreasuryStockCommonShares_da80d008-069b-46cd-b658-baf2cb9c2a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDSTATEMENTSOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5d2a808a-4fcf-4d72-80f0-4a56c0e72566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_45f11181-d22a-4f53-bb11-45902080e625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5d2a808a-4fcf-4d72-80f0-4a56c0e72566" xlink:to="loc_us-gaap_StatementTable_45f11181-d22a-4f53-bb11-45902080e625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3a840a72-859d-4e71-959e-0100eeb1556e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_45f11181-d22a-4f53-bb11-45902080e625" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3a840a72-859d-4e71-959e-0100eeb1556e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a840a72-859d-4e71-959e-0100eeb1556e" xlink:to="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f466aed5-aaf8-4d33-a11f-ba51744fda9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:to="loc_us-gaap_CommonStockMember_f466aed5-aaf8-4d33-a11f-ba51744fda9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_770e864c-b034-4018-b171-07bfab4a803a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_770e864c-b034-4018-b171-07bfab4a803a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_fb4e185a-8554-4358-868c-9dcbe346f775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:to="loc_us-gaap_TreasuryStockCommonMember_fb4e185a-8554-4358-868c-9dcbe346f775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_316c8be5-9a7d-4184-877c-55129fbf8e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:to="loc_us-gaap_RetainedEarningsMember_316c8be5-9a7d-4184-877c-55129fbf8e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6603063e-d888-47f1-afd4-5012a640f864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3c77a63e-ef87-4070-af8d-5d61cb4c78e5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6603063e-d888-47f1-afd4-5012a640f864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5472a847-7c61-4ac2-a295-18497318d2ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_45f11181-d22a-4f53-bb11-45902080e625" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5472a847-7c61-4ac2-a295-18497318d2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71f9420a-fac6-4425-9aca-870cf9d266a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5472a847-7c61-4ac2-a295-18497318d2ce" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71f9420a-fac6-4425-9aca-870cf9d266a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a19963b4-0628-4d5f-b1ab-ca0e2434da6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71f9420a-fac6-4425-9aca-870cf9d266a7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a19963b4-0628-4d5f-b1ab-ca0e2434da6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_58fe2ea8-dd36-4897-907f-d2ddcdae028f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_45f11181-d22a-4f53-bb11-45902080e625" xlink:to="loc_us-gaap_StatementLineItems_58fe2ea8-dd36-4897-907f-d2ddcdae028f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_9224827c-e41c-4d24-ad0f-a5afcb9bc369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_58fe2ea8-dd36-4897-907f-d2ddcdae028f" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_9224827c-e41c-4d24-ad0f-a5afcb9bc369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_58fe2ea8-dd36-4897-907f-d2ddcdae028f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8f755fe8-830f-48ce-9c42-f95441431032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_SharesIssued_8f755fe8-830f-48ce-9c42-f95441431032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_b45471ed-7d16-4778-a876-17df19abdd93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_TreasuryStockCommonShares_b45471ed-7d16-4778-a876-17df19abdd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6a176d73-6ba2-4478-a1e9-713362e435d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_StockholdersEquity_6a176d73-6ba2-4478-a1e9-713362e435d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d5769efa-8dc5-4c21-9242-5179e9330e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_NetIncomeLoss_d5769efa-8dc5-4c21-9242-5179e9330e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1aeea1de-f5dd-4458-a620-cdef4764ddec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1aeea1de-f5dd-4458-a620-cdef4764ddec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_be135300-4ece-4ef9-ab8c-8a53bd430dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_be135300-4ece-4ef9-ab8c-8a53bd430dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_71640c7b-a5ef-4472-aceb-9325efad4eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_71640c7b-a5ef-4472-aceb-9325efad4eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_aad37ea4-f6bb-4ff7-b554-1a9d648de648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_aad37ea4-f6bb-4ff7-b554-1a9d648de648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_38015865-a46d-4edb-a991-f5343e83843e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_DividendsCommonStockCash_38015865-a46d-4edb-a991-f5343e83843e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b0e7a137-c3f8-4144-a25c-912add1910c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b0e7a137-c3f8-4144-a25c-912add1910c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_64dd2553-a6c5-4a27-9da0-b97977d92cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_SharesIssued_64dd2553-a6c5-4a27-9da0-b97977d92cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_17d0f890-559c-4bad-96b7-3f6c74eb8061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_TreasuryStockCommonShares_17d0f890-559c-4bad-96b7-3f6c74eb8061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7f7e0aff-1c7c-4bf6-9703-7cfd84e6aeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b1288d33-0570-4fcf-a10f-fb8bc197b930" xlink:to="loc_us-gaap_StockholdersEquity_7f7e0aff-1c7c-4bf6-9703-7cfd84e6aeb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYParenthetical" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYParenthetical"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d45752df-30f9-4b97-b86a-8b6df54b7049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_8aa076e2-e693-4281-b58c-4b47250cffe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d45752df-30f9-4b97-b86a-8b6df54b7049" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_8aa076e2-e693-4281-b58c-4b47250cffe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="wst-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1e13eb74-21e4-4e5c-99cd-873e9a7c6962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbff1414-1bb0-4393-93f2-6babf3886c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e13eb74-21e4-4e5c-99cd-873e9a7c6962" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbff1414-1bb0-4393-93f2-6babf3886c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_18787e6d-5b96-4816-8234-0037e2b135ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbff1414-1bb0-4393-93f2-6babf3886c68" xlink:to="loc_us-gaap_NetIncomeLoss_18787e6d-5b96-4816-8234-0037e2b135ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbff1414-1bb0-4393-93f2-6babf3886c68" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9b83bcb4-1cb4-4835-80b3-fe65b452ca44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_us-gaap_Depreciation_9b83bcb4-1cb4-4835-80b3-fe65b452ca44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_bca86021-6f1c-4035-b2c5-227ce3e3a4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_us-gaap_AdjustmentForAmortization_bca86021-6f1c-4035-b2c5-227ce3e3a4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_bedcbc39-135a-4675-880a-7b472ae2598c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_us-gaap_ShareBasedCompensation_bedcbc39-135a-4675-880a-7b472ae2598c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_95f76077-a0e5-45bc-b72e-0b56d0b77740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_95f76077-a0e5-45bc-b72e-0b56d0b77740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_f63c532e-23e6-4a8c-a8d1-bb09999f1211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_f63c532e-23e6-4a8c-a8d1-bb09999f1211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_4499fefe-f33a-4210-97ad-3e5b9ad1cf78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_4499fefe-f33a-4210-97ad-3e5b9ad1cf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_700a5ba7-be13-4138-9273-b0d51a965e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_700a5ba7-be13-4138-9273-b0d51a965e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_72325658-6c5f-46ce-b39f-7c49df9ed3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_72325658-6c5f-46ce-b39f-7c49df9ed3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet_b1c65ea6-03cc-4863-acef-5854291bc0bd" xlink:href="wst-20221231.xsd#wst_PensionAndOtherPostretirementBenefitExpenseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet_b1c65ea6-03cc-4863-acef-5854291bc0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_bbb4139e-b36b-4af6-8635-76d11e9c7d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_bbb4139e-b36b-4af6-8635-76d11e9c7d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a87a1aca-9954-465e-a7a8-a8e2e8799eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_255d41bb-aad0-4d41-850e-197b8426bc7a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a87a1aca-9954-465e-a7a8-a8e2e8799eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c6360228-0b44-41fd-bf33-22a56722be30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a87a1aca-9954-465e-a7a8-a8e2e8799eae" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c6360228-0b44-41fd-bf33-22a56722be30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b21b507e-d673-4800-bf00-d39b6896eebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a87a1aca-9954-465e-a7a8-a8e2e8799eae" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b21b507e-d673-4800-bf00-d39b6896eebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_fa685799-689a-4094-80b7-8b165a49d577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a87a1aca-9954-465e-a7a8-a8e2e8799eae" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_fa685799-689a-4094-80b7-8b165a49d577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_50912647-fd27-47ee-857f-a3341fbb6547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a87a1aca-9954-465e-a7a8-a8e2e8799eae" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_50912647-fd27-47ee-857f-a3341fbb6547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c44f806a-90ed-4f81-b9c8-bd9d1289aab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a87a1aca-9954-465e-a7a8-a8e2e8799eae" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c44f806a-90ed-4f81-b9c8-bd9d1289aab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7917af18-aa05-4ebb-acbf-dd8014e59958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dbff1414-1bb0-4393-93f2-6babf3886c68" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7917af18-aa05-4ebb-acbf-dd8014e59958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fe8fb32-f8d4-48aa-9d30-d94846f58d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e13eb74-21e4-4e5c-99cd-873e9a7c6962" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fe8fb32-f8d4-48aa-9d30-d94846f58d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_98280647-a9df-4b77-a0db-e2d10b0a588e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fe8fb32-f8d4-48aa-9d30-d94846f58d68" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_98280647-a9df-4b77-a0db-e2d10b0a588e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_63ede0b3-84c7-4b08-bcae-95ab44bcc9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fe8fb32-f8d4-48aa-9d30-d94846f58d68" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_63ede0b3-84c7-4b08-bcae-95ab44bcc9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_90b4c1eb-ac49-4b6f-a59b-0f701aa6bfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fe8fb32-f8d4-48aa-9d30-d94846f58d68" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_90b4c1eb-ac49-4b6f-a59b-0f701aa6bfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_977d5dbe-1f05-42ce-ba60-1752f6aa9245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fe8fb32-f8d4-48aa-9d30-d94846f58d68" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_977d5dbe-1f05-42ce-ba60-1752f6aa9245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_530c3c8a-2fc5-48f8-92d2-a85e78dd7852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e13eb74-21e4-4e5c-99cd-873e9a7c6962" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_530c3c8a-2fc5-48f8-92d2-a85e78dd7852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a65416a6-90df-44d6-803a-da537acde738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_530c3c8a-2fc5-48f8-92d2-a85e78dd7852" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a65416a6-90df-44d6-803a-da537acde738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_3b3a6db8-b38d-405a-b359-bb797da83413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_530c3c8a-2fc5-48f8-92d2-a85e78dd7852" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_3b3a6db8-b38d-405a-b359-bb797da83413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_6673c529-f383-4f35-80f2-ae948db3c1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_530c3c8a-2fc5-48f8-92d2-a85e78dd7852" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_6673c529-f383-4f35-80f2-ae948db3c1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_cf8601f9-5977-4662-88f3-120eea54d501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_530c3c8a-2fc5-48f8-92d2-a85e78dd7852" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_cf8601f9-5977-4662-88f3-120eea54d501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_cfd9393c-a113-448d-a00f-21189e6550e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_530c3c8a-2fc5-48f8-92d2-a85e78dd7852" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_cfd9393c-a113-448d-a00f-21189e6550e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_aeca2403-b79c-4502-8d65-abfe0c03dcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_530c3c8a-2fc5-48f8-92d2-a85e78dd7852" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_aeca2403-b79c-4502-8d65-abfe0c03dcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_16ae2bf9-16cc-4993-a11f-67e5865fc011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_530c3c8a-2fc5-48f8-92d2-a85e78dd7852" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_16ae2bf9-16cc-4993-a11f-67e5865fc011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_506aee27-a318-4586-9482-eb6dbc0bf8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_530c3c8a-2fc5-48f8-92d2-a85e78dd7852" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_506aee27-a318-4586-9482-eb6dbc0bf8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_caf6b47a-aa41-4580-a358-0a221f007522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e13eb74-21e4-4e5c-99cd-873e9a7c6962" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_caf6b47a-aa41-4580-a358-0a221f007522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_07d62aed-02ae-458a-baad-e2b4ba250c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e13eb74-21e4-4e5c-99cd-873e9a7c6962" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_07d62aed-02ae-458a-baad-e2b4ba250c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d0417cc2-fd80-46db-a76e-1d179a00b890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e13eb74-21e4-4e5c-99cd-873e9a7c6962" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d0417cc2-fd80-46db-a76e-1d179a00b890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fb137d60-210d-455e-8eb3-636b8a687291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e13eb74-21e4-4e5c-99cd-873e9a7c6962" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fb137d60-210d-455e-8eb3-636b8a687291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_05633b41-4f40-419e-8b43-231537e872b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e13eb74-21e4-4e5c-99cd-873e9a7c6962" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_05633b41-4f40-419e-8b43-231537e872b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_d1c807f5-3870-4f39-be41-a16a4f83a3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_05633b41-4f40-419e-8b43-231537e872b9" xlink:to="loc_us-gaap_InterestPaidNet_d1c807f5-3870-4f39-be41-a16a4f83a3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_4e48a7a1-aa62-4526-a896-4e3f306aff4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_05633b41-4f40-419e-8b43-231537e872b9" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_4e48a7a1-aa62-4526-a896-4e3f306aff4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_bb25021e-2556-46f7-a729-a1abeb3406b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_05633b41-4f40-419e-8b43-231537e872b9" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_bb25021e-2556-46f7-a729-a1abeb3406b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_603f683b-9a23-4ca6-aa4f-6168b869c27a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_05633b41-4f40-419e-8b43-231537e872b9" xlink:to="loc_us-gaap_DividendsPayableCurrent_603f683b-9a23-4ca6-aa4f-6168b869c27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="wst-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6586ba42-2cc4-471c-8f66-31792284471b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1d5164ce-88f9-47e8-87c3-87484788214a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6586ba42-2cc4-471c-8f66-31792284471b" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1d5164ce-88f9-47e8-87c3-87484788214a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="simple" xlink:href="wst-20221231.xsd#NewAccountingStandards"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_7dcfc4fa-1dbd-4cff-9641-6a0ad8879e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3dd592a2-a502-4adc-854e-ebb3f90dfdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_7dcfc4fa-1dbd-4cff-9641-6a0ad8879e4b" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3dd592a2-a502-4adc-854e-ebb3f90dfdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Revenue" xlink:type="simple" xlink:href="wst-20221231.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e456ed66-ac92-4c4e-b850-9c17279197d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_30c316e3-3de8-4536-936a-9d9a22d9f066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e456ed66-ac92-4c4e-b850-9c17279197d6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_30c316e3-3de8-4536-936a-9d9a22d9f066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="wst-20221231.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7e8fb886-a35f-4287-b399-7a565106a976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_47491c32-ac86-4657-b25c-b0529e8caa89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7e8fb886-a35f-4287-b399-7a565106a976" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_47491c32-ac86-4657-b25c-b0529e8caa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="wst-20221231.xsd#PropertyPlantandEquipment"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a59eb7ad-eaab-420e-9f97-3b616d5e0c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_105324a2-20a9-4b5c-9fe5-1742b9a5286e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a59eb7ad-eaab-420e-9f97-3b616d5e0c92" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_105324a2-20a9-4b5c-9fe5-1742b9a5286e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Leases" xlink:type="simple" xlink:href="wst-20221231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_483999b2-3c14-4627-816a-19e80266e68b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_f2edc73b-5eb6-4334-83b2-43b578b25dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_483999b2-3c14-4627-816a-19e80266e68b" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_f2edc73b-5eb6-4334-83b2-43b578b25dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="simple" xlink:href="wst-20221231.xsd#AffiliatedCompanies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_82b0ea16-475f-46d5-982b-35af34d97dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_13d9ab11-a3cb-4b26-920a-4d951cead44d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_82b0ea16-475f-46d5-982b-35af34d97dce" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_13d9ab11-a3cb-4b26-920a-4d951cead44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="wst-20221231.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0a989078-f00c-4bbb-bff5-9f28791edace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_af50f95b-e8d7-4c48-874c-b4daf6a7cfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0a989078-f00c-4bbb-bff5-9f28791edace" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_af50f95b-e8d7-4c48-874c-b4daf6a7cfa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract_8813c44f-bc44-41fa-abf2-76544f58212e" xlink:href="wst-20221231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_d089bf2a-a460-472f-bcae-19a4f5d8a231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_8813c44f-bc44-41fa-abf2-76544f58212e" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_d089bf2a-a460-472f-bcae-19a4f5d8a231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Debt" xlink:type="simple" xlink:href="wst-20221231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a0c85d8a-46c5-426b-b7b3-5a20cfc8a1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_d0bfbda7-945b-4769-8df0-7593ba961d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0c85d8a-46c5-426b-b7b3-5a20cfc8a1c0" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_d0bfbda7-945b-4769-8df0-7593ba961d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="wst-20221231.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3488a47a-ef5e-4ac6-920b-34439e8bc4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_cde59951-3637-4192-94bf-fd6eed4bb760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3488a47a-ef5e-4ac6-920b-34439e8bc4d4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_cde59951-3637-4192-94bf-fd6eed4bb760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="wst-20221231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_25bfde0b-9fb6-41b8-a2e3-e4c0927f450c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b8fd84a4-0375-484a-b4bf-43b747b22860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_25bfde0b-9fb6-41b8-a2e3-e4c0927f450c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b8fd84a4-0375-484a-b4bf-43b747b22860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="wst-20221231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4c0af9a3-6383-4f4f-84f5-36e147a023fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_ca6c31e6-944d-4ffc-b4dd-f2ea93f39e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4c0af9a3-6383-4f4f-84f5-36e147a023fc" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_ca6c31e6-944d-4ffc-b4dd-f2ea93f39e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0b58210f-808b-494b-a99c-5cc9ed4194c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0d1f12bc-deff-49fc-a7b5-87c7a7e042aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0b58210f-808b-494b-a99c-5cc9ed4194c7" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0d1f12bc-deff-49fc-a7b5-87c7a7e042aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlans" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1481209b-321e-4ef0-bc4a-2d8b3a809803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e30222c4-d52c-4120-a58e-808380e82cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1481209b-321e-4ef0-bc4a-2d8b3a809803" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e30222c4-d52c-4120-a58e-808380e82cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherExpenseIncome"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_2abad0f1-c302-40f1-9ee9-f0c104da5eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_ea1d38d1-c28d-442b-978d-f6de4f94355a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_2abad0f1-c302-40f1-9ee9-f0c104da5eff" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_ea1d38d1-c28d-442b-978d-f6de4f94355a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f2006bdc-250f-428e-ae0b-6f0aea21036d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_39451b50-e4b0-4fba-b05a-a97cca4f3d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f2006bdc-250f-428e-ae0b-6f0aea21036d" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_39451b50-e4b0-4fba-b05a-a97cca4f3d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="wst-20221231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_34bb72a1-12d4-4668-84b4-a9b37ad12fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e393229e-b72e-4796-9cfb-731c59737869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_34bb72a1-12d4-4668-84b4-a9b37ad12fb1" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e393229e-b72e-4796-9cfb-731c59737869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformation" xlink:type="simple" xlink:href="wst-20221231.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ccfe1d1b-7fa8-41a3-985d-06326994ba04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_dcb7bea4-fc73-4b27-aca2-48625791b258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ccfe1d1b-7fa8-41a3-985d-06326994ba04" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_dcb7bea4-fc73-4b27-aca2-48625791b258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="simple" xlink:href="wst-20221231.xsd#ScheduleIIValuationandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_a52834e6-d190-4b84-a229-3f2a3e13d7cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_c47f0a3b-6ece-4ad7-8ad0-85d062594bff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_a52834e6-d190-4b84-a229-3f2a3e13d7cd" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_c47f0a3b-6ece-4ad7-8ad0-85d062594bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="wst-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_a083ef60-19b2-4d75-92b5-1f06a4f5db37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_a083ef60-19b2-4d75-92b5-1f06a4f5db37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_44d3c9ea-9175-461a-a134-561dade29e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_UseOfEstimates_44d3c9ea-9175-461a-a134-561dade29e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_ea029646-b16c-4bb8-9809-26e0e8cc25a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_ea029646-b16c-4bb8-9809-26e0e8cc25a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_93f55c02-2584-4b47-9f83-3a1ecc4291a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_93f55c02-2584-4b47-9f83-3a1ecc4291a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_877768aa-b022-48d3-9be6-d917cf3269ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_877768aa-b022-48d3-9be6-d917cf3269ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a0a781e2-b7a2-4376-8786-dc069af553ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a0a781e2-b7a2-4376-8786-dc069af553ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_d68ce0ff-a608-413e-97fa-2933ce88f966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_d68ce0ff-a608-413e-97fa-2933ce88f966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_13bac034-4c38-4528-bebe-fbb89891ab61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_13bac034-4c38-4528-bebe-fbb89891ab61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_835e2e77-2e43-43bd-9a9e-4a2f90a69e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_835e2e77-2e43-43bd-9a9e-4a2f90a69e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_204cb714-0d54-4330-9d8d-b9289a94f769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_204cb714-0d54-4330-9d8d-b9289a94f769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_51b1ab9d-d6e8-4717-9815-709cf16ca18e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_51b1ab9d-d6e8-4717-9815-709cf16ca18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_cb7d00bc-cc6b-466e-b4e9-6d8aba194c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_cb7d00bc-cc6b-466e-b4e9-6d8aba194c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_61118ebd-81f4-4937-8b95-20eee6f42ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_61118ebd-81f4-4937-8b95-20eee6f42ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_ec3ef7ac-4f3d-4c08-a690-c856bc9e28a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_ec3ef7ac-4f3d-4c08-a690-c856bc9e28a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_4f970603-3dbd-41eb-b1ec-f55671c80c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_4f970603-3dbd-41eb-b1ec-f55671c80c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalCostsPolicy_fa2a239f-278e-4723-9990-34c8ed2f6de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalCostsPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_EnvironmentalCostsPolicy_fa2a239f-278e-4723-9990-34c8ed2f6de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_958e1c7d-87ae-42b3-86f3-77c9ba41bad6" xlink:href="wst-20221231.xsd#wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_958e1c7d-87ae-42b3-86f3-77c9ba41bad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_6134d1e8-69dd-4a90-bca1-27877f55c0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_6134d1e8-69dd-4a90-bca1-27877f55c0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_edf1af92-dea6-49df-961b-7d848b284a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_edf1af92-dea6-49df-961b-7d848b284a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_e5dcc0b9-0a16-47dd-a009-e744eedda469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_e5dcc0b9-0a16-47dd-a009-e744eedda469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_33aeb8d9-a578-49e6-8e4f-a2c13dd2288e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_603b05f2-def1-4b8e-8215-c573eb54a2e7" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_33aeb8d9-a578-49e6-8e4f-a2c13dd2288e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="wst-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7307320c-8a47-4e1c-809e-fe59e3f146d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_cfad2044-1b34-422d-9aaf-5ccde16dce2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7307320c-8a47-4e1c-809e-fe59e3f146d0" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_cfad2044-1b34-422d-9aaf-5ccde16dce2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueTables" xlink:type="simple" xlink:href="wst-20221231.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f21472e7-09e7-4cc3-b221-d3d21cc01f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_f21dfd40-c8c8-4720-b548-70c7078a828d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f21472e7-09e7-4cc3-b221-d3d21cc01f34" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_f21dfd40-c8c8-4720-b548-70c7078a828d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_e3738554-b7ce-4c14-a1cd-1366785f10bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f21472e7-09e7-4cc3-b221-d3d21cc01f34" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_e3738554-b7ce-4c14-a1cd-1366785f10bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="wst-20221231.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f8a21dd2-b30c-4107-ad3e-6de9a35b3d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cc4642e1-d827-4b72-89c0-3e477d7b10cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8a21dd2-b30c-4107-ad3e-6de9a35b3d18" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cc4642e1-d827-4b72-89c0-3e477d7b10cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="wst-20221231.xsd#PropertyPlantandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_18a101ab-ad77-4f21-bfdd-c8fe3cbca848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b16193c4-d80b-43aa-9c92-dd2b4bc3a793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_18a101ab-ad77-4f21-bfdd-c8fe3cbca848" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b16193c4-d80b-43aa-9c92-dd2b4bc3a793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="wst-20221231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6dae4d07-79ba-4505-8931-d3c3176ca3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_20d21b90-10b2-4fcf-9bb5-1969b17c9be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6dae4d07-79ba-4505-8931-d3c3176ca3a5" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_20d21b90-10b2-4fcf-9bb5-1969b17c9be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_d4f2613d-c5a9-42bc-bc77-a18b72cf2e16" xlink:href="wst-20221231.xsd#wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6dae4d07-79ba-4505-8931-d3c3176ca3a5" xlink:to="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_d4f2613d-c5a9-42bc-bc77-a18b72cf2e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2930a023-29a4-44c0-8ab3-ed5c2fff9d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6dae4d07-79ba-4505-8931-d3c3176ca3a5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2930a023-29a4-44c0-8ab3-ed5c2fff9d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="simple" xlink:href="wst-20221231.xsd#AffiliatedCompaniesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_4eb57e65-2ee1-433b-a94e-ffd97a295ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_047b8c05-ad04-42d9-bd0e-24c746fba26e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_4eb57e65-2ee1-433b-a94e-ffd97a295ae5" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_047b8c05-ad04-42d9-bd0e-24c746fba26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="wst-20221231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4c598eb1-eb74-4cd5-8f43-a3246d1465d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_61dec182-2e5b-4633-b572-d5962721a9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4c598eb1-eb74-4cd5-8f43-a3246d1465d0" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_61dec182-2e5b-4633-b572-d5962721a9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_0cfe4e38-beea-4fe9-b3c4-f8374f013b00" xlink:href="wst-20221231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4c598eb1-eb74-4cd5-8f43-a3246d1465d0" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_0cfe4e38-beea-4fe9-b3c4-f8374f013b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract_8a49e816-22a4-4be5-8e25-841105a8de85" xlink:href="wst-20221231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_be1d01d6-9531-4926-98c7-441a12c02d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_8a49e816-22a4-4be5-8e25-841105a8de85" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_be1d01d6-9531-4926-98c7-441a12c02d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTables" xlink:type="simple" xlink:href="wst-20221231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ebebc022-672c-4e8e-84c7-45d1f1e4e901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_bf0d8209-d147-4e6d-a033-5c9db29dcc35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ebebc022-672c-4e8e-84c7-45d1f1e4e901" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_bf0d8209-d147-4e6d-a033-5c9db29dcc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="wst-20221231.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ae741323-9d04-4f2c-a9f4-68cb1f718795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_44e4c4c4-8e15-4f5b-95be-2cdccd02bd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ae741323-9d04-4f2c-a9f4-68cb1f718795" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_44e4c4c4-8e15-4f5b-95be-2cdccd02bd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_d088b2d8-22fd-495c-80a7-e1566fddb5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ae741323-9d04-4f2c-a9f4-68cb1f718795" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_d088b2d8-22fd-495c-80a7-e1566fddb5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_d2337348-705c-4bef-955d-36bf6f4ac08b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ae741323-9d04-4f2c-a9f4-68cb1f718795" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_d2337348-705c-4bef-955d-36bf6f4ac08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="wst-20221231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cc06c3c0-af00-43fd-aba4-bb428c3283df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_6b8333c8-434f-46aa-ba5c-067ec3800ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cc06c3c0-af00-43fd-aba4-bb428c3283df" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_6b8333c8-434f-46aa-ba5c-067ec3800ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="wst-20221231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2c9ef8a4-cc19-4f8d-a6ce-e5dcf925c469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0c68d97e-27bd-41fe-8dba-43cca8733c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2c9ef8a4-cc19-4f8d-a6ce-e5dcf925c469" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0c68d97e-27bd-41fe-8dba-43cca8733c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_8c4b4e54-90b4-456c-9a4b-d4892af3586b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2c9ef8a4-cc19-4f8d-a6ce-e5dcf925c469" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_8c4b4e54-90b4-456c-9a4b-d4892af3586b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40a67e96-ea97-4d22-b638-1b2fd7b075c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_7042a61b-90fd-442c-bbc0-e12fac4928db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40a67e96-ea97-4d22-b638-1b2fd7b075c8" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_7042a61b-90fd-442c-bbc0-e12fac4928db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_36b05e94-1f64-4219-b989-607fbf8866dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40a67e96-ea97-4d22-b638-1b2fd7b075c8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_36b05e94-1f64-4219-b989-607fbf8866dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_500db53c-e40a-4d37-b1f9-0ad0f04d12c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40a67e96-ea97-4d22-b638-1b2fd7b075c8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_500db53c-e40a-4d37-b1f9-0ad0f04d12c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_31034b90-9a4c-498c-a4ac-0b9f13604106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40a67e96-ea97-4d22-b638-1b2fd7b075c8" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_31034b90-9a4c-498c-a4ac-0b9f13604106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_3f90c42a-0d38-40d0-8f26-091a20bb18be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40a67e96-ea97-4d22-b638-1b2fd7b075c8" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_3f90c42a-0d38-40d0-8f26-091a20bb18be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5a0469e3-7059-45fb-b589-8eb35da94229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_b05a9705-03be-4491-902e-4cdeb68e9574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5a0469e3-7059-45fb-b589-8eb35da94229" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_b05a9705-03be-4491-902e-4cdeb68e9574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_77211f5c-9977-41a8-9894-7401769562f7" xlink:href="wst-20221231.xsd#wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5a0469e3-7059-45fb-b589-8eb35da94229" xlink:to="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_77211f5c-9977-41a8-9894-7401769562f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_5c6a099e-e383-4879-9814-5ee4b4f59248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5a0469e3-7059-45fb-b589-8eb35da94229" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_5c6a099e-e383-4879-9814-5ee4b4f59248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_c09e300c-233c-49fc-a611-4824875f2df1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5a0469e3-7059-45fb-b589-8eb35da94229" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_c09e300c-233c-49fc-a611-4824875f2df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_2e5fdd2c-4690-4dfd-9c88-d5dd9553c37b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5a0469e3-7059-45fb-b589-8eb35da94229" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_2e5fdd2c-4690-4dfd-9c88-d5dd9553c37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_0cff09b2-f533-4ea6-b15d-b943a589b37f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5a0469e3-7059-45fb-b589-8eb35da94229" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_0cff09b2-f533-4ea6-b15d-b943a589b37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_35519ca6-b908-419e-a18d-bcecf3bf3952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5a0469e3-7059-45fb-b589-8eb35da94229" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_35519ca6-b908-419e-a18d-bcecf3bf3952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherExpenseIncomeTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_b814e2d4-9375-46b0-a4e6-43f16f0facd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_bb7c345c-6d90-4174-a04d-c8e6b46306b5" xlink:href="wst-20221231.xsd#wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b814e2d4-9375-46b0-a4e6-43f16f0facd4" xlink:to="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_bb7c345c-6d90-4174-a04d-c8e6b46306b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_5e2a3e9c-b1a6-4ffc-b90c-8d9a3e599de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b814e2d4-9375-46b0-a4e6-43f16f0facd4" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_5e2a3e9c-b1a6-4ffc-b90c-8d9a3e599de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d879ff25-154e-4ad1-8664-d73583e069fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7834be6b-0293-46d5-b005-d8f18034b093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d879ff25-154e-4ad1-8664-d73583e069fd" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7834be6b-0293-46d5-b005-d8f18034b093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_31f11f51-bfb2-4c09-8dd2-8261ad26e2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d879ff25-154e-4ad1-8664-d73583e069fd" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_31f11f51-bfb2-4c09-8dd2-8261ad26e2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_13e84bde-4e38-4edd-8bf7-09a9feffdd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d879ff25-154e-4ad1-8664-d73583e069fd" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_13e84bde-4e38-4edd-8bf7-09a9feffdd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a6ce73e8-bd05-485e-afc0-f0879c9ba0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d879ff25-154e-4ad1-8664-d73583e069fd" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a6ce73e8-bd05-485e-afc0-f0879c9ba0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d1884e39-ac38-4030-a942-4f57cb17b0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d879ff25-154e-4ad1-8664-d73583e069fd" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d1884e39-ac38-4030-a942-4f57cb17b0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="wst-20221231.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3ddc6826-7cc5-4632-95fc-9c47bb5459f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_ea5f47c0-64a1-47d4-8640-568d36a29abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3ddc6826-7cc5-4632-95fc-9c47bb5459f7" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_ea5f47c0-64a1-47d4-8640-568d36a29abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_060d93fc-e6ea-4e65-bde1-180cba29cb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3ddc6826-7cc5-4632-95fc-9c47bb5459f7" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_060d93fc-e6ea-4e65-bde1-180cba29cb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_aab117a0-a1ff-4705-a54f-d5681744783b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3ddc6826-7cc5-4632-95fc-9c47bb5459f7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_aab117a0-a1ff-4705-a54f-d5681744783b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5cb1c504-74f6-48c6-9676-b59b29a73052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c3fa1af2-3997-4407-a4e6-dce69143e2da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5cb1c504-74f6-48c6-9676-b59b29a73052" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c3fa1af2-3997-4407-a4e6-dce69143e2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8acd6cd5-9060-443e-ae4f-e3996d7b5c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5cb1c504-74f6-48c6-9676-b59b29a73052" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8acd6cd5-9060-443e-ae4f-e3996d7b5c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_eb8b8845-85f3-4171-9720-cb0c57195fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5cb1c504-74f6-48c6-9676-b59b29a73052" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_eb8b8845-85f3-4171-9720-cb0c57195fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1ae28b33-5bdd-47e4-9fab-99f4075288e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5cb1c504-74f6-48c6-9676-b59b29a73052" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1ae28b33-5bdd-47e4-9fab-99f4075288e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_15b6281b-bfb3-4fbd-8160-c055ac895083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5cb1c504-74f6-48c6-9676-b59b29a73052" xlink:to="loc_us-gaap_InventoryNet_15b6281b-bfb3-4fbd-8160-c055ac895083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_3744f0a4-d5cd-4ca1-b869-b4adac411755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5cb1c504-74f6-48c6-9676-b59b29a73052" xlink:to="loc_us-gaap_FinanceLeaseLiability_3744f0a4-d5cd-4ca1-b869-b4adac411755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4f14e9d6-b005-497c-bca6-90cb415a8572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5cb1c504-74f6-48c6-9676-b59b29a73052" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4f14e9d6-b005-497c-bca6-90cb415a8572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_445fde7c-70de-4161-b56f-a749c90c4140" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4f14e9d6-b005-497c-bca6-90cb415a8572" xlink:to="loc_srt_RangeAxis_445fde7c-70de-4161-b56f-a749c90c4140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8cc8a4b0-bb46-46fd-bb43-77f4db869166" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_445fde7c-70de-4161-b56f-a749c90c4140" xlink:to="loc_srt_RangeMember_8cc8a4b0-bb46-46fd-bb43-77f4db869166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f109426d-a658-4c32-8cc6-17816654c4b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8cc8a4b0-bb46-46fd-bb43-77f4db869166" xlink:to="loc_srt_MinimumMember_f109426d-a658-4c32-8cc6-17816654c4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2f8ce81b-38ef-4ed9-8643-417506f3ea2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8cc8a4b0-bb46-46fd-bb43-77f4db869166" xlink:to="loc_srt_MaximumMember_2f8ce81b-38ef-4ed9-8643-417506f3ea2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5571fde1-079d-4302-8fe5-a0497e59a03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4f14e9d6-b005-497c-bca6-90cb415a8572" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5571fde1-079d-4302-8fe5-a0497e59a03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d530369c-6160-4392-97de-812dd8bad8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5571fde1-079d-4302-8fe5-a0497e59a03c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d530369c-6160-4392-97de-812dd8bad8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_194200a4-4475-4e64-b76b-52a6ae1aeee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f463e8fe-62f6-4d5a-afb7-71167650c32a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_194200a4-4475-4e64-b76b-52a6ae1aeee5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f463e8fe-62f6-4d5a-afb7-71167650c32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4ceed61c-166a-433a-b358-1c8358915615" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f463e8fe-62f6-4d5a-afb7-71167650c32a" xlink:to="loc_srt_ProductOrServiceAxis_4ceed61c-166a-433a-b358-1c8358915615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e1310c92-efa7-4480-ad28-1f5d8f01d95d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4ceed61c-166a-433a-b358-1c8358915615" xlink:to="loc_srt_ProductsAndServicesDomain_e1310c92-efa7-4480-ad28-1f5d8f01d95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_d84c0f1d-6efd-4c07-a752-e1f78f4d1a07" xlink:href="wst-20221231.xsd#wst_SmartDoseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e1310c92-efa7-4480-ad28-1f5d8f01d95d" xlink:to="loc_wst_SmartDoseMember_d84c0f1d-6efd-4c07-a752-e1f78f4d1a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f463e8fe-62f6-4d5a-afb7-71167650c32a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_60945ef2-49c9-473b-b89b-baffa9a94bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_60945ef2-49c9-473b-b89b-baffa9a94bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6d8c0d5e-33c2-4148-9e61-240185642862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6d8c0d5e-33c2-4148-9e61-240185642862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_e66bc6de-6e9b-406b-b6a4-cab2fec5ab26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_e66bc6de-6e9b-406b-b6a4-cab2fec5ab26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_58c176fd-275b-48fc-b7a6-b0f9d62fbaf0" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_58c176fd-275b-48fc-b7a6-b0f9d62fbaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome_31742ad6-f1d4-4d75-9a8f-217addef65cf" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome_31742ad6-f1d4-4d75-9a8f-217addef65cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2ea43aa3-e3a9-4cd8-bd95-7110fe61946b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bba34a0a-1794-47b4-a383-5900085245c1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2ea43aa3-e3a9-4cd8-bd95-7110fe61946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#RevenueRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_7d6366f7-c060-469f-ba93-e3772de0d51c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_7d6366f7-c060-469f-ba93-e3772de0d51c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ec7e2ec7-e03e-4446-9345-c1d337187281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ec7e2ec7-e03e-4446-9345-c1d337187281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3a5a9561-2d2d-49c8-bfee-c5fa7f7e88cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ec7e2ec7-e03e-4446-9345-c1d337187281" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3a5a9561-2d2d-49c8-bfee-c5fa7f7e88cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_4a79d088-f56d-4bb2-90c3-c40ded23c55f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3a5a9561-2d2d-49c8-bfee-c5fa7f7e88cf" xlink:to="loc_us-gaap_SalesRevenueNetMember_4a79d088-f56d-4bb2-90c3-c40ded23c55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4aa50b30-6b98-409c-8e85-7874c1f04b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4aa50b30-6b98-409c-8e85-7874c1f04b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7164a53b-1034-4dcb-8efe-9e4e2d294783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4aa50b30-6b98-409c-8e85-7874c1f04b5d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7164a53b-1034-4dcb-8efe-9e4e2d294783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_20aaa984-215b-44e3-8d71-3da270dfe42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7164a53b-1034-4dcb-8efe-9e4e2d294783" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_20aaa984-215b-44e3-8d71-3da270dfe42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_45d82017-9639-4e54-a3b6-f5627eb603f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7164a53b-1034-4dcb-8efe-9e4e2d294783" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_45d82017-9639-4e54-a3b6-f5627eb603f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_a812a001-80a7-403c-b0cb-0accc8e10087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7164a53b-1034-4dcb-8efe-9e4e2d294783" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_a812a001-80a7-403c-b0cb-0accc8e10087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_456d2bf7-283e-4f3d-a40c-aa7c80374361" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_srt_MajorCustomersAxis_456d2bf7-283e-4f3d-a40c-aa7c80374361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_456d2bf7-283e-4f3d-a40c-aa7c80374361" xlink:to="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember_2bc3a4c1-c1e3-4a98-8282-f1464fc1d6df" xlink:href="wst-20221231.xsd#wst_BiologicsCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:to="loc_wst_BiologicsCustomersMember_2bc3a4c1-c1e3-4a98-8282-f1464fc1d6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember_d3cb25d9-327c-4518-9a0f-2b75b6b4b5f9" xlink:href="wst-20221231.xsd#wst_GenericsCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:to="loc_wst_GenericsCustomersMember_d3cb25d9-327c-4518-9a0f-2b75b6b4b5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember_e4b2a989-e0f1-4a20-a1f8-9723cc79ecdc" xlink:href="wst-20221231.xsd#wst_PharmaCustomersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:to="loc_wst_PharmaCustomersMember_e4b2a989-e0f1-4a20-a1f8-9723cc79ecdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember_e898244b-12d9-4227-a968-67c99083d413" xlink:href="wst-20221231.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8647e7bb-a236-4390-a5bd-08cd3fadf7df" xlink:to="loc_wst_ContractManufacturedCustomersMember_e898244b-12d9-4227-a968-67c99083d413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_61c15810-4872-4181-b838-9b615ebadf67" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_srt_ProductOrServiceAxis_61c15810-4872-4181-b838-9b615ebadf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_61c15810-4872-4181-b838-9b615ebadf67" xlink:to="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductComponentsMember_bc2e2563-ec70-43f1-a6b3-6feb0af419a7" xlink:href="wst-20221231.xsd#wst_HighValueProductComponentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:to="loc_wst_HighValueProductComponentsMember_bc2e2563-ec70-43f1-a6b3-6feb0af419a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductDeliveryDevicesMember_2c830d43-f9b2-43da-a58e-bf253445ad02" xlink:href="wst-20221231.xsd#wst_HighValueProductDeliveryDevicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:to="loc_wst_HighValueProductDeliveryDevicesMember_2c830d43-f9b2-43da-a58e-bf253445ad02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember_871aa0e3-ef05-4dbb-ba80-f3f2dd217b8c" xlink:href="wst-20221231.xsd#wst_StandardPackagingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:to="loc_wst_StandardPackagingMember_871aa0e3-ef05-4dbb-ba80-f3f2dd217b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_cf83bfb6-1dee-483b-bf18-5a978b7c35f8" xlink:href="wst-20221231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4660d3aa-ed87-47f4-b169-95c205fe561c" xlink:to="loc_wst_ContractManufacturedProductsMember_cf83bfb6-1dee-483b-bf18-5a978b7c35f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_abd1b3e4-8d2b-47c2-ba82-4565ffa6e27f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_srt_StatementGeographicalAxis_abd1b3e4-8d2b-47c2-ba82-4565ffa6e27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5860750e-f92f-4249-9257-5d47d442f358" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_abd1b3e4-8d2b-47c2-ba82-4565ffa6e27f" xlink:to="loc_srt_SegmentGeographicalDomain_5860750e-f92f-4249-9257-5d47d442f358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_ab60cdc6-27f9-4482-9cd7-d6bc5f51ec92" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5860750e-f92f-4249-9257-5d47d442f358" xlink:to="loc_srt_AmericasMember_ab60cdc6-27f9-4482-9cd7-d6bc5f51ec92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_b70d4bde-7c2d-4a96-99d2-d16b2dc1c861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5860750e-f92f-4249-9257-5d47d442f358" xlink:to="loc_us-gaap_EMEAMember_b70d4bde-7c2d-4a96-99d2-d16b2dc1c861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_fc4e30bc-316f-4651-b279-b564ef7b7d8a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5860750e-f92f-4249-9257-5d47d442f358" xlink:to="loc_srt_AsiaPacificMember_fc4e30bc-316f-4651-b279-b564ef7b7d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_362e28c7-d0c3-49b6-8826-377a5da470e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8f28f393-ed21-4c45-8c78-df18a413627f" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_362e28c7-d0c3-49b6-8826-377a5da470e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_57757c56-0789-4a26-b35b-ee3c744719f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_362e28c7-d0c3-49b6-8826-377a5da470e0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_57757c56-0789-4a26-b35b-ee3c744719f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#RevenueContractsAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c4296886-d7fc-4c90-b9ee-8b849f53227b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerAssetRollForward_70fdb2a0-4b41-47a8-9ea3-22a9ab5fe71b" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c4296886-d7fc-4c90-b9ee-8b849f53227b" xlink:to="loc_wst_ContractWithCustomerAssetRollForward_70fdb2a0-4b41-47a8-9ea3-22a9ab5fe71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_53df5a0e-cb3b-4ca1-805b-264bcb80e922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerAssetRollForward_70fdb2a0-4b41-47a8-9ea3-22a9ab5fe71b" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_53df5a0e-cb3b-4ca1-805b-264bcb80e922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_1525af7d-ce41-4734-ac3b-09aa7c5cbed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerAssetRollForward_70fdb2a0-4b41-47a8-9ea3-22a9ab5fe71b" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_1525af7d-ce41-4734-ac3b-09aa7c5cbed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerAssetIncreaseDecrease_b45f787a-2eb2-408c-a089-4d74243f7ecd" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerAssetIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerAssetRollForward_70fdb2a0-4b41-47a8-9ea3-22a9ab5fe71b" xlink:to="loc_wst_ContractWithCustomerAssetIncreaseDecrease_b45f787a-2eb2-408c-a089-4d74243f7ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRollForward_fb55b7d6-ab4f-49cf-90f0-480be675cd76" xlink:href="wst-20221231.xsd#wst_ContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c4296886-d7fc-4c90-b9ee-8b849f53227b" xlink:to="loc_wst_ContractWithCustomerLiabilityRollForward_fb55b7d6-ab4f-49cf-90f0-480be675cd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_b0a5b7a3-12d9-4617-b043-4649c4b9404c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward_fb55b7d6-ab4f-49cf-90f0-480be675cd76" xlink:to="loc_us-gaap_ContractWithCustomerLiability_b0a5b7a3-12d9-4617-b043-4649c4b9404c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_718b2cd3-2ba3-4706-9902-d41c198dff14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward_fb55b7d6-ab4f-49cf-90f0-480be675cd76" xlink:to="loc_us-gaap_ContractWithCustomerLiability_718b2cd3-2ba3-4706-9902-d41c198dff14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_f735aaac-cb9e-431c-916e-07e203335bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward_fb55b7d6-ab4f-49cf-90f0-480be675cd76" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_f735aaac-cb9e-431c-916e-07e203335bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#NetIncomePerShareScheduleofReconciliationofSharesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_87920345-4d14-4492-9581-562980726256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f2cebbdf-cde3-4608-94fc-f834aefc4f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_87920345-4d14-4492-9581-562980726256" xlink:to="loc_us-gaap_NetIncomeLoss_f2cebbdf-cde3-4608-94fc-f834aefc4f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_97b8d767-5e12-46a5-bee0-86cb5edcf6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_87920345-4d14-4492-9581-562980726256" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_97b8d767-5e12-46a5-bee0-86cb5edcf6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_48f5449c-2de6-4175-a13b-a6c004085ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_87920345-4d14-4492-9581-562980726256" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_48f5449c-2de6-4175-a13b-a6c004085ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7bd76ece-6c37-4c1a-863a-a1edcccd3288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_87920345-4d14-4492-9581-562980726256" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7bd76ece-6c37-4c1a-863a-a1edcccd3288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#NetIncomePerShareNarrativesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8dafb748-1600-41c9-b56a-2da99f6cd730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_82208c5c-7b1c-482c-a487-d75cdfc57400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8dafb748-1600-41c9-b56a-2da99f6cd730" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_82208c5c-7b1c-482c-a487-d75cdfc57400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_dc107d8c-d7ec-48ff-a493-2c35d8a25f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_82208c5c-7b1c-482c-a487-d75cdfc57400" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_dc107d8c-d7ec-48ff-a493-2c35d8a25f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_dcf09c86-cbe4-4295-88ad-34e4d6c2f82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_dc107d8c-d7ec-48ff-a493-2c35d8a25f97" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_dcf09c86-cbe4-4295-88ad-34e4d6c2f82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dde84d79-50ad-4f8c-be7d-1dd149edb244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_dcf09c86-cbe4-4295-88ad-34e4d6c2f82f" xlink:to="loc_us-gaap_SubsequentEventMember_dde84d79-50ad-4f8c-be7d-1dd149edb244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_82208c5c-7b1c-482c-a487-d75cdfc57400" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d09aed9-5126-4c17-9aff-0a171011bef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d09aed9-5126-4c17-9aff-0a171011bef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_5d18d21d-e894-4983-9fc5-a68da598ca2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_5d18d21d-e894-4983-9fc5-a68da598ca2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9c7a091a-e284-4863-a8b5-9868866f1bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9c7a091a-e284-4863-a8b5-9868866f1bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9a77536f-23be-4df5-a5a0-fe41ba95f4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9a77536f-23be-4df5-a5a0-fe41ba95f4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_b9e4c627-9688-43dc-99d6-89161765b371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_77fcc72e-c94f-4b26-96c1-5211bb12eb26" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_b9e4c627-9688-43dc-99d6-89161765b371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6bb4f426-1163-4205-b7a4-ac15b495843a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0def709f-a09c-4a46-b3bb-55bf479adbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6bb4f426-1163-4205-b7a4-ac15b495843a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0def709f-a09c-4a46-b3bb-55bf479adbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3865e130-97a1-4870-a406-4b37a43caa83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0def709f-a09c-4a46-b3bb-55bf479adbfb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3865e130-97a1-4870-a406-4b37a43caa83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3865e130-97a1-4870-a406-4b37a43caa83" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_e8fc7dab-ad51-4ee5-8aef-5c0d8af1dbce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_us-gaap_LandMember_e8fc7dab-ad51-4ee5-8aef-5c0d8af1dbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_a3f81262-bbff-4271-a195-8a4670d23be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_a3f81262-bbff-4271-a195-8a4670d23be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_10edfc35-9ce3-4478-a8bd-94cea997e353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_10edfc35-9ce3-4478-a8bd-94cea997e353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_1f2db4e1-8d7d-491f-9691-e29ed45a579a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ToolsDiesAndMoldsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_us-gaap_ToolsDiesAndMoldsMember_1f2db4e1-8d7d-491f-9691-e29ed45a579a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ComputerHardwareAndSoftwareMember_395ed3ee-2cf9-4b4b-8eb8-cdae0cfa7897" xlink:href="wst-20221231.xsd#wst_ComputerHardwareAndSoftwareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_wst_ComputerHardwareAndSoftwareMember_395ed3ee-2cf9-4b4b-8eb8-cdae0cfa7897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_802a9406-206e-4885-b380-6db98ee98ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70b71d30-7cfa-4ca0-a274-3787dcea39b8" xlink:to="loc_us-gaap_ConstructionInProgressMember_802a9406-206e-4885-b380-6db98ee98ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6dc10a4a-d7dc-4024-81dc-a73fca7a1fd5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0def709f-a09c-4a46-b3bb-55bf479adbfb" xlink:to="loc_srt_RangeAxis_6dc10a4a-d7dc-4024-81dc-a73fca7a1fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17abdd33-a994-4412-8267-9f43e8763628" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6dc10a4a-d7dc-4024-81dc-a73fca7a1fd5" xlink:to="loc_srt_RangeMember_17abdd33-a994-4412-8267-9f43e8763628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e22484c3-3c61-4682-8dbc-8c1b648750e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_17abdd33-a994-4412-8267-9f43e8763628" xlink:to="loc_srt_MinimumMember_e22484c3-3c61-4682-8dbc-8c1b648750e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f98d59a3-5bcf-41ad-903a-908d5963f4af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_17abdd33-a994-4412-8267-9f43e8763628" xlink:to="loc_srt_MaximumMember_f98d59a3-5bcf-41ad-903a-908d5963f4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7b42169-1ead-4867-9757-16737aef26df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0def709f-a09c-4a46-b3bb-55bf479adbfb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7b42169-1ead-4867-9757-16737aef26df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ac088f4a-e122-4c45-bf34-7c5a90cb8376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7b42169-1ead-4867-9757-16737aef26df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ac088f4a-e122-4c45-bf34-7c5a90cb8376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_928d4db0-bb8f-4748-bff5-1cf939ffa4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7b42169-1ead-4867-9757-16737aef26df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_928d4db0-bb8f-4748-bff5-1cf939ffa4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#PropertyPlantandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a12b9619-162d-4355-8d11-938cc83b285e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_0a10e9a2-1d57-45bb-ab17-49814dff8b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a12b9619-162d-4355-8d11-938cc83b285e" xlink:to="loc_us-gaap_Depreciation_0a10e9a2-1d57-45bb-ab17-49814dff8b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_c840bb5e-22b5-43ef-b9a8-74f37fa94006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a12b9619-162d-4355-8d11-938cc83b285e" xlink:to="loc_us-gaap_InterestCostsCapitalized_c840bb5e-22b5-43ef-b9a8-74f37fa94006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0a9e3c07-b1ec-42f9-b63d-c3354bbb0d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ee6b1b4b-97f6-4166-822a-b27bf10bed66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a9e3c07-b1ec-42f9-b63d-c3354bbb0d39" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ee6b1b4b-97f6-4166-822a-b27bf10bed66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_18c7cf21-e2d6-4f4c-9c7d-031c7d01761c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ee6b1b4b-97f6-4166-822a-b27bf10bed66" xlink:to="loc_srt_RangeAxis_18c7cf21-e2d6-4f4c-9c7d-031c7d01761c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0521e6af-5fe3-45d0-9021-f810da4b494a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_18c7cf21-e2d6-4f4c-9c7d-031c7d01761c" xlink:to="loc_srt_RangeMember_0521e6af-5fe3-45d0-9021-f810da4b494a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_15641509-35b5-475c-a857-f453fe1a9b2e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0521e6af-5fe3-45d0-9021-f810da4b494a" xlink:to="loc_srt_MaximumMember_15641509-35b5-475c-a857-f453fe1a9b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ee6b1b4b-97f6-4166-822a-b27bf10bed66" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm_a454961c-ee91-40c9-9bb7-28d0710e4094" xlink:href="wst-20221231.xsd#wst_LesseeOperatingLeaseOptionToTerminateTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm_a454961c-ee91-40c9-9bb7-28d0710e4094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_03cd5c39-02e7-4d41-9dd0-ff5fb21dfbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_us-gaap_FinanceLeaseLiability_03cd5c39-02e7-4d41-9dd0-ff5fb21dfbf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_aeee950e-e4b3-4f70-aa37-3729e2e7cec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_aeee950e-e4b3-4f70-aa37-3729e2e7cec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9f1c3890-2081-4193-ba34-ab5f8cdfce73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9f1c3890-2081-4193-ba34-ab5f8cdfce73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b1360514-6dc2-45b7-8546-496b7d2083dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2ceea7ec-43d4-4b74-9ea4-8ebe25ff9e9b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b1360514-6dc2-45b7-8546-496b7d2083dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ed8216a1-162a-4e1e-b7a4-0bd6b340b97a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_9ce8b0ad-e635-4a46-8e19-34b8f562ea8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ed8216a1-162a-4e1e-b7a4-0bd6b340b97a" xlink:to="loc_us-gaap_OperatingLeaseCost_9ce8b0ad-e635-4a46-8e19-34b8f562ea8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_5e594edc-ac41-46a6-a239-07a9527cee4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ed8216a1-162a-4e1e-b7a4-0bd6b340b97a" xlink:to="loc_us-gaap_ShortTermLeaseCost_5e594edc-ac41-46a6-a239-07a9527cee4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_4129452a-7cce-44a5-8016-f339d5a09dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ed8216a1-162a-4e1e-b7a4-0bd6b340b97a" xlink:to="loc_us-gaap_VariableLeaseCost_4129452a-7cce-44a5-8016-f339d5a09dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_89ddc75c-5c4c-4a75-a73e-4f635e966bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ed8216a1-162a-4e1e-b7a4-0bd6b340b97a" xlink:to="loc_us-gaap_LeaseCost_89ddc75c-5c4c-4a75-a73e-4f635e966bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#LeasesLeaseCashFlowandSupplementalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cf0139c9-64a8-4007-8965-edf03f274f24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_bc428dd4-92ae-4ffc-bd97-759343029692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cf0139c9-64a8-4007-8965-edf03f274f24" xlink:to="loc_us-gaap_OperatingLeasePayments_bc428dd4-92ae-4ffc-bd97-759343029692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_60e85312-08e3-48f9-a08c-c75e95e54063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cf0139c9-64a8-4007-8965-edf03f274f24" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_60e85312-08e3-48f9-a08c-c75e95e54063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5e7fbdcb-8170-4fc9-835c-6fa223f4a4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5e7fbdcb-8170-4fc9-835c-6fa223f4a4c5" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_898d9475-a190-46b8-aa26-6692ec70930d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_898d9475-a190-46b8-aa26-6692ec70930d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fa09c9a6-28c2-42ec-91b6-c8269558a2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fa09c9a6-28c2-42ec-91b6-c8269558a2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1da39b0b-baf8-408c-995f-28cbd016adad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1da39b0b-baf8-408c-995f-28cbd016adad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d6270092-904e-40a6-80ef-6effe65c5bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d6270092-904e-40a6-80ef-6effe65c5bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_05b7db96-62a5-442c-ae02-6a1ab23c5a28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_05b7db96-62a5-442c-ae02-6a1ab23c5a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ff5a365d-21e1-4c94-a087-25a23096dd39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ff5a365d-21e1-4c94-a087-25a23096dd39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_10b1a8e3-b694-472e-9f1e-7a56d2789d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_10b1a8e3-b694-472e-9f1e-7a56d2789d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1f02f3e3-167e-4b61-9605-02d4de80d8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1f02f3e3-167e-4b61-9605-02d4de80d8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0b212754-7da5-478d-8030-5852e05632fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_35170688-5a84-4da2-af4e-73d735512cf1" xlink:to="loc_us-gaap_OperatingLeaseLiability_0b212754-7da5-478d-8030-5852e05632fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="wst-20221231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#AffiliatedCompaniesScheduleofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_46dc749e-d0d6-4acb-a49a-50a163c8aaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_be89ef48-ff94-4aad-ba3d-c523fcc5c22d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_46dc749e-d0d6-4acb-a49a-50a163c8aaf0" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_be89ef48-ff94-4aad-ba3d-c523fcc5c22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_119e6099-770e-487a-901d-d6836505a7a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_be89ef48-ff94-4aad-ba3d-c523fcc5c22d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_119e6099-770e-487a-901d-d6836505a7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_119e6099-770e-487a-901d-d6836505a7a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WestCompanyMexicoSADeCVMember_6cb0ff4c-e2c7-4635-9f96-69e7c9f88759" xlink:href="wst-20221231.xsd#wst_WestCompanyMexicoSADeCVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:to="loc_wst_WestCompanyMexicoSADeCVMember_6cb0ff4c-e2c7-4635-9f96-69e7c9f88759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AluplastSADeCVMember_b045f83a-46d6-464c-b6ad-a41896d0e5cc" xlink:href="wst-20221231.xsd#wst_AluplastSADeCVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:to="loc_wst_AluplastSADeCVMember_b045f83a-46d6-464c-b6ad-a41896d0e5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaTapSADeCVMember_4cde6062-1a16-4bf1-ab68-2143647854bf" xlink:href="wst-20221231.xsd#wst_PharmaTapSADeCVMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:to="loc_wst_PharmaTapSADeCVMember_4cde6062-1a16-4bf1-ab68-2143647854bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaRubberSADeCVMember_9f75ba2b-bc93-4993-b59a-720c00c7b8ff" xlink:href="wst-20221231.xsd#wst_PharmaRubberSADeCVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:to="loc_wst_PharmaRubberSADeCVMember_9f75ba2b-bc93-4993-b59a-720c00c7b8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_ea4606f4-a38d-4caa-98bb-47cc7032ff4d" xlink:href="wst-20221231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8dc2276b-a5ab-4d51-b251-2ca5f99d8d65" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_ea4606f4-a38d-4caa-98bb-47cc7032ff4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8561cc81-8cf0-4a4d-aeda-b78633e78a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_be89ef48-ff94-4aad-ba3d-c523fcc5c22d" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8561cc81-8cf0-4a4d-aeda-b78633e78a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_58a8b9fe-f5e0-46e1-850e-a8959f4e4327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8561cc81-8cf0-4a4d-aeda-b78633e78a8c" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_58a8b9fe-f5e0-46e1-850e-a8959f4e4327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#AffiliatedCompaniesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d3e4b28c-fc17-4a9d-bb40-3e5ccab9b226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1dae6deb-56ee-4ab0-b9d6-1edb90144077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d3e4b28c-fc17-4a9d-bb40-3e5ccab9b226" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1dae6deb-56ee-4ab0-b9d6-1edb90144077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_01fe66ad-aa92-46c6-bcc3-622e6376da3d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1dae6deb-56ee-4ab0-b9d6-1edb90144077" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_01fe66ad-aa92-46c6-bcc3-622e6376da3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8fd0c182-05d3-4c0c-938a-ba9f205fca09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_01fe66ad-aa92-46c6-bcc3-622e6376da3d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8fd0c182-05d3-4c0c-938a-ba9f205fca09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_6edc3a61-920e-4183-8efa-6f0f1d09fec0" xlink:href="wst-20221231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8fd0c182-05d3-4c0c-938a-ba9f205fca09" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_6edc3a61-920e-4183-8efa-6f0f1d09fec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1dae6deb-56ee-4ab0-b9d6-1edb90144077" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_0723256b-4b16-4fc4-9d83-154aacdbcd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_0723256b-4b16-4fc4-9d83-154aacdbcd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_4b18bd61-01d8-4c93-a905-cd748da9fb67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_4b18bd61-01d8-4c93-a905-cd748da9fb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_2e3513b2-64f9-40e0-b61c-7f88e947b3d5" xlink:href="wst-20221231.xsd#wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_2e3513b2-64f9-40e0-b61c-7f88e947b3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_a120a8f5-a2c0-4678-8cf0-c38dd374cfa4" xlink:href="wst-20221231.xsd#wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_a120a8f5-a2c0-4678-8cf0-c38dd374cfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_14faee7c-22d4-4f0c-b080-08d2d990be25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_14faee7c-22d4-4f0c-b080-08d2d990be25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesToEquityMethodInvestees_cc96316c-02b0-418d-98c2-eb0141578add" xlink:href="wst-20221231.xsd#wst_SalesToEquityMethodInvestees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_wst_SalesToEquityMethodInvestees_cc96316c-02b0-418d-98c2-eb0141578add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates_2b3027e7-daa2-462d-9235-eda4133cbaec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromAffiliates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_DueFromAffiliates_2b3027e7-daa2-462d-9235-eda4133cbaec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_8034305b-5cc3-4386-838f-62c91762721c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_EquityMethodInvestments_8034305b-5cc3-4386-838f-62c91762721c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c0293baa-662a-4fec-adb1-ad1b1e1041f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_61e5d9e2-e58e-44a9-b73f-811860706478" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c0293baa-662a-4fec-adb1-ad1b1e1041f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_86e10937-bc97-432f-ad1b-b8a41fbdfae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2786fa22-3cea-44b8-b8d6-ea9d66f79bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_86e10937-bc97-432f-ad1b-b8a41fbdfae7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2786fa22-3cea-44b8-b8d6-ea9d66f79bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6b46a448-8efa-46e0-bd3d-bbeca6c5ea32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2786fa22-3cea-44b8-b8d6-ea9d66f79bb6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6b46a448-8efa-46e0-bd3d-bbeca6c5ea32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_670a964b-e777-4ca6-85ff-de3b360d38af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6b46a448-8efa-46e0-bd3d-bbeca6c5ea32" xlink:to="loc_us-gaap_SegmentDomain_670a964b-e777-4ca6-85ff-de3b360d38af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_03caf10e-74de-4495-aed8-1855f2e2f7d4" xlink:href="wst-20221231.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_670a964b-e777-4ca6-85ff-de3b360d38af" xlink:to="loc_wst_ProprietaryProductsMember_03caf10e-74de-4495-aed8-1855f2e2f7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_c69f3547-6a2b-4172-9bb9-f86bcfa12bed" xlink:href="wst-20221231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_670a964b-e777-4ca6-85ff-de3b360d38af" xlink:to="loc_wst_ContractManufacturedProductsMember_c69f3547-6a2b-4172-9bb9-f86bcfa12bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_b788fac7-73fe-410f-a8fd-b9551434226e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2786fa22-3cea-44b8-b8d6-ea9d66f79bb6" xlink:to="loc_us-gaap_GoodwillLineItems_b788fac7-73fe-410f-a8fd-b9551434226e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_b788fac7-73fe-410f-a8fd-b9551434226e" xlink:to="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0eecb988-173e-490b-b442-8abeb2477e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:to="loc_us-gaap_Goodwill_0eecb988-173e-490b-b442-8abeb2477e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a6601b0c-6452-4b58-9a86-2e6703366630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a6601b0c-6452-4b58-9a86-2e6703366630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_37368e37-97e9-4ed3-bf50-348be4815b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_37368e37-97e9-4ed3-bf50-348be4815b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a534ec7a-187d-4021-a97c-d8bd61844ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a534ec7a-187d-4021-a97c-d8bd61844ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_81bfb106-c726-426c-aaad-67aa61be1f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_37313493-23a2-4acc-87fe-04d28ba2f16a" xlink:to="loc_us-gaap_Goodwill_81bfb106-c726-426c-aaad-67aa61be1f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_190c109d-3a7c-4faa-91f9-0c46c8c71e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e35ba711-3b8f-413f-9708-ed3da4ef0c75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_190c109d-3a7c-4faa-91f9-0c46c8c71e7f" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e35ba711-3b8f-413f-9708-ed3da4ef0c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_1292f56e-b9fa-48cc-8dea-1e39f5ec8cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_190c109d-3a7c-4faa-91f9-0c46c8c71e7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_1292f56e-b9fa-48cc-8dea-1e39f5ec8cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_810da4cd-b32f-443e-bce2-4780afb7270c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_190c109d-3a7c-4faa-91f9-0c46c8c71e7f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_810da4cd-b32f-443e-bce2-4780afb7270c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_9a7d5c92-31da-4ca2-8c1a-fe3868db2636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_190c109d-3a7c-4faa-91f9-0c46c8c71e7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_9a7d5c92-31da-4ca2-8c1a-fe3868db2636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f35fdb3a-cce8-4730-bfc7-41283cee9ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_9a7d5c92-31da-4ca2-8c1a-fe3868db2636" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f35fdb3a-cce8-4730-bfc7-41283cee9ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_18520ef6-f79f-44e4-9f5d-b79abc8eaf19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_9a7d5c92-31da-4ca2-8c1a-fe3868db2636" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_18520ef6-f79f-44e4-9f5d-b79abc8eaf19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_53e6dea0-fd25-40e2-b67b-9997eda6da99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_9a7d5c92-31da-4ca2-8c1a-fe3868db2636" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_53e6dea0-fd25-40e2-b67b-9997eda6da99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ff5ce010-3aeb-4ebf-9822-243da32b9159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_9a7d5c92-31da-4ca2-8c1a-fe3868db2636" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ff5ce010-3aeb-4ebf-9822-243da32b9159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1b16dd88-60b8-4cc6-ae4e-6b0b6b5ef5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_9a7d5c92-31da-4ca2-8c1a-fe3868db2636" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1b16dd88-60b8-4cc6-ae4e-6b0b6b5ef5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5204e5ef-585b-4552-92d2-58bc36d24b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_92df9f3c-5662-40e7-a37f-7d4e45a0cb27" xlink:href="wst-20221231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5204e5ef-585b-4552-92d2-58bc36d24b1a" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_92df9f3c-5662-40e7-a37f-7d4e45a0cb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d043e550-8616-4d56-a328-4bef6493b068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_92df9f3c-5662-40e7-a37f-7d4e45a0cb27" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d043e550-8616-4d56-a328-4bef6493b068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d043e550-8616-4d56-a328-4bef6493b068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PatentsAndLicensingMember_c0853cab-e88e-44ba-8238-e259a9e844c1" xlink:href="wst-20221231.xsd#wst_PatentsAndLicensingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:to="loc_wst_PatentsAndLicensingMember_c0853cab-e88e-44ba-8238-e259a9e844c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_7376f268-c73e-4b32-b71c-5eaaef02411c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_7376f268-c73e-4b32-b71c-5eaaef02411c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_f95986ff-d5eb-4e2e-b863-6fed7bb19f18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:to="loc_us-gaap_TrademarksMember_f95986ff-d5eb-4e2e-b863-6fed7bb19f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_66d027fd-fa0a-44fb-8053-8c4654b4e115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_66d027fd-fa0a-44fb-8053-8c4654b4e115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_e35794d3-271a-4932-ab76-7f2a1eff63d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69fd1793-a3a6-48f6-9118-ea263f13fa2f" xlink:to="loc_us-gaap_CustomerContractsMember_e35794d3-271a-4932-ab76-7f2a1eff63d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_e5aaeecf-88c8-47f3-9cb9-01efb7f5eba4" xlink:href="wst-20221231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_92df9f3c-5662-40e7-a37f-7d4e45a0cb27" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_e5aaeecf-88c8-47f3-9cb9-01efb7f5eba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4ccfeb3f-5ded-4895-a31c-540fc9bd39d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_e5aaeecf-88c8-47f3-9cb9-01efb7f5eba4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4ccfeb3f-5ded-4895-a31c-540fc9bd39d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a7fe8691-b608-4955-a41c-5c20f5212f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_e5aaeecf-88c8-47f3-9cb9-01efb7f5eba4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a7fe8691-b608-4955-a41c-5c20f5212f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7d760931-ec8c-4b7f-bd6a-da58390bf5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_e5aaeecf-88c8-47f3-9cb9-01efb7f5eba4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7d760931-ec8c-4b7f-bd6a-da58390bf5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:href="wst-20221231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_3e573f33-088d-4881-bdb4-67cc39d57b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_DeferredRevenueCurrent_3e573f33-088d-4881-bdb4-67cc39d57b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_5a31482f-90f2-4f4f-8f6f-c4f12d17b09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_DividendsPayableCurrent_5a31482f-90f2-4f4f-8f6f-c4f12d17b09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_7695017d-f2f3-44f5-8257-be53d7f44674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_7695017d-f2f3-44f5-8257-be53d7f44674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_ac86f5c3-cce2-42b9-a878-fee15acefb82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_ac86f5c3-cce2-42b9-a878-fee15acefb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_ffa8b317-a13a-4a46-8728-45baf908e70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_ffa8b317-a13a-4a46-8728-45baf908e70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_33469962-5ee0-4d70-b80c-1731d1536d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_33469962-5ee0-4d70-b80c-1731d1536d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_5c193119-e24c-4bc2-a86c-3231ecaf1051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_InterestPayableCurrent_5c193119-e24c-4bc2-a86c-3231ecaf1051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_da01279a-5251-4ce1-925b-7568dabb30ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_RestructuringReserve_da01279a-5251-4ce1-925b-7568dabb30ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_264a1488-279c-4954-84dd-68bd7c811c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_264a1488-279c-4954-84dd-68bd7c811c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_3a51bff3-f036-412f-8870-7711f1ef7809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_3a51bff3-f036-412f-8870-7711f1ef7809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_6c29af8b-f32d-463d-937e-d21eefd7bdec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_e002edd8-9b57-4a69-90fb-c545370bebb7" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_6c29af8b-f32d-463d-937e-d21eefd7bdec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_206833df-a562-4ec4-903e-46e1f1193d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_00d50a14-fe41-40a2-a82c-a96de492bf2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_206833df-a562-4ec4-903e-46e1f1193d3c" xlink:to="loc_us-gaap_DebtInstrumentTable_00d50a14-fe41-40a2-a82c-a96de492bf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5dad6cd0-f1a4-464a-b2f1-f01fc65fc239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_00d50a14-fe41-40a2-a82c-a96de492bf2e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5dad6cd0-f1a4-464a-b2f1-f01fc65fc239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5dad6cd0-f1a4-464a-b2f1-f01fc65fc239" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_c56cdbaa-b42f-4928-960b-1b2bf61fdb7f" xlink:href="wst-20221231.xsd#wst_TermLoanDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:to="loc_wst_TermLoanDue2024Member_c56cdbaa-b42f-4928-960b-1b2bf61fdb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_9773f540-10ad-49c5-b424-72cdd8b2fab8" xlink:href="wst-20221231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:to="loc_wst_SeniorNotesDue2022Member_9773f540-10ad-49c5-b424-72cdd8b2fab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_5b7dd830-bfa0-4a20-8be9-5b7ca2a86a50" xlink:href="wst-20221231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:to="loc_wst_SeniorBNotesDue2024Member_5b7dd830-bfa0-4a20-8be9-5b7ca2a86a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_7a4a7288-4ae7-45d2-93fc-602667a6fcc9" xlink:href="wst-20221231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e809dd6c-b03e-48a4-a27c-889f001b126f" xlink:to="loc_wst_SeniorCNotesDue2027Member_7a4a7288-4ae7-45d2-93fc-602667a6fcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_00d50a14-fe41-40a2-a82c-a96de492bf2e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2efa19a-d26f-4644-b5e9-b72f94af953f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2efa19a-d26f-4644-b5e9-b72f94af953f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c591e546-260f-4293-b117-36edc9e0852d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c591e546-260f-4293-b117-36edc9e0852d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_ae77e9f2-926d-4daa-b616-dbd8602d9b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_ae77e9f2-926d-4daa-b616-dbd8602d9b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_08c01db2-af16-4daf-a4fd-a4091eb16a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_LongTermDebt_08c01db2-af16-4daf-a4fd-a4091eb16a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_042e9c32-1f4f-4834-8d59-c1fa58a9f4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_LongTermDebtCurrent_042e9c32-1f4f-4834-8d59-c1fa58a9f4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_862dea52-2320-483b-bbc3-b5b248e2ecf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40cb9474-4071-47a9-b77b-75c928000ed5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_862dea52-2320-483b-bbc3-b5b248e2ecf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails_1" xlink:type="simple" xlink:href="wst-20221231.xsd#DebtScheduleofDebtDetails_1"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtScheduleofDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ba053e29-ca5c-4455-ba6b-a1b8fd63ac7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ba053e29-ca5c-4455-ba6b-a1b8fd63ac7f" xlink:to="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9e84cf27-974e-4bc2-87d2-700a76ce120f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9e84cf27-974e-4bc2-87d2-700a76ce120f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_58035808-8323-4051-bc21-0a2317aee0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9e84cf27-974e-4bc2-87d2-700a76ce120f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_58035808-8323-4051-bc21-0a2317aee0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_6863308e-1d14-49f7-b6e0-7fa0309b986e" xlink:href="wst-20221231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_58035808-8323-4051-bc21-0a2317aee0b6" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_6863308e-1d14-49f7-b6e0-7fa0309b986e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_309571a1-c44c-429c-a1f5-dc9d0db91d83" xlink:href="wst-20221231.xsd#wst_TermLoanDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_58035808-8323-4051-bc21-0a2317aee0b6" xlink:to="loc_wst_TermLoanDue2024Member_309571a1-c44c-429c-a1f5-dc9d0db91d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_85dcd5af-feab-41f6-9205-081867e0e77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_58035808-8323-4051-bc21-0a2317aee0b6" xlink:to="loc_us-gaap_SeniorNotesMember_85dcd5af-feab-41f6-9205-081867e0e77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_13c8cf3d-18c0-4707-88fd-9406dcbc6938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_us-gaap_CreditFacilityAxis_13c8cf3d-18c0-4707-88fd-9406dcbc6938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_13c8cf3d-18c0-4707-88fd-9406dcbc6938" xlink:to="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_2697b536-9088-455b-9c26-cf232af12f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_2697b536-9088-455b-9c26-cf232af12f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember_ea73645b-7ff4-40c0-a381-7b44a670dbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:to="loc_us-gaap_ForeignLineOfCreditMember_ea73645b-7ff4-40c0-a381-7b44a670dbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_7e552103-5fe9-489d-b259-6facd8080673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:to="loc_us-gaap_LetterOfCreditMember_7e552103-5fe9-489d-b259-6facd8080673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2f4963c4-5b7d-499c-a6ac-df4eaf5953b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2d3f2ee8-ad2f-4527-b71a-e15c4d54afbd" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2f4963c4-5b7d-499c-a6ac-df4eaf5953b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_dc768257-e000-4a94-a42d-66a6d169a5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_us-gaap_VariableRateAxis_dc768257-e000-4a94-a42d-66a6d169a5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_dc768257-e000-4a94-a42d-66a6d169a5de" xlink:to="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ApplicableMarginMember_f5666e9f-dfa8-4bee-bf09-10a2e49833d5" xlink:href="wst-20221231.xsd#wst_ApplicableMarginMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:to="loc_wst_ApplicableMarginMember_f5666e9f-dfa8-4bee-bf09-10a2e49833d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_0d4d64d2-dd59-42e9-9823-3ca1582d2e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_0d4d64d2-dd59-42e9-9823-3ca1582d2e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_5afb3491-2eaf-43c7-91f2-012f4dcd0d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_5afb3491-2eaf-43c7-91f2-012f4dcd0d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_de54364f-ec5e-4684-bcb9-1e4b15d8ee63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_98dad836-a8f6-45ae-b743-23df6a7c7843" xlink:to="loc_us-gaap_BaseRateMember_de54364f-ec5e-4684-bcb9-1e4b15d8ee63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3aa4e41e-40f7-4d4e-b0a1-16e39880f5c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_srt_RangeAxis_3aa4e41e-40f7-4d4e-b0a1-16e39880f5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd732d75-f69f-4b7a-b883-711ae7a51473" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3aa4e41e-40f7-4d4e-b0a1-16e39880f5c7" xlink:to="loc_srt_RangeMember_dd732d75-f69f-4b7a-b883-711ae7a51473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6982338e-2c24-4446-a7bd-cd4f34264104" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dd732d75-f69f-4b7a-b883-711ae7a51473" xlink:to="loc_srt_MinimumMember_6982338e-2c24-4446-a7bd-cd4f34264104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_746a2dcf-d8b5-4ff6-9662-79c926399fe7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dd732d75-f69f-4b7a-b883-711ae7a51473" xlink:to="loc_srt_MaximumMember_746a2dcf-d8b5-4ff6-9662-79c926399fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e40f0474-faf9-4228-8e4b-2b5c85220e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_us-gaap_DebtInstrumentAxis_e40f0474-faf9-4228-8e4b-2b5c85220e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9dbc00e3-9e5f-4739-8dbf-633299aff83b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e40f0474-faf9-4228-8e4b-2b5c85220e47" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9dbc00e3-9e5f-4739-8dbf-633299aff83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_77f0aa17-a55c-43e7-b04b-804aab49189c" xlink:href="wst-20221231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9dbc00e3-9e5f-4739-8dbf-633299aff83b" xlink:to="loc_wst_SeniorNotesDue2022Member_77f0aa17-a55c-43e7-b04b-804aab49189c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_7e922f7c-348f-4f5c-bf67-b48d8630a4cf" xlink:href="wst-20221231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9dbc00e3-9e5f-4739-8dbf-633299aff83b" xlink:to="loc_wst_SeniorBNotesDue2024Member_7e922f7c-348f-4f5c-bf67-b48d8630a4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_2390b179-a69c-4d94-84b0-bddbc60024f4" xlink:href="wst-20221231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9dbc00e3-9e5f-4739-8dbf-633299aff83b" xlink:to="loc_wst_SeniorCNotesDue2027Member_2390b179-a69c-4d94-84b0-bddbc60024f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_935e4646-e39a-47bd-a771-e41b82c2b0aa" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_a6beeb1b-dfd0-4b46-ab58-befec93b798b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_a6beeb1b-dfd0-4b46-ab58-befec93b798b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_cb7aefbb-0eee-452b-93b6-53d3f6198ea6" xlink:href="wst-20221231.xsd#wst_CreditFacilityIsAvailableForSwingLineLoans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_cb7aefbb-0eee-452b-93b6-53d3f6198ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditAvailableForTheIssuanceOfLettersOfCredit_37a6c62a-4f1a-4464-a006-4dd0f1304515" xlink:href="wst-20221231.xsd#wst_CreditAvailableForTheIssuanceOfLettersOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_CreditAvailableForTheIssuanceOfLettersOfCredit_37a6c62a-4f1a-4464-a006-4dd0f1304515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_c2f8924c-aeda-415a-9198-11d3ffb09fa1" xlink:href="wst-20221231.xsd#wst_LineOfCreditFacilityAdditionalBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_c2f8924c-aeda-415a-9198-11d3ffb09fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod_db88a5b1-801c-44fe-a181-5cf078972832" xlink:href="wst-20221231.xsd#wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod_db88a5b1-801c-44fe-a181-5cf078972832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4a0c4841-119e-49d5-9ba3-f637f592b53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4a0c4841-119e-49d5-9ba3-f637f592b53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentApplicableMarginRatio_51700be2-3987-4159-ac4c-2eade81abbc2" xlink:href="wst-20221231.xsd#wst_DebtInstrumentApplicableMarginRatio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentApplicableMarginRatio_51700be2-3987-4159-ac4c-2eade81abbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentRatioOfDebtToEBITDA_5821fe9c-121c-491a-8d6d-700cdf5c86ad" xlink:href="wst-20221231.xsd#wst_DebtInstrumentRatioOfDebtToEBITDA"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentRatioOfDebtToEBITDA_5821fe9c-121c-491a-8d6d-700cdf5c86ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded_8f4dba32-9f51-4135-b9cc-15c3b43f338c" xlink:href="wst-20221231.xsd#wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded_8f4dba32-9f51-4135-b9cc-15c3b43f338c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition_f3daeff7-87fd-41e8-8424-305b1e2247f0" xlink:href="wst-20221231.xsd#wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition_f3daeff7-87fd-41e8-8424-305b1e2247f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition_d8f49f0a-0184-4f81-bdd3-e93505c934d8" xlink:href="wst-20221231.xsd#wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition_d8f49f0a-0184-4f81-bdd3-e93505c934d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_c613677e-60f6-476a-a98d-06af08dc1fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_c613677e-60f6-476a-a98d-06af08dc1fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_4bf244da-cd06-4678-9fac-4bff803f7f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LongTermLineOfCredit_4bf244da-cd06-4678-9fac-4bff803f7f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e92912da-6fa7-4f75-a295-3efc18699066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LineOfCredit_e92912da-6fa7-4f75-a295-3efc18699066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_84f92389-ca38-425c-9a62-7d5c8ac81f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_84f92389-ca38-425c-9a62-7d5c8ac81f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_550d9019-f40b-46c0-9172-b5c0ba60492d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_550d9019-f40b-46c0-9172-b5c0ba60492d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a67946bb-cdb5-423b-8e64-18691de8fdef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a67946bb-cdb5-423b-8e64-18691de8fdef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_97de6603-6536-49bc-a679-6821044d3830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LongTermDebtCurrent_97de6603-6536-49bc-a679-6821044d3830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f309e347-dffd-468e-8100-e68720b80f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f309e347-dffd-468e-8100-e68720b80f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfTranches_2289eccf-a6b4-4e8b-949b-96490f09b563" xlink:href="wst-20221231.xsd#wst_DebtInstrumentNumberOfTranches"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_wst_DebtInstrumentNumberOfTranches_2289eccf-a6b4-4e8b-949b-96490f09b563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_623667a2-2a22-4e21-a22e-089c4c8a3286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_623667a2-2a22-4e21-a22e-089c4c8a3286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_740ddddc-e9e1-476a-be94-7a8c8dfb4721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_740ddddc-e9e1-476a-be94-7a8c8dfb4721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_75640144-a087-4526-9226-23567d9ac2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_75640144-a087-4526-9226-23567d9ac2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_54deb7f2-73a3-4714-813f-5c6ab565b996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_InterestExpenseDebt_54deb7f2-73a3-4714-813f-5c6ab565b996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7f5c018a-4c8a-4bb9-b7b5-7fc39c59d2de" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_254dddc8-304a-4d0d-9123-ca77a1a2642a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_254dddc8-304a-4d0d-9123-ca77a1a2642a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_356aa0f2-15c1-4c86-af45-25f606a7f150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_356aa0f2-15c1-4c86-af45-25f606a7f150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3e632d63-5ef9-4f81-9abf-3e1e14f4087a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3e632d63-5ef9-4f81-9abf-3e1e14f4087a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f41f7ed0-4cde-40ce-894e-e556667c58a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f41f7ed0-4cde-40ce-894e-e556667c58a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_625279fa-50b2-4531-ad44-77e1a96c7252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_625279fa-50b2-4531-ad44-77e1a96c7252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_f6d0a92e-53b3-40d0-a9bc-5c089e396edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_60744fed-fec7-47f7-9ce9-c07575a360ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_f6d0a92e-53b3-40d0-a9bc-5c089e396edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DerivativeFinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c9fa4d2b-464b-4466-bf1e-4226f0e1413f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c9fa4d2b-464b-4466-bf1e-4226f0e1413f" xlink:to="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_665111d6-ece7-4c0b-8c3c-1dbcb916e79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_665111d6-ece7-4c0b-8c3c-1dbcb916e79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_665111d6-ece7-4c0b-8c3c-1dbcb916e79e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_52f3086b-2b79-45f5-89a1-51cbebfc66a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:to="loc_us-gaap_ForwardContractsMember_52f3086b-2b79-45f5-89a1-51cbebfc66a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_27df820e-16e4-4a0e-b4c9-5b8dac3ef7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_27df820e-16e4-4a0e-b4c9-5b8dac3ef7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_a974d4af-f4dc-4c6f-a55b-0e8940c24450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_a974d4af-f4dc-4c6f-a55b-0e8940c24450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember_7c72c9e0-2f15-4e07-8cf0-7619833c3ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45118ec1-f789-4fa4-986f-f2f4dd9c4ed8" xlink:to="loc_us-gaap_OptionMember_7c72c9e0-2f15-4e07-8cf0-7619833c3ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_b97c6dd6-c81b-419e-a070-080edc5a3f87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:to="loc_srt_CurrencyAxis_b97c6dd6-c81b-419e-a070-080edc5a3f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_0f400229-519d-4e75-bfa6-dd5d35ce972a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_b97c6dd6-c81b-419e-a070-080edc5a3f87" xlink:to="loc_currency_AllCurrenciesDomain_0f400229-519d-4e75-bfa6-dd5d35ce972a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_8fb1e92e-ac5b-4730-a23c-c514d1f694ca" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SGD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_0f400229-519d-4e75-bfa6-dd5d35ce972a" xlink:to="loc_currency_SGD_8fb1e92e-ac5b-4730-a23c-c514d1f694ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_b481b08d-0344-4fc6-a1a8-5238aa7756da" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_0f400229-519d-4e75-bfa6-dd5d35ce972a" xlink:to="loc_currency_USD_b481b08d-0344-4fc6-a1a8-5238aa7756da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b3b9267-51e0-452a-919b-4f1ab0ab2fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b3b9267-51e0-452a-919b-4f1ab0ab2fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e570c339-9f18-41aa-9a5a-696ae0b221e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b3b9267-51e0-452a-919b-4f1ab0ab2fc2" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e570c339-9f18-41aa-9a5a-696ae0b221e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_82f9b55d-be70-417d-be7c-9b27a282cdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e570c339-9f18-41aa-9a5a-696ae0b221e2" xlink:to="loc_us-gaap_FairValueHedgingMember_82f9b55d-be70-417d-be7c-9b27a282cdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_0e497a71-6ee0-4778-86fa-fcabb09d258b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e570c339-9f18-41aa-9a5a-696ae0b221e2" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_0e497a71-6ee0-4778-86fa-fcabb09d258b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1dbf457e-7f70-4968-b19c-b433f69bd14e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:to="loc_srt_StatementScenarioAxis_1dbf457e-7f70-4968-b19c-b433f69bd14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_399b4320-2a30-4a8e-a765-d8ebc85d0c46" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1dbf457e-7f70-4968-b19c-b433f69bd14e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_399b4320-2a30-4a8e-a765-d8ebc85d0c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b26c0fe7-b350-4e87-95ad-c91cc66d0aca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_399b4320-2a30-4a8e-a765-d8ebc85d0c46" xlink:to="loc_srt_ScenarioForecastMember_b26c0fe7-b350-4e87-95ad-c91cc66d0aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_db3be5f4-0337-493b-88c1-7b7b7c616b5c" xlink:to="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e5c6fa33-2c19-4d69-a63a-32bd56509481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e5c6fa33-2c19-4d69-a63a-32bd56509481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_247d6aff-ed16-4809-b4bf-6d46dc5c8c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeTermOfContract_247d6aff-ed16-4809-b4bf-6d46dc5c8c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_d325ee78-3603-4773-b2a8-7128d7229baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNonmonetaryNotionalAmountVolume"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_d325ee78-3603-4773-b2a8-7128d7229baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_c22334ae-8b05-4df0-bb82-4d812cb207db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNonmonetaryNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_c22334ae-8b05-4df0-bb82-4d812cb207db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_037cd2ba-dc5c-446b-8857-9b1c3f7219a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_037cd2ba-dc5c-446b-8857-9b1c3f7219a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_7aba03d2-d5c3-47a8-b8e6-5d0fe46d0167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a6eb23d-f4fb-4d07-a9c6-b6924aa46416" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_7aba03d2-d5c3-47a8-b8e6-5d0fe46d0167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c3d20d68-a1dd-4ee8-a761-228ca7bd42d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c3d20d68-a1dd-4ee8-a761-228ca7bd42d0" xlink:to="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_85f982f6-11aa-4866-9267-b1e6af13bf03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_85f982f6-11aa-4866-9267-b1e6af13bf03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9b4735a8-d850-43e6-9619-3ac822a040b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_85f982f6-11aa-4866-9267-b1e6af13bf03" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9b4735a8-d850-43e6-9619-3ac822a040b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_791628dc-2969-4921-bbd9-776678906eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9b4735a8-d850-43e6-9619-3ac822a040b1" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_791628dc-2969-4921-bbd9-776678906eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5c0177c4-35f5-4486-a2ef-16f0d4941892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:to="loc_us-gaap_HedgingDesignationAxis_5c0177c4-35f5-4486-a2ef-16f0d4941892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6f610b82-cec0-4d15-a60a-796d4ef9dacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5c0177c4-35f5-4486-a2ef-16f0d4941892" xlink:to="loc_us-gaap_HedgingDesignationDomain_6f610b82-cec0-4d15-a60a-796d4ef9dacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c5bb7b48-2163-4ce3-9146-ecad2d5ef1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_6f610b82-cec0-4d15-a60a-796d4ef9dacd" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c5bb7b48-2163-4ce3-9146-ecad2d5ef1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_642b560d-5970-43b4-b0cc-da484aa1a2e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:to="loc_srt_CurrencyAxis_642b560d-5970-43b4-b0cc-da484aa1a2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_584b0970-86e1-431f-90e4-0e7cffa5c3b9" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_642b560d-5970-43b4-b0cc-da484aa1a2e1" xlink:to="loc_currency_AllCurrenciesDomain_584b0970-86e1-431f-90e4-0e7cffa5c3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_c1d517e3-6471-46e3-8c7c-f063b455e944" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_584b0970-86e1-431f-90e4-0e7cffa5c3b9" xlink:to="loc_currency_USD_c1d517e3-6471-46e3-8c7c-f063b455e944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_991c1673-e9bf-4d21-ae73-e527846fd0ab" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_584b0970-86e1-431f-90e4-0e7cffa5c3b9" xlink:to="loc_currency_JPY_991c1673-e9bf-4d21-ae73-e527846fd0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_4f9fd2ab-dfaf-45a4-b544-1625874e36bf" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SGD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_584b0970-86e1-431f-90e4-0e7cffa5c3b9" xlink:to="loc_currency_SGD_4f9fd2ab-dfaf-45a4-b544-1625874e36bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_af6e74eb-09fd-44ce-83f6-fd5a8aa3757d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:to="loc_us-gaap_PositionAxis_af6e74eb-09fd-44ce-83f6-fd5a8aa3757d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_52c6b31d-b6ac-448e-aa6d-e1e653ec35ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_af6e74eb-09fd-44ce-83f6-fd5a8aa3757d" xlink:to="loc_us-gaap_PositionDomain_52c6b31d-b6ac-448e-aa6d-e1e653ec35ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_1e1164c5-4eea-468e-83ec-27c4b82bff4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_52c6b31d-b6ac-448e-aa6d-e1e653ec35ac" xlink:to="loc_us-gaap_LongMember_1e1164c5-4eea-468e-83ec-27c4b82bff4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_645d6d91-48f3-460d-b340-19097537ca0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_52c6b31d-b6ac-448e-aa6d-e1e653ec35ac" xlink:to="loc_us-gaap_ShortMember_645d6d91-48f3-460d-b340-19097537ca0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4be8f02a-1c2d-4e34-a0f9-004b71145cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d4f93a6-9466-4457-b1eb-ba8697c06b8f" xlink:to="loc_us-gaap_DerivativeLineItems_4be8f02a-1c2d-4e34-a0f9-004b71145cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_65ee2452-2460-4235-b2e2-ea1735f2c3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4be8f02a-1c2d-4e34-a0f9-004b71145cea" xlink:to="loc_us-gaap_DerivativeNotionalAmount_65ee2452-2460-4235-b2e2-ea1735f2c3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_369c3c88-2ac9-4db7-b892-9df239887910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_369c3c88-2ac9-4db7-b892-9df239887910" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ff9b7cde-6525-4ecb-b7f8-5a5eb0060465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ff9b7cde-6525-4ecb-b7f8-5a5eb0060465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ff9b7cde-6525-4ecb-b7f8-5a5eb0060465" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_26fa1b21-eaa5-4fac-9751-d81162dfe533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_26fa1b21-eaa5-4fac-9751-d81162dfe533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember_0ac064f4-16e4-4052-bc59-7df575344ef1" xlink:href="wst-20221231.xsd#wst_NetSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:to="loc_wst_NetSalesMember_0ac064f4-16e4-4052-bc59-7df575344ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9712bb87-f3a7-4db4-ab42-3e4c0d027935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:to="loc_us-gaap_CostOfSalesMember_9712bb87-f3a7-4db4-ab42-3e4c0d027935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_c5187e05-f831-4e92-9b64-61a1a9b09b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7958f488-42bc-4b0e-8aef-a4b9cab6f028" xlink:to="loc_us-gaap_InterestExpenseMember_c5187e05-f831-4e92-9b64-61a1a9b09b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09cb795a-f342-4deb-877b-a24677098d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09cb795a-f342-4deb-877b-a24677098d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f5c8d9d0-450b-4351-9d31-902e4bf9a5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_09cb795a-f342-4deb-877b-a24677098d18" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f5c8d9d0-450b-4351-9d31-902e4bf9a5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c2ed2004-e8a4-4c43-bd48-a5a0415280e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f5c8d9d0-450b-4351-9d31-902e4bf9a5ff" xlink:to="loc_us-gaap_FairValueHedgingMember_c2ed2004-e8a4-4c43-bd48-a5a0415280e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_77d18d0c-87b3-40bd-b756-1d32754e959e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f5c8d9d0-450b-4351-9d31-902e4bf9a5ff" xlink:to="loc_us-gaap_CashFlowHedgingMember_77d18d0c-87b3-40bd-b756-1d32754e959e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_48e452cb-6e9b-4b1a-8010-713d3715cc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f5c8d9d0-450b-4351-9d31-902e4bf9a5ff" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_48e452cb-6e9b-4b1a-8010-713d3715cc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_83cf23a2-738c-4aaf-b7f9-80ec2e66297f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_83cf23a2-738c-4aaf-b7f9-80ec2e66297f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_83cf23a2-738c-4aaf-b7f9-80ec2e66297f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b417ed4c-dc5c-4dd6-a878-3bcc69243039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b417ed4c-dc5c-4dd6-a878-3bcc69243039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_9b7c0b48-1d2a-47a0-be4f-103c6ad79997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:to="loc_us-gaap_TreasuryLockMember_9b7c0b48-1d2a-47a0-be4f-103c6ad79997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_fef1c703-a9cf-4077-9339-1e1a5ec2e1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:to="loc_us-gaap_CurrencySwapMember_fef1c703-a9cf-4077-9339-1e1a5ec2e1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember_95a2cae9-56e0-447b-93d6-77bde8c7dab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca76c205-2273-48e1-80d8-83bc7d4086c9" xlink:to="loc_us-gaap_CommodityOptionMember_95a2cae9-56e0-447b-93d6-77bde8c7dab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_062c6c04-2adc-407e-aedd-129d55d718b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:to="loc_us-gaap_HedgingDesignationAxis_062c6c04-2adc-407e-aedd-129d55d718b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_250157d7-240a-46ea-aa67-d7f369e62d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_062c6c04-2adc-407e-aedd-129d55d718b8" xlink:to="loc_us-gaap_HedgingDesignationDomain_250157d7-240a-46ea-aa67-d7f369e62d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ed9d6f26-6d71-4aa3-8bb3-17f8b06165dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_250157d7-240a-46ea-aa67-d7f369e62d9d" xlink:to="loc_us-gaap_NondesignatedMember_ed9d6f26-6d71-4aa3-8bb3-17f8b06165dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_34b3a6c6-e929-4df3-9fe6-7593290ed8d1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_d8552a4b-0119-4a66-9844-dbd9084e3679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_d8552a4b-0119-4a66-9844-dbd9084e3679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_4a2e1d42-30de-450e-b9c1-db979e4bfeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_4a2e1d42-30de-450e-b9c1-db979e4bfeb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_23b0a69e-4af3-4cf6-a69f-22be6c0052b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_23b0a69e-4af3-4cf6-a69f-22be6c0052b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_8837d883-a619-439e-9976-34ef9c31ff37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_8837d883-a619-439e-9976-34ef9c31ff37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_9fb61898-163f-47cd-8971-e263b6b394c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_9fb61898-163f-47cd-8971-e263b6b394c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_bf508c32-100c-40c5-9600-b6460dc8700e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_bf508c32-100c-40c5-9600-b6460dc8700e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_62282f46-93cb-4d1f-852a-5b3f25b5f7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_62282f46-93cb-4d1f-852a-5b3f25b5f7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_32c5176d-c8d1-4da5-a963-456c345b99f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_32c5176d-c8d1-4da5-a963-456c345b99f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_7884d4ba-5d3e-40e6-8670-6b2444831e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_7884d4ba-5d3e-40e6-8670-6b2444831e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_366a2b13-0f9f-4b84-8e4f-71413670e690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c77e809f-e970-4520-8148-518b35983330" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_366a2b13-0f9f-4b84-8e4f-71413670e690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ea21dd1c-edd4-4151-93c8-5dab9b5705dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_779a3c24-e02d-4548-b57c-30f060fbeefd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ea21dd1c-edd4-4151-93c8-5dab9b5705dc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_779a3c24-e02d-4548-b57c-30f060fbeefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e3e095af-5918-40b5-bce4-05df4e5893d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_779a3c24-e02d-4548-b57c-30f060fbeefd" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e3e095af-5918-40b5-bce4-05df4e5893d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d43def83-f853-438a-b396-5801d60083a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e3e095af-5918-40b5-bce4-05df4e5893d2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d43def83-f853-438a-b396-5801d60083a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c457a143-7629-481b-b92b-52814d63451f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d43def83-f853-438a-b396-5801d60083a8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c457a143-7629-481b-b92b-52814d63451f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_884ec4a0-8130-4523-99e0-5e272d196e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d43def83-f853-438a-b396-5801d60083a8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_884ec4a0-8130-4523-99e0-5e272d196e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8e1c6a87-c7dc-4f70-ae17-fb69f0838d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d43def83-f853-438a-b396-5801d60083a8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8e1c6a87-c7dc-4f70-ae17-fb69f0838d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2694aa33-ad00-4f3b-b79f-7add86e2f9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_779a3c24-e02d-4548-b57c-30f060fbeefd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2694aa33-ad00-4f3b-b79f-7add86e2f9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00dbe439-75ba-44be-8e45-2a414d802cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2694aa33-ad00-4f3b-b79f-7add86e2f9c8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00dbe439-75ba-44be-8e45-2a414d802cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_52cf50d9-e21d-4d20-b0b1-3066f407b18e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00dbe439-75ba-44be-8e45-2a414d802cc4" xlink:to="loc_us-gaap_CurrencySwapMember_52cf50d9-e21d-4d20-b0b1-3066f407b18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityMember_0f988a78-0199-4905-8897-c3287270597e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00dbe439-75ba-44be-8e45-2a414d802cc4" xlink:to="loc_us-gaap_CommodityMember_0f988a78-0199-4905-8897-c3287270597e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1b0b036f-096b-4448-9d8f-9a7c0217d2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00dbe439-75ba-44be-8e45-2a414d802cc4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1b0b036f-096b-4448-9d8f-9a7c0217d2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9870ee48-73bf-46cc-9c45-d271f5d0e879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_779a3c24-e02d-4548-b57c-30f060fbeefd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9870ee48-73bf-46cc-9c45-d271f5d0e879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9870ee48-73bf-46cc-9c45-d271f5d0e879" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_79111a20-3bc0-498f-99ac-322c018bc777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_79111a20-3bc0-498f-99ac-322c018bc777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_9efe438f-e2a1-4286-b056-5cf16484313d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_9efe438f-e2a1-4286-b056-5cf16484313d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_001282bf-d4b8-468e-8115-3b86f28a40ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:to="loc_us-gaap_DerivativeAssets_001282bf-d4b8-468e-8115-3b86f28a40ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_bb2af9d6-efe9-49f1-952e-13c78c5441c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_da9c7cde-fae3-4c21-b224-19be5c8b6301" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_bb2af9d6-efe9-49f1-952e-13c78c5441c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9870ee48-73bf-46cc-9c45-d271f5d0e879" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_345993dc-65a9-4b66-8141-e36059950728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_345993dc-65a9-4b66-8141-e36059950728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_10db8f27-0cb9-4587-b9d6-f8ab0b773271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:to="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_10db8f27-0cb9-4587-b9d6-f8ab0b773271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_818d1ad7-a293-4466-be75-0a4c5f10ecc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_818d1ad7-a293-4466-be75-0a4c5f10ecc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_9d7bd63c-d186-4782-9a5b-ceb3efbf9ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_059cfb7f-0d9e-493a-b0e3-f52f83d258ec" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_9d7bd63c-d186-4782-9a5b-ceb3efbf9ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#FairValueMeasurementsOtherFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_798cd309-55bd-46ff-bab7-67ff0a0e413a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_b719c64a-ea25-47df-bd2d-0d774bd57aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_798cd309-55bd-46ff-bab7-67ff0a0e413a" xlink:to="loc_us-gaap_LongTermDebtFairValue_b719c64a-ea25-47df-bd2d-0d774bd57aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_dee2645c-2e71-4a91-bd5d-9dc06bc503e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_798cd309-55bd-46ff-bab7-67ff0a0e413a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_dee2645c-2e71-4a91-bd5d-9dc06bc503e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c90ce26c-97be-4091-bd82-4c32b1cfd10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_43575d02-dc9c-459d-87cd-cebc7cfc5838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c90ce26c-97be-4091-bd82-4c32b1cfd10b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_43575d02-dc9c-459d-87cd-cebc7cfc5838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_75633de8-83b0-431f-9234-9b28251f62bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_43575d02-dc9c-459d-87cd-cebc7cfc5838" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_75633de8-83b0-431f-9234-9b28251f62bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_75633de8-83b0-431f-9234-9b28251f62bf" xlink:to="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_20213872-b901-4724-b731-9f316911caaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_20213872-b901-4724-b731-9f316911caaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_f6d4f99f-8698-49e8-bb41-23b0521911ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_f6d4f99f-8698-49e8-bb41-23b0521911ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ac292762-3a90-46b7-9808-b17cd240eab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ac292762-3a90-46b7-9808-b17cd240eab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f44f63ab-7d4b-4c04-a0a8-5e161224831a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f44f63ab-7d4b-4c04-a0a8-5e161224831a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b4a5b445-cad5-46be-a0ba-a39339b3325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4143a80e-82a6-43b1-8f2c-28ae91605ea1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b4a5b445-cad5-46be-a0ba-a39339b3325e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1765280-e85d-4b1b-bac2-6249c6feba1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_43575d02-dc9c-459d-87cd-cebc7cfc5838" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1765280-e85d-4b1b-bac2-6249c6feba1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b1765280-e85d-4b1b-bac2-6249c6feba1f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6497dcc9-e8a0-40cb-9193-77a0461ec5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:to="loc_us-gaap_StockholdersEquity_6497dcc9-e8a0-40cb-9193-77a0461ec5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_d3e1e3de-bdc4-4a85-a8ee-c517a8a25e01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_d3e1e3de-bdc4-4a85-a8ee-c517a8a25e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8d5fc50a-da79-4d02-ad24-989f006401d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8d5fc50a-da79-4d02-ad24-989f006401d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_862fc192-f91a-4275-a6c7-cf1da011dff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_862fc192-f91a-4275-a6c7-cf1da011dff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_23b98619-620f-483f-b24f-7de4d2fcc325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bf195d0b-c2e3-4896-9aff-dcda3d88a3c1" xlink:to="loc_us-gaap_StockholdersEquity_23b98619-620f-483f-b24f-7de4d2fcc325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b6f7e50e-af04-432f-be6a-9ece0de9b3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b6f7e50e-af04-432f-be6a-9ece0de9b3e5" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_919b9ab9-2e06-4559-9fe5-7ac03571cd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_919b9ab9-2e06-4559-9fe5-7ac03571cd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bee59241-00c6-479a-bdf8-613fc41ab854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_919b9ab9-2e06-4559-9fe5-7ac03571cd7a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bee59241-00c6-479a-bdf8-613fc41ab854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_b89cde33-888b-4d61-b89f-cc1290a469b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bee59241-00c6-479a-bdf8-613fc41ab854" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_b89cde33-888b-4d61-b89f-cc1290a469b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_272bdd7d-c33e-4e8d-99a3-f6cfc8f04dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_272bdd7d-c33e-4e8d-99a3-f6cfc8f04dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_99121055-84a9-4327-9d9f-ffc9d42430c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_272bdd7d-c33e-4e8d-99a3-f6cfc8f04dc4" xlink:to="loc_us-gaap_EquityComponentDomain_99121055-84a9-4327-9d9f-ffc9d42430c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f9f98b36-f610-4a61-9cb6-78dd915036e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_99121055-84a9-4327-9d9f-ffc9d42430c7" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f9f98b36-f610-4a61-9cb6-78dd915036e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_64668cf8-995c-4724-bcc3-18f89a957257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_99121055-84a9-4327-9d9f-ffc9d42430c7" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_64668cf8-995c-4724-bcc3-18f89a957257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a54d3583-0374-4a18-a5e0-17bb2f8d35b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a54d3583-0374-4a18-a5e0-17bb2f8d35b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7c9f4486-b0db-4bc0-9a98-d18a3ba344cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a54d3583-0374-4a18-a5e0-17bb2f8d35b9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7c9f4486-b0db-4bc0-9a98-d18a3ba344cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_0a41e504-98b2-4e56-82c2-6c1e0db565a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7c9f4486-b0db-4bc0-9a98-d18a3ba344cd" xlink:to="loc_us-gaap_ForeignExchangeContractMember_0a41e504-98b2-4e56-82c2-6c1e0db565a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_c20682f4-90c4-4d59-a561-5daffa23ddc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7c9f4486-b0db-4bc0-9a98-d18a3ba344cd" xlink:to="loc_us-gaap_TreasuryLockMember_c20682f4-90c4-4d59-a561-5daffa23ddc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b39bb77e-6401-4efb-822d-63bb27dd56f5" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3a89af6-4954-41a6-803d-baeb0352d46e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3a89af6-4954-41a6-803d-baeb0352d46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1f083515-3ca4-4ff5-8cdd-1d6e40b90282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1f083515-3ca4-4ff5-8cdd-1d6e40b90282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_8938d2e5-d79e-4984-a8c7-914e25b7609c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_OtherIncome_8938d2e5-d79e-4984-a8c7-914e25b7609c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_75307cbb-0a08-4529-a2fd-8e79575aaff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_InterestExpense_75307cbb-0a08-4529-a2fd-8e79575aaff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6b8dc802-267a-4077-a42e-492ee4e123f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6b8dc802-267a-4077-a42e-492ee4e123f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_f0539d16-f134-43a7-9f10-0c9aae0a4c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_f0539d16-f134-43a7-9f10-0c9aae0a4c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_d3de4501-1f20-414d-b127-b125ba9d4334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_d3de4501-1f20-414d-b127-b125ba9d4334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_b9b3ccf6-3894-4efb-b939-3c84c7755ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_b9b3ccf6-3894-4efb-b939-3c84c7755ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_33294ed1-49c2-45c7-a6f4-289704a25e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_33294ed1-49c2-45c7-a6f4-289704a25e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a8481333-9370-4fca-a449-f5117576602b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a8481333-9370-4fca-a449-f5117576602b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a8b4b093-7604-4c7f-9c65-43f7b09eecef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bd7b619c-d112-4a64-982b-766257acee35" xlink:to="loc_us-gaap_NetIncomeLoss_a8b4b093-7604-4c7f-9c65-43f7b09eecef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd263439-b9f0-4bc0-a00c-24f8eb21d717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd263439-b9f0-4bc0-a00c-24f8eb21d717" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9ed5a177-5e68-4635-952f-471df70726f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:to="loc_us-gaap_AwardTypeAxis_9ed5a177-5e68-4635-952f-471df70726f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9ed5a177-5e68-4635-952f-471df70726f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_aa388339-b2c7-4f67-8464-1bc19e625d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_us-gaap_EmployeeStockOptionMember_aa388339-b2c7-4f67-8464-1bc19e625d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_ecb492cc-8efa-4872-979b-b835b716d15e" xlink:href="wst-20221231.xsd#wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_ecb492cc-8efa-4872-979b-b835b716d15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_8dcdc7a4-726c-4a34-b706-6b409c3e3b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_8dcdc7a4-726c-4a34-b706-6b409c3e3b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_c383375f-f502-411e-82e1-1284a2e86d20" xlink:href="wst-20221231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_wst_StockSettledPSUAwardsMember_c383375f-f502-411e-82e1-1284a2e86d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_2a08188d-95c6-4100-b448-6a5a1e5407e0" xlink:href="wst-20221231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_2a08188d-95c6-4100-b448-6a5a1e5407e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_73b3730e-2715-4a63-8bca-453960f17c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b02f7dae-edc5-43d9-85d9-8bdcad081267" xlink:to="loc_us-gaap_RestrictedStockMember_73b3730e-2715-4a63-8bca-453960f17c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_a196cca7-34d2-4ae5-baaf-f1529fcacd02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_a196cca7-34d2-4ae5-baaf-f1529fcacd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_465f4691-90db-4223-a3ef-522ab48fdce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_a196cca7-34d2-4ae5-baaf-f1529fcacd02" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_465f4691-90db-4223-a3ef-522ab48fdce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_403a4c13-9091-477f-a642-9ec08c700f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_465f4691-90db-4223-a3ef-522ab48fdce2" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_403a4c13-9091-477f-a642-9ec08c700f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e6234c1f-ccbc-4618-8262-b40eb91c1f99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:to="loc_srt_RangeAxis_e6234c1f-ccbc-4618-8262-b40eb91c1f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a0f7702f-52e2-4830-a828-29c1b4642da0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e6234c1f-ccbc-4618-8262-b40eb91c1f99" xlink:to="loc_srt_RangeMember_a0f7702f-52e2-4830-a828-29c1b4642da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0bbf7cf4-7e03-4bbc-80ff-a16b9e6b4e80" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a0f7702f-52e2-4830-a828-29c1b4642da0" xlink:to="loc_srt_MinimumMember_0bbf7cf4-7e03-4bbc-80ff-a16b9e6b4e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c966eaf8-fea4-4d51-9068-18987db63ef3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a0f7702f-52e2-4830-a828-29c1b4642da0" xlink:to="loc_srt_MaximumMember_c966eaf8-fea4-4d51-9068-18987db63ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_501bb5af-a485-4061-a9cf-7ca4f062e21e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:to="loc_srt_TitleOfIndividualAxis_501bb5af-a485-4061-a9cf-7ca4f062e21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a7d58eb-9456-4e91-8076-97ff173a8afe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_501bb5af-a485-4061-a9cf-7ca4f062e21e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a7d58eb-9456-4e91-8076-97ff173a8afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_1dbabd9d-f762-46db-b50b-476e52e79205" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a7d58eb-9456-4e91-8076-97ff173a8afe" xlink:to="loc_srt_DirectorMember_1dbabd9d-f762-46db-b50b-476e52e79205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af1180da-5d05-49a9-8754-98e95884cbf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_eb24e81b-2787-43cd-a25a-a9c9410b589c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_eb24e81b-2787-43cd-a25a-a9c9410b589c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_62958605-ae28-49f6-bcf8-e568a8bef920" xlink:href="wst-20221231.xsd#wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_62958605-ae28-49f6-bcf8-e568a8bef920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_777ad16e-d324-470d-917e-041717570ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_777ad16e-d324-470d-917e-041717570ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_81162d6e-c9b3-4037-90bf-dbeb66058aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_81162d6e-c9b3-4037-90bf-dbeb66058aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_70f9e032-b657-49a9-a29d-552df42539a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_70f9e032-b657-49a9-a29d-552df42539a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_062f6782-9a3c-4505-bf3d-7961d141325d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_062f6782-9a3c-4505-bf3d-7961d141325d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_5cd43274-aa6c-4878-a8d9-ac76e3769b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_5cd43274-aa6c-4878-a8d9-ac76e3769b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_3df73cc8-a5f8-4263-9614-37274cf1f307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_3df73cc8-a5f8-4263-9614-37274cf1f307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_fe14aa29-f34f-4f73-a070-4cfc6fea4f63" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_fe14aa29-f34f-4f73-a070-4cfc6fea4f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_6021f9f5-db7f-4bf6-a95c-915f978a3d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_6021f9f5-db7f-4bf6-a95c-915f978a3d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_b7c6b38c-f43d-4ff6-b9f7-6e59b50bac6a" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_b7c6b38c-f43d-4ff6-b9f7-6e59b50bac6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_20e4793b-61c6-47a9-8e0a-68594c6d83b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_20e4793b-61c6-47a9-8e0a-68594c6d83b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit_2c76c9e5-0f5d-48a7-9c13-e7dced4a9160" xlink:href="wst-20221231.xsd#wst_DeferredCompensationArrangementWithIndividualConversionUnit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit_2c76c9e5-0f5d-48a7-9c13-e7dced4a9160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_17f1880a-60f4-45ed-ac22-516e327b2e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_17f1880a-60f4-45ed-ac22-516e327b2e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0d87d678-3486-4d42-a5b1-e4cf38abc426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0d87d678-3486-4d42-a5b1-e4cf38abc426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_4c066bfe-205f-45f0-806a-d7ae721743b2" xlink:href="wst-20221231.xsd#wst_DeferredCompensationArrangementWithIndividualNumberOfPlans"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_4c066bfe-205f-45f0-806a-d7ae721743b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_76b06b72-5c31-4a85-92a3-51f3a9aa7c66" xlink:href="wst-20221231.xsd#wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_76b06b72-5c31-4a85-92a3-51f3a9aa7c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredStockUnitsPayableInCash_69b14389-8ede-4ff1-a5ec-4d7ad7218dba" xlink:href="wst-20221231.xsd#wst_DeferredStockUnitsPayableInCash"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_846935fd-2907-4087-b58a-00a489fadffb" xlink:to="loc_wst_DeferredStockUnitsPayableInCash_69b14389-8ede-4ff1-a5ec-4d7ad7218dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1897e4bf-7acc-456d-96b6-9f10c52b9afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95c80cee-249b-4a1e-b787-d777bb7e65aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1897e4bf-7acc-456d-96b6-9f10c52b9afd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95c80cee-249b-4a1e-b787-d777bb7e65aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0aebd705-db50-4f10-bfc0-bbdf708cb1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95c80cee-249b-4a1e-b787-d777bb7e65aa" xlink:to="loc_us-gaap_AwardTypeAxis_0aebd705-db50-4f10-bfc0-bbdf708cb1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0aebd705-db50-4f10-bfc0-bbdf708cb1e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockOptionAndAppreciationRightsMember_3205665c-07cd-4d1a-b5cf-6e73e3c27faf" xlink:href="wst-20221231.xsd#wst_StockOptionAndAppreciationRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_wst_StockOptionAndAppreciationRightsMember_3205665c-07cd-4d1a-b5cf-6e73e3c27faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_880f2258-c39a-4f79-8f56-315ce5e2d97d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_us-gaap_PerformanceSharesMember_880f2258-c39a-4f79-8f56-315ce5e2d97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_2b175825-d416-454b-87ba-40330cdec322" xlink:href="wst-20221231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_wst_CashSettledPSUAwardsMember_2b175825-d416-454b-87ba-40330cdec322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_185d2056-306b-485f-bc14-70ac0eec04bd" xlink:href="wst-20221231.xsd#wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_185d2056-306b-485f-bc14-70ac0eec04bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_9eb6f15a-30d2-412c-9275-8e5d4859fda9" xlink:href="wst-20221231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_9eb6f15a-30d2-412c-9275-8e5d4859fda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_9994d04f-7046-45ac-83ff-b631b1ec5a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8dace87-64f0-4f09-9783-1ae4761222ba" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_9994d04f-7046-45ac-83ff-b631b1ec5a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17be5e38-3f5a-4927-bd26-01ab5d65a92e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95c80cee-249b-4a1e-b787-d777bb7e65aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17be5e38-3f5a-4927-bd26-01ab5d65a92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_23ce6d39-8d16-460c-9eed-81fc0d63f907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17be5e38-3f5a-4927-bd26-01ab5d65a92e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_23ce6d39-8d16-460c-9eed-81fc0d63f907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6fe19b7c-0a7a-4396-be00-a810d045bb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6fe19b7c-0a7a-4396-be00-a810d045bb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f34d177d-1fb5-4fd6-ba56-07fefe86c92b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6fe19b7c-0a7a-4396-be00-a810d045bb8c" xlink:to="loc_us-gaap_AwardTypeAxis_f34d177d-1fb5-4fd6-ba56-07fefe86c92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_baf880ac-82d4-45ae-b7d4-2d6a20987dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f34d177d-1fb5-4fd6-ba56-07fefe86c92b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_baf880ac-82d4-45ae-b7d4-2d6a20987dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1879e548-28ba-4b17-bc02-70ebc9a8410e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_baf880ac-82d4-45ae-b7d4-2d6a20987dcc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1879e548-28ba-4b17-bc02-70ebc9a8410e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6fe19b7c-0a7a-4396-be00-a810d045bb8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_364eb7e4-04b9-42be-a588-7d2432df24eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_364eb7e4-04b9-42be-a588-7d2432df24eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_92e6c7d9-faeb-4825-8707-9f9de7bedeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_92e6c7d9-faeb-4825-8707-9f9de7bedeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_32fd2929-7fb2-4080-87e0-05fdb0a6caeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_32fd2929-7fb2-4080-87e0-05fdb0a6caeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_53119246-0d34-4365-95e7-677e11c9707d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_53119246-0d34-4365-95e7-677e11c9707d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c6d681e7-632b-43de-8ef6-da3d8456498a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cfd4e39b-70f6-4e46-ae28-fd8ad5c21275" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c6d681e7-632b-43de-8ef6-da3d8456498a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3fc6cfe6-4bca-4a76-9e57-270da21b181b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3fc6cfe6-4bca-4a76-9e57-270da21b181b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_eb96afe4-b704-4749-8355-8d22e520f916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_eb96afe4-b704-4749-8355-8d22e520f916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d30217a1-1ecd-4f5a-9970-2d1f130fa8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d30217a1-1ecd-4f5a-9970-2d1f130fa8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_5635f7ea-aef9-4d9b-8326-a8fede6cb5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_5635f7ea-aef9-4d9b-8326-a8fede6cb5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_572b9a44-807a-416e-860c-87dae9889395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_572b9a44-807a-416e-860c-87dae9889395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_308bb590-d6a3-460e-9d4e-eee6acbc336d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_308bb590-d6a3-460e-9d4e-eee6acbc336d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_6194bb2e-06aa-459b-8deb-9c92f868a923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_6194bb2e-06aa-459b-8deb-9c92f868a923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1c4c5d3d-1c03-46fc-9870-6fcd3393e957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1c4c5d3d-1c03-46fc-9870-6fcd3393e957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59d5ee6c-1a91-48b1-a4bf-f2f337c9d211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1c4c5d3d-1c03-46fc-9870-6fcd3393e957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59d5ee6c-1a91-48b1-a4bf-f2f337c9d211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9f2c3312-2e8e-444f-b921-437df05d73f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1c4c5d3d-1c03-46fc-9870-6fcd3393e957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9f2c3312-2e8e-444f-b921-437df05d73f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dffbc333-ff04-42a3-8314-53636be3c0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1c4c5d3d-1c03-46fc-9870-6fcd3393e957" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dffbc333-ff04-42a3-8314-53636be3c0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9ee3607f-7485-4716-934f-42988d44573e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1c4c5d3d-1c03-46fc-9870-6fcd3393e957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9ee3607f-7485-4716-934f-42988d44573e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cbc81f0d-03c0-4506-8937-f95c0fbb0332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1c4c5d3d-1c03-46fc-9870-6fcd3393e957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cbc81f0d-03c0-4506-8937-f95c0fbb0332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_dd66af48-bbaf-4963-8ec0-08cbfe3eee20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_dd66af48-bbaf-4963-8ec0-08cbfe3eee20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f21845c1-5725-4e1f-be98-38e31a811809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f21845c1-5725-4e1f-be98-38e31a811809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3d20c29d-57ef-4157-95cd-fffa18b1ffcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3d20c29d-57ef-4157-95cd-fffa18b1ffcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ea6151a6-db81-4bdb-a2a1-aff6af79c6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3d20c29d-57ef-4157-95cd-fffa18b1ffcc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ea6151a6-db81-4bdb-a2a1-aff6af79c6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_455e6a28-27d5-4ccf-bf67-f16166cae03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3d20c29d-57ef-4157-95cd-fffa18b1ffcc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_455e6a28-27d5-4ccf-bf67-f16166cae03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7e7c3cdb-5d03-4b9c-b914-31e929983260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3d20c29d-57ef-4157-95cd-fffa18b1ffcc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7e7c3cdb-5d03-4b9c-b914-31e929983260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_007fbd2c-f4b1-40de-b4d0-36e5e4b7b4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3d20c29d-57ef-4157-95cd-fffa18b1ffcc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_007fbd2c-f4b1-40de-b4d0-36e5e4b7b4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6fdb6b82-23a1-4092-9601-f2662a95fc38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3d20c29d-57ef-4157-95cd-fffa18b1ffcc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6fdb6b82-23a1-4092-9601-f2662a95fc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_875bebcd-7b19-415a-9d73-5582a89f4b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_875bebcd-7b19-415a-9d73-5582a89f4b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8128a40a-cb54-46ed-9733-a6795560ffa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_835f3edc-064a-4c2b-b969-501cbd1b1956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8128a40a-cb54-46ed-9733-a6795560ffa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationStockAppreciationRightsAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b438ed01-ea04-4fad-b0f6-7467a181a2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a51d1629-5768-4cfb-8544-b2edf9e9cb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b438ed01-ea04-4fad-b0f6-7467a181a2e3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a51d1629-5768-4cfb-8544-b2edf9e9cb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c23d33ee-ee43-4709-a621-fe803d5c87e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a51d1629-5768-4cfb-8544-b2edf9e9cb2a" xlink:to="loc_us-gaap_AwardTypeAxis_c23d33ee-ee43-4709-a621-fe803d5c87e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_df51f9ad-0573-4b26-8938-2619fa644e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c23d33ee-ee43-4709-a621-fe803d5c87e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_df51f9ad-0573-4b26-8938-2619fa644e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_3fe63ee1-d213-4d4b-97f0-f2136b7f2e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_df51f9ad-0573-4b26-8938-2619fa644e83" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_3fe63ee1-d213-4d4b-97f0-f2136b7f2e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a51d1629-5768-4cfb-8544-b2edf9e9cb2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2723fcf0-c2f5-4628-8584-c098a8885751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2723fcf0-c2f5-4628-8584-c098a8885751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_ea3ced4d-677c-4f9f-8fcc-19e769566f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_ea3ced4d-677c-4f9f-8fcc-19e769566f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_fa07a400-11ea-40ad-83d6-fea37aa73154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_fa07a400-11ea-40ad-83d6-fea37aa73154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1da953b9-70ba-4a13-b903-57a5da0749e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1da953b9-70ba-4a13-b903-57a5da0749e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_835b1174-3662-4d7a-8200-f9a437d6fa1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_835b1174-3662-4d7a-8200-f9a437d6fa1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_a2e80a52-87c8-4ef4-9698-7d851750c7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_899255b6-2486-4321-9611-a6264c9fec95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_a2e80a52-87c8-4ef4-9698-7d851750c7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber_292c6b3b-9011-4749-b5da-ab0a1ad2f350" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber_292c6b3b-9011-4749-b5da-ab0a1ad2f350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber_42a78086-2d9a-41d1-b89a-0732dd238b08" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber_42a78086-2d9a-41d1-b89a-0732dd238b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_8a4922d7-bd43-490b-8384-c9dfbd2a398f" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_8a4922d7-bd43-490b-8384-c9dfbd2a398f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_843f55d8-7926-4749-864f-ffe07a64a5c0" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_843f55d8-7926-4749-864f-ffe07a64a5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_37ba1f39-562d-4294-802b-cae28bf1110c" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_37ba1f39-562d-4294-802b-cae28bf1110c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_3e6def2c-4155-49e1-bbfb-23cc4263a194" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_3e6def2c-4155-49e1-bbfb-23cc4263a194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6ed5d02b-f1ba-44ef-8ba7-46bb3d321256" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_44d2a1fa-3daa-4d9e-b3df-10673e7f8533" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6ed5d02b-f1ba-44ef-8ba7-46bb3d321256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice_76f73212-51ad-469a-bbf9-85d551ceade9" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice_76f73212-51ad-469a-bbf9-85d551ceade9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice_95cd27d5-f4a0-4fcb-bebd-26148bb2cc60" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fd653343-e9ba-4e0f-b678-7208dd1a97e7" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice_95cd27d5-f4a0-4fcb-bebd-26148bb2cc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d9c396ba-36a2-4130-8f59-c0dcbae50aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d9c396ba-36a2-4130-8f59-c0dcbae50aa9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a11644a5-35d5-4120-aa6e-3d4d5d4c509b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:to="loc_us-gaap_AwardTypeAxis_a11644a5-35d5-4120-aa6e-3d4d5d4c509b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71c278d7-1779-4b06-af0b-2f1cead84a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a11644a5-35d5-4120-aa6e-3d4d5d4c509b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71c278d7-1779-4b06-af0b-2f1cead84a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_d74d3dea-e9dc-4ee4-87bd-860d5cab026c" xlink:href="wst-20221231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71c278d7-1779-4b06-af0b-2f1cead84a6e" xlink:to="loc_wst_StockSettledPSUAwardsMember_d74d3dea-e9dc-4ee4-87bd-860d5cab026c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_46cd78b0-0093-4a29-a696-9a829b7ebd6a" xlink:href="wst-20221231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71c278d7-1779-4b06-af0b-2f1cead84a6e" xlink:to="loc_wst_CashSettledPSUAwardsMember_46cd78b0-0093-4a29-a696-9a829b7ebd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b3a350a5-e184-48d2-86a4-c7889fff969d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71c278d7-1779-4b06-af0b-2f1cead84a6e" xlink:to="loc_us-gaap_RestrictedStockMember_b3a350a5-e184-48d2-86a4-c7889fff969d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ecd09520-8e9a-44ae-83e7-cc6f0b0e4d8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:to="loc_srt_RangeAxis_ecd09520-8e9a-44ae-83e7-cc6f0b0e4d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_74a80c85-6155-4837-82ed-f01a9934c2f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ecd09520-8e9a-44ae-83e7-cc6f0b0e4d8f" xlink:to="loc_srt_RangeMember_74a80c85-6155-4837-82ed-f01a9934c2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_39774969-694f-4294-8f2c-a396bd647b22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_74a80c85-6155-4837-82ed-f01a9934c2f0" xlink:to="loc_srt_MinimumMember_39774969-694f-4294-8f2c-a396bd647b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d499f2ff-cbc1-4582-9bc6-cfabab30492b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_74a80c85-6155-4837-82ed-f01a9934c2f0" xlink:to="loc_srt_MaximumMember_d499f2ff-cbc1-4582-9bc6-cfabab30492b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_7ba60958-2d4a-4db2-b5e4-8c36db120824" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:to="loc_srt_TitleOfIndividualAxis_7ba60958-2d4a-4db2-b5e4-8c36db120824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3b71dbd3-eb6a-471a-8637-7a8e75767ef2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_7ba60958-2d4a-4db2-b5e4-8c36db120824" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3b71dbd3-eb6a-471a-8637-7a8e75767ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_43d0e9b1-2b73-4333-a4fd-b790d4bb7a6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3b71dbd3-eb6a-471a-8637-7a8e75767ef2" xlink:to="loc_srt_DirectorMember_43d0e9b1-2b73-4333-a4fd-b790d4bb7a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_5e3560bf-d670-4f59-b640-4cee10902275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_5e3560bf-d670-4f59-b640-4cee10902275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_ba2241fa-eda4-43c8-965b-0aed90748718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_5e3560bf-d670-4f59-b640-4cee10902275" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_ba2241fa-eda4-43c8-965b-0aed90748718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_4e13072e-bf62-4105-93af-433f89217f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_ba2241fa-eda4-43c8-965b-0aed90748718" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_4e13072e-bf62-4105-93af-433f89217f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f00b09b5-a0a6-4364-a8f0-fc5395124d21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_d2061124-3fab-4fe7-a079-d2c938d3d3b6" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_d2061124-3fab-4fe7-a079-d2c938d3d3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_b70136f7-6719-4a31-81f9-6980597cfb13" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_b70136f7-6719-4a31-81f9-6980597cfb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_10dae595-57dd-4075-8cd6-488aa211fc97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_10dae595-57dd-4075-8cd6-488aa211fc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30251c39-e04f-40aa-a772-a0ab1fd6fd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30251c39-e04f-40aa-a772-a0ab1fd6fd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c39b1eca-2bcf-4789-a70f-ce32cd250c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c39b1eca-2bcf-4789-a70f-ce32cd250c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_0e6839e2-86b5-404b-bbf0-4eb3f9af031b" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_0e6839e2-86b5-404b-bbf0-4eb3f9af031b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e754a9dc-023d-41de-8358-03007ca2b1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e754a9dc-023d-41de-8358-03007ca2b1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5286fbc7-b196-47cd-9103-8078c1cd86a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5286fbc7-b196-47cd-9103-8078c1cd86a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_70f8112a-e08b-4203-ac2e-7a6c1434640f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_45722499-5f7c-4222-aae2-0d2f5bfced58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_70f8112a-e08b-4203-ac2e-7a6c1434640f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98dceb7c-659e-4fed-9d82-85e26c09adbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b484dc42-f2cf-48b6-b1f9-80c456a95d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b484dc42-f2cf-48b6-b1f9-80c456a95d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_332cafad-e0db-4d1a-a4de-7f56bcf32538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_332cafad-e0db-4d1a-a4de-7f56bcf32538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_8ffa42a2-75c8-4899-ac91-ed09c0d06c0f" xlink:href="wst-20221231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_8ffa42a2-75c8-4899-ac91-ed09c0d06c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ec4f381c-f16e-4222-aff8-e0d9af229e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ec4f381c-f16e-4222-aff8-e0d9af229e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6b6d9151-0ae7-474e-b4f0-a05ea08ede41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6b6d9151-0ae7-474e-b4f0-a05ea08ede41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_878a31b7-5f46-4c99-9ced-f5b57842ad95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6d914487-da6f-4054-b8f1-936d12786374" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_878a31b7-5f46-4c99-9ced-f5b57842ad95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3e9d4654-ba22-4687-8d6b-99ef3ae4308a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_64a3769a-4152-449b-836e-115c7168418a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3e9d4654-ba22-4687-8d6b-99ef3ae4308a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_64a3769a-4152-449b-836e-115c7168418a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_3bad1afc-b875-46aa-b030-6cd03fe822c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_64a3769a-4152-449b-836e-115c7168418a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_3bad1afc-b875-46aa-b030-6cd03fe822c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f9b6ec1b-e261-4533-9bc5-2eb755a6077f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3bad1afc-b875-46aa-b030-6cd03fe822c2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f9b6ec1b-e261-4533-9bc5-2eb755a6077f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_479a5228-137d-40f3-9021-7e2f6f2d4505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f9b6ec1b-e261-4533-9bc5-2eb755a6077f" xlink:to="loc_us-gaap_DomesticPlanMember_479a5228-137d-40f3-9021-7e2f6f2d4505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1abd0f1c-aa74-4117-b0c3-2b67948ca30d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_479a5228-137d-40f3-9021-7e2f6f2d4505" xlink:to="loc_country_US_1abd0f1c-aa74-4117-b0c3-2b67948ca30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_8864c5b5-42ca-4146-8740-1169dcde7455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f9b6ec1b-e261-4533-9bc5-2eb755a6077f" xlink:to="loc_us-gaap_ForeignPlanMember_8864c5b5-42ca-4146-8740-1169dcde7455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_82bbae80-6b78-4579-8534-a8673856af8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_64a3769a-4152-449b-836e-115c7168418a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_82bbae80-6b78-4579-8534-a8673856af8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_10ccfada-237c-4fdd-aead-4da6ca83d3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_82bbae80-6b78-4579-8534-a8673856af8f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_10ccfada-237c-4fdd-aead-4da6ca83d3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9c8fe8af-0fe4-42c7-8a43-e391344dbeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_10ccfada-237c-4fdd-aead-4da6ca83d3ee" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9c8fe8af-0fe4-42c7-8a43-e391344dbeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_47aad40e-fb00-413b-81f1-f4ec1a388644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_10ccfada-237c-4fdd-aead-4da6ca83d3ee" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_47aad40e-fb00-413b-81f1-f4ec1a388644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_64a3769a-4152-449b-836e-115c7168418a" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_514f358d-0529-410e-87a5-0651d1c6068c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_514f358d-0529-410e-87a5-0651d1c6068c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_2f26551f-e44f-4860-bcac-59d3b9b462bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_2f26551f-e44f-4860-bcac-59d3b9b462bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_1555e2e8-077f-43b5-9f62-50fc674f199b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_1555e2e8-077f-43b5-9f62-50fc674f199b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_1f731539-7110-400c-bea0-b8dbba2a5b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_1f731539-7110-400c-bea0-b8dbba2a5b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a2bb1f32-d0df-4351-9d72-437a9b510457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a2bb1f32-d0df-4351-9d72-437a9b510457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_4d743681-70f8-4193-baf4-634b75cde372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_4d743681-70f8-4193-baf4-634b75cde372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_c83d5979-ac03-4dbe-9bfd-fccf8253b723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_c83d5979-ac03-4dbe-9bfd-fccf8253b723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_16fcc818-f36e-41ad-8ab2-2d2d5296b23e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_16fcc818-f36e-41ad-8ab2-2d2d5296b23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0cb4e15d-8b32-418d-b00f-c9badcbc2d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0cb4e15d-8b32-418d-b00f-c9badcbc2d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d7826ba0-4646-4de5-915c-b8c105eec2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d7826ba0-4646-4de5-915c-b8c105eec2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_6b9bf79b-8546-479c-a29f-7911c97f1168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_6b9bf79b-8546-479c-a29f-7911c97f1168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_0c48552a-0a55-4895-b138-7c1dd3b622b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_0c48552a-0a55-4895-b138-7c1dd3b622b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_d11b6d41-4dce-46da-a788-14ff11969d68" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_d11b6d41-4dce-46da-a788-14ff11969d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_8ea42fff-4c6e-4cbb-bef4-03f8be1a971e" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9ff57bec-52e6-434c-97b1-ea16a09a7ac2" xlink:to="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_8ea42fff-4c6e-4cbb-bef4-03f8be1a971e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b24ee710-9249-4575-bb41-b78207cc7dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e4db2740-13af-45c9-beb9-51342e18d90b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b24ee710-9249-4575-bb41-b78207cc7dbf" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e4db2740-13af-45c9-beb9-51342e18d90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a84a4685-2d0b-4b83-8cc7-c8bc639dd426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e4db2740-13af-45c9-beb9-51342e18d90b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a84a4685-2d0b-4b83-8cc7-c8bc639dd426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b42982b0-7e05-42ac-8658-3aa3d5392fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a84a4685-2d0b-4b83-8cc7-c8bc639dd426" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b42982b0-7e05-42ac-8658-3aa3d5392fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7e3832e5-123f-437d-afbb-ee62a0f6eabe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b42982b0-7e05-42ac-8658-3aa3d5392fd3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7e3832e5-123f-437d-afbb-ee62a0f6eabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e067fbc3-d030-4f65-9de0-4de66348701c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b42982b0-7e05-42ac-8658-3aa3d5392fd3" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e067fbc3-d030-4f65-9de0-4de66348701c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_ebcbf54c-ccf4-45c2-a868-6472b060154e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e4db2740-13af-45c9-beb9-51342e18d90b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_ebcbf54c-ccf4-45c2-a868-6472b060154e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_36ac43b3-f888-4f53-80b6-f6beb8e463d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ebcbf54c-ccf4-45c2-a868-6472b060154e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_36ac43b3-f888-4f53-80b6-f6beb8e463d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_cd7f168e-21e6-439a-8d9c-3efdba73d5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_36ac43b3-f888-4f53-80b6-f6beb8e463d4" xlink:to="loc_us-gaap_DomesticPlanMember_cd7f168e-21e6-439a-8d9c-3efdba73d5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8b98e042-a418-441f-96e3-781de4ff7243" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_cd7f168e-21e6-439a-8d9c-3efdba73d5b8" xlink:to="loc_country_US_8b98e042-a418-441f-96e3-781de4ff7243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_e1e5bc21-66f5-43c4-8b81-d6da6d2e6228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_36ac43b3-f888-4f53-80b6-f6beb8e463d4" xlink:to="loc_us-gaap_ForeignPlanMember_e1e5bc21-66f5-43c4-8b81-d6da6d2e6228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_085bc4b7-8c68-4f9f-b9d4-526d5c287576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e4db2740-13af-45c9-beb9-51342e18d90b" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_085bc4b7-8c68-4f9f-b9d4-526d5c287576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_085bc4b7-8c68-4f9f-b9d4-526d5c287576" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_5e97461e-dfbc-4d7a-95f9-5182b2bca403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_5e97461e-dfbc-4d7a-95f9-5182b2bca403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_5b7e50c0-5e32-481e-ab0b-efd41387bfed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_5b7e50c0-5e32-481e-ab0b-efd41387bfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5a3d8f66-a40f-487a-8508-3c8acae94963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5a3d8f66-a40f-487a-8508-3c8acae94963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_650edfcd-5088-4d3d-ae46-58a657cd56f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_650edfcd-5088-4d3d-ae46-58a657cd56f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_70017b39-025c-4b64-9291-8a9c7fe09515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_70017b39-025c-4b64-9291-8a9c7fe09515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_deba4e9c-573c-4836-9e14-44fcbf7e2bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_deba4e9c-573c-4836-9e14-44fcbf7e2bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_54cda807-3bd3-4f44-bf05-b3636d8885e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_54cda807-3bd3-4f44-bf05-b3636d8885e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f565960b-6720-4f2c-a6d3-feb0763f0eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_42525929-81be-4e74-a489-41740ab554bb" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f565960b-6720-4f2c-a6d3-feb0763f0eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_085bc4b7-8c68-4f9f-b9d4-526d5c287576" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_57489ab7-900e-4d4f-8fb5-b4572414af82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_57489ab7-900e-4d4f-8fb5-b4572414af82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_62a756b5-1098-44c2-b488-c8c391a962f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_62a756b5-1098-44c2-b488-c8c391a962f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_55eebf6b-5c1b-45fa-a081-d94532d78039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_55eebf6b-5c1b-45fa-a081-d94532d78039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_fd3afda4-3617-46d9-b2c2-aa309ace3bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_fd3afda4-3617-46d9-b2c2-aa309ace3bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_c052a7b9-3370-4099-953a-39e28ed3b5ab" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_c052a7b9-3370-4099-953a-39e28ed3b5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_f675ab16-6890-4dc2-9aa6-2c6087353038" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_f675ab16-6890-4dc2-9aa6-2c6087353038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax_6979ae8f-d993-45b2-8436-8b55003ac053" xlink:href="wst-20221231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax_6979ae8f-d993-45b2-8436-8b55003ac053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f0f8fb14-1576-40a6-87ca-0e38a001e749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_bcfd138f-aae0-432e-b949-03b3ddb2eb78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f0f8fb14-1576-40a6-87ca-0e38a001e749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_fe7805cc-f5c5-48ff-bc02-afac6104b63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_085bc4b7-8c68-4f9f-b9d4-526d5c287576" xlink:to="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_fe7805cc-f5c5-48ff-bc02-afac6104b63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f6fa9452-9f04-4d07-9e0b-d51b88bc8d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_dcbc4f6a-7269-447e-b226-000bc7004e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f6fa9452-9f04-4d07-9e0b-d51b88bc8d53" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_dcbc4f6a-7269-447e-b226-000bc7004e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0db08ba0-6698-4af0-9b07-27c194f882c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_dcbc4f6a-7269-447e-b226-000bc7004e6e" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0db08ba0-6698-4af0-9b07-27c194f882c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f0cf327a-299c-42f9-bf27-8524e790c378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0db08ba0-6698-4af0-9b07-27c194f882c2" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f0cf327a-299c-42f9-bf27-8524e790c378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8c09b736-f693-4074-a69a-2d0214d87be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f0cf327a-299c-42f9-bf27-8524e790c378" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8c09b736-f693-4074-a69a-2d0214d87be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_bdb0b8f0-4933-4e46-b03a-a3f5fce47ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f0cf327a-299c-42f9-bf27-8524e790c378" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_bdb0b8f0-4933-4e46-b03a-a3f5fce47ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_088ff525-385a-4c71-b53a-cc59f478455b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_dcbc4f6a-7269-447e-b226-000bc7004e6e" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_088ff525-385a-4c71-b53a-cc59f478455b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_088ff525-385a-4c71-b53a-cc59f478455b" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f5e0eb26-467b-47a7-b4ed-5042e6e38bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f5e0eb26-467b-47a7-b4ed-5042e6e38bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_13103ade-d4a0-4b4c-afd1-2d749ecf7fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_13103ade-d4a0-4b4c-afd1-2d749ecf7fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_e0954c29-5780-4913-b79d-6824d209e565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_e0954c29-5780-4913-b79d-6824d209e565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_33ed0cb3-0406-4992-95a6-4318c712f1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_33ed0cb3-0406-4992-95a6-4318c712f1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_656e5c80-c59e-4978-a75e-2b38e66d3ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_656e5c80-c59e-4978-a75e-2b38e66d3ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_98567cb0-e791-40a3-96bd-1607b41a6bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_98567cb0-e791-40a3-96bd-1607b41a6bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c1caa277-f4b9-4989-a5a1-134b464a812c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c1caa277-f4b9-4989-a5a1-134b464a812c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_8d74ba5e-5330-4135-a6de-794e1072b03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_8d74ba5e-5330-4135-a6de-794e1072b03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_4205eaae-7764-4fd3-a06b-207ef366604e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_4205eaae-7764-4fd3-a06b-207ef366604e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7162e7aa-24c3-47df-94f0-6d5773a4246a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f8edb01d-1398-4b2b-9c25-41ebf73359bf" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7162e7aa-24c3-47df-94f0-6d5773a4246a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_088ff525-385a-4c71-b53a-cc59f478455b" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_51b706e1-07c6-4940-b457-4b841cbdf33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_51b706e1-07c6-4940-b457-4b841cbdf33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_f8f6a693-45ae-4cf5-a83d-0228b57ea218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_f8f6a693-45ae-4cf5-a83d-0228b57ea218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_17c6f6f2-39a5-4e22-ac88-80d976e42f60" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_17c6f6f2-39a5-4e22-ac88-80d976e42f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_03d34a99-615a-4973-838d-9622f6742e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_03d34a99-615a-4973-838d-9622f6742e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_a1513f7b-e1fe-4718-a527-e1ca3b0020e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_a1513f7b-e1fe-4718-a527-e1ca3b0020e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3260d2fd-d14d-4104-8b34-60c6b4f8dd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3260d2fd-d14d-4104-8b34-60c6b4f8dd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_ab1ee012-6b75-4b31-a537-9fb51fb1cd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_ab1ee012-6b75-4b31-a537-9fb51fb1cd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e50b6e1d-79f2-4aa8-8a99-444fdcc54abc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a5c0f03-f695-4cb2-ba88-3b063449caf5" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e50b6e1d-79f2-4aa8-8a99-444fdcc54abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_f3874b6d-ba10-4698-a649-c5b0100f82e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_088ff525-385a-4c71-b53a-cc59f478455b" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_f3874b6d-ba10-4698-a649-c5b0100f82e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansAmountsRecognizedinBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0d996aaa-f468-4235-9661-41e351f06d37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_64e4b51c-df7c-4bdc-af12-5ef3dddc2c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0d996aaa-f468-4235-9661-41e351f06d37" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_64e4b51c-df7c-4bdc-af12-5ef3dddc2c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_6e639771-87a1-495d-92b0-f4a1ed63eb41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_64e4b51c-df7c-4bdc-af12-5ef3dddc2c03" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_6e639771-87a1-495d-92b0-f4a1ed63eb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cac11901-17c7-4d0d-b221-eb336e2aae43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6e639771-87a1-495d-92b0-f4a1ed63eb41" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cac11901-17c7-4d0d-b221-eb336e2aae43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_99561d08-eedd-42b0-a314-df3ea3e9bf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cac11901-17c7-4d0d-b221-eb336e2aae43" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_99561d08-eedd-42b0-a314-df3ea3e9bf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b634f24c-f7ab-4cf8-ba75-809203029f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cac11901-17c7-4d0d-b221-eb336e2aae43" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b634f24c-f7ab-4cf8-ba75-809203029f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_64e4b51c-df7c-4bdc-af12-5ef3dddc2c03" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent_adf624ab-1f31-486d-bb66-90f27eee101f" xlink:href="wst-20221231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:to="loc_wst_AssetsDefinedBenefitPlansNoncurrent_adf624ab-1f31-486d-bb66-90f27eee101f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_c0b00ccf-1fdd-4c0d-b38a-029de83f504d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_c0b00ccf-1fdd-4c0d-b38a-029de83f504d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f4f306ed-af6b-4113-b05a-f4f464f8e6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f4f306ed-af6b-4113-b05a-f4f464f8e6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_1490756b-1c3f-4462-a02a-a47e3b520f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a3fb1d3d-612c-4df7-a851-d4c611824713" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_1490756b-1c3f-4462-a02a-a47e3b520f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ab3c7b67-7dc5-4b46-b402-d1fea826c185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e9e6efc2-d037-4b58-85b8-83b03482a9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ab3c7b67-7dc5-4b46-b402-d1fea826c185" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e9e6efc2-d037-4b58-85b8-83b03482a9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_538461b4-357b-44d0-8603-28854903c78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e9e6efc2-d037-4b58-85b8-83b03482a9ce" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_538461b4-357b-44d0-8603-28854903c78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2cec0312-fb0c-44e2-a289-7a591dcd1e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_538461b4-357b-44d0-8603-28854903c78a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2cec0312-fb0c-44e2-a289-7a591dcd1e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_c0081672-ee2e-47d7-8a0e-3a4d54a0e9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2cec0312-fb0c-44e2-a289-7a591dcd1e87" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_c0081672-ee2e-47d7-8a0e-3a4d54a0e9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_c589531e-3b8b-49c8-9a8f-4eeacca2b0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2cec0312-fb0c-44e2-a289-7a591dcd1e87" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_c589531e-3b8b-49c8-9a8f-4eeacca2b0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fa7759bb-e6eb-4a7d-9b38-05d968fc5ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e9e6efc2-d037-4b58-85b8-83b03482a9ce" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fa7759bb-e6eb-4a7d-9b38-05d968fc5ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4e98748f-35d2-4fc7-9d4c-c468fc7629cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fa7759bb-e6eb-4a7d-9b38-05d968fc5ae6" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4e98748f-35d2-4fc7-9d4c-c468fc7629cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_4e4a3867-ea5f-444e-80b8-fe7f0f87f867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fa7759bb-e6eb-4a7d-9b38-05d968fc5ae6" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_4e4a3867-ea5f-444e-80b8-fe7f0f87f867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_d96c55a3-5811-4ed6-b665-3882641cd0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fa7759bb-e6eb-4a7d-9b38-05d968fc5ae6" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_d96c55a3-5811-4ed6-b665-3882641cd0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansExpectedBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b83842a8-6a56-4da0-9dec-ae2082082a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_cdd7a627-2d7f-4bc3-b34a-c0b663ebac38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b83842a8-6a56-4da0-9dec-ae2082082a7a" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_cdd7a627-2d7f-4bc3-b34a-c0b663ebac38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_adaa8df8-c87a-4a7d-965c-b5b3395113a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_cdd7a627-2d7f-4bc3-b34a-c0b663ebac38" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_adaa8df8-c87a-4a7d-965c-b5b3395113a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_77625ba4-be4e-4e4f-8810-70473b2eb965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_adaa8df8-c87a-4a7d-965c-b5b3395113a3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_77625ba4-be4e-4e4f-8810-70473b2eb965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_332880b6-63f4-49f6-a434-d0316003efbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_77625ba4-be4e-4e4f-8810-70473b2eb965" xlink:to="loc_us-gaap_DomesticPlanMember_332880b6-63f4-49f6-a434-d0316003efbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_80d82e28-6a69-4575-be06-10a37e6ee97a" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_332880b6-63f4-49f6-a434-d0316003efbe" xlink:to="loc_country_US_80d82e28-6a69-4575-be06-10a37e6ee97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_11a28b43-a218-48f0-9334-d177b02463b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_77625ba4-be4e-4e4f-8810-70473b2eb965" xlink:to="loc_us-gaap_ForeignPlanMember_11a28b43-a218-48f0-9334-d177b02463b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_cdd7a627-2d7f-4bc3-b34a-c0b663ebac38" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_f5345acf-b3db-46da-a9d3-2311fde2d0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_f5345acf-b3db-46da-a9d3-2311fde2d0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_0ecf9955-e230-4441-89aa-51d545254ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_0ecf9955-e230-4441-89aa-51d545254ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f751443a-1fe0-4607-bfa5-f0cbad2fc288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f751443a-1fe0-4607-bfa5-f0cbad2fc288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_b5b4a9f8-616a-4e7c-b5a4-bd64e43a0e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_b5b4a9f8-616a-4e7c-b5a4-bd64e43a0e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_890e90a1-50a6-4bfc-9947-6a8500bf2e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_890e90a1-50a6-4bfc-9947-6a8500bf2e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_f6f71604-d249-4bbe-99a9-11af5168922a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_f6f71604-d249-4bbe-99a9-11af5168922a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_32bd07f5-d1df-4a1e-9a55-806921053b1e" xlink:href="wst-20221231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ea023b43-f645-4d0f-a1d5-d27a846bc5e9" xlink:to="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_32bd07f5-d1df-4a1e-9a55-806921053b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a99ba496-ca9f-4ffc-880d-35b40cf30b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ea24567f-16f7-4e4e-ab90-0729c8f21a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a99ba496-ca9f-4ffc-880d-35b40cf30b41" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ea24567f-16f7-4e4e-ab90-0729c8f21a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_003ea7a1-0fa9-4224-a72c-c1603efdcec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ea24567f-16f7-4e4e-ab90-0729c8f21a3f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_003ea7a1-0fa9-4224-a72c-c1603efdcec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6fc8c171-b5f9-4cf2-9ba7-9c8756ef5dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_003ea7a1-0fa9-4224-a72c-c1603efdcec3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6fc8c171-b5f9-4cf2-9ba7-9c8756ef5dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8d223f95-ced5-4d60-b739-e11bd463029a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6fc8c171-b5f9-4cf2-9ba7-9c8756ef5dc9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8d223f95-ced5-4d60-b739-e11bd463029a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8599790c-73b4-4373-83c7-11f622ecb0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6fc8c171-b5f9-4cf2-9ba7-9c8756ef5dc9" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8599790c-73b4-4373-83c7-11f622ecb0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9ffa7a03-dc50-4be1-9038-99bb9e72c2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ea24567f-16f7-4e4e-ab90-0729c8f21a3f" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9ffa7a03-dc50-4be1-9038-99bb9e72c2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_786285fa-0543-4dc7-af89-2935795768e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9ffa7a03-dc50-4be1-9038-99bb9e72c2a6" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_786285fa-0543-4dc7-af89-2935795768e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_413ce44d-fb20-441b-ab01-bdd810183df1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_786285fa-0543-4dc7-af89-2935795768e6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_413ce44d-fb20-441b-ab01-bdd810183df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_3862b9db-a956-4eab-9d38-2ea2a0c6f7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_786285fa-0543-4dc7-af89-2935795768e6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_3862b9db-a956-4eab-9d38-2ea2a0c6f7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_ba93582e-1c5b-4db6-888e-d625b5f5cc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_786285fa-0543-4dc7-af89-2935795768e6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_ba93582e-1c5b-4db6-888e-d625b5f5cc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_8282333e-b7b9-4730-afca-309ef45a51d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9ffa7a03-dc50-4be1-9038-99bb9e72c2a6" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_8282333e-b7b9-4730-afca-309ef45a51d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a2dfc3e0-d1a9-4638-bc22-955909088c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_8282333e-b7b9-4730-afca-309ef45a51d6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a2dfc3e0-d1a9-4638-bc22-955909088c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_34a0f493-d0b9-4ddf-b280-73d1fd58476f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_8282333e-b7b9-4730-afca-309ef45a51d6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_34a0f493-d0b9-4ddf-b280-73d1fd58476f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4f006c53-3772-4e44-b64b-b56abdb1791a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bde9ff48-85c9-49e4-9b95-be71ce49859d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4f006c53-3772-4e44-b64b-b56abdb1791a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bde9ff48-85c9-49e4-9b95-be71ce49859d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_665a969d-26f1-472d-ab77-2330a1c85541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bde9ff48-85c9-49e4-9b95-be71ce49859d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_665a969d-26f1-472d-ab77-2330a1c85541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0cacc123-6d68-49c8-8a9c-5197e3507fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_665a969d-26f1-472d-ab77-2330a1c85541" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0cacc123-6d68-49c8-8a9c-5197e3507fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_97a13bde-2d86-4bd6-a47d-447b0b26ac41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0cacc123-6d68-49c8-8a9c-5197e3507fad" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_97a13bde-2d86-4bd6-a47d-447b0b26ac41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_7c8d1160-4ff1-4180-9a51-7ffa077c2549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bde9ff48-85c9-49e4-9b95-be71ce49859d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_7c8d1160-4ff1-4180-9a51-7ffa077c2549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_5fd2a47e-be6b-410c-b142-9c063e6b82c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_7c8d1160-4ff1-4180-9a51-7ffa077c2549" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_5fd2a47e-be6b-410c-b142-9c063e6b82c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_c92263c1-c876-47a1-a380-c81447e4de13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5fd2a47e-be6b-410c-b142-9c063e6b82c5" xlink:to="loc_us-gaap_DomesticPlanMember_c92263c1-c876-47a1-a380-c81447e4de13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_01d48467-7285-4d2e-a04c-511137c0b007" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_c92263c1-c876-47a1-a380-c81447e4de13" xlink:to="loc_country_US_01d48467-7285-4d2e-a04c-511137c0b007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_088f1efa-8201-4405-8084-8dd9f848e144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5fd2a47e-be6b-410c-b142-9c063e6b82c5" xlink:to="loc_us-gaap_ForeignPlanMember_088f1efa-8201-4405-8084-8dd9f848e144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_83051640-881d-42cc-b425-5caa74b3a48f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bde9ff48-85c9-49e4-9b95-be71ce49859d" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_83051640-881d-42cc-b425-5caa74b3a48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_d34dfbd4-e5b1-4220-ae57-433e45514fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_83051640-881d-42cc-b425-5caa74b3a48f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_d34dfbd4-e5b1-4220-ae57-433e45514fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#BenefitPlansAllocationofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a070e221-253f-4967-91b7-32d9d1973026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a070e221-253f-4967-91b7-32d9d1973026" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3b399f6b-44a6-4490-9495-21ed2e9b9e52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:to="loc_srt_RangeAxis_3b399f6b-44a6-4490-9495-21ed2e9b9e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0b352f4c-7e62-4497-8ba7-f946903e705a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3b399f6b-44a6-4490-9495-21ed2e9b9e52" xlink:to="loc_srt_RangeMember_0b352f4c-7e62-4497-8ba7-f946903e705a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6813309c-9b7c-455c-81ad-2937554d0b78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0b352f4c-7e62-4497-8ba7-f946903e705a" xlink:to="loc_srt_MinimumMember_6813309c-9b7c-455c-81ad-2937554d0b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_04af34d7-5b76-4765-919d-8c9b50fb178f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0b352f4c-7e62-4497-8ba7-f946903e705a" xlink:to="loc_srt_MaximumMember_04af34d7-5b76-4765-919d-8c9b50fb178f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8bdbdc04-5df4-4bde-b943-99badaddf714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8bdbdc04-5df4-4bde-b943-99badaddf714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8bdbdc04-5df4-4bde-b943-99badaddf714" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember_4670eebd-2380-4e95-b331-16aa37a24af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_us-gaap_DefinedBenefitPlanCashMember_4670eebd-2380-4e95-b331-16aa37a24af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_aa9fc15f-e70c-4987-aa99-e933bbd7b52c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_aa9fc15f-e70c-4987-aa99-e933bbd7b52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_02ec84d4-4e09-4fa0-a48d-bbd1877778cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_02ec84d4-4e09-4fa0-a48d-bbd1877778cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_427fdf9e-56ef-4e3b-8765-2ee2e4e75260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_us-gaap_OtherInvestmentsMember_427fdf9e-56ef-4e3b-8765-2ee2e4e75260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_12b4abfb-5a38-4c01-99b0-f60b360da9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_us-gaap_MutualFundMember_12b4abfb-5a38-4c01-99b0-f60b360da9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherMutualFundsMember_a4a3aa23-2748-43c5-82f2-5d788e1827dd" xlink:href="wst-20221231.xsd#wst_OtherMutualFundsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_89a6bda6-caa3-4fc5-b7c9-d93c5456db95" xlink:to="loc_wst_OtherMutualFundsMember_a4a3aa23-2748-43c5-82f2-5d788e1827dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8522664b-781d-486b-b706-9ec68ee8a318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8522664b-781d-486b-b706-9ec68ee8a318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f10124d1-e1df-454a-8366-323954c38fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8522664b-781d-486b-b706-9ec68ee8a318" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f10124d1-e1df-454a-8366-323954c38fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_733f48a5-fd03-4e1a-85a2-1cd1d4edbcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f10124d1-e1df-454a-8366-323954c38fed" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_733f48a5-fd03-4e1a-85a2-1cd1d4edbcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_94ab58f1-277f-4700-aacb-cb45e51e8674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_733f48a5-fd03-4e1a-85a2-1cd1d4edbcc9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_94ab58f1-277f-4700-aacb-cb45e51e8674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_caf7b064-1bfb-4b95-8fb5-5424782338e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_733f48a5-fd03-4e1a-85a2-1cd1d4edbcc9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_caf7b064-1bfb-4b95-8fb5-5424782338e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5bd4360a-0a4e-4434-8d60-c2a65b5e75bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_733f48a5-fd03-4e1a-85a2-1cd1d4edbcc9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5bd4360a-0a4e-4434-8d60-c2a65b5e75bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_1849e22e-11b5-42bb-b824-01c9ab21f64a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f10124d1-e1df-454a-8366-323954c38fed" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_1849e22e-11b5-42bb-b824-01c9ab21f64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_fde29c12-2606-4f2a-a7dd-ec1eb4f3f0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_fde29c12-2606-4f2a-a7dd-ec1eb4f3f0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_52e08510-80e5-4805-8251-1747ede42d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_fde29c12-2606-4f2a-a7dd-ec1eb4f3f0c1" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_52e08510-80e5-4805-8251-1747ede42d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_86cdea22-920f-4fc1-b1bf-bc707e82d2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_52e08510-80e5-4805-8251-1747ede42d85" xlink:to="loc_us-gaap_DomesticPlanMember_86cdea22-920f-4fc1-b1bf-bc707e82d2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eedacbef-0837-43b1-bc70-60f070b9114b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_86cdea22-920f-4fc1-b1bf-bc707e82d2a6" xlink:to="loc_country_US_eedacbef-0837-43b1-bc70-60f070b9114b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5754e407-cef3-471b-a3ad-b751278ee772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_755ad4b6-996c-4b38-965e-c7223d96d7f5" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5754e407-cef3-471b-a3ad-b751278ee772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_e091858e-a18e-4581-ac46-b068fd1f2e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5754e407-cef3-471b-a3ad-b751278ee772" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_e091858e-a18e-4581-ac46-b068fd1f2e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_8d36e7db-4f90-4db4-9ffd-76a0682cb67d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5754e407-cef3-471b-a3ad-b751278ee772" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_8d36e7db-4f90-4db4-9ffd-76a0682cb67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6eb51139-72b0-49a3-b018-f39ed84725ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5754e407-cef3-471b-a3ad-b751278ee772" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6eb51139-72b0-49a3-b018-f39ed84725ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_0a3abe01-576c-4417-9d4f-3fb82864e557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_us-gaap_SeveranceCosts1_0a3abe01-576c-4417-9d4f-3fb82864e557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_e3871680-dd0b-495e-8e48-633e5b72e2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_us-gaap_AssetImpairmentCharges_e3871680-dd0b-495e-8e48-633e5b72e2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_64119b5b-c5d4-4c5b-9aa3-d7ac52c3014f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_us-gaap_OtherRestructuringCosts_64119b5b-c5d4-4c5b-9aa3-d7ac52c3014f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_a6fd217e-b92a-414b-a3b3-98bc02dfd5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_a6fd217e-b92a-414b-a3b3-98bc02dfd5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_224e31c6-e907-4cdb-8ca0-8655153f20d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_224e31c6-e907-4cdb-8ca0-8655153f20d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_8457d279-cfbc-4438-a648-9a342f04b1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_8457d279-cfbc-4438-a648-9a342f04b1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4e688408-51bc-4a98-8884-5ec2c4196f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4e688408-51bc-4a98-8884-5ec2c4196f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8b8ebf31-474c-4e9b-98ac-f54718ff2197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8b8ebf31-474c-4e9b-98ac-f54718ff2197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_e170f4b0-a5bb-419f-b87c-41525fb88c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_us-gaap_GainLossOnInvestments_e170f4b0-a5bb-419f-b87c-41525fb88c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_80eb759f-9fe0-4870-ada3-f5e9bc979da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_80eb759f-9fe0-4870-ada3-f5e9bc979da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_90572408-a38d-425b-a52c-d72bf19fad1d" xlink:href="wst-20221231.xsd#wst_OtherIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ed7adef3-3684-498b-81c1-214177fea667" xlink:to="loc_wst_OtherIncomeExpense_90572408-a38d-425b-a52c-d72bf19fad1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherExpenseIncomeNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_88844794-2779-4f02-8b86-12d505f67d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable_e824cd0f-f876-4b84-ac95-34162a6bf85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_88844794-2779-4f02-8b86-12d505f67d76" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsTable_e824cd0f-f876-4b84-ac95-34162a6bf85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_4152b124-e5ae-4a46-a61b-272956eb16c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_e824cd0f-f876-4b84-ac95-34162a6bf85d" xlink:to="loc_us-gaap_RestructuringPlanAxis_4152b124-e5ae-4a46-a61b-272956eb16c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_06e071f2-8f3e-4baa-866e-375685b8c5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_4152b124-e5ae-4a46-a61b-272956eb16c0" xlink:to="loc_us-gaap_RestructuringPlanDomain_06e071f2-8f3e-4baa-866e-375685b8c5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2022RestructuringPlanMember_7b23ce65-0ecf-4c65-84e4-962095561614" xlink:href="wst-20221231.xsd#wst_The2022RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_06e071f2-8f3e-4baa-866e-375685b8c5d3" xlink:to="loc_wst_The2022RestructuringPlanMember_7b23ce65-0ecf-4c65-84e4-962095561614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2020RestructuringPlanMember_9b53c25e-3e23-44f8-b6e6-aa85f9a10c65" xlink:href="wst-20221231.xsd#wst_The2020RestructuringPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_06e071f2-8f3e-4baa-866e-375685b8c5d3" xlink:to="loc_wst_The2020RestructuringPlanMember_9b53c25e-3e23-44f8-b6e6-aa85f9a10c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_08de622f-0722-4afa-8b30-66f35adda48c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_e824cd0f-f876-4b84-ac95-34162a6bf85d" xlink:to="loc_srt_RangeAxis_08de622f-0722-4afa-8b30-66f35adda48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_682ef4f2-f422-4383-b84e-3c15a1f3277d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_08de622f-0722-4afa-8b30-66f35adda48c" xlink:to="loc_srt_RangeMember_682ef4f2-f422-4383-b84e-3c15a1f3277d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2a92b72e-eaba-41db-8816-ea5918f07079" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_682ef4f2-f422-4383-b84e-3c15a1f3277d" xlink:to="loc_srt_MinimumMember_2a92b72e-eaba-41db-8816-ea5918f07079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9310db44-aefc-4c6e-93d1-9db7ea85428b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_682ef4f2-f422-4383-b84e-3c15a1f3277d" xlink:to="loc_srt_MaximumMember_9310db44-aefc-4c6e-93d1-9db7ea85428b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_e824cd0f-f876-4b84-ac95-34162a6bf85d" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_84bd1f15-18a7-4595-8ca3-86ce84edd652" xlink:href="wst-20221231.xsd#wst_RestructuringAndRelatedActivitiesPeriodOfImplementation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_84bd1f15-18a7-4595-8ca3-86ce84edd652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_51cb76fb-d954-4ff4-9339-975bc1290e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_51cb76fb-d954-4ff4-9339-975bc1290e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureEarningsAmount_f9093460-2428-444b-86c2-158326cc362e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOnFutureEarningsAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_EffectOnFutureEarningsAmount_f9093460-2428-444b-86c2-158326cc362e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_32a4bc2a-60f7-40f6-ab23-248d8140f94e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_AssetImpairmentCharges_32a4bc2a-60f7-40f6-ab23-248d8140f94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_eb55e0ae-0758-4a14-b79e-ff66beaa279f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_eb55e0ae-0758-4a14-b79e-ff66beaa279f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4dd5d523-d5cf-4f63-9f91-ae6610f449e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4dd5d523-d5cf-4f63-9f91-ae6610f449e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_1c404aa0-1d7b-4e76-b2b9-3f2744c574ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_GainLossOnInvestments_1c404aa0-1d7b-4e76-b2b9-3f2744c574ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_b850de0a-8e8e-4d9d-acc6-d76032d502a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_b850de0a-8e8e-4d9d-acc6-d76032d502a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_d457da99-b879-4d64-9a4b-ba24fd497ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_24e69ebc-e3b1-4c25-8ad5-ec368b13b14f" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_d457da99-b879-4d64-9a4b-ba24fd497ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_ce284e02-de41-4af5-a8da-5b0c9fd4cf72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_49ea6803-8aab-46e2-afb6-cdcfa55e4a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_ce284e02-de41-4af5-a8da-5b0c9fd4cf72" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_49ea6803-8aab-46e2-afb6-cdcfa55e4a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_8fbd0dda-aec6-4aa1-a16c-8b398f52c00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_49ea6803-8aab-46e2-afb6-cdcfa55e4a10" xlink:to="loc_us-gaap_RestructuringPlanAxis_8fbd0dda-aec6-4aa1-a16c-8b398f52c00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_c391a6dd-a036-46e8-b6bc-b68c40aff973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_8fbd0dda-aec6-4aa1-a16c-8b398f52c00e" xlink:to="loc_us-gaap_RestructuringPlanDomain_c391a6dd-a036-46e8-b6bc-b68c40aff973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2022RestructuringPlanMember_1a09b98d-c164-423d-be6c-960943954ce6" xlink:href="wst-20221231.xsd#wst_The2022RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_c391a6dd-a036-46e8-b6bc-b68c40aff973" xlink:to="loc_wst_The2022RestructuringPlanMember_1a09b98d-c164-423d-be6c-960943954ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2020RestructuringPlanMember_31a7ff5b-305f-44f4-98c0-d4e43180d10c" xlink:href="wst-20221231.xsd#wst_The2020RestructuringPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_c391a6dd-a036-46e8-b6bc-b68c40aff973" xlink:to="loc_wst_The2020RestructuringPlanMember_31a7ff5b-305f-44f4-98c0-d4e43180d10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_d4e815e0-5b4e-412a-a5c3-500f8636a2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_49ea6803-8aab-46e2-afb6-cdcfa55e4a10" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_d4e815e0-5b4e-412a-a5c3-500f8636a2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_9e2b5ec1-0fea-45a9-ab63-f8eedba530cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d4e815e0-5b4e-412a-a5c3-500f8636a2e2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_9e2b5ec1-0fea-45a9-ab63-f8eedba530cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_e487d5fb-5ebd-42e6-8116-97afb09787dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_9e2b5ec1-0fea-45a9-ab63-f8eedba530cd" xlink:to="loc_us-gaap_EmployeeSeveranceMember_e487d5fb-5ebd-42e6-8116-97afb09787dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember_893e5f88-b29b-4b77-bb60-b947d247f18e" xlink:href="wst-20221231.xsd#wst_AssetRelatedChargesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_9e2b5ec1-0fea-45a9-ab63-f8eedba530cd" xlink:to="loc_wst_AssetRelatedChargesMember_893e5f88-b29b-4b77-bb60-b947d247f18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_3b643032-ae15-49c1-8e62-449da040eefe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_9e2b5ec1-0fea-45a9-ab63-f8eedba530cd" xlink:to="loc_us-gaap_OtherRestructuringMember_3b643032-ae15-49c1-8e62-449da040eefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1d6e5c1d-65cb-478d-9038-7513a7005b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_49ea6803-8aab-46e2-afb6-cdcfa55e4a10" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_1d6e5c1d-65cb-478d-9038-7513a7005b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d6e5c1d-65cb-478d-9038-7513a7005b24" xlink:to="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b1f29c58-7deb-44dd-b6c6-23f778cbc43c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:to="loc_us-gaap_RestructuringReserve_b1f29c58-7deb-44dd-b6c6-23f778cbc43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_cbb2084e-cd45-4af3-b9a3-51af91d04c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:to="loc_us-gaap_RestructuringCharges_cbb2084e-cd45-4af3-b9a3-51af91d04c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_df32048a-418c-44c6-b66d-7f1bd32c9575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:to="loc_us-gaap_PaymentsForRestructuring_df32048a-418c-44c6-b66d-7f1bd32c9575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d0b2eecc-7f29-4565-ba7c-be9adcb5893a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8d85e70d-03d5-45fc-9482-f003f09721dc" xlink:to="loc_us-gaap_RestructuringReserve_d0b2eecc-7f29-4565-ba7c-be9adcb5893a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e862d03f-00a1-483d-b1d6-b41c53f65e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6829f584-7ff2-45eb-98c5-86349f429128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e862d03f-00a1-483d-b1d6-b41c53f65e4e" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6829f584-7ff2-45eb-98c5-86349f429128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4519ddae-2b6c-4357-81c1-6d30c6b31804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6829f584-7ff2-45eb-98c5-86349f429128" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4519ddae-2b6c-4357-81c1-6d30c6b31804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_445a515e-6a41-4a97-9a46-4f5fef8c7b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6829f584-7ff2-45eb-98c5-86349f429128" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_445a515e-6a41-4a97-9a46-4f5fef8c7b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_837d7295-baa9-4832-9221-db12826bf3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6829f584-7ff2-45eb-98c5-86349f429128" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_837d7295-baa9-4832-9221-db12826bf3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_bea67b16-ab4b-476e-a37f-afe8d0b3c451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6829f584-7ff2-45eb-98c5-86349f429128" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_bea67b16-ab4b-476e-a37f-afe8d0b3c451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_0666179a-cad6-400d-9f18-0468fd25b584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6829f584-7ff2-45eb-98c5-86349f429128" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_0666179a-cad6-400d-9f18-0468fd25b584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_17d84c66-6e0a-4008-bfc5-3d85c2bdb510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6829f584-7ff2-45eb-98c5-86349f429128" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_17d84c66-6e0a-4008-bfc5-3d85c2bdb510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4763fb7b-ed98-4381-a17c-bc6629b363cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4763fb7b-ed98-4381-a17c-bc6629b363cf" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8447278d-2177-469e-82a6-ff02d8405ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8447278d-2177-469e-82a6-ff02d8405ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_256f6009-f27c-40ef-8aa0-987411e79fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8447278d-2177-469e-82a6-ff02d8405ba5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_256f6009-f27c-40ef-8aa0-987411e79fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_24d5e59b-7be1-4110-9668-eed7cbbb38c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_256f6009-f27c-40ef-8aa0-987411e79fa0" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_24d5e59b-7be1-4110-9668-eed7cbbb38c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_eb4f1ac6-dd26-49b7-8355-fbacf0210f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_256f6009-f27c-40ef-8aa0-987411e79fa0" xlink:to="loc_us-gaap_ForeignCountryMember_eb4f1ac6-dd26-49b7-8355-fbacf0210f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodAxis_cf6e30db-a6ea-4c75-9d30-0e7439a6604f" xlink:href="wst-20221231.xsd#wst_ExpirationPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:to="loc_wst_ExpirationPeriodAxis_cf6e30db-a6ea-4c75-9d30-0e7439a6604f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain_8b6916bf-afdc-4994-8bbc-21303a20a8b6" xlink:href="wst-20221231.xsd#wst_ExpirationPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodAxis_cf6e30db-a6ea-4c75-9d30-0e7439a6604f" xlink:to="loc_wst_ExpirationPeriodDomain_8b6916bf-afdc-4994-8bbc-21303a20a8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2021Member_6b26aad7-2f20-4400-9a85-4a9f51576e8d" xlink:href="wst-20221231.xsd#wst_Year2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_8b6916bf-afdc-4994-8bbc-21303a20a8b6" xlink:to="loc_wst_Year2021Member_6b26aad7-2f20-4400-9a85-4a9f51576e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2022Member_4b380d70-cf66-4e99-bc0d-6e534513e203" xlink:href="wst-20221231.xsd#wst_Year2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_8b6916bf-afdc-4994-8bbc-21303a20a8b6" xlink:to="loc_wst_Year2022Member_4b380d70-cf66-4e99-bc0d-6e534513e203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2022Member_ad3a0be2-1942-43fa-9dac-4192915cb50b" xlink:href="wst-20221231.xsd#wst_YearAfter2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_8b6916bf-afdc-4994-8bbc-21303a20a8b6" xlink:to="loc_wst_YearAfter2022Member_ad3a0be2-1942-43fa-9dac-4192915cb50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_bf7c6e43-abf0-4468-ad81-8efc98f4ef1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_bf7c6e43-abf0-4468-ad81-8efc98f4ef1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_cdae3770-ccb1-42d4-ab4e-a1164f0bad82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_bf7c6e43-abf0-4468-ad81-8efc98f4ef1d" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_cdae3770-ccb1-42d4-ab4e-a1164f0bad82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_f3b718d5-d7b4-46f3-9f30-9fd84052526e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_cdae3770-ccb1-42d4-ab4e-a1164f0bad82" xlink:to="loc_us-gaap_ResearchMember_f3b718d5-d7b4-46f3-9f30-9fd84052526e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_b617c0f5-fd3a-468e-84f2-1d9b14048368" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_bd22f437-b208-46cf-af8a-28e5f859ea8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_bd22f437-b208-46cf-af8a-28e5f859ea8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_42e2680e-c8fd-44e8-81fe-3ea2514e53c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_42e2680e-c8fd-44e8-81fe-3ea2514e53c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2fd5c22e-c363-455f-ac0d-cfa8fa6d3d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2fd5c22e-c363-455f-ac0d-cfa8fa6d3d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_f73457e6-b7fb-4b91-8389-b9e41f07c20d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_f73457e6-b7fb-4b91-8389-b9e41f07c20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount_13c51774-360b-4f84-873c-baae047b2886" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount_13c51774-360b-4f84-873c-baae047b2886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount_aacb06a7-0d72-4bc9-a0ca-d74d90c7399c" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount_aacb06a7-0d72-4bc9-a0ca-d74d90c7399c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount_bc924501-735c-4927-94d6-e0d638ddfaa4" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount_bc924501-735c-4927-94d6-e0d638ddfaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlementsOther_04899b5b-fda6-4f55-9b03-8ba939c97168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlementsOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlementsOther_04899b5b-fda6-4f55-9b03-8ba939c97168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_36c154c2-1f49-48aa-acba-dedde74d2125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_36c154c2-1f49-48aa-acba-dedde74d2125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_15f5ab81-e85a-4588-8acc-1ee6797b8957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_OperatingLossCarryforwards_15f5ab81-e85a-4588-8acc-1ee6797b8957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_f62225be-3206-48aa-997f-cb3140a9148a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_f62225be-3206-48aa-997f-cb3140a9148a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3d07387c-97ed-494e-be87-43e116d0c8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3d07387c-97ed-494e-be87-43e116d0c8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_0e335544-ff9c-4d11-91dc-92e868d0b313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_0e335544-ff9c-4d11-91dc-92e868d0b313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_3c8a91f4-0c36-4a9b-840c-7a5e1a70db5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_3c8a91f4-0c36-4a9b-840c-7a5e1a70db5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_921b2171-bbee-4b7c-a45f-f1c209e23fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ab5646b1-3c5a-44fb-b070-fb877eb973dc" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_921b2171-bbee-4b7c-a45f-f1c209e23fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_36e19b41-6c74-4ca1-a984-3ce0ff16424d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2d3cd82c-5993-49c9-bc16-8b212c786aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36e19b41-6c74-4ca1-a984-3ce0ff16424d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2d3cd82c-5993-49c9-bc16-8b212c786aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9a025eff-e0b0-47d0-ad48-42c4936ee2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36e19b41-6c74-4ca1-a984-3ce0ff16424d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9a025eff-e0b0-47d0-ad48-42c4936ee2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dceb7827-e2aa-4430-9c0f-13de9a642de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36e19b41-6c74-4ca1-a984-3ce0ff16424d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dceb7827-e2aa-4430-9c0f-13de9a642de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2cbf470a-cb20-4628-a94f-2d0d509612a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1b607766-08f5-4436-8672-4218f2aebe79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2cbf470a-cb20-4628-a94f-2d0d509612a2" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1b607766-08f5-4436-8672-4218f2aebe79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e9208cef-6e41-4af4-ac70-0f1261d9586a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1b607766-08f5-4436-8672-4218f2aebe79" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e9208cef-6e41-4af4-ac70-0f1261d9586a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f70aa774-9f1a-412a-a5a7-4dba12cf37de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1b607766-08f5-4436-8672-4218f2aebe79" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f70aa774-9f1a-412a-a5a7-4dba12cf37de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2771609a-48a0-40f6-8dc4-332366aae717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1b607766-08f5-4436-8672-4218f2aebe79" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2771609a-48a0-40f6-8dc4-332366aae717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_522e98f4-aba5-4b7f-a607-393f234416be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1b607766-08f5-4436-8672-4218f2aebe79" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_522e98f4-aba5-4b7f-a607-393f234416be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3c7dd1fe-fc6d-439b-9e3e-224526225cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2cbf470a-cb20-4628-a94f-2d0d509612a2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3c7dd1fe-fc6d-439b-9e3e-224526225cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_523e8b2a-1550-4773-a275-d144aba86048" xlink:href="wst-20221231.xsd#wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3c7dd1fe-fc6d-439b-9e3e-224526225cab" xlink:to="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_523e8b2a-1550-4773-a275-d144aba86048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_c99c9667-1e78-4c14-9c11-931297f58be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3c7dd1fe-fc6d-439b-9e3e-224526225cab" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_c99c9667-1e78-4c14-9c11-931297f58be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b380231b-46c9-4926-8917-5a568a1ebbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3c7dd1fe-fc6d-439b-9e3e-224526225cab" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b380231b-46c9-4926-8917-5a568a1ebbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a848ea58-7df8-41ee-8442-0245b40fea3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2cbf470a-cb20-4628-a94f-2d0d509612a2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a848ea58-7df8-41ee-8442-0245b40fea3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0467c8b0-f759-49bf-b9fd-2505dd45dc24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0467c8b0-f759-49bf-b9fd-2505dd45dc24" xlink:to="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d6ac3ee4-2773-46ed-ad2d-fbefaff12d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d6ac3ee4-2773-46ed-ad2d-fbefaff12d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_d3a862a3-b3c9-4708-9067-276b1be2a2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_d3a862a3-b3c9-4708-9067-276b1be2a2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_f06566aa-e512-4818-8e01-6604db372666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_f06566aa-e512-4818-8e01-6604db372666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsRoyaltyAcceleration_c8743e47-39b8-4c98-8765-111073fa5f38" xlink:href="wst-20221231.xsd#wst_DeferredTaxAssetsRoyaltyAcceleration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:to="loc_wst_DeferredTaxAssetsRoyaltyAcceleration_c8743e47-39b8-4c98-8765-111073fa5f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_f4530048-d743-4f50-9ce4-62c1b9b372c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_f4530048-d743-4f50-9ce4-62c1b9b372c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_705f44f2-cc76-42a9-9649-0dc60b148e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_705f44f2-cc76-42a9-9649-0dc60b148e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsLeasingArrangements_5c30a64d-460d-4f09-8d7d-22b7efdc77d7" xlink:href="wst-20221231.xsd#wst_DeferredTaxAssetsLeasingArrangements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:to="loc_wst_DeferredTaxAssetsLeasingArrangements_5c30a64d-460d-4f09-8d7d-22b7efdc77d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6c5038bf-9cc2-4ffd-90cf-662d065186a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6c5038bf-9cc2-4ffd-90cf-662d065186a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_a57b0bec-d01a-4e23-9fb4-09c2b70a3346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_fced256c-5db3-4729-ad65-06cc40473b93" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_a57b0bec-d01a-4e23-9fb4-09c2b70a3346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bcac4093-1bc2-4715-a735-66af9e3a0aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0467c8b0-f759-49bf-b9fd-2505dd45dc24" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bcac4093-1bc2-4715-a735-66af9e3a0aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_18405d00-d9a5-44ea-81cc-dfa0322f039e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bcac4093-1bc2-4715-a735-66af9e3a0aea" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_18405d00-d9a5-44ea-81cc-dfa0322f039e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_ded2b345-176b-4524-80ed-65adacb6cb44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bcac4093-1bc2-4715-a735-66af9e3a0aea" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_ded2b345-176b-4524-80ed-65adacb6cb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_d810af67-07fe-4f29-949a-466287545203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bcac4093-1bc2-4715-a735-66af9e3a0aea" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_d810af67-07fe-4f29-949a-466287545203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_e4814913-a21a-486b-af07-4ac46887687e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bcac4093-1bc2-4715-a735-66af9e3a0aea" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_e4814913-a21a-486b-af07-4ac46887687e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_bd509c0c-dc5e-4a42-9af1-f81135ee85aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bcac4093-1bc2-4715-a735-66af9e3a0aea" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_bd509c0c-dc5e-4a42-9af1-f81135ee85aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7ac1ad11-5cbc-4939-94ae-f14b1d3f31af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0467c8b0-f759-49bf-b9fd-2505dd45dc24" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7ac1ad11-5cbc-4939-94ae-f14b1d3f31af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4fdb42ba-612a-4ed5-8755-4827398c632c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4fdb42ba-612a-4ed5-8755-4827398c632c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_74d91572-fc89-4c4e-906d-e23b2d4fa2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_74d91572-fc89-4c4e-906d-e23b2d4fa2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a7065b46-f96d-4fc1-bce6-c3c97c2615e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a7065b46-f96d-4fc1-bce6-c3c97c2615e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_92f6bfc7-7a09-4f6f-a8a1-b515e5136f7b" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_92f6bfc7-7a09-4f6f-a8a1-b515e5136f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_9ea71d71-9f51-4035-8066-107cbd3243c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_9ea71d71-9f51-4035-8066-107cbd3243c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6b9f7b77-3388-435f-90ef-7c483e8e3026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6b9f7b77-3388-435f-90ef-7c483e8e3026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_a552b5da-5401-4c2b-a5f5-96eefd261ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_a552b5da-5401-4c2b-a5f5-96eefd261ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_d6ced929-9aee-4e47-96ca-7804a3b83b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_d6ced929-9aee-4e47-96ca-7804a3b83b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent_39ab5a41-5065-4016-87c3-58290a2fc054" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent_39ab5a41-5065-4016-87c3-58290a2fc054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent_d49c0e3e-cff0-4d95-805c-c2736a10ec32" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent_d49c0e3e-cff0-4d95-805c-c2736a10ec32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_cd119a12-a27f-4292-b7c9-2b1d8531ed20" xlink:href="wst-20221231.xsd#wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_cd119a12-a27f-4292-b7c9-2b1d8531ed20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_5e2af0dc-abc7-4b68-a096-9335319b368c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_5e2af0dc-abc7-4b68-a096-9335319b368c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_68ba1308-d42a-49f7-b969-bd51eccc3176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d67aa884-78aa-4671-976a-e0d856f32a21" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_68ba1308-d42a-49f7-b969-bd51eccc3176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9178bdd5-876d-4438-96b8-55c0859d7130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9178bdd5-876d-4438-96b8-55c0859d7130" xlink:to="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1d048a10-2a3b-436c-b872-6b9e36c7d544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:to="loc_us-gaap_CreditFacilityAxis_1d048a10-2a3b-436c-b872-6b9e36c7d544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7819b02a-a576-41d7-94a9-d76ad6cbd47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1d048a10-2a3b-436c-b872-6b9e36c7d544" xlink:to="loc_us-gaap_CreditFacilityDomain_7819b02a-a576-41d7-94a9-d76ad6cbd47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_c38f8d44-a87f-45bc-9513-9f30b5197c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7819b02a-a576-41d7-94a9-d76ad6cbd47b" xlink:to="loc_us-gaap_LetterOfCreditMember_c38f8d44-a87f-45bc-9513-9f30b5197c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_17fa33ca-774f-420b-b6da-88935286632d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_17fa33ca-774f-420b-b6da-88935286632d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0a314cf6-4627-4ece-8901-f8821a0e67de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17fa33ca-774f-420b-b6da-88935286632d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0a314cf6-4627-4ece-8901-f8821a0e67de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_a1a9899f-48b7-4bb0-98f2-ca958466abb3" xlink:href="wst-20221231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0a314cf6-4627-4ece-8901-f8821a0e67de" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_a1a9899f-48b7-4bb0-98f2-ca958466abb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a9412838-200d-4550-abf1-d7f1f381a561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a9412838-200d-4550-abf1-d7f1f381a561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e4e728bf-6473-4f37-96ef-b858a71d546e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a9412838-200d-4550-abf1-d7f1f381a561" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e4e728bf-6473-4f37-96ef-b858a71d546e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceClaimsMember_79fec2ea-b795-4ba8-9750-46a5c6d98285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceClaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e4e728bf-6473-4f37-96ef-b858a71d546e" xlink:to="loc_us-gaap_InsuranceClaimsMember_79fec2ea-b795-4ba8-9750-46a5c6d98285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2090b85a-00bb-4609-b5ea-317197ba6303" xlink:to="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_6fff304e-8ce9-476e-bc7a-838b59c1533a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_6fff304e-8ce9-476e-bc7a-838b59c1533a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_95ad6d44-8fb7-4951-89c3-05f2e41d1c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_95ad6d44-8fb7-4951-89c3-05f2e41d1c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_1e681d04-cc60-4561-b7fc-113569e5818e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_LineOfCredit_1e681d04-cc60-4561-b7fc-113569e5818e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2df44a44-af8a-44ad-a8ce-d9dce32ccae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2df44a44-af8a-44ad-a8ce-d9dce32ccae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyReceivable_ab06e9af-a8f6-4b41-b469-8180f5ddc224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2137634b-5382-4368-a3c1-5a725ea711e0" xlink:to="loc_us-gaap_LossContingencyReceivable_ab06e9af-a8f6-4b41-b469-8180f5ddc224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fb243630-5686-4d04-995d-42b3f4018cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_37798a3e-de46-4f21-8227-46fe8569839c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fb243630-5686-4d04-995d-42b3f4018cc1" xlink:to="loc_us-gaap_NumberOfReportableSegments_37798a3e-de46-4f21-8227-46fe8569839c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#SegmentInformationSalesbyProductGroupDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_070efeaf-7270-4379-9cf8-765edcff11a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_4d8eb0f0-b072-46b7-9f38-7a33129914a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_070efeaf-7270-4379-9cf8-765edcff11a8" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_4d8eb0f0-b072-46b7-9f38-7a33129914a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_31b83fb0-3878-4c1e-82e3-72d8e1c6c84f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_4d8eb0f0-b072-46b7-9f38-7a33129914a5" xlink:to="loc_srt_ConsolidationItemsAxis_31b83fb0-3878-4c1e-82e3-72d8e1c6c84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6bc05504-8f49-43bf-90a7-fcccb1157ef1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_31b83fb0-3878-4c1e-82e3-72d8e1c6c84f" xlink:to="loc_srt_ConsolidationItemsDomain_6bc05504-8f49-43bf-90a7-fcccb1157ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2afa76c9-a97a-497e-bc5d-eb9f0b394f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6bc05504-8f49-43bf-90a7-fcccb1157ef1" xlink:to="loc_us-gaap_OperatingSegmentsMember_2afa76c9-a97a-497e-bc5d-eb9f0b394f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_6ef6de3a-78db-41ad-9396-bee85409e23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6bc05504-8f49-43bf-90a7-fcccb1157ef1" xlink:to="loc_us-gaap_IntersegmentEliminationMember_6ef6de3a-78db-41ad-9396-bee85409e23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a2ec0d29-75b8-483e-8969-b3ad403c7da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_4d8eb0f0-b072-46b7-9f38-7a33129914a5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a2ec0d29-75b8-483e-8969-b3ad403c7da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f4a597d3-776b-4160-b648-aaa0415c9e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2ec0d29-75b8-483e-8969-b3ad403c7da8" xlink:to="loc_us-gaap_SegmentDomain_f4a597d3-776b-4160-b648-aaa0415c9e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_05b974b6-1663-4dd1-b013-e911680ac780" xlink:href="wst-20221231.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f4a597d3-776b-4160-b648-aaa0415c9e91" xlink:to="loc_wst_ProprietaryProductsMember_05b974b6-1663-4dd1-b013-e911680ac780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_a0836e73-bd33-4be8-82e5-29e1ba269b1c" xlink:href="wst-20221231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f4a597d3-776b-4160-b648-aaa0415c9e91" xlink:to="loc_wst_ContractManufacturedProductsMember_a0836e73-bd33-4be8-82e5-29e1ba269b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_da3f2890-2ff9-429e-9c0a-dc9dcf6813ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_4d8eb0f0-b072-46b7-9f38-7a33129914a5" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_da3f2890-2ff9-429e-9c0a-dc9dcf6813ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b959041f-d2ab-4036-8580-d7ba27a1ae6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_da3f2890-2ff9-429e-9c0a-dc9dcf6813ad" xlink:to="loc_us-gaap_Revenues_b959041f-d2ab-4036-8580-d7ba27a1ae6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b7d0ac51-effe-439c-b9e9-90e4e22f48ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2a20fdc1-a3a8-40d5-acab-571947391d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b7d0ac51-effe-439c-b9e9-90e4e22f48ac" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2a20fdc1-a3a8-40d5-acab-571947391d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e8da6a46-55ca-4cd0-9abd-a32f0fc0ebbf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2a20fdc1-a3a8-40d5-acab-571947391d94" xlink:to="loc_srt_StatementGeographicalAxis_e8da6a46-55ca-4cd0-9abd-a32f0fc0ebbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e8da6a46-55ca-4cd0-9abd-a32f0fc0ebbf" xlink:to="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d77f2c7d-0e1f-49d5-9d01-994f0287ea76" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_country_US_d77f2c7d-0e1f-49d5-9d01-994f0287ea76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_7711281d-8a48-4d88-bf0f-e105a67e0f22" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_country_DE_7711281d-8a48-4d88-bf0f-e105a67e0f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_8220d3dc-7535-43a8-91cb-c97b6da003de" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_country_IE_8220d3dc-7535-43a8-91cb-c97b6da003de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_7d19dd9c-53a7-4c00-b643-aa3c18f08ade" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_FR"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_country_FR_7d19dd9c-53a7-4c00-b643-aa3c18f08ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherEuropeCountriesMember_67f7e826-4d79-4ffb-9bcb-cfbdbb899d55" xlink:href="wst-20221231.xsd#wst_OtherEuropeCountriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_wst_OtherEuropeCountriesMember_67f7e826-4d79-4ffb-9bcb-cfbdbb899d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCountriesMember_da9cfcca-2635-4123-99b9-397212bda6b7" xlink:href="wst-20221231.xsd#wst_OtherCountriesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c7b95c3c-a699-47fe-8c6d-79d731d99a2f" xlink:to="loc_wst_OtherCountriesMember_da9cfcca-2635-4123-99b9-397212bda6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_94b8120a-1b0e-4c7a-ac25-68621d7ac4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2a20fdc1-a3a8-40d5-acab-571947391d94" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_94b8120a-1b0e-4c7a-ac25-68621d7ac4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_78ba2914-c668-42bd-821f-6356181a8ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_94b8120a-1b0e-4c7a-ac25-68621d7ac4c0" xlink:to="loc_us-gaap_Revenues_78ba2914-c668-42bd-821f-6356181a8ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_89f26ad8-c512-4e4f-82bb-5c7874d39dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_94b8120a-1b0e-4c7a-ac25-68621d7ac4c0" xlink:to="loc_us-gaap_NoncurrentAssets_89f26ad8-c512-4e4f-82bb-5c7874d39dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_83630a89-7de9-46c8-b25d-0685dabe81b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_83630a89-7de9-46c8-b25d-0685dabe81b4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_11298593-322d-4759-9ff4-1e197daab158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_11298593-322d-4759-9ff4-1e197daab158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_443ab004-c1d5-489c-88db-27325897eb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_11298593-322d-4759-9ff4-1e197daab158" xlink:to="loc_us-gaap_SegmentDomain_443ab004-c1d5-489c-88db-27325897eb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_5a48fb71-92f1-4a90-99ff-499c8bda211d" xlink:href="wst-20221231.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_443ab004-c1d5-489c-88db-27325897eb0f" xlink:to="loc_wst_ProprietaryProductsMember_5a48fb71-92f1-4a90-99ff-499c8bda211d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_42eb7461-6259-4996-97ba-1e2dcee37b2e" xlink:href="wst-20221231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_443ab004-c1d5-489c-88db-27325897eb0f" xlink:to="loc_wst_ContractManufacturedProductsMember_42eb7461-6259-4996-97ba-1e2dcee37b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_57463a28-0e0e-4b99-9eaa-3c503eff2a71" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:to="loc_srt_ConsolidationItemsAxis_57463a28-0e0e-4b99-9eaa-3c503eff2a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4a423b50-a57c-46b4-b09b-bb727d8cd8ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_57463a28-0e0e-4b99-9eaa-3c503eff2a71" xlink:to="loc_srt_ConsolidationItemsDomain_4a423b50-a57c-46b4-b09b-bb727d8cd8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d5eb8b8f-a41c-49ca-b53a-79590fa9a197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4a423b50-a57c-46b4-b09b-bb727d8cd8ec" xlink:to="loc_us-gaap_OperatingSegmentsMember_d5eb8b8f-a41c-49ca-b53a-79590fa9a197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_a8b87ac2-79cd-49e3-96e1-c1183caa5357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4a423b50-a57c-46b4-b09b-bb727d8cd8ec" xlink:to="loc_us-gaap_CorporateNonSegmentMember_a8b87ac2-79cd-49e3-96e1-c1183caa5357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f4b7d367-59bb-4fd5-a09d-9e9fae1f2a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f4b7d367-59bb-4fd5-a09d-9e9fae1f2a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f20b963a-abc8-4783-b36f-f2d8f04af60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f4b7d367-59bb-4fd5-a09d-9e9fae1f2a2c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f20b963a-abc8-4783-b36f-f2d8f04af60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SecondQuarter2020AcquisiitonMember_d84a44e5-1f93-4bef-aba2-97bf290e333e" xlink:href="wst-20221231.xsd#wst_SecondQuarter2020AcquisiitonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f20b963a-abc8-4783-b36f-f2d8f04af60a" xlink:to="loc_wst_SecondQuarter2020AcquisiitonMember_d84a44e5-1f93-4bef-aba2-97bf290e333e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_73854152-1d75-450d-9714-014716686dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_73854152-1d75-450d-9714-014716686dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9dc7838a-6bf1-4b73-8e19-de823d3c8837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_73854152-1d75-450d-9714-014716686dfb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9dc7838a-6bf1-4b73-8e19-de823d3c8837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f457544d-89d2-4fe2-8da4-d331f43a965c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9dc7838a-6bf1-4b73-8e19-de823d3c8837" xlink:to="loc_us-gaap_CostOfSalesMember_f457544d-89d2-4fe2-8da4-d331f43a965c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6d5cad82-e5e6-4d1f-843b-593ea77a616c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9dc7838a-6bf1-4b73-8e19-de823d3c8837" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6d5cad82-e5e6-4d1f-843b-593ea77a616c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_504b94e1-0343-4547-8f12-92d1ee93731f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6cfe4966-1261-4cf7-b562-647d93b28ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_OperatingIncomeLoss_6cfe4966-1261-4cf7-b562-647d93b28ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4ab34073-8f49-4895-9ba6-18df59169c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_ShareBasedCompensation_4ab34073-8f49-4895-9ba6-18df59169c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_eac35670-740b-489a-a576-6b5fd29844e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_eac35670-740b-489a-a576-6b5fd29844e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6a1c4b9d-2d21-4e84-b608-5ee9cc483eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_RestructuringCharges_6a1c4b9d-2d21-4e84-b608-5ee9cc483eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4b806e30-d50d-4432-b790-e5a0279b5f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4b806e30-d50d-4432-b790-e5a0279b5f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_90bcc207-261c-42ef-aa95-56b0fa8ee301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_AssetImpairmentCharges_90bcc207-261c-42ef-aa95-56b0fa8ee301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CostInvestmentImpairment_16c17614-5ba0-446b-8675-69b2af7d0452" xlink:href="wst-20221231.xsd#wst_CostInvestmentImpairment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_wst_CostInvestmentImpairment_16c17614-5ba0-446b-8675-69b2af7d0452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_798fd9d2-18bc-4826-95a5-d8cd6051ab27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_798fd9d2-18bc-4826-95a5-d8cd6051ab27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_423e38c0-ef88-457e-baf6-b20e568d4b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_423e38c0-ef88-457e-baf6-b20e568d4b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_059ac3c7-702e-4c1b-a888-8ccbcb6b5c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_059ac3c7-702e-4c1b-a888-8ccbcb6b5c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5159184f-46bb-4132-b3a8-9cfdf6ce9417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_Assets_5159184f-46bb-4132-b3a8-9cfdf6ce9417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f4834b4c-ae01-45d5-ae95-32940733798c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f4834b4c-ae01-45d5-ae95-32940733798c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_38bb9ba7-b218-4f83-9692-0ff12c6f063b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ea09b8fc-75f8-4d41-a71b-740465edf58c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_38bb9ba7-b218-4f83-9692-0ff12c6f063b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="wst-20221231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_042020fa-400f-448c-bdb7-16288b7f7c1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c1a221d-ff3e-4ccc-822a-25955996c3fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_042020fa-400f-448c-bdb7-16288b7f7c1a" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c1a221d-ff3e-4ccc-822a-25955996c3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_67155607-08a5-4497-8939-97041cdc3c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c1a221d-ff3e-4ccc-822a-25955996c3fb" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_67155607-08a5-4497-8939-97041cdc3c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_435b2736-99d6-41ca-bd40-15cc038621e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_67155607-08a5-4497-8939-97041cdc3c2b" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_435b2736-99d6-41ca-bd40-15cc038621e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_af2b6e4d-4ad4-4d34-b517-8a2978df1fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_435b2736-99d6-41ca-bd40-15cc038621e1" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_af2b6e4d-4ad4-4d34-b517-8a2978df1fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_7c2d4722-2237-40c1-8066-2908b1db6fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_435b2736-99d6-41ca-bd40-15cc038621e1" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_7c2d4722-2237-40c1-8066-2908b1db6fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_54f49cae-8692-41d4-9630-61e3e14b9416" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c1a221d-ff3e-4ccc-822a-25955996c3fb" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_54f49cae-8692-41d4-9630-61e3e14b9416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_54f49cae-8692-41d4-9630-61e3e14b9416" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_5d9db614-2996-488d-b7e4-2472860067ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_5d9db614-2996-488d-b7e4-2472860067ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4934dbd9-2c8d-4fc8-bccb-ee8896b50537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4934dbd9-2c8d-4fc8-bccb-ee8896b50537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d0d7d5f2-c767-444b-a9e6-60fb871b75a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d0d7d5f2-c767-444b-a9e6-60fb871b75a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_18c4f9e3-4fbc-4098-8fa5-93ba666db18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_b4bd38d0-aecb-47e7-95db-f9c5929e2fcd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_18c4f9e3-4fbc-4098-8fa5-93ba666db18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>wst-20221231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 wst-20221231_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUXES';67FR736ZDW,**UPR+&D<C.R@(:^9?&W_!4W_@H'H/_  6"^!'[/?\
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M_;]_9O\ V0?&'@GX6_%#Q)=W?C;XE:L--\ ^!M L_M.J:W<;E4^6A*I%&I8
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MQEI=KXO\!3:'<V]YX973=/U&QGGU-98U^P0^9<PN)9MJLA9E)"G'U]_P<4_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\<?\ !9?]A?\ 9/\
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MGQFR)A3R8)BD?R@]<=3WKTG_ (0?2/\ GYO?_ MJ\C_X)[_\D3U;_L>]9_\
M2DU[I0!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@
M6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M6=X;\-V.K6#W-U<W09;
MB1!LNF P#@=ZZFL?P/\ \@B7_K]F_P#0J #_ (0?2/\ GYO?_ MJ/^$'TC_G
MYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P#
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MP4DW739QC/'-=36/XE_Y"^C_ /7Z?_030 ?\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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M/^?F]_\  MJV** .6\-^&['5K![FZN;H,MQ(@V73 8!P.]:/_"#Z1_S\WO\
MX%M1X'_Y!$O_ %^S?^A5L4 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U;%
M% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'
M_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q10!C_
M /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\ /S>_^!;4?\(/
MI'_/S>_^!;5L44 <M;>&[&7Q)<Z2US=>5%;HZD739R3SWK1_X0?2/^?F]_\
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M% !1110 4444 8]E_P CO>_]>47\S6Q6/9?\CO>_]>47\S6Q0 4444 %%%%
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M;@M^]V8SY1\S[GS5^L-C8V6F64.FZ;9Q6]M;Q+%;V\$81(D48554<*    .
M!7,Q_ CX'Q?$]OC=%\&O"B^-'B\I_%Z^';8:HR;-FPW6SS2NSY<;L8XZ4 <W
M^Q-\#=0_9C_8X^%/[.6L7,<][X$^'.BZ!?3Q-E)9[2QA@E=3Z%T8CZUZ?110
M 4444 ?/7[!?ANPU;X.:M=7,UPK#QQK*XBG*C'VENPKVW_A!](_Y^;W_ ,"V
MKR/_ ()[_P#)$]6_['O6?_2DU[I0!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_
M^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\
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M?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB
M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJH^)
M?"6F6.@W5W#<71:.(D![EB/Q%=-6;XQ_Y%B]_P"N!H J67@O2I;.*5KF\RT2
MDXNFQTJ7_A!](_Y^;W_P+:M+3O\ D'P?]<5_D*FH Q_^$'TC_GYO?_ MJ/\
MA!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?
M_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\  MJ/^$'T
MC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB@#'_ .$'
MTC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Y3PKX5T[4-.DFFGN01<R* EPRC
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M _\ R")?^OV;_P!"K8K'\#_\@B7_ *_9O_0J -BBBB@ HHHH **** "BBB@
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M70^.? /@3XG^%[KP/\2_!6D>(M%OE"WNCZ[IL5W:W #!@'BE5D< @$9!Y -
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\
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MS_\ L$_\%$?'?[,O[-/Q6?Q5X:T2:*4+."TVB3S+YCZ7++]V>2 ,JF0?W@K
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MV[)+$EB222?S^_X+/_\ !(GX=_M;?\$CKWX$?LY_#"PTK7O@\DNL_"?1]'M
M@3[,C"?38P.3]H@WJ!GYIQ"[$E<US'_!J)_P4G/[9/[!"?LU?$77O/\ 'GP1
M$&CR_:),RWNA,&&GS\\GRU1[5L9P+>(L<R"@#]3:*** "BBB@ HHHH ****
M"BBB@ HHHH Q[+_D=[W_ *\HOYFMBL>R_P"1WO?^O*+^9K8H **** "BBB@
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M_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :58_@?_D$2_\
M7[-_Z%4W_"8^&/\ H-0?]]5E^$O$N@V.F20W>J11L;J5@K'L6X- '345F_\
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M0Q,"9_H_TW3=.T;3K?1]'L(;2TM($AM;6VB"1PQJ JHBJ %4   #@ 8KY/\
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M=6[6/X'_ .01+_U^S?\ H5 &E_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
M$/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\
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M/T^P:P@)LH23"N28QZ"IO[.T_P#Y\8?^_0HT[_D'P?\ 7%?Y"IJ (?[.T_\
MY\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ*
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M796<NE2-+:1,?MDHRT8/&ZM?^SM/_P"?&'_OT*S? _\ R")?^OV;_P!"K8H
M_G,_X*!^&-5_X-Y/^#@CPO\ MS^ M#EA^#/QCN[B\U[3K. ^2+:YE1=;L50#
M!:&9XK^*,84%X$'"-7]$/A^_\*>+-!L?%/AFXL;_ $W4[.*ZT^^M-KQ7,$B!
MXY$8<,K*001P017R)_P7F_X)P6__  4Q_P""=WBOX2^'='2?QUX:4^(_AU*%
M'F'4[9'/V4'TN86EM\$[0TB.?N"OE[_@TA_X*/W'[2_[&5]^Q-\4]7<^.?@B
M4M=.BO&(GNO#TC$6W#<DVT@>V8 82,6P/+4 ?K1_9VG_ //C#_WZ%']G:?\
M\^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C
M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
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MC]@/XN:E*GCCX*/MT:WOR5N+CP])*51"K?-NM)RT# XV1R6R^M?K]0 4444
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MO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%8_@?\
MY!$O_7[-_P"A4?\ "2ZO_P!"A>_]]+69X5US4;73I(X?#=S.#<R,71EP"6Z?
MA0!U=%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_
M 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T
M ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_W
MTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?
M2T ;%8]E_P CO>_]>47\S1_PDNK_ /0H7O\ WTM9EKKFHKXINKI?#=RSO;1J
MT 9=R@$\F@#JZ*Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
MH4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_O
MI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V
M*Q_$O_(7T?\ Z_3_ .@FC_A)=7_Z%"]_[Z6LS7-<U&?4=-DD\-W,9CN2R(S+
MF0[>@H ZNBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H
M4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z
M6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI
M:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -
MBLWQC_R+%[_UP-0_\)+J_P#T*%[_ -]+5'Q+KVIW.@W4$WABZA5HB#*[+A?<
MT =!IW_(/@_ZXK_(5-6%9>(]52SB1?"5XP$2@,&7!XZU+_PDNK_]"A>_]]+0
M!L45C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM &Q16/\ \)+J_P#T*%[_
M -]+1_PDNK_]"A>_]]+0!L45C_\ "2ZO_P!"A>_]]+7YU_\ !QY_P6$O/^"<
MO[',_P ._AC/+IOQ9^*%M/IOA&19U\[2+/ 6[U3 .59%<1Q'C]](K#<(G% '
MP3_P6F_:-^*O_!>7_@JQX/\ ^"._[''B!G\ >!O$,B^+-?MLR6DFHP@KJ&IR
MX(#PV41D@B&1YDSRA6;S8Z_>C]F7]G+X5?LC? 'PG^S5\$?#ZZ9X6\&Z-%IV
MDVW!=E49>61@!OED<O)(^,L\C,>37YS?\&Q__!*_5/\ @GO^RB_[0GQ@^&UY
M_P +8^+5G#>ZFUU&!-HVCG$EK8?-\R2/D3S#@[VC1AF &OT[_P"$EU?_ *%"
M]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+
MW_OI:/\ A)=7_P"A0O?^^EH / __ "")?^OV;_T*MBN4\*ZYJ-KITD</ANYG
M!N9&+HRX!+=/PK3_ .$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?
M_H4+W_OI: /Y\/\ @K=X)\6?\$$_^"[_ ('_ ."HGP;T&X7X:_%75)K[Q3I=
M@F(Y)92L>N6&/N[I5D6]BW<><Y(&(:_H2\#>-O"?Q+\%:/\ $;P'KUOJFAZ_
MI=OJ6C:G:/NBN[2>-98ID/=61E8'T-?)_P#P6C_82'_!3C_@G]XQ_9UB\#3#
MQ3;1#6_A_?3%!]EUJV5C"-Q/RK,K26SMV2X8]0*^*O\ @TC_ ."D7B+XE_LW
MZ_\ \$X_B[:7DGC;X-SRRZ!:7C;+E]"DG*O R/\ -NM+IFB.<;4G@0 ;* /V
M:HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C
M_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL
M?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@ LO\ D=[W_KRB_F:V*Y2UUS45\4W5
MTOANY9WMHU: ,NY0">36G_PDNK_]"A>_]]+0!L45C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM &Q16/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+0!L45
MC_\ "2ZO_P!"A>_]]+5K2M5O=0D=+K1)[4*N0TI&&]N* +U%%% !1110!\O?
MMU_";]MK6&\=^*_V;K_PKXF\-^*/@U>^&M6^'7B74+NPN%OU6^:&_L+F&&X0
MRNMX8G@>%1+Y4.9DVC%/]F[]@GQ#=?M'>+?VU/VN--\*7OBKQ=\.M*\#V/@G
M18GO=+TC0K.5KHQSSW,,37]Q+<OYC.T$2QK''&JMM+GZMHH ^0/V_P#_ ()2
M?#/]JNQ^#UM\)?A]\//"K_#[X]>&_&_B-I/"T,?]JZ3I[S-<Z>/)B^8RB11M
M?]V=OS=JZW]I7]AF[\2_'KX2?M?_ +,\?A_1/'OP@@OM)L=$U(/9Z3KWAZ]A
M\JXTJ:2WBD>U",(YX)4BE$4D9!B=9#CZ2HH ^;/V>OV$6T?XY_%W]K3]IDZ'
MKGCGXR:;9Z'J>BZ5YD^EZ%X=M8##%I,$LR))<B0O)-/.T<0E>0 11K&,^.P_
M\$JOCT/V'G_X)-R?%#P\/@:=4-JGC47UT?%/_"*F_P#MO]A_93 +<3;<V?V_
M[01Y'S?9M]?>M% %+PWX<T+P?X=L/"/A?2H;'3-*LHK/3K*W3;';P1($CC4=
ME55  ]!5VBB@ HHHH \+_P"">_\ R1/5O^Q[UG_TI->Z5X7_ ,$]_P#DB>K?
M]CWK/_I2:]TH **** "BBB@ K'\#_P#((E_Z_9O_ $*MBL?P/_R")?\ K]F_
M]"H V**** "BBB@ HHHH **** "BBB@ HHHH *Q[+_D=[W_KRB_F:V*Q[+_D
M=[W_ *\HOYF@#8HHHH **** "BBB@ HHHH **** "BBB@ K'\2_\A?1_^OT_
M^@FMBL?Q+_R%]'_Z_3_Z": -BBBB@ HHHH **** "BBB@ HHHH **** "LWQ
MC_R+%[_UP-:59OC'_D6+W_K@: +FG?\ (/@_ZXK_ "%35#IW_(/@_P"N*_R%
M34 %%%% !1110!R?QU^-WPS_ &;/@WXF^/GQD\30Z/X7\(Z-/J>MZC,>(H(E
M+$*.KNW"J@^9V95 )(%?S]?\$LO@C\3/^#B__@L#XJ_X*A?M5>&9A\(?AKJ\
M \/^'+X>9;/)"2^EZ*N?ED2)3]KNL?*[OAE N>.\_P"#E+]M[XK_ /!1#]L7
MP9_P0B_8:N#JES/XDM1\0IK28^3=:M_K([.5TSBVLH@US<'D*ZC(#6QS^QW_
M  3[_8A^%'_!.W]DGPA^R=\'[<-8>&]/ U'5'A"3:OJ$GSW-[+C/SRR%FQD[
M%V(/E10 #V>BBB@ HHHH **** ,?P/\ \@B7_K]F_P#0JV*Q_ __ "")?^OV
M;_T*MB@ HHHH *_G=_X+1?#OQG_P0Q_X+A_#_P#X*T? O0)QX"^)>L27GBS2
M[%=L<MXP$>M6)_A!N8)/M49?_ENTC ?N1C^B*OE__@L3_P $^-#_ ."F7[ 7
MC;]F>:VMQXB:U_M;P'?SX L]<ME9K9MQ^XLF7MW;M'<28YQ0!]#?#?XB>#/B
M[\/="^*OPYU^#5?#_B71[;5-#U.V;,=W:7$2RQ2K[,C*?QK:K\8_^#0K_@H/
MKGCGX)>*_P#@F'\<KFXM/&OP?NY[KPU8ZGE+DZ.]P4N;1E;YMUI=L5(/W4NH
MD Q&:_9R@ HHHH **** "BBB@#'LO^1WO?\ KRB_F:V*Q[+_ )'>]_Z\HOYF
MMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \+_
M .">_P#R1/5O^Q[UG_TI->Z5X7_P3W_Y(GJW_8]ZS_Z4FO=* "BBB@ HHHH
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M16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^- &Q6;XQ_P"18O?^N!J'[%XW_P"@W9?^ Q_QJCXEM/%J:#=/?:M:O$(C
MYB);D$CV- '0:=_R#X/^N*_R%35A65GXT-G$8M9LPOE+M!MCD#'UJ7[%XW_Z
M#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &OG3_@JA_P % ]+_ ."8/[&7B?\
M:D\?ZWIMU?6D8L?!^@/$5;6=8F5OL]L.<[?E:20CE8HI&&2 " ?G/_P=6_\
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M%;7Q3)ITC6&J6T:?:9 5D@).[=R:T_L7C?\ Z#=E_P" Q_QH V**Q_L7C?\
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M(E_Z_9O_ $*MBL?P/_R")?\ K]F_]"H V**** "BBB@ HHHH **** "BBB@
MHHHH *Q[+_D=[W_KRB_F:V*Q[+_D=[W_ *\HOYF@#8HHHH **** "BBB@ HH
MHH **** "BBB@ K'\2_\A?1_^OT_^@FMBL?Q+_R%]'_Z_3_Z": -BBBB@ HH
MHH **** "BBB@ HHHH **** "LWQC_R+%[_UP-:59OC'_D6+W_K@: +FG?\
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M_P"E)KW2O"_^">__ "1/5O\ L>]9_P#2DU[I0 4444 %%%% !6/X'_Y!$O\
MU^S?^A5L5C^!_P#D$2_]?LW_ *%0!L4444 %%%% !1110 4444 %%%% !111
M0 5CV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\S0!L4444 %%%% !1110 4444
M %%%% !1110 5C^)?^0OH_\ U^G_ -!-;%8_B7_D+Z/_ -?I_P#030!L4444
M %%%% !1110 4444 %%%% !1110 5F^,?^18O?\ K@:TJS?&/_(L7O\ UP-
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MQ16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\
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M (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
MC0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (T ;%%8_P!B\;_]!NR_
M\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P
M&/\ C0 >!_\ D$2_]?LW_H5;%<IX5M?%,FG2-8:I;1I]ID!62 D[MW)K3^Q>
M-_\ H-V7_@,?\: -BBL?[%XW_P"@W9?^ Q_QH^Q>-_\ H-V7_@,?\: -BBL?
M[%XW_P"@W9?^ Q_QH^Q>-_\ H-V7_@,?\: -BBL?[%XW_P"@W9?^ Q_QH^Q>
M-_\ H-V7_@,?\: -BBL?[%XW_P"@W9?^ Q_QH^Q>-_\ H-V7_@,?\: /P:_X
M.</V;_B1_P $Z?\ @H#\*/\ @N)^RMIWV6:X\06EMXR6%2L/]L6T9$1FV_\
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MG_TI->Z4 %%%% !1110 5C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A4
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MP;;>'_#L^ED+I-YXH_LG4;?5-1M-G[MHO.N[5))8\H]Q#<KDF(X\[7XPN?\
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MH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V*Q_$O\ R%]'_P"OT_\
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M[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;4 ;%?@9_P=L?L[WW[(W[37P7_X+#_L[^*;#0/&
M\?B*UTO5H!<(D]YJ%@OVFQOA%D-.HAB>VG_A");(>'.?V;_:J^(.D?LO_LX^
M-/VA?^%?^+/&'_"'^'[C4_\ A&?"VZ>_U#RUSY<2?JS<[5#-@XP?XT_^"B/_
M  40_:$_X*6?M#7_ ,?/CWKK8R\'AKPW;W#M9:!8[LK;6ZL?H7D/S2-EF[
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M.1?^#;K/]O?\%"_^">G@+_GKJ'Q+^&>CVWU:75-/B4?5IK=1ZR(/O+7[_44
M?Q!?\$W?^";O[1O_  5 _:/L/V>/V>M"Y^6X\2^);R-OL/A^PW /=7##\DC'
MS2-A5[D?U_?\$W?^";O[./\ P2__ &<;#]GK]GK0/[MQXF\37D2_;_$%_MP]
MU<./Q"1CY8UPJ]R>I_9\_9:_9U_9B\:>,(_V?/@WH'A!?%NIG6_$:Z'8+ +^
M_E)WS/C\<*,*N3M R<^K4 %%%% !1110 4444 %%%% !1110 45Y_P#M'?M1
M? K]D[P!/\1_CM\0K#1+)(+A[*UFG4W>I20PO,\%I!G?<2^6C-L0$@*2< $B
M3X%_M/? #]I;3[Z^^!WQ8T7Q%)I+1)KFG6-ZIO-)DE4M''=VQQ+:NR@D+*JD
M@$C(YH [RBO!O!__  5%_P""=GQ ^/S_ ++?@K]LWX>ZGX_6]>R7PS:>(X7F
MFNE)#6T;9V2S @@Q(S."K C(./4_BS\9?A7\"O"?_"<?%_QYIOA_2VO(K2"Y
MU&X"?:+J5ML5O"O+332-\J1(&=SPJDT =-17,_";XS?"WXZ^%6\:_"/QQ8:]
MIL=Y+9W,UE+\UK=1'$MM-&P#P3(2 T4BJZD\J*YEOVR_V65^*W_"D3\=/#__
M  DPU@:.VGB\RBZF4WC3C-CRA>%/F%J7\XKSLQS0!Z91110 4444 >%_\$]_
M^2)ZM_V/>L_^E)KW2O"_^">__)$]6_['O6?_ $I->Z4 %%%% !1110 5C^!_
M^01+_P!?LW_H5;%8_@?_ )!$O_7[-_Z%0!L4444 %%%% !1110 4444 %%%%
M !1110 5CV7_ ".][_UY1?S-;%8]E_R.][_UY1?S- &Q1110 4444 %%%% !
M1110 4444 %%%% !6/XE_P"0OH__ %^G_P!!-;%8_B7_ )"^C_\ 7Z?_ $$T
M ;%%%% !1110 5F^,?&'A3X>^$]3\>>.O$=EH^BZ-82WNK:KJ5RL-O9VT2%Y
M)I'8A4154L6)P #6A++%;Q-//*J(BEG=VP% ZDGL*_GF_P""PW_!2CX__P#!
M=']KS3_^"./_  2RN'U'P&NK;?&?BRSF9;/7I() 9;F:9 =NDVI 8-R)Y0I4
M/^X# '*_M??M)_M1?\'4W_!0>P_8E_8\NK_P]^SOX$U$7FJ>(+FV=8&A5C&^
MMWB<;Y7&^.SM&(;#$G86F:/]]/V-?V//@1^P=^SMX>_9B_9S\))I/AOP];;5
M+X:XO[AL&6[N9 !YL\K?,S8 Z*H5551PO_!+_P#X)H_ 7_@EE^R]IG[.WP5L
MA=7C;;OQ?XKN+<)=^(-2*@/<RXSM0?=CB!(C0 99BSM]%T %%%% !1110 5F
M^,?^18O?^N!K2K-\8_\ (L7O_7 T 7-._P"0?!_UQ7^0J:H=._Y!\'_7%?Y"
MIJ "BBB@ HHHH **** "BBB@ HHHH **** ,?P/_ ,@B7_K]F_\ 0JV*Q_ _
M_((E_P"OV;_T*MB@ HHHH **** "BBB@ HHHH **** "BBB@#'LO^1WO?^O*
M+^9K8K'LO^1WO?\ KRB_F:V* "BBB@ HHHH **** "BBB@ HHHH _,C_ (+O
M?#[]K[X.?%'1_P#@HI\ OA++\3_!V@?!;Q5X#^(?@JRF(O\ 1;'4T#MKEDF&
MWF-HX_.VC=Y4 !PC/)%])?L6>/?V)O\ @H5\'-<_:E_9?^)IU+_A8GP]TWP9
MXOU+0[@6FHZ:+)+XQPRKM$MM>1'4[@AGS\OE,F5VLU7_ (*)?M(?$#X3>'/B
M7\.?%GP,\7ZE\/M>^!FI2:1XX\*>%[G5HK#6A%?QW%I>QV8EGAC>%K-TF,0A
M7;-OD'&/&/V*O@3=?"']MOXX?\%(OA7^SOXO\*?#'Q#\)='T]O!UGX6FM-4\
M>>)+9Y)[C5K?2)!'+$VQDMD:=(FFDEFE.%9I& (?^"X?[!OP$\=?L4> OV8_
MV;O@SX<\,_$W4/B9X<TKX&77AC18;2YT"YCO8I[RZB:%0\=O!IL%[-*1\H\I
M&/S!*T?CAXVUCXN_\')?P9_9XUV5I?#GPL_9YUGX@:;8R?ZMM9OKV323<%>C
M/';C",>4\V3;C<<\I\-_^"CG[2%KX^U7]HKXP?\ !%W]JC6OB!<V<^G>';.U
M\(:<--\-Z6T@<6%K(]]OW3-'%)<W1C#S.B#8L4,,2>J_M$_L_P#Q?\"?\%"O
M@5_P53M?AG?:C)8_#B[\ ?&[PWX3MY=4O--L+K_3+:[M(8D\V^BM]0+I*L2-
M*8Y5D2-MC"@#P+]I3]J/QG^PS_P5Q_:Y;X93E+76OV'YOBO)8A=T7_"2:-YE
MA;7!0\ O J*[8^811[L[1@TWX/:3'_P:4RSW5U,=5E^ TOQ$?6O/;[6VO%VU
M];\S9WFX^U[7\S.[('->S_#[]@_4OVR/VT/VC?VR_CKX,UCP[X0^)OP<3X/^
M -+UNP:TU2Y\/21,^IZA-:R@26@FN7"PQ3*DVR$N\:;U%>81?!O]KV7_ ((R
MO_P1L/P8\1GXNIHA^&X\3-H%ROA<Z#]J\D:__:A7[,8/[+P_V82&[\[]UY'\
M5 'W7^P)\:/$7[1W[#/P<^/WC!@=8\:?"_0=;U=E0*#=W.GPS3$ =!YCMCVK
MUNN4^!'PA\,_L^? _P &_ 7P6SG1_!'A73] THR@;C;6=M';Q%L=]D:Y]ZZN
M@ HHHH ^?OV!O$&BZ9\&M6MM0U&.*3_A.=9;:YYQ]I;FO;_^$Q\,?]!J#_OJ
MO&?^"?EI:S_!75GFMHW/_"=:R,L@)_X^37N7]G:?_P ^,/\ WZ% %/\ X3'P
MQ_T&H/\ OJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z% %/_
M (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!
M3_X3'PQ_T&H/^^JR_"7B70;'3)(;O5(HV-U*P5CV+<&N@_L[3_\ GQA_[]"L
MCP796<NE2-+:1,?MDHRT8/&Z@"W_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?57
M/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\ H-0?
M]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z#
M4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z
M#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\
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M]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
M/C#_ -^A1_9VG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJK
MG]G:?_SXP_\ ?H4?V=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[
MZJY_9VG_ //C#_WZ%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H
M/^^JN?V=I_\ SXP_]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^JR]>\2Z#<
MZGIDT&J1,L-T6E8'[HV]370?V=I__/C#_P!^A61XCLK--5TE4M(@&O"& C'(
MVF@"W_PF/AC_ *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8
M?^_0H I_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"OR%_X..?
M^"XE_P#LRVX_X)O_ +!DLFJ_'+QHL5AK6H^'H//NO#,-UA8K:W$8+'4K@.HC
M5?GB1PX =XB #R?_ (.%O^"T'Q)_:2^*"_\ !&'_ ()=W-UX@\2^*+_^Q?B+
MXA\/2_//(^5DT6WE! 1%4,;N;(5$5HRP43X^\/\ @B1_P2@^ 7_!([]F]/#4
M>M:9KGQ/\4013_$3QE$A_?S 96RMBP#+:0DD+G!D;=(P!8(GF_\ P;U?\$)?
M#?\ P3+^$G_"]_VA-'L]6^.OC.P!UJYEVSIX8M'P_P#9L#\AI2<&>93AW 12
M43<_Z5?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN
M?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_O
MJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJL_Q1XH\/WGA
M^[M;758GD>(A$4\DUN?V=I__ #XP_P#?H5G>+K&RC\-7CQV<2L(3@K& 10 6
M/B[PU'90QOK,(98E!!/0XJ7_ (3'PQ_T&H/^^JFT_3[!K" FRA),*Y)C'H*F
M_L[3_P#GQA_[]"@"G_PF/AC_ *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_O
MT*/[.T__ )\8?^_0H I_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_
M +]"C^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_
M /GQA_[]"C^SM/\ ^?&'_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^
MSM/_ .?&'_OT*/[.T_\ Y\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5
M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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M8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\
MPF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*
M *?_  F/AC_H-0?]]58T_6])U5VCTZ_CF9!E@AZ"I/[.T_\ Y\8?^_0I\5M;
M0$F"W1">I1 ,T /HHHH **** (KVRL]2LY=.U&TBN+>XB:.>":,.DB,,,K*>
M"""00>"#4D<:1(L42!54 *JC  ]!2T4 %%%% !1110 4444 %%%% 'A?_!/?
M_DB>K?\ 8]ZS_P"E)KW2O"_^">__ "1/5O\ L>]9_P#2DU[I0 4444 %%%%
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M(VQV\:A!9P !0J)(%")#N_=^@ HHHH **** "BBB@ HHHH *S?&/_(L7O_7
MUI5F^,?^18O?^N!H N:=_P @^#_KBO\ (5-4.G?\@^#_ *XK_(5-0 4444 %
M%%% !1110 4444 %%%8OQ!^)/PZ^$OA:Y\<_%7Q]HOAG1+,9N]8\0:K#96L
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MCWK/_I2:]TKPO_@GO_R1/5O^Q[UG_P!*37NE !1110 4444 %8_@?_D$2_\
M7[-_Z%6Q6/X'_P"01+_U^S?^A4 ;%%%% !1110 4444 %%%% !1110 4444
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MKX$_86^(=G_P51_;G^!_[/?_  5;_;.UJ+X<^%K)-#T&;7;QMKPHV^'2Q<#
M@:Y?9"UW*2^Q$4OE8MO]A/@3P)X,^%_@K2?AQ\.O#%CHF@Z%I\-CHVD:;;K#
M;V=M$@2.*-%X554  #TH T[6UMK*VCLK*W2&&% D442!510,!0!P !QBGT44
M %%%% !1110 4444 %%%% !6;XQ_Y%B]_P"N!K2K-\8_\BQ>_P#7 T 7-._Y
M!\'_ %Q7^0J:H=._Y!\'_7%?Y"IJ "BBB@ HHKR?]IK]NO\ 8W_8ST<ZW^U+
M^TQX-\#H8O,AM-=UR*.[N5_Z8VP)FG/!XC1C0!ZQ17YXZA_P7HUKX^V\T/\
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M5OQUU_\ X3JU_9FM/A]XKC<R6?BWX2ZA-X:O;64]95%BR0LYZ[GB<YYK@?\
MAV__ ,%>?V7/W_[#7_!7S4/&NDV__'MX&_:<\-)KB2X^Z)-9M0MXH[81!Z]A
M0!9_XZA_#_\ T8UXAA'_ &-UI<,?UC X^N6]!1_PO+_@Y(\/?\AC]A7]FSQ%
MM^]_8'Q.O[3?WP/M2''!QSW!/3%5O^'FW_!5K]E__1_V\?\ @CSXA\2:5;_\
M?/CK]FGQ!%XCAE ^\ZZ3,4NXD'7,C]/H:]&_9]_X+U?\$JOVAM:'@RP_:JTK
MP9XH2017?A/XGVTOAN_MYO\ GB1?K'&\G3Y8W?)..M '!?\ #<?_  7W\/\
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M2JX4 ;E5?F96D=]EX?\ "EC_ ,&C+:<8H39M^R-)=XP-OVM],,^?][[0V?\
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MR?\ !-+_ ()TK>:#\8_CQ;:[XOM RGP#X&":GJPD'_+.94<16C>UQ)$2.F:
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M^$EU?_H4+W_OI:/^$EU?_H4+W_OI:V** ,?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EK8ILDD<,;332*B(I+,QP !U)- '$?%CX^^#/@5\-M:^,'QAFC\.
M>&/#M@][K>MZK=)%!:0(.79B?H !DL2  20*_&_]H_\ X/7?V;=$\3WO@_\
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MF.;PG^Q;\,9O"_A^)LX:.7Q9K*"ZB4_<.Z!T/)!]?2_V<?\ @BQ_P4$;6O\
MA,? 7['/P%_9YN[J;S[GQO\ $-I?BMX\2<_\M_.OV;35DQU,21<^Q-?N/965
MEIMG%I^G6D5O;P1B.&"",(D: 8"JHX  XP*EH _.'3_^""7PS^+EQ#K/_!1;
M]I7X\_M&72.KOHGBWQO)I?AV-UY!@TS3VC$ S_")67@#'K];?LZ?LF?LL_LC
M:6-)_9D_8Y\+>!D\ORY9_#?A^UMKB<?]-9U7S9C[NS'WKVBB@#'_ .$EU?\
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M",4?Q#\&ZB-%\>0Z6%2"XG\L/#?1QG_5I/&22G19(Y0/E"U_'M7](7_!DK\
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M9O\ T*MBL?P/_P @B7_K]F_]"H V**** "BBB@ HHHH **** "BBB@ HHHH
M*Q[+_D=[W_KRB_F:V*Q[+_D=[W_KRB_F: -BBBB@ HHHH **X?\ : _:8_9\
M_93\ 3_%']I+XS>'/!&@09!U/Q)JL=JDC@9\N,.099#VC0,[= #7Y#?MK_\
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M (5IXF&T;<9YTWG\*^)O^#G7_@NU^QK^T'^PI)^Q9^Q;\<]$\?:AXX\1V?\
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MFD:M?P:G/:W6GZC9:D;M;>YL;JWE;SDWV-RC+(D4B,@RF&5B >Q45\^>'?\
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MV%%>1:U_P4!_8-\-@MXA_;:^$5@% +&]^).EQ8&<9^:<=^/K7)ZW_P %>/\
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M_@VR_8"A&K?&WX0?!7PS+&OFEOBOXQ-_-<D\[A%JUU*96;KM53G/ K%\&_\
M!:#_ ((T?"?4Y?!W_!.7]ECQ%\4=:M&\K^Q_V;?@%(WEOT"^;Y%M%MZ?,C,
M/7I0!UW_ !$+_!7QWB+]EW]@;]JCXN&7_CVOO!_P8N([ ^C/<7<D7EH?[Q4]
M1Q2_\/$_^"T_Q5RGP)_X(97&@6<G^IUSXK?&K2]/V>F^QA1I_P F]JC_ .&X
M_P#@NG^T1B/]F/\ X))>%_A?IT__ !Z>*/VA/B6F2#WDTO35^U18ZD%CGMTH
M_P"'?'_!:;]H4F;]J[_@L?%X%TV?_CY\)_L]?#NWT_9GKY6K7A-VN.@RA]:
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MB_[<VOF2 R#L\;#\Z_:>B@#^?[_@N!_P;C?&KPC^Q /VA?AG^T[\2_C7XQ\
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M ^>OV"]8O[#X.:M!;:!<7*_\)QK)\R(C&?M+<<U[;_PDNK_]"A>_]]+7D?\
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MZ]B\#_LG_P#!R_.%7X;?MT_#]^"$&A_$[0SQD' \J+U(/U(K]O-?_P""+_\
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MJM_PYV_:J^.(\_\ ;T_X*U?M$^/4EYN] ^'5S9^"-'N >L<MM8K(9$[?>4\
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M/_U^G_T$T '_  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2ZO\
M]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DNK_\
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M/_I2:]TH **** "BBB@ K'\#_P#((E_Z_9O_ $*MBL?P/_R")?\ K]F_]"H
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M31?B5X(U5+[1?$.DVVIZ1?1@[;BUGB66*09[,CJ?QK6H **** /"_P#@GO\
M\D3U;_L>]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)KW2@ HHHH **** "L?P/\
M\@B7_K]F_P#0JV*Q_ __ "")?^OV;_T*@#8HHHH **** "BBB@ HHHH ****
M "BBB@ K'LO^1WO?^O*+^9K8K'LO^1WO?^O*+^9H V**** "BBB@ HHHH **
M** "BBB@ HHHH *Q_$O_ "%]'_Z_3_Z":V*Q_$O_ "%]'_Z_3_Z": -BBBB@
M HHHH **** "BBB@ HHHH **** "LWQC_P BQ>_]<#6E6;XQ_P"18O?^N!H
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M\"?^$N]>]44 >"_\*^_X*'_]'!>!/_"7>C_A7W_!0_\ Z."\"?\ A+O7O5%
M'@O_  K[_@H?_P!'!>!/_"7>C_A7W_!0_P#Z."\"?^$N]>]44 >"_P#"OO\
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MU'7)/V?_ (AVD?A'6=7O'N;W_A&]8MGO-/M)IY2SW#VP26$2R%G:,1!B2"S
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M\$CD_;WQ-^#_ ,)?C7H">%/C)\+O#GBW2X[A;B/3?$VB07]NLJ@@2".=&4,
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M)M$@O[=95! D$<Z,H8 D!L9&3ZT[Q)\)/A3XQ\%P_#;Q?\,O#VJ^';98EM]
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M[+?PYT_4=/N8[FPO['P18136TR,&22-UB#(ZL 0P(((!%>C4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$5E\2/!]_;I^]@;3WW71!'.U;9I9\=VMH_0$?,7[3_PFNO\ @MY_P2R^./\
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M;7QY<)X4EU6Z0B;4/[, \J28L0X67S(E=(R(QY<84 _-GXXD-_P9%: 5.?\
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M::46ZBZ<HR@RQ9:(?8O_  <!R-+9_L32N^YF_;D\ $L>Y(O.:[&R_P"#=_\
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M^&$_C#X5^*]61CJ6AVL%P8?L\S,SND68Y(C&7= 5@:(QAWCI_P#P1*^'\O\
MP4,_X)>>)O ?Q'_;)^(.FZ[K?BGQCH_QT\#Z58>&6-OJ.H:E>O<B5KS1Y[K,
MUO<(P>25B.40@1!5^]_V<OV$_A!^SK\3/$/QZ'B+Q1XW^)/BJPAT_7?B+X^U
M9;W5);")M\=C%Y4<5O9VP<E_(MH8D9SN8,0"/"?CC_P;[?\ !/SXV?M,ZO\
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MUWX9ZA\,--M_'5F^JR6B1ZK8LDVH32SPR1R0R+J,$L[/O4DDL20QS[U\ _\
M@G%\'OV=_P!I?Q]^UGX1^(?CC4?%_P 4Q;#XAR:[JUO/:ZY]FB:*V\R!;=4B
M\E&(00B, ?+RI*GQ?PE_P;L_\$X? ?QBU3XD^#M)\>:9X:UO5_[4UCX06/CJ
MZA\&WUUN#;IM-3 FCW 'R'=H< )Y?EC90!]E?":;P1<?"OPS<?#.)T\-OX?L
MF\/I(DJLMB8$, (F_> ^7LX?YO[W.:Z"O&/CK^PC\$/VAOVE?A)^U5X\O/$<
M7B;X+W6H7'A"'2M<>WLI&O(DBE%S"!^] "+@ KGE6WJ=M>ST %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKX0\6?'_ /X.%+/Q5J=IX._X)^? >\TB+4)DTJ[N_BO<1RSVP<B)W01_*S)M
M)'8DBON^B@#X!_X:'_X../\ I'5^S_\ ^'=N/_C='_#0_P#P<<?](ZOV?_\
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M@\9_$/QEX23X0>#M7/P\U#QM<0Z%+<#2+61%E@M_+>:)&.4BDD9%P %P,5]
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 445^ /_$<Y_P!8NO\ S-G_ -Y: /W^HK\
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MOB5K)TI=7^V1VWG_ &8W7E[=C$^7CR]QW;<\T ?JE17YB_\ !U3K/CGX4_\
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M_P#@XX_Z1U?L_P#_ (=VX_\ C=??U% 'P#_PT/\ \'''_2.K]G__ ,.[<?\
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M^+^J> _ >N>.O%:ZCXITZ.Q=;+7O[)BMM'9AJ%M<6P9I+RYC5I(FV^:SJ49
MP^COV_\ _@FI\!_^"EO@>Q^%?[3GBKQE-X3L-0AU"'PUH&M1V%L][&LBI<.Z
M0^=(P65@%:0H, A W)O?M*_\$ZOV=/VS?V76_9,_:VMM7^(?A]94GL]5U^]C
M35;.XC4K%<Q7-O'$5F169?,(+.KNLGF!V! /-=8_X)\? CX?_P#!0GX<?\%
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M@];WJ7 SYT4VBRI*I/7#*S X/>O;?^"]]Y\/?V:/AA\$?&6EVUE\/O"/B?\
M:I\&)\7O%_AO1+&*5;"UCNI+:XN_.MY8IX[>:"WE'GQRHOV=%VD84^O>,O\
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M_AO']OCQ:?".G-J@_:)NK-=0:S0S+;RQ&66$.1D(\F&91PQ )S@8^C?V;O\
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M?TW0;1+33+SQ9J8O;U+=%"QQ//L5Y0H7 :3<Y[L>, '94444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524484832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 25, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-8036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WEST PHARMACEUTICAL SERVICES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">23-1210010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">530 Herman O. West Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Exton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19341-0645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">594-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.25 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WST<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,135,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.261%"><tr><td style="width:1.0%"/><td style="width:68.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Parts Into Which Incorporated</span></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proxy Statement for the 2023 Annual Meeting of Shareholders to be filed not later than 120 days after the end of the fiscal year covered by this Form 10-K.</span></td><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Part III</span></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000105770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524478128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Philadelphia, Pennsylvania<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524548464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 2,886.9<span></span>
</td>
<td class="nump">$ 2,831.6<span></span>
</td>
<td class="nump">$ 2,146.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">1,750.7<span></span>
</td>
<td class="nump">1,655.8<span></span>
</td>
<td class="nump">1,379.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,136.2<span></span>
</td>
<td class="nump">1,175.8<span></span>
</td>
<td class="nump">767.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">58.5<span></span>
</td>
<td class="nump">52.8<span></span>
</td>
<td class="nump">46.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">316.9<span></span>
</td>
<td class="nump">362.8<span></span>
</td>
<td class="nump">302.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherIncomeExpense', window );">Other expense (income) (Note 16)</a></td>
<td class="nump">26.8<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">734.0<span></span>
</td>
<td class="nump">752.3<span></span>
</td>
<td class="nump">406.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">7.9<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other nonoperating expense (income)</a></td>
<td class="nump">51.3<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="nump">679.9<span></span>
</td>
<td class="nump">748.9<span></span>
</td>
<td class="nump">401.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">114.7<span></span>
</td>
<td class="nump">107.2<span></span>
</td>
<td class="nump">72.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net income of affiliated companies</a></td>
<td class="num">(20.7)<span></span>
</td>
<td class="num">(20.1)<span></span>
</td>
<td class="num">(17.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 585.9<span></span>
</td>
<td class="nump">$ 661.8<span></span>
</td>
<td class="nump">$ 346.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 7.87<span></span>
</td>
<td class="nump">$ 8.89<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 7.73<span></span>
</td>
<td class="nump">$ 8.67<span></span>
</td>
<td class="nump">$ 4.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_WeightedAverageSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">73.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">75.8<span></span>
</td>
<td class="nump">76.3<span></span>
</td>
<td class="nump">75.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_WeightedAverageSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_WeightedAverageSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524525408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 585.9<span></span>
</td>
<td class="nump">$ 661.8<span></span>
</td>
<td class="nump">$ 346.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments, net of tax of $2.2, $2.4, and $(1.0)</a></td>
<td class="num">(47.3)<span></span>
</td>
<td class="num">(59.3)<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax', window );">Prior service cost arising during period, net of tax of $0.0, $0.5, and $0.0</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Net actuarial (loss) gain arising during period, net of tax of $(2.4), $2.1, and $(0.7)</a></td>
<td class="num">(9.3)<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax', window );">Settlement effects arising during period, net of tax of $20.3, $0.4, and $0.9</a></td>
<td class="nump">31.9<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Less: amortization of actuarial (gain) loss, net of tax of $(0.1), $0.1, and $0.0</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax', window );">Less: amortization of prior service credit, net of tax of $0.0, $(0.1), and $(0.1).</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax', window );">Less: amortization of other, net of tax of $0.1, $0.0, and $0.0</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net gain (loss) on equity affiliate accumulated other comprehensive income, net of tax of $0.0, $0.0, and $0.0</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Net gain (loss) on derivatives, net of tax of $0.2, $0.5, and $(0.6)</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(23.4)<span></span>
</td>
<td class="num">(49.0)<span></span>
</td>
<td class="nump">39.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 562.5<span></span>
</td>
<td class="nump">$ 612.8<span></span>
</td>
<td class="nump">$ 385.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment out of other comprehensive income for settlement effects recognized as a component of net periodic benefit cost during the period, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524398208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent', window );">Foreign currency translation adjustments, tax</a></td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="num">$ (1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect', window );">Prior service credit arising during period, tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Net actuarial gain (loss) arising during period, tax</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax', window );">Settlement effects arising during period, tax</a></td>
<td class="nump">20.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax', window );">Less: amortization of actuarial loss, tax</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax', window );">Less: amortization of prior service credit, tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax', window );">Less: amortization of other, net of tax</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Net gain (loss) on investment securities, tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent', window );">Net gain (loss) on derivatives, tax</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="num">$ (0.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520616416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 894.3<span></span>
</td>
<td class="nump">$ 762.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">507.4<span></span>
</td>
<td class="nump">489.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">414.8<span></span>
</td>
<td class="nump">378.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">103.0<span></span>
</td>
<td class="nump">112.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,919.5<span></span>
</td>
<td class="nump">1,742.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">2,386.6<span></span>
</td>
<td class="nump">2,215.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="nump">1,228.3<span></span>
</td>
<td class="nump">1,157.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,158.3<span></span>
</td>
<td class="nump">1,057.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">104.4<span></span>
</td>
<td class="nump">69.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in affiliated companies</a></td>
<td class="nump">204.9<span></span>
</td>
<td class="nump">207.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">107.3<span></span>
</td>
<td class="nump">109.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">18.4<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">65.6<span></span>
</td>
<td class="nump">48.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Pension and other postretirement benefits</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other noncurrent assets</a></td>
<td class="nump">38.1<span></span>
</td>
<td class="nump">39.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">3,616.8<span></span>
</td>
<td class="nump">3,313.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_NotesPayableAndOtherDebtCurrent', window );">Notes payable and other current debt</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">44.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">215.4<span></span>
</td>
<td class="nump">232.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Pension and other postretirement benefits</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_AccruedSalariesWagesAndBenefitsCurrent', window );">Accrued salaries, wages and benefits</a></td>
<td class="nump">76.8<span></span>
</td>
<td class="nump">116.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">24.8<span></span>
</td>
<td class="nump">26.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">181.7<span></span>
</td>
<td class="nump">163.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">519.0<span></span>
</td>
<td class="nump">594.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">206.7<span></span>
</td>
<td class="nump">208.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Pension and other postretirement benefits</a></td>
<td class="nump">28.2<span></span>
</td>
<td class="nump">40.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">93.0<span></span>
</td>
<td class="nump">63.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation benefits</a></td>
<td class="nump">19.1<span></span>
</td>
<td class="nump">28.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">51.6<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">931.9<span></span>
</td>
<td class="nump">978.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 18)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, 3.0 million shares authorized; 0.0 shares issued and outstanding in 2022 and 2021</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.25 per share; 200 million shares authorized; shares issued: 75.3 million in 2022 and 2021; shares outstanding: 74.1 million and 74.2 million in 2022 and 2021</a></td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">18.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in excess of par value</a></td>
<td class="nump">232.2<span></span>
</td>
<td class="nump">249.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">2,987.8<span></span>
</td>
<td class="nump">2,456.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(183.0)<span></span>
</td>
<td class="num">(159.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost (1.2 million and 1.1 million shares in 2022 and 2021)</a></td>
<td class="num">(370.9)<span></span>
</td>
<td class="num">(229.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Equity</a></td>
<td class="nump">2,684.9<span></span>
</td>
<td class="nump">2,335.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">$ 3,616.8<span></span>
</td>
<td class="nump">$ 3,313.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AccruedSalariesWagesAndBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Salaries, Wages, and Benefits, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AccruedSalariesWagesAndBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_NotesPayableAndOtherDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Payable and Other Debt, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_NotesPayableAndOtherDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524423360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200.0<span></span>
</td>
<td class="nump">200.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">75.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">74.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, at cost (in shares)</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521188976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Capital in excess of par value</div></th>
<th class="th"><div>Treasury stock</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 1,573.2<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 272.7<span></span>
</td>
<td class="num">$ (118.1)<span></span>
</td>
<td class="nump">$ 1,549.4<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="num">$ (149.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">346.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Activity related to stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">60.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="nump">$ 65.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">(115.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (115.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(48.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">39.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">1,854.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">267.3<span></span>
</td>
<td class="num">$ (167.7)<span></span>
</td>
<td class="nump">1,846.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">661.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">661.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Activity related to stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">57.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.3)<span></span>
</td>
<td class="nump">$ 75.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">(137.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (137.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(51.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="num">$ (49.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 2,335.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">249.0<span></span>
</td>
<td class="num">$ (229.5)<span></span>
</td>
<td class="nump">2,456.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">585.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Activity related to stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">$ 44.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.8)<span></span>
</td>
<td class="nump">$ 61.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="nump">563,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">$ (202.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (202.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(54.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="num">$ (23.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23.4)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 2,684.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 232.2<span></span>
</td>
<td class="num">$ (370.9)<span></span>
</td>
<td class="nump">$ 2,987.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (183.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923525906352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521523552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 585.9<span></span>
</td>
<td class="nump">$ 661.8<span></span>
</td>
<td class="nump">$ 346.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">116.9<span></span>
</td>
<td class="nump">116.9<span></span>
</td>
<td class="nump">104.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">23.7<span></span>
</td>
<td class="nump">37.5<span></span>
</td>
<td class="nump">34.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash restructuring charges</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Pension settlement charge</a></td>
<td class="nump">52.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Contingent consideration payments in excess of acquisition-date liability</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Fixed asset impairments and sale of equipment, net</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(30.8)<span></span>
</td>
<td class="num">(42.9)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_PensionAndOtherPostretirementBenefitExpenseNet', window );">Pension and other retirement plans, net</a></td>
<td class="num">(14.0)<span></span>
</td>
<td class="nump">14.8<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in undistributed earnings of affiliates, net of dividends</a></td>
<td class="num">(18.1)<span></span>
</td>
<td class="num">(17.4)<span></span>
</td>
<td class="num">(15.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts receivable</a></td>
<td class="num">(35.6)<span></span>
</td>
<td class="num">(123.5)<span></span>
</td>
<td class="num">(46.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(49.8)<span></span>
</td>
<td class="num">(86.5)<span></span>
</td>
<td class="num">(73.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Decrease (increase) in other current assets</a></td>
<td class="nump">18.5<span></span>
</td>
<td class="num">(7.3)<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">(Decrease) increase in accounts payable</a></td>
<td class="num">(2.8)<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
<td class="nump">36.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Changes in other assets and liabilities</a></td>
<td class="nump">58.2<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">67.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">724.0<span></span>
</td>
<td class="nump">584.0<span></span>
</td>
<td class="nump">472.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(284.6)<span></span>
</td>
<td class="num">(253.4)<span></span>
</td>
<td class="num">(174.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisition of business</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="num">(5.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(288.2)<span></span>
</td>
<td class="num">(253.1)<span></span>
</td>
<td class="num">(179.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Debt issuance cost</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Repayments of long-term debt</a></td>
<td class="num">(44.3)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividend payments</a></td>
<td class="num">(54.1)<span></span>
</td>
<td class="num">(51.1)<span></span>
</td>
<td class="num">(48.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock-based compensation awards</a></td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">29.4<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Employee stock purchase plan contributions</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Shares purchased under share repurchase programs</a></td>
<td class="num">(202.8)<span></span>
</td>
<td class="num">(137.1)<span></span>
</td>
<td class="num">(115.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for employee tax withholdings</a></td>
<td class="num">(19.4)<span></span>
</td>
<td class="num">(14.8)<span></span>
</td>
<td class="num">(5.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(293.6)<span></span>
</td>
<td class="num">(168.1)<span></span>
</td>
<td class="num">(137.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rates on cash</a></td>
<td class="num">(10.5)<span></span>
</td>
<td class="num">(15.7)<span></span>
</td>
<td class="nump">20.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">131.7<span></span>
</td>
<td class="nump">147.1<span></span>
</td>
<td class="nump">176.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, including cash equivalents at beginning of period</a></td>
<td class="nump">762.6<span></span>
</td>
<td class="nump">615.5<span></span>
</td>
<td class="nump">439.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, including cash equivalents at end of period</a></td>
<td class="nump">894.3<span></span>
</td>
<td class="nump">762.6<span></span>
</td>
<td class="nump">615.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid, net of amounts capitalized</a></td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net</a></td>
<td class="nump">109.7<span></span>
</td>
<td class="nump">171.8<span></span>
</td>
<td class="nump">48.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued capital expenditures</a></td>
<td class="nump">33.2<span></span>
</td>
<td class="nump">41.1<span></span>
</td>
<td class="nump">31.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends declared, not paid</a></td>
<td class="nump">$ 14.1<span></span>
</td>
<td class="nump">$ 13.4<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PensionAndOtherPostretirementBenefitExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of pension and other (such as medical, dental and life insurance) postretirement benefit costs recognized during the period for (1) defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss) on assets, prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments) and for (2) defined contribution plans (to the extent that a plan's defined contributions to an individual's account are to be made for periods in which that individual renders services, the net cost for a period is the contribution called for in that period; if a plan calls for contributions for periods after an individual retires or terminates, the estimated cost is accrued during the employee's service period); net of cash contributed during the reporting period by the entity to fund its benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PensionAndOtherPostretirementBenefitExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923608735584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The consolidated financial statements include the accounts of West Pharmaceutical Services, Inc. ("West") after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West has been actively monitoring the coronavirus (&#8220;COVID-19&#8221;) situation and its impact globally. Our production facilities continue to operate as they had prior to the COVID-19 pandemic, other than for enhanced safety measures intended to prevent the spread of the virus.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash equivalents include time deposits, certificates of deposit and all highly liquid short-term instruments with maturities of three months or less at the time of purchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our accounts receivable balance was net of an allowance for credit losses of $0.2 million and $0.4 million at December&#160;31, 2022 and 2021, respectively. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Inventories are valued at the lower of cost (on a first-in, first-out basis) or net realizable value. The Company provides for cost adjustments for excess, obsolete or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. The following is a summary of inventories at December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:68.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.875%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other expense (income). Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2022 and 2021. Please refer to Note 6, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuing identifiable intangible assets requires judgment. For example, for recent identifiable customer relationship intangible asset acquisitions, we applied an excess earnings model, which is a form of the income approach. This approach includes projecting revenues and expenses attributable to the existing customers over the remaining economic life of the customer relationships and then subtracting the required return on net tangible assets and any intangible assets used in the business to estimate any residual excess earnings attributable to the customer relationships. The after-tax excess earnings are then discounted to present value using the respective discount rates. Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 3 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. Factors that could trigger an impairment review include the following: 1) significant under-performance relative to historical or projected future operating results; 2) significant changes in the manner of use of the acquired assets or the strategy of the overall business; 3) significant negative industry or economic trends; and 4) recognition of goodwill impairment charges. If we determine that the carrying value of identifiable intangibles assets may not be recoverable based on the existence of one or more of the above indicators of impairment, we measure recoverability of assets by comparing the respective carrying value of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, we measure an impairment based on the amount in which the net carrying amount of the assets exceeds the fair values of the assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Benefits:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a more detailed discussion of our pension and other retirement plans. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#8217;s gain or loss is initially reported as a component of other comprehensive income (&#8220;OCI&#8221;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#8217;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less. In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less. Please refer to Note 3, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Revenue</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">,</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are primarily expensed as incurred. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Remediation and Compliance Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. Please refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other expense (income). The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a more detailed discussion of our stock-based compensation plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923529792944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Standards<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Standards</a></td>
<td class="text">New Accounting Standards<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2021, the Financial Accounting Standards Board ("FASB") issued guidance that seeks to improve the transparency of financial disclosures for government assistance received by business entities. The amendment requires disclosures for transactions with a government accounted for by applying a grant or contribution accounting model by analogy, including (1) the types of transactions, (2) the accounting for those transactions, and (3) the effect of those transactions on an entity&#8217;s financial statements. This guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance as of January 1, 2022, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued guidance which provides optional expedients and exceptions to address the impact of reference rate reform where contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate need to be discontinued. This guidance was effective upon issuance and generally can be applied through December 31, 2022. We adopted this guidance during the year by executing amendments to certain contracts to replace the use of LIBOR. The adoption did not have a material impact on our financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524183856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time, following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose&#174; technology platform within a specific therapeutic area. As of December&#160;31, 2022, there was $3.0 million of deferred income related to this payment, of which $0.9 million was included in other current liabilities and $2.1 million was included in other long-term liabilities. The deferred income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by market group:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by product category: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Components</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Delivery Devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard Packaging </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by geographic location: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.712%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets and liabilities result from transactions with revenue primarily recorded over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet within other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets and liabilities, excluding amounts included in accounts receivable, net:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:83.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.852%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2022</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contract assets - increase (decrease)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2022</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred income - (increase) decrease</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Contract assets are included within other current assets and deferred income is included within other current liabilities and other long-term liabilities. The increase in deferred income during 2022 was primarily due to additional cash payments of $88.3 million received in advance of satisfying future performance obligations, partially offset by the recognition of current year revenue of $54.2 million, and $28.0&#160;million of revenue was recognized that was included in deferred income at the beginning of the year.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923527379648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text">Net Income Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021 and 2020, there were 0.2 million, 0.0 million, and 0.0 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2021, we announced a share repurchase program for calendar-year 2022 authorizing the repurchase of up to 650,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions. There were no shares purchased during the three months ended December 31, 2022. During the year ended December 31, 2022, we purchased 563,334 shares of our common stock under the now completed program at a cost of $202.8 million, or an average price of $360.03 per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2023, the Board of Directors approved a share repurchase program under which we may repurchase up to $1.0&#160;billion in shares of common stock. The share repurchase program does not have an expiration date under which we may repurchase common stock on the open market or in privately-negotiated transactions. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923529902672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, Plant and Equipment<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of gross property, plant and equipment at December 31 is presented in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected useful lives (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15-35</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-12</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds and dies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-10</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December&#160;31, 2022, 2021 and 2020 was $116.9 million, $116.9 million and $104.7 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest on borrowings during the active construction period of major capital projects. Capitalized interest is added to the cost of the underlying assets and is amortized over the useful lives of the assets. Capitalized interest for the years ended December&#160;31, 2022, 2021 and 2020 was $3.7 million, $2.0 million and $1.4 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923608860048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases provide us with an option, exercisable at our sole discretion, to terminate the lease or extend the lease term for one year or more. At this time, the Company is not able to assert whether any of these options will be exercised. We had no finance leases as of December&#160;31, 2022 and 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:64.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.994%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and December&#160;31, 2021, the weighted average remaining lease term for operating leases was 9.31 years and 10.7 years and the weighted average discount rate was 3.25% and 3.58%, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.7)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to adopt practical expedients around the combination of lease and non-lease components and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of 12 months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923523986160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Affiliated Companies</a></td>
<td class="text">Affiliated Companies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the following affiliated companies were accounted for under the equity method:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.215%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The West Company Mexico, S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aluplast S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Tap S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Rubber S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daikyo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unremitted income of affiliated companies included in consolidated retained earnings amounted to $133.6 million, $115.6 million and $98.2 million at December&#160;31, 2022, 2021 and 2020, respectively. Dividends received from affiliated companies were $2.6 million in 2022, $2.7 million in 2021 and $1.6 million in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity in net unrealized gains of Daikyo&#8217;s investment securities and derivative instruments, as well as pension adjustments, included in accumulated other comprehensive loss was $1.6 million, $1.5 million and $0.6 million at December&#160;31, 2022, 2021 and 2020, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases from, and royalty payments made to, affiliates totaled $167.6 million, $155.0 million and $143.3 million, respectively, in 2022, 2021 and 2020, of which $31.2 million and $25.5 million was due and payable as of December&#160;31, 2022 and 2021, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $14.2 million, $12.0 million and $9.7 million, respectively, in 2022, 2021 and 2020, of which $2.2 million and $2.3 million was receivable as of December&#160;31, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $197.0 million and $201.2 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $7.9 million and $6.5 million, respectively. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923528701200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill and Intangible Assets<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill by reportable segment were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill recorded due to acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had $0.1&#160;million of accumulated goodwill impairment losses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and accumulated amortization as of December 31 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licensing</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.4)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The cost basis of intangible assets includes a foreign currency translation loss of $0.9 million and $1.3 million for the years ended December&#160;31, 2022 and 2021, respectively. Amortization expense for the years ended December&#160;31, 2022, 2021 and 2020 was $3.7 million, $5.4 million and $4.4 million, respectively. Estimated annual amortization expense for the next five years is as follows: 2023 - $3.6&#160;million, 2024 - $3.6&#160;million, 2025 - $3.0&#160;million, 2026 - $2.6&#160;million and 2027 - $2.4&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923527496368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherCurrentLiabilitiesAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Current Liabilities</a></td>
<td class="text">Other Current Liabilities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities as of December 31 included the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions, rebates and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued retirement plans (excluding pension)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes other than income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Current Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923621505184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2022 with the exception of the Series A notes which are as of December&#160;31, 2021. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.485%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, due December 31, 2024 (5.56%)</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A notes, due July 5, 2022 (3.67%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B notes, due July 5, 2024 (3.82%)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C notes, due July 5, 2027 (4.02%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs for Term Loan and Series notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we amended and extended the existing credit facility (entered into in March 2019), which was scheduled to expire in March 2024, from $300.0&#160;million to a $500.0&#160;million senior unsecured revolving credit facility by entering into a Second Amendment and Joinder and Assumption Agreement (the "Amended Credit Agreement"). The Amended Credit Agreement, which expires March 2027, contains a senior unsecured, multi-currency revolving credit facility of $500.0&#160;million, with sublimits of up to $50.0&#160;million for swing line loans for Domestic Borrowers in U.S. dollars and a $40.0&#160;million swing line loan for West Pharmaceuticals Services Holding GmbH and up to $50.0&#160;million for the issuance of standby letters of credit. The credit facility may be increased from time-to-time by the greater of (a) $929.0&#160;million or (b) EBITDA for the preceding twelve month period in the aggregate through an increase in the revolving credit facility, subject to the satisfaction of certain conditions. Borrowings under the credit facility bear interest, at the Company&#8217;s option, at either: (a) the Term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) plus 0.10% plus an applicable margin; or (b) a base rate defined as the highest of: (i) the Bank of America &#8220;prime rate&#8221;; (ii) the Federal Funds effective rate plus 0.50%; and (iii) Term SOFR plus 1.00%. The applicable margin is based on the ratio of the Company&#8217;s Net Consolidated Debt to its modified EBITDA, ranging from 0 to 37.5 basis points for base rate loans and 87.5 to 137.5 basis points for Term SOFR loans. The Amended Credit Agreement contains financial covenants providing that the Company shall not permit the ratio of the Company&#8217;s Net Consolidated Debt to its Modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Amended Credit Agreement, upon the occurrence of a Qualified Acquisition for each of the four fiscal quarters of the Company immediately following such Qualified Acquisition, the ratio set forth above shall be increased to 4.0 to 1. The Amended Credit Agreement also contains customary limitations on liens securing indebtedness of the Company and its subsidiaries, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of December&#160;31, 2022 and 2021, total unamortized debt issuance costs of $1.3&#160;million and $0.1&#160;million, respectively, were recorded in other current assets and other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had no outstanding borrowings under the Credit Facility. At December&#160;31, 2022, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $2.4 million, was $497.6 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we entered into a First Amendment and Incremental Facility Amendment (the &#8220;First Amendment&#8221;) to the Credit Agreement. Pursuant to the First Amendment and the Credit Agreement, we established the Term Loan in the amount of $90.0&#160;million, which is due on December 31, 2024. Borrowings under the Term Loan bear interest at the three-month Term SOFR plus 87.5 basis points. As of December&#160;31, 2022 and 2021, there were unamortized debt issuance costs remaining of $0.1&#160;million and $0.1&#160;million, respectively, which are being amortized as additional interest expense over the term of the Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At December&#160;31, 2022, we had $83.2&#160;million in borrowings under the Term Loan, of which $2.2&#160;million was classified as current and $81.0&#160;million was classified as long-term. Please refer to Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for a discussion of the foreign currency hedge associated with the Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Private Placement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, we concluded a private placement issuance of $168.0 million in senior unsecured notes. The total amount of the private placement issuance was divided into three tranches - $42.0 million 3.67% Series A Notes due July 5, 2022, $53.0 million 3.82% Series B Notes due July 5, 2024, and $73.0 million 4.02% Series C Notes due July 5, 2027 (the &#8220;Notes&#8221;). The Notes rank pari passu with our other senior unsecured debt. The weighted average of the coupon interest rates on the Notes outstanding as of December&#160;31, 2022 is 3.94%. As of December&#160;31, 2022 and 2021, there were unamortized debt issuance costs remaining of $0.2&#160;million and $0.3&#160;million, respectively, which are being amortized as additional interest expense over the term of the Notes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2022, we were in compliance with all of our debt covenants. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest costs incurred during 2022, 2021 and 2020 were $11.6 million, $10.2 million and $9.6 million, respectively. The aggregate annual maturities of long-term debt, excluding unamortized debt issuance costs, are as follows: $2.2 million in 2023, 2024 - $134.0 million, 2025 - $0.0 million, 2026 - $0.0 million, 2027 - $73.0 million, and thereafter - $0.0 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923528701200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2022 and December&#160;31, 2021, the total amount of these forward exchange contracts was Singapore Dollar ("SGD") 601.5 million and $13.4 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of December&#160;31, 2022, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EUR</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,123.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Japanese Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as cumulative translation adjustments within accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we entered into a five-year floating-to-floating forward-starting cross-currency swap (the &#8220;cross-currency swap&#8221;) for $90&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#165;9.1&#160;billion ($83.2&#160;million) as of December&#160;31, 2022. Under the cross-currency swap, we receive floating interest rate payments based on USD compounded SOFR plus a margin, in return for paying floating interest rate payments based on Japanese Yen ("Yen") Tokyo Overnight Average Rate ("TONAR") plus a margin. In addition, we receive periodic fixed payments of USD in return for paying fixed principal payments of Yen.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From November 2017 through December 2022, we purchased several series of call options for a total of 867,500 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had outstanding contracts to purchase 258,597 barrels of crude oil from December 2022 to September 2024, at a weighted-average strike price of $108.28 per barrel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the balance sheet location and fair values of our derivative instruments as of December&#160;31, 2022 and 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.046%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged item (intercompany loan)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative designated as hedging instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge. The amounts recognized in earnings, pre-tax, for forward point components for the years ended December&#160;31, 2022, 2021 and 2020 were $4.0 million, $2.6 million and $6.3 million, respectively. We expect to recognize $3.2 million in earnings, pre-tax, for forward point components in 2023.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.278%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts (hedges of net sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts (hedges of cost of goods and services sold)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.268%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the above table which summarizes the effects of derivative instruments designated as fair value hedges within the other expense (income) line in our consolidated statements of income for the years ended December 31. The following table summarizes the effects of derivative instruments designated as cash flow and net investment hedges by line item in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022 and 2021, there was no material ineffectiveness related to our hedges.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520619232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div><div style="margin-top:9pt;padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of the contingent consideration liability, within current and long-term liabilities, related to the SmartDose&#174; technology platform (the &#8220;SmartDose&#174; contingent consideration&#8221;) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#8217; investment selections and is included within other long-term liabilities. The fair value of the cross-currency swap, included within other long-term assets, is valued using a market approach. Please refer to Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our derivatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities, and is classified as Level 2 within the fair value hierarchy. At December&#160;31, 2022, the estimated fair value of long-term debt was $201.8 million compared to a carrying amount of $206.7 million. At December&#160;31, 2021, the estimated fair value of long-term debt was $217.9 million and the carrying amount was $208.8 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923654510720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.358%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and other postretirement plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.3)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.5)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.0)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.1)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.0)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:34.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.360%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Detail of components</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on derivatives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.0)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923608860048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#8220;2016 Plan&#8221;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At December&#160;31, 2022, there were 1,681,526 shares remaining in the 2016 Plan for future grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options and stock appreciation rights reduce the number of shares available by one share for each award granted. All other awards under the 2016 Plan will reduce the total number of shares available for grant by an amount equal to 2.5 times the number of shares awarded. If awards made under previous plans would entitle a plan participant to an amount of West stock in excess of the target amount, the additional shares (up to a maximum threshold amount) will be distributed under the 2016 Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option and appreciation rights</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, stock-settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, cash-settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, dividend equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans and restricted share awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates expected forfeitures. The amount of unrecognized compensation expense for all non-vested awards as of December&#160;31, 2022 was $28.9 million, which is expected to be recognized over a weighted average period of 1.6 years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted to employees vest in equal increments. All awards expire 10 years from the date of grant. Upon the exercise of stock options, shares are issued in exchange for the exercise price of the options. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding options:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest, December 31</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.88&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the weighted average remaining contractual life of options outstanding and of options exercisable was 4.8 years and 4.0 years, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the aggregate intrinsic value of total options outstanding was $241.4 million, of which $225.6 million represented vested options.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options was estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted average assumptions in 2022, 2021 and 2020: a risk-free interest rate of 1.8%, 0.8%, and 1.3%, respectively; stock volatility of 25.1%, 23.9%, and 22.4%, respectively; and dividend yields of 0.2%, 0.3%, and 0.4%, respectively. Stock volatility is estimated based on historical data and the impact from expected future trends. Expected lives, which are based on prior experience, averaged 5.6 years for 2022 and 2021 and 5.7 years for 2020. The weighted average grant date fair value of options granted in 2022, 2021 and 2020 was $96.43, $64.51 and $40.28, respectively. Stock option expense is recognized over the vesting period, net of forfeitures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, the intrinsic value of options exercised was $60.1 million, $147.3 million and $88.8 million, respectively. The grant date fair value of options vested during those same periods was $8.8 million, $8.3 million and $8.4 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock appreciation rights (&#8220;SARs&#8221;) granted to eligible international employees vest in equal annual increments over 4 years of continuous service. All awards expire 10 years from the date of grant. The fair value of each cash-settled SAR is adjusted at the end of each reporting period, with the resulting change reflected in expense. As of December&#160;31, 2022, SARs outstanding were 20,402, all of which were cash-settled. Upon exercise of a cash-settled SAR, the employee receives cash for the difference between the grant date price and the fair market value of the Company&#8217;s stock on the date of exercise. As a result of the cash settlement feature, cash-settled SARs are recorded within other long-term liabilities. Upon exercise of a stock-settled SAR, shares are issued in exchange for the exercise price of the stock-settled SAR. As a result of the stock settlement feature, stock-settled SARs are recorded within equity.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding SARs:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,054&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and expected to vest, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,402&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and exercisable, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.18&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and expected to vest, December 31</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.28&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and exercisable, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Awards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to stock options and SAR awards, we grant performance share unit (&#8220;PSU&#8221;) awards to eligible employees. These awards are earned based on the Company&#8217;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock, whereas recipients of cash-settled PSU awards are entitled to receive a payment in cash per unit based on the fair market value of a share of our common stock at the end of the performance period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding stock-settled PSU awards:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,474&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,966)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,553&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.88&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278.38&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares earned under PSU awards may vary from 0% to 200% of an employee&#8217;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures. The weighted average grant date fair value of stock-settled PSU awards granted during the years 2022, 2021 and 2020 was $362.40, $333.58 and $177.31, respectively. Including forfeiture and target achievement expectations, we expect that the stock-settled PSU awards will convert to 94,480 shares to be issued over an average remaining term of one year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of cash-settled PSU awards is also based on the market price of our stock at the grant date. These awards are revalued at the end of each quarter based on changes in our stock price. As a result of the cash settlement feature, cash-settled PSU awards are recorded within other long-term liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding cash-settled PSU awards:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.53&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer an Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which provides for the sale of our common stock to eligible employees at 85% of the current market price on the last trading day of each quarterly offering period. Payroll deductions are limited to 25% of the employee&#8217;s base salary, not to exceed $25,000 in any one calendar year. In addition, employees may not buy more than 2,000 shares during any offering period (8,000 shares per year). Purchases under the ESPP were 27,894 shares, 27,016 shares and 36,494 shares for the years 2022, 2021 and 2020, respectively. At December&#160;31, 2022, there were approximately 3,738,000 shares available for issuance under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Plans and Restricted Share Awards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred compensation plans include a Non-Qualified Deferred Compensation Plan for Non-Employee Directors, under which non-employee directors may defer all or part of their annual cash retainers. The deferred fees may be credited to a stock-equivalent account. Amounts credited to this account are converted into deferred stock units based on the fair market value of one share of our common stock on the last day of the quarter. For deferred stock units ultimately paid in cash, a liability is calculated at an amount determined by multiplying the number of units by the fair market value of our common stock at the end of each reporting period. In addition, deferred stock awards are granted on the date of our annual meeting, and are distributed in shares of common stock. In 2022, we granted 4,827 deferred stock awards, with a weighted grant date fair value of $300.78. In 2021, we granted 6,034 deferred stock awards, with a grant date fair value of $338.38. Similarly, a non-qualified deferred compensation plan for eligible employees provides for the conversion of compensation into deferred stock units. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the two deferred compensation plans held a total of 383,792 deferred stock units, including 9,366 units to be paid in cash.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, during 2022, we granted 9,648 restricted share awards at a weighted grant-date fair value of $310.52 per share to employees under the 2016 Plan. During 2021, we granted 6,002 restricted share awards at a weighted grant-date fair value of $312.41 per share to employees under the 2016 Plan. During 2020, we granted 8,721 restricted share awards at a weighted grant-date fair value of $200.35 per share to employees under the 2016 Plan. The fair value of these awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524469216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit Plans <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our U.S. and international subsidiaries sponsor defined benefit pension plans. In addition, we provide minimal death benefits for certain U.S. retirees and pay a portion of healthcare costs for retired U.S. salaried employees and their dependents. Benefits for participants are coordinated with Medicare when possible. We also sponsor a defined contribution plan for certain salaried and hourly U.S. employees. Our 401(k) plan contributions were $22.8 million for 2022, $19.5 million for 2021 and $16.8 million for 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension and Other Retirement Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost and other amounts recognized in OCI were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (gain) arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial (loss) gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in OCI</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit cost by geographic location is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:43.755%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost component included within net periodic benefit cost is considered employee compensation and is therefore presented within the selling, general, and administrative and costs of goods and services sold financial statement line items of our consolidated statements of income. The remaining components of net periodic benefit cost are reported separately and are therefore presented within the other nonoperating expense (income) financial statement line item of our consolidated statements of income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During 2021, the Company approved the termination of our U.S. qualified defined benefit pension plan (the "U.S. pension plan"). During 2021, a Notice of Intent to Terminate was sent to all interested parties and in 2022 a favorable determination letter was received from the Internal Revenue Service. During 2022, lump sum payments were offered to all current employees and former employees with vested benefits under the U.S. pension plan. A cash contribution of $7.1&#160;million was made by the Company to ensure the U.S. pension plan was fully funded in preparation for the group annuity contract purchase which was executed in August of 2022 to settle the outstanding benefit obligations, as well as to cover any ancillary benefits and expenses remaining. During 2022, we recorded </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$52.2&#160;million pension settlement charge within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_2be9eb86-8ff4-486b-8e82-82feaaba79be"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_2c156bb7-09f9-4046-a1d8-d4f0d3157eef"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_41e09201-abff-4427-8518-3065d9e10039">other nonoperating expense (income)</span></span></span>, which primarily related to the full settlement and relief of the historical balance sheet position, inclusive of accumulated other comprehensive income, of the U.S. pension plan. During 2021 and 2020, we recorded a $1.8&#160;million and $3.7&#160;million, respectively, pension settlement charge within other nonoperating expense (income), as we determined that normal-course lump-sum payments for the U.S. pension plan exceeded the threshold for settlement accounting under U.S. GAAP for the year.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we contributed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$7.1&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our U.S. pension plan. During 2021, we did not contribute to our U.S. pension plan. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments/transfers in</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, December 31</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.5)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269.8)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, December 31</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International pension plan assets, at fair value, included in the preceding table were $29.4 million and $49.3 million at December&#160;31, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in the balance sheet were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts in accumulated other comprehensive loss, pre-tax, consisted of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation for all defined benefit pension plans was $52.4 million and $265.2 million at December&#160;31, 2022 and 2021, respectively, including $46.0 million and $73.0 million, respectively, for international pension plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our United Kingdom qualified defined benefit pension plan had plan assets in excess of its obligations. As of December&#160;31, 2021, our U.S. and United Kingdom qualified defined benefit pension plan had assets in excess of its obligations. As of December&#160;31, 2022 and December&#160;31, 2021, our other defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows. The expected benefit payments listed correspond to regular ongoing benefit payments expected to be made by the plan during future years. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 to 2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, we expect to contribute $0.6&#160;million to pension plans, all of which is in the U.S. In addition, we expect to contribute $0.6&#160;million for other retirement benefits in 2023. We periodically consider additional, voluntary contributions depending on the investment returns generated by pension plan assets, changes in benefit obligation projections and other factors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit cost were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.29&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine the benefit obligations were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.35&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.55&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate used to determine the benefit obligations for U.S. pension plans was 5.55% and 2.95% as of December 31, 2022 and 2021, respectively. The weighted average discount rate used to determine the benefit obligations for all international plans was 4.20% and 1.32% as of December 31, 2022 and 2021, respectively. The weighted average rate of compensation increase for all international plans was 3.09% for 2022 and 2.79% for 2021, while there was no rate increase for the U.S. plans since they are frozen. Other retirement benefits were only available to U.S. employees. The expected long-term rate of return for U.S. plans was 3.70% for 2022, 5.10% for 2021 and 5.10% for 2020. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumed healthcare cost trend rate used to determine benefit obligations was 6.75% for all participants in 2022, decreasing to 5.0% by 2030. The assumed healthcare cost trend rate used to determine net periodic benefit cost was 6.25% for all participants in 2022, decreasing to 5.0% by 2027.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The defined pension plan benefit obligation decreased for the year ended December&#160;31, 2022 primarily due to settlement losses recognized during the year, as well as an increase in the discount rate used to calculate the obligation. The net actuarial losses will be impacted in future periods by actual asset returns, discount rate changes, currency exchange rate fluctuations, actual demographic experience, and certain other factors. The other retirement plan benefit obligation decreased due an increase in the discount rate used to calculate the obligation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company has cash balance plans and other plans with promised interest crediting rates. For these plans, the interest crediting rates are set in line with plan rules or country legislation and do not change with market conditions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The weighted average interest crediting rating used to determine net periodic benefit cost by geographic location for our pension plans, at December 31, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.31&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.31&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diversification across and within asset classes is the primary means by which we mitigate risk. We maintain guidelines for all asset and sub-asset categories in order to avoid excessive investment concentrations. Fund assets are monitored on a regular basis. If at any time the fund asset allocation is not within the acceptable allocation range, funds will be reallocated. We also review the fund on a regular basis to ensure that the investment returns received are consistent with the short-term and long-term goals of the fund and with comparable market returns. We are prohibited from pledging fund securities and from investing pension fund assets in our own stock, securities on margin or derivative securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the target asset allocations and acceptable allocation ranges across:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target allocation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation range</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25% - 30%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63% - 68%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2% - 7%</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#8220;NAV&#8221;) have not been classified in the fair value hierarchy.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524056256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Expense (Income)</a></td>
<td class="text">Other Expense (Income) <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income) consisted of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and post-employment benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and related charges</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset impairments and sale of equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on oil hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange transaction gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment activity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income) </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and Related Charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company approved a restructuring plan to adjust our operating cost base to better respond to the macroeconomic factors influencing our business. These changes are expected to be implemented over a period of up to twelve months from the date of the approval. The plan is expected to require restructuring and related charges of approximately $25&#160;million to $27&#160;million, with annualized savings in the range of $22&#160;million to $24&#160;million. Included within the expected restructuring charges is an impairment charge of $15.3 million representing the net book value of long-lived fixed assets held in our production facilities that were determined to have no future use to the Company. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:39.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.867%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.867%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, our Board of Directors approved a restructuring plan designed to optimize certain organizational structures within the Company to better support our continued growth and business priorities. These changes were implemented over a period of approximately twenty-four months from the date of the approval. The plan is expected to have annualized savings in the range of $0.9&#160;million to $1.6&#160;million. Since its approval, we recorded a net pre-tax amount equal to $5.2&#160;million in restructuring and related charges associated with this plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2020 restructuring plan:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.893%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.370%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration represents changes in the fair value of the SmartDose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contingent consideration. Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oil Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021 and 2020, we recorded a gain of $1.5&#160;million, a gain of $1.7&#160;million, and a loss of $0.2&#160;million, respectively, related to oil hedges. Please refer to Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our hedging activity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost Investment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, specific to our cost method investments, we recorded a total impairment charge of $3.5 million. During 2021, specific to our cost method investments, we recorded a total impairment charge of $4.6&#160;million which was offset by a net gain of $0.3&#160;million on the sale of a cost investment. During 2020, specific to our cost method investments, we recorded a total impairment charge of $2.5 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI https://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI https://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524036880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global organization, we and our subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. As of December 31, 2022, the statute of limitations for the U.S. federal tax years 2017 through 2022 remain open to examination. For U.S. state and local jurisdictions, tax years 2013 through 2022 are open to examination. We are also subject to examination in various foreign jurisdictions for tax years 2015 through 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) due to prior year position</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction for expiration of statute of limitations/audits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we had balances in accrued liabilities for interest and penalties of $1.6 million and $0.5 million at December&#160;31, 2022 and 2021, respectively. As of December&#160;31, 2022, we had $36.5 million of total gross unrecognized tax benefits, which, if recognized, $36.5 million would favorably impact the effective income tax rate. It is reasonably possible that, due to the expiration of statutes and the closing of tax audits, the amount of gross unrecognized tax benefits may be reduced by approximately $1.7 million during the next twelve months, which would favorably impact our effective tax rate.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income before income taxes and equity in net income of affiliated companies are:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income before income taxes and equity in net income of affiliated companies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related provision for income taxes consists of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.5&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.9)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of our deferred tax assets and liabilities at December 31 are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty acceleration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes and equity in net income of affiliated companies is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal corporate tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on international operations other than U.S. tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reserves for unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on international earnings, net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-Derived Intangible Income Deductions (FDII)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on share-based payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty acceleration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we recorded tax expense of $5.7&#160;million due to the impact of tax law changes enacted during the year, $19.8&#160;million of tax expense due to the Company's recognition of reserves for unrecognized tax benefits, and a tax benefit of $16.5&#160;million associated with stock-based compensation. A tax benefit of $20.6&#160;million was recognized for the 2022 termination of our U.S. pension plan. The company did not elect to reclassify to retained earnings the stranded tax effects on items within AOCI related to the Tax Cuts and Jobs Act of 2017, and therefore included within the $20.6&#160;million pension termination benefit is a deferred tax benefit of $8.0&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we recorded a tax benefit of $1.4&#160;million due to the impact of tax law changes enacted during 2021, a tax benefit of $18.5&#160;million due to the Company's prepayment of future royalties from one of its subsidiaries, and a tax benefit of $31.5&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we recorded a tax benefit of $0.5&#160;million due to the impact of tax law changes enacted during 2020 and a tax benefit of $20.8&#160;million associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State operating loss carryforwards of $123.2 million created a deferred tax asset of $7.3 million, while foreign operating loss carryforwards of $18.4 million created a deferred tax asset of $2.9 million. Management estimates that certain state and foreign operating loss carryforwards are unlikely to be utilized and the associated deferred tax assets have been appropriately reserved. In 2022, it was determined that $3.8 million of previously reserved state loss carryforwards were more likely than not to be utilized prior to expiration. State loss carryforwards expire as follows: $4.7 million in 2023 and $118.5 million thereafter. Foreign loss carryforwards total $18.4 million, none of which will expire.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we utilized all of our remaining U.S. federal research and development credit carryforwards. State research and development credit carryforwards of $1.8&#160;million created a deferred tax asset of $1.4&#160;million. As of December&#160;31, 2022, $0.4 million of state research and development credits expire in 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. </span></div>Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $893.1&#160;million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923527432640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we were obligated under various operating lease agreements. Please refer to Note 6, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we were obligated under various defined benefit pension plans in the U.S. and other countries that cover employees who meet eligibility requirements. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, our outstanding unconditional contractual commitments, including for the purchase of raw materials and finished goods, amounted to $96.8 million, the majority of which is to be paid in the next two years, with $70.9 million due to be paid in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have letters of credit totaling $2.4 million supporting the reimbursement of workers&#8217; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $3.3 million at December&#160;31, 2022, of which $0.7 million is in excess of our deductible and, therefore, is reimbursable by the insurance company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524026688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chief Operating Decision Maker ("CODM") evaluates the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that the CODM considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The segment operating profit metric is what the CODM uses in evaluating our results of operations and the financial measure that provides a valuable insight into our overall performance and financial position. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales information about our reportable segments, reconciled to consolidated totals:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,317.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment sales elimination</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any customers accounting for greater than 10% of consolidated net sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Lived Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,286.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other European countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following tables provide summarized financial information for our segments:</span></div><div><span><br/></span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Proprietary Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business segment operating profit</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate general costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated Items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment activity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Corporate and Unallocated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated operating profit</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734.0&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (income) and other nonoperating expense (income), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net income of affiliated companies</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) During 2022, the Company recorded restructuring and related charges of $23.8 million, which primarily included a charge of $8.7 million in net severance and post-employment benefits primarily in connection with our plan to adjust our operating cost base and $15.3 million in asset-related charges associated with this plan. During 2021 and 2020, the Company recorded a restructuring and severance related charge of $2.2 million and $7.0 million, respectively, to optimize certain organizational structure within the Company.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) During 2022, 2021 and 2020, the company recorded $0.7 million, $0.8&#160;million and $0.6&#160;million, respectively, of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) During 2021, the Company recorded a $2.8 million impairment charge for certain long-lived and intangible assets within the Proprietary Products segment as it determined the carrying value was not fully recoverable. $1.9&#160;million of this charge is recorded in Cost of Goods and Services Sold and $0.9&#160;million of the charge is recorded in Selling, General, and Administrative expense, due to the nature of the impaired assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5) During 2022, the Company recorded a cost investment impairment charge of $3.5 million. During 2021, the net cost investment activity was equal to $4.3 million, inclusive of an impairment charge of $4.6&#160;million partially offset by a $0.3&#160;million gain on the sale of a cost investment. During 2020, the Company recorded a cost investment impairment charge of $2.5 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6) During 2022, the Company recorded </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$52.2&#160;million pension settlement charge, which primarily related to the full settlement and relief of the historical balance sheet position, inclusive of accumulated other comprehensive income, of the U.S. pension plan. During 2021 and 2020, we recorded a $1.8&#160;million and $3.7&#160;million, respectively, pension settlement charge, as we determined that normal-course lump-sum payments for the U.S. pension plan exceeded the threshold for settlement accounting under U.S. GAAP for the year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 16, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_124" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Expense (Income)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of unallocated items. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,152.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,616.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Depreciation and Amortization</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.6&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Capital Expenditures</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524072192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II - Valuation and Qualifying Accounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule II - Valuation and Qualifying Accounts</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.323%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.363%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">beginning of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">period</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">end of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">period</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div>(1)Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520651776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The consolidated financial statements include the accounts of West Pharmaceutical Services, Inc. ("West") after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash equivalents include time deposits, certificates of deposit and all highly liquid short-term instruments with maturities of three months or less at the time of purchase.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text">Accounts Receivable: Our accounts receivable balance was net of an allowance for credit losses of $0.2 million and $0.4 million at December&#160;31, 2022 and 2021, respectively. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories: Inventories are valued at the lower of cost (on a first-in, first-out basis) or net realizable value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other expense (income). Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">Leases: Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Impairment of Goodwill and Other Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuing identifiable intangible assets requires judgment. For example, for recent identifiable customer relationship intangible asset acquisitions, we applied an excess earnings model, which is a form of the income approach. This approach includes projecting revenues and expenses attributable to the existing customers over the remaining economic life of the customer relationships and then subtracting the required return on net tangible assets and any intangible assets used in the business to estimate any residual excess earnings attributable to the customer relationships. The after-tax excess earnings are then discounted to present value using the respective discount rates. Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 3 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. Factors that could trigger an impairment review include the following: 1) significant under-performance relative to historical or projected future operating results; 2) significant changes in the manner of use of the acquired assets or the strategy of the overall business; 3) significant negative industry or economic trends; and 4) recognition of goodwill impairment charges. If we determine that the carrying value of identifiable intangibles assets may not be recoverable based on the existence of one or more of the above indicators of impairment, we measure recoverability of assets by comparing the respective carrying value of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, we measure an impairment based on the amount in which the net carrying amount of the assets exceeds the fair values of the assets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Employee Benefits</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Benefits:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plans</a></span>, for a more detailed discussion of our pension and other retirement plans.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Financial Instruments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#8217;s gain or loss is initially reported as a component of other comprehensive income (&#8220;OCI&#8221;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#8217;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition: Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less. In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text">Research and Development: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are primarily expensed as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EnvironmentalCostsPolicy', window );">Environmental Remediation and Compliance Costs</a></td>
<td class="text">Environmental Remediation and Compliance Costs: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock', window );">Litigation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. Please refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other expense (income). The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text">Stock-Based Compensation: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Standards</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2021, the Financial Accounting Standards Board ("FASB") issued guidance that seeks to improve the transparency of financial disclosures for government assistance received by business entities. The amendment requires disclosures for transactions with a government accounted for by applying a grant or contribution accounting model by analogy, including (1) the types of transactions, (2) the accounting for those transactions, and (3) the effect of those transactions on an entity&#8217;s financial statements. This guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance as of January 1, 2022, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued guidance which provides optional expedients and exceptions to address the impact of reference rate reform where contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate need to be discontinued. This guidance was effective upon issuance and generally can be applied through December 31, 2022. We adopted this guidance during the year by executing amendments to certain contracts to replace the use of LIBOR. The adoption did not have a material impact on our financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13669-110860<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13185-110859<br><br>Reference 4: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13231-110859<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2175709<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Legal Matters, Contingencies and Legal Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923523950016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text">The following is a summary of inventories at December 31:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:68.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.875%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524036320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by market group:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by product category: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Components</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Delivery Devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard Packaging </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by geographic location: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.712%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Change in Contract with Customer, Asset and Liability</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets and liabilities, excluding amounts included in accounts receivable, net:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:83.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.852%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2022</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contract assets - increase (decrease)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2022</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred income - (increase) decrease</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524018512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Reconciliation of Basic to Diluted Net Income Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923523421184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of gross property, plant and equipment at December 31 is presented in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected useful lives (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15-35</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-12</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds and dies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-10</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524546608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease, Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock', window );">Schedule of Cash Flow and Supplemental information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:64.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.994%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.7)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>lessee, lease Cash Flow and Supplemental information [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524018512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the following affiliated companies were accounted for under the equity method:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.215%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The West Company Mexico, S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aluplast S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Tap S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Rubber S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daikyo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923529793072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill by reportable segment were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill recorded due to acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock', window );">Schedule of Intangible Assets by Major Class</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and accumulated amortization as of December 31 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licensing</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.4)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Intangible Assets by Major Class [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524026688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherCurrentLiabilitiesAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities as of December 31 included the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions, rebates and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued retirement plans (excluding pension)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes other than income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Current Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524056256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-term Debt Obligations, Net of Current Maturities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2022 with the exception of the Series A notes which are as of December&#160;31, 2021. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.485%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, due December 31, 2024 (5.56%)</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A notes, due July 5, 2022 (3.67%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B notes, due July 5, 2024 (3.82%)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C notes, due July 5, 2027 (4.02%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs for Term Loan and Series notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923528660608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Foreign Currency Contracts</a></td>
<td class="text">As of December&#160;31, 2022, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EUR</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,123.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.046%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged item (intercompany loan)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative designated as hedging instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.278%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts (hedges of net sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts (hedges of cost of goods and services sold)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.268%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div>The following table summarizes the effects of derivative instruments designated as cash flow and net investment hedges by line item in our consolidated statements of income for the years ended December 31:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923527378240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923522582912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Components of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.358%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and other postretirement plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.3)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.5)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.0)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.1)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.0)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Schedule of Reclassification out of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:34.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.360%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Detail of components</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on derivatives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.0)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923522574976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Allocation of Share-based Compensation Costs by Plan</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option and appreciation rights</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, stock-settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, cash-settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, dividend equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans and restricted share awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding options:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest, December 31</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.88&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of Stock Appreciation Rights Award Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding SARs:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,054&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and expected to vest, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,402&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and exercisable, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.18&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and expected to vest, December 31</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.28&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs vested and exercisable, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of Nonvested Performance-based Share Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding stock-settled PSU awards:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,474&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,966)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,553&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.88&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278.38&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Nonvested Performance-based Units Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding cash-settled PSU awards:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:60.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.53&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521476096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost and other amounts recognized in OCI were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (gain) arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial (loss) gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in OCI</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit cost by geographic location is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:43.755%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock', window );">Schedule of Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments/transfers in</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, December 31</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.5)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269.8)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, December 31</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of Amounts Recognized in Balance Sheet</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in the balance sheet were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts in accumulated other comprehensive loss, pre-tax, consisted of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows. The expected benefit payments listed correspond to regular ongoing benefit payments expected to be made by the plan during future years. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 to 2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Assumptions Used</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit cost were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.29&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine the benefit obligations were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.35&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.55&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The weighted average interest crediting rating used to determine net periodic benefit cost by geographic location for our pension plans, at December 31, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.31&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.31&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Allocation of Plan Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the target asset allocations and acceptable allocation ranges across:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target allocation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation range</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25% - 30%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63% - 68%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2% - 7%</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8148abfe270d4f15aa2ba9319df722dc_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#8220;NAV&#8221;) have not been classified in the fair value hierarchy.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520658304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock', window );">Schedule of Other Expense (Income)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income) consisted of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and post-employment benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and related charges</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset impairments and sale of equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on oil hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange transaction gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment activity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income) </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Obligations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:39.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.867%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.867%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2020 restructuring plan:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.893%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.370%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Other Income and Expense, by Component [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520629616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) due to prior year position</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction for expiration of statute of limitations/audits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Components of Income Before Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income before income taxes and equity in net income of affiliated companies are:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income before income taxes and equity in net income of affiliated companies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related provision for income taxes consists of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.5&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.9)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of our deferred tax assets and liabilities at December 31 are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty acceleration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes and equity in net income of affiliated companies is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal corporate tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on international operations other than U.S. tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reserves for unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on international earnings, net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-Derived Intangible Income Deductions (FDII)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on share-based payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty acceleration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923523979584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of Sales by Significant Product Group</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales information about our reportable segments, reconciled to consolidated totals:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,317.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment sales elimination</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Sales and Long-Lived Assets, by Geographical Areas</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Lived Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,286.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other European countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following tables provide summarized financial information for our segments:</span></div><div><span><br/></span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Proprietary Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business segment operating profit</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844.8&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate general costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated Items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment activity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Corporate and Unallocated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated operating profit</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734.0&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (income) and other nonoperating expense (income), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net income of affiliated companies</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) During 2022, the Company recorded restructuring and related charges of $23.8 million, which primarily included a charge of $8.7 million in net severance and post-employment benefits primarily in connection with our plan to adjust our operating cost base and $15.3 million in asset-related charges associated with this plan. During 2021 and 2020, the Company recorded a restructuring and severance related charge of $2.2 million and $7.0 million, respectively, to optimize certain organizational structure within the Company.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) During 2022, 2021 and 2020, the company recorded $0.7 million, $0.8&#160;million and $0.6&#160;million, respectively, of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) During 2021, the Company recorded a $2.8 million impairment charge for certain long-lived and intangible assets within the Proprietary Products segment as it determined the carrying value was not fully recoverable. $1.9&#160;million of this charge is recorded in Cost of Goods and Services Sold and $0.9&#160;million of the charge is recorded in Selling, General, and Administrative expense, due to the nature of the impaired assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5) During 2022, the Company recorded a cost investment impairment charge of $3.5 million. During 2021, the net cost investment activity was equal to $4.3 million, inclusive of an impairment charge of $4.6&#160;million partially offset by a $0.3&#160;million gain on the sale of a cost investment. During 2020, the Company recorded a cost investment impairment charge of $2.5 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6) During 2022, the Company recorded </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$52.2&#160;million pension settlement charge, which primarily related to the full settlement and relief of the historical balance sheet position, inclusive of accumulated other comprehensive income, of the U.S. pension plan. During 2021 and 2020, we recorded a $1.8&#160;million and $3.7&#160;million, respectively, pension settlement charge, as we determined that normal-course lump-sum payments for the U.S. pension plan exceeded the threshold for settlement accounting under U.S. GAAP for the year.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,152.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,616.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Depreciation and Amortization</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.6&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Capital Expenditures</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923526006560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">170.7<span></span>
</td>
<td class="nump">153.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">79.0<span></span>
</td>
<td class="nump">63.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">165.1<span></span>
</td>
<td class="nump">161.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">414.8<span></span>
</td>
<td class="nump">378.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of finite-lived intangible assets (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of finite-lived intangible assets (in years)</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520700576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 68.2<span></span>
</td>
<td class="nump">$ 61.3<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments', window );">Cash payments received in advance</a></td>
<td class="nump">88.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome', window );">Revenue recognized during the period</a></td>
<td class="nump">54.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was included in the deferred income balance</a></td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wst_SmartDoseMember', window );">SmartDose</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred income, current</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred income, noncurrent</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Increase (Decrease) Due To Additional Cash Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Revenue Recognized From Deferred Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_SmartDoseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_SmartDoseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521308272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Revenue Recognition (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Biologics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Contract-Manufactured Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Product Concentration Risk | High-Value Product Components</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">54.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Product Concentration Risk | High-Value Product Delivery Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Product Concentration Risk | Standard Packaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Product Concentration Risk | Contract-Manufactured Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Geographic Concentration Risk | Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Geographic Concentration Risk | Europe, Middle East, Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Geographic Concentration Risk | Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_BiologicsCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_BiologicsCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_GenericsCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_GenericsCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_PharmaCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_PharmaCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_HighValueProductComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_HighValueProductComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_HighValueProductDeliveryDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_HighValueProductDeliveryDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_StandardPackagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_StandardPackagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923528844784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Contracts Assets and Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ContractWithCustomerAssetRollForward', window );"><strong>Contract With Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets, December 31, 2021</a></td>
<td class="nump">$ 14.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets, December 31, 2022</a></td>
<td class="nump">16.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ContractWithCustomerAssetIncreaseDecrease', window );">Change in contract assets - increase (decrease)</a></td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ContractWithCustomerLiabilityRollForward', window );"><strong>Contract With Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income, December 31, 2021</a></td>
<td class="num">(61.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income, December 31, 2022</a></td>
<td class="num">(68.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized', window );">Change in deferred income - (increase) decrease</a></td>
<td class="num">$ (6.9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerAssetIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerAssetIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923528845072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Schedule of Reconciliation of Shares (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 585.9<span></span>
</td>
<td class="nump">$ 661.8<span></span>
</td>
<td class="nump">$ 346.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding (in shares)</a></td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">73.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of equity awards, based on the treasury stock method (in shares)</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares assuming dilution (in shares)</a></td>
<td class="nump">75.8<span></span>
</td>
<td class="nump">76.3<span></span>
</td>
<td class="nump">75.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923517880688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Narratives (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 21, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive options excluded from computation of diluted net income per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock repurchase program, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">563,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 202.8<span></span>
</td>
<td class="nump">$ 137.1<span></span>
</td>
<td class="nump">$ 115.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Shares purchased under share repurchase program, average cost per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 360.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock repurchase program, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524283072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 2,386.6<span></span>
</td>
<td class="nump">$ 2,215.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">29.0<span></span>
</td>
<td class="nump">29.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 663.6<span></span>
</td>
<td class="nump">644.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Expected useful lives (years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Expected useful lives (years)</a></td>
<td class="text">35 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 1,039.7<span></span>
</td>
<td class="nump">976.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Expected useful lives (years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Expected useful lives (years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds and dies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 154.5<span></span>
</td>
<td class="nump">139.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds and dies | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Expected useful lives (years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds and dies | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Expected useful lives (years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember', window );">Computer hardware and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 193.9<span></span>
</td>
<td class="nump">182.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember', window );">Computer hardware and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Expected useful lives (years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember', window );">Computer hardware and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Expected useful lives (years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 305.9<span></span>
</td>
<td class="nump">$ 242.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923528682880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 116.9<span></span>
</td>
<td class="nump">$ 116.9<span></span>
</td>
<td class="nump">$ 104.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest</a></td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521215552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_LesseeOperatingLeaseOptionToTerminateTerm', window );">Lease, operating lease, terminate term (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">9 years 3 months 21 days<span></span>
</td>
<td class="text">10 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (as a percent)</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.58%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract (in months)</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LesseeOperatingLeaseOptionToTerminateTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Option To Terminate, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LesseeOperatingLeaseOptionToTerminateTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520708992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 15.5<span></span>
</td>
<td class="nump">$ 12.7<span></span>
</td>
<td class="nump">$ 12.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 23.6<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 17.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923528681872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cash Flow and Supplemental Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 13.3<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 47.6<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521213344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating Lease Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 19.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">18.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">16.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">13.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">50.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Operating lease liability payments due</a></td>
<td class="nump">126.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed lease interest</a></td>
<td class="num">(17.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 109.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923517879392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Affiliated Companies - Schedule of Investments (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_WestCompanyMexicoSADeCVMember', window );">The West Company Mexico, S.A. de C.V.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (as a percent)</a></td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_AluplastSADeCVMember', window );">Aluplast S.A. de C.V.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (as a percent)</a></td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaTapSADeCVMember', window );">Pharma Tap S.A. de C.V.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (as a percent)</a></td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaRubberSADeCVMember', window );">Pharma Rubber S.A. de C.V.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (as a percent)</a></td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember', window );">Daikyo</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (as a percent)</a></td>
<td class="nump">49.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_WestCompanyMexicoSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_WestCompanyMexicoSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_AluplastSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_AluplastSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaTapSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaTapSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaRubberSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaRubberSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521002928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees', window );">Unremitted income of affiliated companies</a></td>
<td class="nump">$ 133.6<span></span>
</td>
<td class="nump">$ 115.6<span></span>
</td>
<td class="nump">$ 98.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Dividends received from affiliated companies</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees', window );">Purchases and royalty payments made to affiliates</a></td>
<td class="nump">167.6<span></span>
</td>
<td class="nump">155.0<span></span>
</td>
<td class="nump">143.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrentAndNoncurrent', window );">Amount due and payable to affiliates</a></td>
<td class="nump">31.2<span></span>
</td>
<td class="nump">25.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_SalesToEquityMethodInvestees', window );">Sales to affiliates</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueFromAffiliates', window );">Amount receivable from affiliates</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">197.0<span></span>
</td>
<td class="nump">201.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Aggregate carrying amount of investment in affiliated companies that are not accounted for under the equity method</a></td>
<td class="nump">7.9<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember', window );">Daikyo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect', window );">Equity in unrealized gains (losses) in securities available-for-sale and derivative instruments</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39599-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.12(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=d3e56071-112765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consolidated retained earnings that represent undistributed (not yet received) earnings from 50 percent or less owned persons accounted for by the equity method (equity method investees).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases and Royalty Payments from Equity Method Investees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_SalesToEquityMethodInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales to Equity Method Investees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_SalesToEquityMethodInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521163216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 109.9<span></span>
</td>
<td class="nump">$ 111.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill recorded due to acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">107.3<span></span>
</td>
<td class="nump">109.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember', window );">Proprietary Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">80.1<span></span>
</td>
<td class="nump">80.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill recorded due to acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">77.9<span></span>
</td>
<td class="nump">80.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember', window );">Contract-Manufactured Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">29.8<span></span>
</td>
<td class="nump">30.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill recorded due to acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 29.4<span></span>
</td>
<td class="nump">$ 29.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923517887024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment losses</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation gains (losses)</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">$ (1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2023</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2025</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2026</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated annual amortization expense, 2027</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524286608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Intangible Assets by Major Class (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 80.2<span></span>
</td>
<td class="nump">$ 81.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(61.8)<span></span>
</td>
<td class="num">(58.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">18.4<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wst_PatentsAndLicensingMember', window );">Patents and licensing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">24.5<span></span>
</td>
<td class="nump">25.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(20.6)<span></span>
</td>
<td class="num">(19.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">39.6<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(27.2)<span></span>
</td>
<td class="num">(25.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">14.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">10.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(10.0)<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Intangible Assets by Major Class [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wst_PatentsAndLicensingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wst_PatentsAndLicensingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520905344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherCurrentLiabilitiesAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred income</a></td>
<td class="nump">$ 57.3<span></span>
</td>
<td class="nump">$ 48.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="nump">14.1<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent', window );">Accrued commissions, rebates and royalties</a></td>
<td class="nump">32.1<span></span>
</td>
<td class="nump">38.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent', window );">Accrued retirement plans (excluding pension)</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Accrued taxes other than income</a></td>
<td class="nump">13.7<span></span>
</td>
<td class="nump">13.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional services</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring and severance related charges</a></td>
<td class="nump">11.3<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Short term derivative instruments</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">33.4<span></span>
</td>
<td class="nump">26.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total other current liabilities</a></td>
<td class="nump">$ 181.7<span></span>
</td>
<td class="nump">$ 163.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for retirement benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Current Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520795520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 209.2<span></span>
</td>
<td class="nump">$ 253.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Less: unamortized debt issuance costs for Term Loan and Series notes</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">208.9<span></span>
</td>
<td class="nump">253.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">44.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">$ 206.7<span></span>
</td>
<td class="nump">208.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member', window );">Term Loan, due December 31, 2024 (5.56%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as a percent)</a></td>
<td class="nump">5.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 83.2<span></span>
</td>
<td class="nump">85.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">$ 81.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorNotesDue2022Member', window );">Series A notes, due July 5, 2022 (3.67%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as a percent)</a></td>
<td class="nump">3.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member', window );">Series B notes, due July 5, 2024 (3.82%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as a percent)</a></td>
<td class="nump">3.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 53.0<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorCNotesDue2027Member', window );">Series C notes, due July 5, 2027 (4.02%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as a percent)</a></td>
<td class="nump">4.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorCNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_SeniorCNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923516400800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>fiscal_quarter </div>
<div>instance</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>USD ($) </div>
<div>tranche</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 209.2<span></span>
</td>
<td class="nump">$ 253.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">44.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206.7<span></span>
</td>
<td class="nump">208.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DebtInstrumentNumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Less: unamortized debt issuance costs for Term Loan and Series notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Aggregate annual maturities of long-term debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit facility, current borrowing capacity</a></td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_CreditAvailableForTheIssuanceOfLettersOfCredit', window );">Amount available for issuance of letters of credit</a></td>
<td class="nump">50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_LineOfCreditFacilityAdditionalBorrowingCapacity', window );">Line of credit facility, additional borrowing capacity</a></td>
<td class="nump">$ 929.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod', window );">Preceding period (in months)</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DebtInstrumentRatioOfDebtToEBITDA', window );">Ratio of debt to EBITDA</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded', window );">Number of instances not to exceed | instance</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition', window );">Number of quarters following acquisition | fiscal_quarter</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition', window );">Ratio of debt to EBITDA after acquisition</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Line of credit, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit facility, unused commitment level</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Applicable Margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate (as a percent)</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Fed Funds Effective Rate Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate (as a percent)</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate (as a percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DebtInstrumentApplicableMarginRatio', window );">Applicable margin ratio</a></td>
<td class="nump">0.00875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DebtInstrumentApplicableMarginRatio', window );">Applicable margin ratio</a></td>
<td class="nump">0.01375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Base Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DebtInstrumentApplicableMarginRatio', window );">Applicable margin ratio</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Base Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DebtInstrumentApplicableMarginRatio', window );">Applicable margin ratio</a></td>
<td class="nump">0.00375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Domestic Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_CreditFacilityIsAvailableForSwingLineLoans', window );">Credit facility is available for swing-line loans</a></td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Foreign Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_CreditFacilityIsAvailableForSwingLineLoans', window );">Credit facility is available for swing-line loans</a></td>
<td class="nump">$ 40.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letters of credit supporting the reimbursement of workers' compensation and other claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member', window );">Term Loan, due December 31, 2024 (5.56%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.2<span></span>
</td>
<td class="nump">85.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member', window );">Term Loan, due December 31, 2024 (5.56%) | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average of the coupon interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.94%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Less: unamortized debt issuance costs for Term Loan and Series notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Series A notes, due July 5, 2022 (3.67%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.67%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Series B notes, due July 5, 2024 (3.82%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.82%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Series C notes, due July 5, 2027 (4.02%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.02%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of any adjustment recognized to the balance of unamortized issuance costs associated with a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, due, for example, to default by the share borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL6757497-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CreditAvailableForTheIssuanceOfLettersOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Available For The Issuance Of Letters Of Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CreditAvailableForTheIssuanceOfLettersOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CreditFacilityIsAvailableForSwingLineLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This refers to credit facility is available for swing-line loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CreditFacilityIsAvailableForSwingLineLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DebtInstrumentApplicableMarginRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Applicable Margin Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DebtInstrumentApplicableMarginRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Increase In Facility, Preceding Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Fiscal Quarters Following Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Instances Ratio Of Debt To EBITDA Exceeded</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DebtInstrumentNumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DebtInstrumentNumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DebtInstrumentRatioOfDebtToEBITDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Ratio Of Debt To EBITDA</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DebtInstrumentRatioOfDebtToEBITDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Ratio Of Debt To EBITDA After Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LineOfCreditFacilityAdditionalBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility Additional Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LineOfCreditFacilityAdditionalBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=wst_ApplicableMarginMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=wst_ApplicableMarginMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_ForeignLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_ForeignLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923516316480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Narrative (Details)<br> $ in Millions, $ in Millions, &#165; in Billions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1">62 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>SGD ($) </div>
<div>bbl </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>bbl </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>JPY (&#165;) </div>
<div>bbl </div>
<div>$ / bbl</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Gain recognized in earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4.0)<span></span>
</td>
<td class="num">$ (2.6)<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Gain recognized in earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Forward Contracts | SGD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 601.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Forward Contracts | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative contract term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross Currency Interest Rate Contract | USD | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83.2<span></span>
</td>
<td class="nump">&#165; 9.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative contract term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember', window );">Commodity Call Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNonmonetaryNotionalAmountVolume', window );">Derivative, nonmonetary notional amount, volume | bbl</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">867,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNonmonetaryNotionalAmount', window );">Derivative, nonmonetary notional amount outstanding | bbl</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,597<span></span>
</td>
<td class="nump">258,597<span></span>
</td>
<td class="nump">258,597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice', window );">Derivative, average price risk option strike price | $ / bbl</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108.28<span></span>
</td>
<td class="nump">108.28<span></span>
</td>
<td class="nump">108.28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average strike price on the group of price risk option contracts such as put options or call options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAveragePriceRiskOptionStrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061172-113977<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNonmonetaryNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal number of units used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNonmonetaryNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNonmonetaryNotionalAmountVolume">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal volume used to calculate payments on a derivative instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNonmonetaryNotionalAmountVolume</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:volumeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SGD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SGD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521127024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Foreign Exchange Rate Risk (Details) - Dec. 31, 2022 - Foreign Exchange Forward - Designated as Hedging Instrument<br> &#8364; in Millions, &#165; in Millions, $ in Millions, $ in Millions</strong></div></th>
<th class="th"><div>SGD ($)</div></th>
<th class="th"><div>USD ($)</div></th>
<th class="th"><div>EUR (&#8364;)</div></th>
<th class="th"><div>JPY (&#165;)</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">USD | Purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">USD | Sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">&#8364; 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Yen | Purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 6,123.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Yen | Sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.0<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">SGD | Purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 62.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">SGD | Sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.1<span></span>
</td>
<td class="nump">&#8364; 23.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SGD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SGD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521991056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Derivative (gain) loss recognized in income, fair value hedges</a></td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges | Forward treasury locks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember', window );">Other expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Derivative (gain) loss on hedged item, fair value hedges</a></td>
<td class="num">(28.3)<span></span>
</td>
<td class="num">(22.1)<span></span>
</td>
<td class="nump">28.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</a></td>
<td class="nump">28.3<span></span>
</td>
<td class="nump">22.1<span></span>
</td>
<td class="num">(28.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet', window );">Derivative (gain) loss on amount excluded from effectiveness testing, fair value hedges</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember', window );">Other expense (income) | Fair Value Hedges | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember', window );">Other expense (income) | Net Investment Hedges | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember', window );">Net sales | Cash Flow Hedges | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods and services sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods and services sold | Commodity call options | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods and services sold | Cash Flow Hedges | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense | Cash Flow Hedges | Forward treasury locks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net gain (loss) relating to components of the gain (loss) on the fair value hedging instrument excluded from the assessment of fair value hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923525694608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="nump">$ 15.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">14.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">32.1<span></span>
</td>
<td class="nump">36.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">12.7<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">23.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommodityMember', window );">Commodity call options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">12.7<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">12.7<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Commodity call options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">14.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">19.6<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commodity call options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Commodity call options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the liabilities, classified as other, for deferred compensation arrangements payable after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommodityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommodityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524607744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Other Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 201.8<span></span>
</td>
<td class="nump">$ 217.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 206.7<span></span>
</td>
<td class="nump">$ 208.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923518147712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 2,335.4<span></span>
</td>
<td class="nump">$ 1,854.5<span></span>
</td>
<td class="nump">$ 1,573.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(56.0)<span></span>
</td>
<td class="num">(52.4)<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out</a></td>
<td class="nump">32.6<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(23.4)<span></span>
</td>
<td class="num">(49.0)<span></span>
</td>
<td class="nump">39.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">2,684.9<span></span>
</td>
<td class="nump">2,335.4<span></span>
</td>
<td class="nump">1,854.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Equity affiliate investment AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined benefit pension and other postretirement plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(31.8)<span></span>
</td>
<td class="num">(40.5)<span></span>
</td>
<td class="num">(40.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(9.3)<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out</a></td>
<td class="nump">31.7<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="nump">22.4<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(9.4)<span></span>
</td>
<td class="num">(31.8)<span></span>
</td>
<td class="num">(40.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(128.1)<span></span>
</td>
<td class="num">(68.8)<span></span>
</td>
<td class="num">(108.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(47.3)<span></span>
</td>
<td class="num">(59.3)<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(47.3)<span></span>
</td>
<td class="num">(59.3)<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(175.4)<span></span>
</td>
<td class="num">(128.1)<span></span>
</td>
<td class="num">(68.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(159.6)<span></span>
</td>
<td class="num">(110.6)<span></span>
</td>
<td class="num">(149.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (183.0)<span></span>
</td>
<td class="num">$ (159.6)<span></span>
</td>
<td class="num">$ (110.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923525700592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Proprietary Products</a></td>
<td class="nump">$ 2,886.9<span></span>
</td>
<td class="nump">$ 2,831.6<span></span>
</td>
<td class="nump">$ 2,146.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="num">(1,750.7)<span></span>
</td>
<td class="num">(1,655.8)<span></span>
</td>
<td class="num">(1,379.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(7.9)<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="nump">52.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="nump">679.9<span></span>
</td>
<td class="nump">748.9<span></span>
</td>
<td class="nump">401.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(114.7)<span></span>
</td>
<td class="num">(107.2)<span></span>
</td>
<td class="num">(72.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">585.9<span></span>
</td>
<td class="nump">661.8<span></span>
</td>
<td class="nump">346.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">(32.6)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss | Gains (Losses) on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss | Gains (Losses) on Derivatives | Foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Proprietary Products</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="num">(4.1)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other expense (income)</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss | Gains (Losses) on Derivatives | Forward treasury locks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss | Amortization of Defined Benefit Pension and Other Postretirement Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service credit</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gains (losses)</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="num">(52.2)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanOtherCosts', window );">Other</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="num">(52.0)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">20.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">$ (31.7)<span></span>
</td>
<td class="num">$ (1.3)<span></span>
</td>
<td class="num">$ (2.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of defined benefit plan cost (credit), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923518045296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>plan </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under the 2016 Plan (in shares)</a></td>
<td class="nump">1,681,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense for all nonvested awards | $</a></td>
<td class="nump">$ 28,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period for recognition (in years)</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred compensation plans and restricted share awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DeferredCompensationArrangementWithIndividualConversionUnit', window );">Deferred compensation conversion unit (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans', window );">Number of deferred compensation plans | plan</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance', window );">Number of deferred stock units (in shares)</a></td>
<td class="nump">383,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DeferredStockUnitsPayableInCash', window );">Number of deferred stock units payable in cash (in shares)</a></td>
<td class="nump">9,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred compensation plans and restricted share awards | Non-Employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">4,827<span></span>
</td>
<td class="nump">6,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 300.78<span></span>
</td>
<td class="nump">$ 338.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted', window );">Number of shares reduced for each award granted (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember', window );">Award Types Other than Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted', window );">Number of shares reduced for each award granted (in shares)</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember', window );">Stock-settled PSU awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">32,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 362.40<span></span>
</td>
<td class="nump">$ 333.58<span></span>
</td>
<td class="nump">$ 177.31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under the 2016 Plan (in shares)</a></td>
<td class="nump">3,738,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of current market price for sales to eligible employees (as a percent)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Limitation on payroll deductions of employee's base salary (as a percent)</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount', window );">Limitation on payroll deductions of employee's base salary, amount | $</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee (in shares)</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear', window );">Maximum number of shares per employee, per year (in shares)</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchases of shares (in shares)</a></td>
<td class="nump">27,894<span></span>
</td>
<td class="nump">27,016<span></span>
</td>
<td class="nump">36,494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">9,648<span></span>
</td>
<td class="nump">6,002<span></span>
</td>
<td class="nump">8,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 310.52<span></span>
</td>
<td class="nump">$ 312.41<span></span>
</td>
<td class="nump">$ 200.35<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredCompensationArrangementWithIndividualConversionUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement With Individual, Conversion Unit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredCompensationArrangementWithIndividualConversionUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement With Individual, Number Of Plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredCompensationArrangementWithIndividualNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement With Individual, Share Equivalents Balance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredStockUnitsPayableInCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Stock Units Payable In Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredStockUnitsPayableInCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction In Number Of Shares Available For Grant For Each Award Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520871920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">$ 23.7<span></span>
</td>
<td class="nump">$ 37.5<span></span>
</td>
<td class="nump">$ 34.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockOptionAndAppreciationRightsMember', window );">Stock option and appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance share units, stock-settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="nump">17.6<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember', window );">Performance share units, cash-settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember', window );">Performance share units, dividend equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred compensation plans and restricted share awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 5.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_StockOptionAndAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_StockOptionAndAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923516236624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Options Activity (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of options outstanding (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life of options exercisable (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of total options outstanding</a></td>
<td class="nump">$ 241.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value of total options vested</a></td>
<td class="nump">$ 225.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of options granted (in dollars per share)</a></td>
<td class="nump">$ 96.43<span></span>
</td>
<td class="nump">$ 64.51<span></span>
</td>
<td class="nump">$ 40.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="nump">$ 60.1<span></span>
</td>
<td class="nump">$ 147.3<span></span>
</td>
<td class="nump">$ 88.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Grant date fair value of options vested</a></td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 8.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options Activity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning (in shares)</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, ending (in shares)</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest (in shares)</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options vested and exercisable (in shares)</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Stock Options, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, beginning (in dollars per share)</a></td>
<td class="nump">$ 101.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">364.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">83.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">224.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, ending (in dollars per share)</a></td>
<td class="nump">118.72<span></span>
</td>
<td class="nump">$ 101.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest (in dollars per share)</a></td>
<td class="nump">116.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options vested and exercisable (in dollars per share)</a></td>
<td class="nump">$ 84.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Stock volatility (as a percent)</a></td>
<td class="nump">25.10%<span></span>
</td>
<td class="nump">23.90%<span></span>
</td>
<td class="nump">22.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923517884768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details) - Stock Appreciation Rights (SARs)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>SARs Activity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, beginning (in shares) | shares</a></td>
<td class="nump">21,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted (in shares) | shares</a></td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(1,169)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, ending (in shares) | shares</a></td>
<td class="nump">20,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber', window );">Vested and expected to vest (in shares) | shares</a></td>
<td class="nump">20,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber', window );">Vested and exercisable (in shares) | shares</a></td>
<td class="nump">17,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward', window );"><strong>SARs, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 88.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">369.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">54.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">21.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending (in dollars per share) | $ / shares</a></td>
<td class="nump">97.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice', window );">Vested and expected to vest (in dollars per share) | $ / shares</a></td>
<td class="nump">97.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice', window );">Vested and exercisable (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 74.86<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Exercisable, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Expected to Vest, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Vested and Exercisable, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Vested and Expected to vest, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521395968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Nonvested Performance-based Award Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Non-Employee Directors | Deferred compensation plans and restricted share awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">4,827<span></span>
</td>
<td class="nump">6,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share)</a></td>
<td class="nump">$ 300.78<span></span>
</td>
<td class="nump">$ 338.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember', window );">Stock-settled PSU awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting', window );">Number of shares to be issued upon conversion (in shares)</a></td>
<td class="nump">94,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Average remaining term of shares issued at conversion</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning (in shares)</a></td>
<td class="nump">164,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">32,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget', window );">Adjustments above/(below) target (in shares)</a></td>
<td class="nump">68,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested and converted (in shares)</a></td>
<td class="num">(144,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(7,966)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending (in shares)</a></td>
<td class="nump">112,553<span></span>
</td>
<td class="nump">164,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning (in dollars per share)</a></td>
<td class="nump">$ 179.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share)</a></td>
<td class="nump">362.40<span></span>
</td>
<td class="nump">$ 333.58<span></span>
</td>
<td class="nump">$ 177.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue', window );">Adjustments above/(below) target (in dollars per share)</a></td>
<td class="nump">106.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and converted (in dollars per share)</a></td>
<td class="nump">369.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">240.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, ending (in dollars per share)</a></td>
<td class="nump">$ 278.38<span></span>
</td>
<td class="nump">$ 179.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember', window );">Stock-settled PSU awards | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage', window );">Actual payout range</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember', window );">Stock-settled PSU awards | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage', window );">Actual payout range</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember', window );">Performance share units, cash-settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning (in shares)</a></td>
<td class="nump">1,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget', window );">Adjustments above/(below) target (in shares)</a></td>
<td class="nump">507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested and converted (in shares)</a></td>
<td class="num">(1,071)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending (in shares)</a></td>
<td class="nump">890<span></span>
</td>
<td class="nump">1,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning (in dollars per share)</a></td>
<td class="nump">$ 169.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share)</a></td>
<td class="nump">369.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue', window );">Adjustments above/(below) target (in dollars per share)</a></td>
<td class="nump">104.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and converted (in dollars per share)</a></td>
<td class="nump">369.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, ending (in dollars per share)</a></td>
<td class="nump">$ 242.29<span></span>
</td>
<td class="nump">$ 169.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">9,648<span></span>
</td>
<td class="nump">6,002<span></span>
</td>
<td class="nump">8,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share)</a></td>
<td class="nump">$ 310.52<span></span>
</td>
<td class="nump">$ 312.41<span></span>
</td>
<td class="nump">$ 200.35<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521254864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">401 (k) plan contributions</a></td>
<td class="nump">$ 22.8<span></span>
</td>
<td class="nump">$ 19.5<span></span>
</td>
<td class="nump">$ 16.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contribution</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="nump">52.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">29.4<span></span>
</td>
<td class="nump">249.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">52.4<span></span>
</td>
<td class="nump">265.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected contribution to the plan</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear', window );">Assumed healthcare cost trend rate, benefit obligation</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1', window );">Ultimate healthcare cost trend rate, benefit obligation</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost', window );">Assumed healthcare cost trend rate, net periodic benefit cost</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost', window );">Ultimate healthcare cost trend rate, net periodic benefit cost</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="num">$ (52.2)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 29.4<span></span>
</td>
<td class="nump">$ 249.2<span></span>
</td>
<td class="nump">$ 258.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="nump">4.35%<span></span>
</td>
<td class="nump">2.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.09%<span></span>
</td>
<td class="nump">2.79%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on assets (as a percent)</a></td>
<td class="nump">4.14%<span></span>
</td>
<td class="nump">4.93%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected contribution to the plan</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="nump">5.55%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on assets (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contribution</a></td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="nump">5.55%<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on assets (as a percent)</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">International plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 29.4<span></span>
</td>
<td class="nump">$ 49.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">$ 46.0<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">1.32%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.09%<span></span>
</td>
<td class="nump">2.79%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes components of net periodic benefit cost (credit), excluding service cost component, for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ultimate trend rate for health care cost for defined benefit postretirement plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521561152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Components of Net Periodic Benefit Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlement loss</a></td>
<td class="num">$ (52.2)<span></span>
</td>
<td class="num">$ (1.8)<span></span>
</td>
<td class="num">$ (3.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">(11.9)<span></span>
</td>
<td class="num">(11.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service credit</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of actuarial loss (gain)</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlement loss</a></td>
<td class="nump">52.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanOtherCosts', window );">Other</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">54.1<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net loss (gain) arising during period</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service credit arising during period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service credit</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization of actuarial (loss) gain</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax', window );">Settlement loss</a></td>
<td class="num">(52.2)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges', window );">Foreign currency translation</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax', window );">Other</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in OCI</a></td>
<td class="num">(39.8)<span></span>
</td>
<td class="num">(12.9)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax', window );">Total recognized in net periodic benefit cost and OCI</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="num">(13.3)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">51.7<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits | International plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service credit</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of actuarial loss (gain)</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlement loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanOtherCosts', window );">Other</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net loss (gain) arising during period</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service credit arising during period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service credit</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization of actuarial (loss) gain</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax', window );">Settlement loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax', window );">Other</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in OCI</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax', window );">Total recognized in net periodic benefit cost and OCI</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits | International plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of defined benefit plan cost (credit), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Defined Benefit Plan, Other Costs, before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement Gain (Loss), Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923522008960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">$ 249.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">29.4<span></span>
</td>
<td class="nump">$ 249.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(269.8)<span></span>
</td>
<td class="num">(298.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">$ (1.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(4.2)<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain (loss)</a></td>
<td class="nump">33.0<span></span>
</td>
<td class="nump">12.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Amendments/transfers in</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlement loss</a></td>
<td class="nump">174.4<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency translation</a></td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(55.5)<span></span>
</td>
<td class="num">(269.8)<span></span>
</td>
<td class="num">(298.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">249.2<span></span>
</td>
<td class="nump">258.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(42.4)<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums', window );">Employer contribution</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(7.2)<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlement loss</a></td>
<td class="num">(174.4)<span></span>
</td>
<td class="num">(13.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">29.4<span></span>
</td>
<td class="nump">249.2<span></span>
</td>
<td class="nump">258.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">(26.1)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(5.6)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain (loss)</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Amendments/transfers in</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlement loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(3.9)<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums', window );">Employer contribution</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlement loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">$ (3.9)<span></span>
</td>
<td class="num">$ (5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Contributions By Employer, Net Of Premiums</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923522643408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Amounts Recognized in Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">$ (2.1)<span></span>
</td>
<td class="num">$ (2.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(28.2)<span></span>
</td>
<td class="num">(40.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_AssetsDefinedBenefitPlansNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(24.9)<span></span>
</td>
<td class="num">(35.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent', window );">Total liabilities</a></td>
<td class="num">(26.1)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_AssetsDefinedBenefitPlansNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(3.3)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent', window );">Total liabilities</a></td>
<td class="num">$ (3.9)<span></span>
</td>
<td class="num">$ (5.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AssetsDefinedBenefitPlansNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AssetsDefinedBenefitPlansNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923522590576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">$ 16.7<span></span>
</td>
<td class="nump">$ 56.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost (credit)</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="nump">55.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="num">(5.2)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost (credit)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="num">$ (5.2)<span></span>
</td>
<td class="num">$ (4.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923518126528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Expected Benefit Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">4.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028 to 2032</a></td>
<td class="nump">22.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments', window );">Total benefit payments expected</a></td>
<td class="nump">42.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028 to 2032</a></td>
<td class="nump">4.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments', window );">Total benefit payments expected</a></td>
<td class="nump">10.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">International plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028 to 2032</a></td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments', window );">Total benefit payments expected</a></td>
<td class="nump">$ 32.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Expected Future Benefit Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanExpectedFutureBenefitPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923518128768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Assumptions Used (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Weighted average assumptions used in net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.48%<span></span>
</td>
<td class="nump">2.29%<span></span>
</td>
<td class="nump">2.61%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.79%<span></span>
</td>
<td class="nump">2.41%<span></span>
</td>
<td class="nump">2.33%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on assets</a></td>
<td class="nump">4.14%<span></span>
</td>
<td class="nump">4.93%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Weighted average assumptions used in benefit obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.35%<span></span>
</td>
<td class="nump">2.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.09%<span></span>
</td>
<td class="nump">2.79%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Weighted average assumptions used in net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on assets</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Weighted average assumptions used in benefit obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.55%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923529568720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details) - Pension benefits<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Weighted-average interest crediting rating used to determine net periodic benefit cost</a></td>
<td class="nump">3.31%<span></span>
</td>
<td class="nump">3.31%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Weighted-average interest crediting rating used to determine net periodic benefit cost</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="nump">0.67%<span></span>
</td>
<td class="nump">0.52%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923522203376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Allocation of Plan Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 29.4<span></span>
</td>
<td class="nump">$ 249.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member', window );">Pension plan assets in the fair value hierarchy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">29.4<span></span>
</td>
<td class="nump">49.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">28.7<span></span>
</td>
<td class="nump">47.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Pension plan assets measured at NAV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">199.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Cash | Pension plan assets in the fair value hierarchy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Cash | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Cash | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Cash | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | Pension plan assets in the fair value hierarchy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 8.2<span></span>
</td>
<td class="nump">$ 21.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">21.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="nump">86.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember', window );">Debt securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember', window );">Mutual funds | Pension plan assets in the fair value hierarchy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 20.4<span></span>
</td>
<td class="nump">$ 22.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember', window );">Mutual funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember', window );">Mutual funds | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">20.4<span></span>
</td>
<td class="nump">22.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember', window );">Mutual funds | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember', window );">Other mutual funds | Pension plan assets in the fair value hierarchy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember', window );">Other mutual funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember', window );">Other mutual funds | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember', window );">Other mutual funds | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Equity securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Debt securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">63.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Equity securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Debt securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521460928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) - Schedule of Other (Income) Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and post-employment benefits</a></td>
<td class="nump">$ 8.7<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other charges</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related charges</a></td>
<td class="nump">23.8<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Fixed asset impairments and sale of equipment, net</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">(Gain) loss on oil hedges</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange transaction gains</a></td>
<td class="num">(4.1)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Cost investment activity</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other items</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherIncomeExpense', window );">Total other expense</a></td>
<td class="nump">$ 26.8<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520949968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain (loss) on oil hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Cost investment activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Impairment of cost method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gain on sale of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember', window );">2022 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation', window );">Restructuring and related activities, period of implementation (up to)</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember', window );">2022 Restructuring Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related cost, expected cost</a></td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOnFutureEarningsAmount', window );">Effect on future earnings, amount</a></td>
<td class="nump">22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember', window );">2022 Restructuring Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related cost, expected cost</a></td>
<td class="nump">27.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOnFutureEarningsAmount', window );">Effect on future earnings, amount</a></td>
<td class="nump">$ 24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation', window );">Restructuring and related activities, period of implementation (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and related cost, cumulative cost incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOnFutureEarningsAmount', window );">Effect on future earnings, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOnFutureEarningsAmount', window );">Effect on future earnings, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOnFutureEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The quantified amount of the future effect on earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOnFutureEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfInvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfInvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Related Activities, Period Of Implementation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_RestructuringAndRelatedActivitiesPeriodOfImplementation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521317520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">$ 4.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">11.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember', window );">2022 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">25.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">25.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember', window );">2022 Restructuring Plan | Severance and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember', window );">2022 Restructuring Plan | Asset-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">15.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">15.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan | Severance and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan | Other charges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520698192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at January 1</a></td>
<td class="nump">$ 24.9<span></span>
</td>
<td class="nump">$ 10.4<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase due to current year position</a></td>
<td class="nump">11.4<span></span>
</td>
<td class="nump">16.3<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase due to prior year position</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease due to prior year position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reduction for expiration of statute of limitations/audits</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at December 31</a></td>
<td class="nump">$ 36.5<span></span>
</td>
<td class="nump">$ 24.9<span></span>
</td>
<td class="nump">$ 10.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923516252736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued liabilities for interest and penalties</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Total gross unrecognized tax benefits</a></td>
<td class="nump">36.5<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">$ 10.4<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Estimated increase (decrease) in the liability for unrecognized tax benefits</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Tax expense (benefit) from impact of tax law changes enacted</a></td>
<td class="nump">5.7<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount', window );">Tax expense from recognition of reserves for unrecognized tax benefits</a></td>
<td class="nump">19.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount', window );">Tax benefit from termination of pension plans</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount', window );">Deferred tax benefit</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxSettlementsOther', window );">Tax benefit from prepayment of future royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Tax benefit from stock-based compensation</a></td>
<td class="nump">16.5<span></span>
</td>
<td class="nump">$ 31.5<span></span>
</td>
<td class="nump">$ 20.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Operating loss carryforwards, state and local</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Operating loss carryforwards, foreign</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign subsidiaries</a></td>
<td class="nump">893.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">123.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | Year 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | Year 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | Year After 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">118.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">18.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxSettlementsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other income tax settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxSettlementsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126928070&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Tax Benefit, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Recognition Of Reserves For Unrecognized Tax Benefits, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Termination Of Pension Plan, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ExpirationPeriodAxis=wst_Year2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ExpirationPeriodAxis=wst_Year2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ExpirationPeriodAxis=wst_Year2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ExpirationPeriodAxis=wst_Year2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ExpirationPeriodAxis=wst_YearAfter2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ExpirationPeriodAxis=wst_YearAfter2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923525928336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Before Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. operations</a></td>
<td class="nump">$ 394.4<span></span>
</td>
<td class="nump">$ 420.0<span></span>
</td>
<td class="nump">$ 227.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International operations</a></td>
<td class="nump">285.5<span></span>
</td>
<td class="nump">328.9<span></span>
</td>
<td class="nump">174.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="nump">$ 679.9<span></span>
</td>
<td class="nump">$ 748.9<span></span>
</td>
<td class="nump">$ 401.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923522589872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Tax Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 75.7<span></span>
</td>
<td class="nump">$ 64.8<span></span>
</td>
<td class="nump">$ 28.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">61.4<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">46.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax provision</a></td>
<td class="nump">145.5<span></span>
</td>
<td class="nump">150.1<span></span>
</td>
<td class="nump">78.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit', window );">Federal and state</a></td>
<td class="num">(20.3)<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">International</a></td>
<td class="num">(10.5)<span></span>
</td>
<td class="num">(50.2)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision</a></td>
<td class="num">(30.8)<span></span>
</td>
<td class="num">(42.9)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 114.7<span></span>
</td>
<td class="nump">$ 107.2<span></span>
</td>
<td class="nump">$ 72.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Federal, State and Local Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923521493216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 10.3<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carryforwards</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Pension and deferred compensation</a></td>
<td class="nump">31.4<span></span>
</td>
<td class="nump">31.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DeferredTaxAssetsRoyaltyAcceleration', window );">Royalty acceleration</a></td>
<td class="nump">46.2<span></span>
</td>
<td class="nump">45.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">25.5<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalized R&amp;D expenses</a></td>
<td class="nump">8.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_DeferredTaxAssetsLeasingArrangements', window );">Leases</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(13.3)<span></span>
</td>
<td class="num">(12.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">130.7<span></span>
</td>
<td class="nump">92.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="nump">53.7<span></span>
</td>
<td class="nump">47.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Tax on undistributed earnings of subsidiaries</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Leases</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="nump">79.4<span></span>
</td>
<td class="nump">48.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset (liability)</a></td>
<td class="nump">$ 51.3<span></span>
</td>
<td class="nump">$ 43.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leasing Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredTaxAssetsRoyaltyAcceleration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Royalty Acceleration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredTaxAssetsRoyaltyAcceleration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923529240400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Income Tax Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal corporate tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Tax on international operations other than U.S. tax rate</a></td>
<td class="num">(1.50%)<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Adjustments to reserves for unrecognized tax benefits</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent', window );">U.S. tax on international earnings, net of foreign tax credits</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent', window );">Foreign-Derived Intangible Income Deductions (FDII)</a></td>
<td class="num">(2.10%)<span></span>
</td>
<td class="num">(1.50%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax effect</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">U.S. research and development credits</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Excess tax benefits on share-based payments</a></td>
<td class="num">(2.40%)<span></span>
</td>
<td class="num">(4.20%)<span></span>
</td>
<td class="num">(5.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent', window );">Royalty acceleration</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(2.50%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent', window );">Pension settlement</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage', window );">Tax on undistributed earnings of subsidiaries</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">16.90%<span></span>
</td>
<td class="nump">14.30%<span></span>
</td>
<td class="nump">18.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax benefit from difference to income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Pension Settlement, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Repatriation Of Foreign Earnings, Net Of Foreign Tax Credits, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Royalty Acceleration, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Undistributed Earnings Of Subsidiaries, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923529314848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount', window );">Outstanding unconditional contractual commitments for the purchase of raw materials, utilities and equipment</a></td>
<td class="nump">$ 96.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary', window );">Outstanding unconditional contractual commitments due to be paid in 2021</a></td>
<td class="nump">70.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember', window );">Insurance Claims</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrual for insurance obligations</a></td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyReceivable', window );">Amount reimbursable by the insurance company</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Revolving Credit Facility, Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letters of credit supporting the reimbursement of workers' compensation and other claims</a></td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable related to a loss contingency accrual. For example, an insurance recovery receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923527646480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923520868976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Sales by Product Group (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">$ 2,886.9<span></span>
</td>
<td class="nump">$ 2,831.6<span></span>
</td>
<td class="nump">$ 2,146.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Proprietary Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">2,406.8<span></span>
</td>
<td class="nump">2,317.3<span></span>
</td>
<td class="nump">1,648.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Contract-Manufactured Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">480.4<span></span>
</td>
<td class="nump">514.7<span></span>
</td>
<td class="nump">498.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment sales elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923516357984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Sales and Long-lived Assets by Geographic Location (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">$ 2,886.9<span></span>
</td>
<td class="nump">$ 2,831.6<span></span>
</td>
<td class="nump">$ 2,146.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">1,262.7<span></span>
</td>
<td class="nump">1,126.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">1,286.5<span></span>
</td>
<td class="nump">1,198.0<span></span>
</td>
<td class="nump">975.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">611.5<span></span>
</td>
<td class="nump">504.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">398.7<span></span>
</td>
<td class="nump">474.3<span></span>
</td>
<td class="nump">282.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">139.0<span></span>
</td>
<td class="nump">124.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">240.3<span></span>
</td>
<td class="nump">247.6<span></span>
</td>
<td class="nump">226.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">179.5<span></span>
</td>
<td class="nump">187.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">237.9<span></span>
</td>
<td class="nump">213.0<span></span>
</td>
<td class="nump">172.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">68.8<span></span>
</td>
<td class="nump">86.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=wst_OtherEuropeCountriesMember', window );">Other European countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">359.2<span></span>
</td>
<td class="nump">341.3<span></span>
</td>
<td class="nump">236.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">81.8<span></span>
</td>
<td class="nump">65.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=wst_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">364.3<span></span>
</td>
<td class="nump">357.4<span></span>
</td>
<td class="nump">$ 253.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">$ 182.1<span></span>
</td>
<td class="nump">$ 160.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=wst_OtherEuropeCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=wst_OtherEuropeCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=wst_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=wst_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923522072128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Segment Financial Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Profit</a></td>
<td class="nump">$ 734.0<span></span>
</td>
<td class="nump">$ 752.3<span></span>
</td>
<td class="nump">$ 406.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="num">(23.7)<span></span>
</td>
<td class="num">(37.5)<span></span>
</td>
<td class="num">(34.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquisition-related intangible assets</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="num">(15.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Interest expense (income) and other nonoperating expense (income), net</a></td>
<td class="nump">54.1<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="nump">679.9<span></span>
</td>
<td class="nump">748.9<span></span>
</td>
<td class="nump">401.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Impairment of cost method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">3,616.8<span></span>
</td>
<td class="nump">3,313.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">120.6<span></span>
</td>
<td class="nump">122.3<span></span>
</td>
<td class="nump">109.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital Expenditures</a></td>
<td class="nump">284.6<span></span>
</td>
<td class="nump">253.4<span></span>
</td>
<td class="nump">174.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wst_SecondQuarter2020AcquisiitonMember', window );">Second Quarter 2020 Acquisiiton</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquisition-related intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Profit</a></td>
<td class="nump">844.8<span></span>
</td>
<td class="nump">863.3<span></span>
</td>
<td class="nump">503.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Unallocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Profit</a></td>
<td class="num">(110.8)<span></span>
</td>
<td class="num">(111.0)<span></span>
</td>
<td class="num">(96.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="num">(23.7)<span></span>
</td>
<td class="num">(37.5)<span></span>
</td>
<td class="num">(34.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Corporate general costs</a></td>
<td class="num">(59.1)<span></span>
</td>
<td class="num">(63.4)<span></span>
</td>
<td class="num">(52.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="num">(23.8)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquisition-related intangible assets</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_CostInvestmentImpairment', window );">Cost investment activity</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">558.2<span></span>
</td>
<td class="nump">717.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital Expenditures</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Unallocated | Cost of goods and services sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Unallocated | Selling, General and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember', window );">Proprietary Products | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Profit</a></td>
<td class="nump">784.4<span></span>
</td>
<td class="nump">796.1<span></span>
</td>
<td class="nump">434.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">2,578.3<span></span>
</td>
<td class="nump">2,152.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">96.9<span></span>
</td>
<td class="nump">93.8<span></span>
</td>
<td class="nump">84.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital Expenditures</a></td>
<td class="nump">237.3<span></span>
</td>
<td class="nump">218.0<span></span>
</td>
<td class="nump">139.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember', window );">Contract-Manufactured Products | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Profit</a></td>
<td class="nump">60.4<span></span>
</td>
<td class="nump">67.2<span></span>
</td>
<td class="nump">68.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">480.3<span></span>
</td>
<td class="nump">443.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
<td class="nump">20.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital Expenditures</a></td>
<td class="nump">$ 34.0<span></span>
</td>
<td class="nump">$ 26.6<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CostInvestmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost investment impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CostInvestmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=wst_SecondQuarter2020AcquisiitonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=wst_SecondQuarter2020AcquisiitonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923529128320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="nump">$ 16.2<span></span>
</td>
<td class="nump">$ 16.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Deferred tax asset valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">12.2<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139923524172912">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>wst-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:wst="http://www.westpharma.com/20221231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="wst-20221231.xsd" xlink:type="simple"/>
    <context id="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic8766ff13a5c4bffb4105af8ef735b18_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2a1b49b3369c42dd9827948a3411a736_I20230125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2023-01-25</instant>
        </period>
    </context>
    <context id="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i635169c6599a4431a7816915bd315902_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a763da7bebb49d78fb727a07ced4166_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id962c393773440e097f70db1509b5a4c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib9377c7030f9487bb7299e888531cb40_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie47b13e10f5c43f18b3aba014d8b9557_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i17b8a1175e024b0b91f80042eb871d9e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5ff963c9c54045f29206b3189d452f9b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if4a3a8484e4d4e25a93de4d344e4db3b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5f410a8c4414410fbda82326f2f5f0cd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idca50b3901184ea9bada9c1613654555_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i532be8bdd25444f5bef6c5a83fa6ec14_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i093b685a4dfa4da18da754958b07c8bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06323a1fbe0b4d548901ae093dc4d002_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f3b7a5c69c84fa1a9361b05a767bfa2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i16978dcdc2f041d19d80093c40fff403_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if72c2fa428754de9934583a6add241a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i840ed7b254234d0fbb34c7f7abeabfed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie21b4b5fca6e4ce0884f11bc4cfad4fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida3c98d3c0354b73a89f724be3743416_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1165b131d689444eb6459290c85e0fec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i00b5efe1c17b43d2a2fb2ea3402c0e1d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i989eb46562154074b7d4bd40080dadcf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4ce53383a53d4f1eb000e413d41ebdf9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c3dc3f33c6e40168b8ee2b01cf1da89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2e32d2d077d14623ad4001f6615da739_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i269d9dc747f34c98bd9fd36e958f9112_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic40bf59888ea464bbf38a5e599052b55_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9bbf7836dda448549d12d0144c47661e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e14a309edfa4014932d060921715d47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80e03154cb7d45b6addb0d566c6a2e5d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i21e3c20e3f1049698ccd1b563fee50fd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic414a0567e02472dbd5e6bc8dea1c934_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i42428a99c9ed4d9bb8b558e76dc9a6d0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i27a556c3b4b644d5a2cba539a25d2c52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i297d5b4a9400421e865338046ad94f11_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if051f33d67bc4196a2590dbe46e32868_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3086806657e4a2b89502cfae1ac8883_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1e6cb706114942e4aabe6faaacf4e663_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieca2c70046774b70b2ca24e38603bd11_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibb415db0220846bbbaee31bca93b64e3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib455f8d389b84c90834d838d768dd859_I20130630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2013-06-30</instant>
        </period>
    </context>
    <context id="i530eb90eb2764a55bb62aac980b27711_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79c8219373a3404aaf82ead0cda46716_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i609b68bdcb584f1fa5a8970ccd1759d3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6ff1421dfabb4931b5d3f165e4fa608f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5d95a90ba942409fb7eb38c53be370cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i665253b4d08e4da599894b62da126263_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic40393e675034834a4cb5d8ffa391e4c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97e639bd58654edeb8611e423238d72e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7fa94e736dee414db6421d8880cc2422_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if045da1a86684296aa4c33ad55d60c95_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if7066b92c5e54bc79943066fb6034c7c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i51e337fbb71345fca552db98bf16e460_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i452ba88776d94afb84fbc1b35bcbcd24_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic134acff31094622a91b3143a0e96cd0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia177439c331047b2ab87726450ce39bb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i256eab0010ac4440b58c5fa97329532a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifc55026ca0ea4cd4b78b9007129033b8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i838a650038204c9eafed9990f5a9ee16_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id7120c4b931d4e48b07cf29f80d2b1cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe73169f2a304e4b8511b7c7f5ca3ea2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id1c945b9d9124755884c9318597648c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib8da7f757b5d415e896679c642747d6e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9f44138370e044a39010d4f60177210d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifb8186699d064e74a59fc5b34eed6c40_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0faf4f9784a94f7aa7354566da3204c3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic35adedcc7f44b1b9c0fe04681478c95_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if6651efd4f764b48adb48d2620a076d6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1147923590ae4023add6d186c7abf72f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f618571d5fc44b591d452151b7e1075_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ica414868e28c41ee9837e7414f82083d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ica6ef1a0769a4e648ec274538fd0bbea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i057ed2a2629447fe8340db3a494eaafd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if7ac37da416447fdb298621d726f8906_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia45b0766113a446a94c89d02189621ed_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i93cc0075175a4ee886a144fc0fad49b2_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5259b4fec7824128bebbc2321b046a0f_I20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-21</instant>
        </period>
    </context>
    <context id="ib525a96790ee419f9313dd7892b7b3dd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b995d9f735c49ffaf75d044a0c03b66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ad88a83c00d41a9803dfa1fd8846d50_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id6dfe8c8214549d598f7663164c534f1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57893ac1e0eb4f4f94c5d5b585544e57_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i867bfde87f4d49c6aa3b2e198dd30265_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9bad476918442d094a0b53fc624ea6b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1c3b02cc69744d1c81a95c04444728f3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6e1e4b02c23d40809d6f4748ba485f04_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7cae435921ec4feeb1ccbe93403e73e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2fe30bc7c27942be8f272d9013b321b8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia6c9307eae344809bc9eb362136f13b5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6387f13194fa4168b18b7acddc8a7e66_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i12cc38a53bbb4b5dab6d38a174b78556_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if85a0ce5a6b94dad8023eed11fefec57_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1b1026f47645465da8f39a740c77972a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic052515f57af407a9c8ee85f261cca28_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i90934a86885b435589f1b238bebbd8de_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i392eaf9fb1b54a2e84e87ce96d573162_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i30a3acb1630d4d42961464184cf42df9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a0b48beb7be4ec38b7f1e3807bb5fc1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i83da5dac2d5b4be8a4e3cf6b667f2e1c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:WestCompanyMexicoSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i03c15e3f82e14b2d8ea127a9ace71de2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:AluplastSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id72e5e9a20f24e66a90f5ff4e835e57a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaTapSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3173295a48a4425dafd024e4bcaea4d0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaRubberSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie0e46db508ae452ea86af0980f1d1e00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifd70574b39b442a999ec4c558f63a4fb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93d6a4a1140d4a819a08655c97b0030c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1316e29c4d1347d282b020769df84fb7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10c63b8503e64ef7aecc45e4839041ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c26cc49e6104694b627031996fac9f2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9f533fa13e604ceb9279ba3b5b3ac9c4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7263d8dd9a4b44e0ac64eb6919dd3540_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i965965b0db234e199c7a370813f9bac1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c6727e68757499781a9770aa96a5a3f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id22c437a5e7a415c8d04a385cd6d3bf3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if3a9837d9b47499480dff64b4fcb6b1d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16e0e7a9bae54bee9c9cc1207ec4ae1b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i254460edc0a349ea96b0104f485aed1e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if7ef7fb4150d47649071f5f1b4f490d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic17963791fc94a5d9927fcb81798188f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iadc79f5eb40040f7a6e4a72ff4148eda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6455ee991aeb451d8b8ebd79daef0cf6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0a6b50bf43424e5d8f1090509ea44dcf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93f5765c9a8046e2a6369832660d3253_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia52c083f2095422b99e633dfb6d9a704_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7ccb1f26a7b415b99d59d04309e91b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7e1c2074501a4c8e904e282823fdb207_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c253265028c4a42abd68ab7456d94f4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iacbba1511dcd486088f2748d91395b33_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0cd10fbd48944499bd3e75624d39e738_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id63066ad3a37405a9157d08cee024b89_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59b3a686792245fba4c1cd0fdbe993ad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i978162754bb545bf8cc52ff142f514e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id421927f2814464886c6dde31c2e17a1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie263faaeca58416a9df1dabac7a4b51c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7fb1cd1161ef428f901886b8f8bfae4d_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="i9433ad101e0f40c6a59795056c11ca8d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9775d568a3404cfcb4de79a3df989730_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieef415446df24387a2f0b94ff7a58e73_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ForeignLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if20cb8b7f73343e0b4d7df1ab5592c7f_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">wst:ApplicableMarginMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i39fe04778e964e42b69b3e3667134afb_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8a3f65e2339e46edbd122c6a7e88c734_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3968429e781944ff917fa69ee5084d06_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie9412b7a71714bc19162384ec914aec4_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i17f90a6dc27944f087b669925f30371f_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i14dd74ecfac74fa98fbdb00352369007_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i34794d2072c74e28898377fb07301721_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia9e4ff52db72474081a077b4a2d8bf8a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic2c00c7463cf41a9988d6d2571c4a4e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i36a6e77fe574426b8c780aa1e3956660_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib39e812e09a44972bf2c8d2ad05b403e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icf787da5fc004530a7921f12a8628daa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie3a2571be15e4bbaa4802e0b11fe9e86_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i861ad8987fa54c699465cafe8d5b03b7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i656ea7823b914cb681c9f806732bce7f_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="iad4b14762f724836912187aa55021fd3_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="i34909e1b0bb641229424ae8dea78f236_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="i2bdb4dd782f5429cae42770030a9c63e_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="i63e7117f5e6c48e3bc16493062149b41_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="i5f365909be2c4a33b9535d9625359634_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb457474142548ada94572d36284f1aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d646a9b7feb4e40a68f41f454b189df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i569a84a1b6044847a369af6d7becda42_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33954585607a418e8de125d8e2ad1f27_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9b6ff425fe5240119fb6fedfde9e6e41_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i32dd3ce056004fa288d5cd8119b7d251_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i171c812bedd448199594f8cbe21f5215_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i43ec8e1a30c24bba9c86e74b4d8c13f9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05eec46fb5e34fe797afbe0315ba7370_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2d66ee6c4f140c5ad3cd9497de7f00a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07c6df090c7a49f4ae2283e42ca80a22_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7adb9161e9af4809af615f27c957ccf7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i647595866ae94d7883d164c13e7576df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1717cad3ed8747cfb39d9d04479a590c_D20171101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icd338cc8a5fe470590598ff0e2475ae0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id784d712d09342aebd7b7dfe678f761b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8a46826c2684460eb4fbb56df6e8152a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c00e1dadfb14a658cb637483c6837c2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab197c4924f34c0db38f5eb19ad7f2b1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i055a22dcb77a4206a028877100a4c97b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5e0072e4d3cc422b90a6e91608ad2109_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i85e3c3d286034ff49e528b2c9317d171_D20230101-20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="iae7ed9fa03bd445da0742597c1c5438f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if3195132dd5345a6887a4340147a0564_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i72e42c0a25694e14b9229d1e967b73d5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0e06a7878bb94a07b93f4163c017f6ce_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia05c56f7d4da40bab7b1afb3e4f348f7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaa12cd493a074d5399af3c418b4c5706_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i85aa4b0d24d14148bf70e42bf8953a40_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i61e1ccc194684e27aa2be4350e2a59da_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9601ccbfbc6c4c6e969ee2d307d9045c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i735ee47484304157b7f13947a9b6e46a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7d8fd0ef4c9d44ccbf513c6e6c38b9b1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i397a9fc92bb541bda84bf523b0f0534c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifbf55f1a879b48a78fb1475dceabdc9d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib560936ecece47cf97fd5dfe6464bfb7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ice018ed37eaa49149dc6c63f944f178d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icd37440709c84ad3812e75fb20e0afa6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9e71e4d6cb1c4e27acca2bfaf571e3ac_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i63adabb977604bc4a8c06a77bae5bfd4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5d0bf9f09bfd45009a95e13ff7570373_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4ccb1166712d49a3855a9a39bf66196e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3606e54a0a1946d8bca09748806375ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i450fa254443341388fa92c220d282a50_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i66ee7b68af3241c8ba207622f3731e45_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id841a6055f0e4cfbaacfafc0843a3b62_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4ecf564c7c8643e083fb3f9bc53dd6e6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i172c5bb368534dc6afd5e93d8d03deaf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0a19776470ed4aa9be3c7220853c571b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic31348b180714cf69a4949022e873c8b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i86d021ac1cce433bba24d4fee5778a4b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie516db60841b47beab93458349c39d9e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i21d6d1e179764319939518be6b4755c8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4a05df88c57c4fbba800cd2d6ded4056_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0dc769ee573d4b1eb606de264ddf0ea5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i262cd9dc71574d73902a46c241cb2c0d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iae52261e94e747a89a158b1da3e74546_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6881855e92e84a999adbd921603e22a5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie73452302c0e415ab2556f3eb20f4c00_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i973d62078ba14495ad1278fd1f4d578d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9da752cb333d421ca18f1e5af162195f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia23aa690efbd45fe8cfcb969d018f680_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a65a38a422f4a89a39109cd74bb897d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i754552b393944baa8e31325d5eba5188_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd279fe6b3354a1d94ce2672678400de_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i43611db249a44bdb8e4b0da680b6e710_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icc6ce44539154204a8fdfb1e5e3bcb36_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2c88912680242f1a6463abe80fe7cf4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i32dd82ca504d4e4e8b1e47b0b4f96b7e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib5907fec60b44341a54dc18b426e81a8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66ec8d15453f4f38a06ec86fbf3ff764_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i25a6afe95d6949a9b15847a9e5063bda_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie7c411ebf213498bbc17286b687febec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4463c41232a04445bcdcb36422deee33_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i54f66b73b00546638fb3dfdeea498856_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1ef59879afe401591e29ee824de0517_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia23bb5001acb4d96a0f1e75661196565_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d2482447c6049c1a04840f7c479360b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83c5430234af414c9fcc3b4df8890d9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d763901eafd48cd8a636ca3db465303_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie316bb8a16254f0b8e82e29bc1835be1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d15643e954d4ef2862b5cf9aeaff59b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1371f6ecf2dd4b64b6bf9d8da230988e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ae5843ba66649458ad2eab839e35a52_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b86341c878947cd85fe8ec2548111e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if867c326ea304572bf285d245f2729f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i406f7691b793473590f26cc05c368e11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i805c24fc27444fd38deafff1a2c4bbe9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iafa5b204c1dc4abc86e2792ad48e7b16_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4fbcb98a53e34fcb8a183148ece8920b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iade80d0537714f308a08a338374d6b21_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i32b73b088654490bb5a6be67066e2ae9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i386979849f4a4ca899ce2778bd52f0d5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i54bb101058b8400a88f43f7396f6df6b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaecd545d46d342a39efcb16ad10a6df6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97d694cff77844d882d28c32d629311e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9815180ba0b54d2881441a6cc952417a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie07c502333264b49a0ba4aa4235be632_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79faae59eb5747f094ec247979277f49_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89bf04ee5a4a44318e42a1114576fc19_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ff1cabbd90749c99af71165f285a71c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8a86bade84543889f6b81500c0a8ac5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d46a1f438f8461684e84f9c8c79e508_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5d66b7db239e48d5b1af0749bb3ea343_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0662f0d0f62149118e93596ed7214b5c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib2a17d2034694fe895103701a3db15e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i063266317845420c9c9604cf2e5a3b01_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1289dce1d1384485a949179f19183178_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i56913a13b5944c5587eaaa2f5fb63640_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i99e48d0827e84674a9f7b673ab8b3adf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia8d3089900f144029822b0251c552161_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1d37456ab52c475297384d08d55cb38d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if40187b8b7a64ea69df5cf9e017b64fd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia0818a4e839d4d98b9c9d2fb94135719_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i572ebcf46c464f8480b6b43ea02ed0cb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc24b95cad0a44dfa74ee686cfc4c554_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5e50ef11a0b74e949d7a233e7b69d9df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie5c740ee53d14acab5e8ce562e9ed2b3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i04413dcc613d457fb097e0213020ab3f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i32f586765ed14e30998543a97afb12e6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id1a24648febc446d97d71a944faf23c8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icadfe694aab14a67aa2e38dfb55e6d5f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d89b5b64b2f47fabc89d28b39c6abb3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9ec8f38ddecf4489927d3f56c19b2c35_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8c01348d5d61478b9245598d8ff9f61e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id573bfa61009494da99108c926e21d55_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe8ca4226e454ae6ac3d77c3f63f4645_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57bae4fdbc424d98b421183e9aa884b0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i35a7a2f289af4db3bb7d06fea36d17ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7a283afeb8f40c6817f0e72d6df5ccd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icd99140b0fe444a2968f0cf1a36fa8ce_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id4be6b9f04b6470da6ab0ab85cb527ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i20ebcecb9d2c4a209b92fbebb9207661_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6834a2454c954e5db472d9a40c33b13a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3996b06720ee42ee8d78c7b8b11628f8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5167798386874e29a8044c426c90a599_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2c52a1e553d247a3ae76670f5304a50f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia216fe90970d46f4be2d33c145486b81_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4ef8dd22a4a44f7beffb4e9f338e878_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i33c784d4eec04d78922a4e192bf59230_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia68e46033cf0466e976bea07f5d6efef_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i238ef97a2c414fa79ce155548aec647a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia1b919b91eeb42da9481eb832c9b75c9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic2db706bfea84d8885a041634831858e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id638f8160a6944ce83eb5f9cd2ee6de7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i718facb9187748eebcc936a4e7a55f42_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58930e1b5c274240b867fdb589c2ab06_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie41ef75fe7f74deeb695babb739e40e5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3d21da9c07e842308653dc6c5d692c08_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i756408cda2044016850493d82b241ade_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icbc7d817970f475e8dee97b98a3a0b5a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if14b97867296473e92081e449e76b6d4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i614e5023b53d4eab9f1069365d95f319_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i747f5bde668b43608459580452ed13c2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0b4e19b379674031b1a3259ea2819573_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib8ccc47a7d0f4470933be376826c61d0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5865c2fe32d348938d9c4f301afde2ed_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibacbcc57bab8485890bc85e0309a4c6a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e4d798726024904a0f9840ffb306523_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16b25fe7a8fb4b17a57c7cc7d9884e52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9aa30653f5684e34aaab6637e5921d32_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie73ec10e708d43e191bb939a896cda33_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i26532d87fb9149e18d431a1b831b2c44_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia88b9ad9e7de41e78648c5f18d9cde1c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib4919d2983094e91beec7377b6d8b34f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i560792d170344831a5edf3fe6812792a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i628d30d7315b4fcb9acfb4cf5dc8be01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib08678e6ad8b469ca289e79739970510_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5967145ff293449c900b45f8ce551762_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7479189625164010af6cfb04cc0211f7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i63ad9cb3287243e99846b5f6d49f4739_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2541ce86c9e34ed9941101140a5db110_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i316fa955e9204c2a8df463369185dda4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i441202e7fe0646609be36e2f8d0374b0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia2b3f6d5c25644418416ca4f73542523_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i34d78547c8434c45b5b43dd485a6821a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1fd65a6a4d2b4b7eb7aa097f7f5a03a8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a6c4ac23e3347c3a9d21b0dba11e268_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1b0b580bd80345db9a8c8beba2df1e69_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i94503a5d02c7463b985b14ead7a7b3d9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib445602ff9c740f89a59c9435ece0183_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i040620491325464cab7f6d3871ae4699_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i860f084cabda4ae99bb91cfb68d12843_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5585de920d8a464bb8478eab79b4c886_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7283d2db8a4479785b3c3e131984a7d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9ddd8fa84364291bfce3ba201396757_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07075ee510b147ffa069795d9eba1b83_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d6d4961721d423c8fba5c85a67fc33f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icaebb04c426c456a84deedfc7f59d594_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i405b25944ffd47c88f31893c248bb5cc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d4d0414b55e42238a7ed8c0cade2d85_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i83cbdcf4d95b46f5bb848c5c35e881c4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i83e1434feb5c44cf9a2a52c145c85770_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id534095c984248caac7f60f3f82c38bd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iee3572e584f746e78e030b73cb5e5f0d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c1ae3f134ee48b5bb585005d7de280b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if09fca4c07fa4958ac80820c3bcd7ee3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03e10a75c10f4d2c8f360deba82d8ee1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3309beddc64147aa9d4c3c624ed71776_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1744b600a2c44fb1857cc5d43e752987_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4be1b95cfcd2431b924119c50bfd5a9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic3af093e03e841719efdf12caaaf8448_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i18d85779db1a46ba80e1747766668dc9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9ec9a690a49b4b95844d16d70921814f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1cdc53f36f04478eaf3f3e8a7e98afd5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7c5650da0a7044278560c89a0b64ccb1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i54d8c496618d4192a7e40265b29fe16d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iace17547d7c143dd837ba1fadfa15bea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i937298cf9f8d407e95285a8eda6be83d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb4a0cc0e3284ea38084fdcbfa086cc2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1aff134b217b4ead88b196a40da71390_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7c5abf4f2b824482ba9d0532f850206a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9281c13bb0b5430aa149c75d799cec31_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6814334eaaa54902a2c168a168c3b713_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i334922c320134f52b9aebb9e98f36274_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia8b5e90b3aba4a33ba59bb7ae6badda6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5a372d5590a144cba98ee245f1283178_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc59d5e4aad64e88b0465be91ead9923_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if66e95bc7d5b4db2b517555e37322183_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iace9c5cf6693479d9fcaa3c0f9e210d1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24b1ef1156704a4faf188960f756e3c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1636e6221e9b4dcb9d03af54bcedbeba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaddca4ea08004b0ebdf07f53f5328e24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia29fffd4cd604df186eac9f77ff01597_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i03c8dbef891a41e5b4ae23fc2c17ac38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id96fe41b380c468082cde30cff4a88be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6fdb0e63df94bf78eaf8f55ca5a27cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaba5feb3867044abafc6aeffd95e3f8c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i60bb7b31a5774e6f969d94307712c269_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib72dae6b1cc44b23ac0fd1f3ae38ee3e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ac1499da88c4b44b4f74e0201a577ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3b0f7a0791b4b61be68028ab30483bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b93e203f105432f81fbe65326c6917c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0883d5b213a14846b9cecd02fae80c70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09031663d64a4d89be1f2c8ac603f9a3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5758fc91240f44f58c0d8211b63f96e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia12d474c435e416382e99942998771f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0c18c5f3a6c42509cf4b94e0141bcb5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i38e1e2edfa654b98a2366d1ba0e981bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0bb1b7b296b8458ba1252c6364245ea0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i58483908f99e4d18a4072d007a922d3b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9d11fb26784407a9537aafa6159e23b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i95a83e2185a942eca49ce6709b9ac586_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaf9de54a304d46c781f42375b69365a9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i849944f81aab4b96860b7d3e5eb73e20_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice7d61872f80427da0d9116b49983311_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5f7acdde722448e481784486341104c3_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6d2bb17ed48c41dba32219896e2e8175_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i141e60cb61604823b8430879ea150d99_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63527504ecaa4a10a8def5b5ec6f1894_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea43a3c1ca4f40c0bbab919047a0f8b5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9659ef9de2934f93b6fa46288c5b5b6e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i69af11490d5b4086ad2dfcf3de8f6296_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iffe83e403acf438f85b6dd1d97e8d460_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5d19b063b3c34a448674207e911c6ffb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i26407107db9342c9bf5081c03e7a3fa3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8bd3a366e8d54c4b8cef2c043f15ec29_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="iec709d90491e43ea967136f7e4512e45_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i9559d3f0ca1a41c1b6d4dd22b5a6caa0_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="id631ed0f114043709b097d7fd85636b2_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i3e0e239fe07746a692c5b712876addbe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24e6acff1c7640c38b022c848d7af043_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7a20234e76b4aceb4a563d4757f3a25_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1d8644e185ba45f1aca8a97124127c09_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i498328cc9bd447608019d68a0f1b2953_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib2a5063af9e7457eadff8ecde4a2a0db_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d14abab15aa4e50aae530229040d0ef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if4f7fd511790420c92f6c02a26a4ae95_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id305d29074a84896bb281161842eac04_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i291db1eaff5d4fe183595c6f835e091c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8495f2ee91834fb1a3f9fe1c93572049_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i680df56be5cb4f5e860aab0cf5b550c7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e05940c83de48978c0c9bb32a9d5626_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i908fccc3de554e288be0804e0e181156_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:YearAfter2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic45bcdf6531a4b0dbe32a45651758dbc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2dd0857c331249a9a85539ede4607c70_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6615258597bc4111bd8224a2f4f5be19_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib1eda1ab883d470f907fcc4ff3587bdc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8bd13159e1454ccd9cfc0a729531fc59_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic968e09b002f4e748bff0a829c35d435_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7d70e9583819487dac48027986480d13_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i84403c68951c424f99f535d20528d792_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe48c875c32240ab9ed7fce93ce67305_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie01badda3e434997a4b8e06f3311bc9a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i99c9f5c6fe924651b98fe035da1577d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8177e6120dec43daa5a7c888989f3da2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0b508e52bb8f41c9b7957f921eb2b0b3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i42e7467ce0ae48b9a47889bc1ec6fc4a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i431dce423ad841e6844024553fc98f20_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4aaaf90727654d12b638272fe7f2baf3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6314a6d37b84a358a5605e6ae2afd64_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iceb5fd8b48274ee1a5a308d102c6c25e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iead4344cd65d442aa5006dcd0376f4a2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if6e0d0a05d1348769f058a2ca5f42aab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i62beb24a7bad443180a155119c78b411_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i72bb0f0e78f045deaa478696bdea1be9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib4c8538cbbe04fb58f1ce10c1f2b28e2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia441c6249d0e463fa687f11715bdbe24_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ec4132786b74f858bedca0d55bf9841_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4227815e2274453b99190c759250f43_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8c79157ca814df59f4a743dcc90418b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if3888aacf77145f3a78e6e7189ee1a05_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6fedbb37b25343e993a9a82605d7113a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9a5015f6b1c94dec99eecc4b8658eb7e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e406b7e606f451d8091f5d964b93a58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0eff9689ef84a2ea76ecf78183f8827_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i926da543cc9e4398814ddc43ef95c631_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id0b0ed6a479d444ea07152748eeca4cc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8828a20eda4045f48764034dedf66337_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3307dfcbc00f42bb8997445de20e4919_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie61e6e97e08a4913b0cba163aed4e5a8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i66d771c3fe9d4b339af1cad17d645c10_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i95a551fb427249b6a0f0c397412260fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6ca67d05039a4c1da64a8404c705ce24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8d147dae6a024c4da07595e4f932e0c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idff76b1b03b44f75aa61286e93799b04_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if85fe4e885e9410ea9b477f9f42fe802_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6e909081fe504bcd995d3d053a9e6458_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb578834702c45c985e36276eb4e5209_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia70443dc17684967b5578dd38a080142_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib778b3f359db4b4db7b559dbd58c0693_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:SecondQuarter2020AcquisiitonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5177e5970481482dadb3afc395cb325e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:SecondQuarter2020AcquisiitonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifb2833c3159542918f26feaf0c1d8860_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieb5e02ca65384029bf2dee9c473d0fc2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i244a7dd7a1e34e5aaf1f244eeeca66c7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i585911a48a184294aa02c08de8b96b51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22bf7ca10e524bf19773099096d46440_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i61cdd3ab97d6409eb1fd729bbcf4e3bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c1e5aa461254453a205c4e2315ef26e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0becd841990f40bcb28ada9ac03bea59_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i45c760b6f46f45a1aca96e9c28532938_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i225515b9f9cc44409112978bbc812f54_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i707beb89e95a42328dcd6d2412aa3f9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6cda7d0db84d46a1a162bc0ad54e9fed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d36b5ee016b44859820b1a91b193d45_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9f1502fcf310445290cecc08ffe7e7b3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2501ceeb8ed04db1a417a4d65803126e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icee1c6f02c1b44ed8186b856c69cb13a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c5469d65e0b475cb923c823d47d89ba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i142f68e23d4545d08259d4c707844b97_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d3247d3a01544388bce9b89588c6ec3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i073f657af77647788880cd4518a255a0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib989212096a844a7a71240a6d956563a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia67a3626f5f948b5b1895672cce6e96b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="instance">
        <measure>wst:instance</measure>
    </unit>
    <unit id="fiscal_quarter">
        <measure>wst:fiscal_quarter</measure>
    </unit>
    <unit id="tranche">
        <measure>wst:tranche</measure>
    </unit>
    <unit id="sgd">
        <measure>iso4217:SGD</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="bbl">
        <measure>utr:bbl</measure>
    </unit>
    <unit id="usdPerBbl">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>wst:bbl</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="plan">
        <measure>wst:plan</measure>
    </unit>
    <unit id="segment">
        <measure>wst:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY180L2ZyYWc6MGUzMzEwODgxZjg2NGQ5NzkxMzNjZmNmOTcwZmI2NzMvdGFibGU6MTMxNzcxNGU3NmFiNGZmZDlmMGI4ZjUwOTc0YmU5ZDYvdGFibGVyYW5nZToxMzE3NzE0ZTc2YWI0ZmZkOWYwYjhmNTA5NzRiZTlkNl8zLTEtMS0xLTYwMjYz_93faa908-2584-4320-a7f5-db856e3a374f">0000105770</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY180L2ZyYWc6MGUzMzEwODgxZjg2NGQ5NzkxMzNjZmNmOTcwZmI2NzMvdGFibGU6MTMxNzcxNGU3NmFiNGZmZDlmMGI4ZjUwOTc0YmU5ZDYvdGFibGVyYW5nZToxMzE3NzE0ZTc2YWI0ZmZkOWYwYjhmNTA5NzRiZTlkNl81LTEtMS0xLTYwMjYz_1e90fbb7-c00a-48e6-8319-b2911cc8e7f6">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY180L2ZyYWc6MGUzMzEwODgxZjg2NGQ5NzkxMzNjZmNmOTcwZmI2NzMvdGFibGU6MTMxNzcxNGU3NmFiNGZmZDlmMGI4ZjUwOTc0YmU5ZDYvdGFibGVyYW5nZToxMzE3NzE0ZTc2YWI0ZmZkOWYwYjhmNTA5NzRiZTlkNl82LTEtMS0xLTYwMjYz_f776569a-f254-4b83-af40-de4f469e5fc3">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY180L2ZyYWc6MGUzMzEwODgxZjg2NGQ5NzkxMzNjZmNmOTcwZmI2NzMvdGFibGU6MTMxNzcxNGU3NmFiNGZmZDlmMGI4ZjUwOTc0YmU5ZDYvdGFibGVyYW5nZToxMzE3NzE0ZTc2YWI0ZmZkOWYwYjhmNTA5NzRiZTlkNl83LTEtMS0xLTYwMjYz_27dbc909-9ee7-4acb-80c1-2e1de7079908">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="if4a3a8484e4d4e25a93de4d344e4db3b_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMy0wLTEtMS02MDI2Mw_e15719f8-e673-40ca-a352-c8014dfe8702">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_2be9eb86-8ff4-486b-8e82-82feaaba79be">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_2c156bb7-09f9-4046-a1d8-d4f0d3157eef">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_41e09201-abff-4427-8518-3065d9e10039">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <dei:DocumentType
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6M2U4ZTU1ZGQzNTIwNDYxNmI3NjZjMjc2NjViNzdmNjAvdGFibGVyYW5nZTozZThlNTVkZDM1MjA0NjE2Yjc2NmMyNzY2NWI3N2Y2MF8wLTAtMS0xLTYwMjYzL3RleHRyZWdpb246NTI5NjFiNzNhMGZkNDE1ZDhkZjJlMmZjNmFhNGE5ZDNfOQ_a9983404-f9ee-46c2-b5ec-44131cac2f17">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6MmY4YjBmNGFlMGFlNGRkMDljMzlhZDE4MzFmZjQ1Y2YvdGFibGVyYW5nZToyZjhiMGY0YWUwYWU0ZGQwOWMzOWFkMTgzMWZmNDVjZl8wLTAtMS0xLTYwMjYz_8fb62f81-784a-443d-a550-c183125d98b7">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8zMjk4NTM0ODg2MDUx_ccb7ab64-79c9-4164-97a4-258382c4c960">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8zMjk4NTM0ODg2MDUx_1310c9e0-5ea4-4847-9745-db0df77367c3">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6Y2VlMDRiOGFkNzQ0NGJhNGJkYWIzMzM5ODEzZWU2ZjkvdGFibGVyYW5nZTpjZWUwNGI4YWQ3NDQ0YmE0YmRhYjMzMzk4MTNlZTZmOV8wLTAtMS0xLTYwMjYz_bbd0fa9d-5eac-4257-91f3-3d43398b7e03">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8xNDA_3ccd2a5a-b02c-492e-88c9-f0c3d75f755c">1-8036</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6OGYzZThkYTE3ZTMwNDQ3YThmMzVmYmQyMmIyNWNkNzQvdGFibGVyYW5nZTo4ZjNlOGRhMTdlMzA0NDdhOGYzNWZiZDIyYjI1Y2Q3NF8wLTAtMS0xLTYwMjYzL3RleHRyZWdpb246Y2U1OGYxYjY2ZmY4NDg1M2FmNjQ5MTMxMDMwOTQzYzVfNQ_337c7f62-675a-4eab-9a6c-8ca17752a02e">WEST PHARMACEUTICAL SERVICES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8wLTAtMS0xLTYwMjYz_24e38716-ac46-4dc6-844b-0a68c0eac63c">PA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8wLTEtMS0xLTYwMjYz_a3375e4c-a2f8-4040-9063-31597829e0f9">23-1210010</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8zLTAtMS0xLTYwMjYzL3RleHRyZWdpb246NWVkMjQ4OTZhYzViNDczZThkZjcyMWM4N2IwMzdkZTRfNA_4b0910c0-6b9e-4b89-bcb2-39ab3afcc191">530 Herman O. West Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8zLTAtMS0xLTYwMjYzL3RleHRyZWdpb246NWVkMjQ4OTZhYzViNDczZThkZjcyMWM4N2IwMzdkZTRfOA_b9985590-3fd2-41cf-98a6-6a3afcece19d">Exton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8zLTAtMS0xLTYwMjYzL3RleHRyZWdpb246NWVkMjQ4OTZhYzViNDczZThkZjcyMWM4N2IwMzdkZTRfMTI_7200bf32-6530-4f20-856a-468965059e26">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6N2EwODgzMTZkZmExNDc3Yzk0ZjY0YWVlZGRkMzYyZTUvdGFibGVyYW5nZTo3YTA4ODMxNmRmYTE0NzdjOTRmNjRhZWVkZGQzNjJlNV8zLTEtMS0xLTYwMjYz_3e067466-bbd8-40c2-86e7-f6a3bbbdcbb0">19341-0645</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8xOTg_4b51a9f4-62f2-449c-9d26-ed58ffe9d299">610</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yMDE_47689d89-6b66-449c-a591-c9b6ef500676">594-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6ZjNkOTljZTQwOWMyNDFiNmIzNjBhZDIzMGM5YzA2NTUvdGFibGVyYW5nZTpmM2Q5OWNlNDA5YzI0MWI2YjM2MGFkMjMwYzljMDY1NV8xLTAtMS0xLTYwMjYz_8c04f341-00e9-40e4-984e-46689e554626">Common Stock, par value $.25 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6ZjNkOTljZTQwOWMyNDFiNmIzNjBhZDIzMGM5YzA2NTUvdGFibGVyYW5nZTpmM2Q5OWNlNDA5YzI0MWI2YjM2MGFkMjMwYzljMDY1NV8xLTEtMS0xLTYwMjYz_a931ee8f-867b-4208-ad7c-bda4df568f58">WST</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6ZjNkOTljZTQwOWMyNDFiNmIzNjBhZDIzMGM5YzA2NTUvdGFibGVyYW5nZTpmM2Q5OWNlNDA5YzI0MWI2YjM2MGFkMjMwYzljMDY1NV8xLTItMS0xLTYwMjYz_dc0f3925-7466-427e-86aa-09b9b13def96">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjgy_ed1a74b5-059f-4af9-8114-2d7589fd4721">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjg0_cd2cc46e-f372-4bce-a07a-97e21da093da">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjg2_730b91cd-9e3a-49ad-9fcf-cc4e705785db">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjkz_68e6dba8-8474-47e4-ae98-33291c3f54d9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6NWZkNjk4YWM2M2I5NDc5YjhlNzZjMDVmNjNiZGU5M2UvdGFibGVyYW5nZTo1ZmQ2OThhYzYzYjk0NzliOGU3NmMwNWY2M2JkZTkzZV8wLTAtMS0xLTYwMjYz_1edffb6e-9e73-4c1b-b235-3127694c1994">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6NWZkNjk4YWM2M2I5NDc5YjhlNzZjMDVmNjNiZGU5M2UvdGFibGVyYW5nZTo1ZmQ2OThhYzYzYjk0NzliOGU3NmMwNWY2M2JkZTkzZV8xLTQtMS0xLTYwMjYz_56878f27-732e-4427-bb90-886aec59b12b">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGFibGU6NWZkNjk4YWM2M2I5NDc5YjhlNzZjMDVmNjNiZGU5M2UvdGFibGVyYW5nZTo1ZmQ2OThhYzYzYjk0NzliOGU3NmMwNWY2M2JkZTkzZV8yLTQtMS0xLTYwMjYz_978a3aa4-19de-4fd1-96f3-ba3ce7da47e1">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjg3_6b6dc182-3cfd-4530-b04d-37654ff53f6e">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8xMzc0Mzg5NTM0OTkzNw_5fdbf42d-1c97-4120-ac29-1c0f7f2026aa">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ic8766ff13a5c4bffb4105af8ef735b18_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNDkz_c8fcbaaa-ca75-4275-a16f-b4bae31290c7"
      unitRef="usd">22300000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i2a1b49b3369c42dd9827948a3411a736_I20230125"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNTg5_e57dbba9-37df-429a-9d2d-67abbe3e0449"
      unitRef="shares">74135554</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xL2ZyYWc6M2RjYTFhZmE2NDYxNGY0MWFlZmFkODk4ODY1ODYzZDAvdGV4dHJlZ2lvbjozZGNhMWFmYTY0NjE0ZjQxYWVmYWQ4OTg4NjU4NjNkMF8yNjkw_67ca1414-63ed-4f35-a3c5-9d68dd929688">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.261%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Document&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Parts Into Which Incorporated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Proxy Statement for the 2023 Annual Meeting of Shareholders to be filed not later than 120 days after the end of the fiscal year covered by this Form 10-K.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Part III&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMS0yLTEtMS02MDI2Mw_4f5cafca-f76b-4026-9900-e2f64e6d84af"
      unitRef="usd">2886900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMS00LTEtMS02MDI2Mw_efa1d076-d3eb-423a-a0c9-e836399e400a"
      unitRef="usd">2831600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMS02LTEtMS02MDI2Mw_f77c8a7a-6caf-48ac-b0c9-9f5d10072282"
      unitRef="usd">2146900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMi0yLTEtMS02MDI2Mw_3679da7d-a901-44d3-ae0d-3a4b452ecb4b"
      unitRef="usd">1750700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMi00LTEtMS02MDI2Mw_32386396-4384-4e9a-b0bb-b9e2ea354219"
      unitRef="usd">1655800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMi02LTEtMS02MDI2Mw_18e748aa-cfd1-45e6-87ec-b62c222742c8"
      unitRef="usd">1379100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMy0yLTEtMS02MDI2Mw_d06be643-e559-4012-8e96-d07ae47e31f6"
      unitRef="usd">1136200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMy00LTEtMS02MDI2Mw_6bc445b8-296b-4de7-9070-a8bd798326ca"
      unitRef="usd">1175800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMy02LTEtMS02MDI2Mw_3484bd4e-f7f0-42ae-956d-d65e57c624c1"
      unitRef="usd">767800000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNC0yLTEtMS02MDI2Mw_59cd215f-492f-4c3f-a54b-ee9d2b58c6cc"
      unitRef="usd">58500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNC00LTEtMS02MDI2Mw_8878477d-ba7e-4a2a-8e28-933186b0f23f"
      unitRef="usd">52800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNC02LTEtMS02MDI2Mw_f9c9759b-f346-46c4-a48f-50271560c64d"
      unitRef="usd">46900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNS0yLTEtMS02MDI2Mw_691869fa-2143-4462-8f37-dd8414635acc"
      unitRef="usd">316900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNS00LTEtMS02MDI2Mw_00c3f880-18a4-4417-9298-877970ea3510"
      unitRef="usd">362800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNS02LTEtMS02MDI2Mw_f76e1e77-d7d0-4f0c-b145-b936ab8e48d2"
      unitRef="usd">302000000.0</us-gaap:SellingGeneralAndAdministrativeExpense>
    <wst:OtherIncomeExpense
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNi0yLTEtMS02MDI2Mw_e9ac4ac2-3477-4a1b-9630-1f3598e0a68f"
      unitRef="usd">-26800000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNi00LTEtMS02MDI2Mw_0bfcbe9f-33cb-4ca9-8be6-9c827054724e"
      unitRef="usd">-7900000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNi02LTEtMS02MDI2Mw_9aed2bb8-a26c-492c-a199-b8778e5676b6"
      unitRef="usd">-12000000.0</wst:OtherIncomeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNy0yLTEtMS02MDI2Mw_ccb7b7ef-90f1-438c-9218-91e5e0480942"
      unitRef="usd">734000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNy00LTEtMS02MDI2Mw_20f5103a-b774-412b-8bd7-ed63d97f6ca2"
      unitRef="usd">752300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfNy02LTEtMS02MDI2Mw_9d57937d-55a4-45ea-bd74-4ef072804d3e"
      unitRef="usd">406900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOC0yLTEtMS02MDI2Mw_22e7166a-a5fe-4943-ae3c-6f112620dcbf"
      unitRef="usd">7900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOC00LTEtMS02MDI2Mw_29b7c8a6-9afd-4d55-b282-3372006b57dc"
      unitRef="usd">8200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOC02LTEtMS02MDI2Mw_0a5227fe-1eb3-4947-9257-9e67022ac7e2"
      unitRef="usd">8200000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOS0yLTEtMS02MDI2Mw_3bfa88d4-f7d5-4ed0-ae49-0f8b74365864"
      unitRef="usd">5100000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOS00LTEtMS02MDI2Mw_4afda712-85a9-453d-b4c4-d7e8f9dd8f51"
      unitRef="usd">1000000.0</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfOS02LTEtMS02MDI2Mw_d02fce9d-29ca-4bfc-b035-9babdd5eda8f"
      unitRef="usd">1400000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTAtMi0xLTEtNjAyNjM_4ccba17f-e379-45f8-86c9-ab50c539d45e"
      unitRef="usd">-51300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTAtNC0xLTEtNjAyNjM_dc89239b-aec5-4be6-af45-2cd075cf573c"
      unitRef="usd">3800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTAtNi0xLTEtNjAyNjM_981c0380-ecd9-417d-bc17-6df9f63e0ff6"
      unitRef="usd">1200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTEtMi0xLTEtNjAyNjM_afcd830b-5fe2-41dc-8791-c5327856c2d0"
      unitRef="usd">679900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTEtNC0xLTEtNjAyNjM_58a17b02-17e4-468d-b641-cb47bddc4cde"
      unitRef="usd">748900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTEtNi0xLTEtNjAyNjM_b7cf4667-f86e-4426-9a35-36110b258c38"
      unitRef="usd">401300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTItMi0xLTEtNjAyNjM_b8220741-5368-4399-b5e1-a4da8513ee63"
      unitRef="usd">114700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTItNC0xLTEtNjAyNjM_7ba381ff-ae11-4414-b60f-5be0306e20d6"
      unitRef="usd">107200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTItNi0xLTEtNjAyNjM_d60632dd-50da-4fe3-8779-a8a7ab0a5bd0"
      unitRef="usd">72500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTMtMi0xLTEtNjAyNjM_91305260-928e-42df-bc11-ad294715ead0"
      unitRef="usd">20700000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTMtNC0xLTEtNjAyNjM_e8ca5a3d-732a-4ab7-a737-43bfcc4bdb9e"
      unitRef="usd">20100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTMtNi0xLTEtNjAyNjM_e33daaab-bf9d-49c5-9186-0a71d510bf5f"
      unitRef="usd">17400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTQtMi0xLTEtNjAyNjM_356b2c65-4b06-4cac-b343-8f25f500b491"
      unitRef="usd">585900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTQtNC0xLTEtNjAyNjM_7b8c89dd-7313-478c-aa8b-f20cf35016a4"
      unitRef="usd">661800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTQtNi0xLTEtNjAyNjM_21160f54-4692-4cc5-9c04-2a540bd330f2"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTctMi0xLTEtNjAyNjM_9f97c460-74ba-470a-b221-bd8645a291c0"
      unitRef="usdPerShare">7.87</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTctNC0xLTEtNjAyNjM_b383ce2a-701b-48a5-bb95-b506492feeb7"
      unitRef="usdPerShare">8.89</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTctNi0xLTEtNjAyNjM_02d612e8-f1dc-4272-9a85-1d16800443f7"
      unitRef="usdPerShare">4.68</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTgtMi0xLTEtNjAyNjM_44776b8a-3694-4941-a7f2-441b0d4e080f"
      unitRef="usdPerShare">7.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTgtNC0xLTEtNjAyNjM_4fdae510-74df-461f-b886-11def6b012de"
      unitRef="usdPerShare">8.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMTgtNi0xLTEtNjAyNjM_4e3f9000-b34b-4c9d-aba2-4cb17554a4a9"
      unitRef="usdPerShare">4.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjEtMi0xLTEtNjAyNjM_6a828c3f-5ad9-4501-89f1-2addc4f84832"
      unitRef="shares">74400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjEtNC0xLTEtNjAyNjM_8841d51c-f7f3-4971-b1a4-09b6cda1a62b"
      unitRef="shares">74400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjEtNi0xLTEtNjAyNjM_841af129-d887-4573-a56b-020efd545c91"
      unitRef="shares">73900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjItMi0xLTEtNjAyNjM_f9d20ae2-c8ca-48c5-95c0-d50718715897"
      unitRef="shares">75800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjItNC0xLTEtNjAyNjM_fa713535-60d1-4ad5-9864-2e5ec36507c4"
      unitRef="shares">76300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182MS9mcmFnOjc0NzJmNWJlZmJlNDQ3ODI4NTk4N2IzMmIwNzI0YmMwL3RhYmxlOmYxM2UwZWE0NzFkMTQxNTBiYmE0ZTY2ODQ0OTgzODMyL3RhYmxlcmFuZ2U6ZjEzZTBlYTQ3MWQxNDE1MGJiYTRlNjY4NDQ5ODM4MzJfMjItNi0xLTEtNjAyNjM_9c83fe26-d37a-435c-bb2b-3acc1177cebc"
      unitRef="shares">75800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMS0xLTEtMS02MDI2Mw_d9cd07e5-b9c9-45f9-9434-4e207116052b"
      unitRef="usd">585900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMS0zLTEtMS02MDI2Mw_0fad30e8-1770-4351-b50a-d02d4b56c592"
      unitRef="usd">661800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMS01LTEtMS02MDI2Mw_10d9497e-d5ef-4f5b-8b45-926594e067b8"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjI3MzVhZDg3YTM3MDRjZDVhOWU5NDQwNTIyMzk3OWI0XzIxOTkwMjMyNTU2MTI_99560198-7622-4cd0-8163-15f78d485570"
      unitRef="usd">2200000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjI3MzVhZDg3YTM3MDRjZDVhOWU5NDQwNTIyMzk3OWI0XzIxOTkwMjMyNTU2MTg_250d14e3-319d-49e5-a495-5a92413d2973"
      unitRef="usd">2400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjI3MzVhZDg3YTM3MDRjZDVhOWU5NDQwNTIyMzk3OWI0XzIxOTkwMjMyNTU2Mjc_5c1c1ddd-5495-4e4e-bf75-0b1ee23b785b"
      unitRef="usd">-1000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy0xLTEtMS02MDI2Mw_174bd1a8-760a-44a8-97a5-8da16c017bca"
      unitRef="usd">-47300000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy0zLTEtMS02MDI2Mw_664d0d6a-19b8-42f9-ba92-22ccb0d22c33"
      unitRef="usd">-59300000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMy01LTEtMS02MDI2Mw_6d6f1a9e-db22-41e9-b8de-ae631aae35ff"
      unitRef="usd">40100000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjFkM2Q4ODA5N2Y0YTQ1YWFhYzY1NjI3MTFjMzZkNmI4XzIxOTkwMjMyNTU2MjI_10eb273e-7c04-4c96-a482-3bfcd26dcfab"
      unitRef="usd">0.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjFkM2Q4ODA5N2Y0YTQ1YWFhYzY1NjI3MTFjMzZkNmI4XzIxOTkwMjMyNTU2MTY_68d5e13c-2920-4329-9d53-946e2bc21652"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjFkM2Q4ODA5N2Y0YTQ1YWFhYzY1NjI3MTFjMzZkNmI4XzIxOTkwMjMyNTU2MzU_f5463c84-006d-4065-a829-50add55c7487"
      unitRef="usd">0.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS0xLTEtMS02MDI2Mw_64348537-07b4-4473-a55c-de4cd8e8acb5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS0zLTEtMS02MDI2Mw_5772f26a-4448-48ea-87a8-745d518fe673"
      unitRef="usd">-1500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNS01LTEtMS02MDI2Mw_ea80c75e-92a7-4809-ae63-4fffeed6780e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmQxNzA3ZDlkZDMwMzQxOTNhOWNkOGMyOGFjZDVhYzUyXzY3_8cb2a7cd-9120-4baa-beea-8cc11f658729"
      unitRef="usd">-2400000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmQxNzA3ZDlkZDMwMzQxOTNhOWNkOGMyOGFjZDVhYzUyXzcx_a7eea12c-a094-4240-8ade-2274bcb95d58"
      unitRef="usd">2100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmQxNzA3ZDlkZDMwMzQxOTNhOWNkOGMyOGFjZDVhYzUyXzc5_2283c2f5-3389-46b3-97e1-4e0f66715375"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi0xLTEtMS02MDI2Mw_3ebbbc9f-4b5f-46a5-a801-64d67734c189"
      unitRef="usd">-9300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi0zLTEtMS02MDI2Mw_d224b2b4-a390-4beb-94ef-db33970fb13a"
      unitRef="usd">5900000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNi01LTEtMS02MDI2Mw_786e56ba-353d-4614-97c7-48b99bad1e57"
      unitRef="usd">-2500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmMwZDk2OGE2NTU4MzQyOTJhNzI1MmY0NjllOWEzMDdhXzYw_cd2c5e51-8632-4050-ab8a-dd180010bb13"
      unitRef="usd">20300000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmMwZDk2OGE2NTU4MzQyOTJhNzI1MmY0NjllOWEzMDdhXzY0_bbb5b3b8-6015-42b0-89c7-4f25b14403af"
      unitRef="usd">400000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmMwZDk2OGE2NTU4MzQyOTJhNzI1MmY0NjllOWEzMDdhXzcy_5f4317c8-6fd6-4931-977b-7ce294d637bb"
      unitRef="usd">900000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax>
    <wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy0xLTEtMS02MDI2Mw_2c2354f6-81e1-4cd1-9f90-cee2300e0452"
      unitRef="usd">-31900000</wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax>
    <wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy0zLTEtMS02MDI2Mw_fcde61b7-a942-40ec-91f6-346e33545517"
      unitRef="usd">-1400000</wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax>
    <wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfNy01LTEtMS02MDI2Mw_57b65994-547b-4ed8-8374-5610ef3759d1"
      unitRef="usd">-2900000</wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjQzNGNhMDdkYjU0ZTQ3MGFhMjE2NzQzYWY0NzNlMmY3XzYz_d84678d7-ae3b-4f3c-82e7-f0ed8b3ab34f"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjQzNGNhMDdkYjU0ZTQ3MGFhMjE2NzQzYWY0NzNlMmY3XzY3_283b6f58-1f13-466d-9033-6c0ece04c2a3"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC0wLTEtMS02MDI2My90ZXh0cmVnaW9uOjQzNGNhMDdkYjU0ZTQ3MGFhMjE2NzQzYWY0NzNlMmY3Xzc1_dde5563b-491b-4c3e-8849-2cbe050b93c6"
      unitRef="usd">-0.0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC0xLTEtMS02MDI2Mw_3574cd64-30b8-4e43-a354-5f45bd3b4d0e"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC0zLTEtMS02MDI2Mw_fbcf16b4-de14-46fd-ba7d-5cb25427f135"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOC01LTEtMS02MDI2Mw_982c0c8e-b55c-461d-aa10-c26db37bbb88"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmE1ZTEzYTIwYTM3NjRiNDZhMjIxMGI3ODEzMjllYzcwXzYy_2bb5a33f-853c-4d3f-88d8-31c411fcccab"
      unitRef="usd">0.0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmE1ZTEzYTIwYTM3NjRiNDZhMjIxMGI3ODEzMjllYzcwXzY2_a2162746-4eae-4036-9cf7-b6fd56f236c6"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmE1ZTEzYTIwYTM3NjRiNDZhMjIxMGI3ODEzMjllYzcwXzcz_c85fbc98-7c35-4b66-8f9e-7d85a18add80"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS0xLTEtMS02MDI2Mw_07d070f2-f6e2-40ee-84a7-3b02d055eacc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS0zLTEtMS02MDI2Mw_9569994a-34c5-40ce-a5c9-96f582a92475"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfOS01LTEtMS02MDI2Mw_f34f2926-c257-4b66-b2c4-e408f5740985"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtMC0xLTEtNzc1MjQvdGV4dHJlZ2lvbjo4NzRiZTQzNmJkMjg0OWM1OTc1YzM5YzM0MzU0MGE4OV8yMTk5MDIzMjU1NjA1_71d6435b-17bb-40e9-a19b-b7052a082f44"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtMC0xLTEtNzc1MjQvdGV4dHJlZ2lvbjo4NzRiZTQzNmJkMjg0OWM1OTc1YzM5YzM0MzU0MGE4OV8yMTk5MDIzMjU1NjA4_1de17452-8dfc-4039-bef4-81718f1bfedd"
      unitRef="usd">0.0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtMC0xLTEtNzc1MjQvdGV4dHJlZ2lvbjo4NzRiZTQzNmJkMjg0OWM1OTc1YzM5YzM0MzU0MGE4OV8yMTk5MDIzMjU1NjE3_97023371-9d1b-479a-86e7-0c290a8897c0"
      unitRef="usd">0.0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtMS0xLTEtNjAyNjM_fade6a56-78f2-48c7-8bc8-c6db57c9502d"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtMy0xLTEtNjAyNjM_e33f3491-24e4-482e-949a-9dcb54ea8d04"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTAtNS0xLTEtNjAyNjM_ae40a8a5-a9db-43a2-bbe2-4626de737952"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo2NjVmZDJjZDRjYjI0MDMxYmQ0MDQzNDUzMzIwMDM3MF85NA_4916b012-493f-4f9e-82de-2818d348f428"
      unitRef="usd">0.0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo2NjVmZDJjZDRjYjI0MDMxYmQ0MDQzNDUzMzIwMDM3MF85OA_348d3409-0edf-4413-8fa8-229817d7bd28"
      unitRef="usd">0.0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo2NjVmZDJjZDRjYjI0MDMxYmQ0MDQzNDUzMzIwMDM3MF8xMDY_0ce4375f-2c1e-4f4a-91fb-6b46eed3f97a"
      unitRef="usd">0.0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtMS0xLTEtNjAyNjM_5fa475b7-2479-47d9-9f9e-2e60e985a482"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtMy0xLTEtNjAyNjM_80048c71-3ff8-4552-8026-1a4ba642c6d8"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTEtNS0xLTEtNjAyNjM_affca5e0-05d7-451a-a4b8-12eb1d7fd945"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpmYjc2ODY2YzhjYjg0MDgxOTAxMjExMGI3ZjA5M2QzOV81MA_f719fb92-2a76-4c09-9344-0b74d036610f"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpmYjc2ODY2YzhjYjg0MDgxOTAxMjExMGI3ZjA5M2QzOV81NA_f0dfbfc2-06bc-49ea-bb5c-d960647380f8"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpmYjc2ODY2YzhjYjg0MDgxOTAxMjExMGI3ZjA5M2QzOV82Mg_416bbc3a-7565-439f-ae51-ad1de6659385"
      unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItMS0xLTEtNjAyNjM_fdf04435-65c5-4d9a-b46f-1fb94a941ddb"
      unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItMy0xLTEtNjAyNjM_335acecb-2692-474a-8f83-c9865a41e801"
      unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTItNS0xLTEtNjAyNjM_8938bcb8-0bc5-4b8b-9917-359cb400ea1e"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTMtMS0xLTEtNjAyNjM_34e94f6c-9ed6-4719-aacf-5d7817d3a8fe"
      unitRef="usd">-23400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTMtMy0xLTEtNjAyNjM_9b1f8e4d-cde8-44c9-986c-3a4c42e0b153"
      unitRef="usd">-49000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTMtNS0xLTEtNjAyNjM_0e33d7b1-862f-476d-989f-3d94dc4d751b"
      unitRef="usd">39000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTQtMS0xLTEtNjAyNjM_64e14bb4-d563-4dee-b1af-c5685b4cf2d8"
      unitRef="usd">562500000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTQtMy0xLTEtNjAyNjM_e84d3b44-5bff-495a-880d-f70a3a1c906c"
      unitRef="usd">612800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182NC9mcmFnOjJhYThiMDhhNjQ5NTQ4YzBiZDM0OWRlNzUzODY0ZjNlL3RhYmxlOmZmMDU3MmIzNDc0NTRhNThiMTU4ZTU3NTU1MWM1Nzg4L3RhYmxlcmFuZ2U6ZmYwNTcyYjM0NzQ1NGE1OGIxNThlNTc1NTUxYzU3ODhfMTQtNS0xLTEtNjAyNjM_5ea446b4-c227-42af-884c-244218131acc"
      unitRef="usd">385200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMy0xLTEtMS02MDI2Mw_ea97cf07-b40f-4388-a31f-a4449d901499"
      unitRef="usd">894300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMy0zLTEtMS02MDI2Mw_31782dcf-5a22-446a-b5ff-73126b703b72"
      unitRef="usd">762600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNC0xLTEtMS02MDI2Mw_ddb17ace-3a4e-42b0-b6d9-a96e80b83c29"
      unitRef="usd">507400000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNC0zLTEtMS02MDI2Mw_cc868796-d381-4300-bb51-005b87cfad8a"
      unitRef="usd">489000000.0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNS0xLTEtMS02MDI2Mw_753800ae-6779-41dd-a717-60450e498f2a"
      unitRef="usd">414800000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNS0zLTEtMS02MDI2Mw_9f3a747e-0a8b-4f89-8638-a89c11558176"
      unitRef="usd">378400000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNi0xLTEtMS02MDI2Mw_8c7c5106-173e-4a76-9db8-593a12a0312b"
      unitRef="usd">103000000.0</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNi0zLTEtMS02MDI2Mw_413a5241-9019-47ce-a767-69885266a37c"
      unitRef="usd">112000000.0</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNy0xLTEtMS02MDI2Mw_e8a58ae4-2f1c-472e-b805-20bdddc10076"
      unitRef="usd">1919500000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNy0zLTEtMS02MDI2Mw_6340588f-008d-4882-96ff-6cffbb37ad73"
      unitRef="usd">1742000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfOC0xLTEtMS02MDI2Mw_418f49b2-039d-4a3e-9418-229c35904350"
      unitRef="usd">2386600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfOC0zLTEtMS02MDI2Mw_dc13911c-35ea-45ee-a045-cf10d55c6571"
      unitRef="usd">2215000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfOS0xLTEtMS02MDI2Mw_02943cdc-6188-4a53-8b3f-dc9d12845039"
      unitRef="usd">1228300000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfOS0zLTEtMS02MDI2Mw_f834c377-5f88-444f-a904-7e8b5459c67b"
      unitRef="usd">1157500000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTAtMS0xLTEtNjAyNjM_d0b8b18d-86e8-4a0e-a30d-66764fe3ce72"
      unitRef="usd">1158300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTAtMy0xLTEtNjAyNjM_9c10f6dd-06ac-4ee2-85cb-b2d9aa0ad0b6"
      unitRef="usd">1057500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTEtMS0xLTEtNjAyNjM_653e95f8-aaf8-4f8e-b0fc-bb6e816ca2f7"
      unitRef="usd">104400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTEtMy0xLTEtNjAyNjM_08c8529a-2e30-4aa8-98fc-96a871cfa8c1"
      unitRef="usd">69300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTItMS0xLTEtNjAyNjM_d875a30e-1a0e-4931-b279-7ce5fcdb5899"
      unitRef="usd">204900000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTItMy0xLTEtNjAyNjM_e60b7ccb-a384-401a-af5f-6074846a3044"
      unitRef="usd">207700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Goodwill
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTMtMS0xLTEtNjAyNjM_5c082e0b-5ba8-434f-a25d-dcb21b03fb97"
      unitRef="usd">107300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTMtMy0xLTEtNjAyNjM_05f31c87-d593-4843-9236-ea2abff28ae1"
      unitRef="usd">109900000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTQtMS0xLTEtNjAyNjM_c3a788c8-69e2-4ac0-b758-1d58b65da019"
      unitRef="usd">18400000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTQtMy0xLTEtNjAyNjM_0f9fac12-55b8-441c-bd7d-8353e0265684"
      unitRef="usd">23000000.0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTUtMS0xLTEtNjAyNjM_d65d83e4-6d5c-44c0-bd31-7fc2963c8d76"
      unitRef="usd">65600000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTUtMy0xLTEtNjAyNjM_e4c8efca-71de-4461-bad7-364b03fc80cd"
      unitRef="usd">48500000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTYtMS0xLTEtNjAyNjM_31ebfa26-2c42-417e-a425-2350cd8c5342"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTYtMy0xLTEtNjAyNjM_e85ee963-2064-4c38-8452-6a5ce1b37d3e"
      unitRef="usd">16700000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTctMS0xLTEtNjAyNjM_c9b9c8cf-f025-417d-8411-238e8e9425b7"
      unitRef="usd">38100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTctMy0xLTEtNjAyNjM_368c028c-cb4a-4840-888c-7d9d1c1e902e"
      unitRef="usd">39200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTgtMS0xLTEtNjAyNjM_e7e2e3c1-ceaf-4072-8705-f79a9d104044"
      unitRef="usd">3616800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMTgtMy0xLTEtNjAyNjM_7eb6d94a-d1cd-49ee-8fe4-4a155a10a76e"
      unitRef="usd">3313800000</us-gaap:Assets>
    <wst:NotesPayableAndOtherDebtCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjItMS0xLTEtNjAyNjM_6227e0d3-5a13-4f31-940e-9fb4a1aae65b"
      unitRef="usd">2200000</wst:NotesPayableAndOtherDebtCurrent>
    <wst:NotesPayableAndOtherDebtCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjItMy0xLTEtNjAyNjM_edf37675-b785-401d-8a47-a790798bf281"
      unitRef="usd">44200000</wst:NotesPayableAndOtherDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjMtMS0xLTEtNjAyNjM_c0f59e92-6a98-4a4a-894c-ef23922535a3"
      unitRef="usd">215400000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjMtMy0xLTEtNjAyNjM_c8798ebf-3d4a-413f-b01e-7a51c879e264"
      unitRef="usd">232200000</us-gaap:AccountsPayableCurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjQtMS0xLTEtNjAyNjM_99a45d12-ca8c-4c96-9e48-8355e02d7b91"
      unitRef="usd">2100000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjQtMy0xLTEtNjAyNjM_2726cf0f-f108-4702-85a8-ac207a9ef642"
      unitRef="usd">2400000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <wst:AccruedSalariesWagesAndBenefitsCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjUtMS0xLTEtNjAyNjM_e322cc2d-1cd7-43c3-8169-f4cd14ee0abd"
      unitRef="usd">76800000</wst:AccruedSalariesWagesAndBenefitsCurrent>
    <wst:AccruedSalariesWagesAndBenefitsCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjUtMy0xLTEtNjAyNjM_4530c45f-9334-4666-acc7-0ef46d648ff3"
      unitRef="usd">116300000</wst:AccruedSalariesWagesAndBenefitsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjYtMS0xLTEtNjAyNjM_26c44e56-2f10-4a30-9bce-e900c861c077"
      unitRef="usd">24800000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjYtMy0xLTEtNjAyNjM_cf7d2a7b-6078-4c87-907e-b5997e6bf057"
      unitRef="usd">26300000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjctMS0xLTEtNjAyNjM_4af4e990-7f7c-4316-a8e6-2a8e3d79e900"
      unitRef="usd">16000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjctMy0xLTEtNjAyNjM_0ae39117-2bb0-4b8e-af09-294a91c1c760"
      unitRef="usd">9300000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjgtMS0xLTEtNjAyNjM_f1a1ae4e-8c5a-4cba-ac8a-2d086e61d8a6"
      unitRef="usd">181700000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjgtMy0xLTEtNjAyNjM_93754f70-b9ad-4909-81e1-b73b35d7109a"
      unitRef="usd">163400000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjktMS0xLTEtNjAyNjM_aaffe62d-8bf4-46b4-a1cf-030e1d77e4c9"
      unitRef="usd">519000000.0</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMjktMy0xLTEtNjAyNjM_8908e115-6a80-4e88-9a06-addaf9506267"
      unitRef="usd">594100000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzAtMS0xLTEtNjAyNjM_c271e6c3-e3d9-4823-9e36-5c3d2705da46"
      unitRef="usd">206700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzAtMy0xLTEtNjAyNjM_70e2bc69-a793-4800-a276-06b66d24b7f6"
      unitRef="usd">208800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzEtMS0xLTEtNjAyNjM_0a8a432d-2857-4d2f-9759-9d1a890f8550"
      unitRef="usd">14300000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzEtMy0xLTEtNjAyNjM_a2d24462-db0d-426d-9005-fc0105628e38"
      unitRef="usd">4900000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzItMS0xLTEtNjAyNjM_dce2633e-335e-47cc-a0f3-7441e301c138"
      unitRef="usd">28200000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzItMy0xLTEtNjAyNjM_7242d27a-a0e2-4546-9d33-eaf9e676b3ec"
      unitRef="usd">40500000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzMtMS0xLTEtNjAyNjM_6d862db0-61a0-4fcf-97c0-9d8f2d5fc1f7"
      unitRef="usd">93000000.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzMtMy0xLTEtNjAyNjM_7297295f-5611-456d-ba14-0e9a4c8e5b36"
      unitRef="usd">63000000.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzQtMS0xLTEtNjAyNjM_faba8e53-21ac-4fa2-b131-819c0d07835e"
      unitRef="usd">19100000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzQtMy0xLTEtNjAyNjM_4ed69305-f5b1-40b4-b52c-95d1a7c1f492"
      unitRef="usd">28900000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzUtMS0xLTEtNjAyNjM_76f41859-658b-40b8-82ab-9d6abf6ba710"
      unitRef="usd">51600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzUtMy0xLTEtNjAyNjM_d200ad96-2325-4e44-a0fa-c395da438479"
      unitRef="usd">38200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzYtMS0xLTEtNjAyNjM_d1fa68af-b78f-4912-8f2a-94fe26dcdabb"
      unitRef="usd">931900000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzYtMy0xLTEtNjAyNjM_68d50bf3-2551-4fcd-8d00-ca6ba61b3fd8"
      unitRef="usd">978400000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzgtMS0xLTEtNjAyNjM_79fc0038-4fc8-4830-9316-d56a6ca8d44a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfMzgtMy0xLTEtNjAyNjM_9939d750-30af-4c7d-959a-7dbe44babc9f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM18yMg_19e13d95-78d3-43c1-83ad-a312fca0bc5d"
      unitRef="shares">3000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM18yMg_1b57f6e5-dc90-40c0-b622-072ec6edea41"
      unitRef="shares">3000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM181Mg_3ce651e4-5fea-463e-a63a-7385d6ff1426"
      unitRef="shares">0.0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM181Mg_5ac5890a-ccfd-4999-92d0-9544f225fea9"
      unitRef="shares">0.0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM181Mg_cffda93a-2d0b-4d34-b248-e082a3fa65d3"
      unitRef="shares">0.0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjOGE1YWVhODI0OGQ0OWE5YjQ4YjZmYjFkYzYwNmVlM181Mg_ffdc3b72-f48d-4fc0-b726-92fbc09f20ab"
      unitRef="shares">0.0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMS0xLTEtNjAyNjM_1d78620a-7abe-4dd3-974c-7b08edd4e842"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDEtMy0xLTEtNjAyNjM_9bb9d414-30db-4d12-9b93-f8754571121a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl8yOA_59796a9e-2438-4ee0-a2de-3a00f71c1a63"
      unitRef="usdPerShare">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl8yOA_b10d407c-6633-4575-ae2e-2e8564e6fdd0"
      unitRef="usdPerShare">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl80Mg_005d7ca3-5324-45d5-bc92-241ac152205a"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl80Mg_7a4cbe8d-c655-434b-8cc5-11f303726eb4"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl84Nw_96354407-adc6-42c9-be4f-a7039288b5f3"
      unitRef="shares">75300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl84Nw_aa303b8f-dc74-439c-af28-755f0e90fc99"
      unitRef="shares">75300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl8xMzI_ec69bb82-455a-4516-a625-06fd161bb242"
      unitRef="shares">74100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkYTQ4OTg3MWIxMzU0YTY3YmI0M2FlZmEyMTFlOWM4Nl8xNDc_0027d007-c779-481f-ab5f-c029413c8599"
      unitRef="shares">74200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMS0xLTEtNjAyNjM_8320a548-d187-45d8-a6c7-9d94082ef49f"
      unitRef="usd">18800000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDItMy0xLTEtNjAyNjM_e628a2bb-51c1-4399-8840-d03ab97c32d2"
      unitRef="usd">18800000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDMtMS0xLTEtNjAyNjM_1968f0f4-2ed6-4013-8f90-7ac9812694ce"
      unitRef="usd">232200000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDMtMy0xLTEtNjAyNjM_a8242d2b-1895-4bd1-ad0b-2ed84e75a213"
      unitRef="usd">249000000.0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDQtMS0xLTEtNjAyNjM_4aa2af68-7ce7-4799-9faa-d10536def98e"
      unitRef="usd">2987800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDQtMy0xLTEtNjAyNjM_0919b2b6-340d-4098-b274-a0fa3e343883"
      unitRef="usd">2456700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDUtMS0xLTEtNjAyNjM_2f194a94-4da3-4105-bcb9-ff92b9a9accf"
      unitRef="usd">-183000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDUtMy0xLTEtNjAyNjM_5fdfc482-493d-4911-a0c5-be430cc374f2"
      unitRef="usd">-159600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDYtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjphNTlmNTIwMzNiNzA0YmEzODQyMTdiNDVjMDRmYTJhN18yOQ_953089bc-84a0-4b9a-92b9-98cf309cc157"
      unitRef="shares">1200000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDYtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjphNTlmNTIwMzNiNzA0YmEzODQyMTdiNDVjMDRmYTJhN180NA_2e708559-838c-4a3e-932d-28315f892c8f"
      unitRef="shares">1100000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDYtMS0xLTEtNjAyNjM_0250598c-f533-4b8b-bf50-a1a023425527"
      unitRef="usd">370900000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDYtMy0xLTEtNjAyNjM_a696591d-4cfe-4e63-b3ad-b4dcf56f5cfb"
      unitRef="usd">229500000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDctMS0xLTEtNjAyNjM_5edf9e95-264b-4bc4-82e5-67c307caf192"
      unitRef="usd">2684900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDctMy0xLTEtNjAyNjM_b1e03ad5-8d9e-4f1a-b699-ca2413311ed5"
      unitRef="usd">2335400000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDgtMS0xLTEtNjAyNjM_26eee2bd-6da0-4921-82c6-54cf2c0755ec"
      unitRef="usd">3616800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY182Ny9mcmFnOmNhNmZiZTcyMjhmODQ4MmRhYzQzZTYwZGM5Y2JlYWU1L3RhYmxlOmRhY2VjZTE2ZGRmMzRlMDhhNzA4ZWQ1OTNhN2Q4YzQwL3RhYmxlcmFuZ2U6ZGFjZWNlMTZkZGYzNGUwOGE3MDhlZDU5M2E3ZDhjNDBfNDgtMy0xLTEtNjAyNjM_8b7054bd-aa07-46db-af0f-2400ed92eb76"
      unitRef="usd">3313800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i1a763da7bebb49d78fb727a07ced4166_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS0xLTEtMS02MDI2Mw_7ae5cc37-0b83-4489-99a8-68829644a21b"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1a763da7bebb49d78fb727a07ced4166_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS0zLTEtMS02MDI2Mw_a3b624c9-d79a-4539-882a-43a43693f5fb"
      unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id962c393773440e097f70db1509b5a4c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS01LTEtMS02MDI2Mw_73a11063-37b1-47fa-bb12-d3160e72004b"
      unitRef="usd">272700000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ib9377c7030f9487bb7299e888531cb40_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS03LTEtMS02MDI2Mw_06a2fdd7-1103-4c6a-a33e-eaf9deaef192"
      unitRef="shares">1200000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="ib9377c7030f9487bb7299e888531cb40_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS05LTEtMS02MDI2Mw_9027f727-b35b-4ead-b064-1989b1e68eaa"
      unitRef="usd">-118100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie47b13e10f5c43f18b3aba014d8b9557_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS0xMS0xLTEtNjAyNjM_a390ec00-a467-482e-8157-6d6ba79668d0"
      unitRef="usd">1549400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i17b8a1175e024b0b91f80042eb871d9e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS0xMy0xLTEtNjAyNjM_74c43397-2273-42af-b988-3cd1aff99d96"
      unitRef="usd">-149600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ff963c9c54045f29206b3189d452f9b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMS0xNS0xLTEtNjAyNjM_f97f69fe-a5de-49cf-aab1-f4e13ed411cd"
      unitRef="usd">1573200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5f410a8c4414410fbda82326f2f5f0cd_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMy0xMS0xLTEtNjAyNjM_0073d25a-a278-4b06-b230-89ad69f21816"
      unitRef="usd">-100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idca50b3901184ea9bada9c1613654555_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMy0xNS0xLTEtNjAyNjM_2c933cdc-0ecc-42c4-b0a5-4e4b7ad529a7"
      unitRef="usd">-100000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i532be8bdd25444f5bef6c5a83fa6ec14_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNC0xMS0xLTEtNjAyNjM_b2a108db-0ae1-4711-b9f7-54860aa52ac0"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNC0xNS0xLTEtNjAyNjM_5b683e85-e863-4959-b76b-4372409b12a1"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i093b685a4dfa4da18da754958b07c8bb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNS01LTEtMS02MDI2Mw_e89fcd74-d0d6-466f-af5f-72c2785ee534"
      unitRef="usd">-5400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i06323a1fbe0b4d548901ae093dc4d002_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNS03LTEtMS02MDI2Mw_aabe7ea4-643e-42c1-a8f7-94cd2ef5e633"
      unitRef="shares">-700000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i06323a1fbe0b4d548901ae093dc4d002_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNS05LTEtMS02MDI2Mw_227beb71-029d-4058-a313-35151870f76b"
      unitRef="usd">65900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNS0xNS0xLTEtNjAyNjM_f07ceff5-42fc-4a58-930c-3b24c8c62899"
      unitRef="usd">60500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i06323a1fbe0b4d548901ae093dc4d002_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNi03LTEtMS02MDI2Mw_8d451287-2ce2-4391-8529-4966d2443e76"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i06323a1fbe0b4d548901ae093dc4d002_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNi05LTEtMS02MDI2Mw_37e9201a-f85b-402d-9a53-ca83997ab28e"
      unitRef="usd">115500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNi0xNS0xLTEtNjAyNjM_77b035c2-b707-4d0c-9de9-340c9343ad9e"
      unitRef="usd">115500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNy0wLTEtMS02MDI2My90ZXh0cmVnaW9uOmU5ZDI1MTY3NzM5ODQwMTI4ZWIzNWRlN2JjZmVjZmU5XzI0_48a4ca1b-2956-4367-bb42-4a0aeebc7ac5"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i532be8bdd25444f5bef6c5a83fa6ec14_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNy0xMS0xLTEtNjAyNjM_fedb6af6-d1b9-4af5-9811-6fc4c5d6cefd"
      unitRef="usd">48800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfNy0xNS0xLTEtNjAyNjM_5ff4ac52-1b59-42a3-af46-e13aaf568b96"
      unitRef="usd">48800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5f3b7a5c69c84fa1a9361b05a767bfa2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfOS0xMy0xLTEtNjAyNjM_0ca139af-19ba-427c-b125-a3727c0527ac"
      unitRef="usd">39000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfOS0xNS0xLTEtNjAyNjM_f241ee2d-d114-4bfa-ac18-3d1a8ad5a061"
      unitRef="usd">39000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i16978dcdc2f041d19d80093c40fff403_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtMS0xLTEtNjAyNjM_2de76cb6-d349-4ffe-9d96-5966fe75c833"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i16978dcdc2f041d19d80093c40fff403_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtMy0xLTEtNjAyNjM_744f7128-09a0-469e-bbb6-59f1f37ee1e7"
      unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if72c2fa428754de9934583a6add241a8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtNS0xLTEtNjAyNjM_9af2efe1-342e-4812-9eb6-19f591af0f04"
      unitRef="usd">267300000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i840ed7b254234d0fbb34c7f7abeabfed_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtNy0xLTEtNjAyNjM_c71d9ae6-2119-4f21-a80f-cfc0b581c37f"
      unitRef="shares">1300000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i840ed7b254234d0fbb34c7f7abeabfed_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtOS0xLTEtNjAyNjM_35897a57-42e5-43fe-9497-d968e520b81f"
      unitRef="usd">-167700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie21b4b5fca6e4ce0884f11bc4cfad4fd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtMTEtMS0xLTYwMjYz_9655db5e-22c0-47d9-ab25-34f38527b3f8"
      unitRef="usd">1846700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ida3c98d3c0354b73a89f724be3743416_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtMTMtMS0xLTYwMjYz_7566c2ed-7f79-4e27-b1fd-0b12282ed87f"
      unitRef="usd">-110600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1165b131d689444eb6459290c85e0fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTAtMTUtMS0xLTYwMjYz_a2485061-b767-49fa-b497-a45fbb3ad6a6"
      unitRef="usd">1854500000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i00b5efe1c17b43d2a2fb2ea3402c0e1d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTItMTEtMS0xLTYwMjYz_dd1fe496-9a20-48b8-a5f9-d6a9882794b3"
      unitRef="usd">661800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTItMTUtMS0xLTYwMjYz_393c7339-be84-4811-873a-0179c464f7f6"
      unitRef="usd">661800000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i989eb46562154074b7d4bd40080dadcf_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTMtNS0xLTEtNjAyNjM_6fdf8e19-9bfe-4907-8334-7fe9d601ae2e"
      unitRef="usd">-18300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4ce53383a53d4f1eb000e413d41ebdf9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTMtNy0xLTEtNjAyNjM_9813a106-e21e-4839-b571-5992d73ad8ff"
      unitRef="shares">-700000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4ce53383a53d4f1eb000e413d41ebdf9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTMtOS0xLTEtNjAyNjM_fa92a1a6-60ad-4740-9168-e8a928ccce43"
      unitRef="usd">75300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTMtMTUtMS0xLTYwMjYz_5bcab8a7-feac-4965-a3e8-c840838e5d07"
      unitRef="usd">57000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i4ce53383a53d4f1eb000e413d41ebdf9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTUtNy0xLTEtNjAyNjM_9893d5ea-1e45-427f-8a1b-d4209450be23"
      unitRef="shares">500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4ce53383a53d4f1eb000e413d41ebdf9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTUtOS0xLTEtNjAyNjM_79382c7b-76e4-41c2-9198-ee02c63587ee"
      unitRef="usd">137100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTUtMTUtMS0xLTYwMjYz_a0786882-e7fa-4b1d-b502-eff54581705d"
      unitRef="usd">137100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTctMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjozOTU0MTkwMDljNDA0M2RkODMzMGU3NTJhMDljOThjMV8yNA_2138608d-c887-4881-9f24-1095344692bf"
      unitRef="usdPerShare">0.70</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i00b5efe1c17b43d2a2fb2ea3402c0e1d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTctMTEtMS0xLTYwMjYz_dea9b033-96dc-4c0c-a021-37d2d6f85573"
      unitRef="usd">51800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTctMTUtMS0xLTYwMjYz_81fa2266-81a0-4726-8b77-d9b294d96eb4"
      unitRef="usd">51800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3c3dc3f33c6e40168b8ee2b01cf1da89_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTgtMTMtMS0xLTYwMjYz_6f8808f1-4d18-4f76-be8a-6816b7c00dff"
      unitRef="usd">-49000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTgtMTUtMS0xLTYwMjYz_fca820c7-df1d-42de-bac8-c68bd9121896"
      unitRef="usd">-49000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i2e32d2d077d14623ad4001f6615da739_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktMS0xLTEtNjAyNjM_c20d3de7-0aec-4812-9baf-d5f8d2c63366"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2e32d2d077d14623ad4001f6615da739_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktMy0xLTEtNjAyNjM_2c4ae4a7-b601-45ab-9f03-fd13c180e24f"
      unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i269d9dc747f34c98bd9fd36e958f9112_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktNS0xLTEtNjAyNjM_fd69fd90-b722-413c-a8da-a663ace6609c"
      unitRef="usd">249000000.0</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ic40bf59888ea464bbf38a5e599052b55_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktNy0xLTEtNjAyNjM_f0701b97-7988-4b26-9c94-5f017f3c6477"
      unitRef="shares">1100000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="ic40bf59888ea464bbf38a5e599052b55_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktOS0xLTEtNjAyNjM_d5c90732-19fe-4b32-a20e-9db911fa75bc"
      unitRef="usd">-229500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9bbf7836dda448549d12d0144c47661e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktMTEtMS0xLTYwMjYz_96b895bc-4fbb-4876-b894-8d123f26a2c5"
      unitRef="usd">2456700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e14a309edfa4014932d060921715d47_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktMTMtMS0xLTYwMjYz_14b11bf5-1a00-42eb-8d74-53fa2c21ecef"
      unitRef="usd">-159600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMTktMTUtMS0xLTYwMjYz_0293c340-4b7d-493e-a716-79e15df76f58"
      unitRef="usd">2335400000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i80e03154cb7d45b6addb0d566c6a2e5d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjAtMTEtMS0xLTYwMjYz_210db5b2-a300-44e9-9c09-6ba6845e4953"
      unitRef="usd">585900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjAtMTUtMS0xLTYwMjYz_d65a517b-7363-4492-8b0f-78ed17422700"
      unitRef="usd">585900000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i21e3c20e3f1049698ccd1b563fee50fd_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjEtNS0xLTEtNjAyNjM_944c83ed-efaa-475f-8456-dfcae1565237"
      unitRef="usd">-16800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ic414a0567e02472dbd5e6bc8dea1c934_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjEtNy0xLTEtNjAyNjM_7886abeb-0d03-4225-893a-6dc572b9ee7a"
      unitRef="shares">-500000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic414a0567e02472dbd5e6bc8dea1c934_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjEtOS0xLTEtNjAyNjM_3e62c8d7-e57c-4752-a16a-52b46290019e"
      unitRef="usd">61400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjEtMTUtMS0xLTYwMjYz_8449b7d0-cdc4-43b1-9473-4af292924387"
      unitRef="usd">44600000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic414a0567e02472dbd5e6bc8dea1c934_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjItNy0xLTEtNjAyNjM_555dcb46-bb8a-4e5f-95b9-79502747d0d3"
      unitRef="shares">600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic414a0567e02472dbd5e6bc8dea1c934_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjItOS0xLTEtNjAyNjM_26c24929-c5fe-45da-b45c-998d20bf8f65"
      unitRef="usd">202800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjItMTUtMS0xLTYwMjYz_d5ce1161-e5ba-47d3-832f-5115843803f0"
      unitRef="usd">202800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjMtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjowNTU3NGJmMDlkNGQ0YjA0YTUxNGJhMTE0YzRkYzdkY18yNA_ad2d9ee9-ef71-42a3-a094-5aebfc273f88"
      unitRef="usdPerShare">0.74</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i80e03154cb7d45b6addb0d566c6a2e5d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjMtMTEtMS0xLTYwMjYz_7a741232-b9d3-4394-ba8e-2eea087ac924"
      unitRef="usd">54800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjMtMTUtMS0xLTYwMjYz_3bdacb20-4a78-48e4-b1e1-3ca35f84729a"
      unitRef="usd">54800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i42428a99c9ed4d9bb8b558e76dc9a6d0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjQtMTMtMS0xLTYwMjYz_9cfe38f5-6297-4263-baf3-f1be19da4df3"
      unitRef="usd">-23400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjQtMTUtMS0xLTYwMjYz_e5308f92-133f-45ab-b35d-137bab8d09a4"
      unitRef="usd">-23400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i27a556c3b4b644d5a2cba539a25d2c52_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtMS0xLTEtNjAyNjM_5d14a073-2703-4688-8622-6ced43a3437b"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i27a556c3b4b644d5a2cba539a25d2c52_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtMy0xLTEtNjAyNjM_7a7d75df-3625-4c60-9da9-7e151ab75d48"
      unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i297d5b4a9400421e865338046ad94f11_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtNS0xLTEtNjAyNjM_add47d8f-9af1-4ca2-b5a5-26e34d874cf0"
      unitRef="usd">232200000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="if051f33d67bc4196a2590dbe46e32868_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtNy0xLTEtNjAyNjM_f9b7e0a1-85a8-4d62-abbe-3da9bc54a9ab"
      unitRef="shares">1200000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="if051f33d67bc4196a2590dbe46e32868_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtOS0xLTEtNjAyNjM_38ea1a15-4223-463c-ace3-39ee083ec77c"
      unitRef="usd">-370900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie3086806657e4a2b89502cfae1ac8883_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtMTEtMS0xLTYwMjYz_9e8cc0d6-8391-4c1b-a11a-7daec7f2a39d"
      unitRef="usd">2987800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1e6cb706114942e4aabe6faaacf4e663_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtMTMtMS0xLTYwMjYz_eaded9e3-2411-41eb-b308-80640dc66cc7"
      unitRef="usd">-183000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183MC9mcmFnOjM4NTBlYTViNjYzZDRhZTk4YzM2OGRmY2NjZmNhNWMwL3RhYmxlOjRhOGU1MDVmOWJhMDQ0OGU5Y2M1YjQwMjQ0M2Q0MDBkL3RhYmxlcmFuZ2U6NGE4ZTUwNWY5YmEwNDQ4ZTljYzViNDAyNDQzZDQwMGRfMjUtMTUtMS0xLTYwMjYz_6362e37c-cc6b-4db0-ae47-df47735d57d1"
      unitRef="usd">2684900000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMi0xLTEtMS02MDI2Mw_fd6da5fb-88c7-45bb-9cd6-f5678cb81178"
      unitRef="usd">585900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMi0zLTEtMS02MDI2Mw_5c7cbf08-6475-47fc-a8ea-200977bf6a60"
      unitRef="usd">661800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMi01LTEtMS02MDI2Mw_e1c20fcd-c852-42bc-9c6f-e2d0797f6f74"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNC0xLTEtMS02MDI2Mw_f78670f8-351a-48f1-a90d-e7d97bd4df74"
      unitRef="usd">116900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNC0zLTEtMS02MDI2Mw_99f5edcd-2fd6-4a2f-bf4a-a266faff57c2"
      unitRef="usd">116900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNC01LTEtMS02MDI2Mw_29b436e3-9cb4-4649-a300-34f26d68c150"
      unitRef="usd">104700000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNS0xLTEtMS02MDI2Mw_123fa73b-daa2-4ef7-9ba4-dd9948cee777"
      unitRef="usd">3700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNS0zLTEtMS02MDI2Mw_3075b779-9587-42dd-a250-b16e35e1dac1"
      unitRef="usd">5400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNS01LTEtMS02MDI2Mw_024893be-cbc1-415f-bfe1-48eadee0c468"
      unitRef="usd">4400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNi0xLTEtMS02MDI2Mw_aff7953c-777c-4e79-b04b-36ab65a977d0"
      unitRef="usd">23700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNi0zLTEtMS02MDI2Mw_aa1c0cfc-2107-4c12-b389-2f58893ceb78"
      unitRef="usd">37500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNi01LTEtMS02MDI2Mw_4b2273c1-dd0d-4aaf-aac6-254e8912d948"
      unitRef="usd">34000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNy0xLTEtMS02MDI2Mw_efe2aaa1-18a4-4de3-9185-fb8f2d10ad1e"
      unitRef="usd">15300000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNy0zLTEtMS02MDI2Mw_4f7558fe-784a-42a5-9cb6-de140241ed7f"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNy01LTEtMS02MDI2Mw_3a378ed8-e08f-4d14-ac74-dc93cf311490"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfOC0xLTEtMS02MDI2Mw_bab92364-48fc-4dd2-85c1-44f914a5aa1d"
      unitRef="usd">-52200000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfOC0zLTEtMS02MDI2Mw_6f18e42e-8bdf-4ee9-840d-ce73fe19c657"
      unitRef="usd">-1800000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfOC01LTEtMS02MDI2Mw_901029aa-a775-4af9-9210-501b2f294c71"
      unitRef="usd">-3700000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTAtMS0xLTEtNjAyNjM_639e2ada-fa18-4238-915f-77b3ea6a9067"
      unitRef="usd">2000000.0</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTAtMy0xLTEtNjAyNjM_d5727b24-f740-4654-a9e6-59492b959f55"
      unitRef="usd">1400000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTAtNS0xLTEtNjAyNjM_62f25357-b69e-4f55-b1fc-a5320a23ac9e"
      unitRef="usd">900000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTEtMS0xLTEtNjAyNjM_1a3dfbcc-1b37-4ecf-b863-69e151ee6ae9"
      unitRef="usd">-2700000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTEtMy0xLTEtNjAyNjM_38531072-f319-4e7b-a7bc-d22d71881ac3"
      unitRef="usd">-1300000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTEtNS0xLTEtNjAyNjM_1ca1e7fb-8baf-4b5a-8cfc-43f7f4bdbc70"
      unitRef="usd">-7700000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTItMS0xLTEtNjAyNjM_d5636950-3d53-47c5-9b75-842004128bf9"
      unitRef="usd">-30800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTItMy0xLTEtNjAyNjM_caf58470-7f8d-49a3-b80d-cb53294846ca"
      unitRef="usd">-42900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTItNS0xLTEtNjAyNjM_ef394fbf-2fde-46ca-8ea6-843b69c19e8e"
      unitRef="usd">-5800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <wst:PensionAndOtherPostretirementBenefitExpenseNet
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTMtMS0xLTEtNjAyNjM_568d89da-2595-4121-a6fa-bc34696e24f1"
      unitRef="usd">-14000000.0</wst:PensionAndOtherPostretirementBenefitExpenseNet>
    <wst:PensionAndOtherPostretirementBenefitExpenseNet
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTMtMy0xLTEtNjAyNjM_87cd2ee8-40a3-4f00-88c5-673a9ad409ba"
      unitRef="usd">14800000</wst:PensionAndOtherPostretirementBenefitExpenseNet>
    <wst:PensionAndOtherPostretirementBenefitExpenseNet
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTMtNS0xLTEtNjAyNjM_bc86240c-78fe-4659-8a7e-713d0bcd31fb"
      unitRef="usd">4600000</wst:PensionAndOtherPostretirementBenefitExpenseNet>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTQtMS0xLTEtNjAyNjM_c8c52095-1162-49f5-b2d2-28cbed030e7d"
      unitRef="usd">18100000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTQtMy0xLTEtNjAyNjM_2e35386e-5206-427f-ac96-70ffcc60d7aa"
      unitRef="usd">17400000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTQtNS0xLTEtNjAyNjM_31c62254-121b-419a-acdd-ddff22c58cf8"
      unitRef="usd">15800000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTYtMS0xLTEtNjAyNjM_f3672c3e-4563-4155-ba61-cfea809794dd"
      unitRef="usd">35600000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTYtMy0xLTEtNjAyNjM_73880cc8-46d5-4755-8ab6-c58c7c8bedd0"
      unitRef="usd">123500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTYtNS0xLTEtNjAyNjM_c38bb267-19f6-4eff-9910-b71f1b57700b"
      unitRef="usd">46600000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTctMS0xLTEtNjAyNjM_4841230a-bb57-494b-8b13-5ed9f4b6fe16"
      unitRef="usd">49800000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTctMy0xLTEtNjAyNjM_cd0b563e-0efa-4a99-9ae3-8d7d82595b0b"
      unitRef="usd">86500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTctNS0xLTEtNjAyNjM_8aadce02-3cf0-414a-98a2-56c0db933cf3"
      unitRef="usd">73700000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTgtMS0xLTEtNjAyNjM_e6740913-e0bf-45d1-8e9f-d7263aab813b"
      unitRef="usd">-18500000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTgtMy0xLTEtNjAyNjM_35e122a1-768c-4141-a88c-030ddabe49b2"
      unitRef="usd">7300000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTgtNS0xLTEtNjAyNjM_b7ada2b6-ec87-4eac-9d17-497ba2c993bd"
      unitRef="usd">-5500000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTktMS0xLTEtNjAyNjM_c448f181-fc84-4b3b-9d51-95c139cf96cf"
      unitRef="usd">-2800000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTktMy0xLTEtNjAyNjM_ff11a146-28a0-4fb8-8c4f-03beaa7f631c"
      unitRef="usd">16800000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMTktNS0xLTEtNjAyNjM_2a5ef8ff-81f0-4610-a02f-77473f33b0fa"
      unitRef="usd">36600000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjAtMS0xLTEtNjAyNjM_61287c03-8cbb-46fa-b946-510f6deda22d"
      unitRef="usd">-58200000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjAtMy0xLTEtNjAyNjM_b1c6133b-dc60-410a-819a-213d228c85e0"
      unitRef="usd">-6700000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjAtNS0xLTEtNjAyNjM_9ce64b6a-32b7-4d96-916a-13bab5a1ce9e"
      unitRef="usd">-67900000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjEtMS0xLTEtNjAyNjM_77e9f414-4e4d-4786-9a2a-9b645f96c58c"
      unitRef="usd">724000000.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjEtMy0xLTEtNjAyNjM_330e7cd3-9e05-4a95-99e5-f804b4a5b6f5"
      unitRef="usd">584000000.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjEtNS0xLTEtNjAyNjM_15adbf6c-d293-427a-9411-d4958b8e4019"
      unitRef="usd">472500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjMtMS0xLTEtNjAyNjM_a528de0c-ed61-4faf-88fe-9260d6cd90bc"
      unitRef="usd">284600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjMtMy0xLTEtNjAyNjM_b410cd96-5ba4-4f37-bd0f-e9cdd092cf8c"
      unitRef="usd">253400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjMtNS0xLTEtNjAyNjM_f7ec34e2-c467-4516-9a18-97a5b2b639a7"
      unitRef="usd">174400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjUtMS0xLTEtNjAyNjM_3e56a3c5-6edb-4125-beae-1415abe2a2f3"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjUtMy0xLTEtNjAyNjM_d778dd41-3def-4688-83e5-7716ecf0f11a"
      unitRef="usd">2200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjUtNS0xLTEtNjAyNjM_e054c6f3-6128-4585-9bb3-78ab07e8b80d"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjktMS0xLTEtNjAyNjM_0cdd353a-f932-486f-b1c1-8a75d438adda"
      unitRef="usd">3600000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjktMy0xLTEtNjAyNjM_785b17ae-3377-4d32-bad7-b22ebeb1168c"
      unitRef="usd">-2500000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMjktNS0xLTEtNjAyNjM_e1857cd5-f5b5-427a-91bd-70176f61b706"
      unitRef="usd">5100000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzAtMS0xLTEtNjAyNjM_6041042c-e85e-4793-90d2-904cd1d0004f"
      unitRef="usd">-288200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzAtMy0xLTEtNjAyNjM_4ccaeae9-a721-4377-bade-d01af3669c82"
      unitRef="usd">-253100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzAtNS0xLTEtNjAyNjM_d7371ad3-0b30-4de3-8245-043569f3bbf8"
      unitRef="usd">-179500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzUtMS0xLTEtNjAyNjM_69832912-fe41-4016-b7b5-670d685fb21b"
      unitRef="usd">1200000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzUtMy0xLTEtNjAyNjM_503606cd-4776-4272-b08c-7f53e8d8a9f9"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzUtNS0xLTEtNjAyNjM_e8384f8d-60b7-46d0-bc5e-f813184ead3f"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzYtMS0xLTEtNjAyNjM_887a1939-4483-4ea9-8e48-6855eac4af54"
      unitRef="usd">44300000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzYtMy0xLTEtNjAyNjM_eb4b3e72-1d9a-4f88-8c26-e751996d4fa0"
      unitRef="usd">2200000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzYtNS0xLTEtNjAyNjM_cdd61093-045e-4e83-958d-69aabf11003e"
      unitRef="usd">2300000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzctMS0xLTEtNjAyNjM_12a9f147-d2fe-405a-a18f-00c29b739ddb"
      unitRef="usd">54100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzctMy0xLTEtNjAyNjM_c46345a4-9948-4d76-872f-13769c4447e0"
      unitRef="usd">51100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzctNS0xLTEtNjAyNjM_f3842542-e378-4426-830d-9d95a4e2469a"
      unitRef="usd">48100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzktMS0xLTEtNjAyNjM_18dca4a9-7056-4b2d-b3f2-34e833ece702"
      unitRef="usd">20900000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzktMy0xLTEtNjAyNjM_d0670d6b-d817-4010-a9d5-bb87f4fc8db2"
      unitRef="usd">29400000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfMzktNS0xLTEtNjAyNjM_513cef9a-f44c-49d3-b563-e05ff1ade98a"
      unitRef="usd">28300000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDAtMS0xLTEtNjAyNjM_d6fef02a-d1a4-4dbf-baa6-666c7ea7c8b7"
      unitRef="usd">7300000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDAtMy0xLTEtNjAyNjM_e6eea73d-a167-4fb3-a56b-7a1aca4f41dc"
      unitRef="usd">7700000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDAtNS0xLTEtNjAyNjM_41a7d925-ad55-4743-bb63-200cffabf58c"
      unitRef="usd">6400000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDEtMS0xLTEtNjAyNjM_44850f4a-106d-4f30-9931-f4f3491931c6"
      unitRef="usd">202800000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDEtMy0xLTEtNjAyNjM_659b5bee-8201-480c-8496-979f11f7fc28"
      unitRef="usd">137100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDEtNS0xLTEtNjAyNjM_3e46d3af-a8e4-4545-acae-396436a7ae77"
      unitRef="usd">115500000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDItMS0xLTEtNjAyNjM_060adf3f-634d-4434-9fc8-14200adb5de2"
      unitRef="usd">19400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDItMy0xLTEtNjAyNjM_78db419d-30f4-4b67-a6aa-dd08bfe8fa2b"
      unitRef="usd">14800000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDItNS0xLTEtNjAyNjM_85488171-6d16-4ad1-9b72-4d5674a06381"
      unitRef="usd">5900000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDMtMS0xLTEtNjAyNjM_6c251667-a847-4763-8ea9-d3262ef6ce59"
      unitRef="usd">-293600000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDMtMy0xLTEtNjAyNjM_8a08a8e5-79b9-40c0-812f-08e27abaaf53"
      unitRef="usd">-168100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDMtNS0xLTEtNjAyNjM_2a684fb3-4d44-455e-b3f5-67cf220d662f"
      unitRef="usd">-137100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDQtMS0xLTEtNjAyNjM_7b57cb91-1035-4125-a732-6af19853b6ee"
      unitRef="usd">-10500000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDQtMy0xLTEtNjAyNjM_ffed1606-dc49-445d-897b-f207030f551c"
      unitRef="usd">-15700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDQtNS0xLTEtNjAyNjM_d1a58ef9-2617-498b-a927-b7358d816be4"
      unitRef="usd">20500000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDUtMS0xLTEtNjAyNjM_cb298086-afde-4a11-941c-cfa4dbcd1436"
      unitRef="usd">131700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDUtMy0xLTEtNjAyNjM_fe2a33f9-7565-44f8-933f-b10f0dbf9985"
      unitRef="usd">147100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDUtNS0xLTEtNjAyNjM_1b59c4f1-62a8-46cb-a5db-ca558f1d5518"
      unitRef="usd">176400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDYtMS0xLTEtNjAyNjM_39dd7abc-9953-4fdf-826a-01e85b25fef1"
      unitRef="usd">762600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1165b131d689444eb6459290c85e0fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDYtMy0xLTEtNjAyNjM_25c3088b-b247-43f4-992d-4d1c296b18b0"
      unitRef="usd">615500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5ff963c9c54045f29206b3189d452f9b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDYtNS0xLTEtNjAyNjM_1ee33f90-67ac-4daa-9ffc-9df765283d9e"
      unitRef="usd">439100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDctMS0xLTEtNjAyNjM_bed94462-cc17-48d3-9df5-37af2d07ac30"
      unitRef="usd">894300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDctMy0xLTEtNjAyNjM_78e95bef-92c2-43aa-9a4a-97912da4f1f6"
      unitRef="usd">762600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1165b131d689444eb6459290c85e0fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNDctNS0xLTEtNjAyNjM_2719ba27-1e30-4e8c-9dd2-544c41a11b50"
      unitRef="usd">615500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTAtMS0xLTEtNjAyNjM_0b8450f2-5ce9-4e34-9ede-be07aa7482b0"
      unitRef="usd">6600000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTAtMy0xLTEtNjAyNjM_320481ba-891e-442e-8eee-b43c00965100"
      unitRef="usd">8000000.0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTAtNS0xLTEtNjAyNjM_cb4877db-59a3-4725-823e-311962b639b3"
      unitRef="usd">8100000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTEtMS0xLTEtNjAyNjM_e79746cc-8a1b-482c-82fd-30a4713c8c4d"
      unitRef="usd">109700000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTEtMy0xLTEtNjAyNjM_86ba3007-8229-43f8-bc11-e4a1c3b5cef4"
      unitRef="usd">171800000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTEtNS0xLTEtNjAyNjM_4a695de7-7f8b-4451-87c3-9a56e8cbeb9d"
      unitRef="usd">48400000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTItMS0xLTEtNjAyNjM_efeec5c6-8961-4798-a4ce-0c2e1a7ae449"
      unitRef="usd">33200000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTItMy0xLTEtNjAyNjM_a34fcece-a63d-49ec-bb92-29ca2fdcbbcc"
      unitRef="usd">41100000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTItNS0xLTEtNjAyNjM_4b9a717f-f39d-4e8e-8924-19605115bc36"
      unitRef="usd">31300000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DividendsPayableCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTMtMS0xLTEtNjAyNjM_e4f1da04-6bb2-4f99-8e6d-105e0a3cba4a"
      unitRef="usd">14100000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTMtMy0xLTEtNjAyNjM_921d2ad4-50fc-4599-a434-144dbc069592"
      unitRef="usd">13400000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i1165b131d689444eb6459290c85e0fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183My9mcmFnOmY0NDIzZmRjMGY2MDRhNTFiODMyZGUyOWFlNTUyZjhlL3RhYmxlOjAyMGRkZjQwZjc4NzQ2ZWNhZDFhZTRiMDA2Nzg3NzE5L3RhYmxlcmFuZ2U6MDIwZGRmNDBmNzg3NDZlY2FkMWFlNGIwMDY3ODc3MTlfNTMtNS0xLTEtNjAyNjM_5f81b86a-4b78-4c48-8881-55cf2bf16d79"
      unitRef="usd">12600000</us-gaap:DividendsPayableCurrent>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNTk_40eec6d6-3f89-434a-bdff-bf7cde169586">Basis of Presentation and Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The consolidated financial statements include the accounts of West Pharmaceutical Services, Inc. ("West") after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;West has been actively monitoring the coronavirus (&#x201c;COVID-19&#x201d;) situation and its impact globally. Our production facilities continue to operate as they had prior to the COVID-19 pandemic, other than for enhanced safety measures intended to prevent the spread of the virus.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash equivalents include time deposits, certificates of deposit and all highly liquid short-term instruments with maturities of three months or less at the time of purchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our accounts receivable balance was net of an allowance for credit losses of $0.2 million and $0.4 million at December&#160;31, 2022 and 2021, respectively. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Inventories are valued at the lower of cost (on a first-in, first-out basis) or net realizable value. The Company provides for cost adjustments for excess, obsolete or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. The following is a summary of inventories at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.304%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other expense (income). Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2022 and 2021. Please refer to Note 6, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Leases&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#x2019;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Goodwill and Other Intangible Assets:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#x2019;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuing identifiable intangible assets requires judgment. For example, for recent identifiable customer relationship intangible asset acquisitions, we applied an excess earnings model, which is a form of the income approach. This approach includes projecting revenues and expenses attributable to the existing customers over the remaining economic life of the customer relationships and then subtracting the required return on net tangible assets and any intangible assets used in the business to estimate any residual excess earnings attributable to the customer relationships. The after-tax excess earnings are then discounted to present value using the respective discount rates. Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 3 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. Factors that could trigger an impairment review include the following: 1) significant under-performance relative to historical or projected future operating results; 2) significant changes in the manner of use of the acquired assets or the strategy of the overall business; 3) significant negative industry or economic trends; and 4) recognition of goodwill impairment charges. If we determine that the carrying value of identifiable intangibles assets may not be recoverable based on the existence of one or more of the above indicators of impairment, we measure recoverability of assets by comparing the respective carrying value of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, we measure an impairment based on the amount in which the net carrying amount of the assets exceeds the fair values of the assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Benefits:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Benefit Plans&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for a more detailed discussion of our pension and other retirement plans. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#x2019;s gain or loss is initially reported as a component of other comprehensive income (&#x201c;OCI&#x201d;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#x2019;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less. In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less. Please refer to Note 3, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revenue&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;,&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are primarily expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Environmental Remediation and Compliance Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. Please refer to Note 17, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Income Taxes&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other expense (income). The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stock-Based Compensation&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for a more detailed discussion of our stock-based compensation plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Income Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNDM_de00cd0e-28e6-4661-b48d-73c109762b23">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The consolidated financial statements include the accounts of West Pharmaceutical Services, Inc. ("West") after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities.&lt;/span&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyODg_6a710ff1-512a-47e2-8bc0-676850bf749a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyOTc_02c8c5d8-e240-4636-89a2-0fd75755a3e3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash equivalents include time deposits, certificates of deposit and all highly liquid short-term instruments with maturities of three months or less at the time of purchase.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzMzc_b68be3fb-b3fe-4381-922c-cee1d4d6b169">Accounts Receivable: Our accounts receivable balance was net of an allowance for credit losses of $0.2 million and $0.4 million at December&#160;31, 2022 and 2021, respectively. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMjA2MQ_690cbc2f-8f6d-46a8-98e6-dad15e6863d8"
      unitRef="usd">200000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMjA2OA_bb884dff-a266-4cd1-ad00-1657660c64cf"
      unitRef="usd">400000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzNjU_1a63ed46-b448-45be-b96c-4f07bc882f9b">Inventories: Inventories are valued at the lower of cost (on a first-in, first-out basis) or net realizable value.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyMzA_ec701153-ce71-49f2-94d2-af2421a92b34">The following is a summary of inventories at December 31:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.304%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMS0xLTEtMS02MDI2Mw_c91f29f9-431a-4b84-80e0-6913f03f7ec5"
      unitRef="usd">170700000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMS0zLTEtMS02MDI2Mw_bb2cc559-a428-4424-8331-ee98994054dd"
      unitRef="usd">153800000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMi0xLTEtMS02MDI2Mw_818c4f87-1738-452f-af5a-aa26985ffa56"
      unitRef="usd">79000000.0</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMi0zLTEtMS02MDI2Mw_90390b2f-94a5-4be5-bf29-9e03f853918e"
      unitRef="usd">63500000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMy0xLTEtMS02MDI2Mw_cc45cdfb-c931-44d3-994c-41d09b33b716"
      unitRef="usd">165100000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfMy0zLTEtMS02MDI2Mw_3a9f6213-ec0a-47c1-9920-0b3cd4fee89d"
      unitRef="usd">161100000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfNC0xLTEtMS02MDI2Mw_28fdbb54-2365-4b3f-88ad-a360d44f22a2"
      unitRef="usd">414800000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RhYmxlOjAzYTYzMWExYmM3MTQ5NmY4OGU1ODRjNjhkYmM2OTM2L3RhYmxlcmFuZ2U6MDNhNjMxYTFiYzcxNDk2Zjg4ZTU4NGM2OGRiYzY5MzZfNC0zLTEtMS02MDI2Mw_b8bf019d-6e8d-4aa0-9cf2-08d50a78f82a"
      unitRef="usd">378400000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyODQ_e1558ab0-0e7e-41a8-895d-0cbc1129ea5f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other expense (income). Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyODU_4dad5890-691f-45a0-a7e0-b2d90121522c">Leases: Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:FinanceLeaseLiability
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfNDA2Nw_3dab0b40-534d-42f9-94bd-80f0d82b1a60"
      unitRef="usd">0</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfNDA2Nw_d736a153-a74e-4e71-bb7a-a4c1885069cc"
      unitRef="usd">0</us-gaap:FinanceLeaseLiability>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyMzY_cd1984f3-f4bb-4192-a691-a1ca6dcea6e7">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#x2019;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.&lt;/span&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzMDY_0984e4e6-a770-4f9f-95e6-0fafee9ffe07">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Goodwill and Other Intangible Assets:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#x2019;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuing identifiable intangible assets requires judgment. For example, for recent identifiable customer relationship intangible asset acquisitions, we applied an excess earnings model, which is a form of the income approach. This approach includes projecting revenues and expenses attributable to the existing customers over the remaining economic life of the customer relationships and then subtracting the required return on net tangible assets and any intangible assets used in the business to estimate any residual excess earnings attributable to the customer relationships. The after-tax excess earnings are then discounted to present value using the respective discount rates. Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 3 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. Factors that could trigger an impairment review include the following: 1) significant under-performance relative to historical or projected future operating results; 2) significant changes in the manner of use of the acquired assets or the strategy of the overall business; 3) significant negative industry or economic trends; and 4) recognition of goodwill impairment charges. If we determine that the carrying value of identifiable intangibles assets may not be recoverable based on the existence of one or more of the above indicators of impairment, we measure recoverability of assets by comparing the respective carrying value of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, we measure an impairment based on the amount in which the net carrying amount of the assets exceeds the fair values of the assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ieca2c70046774b70b2ca24e38603bd11_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfNjQ3Mg_a0ea1595-9686-403b-8174-e40a348d8ea7">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibb415db0220846bbbaee31bca93b64e3_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfNjQ3OA_d2510ef9-cae2-41de-a098-f5388642c21d">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyMjM_93f2dc5f-b53e-48a5-8338-d1585acd8324">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Benefits:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Benefit Plans&lt;/a&gt;&lt;/span&gt;, for a more detailed discussion of our pension and other retirement plans.</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzNDQ_c4595592-2125-4565-9385-b05539a3d72b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#x2019;s gain or loss is initially reported as a component of other comprehensive income (&#x201c;OCI&#x201d;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#x2019;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.&lt;/span&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNzQ_06988d4a-7771-4e1f-8846-d81731a8473c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNTc_9894fc3a-aada-45e0-b5cc-5f24ad63f3b4">Revenue Recognition: Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less. In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNTE_eb7cede9-f98d-4dd0-b99d-99e9bfe8b762">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.&lt;/span&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyODI_2a4feb7a-6eec-48ad-90e5-748dff881557">Research and Development: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are primarily expensed as incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:EnvironmentalCostsPolicy
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzNDI_ac005ee8-dc13-489b-8568-62c37bc9fdd5">Environmental Remediation and Compliance Costs: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.</us-gaap:EnvironmentalCostsPolicy>
    <wst:LegalMattersContingenciesAndLegalCostsPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzMzQ_a67b6653-a9cc-4fcd-b9f6-b237f54882b1">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.&lt;/span&gt;</wst:LegalMattersContingenciesAndLegalCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzNTM_215b4b43-0581-413e-abb4-a95c356d9596">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. Please refer to Note 17, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Income Taxes&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other expense (income). The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQzNjA_dfd0a1d3-7488-4402-a668-c8a0bcbf4f70">Stock-Based Compensation: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY183OS9mcmFnOmY5ZDI4M2NmN2ZhNjQyMWRhYWNmZmU2MTA1YjYxYzU4L3RleHRyZWdpb246ZjlkMjgzY2Y3ZmE2NDIxZGFhY2ZmZTYxMDViNjFjNThfMTQyNDY_711351b5-43fa-4ea7-8658-7ec074ef4957">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Income Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.&lt;/span&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184Mi9mcmFnOjFiZTFkNjkyNDI5ZDQyNDViMTY2ZTJlNTcwN2MyNzM5L3RleHRyZWdpb246MWJlMWQ2OTI0MjlkNDI0NWIxNjZlMmU1NzA3YzI3MzlfMTcwNQ_44109f00-9152-4a2d-9237-f39a7e1f15c1">New Accounting Standards&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2021, the Financial Accounting Standards Board ("FASB") issued guidance that seeks to improve the transparency of financial disclosures for government assistance received by business entities. The amendment requires disclosures for transactions with a government accounted for by applying a grant or contribution accounting model by analogy, including (1) the types of transactions, (2) the accounting for those transactions, and (3) the effect of those transactions on an entity&#x2019;s financial statements. This guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance as of January 1, 2022, on a prospective basis. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued guidance which provides optional expedients and exceptions to address the impact of reference rate reform where contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate need to be discontinued. This guidance was effective upon issuance and generally can be applied through December 31, 2022. We adopted this guidance during the year by executing amendments to certain contracts to replace the use of LIBOR. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184Mi9mcmFnOjFiZTFkNjkyNDI5ZDQyNDViMTY2ZTJlNTcwN2MyNzM5L3RleHRyZWdpb246MWJlMWQ2OTI0MjlkNDI0NWIxNjZlMmU1NzA3YzI3MzlfMTY5NQ_c2589b87-9f2c-43cf-9e66-7aab172054c9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2021, the Financial Accounting Standards Board ("FASB") issued guidance that seeks to improve the transparency of financial disclosures for government assistance received by business entities. The amendment requires disclosures for transactions with a government accounted for by applying a grant or contribution accounting model by analogy, including (1) the types of transactions, (2) the accounting for those transactions, and (3) the effect of those transactions on an entity&#x2019;s financial statements. This guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance as of January 1, 2022, on a prospective basis. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued guidance which provides optional expedients and exceptions to address the impact of reference rate reform where contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate need to be discontinued. This guidance was effective upon issuance and generally can be applied through December 31, 2022. We adopted this guidance during the year by executing amendments to certain contracts to replace the use of LIBOR. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfNTc1Mw_17a24ba9-e5f8-4197-aab5-9d47714f1cd2">Revenue&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time, following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose&#xae; technology platform within a specific therapeutic area. As of December&#160;31, 2022, there was $3.0 million of deferred income related to this payment, of which $0.9 million was included in other current liabilities and $2.1 million was included in other long-term liabilities. The deferred income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by market group:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by product category: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Delivery Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard Packaging &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by geographic location: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract assets and liabilities result from transactions with revenue primarily recorded over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet within other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets and liabilities, excluding amounts included in accounts receivable, net:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in contract assets - increase (decrease)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferred income - (increase) decrease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Contract assets are included within other current assets and deferred income is included within other current liabilities and other long-term liabilities. The increase in deferred income during 2022 was primarily due to additional cash payments of $88.3 million received in advance of satisfying future performance obligations, partially offset by the recognition of current year revenue of $54.2 million, and $28.0&#160;million of revenue was recognized that was included in deferred income at the beginning of the year.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ib455f8d389b84c90834d838d768dd859_I20130630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfMTkyOQ_42957aae-b254-4e63-8215-b033d0149010"
      unitRef="usd">20000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i530eb90eb2764a55bb62aac980b27711_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfMjE5OTAyMzI2MjEwMg_135fba3c-d015-42b3-9143-d161a54467cb"
      unitRef="usd">3000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i530eb90eb2764a55bb62aac980b27711_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfMjE5OTAyMzI2MjA4OQ_8986b8d5-72cc-439e-a38d-ec2bde945295"
      unitRef="usd">900000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i530eb90eb2764a55bb62aac980b27711_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfMjE5OTAyMzI2MjA5NQ_cfa93440-3cef-49c8-8da6-f0fb0791e942"
      unitRef="usd">2100000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfNTc1MA_9990c319-de09-4d77-88c1-2f377984c6a4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by market group:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by product category: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Delivery Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard Packaging &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by geographic location: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i79c8219373a3404aaf82ead0cda46716_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMS0xLTEtMS02MDI2Mw_d173e432-306a-4953-8444-0f01a58df36f"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i609b68bdcb584f1fa5a8970ccd1759d3_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMS0zLTEtMS02MDI2Mw_8f461743-242b-4b8f-83a8-d02c3afdba1d"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6ff1421dfabb4931b5d3f165e4fa608f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMS01LTEtMS02MDI2Mw_46604bc5-9e79-4f28-a611-4866b02eef23"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5d95a90ba942409fb7eb38c53be370cb_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMi0xLTEtMS02MDI2Mw_98e2bd9a-c1ef-4a82-b3ea-f1620df2adbf"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i665253b4d08e4da599894b62da126263_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMi0zLTEtMS02MDI2Mw_4a187e69-f31a-42ed-adb6-edfe9968f659"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic40393e675034834a4cb5d8ffa391e4c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMi01LTEtMS02MDI2Mw_68ac9074-fe52-4bcb-ba29-bb7a35838b46"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i97e639bd58654edeb8611e423238d72e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMy0xLTEtMS02MDI2Mw_222080b8-bfef-42e2-84a3-f55074eb44d7"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7fa94e736dee414db6421d8880cc2422_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMy0zLTEtMS02MDI2Mw_52753e62-2d0d-4123-acc2-4018671aaf88"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if045da1a86684296aa4c33ad55d60c95_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfMy01LTEtMS02MDI2Mw_10125750-9a3a-4cf2-92cf-030675fb9adb"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if7066b92c5e54bc79943066fb6034c7c_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNC0xLTEtMS02MDI2Mw_e99ebfeb-8ae3-4d36-979b-836579d7ab16"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i51e337fbb71345fca552db98bf16e460_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNC0zLTEtMS02MDI2Mw_5202d0a8-ceb4-43e3-bb25-1efe2f972285"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i452ba88776d94afb84fbc1b35bcbcd24_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNC01LTEtMS02MDI2Mw_c342bf7a-0c59-41e3-a865-d8f4e7a6a940"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNS0xLTEtMS02MDI2Mw_2e2ef74a-7cbc-4de8-96db-55eccc17cc62"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNS0zLTEtMS02MDI2Mw_2b38c6e1-beaf-473b-9bd6-092f41f7d1b7"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjVjNDIxNjNmMTk1MjRjMWE5NjcxYjlhNzUzN2Y5MmM5L3RhYmxlcmFuZ2U6NWM0MjE2M2YxOTUyNGMxYTk2NzFiOWE3NTM3ZjkyYzlfNS01LTEtMS02MDI2Mw_21a89dce-05b8-43b8-ab6c-746342ab4689"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic134acff31094622a91b3143a0e96cd0_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMS0xLTEtMS02MDI2Mw_d3dd203c-cf97-4942-bb24-294482d2c6d7"
      unitRef="number">0.55</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia177439c331047b2ab87726450ce39bb_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMS0zLTEtMS02MDI2Mw_95cf1c19-22cb-471a-a305-6c8182d5897a"
      unitRef="number">0.54</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i256eab0010ac4440b58c5fa97329532a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMS01LTEtMS02MDI2Mw_0375193b-ae2a-4fd4-ac53-76c71ea4519c"
      unitRef="number">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifc55026ca0ea4cd4b78b9007129033b8_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMi0xLTEtMS02MDI2Mw_3120926a-44ed-42d2-8593-fd3bc41a15ba"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i838a650038204c9eafed9990f5a9ee16_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMi0zLTEtMS02MDI2Mw_49dfa752-b75c-4b92-b32a-0114b77ee887"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id7120c4b931d4e48b07cf29f80d2b1cb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMi01LTEtMS02MDI2Mw_7980e550-5b35-42d3-a681-c0e2dfee5a1d"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibe73169f2a304e4b8511b7c7f5ca3ea2_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMy0xLTEtMS02MDI2Mw_69cfa500-5021-442e-826d-d8699932fe83"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id1c945b9d9124755884c9318597648c1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMy0zLTEtMS02MDI2Mw_d77747b5-bec3-4193-a8df-cc965e1176c6"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib8da7f757b5d415e896679c642747d6e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfMy01LTEtMS02MDI2Mw_cb6bf1c9-b628-4e05-9380-9373a60ec227"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9f44138370e044a39010d4f60177210d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNC0xLTEtMS02MDI2Mw_03fb7254-6786-43eb-b831-fc216ecaec51"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifb8186699d064e74a59fc5b34eed6c40_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNC0zLTEtMS02MDI2Mw_ea0e9de2-f251-4581-9b1d-acc1e04bd29c"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0faf4f9784a94f7aa7354566da3204c3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNC01LTEtMS02MDI2Mw_3919fafa-42e3-4547-b8f1-54cac92eb085"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNS0xLTEtMS02MDI2Mw_826024a8-9dda-4395-8d64-63f68d95b418"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNS0zLTEtMS02MDI2Mw_09f51e2e-1c03-46e0-b28e-91eb831e2a03"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjY1MDcyMGZjZGIyNjRhZTRiZDIxYjEwNTNiZTM1YThlL3RhYmxlcmFuZ2U6NjUwNzIwZmNkYjI2NGFlNGJkMjFiMTA1M2JlMzVhOGVfNS01LTEtMS02MDI2Mw_10175688-7e68-49c0-9425-717fa7d04be9"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic35adedcc7f44b1b9c0fe04681478c95_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMS0xLTEtMS02MDI2Mw_a8365e5a-0b7d-4598-8550-b5627f34d43f"
      unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if6651efd4f764b48adb48d2620a076d6_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMS0zLTEtMS02MDI2Mw_826cb741-7f25-4c1a-9a44-56fde729010b"
      unitRef="number">0.45</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1147923590ae4023add6d186c7abf72f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMS01LTEtMS02MDI2Mw_9580eb5a-00c2-499c-9f46-4de4b23e5b07"
      unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2f618571d5fc44b591d452151b7e1075_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMi0xLTEtMS02MDI2Mw_ec543c0b-da23-4e81-b38c-070aead721f4"
      unitRef="number">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ica414868e28c41ee9837e7414f82083d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMi0zLTEtMS02MDI2Mw_7d4f723a-a7a6-4f35-9e56-0ac081c7e202"
      unitRef="number">0.45</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ica6ef1a0769a4e648ec274538fd0bbea_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMi01LTEtMS02MDI2Mw_4b4d062b-7f0a-4af6-bbc9-d5a9f7beee39"
      unitRef="number">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i057ed2a2629447fe8340db3a494eaafd_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMy0xLTEtMS02MDI2Mw_6017a576-894a-405b-8181-4dbfb8c0a3b8"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if7ac37da416447fdb298621d726f8906_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMy0zLTEtMS02MDI2Mw_913e86fc-c362-4ddf-8406-9756c5b5c675"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia45b0766113a446a94c89d02189621ed_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfMy01LTEtMS02MDI2Mw_e7a15b26-dc31-4358-81d4-7f0a27d1d5bb"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfNC0xLTEtMS02MDI2Mw_72f6a40d-1ea7-424a-b704-53c07a0f01f5"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfNC0zLTEtMS02MDI2Mw_37888031-9dae-4f7e-890d-e70f561982a0"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOmE0ODViNjg3YWEyMTQwMzRhN2MxMjRiMjIzMjY1NzhmL3RhYmxlcmFuZ2U6YTQ4NWI2ODdhYTIxNDAzNGE3YzEyNGIyMjMyNjU3OGZfNC01LTEtMS02MDI2Mw_40c30d95-a58a-4cae-9df1-22b700bc6c1e"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfNTc1Mg_af62cefb-c7d4-40e0-b13e-c2c80adeb813">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets and liabilities, excluding amounts included in accounts receivable, net:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in contract assets - increase (decrease)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferred income - (increase) decrease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfMS0xLTEtMS02MDI2Mw_0fdc13ad-ba7f-4e22-b23f-12528db26c7a"
      unitRef="usd">14600000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfMi0xLTEtMS02MDI2Mw_9039d9d2-02cf-478a-9c5f-b2b31cb61673"
      unitRef="usd">16300000</us-gaap:ContractWithCustomerAssetNet>
    <wst:ContractWithCustomerAssetIncreaseDecrease
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfMy0xLTEtMS02MDI2Mw_aa89347d-7699-47ca-a590-e4a69553ebc4"
      unitRef="usd">1700000</wst:ContractWithCustomerAssetIncreaseDecrease>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfNS0xLTEtMS02MDI2Mw_250030f8-89a8-4a15-b724-fe16ddc9f912"
      unitRef="usd">61300000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfNi0xLTEtMS02MDI2Mw_019ccf8c-c6dc-41d0-b0a1-8f4437c049b7"
      unitRef="usd">68200000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RhYmxlOjc0ODVlNmM2NjljYzRkZjc4ZWExZGVhYmU2ZWM5MmQzL3RhYmxlcmFuZ2U6NzQ4NWU2YzY2OWNjNGRmNzhlYTFkZWFiZTZlYzkyZDNfNy0xLTEtMS02MDI2Mw_13157613-3265-4abd-8b24-cc622ecd54d4"
      unitRef="usd">6900000</us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized>
    <wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfNTQ5NzU1ODIxNDc0_6f67e586-5fe3-4f6a-bcc4-4462f208a57e"
      unitRef="usd">88300000</wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments>
    <wst:ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfNTQ5NzU1ODIxNDgx_313c0f70-4bb6-4c1e-901f-21f9538e2eb5"
      unitRef="usd">54200000</wst:ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184NS9mcmFnOjlkNGNhYmVhNTcyMzQ5OWFhMGRjOTA3MjMxNjRhOGUyL3RleHRyZWdpb246OWQ0Y2FiZWE1NzIzNDk5YWEwZGM5MDcyMzE2NGE4ZTJfMjE5OTAyMzI2MjgwMQ_247990e9-06df-40d8-8e6b-86e66db6a253"
      unitRef="usd">28000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMTQyMA_ff9a1568-0e39-4864-8976-410e46433772">Net Income Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of equity awards, based on the treasury stock method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, 2021 and 2020, there were 0.2 million, 0.0 million, and 0.0 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2021, we announced a share repurchase program for calendar-year 2022 authorizing the repurchase of up to 650,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions. There were no shares purchased during the three months ended December 31, 2022. During the year ended December 31, 2022, we purchased 563,334 shares of our common stock under the now completed program at a cost of $202.8 million, or an average price of $360.03 per share.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In February 2023, the Board of Directors approved a share repurchase program under which we may repurchase up to $1.0&#160;billion in shares of common stock. The share repurchase program does not have an expiration date under which we may repurchase common stock on the open market or in privately-negotiated transactions. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMTQyNw_be987646-fd7e-406e-9688-24452fa8ef94">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of equity awards, based on the treasury stock method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMS0xLTEtMS02MDI2Mw_2444aaff-efc2-48d5-b766-393fe624f199"
      unitRef="usd">585900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMS0zLTEtMS02MDI2Mw_77d23912-3c84-431b-bad4-6aa521fa08e9"
      unitRef="usd">661800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMS01LTEtMS02MDI2Mw_a06bcbc5-284c-46c2-b8a5-28c5c2087ec8"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMi0xLTEtMS02MDI2Mw_ebb3ea10-d5d7-4874-ae5a-943c3d97a212"
      unitRef="shares">74400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMi0zLTEtMS02MDI2Mw_5c842602-0aa3-4ee7-b751-4841e3fda6f7"
      unitRef="shares">74400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMi01LTEtMS02MDI2Mw_1ff0f1f0-da18-4b77-899c-acd58d347925"
      unitRef="shares">73900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMy0xLTEtMS02MDI2Mw_48c7c857-ea14-40db-a933-411fe450f521"
      unitRef="shares">1400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMy0zLTEtMS02MDI2Mw_776476ed-7cf4-490e-9283-41ab3dc40d82"
      unitRef="shares">1900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfMy01LTEtMS02MDI2Mw_4d05d16c-748f-4eb4-bc8f-741562de2991"
      unitRef="shares">1900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfNS0xLTEtMS02MDI2Mw_76d336d1-b605-446e-8dbb-276754254ff2"
      unitRef="shares">75800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfNS0zLTEtMS02MDI2Mw_0275229d-5420-4325-a865-3798ebd36ed5"
      unitRef="shares">76300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RhYmxlOmE2Y2E2MGY0NjBiMjQwOTc4MmE1NTI3NDI2NjZiYjQ2L3RhYmxlcmFuZ2U6YTZjYTYwZjQ2MGIyNDA5NzgyYTU1Mjc0MjY2NmJiNDZfNS01LTEtMS02MDI2Mw_ad3a38a0-fe43-4979-b008-3dfa055436ac"
      unitRef="shares">75800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE1_47655efb-668c-426a-9d45-8c4498d6f5d9"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE5_6cbadc5a-b8f2-4669-8870-3dfb079c4e9d"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjI3_c8a2fd5d-1d18-4eab-9715-52c681306f20"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfNTA4_aa2e90b4-c0a9-4d24-8930-1c638256c91c"
      unitRef="shares">650000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i93cc0075175a4ee886a144fc0fad49b2_D20221001-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfNjcx_47e10520-9fe2-4f5b-9461-c7ceedbe4706"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE5OTAyMzI1NzUzOA_3d77feaa-c7d3-4bc8-b270-62635f2b8b7a"
      unitRef="shares">563334</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE5OTAyMzI1NzU0Mg_3a0b7096-56e4-4e5c-94ab-d7cb4120cee1"
      unitRef="usd">202800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE5OTAyMzI1NzU0OA_05e3da1a-3a3b-485a-b472-e05e2a3f8cd7"
      unitRef="usdPerShare">360.03</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i5259b4fec7824128bebbc2321b046a0f_I20230221"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY184OC9mcmFnOjQwZGY1ZWUyM2MzYzRlZWE4ZDE3Mzg2OWIzMGU3OTRmL3RleHRyZWdpb246NDBkZjVlZTIzYzNjNGVlYThkMTczODY5YjMwZTc5NGZfMjE5OTAyMzI1Nzc4Mw_d3f5f17d-2174-482d-a4ad-4b71ff35492d"
      unitRef="shares">1000000000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfNTUx_8f201bab-049b-4447-82e9-db7229632d79">Property, Plant and Equipment&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of gross property, plant and equipment at December 31 is presented in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected useful lives (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15-35&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds and dies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,215.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for the years ended December&#160;31, 2022, 2021 and 2020 was $116.9 million, $116.9 million and $104.7 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize interest on borrowings during the active construction period of major capital projects. Capitalized interest is added to the cost of the underlying assets and is amortized over the useful lives of the assets. Capitalized interest for the years ended December&#160;31, 2022, 2021 and 2020 was $3.7 million, $2.0 million and $1.4 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfNTUw_7b9bb7fb-90fd-472c-9200-c9631089700b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of gross property, plant and equipment at December 31 is presented in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected useful lives (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15-35&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds and dies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,215.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib525a96790ee419f9313dd7892b7b3dd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMS0zLTEtMS02MDI2Mw_c240af8d-7d18-46b6-8666-ff8c43d82f2a"
      unitRef="usd">29000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9b995d9f735c49ffaf75d044a0c03b66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMS01LTEtMS02MDI2Mw_526f4f79-e9b9-4ec0-8e40-04cd061ee97e"
      unitRef="usd">29300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9ad88a83c00d41a9803dfa1fd8846d50_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMi0xLTEtMS02MDI2My90ZXh0cmVnaW9uOjk4OWNiZjhlZmYyODQzMjM4NGZjMjc1ZGQ1ZjA0NWY5XzQ_784f9267-6134-4698-bcc2-4de642bf3474">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id6dfe8c8214549d598f7663164c534f1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMi0xLTEtMS02MDI2My90ZXh0cmVnaW9uOjk4OWNiZjhlZmYyODQzMjM4NGZjMjc1ZGQ1ZjA0NWY5Xzc_22953641-9bd1-4da6-83de-8b3b738f73aa">P35Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i57893ac1e0eb4f4f94c5d5b585544e57_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMi0zLTEtMS02MDI2Mw_9410276a-8881-407e-b1d6-784fd54567a2"
      unitRef="usd">663600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i867bfde87f4d49c6aa3b2e198dd30265_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMi01LTEtMS02MDI2Mw_31476866-ef62-4027-9874-45e98656b22e"
      unitRef="usd">644800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic9bad476918442d094a0b53fc624ea6b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMy0xLTEtMS02MDI2My90ZXh0cmVnaW9uOjU4MDFiOTBlYWNkYzQxZGQ5NzVhMDkxNTkyNTI3MTE0XzQ_e3d86c31-d0b4-4881-ac2c-778950df0dea">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1c3b02cc69744d1c81a95c04444728f3_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMy0xLTEtMS02MDI2My90ZXh0cmVnaW9uOjU4MDFiOTBlYWNkYzQxZGQ5NzVhMDkxNTkyNTI3MTE0Xzc_67c02208-ce8c-4c74-8581-7ffdc73e0426">P12Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6e1e4b02c23d40809d6f4748ba485f04_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMy0zLTEtMS02MDI2Mw_ac4842de-c567-455c-87c6-32285be46ecb"
      unitRef="usd">1039700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7cae435921ec4feeb1ccbe93403e73e3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfMy01LTEtMS02MDI2Mw_fb7724fa-dd09-4156-a54b-42e91141cbbf"
      unitRef="usd">976100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2fe30bc7c27942be8f272d9013b321b8_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNC0xLTEtMS02MDI2My90ZXh0cmVnaW9uOmRmYTNlODdjYjk0OTRmMTA5YmVhMDNkOGM4YWU2YTFkXzQ_7924bb1e-5052-418c-b6bd-2271b1983f3c">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia6c9307eae344809bc9eb362136f13b5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNC0xLTEtMS02MDI2My90ZXh0cmVnaW9uOmRmYTNlODdjYjk0OTRmMTA5YmVhMDNkOGM4YWU2YTFkXzc_ebc275bb-b844-4122-b27e-b5e4339a1add">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6387f13194fa4168b18b7acddc8a7e66_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNC0zLTEtMS02MDI2Mw_d4c92a73-c22b-4824-9c5c-272e3e71d936"
      unitRef="usd">154500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i12cc38a53bbb4b5dab6d38a174b78556_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNC01LTEtMS02MDI2Mw_fc2443c9-499e-4441-a792-241ff96fe24c"
      unitRef="usd">139500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if85a0ce5a6b94dad8023eed11fefec57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNS0xLTEtMS02MDI2My90ZXh0cmVnaW9uOmU5YjVjYWM0YTMzNjRhYTU4NWQ3MmY0NmY4NDY3MGE2XzQ_15a5c0af-0ec1-4b32-bdb4-d9aee8b22359">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1b1026f47645465da8f39a740c77972a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNS0xLTEtMS02MDI2My90ZXh0cmVnaW9uOmU5YjVjYWM0YTMzNjRhYTU4NWQ3MmY0NmY4NDY3MGE2Xzc_cd72eae1-f9de-4a21-b607-5670df7e7cca">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic052515f57af407a9c8ee85f261cca28_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNS0zLTEtMS02MDI2Mw_d00f2177-2bdb-4ee4-934f-5b624b5dd7ff"
      unitRef="usd">193900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i90934a86885b435589f1b238bebbd8de_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNS01LTEtMS02MDI2Mw_2f14b988-2b31-4aa2-9f41-c352a90ecb08"
      unitRef="usd">182600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i392eaf9fb1b54a2e84e87ce96d573162_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNi0zLTEtMS02MDI2Mw_2d43ea6f-2214-4648-9509-5b2e3f0cf832"
      unitRef="usd">305900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i30a3acb1630d4d42961464184cf42df9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNi01LTEtMS02MDI2Mw_1cf6a594-d6c2-4896-a8d7-af03763f4464"
      unitRef="usd">242700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNy0zLTEtMS02MDI2Mw_49e2f6b9-b617-45d1-8aaf-57b5ec1ad95b"
      unitRef="usd">2386600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RhYmxlOjY0YTZlNWFlYTViNTQ2OTk4MWFiOTg1MjE1YmIzNmYwL3RhYmxlcmFuZ2U6NjRhNmU1YWVhNWI1NDY5OTgxYWI5ODUyMTViYjM2ZjBfNy01LTEtMS02MDI2Mw_8a904b0e-ea1a-4575-9c21-45a7c912cc47"
      unitRef="usd">2215000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:Depreciation
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfMjA4_287db232-681e-4c23-a691-ce35e81463a0"
      unitRef="usd">116900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfMjEy_b84b6434-1389-4c0f-879b-538153ee6421"
      unitRef="usd">116900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfMjE5_a8902f4c-2583-448b-b13f-19b87cd4a6fd"
      unitRef="usd">104700000</us-gaap:Depreciation>
    <us-gaap:InterestCostsCapitalized
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfNTIw_bd57703a-c833-4dbd-a891-0ed2b3a3ad1d"
      unitRef="usd">3700000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfNTI0_c5b4de93-69d4-4dab-9dc2-8e16162dd86b"
      unitRef="usd">2000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185MS9mcmFnOjVjZjVkZmFiZDBhMTRmMTc4ODQzZjEwNTE0MmYzYTQ1L3RleHRyZWdpb246NWNmNWRmYWJkMGExNGYxNzg4NDNmMTA1MTQyZjNhNDVfNTMx_8dae0194-1c24-461a-91b6-5c16922aefc9"
      unitRef="usd">1400000</us-gaap:InterestCostsCapitalized>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNDU1Mg_f4829b49-fb51-4b86-a04e-dcc632f41382">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases provide us with an option, exercisable at our sole discretion, to terminate the lease or extend the lease term for one year or more. At this time, the Company is not able to assert whether any of these options will be exercised. We had no finance leases as of December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and December&#160;31, 2021, the weighted average remaining lease term for operating leases was 9.31 years and 10.7 years and the weighted average discount rate was 3.25% and 3.58%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Practical Expedients and Exemptions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected to adopt practical expedients around the combination of lease and non-lease components and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of 12 months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <wst:LesseeOperatingLeaseOptionToTerminateTerm
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNjk1_95b09907-ad25-45c9-8d7e-07d5370a8c33">P1Y</wst:LesseeOperatingLeaseOptionToTerminateTerm>
    <us-gaap:FinanceLeaseLiability
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfODEw_3bcf5a27-49b2-41b5-b652-786ed7267c06"
      unitRef="usd">0</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfODEw_89dd71bc-f671-43ae-a45e-4057e4a62e74"
      unitRef="usd">0</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNDU1Mw_f485950d-61fe-48e8-b50d-e81b1772ea45">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMS0xLTEtMS02MDI2Mw_2b254a86-f285-40e3-8189-013c70ff85af"
      unitRef="usd">15500000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMS0zLTEtMS02MDI2Mw_c48b6831-aeaf-4eed-a95a-422968e5498f"
      unitRef="usd">12700000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMS01LTEtMS02MDI2Mw_5d7037a2-9cd7-4846-ac0e-3801065a6de1"
      unitRef="usd">12800000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMi0xLTEtMS02MDI2Mw_2a082607-855a-47e0-b5eb-c9a1ed0fda47"
      unitRef="usd">1300000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMi0zLTEtMS02MDI2Mw_68e28a66-e9bc-4d42-b32b-0540831be5fe"
      unitRef="usd">1300000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMi01LTEtMS02MDI2Mw_e35cd381-27e6-43de-8490-3bfe11de4469"
      unitRef="usd">800000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMy0xLTEtMS02MDI2Mw_202e0927-270a-4f42-ab50-ac5b0ab7d8d6"
      unitRef="usd">6800000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMy0zLTEtMS02MDI2Mw_61c00cef-07c6-43d6-be3b-311f47235723"
      unitRef="usd">4800000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfMy01LTEtMS02MDI2Mw_54240934-e3f0-44b5-a1ee-4cce9c3f6f0b"
      unitRef="usd">3800000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfNC0xLTEtMS02MDI2Mw_1659f139-98ed-418f-887c-5e816ff49f8c"
      unitRef="usd">23600000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfNC0zLTEtMS02MDI2Mw_0209409d-5418-4a0f-b538-eb22b2392d0d"
      unitRef="usd">18800000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjg4ZWU2YTRkNmRjZjRmNzQ5MDM1MTljNGM2MjA4YjFmL3RhYmxlcmFuZ2U6ODhlZTZhNGQ2ZGNmNGY3NDkwMzUxOWM0YzYyMDhiMWZfNC01LTEtMS02MDI2Mw_4ce66099-e183-451e-ada3-a970d77b6743"
      unitRef="usd">17400000</us-gaap:LeaseCost>
    <wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNDU1NA_c246c6ab-15dc-48a0-9b12-d605952de778">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfMi0xLTEtMS02MDI2Mw_9bbac164-db5e-4d73-855f-96c81ccf9763"
      unitRef="usd">13300000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfMi0zLTEtMS02MDI2Mw_53fb6a8b-8dc0-4a4e-9f3c-efbb6a124e2f"
      unitRef="usd">12100000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfMi01LTEtMS02MDI2Mw_d4112fc0-09a3-4d5b-ab2a-fa666e05ab46"
      unitRef="usd">12600000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfNC0xLTEtMS02MDI2Mw_bad9e350-ae45-40ed-a79b-b1d27c680ca2"
      unitRef="usd">47600000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfNC0zLTEtMS02MDI2Mw_526b728d-4ec5-48fd-b7eb-d3c6f16183b1"
      unitRef="usd">13300000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjlkMzZiMjdlZmMxYzRkMGM4ZGZjMDcyYjkzNjU2Njc3L3RhYmxlcmFuZ2U6OWQzNmIyN2VmYzFjNGQwYzhkZmMwNzJiOTM2NTY2NzdfNC01LTEtMS02MDI2Mw_ce908111-31b2-437c-b6f2-7ce2a59bec54"
      unitRef="usd">6100000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfMzg1Mg_031e14c8-e169-499b-870b-9563013cd8f1">P9Y3M21D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfMzg2NQ_a8ab9fab-2042-43ba-8e40-8ac003799eeb">P10Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfMzkxNw_4ab84230-3a42-40eb-a624-2a9a33bc1f68"
      unitRef="number">0.0325</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfMzkyNA_c4521921-9df4-42a2-8fa7-7cf7367910c6"
      unitRef="number">0.0358</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNDU1NQ_d13110ef-1ac7-4fa8-a8f2-80253da6c703">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfMi0xLTEtMS02MDI2Mw_77be45aa-54a8-4c57-8457-a4f51185444b"
      unitRef="usd">19000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfMy0xLTEtMS02MDI2Mw_fc5aa80b-2203-4b8b-8d83-6f67556030eb"
      unitRef="usd">18100000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfNC0xLTEtMS02MDI2Mw_8ef319d4-0c31-4ff0-b9a2-cf65a38afa4c"
      unitRef="usd">16000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfNS0xLTEtMS02MDI2Mw_72499332-1e8f-4f8c-9b5d-fe6a4ee9c1e7"
      unitRef="usd">13400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfNi0xLTEtMS02MDI2Mw_2024acd5-753e-4a9b-8b05-d64ac2f1163f"
      unitRef="usd">9400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfNy0xLTEtMS02MDI2Mw_330d427d-db9d-467d-b9ce-55e244f4840d"
      unitRef="usd">50800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfOC0xLTEtMS02MDI2Mw_fabaa885-715f-4c55-9bed-1542f4324aed"
      unitRef="usd">126700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfOS0xLTEtMS02MDI2Mw_36aabffe-39cb-479c-959a-845b3f5b1374"
      unitRef="usd">17700000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RhYmxlOjAzZmM4OTFmOTcxNjRlMGQ4M2NlZmFiY2RmYWM2ZTIzL3RhYmxlcmFuZ2U6MDNmYzg5MWY5NzE2NGUwZDgzY2VmYWJjZGZhYzZlMjNfMTAtMS0xLTEtNjAyNjM_b119c6cf-1e12-4efc-9382-22c121d1ad06"
      unitRef="usd">109000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i5a0b48beb7be4ec38b7f1e3807bb5fc1_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185NC9mcmFnOjJjYzE3M2I2ZTVjNDQ3MjRhZDBmMTcwYWI5ZmQyMmY3L3RleHRyZWdpb246MmNjMTczYjZlNWM0NDcyNGFkMGYxNzBhYjlmZDIyZjdfNDQzNQ_6ab610e2-04ce-444a-9b64-9523cee0c5f6">P12M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTk1Mw_8615dd4e-5b42-4040-a5f4-d1c67f28147a">Affiliated Companies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the following affiliated companies were accounted for under the equity method:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The West Company Mexico, S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aluplast S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Tap S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Rubber S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Daikyo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unremitted income of affiliated companies included in consolidated retained earnings amounted to $133.6 million, $115.6 million and $98.2 million at December&#160;31, 2022, 2021 and 2020, respectively. Dividends received from affiliated companies were $2.6 million in 2022, $2.7 million in 2021 and $1.6 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our equity in net unrealized gains of Daikyo&#x2019;s investment securities and derivative instruments, as well as pension adjustments, included in accumulated other comprehensive loss was $1.6 million, $1.5 million and $0.6 million at December&#160;31, 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our purchases from, and royalty payments made to, affiliates totaled $167.6 million, $155.0 million and $143.3 million, respectively, in 2022, 2021 and 2020, of which $31.2 million and $25.5 million was due and payable as of December&#160;31, 2022 and 2021, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $14.2 million, $12.0 million and $9.7 million, respectively, in 2022, 2021 and 2020, of which $2.2 million and $2.3 million was receivable as of December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 and 2021, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $197.0 million and $201.2 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $7.9 million and $6.5 million, respectively. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTk1Ng_881d6876-cb63-4de2-b201-e03f6715781f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the following affiliated companies were accounted for under the equity method:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The West Company Mexico, S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aluplast S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Tap S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Rubber S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Daikyo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i83da5dac2d5b4be8a4e3cf6b667f2e1c_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RhYmxlOjI0NzZjZDMzMzhkYTQwOWRhNjQxYTNlODMwZWE5Yjc3L3RhYmxlcmFuZ2U6MjQ3NmNkMzMzOGRhNDA5ZGE2NDFhM2U4MzBlYTliNzdfMS0yLTEtMS02MDI2Mw_034aeff5-2091-4c3e-8bd5-0ee4cd1fd57f"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i03c15e3f82e14b2d8ea127a9ace71de2_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RhYmxlOjI0NzZjZDMzMzhkYTQwOWRhNjQxYTNlODMwZWE5Yjc3L3RhYmxlcmFuZ2U6MjQ3NmNkMzMzOGRhNDA5ZGE2NDFhM2U4MzBlYTliNzdfMi0yLTEtMS02MDI2Mw_4421ac54-3440-4a16-a4ab-8858016df4e8"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="id72e5e9a20f24e66a90f5ff4e835e57a_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RhYmxlOjI0NzZjZDMzMzhkYTQwOWRhNjQxYTNlODMwZWE5Yjc3L3RhYmxlcmFuZ2U6MjQ3NmNkMzMzOGRhNDA5ZGE2NDFhM2U4MzBlYTliNzdfMy0yLTEtMS02MDI2Mw_d3b3c864-2708-4638-b26e-881eb17e152d"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i3173295a48a4425dafd024e4bcaea4d0_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RhYmxlOjI0NzZjZDMzMzhkYTQwOWRhNjQxYTNlODMwZWE5Yjc3L3RhYmxlcmFuZ2U6MjQ3NmNkMzMzOGRhNDA5ZGE2NDFhM2U4MzBlYTliNzdfNC0yLTEtMS02MDI2Mw_bc94ebbc-1ac8-4305-8edf-6a3be60af47b"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie0e46db508ae452ea86af0980f1d1e00_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RhYmxlOjI0NzZjZDMzMzhkYTQwOWRhNjQxYTNlODMwZWE5Yjc3L3RhYmxlcmFuZ2U6MjQ3NmNkMzMzOGRhNDA5ZGE2NDFhM2U4MzBlYTliNzdfNS0yLTEtMS02MDI2Mw_ba3f5938-9492-46ea-9724-02d39d5e392c"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNDg0_5d599fc3-ab0c-4d00-9c32-b08101ed4db4"
      unitRef="usd">133600000</us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees>
    <us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNDg4_0daaf56c-3561-47e3-affc-47a46bee64e0"
      unitRef="usd">115600000</us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees>
    <us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
      contextRef="i1165b131d689444eb6459290c85e0fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNDk1_54998a8e-fd94-436f-ae50-5a9e872915db"
      unitRef="usd">98200000</us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNTgw_7e99cd18-d93f-42cb-b2b2-d830aec2ead3"
      unitRef="usd">2600000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNTkw_1e0123bb-bb4f-46f4-863b-291f2f70c209"
      unitRef="usd">2700000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNjAz_48c6cd0d-f697-4d42-803e-c0c0f59d9f63"
      unitRef="usd">1600000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect
      contextRef="ie0e46db508ae452ea86af0980f1d1e00_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfNzk2_60f9c182-c711-45dc-9838-f6bef709b36f"
      unitRef="usd">1600000</wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect>
    <wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect
      contextRef="ifd70574b39b442a999ec4c558f63a4fb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfODAw_87b9e08c-fdd1-470c-b53e-b6234cdb8656"
      unitRef="usd">1500000</wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect>
    <wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect
      contextRef="i93d6a4a1140d4a819a08655c97b0030c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfODA3_8cf5e025-c4cf-4be7-9fb0-f97b94bd0b58"
      unitRef="usd">600000</wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect>
    <wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfOTE2_b89d8fc6-9ced-4924-af33-699f592bf86b"
      unitRef="usd">167600000</wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees>
    <wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfOTIw_5cef63b8-289a-4db1-ad50-f146149f8fd5"
      unitRef="usd">155000000</wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees>
    <wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfOTI3_d8389268-a787-42d2-98f0-0e72d8eebcb8"
      unitRef="usd">143300000</wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees>
    <us-gaap:DueToAffiliateCurrentAndNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfOTcy_3b9cda32-bf62-4230-9f09-b8257325aacd"
      unitRef="usd">31200000</us-gaap:DueToAffiliateCurrentAndNoncurrent>
    <us-gaap:DueToAffiliateCurrentAndNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfOTc5_0293d891-d757-4966-bb6e-36debb7192d4"
      unitRef="usd">25500000</us-gaap:DueToAffiliateCurrentAndNoncurrent>
    <wst:SalesToEquityMethodInvestees
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTIwMA_50ed50d5-db6f-484d-91d9-59d9f50e8653"
      unitRef="usd">14200000</wst:SalesToEquityMethodInvestees>
    <wst:SalesToEquityMethodInvestees
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTIwNA_b182e0e0-7312-47eb-ad7c-b56e184e8e1e"
      unitRef="usd">12000000</wst:SalesToEquityMethodInvestees>
    <wst:SalesToEquityMethodInvestees
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTIxMQ_4f45ab8a-8c25-43c2-b1fe-79a1385688bd"
      unitRef="usd">9700000</wst:SalesToEquityMethodInvestees>
    <us-gaap:DueFromAffiliates
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTI1Ng_2ee6abdd-6d7d-4a72-9266-bb0446505681"
      unitRef="usd">2200000</us-gaap:DueFromAffiliates>
    <us-gaap:DueFromAffiliates
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTI2Mw_cc48cb1c-da22-441c-b510-5bfd25395d00"
      unitRef="usd">2300000</us-gaap:DueFromAffiliates>
    <us-gaap:EquityMethodInvestments
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTQ1MA_eda71417-b7a7-44c8-84ac-dfc853a68452"
      unitRef="usd">197000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTQ1Nw_24ea57ad-5bd3-4e25-a7cc-26223e4b8796"
      unitRef="usd">201200000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTYwNg_e7c33eff-23be-4a6d-b9b7-f9bbf910a189"
      unitRef="usd">7900000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY185Ny9mcmFnOmQwZWE5NzgzMjgzMjRlMmFiNzFhYzEzMTljMGU3MzAzL3RleHRyZWdpb246ZDBlYTk3ODMyODMyNGUyYWI3MWFjMTMxOWMwZTczMDNfMTYxMw_17d36e9a-0dd5-48e9-8cf0-5834f1d9590c"
      unitRef="usd">6500000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY3Ng_5c315420-57b5-4f3c-9884-7aeae4d4ae45">Goodwill and Intangible Assets&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill recorded due to acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, we had $0.1&#160;million of accumulated goodwill impairment losses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets and accumulated amortization as of December 31 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licensing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The cost basis of intangible assets includes a foreign currency translation loss of $0.9 million and $1.3 million for the years ended December&#160;31, 2022 and 2021, respectively. Amortization expense for the years ended December&#160;31, 2022, 2021 and 2020 was $3.7 million, $5.4 million and $4.4 million, respectively. Estimated annual amortization expense for the next five years is as follows: 2023 - $3.6&#160;million, 2024 - $3.6&#160;million, 2025 - $3.0&#160;million, 2026 - $2.6&#160;million and 2027 - $2.4&#160;million.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY4NQ_31bb2319-9a38-4288-b19c-16a7c293ded8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill recorded due to acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i1316e29c4d1347d282b020769df84fb7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzEtMS0xLTEtNjAyNjM_d15b2288-81a1-48d6-8c0e-d329051656c7"
      unitRef="usd">80900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i10c63b8503e64ef7aecc45e4839041ee_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzEtMy0xLTEtNjAyNjM_af03b307-f78b-4392-a365-3a53b400d814"
      unitRef="usd">30200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1165b131d689444eb6459290c85e0fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzEtNS0xLTEtNjAyNjM_24852907-0cfd-4636-ae24-4d4b8bd0e885"
      unitRef="usd">111100000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4c26cc49e6104694b627031996fac9f2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzItMS0xLTEtNjAyNjM_3881e9f0-3d7f-402b-a175-5c5c6db3559f"
      unitRef="usd">1700000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9f533fa13e604ceb9279ba3b5b3ac9c4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzItMy0xLTEtNjAyNjM_7c183f52-ba5f-4a1a-a60f-e744516be6fe"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzItNS0xLTEtNjAyNjM_d353d8f4-5df9-4ad7-b37d-fa178dc391e9"
      unitRef="usd">1700000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4c26cc49e6104694b627031996fac9f2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtMS0xLTEtNjE4ODc_231bcd3b-cb3b-4b68-9a55-57b5fd2abf87"
      unitRef="usd">100000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i9f533fa13e604ceb9279ba3b5b3ac9c4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtMy0xLTEtNjE5MjE_7f115319-5414-4b32-9894-0ad64c2d6842"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtNS0xLTEtNzA2Mzc_c882eb1f-e503-4a76-aeb3-74bb65c67650"
      unitRef="usd">100000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4c26cc49e6104694b627031996fac9f2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtMS0xLTEtNjAyNjM_927b3dba-9ed6-4177-ac23-ff0446290500"
      unitRef="usd">-2400000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i9f533fa13e604ceb9279ba3b5b3ac9c4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtMy0xLTEtNjAyNjM_19bfc636-8c88-4183-82ae-93271f708036"
      unitRef="usd">-400000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzMtNS0xLTEtNjAyNjM_06abcb7f-d35f-4d92-be0d-c151e6a37af1"
      unitRef="usd">-2800000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i7263d8dd9a4b44e0ac64eb6919dd3540_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzQtMS0xLTEtNjAyNjM_9428fc9b-8d4d-4f3f-b4df-ec321a339fa0"
      unitRef="usd">80100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i965965b0db234e199c7a370813f9bac1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzQtMy0xLTEtNjAyNjM_a38c8849-d4a8-4bca-95e5-e1045c23d165"
      unitRef="usd">29800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzQtNS0xLTEtNjAyNjM_0580bc7c-b368-4ea0-9d0a-601f5bf97144"
      unitRef="usd">109900000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5c6727e68757499781a9770aa96a5a3f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzctMS0xLTEtNjAyNjM_f027c347-6092-4e1b-8a7b-48c4c53f3932"
      unitRef="usd">-2200000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id22c437a5e7a415c8d04a385cd6d3bf3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzctMy0xLTEtNjAyNjM_1c152a18-5f4e-40af-b677-69499ab0ed4a"
      unitRef="usd">-400000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzctNS0xLTEtNjAyNjM_d1709ffe-20e9-4f71-bde5-d47758c469c9"
      unitRef="usd">-2600000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="if3a9837d9b47499480dff64b4fcb6b1d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzgtMS0xLTEtNjAyNjM_c7ca8d2f-9bdb-48b7-a51b-570549d95738"
      unitRef="usd">77900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i16e0e7a9bae54bee9c9cc1207ec4ae1b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzgtMy0xLTEtNjAyNjM_64d212e7-e85c-40b2-b159-d1663c66bccd"
      unitRef="usd">29400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZTo2Yzg4OTc3NTU5MzM0MDRkYTQ4MWQwNWZlNjQ4NzlkZS90YWJsZXJhbmdlOjZjODg5Nzc1NTkzMzQwNGRhNDgxZDA1ZmU2NDg3OWRlXzgtNS0xLTEtNjAyNjM_6863e145-dde2-4ae1-9970-43312f43056d"
      unitRef="usd">107300000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzE1Mg_c709bcc1-cc95-4201-9c3d-6a591b1da506"
      unitRef="usd">100000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY3NQ_ff72c7a7-46a6-49f8-8a22-192777275575">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets and accumulated amortization as of December 31 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licensing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i254460edc0a349ea96b0104f485aed1e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItMS0xLTEtNjAyNjM_98baa46a-e4a4-4a1c-875b-5fc1e9bc1e9d"
      unitRef="usd">24500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i254460edc0a349ea96b0104f485aed1e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItMy0xLTEtNjAyNjM_afda62a6-4d97-4621-a14c-5add709bdb37"
      unitRef="usd">20600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i254460edc0a349ea96b0104f485aed1e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItNS0xLTEtNjAyNjM_2d05c105-41c1-4499-8b6a-6e75c782d64f"
      unitRef="usd">3900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if7ef7fb4150d47649071f5f1b4f490d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItNy0xLTEtNjAyNjM_d5ea83c7-4150-4fe4-b36c-4c5acec41809"
      unitRef="usd">25100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if7ef7fb4150d47649071f5f1b4f490d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItOS0xLTEtNjAyNjM_53cc99f7-0d07-474b-9d90-e4ed97672688"
      unitRef="usd">19400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if7ef7fb4150d47649071f5f1b4f490d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzItMTEtMS0xLTYwMjYz_d1e5c44b-087c-4ff1-bb8f-44dfba47ea3a"
      unitRef="usd">5700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic17963791fc94a5d9927fcb81798188f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtMS0xLTEtNjAyNjM_7866679a-a7d9-4ea1-8d3f-b2540b7f5f7b"
      unitRef="usd">3300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic17963791fc94a5d9927fcb81798188f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtMy0xLTEtNjAyNjM_6f62ff79-b7a4-4712-b6af-7f9dfa9b1c3b"
      unitRef="usd">2200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic17963791fc94a5d9927fcb81798188f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtNS0xLTEtNjAyNjM_55376bda-c437-42a2-a24e-d81b6ed06ba3"
      unitRef="usd">1100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iadc79f5eb40040f7a6e4a72ff4148eda_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtNy0xLTEtNjAyNjM_7e2a3abe-6d1a-44a7-9054-8ed2a84e1c73"
      unitRef="usd">3300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iadc79f5eb40040f7a6e4a72ff4148eda_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtOS0xLTEtNjAyNjM_73b8ab8c-9382-4906-9df7-f12c24c82e24"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iadc79f5eb40040f7a6e4a72ff4148eda_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzMtMTEtMS0xLTYwMjYz_5ddfaed3-6a5f-4d63-a684-b1a0b387f637"
      unitRef="usd">1300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6455ee991aeb451d8b8ebd79daef0cf6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtMS0xLTEtNjAyNjM_88dc2719-1c83-4a2a-ab52-74da52fa7ba1"
      unitRef="usd">1900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6455ee991aeb451d8b8ebd79daef0cf6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtMy0xLTEtNjAyNjM_9f2cd134-8858-4989-82b9-3acf4e582b93"
      unitRef="usd">1800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6455ee991aeb451d8b8ebd79daef0cf6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtNS0xLTEtNjAyNjM_a233b6df-74d7-4243-bcf5-78cda816f96b"
      unitRef="usd">100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0a6b50bf43424e5d8f1090509ea44dcf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtNy0xLTEtNjAyNjM_d1da99c2-0c56-4adb-8462-043a610457db"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0a6b50bf43424e5d8f1090509ea44dcf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtOS0xLTEtNjAyNjM_f2af789b-7b1d-4794-9d15-52294e04cc56"
      unitRef="usd">1900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0a6b50bf43424e5d8f1090509ea44dcf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzQtMTEtMS0xLTYwMjYz_71349e28-3527-4bec-b6f5-d84905b08b98"
      unitRef="usd">100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i93f5765c9a8046e2a6369832660d3253_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtMS0xLTEtNjAyNjM_ba66580a-ab31-4799-8778-0fe2ba38d7d5"
      unitRef="usd">39600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i93f5765c9a8046e2a6369832660d3253_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtMy0xLTEtNjAyNjM_143a2ed6-a0d7-46c4-8e9b-4f1ebcd825b7"
      unitRef="usd">27200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i93f5765c9a8046e2a6369832660d3253_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtNS0xLTEtNjAyNjM_d64ce6c1-5040-4c44-bb83-fb36c023ed1b"
      unitRef="usd">12400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia52c083f2095422b99e633dfb6d9a704_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtNy0xLTEtNjAyNjM_de660d4b-020c-419e-a881-f19f912878d3"
      unitRef="usd">40100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia52c083f2095422b99e633dfb6d9a704_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtOS0xLTEtNjAyNjM_a76db902-f8a8-46bc-85ef-988fed1d0fa3"
      unitRef="usd">25400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia52c083f2095422b99e633dfb6d9a704_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzUtMTEtMS0xLTYwMjYz_5e2f082f-0c71-4ce0-93f4-4e81a229e92c"
      unitRef="usd">14700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if7ccb1f26a7b415b99d59d04309e91b2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtMS0xLTEtNjAyNjM_b5d25b5b-222b-4ac1-b0a7-c8e78db2fca0"
      unitRef="usd">10900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if7ccb1f26a7b415b99d59d04309e91b2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtMy0xLTEtNjAyNjM_82479573-0c1a-4c26-b4d8-098e38fd68d9"
      unitRef="usd">10000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if7ccb1f26a7b415b99d59d04309e91b2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtNS0xLTEtNjAyNjM_55a6348d-f728-444c-87c1-5ac660e62cba"
      unitRef="usd">900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7e1c2074501a4c8e904e282823fdb207_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtNy0xLTEtNjAyNjM_4ed954bc-38b7-4676-85c4-e63176aadeed"
      unitRef="usd">10600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e1c2074501a4c8e904e282823fdb207_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtOS0xLTEtNjAyNjM_51b799b9-fc16-42e6-84fc-c6ed4989d783"
      unitRef="usd">9400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7e1c2074501a4c8e904e282823fdb207_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzYtMTEtMS0xLTYwMjYz_d5f10b9c-f310-4bb4-a346-0d00837654e1"
      unitRef="usd">1200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctMS0xLTEtNjAyNjM_acd851e5-9676-4d00-933f-3e08a3f451c7"
      unitRef="usd">80200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctMy0xLTEtNjAyNjM_e30f227e-4de7-40e1-ba56-4c53e3eb66e1"
      unitRef="usd">61800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctNS0xLTEtNjAyNjM_a24538ff-4b95-4e9d-b690-a9dc4cd4688a"
      unitRef="usd">18400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctNy0xLTEtNjAyNjM_086c3fc7-50fc-4cc4-972f-ec6cf2710c30"
      unitRef="usd">81100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctOS0xLTEtNjAyNjM_5d4632a0-e83b-408d-8a32-fa22f4162c7f"
      unitRef="usd">58100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90YWJsZToyYmUzNTU2YmFlMzI0OGI2ODFmMThkYzc4YmRlNjE5YS90YWJsZXJhbmdlOjJiZTM1NTZiYWUzMjQ4YjY4MWYxOGRjNzhiZGU2MTlhXzctMTEtMS0xLTYwMjYz_04f62d23-d8b9-4fd0-b9ef-2c7ffaa98199"
      unitRef="usd">23000000.0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzM2Ng_cad79b69-18bd-494b-bc41-b98c0fcfa31b"
      unitRef="usd">-900000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzQxMA_c22b5342-e686-487f-9c84-987f93b43669"
      unitRef="usd">-1300000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzUxNw_d562f728-4522-4f71-8223-332de1e812c4"
      unitRef="usd">3700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzUyMQ_f9977536-dfa6-4bce-b44e-74e665870540"
      unitRef="usd">5400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzUyOA_72bd794a-eef1-41f4-8226-d30df1a8aabd"
      unitRef="usd">4400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzYyOA_5b50aabe-41fc-433f-b1f5-bae2ea35ffea"
      unitRef="usd">3600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzYzNw_0bc58f3b-41e1-4ab9-bb49-13b8d134f427"
      unitRef="usd">3600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY0Ng_5419b227-8427-4453-99ad-3691c0d13dbe"
      unitRef="usd">3000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY1NQ_900d22a0-293e-4502-8c1b-279697e8845d"
      unitRef="usd">2600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDAvZnJhZzozMjQ0MmU5NjY1Y2Y0NjUxODYxZWY5MzlkNWZhOWRlNi90ZXh0cmVnaW9uOjMyNDQyZTk2NjVjZjQ2NTE4NjFlZjkzOWQ1ZmE5ZGU2XzY2Nw_804c71f0-60fb-46cb-b613-54e04a0989ed"
      unitRef="usd">2400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90ZXh0cmVnaW9uOmNhMTE3Y2UzNmJmNzQ1MWVhYmIzNmExYTA3MWZjMWVjXzEyMQ_ea4108e5-8b53-4f79-b802-b88a456733c5">Other Current Liabilities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities as of December 31 included the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued commissions, rebates and royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued retirement plans (excluding pension)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes other than income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and severance related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90ZXh0cmVnaW9uOmNhMTE3Y2UzNmJmNzQ1MWVhYmIzNmExYTA3MWZjMWVjXzExMg_885eb8d1-fcdb-4f20-b104-6ef481191236">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities as of December 31 included the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued commissions, rebates and royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued retirement plans (excluding pension)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes other than income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and severance related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzEtMS0xLTEtNjAyNjM_c6b6835c-88b0-463c-9dac-b1301539d8fd"
      unitRef="usd">57300000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzEtMy0xLTEtNjAyNjM_f8bc2d6d-be2c-403d-b8f7-e5640c9781e3"
      unitRef="usd">48700000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzItMS0xLTEtNjAyNjM_06979366-4617-4ce8-91cc-b445240bff44"
      unitRef="usd">14100000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzItMy0xLTEtNjAyNjM_24c98969-cab9-48a0-9702-62b522377a62"
      unitRef="usd">13400000</us-gaap:DividendsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzMtMS0xLTEtNjAyNjM_b8a4df02-ab5b-4048-9fe7-231e18c2214c"
      unitRef="usd">32100000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzMtMy0xLTEtNjAyNjM_fba6c340-beb3-454b-bcbd-6beabc2e00e7"
      unitRef="usd">38700000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzQtMS0xLTEtNjAyNjM_a50ee23b-491d-434b-8132-08fcc5bb2502"
      unitRef="usd">10600000</us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent>
    <us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzQtMy0xLTEtNjAyNjM_d470f59e-e97b-4d2e-85f7-749c96e27461"
      unitRef="usd">8800000</us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzUtMS0xLTEtNjAyNjM_e82b3380-48e9-45e1-a53a-46411df01bf5"
      unitRef="usd">13700000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzUtMy0xLTEtNjAyNjM_9ed8db70-2065-4f87-9651-8b2858fa1c2f"
      unitRef="usd">13000000.0</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzYtMS0xLTEtNjAyNjM_e734ab00-29df-4b66-9dd1-a9cef021e3ed"
      unitRef="usd">5400000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzYtMy0xLTEtNjAyNjM_958891c8-71b7-4406-b85b-e5da251e0d05"
      unitRef="usd">3700000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzctMS0xLTEtNjAyNjM_6776c70e-ebd3-48d6-bc3c-c84172624ab6"
      unitRef="usd">2500000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzctMy0xLTEtNjAyNjM_78bf946f-2617-4b7b-b3b6-b2be6b97c4a1"
      unitRef="usd">3200000</us-gaap:InterestPayableCurrent>
    <us-gaap:RestructuringReserve
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzgtMS0xLTEtNjAyNjM_5bea443e-05cb-4876-a344-7a43190cfff3"
      unitRef="usd">11300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzgtMy0xLTEtNjAyNjM_9d7bac88-19ec-4af0-91f1-2112f2685330"
      unitRef="usd">4600000</us-gaap:RestructuringReserve>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzktMS0xLTEtNjAyNjM_d764bf35-5018-4579-b561-652d22cc45c4"
      unitRef="usd">1300000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzktMy0xLTEtNjAyNjM_df9a0c8f-e0af-4ac5-8cf4-3f07fee30a20"
      unitRef="usd">3300000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzEwLTEtMS0xLTYwMjYz_fcc3a755-4ccd-4812-9f91-f214ccf30e42"
      unitRef="usd">33400000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzEwLTMtMS0xLTYwMjYz_cd96cbc3-9810-402c-a587-f237720123c2"
      unitRef="usd">26000000.0</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzExLTEtMS0xLTYwMjYz_451af49d-9f7b-4362-b146-6353b939e683"
      unitRef="usd">181700000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDMvZnJhZzpjYTExN2NlMzZiZjc0NTFlYWJiMzZhMWEwNzFmYzFlYy90YWJsZTo2MjM3YmYwNTUzNzM0MTA4YjAzZmZkY2IwMGNhMjJiYy90YWJsZXJhbmdlOjYyMzdiZjA1NTM3MzQxMDhiMDNmZmRjYjAwY2EyMmJjXzExLTMtMS0xLTYwMjYz_4d365a10-747f-4633-b698-3a2c458c154f"
      unitRef="usd">163400000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0NzQ_285b7039-ee53-4100-a812-63507b137f1b">Debt&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2022 with the exception of the Series A notes which are as of December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, due December 31, 2024 (5.56%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A notes, due July 5, 2022 (3.67%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B notes, due July 5, 2024 (3.82%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C notes, due July 5, 2027 (4.02%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs for Term Loan and Series notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, we amended and extended the existing credit facility (entered into in March 2019), which was scheduled to expire in March 2024, from $300.0&#160;million to a $500.0&#160;million senior unsecured revolving credit facility by entering into a Second Amendment and Joinder and Assumption Agreement (the "Amended Credit Agreement"). The Amended Credit Agreement, which expires March 2027, contains a senior unsecured, multi-currency revolving credit facility of $500.0&#160;million, with sublimits of up to $50.0&#160;million for swing line loans for Domestic Borrowers in U.S. dollars and a $40.0&#160;million swing line loan for West Pharmaceuticals Services Holding GmbH and up to $50.0&#160;million for the issuance of standby letters of credit. The credit facility may be increased from time-to-time by the greater of (a) $929.0&#160;million or (b) EBITDA for the preceding twelve month period in the aggregate through an increase in the revolving credit facility, subject to the satisfaction of certain conditions. Borrowings under the credit facility bear interest, at the Company&#x2019;s option, at either: (a) the Term Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) plus 0.10% plus an applicable margin; or (b) a base rate defined as the highest of: (i) the Bank of America &#x201c;prime rate&#x201d;; (ii) the Federal Funds effective rate plus 0.50%; and (iii) Term SOFR plus 1.00%. The applicable margin is based on the ratio of the Company&#x2019;s Net Consolidated Debt to its modified EBITDA, ranging from 0 to 37.5 basis points for base rate loans and 87.5 to 137.5 basis points for Term SOFR loans. The Amended Credit Agreement contains financial covenants providing that the Company shall not permit the ratio of the Company&#x2019;s Net Consolidated Debt to its Modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Amended Credit Agreement, upon the occurrence of a Qualified Acquisition for each of the four fiscal quarters of the Company immediately following such Qualified Acquisition, the ratio set forth above shall be increased to 4.0 to 1. The Amended Credit Agreement also contains customary limitations on liens securing indebtedness of the Company and its subsidiaries, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of December&#160;31, 2022 and 2021, total unamortized debt issuance costs of $1.3&#160;million and $0.1&#160;million, respectively, were recorded in other current assets and other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had no outstanding borrowings under the Credit Facility. At December&#160;31, 2022, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $2.4 million, was $497.6 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Term Loan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, we entered into a First Amendment and Incremental Facility Amendment (the &#x201c;First Amendment&#x201d;) to the Credit Agreement. Pursuant to the First Amendment and the Credit Agreement, we established the Term Loan in the amount of $90.0&#160;million, which is due on December 31, 2024. Borrowings under the Term Loan bear interest at the three-month Term SOFR plus 87.5 basis points. As of December&#160;31, 2022 and 2021, there were unamortized debt issuance costs remaining of $0.1&#160;million and $0.1&#160;million, respectively, which are being amortized as additional interest expense over the term of the Term Loan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;At December&#160;31, 2022, we had $83.2&#160;million in borrowings under the Term Loan, of which $2.2&#160;million was classified as current and $81.0&#160;million was classified as long-term. Please refer to Note 11, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"&gt;Derivative Financial Instruments&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, for a discussion of the foreign currency hedge associated with the Term Loan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Private Placement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, we concluded a private placement issuance of $168.0 million in senior unsecured notes. The total amount of the private placement issuance was divided into three tranches - $42.0 million 3.67% Series A Notes due July 5, 2022, $53.0 million 3.82% Series B Notes due July 5, 2024, and $73.0 million 4.02% Series C Notes due July 5, 2027 (the &#x201c;Notes&#x201d;). The Notes rank pari passu with our other senior unsecured debt. The weighted average of the coupon interest rates on the Notes outstanding as of December&#160;31, 2022 is 3.94%. As of December&#160;31, 2022 and 2021, there were unamortized debt issuance costs remaining of $0.2&#160;million and $0.3&#160;million, respectively, which are being amortized as additional interest expense over the term of the Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Covenants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2022, we were in compliance with all of our debt covenants. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest costs incurred during 2022, 2021 and 2020 were $11.6 million, $10.2 million and $9.6 million, respectively. The aggregate annual maturities of long-term debt, excluding unamortized debt issuance costs, are as follows: $2.2 million in 2023, 2024 - $134.0 million, 2025 - $0.0 million, 2026 - $0.0 million, 2027 - $73.0 million, and thereafter - $0.0 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0NTg_31ba6c07-0423-42c8-b1d0-97a8719439ff">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2022 with the exception of the Series A notes which are as of December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, due December 31, 2024 (5.56%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A notes, due July 5, 2022 (3.67%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B notes, due July 5, 2024 (3.82%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C notes, due July 5, 2027 (4.02%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs for Term Loan and Series notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5c253265028c4a42abd68ab7456d94f4_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzYtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpmMmY2MzIxNjA1ODY0MTIxODE4ZDAyMTY3ZGJmN2FmZl8zOA_a050a4ca-ef6d-4596-a502-c54e01dd8f99"
      unitRef="number">0.0556</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5c253265028c4a42abd68ab7456d94f4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzYtMS0xLTEtNjAyNjM_b58d1e5b-1013-45e5-b1f5-f7adb93a30ae"
      unitRef="usd">83200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iacbba1511dcd486088f2748d91395b33_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzYtMy0xLTEtNjAyNjM_207fbfc4-05c5-488b-8825-1621794899f5"
      unitRef="usd">85500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0cd10fbd48944499bd3e75624d39e738_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzctMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkZjM2ZjkxZmY0Y2Q0OTdkOGM4MzU1MGM4NzEyMmFiNF8zOA_05ebfe2c-fd58-4b3a-a57c-560b5ad2bb6c"
      unitRef="number">0.0367</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0cd10fbd48944499bd3e75624d39e738_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzctMS0xLTEtNjAyNjM_e8384199-48d8-495b-9cd9-751cbfe156e3"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id63066ad3a37405a9157d08cee024b89_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzctMy0xLTEtNjAyNjM_8997d9b3-a0e9-40c8-b4c5-e6ae1667f92d"
      unitRef="usd">42000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i59b3a686792245fba4c1cd0fdbe993ad_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzgtMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjphNmZkYmQzNWRiNDY0ODFiOWY1OTUzN2IzMWQ2NzcwYl8zOA_6fa562e3-fb2c-40b2-961d-7d1f49f5e8bd"
      unitRef="number">0.0382</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i59b3a686792245fba4c1cd0fdbe993ad_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzgtMS0xLTEtNjAyNjM_7af9a59c-a02b-4f5b-af43-ce6bfa069c5f"
      unitRef="usd">53000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i978162754bb545bf8cc52ff142f514e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzgtMy0xLTEtNjAyNjM_c2d74216-d639-47dd-816f-4881e4f69dcc"
      unitRef="usd">53000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id421927f2814464886c6dde31c2e17a1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzktMC0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo2MmVjNGUwMTU0MmE0MWNkYWQyMGQ5ZTA4OGYzOTU3ZF8zOA_3aa688e4-b878-4f73-aef1-99ea9e4dd447"
      unitRef="number">0.0402</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id421927f2814464886c6dde31c2e17a1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzktMS0xLTEtNjAyNjM_b5a04c46-aea3-4fb6-b2b0-cf73342dc004"
      unitRef="usd">73000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie263faaeca58416a9df1dabac7a4b51c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzktMy0xLTEtNjAyNjM_f6f94168-dd9d-431f-894f-03bb96f112ac"
      unitRef="usd">73000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEwLTEtMS0xLTYwMjYz_e571525b-b788-4026-b5ef-852c9c227e56"
      unitRef="usd">209200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEwLTMtMS0xLTYwMjYz_eaa4e9db-f4eb-4dda-995f-7b4de98ec684"
      unitRef="usd">253500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzExLTEtMS0xLTYwMjYz_a0cfb206-5a25-4d42-8a49-795b5173f5b5"
      unitRef="usd">300000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzExLTMtMS0xLTYwMjYz_743952df-0f67-4f2f-85d3-0d9a61ccae19"
      unitRef="usd">500000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebt
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEyLTEtMS0xLTYwMjYz_a26e7eeb-be78-4dce-b158-56a2d4da3b4e"
      unitRef="usd">208900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEyLTMtMS0xLTYwMjYz_bdab3c61-f7a1-47d5-ae69-126ac8ec6c98"
      unitRef="usd">253000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEzLTEtMS0xLTYwMjYz_ef56aa48-e564-4519-aa7b-0181de684afc"
      unitRef="usd">2200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzEzLTMtMS0xLTYwMjYz_397ca5a3-fa05-47d0-a880-b2da34be2a55"
      unitRef="usd">44200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzE0LTEtMS0xLTYwMjYz_9f601cdf-a3a2-4101-8a5e-f306d859368e"
      unitRef="usd">206700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90YWJsZTowMTRkOTMxNjhkYWM0ODgxYjYwZTExZjc0OTRkMDk5Yy90YWJsZXJhbmdlOjAxNGQ5MzE2OGRhYzQ4ODFiNjBlMTFmNzQ5NGQwOTljXzE0LTMtMS0xLTYwMjYz_cd6bcd95-63af-48bb-8a24-bf41f244b613"
      unitRef="usd">208800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i7fb1cd1161ef428f901886b8f8bfae4d_I20220228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjQzMA_a4e9d321-0687-4ed1-a67d-03c892b5c0a3"
      unitRef="usd">300000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i9433ad101e0f40c6a59795056c11ca8d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjQ2MQ_dcb05886-4dcc-4c35-8132-d37d08c55bac"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i9433ad101e0f40c6a59795056c11ca8d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjQ5Mg_e36ea276-5204-4621-884f-f863a8176c2c"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <wst:CreditFacilityIsAvailableForSwingLineLoans
      contextRef="i9775d568a3404cfcb4de79a3df989730_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjUyMg_5b3fe981-931e-4849-ab7a-110b797f8978"
      unitRef="usd">50000000</wst:CreditFacilityIsAvailableForSwingLineLoans>
    <wst:CreditFacilityIsAvailableForSwingLineLoans
      contextRef="ieef415446df24387a2f0b94ff7a58e73_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjU1MQ_9834819e-6c87-4a39-8e4b-eeaa37110ad7"
      unitRef="usd">40000000</wst:CreditFacilityIsAvailableForSwingLineLoans>
    <wst:CreditAvailableForTheIssuanceOfLettersOfCredit
      contextRef="i9433ad101e0f40c6a59795056c11ca8d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjU4MA_9da7a7f5-3485-4945-a991-03298993df21"
      unitRef="usd">50000000</wst:CreditAvailableForTheIssuanceOfLettersOfCredit>
    <wst:LineOfCreditFacilityAdditionalBorrowingCapacity
      contextRef="i9433ad101e0f40c6a59795056c11ca8d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjYxMA_94ad247c-520b-4d00-bd8e-e5ff66a545f2"
      unitRef="usd">929000000</wst:LineOfCreditFacilityAdditionalBorrowingCapacity>
    <wst:DebtInstrumentIncreaseInFacilityPrecedingPeriod
      contextRef="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzgyNDYzMzcyMTcxODE_b5b54302-6e89-4c1d-896b-4a59cd19a5a8">P12M</wst:DebtInstrumentIncreaseInFacilityPrecedingPeriod>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if20cb8b7f73343e0b4d7df1ab5592c7f_D20220301-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY0MA_f86959e6-1613-4266-bfdb-b27ef2c906bb"
      unitRef="number">0.0010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i39fe04778e964e42b69b3e3667134afb_D20220301-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY1Mw_b25620d9-1f4d-42f0-b5cd-34a232847ac2"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8a3f65e2339e46edbd122c6a7e88c734_D20220301-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY2Ng_3058aa24-700f-4063-a052-84dc76a201a9"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <wst:DebtInstrumentApplicableMarginRatio
      contextRef="i3968429e781944ff917fa69ee5084d06_D20220301-20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY3NQ_d3fae930-3b7a-406f-8bae-eece700e488a"
      unitRef="number">0</wst:DebtInstrumentApplicableMarginRatio>
    <wst:DebtInstrumentApplicableMarginRatio
      contextRef="ie9412b7a71714bc19162384ec914aec4_D20220301-20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY4Mw_23e603b2-4be3-47c4-95ee-0da574d91dc7"
      unitRef="number">0.00375</wst:DebtInstrumentApplicableMarginRatio>
    <wst:DebtInstrumentApplicableMarginRatio
      contextRef="i17f90a6dc27944f087b669925f30371f_D20220301-20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjY5NA_7deb2ef1-00ea-4480-963d-4d967d338a04"
      unitRef="number">0.00875</wst:DebtInstrumentApplicableMarginRatio>
    <wst:DebtInstrumentApplicableMarginRatio
      contextRef="i14dd74ecfac74fa98fbdb00352369007_D20220301-20220331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjcwNg_4a12ad68-2ceb-4d68-b7d5-71bc511b7d7e"
      unitRef="number">0.01375</wst:DebtInstrumentApplicableMarginRatio>
    <wst:DebtInstrumentRatioOfDebtToEBITDA
      contextRef="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjcxNw_e71d10a7-c9ba-4942-a695-968448598f00"
      unitRef="number">3.5</wst:DebtInstrumentRatioOfDebtToEBITDA>
    <wst:DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded
      contextRef="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjczMA_586a7291-5abd-4510-810a-f237d9307d70"
      unitRef="instance">3</wst:DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded>
    <wst:DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition
      contextRef="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjczNg_07b52159-6387-4523-8cc3-68d207d68ad1"
      unitRef="fiscal_quarter">4</wst:DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition>
    <wst:DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition
      contextRef="idf971d508b664c409f75fc5ac4b4bf57_D20220301-20220331"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzU0OTc1NTgyMjc0Mg_b877d114-fc6a-4026-a8d6-7a41e32ad945"
      unitRef="number">4.0</wst:DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment
      contextRef="i34794d2072c74e28898377fb07301721_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzIwMTQ_eaaf42f1-a37d-48fc-ac47-c5db39410543"
      unitRef="usd">1300000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment
      contextRef="ia9e4ff52db72474081a077b4a2d8bf8a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzIwMjE_948b173c-2274-4e1c-9e9c-a21f8f9b734f"
      unitRef="usd">100000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment>
    <us-gaap:LongTermLineOfCredit
      contextRef="ic2c00c7463cf41a9988d6d2571c4a4e9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzIxODk_01d03abe-4c0e-4092-953d-909fd0fb8ebf"
      unitRef="usd">0</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i36a6e77fe574426b8c780aa1e3956660_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzIzNTI_284c2f15-cc6b-4578-a139-20aa6a0e0923"
      unitRef="usd">2400000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="ic2c00c7463cf41a9988d6d2571c4a4e9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzIzNjA_2c0db4d1-7bd0-4749-917b-ed687b48cbb4"
      unitRef="usd">497600000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib39e812e09a44972bf2c8d2ad05b403e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzI2NDY_d21bacda-d4db-4af7-a796-54cf1ba5e53e"
      unitRef="usd">90000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icf787da5fc004530a7921f12a8628daa_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzI3NjA_f7e8f60b-3bc6-4a37-8161-f4dbb87f38b7"
      unitRef="number">0.875</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment
      contextRef="ie3a2571be15e4bbaa4802e0b11fe9e86_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzI4NTA_a21b81ef-766b-473f-b1b6-2003c8518b99"
      unitRef="usd">100000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment
      contextRef="i861ad8987fa54c699465cafe8d5b03b7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzI4NTc_5db58576-157b-4f80-ab6a-f5b579aa0d0d"
      unitRef="usd">100000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5c253265028c4a42abd68ab7456d94f4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzI5Nzk_a6d51983-4d05-4425-9820-8f2cdbe87b5e"
      unitRef="usd">83200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5c253265028c4a42abd68ab7456d94f4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzMwMjY_a08b7994-8c1f-4cdd-891c-ef68266f2e62"
      unitRef="usd">2200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5c253265028c4a42abd68ab7456d94f4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzMwNTk_2bfc126f-241c-4791-a5f3-2bccb5e9e383"
      unitRef="usd">81000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i656ea7823b914cb681c9f806732bce7f_I20121231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzMzMDI_68dffc6d-b41f-4c88-8d52-353b3953738d"
      unitRef="usd">168000000</us-gaap:DebtInstrumentFaceAmount>
    <wst:DebtInstrumentNumberOfTranches
      contextRef="iad4b14762f724836912187aa55021fd3_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0MDA_ce47e0aa-ff06-4528-9ddc-1a73ce355e4e"
      unitRef="tranche">3</wst:DebtInstrumentNumberOfTranches>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i34909e1b0bb641229424ae8dea78f236_I20121231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0MTQ_969ccb11-70ed-458d-b5a7-1560f2009f8b"
      unitRef="usd">42000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i34909e1b0bb641229424ae8dea78f236_I20121231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0MTc_494109b7-ad92-43b6-9829-05d452ffec8e"
      unitRef="number">0.0367</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2bdb4dd782f5429cae42770030a9c63e_I20121231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0NDM_6c875fb1-5da3-4fe4-9578-7a9c71a2d734"
      unitRef="usd">53000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2bdb4dd782f5429cae42770030a9c63e_I20121231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0NDY_03dbb4c2-8e44-4f64-855e-d8cc91c0e223"
      unitRef="number">0.0382</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i63e7117f5e6c48e3bc16493062149b41_I20121231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0NzY_cd7cba2d-fb93-40ce-9b26-57757ef1777e"
      unitRef="usd">73000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i63e7117f5e6c48e3bc16493062149b41_I20121231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM0Nzk_9560f5a9-8189-4979-8d7e-a86956469a65"
      unitRef="number">0.0402</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i656ea7823b914cb681c9f806732bce7f_I20121231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM2NDk_31334534-0afa-4501-ad7b-ae77633a387b"
      unitRef="number">0.0394</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i5f365909be2c4a33b9535d9625359634_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM3MjY_a9d6fe4b-85ef-4bed-97f1-ee036dbd91cc"
      unitRef="usd">200000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ieb457474142548ada94572d36284f1aa_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzM3MzM_7847f27e-368c-4a19-b8a2-eee763cbbccc"
      unitRef="usd">300000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQyNTM_49ad84ba-f54d-43af-bd7e-3f48cf29f807"
      unitRef="usd">11600000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQyNTc_e3791735-4e37-4465-9394-aa167bd48782"
      unitRef="usd">10200000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQyNjQ_55bc5005-b015-49f9-813d-7140cad4c0d2"
      unitRef="usd">9600000</us-gaap:InterestExpenseDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQzOTI_ec98b1aa-6a9f-431f-9f59-3b36eb2f1cf1"
      unitRef="usd">2200000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0MDc_9625cfb7-f770-4d13-91b2-e4e812da100d"
      unitRef="usd">134000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0MTY_e76bd1d8-0c7f-4112-8115-087e88e81bb3"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0MjU_4b49875b-2357-45ab-839e-bf9f46e01062"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0MzQ_26386afe-9b78-450e-9f15-11359fa2044a"
      unitRef="usd">73000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDYvZnJhZzoyYzgzNTU0ZWZhMDQ0MjlkOWYzNTlmN2YwNzA4MTE1MS90ZXh0cmVnaW9uOjJjODM1NTRlZmEwNDQyOWQ5ZjM1OWY3ZjA3MDgxMTUxXzQ0NTU_a51e8149-a38a-4233-b6b0-f89bb2691b45"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQ4Mjc_7d6e1f1e-8822-4bb1-96d9-dba8c26fcaca">Derivative Financial Instruments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Exchange Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2022 and December&#160;31, 2021, the total amount of these forward exchange contracts was Singapore Dollar ("SGD") 601.5 million and $13.4 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of December&#160;31, 2022, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,123.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SGD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Japanese Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as cumulative translation adjustments within accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, we entered into a five-year floating-to-floating forward-starting cross-currency swap (the &#x201c;cross-currency swap&#x201d;) for $90&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#xa5;9.1&#160;billion ($83.2&#160;million) as of December&#160;31, 2022. Under the cross-currency swap, we receive floating interest rate payments based on USD compounded SOFR plus a margin, in return for paying floating interest rate payments based on Japanese Yen ("Yen") Tokyo Overnight Average Rate ("TONAR") plus a margin. In addition, we receive periodic fixed payments of USD in return for paying fixed principal payments of Yen.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Commodity Price Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From November 2017 through December 2022, we purchased several series of call options for a total of 867,500 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, we had outstanding contracts to purchase 258,597 barrels of crude oil from December 2022 to September 2024, at a weighted-average strike price of $108.28 per barrel.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Effects of Derivative Instruments on Financial Position and Results of Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please refer to Note 12, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for the balance sheet location and fair values of our derivative instruments as of December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged item (intercompany loan)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative designated as hedging instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge. The amounts recognized in earnings, pre-tax, for forward point components for the years ended December&#160;31, 2022, 2021 and 2020 were $4.0 million, $2.6 million and $6.3 million, respectively. We expect to recognize $3.2 million in earnings, pre-tax, for forward point components in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts (hedges of net sales)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts (hedges of cost of goods and services sold)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to the above table which summarizes the effects of derivative instruments designated as fair value hedges within the other expense (income) line in our consolidated statements of income for the years ended December 31. The following table summarizes the effects of derivative instruments designated as cash flow and net investment hedges by line item in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022 and 2021, there was no material ineffectiveness related to our hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5d646a9b7feb4e40a68f41f454b189df_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0Xzk1NQ_f7766175-871c-4f91-8541-706d751cc61f"
      unitRef="sgd">601500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i569a84a1b6044847a369af6d7becda42_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0Xzk2Mg_b545c7ef-a845-4e60-8a6b-71c623cf498e"
      unitRef="usd">13400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeTermOfContract
      contextRef="i33954585607a418e8de125d8e2ad1f27_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzEwOTE_d21e9bd7-7409-4b33-9353-c76c37e9f655">P18M</us-gaap:DerivativeTermOfContract>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQ4MTc_c0c4898b-c7c2-4a48-af3f-ccd8cb68833d">As of December&#160;31, 2022, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,123.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SGD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9b6ff425fe5240119fb6fedfde9e6e41_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzItMS0xLTEtNjAyNjM_969542fe-ced8-431f-8290-261ddf210757"
      unitRef="usd">1700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i32dd3ce056004fa288d5cd8119b7d251_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzItMy0xLTEtNjAyNjM_e76669b2-53e1-4745-87fe-2185b181bb56"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i32dd3ce056004fa288d5cd8119b7d251_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzItNC0xLTEtNjAyNjM_5c22dbb4-5551-40df-bd8c-f480842db9be"
      unitRef="eur">1200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i171c812bedd448199594f8cbe21f5215_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzMtMS0xLTEtNjAyNjM_961e1fd7-7fac-46d4-b80e-1af984b37da9"
      unitRef="jpy">6123600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i43ec8e1a30c24bba9c86e74b4d8c13f9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzMtMy0xLTEtNjAyNjM_50b37af8-ace8-4801-b9e9-8066d980f615"
      unitRef="usd">31000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i43ec8e1a30c24bba9c86e74b4d8c13f9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzMtNC0xLTEtNjAyNjM_0b79f215-fd0e-4f7f-ae9c-9952dfc4eede"
      unitRef="eur">15000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i05eec46fb5e34fe797afbe0315ba7370_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzQtMS0xLTEtNjAyNjM_2130cbe7-3975-43b7-9031-9e6546d80388"
      unitRef="sgd">62800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia2d66ee6c4f140c5ad3cd9497de7f00a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzQtMy0xLTEtNjAyNjM_06c97741-bdd1-4dc4-a2ed-ff80e64dca99"
      unitRef="usd">21100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia2d66ee6c4f140c5ad3cd9497de7f00a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTo3MDE1MzEzMTEyYmY0ZGNjOTA3Y2QzMzQyNGQyNGZjOS90YWJsZXJhbmdlOjcwMTUzMTMxMTJiZjRkY2M5MDdjZDMzNDI0ZDI0ZmM5XzQtNC0xLTEtNjAyNjM_70470dfc-ff79-4fa2-9fea-3dc3623aac4f"
      unitRef="eur">23500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeTermOfContract
      contextRef="i07c6df090c7a49f4ae2283e42ca80a22_D20191201-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQ4NDY_2ef4f1bb-e2ae-4741-90ae-7faf3d46931f">P5Y</us-gaap:DerivativeTermOfContract>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7adb9161e9af4809af615f27c957ccf7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzIxMDU_ab317b7c-8a00-4754-aab4-eb317a89f2b6"
      unitRef="usd">90000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i647595866ae94d7883d164c13e7576df_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzIyMjM_1baa79f6-0748-4d45-8ca8-6d287b93e6bd"
      unitRef="jpy">9100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i647595866ae94d7883d164c13e7576df_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzIyMjc_02b51888-da2e-4fba-b5ce-211d05ce196a"
      unitRef="usd">83200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNonmonetaryNotionalAmountVolume
      contextRef="i1717cad3ed8747cfb39d9d04479a590c_D20171101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzMwNDY_f44ad468-ee80-44a8-ab80-b95ecbde3d7f"
      unitRef="bbl">867500</us-gaap:DerivativeNonmonetaryNotionalAmountVolume>
    <us-gaap:DerivativeNonmonetaryNotionalAmount
      contextRef="icd338cc8a5fe470590598ff0e2475ae0_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzMyNzQ_3c614552-3bff-43b5-a89a-79e008d38cb6"
      unitRef="bbl">258597</us-gaap:DerivativeNonmonetaryNotionalAmount>
    <us-gaap:DerivativeAveragePriceRiskOptionStrikePrice
      contextRef="icd338cc8a5fe470590598ff0e2475ae0_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzMzNTc_802a73ac-557a-468e-be4c-f87aa48f2bcb"
      unitRef="usdPerBbl">108.28</us-gaap:DerivativeAveragePriceRiskOptionStrikePrice>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQ4MjY_2a4f4961-5257-4095-abe0-f1eccc6650c4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged item (intercompany loan)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative designated as hedging instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts (hedges of net sales)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts (hedges of cost of goods and services sold)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table summarizes the effects of derivative instruments designated as cash flow and net investment hedges by line item in our consolidated statements of income for the years ended December 31:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="id784d712d09342aebd7b7dfe678f761b_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzMtMS0xLTEtNjAyNjM_0b8be09f-2a83-4919-991d-21b8f4d98f98"
      unitRef="usd">28300000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i8a46826c2684460eb4fbb56df6e8152a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzMtMy0xLTEtNjAyNjM_bb18b513-e6c4-4ac9-b745-56a5a1b8c586"
      unitRef="usd">22100000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i3c00e1dadfb14a658cb637483c6837c2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzMtNS0xLTEtNjAyNjM_6b843f90-3d2d-41f4-9dbf-50ad48e518d4"
      unitRef="usd">-28500000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="id784d712d09342aebd7b7dfe678f761b_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzQtMS0xLTEtNjAyNjM_2238b083-d553-42a8-a1f9-5e13411f5db5"
      unitRef="usd">-28300000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="i8a46826c2684460eb4fbb56df6e8152a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzQtMy0xLTEtNjAyNjM_c391173a-6a31-4bc7-9428-88cce357259c"
      unitRef="usd">-22100000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="i3c00e1dadfb14a658cb637483c6837c2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzQtNS0xLTEtNjAyNjM_c3a72195-35ac-4a67-9ff2-74f16ae812a9"
      unitRef="usd">28500000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="id784d712d09342aebd7b7dfe678f761b_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzUtMS0xLTEtNjAyNjM_d48baab1-23f7-4b48-8934-468fdea576e6"
      unitRef="usd">-5200000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="i8a46826c2684460eb4fbb56df6e8152a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzUtMy0xLTEtNjAyNjM_3f652d05-52c9-4422-a4ed-39b467622abe"
      unitRef="usd">-3000000.0</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="i3c00e1dadfb14a658cb637483c6837c2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzUtNS0xLTEtNjAyNjM_d0abd8a3-01cd-4b32-9683-168a6362defe"
      unitRef="usd">-6100000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzYtMS0xLTEtNjAyNjM_e83b5cbb-76d0-491a-92aa-4fae7a70cf3c"
      unitRef="usd">-5200000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzYtMy0xLTEtNjAyNjM_d034179e-d603-4a2a-9dfa-23d57f2031be"
      unitRef="usd">-3000000.0</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpkYTE0MTczMzg1NWY0NGU0OTMzZDNlNDdjMGUyNzI1Ny90YWJsZXJhbmdlOmRhMTQxNzMzODU1ZjQ0ZTQ5MzNkM2U0N2MwZTI3MjU3XzYtNS0xLTEtNjAyNjM_9f5ade80-bf91-4947-be02-42643f1c213c"
      unitRef="usd">-6100000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="iab197c4924f34c0db38f5eb19ad7f2b1_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQwMjc_65415806-aa7d-4e8f-b1e8-8f11d90f3104"
      unitRef="usd">-4000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i055a22dcb77a4206a028877100a4c97b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQwMzE_b6a04712-a31d-4636-93d9-ba866eff6a60"
      unitRef="usd">-2600000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i5e0072e4d3cc422b90a6e91608ad2109_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQwMzg_8bc8edbb-8e78-49e1-8b40-5fa435c4f66a"
      unitRef="usd">6300000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i85e3c3d286034ff49e528b2c9317d171_D20230101-20231231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQwNzk_c0e99abc-f53f-4d24-aedf-4dc43ceb2f31"
      unitRef="usd">-3200000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="iae7ed9fa03bd445da0742597c1c5438f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzMtMS0xLTEtNjAyNjM_053d6e92-333d-48c9-93a2-ff5dd8fc6002"
      unitRef="usd">1300000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if3195132dd5345a6887a4340147a0564_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzMtMy0xLTEtNjAyNjM_620c34e8-b2a2-4e2f-adf9-5d6e259845a3"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i72e42c0a25694e14b9229d1e967b73d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzMtNS0xLTEtNjAyNjM_38bb6850-8814-44ca-accd-59e6d98ffa18"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="iab197c4924f34c0db38f5eb19ad7f2b1_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzQtMS0xLTEtNjAyNjM_a74d5029-5b05-4886-aef7-2ac695eda496"
      unitRef="usd">1300000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i055a22dcb77a4206a028877100a4c97b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzQtMy0xLTEtNjAyNjM_85b4e9d3-0c6d-4fe4-880a-bf8e25b7a4ff"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5e0072e4d3cc422b90a6e91608ad2109_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzQtNS0xLTEtNjAyNjM_ddc672db-70a6-44f6-9a53-218263069158"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0e06a7878bb94a07b93f4163c017f6ce_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzYtMS0xLTEtNjAyNjM_49510597-601f-4f09-af10-13ff17147421"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia05c56f7d4da40bab7b1afb3e4f348f7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzYtMy0xLTEtNjAyNjM_11841515-1967-405a-b343-7a4486173464"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iaa12cd493a074d5399af3c418b4c5706_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzYtNS0xLTEtNjAyNjM_4029e736-7130-44ce-a5cc-e299281ae778"
      unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i85aa4b0d24d14148bf70e42bf8953a40_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzctMS0xLTEtNjAyNjM_f62a5088-3fe5-4f89-b2f6-4b22cefc8b05"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i61e1ccc194684e27aa2be4350e2a59da_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzctMy0xLTEtNjAyNjM_299a14f7-f57a-4959-8e56-20a66a717f7f"
      unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9601ccbfbc6c4c6e969ee2d307d9045c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzctNS0xLTEtNjAyNjM_340021bd-bd83-4790-87d9-ed250dba1c68"
      unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i735ee47484304157b7f13947a9b6e46a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzgtMS0xLTEtNjAyNjM_0f31687c-7d5c-4125-83a8-262dd0355940"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7d8fd0ef4c9d44ccbf513c6e6c38b9b1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzgtMy0xLTEtNjAyNjM_2121481a-81e7-4644-a530-dbd6eb9b132c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i397a9fc92bb541bda84bf523b0f0534c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzgtNS0xLTEtNjAyNjM_a587746d-bfaa-41e0-9581-872424504290"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ifbf55f1a879b48a78fb1475dceabdc9d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzktMS0xLTEtNjAyNjM_68f99285-4a56-442d-b3c9-99e9b1d8e4ab"
      unitRef="usd">-800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib560936ecece47cf97fd5dfe6464bfb7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzktMy0xLTEtNjAyNjM_3bab29ce-e25a-4748-99b3-1d1ca78c636f"
      unitRef="usd">-2000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ice018ed37eaa49149dc6c63f944f178d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzktNS0xLTEtNjAyNjM_25c47c9c-ddac-4340-bee5-a1655cd71cad"
      unitRef="usd">-1200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="icd37440709c84ad3812e75fb20e0afa6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEyLTEtMS0xLTYwMjYz_f9c6e7ad-0c5e-48d7-95e4-bfd9b5f0a1d6"
      unitRef="usd">9100000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9e71e4d6cb1c4e27acca2bfaf571e3ac_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEyLTMtMS0xLTYwMjYz_eda88651-3f2f-46df-ac6c-268f3c004726"
      unitRef="usd">7700000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i63adabb977604bc4a8c06a77bae5bfd4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEyLTUtMS0xLTYwMjYz_8f7cbc3e-bb46-4cf9-9516-61da9bc9d838"
      unitRef="usd">-3200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5d0bf9f09bfd45009a95e13ff7570373_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEzLTEtMS0xLTYwMjYz_65ed8324-64a8-4af1-9042-48cb25d7fd22"
      unitRef="usd">9100000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i4ccb1166712d49a3855a9a39bf66196e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEzLTMtMS0xLTYwMjYz_10567b7a-283d-42b1-8cec-b9a99a28f13f"
      unitRef="usd">7700000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3606e54a0a1946d8bca09748806375ab_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTphYmY2MzIzN2RlOGY0OWFlODdkM2UzYjFiNjI3YTU2My90YWJsZXJhbmdlOmFiZjYzMjM3ZGU4ZjQ5YWU4N2QzZTNiMWI2MjdhNTYzXzEzLTUtMS0xLTYwMjYz_47fec0ef-a10b-46b5-940e-722732361484"
      unitRef="usd">-3200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="iae7ed9fa03bd445da0742597c1c5438f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzMtMS0xLTEtNjAyNjM_2d33a97f-0cc8-45cd-a709-0294661fe3f9"
      unitRef="usd">1600000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="if3195132dd5345a6887a4340147a0564_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzMtMy0xLTEtNjAyNjM_5d6d31e2-235e-478e-8f36-a39a12dcda70"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i72e42c0a25694e14b9229d1e967b73d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzMtNS0xLTEtNjAyNjM_29cf427a-719d-4508-9fac-84c59543c9ba"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="iab197c4924f34c0db38f5eb19ad7f2b1_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzQtMS0xLTEtNjAyNjM_fe2bce99-7395-44f1-adce-592c17e0d3a6"
      unitRef="usd">1600000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i055a22dcb77a4206a028877100a4c97b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzQtMy0xLTEtNjAyNjM_7094353f-4630-4a9e-93e1-b70106ab12fe"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i5e0072e4d3cc422b90a6e91608ad2109_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzQtNS0xLTEtNjAyNjM_2ca2592a-d841-42f5-b13a-9ee7ad7ff83e"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i0e06a7878bb94a07b93f4163c017f6ce_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzYtMS0xLTEtNjAyNjM_86fe1968-2212-4604-862c-e54c09dd28ff"
      unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="ia05c56f7d4da40bab7b1afb3e4f348f7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzYtMy0xLTEtNjAyNjM_d9b96d6c-c391-4e02-b89c-9391864ee3b8"
      unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="iaa12cd493a074d5399af3c418b4c5706_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzYtNS0xLTEtNjAyNjM_c1b9ae93-cc7f-432b-ab19-8b8bec468c2b"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i85aa4b0d24d14148bf70e42bf8953a40_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzctMS0xLTEtNjAyNjM_c564b6f3-91c5-45ef-af48-6d85c16bbee8"
      unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i61e1ccc194684e27aa2be4350e2a59da_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzctMy0xLTEtNjAyNjM_f29bc9b3-d940-4148-b6c9-31e3f5e661ad"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i9601ccbfbc6c4c6e969ee2d307d9045c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzctNS0xLTEtNjAyNjM_3dea3ac6-a651-4c4c-9330-9a81c3f46f79"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i450fa254443341388fa92c220d282a50_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzktMS0xLTEtNjAyNjM_2f3cb8e5-4c53-4f6b-b31d-12ad79067437"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i66ee7b68af3241c8ba207622f3731e45_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzktMy0xLTEtNjAyNjM_4f450e93-9954-4e8c-9d8c-daceb9557d4d"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="id841a6055f0e4cfbaacfafc0843a3b62_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzktNS0xLTEtNjAyNjM_00b6e8f5-3892-4c34-939e-754a0b0fd0f9"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="ifbf55f1a879b48a78fb1475dceabdc9d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEwLTEtMS0xLTYwMjYz_8cdeed9a-aca0-4241-84bf-f75da2d55dee"
      unitRef="usd">-2500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="ib560936ecece47cf97fd5dfe6464bfb7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEwLTMtMS0xLTYwMjYz_0886cf1a-1a6d-4daf-a07c-2e85de3f376c"
      unitRef="usd">-2900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="ice018ed37eaa49149dc6c63f944f178d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEwLTUtMS0xLTYwMjYz_6b8afb33-d0b2-410e-8c8d-35f41a2d3014"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="icd37440709c84ad3812e75fb20e0afa6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEzLTEtMS0xLTYwMjYz_b5d89709-d19a-4d20-96cd-204ae2488ab6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i9e71e4d6cb1c4e27acca2bfaf571e3ac_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEzLTMtMS0xLTYwMjYz_18e5e10b-e367-4f72-b406-25bc0d1dccbe"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i63adabb977604bc4a8c06a77bae5bfd4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzEzLTUtMS0xLTYwMjYz_72055a3e-98f0-4558-91ff-f99eefea6f81"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i5d0bf9f09bfd45009a95e13ff7570373_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzE0LTEtMS0xLTYwMjYz_bc8796d3-72bf-4a6c-a078-36f469421d5a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i4ccb1166712d49a3855a9a39bf66196e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzE0LTMtMS0xLTYwMjYz_1f3544a8-a234-4db0-be78-96cae66156a0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i3606e54a0a1946d8bca09748806375ab_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTpjMWI4MTdjYWFkOTA0YThlYWViYWU0ZDVhY2FkZjFlYi90YWJsZXJhbmdlOmMxYjgxN2NhYWQ5MDRhOGVhZWJhZTRkNWFjYWRmMWViXzE0LTUtMS0xLTYwMjYz_429a365d-a013-4388-96d1-a16f292e21d0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i4ecf564c7c8643e083fb3f9bc53dd6e6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzEtMS0xLTEtNjAyNjM_6cd6aa6d-a969-4998-8f5a-e95fe10ca789"
      unitRef="usd">-1200000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i172c5bb368534dc6afd5e93d8d03deaf_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzEtMy0xLTEtNjAyNjM_20901595-6a1b-4b26-b12a-730f195d11a3"
      unitRef="usd">900000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i0a19776470ed4aa9be3c7220853c571b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzEtNS0xLTEtNjAyNjM_a247df6b-d2a2-445a-84d9-8ca9df2df6e7"
      unitRef="usd">200000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ic31348b180714cf69a4949022e873c8b_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzItMS0xLTEtNjAyNjM_f6d461a2-b14d-4c4c-bcbf-076dfa759f11"
      unitRef="usd">3500000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i86d021ac1cce433bba24d4fee5778a4b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzItMy0xLTEtNjAyNjM_d0b56130-6bb5-43d2-b209-16b5f4a01fba"
      unitRef="usd">1700000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie516db60841b47beab93458349c39d9e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzItNS0xLTEtNjAyNjM_947a86bc-1c6d-43fa-87ff-6c6f4c0e291b"
      unitRef="usd">-100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i21d6d1e179764319939518be6b4755c8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzQtMS0xLTEtNjAyNjM_a8ff493c-1c04-4346-822d-536c75d477ac"
      unitRef="usd">200000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i4a05df88c57c4fbba800cd2d6ded4056_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzQtMy0xLTEtNjAyNjM_fd5cb270-da59-46bc-a2bf-fefbdab53507"
      unitRef="usd">300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i0dc769ee573d4b1eb606de264ddf0ea5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTplMTY2MmU3OTI0MWQ0ZmRmYjZmMjIzYTdmMzNmMzI4MC90YWJsZXJhbmdlOmUxNjYyZTc5MjQxZDRmZGZiNmYyMjNhN2YzM2YzMjgwXzQtNS0xLTEtNjAyNjM_8281716d-a1fd-401c-878f-b9b4b5018fc7"
      unitRef="usd">300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90ZXh0cmVnaW9uOjcyZjM2NjgxODAzMTRmZjRiYzg3NDkyYzcxZDI0NTI0XzQ4MzE_03c415c1-35f1-4cad-9928-26ff854ca22b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i262cd9dc71574d73902a46c241cb2c0d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzItMS0xLTEtNjAyNjM_fc93148e-6ec7-482e-9bf8-d6b5d271086c"
      unitRef="usd">1500000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="iae52261e94e747a89a158b1da3e74546_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzItMy0xLTEtNjAyNjM_f19d5b43-63cc-4903-ad83-3e1fb2ac9abc"
      unitRef="usd">1700000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i6881855e92e84a999adbd921603e22a5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzItNS0xLTEtNjAyNjM_632d95db-eaf2-4ea9-976e-5555d988a9fa"
      unitRef="usd">-200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ie73452302c0e415ab2556f3eb20f4c00_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzMtMS0xLTEtNjAyNjM_5fa5eba4-5ddd-403a-8894-62f671447863"
      unitRef="usd">1500000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i973d62078ba14495ad1278fd1f4d578d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzMtMy0xLTEtNjAyNjM_b8874654-04b9-4a62-9c54-1dea7fa805bd"
      unitRef="usd">1700000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i9da752cb333d421ca18f1e5af162195f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMDkvZnJhZzo3MmYzNjY4MTgwMzE0ZmY0YmM4NzQ5MmM3MWQyNDUyNC90YWJsZTozYWI0M2RhYTM3ZjM0ZGRlOTYzY2ExMWE0ZWU0M2U0ZC90YWJsZXJhbmdlOjNhYjQzZGFhMzdmMzRkZGU5NjNjYTExYTRlZTQzZTRkXzMtNS0xLTEtNjAyNjM_32f2eff1-641a-4926-9d66-dd0207da1cf0"
      unitRef="usd">-200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUyOTY_0457e2c9-aac5-4b3c-98a4-069357d38467">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Unobservable inputs that reflect the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the assets and liabilities recorded at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of the contingent consideration liability, within current and long-term liabilities, related to the SmartDose&#xae; technology platform (the &#x201c;SmartDose&#xae; contingent consideration&#x201d;) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#x2019; investment selections and is included within other long-term liabilities. The fair value of the cross-currency swap, included within other long-term assets, is valued using a market approach. Please refer to Note 11, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivative Financial Instruments&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion of our derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities, and is classified as Level 2 within the fair value hierarchy. At December&#160;31, 2022, the estimated fair value of long-term debt was $201.8 million compared to a carrying amount of $206.7 million. At December&#160;31, 2021, the estimated fair value of long-term debt was $217.9 million and the carrying amount was $208.8 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUyOTc_53858e0f-6972-4888-9220-29bfb558d762">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the assets and liabilities recorded at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzQtMS0xLTEtNjAyNjM_53c5e814-4927-416f-b261-54e3f38b767e"
      unitRef="usd">12500000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzQtMy0xLTEtNjAyNjM_503c5f18-e6f6-44f0-87b2-0147ca2cce6d"
      unitRef="usd">12500000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzQtNS0xLTEtNjAyNjM_a3a155b9-1c09-4d15-ace9-9e23e369b4fe"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzQtNy0xLTEtNjAyNjM_a8d75911-3f19-4796-bb68-7a3ce5faa499"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzUtMS0xLTEtNjAyNjM_7340758f-eded-4d44-a802-8fcc09e0a7f6"
      unitRef="usd">4500000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzUtMy0xLTEtNjAyNjM_a18875cb-6f15-4cad-b600-65c19ef3a281"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzUtNS0xLTEtNjAyNjM_4f23f3a0-983c-47ab-81f2-dcfd15028e24"
      unitRef="usd">4500000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzUtNy0xLTEtNjAyNjM_f240b563-0c52-4328-9251-ad0cb206f5aa"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="i754552b393944baa8e31325d5eba5188_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzYtMS0xLTEtNjAyNjM_3eea58b1-e5c6-4de4-95d8-232db9c80131"
      unitRef="usd">13900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="icd279fe6b3354a1d94ce2672678400de_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzYtMy0xLTEtNjAyNjM_1b92fe92-9a94-472b-a094-7cb621db30aa"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i43611db249a44bdb8e4b0da680b6e710_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzYtNS0xLTEtNjAyNjM_b532c36c-fc72-42a8-b2c0-4e5bfd7fc127"
      unitRef="usd">13900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="icc6ce44539154204a8fdfb1e5e3bcb36_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzYtNy0xLTEtNjAyNjM_7b7f8a84-827a-45f5-9111-fbe78aaa16bf"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia2c88912680242f1a6463abe80fe7cf4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzctMS0xLTEtNjAyNjM_0f1dcd8d-6686-4476-bb0b-acd8728e9ee7"
      unitRef="usd">1200000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i32dd82ca504d4e4e8b1e47b0b4f96b7e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzctMy0xLTEtNjAyNjM_1929734d-ceaf-4b91-9d13-63024409ba14"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib5907fec60b44341a54dc18b426e81a8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzctNS0xLTEtNjAyNjM_7b8a461e-dda4-4d8a-935c-622a99e1bada"
      unitRef="usd">1200000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i66ec8d15453f4f38a06ec86fbf3ff764_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzctNy0xLTEtNjAyNjM_dcec7645-e75e-4374-9f28-96f29be989dc"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzgtMS0xLTEtNjAyNjM_32f72b74-d693-406e-aa23-36e32ce664fa"
      unitRef="usd">32100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzgtMy0xLTEtNjAyNjM_be11aefe-a0ba-4e8f-ac9d-94483882bac0"
      unitRef="usd">12500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzgtNS0xLTEtNjAyNjM_c8a1c10e-216e-4095-a5d2-263831bf2ba8"
      unitRef="usd">19600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzgtNy0xLTEtNjAyNjM_1574a7af-337b-40d1-833e-72390597149d"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEwLTEtMS0xLTYwMjYz_59701525-b576-43f6-8fa2-7a3b0528b6cd"
      unitRef="usd">4700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEwLTMtMS0xLTYwMjYz_47d72b92-4354-4d6d-8d08-c162445462fd"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEwLTUtMS0xLTYwMjYz_2c937c9b-101a-4087-9bc6-026fbaf6178a"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEwLTctMS0xLTYwMjYz_5764a3b4-782a-4d4d-b439-8f39f744f394"
      unitRef="usd">4700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzExLTEtMS0xLTYwMjYz_cdccc486-31f0-4037-84d4-a20f1ceeacbd"
      unitRef="usd">12700000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzExLTMtMS0xLTYwMjYz_2eff3923-d297-4760-bc7b-22528040a10c"
      unitRef="usd">12700000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzExLTUtMS0xLTYwMjYz_21ca9a31-257e-404a-b628-f2a595e4f99f"
      unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzExLTctMS0xLTYwMjYz_e8565197-ff99-4072-a949-5b082ef3a232"
      unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i25a6afe95d6949a9b15847a9e5063bda_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEzLTEtMS0xLTYwMjYz_d1b75b56-6548-430a-b876-dcb99d77de73"
      unitRef="usd">1400000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ie7c411ebf213498bbc17286b687febec_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEzLTMtMS0xLTYwMjYz_c5e5e0c8-8dd5-4aa7-8bfe-8e8ab0e50c84"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i4463c41232a04445bcdcb36422deee33_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEzLTUtMS0xLTYwMjYz_094cb21b-7bad-48f3-bdec-22718295bf43"
      unitRef="usd">1400000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i54f66b73b00546638fb3dfdeea498856_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzEzLTctMS0xLTYwMjYz_0ea8e949-18ee-4c40-a722-7785d35c673d"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzE0LTEtMS0xLTYwMjYz_5b333b40-90c7-48e1-8bd7-9b5fedf1a18f"
      unitRef="usd">18800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzE0LTMtMS0xLTYwMjYz_b9c15cf5-c42e-41bc-a09d-7efca35d87e2"
      unitRef="usd">12700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzE0LTUtMS0xLTYwMjYz_57cb9565-f05c-4d09-8e0f-ea5945c43e6f"
      unitRef="usd">1400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZToyNThjZDM0NTJmNmY0YjUxYjBkZDQ5ZTc0NzIwMzU2Ny90YWJsZXJhbmdlOjI1OGNkMzQ1MmY2ZjRiNTFiMGRkNDllNzQ3MjAzNTY3XzE0LTctMS0xLTYwMjYz_bdd13ef0-518e-408c-ab02-938c0d6bcf49"
      unitRef="usd">4700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzQtMS0xLTEtNjAyNjM_0de22cb2-b785-4e70-862f-a80815a54378"
      unitRef="usd">15500000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzQtMy0xLTEtNjAyNjM_0911552f-b815-46bd-994e-c5b93232d301"
      unitRef="usd">15500000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="id1ef59879afe401591e29ee824de0517_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzQtNS0xLTEtNjAyNjM_b94a06dd-5fe1-476d-9933-e61b012750d7"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzQtNy0xLTEtNjAyNjM_4cbb6b63-cfaa-4614-bc85-9d8a2518063c"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzUtMS0xLTEtNjAyNjM_1c752a53-8ce1-4a6f-9c99-e477c9e3ba67"
      unitRef="usd">14800000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzUtMy0xLTEtNjAyNjM_0492b7b7-9d79-47e1-88d9-5a8121378fd8"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="id1ef59879afe401591e29ee824de0517_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzUtNS0xLTEtNjAyNjM_a62d3c22-4c6a-46cf-b527-3df8d342d17a"
      unitRef="usd">14800000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzUtNy0xLTEtNjAyNjM_c0528adb-9b53-48ee-97c9-0f169ace09eb"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="i5d2482447c6049c1a04840f7c479360b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtMS0xLTEtNzA2NDY_06e533d5-4ed9-4917-88ed-e824f3c39bbc"
      unitRef="usd">4400000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i83c5430234af414c9fcc3b4df8890d9f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtMy0xLTEtNjIyMzE_af698ba5-1601-42af-8225-e077f513c1e5"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0d763901eafd48cd8a636ca3db465303_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtNS0xLTEtNjIyMjM_92fe2a4a-be2c-4385-ae19-821bab825536"
      unitRef="usd">4400000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie316bb8a16254f0b8e82e29bc1835be1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtNy0xLTEtNjIyMzU_53f29b4a-6334-494c-bd29-b02c26e06a70"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i8d15643e954d4ef2862b5cf9aeaff59b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtMS0xLTEtNjAyNjM_2294f9f3-4b45-4890-8a26-561c2fb3c6a9"
      unitRef="usd">1700000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1371f6ecf2dd4b64b6bf9d8da230988e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtMy0xLTEtNjAyNjM_4dee0409-5528-4c16-8bde-3149d959ad10"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i3ae5843ba66649458ad2eab839e35a52_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtNS0xLTEtNjAyNjM_e70f3fa4-9cbe-4eca-a285-e61249d287dd"
      unitRef="usd">1700000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2b86341c878947cd85fe8ec2548111e7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzYtNy0xLTEtNjAyNjM_cc0ca5db-370d-43a1-8e37-9760da23e117"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzctMS0xLTEtNjAyNjM_00b9ee55-509e-4c95-b775-0b295c69836b"
      unitRef="usd">36400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzctMy0xLTEtNjAyNjM_f96eb9ef-ac7e-4932-86b6-e1de350321a7"
      unitRef="usd">15500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id1ef59879afe401591e29ee824de0517_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzctNS0xLTEtNjAyNjM_42c9b85f-68bb-437b-9538-39ebbd2d24ce"
      unitRef="usd">20900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzctNy0xLTEtNjAyNjM_24ee5790-4900-4192-ad85-f8d8c6963088"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzktMS0xLTEtNjAyNjM_9fafc4c9-8355-4950-ab8a-8d1f1a3ae995"
      unitRef="usd">3700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzktMy0xLTEtNjAyNjM_a731e114-2a0a-475b-84a8-3814e4b24333"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id1ef59879afe401591e29ee824de0517_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzktNS0xLTEtNjAyNjM_fa801393-fd47-4f62-875f-b7282d6729fe"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzktNy0xLTEtNjAyNjM_be7c9228-0fbb-4dd5-9173-94252d29155d"
      unitRef="usd">3700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEwLTEtMS0xLTYwMjYz_13361af8-1d45-42a8-b061-6be8b6ab899a"
      unitRef="usd">16100000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEwLTMtMS0xLTYwMjYz_ffe90df3-f851-48f1-9025-67a620791efa"
      unitRef="usd">16100000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="id1ef59879afe401591e29ee824de0517_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEwLTUtMS0xLTYwMjYz_8af8ca44-d48c-4084-bbd2-6dd98ea02d1f"
      unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEwLTctMS0xLTYwMjYz_44ac0945-5925-469e-9b95-7f44646bc0fb"
      unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="if867c326ea304572bf285d245f2729f3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEyLTEtMS0xLTYwMjYz_c32b4ccf-d8fb-4a81-b867-9a68f480aa1d"
      unitRef="usd">3400000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i406f7691b793473590f26cc05c368e11_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEyLTMtMS0xLTYwMjYz_dcc59fdd-6e36-473c-b089-ec80eed72252"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i805c24fc27444fd38deafff1a2c4bbe9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEyLTUtMS0xLTYwMjYz_7a785cdb-da76-4a01-a9cf-1a4063794cd9"
      unitRef="usd">3400000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="iafa5b204c1dc4abc86e2792ad48e7b16_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEyLTctMS0xLTYwMjYz_408851e4-f1e8-4a33-b65d-285986cf4641"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEzLTEtMS0xLTYwMjYz_8f34bf64-e2f8-4737-ac51-d41f688f2085"
      unitRef="usd">23200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEzLTMtMS0xLTYwMjYz_7a746292-fb06-4c94-ac2f-2f21715106d3"
      unitRef="usd">16100000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id1ef59879afe401591e29ee824de0517_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEzLTUtMS0xLTYwMjYz_f0d23c5a-8d79-4ab3-8e5b-e6c4838a520a"
      unitRef="usd">3400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90YWJsZTo1MzkyZjVkNTVkYjE0ODM5OTFlNmM2NjRhZWE3ODlhYS90YWJsZXJhbmdlOjUzOTJmNWQ1NWRiMTQ4Mzk5MWU2YzY2NGFlYTc4OWFhXzEzLTctMS0xLTYwMjYz_4020901b-253c-4d8c-b0bd-d18a59a7b943"
      unitRef="usd">3700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LongTermDebtFairValue
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUxNTI_1d4f05d4-da96-4dd6-b5c4-768224a2739e"
      unitRef="usd">201800000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUxODg_0610e38f-7eb4-4703-b1f5-6ecb2320c8b7"
      unitRef="usd">206700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtFairValue
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUyNDY_52894503-0bc6-4f97-a0bb-128e8ce22735"
      unitRef="usd">217900000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTIvZnJhZzoxNDhkMzBkZTAzNWQ0ZDU0YjNmOTU2MmU2ZDZlYzM1OC90ZXh0cmVnaW9uOjE0OGQzMGRlMDM1ZDRkNTRiM2Y5NTYyZTZkNmVjMzU4XzUyNzc_1172fc93-64cb-43bd-9a18-5fb365d76c28"
      unitRef="usd">208800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90ZXh0cmVnaW9uOmQ4NWNkMTg1N2NmMzQ4ODdiODE3ZTljY2IyNjI0MmFkXzQ1OA_7e99c6ad-3181-494c-a713-df92c2407522">Accumulated Other Comprehensive Loss&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity affiliate investment AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit pension and other postretirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Detail of components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on derivatives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of defined benefit pension and other postretirement plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Benefit Plans&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90ZXh0cmVnaW9uOmQ4NWNkMTg1N2NmMzQ4ODdiODE3ZTljY2IyNjI0MmFkXzQ2OQ_b15a0875-2234-4424-bf1e-22506bdaadda">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity affiliate investment AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit pension and other postretirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i4fbcb98a53e34fcb8a183148ece8920b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEtMS0xLTEtNjAyNjM_b97d880f-4e1d-459f-a4b5-b452b76b6863"
      unitRef="usd">-800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iade80d0537714f308a08a338374d6b21_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEtMy0xLTEtNjAyNjM_81e04fe0-96af-4133-ae4a-225c325169a3"
      unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i32b73b088654490bb5a6be67066e2ae9_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEtNS0xLTEtNjAyNjM_86e7648f-2476-48ef-88a0-e53bbf79d131"
      unitRef="usd">-40300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i386979849f4a4ca899ce2778bd52f0d5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEtNy0xLTEtNjAyNjM_4f8a6abd-2da3-4104-8765-c129afb0a71f"
      unitRef="usd">-108900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i17b8a1175e024b0b91f80042eb871d9e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEtOS0xLTEtNjAyNjM_bb37e1da-ea9a-4b0c-8145-859c6f7b4ba8"
      unitRef="usd">-149600000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i54bb101058b8400a88f43f7396f6df6b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzItMS0xLTEtNjAyNjM_32141f90-dda9-476e-89ab-1770c21ad6f7"
      unitRef="usd">2800000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="iaecd545d46d342a39efcb16ad10a6df6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzItMy0xLTEtNjAyNjM_0f582526-45f7-46c7-bfa8-2e4162dfc7bc"
      unitRef="usd">200000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i97d694cff77844d882d28c32d629311e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzItNS0xLTEtNjAyNjM_e99b4c20-28cd-4f79-9429-c52a82957a9c"
      unitRef="usd">-2500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i9815180ba0b54d2881441a6cc952417a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzItNy0xLTEtNjAyNjM_adb656d4-d030-48cd-965a-70f4eca471c4"
      unitRef="usd">40100000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzItOS0xLTEtNjAyNjM_242613b1-2fa1-4b62-885d-bdc63ac9b42a"
      unitRef="usd">40600000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i54bb101058b8400a88f43f7396f6df6b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzMtMS0xLTEtNjAyNjM_4199141b-25f9-4c0a-a26b-0b9f602f9445"
      unitRef="usd">3900000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="iaecd545d46d342a39efcb16ad10a6df6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzMtMy0xLTEtNjAyNjM_2d0b3c79-5f5b-45cf-b7a1-6f931f80a9f1"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i97d694cff77844d882d28c32d629311e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzMtNS0xLTEtNjAyNjM_6e5deb43-1d87-408d-a170-63212f439d8b"
      unitRef="usd">-2300000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i9815180ba0b54d2881441a6cc952417a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzMtNy0xLTEtNjAyNjM_cbb532f6-b436-4445-8115-c33f0b323b52"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzMtOS0xLTEtNjAyNjM_eebd6e09-0129-46d4-b166-214167e08e68"
      unitRef="usd">1600000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i54bb101058b8400a88f43f7396f6df6b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzQtMS0xLTEtNjAyNjM_1352ad29-27b1-4962-bf4b-b55aee8fd8f4"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaecd545d46d342a39efcb16ad10a6df6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzQtMy0xLTEtNjAyNjM_33616ead-f4c2-499c-9c13-15364d7266f8"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i97d694cff77844d882d28c32d629311e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzQtNS0xLTEtNjAyNjM_fe51f511-adcc-4d85-a8b5-78ebc86a221b"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9815180ba0b54d2881441a6cc952417a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzQtNy0xLTEtNjAyNjM_e9fdabb1-3905-4003-97ef-88304c088018"
      unitRef="usd">40100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzQtOS0xLTEtNjAyNjM_67d4823a-8a5d-4836-ad74-bf8ab474c99a"
      unitRef="usd">39000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ie07c502333264b49a0ba4aa4235be632_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzUtMS0xLTEtNjAyNjM_6033fd51-ef03-47ef-9619-3e6e8f24250c"
      unitRef="usd">-1900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79faae59eb5747f094ec247979277f49_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzUtMy0xLTEtNjAyNjM_c56c4d81-451c-4a5c-91ac-368577fb355b"
      unitRef="usd">600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i89bf04ee5a4a44318e42a1114576fc19_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzUtNS0xLTEtNjAyNjM_ca5afa6a-c652-41ca-bbc8-c3bd06c7467b"
      unitRef="usd">-40500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4ff1cabbd90749c99af71165f285a71c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzUtNy0xLTEtNjAyNjM_9cdaa459-ea68-4018-bc57-951f35fa87d9"
      unitRef="usd">-68800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ida3c98d3c0354b73a89f724be3743416_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzUtOS0xLTEtNjAyNjM_cf1cc49e-ed63-4ca3-b1e8-1c981a1c4f0d"
      unitRef="usd">-110600000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ia8a86bade84543889f6b81500c0a8ac5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzYtMS0xLTEtNjAyNjM_c45013af-5d51-47ab-a379-c19989549cfa"
      unitRef="usd">-1400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i6d46a1f438f8461684e84f9c8c79e508_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzYtMy0xLTEtNjAyNjM_f346f681-4881-44de-8a63-47673b5de77f"
      unitRef="usd">900000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i5d66b7db239e48d5b1af0749bb3ea343_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzYtNS0xLTEtNjAyNjM_30b70030-f5f8-4ad2-8592-a1027c0d27d7"
      unitRef="usd">7400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i0662f0d0f62149118e93596ed7214b5c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzYtNy0xLTEtNjAyNjM_c2fd6983-b1a1-4631-a53f-cf62f51fc463"
      unitRef="usd">-59300000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzYtOS0xLTEtNjAyNjM_82993d79-c528-4bf0-b56b-3e0af9df6ba3"
      unitRef="usd">-52400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ia8a86bade84543889f6b81500c0a8ac5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzctMS0xLTEtNjAyNjM_1a1c682f-ab82-4599-bcaa-dd020928277f"
      unitRef="usd">-2100000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i6d46a1f438f8461684e84f9c8c79e508_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzctMy0xLTEtNjAyNjM_b1dbe6d4-85ca-4e15-9c42-4c9562c64a51"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i5d66b7db239e48d5b1af0749bb3ea343_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzctNS0xLTEtNjAyNjM_4a2ce4e9-a287-4c8b-9e2c-a48f55defbeb"
      unitRef="usd">-1300000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i0662f0d0f62149118e93596ed7214b5c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzctNy0xLTEtNjAyNjM_57e6a276-4458-4f9b-864b-85a198bf2ab6"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzctOS0xLTEtNjAyNjM_a49dcfc1-1a76-478a-bc90-36c984509c69"
      unitRef="usd">-3400000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia8a86bade84543889f6b81500c0a8ac5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzgtMS0xLTEtNjAyNjM_808238ce-2c6d-4161-96d9-bbba4a8ef5f0"
      unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6d46a1f438f8461684e84f9c8c79e508_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzgtMy0xLTEtNjAyNjM_beeea04f-813f-4400-800f-b5eb586ecfd0"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5d66b7db239e48d5b1af0749bb3ea343_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzgtNS0xLTEtNjAyNjM_475d668d-d32b-47b9-8947-9607dd7d18c9"
      unitRef="usd">8700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0662f0d0f62149118e93596ed7214b5c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzgtNy0xLTEtNjAyNjM_174cf572-d7bd-4252-a40e-f7fb4da8780e"
      unitRef="usd">-59300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzgtOS0xLTEtNjAyNjM_0a957779-430c-46d9-b4c6-b00164331668"
      unitRef="usd">-49000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ib2a17d2034694fe895103701a3db15e7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzktMS0xLTEtNjAyNjM_5de69996-3b6e-489a-9ccd-eb34ed33178a"
      unitRef="usd">-1200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i063266317845420c9c9604cf2e5a3b01_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzktMy0xLTEtNjAyNjM_271a692a-c445-43f6-931a-195813df80a4"
      unitRef="usd">1500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1289dce1d1384485a949179f19183178_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzktNS0xLTEtNjAyNjM_05a0a597-8b10-4500-8582-88bf298010de"
      unitRef="usd">-31800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i56913a13b5944c5587eaaa2f5fb63640_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzktNy0xLTEtNjAyNjM_0897af1a-5878-405e-ba3d-3e24be8dec53"
      unitRef="usd">-128100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e14a309edfa4014932d060921715d47_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzktOS0xLTEtNjAyNjM_2db3ff80-7114-42a4-a854-96660e7b5b2e"
      unitRef="usd">-159600000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i99e48d0827e84674a9f7b673ab8b3adf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEwLTEtMS0xLTYwMjYz_94189774-8c11-4a44-b721-7a8217ecdacd"
      unitRef="usd">500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ia8d3089900f144029822b0251c552161_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEwLTMtMS0xLTYwMjYz_bf89dcb4-def9-4538-9ed6-b23f3ad41d61"
      unitRef="usd">100000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i1d37456ab52c475297384d08d55cb38d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEwLTUtMS0xLTYwMjYz_44e61a2b-ab78-42db-ab6a-9c3e38246e4d"
      unitRef="usd">-9300000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="if40187b8b7a64ea69df5cf9e017b64fd_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEwLTctMS0xLTYwMjYz_3e617c31-fd99-4b7d-b5e1-9d23b624a788"
      unitRef="usd">-47300000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEwLTktMS0xLTYwMjYz_0befaebb-f0ba-4f7d-9c92-84f82e9a8a02"
      unitRef="usd">-56000000.0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i99e48d0827e84674a9f7b673ab8b3adf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzExLTEtMS0xLTYwMjYz_5fb3f871-099a-4e7f-8780-65a24f0794dc"
      unitRef="usd">-900000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ia8d3089900f144029822b0251c552161_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzExLTMtMS0xLTYwMjYz_85b67c77-21a9-4762-a4f7-7a5eb09647b4"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i1d37456ab52c475297384d08d55cb38d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzExLTUtMS0xLTYwMjYz_44e2971b-bb04-4ac7-abf9-9292e09f83e3"
      unitRef="usd">-31700000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="if40187b8b7a64ea69df5cf9e017b64fd_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzExLTctMS0xLTYwMjYz_44f7b411-3fcc-4e1f-bd61-9f0974a71aa6"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzExLTktMS0xLTYwMjYz_ecf7e0ea-4247-476c-bbaf-42841a7670d5"
      unitRef="usd">-32600000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i99e48d0827e84674a9f7b673ab8b3adf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEyLTEtMS0xLTYwMjYz_7117ad93-a0c8-476a-a67c-cce8dfa672a0"
      unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia8d3089900f144029822b0251c552161_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEyLTMtMS0xLTYwMjYz_da9dae30-b0f3-4de1-8c43-442fe3c9b56b"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1d37456ab52c475297384d08d55cb38d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEyLTUtMS0xLTYwMjYz_177c4dce-efe9-4162-b2c1-d36a95491771"
      unitRef="usd">22400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if40187b8b7a64ea69df5cf9e017b64fd_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEyLTctMS0xLTYwMjYz_faadeedf-f9f6-4bf5-978d-3c662d2308e6"
      unitRef="usd">-47300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEyLTktMS0xLTYwMjYz_ca9c1151-0c14-4861-89bd-6f689cfd7efd"
      unitRef="usd">-23400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ia0818a4e839d4d98b9c9d2fb94135719_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEzLTEtMS0xLTYwMjYz_339477a0-d97f-481b-9b77-c94f9918e7f4"
      unitRef="usd">200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i572ebcf46c464f8480b6b43ea02ed0cb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEzLTMtMS0xLTYwMjYz_edad405b-6746-43b6-8179-a18c47fb61e9"
      unitRef="usd">1600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc24b95cad0a44dfa74ee686cfc4c554_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEzLTUtMS0xLTYwMjYz_5c4a28ce-e203-4fe6-9817-7a575441952a"
      unitRef="usd">-9400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e50ef11a0b74e949d7a233e7b69d9df_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEzLTctMS0xLTYwMjYz_6dde1da7-5548-4f3c-a68f-18f8831995de"
      unitRef="usd">-175400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1e6cb706114942e4aabe6faaacf4e663_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZToxNWI5NjZiZGUwYmE0MmM0YmRlYzBlZDQ4OWU5OTk3My90YWJsZXJhbmdlOjE1Yjk2NmJkZTBiYTQyYzRiZGVjMGVkNDg5ZTk5OTczXzEzLTktMS0xLTYwMjYz_9d7bb0cf-d47e-4e7f-92be-fe5ef9190c51"
      unitRef="usd">-183000000.0</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90ZXh0cmVnaW9uOmQ4NWNkMTg1N2NmMzQ4ODdiODE3ZTljY2IyNjI0MmFkXzQ2MQ_59ef8eda-ccb6-4374-af57-6f412247876b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Detail of components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on derivatives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of defined benefit pension and other postretirement plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Benefit Plans&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5c740ee53d14acab5e8ce562e9ed2b3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzItMi0xLTEtNjAyNjM_e308d694-87b6-4ee2-8d2e-19b5ff221887"
      unitRef="usd">1400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04413dcc613d457fb097e0213020ab3f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzItNC0xLTEtNjAyNjM_8e0ec28c-8fd6-4eb5-b75e-eb2da36b844d"
      unitRef="usd">-1100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32f586765ed14e30998543a97afb12e6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzItNi0xLTEtNjAyNjM_d16554f5-83ba-45c9-90bf-d7e59a058d86"
      unitRef="usd">-200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie5c740ee53d14acab5e8ce562e9ed2b3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzMtMi0xLTEtNjAyNjM_2f5efe0b-4e86-4643-aa1d-6a7bfda527af"
      unitRef="usd">4100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i04413dcc613d457fb097e0213020ab3f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzMtNC0xLTEtNjAyNjM_ac9165ac-048e-4844-b6ba-5030d4fe0afc"
      unitRef="usd">2400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i32f586765ed14e30998543a97afb12e6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzMtNi0xLTEtNjAyNjM_4f63ed2b-8969-4069-94f6-b034f1c2185f"
      unitRef="usd">-100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherIncome
      contextRef="ie5c740ee53d14acab5e8ce562e9ed2b3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzQtMi0xLTEtNjAyNjM_f255ffe9-d508-4fd4-9348-ac9cb4ead5a3"
      unitRef="usd">2400000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i04413dcc613d457fb097e0213020ab3f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzQtNC0xLTEtNjAyNjM_ce34f36d-470d-4d5d-a079-6d67e03839d0"
      unitRef="usd">1200000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i32f586765ed14e30998543a97afb12e6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzQtNi0xLTEtNjAyNjM_8884d662-75f2-43a0-961f-25485d307626"
      unitRef="usd">5900000</us-gaap:OtherIncome>
    <us-gaap:InterestExpense
      contextRef="id1a24648febc446d97d71a944faf23c8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzUtMi0xLTEtNjAyNjM_77e54f52-afe0-4109-91af-b2262ac1775b"
      unitRef="usd">300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icadfe694aab14a67aa2e38dfb55e6d5f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzUtNC0xLTEtNjAyNjM_ec82e128-805e-44c8-93a3-ad975c93500d"
      unitRef="usd">400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6d89b5b64b2f47fabc89d28b39c6abb3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzUtNi0xLTEtNjAyNjM_26c309b0-9922-4147-8971-52c9aec46cac"
      unitRef="usd">400000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9ec8f38ddecf4489927d3f56c19b2c35_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzYtMi0xLTEtNjAyNjM_a8021121-bbc1-4b7a-ab8b-8013de819f55"
      unitRef="usd">-600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8c01348d5d61478b9245598d8ff9f61e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzYtNC0xLTEtNjAyNjM_f0dd713e-05d4-4848-a2a9-e15186aa582b"
      unitRef="usd">-2700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id573bfa61009494da99108c926e21d55_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzYtNi0xLTEtNjAyNjM_0fb9aa64-70d1-4ecb-bdfa-979a124e62ea"
      unitRef="usd">5400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9ec8f38ddecf4489927d3f56c19b2c35_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzctMi0xLTEtNjAyNjM_2f7d78a7-c0fb-454a-83ee-c14562f34908"
      unitRef="usd">300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8c01348d5d61478b9245598d8ff9f61e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzctNC0xLTEtNjAyNjM_5da0517d-5208-495c-bf43-c4b4ff32427e"
      unitRef="usd">-600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id573bfa61009494da99108c926e21d55_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzctNi0xLTEtNjAyNjM_60630498-6e7c-4504-8887-3d1628ce01d2"
      unitRef="usd">1500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i9ec8f38ddecf4489927d3f56c19b2c35_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzgtMi0xLTEtNjAyNjM_31bb4345-78f6-408a-9c33-21fb8ed391d4"
      unitRef="usd">-900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8c01348d5d61478b9245598d8ff9f61e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzgtNC0xLTEtNjAyNjM_ba3344ce-70e4-4c0c-bba5-07d6691f07c5"
      unitRef="usd">-2100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id573bfa61009494da99108c926e21d55_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzgtNi0xLTEtNjAyNjM_4042277c-b78b-408f-885b-acfa6ba3e00f"
      unitRef="usd">3900000</us-gaap:NetIncomeLoss>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzExLTItMS0xLTYwMjYz_ce2af7a6-2eaa-45c1-addd-b9f5fc7734da"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzExLTQtMS0xLTYwMjYz_b51298b5-e68d-4376-8fb9-7f7506c5e857"
      unitRef="usd">-300000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzExLTYtMS0xLTYwMjYz_b2f709ba-111f-4ca7-8178-ede1ccc1e9c5"
      unitRef="usd">-600000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEyLTItMS0xLTYwMjYz_32e61eef-9236-4062-8529-77a6fef9dd10"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEyLTQtMS0xLTYwMjYz_f98ce3c9-7d1d-4b29-8363-c0038fbaf151"
      unitRef="usd">-200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEyLTYtMS0xLTYwMjYz_af96c5eb-eb36-4cd7-926b-e614bf532e87"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEzLTItMS0xLTYwMjYz_3ec66b47-d035-4b93-8824-f8839d89afb5"
      unitRef="usd">-52200000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEzLTQtMS0xLTYwMjYz_e56ca579-37ac-48cf-b634-f2e8f0f81b96"
      unitRef="usd">-1800000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzEzLTYtMS0xLTc3NjMx_fbafb532-ece6-42a6-a69a-28b73b9ac574"
      unitRef="usd">-3700000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE0LTItMS0xLTYwMjYz_097e431c-0de4-4aae-8df8-eb5a64862fb2"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE0LTQtMS0xLTYwMjYz_ce17d297-504e-4879-9c15-42c2fcec0498"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE0LTYtMS0xLTYwMjYz_05d669bc-b8bf-4a78-8f27-e652a5fdc55e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE1LTItMS0xLTYwMjYz_4fed5688-09a1-4e8d-bc5c-acd6bf088a7b"
      unitRef="usd">-52000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE1LTQtMS0xLTYwMjYz_7aed06be-eef7-48ae-a896-f793d940a08f"
      unitRef="usd">-1700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE1LTYtMS0xLTYwMjYz_5a7c0eb1-209a-4cbc-80d5-163378fbb9e3"
      unitRef="usd">-3200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE2LTItMS0xLTYwMjYz_aea5b87c-298b-4abb-81cc-18cc64b02ab7"
      unitRef="usd">-20300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE2LTQtMS0xLTYwMjYz_6bbc82ed-90a4-48a5-b6d8-02871c6d969a"
      unitRef="usd">-400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE2LTYtMS0xLTYwMjYz_6c21fcf1-2c87-481e-bc30-8adf4986afd1"
      unitRef="usd">-900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ic055761b579c47b981c810cd39e9aa70_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE3LTItMS0xLTYwMjYz_d222d32f-2fd7-4960-a29b-469b8f4cdf9f"
      unitRef="usd">-31700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3895a7e5ca804355bbf7dca9b8347a70_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE3LTQtMS0xLTYwMjYz_2d211a77-7a83-45b4-8f80-942fcb0108fa"
      unitRef="usd">-1300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibd44e8c5738247789b6b74ded20afe11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE3LTYtMS0xLTYwMjYz_29af54c9-b6ef-47d7-a535-b2797f568f4b"
      unitRef="usd">-2300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibe8ca4226e454ae6ac3d77c3f63f4645_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE4LTItMS0xLTYwMjYz_890280d6-0e61-4d5e-a210-b57dc8550cb7"
      unitRef="usd">-32600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i57bae4fdbc424d98b421183e9aa884b0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE4LTQtMS0xLTYwMjYz_18c16551-bcfc-45c9-b820-16c088c88c82"
      unitRef="usd">-3400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i35a7a2f289af4db3bb7d06fea36d17ae_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTUvZnJhZzpkODVjZDE4NTdjZjM0ODg3YjgxN2U5Y2NiMjYyNDJhZC90YWJsZTowZDRhY2FlN2NjMmI0NWMxOTRjODg5Mjg2OGZhZjY0ZC90YWJsZXJhbmdlOjBkNGFjYWU3Y2MyYjQ1YzE5NGM4ODkyODY4ZmFmNjRkXzE4LTYtMS0xLTYwMjYz_a238ecf0-f1f7-456e-a65d-59b9cd604765"
      unitRef="usd">1600000</us-gaap:NetIncomeLoss>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyNjQ_f5562dc5-3010-4842-848c-472c9645dc7b">Stock-Based Compensation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#x201c;2016 Plan&#x201d;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At December&#160;31, 2022, there were 1,681,526 shares remaining in the 2016 Plan for future grants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options and stock appreciation rights reduce the number of shares available by one share for each award granted. All other awards under the 2016 Plan will reduce the total number of shares available for grant by an amount equal to 2.5 times the number of shares awarded. If awards made under previous plans would entitle a plan participant to an amount of West stock in excess of the target amount, the additional shares (up to a maximum threshold amount) will be distributed under the 2016 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock option and appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, stock-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, cash-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, dividend equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plans and restricted share awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates expected forfeitures. The amount of unrecognized compensation expense for all non-vested awards as of December&#160;31, 2022 was $28.9 million, which is expected to be recognized over a weighted average period of 1.6 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options granted to employees vest in equal increments. All awards expire 10 years from the date of grant. Upon the exercise of stock options, shares are issued in exchange for the exercise price of the options. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in outstanding options:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the weighted average remaining contractual life of options outstanding and of options exercisable was 4.8 years and 4.0 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the aggregate intrinsic value of total options outstanding was $241.4 million, of which $225.6 million represented vested options.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the options was estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted average assumptions in 2022, 2021 and 2020: a risk-free interest rate of 1.8%, 0.8%, and 1.3%, respectively; stock volatility of 25.1%, 23.9%, and 22.4%, respectively; and dividend yields of 0.2%, 0.3%, and 0.4%, respectively. Stock volatility is estimated based on historical data and the impact from expected future trends. Expected lives, which are based on prior experience, averaged 5.6 years for 2022 and 2021 and 5.7 years for 2020. The weighted average grant date fair value of options granted in 2022, 2021 and 2020 was $96.43, $64.51 and $40.28, respectively. Stock option expense is recognized over the vesting period, net of forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2022, 2021 and 2020, the intrinsic value of options exercised was $60.1 million, $147.3 million and $88.8 million, respectively. The grant date fair value of options vested during those same periods was $8.8 million, $8.3 million and $8.4 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Appreciation Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock appreciation rights (&#x201c;SARs&#x201d;) granted to eligible international employees vest in equal annual increments over 4 years of continuous service. All awards expire 10 years from the date of grant. The fair value of each cash-settled SAR is adjusted at the end of each reporting period, with the resulting change reflected in expense. As of December&#160;31, 2022, SARs outstanding were 20,402, all of which were cash-settled. Upon exercise of a cash-settled SAR, the employee receives cash for the difference between the grant date price and the fair market value of the Company&#x2019;s stock on the date of exercise. As a result of the cash settlement feature, cash-settled SARs are recorded within other long-term liabilities. Upon exercise of a stock-settled SAR, shares are issued in exchange for the exercise price of the stock-settled SAR. As a result of the stock settlement feature, stock-settled SARs are recorded within equity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in outstanding SARs:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs vested and expected to vest, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs vested and exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs vested and expected to vest, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs vested and exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Awards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to stock options and SAR awards, we grant performance share unit (&#x201c;PSU&#x201d;) awards to eligible employees. These awards are earned based on the Company&#x2019;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock, whereas recipients of cash-settled PSU awards are entitled to receive a payment in cash per unit based on the fair market value of a share of our common stock at the end of the performance period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in our outstanding stock-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144,490)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares earned under PSU awards may vary from 0% to 200% of an employee&#x2019;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures. The weighted average grant date fair value of stock-settled PSU awards granted during the years 2022, 2021 and 2020 was $362.40, $333.58 and $177.31, respectively. Including forfeiture and target achievement expectations, we expect that the stock-settled PSU awards will convert to 94,480 shares to be issued over an average remaining term of one year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of cash-settled PSU awards is also based on the market price of our stock at the grant date. These awards are revalued at the end of each quarter based on changes in our stock price. As a result of the cash settlement feature, cash-settled PSU awards are recorded within other long-term liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in our outstanding cash-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also offer an Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), which provides for the sale of our common stock to eligible employees at 85% of the current market price on the last trading day of each quarterly offering period. Payroll deductions are limited to 25% of the employee&#x2019;s base salary, not to exceed $25,000 in any one calendar year. In addition, employees may not buy more than 2,000 shares during any offering period (8,000 shares per year). Purchases under the ESPP were 27,894 shares, 27,016 shares and 36,494 shares for the years 2022, 2021 and 2020, respectively. At December&#160;31, 2022, there were approximately 3,738,000 shares available for issuance under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Compensation Plans and Restricted Share Awards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred compensation plans include a Non-Qualified Deferred Compensation Plan for Non-Employee Directors, under which non-employee directors may defer all or part of their annual cash retainers. The deferred fees may be credited to a stock-equivalent account. Amounts credited to this account are converted into deferred stock units based on the fair market value of one share of our common stock on the last day of the quarter. For deferred stock units ultimately paid in cash, a liability is calculated at an amount determined by multiplying the number of units by the fair market value of our common stock at the end of each reporting period. In addition, deferred stock awards are granted on the date of our annual meeting, and are distributed in shares of common stock. In 2022, we granted 4,827 deferred stock awards, with a weighted grant date fair value of $300.78. In 2021, we granted 6,034 deferred stock awards, with a grant date fair value of $338.38. Similarly, a non-qualified deferred compensation plan for eligible employees provides for the conversion of compensation into deferred stock units. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the two deferred compensation plans held a total of 383,792 deferred stock units, including 9,366 units to be paid in cash.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In addition, during 2022, we granted 9,648 restricted share awards at a weighted grant-date fair value of $310.52 per share to employees under the 2016 Plan. During 2021, we granted 6,002 restricted share awards at a weighted grant-date fair value of $312.41 per share to employees under the 2016 Plan. During 2020, we granted 8,721 restricted share awards at a weighted grant-date fair value of $200.35 per share to employees under the 2016 Plan. The fair value of these awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzQ1MQ_d1640efd-755f-4085-8749-586de5f79e1e"
      unitRef="shares">1681526</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted
      contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzU5Mw_c7a1b273-7ec0-4018-bf4f-4564c3d292f0"
      unitRef="shares">1</wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted>
    <wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted
      contextRef="ie7a283afeb8f40c6817f0e72d6df5ccd_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc0NA_f1a6b43a-d886-46a5-8b33-00ec7ba79948"
      unitRef="shares">2.5</wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyNDk_15803c4a-a60a-4b2b-a7f5-2ae53ae29c76">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock option and appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, stock-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, cash-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, dividend equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plans and restricted share awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icd99140b0fe444a2968f0cf1a36fa8ce_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzEtMS0xLTEtNjAyNjM_0cef63f9-d96f-4d52-bf3a-3a42e08088a1"
      unitRef="usd">5600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id4be6b9f04b6470da6ab0ab85cb527ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzEtMy0xLTEtNjAyNjM_b5bfea4e-ea61-435c-9dac-9c0f5778e884"
      unitRef="usd">12500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i20ebcecb9d2c4a209b92fbebb9207661_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzEtNS0xLTEtNjAyNjM_adf86233-d51c-423e-8544-a71f6faa02c0"
      unitRef="usd">10200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6834a2454c954e5db472d9a40c33b13a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzItMS0xLTEtNjAyNjM_c86685f6-f427-439f-b0b9-9584b099f2ed"
      unitRef="usd">15600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3996b06720ee42ee8d78c7b8b11628f8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzItMy0xLTEtNjAyNjM_18a73eea-cf17-4541-9ce3-58074c59d442"
      unitRef="usd">17600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5167798386874e29a8044c426c90a599_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzItNS0xLTEtNjAyNjM_4480f49a-0805-4774-a75a-74172ef8c0f2"
      unitRef="usd">16600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzMtMS0xLTEtNjAyNjM_727678bb-5bca-4327-93fe-ca50e4ebd70c"
      unitRef="usd">-100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2c52a1e553d247a3ae76670f5304a50f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzMtMy0xLTEtNjAyNjM_a3864292-6027-42a5-8c02-ab91fdc61a18"
      unitRef="usd">1000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia216fe90970d46f4be2d33c145486b81_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzMtNS0xLTEtNjAyNjM_a9760ce9-a51c-4b0c-ab2d-001db38233fd"
      unitRef="usd">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia4ef8dd22a4a44f7beffb4e9f338e878_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzQtMS0xLTEtNjAyNjM_174b9e49-d7a0-4f18-9aad-93a92732e26e"
      unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i33c784d4eec04d78922a4e192bf59230_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzQtMy0xLTEtNjAyNjM_9d5a8f04-5a9e-4411-8b60-14c0e8fad2aa"
      unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia68e46033cf0466e976bea07f5d6efef_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzQtNS0xLTEtNjAyNjM_650cbb58-e089-4353-a28d-8aa9a111c8de"
      unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzUtMS0xLTEtNjAyNjM_c5d385bc-df61-4ceb-beaf-bc3033f93094"
      unitRef="usd">1300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i238ef97a2c414fa79ce155548aec647a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzUtMy0xLTEtNjAyNjM_0582a949-156a-4de9-98d6-1f16f5880fb9"
      unitRef="usd">1400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia1b919b91eeb42da9481eb832c9b75c9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzUtNS0xLTEtNjAyNjM_7f2d067a-09b9-4a56-8bcd-ec1e95f8d50a"
      unitRef="usd">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic2db706bfea84d8885a041634831858e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzYtMS0xLTEtNjAyNjM_b94af526-4cd7-4c29-b58c-b9da8028c5d4"
      unitRef="usd">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id638f8160a6944ce83eb5f9cd2ee6de7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzYtMy0xLTEtNjAyNjM_66a05c1c-780d-40a7-9cec-dc9331e60e74"
      unitRef="usd">4800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i718facb9187748eebcc936a4e7a55f42_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzYtNS0xLTEtNjAyNjM_7033ee9b-f225-4b98-9a61-2cc7bbdd0147"
      unitRef="usd">5100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzctMS0xLTEtNjAyNjM_58679a6a-983c-439d-bb31-21fa9c82a2f5"
      unitRef="usd">23700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzctMy0xLTEtNjAyNjM_eeb38042-5c86-46e4-8b21-8badaa1e58fa"
      unitRef="usd">37500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZToxNjNkMzViM2QyN2Y0YWI2OGYyNGRiMTY5M2UyY2VkZC90YWJsZXJhbmdlOjE2M2QzNWIzZDI3ZjRhYjY4ZjI0ZGIxNjkzZTJjZWRkXzctNS0xLTEtNjAyNjM_d3287b5c-72d3-4fa8-9b09-1ad78e6bb6c6"
      unitRef="usd">34000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzEzMjA_9c440b01-8ace-404c-b14c-02374920dc92"
      unitRef="usd">28900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzEzOTM_293803a5-babc-4383-b531-c13fde95ef2b">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzE0OTk_55ed9083-c53e-4fdf-be57-e854f8386b36">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyODQ_dc62e0ef-226b-440b-bbea-eef259bf247e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in outstanding options:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzEtMS0xLTEtNjAyNjM_6e9badaf-e049-41e3-8a74-6ea6fdab9235"
      unitRef="shares">2000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzItMS0xLTEtNjAyNjM_6b54a5df-382d-4ab0-baf1-12ad4e510cdc"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzMtMS0xLTEtNjAyNjM_0e24f790-2e77-4c70-879b-0774561ae48e"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzQtMS0xLTEtNjAyNjM_5ab52d49-5781-428a-9b51-abd4bb3702dc"
      unitRef="shares">-0.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzUtMS0xLTEtNjAyNjM_10383282-cb2f-443b-9079-fa7532b0c519"
      unitRef="shares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzYtMS0xLTEtNzI1MTQ_849434d2-9d09-4b36-9c01-524957ae3f82"
      unitRef="shares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozOTE1Y2Q2YmVjZGY0YzU1OTA0ZDZlZTA0ODFjMzExOC90YWJsZXJhbmdlOjM5MTVjZDZiZWNkZjRjNTU5MDRkNmVlMDQ4MWMzMTE4XzYtMS0xLTEtNjAyNjM_b51e2ec4-ef1c-487a-b247-9ab1ec50cf60"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzEtMS0xLTEtNjAyNjM_2cddacd5-bad9-4ad7-9fdd-e674a426697a"
      unitRef="usdPerShare">101.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzItMS0xLTEtNjAyNjM_8255c80f-df55-435f-85a0-1371eadd5b62"
      unitRef="usdPerShare">364.47</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzMtMS0xLTEtNjAyNjM_0ac8afbe-ce96-44b0-ad8d-9f23cb189662"
      unitRef="usdPerShare">83.77</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzQtMS0xLTEtNjAyNjM_2df02d99-665d-4e5d-b2f1-b6af48bd6237"
      unitRef="usdPerShare">224.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzUtMS0xLTEtNjAyNjM_89e2beac-9814-4fef-ad1b-7ab624fbe2a1"
      unitRef="usdPerShare">118.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzYtMS0xLTEtNzI1MDQ_5c951539-90b6-42b7-9bb7-e13e116a48db"
      unitRef="usdPerShare">116.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4OGVjZWUwOWUzODg0YTY4YTA2Y2E3ZDJkYzQ4OGM1NS90YWJsZXJhbmdlOjg4ZWNlZTA5ZTM4ODRhNjhhMDZjYTdkMmRjNDg4YzU1XzYtMS0xLTEtNjAyNjM_1a548430-480b-4107-bf19-308914b63a0b"
      unitRef="usdPerShare">84.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzE4MjA_9fc89af9-b05f-4266-9feb-6623bf394b93">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzE4MzM_f62dc658-950f-44bc-8a60-8a65f0754791">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzE5MzE_60e94451-13c9-4960-a772-2c2595a7aa1c"
      unitRef="usd">241400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzE5NDQ_08969107-3325-4656-856b-5d2caf483173"
      unitRef="usd">225600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxODY_98711a81-6b05-413a-a329-d977b9985d95"
      unitRef="number">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i58930e1b5c274240b867fdb589c2ab06_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxOTA_ecdf8c91-66b7-4394-b3f0-5ea13f0dc896"
      unitRef="number">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie41ef75fe7f74deeb695babb739e40e5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxOTg_59d8ee72-0355-4139-8e7c-e7cc129b4a0b"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIyMzY_df160480-e304-452a-a42b-e05b95d1b255"
      unitRef="number">0.251</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i58930e1b5c274240b867fdb589c2ab06_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIyNDA_e798b1c7-6fd1-480e-bb52-8740cd131393"
      unitRef="number">0.239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie41ef75fe7f74deeb695babb739e40e5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIyNDg_151baa80-8dbd-4cb4-8a32-54fc54c0cec0"
      unitRef="number">0.224</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIyODk_ab0f0079-03e8-4ad8-bed7-ecdfaa1aa670"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i58930e1b5c274240b867fdb589c2ab06_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIyOTM_ca3dc5a3-dcfe-43fb-b01d-714740f051a2"
      unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie41ef75fe7f74deeb695babb739e40e5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIzMDE_a5a393ac-3eeb-49a7-b1bf-b4c011505ffb"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i035a9a957acc49c986ed0b7322eed14b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI0ODA_16d87623-4ce9-4af3-8e2a-f028ee6bbfd6">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i58930e1b5c274240b867fdb589c2ab06_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI0ODA_7dbee8c1-93b8-4abf-aa4b-1c7f74bf940e">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie41ef75fe7f74deeb695babb739e40e5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxOTkwMjMyNjM4NTM_880e3f04-5a10-47dc-9461-d4ff25dd3022">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI2MDc_8fd91f76-2b8c-4b3d-8515-d7c80c20588e"
      unitRef="usdPerShare">96.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI2MTE_c5b15c15-308e-44bd-a024-ffe4a7429f1b"
      unitRef="usdPerShare">64.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI2MTg_4cd39e2c-3578-4877-9354-5c4f063278f2"
      unitRef="usdPerShare">40.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI4MTA_0b516679-5a24-47f9-a9e7-b59a0e4a8f91"
      unitRef="usd">60100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI4MTQ_7da7dd6d-7ab7-45a5-a84a-742844dec979"
      unitRef="usd">147300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI4MjE_9d93f729-d357-45d7-9f78-f02b7e1ce4fa"
      unitRef="usd">88800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI5MTM_eeb15c23-e573-4ea2-8592-8653a91d0e3c"
      unitRef="usd">8800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI5MTc_5224d242-dd26-4be5-95e8-0591972b01cb"
      unitRef="usd">8300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzI5MjQ_a875e980-32b5-4451-8f8c-3be716f2373d"
      unitRef="usd">8400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzMwODY_fc2b5b9b-2e9b-47cb-be7b-803a59cfb554">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzMxMzA_7c157952-79b2-4cdd-98d7-5f0fdb682659">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzMzMjY_12306caf-b349-4deb-a955-ae6f1b9bb470"
      unitRef="shares">20402</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyNjM_fbe1884b-40cd-4138-9092-0c069f9a664a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in outstanding SARs:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs vested and expected to vest, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs vested and exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs vested and expected to vest, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs vested and exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i756408cda2044016850493d82b241ade_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzEtMS0xLTEtNjAyNjM_a5eb2504-d9aa-46ae-b8f7-c078622215e9"
      unitRef="shares">21054</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzItMS0xLTEtNjAyNjM_396a5baf-2717-42db-b7a9-2f88ce0908b2"
      unitRef="shares">520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzMtMS0xLTEtNjAyNjM_f4ba2f0e-a744-4671-bf23-8f12419878dd"
      unitRef="shares">1169</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzQtMS0xLTEtNjAyNjM_d0dd3bdf-4a76-46f9-af86-076658efcd48"
      unitRef="shares">3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzUtMS0xLTEtNjAyNjM_c88a79fb-29d7-4f3c-9ba6-9d522b0cbb85"
      unitRef="shares">20402</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber
      contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzYtMS0xLTEtNzI1MTY_66d383a7-a781-4ba6-b438-c3e5123216cf"
      unitRef="shares">20402</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber
      contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo1NmMwYTc0OWQ4ZWQ0YWY1OWMwZDQ4NDE4MzUwNDNhNS90YWJsZXJhbmdlOjU2YzBhNzQ5ZDhlZDRhZjU5YzBkNDg0MTgzNTA0M2E1XzYtMS0xLTEtNjAyNjM_be29bd96-0333-42d1-8fc9-e2f589924418"
      unitRef="shares">17450</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i756408cda2044016850493d82b241ade_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzItMS0xLTEtNjAyNjM_66ae7732-0d8d-4b73-b488-4e8589ea7c8a"
      unitRef="usdPerShare">88.18</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzMtMS0xLTEtNjAyNjM_b5c923dd-6c41-43ba-9d10-a64d8e733c8c"
      unitRef="usdPerShare">369.13</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzQtMS0xLTEtNjAyNjM_90149076-be8f-4343-ba5e-ec3a5df7bcdd"
      unitRef="usdPerShare">54.64</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzUtMS0xLTEtNjAyNjM_fd0dee62-bec7-471c-b612-b4086a370b07"
      unitRef="usdPerShare">21.22</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzYtMS0xLTEtNjAyNjM_89133271-df1b-4aee-872e-5ccdd8ffd282"
      unitRef="usdPerShare">97.28</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice
      contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzctMS0xLTEtNzI1MTg_d3555198-dd53-41ec-9c4d-95f1cf823483"
      unitRef="usdPerShare">97.28</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice
      contextRef="i3d21da9c07e842308653dc6c5d692c08_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpmMWEzY2ZjMzEyZTc0MWQyYjdjZTQ2NjJjZmZhNWFjZS90YWJsZXJhbmdlOmYxYTNjZmMzMTJlNzQxZDJiN2NlNDY2MmNmZmE1YWNlXzctMS0xLTEtNjAyNjM_f6deeb7c-48af-4c93-b937-bc66c44edffc"
      unitRef="usdPerShare">74.86</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyNjc_cc11e299-8422-414b-bdca-fc11a465d0e1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in our outstanding stock-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144,490)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="icbc7d817970f475e8dee97b98a3a0b5a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzEtMS0xLTEtNjAyNjM_a28e5132-e3f7-4af0-9898-5f94bba0c009"
      unitRef="shares">164474</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzItMS0xLTEtNjAyNjM_d292de2e-8551-4d44-9b76-2ea6a5216042"
      unitRef="shares">32109</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzMtMS0xLTEtNjAyNjM_523855ca-a9b1-4333-a0d1-4549ab6f1453"
      unitRef="shares">68426</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzQtMS0xLTEtNjAyNjM_6bb1f2ae-8922-4771-8632-879e554900a6"
      unitRef="shares">144490</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzUtMS0xLTEtNjAyNjM_0119eccf-531a-47c5-917b-a373745ee7b7"
      unitRef="shares">7966</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i614e5023b53d4eab9f1069365d95f319_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzYtMS0xLTEtNjAyNjM_57c6af54-0375-4274-8740-e978110b0492"
      unitRef="shares">112553</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="icbc7d817970f475e8dee97b98a3a0b5a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzktMS0xLTEtNjAyNjM_bdb8caee-7ba1-4de5-8c3d-d94ad0d1d160"
      unitRef="usdPerShare">179.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzEwLTEtMS0xLTYwMjYz_ba01a35b-f26f-49f4-a8dc-55675b8eb786"
      unitRef="usdPerShare">362.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzExLTEtMS0xLTYwMjYz_119fb080-f461-4956-8593-158047aa7f33"
      unitRef="usdPerShare">106.57</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzEyLTEtMS0xLTYwMjYz_a6c916b3-8d1f-4fd0-b408-ef7bd1d50cf4"
      unitRef="usdPerShare">369.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzEzLTEtMS0xLTYwMjYz_6cd170e9-d360-4f6b-b08f-8079ab1434b1"
      unitRef="usdPerShare">240.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i614e5023b53d4eab9f1069365d95f319_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTo4NGJiZmUyZGJmOWU0MTM3YWZmNWUyNjJmZjJiYjg1Zi90YWJsZXJhbmdlOjg0YmJmZTJkYmY5ZTQxMzdhZmY1ZTI2MmZmMmJiODVmXzE0LTEtMS0xLTYwMjYz_7471539b-37d9-469d-9599-ca4ca3d8f72e"
      unitRef="usdPerShare">278.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage
      contextRef="i747f5bde668b43608459580452ed13c2_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzQ3NTM_ebafab32-cd95-4159-99aa-3072c6973a9c"
      unitRef="number">0</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage
      contextRef="i0b4e19b379674031b1a3259ea2819573_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzQ3NTk_b5c75370-a035-4a94-94d4-5e3e3e470b5f"
      unitRef="number">2</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzUxMzM_44d49ba2-e3dc-4b40-94a8-86bf14f6455e"
      unitRef="usdPerShare">362.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib8ccc47a7d0f4470933be376826c61d0_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzUxMzc_6a46bb6e-b26c-446f-b9a5-c317663e5f95"
      unitRef="usdPerShare">333.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5865c2fe32d348938d9c4f301afde2ed_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzUxNDQ_63f70d1c-8758-4b8a-a04e-8ff5a44c3836"
      unitRef="usdPerShare">177.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting
      contextRef="i614e5023b53d4eab9f1069365d95f319_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzUyODA_04c2fd16-921d-44de-819b-a3094cd2e3b4"
      unitRef="shares">94480</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="if14b97867296473e92081e449e76b6d4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzUzMzc_9f4bd6f8-20a1-4473-9a1d-40e5c808442a">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzgyNTY_204b2226-a77f-408e-aa0f-d2ea5435b3ad">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in our outstanding cash-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ibacbcc57bab8485890bc85e0309a4c6a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzEtMS0xLTEtNjAyNjM_e4bd0367-e0b3-4cd0-8425-f99cec68c1fb"
      unitRef="shares">1318</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzItMS0xLTEtNjAyNjM_9d5b9504-4293-40ae-a05a-de2ea0a3daf1"
      unitRef="shares">136</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzMtMS0xLTEtNjAyNjM_7bc68d20-630d-457c-84b8-1ae3d6e27209"
      unitRef="shares">507</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzQtMS0xLTEtNjAyNjM_fc6b935e-b690-4d8c-b754-1f3b97bd2a7d"
      unitRef="shares">1071</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzUtMS0xLTEtNjAyNjM_d58b5d09-1295-43d5-850b-4c1dbb3e1132"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2e4d798726024904a0f9840ffb306523_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTpjYjJmNDczOGIyNDQ0NTM0ODM3N2RiYmZhYzY2OWRmOC90YWJsZXJhbmdlOmNiMmY0NzM4YjI0NDQ1MzQ4Mzc3ZGJiZmFjNjY5ZGY4XzYtMS0xLTEtNjAyNjM_37057a59-d248-43ad-bdfc-12f5e93d2de9"
      unitRef="shares">890</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ibacbcc57bab8485890bc85e0309a4c6a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzEtMS0xLTEtNjAyNjM_8ce54f9d-767b-4edf-a67e-bf13a4cbffa7"
      unitRef="usdPerShare">169.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzItMS0xLTEtNjAyNjM_707a9069-7b6f-4845-b089-144aa683f74f"
      unitRef="usdPerShare">369.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzMtMS0xLTEtNjAyNjM_ad664428-3c74-48c2-9500-aa2fb76f559f"
      unitRef="usdPerShare">104.44</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzQtMS0xLTEtNjAyNjM_3c898fe4-0fc5-40b6-b90b-897ffa7a08e0"
      unitRef="usdPerShare">369.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ic3b96b502d6748be8cb8596afb522f43_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzUtMS0xLTEtNjAyNjM_1b624a37-aeea-431d-9e9a-25d94d811120"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2e4d798726024904a0f9840ffb306523_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90YWJsZTozMTcyNDdhZGIwMzA0MmQ1YmMzMzFhYjg5Mjk0ZDEzMC90YWJsZXJhbmdlOjMxNzI0N2FkYjAzMDQyZDViYzMzMWFiODkyOTRkMTMwXzYtMS0xLTEtNjAyNjM_5963f885-a15f-4c20-aba4-dc40c005a402"
      unitRef="usdPerShare">242.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzU5MDY_3cfa2e1f-23b5-4fb4-b0dd-ed69bf5afc37"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i16b25fe7a8fb4b17a57c7cc7d9884e52_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYwMzA_177d2c52-8d48-4470-b646-59b074d65a65"
      unitRef="number">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount
      contextRef="i16b25fe7a8fb4b17a57c7cc7d9884e52_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYwNzg_45b1ed69-3d62-43f8-a964-b4e921e1ecfc"
      unitRef="usd">25000</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYxNTI_17aa71bb-cbb2-4439-9dbe-400038142ab8"
      unitRef="shares">2000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear
      contextRef="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYxOTA_77bb18ae-8205-4267-815c-bff2f6768962"
      unitRef="shares">8000</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ie2f62a23051e455c9c4f913e0b5519a4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYyNDE_ede85acb-41ae-4739-b350-d8a64c775009"
      unitRef="shares">27894</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i238ef97a2c414fa79ce155548aec647a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYyNTI_1271ab6d-7b4b-4d48-bd07-b2ad6e04686d"
      unitRef="shares">27016</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ia1b919b91eeb42da9481eb832c9b75c9_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYyNjY_2850f99d-41ab-4feb-ab04-bba936d0ca55"
      unitRef="shares">36494</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i16b25fe7a8fb4b17a57c7cc7d9884e52_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzYzNTE_832709c5-4053-4f58-83b9-98169e910968"
      unitRef="shares">3738000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <wst:DeferredCompensationArrangementWithIndividualConversionUnit
      contextRef="i9aa30653f5684e34aaab6637e5921d32_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzY4MzA_ac08b34c-49c5-4754-9f30-de6916f028e4"
      unitRef="shares">1</wst:DeferredCompensationArrangementWithIndividualConversionUnit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie73ec10e708d43e191bb939a896cda33_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzcyNTU_84355e6a-93b3-484f-a52b-ac4f87a0dc4f"
      unitRef="shares">4827</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie73ec10e708d43e191bb939a896cda33_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzczMjI_a5264433-bb67-4d29-937f-1e8dc3724f4a"
      unitRef="usdPerShare">300.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i26532d87fb9149e18d431a1b831b2c44_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzczNDY_2a05a75a-e9e3-4176-b37e-ff036619cc42"
      unitRef="shares">6034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i26532d87fb9149e18d431a1b831b2c44_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc0MDQ_c5ae5283-f8a1-4349-a1cd-76dbbe272c39"
      unitRef="usdPerShare">338.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:DeferredCompensationArrangementWithIndividualNumberOfPlans
      contextRef="ia88b9ad9e7de41e78648c5f18d9cde1c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc1NzA_28409861-94bd-4e13-9b4b-9cf04052a03d"
      unitRef="plan">2</wst:DeferredCompensationArrangementWithIndividualNumberOfPlans>
    <wst:DeferredCompensationArrangementWithIndividualShareEquivalentsBalance
      contextRef="ia88b9ad9e7de41e78648c5f18d9cde1c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc2MTc_385c3546-d625-46b7-8a5c-7a8493369529"
      unitRef="shares">383792</wst:DeferredCompensationArrangementWithIndividualShareEquivalentsBalance>
    <wst:DeferredStockUnitsPayableInCash
      contextRef="ia88b9ad9e7de41e78648c5f18d9cde1c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc2NTI_5a2cc44a-fcff-4371-b742-a018bddb7dda"
      unitRef="shares">9366</wst:DeferredStockUnitsPayableInCash>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib4919d2983094e91beec7377b6d8b34f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc3MTc_f365f3a1-8dcd-451d-9205-22fc8018c4b5"
      unitRef="shares">9648</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib4919d2983094e91beec7377b6d8b34f_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc3ODM_715a2af2-001d-4309-b940-90a961b8bd90"
      unitRef="usdPerShare">310.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i560792d170344831a5edf3fe6812792a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc4NTI_ebad866c-2e17-4267-8093-5195a93b8a0f"
      unitRef="shares">6002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i560792d170344831a5edf3fe6812792a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzc5MTg_5775c63f-568a-478e-986c-0ac88898d2cd"
      unitRef="usdPerShare">312.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i628d30d7315b4fcb9acfb4cf5dc8be01_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxOTkwMjMyNjM4OTI_0f89a980-3eb8-40a9-9701-11f060fc2e2f"
      unitRef="shares">8721</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i628d30d7315b4fcb9acfb4cf5dc8be01_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMTgvZnJhZzowY2JiNWFjOGNhMzI0YjhjYTE3ZGMyNTc1MWM4ZDM0Yi90ZXh0cmVnaW9uOjBjYmI1YWM4Y2EzMjRiOGNhMTdkYzI1NzUxYzhkMzRiXzIxOTkwMjMyNjM4OTY_48f7a1d8-541d-4c6a-948d-e55f6bf358e0"
      unitRef="usdPerShare">200.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzgwMDE_6e4bef0a-7acf-4e4a-bfe3-87ce2ba82295">Benefit Plans &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our U.S. and international subsidiaries sponsor defined benefit pension plans. In addition, we provide minimal death benefits for certain U.S. retirees and pay a portion of healthcare costs for retired U.S. salaried employees and their dependents. Benefits for participants are coordinated with Medicare when possible. We also sponsor a defined contribution plan for certain salaried and hourly U.S. employees. Our 401(k) plan contributions were $22.8 million for 2022, $19.5 million for 2021 and $16.8 million for 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pension and Other Retirement Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net periodic benefit cost and other amounts recognized in OCI were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss (gain) arising during period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit arising during period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit cost by geographic location is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.755%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The service cost component included within net periodic benefit cost is considered employee compensation and is therefore presented within the selling, general, and administrative and costs of goods and services sold financial statement line items of our consolidated statements of income. The remaining components of net periodic benefit cost are reported separately and are therefore presented within the other nonoperating expense (income) financial statement line item of our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During 2021, the Company approved the termination of our U.S. qualified defined benefit pension plan (the "U.S. pension plan"). During 2021, a Notice of Intent to Terminate was sent to all interested parties and in 2022 a favorable determination letter was received from the Internal Revenue Service. During 2022, lump sum payments were offered to all current employees and former employees with vested benefits under the U.S. pension plan. A cash contribution of $7.1&#160;million was made by the Company to ensure the U.S. pension plan was fully funded in preparation for the group annuity contract purchase which was executed in August of 2022 to settle the outstanding benefit obligations, as well as to cover any ancillary benefits and expenses remaining. During 2022, we recorded &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$52.2&#160;million pension settlement charge within &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_2be9eb86-8ff4-486b-8e82-82feaaba79be"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_2c156bb7-09f9-4046-a1d8-d4f0d3157eef"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzMyOTg1MzQ4OTQxNDA_41e09201-abff-4427-8518-3065d9e10039"&gt;other nonoperating expense (income)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;, which primarily related to the full settlement and relief of the historical balance sheet position, inclusive of accumulated other comprehensive income, of the U.S. pension plan. During 2021 and 2020, we recorded a $1.8&#160;million and $3.7&#160;million, respectively, pension settlement charge within other nonoperating expense (income), as we determined that normal-course lump-sum payments for the U.S. pension plan exceeded the threshold for settlement accounting under U.S. GAAP for the year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, we contributed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$7.1&#160;million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to our U.S. pension plan. During 2021, we did not contribute to our U.S. pension plan. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amendments/transfers in&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International pension plan assets, at fair value, included in the preceding table were $29.4 million and $49.3 million at December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in the balance sheet were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts in accumulated other comprehensive loss, pre-tax, consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated benefit obligation for all defined benefit pension plans was $52.4 million and $265.2 million at December&#160;31, 2022 and 2021, respectively, including $46.0 million and $73.0 million, respectively, for international pension plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, our United Kingdom qualified defined benefit pension plan had plan assets in excess of its obligations. As of December&#160;31, 2021, our U.S. and United Kingdom qualified defined benefit pension plan had assets in excess of its obligations. As of December&#160;31, 2022 and December&#160;31, 2021, our other defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows. The expected benefit payments listed correspond to regular ongoing benefit payments expected to be made by the plan during future years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 to 2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2023, we expect to contribute $0.6&#160;million to pension plans, all of which is in the U.S. In addition, we expect to contribute $0.6&#160;million for other retirement benefits in 2023. We periodically consider additional, voluntary contributions depending on the investment returns generated by pension plan assets, changes in benefit obligation projections and other factors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine net periodic benefit cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine the benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The discount rate used to determine the benefit obligations for U.S. pension plans was 5.55% and 2.95% as of December 31, 2022 and 2021, respectively. The weighted average discount rate used to determine the benefit obligations for all international plans was 4.20% and 1.32% as of December 31, 2022 and 2021, respectively. The weighted average rate of compensation increase for all international plans was 3.09% for 2022 and 2.79% for 2021, while there was no rate increase for the U.S. plans since they are frozen. Other retirement benefits were only available to U.S. employees. The expected long-term rate of return for U.S. plans was 3.70% for 2022, 5.10% for 2021 and 5.10% for 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumed healthcare cost trend rate used to determine benefit obligations was 6.75% for all participants in 2022, decreasing to 5.0% by 2030. The assumed healthcare cost trend rate used to determine net periodic benefit cost was 6.25% for all participants in 2022, decreasing to 5.0% by 2027.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The defined pension plan benefit obligation decreased for the year ended December&#160;31, 2022 primarily due to settlement losses recognized during the year, as well as an increase in the discount rate used to calculate the obligation. The net actuarial losses will be impacted in future periods by actual asset returns, discount rate changes, currency exchange rate fluctuations, actual demographic experience, and certain other factors. The other retirement plan benefit obligation decreased due an increase in the discount rate used to calculate the obligation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company has cash balance plans and other plans with promised interest crediting rates. For these plans, the interest crediting rates are set in line with plan rules or country legislation and do not change with market conditions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The weighted average interest crediting rating used to determine net periodic benefit cost by geographic location for our pension plans, at December 31, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diversification across and within asset classes is the primary means by which we mitigate risk. We maintain guidelines for all asset and sub-asset categories in order to avoid excessive investment concentrations. Fund assets are monitored on a regular basis. If at any time the fund asset allocation is not within the acceptable allocation range, funds will be reallocated. We also review the fund on a regular basis to ensure that the investment returns received are consistent with the short-term and long-term goals of the fund and with comparable market returns. We are prohibited from pledging fund securities and from investing pension fund assets in our own stock, securities on margin or derivative securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the target asset allocations and acceptable allocation ranges across:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25% - 30%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63% - 68%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2% - 7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#x201c;NAV&#x201d;) have not been classified in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ4OA_1da5a3ad-2386-4510-be8d-87fae94b484f"
      unitRef="usd">22800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ5OQ_3daf23bd-27e7-4d2b-bf0d-fbc56f99c76b"
      unitRef="usd">19500000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzUxMw_113fa090-800a-4c40-983e-7c039e4ff1c8"
      unitRef="usd">16800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzgwMTI_ec6b3372-0d59-4b0e-8d62-d360ad45a2fc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net periodic benefit cost and other amounts recognized in OCI were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss (gain) arising during period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit arising during period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit cost by geographic location is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.755%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtMS0xLTEtNjAyNjM_9e03eca6-0852-4ee4-9742-6a108bb1d2b1"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtMy0xLTEtNjAyNjM_1feb771c-371d-4a78-b78a-cbf3a173d791"
      unitRef="usd">1600000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtNS0xLTEtNjAyNjM_3c1ba90e-713b-4ee0-9d1c-03abe5cda0fa"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtNy0xLTEtNjAyNjM_f514688c-f3dd-4b1b-8ef4-c287357cf683"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtOS0xLTEtNjAyNjM_0d1b77bb-1a1c-4c77-893c-d8118c12bd34"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzMtMTEtMS0xLTYwMjYz_a86e7d47-ce4e-4171-adad-ee68bfd665a3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtMS0xLTEtNjAyNjM_99456715-9f3c-4688-a0e8-afe59cb3bb8a"
      unitRef="usd">4200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtMy0xLTEtNjAyNjM_40518726-7a0a-44a8-8d70-27e54cc0ca43"
      unitRef="usd">6200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtNS0xLTEtNjAyNjM_04bf606c-4250-400f-afb5-5d0f245663fe"
      unitRef="usd">7100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtNy0xLTEtNjAyNjM_a04b0a09-f4c9-490e-aafe-ccff712936d2"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtOS0xLTEtNjAyNjM_5edef238-4338-424a-a07c-9d62ef5d99db"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzQtMTEtMS0xLTYwMjYz_7d73d31a-a7f6-4a94-8c10-6338df2caa19"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtMS0xLTEtNjAyNjM_a4ba013b-559f-4a70-83e4-f881a28025c4"
      unitRef="usd">6100000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtMy0xLTEtNjAyNjM_a10ae0eb-f58a-4e98-aeb5-77d6d653c857"
      unitRef="usd">11900000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtNS0xLTEtNjAyNjM_178de7ab-79a9-4ddd-897b-a03b8e48cdf8"
      unitRef="usd">11700000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtNy0xLTEtNjAyNjM_2523bf88-191a-4423-88a9-b7c6440c0dd1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtOS0xLTEtNjAyNjM_2a31e586-d516-4d4a-8625-61371d4a804b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzUtMTEtMS0xLTYwMjYz_949338cf-128a-4f60-af14-86466998260d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtMS0xLTEtNjAyNjM_39979153-63da-4917-9e48-bcacb244716f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtMy0xLTEtNjAyNjM_6ad6d7d2-65d5-4abe-8d10-de26b910de26"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtNS0xLTEtNjAyNjM_195a9026-03e7-4d35-a680-8c695c5c368b"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtNy0xLTEtNjAyNjM_4ef80348-3ba6-4377-ae91-5b26ed923142"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtOS0xLTEtNjAyNjM_04889ba8-2034-404a-a242-91ae8025943e"
      unitRef="usd">-400000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzYtMTEtMS0xLTYwMjYz_fd5148bb-8f55-4ee9-b731-611f6e380909"
      unitRef="usd">-700000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtMS0xLTEtNjAyNjM_05491a4f-decb-4243-8cf5-9b28b1e9fc99"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtMy0xLTEtNjAyNjM_c270cb75-3588-4f1e-859c-c05596286ef6"
      unitRef="usd">-1800000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtNS0xLTEtNjAyNjM_534a59ef-cdd6-4480-bed7-93a65b4cdea7"
      unitRef="usd">-2000000.0</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtNy0xLTEtNjAyNjM_31dd0a42-1d53-467e-90cb-0f4add74070e"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtOS0xLTEtNjAyNjM_5402751e-c776-467e-b6e5-bf8c06d4dcda"
      unitRef="usd">1600000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzgtMTEtMS0xLTYwMjYz_22e3a1ac-45e3-43ab-9a6d-a2cde4c04ff3"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktMS0xLTEtNjAyNjM_5b3ee8a5-2aa7-4bf3-a11c-1217901ed27e"
      unitRef="usd">-52200000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktMy0xLTEtNjAyNjM_126389d1-4125-4478-a7b1-2877a62d74a6"
      unitRef="usd">-1800000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktNS0xLTEtNjAyNjM_58025b61-53fd-4cf3-b5d2-a6cfc105dcaf"
      unitRef="usd">-3700000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktNy0xLTEtNjAyNjM_c04f4331-206f-4dd2-947c-4c71a06ba421"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktOS0xLTEtNjAyNjM_a8dd0908-73f6-429a-abb0-7f457b852e69"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzktMTEtMS0xLTYwMjYz_cf261c72-e468-43db-9807-445d6cebf178"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTEtMS0xLTYwMjYz_e82f5fdf-5e39-4545-8a4a-53e0e0429a39"
      unitRef="usd">1000000.0</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTMtMS0xLTYwMjYz_333db657-f0f1-4ee9-bc0c-e22ca63664c3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTUtMS0xLTYwMjYz_53a77c89-edec-41f6-917a-99f5586ae92e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTctMS0xLTYwMjYz_8e7c5b97-23c5-4b76-a7c4-d4d9911c074d"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTktMS0xLTYwMjYz_14eb7ee3-6397-4c71-997b-9176808af931"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEwLTExLTEtMS02MDI2Mw_d5dfacd8-4597-4fe6-b6f3-5086e7fb6f10"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTEtMS0xLTYwMjYz_cc9b202e-3697-45fd-bfc0-c2d1d1f7e66c"
      unitRef="usd">54100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTMtMS0xLTYwMjYz_9660b910-decf-47d6-ba18-2a37c4bd48c8"
      unitRef="usd">-400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTUtMS0xLTYwMjYz_43602cb3-cfd6-4332-a5ef-3e4c31da4d98"
      unitRef="usd">2700000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTctMS0xLTYwMjYz_d25d2368-8598-47ed-bd38-a5bcabae231b"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTktMS0xLTYwMjYz_36193b6a-fd48-4e2b-a0cb-1b0f38b7a9f4"
      unitRef="usd">-1800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzExLTExLTEtMS02MDI2Mw_279b4017-e89b-4270-ae5c-9b87723cdf9e"
      unitRef="usd">-2400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTEtMS0xLTYwMjYz_4d7a07f9-f4cb-4833-b92b-3e3d2f9cd200"
      unitRef="usd">-16000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTMtMS0xLTYwMjYz_df32f012-c3b0-4899-af6e-3d101f7e5485"
      unitRef="usd">6300000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTUtMS0xLTYwMjYz_a9433e11-0dce-4db5-9700-df5fd9d60e10"
      unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTctMS0xLTYwMjYz_604f82bd-67d8-413b-bdd1-62711b05c9f8"
      unitRef="usd">2000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTktMS0xLTYwMjYz_9ee66caf-6217-4550-af99-ca4a515a943a"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzEzLTExLTEtMS02MDI2Mw_3d93d96d-1366-4377-b15a-ce0e7d9e20e8"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTEtMS0xLTYwMjYz_fbbc4a41-ec80-427d-a0ec-7fc0c1abe86c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTMtMS0xLTYwMjYz_8a308029-815c-495e-9564-597fa0a3c807"
      unitRef="usd">-2000000.0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTUtMS0xLTYwMjYz_3fd7d4b1-2850-4a83-9c3a-613c65e53d2f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTctMS0xLTYwMjYz_f08bd9ee-22d6-4f74-904a-d4185dac51b9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTktMS0xLTYwMjYz_6aea0165-a405-42e4-b765-8ae7829ee435"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE0LTExLTEtMS02MDI2Mw_4a576a63-fffd-4e66-b7d0-73f5542dda8f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTEtMS0xLTYwMjYz_1ca6055b-2cd0-4b5f-9fe5-ae5a125b5bf4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTMtMS0xLTYwMjYz_86c87f73-5d97-4acc-9a71-9d8c45624365"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTUtMS0xLTYwMjYz_512f8a24-bcfb-4cd4-ad2c-014cb5974356"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTctMS0xLTYwMjYz_c9f92258-8b34-460b-9a57-4deacf73e3b5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTktMS0xLTYwMjYz_93256487-17f1-4670-bf24-aab1cb89d2b9"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE1LTExLTEtMS02MDI2Mw_55c9d415-5f14-49c0-bb68-fcec72588d10"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTEtMS0xLTYwMjYz_e9332a88-87ab-401b-8a35-ac32a9779acd"
      unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTMtMS0xLTYwMjYz_fb739419-9925-4ad2-a40b-8263bcac52bc"
      unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTUtMS0xLTYwMjYz_7f7a1567-60fb-4123-bdf5-026cbb5a49b7"
      unitRef="usd">-2000000.0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTctMS0xLTYwMjYz_1a3a5cff-c415-45ed-ad0a-2dd87b8ebf13"
      unitRef="usd">1900000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTktMS0xLTYwMjYz_e6279c14-9626-4d64-b5fe-c7f97fbab49f"
      unitRef="usd">1600000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE3LTExLTEtMS02MDI2Mw_335a567a-ed3c-4b97-9a69-3a8973d7a3bb"
      unitRef="usd">1900000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTEtMS0xLTYwMjYz_38e3323d-3a77-4ef8-bc62-6841041caf05"
      unitRef="usd">52200000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTMtMS0xLTYwMjYz_3e92a83c-fc90-4b05-a61b-a8cc3d3d5beb"
      unitRef="usd">1800000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTUtMS0xLTYwMjYz_dfc9f1d6-ba41-44a7-99a1-a42cf7df0295"
      unitRef="usd">3700000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTctMS0xLTYwMjYz_008c11d4-6d1d-49d8-b000-634cf45e3ec2"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTktMS0xLTYwMjYz_8066a174-5520-4475-b1db-5fe8a5053502"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE4LTExLTEtMS02MDI2Mw_e6b1a342-5165-42db-b27e-04c4b183dc03"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTEtMS0xLTYwMjYz_b2c3104f-b1d8-4339-b257-6ad14b90aa85"
      unitRef="usd">2300000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTMtMS0xLTYwMjYz_984e454f-1b38-494b-b4b0-786e45f270ff"
      unitRef="usd">900000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTUtMS0xLTYwMjYz_21e945b3-1e53-4bca-a3a9-968596ad06b5"
      unitRef="usd">-1800000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTctMS0xLTYwMjYz_ea6a50d1-cb18-46d0-8ea3-bc3a3b4df0b4"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTktMS0xLTYwMjYz_4e5a2ef9-c3d0-45d9-9996-1f8a064484d4"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzE5LTExLTEtMS02MDI2Mw_f9e55912-4a6b-41b6-975a-3da3dac7cceb"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTEtMS0xLTYwMjYz_815abf37-0094-4156-b968-6b0bf0c169f5"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTMtMS0xLTYwMjYz_2d89f27f-2ba1-4786-a3aa-25185d8b046b"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTUtMS0xLTYwMjYz_ad3950d1-c3a8-436b-b800-c83c6120c1f9"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTctMS0xLTYwMjYz_0b63f588-930b-4513-a424-96867f4ba7bb"
      unitRef="usd">400000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTktMS0xLTYwMjYz_15d30260-d441-4a7c-bf2b-bfdc267e4c85"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIwLTExLTEtMS02MDI2Mw_1bd388a1-e14a-41cf-b9d8-e4e9f26a8d7f"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTEtMS0xLTYwMjYz_82d4822e-7ab8-4b15-be28-2de297331c72"
      unitRef="usd">-39800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTMtMS0xLTYwMjYz_304f90d3-bcc3-46c0-a154-7a46d7ecb168"
      unitRef="usd">-12900000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTUtMS0xLTYwMjYz_d1ab57fd-35c9-48c6-97c7-6165727fc1ce"
      unitRef="usd">-2200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTctMS0xLTYwMjYz_c7c7901e-a747-409d-a06e-0b525a85acc7"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTktMS0xLTYwMjYz_7cc77dca-d429-4a28-86d4-35a993e2302d"
      unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIxLTExLTEtMS02MDI2Mw_1b981c33-5be0-4414-81ae-67103a18a6cd"
      unitRef="usd">2200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTEtMS0xLTYwMjYz_b93bc5ba-e7d7-48cc-aca7-f5daaee36797"
      unitRef="usd">14300000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTMtMS0xLTYwMjYz_9ce98c07-13cd-4120-bb3b-1542da773275"
      unitRef="usd">-13300000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTUtMS0xLTYwMjYz_1c5cdb90-afb0-42ac-8bfd-3adfe7ee8ba0"
      unitRef="usd">500000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTctMS0xLTYwMjYz_9d4e9bb3-285e-4040-8a0f-3841887bfb2d"
      unitRef="usd">-1800000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTktMS0xLTYwMjYz_bf238d77-9085-4a12-95a6-12049f335efc"
      unitRef="usd">-700000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphOGQ1ZTE1YTlhYjU0MDM0ODU1N2M5Y2UwODAxNzBkYi90YWJsZXJhbmdlOmE4ZDVlMTVhOWFiNTQwMzQ4NTU3YzljZTA4MDE3MGRiXzIyLTExLTEtMS02MDI2Mw_7b3a6108-70e2-4182-a11b-178eb25ac4f6"
      unitRef="usd">-200000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i7479189625164010af6cfb04cc0211f7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItMS0xLTEtNjAyNjM_9967d7cd-8b87-4117-bd2e-913cc38bddc6"
      unitRef="usd">51700000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i63ad9cb3287243e99846b5f6d49f4739_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItMy0xLTEtNjAyNjM_5405f987-4031-4778-b191-27a3f3a849e2"
      unitRef="usd">-2300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2541ce86c9e34ed9941101140a5db110_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItNS0xLTEtNjAyNjM_d0f10e8c-717e-4e6d-9382-22f22662b279"
      unitRef="usd">1200000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i316fa955e9204c2a8df463369185dda4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItNy0xLTEtNjAyNjM_c8ed87be-d9b4-4943-a71e-be9fb64d5881"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i441202e7fe0646609be36e2f8d0374b0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItOS0xLTEtNjAyNjM_73fa96ce-c002-4cca-a2e1-0c57ecde5bc6"
      unitRef="usd">-1800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia2b3f6d5c25644418416ca4f73542523_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzItMTEtMS0xLTYwMjYz_1b01d1a0-0a70-4bf4-8bb9-7f61f5f50960"
      unitRef="usd">-2400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i34d78547c8434c45b5b43dd485a6821a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtMS0xLTEtNjAyNjM_a39327c9-86f0-4d1d-bc7c-e61a5764de67"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1fd65a6a4d2b4b7eb7aa097f7f5a03a8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtMy0xLTEtNjAyNjM_2ba5479d-10d9-43d9-96e1-1c66c880af66"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4a6c4ac23e3347c3a9d21b0dba11e268_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtNS0xLTEtNjAyNjM_07785db0-500c-4970-a166-6e9b783b966e"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1b0b580bd80345db9a8c8beba2df1e69_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtNy0xLTEtNjAyNjM_66d1892d-65c4-4944-9760-25d159159a0b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i94503a5d02c7463b985b14ead7a7b3d9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtOS0xLTEtNjAyNjM_d3831c52-2526-457c-a544-8cc5644747b9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib445602ff9c740f89a59c9435ece0183_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzMtMTEtMS0xLTYwMjYz_25419785-695f-4986-8814-47e251a43057"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtMS0xLTEtNjAyNjM_f16b7c1e-0765-4fbf-94c7-b6cec596d8f9"
      unitRef="usd">54100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtMy0xLTEtNjAyNjM_859e5440-4e33-470d-9ebe-ca2229a2c48d"
      unitRef="usd">-400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtNS0xLTEtNjAyNjM_04ad1e50-7952-4793-9cd0-98f9689de73d"
      unitRef="usd">2700000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtNy0xLTEtNjAyNjM_e3e54ad4-3eb5-4a81-bfb9-5e683261239c"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtOS0xLTEtNjAyNjM_3821bed9-cf4d-4d23-b58e-d2d9b36758e8"
      unitRef="usd">-1800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzNhMzIzZmYyZmU0MTA2OWE4OGU3NzMzMDFkN2I4Yy90YWJsZXJhbmdlOjQ3M2EzMjNmZjJmZTQxMDY5YTg4ZTc3MzMwMWQ3YjhjXzQtMTEtMS0xLTYwMjYz_d8c4b911-b8fb-4248-b450-4f9e1f8ac17b"
      unitRef="usd">-2400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i040620491325464cab7f6d3871ae4699_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIxOTkwMjMyNjU1MTc_4c0d85d3-7c10-4c61-a370-7394d2aff6a3"
      unitRef="usd">7100000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIxOTkwMjMyNjQyMzI_665c7078-041a-42a0-8d9a-d6347898ff2d"
      unitRef="usd">52200000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIxOTkwMjMyNjQ0MzA_ef760436-e23f-4b1b-a216-81b463906492"
      unitRef="usd">1800000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIxOTkwMjMyNjQ0Mzg_da05ec7d-9f5b-46b6-b733-e996f85250dc"
      unitRef="usd">3700000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i040620491325464cab7f6d3871ae4699_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIxOTkwMjMyNjczMzQ_4c0d85d3-7c10-4c61-a370-7394d2aff6a3"
      unitRef="usd">7100000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzE3NjQ_43e12636-4f7d-42bb-8510-77acea9c4b4c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzE3NjQ_c6d8fee3-4355-4309-acf5-a31adb5e6ac4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3Xzc5OTI_4c27a324-2cb4-4b95-8290-aef009a286dd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amendments/transfers in&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzMtMS0xLTEtNjAyNjM_764fe824-1ea1-4d43-b06f-7ddf777148b3"
      unitRef="usd">269800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i860f084cabda4ae99bb91cfb68d12843_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzMtMy0xLTEtNjAyNjM_5e552e90-f942-4235-9122-b5e88bfc1ad2"
      unitRef="usd">298900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzMtNS0xLTEtNjAyNjM_927f7e34-391e-4ab7-b5f4-8b2ee9b5f7dd"
      unitRef="usd">5600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5585de920d8a464bb8478eab79b4c886_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzMtNy0xLTEtNjAyNjM_1c414593-1283-4a23-a147-476a0d0c67f8"
      unitRef="usd">6100000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzQtMS0xLTEtNjAyNjM_00d5af3e-8c39-44b3-8170-825fa77a36db"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzQtMy0xLTEtNjAyNjM_0a27f56e-a677-423a-ae09-8080b755dacc"
      unitRef="usd">1600000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzQtNS0xLTEtNjAyNjM_08e98a16-c1fd-40c6-88fa-57ed067f391b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzQtNy0xLTEtNjAyNjM_ae3548c5-1bfb-476c-85b7-58cc32a318b9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzUtMS0xLTEtNjAyNjM_4a8e9d34-3f12-4210-9617-a52114c3df89"
      unitRef="usd">4200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzUtMy0xLTEtNjAyNjM_e959da5d-e350-4ad0-895f-a9ed3b382c1d"
      unitRef="usd">6200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzUtNS0xLTEtNjAyNjM_71e7eaf1-b4c4-412e-9ffa-f95fef35fbbb"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzUtNy0xLTEtNjAyNjM_8e5373cd-2274-4680-8c0a-704b29f907d3"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzYtMS0xLTEtNjAyNjM_fc4722a5-d247-456a-b018-9378439216f6"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzYtMy0xLTEtNjAyNjM_bad7c415-88c3-4772-aa53-d1c42e3373c7"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzYtNS0xLTEtNjAyNjM_6d537773-6632-40b9-9b79-e0c34d21521f"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzYtNy0xLTEtNjAyNjM_c8376b99-c515-4a15-ad74-525c04f3334f"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzctMS0xLTEtNjAyNjM_b7f91db2-a1dc-41e3-825e-ce8cfd08d5e3"
      unitRef="usd">33000000.0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzctMy0xLTEtNjAyNjM_f8fe4574-b3e8-4307-a4e0-d2b6ccb44c14"
      unitRef="usd">12100000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzctNS0xLTEtNjAyNjM_9c58299e-3b12-4af2-8d3e-a490bcc4a34b"
      unitRef="usd">2000000.0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzctNy0xLTEtNjAyNjM_517fc113-6d00-4bf3-bc0e-a957c2c580a2"
      unitRef="usd">900000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzgtMS0xLTEtNjAyNjM_8c2167e9-f265-4d67-85a2-9568e17f7ee3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzgtMy0xLTEtNjAyNjM_b485d495-1c5f-4222-ae34-9dbb4ddbec82"
      unitRef="usd">2000000.0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzgtNS0xLTEtNjAyNjM_671396d5-c7ab-4e0c-8f12-c58e3c4460dc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzgtNy0xLTEtNjAyNjM_84b053db-f581-4847-bb49-8ba999b3c27b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzktMS0xLTEtNjAyNjM_ad0d6740-2036-40dc-a0b5-dff78343ef80"
      unitRef="usd">6900000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzktMy0xLTEtNjAyNjM_03053644-08ee-4b31-a52a-50baeac2a2ff"
      unitRef="usd">7100000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzktNS0xLTEtNjAyNjM_8b272539-51ad-4a5a-be58-0051611d7a8c"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzktNy0xLTEtNjAyNjM_0186a023-d505-4da4-ac10-943d4730a46a"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzExLTEtMS0xLTYwMjYz_b778594f-20e0-4a64-92ed-81f6853b5631"
      unitRef="usd">174400000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzExLTMtMS0xLTYwMjYz_bc0436a8-b4d4-4e82-8678-cf7583a34b73"
      unitRef="usd">13100000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzExLTUtMS0xLTYwMjYz_e11433bc-f72c-418a-9dcc-ef4c70cf5ba0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzExLTctMS0xLTYwMjYz_e57554ea-be18-4e9c-ba3e-8e88992c5464"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEyLTEtMS0xLTYwMjYz_2aa5cfc9-09c9-4620-b5bb-eb07ca1ef1f1"
      unitRef="usd">6100000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEyLTMtMS0xLTYwMjYz_8afebc1f-5af2-441f-b3d7-ad9be826d194"
      unitRef="usd">3200000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEyLTUtMS0xLTYwMjYz_aca679bb-f6eb-4dd6-9651-c3e6e073955d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEyLTctMS0xLTYwMjYz_57209d62-941d-41d6-a478-c18423647144"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEzLTEtMS0xLTYwMjYz_f2d322a6-5a09-4ec4-b0af-f5fb7adaa8b9"
      unitRef="usd">55500000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEzLTMtMS0xLTYwMjYz_628c899c-8853-431f-ae4f-e5ee7c6d8c95"
      unitRef="usd">269800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEzLTUtMS0xLTYwMjYz_cd02b2ba-505b-40b7-a14d-7688d4699425"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzEzLTctMS0xLTYwMjYz_60394c17-bc60-44ae-8599-518b5402df16"
      unitRef="usd">5600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE2LTEtMS0xLTYwMjYz_a4a280db-d569-4efc-a9b6-7cd6ecb29b4e"
      unitRef="usd">249200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i860f084cabda4ae99bb91cfb68d12843_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE2LTMtMS0xLTYwMjYz_35598c9a-39e2-4009-97a7-4ec6b3bfef43"
      unitRef="usd">258100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE2LTUtMS0xLTYwMjYz_d18399b3-2c2b-4ee4-afbf-04ff8a18122e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5585de920d8a464bb8478eab79b4c886_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE2LTctMS0xLTYwMjYz_6882cf13-96e3-415f-96b1-6600032d86e7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE3LTEtMS0xLTYwMjYz_d767471b-68f0-4197-8a02-2162bfab229a"
      unitRef="usd">-42400000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE3LTMtMS0xLTYwMjYz_ed891734-b466-492d-bb73-5d23351159e1"
      unitRef="usd">6100000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE3LTUtMS0xLTYwMjYz_f3eb7fb6-e42e-4eeb-a072-3b4d7c408ea1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE3LTctMS0xLTYwMjYz_579448ec-e7a8-45db-9345-d3c3b72d6a3a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE4LTEtMS0xLTYwMjYz_12d0af1f-ecf0-45ad-9c70-77ae2637670a"
      unitRef="usd">8400000</wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums>
    <wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE4LTMtMS0xLTYwMjYz_eff4b586-2d77-40f6-8de7-cd7c529ff268"
      unitRef="usd">3600000</wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums>
    <wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE4LTUtMS0xLTYwMjYz_ad2f458b-7ff6-4afd-8e14-2e422851f90c"
      unitRef="usd">-100000</wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums>
    <wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE4LTctMS0xLTYwMjYz_53f313aa-44ca-463b-a7eb-8c98887c4d49"
      unitRef="usd">-200000</wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE5LTEtMS0xLTYwMjYz_99efa2ff-10fc-45ac-a9e9-6735ee61679f"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE5LTMtMS0xLTYwMjYz_eebff0cc-20c0-42b4-8eb6-3e3d4608b3ee"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE5LTUtMS0xLTYwMjYz_9ca601bd-5a44-4096-a23a-c3b6fccfe323"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzE5LTctMS0xLTYwMjYz_2103ebac-c3d0-44db-8f24-80d97506389d"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIwLTEtMS0xLTYwMjYz_43737c87-9a18-4794-be95-e5875abd2a5d"
      unitRef="usd">7200000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIwLTMtMS0xLTYwMjYz_e4caf5dc-79ac-4d40-a7b8-ea650c4ba158"
      unitRef="usd">5200000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIwLTUtMS0xLTYwMjYz_7b222c4b-5090-4974-8547-3adc36eaf7bb"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIwLTctMS0xLTYwMjYz_08937585-805d-4fc8-9352-c4571662e92d"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIyLTEtMS0xLTYwMjYz_5b490b21-dbc3-446b-9588-483ac2beb152"
      unitRef="usd">174400000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIyLTMtMS0xLTYwMjYz_f8bff4f8-1cf8-4fda-8196-220d8c64bfa3"
      unitRef="usd">13100000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIyLTUtMS0xLTYwMjYz_6b07ca50-7707-43e5-b63f-4174ea8d585c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIyLTctMS0xLTYwMjYz_1196b741-c021-4950-a10a-ab679f41314b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIzLTEtMS0xLTYwMjYz_bd1ea3f9-ac15-4c2c-a4b3-0462f16a5577"
      unitRef="usd">4600000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIzLTMtMS0xLTYwMjYz_8ff69cf9-201b-4836-8405-3f1ee00085ca"
      unitRef="usd">900000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIzLTUtMS0xLTYwMjYz_54fd96b7-0dc6-4a71-8589-870c8ba0899a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzIzLTctMS0xLTYwMjYz_3a7e889d-c456-438c-adcf-4d29a95975fb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI0LTEtMS0xLTYwMjYz_c2d7a972-d5e8-4f60-aeac-c0350e9a9584"
      unitRef="usd">29400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI0LTMtMS0xLTYwMjYz_ee5915c6-f54b-48a3-ba12-b552950df5e9"
      unitRef="usd">249200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI0LTUtMS0xLTYwMjYz_6ef5a8a8-d14b-4a5f-ada2-d6a9dce26da3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI0LTctMS0xLTYwMjYz_a8faf470-2c71-4c82-a823-4b03f397df5d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI2LTEtMS0xLTYwMjYz_6d18ebdf-1ddb-40c3-a625-b4cf34b98c1a"
      unitRef="usd">-26100000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI2LTMtMS0xLTYwMjYz_d7cd86ed-1d9f-47d4-adf2-1f992311b56e"
      unitRef="usd">-20600000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI2LTUtMS0xLTYwMjYz_3717a381-08f6-4d26-a3f6-d3d413ea051c"
      unitRef="usd">-3900000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0NzU2MTQzYWI2MjE0NWNhOTE1MmJhOTc3Y2I3N2M2MC90YWJsZXJhbmdlOjQ3NTYxNDNhYjYyMTQ1Y2E5MTUyYmE5NzdjYjc3YzYwXzI2LTctMS0xLTYwMjYz_8e626a08-2444-4a9b-aa71-d4935fac03fb"
      unitRef="usd">-5600000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIwNjg_66c60a0d-2091-4621-817a-1fbab5ba6286"
      unitRef="usd">29400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i07075ee510b147ffa069795d9eba1b83_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIwNzU_f390e778-d6f6-449c-81ee-96c9607d9897"
      unitRef="usd">49300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3Xzc5ODU_c90752e9-b7e9-4111-9585-1aed85603d1c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in the balance sheet were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <wst:AssetsDefinedBenefitPlansNoncurrent
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzItMS0xLTEtNjAyNjM_ffec6801-3c1f-48ad-842b-a13d57a8628e"
      unitRef="usd">300000</wst:AssetsDefinedBenefitPlansNoncurrent>
    <wst:AssetsDefinedBenefitPlansNoncurrent
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzItMy0xLTEtNjAyNjM_4fdc9a57-2bd5-48f1-9926-2244787fea53"
      unitRef="usd">16700000</wst:AssetsDefinedBenefitPlansNoncurrent>
    <wst:AssetsDefinedBenefitPlansNoncurrent
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzItNS0xLTEtNjAyNjM_62d4f81c-3b67-40dd-9448-662adb5f14e5"
      unitRef="usd">0</wst:AssetsDefinedBenefitPlansNoncurrent>
    <wst:AssetsDefinedBenefitPlansNoncurrent
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzItNy0xLTEtNjAyNjM_ac2d8d4e-b9bb-4744-aa9a-92a52caaa3ab"
      unitRef="usd">0</wst:AssetsDefinedBenefitPlansNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzMtMS0xLTEtNjAyNjM_b75c62ad-bd22-4213-a2e7-cb27a7b4bb1b"
      unitRef="usd">1500000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzMtMy0xLTEtNjAyNjM_45606093-7e56-4240-81a1-6ea9ad763aba"
      unitRef="usd">1700000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzMtNS0xLTEtNjAyNjM_f1894429-7b44-4fb5-b39e-88a1b84dfe2d"
      unitRef="usd">600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzMtNy0xLTEtNjAyNjM_4283e9f1-7636-4154-8cf4-2fc635cf43f5"
      unitRef="usd">700000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzQtMS0xLTEtNjAyNjM_547acc5c-a8c3-47c7-b54b-f9b856be05ec"
      unitRef="usd">24900000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzQtMy0xLTEtNjAyNjM_0a4dafef-8f04-41f7-af7c-13db269bb406"
      unitRef="usd">35600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzQtNS0xLTEtNjAyNjM_ca11d6a6-6bbc-461c-9913-07702351e798"
      unitRef="usd">3300000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzQtNy0xLTEtNjAyNjM_a6af5d1f-a4bb-4e7c-8ac1-c92c7277fb2a"
      unitRef="usd">4900000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzUtMS0xLTEtNjAyNjM_fe98be48-b966-4982-922e-9f048f4ef324"
      unitRef="usd">26100000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzUtMy0xLTEtNjAyNjM_b83bdaf5-f2b9-4670-bcb5-5f37d99c35e2"
      unitRef="usd">20600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzUtNS0xLTEtNjAyNjM_6456b382-4841-4957-977b-e62c0d6dd3bc"
      unitRef="usd">3900000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToxMjY0YTliYjM2NmY0NTlkYTBmOTg0YzkzMTI2ZWU1Yy90YWJsZXJhbmdlOjEyNjRhOWJiMzY2ZjQ1OWRhMGY5ODRjOTMxMjZlZTVjXzUtNy0xLTEtNjAyNjM_29e5a4f6-2fca-4915-888c-88bed6036823"
      unitRef="usd">5600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3Xzc5OTM_412a0b90-1f41-4a97-abae-87d9a2abb97b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts in accumulated other comprehensive loss, pre-tax, consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzItMS0xLTEtNjAyNjM_b9ddb0be-1f6b-4219-8bf0-79be5cf0387e"
      unitRef="usd">-16700000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzItMy0xLTEtNjAyNjM_f1f5e4d9-fba7-48e4-b9f0-eb7be99ea856"
      unitRef="usd">-56500000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzItNS0xLTEtNjAyNjM_ddbf0c52-e694-4feb-9474-65fc74dccd7a"
      unitRef="usd">5200000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzItNy0xLTEtNjAyNjM_9951bf1c-d462-4494-85bc-263d42439de4"
      unitRef="usd">4700000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzQtMS0xLTEtNjAyNjM_13729888-0905-44c1-869b-1a4a39f67bf7"
      unitRef="usd">-1100000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzQtMy0xLTEtNjAyNjM_6d72d229-4fd7-4f78-88fc-fb18e1749c4b"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzQtNS0xLTEtNjAyNjM_3f0cf811-bef3-42c3-8596-207d6821728d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzQtNy0xLTEtNjAyNjM_d3779421-0acb-4a30-ac88-194939da3c41"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzUtMS0xLTEtNjAyNjM_8f6780ed-ead1-4e68-8546-d1bfcf20e494"
      unitRef="usd">15600000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzUtMy0xLTEtNjAyNjM_889282aa-1f8a-4a2a-bde1-d3a2db3f6095"
      unitRef="usd">55200000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzUtNS0xLTEtNjAyNjM_3f6747f9-3027-441b-82f3-99c561fb85c3"
      unitRef="usd">-5200000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDhkNDEyNzY0ZTY0MGVlYjUzMWNhYzY5M2VjNDk1YS90YWJsZXJhbmdlOmM0OGQ0MTI3NjRlNjQwZWViNTMxY2FjNjkzZWM0OTVhXzUtNy0xLTEtNjAyNjM_9a258d45-9ff7-4d8d-ae8a-9db60f63b58b"
      unitRef="usd">-4700000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIzMjM_1cee180f-f816-43d6-8456-e6c4b06dd8f6"
      unitRef="usd">52400000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIzMzA_adba7b28-5b00-4411-a381-56bfb26326a9"
      unitRef="usd">265200000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIzNzE_3fef8bfe-5d98-4e4b-806c-295f4ea8300f"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i07075ee510b147ffa069795d9eba1b83_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzIzNzg_8b963f94-0b32-4202-910e-b92263279440"
      unitRef="usd">73000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3Xzc5Nzg_7a56f86b-e377-4ca2-84cc-1bfcb235c285">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows. The expected benefit payments listed correspond to regular ongoing benefit payments expected to be made by the plan during future years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 to 2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzEtMS0xLTEtNjAyNjM_5c4ffe3b-36bc-497d-ad8f-9c5c5d8c51e8"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzEtMy0xLTEtNjAyNjM_3793bbca-cc53-4b06-a5bb-4d44089d8770"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzEtNS0xLTEtNjAyNjM_bf693dd4-561d-4694-ac77-35ea1ce5e7b2"
      unitRef="usd">3700000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzItMS0xLTEtNjAyNjM_e48bb9b4-ff0f-4a71-9aa6-b0107fe1ba0c"
      unitRef="usd">1400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzItMy0xLTEtNjAyNjM_42d237a6-7895-44dc-bd3a-544dc7cd890c"
      unitRef="usd">2500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzItNS0xLTEtNjAyNjM_94607b17-61a8-4917-98e2-1449b2c35558"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzMtMS0xLTEtNjAyNjM_43a6e70a-99ef-4657-919a-c3ae9f22b345"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzMtMy0xLTEtNjAyNjM_2bc8668e-f5c2-4ea5-b672-fa6f1af7c3f8"
      unitRef="usd">2800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzMtNS0xLTEtNjAyNjM_d12e3154-5239-40ad-9873-28452a883f00"
      unitRef="usd">4100000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzQtMS0xLTEtNjAyNjM_bf66da91-4c41-4ea7-9307-1935d2af60b5"
      unitRef="usd">1200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzQtMy0xLTEtNjAyNjM_a6f2949f-f8d6-4b20-8cf7-d45de784b71b"
      unitRef="usd">3300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzQtNS0xLTEtNjAyNjM_aeca8c3d-9939-485f-a56d-085f7f173415"
      unitRef="usd">4500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzUtMS0xLTEtNjAyNjM_bae557cb-f747-4657-afc8-3c110c0338d2"
      unitRef="usd">1000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzUtMy0xLTEtNjAyNjM_0ed53322-4dbe-4d22-bd6c-7ac1b341ead1"
      unitRef="usd">3700000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzUtNS0xLTEtNjAyNjM_6a4acf85-acec-49ec-b175-85110549c806"
      unitRef="usd">4700000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzYtMS0xLTEtNjAyNjM_27d9a924-4f1f-4ae9-aa1a-0c0f633a02d9"
      unitRef="usd">4200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzYtMy0xLTEtNjAyNjM_3a856ea6-2410-4836-829d-1a050a796076"
      unitRef="usd">17800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzYtNS0xLTEtNjAyNjM_862fe971-29b9-4786-b099-79fc927717d2"
      unitRef="usd">22000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <wst:DefinedBenefitPlanExpectedFutureBenefitPayments
      contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzctMS0xLTEtNjAyNjM_78c6ba3f-526b-4422-8c1e-2a83c08dff30"
      unitRef="usd">10600000</wst:DefinedBenefitPlanExpectedFutureBenefitPayments>
    <wst:DefinedBenefitPlanExpectedFutureBenefitPayments
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzctMy0xLTEtNjAyNjM_c3e19168-14cb-44ee-a609-a90d8b8bb6a2"
      unitRef="usd">32300000</wst:DefinedBenefitPlanExpectedFutureBenefitPayments>
    <wst:DefinedBenefitPlanExpectedFutureBenefitPayments
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpmZWM4ZDU0Y2M3ZjM0YTM3OWI3Y2EzYTQ3ZWEwYjk1Yi90YWJsZXJhbmdlOmZlYzhkNTRjYzdmMzRhMzc5YjdjYTNhNDdlYTBiOTViXzctNS0xLTEtNjAyNjM_eb011b50-0bce-41e0-8eb7-e400df97962c"
      unitRef="usd">42900000</wst:DefinedBenefitPlanExpectedFutureBenefitPayments>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzM0MTI_17a11d31-4c64-4ff1-b49a-373ce81255bd"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzM0OTg_f405dc09-81e8-447a-8b6a-b0ffa332e9c3"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzgwMTc_4bb15520-1c4a-4df6-b42e-44e9915800ad">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine net periodic benefit cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine the benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The weighted average interest crediting rating used to determine net periodic benefit cost by geographic location for our pension plans, at December 31, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItMS0xLTEtNjAyNjM_44a22a96-db4a-4972-aef1-4597e838e829"
      unitRef="number">0.0248</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItMy0xLTEtNjAyNjM_ad5b73ef-a9f4-4d2a-937e-8053ceb4c2b2"
      unitRef="number">0.0229</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItNS0xLTEtNjAyNjM_33db72ba-08f8-4b05-9208-2bbcbc8a0dc9"
      unitRef="number">0.0261</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItNy0xLTEtNjAyNjM_e69ed932-2a9a-4170-bd5a-63cbd7d2d56b"
      unitRef="number">0.0275</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItOS0xLTEtNjAyNjM_6b4ac755-7276-4582-9f84-b256f49b78ba"
      unitRef="number">0.0230</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzItMTEtMS0xLTYwMjYz_bda143ec-7801-4721-be3f-2235c76ea77e"
      unitRef="number">0.0320</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtMS0xLTEtNjAyNjM_53ec76d8-7e7c-4e18-944c-311be6bbda46"
      unitRef="number">0.0279</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtMy0xLTEtNjAyNjM_04d7cc96-498b-4de9-8526-a7fa840040ef"
      unitRef="number">0.0241</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtNS0xLTEtNjAyNjM_234a497d-c216-4682-a152-229121b77a7b"
      unitRef="number">0.0233</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtNy0xLTEtNzA3Mjk_5900b4c3-711f-4ae9-9238-4c2e022abc80"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtOS0xLTEtNzA3Mjk_b3f136cb-a036-4010-980e-16e5985de2e6"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzMtMTEtMS0xLTcwNzI5_cb60cf87-2452-4b19-a69f-e1902804c3e2"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtMS0xLTEtNjAyNjM_675a7604-ca07-462c-a5bd-d412f666874d"
      unitRef="number">0.0414</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i6c68eed40fb74163a6297c74a1253882_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtMy0xLTEtNjAyNjM_8e7e5485-b65b-42e6-8b6c-699319f672a0"
      unitRef="number">0.0493</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ib21c2821eaa44ec9b20943e7798afaba_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtNS0xLTEtNjAyNjM_1733d8ea-b4fc-48f2-9239-53ac9549d20f"
      unitRef="number">0.0510</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ib08678e6ad8b469ca289e79739970510_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtNy0xLTEtNzA3Mjk_0257b1b5-3fb2-4b88-bfe9-f91a23a44f06"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i1c599294d78c4bbb86842c16cac2243e_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtOS0xLTEtNzA3Mjk_2e92e468-4e24-4404-b80f-3c722cec71e4"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i5967145ff293449c900b45f8ce551762_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZToyNWI4YTk5N2I3NTU0MjJiYTgwZDg1MWVmZDc5NzEyMS90YWJsZXJhbmdlOjI1YjhhOTk3Yjc1NTQyMmJhODBkODUxZWZkNzk3MTIxXzQtMTEtMS0xLTcwNzI5_d1d7a7ba-a103-40be-b405-47b1adcf453e"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzItMS0xLTEtNjAyNjM_01578f2e-6380-40d1-b5cd-1a4a207845c0"
      unitRef="number">0.0435</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzItMy0xLTEtNjAyNjM_0fea5ef2-4ad4-431d-9dd7-c17b0983f07c"
      unitRef="number">0.0248</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzItNS0xLTEtNjAyNjM_37c8e134-fccf-4bd2-815d-d8263d223dc0"
      unitRef="number">0.0555</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzItNy0xLTEtNjAyNjM_a5709e87-93a9-4c74-89f8-c1a1578e9bff"
      unitRef="number">0.0275</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="ib7283d2db8a4479785b3c3e131984a7d_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzMtMS0xLTEtNjAyNjM_d8e6f773-9b60-4539-beac-8a18291b66ca"
      unitRef="number">0.0309</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="ie7a7ed07fb9e4d1ebcdcebd80fa22ab1_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzMtMy0xLTEtNjAyNjM_c92523c2-b47d-40ad-bdc5-9be441b79b81"
      unitRef="number">0.0279</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="id9ddd8fa84364291bfce3ba201396757_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzMtNS0xLTEtNzA3MzI_3a6d7702-7597-4f89-93e8-56ec5ce722fe"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i0b5a1b89c9614c53804b0db0a7c3572f_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphYTM5NzFmMTM0ZTU0NWFjOTFiZDk0OGEwYWNhNDJlNC90YWJsZXJhbmdlOmFhMzk3MWYxMzRlNTQ1YWM5MWJkOTQ4YTBhY2E0MmU0XzMtNy0xLTEtNzA3MzI_77201a6b-ce94-4327-8c30-1bcbafc6848c"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i3d6d4961721d423c8fba5c85a67fc33f_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQxNzE_3ee2aa85-7660-4b10-8027-4f6b35d2d4b7"
      unitRef="number">0.0555</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="icaebb04c426c456a84deedfc7f59d594_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQxNzg_883bc9bc-efee-45cf-b74b-9614f9b35af3"
      unitRef="number">0.0295</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQzMzQ_3150983e-5dc5-418e-8421-e75daf478ddf"
      unitRef="number">0.0420</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i07075ee510b147ffa069795d9eba1b83_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQzNDE_7c9af3d8-b9a9-4419-a292-2bf527ff8a17"
      unitRef="number">0.0132</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i778c59da914d4efaa1ca8dcc39e7ee74_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ0NzE_63432b87-f040-4788-abc1-f3757dcc4269"
      unitRef="number">0.0309</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i07075ee510b147ffa069795d9eba1b83_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ0ODU_99ba03f4-8882-4715-92bd-3429db69a143"
      unitRef="number">0.0279</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i040620491325464cab7f6d3871ae4699_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ3Mzk_f1adc29e-0a22-40c9-bfaf-eb11af2fc21e"
      unitRef="number">0.0370</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i405b25944ffd47c88f31893c248bb5cc_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ3NTA_d63183bc-a62e-4d8d-82db-e1bbdf03bfc2"
      unitRef="number">0.0510</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i6d4d0414b55e42238a7ed8c0cade2d85_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ3NjQ_b91c6897-3c56-435d-bba7-9d43572d3729"
      unitRef="number">0.0510</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ4NTg_4f480ce9-19a2-40b7-8b51-ebe45b85dfc2"
      unitRef="number">0.0675</us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzQ5MDM_8fd9b6f5-ede2-448a-8485-8faaf4f77a75"
      unitRef="number">0.050</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <wst:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzUwMDA_62d17063-e66b-4676-b8c1-98a364d738ba"
      unitRef="number">0.0625</wst:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost>
    <wst:DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3XzUwNDU_3cb32024-c494-400c-99be-20a391ad7299"
      unitRef="number">0.050</wst:DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i7479189625164010af6cfb04cc0211f7_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzEtMS0xLTEtNjAyNjM_a8caf1b6-b7e1-4f90-9ef5-33f54c4886ec"
      unitRef="number">0.0331</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i63ad9cb3287243e99846b5f6d49f4739_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzEtMy0xLTEtNjAyNjM_3339d27a-56e0-414d-ab0b-db7fa4405f87"
      unitRef="number">0.0331</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i2541ce86c9e34ed9941101140a5db110_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzEtNS0xLTEtNjAyNjM_2e8645a0-8e92-44e7-bd0d-b6727a85dc5c"
      unitRef="number">0.0330</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i34d78547c8434c45b5b43dd485a6821a_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzItMS0xLTEtNjAyNjM_9031d4fe-6c42-4285-ada9-09c9d91f8db1"
      unitRef="number">0.0175</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i1fd65a6a4d2b4b7eb7aa097f7f5a03a8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzItMy0xLTEtNjAyNjM_37beb615-425f-4728-b40c-92fdfa3f361f"
      unitRef="number">0.0067</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i4a6c4ac23e3347c3a9d21b0dba11e268_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo1YTgxNDkxNGYyOWI0MWQ5YjljY2VlOTFjMDYwOWJjOC90YWJsZXJhbmdlOjVhODE0OTE0ZjI5YjQxZDliOWNjZWU5MWMwNjA5YmM4XzItNS0xLTEtNjAyNjM_dd168ba1-a10a-4f43-ab80-6ddbb23ee200"
      unitRef="number">0.0052</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90ZXh0cmVnaW9uOmUxZDgzMjYyMGE5YzRmZjU5MDA5YjkxNDEzODY1MWQ3Xzc5NzI_bb0e7e1c-0709-4853-adf9-f089c516dce9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the target asset allocations and acceptable allocation ranges across:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25% - 30%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63% - 68%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2% - 7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#x201c;NAV&#x201d;) have not been classified in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i83cbdcf4d95b46f5bb848c5c35e881c4_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzEtMS0xLTEtNjAyNjM_fc8dd683-df84-4d1d-ae2c-3f600a513e18"
      unitRef="number">0.28</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i83e1434feb5c44cf9a2a52c145c85770_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzEtMy0xLTEtNjAyNjM_2ba770be-f1c1-43bc-b7d1-905b2045762f"
      unitRef="number">0.12</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="id534095c984248caac7f60f3f82c38bd_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzItMS0xLTEtNjAyNjM_f0a25780-ec19-455b-9e8b-3c770ce124e3"
      unitRef="number">0.68</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="iee3572e584f746e78e030b73cb5e5f0d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzItMy0xLTEtNjAyNjM_def04753-0c7d-4a74-8ca9-fdc9ea3ecae9"
      unitRef="number">0.86</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i4c1ae3f134ee48b5bb585005d7de280b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzMtMS0xLTEtNjAyNjM_03a2866e-952a-4771-8a96-1e6fbc9b3df2"
      unitRef="number">0.04</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="if09fca4c07fa4958ac80820c3bcd7ee3_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzMtMy0xLTEtNjAyNjM_45865c04-a972-4704-aa4d-7103070007c8"
      unitRef="number">0.02</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzQtMS0xLTEtNjAyNjM_5cde5233-351b-45f3-a4ec-f87841cf1230"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo2YzQ3MDFkYTJhOGM0NjJiYjM5ZjBmYWVjYWQ0OGJhOC90YWJsZXJhbmdlOjZjNDcwMWRhMmE4YzQ2MmJiMzlmMGZhZWNhZDQ4YmE4XzQtMy0xLTEtNjAyNjM_c01f792c-cbc6-4cc9-84ec-d3cd09344ca9"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i03e10a75c10f4d2c8f360deba82d8ee1_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzEtMS0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpjNTZkNjFlYWJlZDY0MWVjOGJmNjliZGIzMTNhNmI1M180_f904946e-f42e-4af5-a40b-e589b5aefeda"
      unitRef="number">0.27</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i3309beddc64147aa9d4c3c624ed71776_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzEtMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjoxYmFjMWJiMzE5OGU0YjljOWYxMTAyOWQ2NjRhMzU0NV80_dfb6f0b8-7fa9-4ef9-952e-9204d461155d"
      unitRef="number">0.25</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i1744b600a2c44fb1857cc5d43e752987_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzEtMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjoxYmFjMWJiMzE5OGU0YjljOWYxMTAyOWQ2NjRhMzU0NV85_e9c9126c-bd64-40e0-ab9b-fd877dc4fa78"
      unitRef="number">0.30</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i4be1b95cfcd2431b924119c50bfd5a9d_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzItMS0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpmODllMmY4MDE3MjM0ZWMzYmY5ZTE2NjZjZWFmMzc1Nl80_b2e44142-6a4b-4441-a284-a02fb0760b2e"
      unitRef="number">0.68</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ic3af093e03e841719efdf12caaaf8448_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzItMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo3YjU5ODZmZjM2ZTg0YTcxOGUwNjdiMDBlNmIxZGI4N180_adde2318-f9b4-405f-9f57-56f4643773ff"
      unitRef="number">0.63</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i18d85779db1a46ba80e1747766668dc9_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzItMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo3YjU5ODZmZjM2ZTg0YTcxOGUwNjdiMDBlNmIxZGI4N185_89de2294-c232-4293-92ce-94bcffcc6c5f"
      unitRef="number">0.68</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i9ec9a690a49b4b95844d16d70921814f_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzMtMS0xLTEtNjAyNjMvdGV4dHJlZ2lvbjo0ZDk0ZmUyOWU5Yzk0NDY1ODcxZmYwY2EwNzA2YzQ3Zl80_e97f29e0-d357-4eb5-82d4-c5f7e2d1ff5f"
      unitRef="number">0.05</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i1cdc53f36f04478eaf3f3e8a7e98afd5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzMtMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkMmYxMzk1NTkzOTA0MGRhOTA4NGMwOTBjZmIzZjE4OF80_62228ea0-5578-4e47-8627-ce51eb0e4fc5"
      unitRef="number">0.02</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i7c5650da0a7044278560c89a0b64ccb1_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTphY2M2ODRiMWMxYjA0M2U4OWU5YTM1NDliOWU4ODlkNS90YWJsZXJhbmdlOmFjYzY4NGIxYzFiMDQzZTg5ZTlhMzU0OWI5ZTg4OWQ1XzMtMy0xLTEtNjAyNjMvdGV4dHJlZ2lvbjpkMmYxMzk1NTkzOTA0MGRhOTA4NGMwOTBjZmIzZjE4OF85_1c1668e7-554e-4ab4-818f-5676ebe9150e"
      unitRef="number">0.07</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i54d8c496618d4192a7e40265b29fe16d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzMtMS0xLTEtNjAyNjM_60761b9a-eb6e-4624-9588-3ddfd7a157e1"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iace17547d7c143dd837ba1fadfa15bea_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzMtMy0xLTEtNjAyNjM_8151ae51-26ae-41f6-a44e-ff45733304c6"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i937298cf9f8d407e95285a8eda6be83d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzMtNS0xLTEtNjAyNjM_10c2e96f-b291-4cf4-ac3d-f72859f97816"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idb4a0cc0e3284ea38084fdcbfa086cc2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzMtNy0xLTEtNjAyNjM_d55a3ca3-7c5c-43ee-a9f0-ab5d27de17c2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1aff134b217b4ead88b196a40da71390_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzYtMS0xLTEtNjAyNjM_08524c0a-3419-4961-ae44-e26e9cd79122"
      unitRef="usd">8200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7c5abf4f2b824482ba9d0532f850206a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzYtMy0xLTEtNjAyNjM_a70900ad-5a90-4fc2-94a0-d78af7ccf5f2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9281c13bb0b5430aa149c75d799cec31_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzYtNS0xLTEtNjAyNjM_fd463562-f6cd-4072-89e1-41904b9d4625"
      unitRef="usd">8200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6814334eaaa54902a2c168a168c3b713_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzYtNy0xLTEtNjAyNjM_0ce03421-ea10-47bf-84ac-2bcc94cf620e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i334922c320134f52b9aebb9e98f36274_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzgtMS0xLTEtNjAyNjM_18df85c5-c5af-4577-8ad9-e8673075bacc"
      unitRef="usd">20400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia8b5e90b3aba4a33ba59bb7ae6badda6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzgtMy0xLTEtNjAyNjM_06fb0ad4-3777-405a-84e0-00062fd16d09"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5a372d5590a144cba98ee245f1283178_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzgtNS0xLTEtNjAyNjM_d5808d30-a90e-425a-ba25-1606e59a2bde"
      unitRef="usd">20400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idc59d5e4aad64e88b0465be91ead9923_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzgtNy0xLTEtNjAyNjM_9252047e-3be5-44db-8882-69004c619b12"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if66e95bc7d5b4db2b517555e37322183_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzExLTEtMS0xLTYwMjYz_b5c98ed8-d8f9-401e-a6de-5203f3762610"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iace9c5cf6693479d9fcaa3c0f9e210d1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzExLTMtMS0xLTYwMjYz_6b68b8b0-feea-4bb2-b2fc-43378c018e45"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i24b1ef1156704a4faf188960f756e3c3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzExLTUtMS0xLTYwMjYz_17989927-7baa-4eef-898c-85596d484651"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1636e6221e9b4dcb9d03af54bcedbeba_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzExLTctMS0xLTYwMjYz_81105411-6e82-4e12-b9c1-d8bc7906d871"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iaddca4ea08004b0ebdf07f53f5328e24_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzEyLTEtMS0xLTYwMjYz_35bf9ac0-55e7-4b40-96da-8b04a09305a7"
      unitRef="usd">29400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic1c7c1085a39480cb3fd67e4108c3e80_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzEyLTMtMS0xLTYwMjYz_b378e9c9-f500-41cc-82c1-2f069c42bfd9"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia23aa690efbd45fe8cfcb969d018f680_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzEyLTUtMS0xLTYwMjYz_1462535e-f6c1-47a2-8239-ca955bc9c2c8"
      unitRef="usd">28700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6a65a38a422f4a89a39109cd74bb897d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzEyLTctMS0xLTYwMjYz_0e68cdd4-3539-41b1-8d5c-627e388e2ff8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia29fffd4cd604df186eac9f77ff01597_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzEzLTEtMS0xLTYwMjYz_36e46575-f96a-443e-80a4-f124d2dc2045"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTo0MGZmZWUyZDZiODY0NTQ3OWYwMjRhMmFlY2JlYzU0My90YWJsZXJhbmdlOjQwZmZlZTJkNmI4NjQ1NDc5ZjAyNGEyYWVjYmVjNTQzXzE0LTEtMS0xLTYwMjYz_5409a9de-3c3b-4fda-b48e-3a7e7d626234"
      unitRef="usd">29400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i03c8dbef891a41e5b4ae23fc2c17ac38_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzMtMS0xLTEtNjAyNjM_772ca351-ab2a-4e87-a851-77adb9df1829"
      unitRef="usd">1600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id96fe41b380c468082cde30cff4a88be_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzMtMy0xLTEtNjAyNjM_3b975188-ac7a-4a64-ba2a-5a9e09a0169a"
      unitRef="usd">1600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic6fdb0e63df94bf78eaf8f55ca5a27cd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzMtNS0xLTEtNjAyNjM_e3212d0e-0ef2-46b9-ae7e-959278985892"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iaba5feb3867044abafc6aeffd95e3f8c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzMtNy0xLTEtNjAyNjM_42e6c11f-024f-4dc0-a323-b5038a0b6ccc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i60bb7b31a5774e6f969d94307712c269_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzYtMS0xLTEtNjAyNjM_36dcc2f3-1a70-42f3-85a4-3cd448d93ee6"
      unitRef="usd">21200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib72dae6b1cc44b23ac0fd1f3ae38ee3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzYtMy0xLTEtNjAyNjM_34e0da23-b525-4883-8cff-92ec87446908"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4ac1499da88c4b44b4f74e0201a577ba_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzYtNS0xLTEtNjAyNjM_05775ee2-2c09-49ae-9682-a6f5ef430eab"
      unitRef="usd">21200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic3b0f7a0791b4b61be68028ab30483bf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzYtNy0xLTEtNjAyNjM_4e31eb02-64a3-413a-9f99-fcb049c5ba47"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0b93e203f105432f81fbe65326c6917c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzgtMS0xLTEtNjAyNjM_40b4161c-7089-4520-82aa-0dbb618762d7"
      unitRef="usd">22100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0883d5b213a14846b9cecd02fae80c70_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzgtMy0xLTEtNjAyNjM_3375cb4a-63e8-440d-b448-4ec30949698b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i09031663d64a4d89be1f2c8ac603f9a3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzgtNS0xLTEtNjAyNjM_dffb21d5-3fa1-42b6-a5e5-7c7050194acc"
      unitRef="usd">22100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5758fc91240f44f58c0d8211b63f96e8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzgtNy0xLTEtNjAyNjM_f156eacc-c492-4d55-809a-15d6d8147146"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia12d474c435e416382e99942998771f6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEwLTEtMS0xLTYwMjYz_2330288b-af2e-4605-9a20-059c7e79e775"
      unitRef="usd">4600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia0c18c5f3a6c42509cf4b94e0141bcb5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEwLTMtMS0xLTYwMjYz_e754982c-af5b-4f3c-a535-3db3e7d89a42"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i38e1e2edfa654b98a2366d1ba0e981bf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEwLTUtMS0xLTYwMjYz_e8730abf-b930-4d39-91ac-62f790b4dad4"
      unitRef="usd">4600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0bb1b7b296b8458ba1252c6364245ea0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEwLTctMS0xLTYwMjYz_7649b5e2-a217-4889-98e3-e17eca8f4381"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i58483908f99e4d18a4072d007a922d3b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEyLTEtMS0xLTYwMjYz_05fe8bc5-6196-4c8a-a71a-fbe2b825921b"
      unitRef="usd">49500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if9b36f0814ae4ba4af6d9b6d96d6c997_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEyLTMtMS0xLTYwMjYz_d5a7941b-c271-48ff-8069-feb232f414d9"
      unitRef="usd">1600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id1ef59879afe401591e29ee824de0517_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEyLTUtMS0xLTYwMjYz_57ff5022-73e6-445f-b326-e5d90b184e92"
      unitRef="usd">47900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia23bb5001acb4d96a0f1e75661196565_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEyLTctMS0xLTYwMjYz_6238cbfa-2994-4a97-9604-6377e57b45b8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic9d11fb26784407a9537aafa6159e23b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzEzLTEtMS0xLTYwMjYz_0d9d60fc-c27f-4961-9782-3cf3831bccda"
      unitRef="usd">199700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjEvZnJhZzplMWQ4MzI2MjBhOWM0ZmY1OTAwOWI5MTQxMzg2NTFkNy90YWJsZTpjNDExOTRkYTcwZGM0MDNjOTJiMjgzOGQ5OTg2OTBkNi90YWJsZXJhbmdlOmM0MTE5NGRhNzBkYzQwM2M5MmIyODM4ZDk5ODY5MGQ2XzE0LTEtMS0xLTYwMjYz_b2e45b53-2e8a-4a2e-adb2-44fa0021ff59"
      unitRef="usd">249200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzM0NzI_b01ca7ac-9636-4138-a6a6-2dc2ac5a4221">Other Expense (Income) &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense (income) consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and related charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and post-employment benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring and related charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed asset impairments and sale of equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Gain) loss on oil hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange transaction gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost investment activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restructuring and Related Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company approved a restructuring plan to adjust our operating cost base to better respond to the macroeconomic factors influencing our business. These changes are expected to be implemented over a period of up to twelve months from the date of the approval. The plan is expected to require restructuring and related charges of approximately $25&#160;million to $27&#160;million, with annualized savings in the range of $22&#160;million to $24&#160;million. Included within the expected restructuring charges is an impairment charge of $15.3 million representing the net book value of long-lived fixed assets held in our production facilities that were determined to have no future use to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, our Board of Directors approved a restructuring plan designed to optimize certain organizational structures within the Company to better support our continued growth and business priorities. These changes were implemented over a period of approximately twenty-four months from the date of the approval. The plan is expected to have annualized savings in the range of $0.9&#160;million to $1.6&#160;million. Since its approval, we recorded a net pre-tax amount equal to $5.2&#160;million in restructuring and related charges associated with this plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents activity related to our restructuring obligations related to our 2020 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.893%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration represents changes in the fair value of the SmartDose&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; contingent consideration. Please refer to Note 12, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Oil Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, 2021 and 2020, we recorded a gain of $1.5&#160;million, a gain of $1.7&#160;million, and a loss of $0.2&#160;million, respectively, related to oil hedges. Please refer to Note 11, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivative Financial Instruments&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion of our hedging activity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost Investment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, specific to our cost method investments, we recorded a total impairment charge of $3.5 million. During 2021, specific to our cost method investments, we recorded a total impairment charge of $4.6&#160;million which was offset by a net gain of $0.3&#160;million on the sale of a cost investment. During 2020, specific to our cost method investments, we recorded a total impairment charge of $2.5 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzM0NTI_879fc917-efc7-4153-95d4-512a3b3cee65">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense (income) consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and related charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and post-employment benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring and related charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed asset impairments and sale of equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Gain) loss on oil hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange transaction gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost investment activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzItMS0xLTEtNjAyNjM_a26311ae-d7b1-43b4-8687-5638b11b64ca"
      unitRef="usd">8700000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzItMy0xLTEtNjAyNjM_2d39eee7-20fa-4808-bc51-b0bbbb56f936"
      unitRef="usd">600000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzItNS0xLTEtNjAyNjM_de72216d-9061-411e-9f17-c307d42c4074"
      unitRef="usd">4600000</us-gaap:SeveranceCosts1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzMtMS0xLTEtNjAyNjM_e56b269c-3e90-4578-8369-67aebcc95436"
      unitRef="usd">15300000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzMtMy0xLTEtNjAyNjM_2ec14764-d736-4504-8da9-903c8cadcbe6"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzMtNS0xLTEtNjAyNjM_574ef23b-1e80-42af-9f37-3d574954ce61"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherRestructuringCosts
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzQtMS0xLTEtNjAyNjM_72ac94e9-adcc-451c-bcb0-c1f23b4cfa3e"
      unitRef="usd">-200000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzQtMy0xLTEtNjAyNjM_0bb18811-e3d6-4500-a7b3-6ef292feace2"
      unitRef="usd">1600000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzQtNS0xLTEtNjAyNjM_6359c0ef-78be-4b97-8b1e-417ca7cb330d"
      unitRef="usd">0</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzUtMS0xLTEtNjAyNjM_b3d40d0c-9ec6-41c4-9bd2-3d199232016a"
      unitRef="usd">23800000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzUtMy0xLTEtNjAyNjM_202443b7-b9f3-4661-a886-b3b936a44ad1"
      unitRef="usd">2200000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzUtNS0xLTEtNjAyNjM_5f6a1da1-681e-41be-9174-21d5b93b7150"
      unitRef="usd">4600000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzYtMS0xLTEtNjAyNjM_fae84aba-32ae-418d-921e-672121d7c64b"
      unitRef="usd">2700000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzYtMy0xLTEtNjAyNjM_f9d36c95-be69-4330-8aa9-1775be1213f6"
      unitRef="usd">1300000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzYtNS0xLTEtNjAyNjM_bb38e493-9a26-4155-845b-fad41a5529b3"
      unitRef="usd">7700000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzgtMS0xLTEtNjAyNjM_ced57049-1a63-4b55-9c66-c839d7b14598"
      unitRef="usd">1500000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzgtMy0xLTEtNjAyNjM_b1f63b7f-7ef6-4550-becc-ebcf8f8f98d4"
      unitRef="usd">1700000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzgtNS0xLTEtNjAyNjM_8107d313-eb9b-4f12-93d9-6867b3b738b2"
      unitRef="usd">-200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEwLTEtMS0xLTYwMjYz_a8038ad3-d5c5-4641-b2de-5217b38ca06b"
      unitRef="usd">3000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEwLTMtMS0xLTYwMjYz_305baae8-236d-4601-832f-e24f14d25ccb"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEwLTUtMS0xLTYwMjYz_2ef538b2-989e-473d-a6cf-fd36f84b8f4f"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzExLTEtMS0xLTYwMjYz_37e379c8-4008-4eb8-9ece-a3aa7a83b059"
      unitRef="usd">4100000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzExLTMtMS0xLTYwMjYz_924fe8f5-746a-44d4-b6bc-c07572b06c58"
      unitRef="usd">1400000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzExLTUtMS0xLTYwMjYz_045888f5-ecda-4fc5-8874-7fc7f85a57f4"
      unitRef="usd">1500000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:GainLossOnInvestments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEyLTEtMS0xLTYwMjYz_27411d54-d018-4a25-a8c8-0226f04932b5"
      unitRef="usd">-3500000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEyLTMtMS0xLTYwMjYz_c64e06db-abff-4def-b72b-b68461bf6761"
      unitRef="usd">-4300000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEyLTUtMS0xLTYwMjYz_55302856-c130-4334-9ebe-73c4cc35abcd"
      unitRef="usd">-2500000</us-gaap:GainLossOnInvestments>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEzLTEtMS0xLTYwMjYz_7721bdc1-7bda-4529-a5ee-37a0fb548ccd"
      unitRef="usd">600000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEzLTMtMS0xLTYwMjYz_05c93230-4e2c-4a82-89c1-d0125b0b6213"
      unitRef="usd">-1700000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzEzLTUtMS0xLTYwMjYz_83d8b71c-0087-42d8-aa70-ffcb96ac3c5e"
      unitRef="usd">2700000</us-gaap:OtherOperatingIncomeExpenseNet>
    <wst:OtherIncomeExpense
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzE0LTEtMS0xLTYwMjYz_a82c969e-808e-4311-bbb4-b32d9955f7d3"
      unitRef="usd">-26800000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzE0LTMtMS0xLTYwMjYz_053d4cf2-ff72-466b-a9b3-478d337d0eb6"
      unitRef="usd">-7900000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTpkZjJmZjllZjBlM2Y0MzdkYjFkZDQ3MDMzZTFhNzNmMy90YWJsZXJhbmdlOmRmMmZmOWVmMGUzZjQzN2RiMWRkNDcwMzNlMWE3M2YzXzE0LTUtMS0xLTYwMjYz_d83966d2-6714-4d97-9c68-35132270abd0"
      unitRef="usd">-12000000.0</wst:OtherIncomeExpense>
    <wst:RestructuringAndRelatedActivitiesPeriodOfImplementation
      contextRef="i95a83e2185a942eca49ce6709b9ac586_D20221201-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjQyMTM_23f389f9-0289-4c89-83ef-991e0f43f103">P12M</wst:RestructuringAndRelatedActivitiesPeriodOfImplementation>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="iaf9de54a304d46c781f42375b69365a9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjQyNDM_8e748ba1-325d-40d1-8e0e-6f3d84a41889"
      unitRef="usd">25000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i849944f81aab4b96860b7d3e5eb73e20_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjQyNTY_31f11023-21b3-4d5e-aa2b-9e051a716460"
      unitRef="usd">27000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:EffectOnFutureEarningsAmount
      contextRef="ice7d61872f80427da0d9116b49983311_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjQzMTk_06e152bc-aadb-410b-a9ff-a9c5871e0b01"
      unitRef="usd">22000000</us-gaap:EffectOnFutureEarningsAmount>
    <us-gaap:EffectOnFutureEarningsAmount
      contextRef="i5f7acdde722448e481784486341104c3_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjQzMDY_09b38d68-9913-43c2-9ff8-d019b19a3d8b"
      unitRef="usd">24000000</us-gaap:EffectOnFutureEarningsAmount>
    <us-gaap:AssetImpairmentCharges
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzEyMDk0NjI3OTE1MTU0_e56b269c-3e90-4578-8369-67aebcc95436"
      unitRef="usd">15300000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2Xzc2OTY1ODE0MDI0Mzk_aaf8d90f-b51d-46c9-a66e-fa4237c91048">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents activity related to our restructuring obligations related to our 2020 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.893%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i6d2bb17ed48c41dba32219896e2e8175_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzEtMS0xLTEtNzQ5NDc_ca668d02-8b71-4cc4-8942-3cd2af1b754f"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i141e60cb61604823b8430879ea150d99_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzEtMy0xLTEtNzQ5NDk_002735a7-bc43-4e78-95d9-2886a10d36cf"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i63527504ecaa4a10a8def5b5ec6f1894_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzEtNy0xLTEtNzQ5NTM_65857265-a915-4c1a-ac06-cdae02766bce"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="iea43a3c1ca4f40c0bbab919047a0f8b5_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzItMS0xLTEtNzQ5NDc_8a231fdc-6370-4f84-8956-266846e78c7f"
      unitRef="usd">10100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9659ef9de2934f93b6fa46288c5b5b6e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzItMy0xLTEtNzQ5NDk_4dd6b1a9-f571-453b-99dc-b9e033d4409b"
      unitRef="usd">15300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i69af11490d5b4086ad2dfcf3de8f6296_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzItNy0xLTEtNzQ5NTM_f1d7b399-7664-4545-99c9-dc5395697d85"
      unitRef="usd">25400000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="iea43a3c1ca4f40c0bbab919047a0f8b5_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzMtMS0xLTEtNzQ5NDc_9e50f83f-4fa7-4335-96bc-9e1d3b67b990"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9659ef9de2934f93b6fa46288c5b5b6e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzMtMy0xLTEtNzQ5NDk_75b3e059-29c4-4597-bb16-87cbea254be4"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i69af11490d5b4086ad2dfcf3de8f6296_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzMtNy0xLTEtNzQ5NTM_1383b345-e544-4f39-8582-962d40056f31"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="iffe83e403acf438f85b6dd1d97e8d460_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzQtMS0xLTEtNzQ5NDc_e576c428-d38a-49de-8d77-c39018082d4d"
      unitRef="usd">10100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i5d19b063b3c34a448674207e911c6ffb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzQtMy0xLTEtNzQ5NDk_62f1b3da-b079-4a35-a034-cd23864c01d7"
      unitRef="usd">15300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i26407107db9342c9bf5081c03e7a3fa3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTplMjBiZGY3ZjFkOTM0ZmQzOWFiZGJiM2EwZTNiZjAwYS90YWJsZXJhbmdlOmUyMGJkZjdmMWQ5MzRmZDM5YWJkYmIzYTBlM2JmMDBhXzQtNy0xLTEtNzQ5NTM_753b9b74-a589-4259-a72c-429b90cafb45"
      unitRef="usd">25400000</us-gaap:RestructuringReserve>
    <wst:RestructuringAndRelatedActivitiesPeriodOfImplementation
      contextRef="i8bd3a366e8d54c4b8cef2c043f15ec29_D20200701-20200731"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzM4OA_15865e15-bb5f-434f-83e0-c09c604abc03">P24M</wst:RestructuringAndRelatedActivitiesPeriodOfImplementation>
    <us-gaap:EffectOnFutureEarningsAmount
      contextRef="iec709d90491e43ea967136f7e4512e45_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2Xzc2OTY1ODE0MDMzOTg_b65c6dea-6f75-48a0-892e-51109730c8e1"
      unitRef="usd">900000</us-gaap:EffectOnFutureEarningsAmount>
    <us-gaap:EffectOnFutureEarningsAmount
      contextRef="i9559d3f0ca1a41c1b6d4dd22b5a6caa0_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjAwNTE_33f861e4-e124-40c1-90fb-ad10667367e4"
      unitRef="usd">1600000</us-gaap:EffectOnFutureEarningsAmount>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="id631ed0f114043709b097d7fd85636b2_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjAwMzc_dd1df71d-f525-40d0-8a13-db23e0baad46"
      unitRef="usd">5200000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringReserve
      contextRef="i3e0e239fe07746a692c5b712876addbe_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzEtMS0xLTEtNjAyNjM_2919b750-15ed-44c6-91f5-e8a72131d73a"
      unitRef="usd">2800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i24e6acff1c7640c38b022c848d7af043_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzEtNC0xLTEtNjAyNjM_3d9613c0-bc32-4adb-9b6f-75a5544e4f95"
      unitRef="usd">500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib7a20234e76b4aceb4a563d4757f3a25_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzEtNi0xLTEtNjAyNjM_1e4810f2-10f7-44ba-ba0f-cf2d25b2c3c9"
      unitRef="usd">3300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i1d8644e185ba45f1aca8a97124127c09_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzItMS0xLTEtNjAyNjM_07db4614-38e8-487b-a03e-399a4b81dc2e"
      unitRef="usd">-1400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i498328cc9bd447608019d68a0f1b2953_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzItNC0xLTEtNjAyNjM_55d61ab9-3f67-45ac-b846-d0f85326a464"
      unitRef="usd">-200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib2a5063af9e7457eadff8ecde4a2a0db_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzItNi0xLTEtNjAyNjM_a139d97c-0051-4309-9ea7-514dcc9bacf1"
      unitRef="usd">-1600000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i1d8644e185ba45f1aca8a97124127c09_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzMtMS0xLTEtNjAyNjM_9c11bce5-ba63-4723-82a3-8702ef855118"
      unitRef="usd">700000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i498328cc9bd447608019d68a0f1b2953_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzMtNC0xLTEtNjAyNjM_1f9f5d96-fecb-4073-84c5-23de4228f597"
      unitRef="usd">300000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib2a5063af9e7457eadff8ecde4a2a0db_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzMtNi0xLTEtNjAyNjM_13521904-94a1-4e47-8a56-aaaeb3ed5aa1"
      unitRef="usd">1000000.0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i9d14abab15aa4e50aae530229040d0ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzQtMS0xLTEtNjAyNjM_9aef67f3-5e69-4716-b4a3-e71867d9ab72"
      unitRef="usd">700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if4f7fd511790420c92f6c02a26a4ae95_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzQtNC0xLTEtNjAyNjM_d864fc3d-0018-400a-b42f-2a43fe2f429a"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id305d29074a84896bb281161842eac04_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90YWJsZTozZGVmYWRjM2U5ZDA0YTZkODM3ZTQ0YzFlYTFiNTA3OC90YWJsZXJhbmdlOjNkZWZhZGMzZTlkMDRhNmQ4MzdlNDRjMWVhMWI1MDc4XzQtNi0xLTEtNjAyNjM_58429d32-dbbf-43b9-a9b0-32af306839ef"
      unitRef="usd">700000</us-gaap:RestructuringReserve>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjI4NDk_ced57049-1a63-4b55-9c66-c839d7b14598"
      unitRef="usd">1500000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjI4NTk_b1f63b7f-7ef6-4550-becc-ebcf8f8f98d4"
      unitRef="usd">1700000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjI4NjU_8107d313-eb9b-4f12-93d9-6867b3b738b2"
      unitRef="usd">-200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:GainLossOnInvestments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjMxNzk_27411d54-d018-4a25-a8c8-0226f04932b5"
      unitRef="usd">-3500000</us-gaap:GainLossOnInvestments>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzI3MDQ_1800e932-0c64-4f2c-a7b3-7703a63553ab"
      unitRef="usd">-4600000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzE2NDkyNjc0NDUyMzk_f68d24c8-184d-46d7-8268-428b8f934e6c"
      unitRef="usd">300000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjQvZnJhZzplNDdjMjUwOWQ5OGM0ZjBmODZjODM4MmZmZDIxYmVjNi90ZXh0cmVnaW9uOmU0N2MyNTA5ZDk4YzRmMGY4NmM4MzgyZmZkMjFiZWM2XzIxOTkwMjMyNjMxMDE_55302856-c130-4334-9ebe-73c4cc35abcd"
      unitRef="usd">-2500000</us-gaap:GainLossOnInvestments>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1NTQ_28d565b5-735e-4c3c-ad04-e6f33594b9f2">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a global organization, we and our subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. As of December 31, 2022, the statute of limitations for the U.S. federal tax years 2017 through 2022 remain open to examination. For U.S. state and local jurisdictions, tax years 2013 through 2022 are open to examination. We are also subject to examination in various foreign jurisdictions for tax years 2015 through 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to current year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) due to prior year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction for expiration of statute of limitations/audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we had balances in accrued liabilities for interest and penalties of $1.6 million and $0.5 million at December&#160;31, 2022 and 2021, respectively. As of December&#160;31, 2022, we had $36.5 million of total gross unrecognized tax benefits, which, if recognized, $36.5 million would favorably impact the effective income tax rate. It is reasonably possible that, due to the expiration of statutes and the closing of tax audits, the amount of gross unrecognized tax benefits may be reduced by approximately $1.7 million during the next twelve months, which would favorably impact our effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of income before income taxes and equity in net income of affiliated companies are:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income before income taxes and equity in net income of affiliated companies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related provision for income taxes consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal and state&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant components of our deferred tax assets and liabilities at December 31 are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty acceleration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized R&amp;amp;D expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes and equity in net income of affiliated companies is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal corporate tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on international operations other than U.S. tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reserves for unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. tax on international earnings, net of foreign tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign-Derived Intangible Income Deductions (FDII)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess tax benefits on share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty acceleration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, we recorded tax expense of $5.7&#160;million due to the impact of tax law changes enacted during the year, $19.8&#160;million of tax expense due to the Company's recognition of reserves for unrecognized tax benefits, and a tax benefit of $16.5&#160;million associated with stock-based compensation. A tax benefit of $20.6&#160;million was recognized for the 2022 termination of our U.S. pension plan. The company did not elect to reclassify to retained earnings the stranded tax effects on items within AOCI related to the Tax Cuts and Jobs Act of 2017, and therefore included within the $20.6&#160;million pension termination benefit is a deferred tax benefit of $8.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, we recorded a tax benefit of $1.4&#160;million due to the impact of tax law changes enacted during 2021, a tax benefit of $18.5&#160;million due to the Company's prepayment of future royalties from one of its subsidiaries, and a tax benefit of $31.5&#160;million associated with stock-based compensation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, we recorded a tax benefit of $0.5&#160;million due to the impact of tax law changes enacted during 2020 and a tax benefit of $20.8&#160;million associated with stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State operating loss carryforwards of $123.2 million created a deferred tax asset of $7.3 million, while foreign operating loss carryforwards of $18.4 million created a deferred tax asset of $2.9 million. Management estimates that certain state and foreign operating loss carryforwards are unlikely to be utilized and the associated deferred tax assets have been appropriately reserved. In 2022, it was determined that $3.8 million of previously reserved state loss carryforwards were more likely than not to be utilized prior to expiration. State loss carryforwards expire as follows: $4.7 million in 2023 and $118.5 million thereafter. Foreign loss carryforwards total $18.4 million, none of which will expire.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, we utilized all of our remaining U.S. federal research and development credit carryforwards. State research and development credit carryforwards of $1.8&#160;million created a deferred tax asset of $1.4&#160;million. As of December&#160;31, 2022, $0.4 million of state research and development credits expire in 2025.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. &lt;/span&gt;&lt;/div&gt;Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $893.1&#160;million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1NDI_517709ea-418d-4bb5-9952-d5b92653d115">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to current year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) due to prior year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction for expiration of statute of limitations/audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzEtMS0xLTEtNjAyNjM_7c3a3659-2acb-49e2-b31f-2309fbf00fe4"
      unitRef="usd">24900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1165b131d689444eb6459290c85e0fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzEtMy0xLTEtNjAyNjM_873cb623-7c11-4aa8-af94-005fe2703b99"
      unitRef="usd">10400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5ff963c9c54045f29206b3189d452f9b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzEtNS0xLTEtNzk5NDI_27651b4e-cb97-4747-8b18-3c37d4536cd9"
      unitRef="usd">5000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzItMS0xLTEtNjAyNjM_24886cc2-5f95-4dfd-b85c-e4f0551062f2"
      unitRef="usd">11400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzItMy0xLTEtNjAyNjM_c1e796cb-0712-4dfd-bc50-45542b7fa135"
      unitRef="usd">16300000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzItNS0xLTEtNzk5NDI_52e20424-62f5-4b4d-ab88-c751600f22cd"
      unitRef="usd">4900000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzMtMS0xLTEtNjAyNjM_f8a8fe80-6045-4f9b-a203-0a03e1f975ca"
      unitRef="usd">600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzMtMy0xLTEtNjAyNjM_59bb123c-7b9f-4919-80b1-7039316aac91"
      unitRef="usd">1000000.0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzMtNS0xLTEtNzk5NDI_a742b7f6-b0b8-4da3-8475-5905bbc23158"
      unitRef="usd">600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzQtMS0xLTEtNjAyNjM_60a28ef2-edff-44c7-8f5c-83b7a495f8ef"
      unitRef="usd">400000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzQtMy0xLTEtNjAyNjM_c0f96c97-89e2-4557-9d52-7cae2e3112f2"
      unitRef="usd">800000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzQtNS0xLTEtNzk5NDI_428de074-bdb2-47a5-9219-e70da6e0d414"
      unitRef="usd">100000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzUtMS0xLTEtNjAyNjM_9eaa81d0-649d-4133-a9aa-07ccfb16f8b6"
      unitRef="usd">36500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzUtMy0xLTEtNjAyNjM_e84ef6e9-88f2-4fff-a590-8be6ea7a7af5"
      unitRef="usd">24900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1165b131d689444eb6459290c85e0fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1OWNmNmUyYjIwZmE0NWY0OWJmYTBiZGY3MjAxOGJiNS90YWJsZXJhbmdlOjU5Y2Y2ZTJiMjBmYTQ1ZjQ5YmZhMGJkZjcyMDE4YmI1XzUtNS0xLTEtNzk5NTA_8e8a3f7e-e48e-4c67-bad6-eafb890185ad"
      unitRef="usd">10400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzY4MQ_0cb17eb3-1737-494b-8e8f-e24cb63ac2d6"
      unitRef="usd">1600000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzY4OA_3c11d74b-287f-4bf3-8b48-245ade9064ec"
      unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzczNg_1fd2ddab-5317-4083-a619-f88f21215bcd"
      unitRef="usd">36500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjAxNDk_1fd2ddab-5317-4083-a619-f88f21215bcd"
      unitRef="usd">36500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzEwMzU_09ebd363-abd7-4663-b59a-74ff40e5a2b5"
      unitRef="usd">1700000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1MjM_a12b415a-eddd-4a84-8ad6-7256c5311138">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of income before income taxes and equity in net income of affiliated companies are:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income before income taxes and equity in net income of affiliated companies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzEtMS0xLTEtNjAyNjM_dab1f7b1-ef67-46df-a5a4-af321c8154b5"
      unitRef="usd">394400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzEtMy0xLTEtNjAyNjM_361e0119-f357-4efa-9b37-29a59d6e2576"
      unitRef="usd">420000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzEtNS0xLTEtNjAyNjM_a3a6f97b-e00b-4ff7-aff3-09246607d7ac"
      unitRef="usd">227000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzItMS0xLTEtNjAyNjM_770a1b0f-2712-4391-ba6e-cc14423a4daa"
      unitRef="usd">285500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzItMy0xLTEtNjAyNjM_3e17332e-54bc-4458-a1e7-9343a726c161"
      unitRef="usd">328900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzItNS0xLTEtNjAyNjM_480bea16-c1b7-4a0e-8c2d-e0372f0672b1"
      unitRef="usd">174300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzMtMS0xLTEtNjAyNjM_2359f821-bab4-437e-8c86-bdb892e540ab"
      unitRef="usd">679900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzMtMy0xLTEtNjAyNjM_75f2576c-7e40-4154-810c-07a7b14aadde"
      unitRef="usd">748900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpkN2QyMmIzMGJmZjg0MGZmOTAwNmUwZDgxYjAwN2VjMC90YWJsZXJhbmdlOmQ3ZDIyYjMwYmZmODQwZmY5MDA2ZTBkODFiMDA3ZWMwXzMtNS0xLTEtNjAyNjM_97fc8b4d-7dc2-4f63-aa1c-824d698d5a06"
      unitRef="usd">401300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1NTI_562cbd5b-c126-4ac6-b35e-c8680e3fb86b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related provision for income taxes consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal and state&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzItMS0xLTEtNjAyNjM_1162d7f7-2c7a-42e5-a563-cec15b10e578"
      unitRef="usd">75700000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzItMy0xLTEtNjAyNjM_e3160cd1-3768-4fca-ba81-b06a70cf8cf7"
      unitRef="usd">64800000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzItNS0xLTEtNjAyNjM_8b3b5ba9-8e3b-4826-9f3a-26eff3491145"
      unitRef="usd">28900000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzMtMS0xLTEtNjAyNjM_549ea035-ab1e-425c-8b67-9caaaccebea5"
      unitRef="usd">8400000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzMtMy0xLTEtNjAyNjM_f1647822-1663-4f4d-8bf0-d3764322897f"
      unitRef="usd">10900000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzMtNS0xLTEtNjAyNjM_89067e9c-7226-4f47-8759-98b399aa9268"
      unitRef="usd">3400000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzQtMS0xLTEtNjAyNjM_e77d702a-18db-44c0-a120-e263a097d804"
      unitRef="usd">61400000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzQtMy0xLTEtNjAyNjM_4db594d7-0911-40c7-acca-2ea240dd0375"
      unitRef="usd">74400000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzQtNS0xLTEtNjAyNjM_98c4309b-2b3c-46ee-a18a-c57db1db3df7"
      unitRef="usd">46000000.0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzUtMS0xLTEtNjAyNjM_b68a6c40-6d35-423e-9bcb-2aa9cc09b3f3"
      unitRef="usd">145500000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzUtMy0xLTEtNjAyNjM_f0496c5a-6e4d-48ad-86a5-02e026ccf922"
      unitRef="usd">150100000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzUtNS0xLTEtNjAyNjM_54f93b8f-d6b7-4e83-a8c6-38e277c23e3b"
      unitRef="usd">78300000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzctMS0xLTEtNjAyNjM_f7eadd92-0a5b-4e18-9373-72f18b25d73c"
      unitRef="usd">-20300000</wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit>
    <wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzctMy0xLTEtNjAyNjM_7db317e4-2df9-4086-ab29-a66d9a4be033"
      unitRef="usd">7300000</wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit>
    <wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzctNS0xLTEtNjAyNjM_8efd8ffb-3802-423e-b1eb-604fde5d16ef"
      unitRef="usd">200000</wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzgtMS0xLTEtNjAyNjM_a7d42ae0-312d-4b92-915d-77ea62ee00c2"
      unitRef="usd">-10500000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzgtMy0xLTEtNjAyNjM_26a02c97-6483-4a13-8217-1aa60aa5ac20"
      unitRef="usd">-50200000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzgtNS0xLTEtNjAyNjM_465b7f97-6d51-4089-bcff-1b28172b322f"
      unitRef="usd">-6000000.0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzktMS0xLTEtNjAyNjM_d8128fb5-1727-4083-88d5-473ca91124b5"
      unitRef="usd">-30800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzktMy0xLTEtNjAyNjM_166ce3a4-e9c7-49f1-b1a0-8e962f1c652f"
      unitRef="usd">-42900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzktNS0xLTEtNjAyNjM_ab4916ea-3025-454f-b843-64dc52404c10"
      unitRef="usd">-5800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzEwLTEtMS0xLTYwMjYz_469bdff4-807c-42fd-8bf0-da41cfffdd5c"
      unitRef="usd">114700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzEwLTMtMS0xLTYwMjYz_35c7878d-e71f-4af0-93b0-1f635c27271a"
      unitRef="usd">107200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTpmNmQ2MjZlNjgxODM0NTRhYTIxMGU2OTFhMWVlZjU4NS90YWJsZXJhbmdlOmY2ZDYyNmU2ODE4MzQ1NGFhMjEwZTY5MWExZWVmNTg1XzEwLTUtMS0xLTYwMjYz_dfeb5112-9fb5-4738-a1bc-00189de0a928"
      unitRef="usd">72500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1MjY_464e9691-d9bd-4247-ad4b-3265a9503747">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant components of our deferred tax assets and liabilities at December 31 are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty acceleration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized R&amp;amp;D expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzItMS0xLTEtNjAyNjM_173d9148-5756-4ffa-a275-15ab659540c2"
      unitRef="usd">10300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzItMy0xLTEtNjAyNjM_48a67069-e55b-4dc9-aa93-9350bd5dff0c"
      unitRef="usd">14000000.0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzMtMS0xLTEtNjAyNjM_240ed16e-3f7f-4d42-86d5-6c6c62440622"
      unitRef="usd">1900000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzMtMy0xLTEtNjAyNjM_9016da3f-2a3d-4804-bb0e-8eeb2955a2ec"
      unitRef="usd">1500000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzUtMS0xLTEtNjAyNjM_0000fcc7-bf02-4d4a-b564-8e1916d6d374"
      unitRef="usd">31400000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzUtMy0xLTEtNjAyNjM_2f82584f-d365-40dc-9ca9-48c5dfae7596"
      unitRef="usd">31600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <wst:DeferredTaxAssetsRoyaltyAcceleration
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzYtMS0xLTEtNjAyNjM_54796912-e8b6-42e1-a501-ddc0506ace56"
      unitRef="usd">46200000</wst:DeferredTaxAssetsRoyaltyAcceleration>
    <wst:DeferredTaxAssetsRoyaltyAcceleration
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzYtMy0xLTEtNjAyNjM_b980d068-2cc3-48ff-81a6-ac296186fe00"
      unitRef="usd">45100000</wst:DeferredTaxAssetsRoyaltyAcceleration>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzctMS0xLTEtNjAyNjM_3d556406-c599-4440-9992-97a589c4d560"
      unitRef="usd">25500000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzctMy0xLTEtNjAyNjM_7cf24c1c-b28b-4b91-bfc4-d65be46bcf05"
      unitRef="usd">12200000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzgtMS0xLTEtNzkwNzk_440b5c1b-283f-400c-b568-c96f28553457"
      unitRef="usd">8100000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzgtMy0xLTEtNzkwODc_d6d89a72-842d-416d-abce-0584c04015c9"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <wst:DeferredTaxAssetsLeasingArrangements
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzktMS0xLTEtNzk0MDc_4b2ceefb-b8b9-4bbb-bc66-887e31255a10"
      unitRef="usd">20600000</wst:DeferredTaxAssetsLeasingArrangements>
    <wst:DeferredTaxAssetsLeasingArrangements
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzktMy0xLTEtNzk0MTU_b31c607c-fe68-4ad2-8354-b36e33f1ceb9"
      unitRef="usd">0</wst:DeferredTaxAssetsLeasingArrangements>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzgtMS0xLTEtNjAyNjM_bf38dca2-d2e2-43b3-a64c-07ccf66864f9"
      unitRef="usd">13300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzgtMy0xLTEtNjAyNjM_7c49d0d5-ce79-4adb-8143-6f1919f2ee9b"
      unitRef="usd">12200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzktMS0xLTEtNjAyNjM_e2280501-1a6b-4ccf-89c5-330f5e5ce087"
      unitRef="usd">130700000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzktMy0xLTEtNjAyNjM_998f39a7-e5e7-4fdd-b578-3ced281d767e"
      unitRef="usd">92200000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzExLTEtMS0xLTYwMjYz_15fbab9c-800f-490c-9553-c352e945f73a"
      unitRef="usd">53700000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzExLTMtMS0xLTYwMjYz_ef3f8857-0705-4f11-9ec2-6b35a92a44a5"
      unitRef="usd">47200000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzEyLTEtMS0xLTYwMjYz_13bb1fc2-db78-467b-82ac-74e3169df3bd"
      unitRef="usd">1500000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzEyLTMtMS0xLTYwMjYz_8a112877-6df7-405c-be6c-5f2d52a15a85"
      unitRef="usd">1800000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE1LTEtMS0xLTc5NDI1_63409564-a5de-4554-9db9-b28a49b7f2b1"
      unitRef="usd">19700000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE1LTMtMS0xLTc5NDMz_de2c0d43-cd57-405e-bf6b-6974f98c649e"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzEzLTEtMS0xLTYwMjYz_b3443bab-89e1-4ee6-81eb-70a682a9f6b2"
      unitRef="usd">4500000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzEzLTMtMS0xLTYwMjYz_8ee44185-ff0f-4ab9-a31a-3269c7691bec"
      unitRef="usd">-400000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE0LTEtMS0xLTYwMjYz_6cd3a823-d396-4f30-91ea-34f45972782d"
      unitRef="usd">79400000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE0LTMtMS0xLTYwMjYz_63066e0b-bb2a-41d2-87b9-64690c2e4bbf"
      unitRef="usd">48600000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE1LTEtMS0xLTYwMjYz_ddbd441f-b3ad-4460-8812-5dda4730823b"
      unitRef="usd">51300000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo2NWJiMTczZTYwMzk0ZTJmYjJkZWI0Y2YxZWY1MGEyNi90YWJsZXJhbmdlOjY1YmIxNzNlNjAzOTRlMmZiMmRlYjRjZjFlZjUwYTI2XzE1LTMtMS0xLTYwMjYz_15b8b661-11b4-4f49-9625-813edd9bb47b"
      unitRef="usd">43600000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzQ1MjA_9f471e7c-066f-4cff-892a-5df6a1b822d8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes and equity in net income of affiliated companies is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal corporate tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on international operations other than U.S. tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reserves for unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. tax on international earnings, net of foreign tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign-Derived Intangible Income Deductions (FDII)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess tax benefits on share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty acceleration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEtMS0xLTEtNjAyNjM_d592dea2-2bff-4770-88d6-e68c2d41271f"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEtMy0xLTEtNjAyNjM_6d0b1288-1285-460a-97b3-6121a02e2a18"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEtNS0xLTEtNjAyNjM_9a5bc859-13e7-4aad-b1e8-d80518b47919"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzItMS0xLTEtNjAyNjM_957d08c8-7410-4d00-aa77-1f72f89b90b4"
      unitRef="number">-0.015</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzItMy0xLTEtNjAyNjM_924c6e2f-aed8-4720-8d57-060a7495e51d"
      unitRef="number">0.019</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzItNS0xLTEtNjAyNjM_f31772be-1795-44b7-b928-aa1c68327f62"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzUtMS0xLTEtNjAyNjM_9e886565-12f0-46d1-b3a7-6f45c1d6b7be"
      unitRef="number">0.029</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzUtMy0xLTEtNjAyNjM_ce4d9789-cc2f-4dd3-ac6b-3aa20093686c"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzUtNS0xLTEtNjAyNjM_1f53ae71-348b-403b-bf65-4d66fec84cca"
      unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzYtMS0xLTEtNjAyNjM_4a33b5c7-13da-45ba-bca2-53f434c68a54"
      unitRef="number">-0.003</wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent>
    <wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzYtMy0xLTEtNjAyNjM_17a9cce3-d966-41b8-8691-1f36ec9bc4bb"
      unitRef="number">0.003</wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent>
    <wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzYtNS0xLTEtNjAyNjM_2bb1c276-34cd-4717-9f04-0501648c48a2"
      unitRef="number">0.004</wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzctMS0xLTEtNjAyNjM_6e8e4431-28de-4818-8b1f-e21b192723ec"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzctMy0xLTEtNjAyNjM_5210fbe5-091b-47f3-9b3c-408a7da16bb2"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzctNS0xLTEtNjAyNjM_01cb97d7-f1c4-4f87-b82f-e5f6e3647b0f"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzgtMS0xLTEtNjAyNjM_c48d00a5-f124-418a-8491-90787d536ced"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzgtMy0xLTEtNjAyNjM_4a037726-99f9-43fb-aab9-da5eb51b386b"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzgtNS0xLTEtNjAyNjM_bf4cd3d8-3ddb-4697-81a3-a1b7eb8f4812"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzktMS0xLTEtNjAyNjM_d76280b3-08b0-4ad0-abac-d2ed46ba6d1f"
      unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzktMy0xLTEtNjAyNjM_30f2a725-1a56-4307-bab3-ce7840a674ec"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzktNS0xLTEtNjAyNjM_e1c1cef1-edc0-4379-bcaa-80c83ff0727f"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEwLTEtMS0xLTYwMjYz_8af706ae-75c9-4e1b-b9e2-460a1fbe7909"
      unitRef="number">-0.024</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEwLTMtMS0xLTYwMjYz_90395113-f1c2-481f-ac9b-306e3f06a4ce"
      unitRef="number">-0.042</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEwLTUtMS0xLTYwMjYz_a707a1de-d3ee-4ccd-a0ec-909678894ecf"
      unitRef="number">-0.052</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <wst:EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzExLTEtMS0xLTYwMjYz_c7defb44-bc21-4da0-bf28-65a6fae96f3f"
      unitRef="number">0</wst:EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent>
    <wst:EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzExLTMtMS0xLTYwMjYz_94c8248b-1ec1-4c05-a193-aa4355200764"
      unitRef="number">-0.025</wst:EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent>
    <wst:EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzExLTUtMS0xLTYwMjYz_35325a27-04e0-45ab-8df4-08fe52828a3b"
      unitRef="number">0</wst:EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent>
    <wst:EffectiveIncomeTaxRateReconciliationPensionSettlementPercent
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEyLTEtMS0xLTYwMjYz_61f32694-a9dd-46ab-a62e-65174691e140"
      unitRef="number">-0.012</wst:EffectiveIncomeTaxRateReconciliationPensionSettlementPercent>
    <wst:EffectiveIncomeTaxRateReconciliationPensionSettlementPercent
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEyLTMtMS0xLTYwMjYz_6255316e-ea00-4ab3-9a29-ec253b44b8a6"
      unitRef="number">0</wst:EffectiveIncomeTaxRateReconciliationPensionSettlementPercent>
    <wst:EffectiveIncomeTaxRateReconciliationPensionSettlementPercent
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzEyLTUtMS0xLTYwMjYz_453e9680-12c8-4c35-af40-4b21e16de18d"
      unitRef="number">0</wst:EffectiveIncomeTaxRateReconciliationPensionSettlementPercent>
    <wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE0LTEtMS0xLTYwMjYz_8b241ffb-31e1-4e1c-af8d-d4c795ad2caa"
      unitRef="number">0</wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage>
    <wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE0LTMtMS0xLTYwMjYz_7f0cac59-e362-4a66-8224-60e88db59e4e"
      unitRef="number">-0.006</wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage>
    <wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE0LTUtMS0xLTYwMjYz_bb01bbe5-8121-4c3e-81b8-7c906f4d1da2"
      unitRef="number">0.001</wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE3LTEtMS0xLTYwMjYz_5bce9f40-6e19-47a9-9a70-188770e403c0"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE3LTMtMS0xLTYwMjYz_261bda97-30f7-4a49-980b-47847340fd24"
      unitRef="number">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE3LTUtMS0xLTYwMjYz_746be511-bce5-4caf-94bd-95d5fb61ed2e"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE4LTEtMS0xLTYwMjYz_6f7c3bf2-dab4-44b5-81a4-aa8ec5306464"
      unitRef="number">0.169</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE4LTMtMS0xLTYwMjYz_a6b2be04-2479-4d33-805d-7be7e372d436"
      unitRef="number">0.143</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90YWJsZTo1MGVlNGI1NzU0MGI0MjJjOTlhODMxMjZjZjY1ZmJlZC90YWJsZXJhbmdlOjUwZWU0YjU3NTQwYjQyMmM5OWE4MzEyNmNmNjVmYmVkXzE4LTUtMS0xLTYwMjYz_a03d9cd0-ef30-477d-828b-88ba298253aa"
      unitRef="number">0.181</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzEyMDk0NjI3OTE0MTU4_04a8bf7e-5a3d-482a-9ef9-ee291e17acef"
      unitRef="usd">5700000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <wst:EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjU3MzM_5749458b-d6f6-4985-940c-a3fab27c9064"
      unitRef="usd">19800000</wst:EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjU3NDg_93146d4d-4535-4eac-94e7-b57246c1491c"
      unitRef="usd">-16500000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <wst:EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjU3NzA_37528d27-d097-4fc2-8b99-86852f1ea665"
      unitRef="usd">-20600000</wst:EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount>
    <wst:EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjU3OTg_37528d27-d097-4fc2-8b99-86852f1ea665"
      unitRef="usd">-20600000</wst:EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount>
    <wst:EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjU4MDE_dcaa2cdb-e057-4f51-989a-24f1c1159e35"
      unitRef="usd">-8000000</wst:EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzE5MzY_3c40c0d8-013d-40eb-b010-c2913ef48116"
      unitRef="usd">-1400000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationTaxSettlementsOther
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxOTkwMjMyNjAzNjI_c3ea7480-42d3-457b-9a75-eabbaa8b75b4"
      unitRef="usd">-18500000</us-gaap:IncomeTaxReconciliationTaxSettlementsOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIwMjE_ea9f1cd0-5bb9-4b9d-86b0-08d4d7ee06bd"
      unitRef="usd">-31500000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxMTI_5ffc9744-1759-4e44-a535-06f90e3bc845"
      unitRef="usd">-500000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIxODE_b77953ed-765d-4632-80c7-a1044c146fa4"
      unitRef="usd">-20800000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i291db1eaff5d4fe183595c6f835e091c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIyNjU_537ba243-4874-4d1f-ac7c-1647ac6ba873"
      unitRef="usd">123200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIzMDA_fe66ff6e-041f-4b62-9a90-769c7deec8ee"
      unitRef="usd">7300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i8495f2ee91834fb1a3f9fe1c93572049_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIzNTA_1da817ba-946c-4842-b7e3-e5e704206d68"
      unitRef="usd">18400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzIzODU_14a8e96e-a449-4ce3-b2f0-2b2c4fab6191"
      unitRef="usd">2900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i680df56be5cb4f5e860aab0cf5b550c7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzI1OTU_5a4a41ba-bb74-453b-ace9-ca585409c7d7"
      unitRef="usd">3800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i4e05940c83de48978c0c9bb32a9d5626_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzI3NTI_73a5462d-06fd-4e46-b7f1-c1cd6eede8e5"
      unitRef="usd">4700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i908fccc3de554e288be0804e0e181156_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzI3NjU_e5110ab3-01f6-403e-a7cd-0829add7c8cc"
      unitRef="usd">118500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i8495f2ee91834fb1a3f9fe1c93572049_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzI4NTk_1da817ba-946c-4842-b7e3-e5e704206d68"
      unitRef="usd">18400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i8495f2ee91834fb1a3f9fe1c93572049_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzMyOTg1MzQ4OTc3NDk_7090b52c-bc42-4b6e-83ee-0c975c5de16f"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ic45bcdf6531a4b0dbe32a45651758dbc_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzMwNDE_7f8f8cc8-325e-409c-9b66-f22b99b8d50d"
      unitRef="usd">1800000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="i5ff963c9c54045f29206b3189d452f9b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzMwNzY_2edd55c9-e28b-499e-b337-42b1cf8ddf5d"
      unitRef="usd">1400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i2dd0857c331249a9a85539ede4607c70_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzMwOTA_5c74e066-0fd6-46ea-954d-90253c5b4c5c"
      unitRef="usd">400000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMjcvZnJhZzo2OTFiMzlhMWJjYmE0MGY4OGZkZGQ5ZmU2MDllMDM5Mi90ZXh0cmVnaW9uOjY5MWIzOWExYmNiYTQwZjg4ZmRkZDlmZTYwOWUwMzkyXzM5ODc_12fafd7d-5af5-45d0-a877-e51ed9afe134"
      unitRef="usd">893100000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzkyNw_a32f0adb-6b1c-4d38-8eb4-013ae407fa03">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we were obligated under various operating lease agreements. Please refer to Note 6, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Leases&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we were obligated under various defined benefit pension plans in the U.S. and other countries that cover employees who meet eligibility requirements. Please refer to Note 15, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Benefit Plans&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, our outstanding unconditional contractual commitments, including for the purchase of raw materials and finished goods, amounted to $96.8 million, the majority of which is to be paid in the next two years, with $70.9 million due to be paid in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have letters of credit totaling $2.4 million supporting the reimbursement of workers&#x2019; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $3.3 million at December&#160;31, 2022, of which $0.7 million is in excess of our deductible and, therefore, is reimbursable by the insurance company.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzUzMA_51b5eaef-3b0d-4c17-847e-cfb0c2dbe53a"
      unitRef="usd">96800000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzU5OA_ed3ee6fc-5e17-4e33-a7ea-5b9e7e141256"
      unitRef="usd">70900000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary>
    <us-gaap:LineOfCredit
      contextRef="i36a6e77fe574426b8c780aa1e3956660_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzY1OQ_284c2f15-cc6b-4578-a139-20aa6a0e0923"
      unitRef="usd">2400000</us-gaap:LineOfCredit>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i6615258597bc4111bd8224a2f4f5be19_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzgxNw_a5ab54f2-2cb8-4564-a843-4906b35c0776"
      unitRef="usd">3300000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyReceivable
      contextRef="i6615258597bc4111bd8224a2f4f5be19_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzAvZnJhZzowODRmYjQ2ZjE5MjM0Mzk3YmE4OTMzNmMxMGEyNDc3OS90ZXh0cmVnaW9uOjA4NGZiNDZmMTkyMzQzOTdiYTg5MzM2YzEwYTI0Nzc5XzgzNg_c9528322-d064-4c90-a59e-00fb954395f8"
      unitRef="usd">700000</us-gaap:LossContingencyReceivable>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzQwNTA_3669715e-8cfe-4f5c-a87d-130f3f076e86">Segment Information&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Chief Operating Decision Maker ("CODM") evaluates the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that the CODM considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The segment operating profit metric is what the CODM uses in evaluating our results of operations and the financial measure that provides a valuable insight into our overall performance and financial position. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales information about our reportable segments, reconciled to consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,406.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,317.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment sales elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,886.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,831.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not have any customers accounting for greater than 10% of consolidated net sales.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,286.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,198.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other European countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,886.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,831.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The following tables provide summarized financial information for our segments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating profit (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total business segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate general costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated Items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and severance related charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of acquisition-related intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost investment activity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;734.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense (income) and other nonoperating expense (income), net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes and equity in net income of affiliated companies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) During 2022, the Company recorded restructuring and related charges of $23.8 million, which primarily included a charge of $8.7 million in net severance and post-employment benefits primarily in connection with our plan to adjust our operating cost base and $15.3 million in asset-related charges associated with this plan. During 2021 and 2020, the Company recorded a restructuring and severance related charge of $2.2 million and $7.0 million, respectively, to optimize certain organizational structure within the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) During 2022, 2021 and 2020, the company recorded $0.7 million, $0.8&#160;million and $0.6&#160;million, respectively, of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4) During 2021, the Company recorded a $2.8 million impairment charge for certain long-lived and intangible assets within the Proprietary Products segment as it determined the carrying value was not fully recoverable. $1.9&#160;million of this charge is recorded in Cost of Goods and Services Sold and $0.9&#160;million of the charge is recorded in Selling, General, and Administrative expense, due to the nature of the impaired assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5) During 2022, the Company recorded a cost investment impairment charge of $3.5 million. During 2021, the net cost investment activity was equal to $4.3 million, inclusive of an impairment charge of $4.6&#160;million partially offset by a $0.3&#160;million gain on the sale of a cost investment. During 2020, the Company recorded a cost investment impairment charge of $2.5 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6) During 2022, the Company recorded &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$52.2&#160;million pension settlement charge, which primarily related to the full settlement and relief of the historical balance sheet position, inclusive of accumulated other comprehensive income, of the U.S. pension plan. During 2021 and 2020, we recorded a $1.8&#160;million and $3.7&#160;million, respectively, pension settlement charge, as we determined that normal-course lump-sum payments for the U.S. pension plan exceeded the threshold for settlement accounting under U.S. GAAP for the year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please refer to Note 16, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8148abfe270d4f15aa2ba9319df722dc_124" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Expense (Income)&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion of unallocated items. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,152.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,616.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3Xzc5_977a1ba3-8062-4b6a-873f-492a195e7330"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzQwNjg_31945fc1-ed65-459a-ae95-838d0d0bfac7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales information about our reportable segments, reconciled to consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,406.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,317.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment sales elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,886.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,831.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzItMS0xLTEtNjAyNjM_81745313-5dcc-401d-a6cc-77a730db3b2b"
      unitRef="usd">2406800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib1eda1ab883d470f907fcc4ff3587bdc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzItMy0xLTEtNjAyNjM_edd35757-eb19-4ce2-b4a8-cca4fad258e5"
      unitRef="usd">2317300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8bd13159e1454ccd9cfc0a729531fc59_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzItNS0xLTEtNjAyNjM_0eec7555-ba2e-4c87-ae8f-0122632e32b5"
      unitRef="usd">1648600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic968e09b002f4e748bff0a829c35d435_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzMtMS0xLTEtNjAyNjM_2ba2c348-9e26-47a4-ad17-bae7a05f3828"
      unitRef="usd">480400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d70e9583819487dac48027986480d13_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzMtMy0xLTEtNjAyNjM_c793ff6c-ab0c-4f66-8b35-2b02c3c82aa9"
      unitRef="usd">514700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84403c68951c424f99f535d20528d792_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzMtNS0xLTEtNjAyNjM_a3dd12c4-b302-441e-b2c0-c1ee55117ebf"
      unitRef="usd">498600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibe48c875c32240ab9ed7fce93ce67305_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzQtMS0xLTEtNjAyNjM_1be9e3a9-d745-4b4e-a43e-611a3ddf1ef9"
      unitRef="usd">-300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie01badda3e434997a4b8e06f3311bc9a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzQtMy0xLTEtNjAyNjM_3165e39c-2787-4a80-9c10-1c1c564ce7f0"
      unitRef="usd">-400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i99c9f5c6fe924651b98fe035da1577d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzQtNS0xLTEtNjAyNjM_3d20f7a5-b94c-4d68-8d85-250dd3faac5a"
      unitRef="usd">-300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzUtMS0xLTEtNjAyNjM_4a84edb0-c0bd-4766-8269-a6244eef50c9"
      unitRef="usd">2886900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzUtMy0xLTEtNjAyNjM_e00a773b-4142-442b-939d-3b3083e7e730"
      unitRef="usd">2831600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTplZDg2ZWNjNmE3MmU0YmI0ODM4ZDA2ZjI0NzRjNmEzZC90YWJsZXJhbmdlOmVkODZlY2M2YTcyZTRiYjQ4MzhkMDZmMjQ3NGM2YTNkXzUtNS0xLTEtNjAyNjM_ba585696-65a6-487a-82d8-decf0d004686"
      unitRef="usd">2146900000</us-gaap:Revenues>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzQwNDA_1293bd29-cf16-4395-9aee-a4b0ee42b441">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,286.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,198.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other European countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,886.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,831.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="i8177e6120dec43daa5a7c888989f3da2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzItMS0xLTEtNjAyNjM_e45e8a26-4370-4420-a4c5-4734ac79ee60"
      unitRef="usd">1286500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0b508e52bb8f41c9b7957f921eb2b0b3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzItMy0xLTEtNjAyNjM_b1f0b7e5-0468-4e0b-8307-5fe6b2c7ed3e"
      unitRef="usd">1198000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i42e7467ce0ae48b9a47889bc1ec6fc4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzItNS0xLTEtNjAyNjM_0fbf2ac0-1572-4310-a16f-27c3cd01597d"
      unitRef="usd">975600000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="i431dce423ad841e6844024553fc98f20_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzItNy0xLTEtNjAyNjM_8dad6def-19cc-41f1-a963-887ee80d1e25"
      unitRef="usd">611500000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i4aaaf90727654d12b638272fe7f2baf3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzItOS0xLTEtNjAyNjM_68262e0d-0dea-4c22-a28d-d808513560de"
      unitRef="usd">504100000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="ia6314a6d37b84a358a5605e6ae2afd64_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzMtMS0xLTEtNjAyNjM_ef8823b5-3522-437f-a9ae-068756b98ff5"
      unitRef="usd">398700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iceb5fd8b48274ee1a5a308d102c6c25e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzMtMy0xLTEtNjAyNjM_710a72e8-8b52-4a7e-b2f5-359ee6b7fc39"
      unitRef="usd">474300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iead4344cd65d442aa5006dcd0376f4a2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzMtNS0xLTEtNjAyNjM_a7114ab0-06d9-4298-920b-2a20cd450369"
      unitRef="usd">282100000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="if6e0d0a05d1348769f058a2ca5f42aab_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzMtNy0xLTEtNjAyNjM_fd2e7334-28e8-402f-84da-489d8bbf274f"
      unitRef="usd">139000000.0</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i62beb24a7bad443180a155119c78b411_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzMtOS0xLTEtNjAyNjM_717981a3-1592-4310-8c3a-68e883f82c33"
      unitRef="usd">124100000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="i72bb0f0e78f045deaa478696bdea1be9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzQtMS0xLTEtNjAyNjM_b1526553-664c-4392-bd55-466221385ecf"
      unitRef="usd">240300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib4c8538cbbe04fb58f1ce10c1f2b28e2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzQtMy0xLTEtNjAyNjM_47b3ca87-00ad-4351-a02f-6cea649fab92"
      unitRef="usd">247600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia441c6249d0e463fa687f11715bdbe24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzQtNS0xLTEtNjAyNjM_f81c0ee2-44a5-4f09-a76f-8f34b570803b"
      unitRef="usd">226000000.0</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="i8ec4132786b74f858bedca0d55bf9841_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzQtNy0xLTEtNjAyNjM_7a90e454-46a3-40c6-94a0-ac03d5791120"
      unitRef="usd">179500000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="id4227815e2274453b99190c759250f43_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzQtOS0xLTEtNjAyNjM_1a51d76f-9a6a-4476-b7e1-bf1a43d44c97"
      unitRef="usd">187300000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="ic8c79157ca814df59f4a743dcc90418b_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzUtMS0xLTEtNjAyNjM_9e75b459-53b2-43a8-8e98-6a5a54389dc6"
      unitRef="usd">237900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if3888aacf77145f3a78e6e7189ee1a05_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzUtMy0xLTEtNjAyNjM_74f809d3-98d9-4900-bdec-5845f8ecca7e"
      unitRef="usd">213000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6fedbb37b25343e993a9a82605d7113a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzUtNS0xLTEtNjAyNjM_90bbfea4-b6b3-46b0-91e1-c449b63c07a4"
      unitRef="usd">172700000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="i9a5015f6b1c94dec99eecc4b8658eb7e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzUtNy0xLTEtNjAyNjM_a762aefa-eaff-4bab-9496-deb6facab3e0"
      unitRef="usd">68800000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i3e406b7e606f451d8091f5d964b93a58_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzUtOS0xLTEtNjAyNjM_67219233-d425-4449-b399-79b6784b2e9d"
      unitRef="usd">86100000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="ia0eff9689ef84a2ea76ecf78183f8827_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzYtMS0xLTEtNjAyNjM_c127e554-5790-43f9-964e-740dfa3124dd"
      unitRef="usd">359200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i926da543cc9e4398814ddc43ef95c631_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzYtMy0xLTEtNjAyNjM_fa23448d-b389-4a87-9cc1-a1f162686077"
      unitRef="usd">341300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id0b0ed6a479d444ea07152748eeca4cc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzYtNS0xLTEtNjAyNjM_7550dce4-e524-4dcb-aa7c-4115de169230"
      unitRef="usd">236800000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="i8828a20eda4045f48764034dedf66337_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzYtNy0xLTEtNjAyNjM_e45057e1-b0db-4bca-9b08-b7f660388b1d"
      unitRef="usd">81800000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i3307dfcbc00f42bb8997445de20e4919_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzYtOS0xLTEtNjAyNjM_28552504-63ff-4e88-9182-53562eb4e065"
      unitRef="usd">65100000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="ie61e6e97e08a4913b0cba163aed4e5a8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzctMS0xLTEtNjAyNjM_c150b44f-0b3f-4369-9f26-a3b9fa912abf"
      unitRef="usd">364300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i66d771c3fe9d4b339af1cad17d645c10_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzctMy0xLTEtNjAyNjM_d3ea254c-3d56-4111-902c-b9a230114c86"
      unitRef="usd">357400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i95a551fb427249b6a0f0c397412260fb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzctNS0xLTEtNjAyNjM_180a00ff-836d-4e3a-b298-437c9a04093e"
      unitRef="usd">253700000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="i6ca67d05039a4c1da64a8404c705ce24_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzctNy0xLTEtNjAyNjM_c2a6b0f1-624e-4007-8844-c13d191f10bf"
      unitRef="usd">182100000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i8d147dae6a024c4da07595e4f932e0c5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzctOS0xLTEtNjAyNjM_119696f8-dd28-4a8e-a4a6-3dd0efef31e4"
      unitRef="usd">160100000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzgtMS0xLTEtNjAyNjM_e68f407d-2277-4723-b34b-5764d2f31559"
      unitRef="usd">2886900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzgtMy0xLTEtNjAyNjM_2f3813b3-0697-465b-8300-51563f95216a"
      unitRef="usd">2831600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzgtNS0xLTEtNjAyNjM_a94ffe92-b67c-4816-849a-02f52397790d"
      unitRef="usd">2146900000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzgtNy0xLTEtNjAyNjM_c17fc5c7-350f-4e10-a71f-b4f03522c9e9"
      unitRef="usd">1262700000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTo5NDI5YzJkNTYxNWQ0ZGMxYTAxYThiYjJiOTlmODcwMy90YWJsZXJhbmdlOjk0MjljMmQ1NjE1ZDRkYzFhMDFhOGJiMmI5OWY4NzAzXzgtOS0xLTEtNjAyNjM_10f01335-1056-41d7-aed5-17d21f0cbd63"
      unitRef="usd">1126800000</us-gaap:NoncurrentAssets>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzQwNjU_aa09b51f-1922-4c7a-a00b-aa193a89a4fb">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The following tables provide summarized financial information for our segments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating profit (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total business segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate general costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated Items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and severance related charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of acquisition-related intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost investment activity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;734.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense (income) and other nonoperating expense (income), net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes and equity in net income of affiliated companies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) During 2022, the Company recorded restructuring and related charges of $23.8 million, which primarily included a charge of $8.7 million in net severance and post-employment benefits primarily in connection with our plan to adjust our operating cost base and $15.3 million in asset-related charges associated with this plan. During 2021 and 2020, the Company recorded a restructuring and severance related charge of $2.2 million and $7.0 million, respectively, to optimize certain organizational structure within the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) During 2022, 2021 and 2020, the company recorded $0.7 million, $0.8&#160;million and $0.6&#160;million, respectively, of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4) During 2021, the Company recorded a $2.8 million impairment charge for certain long-lived and intangible assets within the Proprietary Products segment as it determined the carrying value was not fully recoverable. $1.9&#160;million of this charge is recorded in Cost of Goods and Services Sold and $0.9&#160;million of the charge is recorded in Selling, General, and Administrative expense, due to the nature of the impaired assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5) During 2022, the Company recorded a cost investment impairment charge of $3.5 million. During 2021, the net cost investment activity was equal to $4.3 million, inclusive of an impairment charge of $4.6&#160;million partially offset by a $0.3&#160;million gain on the sale of a cost investment. During 2020, the Company recorded a cost investment impairment charge of $2.5 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6) During 2022, the Company recorded &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$52.2&#160;million pension settlement charge, which primarily related to the full settlement and relief of the historical balance sheet position, inclusive of accumulated other comprehensive income, of the U.S. pension plan. During 2021 and 2020, we recorded a $1.8&#160;million and $3.7&#160;million, respectively, pension settlement charge, as we determined that normal-course lump-sum payments for the U.S. pension plan exceeded the threshold for settlement accounting under U.S. GAAP for the year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,152.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,616.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzItMS0xLTEtNjAyNjM_ce339642-1c87-4a3b-9d1f-a2d396b81fa7"
      unitRef="usd">784400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib1eda1ab883d470f907fcc4ff3587bdc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzItMy0xLTEtNjAyNjM_1be49f16-2096-48ca-b46f-5fe6549db845"
      unitRef="usd">796100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8bd13159e1454ccd9cfc0a729531fc59_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzItNS0xLTEtNjAyNjM_9a361778-a220-44ec-bea3-acc020d928d6"
      unitRef="usd">434500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic968e09b002f4e748bff0a829c35d435_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzMtMS0xLTEtNjAyNjM_a3c156e5-c0ca-4d04-bd7d-91ef46dbdb75"
      unitRef="usd">60400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7d70e9583819487dac48027986480d13_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzMtMy0xLTEtNjAyNjM_164a4a52-2855-4e00-94f1-077fd0c4b8f2"
      unitRef="usd">67200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i84403c68951c424f99f535d20528d792_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzMtNS0xLTEtNjAyNjM_89e1b591-505c-4de6-8bd4-87113c807a76"
      unitRef="usd">68600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idff76b1b03b44f75aa61286e93799b04_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzQtMS0xLTEtNjAyNjM_267befc8-bef4-414a-b449-7b10a816fdad"
      unitRef="usd">844800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if85fe4e885e9410ea9b477f9f42fe802_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzQtMy0xLTEtNjAyNjM_09384de5-9f7f-4985-a214-9128e7944f17"
      unitRef="usd">863300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6e909081fe504bcd995d3d053a9e6458_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzQtNS0xLTEtNjAyNjM_9633a5c0-75f2-4ca3-9382-7bf72cda1a5c"
      unitRef="usd">503100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzYtMS0xLTEtNjAyNjM_e89e166b-0cad-4961-902f-5aa4dc3aff37"
      unitRef="usd">23700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzYtMy0xLTEtNjAyNjM_7e816ced-4485-4baa-8250-fa314a99879b"
      unitRef="usd">37500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzYtNS0xLTEtNjAyNjM_f6fee8c4-10b9-4bda-a39d-17dfebe161de"
      unitRef="usd">34000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzctMS0xLTEtNjAyNjM_1d5a5fed-43d5-48ca-bf62-044eba6cbcf5"
      unitRef="usd">59100000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzctMy0xLTEtNjAyNjM_5d85b44f-49c7-487e-ae26-2192f76ab6d0"
      unitRef="usd">63400000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzctNS0xLTEtNjAyNjM_700fa7c9-b705-4662-ae77-a3b7fce5bfe3"
      unitRef="usd">52100000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCharges
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzktMS0xLTEtNjAyNjM_fc278836-f8ce-470f-823f-361754e832b0"
      unitRef="usd">23800000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzktMy0xLTEtNjAyNjM_539aca39-8f45-4d70-8f1d-2093a872fb01"
      unitRef="usd">2200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzktNS0xLTEtNjAyNjM_9554746b-79ba-4e4a-abb1-cbcf25796444"
      unitRef="usd">7000000.0</us-gaap:RestructuringCharges>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEwLTEtMS0xLTYwMjYz_0c9f5147-37a4-4982-b432-bd1fbfb09959"
      unitRef="usd">700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEwLTMtMS0xLTYwMjYz_903f244c-8d79-42bc-8907-d7ac0e3864ad"
      unitRef="usd">800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEwLTUtMS0xLTYwMjYz_bc40306e-7e82-46d9-a0d3-d1fb96da7b6d"
      unitRef="usd">600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AssetImpairmentCharges
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzExLTEtMS0xLTYwMjYz_43a9a577-6b09-40ac-bf94-9be3f6bca851"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzExLTMtMS0xLTYwMjYz_7f0eb6e3-f23c-4b2b-b7ce-3fd8faf082cd"
      unitRef="usd">2800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzExLTUtMS0xLTYwMjYz_de417057-405c-4c6e-8836-bc3213982687"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <wst:CostInvestmentImpairment
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEyLTEtMS0xLTYwMjYz_6e75f243-c1fa-4a05-b4bb-42a4cd9b891e"
      unitRef="usd">3500000</wst:CostInvestmentImpairment>
    <wst:CostInvestmentImpairment
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEyLTMtMS0xLTYwMjYz_f9b5afae-851a-4066-9755-3bc68803f70d"
      unitRef="usd">4300000</wst:CostInvestmentImpairment>
    <wst:CostInvestmentImpairment
      contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzEyLTUtMS0xLTYwMjYz_35c3a5a4-2a17-48e7-9ab1-1f9445318d9e"
      unitRef="usd">2500000</wst:CostInvestmentImpairment>
    <us-gaap:OperatingIncomeLoss
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE2LTEtMS0xLTYwMjYz_72f39769-157d-4b23-b3cf-ac111448092a"
      unitRef="usd">-110800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE2LTMtMS0xLTYwMjYz_3c903d66-7f86-43e8-b235-19184328bcad"
      unitRef="usd">-111000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE2LTUtMS0xLTYwMjYz_dabc6d9b-c1fa-448c-91d8-de251746bf29"
      unitRef="usd">-96200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE3LTEtMS0xLTYwMjYz_e9843085-5672-4862-9398-e524f047f746"
      unitRef="usd">734000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE3LTMtMS0xLTYwMjYz_137a5453-e5ca-40b8-af33-bccf9e1c6d00"
      unitRef="usd">752300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE3LTUtMS0xLTYwMjYz_6cb16fbd-cde0-4f82-a8a9-d54e5bf249f1"
      unitRef="usd">406900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE4LTEtMS0xLTYwMjYz_0b377ed2-dd97-42d3-a4b4-b8c5e386a874"
      unitRef="usd">-54100000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE4LTMtMS0xLTYwMjYz_b3640308-3e5e-47c5-a632-21dea827370c"
      unitRef="usd">-3400000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE4LTUtMS0xLTYwMjYz_f29bca9e-74bb-4dc4-a3bb-6ebb7282cc04"
      unitRef="usd">-5600000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE5LTEtMS0xLTYwMjYz_3f2eb807-0899-4a79-9f5c-903f24193243"
      unitRef="usd">679900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE5LTMtMS0xLTYwMjYz_4790a683-4a60-4686-a2cf-fdaf1a851565"
      unitRef="usd">748900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpjZmU2YzA5YTVlNjg0ZDVlYjViMDg0MzRmZTAxZWRlMC90YWJsZXJhbmdlOmNmZTZjMDlhNWU2ODRkNWViNWIwODQzNGZlMDFlZGUwXzE5LTUtMS0xLTYwMjYz_5c262033-991b-4e8e-879f-1de68b920b46"
      unitRef="usd">401300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:RestructuringCharges
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjEwMjI_fc278836-f8ce-470f-823f-361754e832b0"
      unitRef="usd">23800000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjExMTQ_a26311ae-d7b1-43b4-8687-5638b11b64ca"
      unitRef="usd">8700000</us-gaap:SeveranceCosts1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjExNjE_e56b269c-3e90-4578-8369-67aebcc95436"
      unitRef="usd">15300000</us-gaap:AssetImpairmentCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjAwNjE_539aca39-8f45-4d70-8f1d-2093a872fb01"
      unitRef="usd">2200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjAwNTQ_9554746b-79ba-4e4a-abb1-cbcf25796444"
      unitRef="usd">7000000</us-gaap:RestructuringCharges>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjAyOTQ_0c9f5147-37a4-4982-b432-bd1fbfb09959"
      unitRef="usd">700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib778b3f359db4b4db7b559dbd58c0693_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzI2ODA_81a1b743-2181-4a3d-a537-64c3468a95fb"
      unitRef="usd">800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5177e5970481482dadb3afc395cb325e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjAxMDY_11df3dd1-3c74-4ada-b2bb-60b29b4c2082"
      unitRef="usd">600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AssetImpairmentCharges
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjAzMDY_7f0eb6e3-f23c-4b2b-b7ce-3fd8faf082cd"
      unitRef="usd">2800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ifb2833c3159542918f26feaf0c1d8860_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzMxOTE_08b4f6a2-ad90-4f4a-9e08-d3da18561c9f"
      unitRef="usd">1900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ieb5e02ca65384029bf2dee9c473d0fc2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzMyNDc_51dbe0e5-c78c-4f8f-a6e3-4a915ac45d17"
      unitRef="usd">900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainLossOnInvestments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA0MDE_27411d54-d018-4a25-a8c8-0226f04932b5"
      unitRef="usd">-3500000</us-gaap:GainLossOnInvestments>
    <wst:CostInvestmentImpairment
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA0MTk_f9b5afae-851a-4066-9755-3bc68803f70d"
      unitRef="usd">4300000</wst:CostInvestmentImpairment>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA0MDc_1800e932-0c64-4f2c-a7b3-7703a63553ab"
      unitRef="usd">-4600000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA0MTE_f68d24c8-184d-46d7-8268-428b8f934e6c"
      unitRef="usd">300000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA0MTU_55302856-c130-4334-9ebe-73c4cc35abcd"
      unitRef="usd">-2500000</us-gaap:GainLossOnInvestments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA1MDE_665c7078-041a-42a0-8d9a-d6347898ff2d"
      unitRef="usd">52200000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjA5Mzk_ef760436-e23f-4b1b-a216-81b463906492"
      unitRef="usd">1800000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzIxOTkwMjMyNjEyNjU_da05ec7d-9f5b-46b6-b733-e996f85250dc"
      unitRef="usd">3700000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:NumberOfReportableSegments
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90ZXh0cmVnaW9uOjY1YTI1NmMwNGIyMjQ4OWQ4ZTYyY2NjMjNhZTE1OTc3XzM5Nzc_977a1ba3-8062-4b6a-873f-492a195e7330"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:Assets
      contextRef="i244a7dd7a1e34e5aaf1f244eeeca66c7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzItMS0xLTEtNjAyNjM_c551816f-4bca-47ec-9232-a1c68347d210"
      unitRef="usd">2578300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i585911a48a184294aa02c08de8b96b51_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzItMy0xLTEtNjAyNjM_a35fdff9-7a65-45ca-933f-26f482fcf0a5"
      unitRef="usd">2152600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i22bf7ca10e524bf19773099096d46440_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzMtMS0xLTEtNjAyNjM_9d6b411d-2f19-4abb-9f29-f4e6c07f3bda"
      unitRef="usd">480300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i61cdd3ab97d6409eb1fd729bbcf4e3bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzMtMy0xLTEtNjAyNjM_97e029d5-29b5-473e-8c69-0bb9e0b7e3cf"
      unitRef="usd">443700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2c1e5aa461254453a205c4e2315ef26e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzQtMS0xLTEtNjAyNjM_34fb2627-8875-4a86-8f0d-9a6ae2be841f"
      unitRef="usd">558200000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0becd841990f40bcb28ada9ac03bea59_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzQtMy0xLTEtNjAyNjM_f18698cd-b8fb-455b-95bc-9005ad0af1ff"
      unitRef="usd">717500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzUtMS0xLTEtNjAyNjM_dca8db49-2364-4f1d-a5d4-f1dfd9edce35"
      unitRef="usd">3616800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTpmMTUyZTdlNjBhMGE0ODIzYjNlNTljNmE1MWMxMTAxZS90YWJsZXJhbmdlOmYxNTJlN2U2MGEwYTQ4MjNiM2U1OWM2YTUxYzExMDFlXzUtMy0xLTEtNjAyNjM_7ed4c3e8-99cb-4893-b90e-306ac41e54e2"
      unitRef="usd">3313800000</us-gaap:Assets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzItMS0xLTEtNjAyNjM_11c5cc48-fd12-4eda-8fe6-5cae716a3124"
      unitRef="usd">96900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib1eda1ab883d470f907fcc4ff3587bdc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzItMy0xLTEtNjAyNjM_6ee64f83-ad01-41b2-805a-4856be005926"
      unitRef="usd">93800000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8bd13159e1454ccd9cfc0a729531fc59_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzItNS0xLTEtNjAyNjM_5c28a470-715e-4571-8f87-eb7523beb2ba"
      unitRef="usd">84600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic968e09b002f4e748bff0a829c35d435_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzMtMS0xLTEtNjAyNjM_84c3529d-dec9-444c-9962-a9a52fa74ebf"
      unitRef="usd">19000000.0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7d70e9583819487dac48027986480d13_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzMtMy0xLTEtNjAyNjM_e5171f0a-6fb1-4f02-a1b1-b24c5faf928e"
      unitRef="usd">21100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i84403c68951c424f99f535d20528d792_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzMtNS0xLTEtNjAyNjM_8309b8c0-d8de-487b-8601-072aea06b478"
      unitRef="usd">20400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzQtMS0xLTEtNjAyNjM_5fd7e25e-cb8b-4b95-b817-4b18421906ec"
      unitRef="usd">4700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzQtMy0xLTEtNjAyNjM_e44684df-aad8-4fdb-92c0-9fd3b7971158"
      unitRef="usd">7400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzQtNS0xLTEtNjAyNjM_d162d722-04fe-4408-b78b-6228f5f98b48"
      unitRef="usd">4100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzUtMS0xLTEtNjAyNjM_a62cda55-28b4-4c71-8508-b6581ec360aa"
      unitRef="usd">120600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzUtMy0xLTEtNjAyNjM_f47b5dda-7597-4d96-b864-36f08b9b6eb8"
      unitRef="usd">122300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzUtNS0xLTEtNjAyNjM_1a0b86fb-b879-4ba5-88cf-d8037c64f608"
      unitRef="usd">109100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzktMS0xLTEtNjAyNjM_f18f61d3-3ff5-4be3-b05d-05924633d81a"
      unitRef="usd">237300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib1eda1ab883d470f907fcc4ff3587bdc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzktMy0xLTEtNjAyNjM_337dbb94-d4f1-4c6d-8e14-bff3b9c2f97e"
      unitRef="usd">218000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8bd13159e1454ccd9cfc0a729531fc59_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzktNS0xLTEtNjAyNjM_5ad2175b-f80f-454f-bb72-b3dc6ac9d6f7"
      unitRef="usd">139500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic968e09b002f4e748bff0a829c35d435_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEwLTEtMS0xLTYwMjYz_2aa16ff1-8682-4f24-a745-93ebcf5dcf1c"
      unitRef="usd">34000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7d70e9583819487dac48027986480d13_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEwLTMtMS0xLTYwMjYz_9755bae8-6911-4ee1-95cc-2790052abfdd"
      unitRef="usd">26600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i84403c68951c424f99f535d20528d792_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEwLTUtMS0xLTYwMjYz_b60f47ca-9069-48c3-a82a-d56e9a312144"
      unitRef="usd">25000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idb578834702c45c985e36276eb4e5209_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzExLTEtMS0xLTYwMjYz_f7c40591-3cd8-4b63-8b12-2dc0e39e34be"
      unitRef="usd">13300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia70443dc17684967b5578dd38a080142_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzExLTMtMS0xLTYwMjYz_b1721069-250d-4a46-97e4-8c625e0bdd5f"
      unitRef="usd">8800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if7f77ec4997d4a1ab77dc1b70f801610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzExLTUtMS0xLTYwMjYz_141936d5-cd1d-45fb-90a5-2d46a8292f38"
      unitRef="usd">9900000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEyLTEtMS0xLTYwMjYz_b8808d88-7ef5-4cf8-903e-98e0bb01319d"
      unitRef="usd">284600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEyLTMtMS0xLTYwMjYz_6f9fb9ad-4124-44f3-b565-343da477c879"
      unitRef="usd">253400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzMvZnJhZzo2NWEyNTZjMDRiMjI0ODlkOGU2MmNjYzIzYWUxNTk3Ny90YWJsZTozMzUwYTUxOWMxMGQ0NGZlYTdkNjYxZjQxYjBjMDhiNS90YWJsZXJhbmdlOjMzNTBhNTE5YzEwZDQ0ZmVhN2Q2NjFmNDFiMGMwOGI1XzEyLTUtMS0xLTYwMjYz_67e6b0e5-770a-4bf1-bc36-5af2356e82a5"
      unitRef="usd">174400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <dei:AuditorName
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzYvZnJhZzoxMWNlODk5ZDIwMWI0MGFiODg3NGQ3MTk3OTdhZTgzNS90ZXh0cmVnaW9uOjExY2U4OTlkMjAxYjQwYWI4ODc0ZDcxOTc5N2FlODM1XzkzMDQ_e7e456d2-28a8-4ce7-8e42-59f12238ec60">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xMzYvZnJhZzoxMWNlODk5ZDIwMWI0MGFiODg3NGQ3MTk3OTdhZTgzNS90ZXh0cmVnaW9uOjExY2U4OTlkMjAxYjQwYWI4ODc0ZDcxOTc5N2FlODM1XzkzMDY_05d9f049-9ce0-4a9c-90ba-c3427c4ee0e4">Philadelphia, Pennsylvania</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90ZXh0cmVnaW9uOjZhYTRkNzcxM2E0OTQzNDZiMTc4MzQ4YzllZjU5YTE1XzU5MQ_5ce6d603-eff0-4af2-8aac-213ecd2b1557">238</dei:AuditorFirmId>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90ZXh0cmVnaW9uOjZhYTRkNzcxM2E0OTQzNDZiMTc4MzQ4YzllZjU5YTE1XzEzMzU_48608d1f-179b-420e-bef9-7c0fd7b4f992">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Schedule II - Valuation and Qualifying Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;beginning of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;end of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the year ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances deducted from assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total allowances deducted from assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances deducted from assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total allowances deducted from assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances deducted from assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total allowances deducted from assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments.</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i45c760b6f46f45a1aca96e9c28532938_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzMtMS0xLTEtNjAyNjM_43187723-c75e-4992-aa49-759ac2a41ec4"
      unitRef="usd">12200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i225515b9f9cc44409112978bbc812f54_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzMtMi0xLTEtNjAyNjM_fefec616-b946-4a6b-a2aa-88514527f67e"
      unitRef="usd">1100000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i225515b9f9cc44409112978bbc812f54_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzMtMy0xLTEtNjAyNjM_fe4e8c63-36c6-4da5-bb21-10f1b6ff7497"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i707beb89e95a42328dcd6d2412aa3f9d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzMtNC0xLTEtNjAyNjM_bfd6e697-c8ff-472d-bfb2-8dd248994fd7"
      unitRef="usd">13300000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6cda7d0db84d46a1a162bc0ad54e9fed_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzQtMS0xLTEtNjAyNjM_ec77492f-8e06-4dab-a6e1-4f982ba1400c"
      unitRef="usd">400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i9d36b5ee016b44859820b1a91b193d45_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzQtMi0xLTEtNjAyNjM_8997cb23-e7bc-479b-b14d-ac55b352288f"
      unitRef="usd">300000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i9d36b5ee016b44859820b1a91b193d45_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzQtMy0xLTEtNjAyNjM_5f886b46-819b-4441-b372-5ae7feb445bb"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i9f1502fcf310445290cecc08ffe7e7b3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzQtNC0xLTEtNjAyNjM_a387c642-b66a-4db1-a165-c205b341793e"
      unitRef="usd">200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzUtMS0xLTEtNjAyNjM_74732121-b2f9-458e-a83b-c5406c0c0487"
      unitRef="usd">12600000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzUtMi0xLTEtNjAyNjM_efff2307-47b6-4b99-93a3-ef587953fb43"
      unitRef="usd">1400000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzUtMy0xLTEtNjAyNjM_c04aea19-fa8c-462c-bfdd-5c5851adbbe4"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzUtNC0xLTEtNjAyNjM_625f0b03-ea4f-4d52-a872-b249e6c07494"
      unitRef="usd">13500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2501ceeb8ed04db1a417a4d65803126e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzktMS0xLTEtNjAyNjM_bfdc0362-f866-4c0d-9722-81c51b8bc764"
      unitRef="usd">15100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="icee1c6f02c1b44ed8186b856c69cb13a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzktMi0xLTEtNjAyNjM_2f2ff20a-1cba-466e-b405-df00fe1633f8"
      unitRef="usd">-2900000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="icee1c6f02c1b44ed8186b856c69cb13a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzktMy0xLTEtNjAyNjM_ad486fed-b3b0-41b8-adfb-84532604dba7"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i45c760b6f46f45a1aca96e9c28532938_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzktNC0xLTEtNjAyNjM_7361b9c6-aa23-4e57-b14d-a1c3c226d764"
      unitRef="usd">12200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i3c5469d65e0b475cb923c823d47d89ba_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzEwLTEtMS0xLTYwMjYz_74e31b6c-555d-4e00-bbea-ad4ad91f409e"
      unitRef="usd">1100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i142f68e23d4545d08259d4c707844b97_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzEwLTItMS0xLTYwMjYz_53eec05e-563a-4ad0-8210-351d297b5809"
      unitRef="usd">-700000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i142f68e23d4545d08259d4c707844b97_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzEwLTMtMS0xLTYwMjYz_6d1ab576-490e-45dd-b6a0-971a812236b8"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6cda7d0db84d46a1a162bc0ad54e9fed_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzEwLTQtMS0xLTYwMjYz_ba408879-f845-4d81-9c0b-d1119a8e1a26"
      unitRef="usd">400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i1165b131d689444eb6459290c85e0fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzExLTEtMS0xLTYwMjYz_36bdd8af-8cea-4b12-8cf0-766f3fe5c998"
      unitRef="usd">16200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzExLTItMS0xLTYwMjYz_a888e6c3-8ba1-433e-8a89-56dc41305b89"
      unitRef="usd">-3600000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzExLTMtMS0xLTYwMjYz_ec23034c-165a-4d4e-89ce-0d10102a4119"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i635169c6599a4431a7816915bd315902_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzExLTQtMS0xLTYwMjYz_cc481175-7e26-40f3-bd26-8c52959dc8e2"
      unitRef="usd">12600000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6d3247d3a01544388bce9b89588c6ec3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE1LTEtMS0xLTYwMjYz_b12d36ae-5915-4db6-abdd-d1cc9a64f32d"
      unitRef="usd">15900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i073f657af77647788880cd4518a255a0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE1LTItMS0xLTYwMjYz_49b9c90c-ba73-4a32-8cac-4cdb61e05745"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i073f657af77647788880cd4518a255a0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE1LTMtMS0xLTYwMjYz_c078b99b-9cff-44af-b31a-4a897855a356"
      unitRef="usd">800000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2501ceeb8ed04db1a417a4d65803126e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE1LTQtMS0xLTYwMjYz_557c9120-5f9e-420b-9099-c1760c104829"
      unitRef="usd">15100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib989212096a844a7a71240a6d956563a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE2LTEtMS0xLTYwMjYz_9502eeb0-67f3-4e38-84e1-57e10675f695"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia67a3626f5f948b5b1895672cce6e96b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE2LTItMS0xLTYwMjYz_d66c2dc9-a59a-4db4-b966-064be865c03e"
      unitRef="usd">700000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia67a3626f5f948b5b1895672cce6e96b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE2LTMtMS0xLTYwMjYz_bc3883ee-5a9b-4b60-986b-886c464e3535"
      unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i3c5469d65e0b475cb923c823d47d89ba_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE2LTQtMS0xLTYwMjYz_f13688b4-e59f-491a-9adb-116844d786a5"
      unitRef="usd">1100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i5ff963c9c54045f29206b3189d452f9b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE3LTEtMS0xLTYwMjYz_2a0395d4-77fb-46d5-ab8b-5e1707ee4a02"
      unitRef="usd">16400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE3LTItMS0xLTYwMjYz_da8fbf15-11fb-46f5-811e-9cdba18be4d0"
      unitRef="usd">700000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i42f410d7f1cf4d6c88aa8d7f4ff7dadf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE3LTMtMS0xLTYwMjYz_6ddfde6d-8d7a-4919-b558-224226dee875"
      unitRef="usd">900000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i1165b131d689444eb6459290c85e0fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgxNDhhYmZlMjcwZDRmMTVhYTJiYTkzMTlkZjcyMmRjL3NlYzo4MTQ4YWJmZTI3MGQ0ZjE1YWEyYmE5MzE5ZGY3MjJkY18xNzUvZnJhZzo2YWE0ZDc3MTNhNDk0MzQ2YjE3ODM0OGM5ZWY1OWExNS90YWJsZTpjNTYwN2QxNjNiMzY0NTM3YmY3NzQxNmQ1ZTJjOWZkMy90YWJsZXJhbmdlOmM1NjA3ZDE2M2IzNjQ1MzdiZjc3NDE2ZDVlMmM5ZmQzXzE3LTQtMS0xLTYwMjYz_536b1d88-3e1f-47b8-ac82-4f22bc087676"
      unitRef="usd">16200000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>120
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $."558'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !#@E56\JZGP.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>*';*!B;-I:.G#@8K;.QF;+4UBQUC:R1]^R5>FS*V!]C1TN]/
MGT"-#E+W$9]C'S"2Q70WNLXGJ<.:G8B"!$CZA$ZE<DKXJ7GHHU,T/>,1@M(?
MZH@@JNH>')(RBA3,P"(L1-8V1DL=45$?+WBC%WSXC%V&&0W8H4-/"7C)@;7S
MQ' >NP9N@!E&&%WZ+J!9B+GZ)S9W@%V28[)+:AB&<JAS;MJ!P]O3[B6O6UB?
M2'F-TZ]D)9T#KMEU\FN]>=QO62LJ41>5* 3?"R[Y@URMWF?7'WXW8=<;>[#_
MV/@JV#;PZR[:+U!+ P04    " !#@E56F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M $."55:KQ!Q>GP<  "4O   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MM9IK;Z,X%(;_BI4=K6:E)@&3]#+;1DIINI.=3B=J.E/-KO:# TY  SAK3"__
M?H\A"6%D'%@Y7UH@G!?\8)OSFG/YPOB/-*!4H-<X2M*K3B#$^D._GWH!C4G:
M8VN:P"]+QF,B8)>O^NF:4^+G07'4QY9UVH])F'1&E_FQ&1]=LDQ$84)G'*59
M'!/^=DTC]G+5L3O; P_A*A#R0']TN28K.J?BZWK&8:^_4_'#F"9IR!+$Z?*J
M,[8_W#AG,B _XUM(7]*];22;LF#LA]R9^E<=2]X1C:@GI 2!?\_4I5$DE> ^
M_MV(=G;7E('[VUOUV[SQT)@%2:G+HJ?0%\%5Y[R#?+HD620>V,M'NFG04.IY
M+$KSO^BE.'<PZ" O2P6+-\%P!W&8%/_)ZP;$7L"Y51. -P'XIP"[[@K.)L!I
M&C#8! QR,D53<@XW1)#1)6<OB,NS04UNY##S:&A^F,CG/A<<?@TA3HQ<]DPY
MZJ*O\QOT_MUOZ!T*$W0=1A$\E/2R+^ 2\L2^MY&[+N1PC9R-T6>6B"!%D\2G
M?E6@#_>VNT&\O<%KK%6\H5X/.?8)PA;&BAMR]>%_DJ2'\# /=Q3A-P?",PAW
M+-75*ZUQ=KB=7,_1XOY[O$@%AR[_CXIPH3!0*\AYX$.Z)AZ]ZL! 3RE_IIW1
MK[_8I];O*CHFQ6X,B57(#7;D!CKUT0WS,IAO!'I\6U,5-GVX;74_J?AHH]KR
M,216X3/<\1DVXS-.DHQ$Z(&N&1<J4'H=P3,57E<;U1:4(;$*J-,=J--FH&:4
MA\R7$Q6"J5/9IPXH;:>FVKE)&]\6FB&Q"K2S';0S;5/=C'/)[#9,/>A<WRGA
M6G!ZM6[7QEW'5A'3!K8E9DBL0NQ\1^R\X7S%"61)>9)3/R;U6DL2I<I!J0UK
M2\N06(76Q8[6A;:%DT2$X@VZ5T31?18O*%=1TFO8W7/+.55ATL:UQ61(K(+)
MMLITS6H"ZH&N0IE"0/^Z)[%R"!X0>IK,']'LX_CA\]B=?'V<NN,[-)\\?)NZ
MD_D)FMZ[/15)O6A;E*;4JBSW4E^["<MIXC$. Y/(,7J"Y@+F-,0X<EF6"/X&
M_WTU8+WZ;*P$J UJ#="06A4@+@'B)@ ?R2N:^C#7A<O0RREJQO !2>S N\&V
M+-M2TM,&MZ9G2*U*K[0"MC9?WM(;^SZHIR?;#70'YZ$OB;K/Z26'CH4^4K##
M"?K20T\T%>B&@Z]6LC1J#4RI55F6YL#6I_<_LW3E'HSA1_:2*#D>D'L53!7G
MZN-:0SN&8;!+QV#K4_V?H>UFOAEGSV'BJ7N@7K-FUC/J'DRI5;&5_L'6I_T_
M8YNQ5$!._%>XKG]5Z!7M"V=@=ZW3P5 )SZB+,*56A5?Z"/N D<C1<4KJ6>D%
M3FO>#$:-@RFU*J32.MCZ?/^.29,U"UBBRX8/B PO!EU\8:EI&34.IM2JM$KK
M8.OS_L=0@&M@2V3C]XO?T)QZ&8=>ID2F5W)9'$/R,A?,^W&"UN!QGTF44?2N
MAX=H33E* \+5+U.C%L.46G7!M?086&\-P+'Z8;)"\[=XP2(5QP,"3_-'Y4JM
M4?-@2JT*J30/6)_>;[L9FKQZ 4E6M-:('1"Z_SZ?*&D9=0JFU*JT2J> &SF%
M)QI%W1\))&4P3$D*\YN/IFF:J2>X YK?J>H#A:N/:LWM&!X!EQX!-_((WU@$
M7I3P8H6$*S_,'%"Z9TI81DV *;4JK-($X$8F8+M66:RVY1,9)+:9&II>L:Z+
M&74!IM2JU$H7@!NY@&DB*"^^PLI57;+%J*2F5ZRC9M0$F%*K4BM- &YD O+A
MB%SP32O&E2G' 9T[PN'5,?8\"D(@XQ>22GY&?8 IM2J_T@=@?1J_X3>/212A
MZRR%GU/U"-7KU"Z-Z^-:TSJ&(<"E(<#Z7'Y#:Q)3OI(3VA^@( *P4/&:).IN
M]S^_*.CC6F,[AC/ I3/ ^GQ^ZMX^H''FAX)Q-!:"@E'/ER=O([)24M/KU7T;
MU8>UAG:,[-\ILW^GT1>&>0"YFJZ''9"I[6'ZN-8E"<=P 4[I IQ&GQ!FV2(*
M/>A6C"A?F'J5UC4=1IW!1FV8J\DRL><1QCWGLO^L(E-F_$ZCC+]JJ>?2/Z?H
M2R9@)";29"IIF<S@W8W:Z5[[S@:V,QP.![LV;D@<(]=W]DJ#]!GZ]HMQNO=%
M"O*!A?S:MZ20BZD79!NJHAGAN;1@Z"D(O:!ZE1EGKV_%"G!^]A)F3!'0O&QJ
M6U+RF=(\G6;+XD$&+/+!C"!07%"TA+S%1PD3* (1&4T29&,+^>0M1619'*.(
M)KY4D)O+HIK@3583>+(RJFBN",(4R:H^)*MV>OF=H^ETJGRZ9@N<CF%@G-+
M.,T,##P #ERFB4]?T2>JGG[U4I8EOZ$-S\Z4ZW_ZX-;4CF%@G-+ . TKG_:+
M4V[AH#*?/"!65\FC#VM-[!CFQ2G-B].P!&I#;%,)5<],+W?[74G,J%TQI58E
M5MH51V\SQH#++Y#5I(X'!.K3(:,^Q91:@:F_5U<LK4=>GYW"5)TEHB@QWAW=
MU8"/\\KG?GEZ44#^F4CGDJ*(+B'4ZIW!".!%37:Q(]@ZKU)>,"%8G&\&E,#[
M19X OR\9$]L=>8%=9?SH/U!+ P04    " !#@E56LH/"BD$"  #(!0  &
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MTVI!6@>SOQ-"'PU[0-^\L[]02P,$%     @ 0X)55C?;2QF+!0  ;1<  !@
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M+2>1!4=V9T">A=Q@^CP*E3DY4$TC#<I7^54HOXNRD9[>K*$W,]*[Y3M2' F
M]TE95S^ ]S>4$P#]#SI*,V6RR!_.=:F"@B'K:*;P@2-TH-WV;=M,:$_DJN1;
M0P+5+KH#!XX[(%"#>@S$GG,&'#0PUQ[==;"C/Z"1QU7.B2CY_+@V6A[PUT%>
M:D"A!6>]SY#3:TSZ_%#+#[V,7[7EM/20,HT3KU-<:WY(6<P3."2D\00M=X1#
M*T*@L3W7R9/3G#:;;IA)6EZ.6LS@<&,M-:@31RD).A2TQK*H50;0+ UJ??5
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M'CH_ZZ$S%*7H+HICV#X^&0A8C#0Y"(J);_*)S1,38Q/=T52L.9JG(0GK!@:
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M"_#_%>?JY4%_(#N:C?X'4$L#!!0    ( $."55;P&JP%I0<  &@B   8
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M/#NG9!W)XG2K7S"I#@YI,U!G.^ Z0-U?,B:W'7UZ*$Z+[E]02P,$%     @
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M9!=,(&Q(FKG;D/U\808.8SV=@S\DM3>/S0XG"BX/"N/L]O\?3+]3OZOK@#7
M2I#2<FG;/82J!(ZNGA*6N#77O(D9[KUZ%GHO,J<=Y'LG@L\JM%+S$:L9H.(0
M@R&XONK\,W,S7CZK.I(.[%!KN;3W ^ J@[('!@3$3*%U=KF+PV*HB>K\S#P<
M[U7;I1*>0EF352X[@.\Y)E&$CQ[$A#8"JM.X@:JW&,6#^R1YPI'Z^X4[KGF+
MG[$A;R?VP3$DXD1^S1H])/6*&L%]$]GB0$,N/>RA]9ATYT/8(Q>'[1'+NR<=
M\X,WT%)[=)KET01B(L6"&DIVD=F_5 LF 8<O832MIA],+WQ/*"9;"=_U-Q+K
M'2L,T9;\%QN3TSB9\7K$G['AC*00 C 45V.-W$80$QTO[X3]\G1UP %[Y;RI
M>8NXV>RL-:]Q_(7KPM5A("LF%Z+UL\HMU=^JK0J0F&,2\<!,IYM-:$6A.%AW
MS<JIK-_2?ID1I+J6E&LU:4L7+-GM8;R$S%V(7+EBV!"1N&(\]SF=X:*7JU/9
MZ4&Z,M2[VBYC8_0>V=&DFGTZ1"C>X,GS/424$:.>5LL ,A1SRVX!CF4'F+ 4
MM+7$YC[W>J.%VGB!J#P@9M[/,B4%DVK@O?R:#A>^ [A2,QRYI52;8%$NE55C
M32'P@M>LO5[H'BK&6!E(@APU%=MFN_O*$V,H.^*7(W6[21)SW'&0:LCMDW+J
MYL?'QK1O"#&'8YYIK0W 16LM1\\6'(BD<WQES<H6%8#"E^R>WRCLK7[L>$=K
M@]>/)]&JY8XIU0C5AR.*%*[BC06TO?<^2^AS(PX]&N/306W>I3SK?78W?6M>
M07.E3E-T"0EE-5LPQ#I9<HBQ>24V(L50+]:>.P4[H<JE[A;:<%",RO;%GPS(
M>CO#>LY\&0T#1J1M ^!3:CC)2DVBO?&"EAY@:&<QY\+A-M29*-LT4?:P#U2P
M5MH=2(>D6<I9T>Y$8<KJ>1\4KX.,\UD=>NB4D)T0)1&#U2&K5.0FQ*XHK;N4
M<L2VEQ_?O(\=+Y-X<P]@K'8RNE' 42M( V!!H#K!>43-A)(!MQUEB/9U###[
M?RV)/7@V-O=BK$$';DBV7"!V2LG=:8WN4%;9HKFPOD FX_NYQ)U ++"G:Z0E
M1T^!#9=:8)#$0(+G8@&JM3[.-;&V[J$K"#DLL=KU_XB#E I>A6A3[@:6"M<H
M]:QJZ>J@V9P2$',37-'AB8/NX3$T:4^#O/1R#3FEN"I!ZM2-*EQ(IE8!S<T0
M#HZ9!=UH=MB8+Q;#03-]VY-%=B<\TEO>E:85AXI0WD6C;4FM%51VR.&8P['2
ME;N>O,Z6I!O$[NI<Q;Z,SM\@WD9HB/TYE,*JJ>;[C#EVC/VZ-,-Q6^B532A1
MBSZ)Q-]$)?DY$])M>IUT*.>W7E9K2??$;;6:D&8DJ2%0-8_^:'IB@P,E$<]+
MO^3 JC9>^\/!P,85[J0<K^D[(JVH?X)@1%I9U$P7(6,GR6-,>&W(#C@"HY%;
M)0#J=E/SDY9BV" 509!V2(4:3<PRAYN(6+?7Q@_>'(0>RA"\I"_(AP)Z5LND
M<U(\NHV72"$?D<)J%3S.YZ!B"K@@U\.-1)=451.9*8^@>[RS%_#?FUBXHHV5
M'*WM7=3EK-;[$0GCO&BQQ9MFKBUK$@!#<'GU\4UJIWQR]81"SN\(8O)9)H4H
MI$6/E27=JDAE','.8<(N^M-4 \BA^?G!F1]$!8R+3T;)L1WI\@9 FOU:H>1]
M_'U,*T_1<+!?Q"9B$ $Y*_,E=I[+I=(#GM%C"?\71YP%ZV#DRNZ+ULZGIJ)<
MM]B#"JU,9<!X\9 -$D09E^0E84[5J)RF;3O:X=HVE5H77-[>@D-+;U;U!H9L
M[1+ZDL&? *7RPDCP8:Q<1K,+^4[0_4F\F&%_P":_9(H<9[X>4^X0>&.>($?;
MVG1<[?X;>)=S9;^62#$FL).>;MCJIS9WR @C91I8*BLC+,O%SDN6"---_-"3
MF+$+1'4AV\F[6+4P]3LR/BV1:*4^UG-/Z$PL04M"+2KFLKO@ ]*.I@H/)\GE
MW=]'\''E-AN]2IV;?^,_%7]HB]CM^.TJO@W]4FW*XD/?L>\&ARF8-&JU1_2;
MWKL8<%^EG!PJX-K+7(</65)L%L>\OSG#$U]XNGH/_I3:V?MMUG]V.WZ5MZ9)
M<1X,DD9MKAWSX+*U 5/9&MC%VC8>(.]RD_BX-5JT;9L[Z=>27G-E1+@I)75O
M\YUB$02.:HT("3"!,PRA,D;%Q,<A6&A3CZ"/NZ:Z4R:TIXZWUWFG'>-QR]1[
M-VH2?%O?N;:II;^N N,4[\0<DNVD".)4W*@JXPEM-F%0E]!BI'8IZ?3P#CR:
M:5>>^-_"0U?Y,^M#;S-<(G5K[IT-B.Q4_!3,:6)*&$C=;_3V<?BZ8&#*,Z5E
MO%-L,)-R1+H,FV01>+"H!:N'@O[&7"@'-@T'/<;O'(#7-,YJ@/-8]3L73T-X
M)PB%/>!T>?A7[[7$( 9=J."\J]B90-HF8[:H)B!-=&L?*J65J%,ID1MS0R@*
MY*2;GKS/\OTAXDC%)Z5*!*Z-7\Q#QEW]H@9Z99NDKR@^2P73%R(#KT)9:*\)
M3M8O:JU_!_79#?<OL? XEO(@S7JH!4O_X&PW=+IJJ2[\4,X25WE;)>RGK=')
ML9I/=;.M\XY]-L/I1.TJ//!M1QAT2EW(>2D-_%Q\9BOFMS$Q#A6#CH_WD3T.
M1)\E!69;%Q*YI+XGS=R\8=,B)+4*/P(_VW:'0VT%. KC+<)\RVOAH:[G1X4]
M3M:N/6F,/_QD8Z^PGFJFV<UC5D#25/,TP>E&U^WU]\O+5&!5"!Z<MKB9\<<4
M>R41_9(@>?=,P0:&:'/Q'4)54<5!Q]BC=^'!><;/++R1[NA8T,!ALO90Z"AH
MU,;SS$A.]P;P\DH+HED:?F1Y13CIEDB;MI7#\;N!=)USC#@0D97X*;3!G(8/
M'S A7%)1&R>9>TE-.NE&*.6'X=:HWB7[EM2EW6E_SJF2Z-/)R!;^ NW\EEG$
M\$V:FF3L_<;2(S-R=?;U6NRG9U"'3E824^]MTU/NBD45A C!5PR- ^%&73K?
M0XJO[-=(Q\&QO65H6A C"Z7@Y"'3ET_S/N4:Q(J 7EU3?KK0IA3&;E 8P\GP
M.4Y6ZDC?V @IF4_WLI#:69DO).C/^8-6VV5;A%[9L76.+P#%G*0GT9N]VG)@
M9VJ'D!BFX!FI@L0@8>JX(>BPY"B4(ZJ&:YIZCSH)5[PYYN/758%3?BQ7#>]7
M[Y+U2J)]2A,?34ZS^4OK]"?9&VKT/\"$@[I_P-X?5_06M^PV<F56HB%SC)>7
MTGD:OB&8T2O=.:DF98/W6S)8<F7C(N>S;D4L'NYRMO*Y-R7#*\]E_A&5#/?Z
MN9+.5X8#P[+RP#V#6DK;4A3?#\>(EOM"F>&J/JB7AED?DBP^OHMYJ7)OV&<L
MZN'.0Y\7&LQ&VMBUHK:[,$3;.(+E'GNE%(:+M=!O8#_;MG1^W [:VE0%'+$E
M6$=DHZAJZ(Q3C1U5HJ?'/I:^S#Y_1[ZTE(_\O7I-_1(^/4W_'X%7^OG\,%S_
M)P3?%^V2A8+*+C#U:OKT\9GV>\<?7;.1C^EG38?D3/Y<6:"DE@/P?M' !,(/
M;I#^[PHO_P-02P,$%     @ 0X)55I%TV^AI!   . H  !D   !X;"]W;W)K
M<VAE971S+W-H965T,3(N>&ULK59M3^,X$/XKHZRT8B5$7X %L;0290\=JWU!
M<'O[X70?W'B26"1VUG8H_??WC-.6P@+2G>Y+&SLSS\P\\XSCTX7SMZ%BCG3?
MU#9,LBK&]F0P"'G%C0I[KF6+-X7SC8I8^G(06L]*)Z>F'HR'P_>#1AF;34_3
MWI6?GKHNUL;RE:?0-8WRRQG7;C')1MEZX]J4592-P?2T527?</S>7GFL!AL4
M;1JVP3A+GHM)=C8ZF1V(?3+XT_ B;#V35#)W[E86EWJ2#24AKCF/@J#P=\?G
M7-<"A#1^KC"S34AQW'Y>HU^DVE'+7 4^=_4/HV,UR8XSTERHKH[7;O$[K^HY
M%+S<U2']TJ*W/3K(*.]"=,W*&1DTQO;_ZG[%PY;#\? %A_'*89SR[@.E+#^J
MJ*:GWBW(BS70Y"&5FKR1G+'2E)OH\=; +TZ_@K>S/'>=C<:6=!.5U<KK<#J(
M0!>;0;Y"FO5(XQ>01F/ZXFRL OUF->O'  .DM<EMO,YM-GX5\2/G>[0_VJ7Q
M<#Q^!6]_4^M^PMM_ >^Y.NE[JU5DPI+.*V5+)F.W&;GRQN:FK9G^.IN'Z"&C
MOY\CIP]]\'QH&:V3T*J<)QEF)["_XVSZ]LWH_?##*X4=; H[> W]7S7QOR'1
M->=L8[VD,^W:R'KKU:6EK^Z.FSE[Z13Z%2NF"V,5B%/U\W@SAS_:R2[.;F;9
M.S(A=  M.Z/AQ4!0D0+S;:#HR#2M1X2$BPY8,.G9YDMR!16;.-J$O':A [^$
MTXI*N'B+ R22"L&$F) ]"L$YH&F^I'D74'\(!!L3#8<]^@,A%'QT\O/\LS."
M]Q0[9:'2P1(PL;$B]2A>7S*BB#$BJ;:ME\( S. :"=LYIL6;>;<ZG38D-4YS
MG9RLJEVYW(4B\[K3\FYG]*YG8=DB$Y2_G<@N[8S[UUMH*=O*!7YB*H+?V>_-
MN2AP2":X7RQ)DK,]0\NW;X['HZ,/88MUT!I9BD[DF?#00SSWP* [I5& 1'@L
M6?E <RZ-M8F2(D(Y&/9>0J/#-/"C/?J!0E9JBX^052K]D[(=OB.T.B!V4Z8$
MI81V%13'M5GW5("$:&TT61>I4C!0.$H17.J QI1P8,EU_H7ZH/0ORN>5Q!NN
M9 []_J+>165@))HU6MJ4(@.+[UO61K 2_7R?<]N3#)$KK;UH45#7R13RW6/1
M.H0KQQ26^!8A #9[ <$.W:Q8E\*EYUHEQ,JT?1 'O"=Z3</U "P!/SNK4?HE
M-.OGRM[2MT)>:[J6J#O9Y\O9MVO,*;JH; _Y)#/+TB:'OJ9A<:(^D/)4% NU
MK8JN15!AKV\KTBW9LE<U#IH<J@.83(Y)"O"N*ZL'G:P_#*_H1'=>2)$"170R
M4WS/>9<&8S/EB?V<?<05YH%3V?3<UFK%4(>Y0#\2$?^?I)X[_ =;7_.&?9GN
M+('21/<?]LWNYEITUM\&'LS[.Q74"ED$JKF ZW#OZ# CW]]3^D5T;;H;S%W$
M32,]5KC:L1<#O"^<B^N%!-A<%J?_ %!+ P04    " !#@E56\B:05F )   %
M&@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6S-65MOX[@5_BN$FRT2
MP/%],C/9)$#FTNX6.V@P:7<?BC[0$FVQ(XE:DHKC_OK]SB$IRTF<9( ^]"&*
M*!V>^_G.H7RQ,?:;*Y3RXKXJ:W<Y*+QOSL=CEQ6JDFYD&E7CS<K82GHL[7KL
M&JMDSINJ<CR;3,[&E=3UX.J"G]W8JPO3^E+7ZL8*UU:5M-L/JC2;R\%TD!Y\
MU>O"TX/QU44CU^I6^7\V-Q:K<<<EUY6JG3:UL&IU.;B>GG]8$#T3_*K5QO7N
M!5FR-.8;+7[.+P<34DB5*O/$0>+?G?JHRI(808W?(\]!)Y(V]N\3][^P[;!E
M*9WZ:,K?=.Z+R\&[@<C52K:E_VHV/ZEHSQOBEYG2\55L NWB[4!DK?.FBINA
M0:7K\%_>1S_T-KR;'-@PBQMFK'<0Q%I^DEY>75BS$9:HP8UNV%3>#>5T34&Y
M]19O-?;YJZ_J3M6MNAA[,*-'XRQN_! VS@YLG,[$%U/[PHG/=:[R?09C:-&I
M,DNJ?)@]R_&3RD9B/AV*V60V>X;?O#-MSOSFSYLF5M94XB-TM4@!N-<7XB,[
M5EGQK^NEX^?_?LH#@?_B:?Y4+N>ND9FZ'* >G+)W:G#UYS]-SR8_/J/]HM-^
M\1SWYP+SJHUB]S\SZUIS#?RF4$B\_*\2OE#(I/\8J_U6F)4PK<5;WC04C=4H
M4EUN\:B47M=KX8VXL08OE$?YTGW>9MZ!E&^$DZ5R0R&]D*(QNO9"U\*C@H=B
M94I4/S.!4#B\=BMX'T(SB@NR/LIO$E,(HW46 P6^FT)GA?#;1F>RA%XFRUKK
M1-O +E?H!DCAA;$HR1)U;K=#W &Z<I(*$A:L;.5(%"W8+I4+N;9*T68WVO=/
M],6> TBGE$JG7V3=KG#36K!YVAU"UKG(E/6 QU=X3QAH'GTF7?"(L@R]=:9$
M;D!2&R\RX*]78 XJIV)2TZJ$B;4DH!.M4Z1Q&W38*%'(.]ZB:C#,E%R6L(U
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M)&*&%@.L\(#X+'8;='32AY*EPZN41)E,#6<WP)525[',>\<%UH^/5W6<6S"
M67,?-(24#"_D6J5F7:LT2F-6 Z9^PWIM3=N<,P[294J7B?B@"5YUYL1B*GX(
MESE=_DJ52,^G[[":OL4%Y#^(FT*B;,1L00_X<H;+"R,/;V=&LSG=328/KO]+
M>U/<J?[6QFX?V?P3D/#T5UD"=J*&T+]"WK.T-V^@SQNR;$&6/4'\*9ZM<!-F
M0]X1_VZ1"#G-O#<R^R;79 [;'"[_;[Y:*\S,LD$_$PQ8R,='[KJN*!%0/ M2
M:D%&\MWG%A,K)KDO.L^APF?IT!VO5T0K%O..E.ZNG9;D$$[_]VP)+N^?-*_[
M1G%-AY?0+W_I]<_NO=R][_=7> (@'_O-#IMC"TG]IG^RCU-R=^X9B9]7\>1
M9PL5ZC[U2#XLTGR:*96[AW3[_?1@E]ETV"F[)A<,&CTVT*J>DJ&14/O R)_'
M%E.RA/#]DJ PRPBO$LA3A@PI[O$ P?-%9'Z<1A1Z@UDO+1L,^T%5^),Z$S*^
MW)X\UJX_N1R6&Z:IU)3:&M&B]A9PU3WX[A'3DS \3%KIV-Z;;[JCRBYHSVFV
M9[-5L5Q>%ZVDW<N'+M8!"N'PN1T*_2B)7B?N59D5LO! (J5RV/:<LC>"?E]&
MI9-&F$M[?+XS>9ALYWQ 2I'&ZFX>"7F4WP6OK!Y^$'FZ,X9OZ7R$[9^8#B#$
M,)P]^)-82L#79/&Y.#ZB]W%N=R</,V[XZ,0Q%4=BNAB=O4PY$].ST5Q\#*.>
MKA\9<4HZTGRBQ'&NPMT)L1^]!;.] \'3>AR?34?SDY=I9Z!\-YJ=]'1Y>. X
M%<=)F1.1E&$1H_<G3WWU'?<^S:.;K/D'"#KYP\_A*WWWM/N-XSI\VM^1AQ](
MODB+INIPUEUAZV3T]LT@%$-:>-/PA_ZE\9BI^+90$J,V$>#]RAB?%B2@^^7G
MZ@]02P,$%     @ 0X)55AA -KNM!   [PH  !D   !X;"]W;W)K<VAE971S
M+W-H965T,30N>&ULI59=;]LV%/TKA!8,&^#:LF4[6988:)H6[4.+H-W6AV$/
MM'1M$:%(E:3B9K]^YY*R[&*)MV$/ED7IWL-S[I=XM;/NWM=$07QMM/'761U"
M>SF9^+*F1OJQ;<G@S<:Z1@8LW7;B6T>RBDZ-GLSR?#EII#+9ZBH^NW.K*]L%
MK0S=.>&[II'N\8:TW5UGTVS_X*/:UH$?3%97K=S2)PJ_MG<.J\F 4JF&C%?6
M"$>;Z^SE]/)FSO;1X#=%.W]T+UC)VMI[7KRKKK.<"9&F,C""Q-\#O2*M&0@T
MOO28V; E.Q[?[]'?1.W0LI:>7EG]656AOLXN,E'11G8Z?+2[M]3K63!>:;6/
M5[%+MD6>B;+SP3:],Q@TRJ1_^;6/PY'#Q7,.L]YA%GFGC2++6QGDZLK9G7!L
M#32^B5*C-\@IPTGY%!S>*OB%U0?D_9TI;4/BCISX5$M'5Y, 9'X_*7N4FX0R
M>P9E.A/OK0FU%Z]-1=6W !-0&GC-]KQN9B<1;ZD<BV(Z$K-\-CN!5PPZBXA7
M/(/W6CJCS-8?5(K?7ZY]<"B+/YX2G.#F3\-QJUSZ5I9TG:$7/+D'RE;??S==
MYC^?(#L?R,Y/H?_KI/QW%/%+36)C-7H1T1!!KC6AMTIK2J7)BX#7G@V]Z#Q5
M0IGXJ)2Z[+2,?60WW :J% ;X*N&WP(]N(E@X6$_)'4-#5$IW ?=/F5^*'[!#
MH[0&LO\Q)ILO4[[DXL/!Y4PL+A;CG_"_7$['%_@OYLOQ3'R.;0=X^4 .4T3
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M:SX^7V3"I>-56@3;QB/-V@8<D.)MC1,I.3; ^XVU8;_@#88S[NHO4$L#!!0
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M^M<S#U1_B?43(UMW<>REH6O(#2NZ]U'9 /I>2FG.$UM@_">Q_@=02P,$%
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MNB:RV[-VM\X QK5TW^+KHW2YX$G *.>&\<4R?5%Z-SLQ2TAB1LI%9DWYLEW
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M'"M+!'B?&>.[&U+0?SN\_P=02P,$%     @ 0X)55DCBU4LY!0  9@T  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3<N>&ULK5?;<MLV$/T5#./F2:5$2O(M
MMF9D.YTFTTP\=BX/G3Y Y$I$ @(, $I6O[Z[ $51LNS&G;Y(N.P>[)Z] +Q8
M:?/=%@"./912V<NH<*XZ[_=M5D#);:PK4+@SUZ;D#J=FT;>5 9Y[I5+VT\'@
MN%]RH:+)A5^[-9,+73LI%-P:9NNRY&9]!5*O+J,DVBS<B47A:*$_N:CX N[!
M?:YN#<[Z+4HN2E!6:,4,S"^C:7)^-2)Y+_!%P,IVQHP\F6G]G2;O\LMH0 :!
MA,P1 L>_)5R#E 2$9OQH,*/V2%+LCC?HOWG?T9<9MW"MY5>1N^(R.HU8#G->
M2W>G5[]#X\^8\#(MK?]EJR [/HY85ENGRT89+2B%"O_\H>&AHW Z>$(A;112
M;W<XR%MYPQV?7!B]8H:D$8T&WE6OC<8)14&Y=P9W!>JYR70^%U)P!SF[UF7%
ME0![T7>(3/O]K$&Y"BCI$RA)RCYHY0K+WJH<\EV /IK4VI5N[+I*GT6\@2QF
MPZ3'TD&:/H,W;/T<>KSA$WAO?]3"K=D'<(7.V3NU!.LPMYQE7.7LO1;*L2\X
MKPU8]N=T9IW!A/GK$!7AH-'A@ZB(SFW%,[B,L$HLF"5$D]>ODN/!FV?<&+5N
MC)Y#_^EPO1R%31U#TJ&<@6F)[S%7 )MKB;4KU(+QK6+6*J[  %97IFM%&]@H
M6(U98+PN!-Y+S_LY^T-GW%?CQY4"8PM1,60> :QCGU#\*PV"312L!Y'I'KN/
MIS%6&KN.O\3-(AN=_<*FLJXD1X6G!&X+CH7+/O'JWT3NZAGY_934#1??UYJ]
MYVB77_BL#)3"D;]"(17 ]/PP.[@MZ]S+X:JR6HK<BQAPV#-Q -PH)!<SL6PH
M=)H=)<-A?(P5+R72U<-Y,M[.?=(>G9W&Z7;E8/CP-_'".!CT\$Q;@>^#<AVS
M&[$4.:C<XGH&N(C!,[I\)LI':<<&="@<@JLG>ZOAT*/DD?@@9A]KLTD+7%-X
M\=3()I?B;SQP@9Q8(C-0_OK5:9J<O"$:-Q7++&2U$8Z,HD,PT\22DT\HA&5;
M^[+N,4XV2TG_57.)\/Q;W91];R<PF+UU64OOLL:T-=YQ P4I(K#4%M$0J>L1
M!24>[X9DT(W1RR-"U%2UR0J\9ZP/1L_+&KWF$OFJ^#HTK9)CECJLC396%J>.
M2R#6CT]VK1R/X\&NG<EH& ^W(ETK>MO [MF*45D5(BO8T3#I9AX!IN,.%<14
M7H/?09/Y3 *%@:*Z3\@&/MFG@KI!R;]I0WF"FA@5BRX;KBSW%SIE;8@8E@MG
MN<#8BUGM=&@K?&$ ?+ZLA"LV%>P*C JG=F99392U= >>X5=+.=-(5T;G=8:/
M'G:/S'KQ#M^A(I+1E@KB.MVG^FQ;'"\G.GW$\S9LGN90N?^)X4,-OR-,W9LO
MD,4%>LLR;LS:7P&^2=%)&I.U4Y941H<:1Z#\9Z^(ILK.3O9I3 =)E^A=(DGB
M?[=7:?<2FT_BLUV+C[<5L4_]5V %Q[[B'Z<A@S&0VN1-FF_-Q$9%)X=TF'-A
MV))++"TZD@RDA[B0:^R">(OB^Y RH4>M)]/6]1AF+?9.=$T80NLU+;#QQ]8S
MBYX0&WI&3Q6?1Y41&1)8<+4 ZVUU="L_LLQ#;+'11E"PI-XI#+93Z[C*_ 68
MBXQ"XHDE\MK8!%="<>\@EWSMO9N!YP5!R;+XT .JWWG[EF 6_H5OF0];> :W
MJ^U'Q#2\G;?BX0OD S<+NGTDS%%U$)^,(V;"JSY,G*[\2WJF';[+_;! _L&0
M .[/M7:;"1W0?EI-_@%02P,$%     @ 0X)55M_5607L P  $PD  !D   !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&ULG59M;]LX#/XKA%<,*=#S:](D71(@
M;>]E'SH$6^_NP^$^*#9C"Y,E3Y*7]7[]*-GQ<EN: OMBBS+Y\"%%BE[LE?YH
M*D0+7VHAS3*HK&UNHLCD%=;,A*I!25]V2M?,DJC+R#0:6>&-:A&E<7P=U8S+
M8+7P>QN]6JC6"BYQH\&T=<WTTRT*M5\&27#8>,_+RKJ-:+5H6(D?T/[9;#1)
MT8!2\!JEX4J"QMTR6"<WMV.G[Q7^XK@W1VMPD6R5^NB$M\4RB!TA%)A;A\#H
M]1GO4 @'1#0^]9C!X-(9'J\/Z+_YV"F6+3-XI\3?O+#5,I@%4.".M<*^5_L_
ML(]GXO!R)8Q_PK[3G60!Y*VQJNZ-B4'-9?=F7_H\'!G,XF<,TMX@];P[1Y[E
M/;-LM=!J#]II$YI;^%"]-9'CTAW*!ZOI*R<[N_I=J6+/A0 F"W@K+9,EWPJ$
MM3%HS2*RY,-I1GF/=]OAI<_@)2D\*&DK [_* HO_ T1$;F"8'AC>IF<1[S$/
M(4NN((W3] Q>-D2<>;SLIR*&>VYRH4RK$?Y9;XW55#?_GLI#YV5\VHOKI1O3
ML!R7 36+0?T9@]7K5\EU_.9,#.,AAO$Y])\XM;-XI]F^D*C'"B&O:!,-< G6
MB4SK)RY+8+5JI06U@_( LGVB'FZ4MLQA&"RILRWLD?+,#.R4H.O!W,#HPH'5
M9$$]:RYAHU6C.5JZ,-RZ:'-R?4<5YL[EEP<FVQTMZ+2*;Y\?E64";IE@,L<K
MH +">HOZ4$0Q7, L#N?TRN(PI5>2)&$"0[P:<Z6I>*%H$:RBF^-3RPWWMT@2
M3N'UJUF:I&_\>C#B=<.X]D%15G2),(K#Y')0[B2Z2>B>D-396J/,GX#BD$8P
MCSU*P_&E4W3/-)Q=/A]#XB)(()V',TCB.07S$G)ZA'Q]!MGE8SKUV2'TL<M.
M/ TS.G5WG#]H7]$10L4*N'!\^G-SFBS/V[HE_Y3'\D22J,<,FO"XL%A76*[<
MCJVIF+3E_W61L.]I_%A"/@B?H^^+Z4X9"^OGH-_1"'Q98T/;LF<I>.[&$Q4\
M)6L<3N@U2F.77BJM+H43R@KM)G.7^@N84,D\8EY))53Y1$I9?S:N 'LI=E(&
MCYH5-(!I.),X)PA7$/[0P]A)\TZZ\S."4J&Q.VQ3\<9 -@^O"6SJL:FN8.R4
M1\2'>"1CHC$8YGTWD9_8.XH=!;>D%8%XZHEOE%G7+Z-K3X9*8^8K9)9T44YF
MKL8IZHPHGKKFHJ-!1:Y+/XX-,:#;HIM9P^XP\=?=H/NFWOTN/%"/<6E X(Y,
MXW Z"4!W([@3K&K\V-LJ2W'Z945_+:B= GW?*64/@G,P_ >MO@)02P,$%
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M$NIEM== L40?M##I.N1\I 2K@KA!Y*LM##BK?K5!WK3."@9LYF$@GDI+T=8
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M.L+ZUU3^1V%R?C4T,07BD;_.E43(T08\GQKD8_6##FC>%5[_&U!+ P04
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MD=K;C&,7S&YUE.3;591IM;+.CY<AL8QW44+\QDKO]HE]*BGE6VV(=W ;PPO
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M643XN:"B*AP__^GV-SX+G@^PD,*^%'-+K5/)0=(W]/'7)\Y(O?:K;C>MON:
M@K*.B=;;^OXOC3I%!?Y87D_4&UK@S_DKNO+W< OAP"EN.JO,KF"X([GBJK%/
MV#Q_9QY99MI<;]'ZT!P=-K^V;%V(<[6F:GY$VCR_Z[':"677FURB@?"JI8@^
M:DT?@*U/OMO:O2KG^I[F#3YGWO*SX?EW,&\8-&S:NOA" X<-0[4N>@P\!<OE
MX^;YUQMX>MWX@'JZ&%U_I8&#ZVLXQ1>9ES=*^_[EXK+QWS [C5Q,__/C!,C*
M/\94=ZM_*[J5_Z:I7Y?_2?K :X@#^%UC*-QV=@:LPO_G(Q>YW?/_UBQMGML=
MGZ(PQ8)#+^#YVB)%^@N:H/IGJU?_!E!+ P04    " !#@E56]7P5%/ &  !-
M$@  &0   'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6R]6%MOVS88_2N$%PP)
MX,B2;"=9F@3(9=TRH&O1=-O#L =:HBQNE*B15!SWU^]\I"3;:9)V&[8'R[J0
MY[N>0TIG*VW^L*40CCU4JK;GH]*YYG0RL5DI*FXCW8@:3PIM*NYP:983VQC!
M<S^I4I,TCH\F%9?UZ.+,WWMG+LYTZY2LQ3O#;%M5W*ROA-*K\U$RZF^\E\O2
MT8W)Q5G#E^).N)^:=P97DP$EEY6HK=0U,Z(X'UTFIU<S&N\'_"S%RFZ=,XID
MH?4?='&;GX]B<D@HD3E"X/B[%]="*0*"&W]VF*/!)$W</N_17_O8$<N"6W&M
MU2\R=^7YZ&3$<E'P5KGW>O6]Z.*9$UZFE?5'M@ICI\<CEK76Z:J;# \J68=_
M_M#E86O"2?S,A+2;D'J_@R'OY0UW_.+,Z!4S-!IH=.)#];/AG*RI*'?.X*G$
M/'?QUI7"L&\?4&0KV/YMG>E*')Q-'+!IQ"3K<*X"3OH,3I*R-[IVI67?UKG(
M=P$F<&KP+.T]NTI?1+P16<2FR9BE<9J^@#<=(IUZO.F+D88 &:_S/FC+?KU<
M6&?0'[\]%7= G3V-2IPYM0W/Q/D(I+#"W(O1Q==?)4?QJQ=\G@T^SUY"_QO5
M^2<X+-P6_6W9W<XT.&>=R)DN3MG^'I,U6D\IL,@>^'+0(:%#S-X+Y*[-7&MD
MO?1Y-4)QFIR5W"R%/65WXEX87F<A[8VV[E!4C=)KD-NQA:A%(9UE>^PD.L8Q
MCHYPG.%X::UPAX_P6#*/INSKKT[2)'TU_(=0^B'[<90>L 00_?,/VG$%US[C
M+ RGT^B$_J*T\^*U?,  3KXP635<&O+;^NF6*X$L,?%G*QNZ/68UAJ4()(&7
MQ_C?_P[2>,"4MI9!AK14K!2Y]S*)Y@=T/#Y T"F[!H'@%R7%ER!'UKQT3:,8
M<'/\4@8M@M+4J!I<QF"&SJTM#QJWA"G@SJ+$X\X..AO7R#FJ>(_P?<Z]%DJW
M!O(<,4[A\+Q+H72B\@D\H@3"_93<"^G33_<+DG7D<W8<?8-CDD9/M<7[+M/7
M7:9O:P:*BVH!2-]38P9XN(H4UVO&F\;H>TK\HZHUBM?,:<;SWR&/3+>&88FB
M3.%A1H&22M.(A7 .X)C>:#B .V2@XIG1 @G6E<Q8@51H8Y&<0K6BS@B$(!>M
M!8>LC=B'$K1F(=DHNA$^ 1F%XFU03RA!:27"H-/A,?R1FNC#VL;;70EU#]-!
M(0NC*^]*CH30(#H/\7+E#88@I=TQ9:C)8/[S30Q(#_<@L6P)M69[Z;QG,"'M
MI<?]Y1CKC2N!4K=<R8^"6OH>N)01[Y?Q30;$/91H!V/67T:DJJJ%['NP;N+@
M^JZ_O8^2"+3%I^Z!M^09WMLRP@NKIX8')H+1,L^0K=9/4+I>'BI)W5)LR&K!
M,Y53'%10I"-O TM0<ZFDD_#"E=RQE4!6<X%>P0(;<EURE*O6K&CAMF!M:*BM
M_@QE*K3"KL8[QA=0@LY3NR%87QK,)B]V<Z$72BX]Q>WC@9X1GS;^IW*\*ZZ#
MF#XMG8'&5US1A/&&?]TRFX"]O6 ^==93-XFC),AP.H]F[)K;DC5\'63QL3+W
M_\]:)9WUB'L!<R^@0A]^:-&[M,J,?4ZN-#>>5#>@0:#MRRJ1"PNI[)+:.%FA
MP5DFC./4%&;):_G1IQ])Z2<CO*TF[M5HHR:V;1IM@NYD7K!;&%AB8?<TR@?E
M0#-(;7R;/181WW ORL8N?2$?M5L?%F3SWVF([^LO(7L,*=]F.ZVE ]WO)/4;
MM5EO$3)"PI1ID_MB$$=!AD/''QBO= M^0[V09L*:1QLED?47Z!GHK#/I;WFU
M0GFL#^]_8&'\;UBXNROY O:E?AV-L1KO86V>#HSK%G._K<$YUN9=TN')L7\^
M]<_C@Y?I%ON-UH;@=+VU^[C>V7T\NRT9E-D.G=WU40%1W\@SW;G#*Y^[T2 !
M-L?'LU<==SY%C=@[)6@!Q]L9G$8A?M3H\"0=L]>$^K-'?8,AX&H(?HP. 'WR
M7'9<AI9SJ4"[M]AL?1\V6S>A?)2 +MM4J2 NN[V[].I RU TWRR3._>WED]"
MX=WNSO,FW3RCG8?PKYUJ/=[IK6$3^%RX"17.R'M.L[$%K5%,B=!N:VK&[;B+
MUO@NRZ7%^Z)_688CU+UDP5.JHT$4]H&WFWW@3E+(5UE@3]0UO]]+5<*5.M_:
M.]K'Z7*^JY]>R*>;#$9;QI+_Q-AL(U%L5<JL9"M.12EHX[Y8=ZHT5#'>VF/H
MT+;];IX'=S9^;#L?_R?.IUN9>NK%<;+UBE\)S*(/&> =26MXVQ_N#M]*+L,G
M@LWP\*'E#8S2:X(2!::"^O,1,^'C1;APNO$?#!;:.5WYTU)P$)0&X'FAT:+=
M!1D8OB!=_ 502P,$%     @ 0X)55MRYRIIL"P  =!\  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&ULK5E=<]LV%OTK&-7MVC..+%*2+:>)9QP[G;JS
MV6:2?CSL[ -$0A(:DE !T++VU^^Y%R!%R;3==OLBBB1P<3_//0#?;(S]XE9*
M>?%0%I5[.UAYOWY]=N:RE2JE&YJUJO!F86PI/6[M\LRMK9(Y3RJ+LW0T.C\K
MI:X&5V_XV4=[]<;4OM"5^FB%J\M2VNT[59C-VT$R:!Y\TLN5IP=G5V_6<JD^
M*__S^J/%W5DK)=>EJIPVE;!J\79PG;Q^-Z'Q/. 7K3:N\U^0)7-COM#-7?YV
M,"*%5*$R3Q(D+O?J1A4%"8(:OT>9@W9)FMC]WTC_CFV'+7/IU(TI?M6Y7[T=
MS 8B5PM9%_Z3V7ROHCU3DI>9PO&OV(2QX_% 9+7SIHR3H4&IJW"5#]$/G0FS
MT1,3TC@A9;W#0JSEK?3RZHTU&V%I-*31'S:59T,Y75%0/GN+MQKS_-5=E9E2
MB9_D@W)OSCPDTO.S+,Y^%V:G3\Q.4O'!5'[EQ/LJ5_F^@#.HTNJ3-OJ\2Y^5
M>*NRH1@GIR(=I>DS\L:M?6.6-W[1/G&K75885ULE_GT]=]XB(_[39W.0..F7
M2%7RVJUEIMX.4 9.V7LUN/KFJ^1\].TS^DY:?2?/27\Q'L_.[M>M*U)<.R'%
MLC!S60B4LJST?R65QZG8*"&K7)B:2G;N=*ZEU9BQT(42.LCP<*-5OK:5PR/A
M5TK\//P\% N5*PN)O]56NUS'@H.T>\@PM1/.2Q_D T=0*=7>4#<DO<Q"(/JJ
MG"O;9L IKT&S:\S'B$*7VK/&CD0]5H%4W"II'>8G%WAO3;U<L3"H3C E"-&$
M-T(]2%04"QL*U'@0M%.U,-F!3>YT7_YX7[Y$:O4*_U7Q.UDX0\[]#9!T,(;<
MV3BKUT7!VN[BT[W%X4+8EYDJTX4.(N$N<L]<+755Z6K)1JDJY[^EJ2O?#,&,
M.:;Y+:]25R1HB=10.2\Y5Y5::(^8(WM(DP)8[EZ+XR-2N]1%01J>!"?@)Z&?
MD7@G"UEE,-N+'V15 _-%(HY$.AE>XI*,AA-<IL.10(:BH3@E\EJ17[+:6@7M
MR%2Q-DZS.4F""<GY<"Q(0#OG.%?AWTDS?0TWVH/)H^&Y.$Z&HQ/^]TGE=4A2
MLE<]K+5M7=:?;&>RSLD#Q]#ZA'YG_)N<=*WLI"\L&Y\/IP?FWJ$J\ERW!;>2
M.7H*S^>"DEEF:SB]B0?7'S34E5>H9\\11(+)@E]!Q:,$YL0(\-NC$59M'_C'
M)<6C*$BGR!>W5MP6B^TS)1@5/6*#&M&4.<:C/I;6./=TSF#Z2F>K4Z$78C?D
M]$#:QM0%L$'>&ROGQ5;H$BCF.3?58A%TW ,AU.A0W'G*2 J^J7@:PNWT''CE
M5]*?-OG 4OIB[-@7])H: Y4%607Q(=@!?':5\H*E:,M;W$ ?)!?>S;="KM?6
M/&B0!WB88G716IRCN+$@K5"I!YBZ405L++F=1J<]Y1;"Z)U;=O[XB2PQY=I4
MJ!Z.9G397!&F=!P835>_UU3TR+P*_"^^QC2Y6#"*P J2ARY!$ZQZL>0900&!
M-D(TJN!RPG4^24>H=)1#>L$5CX0.R$>-:#<AG4V1%N-TAJ))+B8H]I\XR_Y.
M0X[$^<4E%^7%9,;7R2BAE584O()'(V[WVC4(L;<>,-9IQ_Y]T1\W <E>B^]B
M>\*:4V0!5)@,9^0.4N SMYP9P=L(MV-&BJZ#S@GZ+LB1D_-A*[5;$#M]DPEY
M,)D"G,3%#&;=JH7"^'RG!'DLM+EC1&5\(BXP;#1,#U8]AC93P!Q$I;B<$WHV
MPOK7/AX'8)RDPTN:2#=WNX$H0M!Y16B83-@+R>@"R\(I*73ND:VHO!T8MEA8
M4PJOD-R6&DFND?]P @'G7*%X5'50K=(YY4-V=.&T4[P4V07Z+UHFK+4*HGW3
M)MFNV@)0E N%Y="2]4)G$N+WBXS*,6]T9_CH7_J@0Q C>"Z!;GM$_@O9':L%
MBA:$1YFT=@M3-M+F+C2:,5TF2!2BO6B. +.#80F5%US^,6ZO2-76!+(.SP-:
MCBGUQM1E/IDM^LZ6FA0V51%,D8^I0,8EXD>XWXJ4DR_%PQNY1O,LV-.?OI'E
M^MO;)@$<<CT1WWPU2Y/T6_%/:M[$:+!&\^P76=1A 4E<@QOL<3*F7#TFZ2<1
M%OK<GB )+\0EZ;#GPDXH7HN/EMSHMZ=BC?:+7M&@R+JDRIJ.(6)"N4DNA!HU
M:!.V#'I>$SJ 6A"AXNCOD67R:8+"CC8EEQ#3V!0<-,&(0")Z+.AF"R *Y3Z#
M4RCHCPT5QRUK.R$>E7#8)V-,>(H)[A'ES%BJ);]K(-0K]UL+09TI=,Z0V YC
MMOKWP?$!J>SK*,_HG(+4B:\/+C%H^JDN8S@4( E5D-]* T4$XH7J2,5U_AMV
MX"77.7P3=U3N!9(,[!,$OE0XK?1'VC0I=,HN@F\:UN_;FF6V.2;&2N@\H2T*
MC7AUJRR"DQ-:RVK)?">"[&W#:S'UN]N[.U1+2APUF(5?_ _-IANRG0J=/51(
M D'^##R7',+FD!ND!3L)H 'R:$+1=+0^/]DQY8L3\?X!..WVW02/N!4P\!4=
MJJ#ARFUP-#2F>1/N.5/Z[06>IJHP'*8U=PV>H3Y\H5@K6)WN!C37/U?6[6)L
MV:A%._I'T3GF#OG^$26C[<HE\C$A(H,+P=[7XC90OY9<4R+9/*91TR.)VT_W
M^&++91L6&+AJ(3<B0R8OH2=V!AD9TB&7M T"VP82S?:X>V>ICN@;KLKM/]H^
MV<#''\O] *.R^RQL4KI<'^AEL@ "&^U78"(F^Q*SH-MZ:$=[*(B;1+MID(_:
M.=G  ()2:[?6L45S\JYC@A#J[P@S3 :CR$5EO. #PU#N60%=]6(;[KS453=)
MPLF$E54;.HX_9[8&4W%L'C#P^L>;NY981D=3_MW4D23\8.9.7(>0TJG%:;,O
ML2V^%G4>_17/7?9=T9C5-;OQ&^'K?O_H>G2& H]2AIW,3/8SLR>D *3_)S?#
M&CUR9YU4Z<W,-9A:  O&K-K3B9YEC.#],A%%D#/>_L#!W4)^*C_'R5_*SYV[
M1B^Y:]1OU9]QU^@)Y9$(L[^@?.@#SY))CD<Z!O WXNFDQ;.!/82$AM-.(@[F
M32QZ4]/87EYJULFI%U>B-MLF[@=9R67 >^4\;[@='P*(#"R/#OT>GT ^JP^1
M\[HJ]!?:N"-8V-?77@<VVQP:='S=QT-7\IX8$C8F? RPMCH< T0HS8=T'!2:
M "))8):K4+\DAW0_&N^#-C+_GDX(.T*B73T6;( >HB3X:*P@ND,(=V!.."[C
MX\CFC*3)CAZQ/$CM,;:C2:=/:;9I',ZBDKUJ9D"3"]@X;+A,WPKA6&DO&\!0
M8D7'<Q$\CIITJC"YY"K<Q0F#(O:'DU\:ML<G7Z R^XHU3OE3DR)6SOYX7G>
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M*HC;K.*I"F5H;%6:8(J^1.I2NX:HP/-M5JP #80RH9'EO!SV@^2KF&$HY5?
M:(@%>8JS: 60<65[<C D@0ARJ73FYAYUW_>U[:SS);14=LG?>^G(KJY\^"C:
M/FT_*5^'+ZF[X>%[] =IEQH;J4(M,!7;F.E V/"--]QXL^;OJG/CO2GY[TI)
MF$ #\'YAH&V\H07:#^U7_P-02P,$%     @ 0X)55NNI/MS7 P  P@@  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C@N>&ULI59M;]M&#/XKA&KTDR'9<MZ:
MV@;RLF$#VC5HT/7#L ^41%NWGNY4WBF*__UX)UM)A]1 .R".[X5\R(?DD5[V
MEK^XFLC#8Z.-6R6U]^UEEKFRI@9=:ELR<K.QW*"7+6\SUS)A%94:G>6SV5G6
MH#+)>AG/[GB]M)W7RM =@^N:!GEW3=KVJV2>' X^JFWMPT&V7K:XI7ORG]H[
MEETVHE2J(>.4-<"T6257\\OKDR ?!?Y4U+MG:PA,"FN_A,WOU2J9!8=(4^D#
M LK7 ]V0U@%(W/BZQTQ&DT'Q^?J _FOD+EP*='1C]6=5^7J57"10T08[[3_:
M_C?:\SD->*75+OZ'?I ]S1,H.^=MLU<6#QIEAF]\W,?AF<+%[#L*^5XACWX/
MAJ*7M^AQO63; P=I00N+2#5JBW/*A*3<>Y9;)7I^?6.;1GF)LG> IH(;:[PR
M6S*E(K?,O)@(@EFYA[L>X/+OP,US>"\(M8-?3$75MP"9^#8ZF!\<O,Z/(MY2
MF<)B/H5\EN='\!8CX47$6_P,8;A5KM36=4SPUU7A/$O5_/U2& 8C)R\;"2_I
MTK58TBJ1I^*('RA9OWXU/YN]/4+A9*1P<@S]QW/V/^#@RH.D@)J">$S#%'J2
M/PF2+;3:HJ<*.LDWPP.RLIT#:1J, 04TR9L!W#)1-)'"W7 DKT\4O(4_K"<X
MF\*[<.Q@"M)J *M*A6>+6MZ81Z5%\>=<D2<JA"LHR,C*0[OO**U&XT 9\#7!
MI_0^C>2M[!A*VQG/@;ZOT<OV00ZI:;7=D1SVM84F=$P2DZI06OF=\/G:*3Y*
M<GXZA>N]&W?1_(^2M1W+QSLOOH;H=J:T9E26=:S8+J['K$Z%9:F[J!#,!<)M
MQV4=/+0;8.REI7ABA7HH 8F8DIY2P=;:2O2Q"0&1O3"9O#E++Z05:2U&IQ&L
MP7\LAQ@(6%^KL@;E@F@A=E!5AR ;>O3@>PL[0A;47OD:)N>S],T!#JJ._J,H
MO!<I?":H\8&DFKSXZ8*ADDF(B[1''9A-\O1DQ'%=VUJ.!1@L,ZFFZ-C%[$0O
M950(SNM7%_G\_&T(5B@+' ;%4QEH5(T;7)&+$/R":M0;*';BF[0)-"5!B2RU
MPI*T#R*!9<DA 2'23S+[ZA1\*1]T,%FDB]%;?#G7AV!.9NGY**MBS=)C22Z&
M(3@EG;:3Z59H"L['G$CA6:9I$#^0QW OCH> /'->J*/9I2_UI>S97&F(MW%Z
MNN%U#"-F/!T']-4PEY[$A^G^'GDK1B6!&U$50J<)\# QAXVW;9Q2A?4R\^*R
MEA\9Q$% [C=67M!^$PR,/UO6_P)02P,$%     @ 0X)55BZC)B^4"P  I1\
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M$G$2DOR8LFH6XF<RWDV*)Z1;/)XB<:)Q#+&AUW,RPN_3L&>/3$@5]DA$\H\
MP;;,UG20O#'M^*I//P2[/F"?I9./AT1]GAMK+TZ2RW26P%#\OYZP>4F<P-'/
MT,J$6&4RA2<GQ"E_$M-U>^^3->-,S)*$B6PVB9G&QJ,8J][ORCH%_W.O+#Z<
MV$CL2M69.(\0HPNZ ![&_B()1A<]J=W6QA+:0U ;8$#_H 81W3BBN_["[ZD$
MWJ#+.BR]5E&](?P=%&$H<L'*S.A?0#=34N.NH#[M[QTMR11LYPO292L"5"G+
MI2:.:'+WW+/PE']G_#NY\/G:*^_B'-K_^,,L"J.?:-%9=W</6R$7&VK'(_G0
M0+LMC(6TF#QUGC#71W3M0W@Z$/!J&+(F?!629;@":*)V\AX3'HG]E,)"_^%M
MBCT5M6M?CZ#D+J+G?C]RT=NYE*;LY!V.&S*;GL,[8Z*0F.H=USG>U<P5,DBU
M>QPGOS><2R7',;'2['8+A.@L%MA7^K@";V@:F>@FH!]*[RF*[C7K3@1"2#J%
MLF;S9E^V8?[_VA83DM]ZR!.[#/WNCMVQY1U/1=OE9[>EY,\S2HB6K=J:W[5<
MC9>@:3.)YU"):*:T$>K2CMM/>.!2H9$SV[YG[)YD F39')EQ<TP\ND9]X4UX
M]A]4>;^!W$&+',L=%R]R%HX1XYX>G)J7AT;BJ4D]8G@5=&:6EPEZ/@Q9(A'T
M"6?*(^X\137>KR#?5C?6%F33^1G"UHJ/"?/MD.PU:X?-T=]JA[3F1(3Q1]N)
M9FW%1NBRKV7 ;+0'B",FI8<FG8VZ, [I;K:O,!CME,*4B'W:;'.^T>T1N1S&
M0)9]FF5QY2.2%9FWR&,?8,G$UUI6M,'#!#(L8'[M1?%D\!".SKH>/S<!HRK>
M.KZ_VRN/47\O $=K=EM>T4?"]$Q!862Y\IU4*JMJ2^I2PP2'29_L_CB%%"9(
M8;$ \ :3M2K#8,9MHR]ORAOCH K7$@QY9TSFB>6A/3IZH)UU$\X#<>J$M >%
M0732]<X3IF>RNZ-4-4205$M0V-H30!OAWLN[/7/ A>UYUI(^RWN5\7&X*+]0
M(5MS@L<0($HZE+.KL.1TU!=D%10_2SH2&7J^L\VY@3P&%5H[Z3)#K(%(S<<!
M9K$@U*(UD.3MCIJ6G,\>,=15L.Q#]?I&G":AE_DFZON&*N]+W'XV[E-66^A@
MD<M5;X''-:(EOP8%!.7^M*;PT,%;@PP &166C^GF,F<"]9^%VH. PSBD:5W4
M?I&VH!;HU5:DX[=V\S!LQ7\.'H*=_D\1_4;MV1\>$F#<Y\=] GS"/0#71NVG
MO71(<G0,^24:';3<(J^+]25Z"Z!GZX^!VM;ZD?)T_*54UM"'6T&/%>4T3>A[
MN>N$ZS*#BUC0N[N[3SO16R6K0'S*%150/O"BD/UNL"T))\.V)6MW;^^;7=Z0
MYR_JBE]GVJ+[M@V'/#H@.]I6_P_=U(GS?PY+NK<'[JGPN/5JVN>N SMY@#.>
MSGC/BT81:?"B8YM8) DAY/2>?#R>(:.F(=J>8UOP,Q$/)Z$_.(J'<4@;L4,+
MWM()"E7.%I1[W<I!:WG"NFO?^5['OK-+GC<OI(X_"@.2B^WZ:0OIV(KZ<-K8
M'[4PC$;<@(>1[RG"$?JZ1U;>R[6FR0R^3),V]H7&T2$#!R[TIQMT6O%L>\R-
M#IK_B8C&N#IM7TA=,!U:4'=QU,"(_7G&)Q'4IH=3:M>/?9N[ZGTZ+12H@CX0
M6W_TX;^B[I[NOD'?^4^OW7#_ ?L#F$:75N1J@:G8QHT'HO(?A?V-,VO^$#LW
MSIF"+U=*@A9H -XO#+*^N:$%=E_F;_\+4$L#!!0    ( $."559VQO#,+0,
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M](<1V+8IMA-O5J$1+8RGMA:&-?V/0,L!]+PRQN\F+-#],YG^"U!+ P04
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MP/-E"^3O/] "\4?47O\O4$L#!!0    ( $."55:_#C EF@(  )T%   9
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M3(;^&&ZYY%3V&11*90:BR=B/:(UH'< H&I'R (;3F3^"<W$-3EJF0EVT@\%
MF^NN>_K7?O:LNI9[$^\&USW3!9<&!.:D2NS''NAN&'07J^JV 7?*4CNWQY+F
M)VHG0/^Y4O9X<0;ZB9S\ U!+ P04    " !#@E56EUT2(/8#   #"@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6S-5DMOXS80_BL#=;>( <>RY$<>
MM0TXC^T6:( @V6X/10^T-)*(4*)*4G;27]\92O9Z=QVGAQYZ\)B/F6^^&<Z(
MG&VT>;(%HH/G4E5V'A3.U9=A:),"2V$'NL:*=C)M2N%H:O+0U@9%ZHU*%<;#
MX30LA:R"Q<ROW9O%3#=.R0KO#=BF+(5YN4*E-_,@"K8+#S(O'"^$BUDM<GQ$
M]UM];V@6[E!266)EI:[ 8#8/EM'EU83UO<)GB1N[-P:.9*7U$T]^2>?!D FA
MPL0Q@J"_-5ZC4@Q$-/[J,(.=2S;<'V_1/_C8*9:5L'BMU>\R=<4\. \@Q4PT
MRCWHS4?LXO$$$ZVLE[!I=:?3 )+&.EUVQL2@E%7[+YZ[/.P9G ]?,8@[@]CS
M;AUYEC?"B<7,Z T8UB8T'OA0O361DQ4?RJ,SM"O)SBT><(U5@W#R2:P4VMXL
M=(3*>V'2(5RU"/$K"%$,=[IRA87;*L7T:X"0Z.PXQ5M.5_%1Q!M,!C"*^A /
MX_@(WF@7X\CCC=Z(,3.ZA&OB:J@6*,^N@&N?833PQW)E_?J?AS+0XH\/XW/?
M7-I:)#@/J#$LFC4&BQ]_B*;#GXZP'^_8CX^A+QZI#]-&(>@,;J05>6XP%[ZD
M::6+[1#IX["?"DJ(5M24LLK!\>F#9U\Y"XXV15T;_2RI\&D#34(;U*7L4S<&
M*OI>6$$5 ZL7JD?S1//<Z*:^]*?&(F(QA"NIE<YE8F$<P?M6C%C\C!4:7H_.
M:1:=D2#U]W!?"&HWB,>\X,64Q/;<3N]$U60T: RF<&]TVB3$V)M[H'C$H^'P
M&_E?QENW7B$AW5R;E^]B_DC?@M//0E'1=0R)?UGKRGN;3(C/A",;<V0'E&]0
MT;?*O-!@+1-RZBVZWZ,352H,!2^2)Y%S.#[F5OS?<I6CSHVH"YF THFOV^_2
MM2RY$ 15"),:<Y!^=-L8NGWZ<"?3E"C<"NOZL,Q8%\:CG2J/EE8*3HC,R-&%
MCX3$Q:'PCO3D9->3DW_=D]>%J"AV6;WR:2'&UE)&Z-#@5RE64DGW<JA?C[L\
M=";M32K_IDQSWI.M?\$.K?>H.H\2;1_P.5%-RO:BU T?IJQXA8I#\@69M(L&
M$Y1K]M#GL[R$DW>\7TJEZ/1L[TN@K:,^E6F"Y8H^H]U7.X)W$(T'T[<U8XBF
M@]%>$K\-XI0YTG/#TAV58COJ,?S@C, R-,:S3RC5AWF<3*/!J/>V;DR:YX.X
MM\<E_=J&N)QLR?1@2\:[&%ST#I55N'<Q4RGD_OEAP>>YO:-WJ[L7SK*]V+^H
MM\^C.V&HU2THS,AT.#BC<C'MDZ.=.%W[:WZE'=6='Q;T2D/#"K2?:>VV$W:P
M>_<M_@%02P,$%     @ 0X)55KX-]!SS @  =08  !D   !X;"]W;W)K<VAE
M971S+W-H965T,S0N>&UL?57+;MLP$/R5A5H4"1!8EORL:PN(DQ3-(841I\VA
MZ(&65A81BE1(*D[^ODM*5EW4\<%\[L[.4.1XOE/ZR12(%EY+(<TB**RM9F%H
MT@)+9GJJ0DD[N=(ELS35V]!4&EGFDTH1QOW^."P9ET$R]VLKG<Q5;067N-)@
MZK)D^FV)0NT6013L%^[YMK!N(4SF%=OB&NV/:J5I%G8H&2]1&JXD:,P7P64T
M6PY=O _XR7%G#L;@E&R4>G*3VVP1]!TA%)A:A\"H>\$K%,(!$8WG%C/H2KK$
MP_$>_:O73EHVS."5$H\\L\4BF :08<YJ8>_5[ANV>D8.+U7"^!9V3>R8@M/:
M6%6VR<2@Y++IV6M[#@<)T_X["7&;$'O>32'/\II9ELRUVH%VT83F!EZJSR9R
M7+J/LK::=CGEV>0[??=;F:H2884:U@73"&</;"/0G,]#2R5<8)BV<,L&+GX'
M+HKA3DE;&+B1&6;_ H3$K2,8[PDNXY.(UYCV8!!=0-R/XQ-X@T[PP.,-WL&[
M85IRN34'<G]=;HS5=#]^'Q/<P V/P[DW,S,52W$1T*,PJ%\P2#Y]B,;]+R?(
M#CNRPU/HR9K>8%8+!)7#/:9*IEQPYJ\SK2R9X2E8!==<U!8S./8QCTDZ6?2X
MI(<"(5>"WC ='EAW/^A--HS0@*5MX\H9J TQX=(OI4RDM>@(;SQA22QYP[(B
MEC[-J;"%,MBDD]E UHHZ%CZ#,ZI0<B$(V9S[N^&:R#5]?PYMRD<834>]S]2/
MQU%O2OU@..[%\.B?*\&S%]3D/D#1);%L19!]&<MDYL1.AKUAVPP(R1\V.0E@
MGI.U.%WX7'/[!FS'=&8NO$MDH)HCL&25IM9O0$\Y?8(2268&$:%%!.9^_U%I
M.3!#3ND(^)-P1S@9D8+)N#=H1L<N6'A@!27JK3<\0^IJ:1M7Z%8[3[ULK.1O
M>&/(=TQON30@,*?4?F\R"D W)M=,K*J\L6R4)9ORPX+^%U"[ -K/E;+[B2O0
M_=,D?P!02P,$%     @ 0X)55LDX8+/^ @  :P8  !D   !X;"]W;W)K<VAE
M971S+W-H965T,S4N>&ULG55M3]LP$/XKIPQ-($'>4UK65J+ M$E#JF O'Z9]
M<)-+8^'8P78H_/N=DS8#J?3#OL0^^^ZYY[%]E^E&Z0=3(5IXKH4T,Z^RMKD(
M I-76#/CJP8E[91*U\R2J=>!:32RH@NJ11"'X2BH&9?>?-JM+?5\JEHKN,2E
M!M/6-=,O"Q1J,_,B;[=PQ]>5=0O!?-JP-=ZC_=$L-5G!@%+P&J7A2H+&<N9=
M1A>+U/EW#C\Y;LRK.3@E*Z4>G/&UF'FA(X0"<^L0& U/>(5".""B\;C%](:4
M+O#U?(?^N=-.6E;,X)42OWAAJYDW]J# DK7"WJG-%]SJR1Q>KH3IOK#I?=/8
M@[PU5M7;8&)0<]F/['E[#J\"QN$[ ?$V(.YX]XDZEM?,LOE4JPUHYTUH;M))
M[:*)')?N4NZMIEU.<7:^U'2_VKZ<PE(P:8') FX>6][0P5LX_LY6 LW)-+"4
MRT4$^19WT>/&[^!&,=PJ:2L#-[+ XBU 0"0'IO&.Z2(^B'B-N0])= IQ&,<'
M\))!>=+A)?^E_/?EREA-;^;//NT]<KH?V=71A6E8CC./"L6@?D)O_O%#- H_
M'>"=#KS30^CS>ZK+HA4(JH2#&O81/PB]G_CEKF!=PK56QD SI&V&M#@<';-
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M@-HYT'ZIE-T9+L'P?YG_!5!+ P04    " !#@E56XFD"=Z\#   Z"0  &0
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M\737AFY-/S=H>0.M5\;XIP$[&'^7UO\ 4$L#!!0    ( $."559>'K% JP(
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M7--X NV9[@+O#*>;<&FNM4.>85CAGX<;OP#?-UJ[@^$#]']1R[\!4$L#!!0
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M>WPQ@;(&N%Y+:8X#N\'P!EO_"U!+ P04    " !#@E56Y6X8J9L%  !_#@
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M+"XLKKG"#5%H&H#_"X4)U1T*T-XYIW\#4$L#!!0    ( $."55;U"4>MPP4
M !(3   9    >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;*U86W/:.!3^*QJ:
MZ809UUB^DR;,D+3=RTQWF:27AYU]$/8!O+4M*@E(]M?OD6P<TV*'=/N +=OG
M?KY/$KK<<?%%K@ 4N2_R4EX-5DJM+T8CF:R@8-+F:RCQRX*+@BE\%,N17 M@
MJ5$J\I'K..&H8%DYF%R:=S,QN>0;E6<ES 21FZ)@XN$:<KZ[&M#!_L5MMEPI
M_6(TN5RS)=R!^KB>"7P:-5;2K(!29KPD A97@RF]N(ZUO!'XE,%.ML9$9S+G
M_(M^^"V]&C@Z(,@A4=H"P]L6;B#/M2$,XVMM<]"XU(KM\=[Z.Y,[YC)G$FYX
M_CE+U>IJ$ ]("@NVR=4MW_T*=3Z!MI?P7)HKV56R83 @R48J7M3*&$&1E=6=
MW==U:"G$3H>"6RNX)N[*D8GR#5-L<BGXC@@MC=;TP*1JM#&XK-1-N5,"OV:H
MIR9WBB=?7EUC7BFYX07V6C)3KO,/;)Z#'%Z.%+K1PJ.D-GE=F70[3%*7O.>E
M6DGRMDPA/30PPOB:(-U]D-=NK\4WD-C$HQ9Q'=?ML><U27O&GM>5](H)J).>
ML0?$F")3(5BY!#/^:SJ72B!@_CZ6?67;/VY;D^A"KED"5P-DB02QA<'DY0L:
M.J][(O>;R/T^ZY,[)&6ZR8'P!9GF.4^J9N%3E=/\^T;><*DDF3^06<[*8_GT
M>CR>SX<5D 5'_[NL7!*ED5+3.OL7).$;I+T!5A5/THX'[O48D-$)%X@/!+Q:
M925!IJ+OI4664()@.6%E2EB*F,]T,S1Y][H2G0NB,(@'8$(2T#@CB!(HYB 0
M*1?D_(R@S2)#F[R40X,<?:'ZXA #>\+7U<R@':TQNR2K0A2:RI*<D< .\4I=
M.] WQW;)#(29"<L$,]8E)YLR4]*J\Y6@5(ZQ4*U)(WT)\=*IE3"Y:I3.'9L.
M";4=XMA^MTZ:;;,44R;P=9-M68Z(E:A!B8[/06]OBW7.'P"JF,AZ(Y(5]H&L
M$0!HWL.?CS^*%5N $-\V2(M)4Q3LMQ)9HE"BBH#MF$@EZKK$MV,L#R4?N,)>
M/=GM,^)Z=H0W+S+%]'Q,LX<004.(X&1"5$W]TS15DJF>[S/U< SRO39_"/)8
M89P]I 8=+GU28?FT7(4PB7ALH='"JB2P5F2-8*T*F^+<78-T'W_+C$5^9^4&
MUTR"\,6Z_8)3E6Z*;OK;>Q!))BOXN$.":]4"LNJK<]Q8BRC8RG$CM,5VHY[N
MO&Z;Z;OBYO6)2B8479IOY0/RV:R/*#G=(KN7T 1.9@@Q."EWS4%J1UY3 "_T
M;3]JU2!&D$6M&KBN;[OATV5 RS2V(_?YM=":H1W'SRK(&8E]F](^ H0- <)G
M$F#:GLINJZELJHG;2XE>+S^3$G?36^2#:;<>=N*<6D[@-YT.<-)N09U:-!RW
MP7[N#8^8:]?<=2S?J7V>W-U.I2ZD1Y8?.*>!O2][!$ALT[@%]+%-O58% M\.
M_3;0<4X^9O(0=>/(=N-GEJ!;JQ/<$2X.81^XHP;<T<G@_H.7M??6RE@O.6;S
MTPOO7C__'][B .*'>X'9W<=ZX:QACYF\JE/IDFQC@8:^Y4>/5& *@Q%+_,.6
MPQ9RXKD6=<9DFOZ#?Q<*LQM@<[Z%T?E<_^<:[J7#V/)Q+OSTV,)$EU08^E ?
MG8R= TI%UC@,AZ>%>T "ZEI!X'W/@G<L$^03RS?P0X7 J38:ZZFVLQ*A:_O.
MTY6@3F@'T?%*U$QK,<O'97;\_"K@CB>*;2_NXT'<\"#^*3SXJ'>(O3SH]?.S
M>7"PN^VC08?@ 0LLCW9WGGKATVT/G(Z>XW+B1+2-_9<O8I>ZKT^*L=WT>'QD
M\N^!_0F)(^H1DH'7@WJ#V!-0CYLE_T34_V@!$/6^:[OCHZ@?M<XI"L"@]&D,
M(HAO2E4=631OFP.?:77.\2A>G1:]QYPRW&WEL$!5QXYP2R^J$YCJ0?&U.?68
M<Z5X888K8"D(+8#?%YRK_8-VT!R#3?X#4$L#!!0    ( $."55:(,H(M;0H
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MF@:O7MX'P,_::\#:"\*QS3S#,L,-T+A[50M%.EM2D"M088N6;<^I@79(I3;
MN;=/N\/*T]K*TV=;N:["ZS,L_D11L<V.G63;SW(JLGE)EHEJ02/!%A:9$=,4
MDX7"HT"@NJT\\]*>VX.30U.6"7 )$IEX-,R(C! 1$'(')(8,G:UF8;'/7&(]
M*9*P,74N,^)2B36X(_"7K24FAP>S]D1*^5)@95$E<U69NBH@- K+U_# _=["
M%M(0W_:2>^L1X(Q^??3BD5/@:0(\QJ0_@$<A/)CA@Y".)SPH]C"AAP=C*B4
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M[,YFX!3/,B^=\;0%T%'C2X14 !;C]Q::43YC/TJHG];?=,SMEPS;X?:#D \
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M&Q52E;V+,__LUER<Z=KEJJ1;(VQ=%-(\7U&N'\][4:]]<*<>-HX?C"[.*OE
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MV.610P [NLMA@'T"4M*]+5789!6V;.Z<IRZ/M=]KQA0P4J*;-:^Q3*[7'J2
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MVCE=^,L-262>!?!^K;5K;WB#[F?3Q?\!4$L#!!0    ( $."559(B#@CA D
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M+)$(^H SY1YW'J(:[U>0;ZL;:PNRV?H9PM:*#Z;%8Y_L-6N'3O.GVB -YVV
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MCNWK%_2/-G@=S )+N.?T*RG4:AP, U1 B3=4/?'='[ /R!+,.97V%^WVME&
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MT*]C;T_,IOCY; I<M#5?"NTXSD-SCKL_-06\O?_-6EP([5B+0_N/_?W_)Z6
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MN48JLKQBE@TM]L6EZTEH+,SB,<%K.4AC@.]W0NA3PP2H+_J;_P!02P,$%
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M:/00FAF0SM3#_ET_!Q^:!2-EO<D6++)&#OKR'Q0-0Z&9=.LZ(CQ5_T\(6AZ
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MP4QR[7[)NO(]ZWLD6VHCBQJ,&11,5%_Z5-=A"Q"^!8AJ0+0+B-\ =&M ]U!
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MSZ'MQ%PE8=COG _\U78Y#O)*6[R"N'/6>+T0T&L$]/8*&-.2&<K9'\CQ[AG
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M4=D+]'TLI5EOK(%RU![^ E!+ P04    " !#@E56B>6X-,@"  # "   &0
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M:;#XNF&)_124#<#]0DJSG=@/=!TZ^0=02P,$%     @ 0X)55N=<':NP @
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M'*T26**D,Q@C+5D4L45#BTU>UBV$QB(QOUUCX0_2#,#G2R'TKF$FJ/Y*F/T
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M#&XSB;-MLJ8$7 M!I !O#<?63^ ._\,X6%$L!'A]0R1.J'BCC#\]W(#7K]Z
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M:&J>(/<.KO<&T]O6<:=Q@ZNST05UZ(L#8N^@$MNV3@>Q>Q2X@<(AC6?I&A[
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M/^(L?D'[WD\?@S@CH=C+,?/I0JI&6OTHM7J3)\?R=YT/29XG4?GR('QIVHH
M^?T^2?(?;XJ?BIY_&KSY'U!+ P04    " !#@E56\\V82E<"  #(!0  &0
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M?2!_(+Y>!V&@=F<5&U7V9*3V;73[8?D.5&6EO'CC[9.-]<767$YM[O#D9=5
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M52,IU!TD4\.=0[CQU,A0D,Z==K5UZ-&#9KO![;=*4J!#Z$W:56()P48SHY@
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M]1"CNGLY5VB%Y%FJP9ONW#3*/K;>C(X-G9!B"9"8 SC> H[?>,B*(;E#BB5
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MTRG!Z0VY NE7X.M.'B;@3MX@R@_@PB4<TR#Y*)I\>W+!Q8>/X ,8@V2+&4D
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M*=\./>P=)I[98JG,A#\:K.@"7D#]M9H*/?)++0G+()>,YTC ?.B-\<.$!$;
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MTSC[N29X09@T$,^7E/*/"]E!>81[_A]02P,$%     @ 0X)55KW2E/\5"
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M1#=>R2L/+WYU5B(\LVQEC):%9U:M#*,QB'YM0DD9WZ*4\<'257M_#J.,.Q0
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MF^+AFK,%%[E O[_,,O7R)/^ _>\Z9O\#4$L#!!0    ( $."558-D3K;< ,
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M0QTV5*]VI#'GR1LBEE07%X.%-M.!U_:B.*(5"\77^2EGQI4^,^67*WVL!6$
M^OF"<_6X, >GZJ <_P502P,$%     @ 0X)55NX+-3$? P  B L  !D   !X
M;"]W;W)K<VAE971S+W-H965T.#4N>&ULQ5;O;]HP$/U7K*R:J+3F%R30#I!:
MJFF5V@VUZ_9AV@>3'&#-B9EMH-M?OW.29@F$J)N0]H78R;V7]RYWYH9;(;^K
M)8 F3PE/U<A::KVZ<!P5+2&ARA8K2/')7,B$:MS*A:-6$FB<@1+N^*X;.@EE
MJ34>9O>F<CP4:\U9"E-)U#I)J/QY!5QL1Y9G/=^X9XNE-C><\7!%%_  ^G$U
ME;AS2I:8)9 J)E(B83ZR+KV+B9<!LHC/#+:JLB;&RDR([V9S$X\LUR@"#I$V
M%!0O&Y@ YX8)=?PH2*WRG09873^SO\O,HYD953 1_ N+]7)D#2P2PYRNN;X7
MV_=0& H,7R2XRG[)MHAU+1*ME19) 48%"4OS*WTJ$E$!>+T# +\ ^"\%= M
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M:XK:SYU3&9/,C'I'Y8)AS7*8(\RU^XB7^=B7;[1899/33&B<P[+E$D=ED"8
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M #P": 10Y5T;55E>,\W2M10G(NW;)IJ]J$JMU"8Y7MA5N=72/.5&I],K+/#
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MHRP=99V71HVLO]34UTVT0Q^=9)\32(WLW&WN<>OH1R?QYV02'?*/AC./6P=
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M& Q@(AO/%?T5Y0^"9Z4S]J66'4(J?JA3IP)$8^-$(W,V02H!/ZKR<NO(!-E
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ME5=:1[[( ]CR]!;O/%+RHE(3@P'DY>&)*:7KN59+R.0:>X_FR%I9TY&GWSS
M(@_'HH&KD50O+J2\0%J>(.L]0J;Y&3+:A\ATD)8'I.41/D?6:F&I7K2).$8
M( \'(*E/I5E>7$AY:70DACQ *$]O2<TC)2LJ-?%I1R KG["DYN\_-28YJ\I:
MC9Y5?< >'\<>J5NE.5U<2'6!J-3$:0,B^7H+:#XI$%&IB<$ (/()"VC^X0(:
MVD0<(W"*CW/*[@HM)2=;_+#*"ZDC<^0#(OEZ*VT^*3A1J8G! '#R"2MM_G[9
MS)@.]W20-'+&[C[W>X_&XTPC=39"M[B<\B+IR!;Y $N^WMJ:3XI05&IB, "A
M?,+:FG_X^32TB;A# I!-@),-XE8IX^)RRCLGZ,@1!0!+@=Y"6T"*4%1J8C
MH0+")] "V1-HP_.KI-'H^34 N@EPND$<*^5<7$YYD72D=P+ ID!O82T@Q2,J
M-3$8@$<!X?-HK19V[P+:1!PC4$N 4\M-O(G3;5I9]*0[U'%UY?72D>T)@(P"
MO76U@)24J-3$8/3V)M)15PND!3-K6+# CWWJW !\ AQ\P/0GW B!:RNOLH[$
M40AX%>HMR86DN$6E)@8#<"O$<U.G63Z4UN@\>V!Y_-BGS@WH*3Q0H^LL?W3M
M&5=47EL=.:<0J"S46X0+22F-2DT,!E!:B">W3C2Z<^!FB'9N.J K!.@*#Y3M
MHF__!VAP=>5UUI&2"@'N0KVUO)"4[JC4Q&  W85XWNM$TTN?P=L[N>M@M1!8
M+3Q0 NP\?P+/X-K*BZQEL\G>;I.:MYNDW6]2SX:3_1TG\>S9:9Y_43UTL^>!
MHY\\O]Y.E<:!:F)G_*.IYH"D\A9C5'*#&%B]&&C>QM*@W<>22FX0D-Y.EH:.
M/;9?5(=XXQO"GV$.\<!@5*<[Z^TW7^_V?Q/E#_&F8 E?5?+&M*YQY;O]\W=O
MRNRQV8+^/BO++&U>KGFTY'G=H/K]*LO*ES?UKO;=?V,P_P]02P,$%     @
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MF1.>,2<(R;W@>JO(!YY">JK 0VX-P?"%X&TXJ#&&Q"6CX#T)_3"T&'3W=O'
M(AZ_7=P?8#-JPC4J]8T&PU4%@E">OL1"D7]NGI266$;_VKQ>:1W;M9K><JT*
MFL#2P>:A0.[!6?W^6Q#Y?]@\]BN5Q;](V8DWQXTWQT/:5X^P!TEY4KFR$$I?
M05YDXAD;FR9/P&'-M#6+*[V34J]IK?O5S(WF)W\+;]]V6E_"=Z-33-S'C%N8
M$XJ3AN)DD.*-4J"O)&140TJ2+94;L#*JU$Q;WPXF[JA#H@)%;1(="D.($P)1
M0R :)%!E_(#A4<_P*]\-.X;W04'/^]%;39\VID\'3?\F-,UP.&)=[A*]DXQO
MRD1[0S2F/7O#D3OKD+* NL3C/N9L2LT:6K-!6A_9$8VG)K$(RPO*I"D755)3
MM)H8\'/'"O/X/>&@;0QG%N.G'8)]3-!-R;B/F;;TG!"<-P3G@P0O/N&^=$DR
MH13!U42PC. L/!.I>3_] G?2(6(%==C&?5 [CT^8!/[K>/<'N=SA-,6\,_TL
MP8G,4FQX9N&RCF:_5P'=!E!#3D/281M;0>>8M!:58#CMA,0ECA,X8MT@(X+3
MCBM:K8\;C)A]W0CZKA^[09>6!16XXRXO*VIRAECX2BS\GQ I+"2^QSY1SIUR
M%6;ZV4HG[)DPZF6;!33NU8T%%)[E\KJ>!(/SNN[63$-NC\;(UJRCKOU]5+]:
M;*K"<Y4?O&X$P?!*4/5L4=* :K>R$NF/ZC#J-6@+:NK.NT0JT+S-MELL7FO!
MSP&'ACDH*:SH'=?5*MP\;0YC-^41I//\UAS2RH/#JYKJA'>/LPAKB&2P1I6^
M.T6K975HJFZT*,ICQ)/0>"@I+[=XT 1I /A^+81^N3$?:(ZNJ_\ 4$L#!!0
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MTIV/I!$S"KZ@FA76535(F <)\R\:-XK3N)F $E94FQ6JS:RJF0=)]%$+)=)
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MG"3FF:N1KXW'+)(?EG[N"C^DP0\FZ%%PO5#H$X\@VA7P37)5AN0MPSOB5'R
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MW3/L<*$_ T 8@-XO.%?;B3F@^;!(_@%02P,$%     @ 0X)55H,ZD4F1 P
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MO9$^XV;>7[3$MPS]]/21IZ( \AM]!47.R?UB 78FR.$%>894\)3EC-JI.DM
M4Y:KG\=]C1$8G'Y:C797CA:WC!;%Y(O@>J7(/<\@.P7H8^AU_/$^_KO8BYA
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M]X!3X#I /=\R)A\Z>H#V(\KJ!U!+ P04    " !#@E56=>Z&!E4%  !5(@
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M!I413\_CTAO)=LD)U2N3DD7)Y19( %P#U.=KQN3I1G]!?BJZ_!=02P,$%
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MPB:+KB)2P99U I]T?P^CGX7G*[6PX4OZ(7<QCTC96=1R!+L*)%?#R';C.1P
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M--EJ!P  T$0   \   !X;"]W;W)K8F]O:RYX;6S%G%USVC@40/^*AJ?LS+*
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MH>,#E5CD8P+RB06$8\+12!\3D$\L(!P3=C1]3$#^1?*>VM&6/'9"3'0V&+&
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MQNX/>12N-,M?BFLY7C]?MK?)HFAB]RV3.\77QS_D./Z9R(=_ 5!+ P04
M" !#@E56XE4/'/@"  "P/0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QSS=O+;MI &(;A6T&^@'C.ARK)JIMLJ]P (@:B<!)VU>3NBY(%?*,NNHG\
MKM 8,;P;/T)F_OM?PVXYO1X/X_;U-"[>][O#^-!MI^GTH^_'U7;8+\>[XVDX
M7-Y9'\_[Y719GC?]:;EZ6VZ&WAF3^O/M'MWC_>V>B^>/T_ _.Q[7Z]?5\/.X
M^KT?#M,_-N[_',]OXW88IF[QO#QOANFAZ]]WU\MC__EB[RX[=XNGEX?N_/1B
MNW[N("=!;OX@+T%^_J @06'^H"A!<?Z@)$%I_J L07G^H")!9?Z@*D%U_B!K
M5$8#2&JP!FAME6L+\-HJV!8@ME6R+<!LJVA;@-I6V;8 MZW";0%R6Z7; NRV
MBK<%Z.U4;P?0VZG>#J"W:WYL _1VJK<#Z.U4;P?0VZG>#J"W4[T=0&^G>CN
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MD5)P%2E%5Y%2>!7I__3U^S3M_W'\\HR'NAM?\Y/EW[8W/P%02P$"% ,4
M" !#@E56!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( $."55;RKJ? [@   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $."55:97)PC
M$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ 0X)55JO$'%Z?!P  )2\  !@              ("!#0@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $."55:R@\**
M00(  ,@%   8              " @>(/  !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6Q02P$"% ,4    " !#@E56-]M+&8L%  !M%P  &
M@(%9$@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ 0X)5
M5J=.0@H !0  RQ(  !@              ("!&A@  'AL+W=O<FMS:&5E=',O
M<VAE970T+GAM;%!+ 0(4 Q0    ( $."5581O[DE[P,  *8-   8
M      " @5 =  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M" !#@E56\!JL!:4'  !H(@  &               @(%U(0  >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 0X)55BY*H: 6 P  .0H  !@
M             ("!4"D  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4
M Q0    ( $."55:@K.Y.@0D  /AA   8              " @9PL  !X;"]W
M;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !#@E56/'YCLID"  "Z
M!@  &               @(%3-@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
M4$L! A0#%     @ 0X)55F!$/,5""0  ZBL  !D              ("!(CD
M 'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !#@E563XZ!
M88(6  !I00  &0              @(&;0@  >&PO=V]R:W-H965T<R]S:&5E
M=#$Q+GAM;%!+ 0(4 Q0    ( $."55:1=-OH:00  #@*   9
M  " @519  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @
M0X)55O(FD%9@"0  !1H  !D              ("!]%T  'AL+W=O<FMS:&5E
M=',O<VAE970Q,RYX;6Q02P$"% ,4    " !#@E56&$ VNZT$  #O"@  &0
M            @(&+9P  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4
M Q0    ( $."559+K6)KI@,  %4(   9              " @6]L  !X;"]W
M;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ 0X)55O1P7;#W!P
M1Q0  !D              ("!3'   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q02P$"% ,4    " !#@E562.+52SD%  !F#0  &0              @(%Z
M>   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( $."55;?
MU5D%[ ,  !,)   9              " @>I]  !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL4$L! A0#%     @ 0X)55J?_\$\5 P  WP8  !D
M     ("!#8(  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $."55;7):I!] X  /(O   9              "
M@=6H  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ 0X)5
M5CH?DV^=$   >#4  !D              ("! +@  'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6Q02P$"% ,4    " !#@E56]7P5%/ &  !-$@  &0
M        @('4R   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0
M   ( $."55;<N<J:; L  '0?   9              " @?O/  !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ 0X)55NNI/MS7 P  P@@
M !D              ("!GML  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q0
M2P$"% ,4    " !#@E56+J,F+Y0+  "E'P  &0              @(&LWP
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( $."559VQO#,
M+0,  *4(   9              " @7?K  !X;"]W;W)K<VAE971S+W-H965T
M,S N>&UL4$L! A0#%     @ 0X)55O3!I"DB&   4$T  !D
M ("!V^X  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " !#
M@E56OPXP)9H"  "=!0  &0              @($T!P$ >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( $."55:771(@]@,   ,*   9
M          " @04* 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#
M%     @ 0X)55KX-]!SS @  =08  !D              ("!,@X! 'AL+W=O
M<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !#@E56R3A@L_X"  !K
M!@  &0              @(%<$0$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM
M;%!+ 0(4 Q0    ( $."55;B:0)WKP,  #H)   9              " @9$4
M 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ 0X)55EX>
ML4"K @  ] 4  !D              ("!=Q@! 'AL+W=O<FMS:&5E=',O<VAE
M970S-RYX;6Q02P$"% ,4    " !#@E56$A7F:_X#  !1"0  &0
M    @(%9&P$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (
M $."559+('$0)0,  -H&   9              " @8X? 0!X;"]W;W)K<VAE
M971S+W-H965T,SDN>&UL4$L! A0#%     @ 0X)55E!"*?1C P  G <  !D
M             ("!ZB(! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"
M% ,4    " !#@E56'>2)NI<%   '$0  &0              @(&$)@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( $."559#9"/:=P,
M (\)   9              " @5(L 0!X;"]W;W)K<VAE971S+W-H965T-#(N
M>&UL4$L! A0#%     @ 0X)55N5N&*F;!0  ?PX  !D              ("!
M # ! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !#@E56
M]0E'K<,%   2$P  &0              @('2-0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;%!+ 0(4 Q0    ( $."55:(,H(M;0H  /4B   9
M      " @<P[ 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%
M  @ 0X)55G2Z9:X)!   ?0H  !D              ("!<$8! 'AL+W=O<FMS
M:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " !#@E56C&CQ[-X&  !X$@
M&0              @(&P2@$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+
M 0(4 Q0    ( $."559(B#@CA D  +@9   9              " @<51 0!X
M;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ 0X)55E$=1,W5
M P  U X  !D              ("!@%L! 'AL+W=O<FMS:&5E=',O<VAE970T
M.2YX;6Q02P$"% ,4    " !#@E56'K;N[:0#  #T#P  &0
M@(&,7P$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( $."
M558GD!"UN04   4N   9              " @6=C 0!X;"]W;W)K<VAE971S
M+W-H965T-3$N>&UL4$L! A0#%     @ 0X)55F(F+MOD @  :P@  !D
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M=#4V+GAM;%!+ 0(4 Q0    ( $."55;,K_O12P,  '8+   9
M  " @2I] 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @
M0X)55HGEN#3( @  P @  !D              ("!K( ! 'AL+W=O<FMS:&5E
M=',O<VAE970U."YX;6Q02P$"% ,4    " !#@E56YBR8],L"  "M!P  &0
M            @(&K@P$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4
M Q0    ( $."55;G7!VKL (  -$'   9              " @:V& 0!X;"]W
M;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ 0X)55I#L,F#M @
MR P  !D              ("!E(D! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX
M;6Q02P$"% ,4    " !#@E56VUV3I&4$   T$0  &0              @(&X
MC $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( $."55:-
MG,^N,P0  "04   9              " @521 0!X;"]W;W)K<VAE971S+W-H
M965T-C,N>&UL4$L! A0#%     @ 0X)55O37Q*G* P  5A   !D
M     ("!OI4! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $."55;\>49T_08  ,-(   9              "
M@5VX 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ 0X)5
M5H"8J\)'!   K1\  !D              ("!D;\! 'AL+W=O<FMS:&5E=',O
M<VAE970W,"YX;6Q02P$"% ,4    " !#@E56(S0!L/$(  #'2   &0
M        @($/Q $ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0
M   ( $."55;RK"7O<0<  "8\   9              " @3?- 0!X;"]W;W)K
M<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ 0X)55O/-F$I7 @  R 4
M !D              ("!W]0! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q0
M2P$"% ,4    " !#@E56 X/Z(=$&  #G*@  &0              @(%MUP$
M>&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( $."55;JP[SW
MI08  %0G   9              " @77> 0!X;"]W;W)K<VAE971S+W-H965T
M-S4N>&UL4$L! A0#%     @ 0X)55M?#.^,^"   ?SH  !D
M ("!4>4! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " !#
M@E56@<-+'*($  "D'   &0              @('&[0$ >&PO=V]R:W-H965T
M<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( $."55;%9<<+V 8  $$I   9
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M970X,BYX;6Q02P$"% ,4    " !#@E565UYU E '  #C,0  &0
M    @('Y%0( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    (
M $."558-D3K;< ,  #0/   9              " @8 = @!X;"]W;W)K<VAE
M971S+W-H965T.#0N>&UL4$L! A0#%     @ 0X)55NX+-3$? P  B L  !D
M             ("!)R$" 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q02P$"
M% ,4    " !#@E565PXD?J\#   Y$   &0              @(%]) ( >&PO
M=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( $."55:_#TX "00
M &05   9              " @6,H @!X;"]W;W)K<VAE971S+W-H965T.#<N
M>&UL4$L! A0#%     @ 0X)55ASJBY$G P  *PP  !D              ("!
MHRP" 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4    " !#@E56
MAC&V8W,)  #28   &0              @($!, ( >&PO=V]R:W-H965T<R]S
M:&5E=#@Y+GAM;%!+ 0(4 Q0    ( $."5582CMSE,@0  ,8.   9
M      " @:LY @!X;"]W;W)K<VAE971S+W-H965T.3 N>&UL4$L! A0#%
M  @ 0X)55FS%)\=,!@  GC8  !D              ("!%#X" 'AL+W=O<FMS
M:&5E=',O<VAE970Y,2YX;6Q02P$"% ,4    " !#@E56K/C8=I4$  #7&0
M&0              @(&71 ( >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;%!+
M 0(4 Q0    ( $."5598&?/U8 ,  %H+   9              " @6-) @!X
M;"]W;W)K<VAE971S+W-H965T.3,N>&UL4$L! A0#%     @ 0X)55J(.L[,$
M!P  O30  !D              ("!^DP" 'AL+W=O<FMS:&5E=',O<VAE970Y
M-"YX;6Q02P$"% ,4    " !#@E56ARY6$N@"  !D"   &0
M@($U5 ( >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4 Q0    ( $."
M55:#.I%)D0,  "@-   9              " @517 @!X;"]W;W)K<VAE971S
M+W-H965T.38N>&UL4$L! A0#%     @ 0X)55J6O%I(6!   ) \  !D
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M970Q,#$N>&UL4$L! A0#%     @ 0X)55G7NA@95!0  52(  !H
M     ("!_6T" 'AL+W=O<FMS:&5E=',O<VAE970Q,#(N>&UL4$L! A0#%
M  @ 0X)55O7^OB-7"   X#0  !H              ("!BG," 'AL+W=O<FMS
M:&5E=',O<VAE970Q,#,N>&UL4$L! A0#%     @ 0X)55C5=N.IA!   (14
M !H              ("!&7P" 'AL+W=O<FMS:&5E=',O<VAE970Q,#0N>&UL
M4$L! A0#%     @ 0X)55O,OT!KH 0  6@0  !H              ("!LH "
M 'AL+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L! A0#%     @ 0X)55AC8
MNA]Q P  L!8   T              ( !TH(" 'AL+W-T>6QE<RYX;6Q02P$"
M% ,4    " !#@E56EXJ[',     3 @  "P              @ %NA@( 7W)E
M;',O+G)E;'-02P$"% ,4    " !#@E56[0\TV6H'  #01   #P
M    @ %7AP( >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 0X)55N)5#QSX
M @  L#T  !H              ( ![HX" 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ 0X)55@Y(+SEJ @  =3L  !,
M ( !'I(" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     '$ <0 4'P  N90"
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>527</ContextCount>
  <ElementCount>593</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>144</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>14</UnitCount>
  <MyReports>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - New Accounting Standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NewAccountingStandards</Role>
      <ShortName>New Accounting Standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Affiliated Companies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompanies</Role>
      <ShortName>Affiliated Companies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherCurrentLiabilities</Role>
      <ShortName>Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Other Expense (Income)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncome</Role>
      <ShortName>Other Expense (Income)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Schedule II - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Revenue</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/NetIncomePerShare</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/PropertyPlantandEquipment</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Leases</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Affiliated Companies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompaniesTables</Role>
      <ShortName>Affiliated Companies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/AffiliatedCompanies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Debt</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/FairValueMeasurements</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/StockBasedCompensation</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansTables</Role>
      <ShortName>Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlans</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Other Expense (Income) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeTables</Role>
      <ShortName>Other Expense (Income) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncome</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/IncomeTaxes</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SegmentInformation</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Revenue - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueRevenueRecognitionDetails</Role>
      <ShortName>Revenue - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Revenue - Contracts Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails</Role>
      <ShortName>Revenue - Contracts Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Net Income Per Share - Schedule of Reconciliation of Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails</Role>
      <ShortName>Net Income Per Share - Schedule of Reconciliation of Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Net Income Per Share - Narratives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails</Role>
      <ShortName>Net Income Per Share - Narratives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails</Role>
      <ShortName>Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Property, Plant and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails</Role>
      <ShortName>Property, Plant and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Leases - Lease Cash Flow and Supplemental Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails</Role>
      <ShortName>Leases - Lease Cash Flow and Supplemental Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Affiliated Companies - Schedule of Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails</Role>
      <ShortName>Affiliated Companies - Schedule of Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Affiliated Companies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails</Role>
      <ShortName>Affiliated Companies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Goodwill and Intangible Assets - Intangible Assets by Major Class (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Intangible Assets by Major Class (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherCurrentLiabilitiesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Debt - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtScheduleofDebtDetails</Role>
      <ShortName>Debt - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Derivative Financial Instruments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Derivative Financial Instruments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Derivative Financial Instruments - Foreign Exchange Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails</Role>
      <ShortName>Derivative Financial Instruments - Foreign Exchange Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails</Role>
      <ShortName>Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Fair Value Measurements - Fair Value of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Fair Value Measurements - Other Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Other Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails</Role>
      <ShortName>Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Stock-Based Compensation - Nonvested Performance-based Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Nonvested Performance-based Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Benefit Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansNarrativeDetails</Role>
      <ShortName>Benefit Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Benefit Plans - Components of Net Periodic Benefit Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails</Role>
      <ShortName>Benefit Plans - Components of Net Periodic Benefit Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails</Role>
      <ShortName>Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Benefit Plans - Amounts Recognized in Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails</Role>
      <ShortName>Benefit Plans - Amounts Recognized in Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Benefit Plans - Expected Benefit Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails</Role>
      <ShortName>Benefit Plans - Expected Benefit Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Benefit Plans - Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails</Role>
      <ShortName>Benefit Plans - Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails</Role>
      <ShortName>Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Benefit Plans - Allocation of Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails</Role>
      <ShortName>Benefit Plans - Allocation of Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Other Expense (Income) - Schedule of Other (Income) Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails</Role>
      <ShortName>Other Expense (Income) - Schedule of Other (Income) Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncomeTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Other Expense (Income) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails</Role>
      <ShortName>Other Expense (Income) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncomeTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails</Role>
      <ShortName>Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncomeTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Income Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes - Components of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Income Tax Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/CommitmentsandContingencies</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Segment Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Segment Information - Sales by Product Group (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails</Role>
      <ShortName>Segment Information - Sales by Product Group (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - Segment Information - Sales and Long-lived Assets by Geographic Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails</Role>
      <ShortName>Segment Information - Sales and Long-lived Assets by Geographic Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - Segment Information - Segment Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails</Role>
      <ShortName>Segment Information - Segment Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0000104 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="wst-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - wst-20221231.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - wst-20221231.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="wst-20221231.htm">wst-20221231.htm</File>
    <File>ex21listofsubsidiaries_2022.htm</File>
    <File>ex23consent_2022.htm</File>
    <File>ex311ceo302certification_2.htm</File>
    <File>ex312cfo302certification_2.htm</File>
    <File>ex321ceo906certification_2.htm</File>
    <File>ex322cfo906certification_2.htm</File>
    <File>wst-20221231.xsd</File>
    <File>wst-20221231_cal.xml</File>
    <File>wst-20221231_def.xml</File>
    <File>wst-20221231_lab.xml</File>
    <File>wst-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>wst-20221231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="1884">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>125
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "wst-20221231.htm": {
   "axisCustom": 1,
   "axisStandard": 41,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 1,
    "http://fasb.org/us-gaap/2022": 1884,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 527,
   "dts": {
    "calculationLink": {
     "local": [
      "wst-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "wst-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "wst-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "wst-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wst-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "wst-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 934,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 4,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 8
   },
   "keyCustom": 67,
   "keyStandard": 526,
   "memberCustom": 40,
   "memberStandard": 96,
   "nsprefix": "wst",
   "nsuri": "http://www.westpharma.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.westpharma.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000010 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "10",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Segment Information - Narrative (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.westpharma.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Segment Information - Sales by Product Group (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
     "shortName": "Segment Information - Sales by Product Group (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "icaaaae353c954ac08d48f920067dcb7f_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Segment Information - Sales and Long-lived Assets by Geographic Location (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails",
     "shortName": "Segment Information - Sales and Long-lived Assets by Geographic Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - Segment Information - Segment Financial Information (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails",
     "shortName": "Segment Information - Segment Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NonoperatingIncomeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i635169c6599a4431a7816915bd315902_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails",
     "shortName": "Schedule II - Valuation and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i5ff963c9c54045f29206b3189d452f9b_I20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - New Accounting Standards",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.westpharma.com/role/NewAccountingStandards",
     "shortName": "New Accounting Standards",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Revenue",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.westpharma.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Net Income Per Share",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.westpharma.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Property, Plant and Equipment",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipment",
     "shortName": "Property, Plant and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.westpharma.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Affiliated Companies",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.westpharma.com/role/AffiliatedCompanies",
     "shortName": "Affiliated Companies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Goodwill and Intangible Assets",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Other Current Liabilities",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.westpharma.com/role/OtherCurrentLiabilities",
     "shortName": "Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.westpharma.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.westpharma.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Derivative Financial Instruments",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.westpharma.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Accumulated Other Comprehensive Loss",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.westpharma.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Benefit Plans",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.westpharma.com/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Other Expense (Income)",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.westpharma.com/role/OtherExpenseIncome",
     "shortName": "Other Expense (Income)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.westpharma.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://www.westpharma.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Segment Information",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://www.westpharma.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Schedule II - Valuation and Qualifying Accounts",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts",
     "shortName": "Schedule II - Valuation and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "31",
     "role": "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Revenue (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.westpharma.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Net Income Per Share (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.westpharma.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Property, Plant and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipmentTables",
     "shortName": "Property, Plant and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.westpharma.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Affiliated Companies (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.westpharma.com/role/AffiliatedCompaniesTables",
     "shortName": "Affiliated Companies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Other Current Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.westpharma.com/role/OtherCurrentLiabilitiesTables",
     "shortName": "Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.westpharma.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Derivative Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Stock-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.westpharma.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Benefit Plans (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://www.westpharma.com/role/BenefitPlansTables",
     "shortName": "Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Other Expense (Income) (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeTables",
     "shortName": "Other Expense (Income) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://www.westpharma.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Segment Information (Tables)",
     "menuCat": "Tables",
     "order": "48",
     "role": "http://www.westpharma.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Revenue - Narrative (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.westpharma.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "ib455f8d389b84c90834d838d768dd859_I20130630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Revenue - Revenue Recognition (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
     "shortName": "Revenue - Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i635169c6599a4431a7816915bd315902_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Revenue - Contracts Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails",
     "shortName": "Revenue - Contracts Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i635169c6599a4431a7816915bd315902_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Net Income Per Share - Schedule of Reconciliation of Shares (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails",
     "shortName": "Net Income Per Share - Schedule of Reconciliation of Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Net Income Per Share - Narratives (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails",
     "shortName": "Net Income Per Share - Narratives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
     "shortName": "Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "ib525a96790ee419f9313dd7892b7b3dd_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Property, Plant and Equipment - Narrative (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails",
     "shortName": "Property, Plant and Equipment - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestCostsCapitalized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "wst:LesseeOperatingLeaseOptionToTerminateTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.westpharma.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "wst:LesseeOperatingLeaseOptionToTerminateTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Leases - Lease Cost (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.westpharma.com/role/LeasesLeaseCostDetails",
     "shortName": "Leases - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Leases - Lease Cash Flow and Supplemental Information (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails",
     "shortName": "Leases - Lease Cash Flow and Supplemental Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i83da5dac2d5b4be8a4e3cf6b667f2e1c_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Affiliated Companies - Schedule of Investments (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails",
     "shortName": "Affiliated Companies - Schedule of Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i83da5dac2d5b4be8a4e3cf6b667f2e1c_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Affiliated Companies - Narrative (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
     "shortName": "Affiliated Companies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i635169c6599a4431a7816915bd315902_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i1165b131d689444eb6459290c85e0fec_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Goodwill and Intangible Assets - Intangible Assets by Major Class (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails",
     "shortName": "Goodwill and Intangible Assets - Intangible Assets by Major Class (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredRevenueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails",
     "shortName": "Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredRevenueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Debt - Schedule of Debt (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.westpharma.com/role/DebtScheduleofDebtDetails",
     "shortName": "Debt - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Debt - Narrative (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.westpharma.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "iad4b14762f724836912187aa55021fd3_I20121231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "wst:DebtInstrumentNumberOfTranches",
      "reportCount": 1,
      "unique": true,
      "unitRef": "tranche",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "iab197c4924f34c0db38f5eb19ad7f2b1_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Derivative Financial Instruments - Narrative (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
     "shortName": "Derivative Financial Instruments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "iab197c4924f34c0db38f5eb19ad7f2b1_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9b6ff425fe5240119fb6fedfde9e6e41_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Derivative Financial Instruments - Foreign Exchange Rate Risk (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
     "shortName": "Derivative Financial Instruments - Foreign Exchange Rate Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9b6ff425fe5240119fb6fedfde9e6e41_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
     "shortName": "Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Fair Value Measurements - Fair Value of Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Fair Value of Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Fair Value Measurements - Other Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements - Other Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i635169c6599a4431a7816915bd315902_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
     "shortName": "Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "ibe8ca4226e454ae6ac3d77c3f63f4645_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
     "shortName": "Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
     "shortName": "Stock-Based Compensation - Stock Options Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i8f96ef1285984637b015aa0c2e0daed7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
     "shortName": "Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i756408cda2044016850493d82b241ade_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i1a763da7bebb49d78fb727a07ced4166_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF EQUITY",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i1a763da7bebb49d78fb727a07ced4166_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "ie73ec10e708d43e191bb939a896cda33_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Stock-Based Compensation - Nonvested Performance-based Award Activity (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
     "shortName": "Stock-Based Compensation - Nonvested Performance-based Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i614e5023b53d4eab9f1069365d95f319_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Benefit Plans - Narrative (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
     "shortName": "Benefit Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Benefit Plans - Components of Net Periodic Benefit Cost (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
     "shortName": "Benefit Plans - Components of Net Periodic Benefit Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i635169c6599a4431a7816915bd315902_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
     "shortName": "Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Benefit Plans - Amounts Recognized in Balance Sheet (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
     "shortName": "Benefit Plans - Amounts Recognized in Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "ib7283d2db8a4479785b3c3e131984a7d_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "wst:AssetsDefinedBenefitPlansNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "ib7283d2db8a4479785b3c3e131984a7d_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
     "shortName": "Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "ib7283d2db8a4479785b3c3e131984a7d_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Benefit Plans - Expected Benefit Payments (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
     "shortName": "Benefit Plans - Expected Benefit Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Benefit Plans - Assumptions Used (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
     "shortName": "Benefit Plans - Assumptions Used (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i43aa223ae6224bc2a023082dd67356a3_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i7479189625164010af6cfb04cc0211f7_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails",
     "shortName": "Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i7479189625164010af6cfb04cc0211f7_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Benefit Plans - Allocation of Plan Assets (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
     "shortName": "Benefit Plans - Allocation of Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical)",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Other Expense (Income) - Schedule of Other (Income) Expense (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails",
     "shortName": "Other Expense (Income) - Schedule of Other (Income) Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Other Expense (Income) - Narrative (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
     "shortName": "Other Expense (Income) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i739a2b68896f4736a2d8f3353a35af2a_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i635169c6599a4431a7816915bd315902_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails",
     "shortName": "Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i63527504ecaa4a10a8def5b5ec6f1894_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i635169c6599a4431a7816915bd315902_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Income Taxes - Income Before Income Taxes (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Income Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails",
     "shortName": "Income Taxes - Components of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails",
     "shortName": "Income Taxes - Effective Income Tax Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i94aed5d11b5b48f495527e084e9bd524_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20221231.htm",
      "contextRef": "i9c2e17c9d7a541f3b0d7fd230ac8289b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - wst-20221231.htm",
     "menuCat": "Cover",
     "order": "105",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - wst-20221231.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 144,
   "tag": {
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "Germany"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "France"
       }
      }
     },
     "localname": "FR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SGD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Singapore, Dollars",
        "terseLabel": "SGD"
       }
      }
     },
     "localname": "SGD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "USD"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r999",
      "r1000",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r999",
      "r1000",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r999",
      "r1000",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r999",
      "r1000",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r997"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r1004"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r999",
      "r1000",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r995"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r998"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continents of North and South America.",
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Asia Pacific.",
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r339",
      "r394",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r412",
      "r416",
      "r498",
      "r499",
      "r500",
      "r501",
      "r503",
      "r504",
      "r506",
      "r508",
      "r509",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r1063",
      "r1064",
      "r1127",
      "r1128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r339",
      "r394",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r412",
      "r416",
      "r498",
      "r499",
      "r500",
      "r501",
      "r503",
      "r504",
      "r506",
      "r508",
      "r509",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r1063",
      "r1064",
      "r1127",
      "r1128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r279",
      "r350",
      "r360",
      "r366",
      "r443",
      "r682",
      "r683",
      "r684",
      "r713",
      "r714",
      "r755",
      "r758",
      "r761",
      "r762",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r279",
      "r350",
      "r360",
      "r366",
      "r443",
      "r682",
      "r683",
      "r684",
      "r713",
      "r714",
      "r755",
      "r758",
      "r761",
      "r762",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r279",
      "r350",
      "r360",
      "r366",
      "r443",
      "r682",
      "r683",
      "r684",
      "r713",
      "r714",
      "r755",
      "r758",
      "r761",
      "r762",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by currency.",
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r1038"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Non-Employee Directors"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Equity Method Investee, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r422",
      "r970",
      "r1068",
      "r1116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r494",
      "r495",
      "r496",
      "r497",
      "r640",
      "r865",
      "r888",
      "r917",
      "r918",
      "r966",
      "r985",
      "r994",
      "r1065",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/LeasesNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r494",
      "r495",
      "r496",
      "r497",
      "r640",
      "r865",
      "r888",
      "r917",
      "r918",
      "r966",
      "r985",
      "r994",
      "r1065",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r422",
      "r970",
      "r1068",
      "r1116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r418",
      "r867",
      "r968",
      "r992",
      "r1060",
      "r1061",
      "r1068",
      "r1115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r418",
      "r867",
      "r968",
      "r992",
      "r1060",
      "r1061",
      "r1068",
      "r1115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r494",
      "r495",
      "r496",
      "r497",
      "r586",
      "r640",
      "r673",
      "r674",
      "r675",
      "r841",
      "r865",
      "r888",
      "r917",
      "r918",
      "r966",
      "r985",
      "r994",
      "r1056",
      "r1065",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/LeasesNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r494",
      "r495",
      "r496",
      "r497",
      "r586",
      "r640",
      "r673",
      "r674",
      "r675",
      "r841",
      "r865",
      "r888",
      "r917",
      "r918",
      "r966",
      "r985",
      "r994",
      "r1056",
      "r1065",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/LeasesNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r641",
      "r1033",
      "r1126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r366",
      "r641",
      "r1007",
      "r1033"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Equity Method Investee, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r346",
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule II - Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r419",
      "r420",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r919",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r969",
      "r993",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r419",
      "r420",
      "r902",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r919",
      "r920",
      "r969",
      "r993",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r366",
      "r641",
      "r1007",
      "r1008",
      "r1033"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r1038",
      "r1105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual with Relationship to Entity [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r344",
      "r345",
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r353",
      "r354",
      "r355",
      "r430",
      "r431",
      "r440",
      "r441",
      "r442",
      "r443",
      "r446",
      "r447",
      "r682",
      "r683",
      "r684",
      "r713",
      "r714",
      "r731",
      "r732",
      "r733",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r785",
      "r786",
      "r800",
      "r801",
      "r804",
      "r805",
      "r806",
      "r824",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r1032"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r17",
      "r991"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r424",
      "r425"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": {
     "auth_ref": [
      "r21",
      "r174",
      "r941"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrual for Taxes Other than Income Taxes, Current",
        "terseLabel": "Accrued taxes other than income"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r2",
      "r240",
      "r258"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrentAndNoncurrent": {
     "auth_ref": [
      "r2",
      "r4",
      "r242",
      "r257"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.",
        "label": "Accrued Sales Commission",
        "terseLabel": "Accrued commissions, rebates and royalties"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r32",
      "r39",
      "r200",
      "r1013",
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined benefit pension and other postretirement plans",
        "verboseLabel": "Amortization of Defined Benefit Pension and Other Postretirement Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r118",
      "r290"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r310",
      "r319",
      "r320",
      "r739",
      "r946",
      "r1013"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Derivatives",
        "verboseLabel": "Gains (Losses) on Derivatives"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r310",
      "r319",
      "r320",
      "r1013"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "terseLabel": "Equity affiliate investment AOCI"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r36",
      "r38",
      "r39",
      "r296",
      "r882",
      "r896",
      "r900"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r318",
      "r319",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r35",
      "r39",
      "r200",
      "r830",
      "r891",
      "r892",
      "r1013",
      "r1014",
      "r1015",
      "r1029",
      "r1030",
      "r1031"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r30",
      "r39",
      "r200",
      "r319",
      "r320",
      "r792",
      "r793",
      "r794",
      "r795",
      "r797",
      "r1013"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r9",
      "r991"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r682",
      "r683",
      "r684",
      "r1029",
      "r1030",
      "r1031",
      "r1097"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r67",
      "r111"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r677"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r297",
      "r428",
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r67",
      "r105",
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization of acquisition-related intangible assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r977"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss.",
        "label": "Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total recognized in net periodic benefit cost and OCI"
       }
      }
     },
     "localname": "AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive options excluded from computation of diluted net income per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r67",
      "r115"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringAndRelatedCostIncurredCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "negatedTerseLabel": "Asset-related charges",
        "terseLabel": "Asset-related charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r238",
      "r256",
      "r294",
      "r334",
      "r402",
      "r408",
      "r414",
      "r438",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r505",
      "r507",
      "r509",
      "r510",
      "r737",
      "r740",
      "r775",
      "r991",
      "r1063",
      "r1064",
      "r1106"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r285",
      "r301",
      "r334",
      "r438",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r505",
      "r507",
      "r509",
      "r510",
      "r737",
      "r740",
      "r775",
      "r991",
      "r1063",
      "r1064",
      "r1106"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r648",
      "r649",
      "r650",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r730",
      "r979",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r190",
      "r191",
      "r730",
      "r979",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r736",
      "r1019"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 6.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r194",
      "r195",
      "r735"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r72",
      "r73",
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r69",
      "r288",
      "r939"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r64",
      "r69",
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, including cash equivalents at end of period",
        "periodStartLabel": "Cash, including cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r64",
      "r230"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "auth_ref": [
      "r223"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
        "negatedLabel": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "auth_ref": [
      "r223"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "negatedTerseLabel": "Derivative (gain) loss on hedged item, fair value hedges"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r27",
      "r247",
      "r264"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 18)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r490",
      "r492",
      "r904",
      "r1062"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommodityMember": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading in a derivative instrument whose primary underlying risk is tied to commodity prices.",
        "label": "Commodity [Member]",
        "terseLabel": "Commodity call options"
       }
      }
     },
     "localname": "CommodityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommodityOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option contract in which the underlying asset is a commodity.",
        "label": "Commodity Option [Member]",
        "terseLabel": "Commodity call options"
       }
      }
     },
     "localname": "CommodityOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r1029",
      "r1030",
      "r1097"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r8",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r8",
      "r991"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.25 per share; 200 million shares authorized; shares issued: 75.3 million in 2022 and 2021; shares outstanding: 74.1 million and 74.2 million in 2022 and 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r41",
      "r314",
      "r316",
      "r324",
      "r878",
      "r884"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r55",
      "r323",
      "r877",
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r83",
      "r84",
      "r228",
      "r229",
      "r422",
      "r903"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r83",
      "r84",
      "r228",
      "r229",
      "r422",
      "r901",
      "r903"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r83",
      "r84",
      "r228",
      "r229",
      "r422",
      "r903",
      "r1117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r83",
      "r84",
      "r228",
      "r229",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of net sales"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r83",
      "r84",
      "r228",
      "r229",
      "r422",
      "r903"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r198",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r1067"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Change in Contract with Customer, Asset and Liability"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r544",
      "r546",
      "r557"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Contract assets, December 31, 2022",
        "periodStartLabel": "Contract assets, December 31, 2021"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r544",
      "r545",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "negatedPeriodEndLabel": "Deferred income, December 31, 2022",
        "negatedPeriodStartLabel": "Deferred income, December 31, 2021",
        "terseLabel": "Contract with customer, liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails",
      "http://www.westpharma.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized": {
     "auth_ref": [
      "r967"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.",
        "label": "Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized",
        "negatedLabel": "Change in deferred income - (increase) decrease"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r544",
      "r545",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred income, current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r544",
      "r545",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred income, noncurrent"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was included in the deferred income balance"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r93",
      "r407",
      "r408",
      "r409",
      "r410",
      "r416",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and Unallocated"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r48",
      "r867"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedTerseLabel": "Cost of goods and services sold",
        "terseLabel": "Cost of goods and services sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods and services sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r1070"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Shipping and Handling Costs"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r1072",
      "r1094"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross Currency Interest Rate Contract"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r1023",
      "r1085",
      "r1087"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r1023",
      "r1085"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r189",
      "r708",
      "r721",
      "r1023"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Current income tax provision"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r1023",
      "r1085",
      "r1087"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r80",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Customer contracts"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r332",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r527",
      "r534",
      "r535",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r239",
      "r244",
      "r254",
      "r339",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r523",
      "r524",
      "r525",
      "r526",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r803",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r1021"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r244",
      "r254",
      "r538"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r233",
      "r235",
      "r511",
      "r803",
      "r962",
      "r963"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r24",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, stated interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "verboseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r25",
      "r339",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r523",
      "r524",
      "r525",
      "r526",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r803",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r1021"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r25",
      "r136",
      "r137",
      "r138",
      "r139",
      "r232",
      "r233",
      "r235",
      "r251",
      "r339",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r523",
      "r524",
      "r525",
      "r526",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r536",
      "r803",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r1021"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan.",
        "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]",
        "terseLabel": "Type of Deferred Compensation [Axis]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "verboseLabel": "Deferred compensation benefits"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r1010"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Deferred compensation assets"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationShareBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation arrangements (such as stock or unit options and share or unit awards) that are equity-based payments with individual employees. The arrangements are generally based on employment contracts between the entity and one or more selected officers or key employees, and contain a promise by the employer to pay certain amounts or benefits at designated future dates, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Other \"sub-members\" can be added as necessary.",
        "label": "Deferred Compensation, Share-Based Payments [Member]",
        "terseLabel": "Deferred compensation plans and restricted share awards"
       }
      }
     },
     "localname": "DeferredCompensationShareBasedPaymentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of any adjustment recognized to the balance of unamortized issuance costs associated with a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, due, for example, to default by the share borrower.",
        "label": "Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Adjustment",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r189",
      "r1023",
      "r1086"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r692",
      "r693"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r67",
      "r189",
      "r709",
      "r720",
      "r721",
      "r1023"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Deferred income tax provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r5",
      "r6",
      "r241",
      "r253",
      "r704"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r692",
      "r693"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r1012"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r186",
      "r1084"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "Capitalized R&amp;D expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r1083"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax asset (liability)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r1083"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance [Abstract]",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r186",
      "r1084"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r186",
      "r1084"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Operating loss carryforwards, foreign"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r186",
      "r1084"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "Operating loss carryforwards, state and local"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r186",
      "r1084"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r184",
      "r186",
      "r1084"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r186",
      "r1084"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Pension and deferred compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r705"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r186",
      "r1084"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r186",
      "r1084"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r186",
      "r1084"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "auth_ref": [
      "r1084"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "terseLabel": "Tax on undistributed earnings of subsidiaries"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r33",
      "r39",
      "r1075"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r39",
      "r607"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedTerseLabel": "Net actuarial loss (gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r39",
      "r607"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r577",
      "r977"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Actuarial gains (losses)",
        "verboseLabel": "Actuarial gain (loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r563",
      "r602",
      "r628",
      "r977",
      "r978"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Amortization of actuarial loss (gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r563",
      "r603",
      "r629",
      "r977",
      "r978"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "negatedTerseLabel": "Prior service credit",
        "terseLabel": "Amortization of prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]",
        "terseLabel": "Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r237",
      "r255",
      "r561",
      "r562",
      "r585",
      "r977"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate",
        "verboseLabel": "Discount rate (as a percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r611",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term rate of return on assets",
        "verboseLabel": "Expected long-term rate of return on assets (as a percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate",
        "terseLabel": "Weighted-average interest crediting rating used to determine net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "negatedPeriodEndLabel": "Balance",
        "negatedPeriodStartLabel": "Balance"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r572",
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "negatedTerseLabel": "Participants\u2019 contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r586",
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r614",
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashMember": {
     "auth_ref": [
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligation:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r579",
      "r589",
      "r632",
      "r975",
      "r976",
      "r977",
      "r978"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDebtSecurityMember": {
     "auth_ref": [
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporation, government and governmental agency, municipality, and other institution; in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Debt Security [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanDebtSecurityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "auth_ref": [
      "r975",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 6.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2028 to 2032"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 1.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 5.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 4.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 3.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 2.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r597",
      "r978"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Expected contribution to the plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r563",
      "r601",
      "r627",
      "r977",
      "r978"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r576",
      "r587",
      "r589",
      "r590",
      "r975",
      "r976",
      "r977"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r561",
      "r585",
      "r977"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status at end of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.",
        "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year",
        "terseLabel": "Assumed healthcare cost trend rate, benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r563",
      "r568",
      "r600",
      "r626",
      "r977",
      "r978"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "negatedTerseLabel": "Interest cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r598",
      "r624",
      "r977",
      "r978"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Net periodic benefit cost:"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "auth_ref": [
      "r598",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes components of net periodic benefit cost (credit), excluding service cost component, for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DefinedBenefitPlanOtherCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of defined benefit plan cost (credit), classified as other.",
        "label": "Defined Benefit Plan, Other Cost (Credit)",
        "negatedTerseLabel": "Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "terseLabel": "Amendments/transfers in"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r581",
      "r1076"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Participants\u2019 contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r578"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r586",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Target allocation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": {
     "auth_ref": [
      "r564",
      "r605",
      "r631"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment",
        "negatedTerseLabel": "Pension settlement charge"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r564",
      "r605",
      "r631"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedLabel": "Settlement loss",
        "terseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r566",
      "r599",
      "r625",
      "r977",
      "r978"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "negatedTerseLabel": "Service cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r567"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "terseLabel": "Settlement loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Settlement loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate",
        "terseLabel": "Ultimate healthcare cost trend rate, benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Weighted average asset allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Weighted average assumptions used in benefit obligations:"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Weighted average assumptions used in net periodic benefit cost:"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "verboseLabel": "401 (k) plan contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r67",
      "r116"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r67",
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r302",
      "r303",
      "r774",
      "r945"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Commodity call options"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAveragePriceRiskOptionStrikePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average strike price on the group of price risk option contracts such as put options or call options.",
        "label": "Derivative, Average Price Risk Option Strike Price",
        "terseLabel": "Derivative, average price risk option strike price"
       }
      }
     },
     "localname": "DerivativeAveragePriceRiskOptionStrikePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "perUnitItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings": {
     "auth_ref": [
      "r749",
      "r1091"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.",
        "label": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings",
        "terseLabel": "Gain recognized in earnings"
       }
      }
     },
     "localname": "DerivativeExcludedComponentGainLossRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r210",
      "r211",
      "r215",
      "r217",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument Risk [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r226",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "verboseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r208",
      "r210",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r208",
      "r210",
      "r215",
      "r217",
      "r222",
      "r225",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r214",
      "r1092"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 3.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "negatedTerseLabel": "(Gain) loss on oil hedges",
        "terseLabel": "Derivative instruments not designated as hedging instruments, gain (loss), net",
        "verboseLabel": "Gain (loss) on oil hedges"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r302"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Short term derivative instruments"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNonmonetaryNotionalAmount": {
     "auth_ref": [
      "r536",
      "r542",
      "r751",
      "r1089",
      "r1090"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal number of units used to calculate payment on derivative.",
        "label": "Derivative, Nonmonetary Notional Amount",
        "terseLabel": "Derivative, nonmonetary notional amount outstanding"
       }
      }
     },
     "localname": "DerivativeNonmonetaryNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeNonmonetaryNotionalAmountVolume": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal volume used to calculate payments on a derivative instrument.",
        "label": "Derivative, Nonmonetary Notional Amount, Volume",
        "terseLabel": "Derivative, nonmonetary notional amount, volume"
       }
      }
     },
     "localname": "DerivativeNonmonetaryNotionalAmountVolume",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "volumeItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r1089",
      "r1090"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r208",
      "r209",
      "r212",
      "r215",
      "r219",
      "r221",
      "r225",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "terseLabel": "Derivative contract term"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r202",
      "r203",
      "r208",
      "r209",
      "r220",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r556",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r647",
      "r678",
      "r679",
      "r681",
      "r686",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "verboseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends declared, not paid",
        "verboseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.",
        "label": "Domestic Line of Credit [Member]",
        "terseLabel": "Domestic Line of Credit"
       }
      }
     },
     "localname": "DomesticLineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r1077",
      "r1078",
      "r1079"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromAffiliates": {
     "auth_ref": [
      "r236",
      "r266",
      "r832"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Due from Affiliates",
        "terseLabel": "Amount receivable from affiliates"
       }
      }
     },
     "localname": "DueFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToAffiliateCurrentAndNoncurrent": {
     "auth_ref": [
      "r236",
      "r246",
      "r265",
      "r272",
      "r833"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Due to Affiliate",
        "terseLabel": "Amount due and payable to affiliates"
       }
      }
     },
     "localname": "DueToAffiliateCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "Europe, Middle East, Africa"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r325",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r369",
      "r371",
      "r376",
      "r377",
      "r378",
      "r382",
      "r762",
      "r763",
      "r879",
      "r885",
      "r951"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r325",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r371",
      "r376",
      "r377",
      "r378",
      "r382",
      "r762",
      "r763",
      "r879",
      "r885",
      "r951"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r78",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r1099"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of exchange rates on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectOnFutureEarningsAmount": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The quantified amount of the future effect on earnings.",
        "label": "Effect on Future Earnings, Amount",
        "terseLabel": "Effect on future earnings, amount"
       }
      }
     },
     "localname": "EffectOnFutureEarningsAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r695"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r336",
      "r695",
      "r723"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal corporate tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent": {
     "auth_ref": [
      "r1081"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reported income tax benefit from difference to income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII).",
        "label": "Effective Income Tax Rate Reconciliation, FDII, Percent",
        "negatedTerseLabel": "Foreign-Derived Intangible Income Deductions (FDII)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationFdiiPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r1081",
      "r1088"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Tax on international operations other than U.S. tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r1081",
      "r1088"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r1081",
      "r1088"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Adjustments to reserves for unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r1080",
      "r1081"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent",
        "terseLabel": "Excess tax benefits on share-based payments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r1081",
      "r1088"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal tax effect"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r1081",
      "r1088"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "U.S. research and development credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r680"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "verboseLabel": "Unrecognized compensation expense for all nonvested awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period for recognition (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Severance and benefits"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalCostsPolicy": {
     "auth_ref": [
      "r479",
      "r480",
      "r497",
      "r956",
      "r1006"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.",
        "label": "Environmental Costs, Policy [Policy Text Block]",
        "terseLabel": "Environmental Remediation and Compliance Costs"
       }
      }
     },
     "localname": "EnvironmentalCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan.",
        "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]",
        "terseLabel": "Type of Deferred Compensation, All Types [Domain]"
       }
      }
     },
     "localname": "EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r135",
      "r279",
      "r318",
      "r319",
      "r320",
      "r347",
      "r348",
      "r349",
      "r354",
      "r363",
      "r365",
      "r385",
      "r443",
      "r543",
      "r682",
      "r683",
      "r684",
      "r713",
      "r714",
      "r761",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r797",
      "r830",
      "r891",
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r44",
      "r63",
      "r67",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Dividends received from affiliated companies"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest (as a percent)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r98",
      "r403",
      "r1009"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Affiliated Companies"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompanies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r886",
      "r1042"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Impairment of cost method investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Aggregate carrying amount of investment in affiliated companies that are not accounted for under the equity method"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r769",
      "r770",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r525",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r770",
      "r838",
      "r839",
      "r840",
      "r962",
      "r963",
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedges"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]",
        "terseLabel": "Pension plan assets in the fair value hierarchy"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r525",
      "r589",
      "r594",
      "r770",
      "r838",
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r525",
      "r589",
      "r594",
      "r770",
      "r839",
      "r962",
      "r963",
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r525",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r770",
      "r840",
      "r962",
      "r963",
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r589",
      "r768",
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "Pension plan assets measured at NAV"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r525",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r838",
      "r839",
      "r840",
      "r962",
      "r963",
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r1096"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Fed Funds Effective Rate Overnight Index Swap Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r811",
      "r822"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance lease"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r434",
      "r435",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r536",
      "r542",
      "r751",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r954",
      "r1039",
      "r1040",
      "r1041",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful life of finite-lived intangible assets (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r292",
      "r475"
     ],
     "calculation": {
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated annual amortization expense, 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r473",
      "r474",
      "r475",
      "r476",
      "r868",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation gains (losses)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r110",
      "r875"
     ],
     "calculation": {
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r106",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r110",
      "r868"
     ],
     "calculation": {
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign currency contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign currency contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyGainLossMember": {
     "auth_ref": [
      "r1095"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing foreign currency gain (loss).",
        "label": "Foreign Currency Gain (Loss) [Member]",
        "terseLabel": "Other expense (income)"
       }
      }
     },
     "localname": "ForeignCurrencyGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r787",
      "r788",
      "r789",
      "r790"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 1.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Foreign exchange transaction gains"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r945",
      "r975",
      "r989"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency hedge contracts",
        "verboseLabel": "Foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward",
        "verboseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.",
        "label": "Foreign Line of Credit [Member]",
        "terseLabel": "Foreign Line of Credit"
       }
      }
     },
     "localname": "ForeignLineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r1077",
      "r1078",
      "r1079"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "International plans"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r1093"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet": {
     "auth_ref": [
      "r224",
      "r744"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net gain (loss) relating to components of the gain (loss) on the fair value hedging instrument excluded from the assessment of fair value hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net",
        "negatedLabel": "Derivative (gain) loss on amount excluded from effectiveness testing, fair value hedges"
       }
      }
     },
     "localname": "GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "terseLabel": "Gain (loss) on derivative instruments, net, pretax"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "negatedTotalLabel": "Derivative (gain) loss recognized in income, fair value hedges"
       }
      }
     },
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r51",
      "r97",
      "r1005"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 2.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Cost investment activity"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "terseLabel": "Gain on sale of investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Fixed asset impairments and sale of equipment, net"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedTerseLabel": "Corporate general costs"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r82",
      "r903"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r291",
      "r460",
      "r876",
      "r955",
      "r991",
      "r1044",
      "r1051"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r463",
      "r955"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill recorded due to acquisition"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r462",
      "r469",
      "r955"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated goodwill impairment losses"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r67",
      "r461",
      "r466",
      "r472",
      "r955"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r47",
      "r334",
      "r402",
      "r407",
      "r413",
      "r416",
      "r438",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r505",
      "r507",
      "r509",
      "r510",
      "r775",
      "r953",
      "r1063"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r208",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r335",
      "r722"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r335",
      "r722"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "International operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r402",
      "r407",
      "r413",
      "r416",
      "r953"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income taxes and equity in net income of affiliated companies",
        "totalLabel": "Income before income taxes and equity in net income of affiliated companies"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r44",
      "r67",
      "r98",
      "r248",
      "r267",
      "r399"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity in net income of affiliated companies"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedTerseLabel": "Equity in undistributed earnings of affiliates, net of dividends"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r477",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r336",
      "r696",
      "r702",
      "r707",
      "r718",
      "r724",
      "r726",
      "r727",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r337",
      "r364",
      "r365",
      "r400",
      "r694",
      "r719",
      "r725",
      "r887"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense",
        "terseLabel": "Income tax expense",
        "totalLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r317",
      "r690",
      "r691",
      "r702",
      "r703",
      "r706",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r689",
      "r695"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Tax expense (benefit) from impact of tax law changes enacted"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r1081"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "negatedTerseLabel": "Tax benefit from stock-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxSettlementsOther": {
     "auth_ref": [
      "r1081"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other income tax settlements.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Amount",
        "negatedTerseLabel": "Tax benefit from prepayment of future royalties"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxSettlementsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid, net"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "(Decrease) increase in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Increase in accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r1019"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedTerseLabel": "Decrease (increase) in other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Changes in other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "verboseLabel": "Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r372",
      "r373",
      "r374",
      "r378",
      "r646"
     ],
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of equity awards, based on the treasury stock method (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InsuranceClaimsMember": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A demand for payment of a policy benefit because of the occurrence of an insured event, such as the death or disability of the insured; the maturity of an endowment; the incurrence of hospital or medical bills; the destruction or damage of property and related deaths or injuries; defects in, liens on, or challenges to the title to real estate; or the occurrence of a surety loss; and the costs to process claims.",
        "label": "Insurance Claims [Member]",
        "terseLabel": "Insurance Claims"
       }
      }
     },
     "localname": "InsuranceClaimsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r104",
      "r108"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Capitalized interest"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r234",
      "r250",
      "r321",
      "r396",
      "r802"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r53",
      "r531",
      "r540",
      "r964",
      "r965"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r327",
      "r329",
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid, net of amounts capitalized"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r394",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r412",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment sales elimination"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r102",
      "r942"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r299",
      "r940",
      "r991"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r287",
      "r298",
      "r384",
      "r457",
      "r458",
      "r459",
      "r866",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r102",
      "r944"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r102",
      "r943"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r50",
      "r53"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "negatedTerseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r1011"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in affiliated companies"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r1069"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r821",
      "r990"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r1103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r822"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Operating lease liability payments due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r822"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r822"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r822"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r822"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r822"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r822"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r822"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed lease interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r1102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract (in months)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r20",
      "r334",
      "r438",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r505",
      "r507",
      "r509",
      "r510",
      "r738",
      "r740",
      "r741",
      "r775",
      "r952",
      "r1063",
      "r1106",
      "r1107"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r13",
      "r245",
      "r262",
      "r991",
      "r1022",
      "r1043",
      "r1098"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r23",
      "r286",
      "r334",
      "r438",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r505",
      "r507",
      "r509",
      "r510",
      "r738",
      "r740",
      "r741",
      "r775",
      "r991",
      "r1063",
      "r1106",
      "r1107"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r3",
      "r244",
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Letters of credit supporting the reimbursement of workers' compensation and other claims"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of credit facility, current borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of credit facility, unused commitment level"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates an ownership position in, or purchase of, a security.",
        "label": "Long [Member]",
        "terseLabel": "Purchase"
       }
      }
     },
     "localname": "LongMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r244",
      "r260",
      "r524",
      "r539",
      "r962",
      "r963"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Aggregate annual maturities of long-term debt [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Less: current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r131",
      "r339",
      "r1066"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r131",
      "r339",
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r131",
      "r339",
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r131",
      "r339",
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r131",
      "r339",
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r131",
      "r339",
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r295"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r25",
      "r129",
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit, Noncurrent",
        "terseLabel": "Line of credit, noncurrent"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r25",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average of the coupon interest rate (as a percent)"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r126",
      "r127",
      "r493",
      "r494",
      "r495",
      "r1058",
      "r1059"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r126",
      "r127",
      "r493",
      "r494",
      "r495",
      "r1058",
      "r1059"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r493",
      "r1007"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Accrual for insurance obligations"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r126",
      "r127",
      "r493",
      "r494",
      "r495",
      "r1058",
      "r1059"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyReceivable": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of receivable related to a loss contingency accrual. For example, an insurance recovery receivable.",
        "label": "Loss Contingency, Receivable",
        "terseLabel": "Amount reimbursable by the insurance company"
       }
      }
     },
     "localname": "LossContingencyReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual funds"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r64",
      "r65",
      "r68"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r45",
      "r68",
      "r249",
      "r268",
      "r284",
      "r312",
      "r315",
      "r320",
      "r334",
      "r353",
      "r358",
      "r359",
      "r360",
      "r361",
      "r364",
      "r365",
      "r375",
      "r402",
      "r407",
      "r413",
      "r416",
      "r438",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r505",
      "r507",
      "r509",
      "r510",
      "r763",
      "r775",
      "r953",
      "r1063"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r282",
      "r351",
      "r352",
      "r355",
      "r356",
      "r366",
      "r367",
      "r368",
      "r432",
      "r433",
      "r444",
      "r445",
      "r715",
      "r716",
      "r717",
      "r759",
      "r765",
      "r766",
      "r767",
      "r782",
      "r783",
      "r784",
      "r808",
      "r809",
      "r825",
      "r831",
      "r872",
      "r873",
      "r874",
      "r895",
      "r896",
      "r897",
      "r898",
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r77",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r350",
      "r353",
      "r354",
      "r355",
      "r357",
      "r360",
      "r366",
      "r382",
      "r430",
      "r431",
      "r440",
      "r441",
      "r442",
      "r443",
      "r446",
      "r447",
      "r682",
      "r683",
      "r684",
      "r711",
      "r712",
      "r713",
      "r714",
      "r731",
      "r732",
      "r733",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r785",
      "r786",
      "r800",
      "r801",
      "r804",
      "r805",
      "r806",
      "r807",
      "r824",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r869",
      "r870",
      "r871",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTerseLabel": "Interest expense (income) and other nonoperating expense (income), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r1036"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r39",
      "r42"
     ],
     "calculation": {
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive (loss) income before reclassifications"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r402",
      "r407",
      "r413",
      "r416",
      "r953"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating Profit",
        "totalLabel": "Operating profit"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r814",
      "r990"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r811"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r811"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r811"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r812",
      "r817"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r810"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r820",
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate (as a percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r819",
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OptionMember": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received).",
        "label": "Options Held [Member]",
        "terseLabel": "Commodity Call Options"
       }
      }
     },
     "localname": "OptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r1020",
      "r1055"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 5.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Fixed asset impairments and sale of equipment, net"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r300",
      "r991"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r293"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r34",
      "r36",
      "r606"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Prior service credit arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r34",
      "r36",
      "r606"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax",
        "negatedTerseLabel": "Prior service cost arising during period, net of tax of $0.0, $0.5, and $0.0"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r31",
      "r36",
      "r606"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Net actuarial (loss) gain arising during period, net of tax of $(2.4), $2.1, and $(0.7)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "terseLabel": "Net actuarial gain (loss) arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r196",
      "r197",
      "r199"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments, net of tax of $2.2, $2.4, and $(1.0)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent": {
     "auth_ref": [
      "r196",
      "r197",
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r36",
      "r40",
      "r311",
      "r606"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Amortization of prior service credit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": {
     "auth_ref": [
      "r36",
      "r40",
      "r311",
      "r606"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Less: amortization of prior service credit, net of tax of $0.0, $(0.1), and $(0.1)."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Less: amortization of prior service credit, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r305",
      "r306",
      "r308"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net gain (loss) on equity affiliate accumulated other comprehensive income, net of tax of $0.0, $0.0, and $0.0"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r305",
      "r306",
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "terseLabel": "Net gain (loss) on investment securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent",
        "terseLabel": "Net gain (loss) on derivatives, net of tax of $0.2, $0.5, and $(0.6)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent",
        "terseLabel": "Net gain (loss) on derivatives, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r304",
      "r308",
      "r742",
      "r743",
      "r750"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Cash flow hedges, amount of gain (loss) recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax": {
     "auth_ref": [
      "r745"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax",
        "negatedLabel": "Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r746"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Fair value and net investment hedges, amount of gain (loss) recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r747"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTerseLabel": "Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r42",
      "r135",
      "r313",
      "r316",
      "r323",
      "r791",
      "r796",
      "r797",
      "r877",
      "r883",
      "r1013",
      "r1014"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r196",
      "r197",
      "r199",
      "r313",
      "r316"
     ],
     "calculation": {
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive (loss) income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r33",
      "r36",
      "r977",
      "r1074"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "totalLabel": "Total recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect": {
     "auth_ref": [
      "r37",
      "r196"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax",
        "terseLabel": "Prior service credit arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r31",
      "r36",
      "r150"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "negatedTerseLabel": "Net loss (gain) arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r36",
      "r40",
      "r311",
      "r606"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Amortization of actuarial (loss) gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r36",
      "r40",
      "r311",
      "r606"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Less: amortization of actuarial (gain) loss, net of tax of $(0.1), $0.1, and $0.0"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax",
        "negatedTerseLabel": "Less: amortization of actuarial loss, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax": {
     "auth_ref": [
      "r36",
      "r40",
      "r311",
      "r606"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Less: amortization of other, net of tax of $0.1, $0.0, and $0.0"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Less: amortization of other, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the liabilities, classified as other, for deferred compensation arrangements payable after one year or the operating cycle, if longer.",
        "label": "Other Deferred Compensation Arrangements, Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other expense (income)"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r143",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "verboseLabel": "Other Expense (Income)"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r21",
      "r991"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Total other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other nonoperating expense (income)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 7.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other items"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r145",
      "r561",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r611",
      "r612",
      "r614",
      "r617",
      "r620",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r637",
      "r638",
      "r639",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other retirement benefits"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r243",
      "r259"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for retirement benefits, classified as other.",
        "label": "Liability, Other Retirement Benefits",
        "terseLabel": "Accrued retirement plans (excluding pension)"
       }
      }
     },
     "localname": "OtherPostretirementBenefitsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringAndRelatedCostIncurredCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other charges"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r957",
      "r958",
      "r959",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other charges"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r21",
      "r128"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "negatedTerseLabel": "Contingent consideration payments in excess of acquisition-date liability"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r1016",
      "r1017"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Shares purchased under share repurchase programs"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r482",
      "r1018"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividend payments"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Shares repurchased for employee tax withholdings"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r56",
      "r734"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedTerseLabel": "Acquisition of business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures",
        "terseLabel": "Capital Expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r586",
      "r588",
      "r594",
      "r613",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r634",
      "r635",
      "r637",
      "r643",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "verboseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r2",
      "r561",
      "r562",
      "r585",
      "r977"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities",
        "verboseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r243",
      "r259",
      "r562",
      "r585"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Liability, Defined Benefit Plan",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r4",
      "r561",
      "r562",
      "r585",
      "r977"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Noncurrent liabilities",
        "verboseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r151",
      "r156",
      "r157",
      "r158",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r144",
      "r561",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r611",
      "r612",
      "r614",
      "r617",
      "r620",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r637",
      "r638",
      "r642",
      "r977",
      "r978",
      "r982",
      "r983",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension benefits"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance share units, stock-settled"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r586",
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r614",
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r7",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r7",
      "r991"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, 3.0 million shares authorized; 0.0 shares issued and outstanding in 2022 and 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r58",
      "r173"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from stock-based compensation awards"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "terseLabel": "Employee stock purchase plan contributions"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r121",
      "r905",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r117",
      "r289"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r119",
      "r263",
      "r881",
      "r991"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r119",
      "r905",
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Expected useful lives (years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r39",
      "r42"
     ],
     "calculation": {
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedTerseLabel": "Amounts reclassified out"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Schedule of Reclassification out of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r90",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Debt issuance cost"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r176",
      "r273",
      "r1114"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research Tax Credit Carryforward"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r481",
      "r484",
      "r487",
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring and related cost, cumulative cost incurred"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r481",
      "r484",
      "r487",
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "verboseLabel": "Restructuring and related cost, expected cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r481",
      "r484",
      "r487",
      "r489"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 4.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "totalLabel": "Total restructuring and related charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r67",
      "r485",
      "r487",
      "r1057"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "negatedTerseLabel": "Restructuring charges",
        "verboseLabel": "Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r481",
      "r482",
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r482",
      "r486"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring , ending balance",
        "periodStartLabel": "Restructuring beginning balance",
        "terseLabel": "Restructuring and severance related charges"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r482",
      "r488"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "terseLabel": "Non-cash restructuring charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r10",
      "r140",
      "r261",
      "r895",
      "r900",
      "r991"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r279",
      "r347",
      "r348",
      "r349",
      "r354",
      "r363",
      "r365",
      "r443",
      "r682",
      "r683",
      "r684",
      "r713",
      "r714",
      "r761",
      "r891",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees": {
     "auth_ref": [
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consolidated retained earnings that represent undistributed (not yet received) earnings from 50 percent or less owned persons accounted for by the equity method (equity method investees).",
        "label": "Retained Earnings, Undistributed Earnings from Equity Method Investees",
        "terseLabel": "Unremitted income of affiliated companies"
       }
      }
     },
     "localname": "RetainedEarningsUndistributedEarningsFromEquityMethodInvestees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r610",
      "r611",
      "r612",
      "r614",
      "r617",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r1077",
      "r1078",
      "r1079"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r610",
      "r611",
      "r612",
      "r614",
      "r617",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r1077",
      "r1078",
      "r1079"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r144",
      "r145",
      "r561",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r611",
      "r612",
      "r614",
      "r617",
      "r620",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r637",
      "r638",
      "r639",
      "r642",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r144",
      "r145",
      "r561",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r611",
      "r612",
      "r614",
      "r617",
      "r620",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r637",
      "r638",
      "r639",
      "r642",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r393",
      "r394",
      "r406",
      "r411",
      "r412",
      "r418",
      "r419",
      "r422",
      "r555",
      "r556",
      "r867"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Proprietary Products",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition and Deferred Revenue [Abstract]",
        "terseLabel": "Revenue Recognition and Deferred Revenue [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAndDeferredRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r949",
      "r950"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r322",
      "r334",
      "r393",
      "r394",
      "r406",
      "r411",
      "r412",
      "r418",
      "r419",
      "r422",
      "r438",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r505",
      "r507",
      "r509",
      "r510",
      "r775",
      "r880",
      "r1063"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Proprietary Products"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r818",
      "r990"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r422",
      "r1035"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r39",
      "r1100",
      "r1101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Components of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Share-based Compensation Costs by Plan"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Obligations, Net of Current Maturities"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r210",
      "r215",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r208",
      "r209",
      "r212",
      "r215",
      "r219",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Foreign Currency Contracts"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Basic to Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of Sales by Significant Product Group"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r100",
      "r284",
      "r334",
      "r438",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r106",
      "r109",
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r955",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r1023"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r0",
      "r14",
      "r15",
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-Based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Performance-based Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Performance-based Share Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r214",
      "r1092"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r484",
      "r487",
      "r488",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r122",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Obligations"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r46",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of Sales and Long-Lived Assets, by Geographical Areas"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r43",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r88",
      "r89",
      "r91",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r88",
      "r89",
      "r91",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r644",
      "r645",
      "r648",
      "r649",
      "r650",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.",
        "label": "Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Appreciation Rights Award Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r160",
      "r167",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r988",
      "r1082"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r1096"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r422",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r484",
      "r489",
      "r955",
      "r1115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r402",
      "r405",
      "r410",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r421",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Items [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringAndRelatedCostIncurredCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "verboseLabel": "Severance and post-employment benefits"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "negatedTerseLabel": "Stock-based compensation expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted at target level (in shares)",
        "verboseLabel": "Granted at target level (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted at target level (in dollars per share)",
        "verboseLabel": "Granted at target level (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, ending (in shares)",
        "periodStartLabel": "Outstanding, beginning (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Non-vested PSU Awards [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, ending (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Non-vested PSU Awards, Weighted Average Fair Value [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Average remaining term of shares issued at conversion"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested and converted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested and converted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Stock volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Limitation on payroll deductions of employee's base salary (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per employee (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-option equity instruments exercised by participants.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of non-option equity instruments granted to participants.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r161",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending (in shares)",
        "periodStartLabel": "Outstanding, beginning (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "SARs Activity [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for issuance under the 2016 Plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options vested and exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options vested and exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r667"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of total options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, ending (in shares)",
        "periodStartLabel": "Options outstanding, beginning (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock Options Activity [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding, ending (in dollars per share)",
        "periodStartLabel": "Options outstanding, beginning (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Stock Options, Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r669"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of total options vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r648",
      "r649",
      "r650",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r651",
      "r670",
      "r671",
      "r672",
      "r673",
      "r676",
      "r685",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r987"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Awards, expiration period (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life of options exercisable (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life of options outstanding (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r667"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Grant date fair value of options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Percentage of current market price for sales to eligible employees (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates the sale of a borrowed security or written option.",
        "label": "Short [Member]",
        "terseLabel": "Sell"
       }
      }
     },
     "localname": "ShortMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r815",
      "r990"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r76",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r178"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Estimated increase (decrease) in the liability for unrecognized tax benefits"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r283",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r422",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r478",
      "r484",
      "r489",
      "r955",
      "r1115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r29",
      "r135",
      "r279",
      "r318",
      "r319",
      "r320",
      "r347",
      "r348",
      "r349",
      "r354",
      "r363",
      "r365",
      "r385",
      "r443",
      "r543",
      "r682",
      "r683",
      "r684",
      "r713",
      "r714",
      "r761",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r797",
      "r830",
      "r891",
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r385",
      "r867"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r7",
      "r8",
      "r135",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Purchases of shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r135",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Activity related to stock-based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r7",
      "r8",
      "r135",
      "r140",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r140",
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Activity related to stock-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock repurchase program, shares authorized (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r8",
      "r11",
      "r12",
      "r96",
      "r991",
      "r1022",
      "r1043",
      "r1098"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r798",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r798",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r798",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfInvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Summary of Investment Holdings [Line Items]",
        "terseLabel": "Summary of Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "SummaryOfInvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfInvestmentHoldingsTable": {
     "auth_ref": [
      "r1118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The summary of investment holding table is used for any listing of investment in a summary form. Table lists the 50 largest investments and any other investment the value of which exceeded 1 percent of net asset value of the registrant as of the close of the period.",
        "label": "Summary of Investment Holdings [Table]",
        "terseLabel": "Summary of Investment Holdings [Table]"
       }
      }
     },
     "localname": "SummaryOfInvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ToolsDiesAndMoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used to cut, shape, and form metal and other materials into goods for sale.",
        "label": "Tools, Dies and Molds [Member]",
        "terseLabel": "Molds and dies"
       }
      }
     },
     "localname": "ToolsDiesAndMoldsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r426",
      "r427",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r434",
      "r435",
      "r536",
      "r542",
      "r751",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r1039",
      "r1040",
      "r1041",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryLockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.",
        "label": "Treasury Lock [Member]",
        "terseLabel": "Forward treasury locks"
       }
      }
     },
     "localname": "TreasuryLockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Shares purchased under share repurchase program, average cost per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Treasury stock, at cost (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r8",
      "r135",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Shares purchased under share repurchase program (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r28",
      "r141",
      "r142"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost (1.2 million and 1.1 million shares in 2022 and 2021)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r135",
      "r140",
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Shares purchased under share repurchase program",
        "terseLabel": "Shares purchased under share repurchase program"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.westpharma.com/role/NetIncomePerShareNarrativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r481",
      "r482",
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Less: unamortized debt issuance costs for Term Loan and Series notes"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r252",
      "r271",
      "r687",
      "r728"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed earnings of foreign subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r688",
      "r698"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at December 31",
        "periodStartLabel": "Balance at January 1",
        "terseLabel": "Total gross unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails",
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r699"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Decrease due to prior year position"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r697"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued liabilities for interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r700"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase due to current year position"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increase due to prior year position"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r701"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Reduction for expiration of statute of limitations/audits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Outstanding unconditional contractual commitments due to be paid in 2021"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).",
        "label": "Unrecorded Unconditional Purchase Obligation",
        "terseLabel": "Outstanding unconditional contractual commitments for the purchase of raw materials, utilities and equipment"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r386",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "Deferred tax asset valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r340",
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to costs and expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r816",
      "r990"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r370",
      "r378"
     ],
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares assuming dilution (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r369",
      "r378"
     ],
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/NetIncomePerShareScheduleofReconciliationofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_AccruedSalariesWagesAndBenefitsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Salaries, Wages, and Benefits, Current",
        "label": "Accrued Salaries, Wages, and Benefits, Current",
        "terseLabel": "Accrued salaries, wages and benefits"
       }
      }
     },
     "localname": "AccruedSalariesWagesAndBenefitsCurrent",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect",
        "label": "Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect",
        "terseLabel": "Equity in unrealized gains (losses) in securities available-for-sale and derivative instruments"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AluplastSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aluplast S.A. de C.V. [Member]",
        "label": "Aluplast S.A. de C.V. [Member]",
        "terseLabel": "Aluplast S.A. de C.V."
       }
      }
     },
     "localname": "AluplastSADeCVMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ApplicableMarginMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin",
        "label": "Applicable Margin [Member]",
        "terseLabel": "Applicable Margin"
       }
      }
     },
     "localname": "ApplicableMarginMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_AssetRelatedChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset-Related Charges [Member]",
        "label": "Asset-Related Charges [Member]",
        "terseLabel": "Asset-related charges"
       }
      }
     },
     "localname": "AssetRelatedChargesMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_AssetsDefinedBenefitPlansNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent",
        "label": "Assets, Defined Benefit Plans, Noncurrent",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "AssetsDefinedBenefitPlansNoncurrent",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.westpharma.com/20221231",
     "xbrltype": "stringItemType"
    },
    "wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award Types Other than Stock Options and Stock Appreciation Rights [Member]",
        "label": "Award Types Other than Stock Options and Stock Appreciation Rights [Member]",
        "terseLabel": "Award Types Other than Stock Options and Stock Appreciation Rights"
       }
      }
     },
     "localname": "AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_BiologicsCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biologics Customers [Member]",
        "label": "Biologics Customers [Member]",
        "terseLabel": "Biologics"
       }
      }
     },
     "localname": "BiologicsCustomersMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_CashSettledPSUAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash-Settled PSU Awards",
        "label": "Cash-Settled PSU Awards [Member]",
        "terseLabel": "Performance share units, cash-settled"
       }
      }
     },
     "localname": "CashSettledPSUAwardsMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ComputerHardwareAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Hardware and Software [Member]",
        "label": "Computer Hardware and Software [Member]",
        "terseLabel": "Computer hardware and software"
       }
      }
     },
     "localname": "ComputerHardwareAndSoftwareMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ContractManufacturedCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract-Manufactured Customers [Member]",
        "label": "Contract-Manufactured Customers [Member]",
        "terseLabel": "Contract-Manufactured Products"
       }
      }
     },
     "localname": "ContractManufacturedCustomersMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ContractManufacturedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Manufactured Products [Member]",
        "label": "Contract Manufactured Products [Member]",
        "terseLabel": "Contract-Manufactured Products",
        "verboseLabel": "Contract-Manufactured Products"
       }
      }
     },
     "localname": "ContractManufacturedProductsMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ContractWithCustomerAssetIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset, Increase (Decrease)",
        "label": "Contract With Customer, Asset, Increase (Decrease)",
        "terseLabel": "Change in contract assets - increase (decrease)"
       }
      }
     },
     "localname": "ContractWithCustomerAssetIncreaseDecrease",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ContractWithCustomerAssetRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset [Roll Forward]",
        "label": "Contract With Customer, Asset [Roll Forward]",
        "terseLabel": "Contract With Customer, Asset [Roll Forward]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetRollForward",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Increase (Decrease) Due To Additional Cash Payments",
        "label": "Contract With Customer, Liability, Increase (Decrease) Due To Additional Cash Payments",
        "terseLabel": "Cash payments received in advance"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Revenue Recognized From Deferred Income",
        "label": "Contract With Customer, Liability, Revenue Recognized From Deferred Income",
        "terseLabel": "Revenue recognized during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognizedFromDeferredIncome",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability [Roll Forward]",
        "label": "Contract With Customer, Liability [Roll Forward]",
        "terseLabel": "Contract With Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRollForward",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_CostInvestmentImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost investment impairment",
        "label": "Cost investment impairment",
        "negatedTerseLabel": "Cost investment activity"
       }
      }
     },
     "localname": "CostInvestmentImpairment",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_CreditAvailableForTheIssuanceOfLettersOfCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Available For The Issuance Of Letters Of Credit",
        "label": "Credit Available For The Issuance Of Letters Of Credit",
        "terseLabel": "Amount available for issuance of letters of credit"
       }
      }
     },
     "localname": "CreditAvailableForTheIssuanceOfLettersOfCredit",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_CreditFacilityIsAvailableForSwingLineLoans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This refers to credit facility is available for swing-line loans",
        "label": "Credit facility is available for swing-line loans",
        "terseLabel": "Credit facility is available for swing-line loans"
       }
      }
     },
     "localname": "CreditFacilityIsAvailableForSwingLineLoans",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DaikyoSeikoLtdDaikyoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Daikyo Seiko, Ltd. (Daikyo) [Member]",
        "label": "Daikyo Seiko, Ltd. (Daikyo) [Member]",
        "terseLabel": "Daikyo"
       }
      }
     },
     "localname": "DaikyoSeikoLtdDaikyoMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_DebtInstrumentApplicableMarginRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Applicable Margin Ratio",
        "label": "Debt Instrument, Applicable Margin Ratio",
        "terseLabel": "Applicable margin ratio"
       }
      }
     },
     "localname": "DebtInstrumentApplicableMarginRatio",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "wst_DebtInstrumentIncreaseInFacilityPrecedingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Increase In Facility, Preceding Period",
        "label": "Debt Instrument, Increase In Facility, Preceding Period",
        "terseLabel": "Preceding period (in months)"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseInFacilityPrecedingPeriod",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "wst_DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number Of Fiscal Quarters Following Acquisition",
        "label": "Debt Instrument, Number Of Fiscal Quarters Following Acquisition",
        "terseLabel": "Number of quarters following acquisition"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfFiscalQuartersFollowingAcquisition",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "wst_DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number Of Instances Ratio Of Debt To EBITDA Exceeded",
        "label": "Debt Instrument, Number Of Instances Ratio Of Debt To EBITDA Exceeded",
        "terseLabel": "Number of instances not to exceed"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfInstancesRatioOfDebtToEBITDAExceeded",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "wst_DebtInstrumentNumberOfTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number Of Tranches",
        "label": "Debt Instrument, Number Of Tranches",
        "terseLabel": "Number of tranches"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfTranches",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "wst_DebtInstrumentRatioOfDebtToEBITDA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Ratio Of Debt To EBITDA",
        "label": "Debt Instrument, Ratio Of Debt To EBITDA",
        "terseLabel": "Ratio of debt to EBITDA"
       }
      }
     },
     "localname": "DebtInstrumentRatioOfDebtToEBITDA",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "wst_DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Ratio Of Debt To EBITDA After Acquisition",
        "label": "Debt Instrument, Ratio Of Debt To EBITDA After Acquisition",
        "terseLabel": "Ratio of debt to EBITDA after acquisition"
       }
      }
     },
     "localname": "DebtInstrumentRatioOfDebtToEBITDAAfterAcquisition",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "wst_DeferredCompensationArrangementWithIndividualConversionUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Arrangement With Individual, Conversion Unit",
        "label": "Deferred Compensation Arrangement With Individual, Conversion Unit",
        "terseLabel": "Deferred compensation conversion unit (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualConversionUnit",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_DeferredCompensationArrangementWithIndividualNumberOfPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Arrangement With Individual, Number Of Plans",
        "label": "Deferred Compensation Arrangement With Individual, Number Of Plans",
        "terseLabel": "Number of deferred compensation plans"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualNumberOfPlans",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Arrangement With Individual, Share Equivalents Balance",
        "label": "Deferred Compensation Arrangement With Individual, Share Equivalents Balance",
        "terseLabel": "Number of deferred stock units (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualShareEquivalentsBalance",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Federal, State and Local Income Tax Expense (Benefit)",
        "label": "Deferred Federal, State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Federal and state"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DeferredStockUnitsPayableInCash": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Stock Units Payable In Cash",
        "label": "Deferred Stock Units Payable In Cash",
        "terseLabel": "Number of deferred stock units payable in cash (in shares)"
       }
      }
     },
     "localname": "DeferredStockUnitsPayableInCash",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_DeferredTaxAssetsLeasingArrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Leasing Arrangements",
        "label": "Deferred Tax Assets, Leasing Arrangements",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DeferredTaxAssetsRoyaltyAcceleration": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Royalty Acceleration",
        "label": "Deferred Tax Assets, Royalty Acceleration",
        "terseLabel": "Royalty acceleration"
       }
      }
     },
     "localname": "DeferredTaxAssetsRoyaltyAcceleration",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DefinedBenefitPlanExpectedFutureBenefitPayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Expected Future Benefit Payments",
        "label": "Defined Benefit Plan, Expected Future Benefit Payments",
        "totalLabel": "Total benefit payments expected"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPayments",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost",
        "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost",
        "terseLabel": "Assumed healthcare cost trend rate, net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Contributions By Employer, Net Of Premiums",
        "label": "Defined Benefit Plan, Plan Assets, Contributions By Employer, Net Of Premiums",
        "terseLabel": "Employer contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost",
        "terseLabel": "Ultimate healthcare cost trend rate, net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deferred Tax Benefit, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Deferred Tax Benefit, Amount",
        "negatedTerseLabel": "Deferred tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredTaxBenefitAmount",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationPensionSettlementPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Pension Settlement, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Pension Settlement, Percent",
        "terseLabel": "Pension settlement"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPensionSettlementPercent",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Recognition Of Reserves For Unrecognized Tax Benefits, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Recognition Of Reserves For Unrecognized Tax Benefits, Amount",
        "terseLabel": "Tax expense from recognition of reserves for unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRecognitionOfReservesForUnrecognizedTaxBenefitsAmount",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Repatriation Of Foreign Earnings, Net Of Foreign Tax Credits, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation Of Foreign Earnings, Net Of Foreign Tax Credits, Percent",
        "terseLabel": "U.S. tax on international earnings, net of foreign tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Royalty Acceleration, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Royalty Acceleration, Percent",
        "terseLabel": "Royalty acceleration"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRoyaltyAccelerationPercent",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Termination Of Pension Plan, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Termination Of Pension Plan, Amount",
        "negatedTerseLabel": "Tax benefit from termination of pension plans"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTerminationOfPensionPlanAmount",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Undistributed Earnings Of Subsidiaries, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Undistributed Earnings Of Subsidiaries, Percentage",
        "terseLabel": "Tax on undistributed earnings of subsidiaries"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_EmployeeStockPurchasePlanEsppMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan (ESPP) [Member]",
        "label": "Employee Stock Purchase Plan (ESPP) [Member]",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanEsppMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ExpirationPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration Period [Axis]",
        "label": "Expiration Period [Axis]",
        "terseLabel": "Expiration Period [Axis]"
       }
      }
     },
     "localname": "ExpirationPeriodAxis",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ExpirationPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Expiration Period [Axis]",
        "label": "Expiration Period [Domain]",
        "terseLabel": "Expiration Period [Domain]"
       }
      }
     },
     "localname": "ExpirationPeriodDomain",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_GenericsCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generics Customers [Member]",
        "label": "Generics Customers [Member]",
        "terseLabel": "Generics"
       }
      }
     },
     "localname": "GenericsCustomersMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_HighValueProductComponentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "High-Value Components [Member]",
        "label": "High-Value Product Components [Member]",
        "terseLabel": "High-Value Product Components"
       }
      }
     },
     "localname": "HighValueProductComponentsMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_HighValueProductDeliveryDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "High Value Product Delivery Devices Member",
        "label": "High Value Product Delivery Devices [Member]",
        "terseLabel": "High-Value Product Delivery Devices"
       }
      }
     },
     "localname": "HighValueProductDeliveryDevicesMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Matters, Contingencies and Legal Costs [Policy Text Block]",
        "label": "Legal Matters, Contingencies and Legal Costs [Policy Text Block]",
        "terseLabel": "Litigation"
       }
      }
     },
     "localname": "LegalMattersContingenciesAndLegalCostsPolicyTextBlock",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "lessee, lease Cash Flow and Supplemental information [Table Text Block]",
        "label": "lessee, lease Cash Flow and Supplemental information [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow and Supplemental information"
       }
      }
     },
     "localname": "LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_LesseeOperatingLeaseOptionToTerminateTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Option To Terminate, Term",
        "label": "Lessee, Operating Lease, Option To Terminate, Term",
        "terseLabel": "Lease, operating lease, terminate term (in years)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToTerminateTerm",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "wst_LineOfCreditFacilityAdditionalBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility Additional Borrowing Capacity",
        "label": "Line Of Credit Facility Additional Borrowing Capacity",
        "terseLabel": "Line of credit facility, additional borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityAdditionalBorrowingCapacity",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_NetSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net sales member",
        "label": "Net Sales [Member]",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "NetSalesMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_NotesPayableAndOtherDebtCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Payable and Other Debt, Current",
        "label": "Notes Payable and Other Debt, Current",
        "terseLabel": "Notes payable and other current debt"
       }
      }
     },
     "localname": "NotesPayableAndOtherDebtCurrent",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes",
        "negatedTerseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Defined Benefit Plan, Other Costs, before Tax",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Other Costs, before Tax",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanOtherCostsBeforeTax",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement Gain (Loss), Before Tax",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement Gain (Loss), Before Tax",
        "negatedTerseLabel": "Settlement loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax",
        "terseLabel": "Settlement effects arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The adjustment out of other comprehensive income for settlement effects recognized as a component of net periodic benefit cost during the period, net of tax.",
        "label": "Other Comprehensive Loss, Defined Benefit Plans Settlement Effects, Net Of Tax",
        "negatedTerseLabel": "Settlement effects arising during period, net of tax of $20.3, $0.4, and $0.9"
       }
      }
     },
     "localname": "OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Non-European Countries [Member]",
        "label": "Other Countries [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_OtherCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Liabilities [Abstract]",
        "label": "Other Current Liabilities [Abstract]",
        "terseLabel": "Other Current Liabilities [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesAbstract",
     "nsuri": "http://www.westpharma.com/20221231",
     "xbrltype": "stringItemType"
    },
    "wst_OtherEuropeCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Europe Countries [Member]",
        "label": "Other Europe Countries [Member]",
        "terseLabel": "Other European countries"
       }
      }
     },
     "localname": "OtherEuropeCountriesMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_OtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Income (Expense)",
        "negatedTerseLabel": "Other expense (income) (Note 16)",
        "negatedTotalLabel": "Total other expense"
       }
      }
     },
     "localname": "OtherIncomeExpense",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherMutualFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Mutual Funds",
        "label": "Other Mutual Funds [Member]",
        "terseLabel": "Other mutual funds"
       }
      }
     },
     "localname": "OtherMutualFundsMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PatentsAndLicensingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents and Licensing [Member]",
        "label": "Patents and Licensing [Member]",
        "terseLabel": "Patents and licensing"
       }
      }
     },
     "localname": "PatentsAndLicensingMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PensionAndOtherPostretirementBenefitExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of pension and other (such as medical, dental and life insurance) postretirement benefit costs recognized during the period for (1) defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss) on assets, prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments) and for (2) defined contribution plans (to the extent that a plan's defined contributions to an individual's account are to be made for periods in which that individual renders services, the net cost for a period is the contribution called for in that period; if a plan calls for contributions for periods after an individual retires or terminates, the estimated cost is accrued during the employee's service period); net of cash contributed during the reporting period by the entity to fund its benefit plans.",
        "label": "Pension And Other Postretirement Benefit Expense, Net",
        "terseLabel": "Pension and other retirement plans, net"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitExpenseNet",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-vesting Shares or Units Dividend Equivalents [Member]",
        "label": "Performance-vesting Shares or Units Dividend Equivalents [Member]",
        "terseLabel": "Performance share units, dividend equivalents"
       }
      }
     },
     "localname": "PerformanceVestingSharesOrUnitsDividendEquivalentsMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PharmaCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharma Customers [Member]",
        "label": "Pharma Customers [Member]",
        "terseLabel": "Pharma"
       }
      }
     },
     "localname": "PharmaCustomersMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PharmaRubberSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharma Rubber S.A. de C.V. [Member]",
        "label": "Pharma Rubber S.A. de C.V. [Member]",
        "terseLabel": "Pharma Rubber S.A. de C.V."
       }
      }
     },
     "localname": "PharmaRubberSADeCVMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PharmaTapSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharma Tap S.A de C.V. [Member]",
        "label": "Pharma Tap S.A de C.V. [Member]",
        "terseLabel": "Pharma Tap S.A. de C.V."
       }
      }
     },
     "localname": "PharmaTapSADeCVMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ProprietaryProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proprietary Products [Member]",
        "label": "Proprietary Products [Member]",
        "terseLabel": "Proprietary Products"
       }
      }
     },
     "localname": "ProprietaryProductsMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases and Royalty Payments from Equity Method Investees",
        "label": "Purchases and Royalty Payments from Equity Method Investees",
        "terseLabel": "Purchases and royalty payments made to affiliates"
       }
      }
     },
     "localname": "PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction In Number Of Shares Available For Grant For Each Award Granted",
        "label": "Reduction In Number Of Shares Available For Grant For Each Award Granted",
        "terseLabel": "Number of shares reduced for each award granted (in shares)"
       }
      }
     },
     "localname": "ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_RestructuringAndRelatedActivitiesPeriodOfImplementation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring And Related Activities, Period Of Implementation",
        "label": "Restructuring And Related Activities, Period Of Implementation",
        "terseLabel": "Restructuring and related activities, period of implementation (up to)"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesPeriodOfImplementation",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "wst_RevolvingCreditFacilityDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Due 2024",
        "label": "Revolving Credit Facility, Due 2024 [Member]",
        "terseLabel": "Revolving Credit Facility, Due 2024"
       }
      }
     },
     "localname": "RevolvingCreditFacilityDue2024Member",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SalesToEquityMethodInvestees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales to Equity Method Investees",
        "label": "Sales to Equity Method Investees",
        "terseLabel": "Sales to affiliates"
       }
      }
     },
     "localname": "SalesToEquityMethodInvestees",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]",
        "label": "Schedule Of Changes In Fair Value Of Plan Assets, Projected Benefit Obligations And Net Funded Status [Table Text Block]",
        "terseLabel": "Schedule of Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_ScheduleOfIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Intangible Assets by Major Class [Table]",
        "label": "Schedule Of Intangible Assets By Major Class [Line Items]",
        "terseLabel": "Schedule of Intangible Assets by Major Class [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ScheduleOfIntangibleAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets by Major Class [Table]",
        "label": "Schedule Of Intangible Assets By Major Class [Table]",
        "terseLabel": "Schedule of Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassTable",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets by Major Class [Table Text Block]",
        "label": "Schedule Of Intangible Assets By Major Class [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets by Major Class"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassTableTextBlock",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Other Income and Expense, by Component [Table Text Block]",
        "label": "Schedule Of Other Income And Expense, By Component [Table Text Block]",
        "terseLabel": "Schedule of Other Expense (Income)"
       }
      }
     },
     "localname": "ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_SecondQuarter2020AcquisiitonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Quarter 2020 Acquisiiton",
        "label": "Second Quarter 2020 Acquisiiton [Member]",
        "terseLabel": "Second Quarter 2020 Acquisiiton"
       }
      }
     },
     "localname": "SecondQuarter2020AcquisiitonMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SeniorBNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior B Notes Due 2024 [Member]",
        "label": "Senior B Notes Due 2024 [Member]",
        "terseLabel": "Series B notes, due July 5, 2024 (3.82%)"
       }
      }
     },
     "localname": "SeniorBNotesDue2024Member",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SeniorCNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior C Notes Due 2027 [Member]",
        "label": "Senior C Notes Due 2027 [Member]",
        "terseLabel": "Series C notes, due July 5, 2027 (4.02%)"
       }
      }
     },
     "localname": "SeniorCNotesDue2027Member",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior A Notes Due 2022 [Member]",
        "label": "Senior A Notes Due 2022 [Member]",
        "terseLabel": "Series A notes, due July 5, 2022 (3.67%)"
       }
      }
     },
     "localname": "SeniorNotesDue2022Member",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage",
        "terseLabel": "Actual payout range"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target",
        "terseLabel": "Adjustments above/(below) target (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value",
        "terseLabel": "Adjustments above/(below) target (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting",
        "verboseLabel": "Number of shares to be issued upon conversion (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount",
        "terseLabel": "Limitation on payroll deductions of employee's base salary, amount"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year",
        "terseLabel": "Maximum number of shares per employee, per year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]",
        "terseLabel": "SARs, Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Exercisable, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Exercisable, Number",
        "terseLabel": "Vested and exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableNumber",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Expected to Vest, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Expected to Vest, Number",
        "terseLabel": "Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestNumber",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Vested and Exercisable, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Vested and Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Vested and exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExercisableWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Vested and Expected to vest, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Vested and Expected to vest, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_SmartDoseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SmartDose [Member]",
        "label": "SmartDose [Member]",
        "terseLabel": "SmartDose"
       }
      }
     },
     "localname": "SmartDoseMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StandardPackagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standard Packaging [Member]",
        "label": "Standard Packaging [Member]",
        "terseLabel": "Standard Packaging"
       }
      }
     },
     "localname": "StandardPackagingMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StockOptionAndAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option and Appreciation Rights [Member]",
        "label": "Stock Option and Appreciation Rights [Member]",
        "terseLabel": "Stock option and appreciation rights"
       }
      }
     },
     "localname": "StockOptionAndAppreciationRightsMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StockSettledPSUAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock-Settled PSU Awards",
        "label": "Stock-Settled PSU Awards [Member]",
        "terseLabel": "Stock-settled PSU awards"
       }
      }
     },
     "localname": "StockSettledPSUAwardsMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_TermLoanDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Due 2024",
        "label": "Term Loan Due 2024 [Member]",
        "terseLabel": "Term Loan, due December 31, 2024 (5.56%)"
       }
      }
     },
     "localname": "TermLoanDue2024Member",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_The2020RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2020 Restructuring Plan",
        "label": "The 2020 Restructuring Plan [Member]",
        "terseLabel": "2020 Restructuring Plan",
        "verboseLabel": "2020 Restructuring Plan"
       }
      }
     },
     "localname": "The2020RestructuringPlanMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_The2022RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2022 Restructuring Plan",
        "label": "The 2022 Restructuring Plan [Member]",
        "terseLabel": "2022 Restructuring Plan"
       }
      }
     },
     "localname": "The2022RestructuringPlanMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_WeightedAverageSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Weighted average shares outstanding: [Abstract]",
        "verboseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageSharesOutstandingAbstract",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_WestCompanyMexicoSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The West Company Mexico, S.A. de C.V. [Member]",
        "label": "The West Company Mexico, S.A. de C.V. [Member]",
        "terseLabel": "The West Company Mexico, S.A. de C.V."
       }
      }
     },
     "localname": "WestCompanyMexicoSADeCVMember",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Year2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year 2021",
        "label": "Year 2021 [Member]",
        "terseLabel": "Year 2022"
       }
      }
     },
     "localname": "Year2021Member",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Year2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year 2022",
        "label": "Year 2022 [Member]",
        "terseLabel": "Year 2023"
       }
      }
     },
     "localname": "Year2022Member",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_YearAfter2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year After 2022",
        "label": "Year After 2022 [Member]",
        "terseLabel": "Year After 2023"
       }
      }
     },
     "localname": "YearAfter2022Member",
     "nsuri": "http://www.westpharma.com/20221231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 14
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1001": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1002": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1003": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1004": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13231-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1045": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1046": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1049": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1051": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1052": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1053": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1054": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1055": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1056": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1057": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1058": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1059": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1060": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1061": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1062": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1063": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1064": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1065": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1066": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1067": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1068": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1069": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1070": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1071": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1072": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1073": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1074": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1075": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1076": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1077": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1078": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1079": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1080": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1081": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1082": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1083": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1084": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1085": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1086": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1087": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1088": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1089": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1090": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1091": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1092": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1093": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1094": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1095": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1096": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1097": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1098": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1099": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1119": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1120": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1121": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1122": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1123": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1124": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1125": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1126": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1127": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1128": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL6757497-112611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "https://asc.fasb.org/topic&trid=49130413",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "https://asc.fasb.org/topic&trid=2122503",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "83",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126929950&loc=d3e34841-113949",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB Topic 5.W)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04.12(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13185-110859",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/subtopic&trid=2175709",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28200-109314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061172-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=d3e56071-112765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r919": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r921": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r922": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r923": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r924": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r925": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r926": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r927": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r928": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r929": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r931": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r932": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r933": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r934": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r935": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r936": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r937": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r938": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13669-110860",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r995": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r996": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r997": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r998": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r999": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>126
<FILENAME>0000105770-23-000012-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000105770-23-000012-xbrl.zip
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M>S-H$,Q.T=.#VG'ZR!8+O1L8AM" ZB+@*R (""J0H+<2<Y>FLP.&X9(+ UJ
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M9%KJ+Y=\Q4_J%]?Z]:=Z$1O\"5!+ P04    " !#@E56'C=L015.! !E%#0
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ME@LB^JV!Z$J3]<WA8R5JTF>BU3P=G$+$66)CYM) 8MP>?(9.UC=H4D650M+
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MBJSJPGNN(=1H"H6)BXL=D:^+M&C)Q)C)E2 !<DE$X/6=EJ/I14O*Q*6%8JU
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M8@5Z'_E V%0E>\WY2O#0IMI*ZY,Z,^U(M"E9I8':<[%B1-45-$VN0@TY8 @
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MWP:'\TM,+DG$I,D;4>K["/1!,E/DP+Y-8/7"V.QI^%4%U;D"/G&0Q&!#P6J
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M,I%$[VO+L1*G\^H&VV=:5P_9!K??I5*R;2YRZ@I?(:N!J@&O_I!L'O'*R(U
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MAY77P='2>7 <-S2_:ZW'\]K[5BATF>?/[[<F>G1/*>[>N7G_P>6;[Z6SX]V
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M*<CV20F :;,%E1<.6G$) %KUV&M MF;9%<A9Z'JP9;NG23<X.-\X9&>@V%J
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M'%LL## >0 ]X:"2Q!V@EC!*;6V&X$QA;QQP/*#DB W&%[1JF@WEES-2=R.;
M# X'HVC#H_0W B8^RJ;50QYA92<0XHFMAQ$8K"QF 8MT*^3,V?"8N4VCR\/M
M%]N)/%</W<3&C IFL(@%+MA\IN]89F!M<$:%6ON/+)L)XR[+\FOLX5+6#6O+
M_GRRU+7VYO4GR1%/> '"#CL)E27?'FEG.H[AA$$21)$-N B M!EX/JA"WS 3
M9QNB#K:,C.L_-_-T+^2A'_# 8;9IF7X<Q6YLVH;)L!-KO+D:;LM(_3C@-8J9
M%^MQZ-M@RH"\-5PSC'06.S8/$AX_/WE;7?8Z+T2O-&S0M24"-H@M-W0XUPTW
MM&W?"7Q3#PT6&*$16+&]#:73-YUNZY>H06(XNIE$B67H8#.8@1[Q*-+]).$>
M]T+K^4G4->S)!^P0[^A&Q$$%\EBW8]B-MN$Q.W8=7[<,9>)M]-GE]BE _<&H
M!Y0S(C?1P5 'B<ICW_#=T'?<R VB4!5 V(Y#IBTAX_J/?:S(L=T =BC70]MS
MHC PK<@WL35@[ <A>WX[=@T"]N&VJ&&;B>MSI(]C.['NFTX08[:'Y]MV&'C/
M>(NN!?2L)S ZMDS8?A;3#<>V+=\/(QZ 6>GX?N3RR-K\CN!;(GX?I76W[EF)
MZW@L\3S7]CP?_M,CV*Z&STS'8=L0;KEE9%Q_D%<8^ %8(7K@,A_C*)AG8#LO
M-PX<UW$M]OQV[--KT0?<HLSUF.6:;N(D@>V'3FB <'4],XHP2=W=ANS73:?;
M$^_)?Z5?7A2\S&<%+(#X=<A93(./T\^O_@?^4KV?;)^%"3<]/;83PV',#%E@
M&4&<>*891W\CJ>M[RND\ Z*.TG%[R-/!</K"#O:=R?3E=1I/AR\,7?_G'EWY
MZG_*"1N_^I^P^!?<+WX6C[GQ,!QRFV7I8/PBXMAU:^_VF[]SVY2%&5<7A'D!
M,VY'>9:Q2<E?J!]>QFDYR=@<MDR6CGF;;GHY8L4 9A7FTVD^>H%3^LR+*>9[
MRI?0^\37<K9!L.\[!DYX"@L[C=6+Y5KLTUK\:QK?_"[P]P/]]J_U?:/Z[E_T
M;/%\F $NQO_N67M+DYSFDQ?69*K%^0Q7X!\Z_?=RPN(X'0]>F),OF@%3NK%F
M-R:93^3JJQ? ._/BA7I@ AS63M@HS>8O_KL/^Z_4>OQ:.\U';/S?K9*-RS9L
MM301%Y;I5_["P!?3K]>"8SQX#BV\Y"#!-!]ZW7[G2#OK'_0[9Q71[[ "6S3'
ML\[AA]-NO]LYTPYZ1UKG_P[_/.B]Z6B')\?'W;.S[DGO42<NF/?!YZ[?:>Z?
M6#F$T4[S<4L[VC_<_Z]_&*[^TM0=.[@YZ7_1GMQM^F]O>CELH+U&9_[5MF\(
MA9M??H-M,I[<6(%1&L<9W[N3Q'XXGC+OQ%.O3TZ/M?\!Y3;.Q[W9"!X2:5('
MGO($_>4VX[$3&P: &MM/[,!Q3"RZ8X,!&3OFRE-G;<P0M\0\?7&41S-4\8@;
M]F1FI_5Q'A[EG]^:IY_/K>-9?-GY?/$FN#RY''SI'0V'YZ.+[/@RNKXX.AT=
M]S\.S_M_I>?]JZ_'_>SJXC*:'X].+]]:O>S\:VX?]]_;YY_^&EWTN];QF_?Z
MQ67'./_4F9^/.L[QUXYS\0;></G7U;GA?WEK7LS//T7NL7EZ>=Y_/;P8=<S>
MT?F7WIMS_?C3Z^QB]/KJY.C*/CDZ-^#/UXNC@\_QF]=I^.8#W//!ONA_,"[>
MO/_:ZW>OZ;Y1U^I=7ES"6,W>Y<>T]S4>]2[5/1_A7<[XHI]_O>@/LU[_X]7%
MT;%Q?'F@]RX[YCG>,SJ>][Z>F[U/\!SSW#Q^[5^_[1],C\_T+V_[Y]?'E^=?
MWUJG&?_S='[Q*9Z$INW"NYW>Y6MX5V]X_.;BJG?4,2Z.AK N?V7'HXO+WNCU
M$,2A<W'42T[>_\V"P+=LW6XG >=MVXW,=NCPJ&W;AF5$+#(3P]M[9>CM?Q/
MJ7E@&7#\F%CY!@1Y8&X/[L3LOQVSXDH[&?/?U7B>5O#!*/9U(;_N*_G,_<#P
M[B3X[B5/[7W?MQY"GMY3)-X+0'R"!^/#RSL2WUY)_"<0<@?C\8QEIWR2%],]
M+<F+$9O"T[],7R3I%QZWI\5LJX7@Z-P^O_QCU'OS.CN&/[TWIU?'1]GE\==L
M>''4L8^_O@81]-XX-\^7A>#\XG*8'L,[SC]]N(8_.@C2ZY-/QU]//KV^.NX/
MOAY_NACUCCY>7F0WA>#??A*Z9N(;;<^W61L3R=O,<?1V9/B683IQX(<@QO[K
M'X%G.R]OE622PY^8>1]2?AWT>A\.WFJGG7<GIWWMW8?3LP\'O;[6/]$ %O<!
M^VJ&I9V<:H;S6_R[=O):Z__9T1J(N4++!X=]_-H(+/LGD>.#KH)_-\B2%]IT
MR+4D+8$FVIRS0@.KGL=/@6/>D;N@(YP(BWL\AD_:(WCG$&]KQVS>QK&U^7@K
M]_Q'._[SK^S"S#Z'EP!BW@#@^/1Z=-X_1P #[WO_Y?S3Q]'YI_?V27]@]RX_
MP)_>%8"8K\>75W:O?ZR?' W,XZ,/7_Z.HM!CH6NWO2 *VK8!/V$;^[;I^)9O
M1G84N/JC"NC#65$ \5X3QYP#4>Y*P!WM "CJ4<#UML.!8K9O>VT4L^TXU./$
M\RS7BZR]5T<\(L^>,$G1V[8HA%L:DN7;('.=DF8U9,B+'4[<X<1',(8+&!Y5
M,;@=*R8L*[<9+)Z;'[/CH]/TY,WKJ][7]WKOS5]@F<)S/W6_'G\]=DZ..E\O
M/GTP+RZOEL#BY!(^O^Z]Z<(XWUN]H_<ZC W^G [/ 6H>?[V".?2RB_[%Z.3C
M"K 8AK&>L"!&@066KNF P#(2JVW%MF4A4N2Z)<&B_9S!8O_TH'?6)53XZP)&
MLPD8I]6VT\2ICY84^4BHK)__>YK?6YW]P/',&I;O,!^-TA(/";77*6A!V"MX
M=/B(<K)#QX#X,O&NK12#/XS!8"X'?UM1%)O,8>U0-T&*!29O^SZ 9RRJ''M.
MXCE.M/?*:/NZY=XFQ'Y9K_Z#>.VKHYXG]=I;=Y+MC[[W3OF 2J.,ISWX9BOW
MGX A)V_.T0%_==[O6!?]XVN $]9Y?S@Z_@I[;_0>QM2=]S[U$*(L^ZSLB\M>
M=O+F='C<C[/CKP=Z[R@>XO-ZGR[2BZ/N_/RR:YR; %'NX+@_-S\8<.^7\\MS
M\V)T;O>.!L:Q^7K4NWSO'/>/OQP?'5^?]-]_/?_Z,>F]_]NRO,A+7+/M>B #
M;,["=L#<J.U'S/ \QV2ZR?=>?>J<@5;_\^#T^."P\Z'?/3QX"]K[]&/WL'/6
MTKJ]P_W-L;CNZ*'O?&'1E-A1RQ.MJ-A08Z563GB$P2VQEHZU=%IJT9!J?OW^
M((<5VR(M;9"6GOW@)AX\UC?=1S;QGBR:X&Z>Q$<7HUB92B2+ WJBF@RBU/G\
M,(\7G4\P@PC#F*9\4N2?\3E;ZGH28K=G=JY/C@8PAHLKN _&&5GG7Z_@?7@$
M\#&[P*.#K^?SB_Z'9;$+XOD GGG\I3<Z!;C4T7M?X\N3_BF(RM/AQ:>/5W0&
M>_E7UEME_9DVMWS/<-LLLMVV'4=N&^/8VSIS_4@'B]"U #>]X^-Q.<\^LW'*
M'M8$_-4XO,^^=&70H:BZML6(_:E9M[/(N@R4OL/MJ,W,Q&_;NJVW ]VUVECH
MT?/-@.M)L/?*M-J&:6#@YS<9=SL"G^[FAOV-)*<&5GR.W2*TRUF1EG$:D24/
M*"%M2EFZK!C SOY*O__^&/MYK:O1W3_=/]O7.J-)EL]A.1;WGS3/?W\@;G@B
ME];=IBX<+5OAH_OA"3TLJ=9BQ&Z(:CJ(XP)K!HM_WL( C)U:^IY:^OK="#2X
M_O@2G5870S!64Q@'&=BT+I^.[9[9O3[^&E]=]$^3WL'?=J@'AA[I;3<,>-L.
M_:"-]:#:5L"H&G5D!,;>*\?2M3\Y@.&Q=K*O?>+E5#LJTL_\YC'B4W'-(?QX
M4O3SZQT*?UJ>.3GX.PP"WW$"O6TEL=FVC2AI!SYSVRY#CN$1-X)X[U7GRS0?
MKX]!").<%._ 6@/\L<TNLFWDDN-^]V_/U/4PL<RV"^*C;2>FWO8=E[5MUP]<
M1W<";KI@ZAW<(;1UJV#A>M7IN[R<LNPBG0@7QH[KO\OU2V:>Q777LUVW'88Q
MFGF1V?9=[K43$&\A?!:%H;[W"D]:C;;NVLZ3FGEK0\*_2?9">VY2@$1-)RS3
M^!<>S; \.WP,!@XO'\6:6]^D81MIN(]66&N;<ZA^8^QT*ER?$/W7/WS3\%Z6
MVI1G?#+,QUP;DPW:0LL\FR$Q-%9P!L2*^0M-S74-1]F/&6*((A(FN;5B\<?/
MJ^%WP/F.P8+$;KMF IC-#J)V$)MN&Y842VO!ST&P]\J]Z;5J/R)-L!-$]@XY
M<HN]DC],E_GQ4>=OVP,T%(/5Y8:@<H@NS F,=A2$+D\<'701@"0GL-MFH-_N
M4GQ>$2UGH%6*=)K" \4)(R]XK$UF13G#H\9IKL$5Y$PSS-_"WU$G8?S0031]
ML:;8"G\_</P?.BTT]W7GX0-"#6O?\)V'/X0T]FTQSR<_A%PG=N^GTXS.NSF+
MAEJ4L;+<7J_U+5,L&.& L_DHS+/G-KN>C%<@^O$OT9"-!_#!6+L>IO!)+62>
M)WA_1!4N1?7<,$/:)5NIPH7%>0%J^:2?75[T*?5MWCMZG?9&7; 4_QA>''6_
M'K\Y=LZ_'IB]&Q;G9'1LOG=./O6RWM$!7-.%=W7-\\MC\_C-ZZOCR^/K\Z_9
MY3&\$RS.+S?3YR+=3LB<U'D %B>WVP&L?QN,4#_@CF.[Z"C!,$_@V+-I'EVU
MM DKM,\LFW'M_^V;#L;+:N400/PS.2U_<CZ6\D^(OQT3WX&)ET_' \O@W$_:
MONN%;=O4_3:+O:@=QLR.$\?U$\??>_7IK+_CT)^3M!VIOD3@YW*($BJWK8].
M>CHF[BXR<1SIB1683IL<@#:0!]B9L;8>A$%H6#%/ I#$R"KG>7$E9+&F"/)]
M1^#F^(P>P.X:+-A=FO8T?J/5SJY>/N8/90NO16YTQS'&AW MG&O1D -7C; 4
M1BH6N!%FFY8:TZYYEK6OQODU#).S$B8?PQ?E#%UZK-2 3=.QB,(]G8'A8NN.
M(E6#PD"U_=MR91[]L.(3S.#?.($S.?XN#7\K9=:/.X!ZEX/YWSPVF&>'3EMW
M@J1MLR1H^X9AM\W8<_P@B6W/-/9>G?-R6;[<=\-5Z9>:^9-!,;*.PX^]_:?>
MO28A(XS(?*TK;K^\151MJQP;YU/XY#^S%)4,Z)8$D]<*2K@M5RL="X,'J]\H
M)[)60;<*,]@ZVM(*_C(\^^B"_&.>S<;8U!2S 8ORUQ/@^M]1;$:1[?)V8GEF
MVPXCWF:ZQ]J!QTTC9GI@Q0REQX;*[^V3)M=#3G'&2R+E-^-W;0CP!^5(K+$L
MJX1)4\J$7%X SUP4+ L"I0&4%+Y'(8-?X]&_%L.WXP%=.BEXQ,EY:I@:E2<I
MM=_@>6"::>4L&FKE,,<T*)74/!VRZ?+8KUEY4Q;2S7(.OP.R&\?:;Z:88P@&
M'GP?7L(,\'JZ%&["4<CG4#M1&@0-DI53+="UF,W+6R7EMOS]Z%)-UJ,1U1_0
M+31ET]DO*-S,OSU+#P,CBML!MUC;#AC\E$1)&R0>]W3'\YTX?%AT^I.RS73L
ME^M%B8M!XT\Z_9LE#K9=J*.P SDW2J=3D(P\ WE7Y&-T]65SC7_FQ5SKHDW/
M(@I#.F)3)JH@+,G\^AE-9-DTCT_Y8):)%(VS=E_[#<GHO=1,R]RO#.B4<EHG
MF-/ZV!I #+@2[+S\?>O%]M:(_P9'(4-);?#+B?^KKW^[/G?CD/EMW_;LMNUQ
MN\UXX+<MRP2M8"6.'0<KQ?\:A>!.!SPS'4 ^SXP5 ,%9%($.P.;>,4E%='B.
M5WZJ 3.V5WY1CD!YP%L*A>Y @HQ@#>8MM +@<0"=,0)HH V*_'HZ5%]+^7O&
M.0V0O*Q4K8B"8C'*TH2YWC),^MIXJ2[[[@6W#U)=B.: O/B6 :LKE1_8,,.V
MJ0R<IE6SOX(KGCB RMPW#.N'"NH9^ZYWMY"D^SS6VC?=V^_\X?@I<U^W'KXV
MA&G#:.]6_N^^:W"WP3Z3_-4G*9E5',*N'^3%?,7A+5U$\B"2%VWU.6[OT\45
MP AXU[%Y;':=WE'DG%\.L][7B\OCHX\C@!KIQ9L/SK%Y(X?#N!B]-T_Z,*^O
M\+_+*[WW-4M/WGRP>J/CZ]ZG<WC>7U<7,+^+554F#!XG2>ARL%H]JVU'1M@.
M3<MI6X;IN0'\'@3VWJNWJV7UAM4<?"A0M.CT>Y:YV=L]H8.;C/A<&,]^S!SZ
MM1&LMPIA/ENB?7LN.LYD[UGLP[/;H/>S(.VC8QQ:OC]F);RY+)]CY>0G0C6
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MD(VBEX !\$G-UY-[U'CYPT=PVADY199G@6]A493/QC@;Y$O'V;?_J?S28PX
MBFX$,6?JIKEAK'=;G.IT6"WS0 2PU"O=<- 72&T8 *L"]6) 'P@C&L@P;3+R
M\O$I:-F\K%RA:D.C%[8";_1+A=Q$D!J>V&1 EYE\E++9U#"(+D=YAB.K>.OL
MJ&8M@F<3]**R+]HE2(D2$&1U+->BT_LTFL']!'AON$$8'EJ,*W=(MRP8!QQU
M.$S'0H/A*([3.(97X,48-Q>!^&1T]J]%0S8FOUC#%8<!H2/$O@AX<_3%(*05
M!WD4Y"B<W"UYO)//!+X01V%?N9;E$07K%%=<LC2C: *)QT?X"3)H/MLR6';&
M.5@>A0QV+@'CEM+GB%.YC;U:E3\?90(MX52YM+]]'VD+N()- 6U,*& $C]E&
MN,@E.N3%YF^PI@PTE7&FQL$.H#PQ0#&"O5>G>'3S&@1W7CP%1+FG&V&] >F+
M@=#>CC^?F#]M=^_5<14P5AW5'M72C!SJ>.A3IB+\NHIM!V B#Z/PFE->@NJB
M2TXJF;5Y[/X]!GM4=B<*B3,J-J&5VZS%64';EO8V_<\LC56$RR&;X..0W*"*
M &^]7.N*+LF/G8)[:@'B@ 7^?@8F%;R4@"XRR7N*CQ"_HRC)<@R:*K6#$/-M
MC@D):J@6-T\^K%<=8CJ19NR8^(F9V .4]@>3"NX=<"KHPMH#>C8;40 !?'?6
M<"$<".L:C:5W8!5%3^. VFIU5VZLONN.RVDQ6PC\7HL 0'[;L#7*"XY' X?*
MO]''8,N,ML=Z=3^NE1"8.XGYY':M#B+S" ;T66CY6W;2>OWQ&^9$6NU./V77
M@(@PTIAE]TPZN27747^"7,=;/>UT[@QLQ+40%&JD%3"]D9J>BFYKG@RK0&GI
M^'NA\8S)4W),-YB-TO%L)!(!\(LTVM<ZU165]Q7F/M3*^1B>/I5Y V,&SR?'
MHWP['4K+7.)L+LX$6$3'G^3EY?^984@V!A7BR6;#F[8P!_2Z8;Y88]2(%$20
M?!6U/H E$'Y_<NS)AQ8R*KVHZEZ0ASEB!9Y7-\ %&R&VD$'WG^$YZ(A5;U:'
MZ>H9])ZER%_E#Q15%N#E\^:85*J:S @#0V[(Z$!9O0H(%<ZR*Y$.5@45J,#9
MLG%EAL?-)5R-A]#JZV;$LGP[N36+&>& VS;F&OB5CR99#FNCA@D+(3+OI$M$
MHR0&/J ER9OY5G7VE%J<SWF&$2ER.2EXL<A'"X&@B@V4KWP\+?(,ERLMM/P:
M%D 8U?6Z[6M',SH]:#CDU6TYYN<ML6%U"((L@$?=]$"-?69I)G-36M4Y0)27
M(J9T"JNJ)D 1&!3AGLQ5Y"Z-F:*("XZ!,3!0^"KC;?GX>E[HR(?5@T$6\J!@
M8?<0^\N3&WA0Q7GJ"&*EN,@G?"S/#]3004\!+A%\5CN><"T:YS@C-L>H<7':
M@$%!& 2,82K-(QJ9H]D@\PTF)EHU-I+B$7IZQ=>J,@KPU&>1>:6X*N4+),KI
MM&!:I.%,D2S,^&CQ6*EQN(@,QH4I<HTSQ]CA,J70%YA1R3.,XV\22HB<ZB1I
M\<B9#II;\)9!#J*JK!)6%%-543-@LD^RV8JM7A]:C_ATF(O4H!$L"5*P&@AM
MF AIBPLQ7MC_C<B5%0NRK_U)FY2/:4D3@35IO06M\?;9.&&? <%@.$>DG%4J
M4KU$2*)>*V/]EYB+>!^6/->P9 >Q-BF$D.-24QI#+@D@M4#]%EI?]&0T)3;,
M0,U.QN8K2;&+ ;V;-'8V, ;TR3429?Y<4SK[E8:.,Y2WU=E@0Q:/<SP]!(2#
MF6<R/V8 G#$6XDKP+$] 3!(&R3*\H)P1WDEF6:N6I$J2D=BJDO00R*U0W2V1
MEJ3V+7Q19:R)[)T8E!(-.AU-,)F>#BQE-I384A7T$WET,#(E_>M:";<?K=:'
MI[07!("BL(NF<*825LNZ1!Z"[N^,Q6=_"/J0=N$*.7D)"!S@T;I*RL!^S%#K
M8ZTH&?XVO_^P-R66PC!E#'C:G%==3JZ.89VPJ4#<XH>E_..Z3AVF<DWF!3X>
M?KX:Y]?M87ZM4H4Q*QPM%4J#+E%.85RH*,"QH+<1JR(H!SD'K^'CDJ\>HJ;>
M5(]TX9T4'Q.KT0M;EH\;,UJ8B$*1(H2+"JQ(N$7^9E$JCV2M$( X; P:SRF3
M#/.7*RQ<SZ0KHKQ:VDC 9B"PX>C5D*Y1#<AAJMJ'+"IRF0"*A2/XOG8HQ?05
MGV.4\(RWP=[$:&!1;*?.KFN&KRU&9?$O$IZ!I)9K&@LK2=20HS7'^'-01BT-
M%A#^+>1T0>,)JT,.NU4'N,\;U&_=0B2,69XNT+*LT2"B0RZ!YA(;B R#ZV&.
M@#NG@#*T;Y;MP*UP-KU!DU&D$IX*>Q(FO%D#OUT\U 3!L@HB)1!Y2I8UH< R
M#/R;A9<4759OBX3':'"V,/\:P3Y%I D$E$CW=L:NT2J:95P&6A75^I2B^(.J
MZ-1J)FL+!IN*3&I@CRB:353HELQ*)I3#$BX,;\J]J,$4AAD6E2.@59<>HAOJ
M4CHLPKJ:Y*L0@?T3=+U&\X8QQM#.(2.RBNY?2 58JB8D[&D5A*R2/BCM1(4#
M+GKFJO"S*HM%AHLL%5/"%/AB@GB!+]V_2)QZ@=&,'52<B:2<@7U55$F?2AJJ
M+,_&I!LBL1:^E?1\G>=".AUA8LC!8E&*JJ#BT4$=?HFWBI<P3!*5*;7:P8".
M/I3?I*=(?"SS>ZJ W>5W4-SE[_MJMZ$5W9A<<] + 9>?4RY4!ZY*B?N@11A?
M8FH< [EL1)$(%-9+@80BM+*BOKP03RM1Q#>]0<MDK@R#>9T]KX9,"'[*KGBM
M<!KSE8?_&1\@"570Z@!8"0:(*F7#1.1J27.($;"2[]@7"GB-J(2M0 X-L5 5
M-48$(;.Y83'', Y0@VF24,TO 2]XW%A@$2(K_,]C93')$ELJ3Z 6=B2+:A=7
MY=[:IT+(64H&H"(Z/*<AR6X(LCB-L;QNY?^MO2$RK >3B]#-0>$:J0(- L30
MG:*PF2R(0S.H'[(X@U6/;*V>2E7L! 02\5&UGF((EDC= N8O5"6*%(.1X;5Y
M7.(^+P2P64JX6*S\(#8/O;J6-@O+(SR%) 8;) "U =;HWN99C\"O&VP]?GMT
M6VD]DH#8(QU;< &:QWE]DO/MW21R@V3!$04R:T9L9SQN*H&ZPJ \>%@LA( ;
MLTKZH"(MR/CHUIP5PN=:LV_MZ6%%\P0,QHZG5I@<6^#IVGC<G,2-P>-&W'@1
M[M"Q#BB<M%0EMFZ#@ZIBUU3)3 &$KLN%=5W(!Z(:(8"/QN)PA\T$O&"PUH +
M*R"Z!/)D0<@&T-O7CM&&D.XLAN@"Z<I1?*F2/U*4"RFKW-BQ/"L25XH3*J5J
M20< L29RNHTBI,U*J:4P=M#5J\TYDT>2!4</OBQ'*5(\177*"0Z4RA6-)LH5
MR;),C&U9OT@[5KK/%TW0#>><[[CB.@N8OS:>MJ).I#QR7K$55)Z)-(W$%J!\
M'2H75,HD)C%;":W1'SMDA:ARTW2P2D=LPSQ"P=)L]:">(BZL+2>U$QJWRA*R
MMT*<&[R'R;R(4(8L;H(2Y8:60K2*4U$0XS9(@LE0K!QJ299?ES\A\A>-1;G_
MOR74GZ^T7NV3.%:&Z&8-]IZE-^N*6G6%"!6<,FK(>NH5LJK^\:VE+E<6.FY$
M9"P8VTN%%821G,OJ6/4>31<K8*I)),M'TVJCYJDXT"9E0B7L,K _\:7 =%BE
MK1"FLZSN)O;N=TIZW*P.W5PGFF65CY*AN &E_J-%HE=HGU_VF-7=';-^KW9.
M8Q?5L2J,[,MJN\FZRBL=8HL1%QFYD'!OJ1--Z1,G0[-H%$TY67:WU65S47UC
MX0ZJ\*&V*'D5J@*ZC;XZ%$I$Z=T$$Q?O$M%J4SQAEE72LG1$('<F+(>J"KQX
M!,+3:=T5B!Q?U</R8BN@G9#<4SZN1$DM?A;3Y&UGWZW2Y*-F5Y<;.?,MBGK#
M7FQUK&!3JL%<TW@FF&?A'8U#&/V?<L57O.=FF1$*=[9VT<Y/?(#M.WNO3C$\
M8L;7?78M])P(>P]VC/#4D0R6A6G_HGI0HV_1^KGB^Y5G;I$QFR6[5YL(A\HU
MO/&'E<+<5N%:52W8YNEXLRH;Q1T*Q[<T<$L\\"9#4<%^>0[_W6J_!#/$H8!<
M*U7)O6R6?D?'6$B>I!HZY"L+B8$M3$P$QG=+J_KC+,0A*^-<2*5&@Y)F^=ZZ
M9< TGZK(RVV@XT) ?6V2,VT\&X5D5U6'%@"#9  :@KI%,Z2\S32Y68N_^>@E
M8W#1A7<]S,58J+Y]=<11HP\)8%:-I'ZUR(B0[*=:K\E :WE\$JJT2.)G/IG)
MQ$AD+14Z+) A<((J>CY>*/$LHT#(]=1L3M,HRX</QY"9C,>T82J?*3Q!=L-I
MW? %+9R8-A(AMH&UJII4V&.!9=2GI;D JNHS'G&+[.D%CI'&?ZER"S+1L8?.
M>T55[<4:B$#HGY!)8WD8335]LK0<+E=3)B<V&(NJ>\.*2MDUC]=AZC0(GJ19
M)JKRR=+\+2HT* O4YQCK*J,AT/U5Q6?DRI*J)J'FNB7T+SF_(K*E";6<G*;2
MB5-R2B.AJ"CETU$2G0+^P2;$;84.>GGD4*49+-8=O]%18647LZHKAZH0_Q"E
MW._;,>QNQ=]7U7X_K TY%(8X<$ZA$%7H&EX=8=R($HH+YGG$)JS1PF4I7EGH
M1>F;JFWS:9U>L8F5^WZXSNY2-RFQO8E;FL?SJI87==*I(8B,/FKR*U6SE;Q<
MCL 4IJPUZ42H90@L--GEU1&:JFN[H/7VM3<RP%VF+DVP105YO"E>!2[DK<J+
MN-CG(,OS*Q%U1.3$VTO:39C 5*5J9?EUFYZ,9R RRN(.6S44N3&%V!]TKBOF
M4?%6*ED?KA117'@A18JLJM'[K9JK%! +##!M5Y5[14G?<IC3BD2BETWU;:5)
MJ6;L0FI0>Y)R7 RI8393@-Z2-@NHEA61"*\[:D0Z'53!@9LUC5OU@,J<JAQW
MA9Q:NXQ8[9TGT%6?%LF@/31F<['%T'=?(P#DK<7(/>H#4[GV%@7WJN+!"RV.
M@/G2!:=9!0QJPZ&Z4S@REQ++%@3\PN@1?I33!5&L0CMGL@2C[+JUC  ;Q\TW
MZZJNC*6@HMU2HPD'*Z9UD7Y;A-NK.H2L5)\@\YJ=156_JG+9(L)34PSVP*E5
MJ<<9%VI0G)U$ OE1 !KU?Y3@O0YSW@Y7*YB@P"-TRMKDIZKTZ/4M3FYRC<HY
MKS@.6PB2QT"%?)Q5T+^L+&<9T]!KOH8@SG45$BES"44,7,DGC,[/*LB#5:$7
M[::6,F(:CQ/G 6!YQ8)'0U[5+Y?DE RTW+1EF=-NB8^EE/8JU1NY93(EUE\5
ME]O<6VH:\B1-/6*Y#Q>N=P8*3ZFL)JE$9-V&*8+5X5ADP8K 5IG+7LZX2N>%
M?9>.4U37Z6>!96Y XJ99=;,#F4J&'</6S6ZS;1K!VJL;W^TR0.\F.+S=T>0K
MU;2PR=2$/U%NIF-@1!%JG9/Y,QL+94GNWP@$F@IJ$4DN! !EPU]YVK@DD>NH
MY 43;:&1XF:)@5M<Q/,0HZBC&86IBSP7E):;-?;;DUM(:K-H2*%V"W,)08RI
MZ#[AA"M!8)6JPR!2'N0-^E@'U:RK>'^,-<)LVL5G,9E" )I054T0W8*98!Y1
M9N!0!O^)SF3E,)W0&0)(-Q&0A"IXAL;X5!5+:'CA:%R?TT&:-<93H3=Y5HTY
M]%3@8>'M,@!J3"\FXXI_8=B&19J7"ZL#JS8HV A]89DH\8#3.8(73R6*H'I5
M]6G(E+-1B_RGRMT!0+4 .0(SFDUB,1D1]G(PB],I+@.%1%:*]X\<H"3^<@23
ME1XJ-AYCLMG2 U9?J;1U(5M25)=3W.K;>K7[,%2-A6J5Y%07FWK4$Q,7TNJ(
MLA6-(B9+G$'ITE,VG0G/[GB0X\-4LC@*G"E8N0,BPN)R5WW 14QGQ5A57-O-
ME#\I<&2>H+)VJHZ2& $(LF=<IE4&"3PL <+(J/W&%$5?3#(&"%@UTUAJQQ+\
MMATX68EZ=$FHX,MRB&L64K 3&FHDD84WH5D(0#@1N&"U@E'O]VNX4_ANDB6J
M84$FANZ9@Y*T0;7KQR%RJ&Q/&U&P.*!D0"^80I]EI'/J5^7+W- D**6RB%U0
M<'H">550+\&#OO&0RCA;.!' W%ERUT3Y -N85TFFM%&%#!0L-$RIB6^S('W3
MN"VC(>P!X<<ANROF-!0,$JWNC;D*1!6(3;R:O)SEK)RD$07+8HATMM >.LG8
M8""#.E1PC\C>6NP-.6[X<<!LF0ZS>=5ZAUXEEKQ>)91/<4[QK L++*P T;8:
M[A5Q?\)U4$U&KIF0=I(0,IIV8>%CGF >K/2;@C5"U?I7.J3& !!E*)1P1( \
MNP:ZPF)<\"('&0M&!FP+"BK"RIB<>N%.X>.4.LRJY154I$H3Y*3BK!1Y0=6H
M%D0:NJZHF,["N1'&UX\0]5'O+F%O2QY?R,8D-U="62.4PH8OC:22D0%0*GNW
M\;YQ5,RK.B[2\2#$;YUQ68UVV<^H(L! #;"Z ;5,E(K)J*1L G5_72I;.R3D
MC1G:8SQ/5&;9@M4KA%Q2,*RQ)^NGP; UTVZ'\[8G3^N63X<6V@O06V N>"@,
M?].!7Z4GX,DCCNM"E7% 1Y-#7!;QJ.1+I8BNFZ=8B:R[II3;@@SXCE*&)R:<
M2GQ@C:C-DMVK\>:?,WB$=LA617V$8/H/:/':<C@)_??RJ09'H>A/$X^R>@!:
M75-^0XAY:ZS0Z@E0G#?/ 71NR/B_W1>'=/X1CS@&#XA&Y9;1DD&*UZK*'>H\
M-#.^4.@VJ"!#;\'TM0E-M"6*,\3"YRG<Q!C6(,Q!S&)%-RD*!ZH_I!S6M0!;
M O44P8WEZTB4X5#6O%=N"YTBV#VD=([%Y3%;OJ/+4QI XB-:W7(I-"$FO3R=
M%D+A"HV<+#_)_*<P7FJ7FPJ]IV+3PGYJW+/6(L0P-70#L4%E\M3 ))S+\[L7
MJR"V;*^G'%%8/!+)FK%)R5^H'U[&:3G)V/Q%.J:7TTTO%XN8.C#2SWAD%;%,
M>J;(226^KKTY^[KPZ$P+^!.K-\NO]^FK?TWCF]]YP;YN^K=^K>\;MW[WK<<:
M_K[GF7=Z[+]HR&+8L#*XE/^[9^W=OB\ 5('U]7*"(4GCP0MS\D4S8)4:OKN,
M)S=632S8T_OSB"P+_1,K=I$K\T"3%@[+C9JV;?]S8;+W)K44@=M$:E$TXX=H
M_/W9;B*-]9^D\19NYX,R9=H[1E#_U]G-AO7K[>:%KH*_SJ;^64IOX9[N4TCV
MS^QF"?,D<+,F4RW.9P@#<?#JVVD^>0%+H5$&@OAFNU@#_[[)'/\B[+K-QN'T
M'D;)]PR#*G@03R5W]L'./OC>IGHCHB2;_0)_%53A_XJH@JF:9#=K/CQ[;.'\
M>MCB4.7*_SK;^F>IO(6[6AWK_!<;35[6P;!S[;<C^JC_^Z^SR7_6\;.%F[P*
MQ!?T;X3B_SJ[_A?4Y60W_LS&WIF-]S,;?^3+7S:0V-\%$G__4!@+Y2V:_S)K
M;<"I<6O,1QCG,1FF4;G=UKP3[!N.^SC6_.VW_M1CK8=P$BA9J:.DW/NFG-Y4
ML7HC/(,XX)B/[Z![MFM.G_+1TJQ^!?A(P1?2#]11SL0'<$<C<M#WG6W&#NZ2
M-?'++H3E;J[K_9YQ94<I-73 0CJ=_\Q4#'57-"W<DNI&7#1@P;BF)"^GF)PX
M;O1=%!'\F4SOQ4^B65;U>Q-8\G,5DL8;H51E%2JZ$&\ELE&JW'L-PZM5%Z6"
MJEU3<A^C^KQ9!&)4I!I0BZ(8DUVH^81JO!OEX\\I!6[)1GEI66??A*).:D*!
M*RK;BO*IP,@=JS!SV&_7\/W*T5(\K@12%(XK K\.ARE/M,X7'LUH^B?8U066
M[K>]P\[)WN]56@:OKEAXJFP)$M?LPVOV217[:#EEC])R+$7C85;L0B8U99=1
M-?0\FLG4Y@+?FXXP,8:+1.YO@\B$(@!G4Y5JBO45JW5(:-G_N[R9T8*$0F77
MD@D=F+D[ONTYU=4XQ']1UP>,5A0U<H#C-R5:^)Z"H"^CHUO-+AX4&<TR9/)5
M?I3-% JRY+Y,0@.A %L9^((."9<W!S'@@(GT]@8/JMU5Y5E38M9"JN)"NN-B
MBE)=:5,KK]),9B%AXQF1P-(0,%5SG$$NBB:%LS2#G2<6G6J X"7I6#1_HYH)
M!5==F54Z!,UK)@,^>3H*L1*(2)R6Z6BJDDQ.1D\M/2(&K\H'K:I^02-(U#9;
M0"39P:%4V4V8]H8YSAPC<C-1$@47D-X@\N8P": -DVI?YF$5=D]E0BA+("^H
MMX3Z0I:#$ .K/Q1=K^<-.9NQ\6#&!BHC-)^ ';A0959*N;=J<G70MW9&:32;
MLC>_R;HGRTR:47HM?$H*I-1^>\=$]U&4]ZK:4*LIUF#MWC=JH9V,92X?BKO?
MD6&H/ WEFTSS :<T(61A64B):A*EXAWPL13 JIAV^=\T(LI@*J=5%O]A'I,0
M/,S'F,#;JOF%2*FJ$]5$Q/PY>("H/K /:K*E-EJI#69IS!IM26YHM(DHM*6R
MU& *5+L@$B_?USJ4$=^X#=-/FBWNJ=KF(%\>MD@AFTU%VIAH75'7.;^:9%@4
MH\HD$?EEV>:G]U6,)90KTE5(F(4<[4:!Q84$)R5P1)7_JD5;S6]8"J@L146O
MHB%Y":LWDWV^AQ=4F029'T=$HGP\@8VJVV4J+M!Q@%E62-X&-J)RQ@L"NJ6%
M?#J592M$CIM: .JY@N/EC297C978&-K>4Z%3W<UQ62>2_<''/$FGFUZ&:*%C
M3MW^9:KRHRF#BZ7%C1Y=T?*$0SEAI01%X: I)9(@4T^KQLS\&O.BJ<J5I#P%
M'RTD64Q%EQEJ.=]0QJ(G3<&'F#&,*)GBU\03JS<WA2N*$M$)I]7H_H'#&((<
M;V=IPJFP8%7DLCD,3(,3_5[$\Z4M(?.:$TIC%N)=* L%8&]EAGIM:#JRNI'R
M>U2II:G,0$TR+MO]+3P>];PR&"A51Y5UE]_7@$A!;"#Y%>5XJU=5O1L;,HC@
M4*/M')I75*A-=DC9U_Z@PK&8PDM]%RG_L=F5DA8'B^LH""=[8%9](X +9(4
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MZNO$F$U"_/^"=AM>5=7 IF@#I4=/4:YNB."YM6:551?PK@! 96>62UUJLSI
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M2J_\C7V:_G_VWK2Y;219%_XK"$_/N?8;%%ND=NM,1ZAEV:-I;T=R3[]SOYR
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M\4C@ X=<52);MS">OL9X/\)Z$1"-#^M(<^0<?,^!Q@8*1@.K@H2/C+M4(W*
M3=)##@MRZASFN4%Y<1@U@?_A8TUA<8CH=^H73!5Z:'50W=VA6VTD&&8I/H?5
M,V<FM8&H0[-1^JZEE:/>R])9^M LI%S?ATZ';@%;'G*AU'64I1I@-$;K*S/(
MN(C\9@/9P8Y9E 2SM-SF-9I2@*P7W3D75N+?AE2"+4\P*)SIXI==#ORZ@,?=
MU$)A.6IO>^"2.J)A'M;\1*:/O[*!M/G0ZWDT];15UUAD?:&)7EC&'JL(KF%K
MO""OP(V^W+H:#3EGS4K9!-_?,:4VB:ND9W>L@MJNR+Y!ZS'$AU(:L1U(3DH:
MG.J7?O,[5,Q>7M$V%;]+S9(>>TUMU*NEI F1-!6)TBWQB$K]-:)SDISR&J0:
MP(/#AI*&HE#3BA[.J_-SJY!\XJH95+# RW^#_QZF8]N@%2Z)81;>($D'-XI0
MP4F)13 P>/A-FAQ6$)?#TM24%2$(U2@_U*4D@F'&?]6E]H<& IDSC\DU\<,X
MXE0E_ >7F^\6BNLZN8LHN:+,"H4S<-YQE%_9GO*VN;A;_)#,UB =4I(&7?M"
M*I+@8? '\Z2$ 0MC_,)&C:@>"J,8WN9?;0$]+#XH67P^A?(U^8E5R;!>WRB\
M2&GE 6;=WIN[.:\Q"04T*R3S4H;$^0;TXI4IOG+X&'0I_9]IA,1F*F$2'_@P
M(51I3<&?P](DL%4-*)N%P>'MA4@Z!Q\N95Q!E,S 9?7:$ZZ4!VZ( R@NX9(*
M.!4J[%B;!A<N?E[G\+PG%;H]G([Q5@@*J$B2S1H<">ED^P68@ZE)DUB*'/&.
M5F":W\ 0U]0]AT?(>%N3,!5Z</?^2.;<&W-58X6J1$(E^F0OB)/XM+,Z#&UX
MEIC<@2T+]Z<=C\W\EE'7V ^=.Q7F-.T&O,WQ,_M@+=6O:NH1X<YFL9QJF!6\
M^Z7B#3N5<]J%DY?^E)WJ8H>M7Q/0.FQ3]96"N"ZZ-I<J&HS# ]\WQKZ&HF+H
M&-G_*11<*43,&$)@<*E<BBG,?7!#)::$M#(!K]6]:',]X2%[?A+Z)C"",FFC
M;O"F- 1^EM?150JL]5QR/=:\;]\<.=Z64_@I50$%KZ:N)_-]V-FHI\;;54LS
M*03K37>>&H<A#KXBP["^6MV$%O/#H+/#'I!$XF63<^4N<%H5$%1$*?S&>*2@
MS!U81J4 T0V5IIEG"-%=38>/0^>)'YTEGA_EA<WU0+$C7'5,=LB=1S#OFW7"
MZW7;F<OA3<8;'/?+J;XG:NJQ_,B3!U<@:$96>>+/Y&Z[#]71<Y/6$GJA29CK
M GKNU>9P)R>:'\U)[\Z\?UZ188-A%'/U;BF44HPT&E1DUR1-YZJ#UP%X$CI?
M_U(7TDK_IFD"O]94Z#J0HY_^"M-.Y1C<)J8JF.!SD%9UIEIM0?R3B'IUHA )
M(!4K(R,)&B")I)XJ[B 0H!"H3QK/7)9?M.EBKQK'P/(O(GF%/O=$GCX=Q,9U
MDK)597G*+Y1E(&8KOB;VMC#49M%8^559"+>J^=L@A(<+^QAZK!$IG%K/KQ-4
MN.9]P *J;B0W@XV=3!@?*8Z(I?Z_5*GU%9VT'J^.5UGGWCF#>7;)^N9X=M8C
MQ[-P$=Y:,MY.!<CBLK.D0ZGELSES-!D5GA-5CC<8&UJQ0K@>,Q'F *H:I>Y9
MZML5>/P%_0!!$18&P7:=&$,#"4%9=>:H/$]SF5HJ:\U*PIW3_'B38[3;3>QJ
MSJ[Z @1LK82OIG!CY;;J.&T'XZG45"$*Z4(I1$<BHIF/._REN,$_WG9I.E=A
M79!,/EP(--+ID4&4#<JQ29'46X)W>*+I<.* ?@SHR9JUPAY3C]JL77EO+;2_
M:O5Z_<;46 ,=L8C+?+Z3.K=_P$H8;W9)J1\P ^7Q,BB)='%48@0-H1P;.G,2
M@:%U'6K#NJC@/@1I*U1+ MF3*@]#0,HQ,6,Y.^QU=X1IVB17XY=]?ET-1HJ1
MP1ZTG2F4(C-USFIKY^RAEIM,$Z<@AJI8PB%<,Q'%Q$V-)!U"!UTJ(3:Y[#\;
M?/YMPZ*V@QQ]G:'+]X%L-=Q1;LQQC@&%+GI";4U"HCZRALD$\VK:N+,#(V;1
M":FQ:J1!#$9<N3&5X$=C'=IUCD;MTGO01#<S*PY\[M=.&6H7RW=E*'HZUH)E
MYM*(D/*5+E77T1P6I9IN/7+"J:;6Y!@KWCX6R1#[C+8Y87,0KL4#QH;<V M)
M,CH,H07-R.K;9A(*:T[+BW7.O&[19@K'W/C.<08K"*_^ORK!$.\U7_WYE"(E
M.B"8P0N1'Z0;O#%FL)/]H"0E9W1S!D^1N.I-=0>%?ZL_@P87=MO1F@-#OQ,$
MO0(DD^B!4VYO2$,==EY^,%@YF5"@804;>-S_8;\DRH1W@:V>,,N([]-C4D+$
M-I4ZV4./V9#D,J* EI1W?T_M=3-Y5>;R,&BCA@X\PSA@+D-'9,"BI9T+!W"R
M\\B(B)2_<&:1NMC!2$Q3X]DEG!<5]ZB/5B%"M!B(X]FT*KE$[F3FL#++9YBJ
M361GEF6=?UGYX1W670-)O:264+(C'TFE9SGJ.V%_<>E6M'FK&WKG9<3W)S.^
MHQ5#94QE0M5.7A*$&Y,L,VI_ZMH$-B\/[>L'F)P>$A-BQ;:W%Q:G$B0;+M'F
MV9<&-]R<F"P2KL9RPB\U7(Z5]Z47=*W+N<?/$WW3TCJI3 @M-#7.U-(_>CTR
MJ)E4E B"JL1,U$7A$#EV@_-YBW:-+00UB525]W"6;X.+2;17Z%/9NTGARJ<A
M]GRFPE,5O,1.OR;Y^*KCZ3UB944X%:9W^?LN[KFCRQKS%%MB$&W20%(@#NA[
M5G U@Z/YTJ'-/%\JK$^<7,EYPS>CBAE6IE>5/N<L<-J=LNVYW-,6P&22_^@&
M)Q8MS\\SFDMWY3N4ZA?)OG,N'W/P>$E[@(E,4'0.E8E'^,F,9Y%P ''?%JP(
MP;))I$-URISXI;:#B";MQ(R;RX+D%0K:I;#Y[KONAX6MNR-FL-97-6^5JYE^
M7D*O+;E10N9",@=:5T*1_:M7K 9;+P.1B02IL^DL(%)][BM;'>#$]X;<73UP
MV;_%EI$;,<<00 +F8.$S8!G2\7HM-_<@B]JEBLB<J-XH\L'!88NUF 8<$Q64
MFL1M%SY51RL&@TQQ;02' RP_M)YX;5^4.:EIKURN@W5UJ/YH.Q%O>2F-BHC>
M/=,-CE"K(3NBVJ#)W60@TAM8@XH?:JNLX['!:P..(QE$\E4(TSMQ]>!A(BKH
M41I'J>@7& UH(;&Y>4DE)E-O[%4LT3D7E";\(_ABF>6E]LZM=3H$LYLAQWE>
M,GD1QO%!#K&8V+1@;Y@M4V\76G>7"X/G6/H+F4P;-M'YI6=<<]^I02';BBH4
M/A^V9]E:Z)M>I9"]FRUQLGLE=(,//L8ZTX7_LN"=2O>!,I_)6W6DXD;[MW#S
M#6*FML(,+MT\KG)RZ"Z]Z"2B6K!S'$<S_RRSJ;TOC;U^K31\NPK3T3^%.PGT
M*^EC01J'L<HJ"M)[\4NYW6"ARH3\3+KJY0(2ZD9,_:>V>YA/=^AD_V<[!+_J
MB+:VIY0@2B88SQ%H$U4?8^R$[D #GS8H/XVX:%,^)N6SVZ9\?CD2J9^Y"OS*
M4^KW[32B,+4IW"[0 %*YF90<$Z<1#P-DY154]S<'QM8-/DN?'S[)D;J["JB$
M6FRIAZ%UBL-HG L)QP75E13<N#I'[LNY>1/V1SU%XJ$HJ>9/T+S2@U._W$0T
MFP9&J+\TCSS+V_%S,MT\-?\*-@YR7YC&8[P2]1W&5N("_623&6*PZR _Z58N
M;D87HU,#V@6C%%5QQ5'Q76[U#4PG.BXI(I&U_X(AJNMH6&J0A^97Z=A+6[A>
M.SJN!$8O4C.*KA7F&E,#S=S^IJN],QXO4SLRW;0$4>S62-/^HJO%O)#4%D2:
MUC$3!/5>HZ9<8++&C*$OZGOS?JHNU2 #2Y*/$]Q^:$M0'-,-8"SL14'Y1[!H
M3<I#^S "E: ^)_HS^HM3_%-I<.;R6>J1\2K3AA(4D:9I=D]2DW95O<C?HDQ7
M<*2YCVZP]V!,SMD\ FYPTY'7V1T,+Y9R(P_\*1<D^6<UOZ*1$.4H1D/#C ):
M##EVMH-!>JG.4L-XF>?(/\_5,,M(6.9QM73_=='ANF+#!?-XCLF%3SK%<=EO
M#NF4V][&R\QH"J>.3H+:Y+Y'7(C= >%79'"2R%:4EDN#A%4 1E (><\2Z](Z
MSY;H75 L3Q X9&L9*.F,:FR8]JLKXS7Q<S]FJB$!)K.$JD73(%'W7-KPFV0N
M+LR/GM=6J2WLG])9W5"Z[HL^+G.DB?D3_^%(-.HGLZ[8I+K"@*#;XU D &FR
M4O@& 9,=BC3G"53'%J5E[J+R7*(K^"H6=9L"JGI\QNR>QQAGHOH!<B_00[M1
M4L"CZ:Y*K%F!>XE(TW*WF3A, TX#SV0FC.O4*5#EE)X+JZIZG(H.:OFI*@GF
M&YFHV>O1Z)'WNF&F7?T@_:9/LOV838T*:2TDM&[,4(<Q2QN8FE'*VFXW$5GT
MK,G&QP>.J=TI@WW8PKB*1A+_$L-X''USDG/?*)'D-R\D^A9#RHE.-6,6^'QL
MX&V3ST1DJZ"NRI6#]P$(SS?YW+EZ?(6$/R)BF_1&$0 DSS5#I,9"$=_!!GJ[
MF>EMRED+^_SF6_UT!7R:'R=-G$9\^DP2+<IE&0UU3;%;T[?@'/YPCHH7ORQ2
M"X\ZG-DSN+,"BD(G@0VM)'GWSEXGNA4.&W[U0H.Z0?PIZ4@@G0O,<X1H"K7]
M4#H2W839<"-.TZ]BFQ52/W-[]6VU]'5>D>Y0Y8,LNN D)9%=O45D9V]SXS=-
MFT5&#=U>,O-1%)L<@_S)CJVC 5$74CA$=4MC@;'0)8;%_(7!\^#?]-*2$Z07
MA U/LSPFC4.A)LE^E'@!X]7=\1,_G05I#DIBN]16TOD*3']SD%/WS8*M\HMT
M1TX2#*8<QM-<QV[)CG!X+LV#9F6@XX0A!>AJ$&+C,9+S%>G@J_8^%$*H//XS
M[/79K.-3KW(^NIT4Q(N^E/9<CL/GTCU.PJF4;\;$JHU1 0P_-&W"2X!&)F$T
M="?R=X>=94[7"6]YYBU)%6:!R0_I<,/?M?Z_=.T@_<*2:)["LFC)-$W6T_F&
MQL.9 CG], 1L94/O%4/N\A71DSI5U@!L^YYAGQP:FO#<_YJ"PL/'O:%<. (G
MB;3OWR6<5LQ;C*@-%V4?KB-+0P-#2C9T*P]MT7?<:FK"7F#K$TR_5)NQN6P@
M;#OEVMV:28&R5EIB6:LLA[?K:UJ:2"BD3*? FJHN#%G)4 \K80P1D=",HZXT
MW>V'*+7<_CH=<GVA^$!R%U#U,@91W/)J!C09KQ^_<VBDQ82#_BR'EWJ=\(.:
M_6:Z&&^!*7=CYY&3FI;!7"@BEN=FKVW[DSLF>?;6*LFSJ'; ]E^P2"XR>$"[
MZ09?Y-0P@LOI*78531CM,^!8L&W02P]Y$T9?IZFV'=SVO1F#R%#U*7(DN&8!
MA1KTE[K!3H@W&H80H^^DW^&P7X0<DG=:1)OD2C)TR58-\:<ECY=,E.FTM KW
MZ6]JZG&32_S30)FK@5%AZ*1F+KQZ0TNMCDPG<41@0]XF5_O"[M)>:'!6 9_Z
M$.Y.\#8NL_2+&CR*([7;W;G#DM1HJB*=O-[8HE^#54%H!M$V:(LS"^%__:6W
MMWWXR [@PIVD'?JUOS%()7_IH+SX<A4QY\2FTV]AT=X2=D>$VSEL)/U@N$=$
M*XY][/<<LRL:W>MPWI;AT*6TC;%4[QX?0,%:P&'YGDAX<!O.;'W*RO!72G-"
MUQ@S)!5H@;K-V\,,S."A)>X2MU877'OL%J:Q'EI7$L[M@-1%>:%A1&(4.EZH
MI!? : 7M'>ONMS=.<9@S3I.M;XQ(+<9/()"0BDL,DP](TT1;M'S)^O$TCQ<2
M@YD)1MGK>"Y-F-:MN$*D%F84W&N<^CH1PT8=]9+VF>:UG$:813Z,+([=1_#>
M9?C,Y.+5#FM(FE-N5L&G.7EN>K+;NEY?]77)0"_N/%.&I'D<91=4Y?=W.Q6S
MT"Q-G]41OC1G_0Q>JQJ)>OOFJ.-3K'U C!V!IH\N.9,F)^^CEIX/@L+[K$=\
MY!?ZO3P&WRQ\Q9G_F+"EW*V^IM:?,TWD:6,T6LK)\"\VRF[0:EC6/9)J0<TA
M+E1QB '51]S;";^[&)<YF_8)A4<%Y!;;@;0(XW;%''6\-*<JT.?3,=5A3@5#
M30FAQ+Y<+([NZN;VNJ4FPAVG;:W)7YFFPBYXZ;;.M9W[)S570MUAN$4:_M2G
M3A@1-099SX7'SB1YV!N72@]=XD--IR\P+,MLB5X+:EC#+"R''89*=WPF5Z^A
M"5+51]?A8.IV-7*D0EA?.[.Q-Q)L*;,TL&T>N=NXVCWM^&/=IIKK\#"0+5!+
M#/.B.0?_O"4%7M:5?8;#=.(>F1KB.6;2DR2Q/6TJFR!:1/_8'-C:)_B9-A?K
MYX-V[19:&2=N0D( (_.=#D79>"__)O76WUU*C2]!P]TI4_D_LP4J/AC#'ATF
MAK**A]\X6@'$A8M,GW-5>:4@=;AL'2=EM;; T)/TG;$-C&I$^8G!X)?.Q>)E
MV/YX7Y5;">R44HM4;EB-6JT0-ER;W&((A[YLK.H)>S7Q4I!.N]"59 RBMY5E
M528WN3YKJ]BCW%;$\%4/0]XP13'@GSDQ\P[S[-9N]W<+"5ERQ$GBB(K8**9
M;*>W^?+K*]<JTQ(C*Z-%I)A.),Z/K"O2[BZ/ON%#$\S;C&&]K["N!VF1E%@E
MI"*(U5IM2![(O("#W*;TWN<AP_<0/[GDDCIL:@@BT)= ,(RL:G3L(+=773[
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MD)^51&GTQ2?/DW$Y=*=F2'<A4;: *:?^T]"]<^5BJG/ _(FD.?V07\W*B8*
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M>LJ:*Z^YZ(V:K96PY$/QU%"0450ANDPQ8L$!40Q9%C0P3$'$T<" :3ON6<$
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M%!R1UA?KFO>FO]/!2W&K$]S [0 VT>[6)AC!MNX-?Y%AK<D00\EHM*IO&*6
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MFR^G'%4P7AJC,H[=]_)^!)2"^'<)(C>*8*!#N*\3^*<V@.E>?HE??$'?U!/
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M#0V3ND8#SA)-AE<.#C7T-Q5$UE421<S$7DBS6'H*I<][22UM24_)"JWG*13
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M(XOU&-D#L+,L>L"OM")YT*#)GRQY-!MS36E<$P58KZCXSKTJ_@BK1ZJ/N>L
MR?N-79']O.T,1:$#]2N3G=$\>MN5:V94NOJ^"M=STGDE0&:#ZNGZL^OIXG2S
MY+^W'H9$CVT5#VU,$=[W^X<[A^_V=SXVWAT=[NZ?[!\=;C<^[G_^N@^_G#9V
M#G<;[W8^[9_ %[[L'1]]_?)N[[A>8#5]7>]$[[SQ'N2CE8#6>RL*2UQ*"I\U
M$M$7%9148^4TC:#JTN57%8ZBIA]$3RDJ[-,FI2]35-@+7J2:K&LGZR^T].TJ
M./OGKVRZ<N7ZV!R+FB-D<V76_Y@RC^N\_LVKU(B*FKYNM54U,:K"2-X7J'AD
M_;*^9HN&;5#1L(#Q-6\U;NEX$^C8"RT=6SI>?3KFZ+BL)QUO0EVTH;0TZ!E_
M7]:^5KW'24KKPV0KQ"^O61@V67W*8%E:6"8M>.[L-"Y+"QM%"S2(FMY+TL)&
M&0^*ZS U'3:?93A8'WYXW!)KSB@L<IO^W/E,*Z0867JKT]I>4S]\0JZUI3=+
M;T^D-S=8$KW5,(%H>F0!7O,ZNN!3R4=P-/01[ RO^L8J1!X\VN-1"9^BW&DZ
MDZD\DYE1.DZAT8&S-S]EE_@FDZ< C]UTNC_Q144R%"Q(G)E/1V-AM"N&$TL)
MQ-?7<= JN];Q#!APA6:'=K_3O87W"R QT8)G1N%68IC<-1XHMA)!A$-J^YH+
ME?M#&\O.A%"Y# ):+2J_SU)5H7#7FY:K-D'@Q4.]4N+?>$H?!NR4(OUA,8,4
MWCKHYG0O9![#:*+(.XU+S,.1@QZ@(T;"*G@B:=9LGQ])K>^'*M"JXN)]REP5
M$YE7RJ-Y),E<#;KR7/^BH[AUJ'/O7&#^A2H^0W ^ZXK+(9$@ZI5(*E$Q9D'D
M*1R]T==DD;B6IY)<"B0[H+:D?ND"TRGJ8_:?09;@E''->2>.QA?5@WV2JQ$W
M?:*S2O"RBA5&\0T#^WJJI23&*+?&%CF\"H%&-(#H')65#NF+FCQX@9 ^M\F<
MIPV[A"@YF"Q]W(1LE-S*1$F5^]@W-CUDKKH9X_%SFV "UK*/P7#X00&J7XL6
M8KV-%]O$^(0PXDOI&5<?\YZEXW6@X\!G=6V7N@EQ-CN3=J_Y&OI,6?.Z,=RT
M)=:;J3PG:/(YF6HZ\2ZS.Z"EN56B.1Y&<P?^+I#F-D$%V,^=$3;68\5]H9SR
MHF:.];_7Z%S6F>;<()Q;)EBT#WY3A.DK<8N2M!6B5UF@8=2S0K2EN=]+<RZ;
MNZ^?%:+G]"3$<[<K7F<F63U)ACGA4YL/6^G9TMS3:,YSGYK6;*7GQVVQ*;AG
M9>:5EE^V_9#/#<Y6:K94]SRJ<]VEZFJ;(#=_&X^FMR+T*HLS=!O^_M3Z%E:(
MME3W1*JC/%BFZE;#1+#I<=TS@_U,YY1$-42K!3_W^MV!B<OOGXM^XUQ<#P/Q
M,8>@DS;:,+8.RK_M82GJENKU&C?G:I0<D#0;%6C7/2)4"@\FNE64+A[=AQ][
M"EZD1RC^ULI$G+7TRU8BY'_VOOY__R=DE ZI<BGI3D>#KIG8U!D6O72P(GBE
M)J^)#P9$;?>RGFZCDYKGSU5+9Y@D2A?>[G1O1YENNL]#+-H_>PVA&4ZG<=QT
MNO#(< (FF<FDJ6#S+/*? 3!6_W:[T3OO=/L$&U/D7])TB+TOU+,6D1-XTGCE
MTJ 9#G->QI84WXXW"LFS^(;M@70!>"_P2SDS]S[?&?3A%S768NA]J65 UDX[
MW<N\_X;I$E)4,F]TU9DPF3!7L!FBC7S15:,]*1=B'[[T=M2  ^=ZU>WH?BJV
M=85M73$."BL!J]4+A"P51JNSN1=K2CEVS&.5Q@V,Z<X-E7Z)4P<;-BG*\0OY
MNC%HCUH[W->+H=2RX95?"$CY1)J-O5\XHDZU&^ON,!Q)_3)]\4P[P^W9\+L]
M+<]Y>RS1>2+U\*%.$%Z(L;<;T@LBF-T+8@W;.LSH$T@Y*[=YPVSF2A\N??WR
MJ!F,_;G:VZV6C1F!B5N828O ,47*'6_FNM1VC;Y3Z;O6K.>.5CO;S18.L;%/
MGL>L/\,T4Y5W)3-]XDSQ"/B]W/.FFM+<VY[(6M8RUJ@+G6BW!ZCGM!%-L+_>
M6#^WQ*3/EU/NEGKSU^HT&]7CG%8YHW20H[ND!Z?<*S+<;YL3 Y5O(*W-=J1F
MP*1HAPB'GW42/3@,#,>%G01OE-%Z>X,TS61F2G_D-3M05#_7;9,Z\/G5%2@L
M>J"V4DFOZ/U5%$/(59=R/8_9*(!SD&*0PT#?/(>;E>](=V 6K+4+D S@1C!$
M..R<J-/L*_%B*R'K8?R$85\XFJS?2(4L=F6Y8A^>WBM>[@(]>98:%V;*@X^6
M](:-* TJ 16]@CNQTE?R"E!$9E?PUK$.F$@LQTI3^4ZCW<'^T_#EOP>MVX:W
M/2K! 'IV%V0'^&L)QN#QT:BCF@XGJ(1_[-2N$^Z,/L]8A<*46, %C0H4%*8M
M7-([0USO#7$!6NS,/C0- 0GLI5;C^[!["-]QI]O5/8^*ZA>ZW^D<P^+WAX.,
MBJF(:Y&U-,K-'#;O;VS:.I>FU%)].%*]ZIQY=!?049NZ;=/;CD?!2!%I-KX!
MNG205'3M%XG<!Y<>",,9()[0R'0)BHZY)W/KA(&J6UTF24HTV?6Q)ZG9=].(
MM9T Y$UOF>ELOS GSZ78EPH!62O([[&".'X1*%?OQIU5?EX%_/LTZ/8&R+9Y
MX9R\^@]*&AT07$1>90>79ZZKLZ[25<MZ&NJ,K N8F=]1ER)K]^'_#=5#QT;6
M.]<2$P -_$$/V17&-)!UC-C1+\!$@APT]EA+C7V[V=AO#VL!&4 <30:MS?J]
M><MV+4:A87.XBFUXC6GL;"PC-\I8J!$U<7+=+&]NW=&+'0GW#Z']#:Q-:Q)P
M58-4AO9DT[2XU2H(0^]<:2:X;G@R!U!4,&#V6=O(J/'4T73'9KA9>_FMW1M;
M??\<I/"S<X!WG)=;MQI:TTGOFZX3E"G<=)2PM995",E#E>P,9-2N&(DW):6K
MWSE3^KC-?INKT-PT(W%DXC:\@9L,-UDD0+?8Q1QOI23IXK6$#Z!IK*>4OE1'
MXH"1TDV_[?Q6*T1Q<XS%C6=./![T8+TX8FF^4XNFX4)[$NA]T%)#M5"/HZFF
M ]QPEH]=(92IU=/J=? S_%Z=2Q 11KKP.WBBBX7B8&^.1NN=:>O3ETH&)]SN
MOW%][8)_]!J7KK*6%UL^7-'K=:3IY*O)N=,^ZVC)L:"D4C4V1%U#=09UC08P
M-&>4RZ/E+>Z-MMHKK*M&M.V/->.\A'=W$?BSOKKLO9D30BJ%? B&,NC#^;-\
M6H2&P^.JS8F@LY7Y4YVM2Y[;GV.[23G:MHW*,J0*U"E1:Q,:H8PIHJ]]A/#C
M-6C\G8'6(H<,IXD+[0^ O-U>63DH^JT.B_$!!G7%S9 P>DNU,"+A@G!B1(.S
M3B?)!0)=^6]T3VIGZ8>=G4_;^2TY6DV9V8 E4.H $32O3)=;=7 X;*-]J[4L
M^"H6\=!,6?B*X?VJ?[]0H.6'DJ8U:,-(PQJ&L@0 I8.9[R0F=P-8^Q+M-X8(
M7D7^R%N]/9)Z7@5.,QI5;AP:QN ^O!)9DA=4=+7UJ;QY90I*QB0V[7WN=B[,
M-N:RX C;A1&.M*$+G=:X9A Y]9(*(C:V+M,B_A:K!EXCU;9N#2D; 1(+[ X1
M2I/O[4@ TAL6#X @&U>=UBW:STPY2X&,43)]E/90V\8:<;<#RGI7^ZMR<T@^
M#QV"$?S9*T8DYNZ_.A>P"JD&.JX'-DW^%&?:W=[M) /9GS?RY.FX^1L8C[+[
MX?'W3&$V"K;@DC1!'U5929>-P1,=M($MNGUX66*^E/50WY%(TKUA!)-FNNR7
M,G(GPB:*?P3E3OW4-K)*1?$SH%&8*.IC%, =JZ]1X/[9K9910+/'"O/[=.E\
MN?Q^K]0S*M=N#(7E*WU4?%C[_,TU"%=VL@TW0];" 7/Q%^#['%[9-45H\<*Z
MPDMDVP@09F2C:N=J-5R)/+B'_?T:<?]FF 0COO7VHZXLO6R;X&HHW%_V3_;?
M[7QL[+Q[=_3U\&3_\$-C[_AD_V#G9.^X7@N8OLL'PV8)0[&L9'XU]B+1NNW!
M+9V;<E1O7'P?V35!+.^K4I@R2JA7Z-;*G;LS-0HCI@K4G&0>?%F8XG(1$UW*
MN03<*S=XT(;1GPJMF]FE4==PRB")7%[EXDH/8_R&8CK.J3>(+TQXBC&&H4%0
M_=K.)YVFVG2($[HL/-[H4AZI,@\N7_MR1A:XLBT@]P5KN1;&D%D^Y=("8(82
M [M1"H;U:2X>:CSZN]>B-3!HC3J"L5$8 ]G0)E;H,?G<AC%83S0^;&(06+A1
M06 3^*9EL'W0V+)NX=/^B%K!1SCOI+&CLP3>+,MPH2>GI]/2TS%)"V5-'[1&
M8 8T2U^UT LS)I'HWZHRCTXL(9V4#- %D ^(W-@WH?&H"F>C_<#L"O2C-&36
ME8-+Y%")02"] <),3_>,084XOXT1/(S%'?MWR&X'[NEVYS*3C:$)0V=NB$8>
MY)F[*K03N(_ZTIEQ..=A-CJ4J9^[;$Q42DE9SHW69O':OHTE_#O&.@ GI9>G
M7Z=_0$O<E0Z%Q>@>5/N'R*&32<[@!VPXTNGFT X@AAD')D85$6YH--5VTA30
M3I]&@H">>R$T=(IN5UN $,)4R>-BDDXNQ:VV@,3H^S(^+8R7:>P4,\YZ0]^2
M2O+3P!_2V:/G3QJC2D__!6Z'XL/<BCN</J M7'^YN6>TEMR2 Z_5Y*8=)L.Q
MFXT2FZ"-1=T8&!\Z-41["/!)\<KAX'CQ=3L@.IMM&EYS9=?_Q2 Y,U2'%V<>
M7XF3R@>#MRIT7F@J1R<(["D<Z@U^V00+FTX1^=VJWPA7J];"\_7J+VZ7"6(D
MV!O?7^E:';^SQLU, Q011O?94!0HTE:*56!XU-#::NA47]Y !=V?, ?=B G-
M2_  [NG8><*C"D\ZOPLQO>E()YS<3RFXG#(3MSKP[DP'M6&5X:3(,#$++G;R
MM>GV],?0?)AD("5@4#9>\_T;I=JCF0WEJ HU:O\ S#N%=YL_F=R3?#DZ7P6_
M4W2+T7$I^?9LEV4>#2N7^/?26 W\YMD]5'8_"6\W2F2O38)HY<G;C(R] 3=X
M%O5,+@@W# ,"$48T?H[29:X&702DQZPMOBT65D3'PP1R=N[D8*'TJ@970.#F
MA6EY=3J;S4"@R>;1-JJZJQA3KN /G4ZB_:Q(*D>:2O?;</6<9>A5S6_E95[*
MHQD"6TV_.0$/\,;MY_&Y&",^$I"-@(T2>;\4 ))'\L8 @\K<WMI":<S+B!W%
MY2<UM\#[IE_/B[N2'K5,'-]H#\9;D?5U[$5KF$22WT?B$M^GYXVA%/H[IM7/
M=CEF L;HJ;-<Q=C1W@DSA=%+07CHGNF7%BV"1IH,\E&N!55F-8E9^1/%K3D.
M7-MZ1] C9CP5.H1"!U[FC\$F#B<'!]R1A=DHO^'*[VZBEUKCM X,*('!\-*#
M;6HK/%F,.\'7YB@WAJ4[N;9640"'>(K[.&W'\/!&4EL.FSJ(>7L*B Y)3QO'
MQZ_8J9<<:C#HG,H].</+<W2D^NI[WOSUJT6KAW8Y.'[L$Z8P$D*#QE!IU?$-
MR1 >D^Y@Y%R!!U"2[II(YZR=S]4$$B'@#MTQU2=U-.V-PI,V81YP-JJ5>]8Q
M!&-@ A-UX\0;4@BH6;O=N<Z5_?Q21:KOC.1S](RI+@JAV=W0*F!N'M5'2K@$
MM3<C"!8=G8W9N^VA@QT(2DO0O>(6'9(+QD.6B'BD+$Q\JWKNV[G$JV/02_ZR
M(DO+',]0&'N\0@[G/K((G TR8Q[11XF, Q2'J0LZ-@&EO:S;,QG:L*$F15?K
MWX5P7E[3+"5#B^4#4"EN<YNM%K8*66D840/WXVA43; (?7#*I36HKDZ7A1EO
M:Q6CN+P1?$T^[23OY@_I+?\/QL<52YA%V]J84K0YPSW05X6)<QUN&$)OZ9Z8
M&&(_W<ZE<2TAZ*_J7<SMTVHT^<2 %$P=@W01Z"X[70Q8^HE\!9^U#?H5]T=)
M3H$#5RC'YY?6.,Z9;(*6B=%%*;0_ ;?:L][6K];4EM\[S]R_>@DYTXTM_\#^
MX3YD"%F@].BK(!L)-OEE/-2-BJO!2)SJET"!P421YAKLV$C#6"YCL (*/\^N
M)L9O" G#]PHVN<E-DMIWJ:\Z.+IA.O=E)QF[QT5#'TLN=AJ%8:C9H8*$WRD4
MO6'R:'$KP-)S%:Y7UN'@EWZ_F\4#TZ8OCR15OS+3>'28TV*:XQII P-%M2I0
ML'XK2X?B\-2-Z!4HKQ/7=0A% 8K#"-2N FC32?&H&%3/Q=B);Z><V#1M9NP*
MQ\?@1+-DH./WQC=YVNJG+R$W(:,)CO3%K\F1NLJL<%S/F:;AF'47&8SC&HX.
MC:FN45_T&#/21YBXSFVX(^_X:%@TY&@KD\XAN@20["3#LP,8&:EOL&_IH&6&
M,_AK# N/M4,M3M!]/VGW@4,Y.T.#P)@N;28X/0;N38/^,6;0T%9M4KI!&H4M
M&8\%F 4SQ*2Q/XV"8/(+=B0[Y5?MGPTV/KP<EP#@#6V,6DUQ7X>JH<QI.]^
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M:1%<5U:9;#-7B>=OF@86HV?SL/2A@'R"GWSLB#S[26DA^"_321>Y</[DG^4
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M#SM]U:#^']8'47-5H@?KA9\*7+OI]=_H,]W7)VGQZPGX-9FTH2(AN9",N!Q
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MVG3N:2EO(I(V(SEV'N9<@(2S .8T\]QI)U-9]5#UCU++KXODUZKWB08\3JA
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MTW=&CX@89C#HSWZD+MO+>26>MO0O3E?#4$AY*.)4L<!)>$H] ;*DB%P:)6G
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M"OBYI?(N)SNE$YD)>A;O%H9WD^$?#HNX*Q-)?!J&(/1X+@EC-R4)G#]E(?=
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M4"B*C!D]7VJW1H5YC0I]T3[+L,F2<3?8:IZ_RXY0;+Q)SSM4_;U?LC7 O;/
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M_SMQ_U&KG\[@"W7-K/^.;80Q/._=TFAE(LY:63]3O3=/HIN'%U]#Z>@9?+)
M#%_Y/=NX)K2'G3Z,=B5NA4YO&8:G%!ZE1,43F2[/=F37;QOFUJK65'-ZKDWH
MIM=_HTGJDZ&HG7:BK?"[0$:VE^<3-*:+R?H>/F.!<A*7@'KD$IZZE$3<421*
M8U":A%"^%V^]9<^WO]<OG,8BS]HBSW-M-A9Y7@!YJI% 2>H&?N"1. @]K$62
MD%#P@(@@<H(HC%,6TJVWG-<*>A:D_*R.2+<C)2RG/Y3J;#C0[^A9H[<\QQZ+
M-T_!F\EB)=))O4A%&&H88=EV+D@8<4E4RMR(,<_UA N2#O5L5=2U9M,%]IBQ
M;+H -JV(!3*$RU_%*7$3C BB;DIBARH"H(H532+%?)V-O "5I'XA0:LC%VQ<
M#E*-!8;\+ HEY=/804RF.!2-R3^.;-L6M>9"K<FZ)WB7> EE1(I0$BXCGT2*
MAUA#P5,.2X(XPI:=SX\UKI\9Q3+TXONZ6(;^[0Q=$4-8P'R9.BE)J0/:0N!@
M@Q<1$B&9$XA(I3ZF&;):U3':1.-$=Z!@<T5+5P[>;MR(,Q@?A9)GR1^;H0DM
MPC^3'\%Q?@+?</\!MXK,2:L5/06.)LNF*)<Q*5E"J$P"PEWI$KQ:2,IE0KE2
MCHB3K;?! N)UK>VBQAR["+^&Y=B7X=B* ,$]UY'<2TGDNIQPW_=!=I !<53*
M_<3G89JZ6V\I]6M5&_G_L??N36T=V?KP5U%QID[E5'DQ?;\XYZ6*&"?'4P,X
M,4E^]C^IOAK90F(D81M_^G?U%L)8P@Y"$FQ0UTPP0M*^K7Z>7O>U<7Z,%U<Z
MJRT5X]@,"V>%,8Y"0I=MFU+EG5OQSGQ_%#1;A$A2 4/+!83C!*P/"9(E)!A%
M ]$:#1>QLOSWZHIH(U!7&.6H0%T-4&<#'5E'YK0OPU<,B-*MW1*=P*/(=%(^
M$UF N@+]H+H85C<O]DI">/4LW/&<V*E_\[Q2T&TH:+Y%BG!9)&L)Z*P#X"Z!
M-HI)J#K@3QZU+3I#TXQIZ<[/U:O08K2N9TYL1>NR:)WMT^X2MY1J8-ZC9N]-
M I>)!6:%LS30H!6B]5'.B7U ^L)7!2_+:@N;8:NLM(_:E2!H)9[;$,]\OY!,
M'75))#!!.K14O .4C ,6B5%)T6B<*D-=:*N:-E:?0FOUA(K3U>!T1D&P7$N1
M-0%O7>E^@;J!H8F"U]QS&34EUA5UGC_&K(5VJP63;FJK4@OFFUPLWHSH85/1
MJE2&RD)+LM#[.6W!N9R38A&,SR7PZ04X&C(03A*-6B<1[-:.I'9E7H6V]!9;
MH<=A@Z&]*BVC0GMY:,\H&,82DRB5H)PA()(Q8!U1@ O292N)8DHCM*U864_E
M.VJN]<B;/@WZ;V&<AB?7-N!8Q,#98%I:F<:!PCA"6912\MI(^G;4]'EWOKJ3
M:9I4X)!XM" ,XV 35R #CTP3&9U06SN,K&ZP1%NTCA7Z+S88WBO3.BJ\5P+O
MV<:>)#$?E"W=(<I >T+ ,:V **]49,+KW,#;/+2VGH_;[5$'V+9D@.T58ZC.
MQER4CI[/:1O$&2<XB\",U" BRV"UM& C=6@D92-E29P0K8K%UL2)MBH-%:XK
MANN,]N 8J@A",8A(J""8BF!)&7@0""52,9.XV=H1V[9%:-T(ST3M(M$>G6'1
MHO.K'%4-G=M1U7P_SA@24YPGX%PF$#H$<"1ST$+0Q D-M% 5,ZWJBE=3+=JJ
M6510WPNH9[T73* &HAU".3$04BBT%#B'Y+)-2BO/4T#]@VS+%H%Z(QP4M;RC
MA>4=E7ENR3SS32]5-(JAU0.*.@(BA^*H" 3IQV0690XTZZT=RVN%QZ,&[)HK
M/"I@;P_8.57!XO]E!JDH155!1?"."B ))1=,DIZKK1W5+L!NA*_B,I81!B>G
MJ%:[!G3507'G08UG5Y[_ER*SGAN-NKF;8B6C6Y+1?%?+[+Q#RN' J NH/3@&
MGG(*AMI (M&&R[2U0VUM:_FH ;SJ,$<%\-H /-N$*D5E>8ET2(_:!/$"O&0!
MK(PH153^A66--W'IR$=U/-RF3K1WF9E9'0_W62E:*>>6E#/?J5*K+*B1%I0T
MOE". <.<!QN5\UEYIRDIY1_;JD4&3/4XM%5GJ$A='5)GE(/("''1*F"<21!)
MB!)J=!"X+>G2W AMMW;X"D*-U=5PFVK1?Z^F><0&)W6OH4JTLLY"K#/?GS+2
M[)1QN8S]RR L96 R<V!%3DS%$)WW)2)!5V:3U$*-QX3I-92'5DPOBND934*9
M*(G/')B4M$09(YA(" 2'^KZBGN=H$-/:K*SQQ!U59TROXV*QJ@:PJS86;G",
MF]SN,L>_EVN\(U7NI!MC+]T7LST;G)QTQR7;:C*6I' 97GSJ!R2>S@]ER'"'
MFO_YIH)WBPUE/?K1IU'W:;_;^_^VQL.S-$NF5^YRMQ^?7;W'2JX+D>M\]RUM
M<R"$F\*K^,.4AMZE4V>4RJG@3!3"%4C-\.IZ=).U+L=%MO;;+\>Z"&^R"&=;
M2UF.+"$)(#>@UAYT!"NM QU]$L(['VS^YB)LV6;:ZF-LA'_C^7_.NN/SIZO<
M]%IUC+N.8,7NA^FQ+PX!Y?-/*2\"N;?BGN$T8V8T'H3W3SK?W I&QVY8J'D]
M*?#3RWA5KN)5<ZK=L_'Q8(@W$ZMZLL#.<+#W?+S_[*N=X4/\Y0\1_^]?O3>L
M]\&_.WV'W\5[_./X<.\%.<1[/OSSN7S]#L_][LW)ZW<_OW_]^?7'@Y,_>OO4
MG.^__8O:1'FT$K2)O PVHV"XB^ X93DXXH.,WU$BKETY*ZN(JBNGS2O'2YU5
MDA"#)2!((. 58T T2T&EF)R@6SO7)4K._:&#]-<KZVJRG#KN4L@_MHBT#L_&
MHS':D$CO=>W=W]JCN/9X2$K2)$#FY$ HGL ICNHP-S*JG*E@:E'66N?2>3$:
MG57&NN]5(UV0QA('(>32G]=:L"RB.2^%R(R5M63;M-=5PFG-T@DY1V=YTW/=
M@XA<@&?"0"*&.9Z=DI&W:>E4PFG#JL%%$[C7#+(PL?@/44723"'K9!^(S8PX
MO[5#;J(BW4")NE">NHWH)RT=OA!(I]OOE.74_+UL9)?&/QJO-8-JG7T=OH+G
M'ZY7_*5Y,#QQ8SS+I_'3W/V4(GQ.PT'%ZZ)XG?'5TZB-0E2!=CXA3:-):[4(
MH#TQ*4:1C&!;.__]7P;E]F.+LJIJ_F-;TQ0J>M>(WMD@A_<V"BJ DUB4+,K
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MP=JM'2VOZ;'^;=J:]4)?LM855W5KJ*O&WUJQ&/']%W^EH*SWIG3O+#.0D7G
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M8+3QPWP>Q4>PT<_A=@U^-N#)')P5A;LQ:R_S_1OT;/)#^;KT89.?Q,T[7FS
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MJ*23M SXX(HC>UL&QI,,VJ1(M6!,$_*PV'L3:G)V40 ?NN/SSC#UW#C%SGB
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M"XL_I3[^,G[9<_W?4AB\[>-MQ(,T_L5U^Z7R;>\L'0V>G0W'KMMK*GXJ52U
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M$SKLOT*1'.:7P])Z;7Q>G$?CYU/I5*9:B*F>S]D1U/&8?0A /=<@4LC@C>*
MO$4E34FY9(L=T28/4?7[/I1H3@7Q>D \8SUP(SDEFD'FU):R+@].^P"1L:BI
M,=0%7JR'I5,]*XA;"^+U!6\JB-<"XEF;@09'DRYS%+S+(+QT8$KYE^ 9I>BC
M#YIL[>A6[<0;5D*REW(:#M%VF#8)=I\VK7+DCD,.WXXG-X*8=#@_<I^>?RJU
M;.DBP%RY:"$N>C%G%42IN+*2 (^2@]!!@O5:@A&XA0C*C,]H%2!BY]-!JC_R
M,4!WK0E>%;JKA.Z,+1!<ED9H CJ;",(ZC@9]2>3RDC,KC%#!;>T(UA;?8X5N
M^T()%;IW MU9"R!E;D7VN?1B3E" "B8YA;LN]\H&:I-)I8U;2S;=#8L:3(L_
M2I1@,#Y.P\XPC;O#21G(*=K"HPT,%=RO.?!Q-'YZ(9;=?CPL0GDY&(V_R.6"
MF2YXZB!5CEJ,H_;G+ .I3#0V.F#22D!3@()3V8$/7"BK$A.9;NW0ZSI=W)RD
MJINQM6[&E>4=5>RN'[LSIH'1(;*4# B"5H'(A)29K1*4YLZZ*(CUKL%N+?)X
MO !>6:91!?#: 3QK(/A@%!,D@"X]((22%HS3"33ED?@0.<V^=(Y5+<+OAH4(
M2CQL?%[*%?"6N@B'KC\;I]A);MC'VYF4+^3<[77=.$TLAO*GV"T3!ONQ1A/N
MKH#ARWC4GX>#DXG@]M/X>!!?]#^DBP&12%N'>6\JG</AWE2F>+4U3W(Q0OMU
MSIH(J'XP@H8$I8J!L%F"9Y$!,\&G2#A).J)&8K9I.UP>U5G9OCA#!?5]@WK&
MS& )Y6=4 H2V L%T!A>L DUR#D&A[NF*F:%K,<,C!?7*BQDJJ.\<U+.F!Z=!
M,28%4$8]"&H=@CI&B#%GQH(T(9NFG>0C#$Y0UGJSX]FQZ[]-39ET4]<P*6:8
MED5_-:-\'4Z5>HR-,W21DX?)C5*SY$+ &\-%-TPA=3\XW[M=1[2-V!W78<<V
MDMA+DW]?]'<OY/';I3CJ_K?0_O=ZSE+-7&D6> (A%2]#F]!2=8I"R,D98K45
M$2U5+J_QO56E]C' =AV6:H7MRF$[8XMJ;@P)P8!048+0"%OCO(*BL.I@?(IE
MX!$*ZYHI*A6WCP&WZS!&*VY7C=M9<S-PXSU3&JC-JLP?SF M)> US:@X:4U(
MB72IMFRW&Y8+=U7Y[_8_I/YX,.S>LA3FP0;=6Z;TO_@BATH_"]%/F-/VA1$H
M N+ (]> L*)4Y5$.,D6;A5<Y487T8Y?R=M4DF?;B]0ZT_8K7)? Z6_02B4>[
M/ %)V8%PUH)UB0,J>M&43%5?U 6CEM+R*U[;B]<[T/(K7F^/UUGU'J430R(,
M>,@$!!4.K'$,I HD>LO+T).M'7U=8^)[P>N&^?:GB[[S0_<"!O]3-/U)U4LX
M&PY+R<LDSK19?OY6%+_/4U.3?/ML(I?=1BR5H19BJ+=S%D!26A"+*G\B/H-
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MR6EO<)[2Q';IG)X-PS%"I(.&7;\![[#KSQHX;%;HIBW62],*JDR3&9]7/EJ
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MFW8^:5JHFU9Q&N3< 6<&@TZ9/)"B^'=:>R:SDN1DR'376:?7'R1F!-,9E E
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M4TYCILM(/YZ;RS*7Z\SXD-X!O]B0\DQGG@#O@HM<B:V)MBUM;>.$I)>3-WO
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M9H5YKM;Z83'NY4!7&!)<K4188DL+K$Q:R\XIG]/E*S=Z<A+Y3EEB.<=H5'F
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M@!>RP8L-,.":<[W9F;F9$J<Y[;L)H@LLI86%+H+@UA5:<UCO,EJ)&7>%:TS
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MR.!,<((T#'J-)_\AXP2L(DI*K3V6/!3<"!V=L(R'X*7C#8/>.O%BT00,*:/
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MC>J^=CQ:K*NTI+J_%X?0_L,/>]">O:OT[,.#][S]X2V#-F-X/X?GPUB\I,D
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MO<V4O#=C<NT5B1M$;1!U,Q'UV^H%-HBZ1D1=U'J5T9A;'%!()7&X* 2"?9+
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MALP5@787?*V([2L@^J@?WX]_^1WV8&"DI^^;G6(0Q9=^;]O>/FCDB.2)HZG
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M6F1:!*N3NSHYY(TE,> 4;*ZF0%;9?)CR>%1GCN)]KUNY%FY]5,KU4.6:M#[
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MN@"^6[C>_BX:ASMDA^[@QN'WD\V-G9/='SOPO=;/QH_=@\T?7UN-IL&[_SG
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ML<;67DJ*^J)OL[02<9,TTKEO.C%4*465$$HL3_.K2]W<;+&<18^WRY)IVUV
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MG3%1,A:2D\%8A7GE\GXN=9UT><>,GSFIFF*/.#$16:T)2L0D0ZA6.K"5-;X
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MSG7KP-:>0LQ&#WKI.;?ST>(;%K23^OZ>UB)FRP8E'W*["XK!"L8<R9BX)L3
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MH\^AJA-TU-.@."42@?$ =%2%@&#54G:ODLB3-,'[I5/5M^8X_7 -'57STM$
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MJP3K#H+%P1PPP2JKDD @7P)QPP6RQH!UP"AL'P9V$4KN#%.9A)UG@,%FUA^
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MW^6BYZSLHZ,64+Y\PE2VO?Y]C)ZVYK).Y!;@L'0)-KV0&W1G83L V<JLL9M
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MEY-'.KW8O'WR;,,1XG-UW,$@O1C_\%ML#PXZ[OA%N]L(7_.AW_9=_^]V=_S
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MKX#>N7:_]6_7.4J+Y/@O1WJ6O)D>^S<^V03SJXB[:[;Y4\E]<DFG:+.CPD<
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M=DJOQI "KHLD2<M$0&@@-I<#;96Y]<D:&\,JZM6G<,A]MYWKU[149DUZ@#U
M0OL0:6OJWFU!]N_9<WZ>-?<(K5%900!U(G&."R)4$CPDI:#T;1=\@RTIJ+DJ
MW;IN6=E7H>R)0=FR*@4JE"T-RJ9[OR;&7,H(8-0[ LEDXE#U$ M@A#$<-S-=
M*C]"A;(*92OSW ]09E&A;%E0-AVP"L8Q5#:)<(8&&5 KB9.1$ZZ$$<QGQ#*#
M4&8W5(6R"F5/&,J65;]R"935Z-YR(&[ZU$QJ<-IE(H3V"'&1$2-$(IH+2Z75
M#&Q<=D+-7:/<^B?;7-J:Z[3OS[4HMJ]H^%U6:4ZW[TOF:O60[-HTRG?:3;Q.
M:)W0.J$KRPZ^%@="I>(7QUK:P:&!-FCC<C8*HA)8/Q'&M&4=]?Q^-,!A# :O
M>_N^W6WVT.G>>GUV:XWMC>-JBR]DB[_]4>SPX4'0[H_-O=V3+VAO4R:Y)%YJ
M14!D14QVO/"E>2JY\2K$0N"@5RBSO5(X5D"ZCP.;&P%2#1HL":@VSP,5Z*BY
MMX7:0I9,/A6)B=20P!0'D*!X7GK4H()5!:O'<B13P>HAP>KC>;#BP0JTB#UA
ME#D"U&AB?5"$<I6]RXIIL\[%^!6LUA2LEG7H4EV]^P"E,.7J:07HU0'1AKO"
M51N)!V'1WQ,V:P#\!U;-U5O_<Y6+NL!U3L]4:CWS78>>M@^_IOX\QOY7_;Y#
M4&KZDD^@Z'7'#0;MW$YQJ]<=TKT=5GA:#)Y^SD2B0@PA@%%$L$S19A*:& 0I
MXCC-#!'%!3]L<G1K?*JU6JLKT<N*W52)?@")G@K9<+0"A.6"1&XU :TH\4%[
MPKGDA@)UC(8JT>LNT<L*<"Q#HFN\8TF2/AWO8,&A,\@(E[IDK8(C7G%#,G?2
MR@39VN5Q)%5A7UUA7U: H K["@G[5!PA&:DD0XV>4:Q1V#4GSH(ETE/#FTX;
M@J^BL%\12[BOQO;K]\ZGD.5TJ]YE3Y3JDDNG7$Y61H7XX*QGTH!V-DFJA(_N
MEBTF3O&_%B+=&N9/9N(QD7DMO51$23 $!$6;SFA%(EKO-FH=DQ:%.@=6*%Q<
MV6J7+,))!V L^<R9 &N\#TQSH[PR.B>?PMV*<+7@EB3:4X&9()-,-!AB8I0$
MG-/$^)R(2<9YBO <S/)XZZIXKZYX RB! HX&NZ, ('V(A8,:O;>84A*B:NB5
M$N.IJ NU$#QGGFCO(@&3!?&X2H1SS0RWTF>H&GK=15A"5LIKX2F5H)0PV8N8
M47P=ZFOTU*N&?A2B/15CH<F95((JS*1$(  E3G-.M#8R"AF4%BN9[?H4\C5N
M%L$:%;H-1SZOUNVI,A@L?7[6!MJ7E=URICR[VF&W!FLZ6T/EA1 >(=K2H-$.
M2PS=J5A2?F5.,3/'3$8[S&R8)47#ER8K#WQN5C&S8N:*Y@]5S%PR9DZ%H+P-
M3(8L20".!B[SH;0KC$2G')R0T>C$EYH;5#&S8F;%S#O-T*J8N63,_#A=P('+
M(I4DF<I (%)+3**9)"<MR  BJ;R4>%^%S J9%3+O(\^M0N:2(7,JCNIC9")E
M2B0S)3'5H)GI*2=6F$"C\B&#74K-VZI 9A. _<>AP^_$?V/[^\O_;OX:/H;O
M_^/EY)%.+S9OGSS;<(3X7!UW,$@OQC_\-D[]:G<;T6D^]-N^Z__=[HX?&!]H
M>GC-\(>7?_O1CH=?B[!MT*' C2+%HV\>7=YH+DW-^/ :T W-U867Z0:[\-IE
MMT4WPP"_T6TOOZ;HS3Y9!_M@@Y77NNT5YQR/_SACL8<*"75C?Z4>ZW?7<=V0
M6NYP@4>[\)B9R96?!GW!- S:@U8OMXIYT6KLB]9F<L6Z:'+H%Z$K?$R[^I?_
M:K6[+;QQIW2$_G7MMO>;%-*^3_V68,\;M8[V)EO&3C_C9UW?5%GQR?IG^IXZ
MK>M,SW6>^0E.':]3=].I$^N)L)?1@0\I]:_%!'ZSQ5ZQN;B!#75W@E#GIL[-
MNLY-K>"K%7Q+IEERC:ZJ7.5/A<!.2*9L4-):!R"8TP9_9])'P:2EO(G;L^NT
M I\M3?]7QW7'C<'7(V[/-D^^'7_>^_>WK9U_?]O=>TNWWVS*[9UWG:W]3;ZU
M]^'KYT]OQ?:;SM?=OZ;C]A]/MDNL_].?;.O3AW89,]Y+;G[ZR'=/=OG6'^\Z
MNSL!MC^]^_J?DS]G>M/2F#@/GA.OC220-"5&\4R<H89))T'HT@5-+JVAXPJ5
M-E3L65/LR=8+E7$#@TO@';BLHO7X1T45K-45>QX&>Z;:DU'+F)0(-AZAAH#R
MD5@+B03IK>""1T%9Q9Z*/0__; M@3V0I2VNT=3D!15.')6Y3,AQBHI(M#7O6
MNQ[LWC!INBNLM^"HBI'(G%AATBN8) 1)BGG*N)8TZE4L!ZNP5&'IBLQ3[R6E
MS 4/: @YFEG24BG&K))*5EA:+5B:,I4@>*^\$B1DY]!48D!\0(?-1N.X9(8J
M$581EIY"E>JM"*O6NV1^64&@"TKF&]!9XVS.>X*;CS-1(1:TY$X*8D*Q@IS*
MQ*+C3!)H'6P2WBFT@A@L6F=Y=Y;. O05ZRURRXI]+"QR5?,O1Q2G@R1@N==>
MHZK7%AV24O)LHB72&<:9T"9'<T/-7Z7QT40#J@*\6ZF;#@,XQ:,(G!,(JMC;
M(1,ON28B9A,%\,BTJPIP)45N69YN58 /)(I3"C"4YL@N^D+R(0KG1R(6C5""
MRZJL"XG:Y!]0 3Z%A([7_=Y@0";^[>"'.ZA<S!?2Q$4.J-]!!X6V6V".@@&:
M=0!MA:+^^I&V?ON[.VQ_3_6X\09 LGOJU)Z\XEMO=K]0E:00A88UH?T,EFFT
MI!&EBS6611#6^U J%"N)XQI+IQ%!@J!<H&,,#(+-(0BT$[(QED:;;RZ=5?TO
M1VHGZO_],3[#%Y>5-=Y)@B+("'"7B>%<DD2USI*)P))<Q<AWE=PE2RZ-6@E+
M67(Y@@G1."54<")Z4%)04?7J/4GHJ:^,$HH&NN4Y<5<:424>" @CB4O,HI@R
M[[SA4@I5]>J:2V<23'EO'%-<0J;>H%65N/6!&2%]8E6O/K34GM.K'[](D7%Y
M4&J5$(#6, 3B([?$4QZX2E0Y35=1KSZ%$^77O?W]7FP?'K=P0)U6[Z#,>6U.
M?;%1'YE4()*5$"%E;A3W,F3KT%;(TE:7^]Y=[E'LCG,+V69!P /ZW>AB$>.X
M(E*QP+,703E;>-1J6]HUEDXF-,LJA<QC!*_P/Y]M--%Q0:TQJ9H&#RVUT\EF
M,24*U!(IN2$0F"HLVXD(!C9::5UDRS,-JN2NKN0*EZ2!DNVC%%J(TKC($[IT
MPB8AG5R@AJ_JU26YW$,)39IFD1T0&WPBD((CCJ/?G13C**/<Z!BK7EUSZ>3>
M* $L&&TLZ!!-(11. ?UOPQA+"U2:5+UZQR[WZ"0[T.!D]$1H&@D(QXA)0A.K
M%2W64&)L>;4E]]?.>2V.N&\6T'BJ=,6+/O[:8.ZR$MJ'2%LS]VX+LF&6T(!Z
MFY*41%);^KE92;S6DE#/K0S*&J'\LY="+>TX8E6HV6]9V5>A[(E!V;(*!2J4
M+0W*INS%;%5",,O$!8U09@4GI2$X22RB_TT%1_6S5'Z$"F45RE;FN1^@RJ)"
MV;*@;#I@!3Q8;V0FRGB/KJ_VQ$IAB+#)^\@CAY">O>1TPU8HJU#VA*%L6=4K
MET!9C>XM!^*FK#4.Z'9J2]%0H_@7LYRX:"3))AKT.Y6@YJ:%F@^&<NN?;',9
MN_:9EE'7HMB^HE516:4Y?8HNF:O50[)KTRC?_%RG3FB=T#JA*SVA3^% J-3[
MXEA3][ 8:(,V+F>C("J!]1-A3%O64<_O1P,<QF#PNK?OV]UF#YWNK==GM];8
MWCBNMOA"MOBWF4,@FUT.$"PQ0DHTR"4ESAM'3&29.>&2M?+92W'[_)C5*TFI
M>+2F>+2L\YH;X5&-&2P'IZ9B!DX+EA@#PAUU!+3TQ( S1. JXR)S$$*L8A%.
MQ:J*5?=Q(%.QZN&P:OH()SM#F;""Y B:0%:<&"TS\9H;'I7F-J>*516K5N+9
M'N#$I?IY]X!)4_:33SI8S@VAN1PKQRB)95H0"USRR-%;EW'5_+SU/U.YJ -<
MY_0\I=8RWW78:?OP:^K/8^M_U>\[Q*2F)_D$B5YWW&#0SNT4MWK=(=';846G
MA=#I[8^"3,-(U.Z/S;W=DR],",5<-H3%4O[,T;/S5#&B?#)>.6]PC9^]9&J#
MK5"U1ZW36M' 397H!Y#HS?,2G7.R-&9T@HQD!$QF!#%9$J6=XE2CGYNK1*^]
M1"\KO+$,B:[1CB5)^L?SDFY0;P>TP$@AFR- #9"2J4I4C-8D1WED>16+-:NP
MKVA\H K["@E[."_L "Y0BS:ZM+QT(K6)6&\ET1E @?*!YIMRC#]D9?9]-;5?
MOW<^A0RG6_4M>Z(TE]DH'017R0D*4G.?N2F$[S+S<@!R;1+:"YI+G.)_+4*Z
M-<P?S\1C<.4\A)!)--D3<(81CPM*K%,F@Z'.L29<7)EJUUB$@:JLE65>6P%:
M2$LS5R%0&80RB5V;J?9F(EPMN"6)]E1@)H8@;8Z1J"04P74-Q%-C20J&IA0U
MYY*O\>ET%>\)%RP*,H<<N : '(6)A00V,\<#>)]LU= K)<9341?MM)$A>A*=
M1C%VE!%G46$SA[ MM(40;=70:R["+COI.87 8@#G@U&):\M=!).T9ZIJZ$<A
MVM,Q%FJ,9 E(9LF@: M!O)*1H -EC0H9%+!5U-!/(5_C9A&L49';<.3SZMR>
M*GO!TN=G;:!]6=DM9TJSJQUV:[ ^F8F4F"S 9P4D\6R*.Z6)"Y*1""PK8S*G
M1CY[R<4&7U(T?&FR\L#G9A4S*V:N:/Y0Q<PE8^;FC.\*BEM.LJ>J,(\"8B;/
MA&?.-).,JBB6FAM4,;-B9L7,.\W0JIBY9,R<BO=E&KD(LE3F:TO >4%,DIXD
M%< (XR2G;BGQO@J9%3(K9-Y'GEN%S"5#YDP<E5-+F2=<BD @FO_'WK<WM74D
M?7\5%<\^;R55'C+WB[-%E;,X*6\]0.S@>.$?JN<&PD)B)6$;?_JWYTC"( EL
M0(" J4IDI".=,Y?N7U^GNT0Z?221(5PZ,-Y)L9 S;\L"F8T#]I<AX#/QW]C^
MM#:9V>;)$;)%&+T/S6'+DR:E<NV?S==&$_7]7];.)MU\CB^3:8^YQ7!DI^/>
MH-W4 .RG3M,/Y]?/[3@\F+#2N5^-%X-^^PEXG/7)\/*?G)MS2,AV_?M'!%[&
MI.7%M3C_>M"?C.88]A/Q_00?"60<[$OH?(;3P<HO%^9TU.Z2\PLX/??+=V#T
M.K5K(T PN6AK*?@8J.1.68I: $M,">M2 '[^UO>]>///-4)3:[4%_=1J=T/G
M).(7/K>'!^UNJU>2?EO=LQ3>L^]V8_/]3P4=8ZL<'=YO0>L(^A\3?NGXN-^#
M<-#R,,"K^(C_GO2&^-?X^C$2/4X*[X]+4)C[4QI?6FUM'Z161MP=W;K5RZW>
M2;\$M2[)]7MQR9C/!HPCO606+_#?UN?4Z91_+_M5I]?=)TA!1^>/?^)#!U-S
M[Y9Q]([2Y9/'.7R&?CR;2_H2#DKB=*L/PS1:TL%Q;SAY.VSA\UO]=-SKET/8
MK8@?7[8\86[#W5LMS<P$IS=WWEC*B,,EA>?.UN_TQ60XYP=RR3HW4(:#&/::
MF_^%@QBN]P8)98&1O[:&*1QTD7GV3UO'^,42^VS]5+Y8XG"<_CK]_<L&UWR=
M_?ISZS,4NL2'XSJ>HIY01H1L]&T5</)^/(\QK^'%J:U_T<P(5["?QFN(NYD*
M35S<SE:OWSI":FCE?OKO"0X*']G.K=#NAY.CP1"ZA4MB.PPOV?KXO6/*90S3
M9#AFOO%NC<K%GI81I:/C3N\TI4$3PS2_XJP^I<&PY/6W!JF3&B$\F$QM/FG-
MW<5+*:7?&PS(&4L//L/Q923[[;[7H,\_.PGGCFN.JU0(:!/GWV+L16N"Y9=
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M<8(IY41"BBHRYI67-DNG%#>)6IF<CXK+O?6BG%!&&?FFI5S$E5+%H9\.4G>
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M_,0B5*..3NG+<>H.4NNG41>GGY]UN.HS]&-KV$\P..F?MLHYV1JJNEOO=V3
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MUFD5;CF-G;_.8T;#A)?"!DX^GB HE&EW&UIL0&>T,# AQ\*&U^,L*A0X<,I
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M;$*VFE"CM;(IARCMRMIL&MV/ U55N&[I+[NBS]$-/6;7[6JT?+!6<Q(JWOT
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M+?%@K"[VKB,FD:KJU0R2RF^/4>K\6>>7K(KTYO-+J%=,.*[!I>1 <!K!)NN
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MX:P $R@!A2".F07GJ%TWU&["P9BW7X]34U1ZF,8GPWYG5HG1C4;I.P4;OD=
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M1D+Q&X&53@%E1-C,N4PY%%5W"8U\*^56RJV4^V )%Y5RUY5RYS(NM.=.46)
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M&]Q5^#X;^ JG@G"!\<0Y[L'<V<A0VXS>49J8,C6<M2[P;8>SB"Y',3T!24@
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M-AIA12WPPJU\HQ+6P"MV$59KY8JXE61?<Y":;)Q0O^6X67X2/%&F4*<2J,N
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MY_'+P1>\_OS@]+J645J)G P30).C(*+@X(G*H&/,6FLJC.>XORJ[C-/"3^C
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MQ/]X1?'S1?%CI-]7%-\'Q>V]F!I5S""(DI20F1/@0BE1)7@4FA,GE%LW%/_
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M'AS1#+@740=!T JDZUALJ:+[Z1UXKNA^<'3/G6JV0I@4(&EG0,CHP7(A(?+
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M=Z5F?<7NO;#;,N*U9XPA1D$2BRJ_U:CM2Z&!NQBX2BYK[XO*SRMVGR=V5VK
M5^S>"[LM<YT8R[4T$NUS&4'D8,!RR2 (J:E2+%D6UPB[/[#48W=TW'-G99SI
M^W"OW[SZS4U(C/@]C<>]=)3ZXTYO,-JT-(@U<X)\6XQ1/6Q]5SZ?[RHOO;#$
M,PK1!PY"* ]6&@/"<-R,??)4LJT=JD6ME?!<P;L"+T@%[W+ VW*"9.-S%MD
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MNP<(J/'=P6\.92BD/_92&FT5K-O"G_ZMVP]?5DY6@MQ<__@Y6%1<GBSQ&O\
M8ZS0WTG"<!Z,5%1$]%=:"37J$,=X-#@J!)B/MM1-9A0E[VQ*SY8P/Y[8UK#,
M['@!<T-$B6ZW?SQ\<8EPCE>Z,\MC;&!@-[KN<)A>G+WXYQGS9^>@:4QSTS][
M;K#;.3@S1^3AC&'1&![CK_]YW(FCO6(5K]%Q6LED5W/RRY.OUYJOINRA\7=
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MG+4Q%+A@60#EF+$4F,S.6^><9C:K+ ++8V3#>U)\5;:*C&9:0[(N2P9H&_J
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MRVI-+Z?(JJ#S"* S%2[EWN'\^$0R"XQ X8SQ.C)B"^</!:D5S\]>LCO'*U8
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M@#.2',-56/M,#+A N _!0LB*ET.OB[<*KT),\$T1\U;G(/1[J48&5_ 9*Q7
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M+Y:V&_*KV)Y[;_M'C5-[7E+'UGSY3Q81_#F:\H^]XAK@U!F)A2!0<R9:,%'
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MUD#V9$!V?AW(M&+>2<J0\H0@;JU&-AF>:0W+707FC%E9)_@&2N$:R&H@>SM
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M.<T9DCQX<- P]R3G$EZ"F7\+97=;5[%)K!2A;E1;-^5Z:<>E:C!?!)A_.,M
M7@5N>V?-X[V+ RYA15+B2&/E$5CE,=62Y6"94PI!^)5U0OC"Z*J?O8-6W<NP
MALWEA,U'ZBI;P^;#8;-Y'3:9\$HK'5!4)"%N 3$-<QB1).$CJJ@B-N^)JX>7
MZ-2P6<-F#9O/T *VALV'P^:7Z[ 94G0"[!8R>:, 3)Q&ECB/8'&T"1%;0W-O
M%/KP4_G+@IK7V[66W2^GF[;^L%WKLW7ZO&%S$QY>Q/ZP/6BDHM=I#&+GM%?8
MXKP16@DNCET/5[@X.(NQVQ@<Q8;MP)(,&KW4L/U^'/3+TU3MEG6M=FO0*A_G
M>X==>*M0]A!-K:[M^I9MPP?PZ %,?GE+N;$Z+$Y[_=A?:]PR0<_9['8\60 9
M&^5(<X'TU3C??*-;4'Z(-&%JI2$HP 1#I,D5LH$[Q*@4U@C,%%?+U>@V)YA;
M"50;9-A?MC/.XMP;%F! 1@J2I?,6^;:#QF;TL>-BT6"D88O+Y-MBQT3O-*87
MW8I7ZC5JZNZV&M^M'?$KZI!9=[>]-JC7V-WU>G?;5R2[F[-&XG4T>GUKIWVV
M(_BQI[&PI5/:[O7[#6^+XAS<UC-;A)E5?7"Y\=+-0-V#K(H;/(U$>1.4%9PD
MYG+B(5"&K==4&W>P=;<=K9F086<L77^ <+V?E*U7DG?HT>VOO[>:N_XBAP<0
M&N#]W=\[>_#L_:];>(_N?=__ND>:OWTXWVY-Y1V.]\A>9^O[]L5V>_MXXV)G
M]W.[V=EOP3C:>\>?C_>//^9\Q=G>[A:]L26K8L$0KI%0(K<D2!99J@0BPCHI
MC.#C$TP//A6]?&<@:B!ZI4 DF2#2>)!?8SEGQ"H-?R?"!4:$P;0$HCOL$=5
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MN_O\VGE_HI$W$<H\KBM1$QG< VLN9I(.CH&Q<-8A;2)!/$:)-(D.*6REIM8
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M%-H]'1PE1I2B+B*BC$"<.X6<H1IL-_%2,ZJ2I%F['TQ ^72G-L<E"?"R\<>
M\)*OK"?AC>R*;H3C87]0\MKD4J$BPG.^Q5RZ4P!BYY*CPRX\KJH4<K$;4^MA
M;7A>O25[>"0ZOR7[LVCUBKUHB\MK)D[_U=;K3M;KRVS0&;660@I$:(*@4P:2
M#XDH!/&'\"1(IQQ@!7VX;UK3BRVU1C]'Y%EK]$(T>BK:])$'H[1!WD/(R4-@
MR'KI$+,6@@O#I)8E@0BI-?I5:_1S1)NU1B]"HZ<C3)( AJ,BB''M$,?,9<I
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MPX@K%9"FVB&MG:5&4[! %K!++VR?\4UC5QGR_FM@8;SPW]#ZMCZ>U>UA![[
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M[?-^JS*-(,!^V*[8;/*4P?3&,K_Q#2:YE\=>U3?V2RM56KR211+^[EN%'W;
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M^"R>_Q#LE['L[%=7_5:%OT?_@D5LP8,[L(:#WRY,P[G4[#RL>^ROU/SR ;S
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MQYU#G%KN@W':D)RL>\^*!#1\NGPMI^'3I?+IC(Z3C!,V61",! $^Q5(BHX1
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MZ4L0$+Z$ 2E<$ZYIL,$QFSPSPCL&J+KT9I4-$?P4#;[M;KW[0$A(+ 2"F%>
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MGS'8!#Z!:4".J'@&U")83A@3X$#T(SX:=D?C*4L!"EE%W.M9"%S/=TWQ_LR
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M8]@\R9N4$G,DTH EY30$[9.,5K,8+36)FK56''A[G/UC_6&\EIRO2U+NB!Y
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M#-&WCVQG\/^M(3$R"@X'Z*.UQX\GYL Q&&UVPZLJTG]0"V3 5;!"<)>\H\9
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ML4K#[T2XP(@PF#9&@-N#Y3?GC "**P9G)(@]-!G$A8[(:N:0%QQ+CSWF6I5
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M9$.AR\!%Q4T2LK+#=P318>8O4<1SAL4B=23UACIO!IXH8*B$KH8OX!$2L6-
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M0\G)!&.X%7R4<):D:!4><6@A3.S(P<8(9;^,$2IGH01'"NOQ$Q!9@U4<BCA
ML^E7$]>RBLD!GFWAJ6^J%%(K 9'"KC$@[;8\J@_\;(.1$5\E>E*<57FDZ(!L
M%0*W/L5DYMV\V'.PO_ C>,R/)/B^8YP54E2HORLXY:=$/99I)4(M)M5B8@]J
M( %T,YUB.PS8ZI842[WUO4&OS_:($?6(-S,W0/<A7*DTYJ</.U9<%;$HKTNG
MR_B>!?416]IQC5JI3X4G#M</_>E.4@>W$:+4#^UCCYDWH!F'],)J+>#>8=%
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M$D@I8E0,)!?!HO>Q$(M+.:"ZZ7]FJ_C>S 5E=Y+[A':PU[,3:4HMD")(55K
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MW?G4E5J:K\18VDW'E#)_W3QGG=2A>%-C<RQ@%]>%E3-MPIJPATTQ?L2K<<>
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M^#A_(IB0UW\[_;-):)D3!91."I37"%YAA!2"5)$)50+[/Q_^K*QE.4@'0O)
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M+ 4G66[/IQLP^I07>3R4.DZ:[7(LU1=Z/1E/KNK,"_^6F1(4!<NY9$=JD]4
MNDC(&D.N Z2!MC:"=R+JDT_Z6,C64,;7>/?O/UX7P\_T<_MBDF=GO[QY^^+O
M+UZ_>_6/%\TK2[9]>K=E)O>.IU'-R;/)I\]3_$ABIICU0M.<E;K'+Y%C$,*"
M\W4'0!D&WE(<E5,T6OI@573-]]1OA=-VOU@&DQ2* $9* \KXNEO-%0@9LZ21
M%H.MJTWNV"]^6*^]%0>N:Y7#9[RM\=HROHKH?(QO)M/EQ,_GTV%<S$,<X?O)
MFS EK3J0TO&8O >4A1PY32,/4M'P49?BD06961?6[7#(>_KOCY)8IY1J;ZAH
M2@D.>02NO::8P@@( BT8AEYHEDVQS;,-+:G8;L9>DL<T_#!^MIC24]+W]],P
MGH6T1#'.RY_6C,__7*R\HUWFU]L2- L1M*@UP8EYB#8J*)B8BD%PJ=2)YK>3
M ?;)XIQR+>RJ/!Z>59VKFN=8AF/,ZPJ/-Z,PIB&\F0XGTW4Y7ZWQFSV;8A[.
MGTZ',PH$GB^F]/4-TIORA>XNW!:%3(((O@ -PT(4 8&;5,L)$9UN77_1\9!Z
ME?7JX^IX".H\P'JH\_OK.'RJL_L_F/\6AN,ZZW>.2&?G8[3@4]WE<TBS;9T%
M&2EF=D%9;UIOTG<YGC[EZA['0NB8,^TVA:^,ID+<,I9W.)^/<%GY4,A&S2_F
M>9 +N<U&"4B%UJOB6D(T,4((AB/CTBIVC>>W;R(?A63/!-_O3U<_@$!/$@6]
MQ30*L]FP#-,U3ZOF/9^>/7OUIO[)TB%;?LX;LCE3G ^GR_%MCIJ<.1KG^5*\
M'++7)K@H(6=RQ!33A=:=9F"2M)%GQVE5GC"&ZGS NRP5_7M>*KV0PEZT.\E*
M>[HR5FV&>]T+7#F!%X,W(B7T-I"?QVL55+;@6/2 VG"=68DQ^A.NN1,.?9?5
M9_[ KE2?F?@X#=XR33%<?M1L1L..H^&'Y2=?S &WUI'=]U"4RF3TZ3LOG 0=
M"C,N>QY<ZX* ?LW +HO2_G^3V&MBGL9&?@G#49UM&L&[,,)WF"B4FP]Q=C,#
M.$BIH"S"$69=+7P)X(M9-I]@##%+$T^YK/;!OLN"<']T*]45%T["Y&=A]O'E
M:/+U[Y@_X$5ZHLQQ>F.=C^OA_O/4=<DJ&>: 6\U!.><I/E01B@A*^^1*BJU/
M7K8?Q2[L]G]P=I^ 'R>L"OKIZ<]/7S][\>[O+UZ\?W=D#=#5SVI?\7,'UD;U
M/3\/0QR.5JIJG-_-)^E?'R<CHOUL54<V2,%ZKJR 2"$I23$C1)\2)&9=5B8A
M:^X0WH?I6%VX\?D#E6(D-@9PA='PD"?R^;D$)C*+$K-0OL/A]6G/M2D3KJN7
M0Z>\86N83Y^&JTI(&MVJTO(#CE,%%#$F[:0 RZ6KIX H M260S#>*0*3V?7,
M=8LZMMO@]*E IU-.M!))N^.4-\>7C?>220E*(/EJGI&;9@(#;1R:H@OGIK6/
M<Y^^>]@MMTX9<:0 FA%A&8/.5I4>\T%2C(<4##A7ZLD^E-6MRA"L)7<].(FZ
M]:; %0!'JSYRW^H"HW_JI'ZA^*0NN?FS,)U^IR7WCS!:X( %4U3.$8(*Y*W)
MXL!QQ4"4C"Z:P%UHWB!K%V!],I&'\^*&[FLNDW;D3VFR(##DVR,!HP"#8H_S
M,6>%G@4E0!D3")%+A*VJ::L32@HY;&G=:N(N/'VRE>W(T4P"38^.C>DMW^LI
MHVB2QMH--7A,Y+^93+I>%@@2@V>R>-:< YO/[Y,U;"?S@V>X;8;HZH DEX'G
MZ$'X4&TY*2%'9AQ*XI)%'9(6V%C2-U'TZ;Q6.WD?.=O-I+[ASYWC\!QSXF@!
MN:U-()T!S[*%4,CSXDD5;5NO[YLHFK!YR^"*L;X8%R$:[>HIDP0^,04Z&J.E
MQ:!C)\<1[QMA;V+_0UBPE=Q'3GYS?^9-^%Y-Z3F6:'.FX") "-K2:O,%(NH
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MA0[:X!V$]3'L([1W>4X@U]9I"3+!SY8%A!_H!_IN1C,TO=KH;]L\$2)=.QL
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MKLTD'XA,F$J.8-&G>L>$),N5&8@D70E:),]:;UX?"+5/)O]TS#R%7$]"PBL
M:5HV+!^GP#D:BIT5L(P.%/?DXGB.$+,O3$HE K9NMW@HUC[5;/6#ALTDV['S
M>H'S%PRSQ:H^9';QXJ2LZNK) VM2JW[,T]HXH\W&V\CI7#WO L#SX2R-)A78
M(,IZH5%.8$2TH'3F$'5RQ,QH4)H<<FZ=4[\5S-%';B936OKK(L?TO=XN/PUI
M=1/<MK%+JV/60@ &4[N$B0B>BU";+=8&4*PPW3I!M"?$/KF$;3ATXYA-AS)K
M7C%6_5,<SY:S5:^17]\QF!2+R&W-"-=C1LG6<S_.@):D\VDB2DBM>70WHC[Y
M:]W0IJ%$.MCZ7Z/@5M9]Y *A'LU6W!!7C2Z0K.6!8A%T,G:VW;\[$T[E,G7%
MA"-FO5W2]M*.;QL@%PRQ2 Z\++>0M >G9((4+"\V)PR^^5;$G8B.'>]/B]FP
M!MVT_N)PO)1^5=WD@M:=U<EX-LS+]@+5=3IONEC0F*PS A>ND)0I./(Z*P@&
MT6?!-6^^FWD S#Z9W(:LNKYLNA9@VXJ[;>I^\Z:*"XS+O@?#,L3-*G-MN-1:
M>C"NU$"(HB_GR'O0/-HB=696M%Y]QZ/NDPWOD(<G%F^[X_W;_=9+J-LF2N7B
MZW6*P(TJM6=/)N<U&6"IY&)B3-:WUH"'X.R3T] A]3H78<=)E8TV!*N#\[1Z
MIOB1%E M>)PL=?LZG3XI=[YY=;CT\(1+5TC:)&-.,D\MVQ%L>6:%N;Q+\7WX
M]J;6*M%BO'*1TYNPJI8-A7A8KW1QDM:#J[5*+BJPJ!BR$HMI7B!R).2C_8,T
M_ D++>6WF-;6(2UI<O'PK1/%3>%"^ C<BWK*D2Q'%.3::*Z93&A1F]:QV6%(
M^^2/GI*=-QR%[N7<S#FX#G&YBSE)PW5=T1L*62?Y3MC>1QT#&1?'EP>@C*X7
ML7*PRA1'/UK?07^.(T'WJCCT(:EZ6O%W[&6LC_'6Y-H50TGX5P,9IO5;CKN7
M[[#GM/$0&HRQU4;-LAA]<P]Q.X:GXUO=D\KPE:8D=@V*=CYGH4 SK+T; W%*
ME&4%,^:0>-*B];F"UF-HD+T?CC%O"'D[GH%7.994NULR@;3JLH4HA0-G63!6
MRFB:-RS9%5N?O( 'Y>B6C8#VPFV;O+IE_&_J"R3 ]2QM;9ZPU$A/\S\7L_GJ
MU?,I\^33>),L2%%[_V2R3(%S6<-@B2AYQ.8W\78UECXENGI%[5Z0I^4>ZFX+
M56@E4D::LI3(][&VMC96"&A8<=G2=+I^:.$6<[#9/_*LO*$G3M_A],LP+2]P
M?#;%/)P/6#:"U49?05F:$6=DO2Y<0(I%6LX-M[%UC<9A2/MDI3KAV_W6I[E
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MR8GYC-/Y]]IHL-:NUVKUE0-3K,@Y%@/:1P/**;);TA1P3#L1/2]D#+O3G;M
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MD]G?OQZE,)VIY]XI_+3V-^I7L/@UJ-\"+D#ROWR;Y)__[5]^^FDNN3!.X]$
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MFG$1C&*%EK#VR<O;@3L%?G2CB8;9)I/QM/=\#I$0O2P%TW1^CORFG.71YYG
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M1. @%WI/%2>9V-8]=)Z$@WD(&9H)_*$=S+7L?O;]&0[3)]I]_YR97I@L"OH
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MQ.U ][_4V)06UI< FD5!;J7D$#)YF=8B#]XD2S]_<'X1T!^<7[NJJH.2C#N
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M#)2L@PM!6FU;>[\WQW_*%N_!\NR@4.4"RR55MT'34<#K-I*'"7/MKYDU*CY
MK!V$,Y90:9%,E#Q#-*'62*VY;\%D0(Y&2TQ2A]:5(X^AY'O"5UWI>!=I=J#;
MUZ.KJP,<.3<JU<H@&&H_X3HI3"!L4M&)6(IJO41?CW[\P-,A>A@U$6('AU'O
M/XW&BP"743J;[,ET<$42%'++HE0,N">K0DN; FN=\G1C^">MT'W%N/8%/6IN
M[LM2,$TGH[+RAN)H^.;YJS#,B\+$7:7L[H?B")F\#<2SE.!KK>/>J%RB$LH6
M$S#+[%*RC//HH[TGP7<_0!U6&GA]E3B8K$5'FQQY@'9V696\$:X<:.ZBU+5J
ME&Q=HFT[9 ?7J)LE$KP:_C$<8QC44MV+(=X,ZXD!YCK,J^&M"Y<ULNBT%D'1
MSL]KEYI0$UL<^50Y9L]<]:ELZ^3A/:$^9/I',T[=J69W!+5UL"UO@KU\I?>&
M['A/U8AI5@(DRTBRJI4<?>*$VUN/*A:,K7-3]\7ZP_&MF>(Z,.L7*'\EH5VU
M)Y@L&A;4[YY-)CB95+1ORNVW9;X=D52'] N_X[0G9&3!>)I&J!90(D<GU-;?
M0D0TB3$M8NM4II;X3Y*8#Z;@#@*%:UXI7-U'PSEI<^TW'VKVH)($VWMK0-:D
M@"1Y*;)U<="= )XTW=JKJ(-:1V^FGW!<7XHQ?JK1G2H7\@VP3N!.Z02\JMB"
M930F+RP-PF32+_TTSU$:Y@_A6\^7:+CS#KB1M1-KRN"\Y8#"R$ANIE=ITQG@
M7A5IF\_B))GYP,KN(+:^:4;/P^33KX/1U^TG$XMF+DD!G+$$BB4-WC &T=10
M1G*6L=;-7)I.X(<C;;<J[J"SU'YOX/)<YC.LTS%".%$4>6@RU=Y,O("K5;)T
ME$7HJ(MMWDND\11^.,YVK>:[K#5'6V679_#K:/RB/ZD75?O#BS!,>#TE*9+F
MUF1(+G.:4M 0?$TNU29)I:/WI7G=^O;3^.'8>PQUWV6P;><VK90?O9-OQS@E
MG-8YE56D5RM+\O$8&G"&)&BB4$HYR=&V-@&VQ7:27.M$,7<)Y#JI-OS[:+HQ
M>_Y*5C5P((T)(G()K)"H5'0*'*H"EBLN:29H_%&.!W8!?9*4.ZXJ[W+1'[_R
M];/O\Q7\JA+7Z]&EB?%]W=7D>0Z65%$&DPS)6?C:&EJ"+_3J6>VE\ PSK>;'
M/--J.KOC5QDY+J<?GA*/I:;)FJG.\I-*\=&FC&"TJ*DH9&!'6TCL06-DS#!E
M6M?=W0#GX9,O'Q>!1MTHLH-CI#70+C-LM@'74=;G1F /DP3:3(W;T>, '1R=
M*-9K5Y1SH$1,9%LP!!>P0%#1IQ!-8:)U1.<!"')/ NG#\&,7T7=7+V5Q26RQ
M^"[Z5)H2>!0<,)#OK$I(X*WFD!WG1N2"6G;4'G0UH..[!@V5M[ID2@/)-\R'
M^3J9UN+E[\, %TA82,RHHBY[E3(M(";MP>:BK99*85FRQN_D(=Y]ZBDH\D!9
M=='7=329OBDW 7G+18S.0I'!DMD3%818DUY0)9:9L%ZVMC/O@#@%7;>1< >I
M&8N&L2^_?:9M#J]*)W!GD6DH3G+:KKP 'XT"PP,//C(?9>O3\)5 3DGUATNZ
M@TR*/5O<,)\BR2(0:8FJ*F,$9VV$()2QEGERAMK7-GF:_<@>M6=Z!/5W5Y9K
M1<^5;8#]L]59*\UNW;MJ'[4<M=59T<EEGVL DT50D@QEGVD]]DS45%X?=&E]
MD^HD6IUU0Y==M'&\5F=)8!:,*4 7R#9/2D+,RD'0@2FNA6/8^F+(XV]UMI.J
MMFMUMHN<N[C)<2-7X!J4M<3DS!+1.TIRS&*&:+4!GJ6PFLPV[5N?L*\$<BJZ
M/US*';SX&[JN*8=*BQ3!8.WD&'D QS@#RV66ENN49.N.&4^CR]TA)&@D[PXL
MS,VEKV4J0@8!5CIR D,H-9;K"2#2VF6,\+:[3A./L9W DW-Q]E)EI][WJC+Y
M6V#[9Z>"G;6X4Z>"/51P[$X%*5B3!-,@A*4]TR$G>-F!DS'9K)@SJ;MF1T^B
M4T%7[-A%\MUW*E@ 7#2<4]QB5@ERTC3KG T$9QT0MF2\4)+)YM[*)D"/K%?!
M3KK;W*O@ ,%WX+Y\&&.87(R_T];ZY^*$(=K$:AUDGD4 90.#6!/_.)/)A&R]
M]ZV3UN^B."']'RCB+L[M+L^ WW\-GR\1%2P\628A^%3(E;(6?&U&S9$'71<^
MOK&JXEX.ZQT4)Z3T T7<@8_R?'1^/LK]Z?<WGZM,%TS40:2 'K2I[<&5C02*
MUB!K8T9'TPRQ]<G,2B"GI/J#!=V!Z["FV0(S(IG$%(B0ZTU!BQ P9^#"9ZVS
MY:ZY^A]K4YI'[94V4%\'%Y/7MFK8!M>/W.]F)[UMV^-D'Z$?L]^-T(QKFRT(
MQ6HE1 RU_IZ%;(LT'HW(_D?L=],)%W:1=1>1\=$P7UTTNMP D88T11@PN99^
M#T&"BU$"M\5%9KC1N;7Z5\!X1/UL=M+1<BC\0 &O]20;UZ6\.K/[;>8#X;Q_
M^>*;HU)K$DTG89A?]T/L#VA$/*#^Y"&C-:DSV6RZ2_4D94$5T*"RS*O =2!;
M0I>4:C,%(87H'3)PH]/O^1!GMX:X1)/?#-]AK41/[P'] I%WO/CR69CT;UP/
M\\XR1'*,K:P-!DQ*X)/2D(7E16>&KGDUQ:83.'3AG&.X@E0OF@]&%<%9G,Q\
ME%XF[W%V,Z $K*6Y:G-+(11P'U$G%XUDK2\KW@OJ^(OJP[%N>25NJ[$.(GPO
ML."8I%%K'9"E,MN!W@["< Z\-DOE/ A6 X[DEWI7P/N0@%:5Q,CV2-:VCO9M
M1G1\,C56X9TS@6;R[_X^SB(4,@.W0B(]3[-1DD"B"&1D"&<@,FU I\*-<DIR
MV=J*VQ'BJ?&G2PUUF@IQ27#&N*AU[B&KZ"X+X'.NB>^.K%47%"V]G1TXGNJ2
M<H",.P@NKIUM+T81"KDE0*2LK;@+!Z\% I?)NJ25XJGU[K(6S*FQH(W4.P@+
MWC#%-LV=:9]*M 58KI5FO0RT4)$4BA;%R2RTP]9M8[9#]B.;LQWHK@.KY=G%
MI%]K%9--%?OSH,KS64&NC^3WTF>3/HT3YA[\?#[?>U)I[V5.8'2@ER(:4RN/
M<$!I:#9>,]O\SOD>,(_/O2XT/CJNNCI@V*P\W"K3_6P\KED<LP#+%=KGEQ7B
ML+Z6\Y9[TQYG.;HB++ 4:0;:68AU42XN1!:ME?0Z-B;<X:A/DG]'5F8'5O4:
M)^ :]"HSP'&7><@6@O!D7-0&@Q&M!A94TH4S3*GUBK</SI.D7.<*Z\",WRR6
MGL\V9B,39$X^I;).@ \Z0L(HL<3B,39O![<1T4D2IZ$2.C#M6QBJ\VP(:WV0
MB5P=9"+3@DKF:M0V@62%&58B8FD>2&H%_E@U]1Z/6_ P>G\LE?6N9O_L>MG^
M]SZ9K./TZ?MK_(*#V4D^2F1>AP+:<U>OHVF(J?9GUKDHU([,V=9M<;9#]E#)
M50_$FG7<;:>]+F\1KSS!O<)[F3NP#=B.$JQV OHP65==:'P=J3I3UX-S+"M)
MD!R9+4Z3-2H=63'2&]".\6P8<S(T=Q\>GEOW)'$].FKMHJ4N*?5J^/F"W)LJ
M ;ZXF:^T#5Q)L*8FO#H>R6<6$;1P7)$1JS1O?:=@ YP'C.JV5^0ZRARHA0[2
M#U9!$Y?0G%.85*@EH.6L&+0$[Y&!1F%%YMZ@:7TTN '.CT:0?;1PI!5$+J A
M3R8X"\G6W-AB&03D%DHTOM"$7>:MCX@VP/G1"+*/%KJ(?=[MD#W;8X7Q-<E5
M0LB,>%MDK9'K"]B0LS,HBF\?WEP-Y0?WKQKHIP/:?!B'X:3@N(KE/8Z_]!--
M^4U9U6^]7OR:K/[1(E=[B[ETY&^UG,<#N6,M"'+G4NT#:[>#G;#IG!C+$97T
M8'4,H!2M*+5&#HB@R.QS3*3F#4H?/U/O<^X>.U%W4>IQ[HUKD8IFV0,*3AM'
M%@PBBYPV#F.*8C9RU[S0V2.X-_YP6KW_GODN*NFB(-[B^O.B1GGQS@7K@'%?
MD]&8!N<\&9-2."LLT[YYL[DE"#\R/0Y0QM%KT'"B*9.F /,F0FUX!S[7?/A@
M$Q/<9E%:-X][9#5H'@UOVBEJK67?^*;A64H7YQ>#>A_R;FO/65-/^L9H6.4S
M*AM_>7Z]?_];B%TA:7)#\2AB6KJ]F$S0 G,HWA!5+'."<ZDU#QA8L:7TN@)U
M8%;[_0/=[FT7N36UWBR@T[D6H20S,20!1BB?3,$8FL>[=\78H*U3K69$$I[_
M^VKX?CI*?WX:#>C5GKS\[PO::MZ-!@-:/[Z&<>[%PKW.+$(2-;_=>4.+1"F0
M4PXRTU8D4^L<R!TA/L"M@"YYM:(95&<*Z\!XO NN9Y2W.25?ZSNSVLP^@N=>
M@K6!*<,QZ>;=.>^B>)#&(MTI;M14ZEVD7Z?^O*WV<O?MVIKV3?D0OIU-I^-^
MO)C6\.6'T=LPR]+-$CG*C!!S4J""TQ <(M2VW,$%H;'YY>C]D)XVGXZ@O0X"
MQG<:O9,,ST:I/W>QIV]QW!_EC1-P69>D68 <;*WPQ 2$+!1XYPMC1C&>6Y](
M' SZM)EX7)UVD).]R4)8X'X[&L\TMA*^$25Q+Z!X3DZ@L/1.F40.?^$Y,,YS
M*:T+:AP(^;0)>4Q]=I#_O<)2$#)Z9[@G<Y05DH8L$$7M$Y]190*;I&C=\N\^
M^ZPS7V]^6*JDMKHN!#GY!$K[#,ZF7'/PDTVT6CC9>IG?!=^QLM./ZL=TIJ#'
MDF-^54YR3NCKB,?L!,IJ(\DRFA4@)7-<\@)>2-J%HG!"\V)$\_*\&P$]5,9#
M=S2XXQ*U4D<'WM$2ID6SR2U =92CL!+0PR0;-%3<J"NI'XT2BBL97.TZ*H(A
M<)&#*R*!< $]-TQC:.T/'Y$*]YSF'YL)NPB[ P;<6!H7]8O)H+S9. OG-N2B
MXS<37#HK('K&05GR::*MG9B*Y,9SGD)HW:)J1XC']P0:*':]W=)<*QW$7V_
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M([E3FI7@K9,H>?36)"?D_9E".X)I>V)XO3*^N9B^V293Z49P--MHN*^%7;@
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M/@;;R3H+^&6YO*3RX^7B:Q)\)>_7PV>=*MPD$:T:>Z8$&1]U B?7'8T8(9!
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M=:IV:Q).:G]I5*Z+8=\Z(MO%'NK?X;O FB49(X-#:03E)!V'@R+Z7/DG,CS
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M<3N(W.;H8#O$M;U'<S2FBS]HM3IC:?_X<RWD\IH9I7A3="$$:@6!ALA \*E
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MXDQ((DB==$Y16)MI]N@G[[W6Y^=4;GW#C_-EJTV^7-"OWTJO:[4^40:KJ,7
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M4VBL18(JWD3*U5<<GTGBR-@F#X":75TR23G3=R2'C:;)9!7!^L#21:DA^5C
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M&HPO%:*I ERQWFLTRCB<_I =[]WBZSO4VUOO4+=1X]%F486&ZB)C)2<%"4,
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M*@0JRJ5P:>00\GIMJ1_%?_IP,HK?_"V_3CDMEY@JP;^VVB;[2=',O4X2DR3
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M]%2!;1^ B>$#X011?&WZ+9-#98L>',.UPC,63\R1SUR_$="Z/<2]FR+NS8\
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MTGF--\^DM+IS "F'W^\(+RI*<# FH"+E@^:G:LX2&:)&- G0@C) UKD=1I1
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M90QM6W&SXF3>I5NN;O6U]MI7_=(5'!ZF]4DF#Z2/VH.'5TE9/0A"(8M?NC
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MDVT(LS?=NN%\S3:%J!";EU69\XL.K0TCOM$RN^)5?:_[JQQM(RG\#MC=U+(
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M/_R9:^'#&51A1CRU!1'7OPGC$K!NHF31?)DY+([S,S,,?B:N693TO%9GDV^
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MQCH*X:N))>*6)'#Y+Y -\ <P\X?EG6W=?T7L/,$LUK$M.!.#8W)#9.N7=_]
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M:BX4L:U9HU4?U5Q,O0%>_Q!P.\?PLI&;R7"3V?G@GH/?CB@0E^PH1J>8#]F
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MT%. 2X&>M.9%F$W7-*VZ<[;8H,9QL]7EL9359U^^W,5[=I?TG#I+]A9'B!P
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M8*.Q5ZXEFP1,O@?D=Y[L7].R<FS> 37@XJD>KC[<S0<+<QE%0(9D"T:ZTSB
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M!-&CDZ'6:3G/R-:W+!P6*IU=2P^)#5L77%UAX<LX]Z>BC7X:@?230+SKHUC
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MD+-;BZ=JUNH1F;+@&XWK7,L"K@;B5K/C:WF'T>O8%9QM6+)5K33G#4<'R&^
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M&"V4]AQL^!5\#_%/2T?67V P94'!LMS?I%<1B+2Z1G?#?@/(C[<-TM4G%KK
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M"T5.M3#/Y-^*(X.\)"7S A[&@6=T8NEEM-DNWA))MF10$ 9Y 7#V L L]S.
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M_<,%MY58;- MZS'/BWY<JEN/\E/]("+!<1F?"\>N(.WJK]M!NI"!6TMT::I
M!Q7.!!9V'UKQ>-6>&\[D$*'DYA A55$^0? (\78_Z$.5!SDF<XCYN=$'VYIA
M_2Z9=RK-]O185M=1!N9'DD.<0YIZ8.*.UL%6&VMA0QAM+"C_'D<;XC%M9Y^
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M<I0,<"OYAXI+'1SPRM#9PVHO(\B?#&^_%G4\_,K(8F1SPGI3VC9>0BR*OUN
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M]_=XA3T'K%43/Q@]+SNQ;4^ DIE5,^!5/D4K=9O-XAF0V[)1&#'$;\V%83>
MNR(F U+.0D%6YMB>K;J3[\:GLH]>K3M\J5[8X//I?U@3XZ^.;_WGSQ^OX_Y9
M9.?OB_U!B/SW:QU_G5"ODPYI&_*EWK)H;>C5./803Y5/L%[&/P.Y@#-./3I2
M)\+?]Y"LF?EQ <H+EJ\<"TY4_(R7#C5?.QIAM"5NZ5#G::#!C+2'YXI>1U*
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MYK6'>5/05=N\O\TF]*^4'/UMY?0!$FL(0[:PJ"NX#UY![L.N"#[2*M_Q/J[
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M#[9*4T7_0%7HI='6@''3;Q-U+B_O9WL"T;25\#K^^8J*4J@2S&\B;XMLOU?
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M7GV58739LRUVF*,#UU\7L8=Z)\ZV;2])1A^X%?OI.FZ0Q[4 WY=[L*S%X;?
MVNL",VL$?S7";0WK):R\=^ZXF&QX-EPE'W5@V:J-$J:8S>1.#'IN$74)#^W6
MX894<Y*#TRT%C^KDB/[-9)%>M9_.U:\^,!UQQXOC.\7W:L9<<\'LB#4=K-^-
M8]S&K_V!4X1'<151;)YGI+4H H0?/H6"ZG_%SJ_/]V#.V%UVJZN\T%SQS5JE
M-7G;]M:/H#DRV3F&R% TXN,#EQ%/C:LUSJTE5EHF,'U4>DA6.?L GY*\C>8J
M6?('4.;BMVY1[$>Z]>/53+L+R[1$CE:6E)2&;BHM+0MUB5UU9\7I@\>7Y:%0
MJ/IE(5A109B!&!+5:_"5?8]MB_4?F4.V=_M-'28^%%5>9;_R_?(R<. !>8Q2
M,C?K"XZS+! KO0?Q6%/QL R1?@"$/E!K+, 1NP2QN?7V>N$K$[?<?_$NXU;W
M$9E-\?\/>^\=U50;O0L&08KT+B $J2I-N@HF*M)$C8TN1 6D@TH+$A($Z4WP
M$Q0_B4A3JG2IH26H")'>A) @(CU!"4=3N(?[6W>M>V?][JRY,VMFS:PU?QR2
M/\(YY]WONY_]/.\Y>V_57U.L]Y5;&N0WYII,8\X@9A_]&K#:28:@)=^L^MPL
MJ2L"' :GU^UBJY,+TTY\$^#+/ZN\77F4(\)2;0$290G]N/C\0T\)3WKO)/9N
M^80O7<TP*+B@\PEAI/M5EJLF9C\$O9>G?)J=##O*&< *=JARAI'U=]/?^6(E
M,'" @959S>.M*>_'1K[VQ1LLM[@1>K]L&M&Z-SSOWK&X<&7K!?S>T/_X7"T$
M*L<Q0FNQ7W%D5G$*,%/4YF4:*1Y]\M9.WGA3&6FQ)U!B1[-<7^W8F]C!+V6O
MZR 8)< 1Y%=[>X7^K&L P9OIR;K#KN\X. OD:PD8!3_&"OW&RDWYY>7'^Z+H
MY=3Q<5NE:/<_.5)9'D*'TST:SV&QVKL0%&J50@9#? H,BA5@7:3IIE-UCMDZ
M6(\8SQIHM8:'G730_UQ1%/=U0:59490!8V>C#2M=4$][L+7DGE?PJR,;'LWO
M\34TR\?772^FR:FECRM_7.D4ZXSEY[G"]Q%7U]<#<L"I7(Z((/NU+LL3YS6\
M"_'93%!2I$,?;0MPG*HV0D\X(D:U/4)Z+J>JW'S>]T7EB<EQD9.9@"8B&09%
MZ^Y580DB 5K61,0A7XXB8$\%1? IS+/70-WU?]6+?^ H,WL+]A$1#7@U/^F1
MU-@TIAQ[E"S'W@^\I&$I>L1V+O.C]*>4B$1SU^*^>TWBRQT:0\KX)N<;8FKB
M@VD%,6J\1"M$I5DO3@ F!?1UW6.9T+$]>J)^'8J-3CGD,Z/U3IJUR7<.IFF+
M)!CS0P0?;3$($+0^K1HD57O)3D Q/87$^ 00F+YH_5:ZN8.$#YF?(_>38U@[
M9GSZP#!]P9%069%M_K?]E_91%>)!"_F^@,<<CO,2.Q\&)7.^X&GWD.M<$0MJ
M3-U<IC7Z.&TSB27Z%K%%B @IZ&[!%'@HY,N'.DM\)\)N2SVJB;F_/9?(A&(^
MP>3&*\UM*?BI8,H@[NWRCOZW2>0DH-)]M++$2BC;:E7,,^P6_ZVS//NT"O^7
M[ !!6X"CB@4BW@%D!H5=#P^>N6& ND[-)0B;]LSQC3H^;W!%B+KT>YS>;A51
M;\J.5#+*LG4PV8RUUOS-6[XL;_7TM:_#M$Q<B>N4LW/GDZFIZ3,U!)X+^\I4
MCG#= +W^%I?#_\!/N>2>W:@3@\BI,:I)^'0X[=HFH(%8]Z9?QC[&2<.#R(]=
MX-UX+E3VT3:+XE6HF!'@16^L\3[6+UV3O"C,S@T\I99FLPNYF*]F/] 6S,!]
M%9S1.GUAT,WL:GT*=8ZJD8'22#MEDW;\\V>4<NQ9OECAR&J6ONP:<A=BE4S#
M[T+X%<UV(6E?^7KQM*NB$H >%;FN]U]W[IPQ!_V1TSC!-@6ZIL/7;;($OY(9
MRFA3[%Q+8%79VGQ '?/\,9XE?H<5S<%QWA;LM *%4\"TPW9UX2$->OQW5FW8
M_V)D@=1>V E\?).%1T1E][B,B<$)BJ[BU8WSWL*+EG@%&])L7^?<@6!>T43A
M>;8V@/+M0<@+C"PPQ>H%%E.QJD$D+>_^.H5P>II#1$R'$%H)L*<(=$#1>L!5
M2K7P3UEA543!3WGI]E?_)IQ-U!$Z\M9.1,1:%9Q!.+WT/Q;G)W8%YRB)]I1:
MNCY#2[4&'.?U)"Q-DT+;/:B\.*$.DW'M1><[C?KF!?C:]=+S6<G0Y:>]*<U-
MZ9P1!KD+E[[7$<5'-#[/D8B/5U)Q0W3__2YQT^?OA_B%C*U9SU!9\4U(/:+N
M(>SXS\\+AQ]5^7,.IC+T=B&%YP'0OH_W7EH@^C=T ,&TS1LT ];Q4=;^-]]0
MOMK4>H0(J;B;H16L1-85YT)JJZR[E3=Q^W0>E.*B;;(41*.\H\";=P0<QB.N
M?I9THE\)48BKQTFL!'#U(9[]P^8_O;KY^4?'(98L8$9[J%".?0P"ES'%9_.%
M_+;YR0+7R=38YNF;YU+Q"B_E!DVA+LL^_V-+RBQL$"A'CT:L#=!2J6+L-%UL
M0#6$902NJY+43 G@96^'=DTM5L#W@5#DD'K/(]W"8]DZ!<H5D<SSG<1WTGT3
M]DN<(^RG6"_L(53L*B'?B)T'@Z[*5_[N\-HH+4,9$*E4"CV=I)8E$Q)S4BW_
M"#=%=*8)E$IKU7L/!?=:U* ]V4GX^9Q\G2%S7P\:&%6GD0PU]P.MI^(KFAP<
MK_J=(YH5:S<Y9A>7!_^9ME ?-GPU_'T1VW73W*T$VV4)$J(G2%ZL-_[1J7]<
M<O!,.U1JMXS\_O2GB7ES_$4INY"KS5F\SJJU=K[F#%5Q@_4 ?0CG*?HTX$SK
MHRBEZB5PI- GOZ+U2Q$/)@R=4%$V"9_E-(Z5>7K&V]L].[\_:5#:^O:--E6:
MZCPVQMRW#&U#@W95'_#)5YD05 QV'S8W"PR,>BL3^,4[WTA4U_6'6?*G'S&P
M '8S?+X(7\?7A3ADP900G8%VPH7:/-[Y'M5+0MM2D3)3SO#'H:5<YX?4^_<,
M^J_K>0OM_S"H8I\U\R1F:B\9!)L K9UK,EU;IC.[>BC0+AV9Z1D7NDEF&;O<
M=F2T\'C2W%&OEI8 OC"';.]LJL%,_NW6<=95I@;G,^<$??]$JKDOTP@-'S=V
M74;WSR)NT+S2"82>!85\6Q7M)<@#6W/[<NQ4(>-^/<UH%R*XOK>;RD.@E)=3
MHD(HDZRC=QL-;\:4:?K?A^8,WY8*UFH]<'+^"A\!?P T>#&9=@F;@CQ8L0L)
MP*4A&W-[%/"2A-L:Z;1,2G[F@IG.]>M?*_64C-$NTY]42>5D@^YL[=N/]2O"
M/R(V%W&_5=J6+-B9>$^<T*I#OAJ-O-9$6T*,AC*?;P3HK:'%;TN-CZCRVJJ&
M)1F<>L]S7#F62_KG_S2'__\__C]Y8/:VXS_B:0]TX4U[]:1H"(32+H3D!J<B
M>P>4EE9JEQ^BRS#EQMTXIZ_L'Z]%R2M:-#Z.<,LN)"XKA+U'-7_O;24".YQ(
MWUV(,$S#7Q9NF6HWJN[QVRGHX%^KI8T&S"[DOWNNB+G!BFZB>Z]9[T+XI%B2
MK71OHFB2(Y27 T?Y@0%SR-ST'>O\6,FP4:;L3/RQ:U,;%UV]=B'GSR<_0AAL
MG9,*/-@-7B\+E3/#T 2_['#ZE73'L3XDI3[:R,(E N<IM3I1F&[H(.]5!>*:
MTOC#1PU,Q#,I@YM(EQ_F_'6^6H%\&C'PFS^K_P'=IW".%Y$!EX;Q8 ;R^-+;
MW K\.)I S-^JNFB*J)R?O/D0X&W;Y%]YWF;\NI7[R9)HV,<E]<NOY2X\XVVO
MIN;V[4(>8>N4,@M_XL3-/=3_R758ETDL='%Q]VLI_NWP\XUUROB41DNSTVA!
M]IGTI@>YMS](</TT<GR!/LRNPWLA,J$\8=!I"PJ\#R_L-\<WE/-]M4/5[>SM
M.%N3_@Y*L/ELI0^]],OR<2M[Y2=<O'7FHLQ(SN==B!A,V9=\H!Z9-!&.41D/
MG4FWLQHVMZ $(FQ?7JEY9-H?&:176?!K?>S>Q>46^ NKM?<?^=Y?1<IRB%B:
M,VYJDT%D5W..84@=XN/>]2,L:.5RB^ACM?:OU2HXM_;CW^RB[O^R3BH04LW0
MU^CN5EE0.<,W,:='RTE=P(E\ UQ[;4,#-D8"R'=&-1IRY08=G!35+++&G.0A
MPV_P\MCY>&@=;PTS"M.-E&YS!'5I.[ +"5Z(UEJP3C(WHV 5E\E*;7:*X^F!
M_L%W U.Z&+N0VH&:'UE).9IS"L)/9)4N4<@S9HSXO?P_<%768.OU,K!^4$6_
MO[@TF!@J=J'G;W!&O;#?$@(I9BFX/*R=J^5')X2'WZR_J.9@[99Q-NM%$M]F
MM/06?&T C&G:[#BTZ&NT/#L#[<B\"CCT4QTJY]WV?>[K'I[3SZHB(YJ.^@S'
MZUO?ZQH)$%E5C4R.-YN K=)QC') D,:-'&J#TDW[1$7PU"-+3\_2B)E%;BLM
MC052RG+%"43BT2K/E...Z%2Y\]],Q;/.*"5:1IK&X8/(D^0^'&03[H<0Q0SG
MBT%%ZV?>!88AI5=.?0EW: G[<E'&+NKIO2LS%XO>ZE^0)B[^P=S.WVLI']N)
M[=+?QHNC[+H;L8WX1QX==&+Z_7+47;.!BS.5 VF\M]5[VLK>!>%^_@HTE/K%
M$W#]WFO1(I_J%VU[66W9X F0@!WE!E*A(7/&NJNO>T)^8#S7MWSJIEUHKJ,,
M4?_>;2>/B+PC7VIX7TF_X3W_AW/[%30-2W/  AI+G8IFW=-]A,P9:)>+5VFZ
MT6J@=4_$U16-%;.76G%)NE.58[TF6V+G!G0_?G+@ZG#HY!N2<I2D8QF9@!Q-
MMK,1+H'11E\<"7T%=6AOK!T*$DHW6VERA-(W [VE#G]OS;M\P?) ZP>>F#/&
MN30H \_^=Q?B&XCMS1<%S.B'];9W(;S?"'RI:,.WR[DN096%YF4N>@U.<P3I
M+URC$FGTF,Y#DG%GE)Y9HJJ)F< 1W)H7\_2J?%4JW7\AOB0/#3<Z#N0SR'9M
M;;4TUM. K:=76QH3;(Q^W%8+V-]/O-#2-*L\$;6 RX3S=BBP3C8"S0MZR:<N
ME29L$O ,]XK<.S[;,A_ZIH8G^K\%Y0?V+Q:=G;[4J1R0 EGUJ58";)EHSB><
M(E]J($::Y<@9&S,7:-KKU[4+N47NJO3E2K O&=%XI"?M]$#A4U=7UXD3V%A\
M,'P*2MWK\?J.,[H+$849._GC1>O]7ZQO!TO^9$28'G=N.VCX)_9$ZALBORXA
M_/5BTKZ8TP]3@#[. 1#/]N>Q7V(]X8"F,7F]CU9--.DP0DCZFHJSM$[95S3)
M3'<4M'[,L#UX1-S5VE O;^/*K8!K;D,NB)G5A1V61"KC-3O>.%J2,< N_CTK
M2 G'O[/83_@VO3B8&AD9X67<3G[F+W?CPP>O8/47*NE T+^>D.AGE@^PXA@=
MEBK 16/HR;$NTP=RX@K.C#/"FQX^&Y')=^;/$$1U?<F5_-A[S*J@*"L)HF\\
MB-[/KH/?Q4U[]'8HTTR[2,DT,I#:G2Y&-XW?5C19O3A67W,L(7FIICU%(2EK
M-+9J*#ZH]RM?Z9"[ !8<(IP=][O]P83-*-PG$*9@MRF)$W$&7OSN'WI-*D_4
M?[E_C)7YWK@SS%-?8(?W6I&G./(HB 5=<S*-#4 <\R#Z?-WX]H?@N^Q:EG#A
MS6D+JF##^_RQ#>\/A]=Z\=Z1/.^MSI? C^\7;/4A0#!/ARPQ+JA-QG- CE['
M$7Q'MV H[-731-N-ML$I[=S='8K0NJ4XO;9+$84_,2IY&Q.#H\%W?=23]?30
M2W918<]>W+ T(';<4HO!% \A=3@#R!KO#*P7>2:JM^,(K9I 4ES%'S F)9K0
M4"$]2GKTL!\U?/';1S93;UKXJW^KO?!^0/+<Y[2!^MZ5(N7S[IL+I2PI:P;(
MR[<O6=L!)'K+A"VG-X^_S3)2)#<RTK?@TW$+"3]9DZ^?1/('J]+>4!;4W9S0
M1?(01I[6IXZCF#EH#:[+%<^[3);$^E;S^N9BQ74#;M/4DR=4\A;<F9[ETO4Y
M->>=?R18A^WSXM7_-X<[[Y<M&.4:0 Y[X8/1Z6"")F.2]C@/D6@,LGXW?Z>8
M;[;>_FC[%RJ^PZIRO_;9>-PB>&T53;KV1[^&7KOJ'D%78%2!4)@Z/X9;YZ/K
M$8=_=HBTFU!U'NQ8MMTX:[;_\>?\RX"#E9>]K[2%4=+KQ5&H'%!3MI?]!SL&
M"H(.OI4.,X#BASD-("^/*U!*8P/1=N:.^98;SW^YG?[Q;Z*^:*VEZKL/3K^:
MH/H'7G.OE&D-=AACQJ$0O/? M9$>O"0K].NJ+..:^Q2 M1[6W7:[[&HSJ9U[
M[C.(ON:/[Y2-!&R-OM__2*42?91=N@OQ#LZ \A2RBS!2:%_:CZ;YH]H_6H)E
M7/QJ4@^J),)"[%3%#F\QFIZK37M,6W#%G5&<E:;B1?#S;Y U. (B308*:5.E
MMXRA;U?X;F(I;%&GX6JC*>-6>YYZAG"DD"WVX!77Z%8;D]BI:4-'C#9G%E_;
MU,F.<@5U4F]UBK"W9OSZPDM"4^-#8?9Z;N(UF]ZW85JM/FI-(ZE6#F=T/=/^
M\;IE\EZ->\*G8J_98GD/QXQ6\F(!*^#G&U7L?PIM.NWUW:_+NRG/./LDY!:_
M4(4(/U^^I<\>87)@7:)Q&OA8BESSF5,K,]2E7B<T5SF&)(EJO4:[")=H^&>X
M="S^1T& ADGW:K]@[1%2#N321X6@!_X;<$EP-BY@;R%Y619TQ^Y,"<P$C*>1
MSO?HMT #3LZ7/#-T<DA'Y4/"U,#(NZ,\'=%?Q),.)3L77WD;<D:);!F9N%;*
M],'T8YOX8C8X&IC/2/G03'F?:4S17TQA2(F<^+KN/[SZEZ3*LL_/.!T7*E2.
M-3A9%=Q'IETC3?I3L,G('O?3[(+Z=N/#$\3XB*H![]!IG?RWKMZ3WF,.JA[!
M]Q06?3Q?N"&$N%Z+AKS)<G:S*-S'_U%YN_A_-[7I_]2!Y]^;,20M(N<I'=$[
M[=B#FUQ8ARDUTO>ON0B36%HSUK\"<B+$8 LG=)YW_[LS@-F\>@8: Z>1D;1(
M3;;<E5U(3PA(;_M^[D(2_H+4]Q/\Y^=$CL)+! >.Q(]>X?L5QG3#3(!^%N'8
M6SW51^@0 4J91JC"'G>9UJ$?2NIC:,5Y&YW-X<ZCAF5V@FTU[RYN^G0&MC9S
M&P-92/+B?R/A@>-8D(078$$2SH4EN5E0D3VGE696AE?RT!=@E<8MF<YBT8NO
M13OEV4WL+*S_+@0P*Z=4KRU0]/C0VNP\\ZM4I*"+#RU3V*]#GZ8F*[MYZ\9!
MZ<47P\Y2&B9&,8VS;5DIO[& R2K(W_L8HBPI/<X!V7F]/XMOT4: =X5KM+S.
M]2O)B4,%3;>753-;&ICL_R4CS(NR3"=82B#D6-V T[Y-8^E_V7, XBVJWP%P
MIE1>IQKG3K59A%"81\-F@K4UGSW\>OB528:LA,S!]92?1UZ+QL#GOY.GJ@E(
M.?C\2Y?<ON#'% I]%]*I)^X,JOUH=@N&P3M"#AOB"6D(S'.FSU86_N9!$Y@(
ME@:H1F+GL%W:'2?V"FBAU2GE_3H/F.>^;D,?#1D%-)F(H>[,V95W\49*7GH[
MYS]>D+N9%#BCZ;? @/?F*WYE(2DS>SZ)LTM@7AK3+JX?#:B2#8T0LXE72T\,
M\[K#_]OX$V> 7%<-*H\I!".:EKO63TNUS29WSPE]51XV>JO[S5;["?'EQ>SW
M$/.,"+-&R-WP$W*$_]B(O\LNVH8#1_]]"MZ9+<NZN#]8L;JG7;)37NU!I\?9
MMT7B*TJJS8_%OUPC#_C[*<1@:[FXV^]WB-%+6A? Z3V!6-CLS)3!C.0? R*K
M]+KU^*'Q]WP<6K33RWSHUB&PXD/(Z99HLEW_J\5;DT[G%W>2;O3M:*X5,K71
M"NQ4&+</KBZX$RIJDDM!B+:/^#8&*X=;W _3&2UZSWTRV_OTJ5OAU6J@[< ;
M[3J,]< "1ZTJ*20%=-A0V]E"5'^W<FD""SL?>+]^X"Y1A<!Z]J^6UNL'H)L&
MW+T3']$Q+RI 7V))F#&NTDICL'[XV%-ZZP4+_4A9S%#.M/HN)*-!3]*N]'1'
M9MF<GZS8<FZ-ZS+#Y#YQPK%U(?MTYV=)J.9<53##EUT+#\R,W84T.78C)N,X
M@II,,P"4C$3YEWY/6!+L A;7O;[+$TMV&K)7W,[&'[?35@Y2\%"Z]?@/U_TC
M?W$]2-H%Q)16-[Z6+VD7<F?]%(E@ $01'>_-H?"]$1U:S;A>^;'O#[I49F_Z
M7;XX<(1I?JRB^)S*_C,Q0J&P ^RX-L%"E@,MEXA-P<JB(^B&;D!T8)AHSQ]6
M]%OG"QU0T^-)FGF'?7V#@G25#B^^3"TT[W+N_C#'C('= NT&+K?/EMCYUQ9X
MEIZBX2[$1JUZ2/[/:O?>IA%R*J0+UV@-"IG 78C066JYGA3PF3K\J_>O8E/J
MQL+7,)USXW#=.4[TR9L6QKW^V>G*7M8PO[)/OR8^H&9Z'$'119A(#-V4\VOA
M:;*193J>/R[XUBIRTCOEQC4KJ_5FN<_/E,6X]JKS\ZYQ/G8HL=_BYW&[$'ES
M8^IF.E3"2%'!@5W09E_J+P^/0]_\&V#:^&.NYT&=5<)Y[2K[/--S_3&V^SK2
MP#&T@_@.P7L@ -.9!<>U':8AR[B&5OHX%+&?RZ/8*1?=2IZIZU?+-K0UJNC3
M44O[,DO:U_%HKPGF_ LH%Q9T5)FZ>?+42Z*[:6+/G/+XW;%MK"@0YW[IW%RT
ME=-"^L:.G>B_V=(IQ\-MRF;.WNKE=JM>?\%41AN#[LSCAZ_S)F+%4 DSW:>
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M7(]7RCGSVW0GW2NY^U>+L9<2(('I(;\G]4;#J=8]EQ!4:))KSZ]^>)P1]!!
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M9%,9_TQT"*$OL9_!I% S?7^KXV'"Z O 9Z/JU+\_GE;8E;P(O'8BO3)M)\O
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M\+(>39>+'N-JZ6>Q1RS-.NHU0Q+M-.6^7BIR4W+<9ZNQ92/ _?R')"C_G-\
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MQB@).(9))$*( B0AR86$+*6<9SR*$;,J-GA2RMSFJ,^BU!MUK\!*JWH%^$:
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MA*7NTB,K]=N.J"P$3$(^]H9VA.+PC6%^WK\+?JMXZ+6HBMN5.61K']T@443
M409%G"K/#>=<401.89YPQC-*6>26O7E,T-P(HM43]!0=N.US%%H[I\H'8"-S
MPB"LG'V><T!X\F*.BIG4+SEG[%-/X^SUPVA!N2&O2L&+^A4IRP>Y+G4:3&]B
M2T2F7(4<PY0*K-@A0!#G*89!BF,N,RP8<]H7/B-O;B2AO?M&7]!7>) ;80NY
M'6MX!')D\K@00V<:L43&$YN<DS8IJ5B:_I1;;+_F*]OC+2G*OY'E1MS(7GU
M'*91D$=JK4*%4%0C HBQ/HY6#DC 6"21""]+]C@H=VZ4HY4$W[26.K7[7I<1
M)$;12W,^#J,>4AZF/ E@&NKP=9Q$D-"0PX0G&<)Q2))4+II"_Y]K4M;/AOU3
M'<8;@9=DJ7M\CH.W6H^'ZO^9[I7#(0I(!"D*,IC32"W40Y0GZBEO;'VSXL^,
M=J?!GQ1KNYET!/1&GE$M*H[ZKG3G"-)H64R'I3YS$M-)*,[G,)W^NGL.^GMU
M_QO9S.AO"3.19-><F[U&LGRY+LOU'VHI\8JHQTO]:1$H/HJQ2"&C<0A1CB2D
M@6*H@ 8T#2@1>6CEXP^0/;?)5ZNOIUW6^*NRM> *D*T-@'9& -9:89^3[3HT
MIQEL9,!'9C&#]8WLU@:=\F"G/=BJ#UZ-#K5]4OR(D$^4*N\7>J?\^8'@G<BJ
M=[WC9+GV TWM9^ /O<70\,#[^Z;4-5F^(M77M\OU'^]6IN>]%KC-O:2I#%*1
M(Q@QTWD^DA"S0,(4<Z+^C\>1B-R"!:WDSFVRZ*NMYH+J*Y!*<5#L-/^K:_R@
M'?YV?NT(J(X\(SP"5*L,M,Z@I_0HJ:Z.0'D+/+23.G$8HA,4^T&);E\?2%.Z
MD--+4@FNHZ/%JFIN7I;J66H*];]\V%W3YE"8^DYM'_.WZU**HMZH9_?=JCF.
M_[O0?<P%O_XF2G(KWGP7)2LJ\;$LF%C0."-Q%E'(B"ZTCRF!.4$!Q &5(B$L
M%K%3<-/4!LR-.%OUVYJ$?+U<DK+:%=EWK)XZ^>-@2;\S'N2Q>5R;!8U=H&\\
MZ%L/Z /H7]CU2+EN#@=:$*Y #P8UM;9A5U>@@P*T6( .#&#0\#@[/-,X^IIF
MIE9_VOGJF09G;^)[+CT&)D3WEA6+3'#)$Y9#00F!*(MRF*<IAECO"24L3:+4
MJ>- _^9SFWG>BUJ+Z6WQ5,IE69<FO+/^*D IBCNZ48H8+E*7_;$N?U??^&?3
M)69+9+IS>=.1@"U)<>=X-O,(?KO99"BH8^_AK%>W\(LH[T"W<]:HZ#$G^8#A
MOE*-^[>>-H/X@%%[B<&'KG%[W;DH%F]6=;-GH(:],LW;;\J/Y?I;H11=8"P#
M(44 XSCG$%$LH!KQ#,:,1EPB&6%LM9 _)VAN--#H"EIEKX!15T$*.H7MWN>S
M^)Y^MWVB-O)[/APPZQ?>%HT#+W\EV(^WZV\_J5LT[[WZ8?>ZG[WQ)*^^K7D=
M#5A?/^!\Z$#)@<8-^;+67%ZLE"3]PP)+H3A!Y)#RC"K7(-3\0!DDB">1/AF2
MH14_.$F=&UFTQ3C6V^H<R^:#NE/:_&26LCJ/QZ6ZOOU(6!P$C8'OV.[#L<HG
MC>+@RQIL5;\R/XZ!K</)SQ@83W7FXP]KMP,?5\Q.'?58WVNZ0QY7\QX=[SA_
M>7 (GBA+DZ+4*SCXZXH755T65+>[;)N_=.WO%BS+TR"4$J8\R2%" JD%8:9^
M"@F-,,D2ZE8-QEV%N<T#.HY5O2>;OLI =%TF=1N6#:T*7I!R2(%FU_&Q6S:.
MB_K(LT.GO,FQ[*E_!1X9 +J64IT)7J.>!L+G+P#*58&I8Z$& G0@+&KHG086
M>=;;-WJWKA1?Q:K:%B34+:\^B/I&Z@Q-LQ'797.^%LU_M^>PFA\CG <PP:&.
MG:4AI*F@D+$DC7,1XL!MY^QRE>;&F4T%3]8W";Q8FEYO3:>\*]-F69%G3;X[
MGI9[&$ [$IUV6$8FU69$'EG3U6%MFO!=@0_-B&C6':6RM#<X?=6;OERA::M0
M>P-PKS:UOSM?<+1/3YRCM,<H],@QRLVFKFJB)HW5[9/CDT]"I[+H6*GURFBZ
M(4OM64<+3L,\P(3"5(0Z_#7!D!(20A'%6)(PRQAU/]V?UH:YT?[V<):TA[-E
MI[F:"[:J@V4AS9G!NC$<K'>6.V^G/.<3Y! 0,-_G8@8Q ;8A 3TD#@0";-$
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M&8T2 5F891 )1B'%80)ECH2,F$Q2[M3SPE6!N<T&/?W;YFR/+.C6JB^T$3^
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MN "L\G>Z.I,)9FR"JI(QO9A-#<D$4^52,3*%.?W[U/Y*USM%C7:'%/N]V"9
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M6*AHK%_46*_QA0PUGE%B7MZ"L0 K'),&Q;=K,3:&[1!3("CKA< P^.Q>I7T
M&?FM>/7A<WZ//7?2TRMI?]E)WR[/G7G^HCCZ>\\-MZWI'U(^FI8OI4E]^^]=
M?E\?0W_35ZS$H!.&%*5) ,.4*X@2KE\'*8^ACK=C$II.3YF3QJ+%F'-[4[0F
MUSV*RCKILS5[ 8S9O>2X;>"WW,CS"^K81[@'Q:)O^O>Y.4^HY&N\JW [X.)K
M!]!BQ&FW!>TA.-HK=/AJ;X$ATPFLK20SG:=XN:.K+U*'M.M/ZWTOJF*)9)@J
MGE*(HR"!B" )F=*1 HXD9S1+"!9.E<#V0\^-CFH[P;8RU!3WFC:3@/:06W.
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M_=@'Q"BO1)#@B" 6,J$X[Q%660P]TQ!K;RB@K:4#&XR>0-UZC>T%Q!=L(WI
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M0D 5"P61B!)(E(Q@%K(X0Q$+<.+4\.K<0',CFH.=U<X1,);V5,4ZBZT=P_A
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M=S$QL&H\;3RL"\2>-*I9 &H\!<]=79AMQP6HW9TFGW# /$R0>MC'NMED*0Z
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MHK%^#M[+E.0+M+'W#"L3-5Z5E4";6</DWF7H+$X."FT>\)I*';LO;FXJ:U<
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M"0J<]IN'FS0W=C[=5'S5N)#;JGI[G#,[LIUV)D8FW;K,[63#<=#U9W%X,R[
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M="K)S $<7R:A"&F$.)0*F_3H1,*,IP(BI4C,2)+JMY';@9G3^/,[4:O,<A?
MZ8=^)BE*$I-_)Q.-.0\H9%A0J&=$! &-=23@M+$W&O8OTNW6%#1NVGD FTX1
MY$338[=#.!KH([_L]W@WAH/:<O.RJ6T''>,755H.][>CV LU3QN-;F-/NO_8
M"Y;GVY+]+M*WNVU1=-0F;SC?[NCJIGQ-M]M'_<LJ162)<"@X00R&)-1$QW@
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MYF<F8R[YW^[73W^O'R\G8_VOPT0\:FZ4J7=.@7JRG?U=GS2C>PN6R"Q&4<I
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M#GZZ]-W5L_)%?7#]E_IG[\M2($>RK\3;LBY(/N<L(:DV6P"-8@@08@0PEJ5
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M4J?Z 'V$F1H]E+J 0IG@H,W^NDD;L+.@J<_ASJFJ)/5?DFZ"7ZG6VS(RT/\
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M*]W'>8+S\N6<KPXZ)D>RN!K\LEFL-V8#MG]&YO,4Q8I+(@'/&#85;%* *<9
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MGF3^;A_\-<^PBCD7,8"AQ !QE&FZ"SE(8ZD%3E5"".I0(M>V?ZLY.'Z5W(.
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MVJCMW4WM*&]_N7>4!+8LQ=7?.[@!L]LM:7_PQKH4/7*Q+1V]VL'SXF=[BLF
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M74U<0'BY>CB]V]'11VX/F:SG'*<)S8@""1'"%(E+ !$A!1F#$BH%)4^8BS/
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M1O?6I7]R4GJ+?N>\3'PGQ25-3574L]F#WDJUWIC::'-M(F0T)1#$')I81\(
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MBS".)8;$% Q<;^G2CF?+9IWH<M_X<%/RN^FC4U+("B9(5*QP:'S2D$FPDD&
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MC^"I4*1#XH$A1MF..Z<P=@/3K4TR =M< J6ZS40"0P1^#3TH/K,##"'F^'D
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MH9P#>E)*ROT(-WNM6C_81U'J \0/J\V?5310[2MH-B^4)1$5*0-21[Q#%H4
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MG39X%,WQ_@=[U)OH+\J.>5O]5#07?Z*K[*$.E98!$JD?I2#1]=8AH2&@(93
M]X- $5#@$V1%-TZDFALMN0O,<#-I9N0U^52,3'*-/EXCHZ<U6NS^M1?Y-6+4
MG&+MKGB< YFF+BCG#L8S1>8</MRR=+5N+IB_+-^]7RI2)8IP0^!+@965)WQ
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MKX4>W O<=%Z,SV%&1/LU6'Z/OM; >WN(_H<KZ-_25-P20/>]QDT%>*T6Y)8
M]70FMWW20"<<>Q1\NQ*?Y-<Z%O"+>-[D>L#[=55,5J^U;UZ:7]85Y%,:"H[5
MQC>2) 8P"F. 8V6ILHC',N PQ78%^@?(,#<^;%70N[E&3F^GA==18U&U=VJN
M&%39?\B,&3KQQIV'L7UZHTR!O9MO.(BNO'X#))C6"3@<HA.?X V/&D:8WW)E
MD6[SEZ_EAOWK[>;I:9\>@62, \D C2(((,4$(!&$ /. <)](X0=6M'AQI+F1
M7RNH5VA)[=CL,IQFG.4$I)&9:8=/)>3"J\4<(?_A*AB.&.;R.)/RR%5UC]GB
M^@WVQ9;NMCQ3LZ+[(BU)R! B(08IU\GV$<* 2-V)WH]DR(3DC!D%BAP]=V[?
M>R.:IV4S+Z+4!:K_V[Y!_9&_9"/-K8HCG=%S4$&D[G,F*X)T1OANX:-SOQZV
MZ'X6ZT(MY#H^K#@,&6L6BYCY'*>0 Q'[:NV-9 2(SDN.J8AAY$,>(VRS]EX;
M<&Z?9".O1VLA+8_EKL)KMA:[!&WD#[G%2\LZPD)LBH2C]?CJ<),NRZ;*'Z_.
MQO?9'[MUJB9\*A]%KD.;<O&H!_PNZO9EVK]R]YUD*[U'^+#)OY*5^"K8-L_*
M3!3[2JZZU7K]+'5KDXISO_XHRK8<PP<%R$$]AN*]E(*52\FTPQY&((U"Q5%8
M'^M%) #(3T6"610$OE%VS5P4FAL'UC6:=$/L[5H9>JOLWX)[#W71F553=$;]
MLMAAX)$6'J#VBD G=5<QA7Q7ED9=K_LG6!ZCS6%R#,X[YR#FC):$;@V="@_O
M !"OZ3;95M:Y.WUW]LAT2WGK-VH/CM>@H]]$'?W12?GT-)4>%^LI%EZ-U%_L
M]3,_)9Z#N#,\A?ZKOHY69]]SFON>L_59B#G9V?TLM#T3&S KN8;M8R^?YBU%
MQ/THIA!$B8@!Y(D/,(PI$(AP*F02R=BJJ-;EH>9FM_7%$MCM8WO@-=O!N@%M
M9$.E[_3?W1;V.A2.-J\] TVZ;;VN\/&&U> .^ZWJ5]VXM2HTVZT=VXE_>O.R
MOZ3)BZPZ1G[<K#\]ZVOK?=#]?N?R=U$HSE2<U^96?MOH__JXK7OEQC2E4"*0
MA$Q7]5)_D)0B0#&# 8&^@)28;DNG%GYN5%8+6]E8HDV*+C>>[GSL_:3WGEKY
MGN(NK_\V7-\VSGF.QPXQT'H!6A46/Z@1WM&^"B[H7-<@4+?'77@*!%"CX#7^
MB@X."Z_S KWOO$#ZO]6]%1XS?GG,-WUS?HDFVN#-^V6RVL:]UFSV;-DF%VFR
M[=EK@=W=BKV:# /*.^2"9^4'PK*5'O!P>_BG-MZRM=HWDG6Q)!%E*%7V#^6A
MSKN!(<"1Y" D, C3)*$4&H5YVPT[-QNFEMR3C>A>UO&35Y5;"BT^4*,+M6%3
M"EB4,#"?B^MVR#@(CVQ!S -<BT(1HX \T0K[[5'!F^N(ZD*O>\P9]G:E)*PA
M[*LI8?ZPZ8I+6"MX4&7"_FYG@9O5&E4L4432)(X#D/A"\SYE0"T%NO8A#01.
M(:615?#(Q9'F1O6'@9L+CY0>VPS9JAI@'# DHS  *:<20)1*@ 7R0:0;T21$
M(I@$RV>19QO^M21Y.2'2QZ..A_<;\9"MU]IS1\FJJI@_ M(!))'/) 62^0C
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M#'.)4D2Y50#.5(+/C8L:\:M\$V=I*)._#6:D-\<Y'ONTMLH$>&.8,?#F7,9
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MYO7/GV13-> ]R=>*;PM%SKO_4W>_57N#K"P^BUP'VBX9USW!20PHU?''$0D
M"6*=R<%0PE#$_#@U=16-*^K<J//W7[[^XI7DAZ=VS=E:C5AWER(K3S3J+"H;
M>R,]V130T%>S6BESS\;(+\!U7]1\IG5DRMXIVAK3NN!)U1[]4%E]4+Q75[M#
MV@HI[W<SKTWRSB_TDQJ]%UZC^6Q> 7,'V'Q>A8F<9'-Y):P\:M/,4H_7;60!
M)O/,30-DUWLWT8C#=EIJ3Z=V<>6+]A:6RO#1'7&>]4=XG$N#(QQ3$D*0)CX%
M,$ $8,$DB @* BX3!IF146$[\-Q,A%;N1>4O+ZNMP$YVN\V5,?9FVZHQ$!UY
M=>X%<YK\)5O4'.VFC(>==!]E"\;Q#LKZ_H%Y!$)MRL1A,YU=W]:VDM"[K=#%
MA#ZHEW49!#Z)$8^!I%0 Z.N,=A0F0(H@2A+)HLBW*G]H*\#<2$R]CHEE0H$M
MY&:<-2:0(W-7+?JBXWAOFFWMY%]HEST5WF>2\::BF=;!82["0/1<92?8#C]M
MOL) <$XR&(8^9QBWU49BE8=5]2ML3\L(XBF*HP0D0A?E@+&ROP(? X$2*BCR
M>>I;^;@OC#,WIFJV:#LY38ZTK' UXRD':(U,1T. LB:<*S XXI5+HTQ*'U=4
M/6:):Y</3,0>VN&T*1GTJ[JPW'4R_377-55(PH5,"0))&C$ 210 !#D$OB^E
M'ZI]79):$<D(,LZ-A"H1FU[O57_WGO(MD\VC&7&]\NR,3'K=.FL70]YV;;"/
MZK'5;; ;/1=>K6FWUW6EK<-L]/&FPE4&^P@23IOU/A[$)YGR(PXU-%B/9_5I
ME=YPW*_?DN>L)*LFZ8$F,D8,$\!AH&@?\Q#HJ'%E1&(>T3",2<3MHNYZ1IL;
M@3?"Z8];_&#*H-<G>,]D4&I]/\QFK.P,O)'Y=2]GM8D%"K\6RA'ZBYJ XBQ"
MK&^LB4.]#-0^C=DRN6EXEZ /6:%K_U;<]$']7[&,6!@2Z0L0TI "& FF\T\8
MP%'BARB$84!\VS9!)Z/,C3=V77!J21O+P*MDM>\4= IJ/ULX@VIDEAB$TJ!N
M01=1N*E=T.E3)^\7=%&Q<PV#+E\\T)VN;(^WFZJVF%BS%UVN+_NNB\PNPX"%
M$?8)B(@, /0I!ICI+IX)H3#"(8N2P,IO?FFDN7WX=T^ZV)J7B^R);O.BJLVL
M]A'EHU V1+%5MAL35:8965L6U+X,MJ''W 6$8[O&E8Q>1\BJ"D,CID/O]S4D
M7+FY+XXSK3_[FKHGCNNK-[R.4^K]#Y&SK!"[S4]5^>I^7>;JT\I852)HF0@4
M<RHD"&$L 8R5N8&YC &)"!'$#V(4&U4&F%+HN9'83KIZFZ/W/)NF&8!HU.'3
M^K&,IGX:QY;K"?T+>;IVJG>=7?N7Y>^]>^+)W5XV$S43/YB1R'\IQYC-)+CV
ME%F-/;2#7JZ61AVC]UNV%O>E>"J6:O'Q0XP04)M>M0+Y/M2VKP]HP"B*<4 )
M(W;M\4[&F-N"L1?1^T,+Z5526AZTGL/2C-)O1&CL7:XE. ,:U%U4WUGWN=,1
M)FXM=U'%T[YQER]U6RVR[<BYS7-M)U?M>%='5;2^D1^?=3E"]7^EXAVZ+:LF
M+)O/BK?6Y3)F88QHG( X2!17L)0#E(1<<04.4\(32F*K,]7Q1)T;Y;21\ZQ1
MR2OW.GEDGYFZT(DV;JH].IAO,SZ;QRR.3(L&51K;.6X5]CH:=\HQ+G3ZA [Z
MS>M?=/36@72UYN-79W0W.R-77G0@Z"RJ*KH#W+1BHL,1ARU%_U##/Y:"WWT7
M.7D0;<F6=]EJJ_ZWLH:+3]NRT'U2LO7#DB$IDS#1:>W$5^M+) !*?0P"&' _
M9<@7'-FL+Y;CSVW1:.0<'H]CBS]B E*<Z!:R4.%/>0@(IRGP!<1)'/@AE%8=
MT<;$?X)2]:WX'JGE;R;!(T6Q?=*1T%PKHDE\LADR6Y%'Q'WD978'>2.ZMZ]\
M5XOM=>1>>(U&[E;+@<@Y6@)M1Y]T71L(S?%B-?0Q3L[\/A+=B_O=YHEDZR7T
MN1^E00!\/R  ^DSQ7LIC$,=<BHCQ&"*KU:9GK+FM+*<G5[6TWA^UO):^D#Z4
M!QWW#<5N\@,_4]AN/?4[!\@XYWX'([WFR=\YE:^<_9V]Y=8NWO?K[\H2WN0O
MM1U='K5]1C&2(800^(109;/&.G9 4) D*4\)YB+A;*FXCF[LNW7W#VWS870%
M&/'TIM.5NY4],RWZ;8V\X0':"&B.?0AV!D;%-8W8$_70-D/+>:?L*\.^4C]L
M,S N=[TVO/^&0 5Z_>")'A\\[3H5W>D-37L*]2R8,L2^B?PI6*:^>EEC2 &1
M(@$08K4A%)0#'!(8^(*EDMLGT8PBZMPLK%8X;Y5)4>T/7P3)!R74C#.U%N$'
MKSYA\P\ZZ'1CZRBL8Q":UT#K[#C88-1I<1EB,(Z@TP<6C KXV7""<4>TK^CW
M7VKO7CW[<[[A6U9JT39K?7#5Y(5@$L X"0- 11( *)$ %(<8:+>BCQ,J)9>F
M-?FN#38WRM?R@IH#&HF]O<CF%=.N8MS/W*Z1&YE[>T$;T [G*GKF%>-<HCA1
MS;<.FC8H6I5H,X6EI\C:U4=,5B;-5)ENH3/C>X:9\V^VV4I[/N_6O/WQ_DD7
MNJ\;H3>O<1BS /)(@+1*;\=QJHB6(4#\D(6!GT+N6_4F-QIU;HS;2EI4%;6R
MCKQV9K89Y&86LW,@1R;@5L@*PMT_NB*/D -I!9(C4]1LS$FM2BL8C@U$NYOM
M<R3OF<SOMCQ3,WE7EJ*HUZX/*_*P#+&/$.(<4(25;9<D"""9$B!1$(<A3E$<
M&M49ZQ]F;FQS__;#%Z\1U>O(ZFEAS=,D>W#M9QAW:(U,*<. LLJ4O([#H%3)
MGL=.EBMY7;5NLJ3!U0/-$+6OU 5<F\6/Q"CB 10@QM('$ H*:!)0P&!*E+W!
MXA1&5O;&P>/G]JEKZ:I:R99VQ"%FA@;#8"3&M@Q:$,8P ,XJ[6JE/WSXM$OZ
M6<5.UN[S5]D[9$Y#__21:-,OO-ON^*LHRU5E&=1UFNMJR[I=.PL3RA.* 0U9
MK'82* 5$]RJF 0V(SR@DF"_7XH'4_B,3S\WM4AE]!KC^#$YD&]%3O)/7$[7
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M<A-XU11H!P>&:B]:B>G6>=:#@T,OV;E1)G>']:AZSN_5=[E32V09A91CDG!
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MV[3+PQBPGBP7HPPR;/GX*$J]'_B<;[YG7/ W+[\7>A&KCV/TV*S,OE>"+>/
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MVUZ*L1$J;>1!6V%CI'M>T0)0,SDSVBU35<RT[G;+B*\Y=>8<)ES=53*-UZ4
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M*]:/SXVN@_/",(JB& O($4D@QIF C.M%4BJPC$@<(&(G8=JG\;F-F ?[0>7
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M^^7FQ5_FL$"L= M]@]]8_WEYR2%$P+<E3!.LEG;UCLDLWOJE26'L[/HO)S[
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MR!4!FD1-4V0RL@0U8DP[7K\?.)J/0M9@;A,H^<=L<HD"F'<7=O/%B <1F:)
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M.8Y7Z0(N6!%B*(VC\8.T0A%+@R 9M I2\>AE[5KRS?</JT*'1\/=^ZE#1=,
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M._X*9].TO9RX1)H6^&N3R]1-!44^O/NR2I>,V6K*LB,*;5HBM>;$VBP(XQ3
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M!>3$DF_7@/P 7V%Z"0=HT*N_K*0RMQ)224>NGUUR=<ODD(*?DI7V_'*QG%W
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M8)@D-"E9NC=3XI)-)#AN<8$RF^I)//O2ME]\E?Y@F.M%,@T@[J8ARKV]HUA
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MF5I08G=7W5-6/2E&@AG)?=($721D=C**.&\SX<SXE"!K%?.QT-R#CL&G\0T
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M"8X,@M]7 >V[#*"*@J#K 5FARS.(51-Q5]M,RI2LQW2W[GLG!'9^^#@VPS
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MAHL?-P6V884SS"5)#3[5*AQE77UWS. 52<I[BU*WMK$>(6?<1^*AP=5*#QU
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M#BTQDQG?^GGV( +;Q?RVRZ[#4\*Z51MLD EIYZCHB.5L (//QA3K8VR=@O8
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M>V=JE:=>/2()A.B,!%,PVQBY+[RUD7:7AF[?K)M#ZB3I=X">EU?+R_E77'S
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M?XR@7@!UJMX?;UQR@A(Z0-2G!8;EU>(''>Q_;!^/HTVL%JOS+$+ML\@@HBK
MF4PF9.N];]T7\SX5O;Q[-<;.B>+N ##;D.3'/\.W#0<%"T^6R=H"M)#;82WX
M.LV*(P^Z'M#\T;+ HQR]>U3T8EHU!LR)XNX!,/.O7^=Y>OGCUGAXKX-( 3UH
M4V>3*1N)"3HKK8T9'8DEQ-8/\#L)Z:6@L#5L3A9Z!\AYH ,0,R*9Q!2(D%/%
M/T+ G($+G[7.EKOFT#FAI]89L-.U-]= B5U"<;-)A69<VVQ!*%8K\S#4FBX+
MV19I/!J1_?_H=ET'Z7G?=EV'"+T#\/PVG^7K)E&;HQB)1%.$ 9-KYX\0)+@8
M)7!;7&2&&YU;XV8'&;U!YAC]WGW8/%'8'>#ET9/]W77I5[(6'?.%3F6[&EK-
MP''R(S3M*:F]DU*>I;3E'F6]E%5V?2\.H.0.H/MR]23R=O;/&3FZ%W6 PY:E
M][,J><R5K;>S6W%/Y)/LM!9!16"\SGD+M2^Q4PIRS)ZYVA+%MGZZ.I+47AZU
MVJ'FKNMP!A4>CE2_1NH,/]=S_=-9 'LW.']#Y'RB:I^W7',J6<8:@4.(/G%B
MUUM?PV\86V?"'TMK+V]IHT"VF1)/Q6P3N&[Y>D-BOIZ:L]S.T:D_?;%<XG)9
M^7M?;F_1=4$OZ6%&?^$WO)P(&5D@>XHV:^TCD8H!^F,!(2*2S<ZTB*V;4[>D
MOY<7O\%@/9JRNX+ZG2V,NX=#.2=MIB_$5+U])#'JO34@:_O>)'DILG70XB "
M.WXK:@O6]NHZV5B87X:+)I!\?_D%%W4G+O +SI8K<5;'H?)]+Z$&KWT.+/,%
MDA@NPG(Y+=--U>$L?PI_37R)ACOO@!M90-F4P7ER4E$8&4V47J7610[MN>C8
MX6L#[I$5WX%C]Y@$;B8C[L=\+)JY) 5PQNJK8-+@#6,03>UFE9QEK'5J:%,&
M>AG(. K@AU5WYUA_>+??Y7TMD<J^$<*)HL@?EJD.R^0%'+G*H*,L0D==Z"KL
MXHQ_D(6]\&[_IG@?6N7]/(;LO>OO,OYFOJB]:.:SR^GL*LP2_I2$%$ES:S(D
MESE)(F@(O@[!T"9)I:/WI;5A/@ ;>VT ]S?= .=0?6<NYTZ)TT'P^P(OB3/K
MG,HJTG[.DCQJA@:<(9F;*)123G*TK>V7?6G;"ZG^&2-U$"5U8'7LYF9^^>A\
MH6O9UB<>:4P0D4M@A42KHE/@:B:AY8I+XAR-/TM \!"B]PNGL&>,U_/JM=]V
MG-?/0K^N4F!Q/?Q[^\-YJ6^9E\LPR^^F(4XOU@WNCFZ[><IJC=IK-F.X41O-
MZZ5_M@U<7O<-Q"!XSCP!YJQ \5I+)A,A/(?HH[9,Y]8]_!^CIUDM\UK(+VX)
M>:./_'Y&QLS58E%[*L[R;_/98OO'7\)RNES'^*WU02:A %EML*MIUY,X$DA6
MF&$E(I;6B3K-B!\W5MT,;P\639]5N1V8"->,__+CYR/[%!=$U)<?[_ [7JQR
M[E B\SH4T)Z[6@:L(:8ZH$;GHE [+W/KN-Y^E'6"Q_/"YB'PMM-A3\C<>===
M\[?)[\M*9BQ.0G&:W$'I D3I#6C'>#:,.=E\-NE!!':"TX8(>0B$S=75$Q;?
MSKY=72Y7$N/;QAI*V\"5!&MJQI[C$:(7$;0@>SX;J31O7:KT"#F=X*P]"!Z"
MVXD:Z11<8L.*<PJ3"M4WE"LO48+WR$"CL")S;]"T?A5ZA)QQL[[&!=<Q&ND4
M7'++"O)D@K.0;"VD*)9!0&ZA1.,+"<B1,7T&<,D>JBW'!=<Q&ND!7/=G?*SL
M"&%\K8B0$#*C/5)D[7SM"]B0LS,HBD_-C;'=I'1R8HWK'C304@=@^[0(LR6M
M7,7X$1??IXE$]+[LFC-3*UZ7NW^UV<",Y8A*>K Z!E J8GW_U"""(A/!,9&:
MYTBUI']D*Z\%H.YU,1A)NQT@>T=!OA:I:)8]H."YCG)F$%GDM-^-*8K9R%WS
M1G?']3\8#&7C(>+I?@F'J*<'@&U+][>MWXMW+E@'C'MRD#S3X)PGJT,*9X5E
MVC>/-=\A8=Q[N1]HG:"8#G#U>-LB3EN"25. >1.AQL?!9U? !YN8X#:+TCIV
M?'KOJ,$<C&XPUTYI/2"P@87],R;OG66(Q+*5L8 R*8%/)-8L+"\Z,W3-2T:;
M,M")"]U',.3LB.A@.ZQYWA$EO0Z2YN#3:BA5"5AKM@2'*$C2W$?4R44C6>L9
MBT\2U<F;]?D!,Q]2>QW \=5FV9H$BK/E2J6_7X39FM&)]9SS0+:SC(G\15^O
M&1]HFPN1&'<Q6=LZC_=QBL8%8F/UW\L9:Z:+#I!U9YC9UHA9,;-#@A-/9"I)
M3*$(')1PAAPV;4"GPHUR2G+9/.7F,!+']8B&Q=Z0VNH C#_3,3>;B3$NG*#S
M/ZOHZ!)P9)YSKFEO.5.$"XJNB,&R9@\XR@8S!8<^RDZ0=P=X>5 ZDQA%*#X;
M(,*J_U\X>"T0N$S6):T43ZUOQ >)&;>\?%@$M=' \5!J5CY^PU1]3%9,^U2B
M):\^UW8-7@8Z4$EJ18OB9!;:8>M([WZ4/?_X7!O3?P ]=G#0_7*UG-9F(61S
MQNFZ'=_+55779U(.?;><DGXWB?!K_G],I-+>RYS Z$ ;,!I3ZR(XH#3$O=?,
M-I\O?029XWH*0Z!E?E[5=8#.57WB+K?HQ6)17T97#Z[7W+W<E"AB/0+2RI*]
MG'"6HRO" DN1.-;.0JR71W$ALFBMI*W?&*RG4SWNF7L&[)Y9L1U ^0$'ZR>3
MNTP=QUWF(5L(PI,!I6B[1K0:6%!)%\XPM<_2.8+.<3V9,\!U<.5U -#'Q3CQ
MV<9L9(+,R==7U@GP04=(&"666#S&UL\SCU,TKO-S!M U5$@S-^@\]:&KVV%G
M;+5M9>B3ZPQ9$WH8D^>H!K7>I2R9!ZUC)N^H%(@A6C"V%!88*MY\_.*0U:#O
MYK//GW#Q]17&GT^8DVBY3T8%P" T;9M,3&:1:8-:JV+6-H36]N!.0CJ)J)V*
M@WN'ULE"[^$JO,'$#8LS(PJC= *!JX;RGA,7.H//B9F8-)/8.B-U-R6=/,D,
MB9TCQ=YO(X07*5U]O;JHG1_N=]U9]=NY[O4Z+X_^Y76+GN.OPJ$H:719GD50
MC:[3U_]]1<;_-?B39XFPFL#;6'O/K)!*=IE*4D2>2N8L-CX@;E-P<MCC:7%6
M#:Q3@)345F<F(">?R 'W&5QM:$D&:+*I).UD:^?T$/K&O6!/0,:]2,A02NG@
MIKT>OK&6U\^MO:I6L-I(F7$U_(R!DKR %U*!C\()S8L1S4<,/DK0R,DG@^%@
M/I12.D#8'1XVV;F**QD<0W BD/,L(P=7!)D8+J#GAFEL[@7L)&1<1#54]+RU
MU#N SHT-=Z,QUZV^B+^OY+Q)S":5<^FL@.@9&:I6*(A6<O!%<N,Y3R&T]I\/
M)+&'._$D4#Q\-3;74%\ )+9^SCGYV9AVR_5V2*S)JGA?P!GO0'G:O#$J#G4,
MA!:<. RMDP@.I7%<WW50"+;745\8?(5E.L/\"\[HF\N:F;I\D?_K:LWEAKN0
MA!?6")#!TZ5AR/7WCA&+G*P/H1B&V#QY_2 *QXU5#8J_UOKI"WVKZJSU^+Y[
M7!6EBI$A@LTJDE/%% 06'&CDA@M1V[X.>/,^0MFX0:I!T=9*'WVA["'/:L-8
M5$%'I32DD'7=/DB,Q0!!UF'L44JA6Z<-[TW<N/-8!L5:0ZT<#;?ON(CS\P'N
M=BMB.IZ-%HX!.IU!Q=HOBXYR,$+Y9 K&T+R#V:$TCEP=<:['D4%5U\%92"R0
M";O$5[C^[]O9Q\MY^N/+_((4N%SO\@_SBXLW\\6?89$GL7!/LHR01,WQ=MZ
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MZU#TBF/FQWZ$5JM07S<R(7,=?5'?$6@'3#)F4Q 4'YS.X7=7MA/-],[I\#L
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MWQ"M]XD3I#L[9)LX3.<=@&:OR' =#G[$/U<_T:_ZGYOB'7,DNHH67#)5D[Y
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M;_-96A<!5I.0BQ&*/)H722&1JU=9T1CPK B+B)SQ>_1)CS8<;?%1)YA[-,'
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M!N+;0*&[V8#/RCR1(F9F"RF4YP*5H11\T)5PSWC!F9:1O]3#M,?']C8TY<@
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M\7:X\L=O9_T1KMZ;R/G+M]^F?\P6&"ZF_XOY6M))=)IEVN?!8>7MRCY#2,E
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MRX 5+@Q/7I/9/@P8]Y$T+N(NA8S' =E$3/V@[H=(Z<^+*J2]6+.2?>%U:*9
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MQED3'=HNXV..Y"VMIWGUYMOOT[_FRXRSZ?_D] ^<SC<7ADQ[<L.C!<M$;0!
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MX=U1%02#=+<8WI8;7E(=[&Z_+;[E;3OBI[7WPV(V(ZW[%R[3)*B0I$L,,,<
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M              "  ><&  !E>#(S8V]N<V5N=%\R,#(R+FAT;5!+ 0(4 Q0
M   ( $."55;<Z&$R4@<  %$B   >              "  94*  !E>#,Q,6-E
M;S,P,F-E<G1I9FEC871I;VY?,BYH=&U02P$"% ,4    " !#@E56#"KJ&TL'
M  !,(@  '@              @ $C$@  97@S,3)C9F\S,#)C97)T:69I8V%T
M:6]N7S(N:'1M4$L! A0#%     @ 0X)55@W$T6H&!   R@T  !X
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M<W0M,C R,C$R,S$N>'-D4$L! A0#%     @ 0X)55K[3R\;V.   &DP" !0
M             ( !T(H$ '=S="TR,#(R,3(S,5]C86PN>&UL4$L! A0#%
M  @ 0X)55@60RN&2K   3\ ' !0              ( !^,,$ '=S="TR,#(R
M,3(S,5]D968N>&UL4$L! A0#%     @ 0X)55MB,0O7U%0$ YG(! !,
M         ( !O' % '=S="TR,#(R,3(S,5]G,2YJ<&=02P$"% ,4    " !#
M@E56OGU<M=7& 0 BT!( %               @ 'BA@8 =W-T+3(P,C(Q,C,Q
M7VQA8BYX;6Q02P$"% ,4    " !$@E56JOB+4#$0 0!ZG@P %
M    @ 'I30@ =W-T+3(P,C(Q,C,Q7W!R92YX;6Q02P4&      T #0"$ P
&3%X)

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
